,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
2636,GO:0005576,1.0996229377052e-12,1,57,3793,extracellular region,CC,LTF;VIM;CP;CHI3L2;MOXD1;CRTAC1;APOL4;TIMP1;SRPX2;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;IGFBP2;TNR;GBP1;SPP1;FMOD;PLAU;GDF15;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;ANXA1;MDGA2;GNAL;COL6A2;INA;ADAM12;ADM;SERPING1;SPHKAP;C1R;S100A11;PTX3;FABP5;ELFN2;COL3A1;CXCL10;VSTM2A;RIMS2;GRIN1;CD163;SLITRK1;ANXA2;COL4A1;PLA2G2A;SERPINA3;SMOC1;GABBR1;CFI;IFI30
11646,GO:0044421,9.11698751668674e-11,1,50,3312,extracellular region part,CC,LTF;VIM;CP;CHI3L2;MOXD1;CRTAC1;APOL4;TIMP1;SRPX2;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;IGFBP2;TNR;SPP1;FMOD;PLAU;GDF15;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;INA;ADAM12;ADM;SERPING1;SPHKAP;C1R;S100A11;PTX3;FABP5;ELFN2;COL3A1;CXCL10;RIMS2;SLITRK1;ANXA2;COL4A1;PLA2G2A;SERPINA3;SMOC1;CFI
7638,GO:0031012,9.4075568214699e-11,1,19,431,extracellular matrix,CC,CRTAC1;TIMP1;SERPINE1;AEBP1;COL1A1;LOX;TNR;FMOD;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;COL6A2;COL3A1;SLITRK1;ANXA2;COL4A1;SMOC1
2667,GO:0005615,1.65367427385118e-10,0.99999999996607,48,3125,extracellular space,CC,LTF;VIM;CP;CHI3L2;MOXD1;CRTAC1;APOL4;TIMP1;SRPX2;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;IGFBP2;SPP1;FMOD;PLAU;GDF15;LGALS3;EMILIN2;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;INA;ADAM12;ADM;SERPING1;SPHKAP;C1R;S100A11;PTX3;FABP5;ELFN2;COL3A1;CXCL10;RIMS2;SLITRK1;ANXA2;COL4A1;PLA2G2A;SERPINA3;CFI
11041,GO:0043062,4.48865050454084e-10,0.999999999953981,17,356,extracellular structure organization,BP,FERMT1;TIMP1;SERPINE1;COL1A1;LOX;TNR;SPP1;FMOD;POSTN;COL4A2;COL6A2;ADAM12;PDPN;COL3A1;ANXA2;COL4A1;PLA2G2A
7224,GO:0030198,5.86540909682531e-10,0.99999999994328,16,310,extracellular matrix organization,BP,FERMT1;TIMP1;SERPINE1;COL1A1;LOX;TNR;SPP1;FMOD;POSTN;COL4A2;COL6A2;ADAM12;PDPN;COL3A1;ANXA2;COL4A1
2638,GO:0005578,2.4092111196447e-09,0.999999999719225,16,340,proteinaceous extracellular matrix,CC,CRTAC1;TIMP1;COL1A1;LOX;TNR;FMOD;EMILIN2;CHI3L1;POSTN;COL4A2;COL6A2;COL3A1;SLITRK1;ANXA2;COL4A1;SMOC1
7044,GO:0022610,1.43670187498302e-08,0.999999996811025,27,1168,biological adhesion,BP,TNFRSF12A;LTF;FERMT1;SRPX2;SERPINE1;CCL2;COL1A1;IGFBP2;TNR;GBP1;SPP1;PLAU;LGALS3;EMILIN2;POSTN;ANXA1;COL6A2;CDHR1;ADAM12;PDPN;S100A11;COL3A1;PCDH7;HLA-DQB1;ANXA2;PTPRT;HLA-DQA1
3625,GO:0007155,5.5284786609007e-08,0.999999987179765,26,1161,cell adhesion,BP,TNFRSF12A;FERMT1;SRPX2;SERPINE1;CCL2;COL1A1;IGFBP2;TNR;GBP1;SPP1;PLAU;LGALS3;EMILIN2;POSTN;ANXA1;COL6A2;CDHR1;ADAM12;PDPN;S100A11;COL3A1;PCDH7;HLA-DQB1;ANXA2;PTPRT;HLA-DQA1
13496,GO:0050793,1.74366237920375e-07,0.99999994817779,36,2208,regulation of developmental process,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;CUX2;TNR;GBP1;SPP1;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;ADAM12;ADM;SHANK2;PDPN;CSMD3;COL3A1;CXCL10;VSTM2A;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;PLA2G2A;SMOC1
760,GO:0001944,1.88124654602207e-07,0.999999965305357,18,610,vasculature development,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;COL1A1;LOX;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;PDPN;COL3A1;CXCL10;ANXA2;SOCS3;COL4A1
19545,GO:1903034,2.01789018244809e-07,0.999999985104136,9,133,regulation of response to wounding,BP,TNFRSF12A;SERPINE1;TNR;SPP1;PLAU;ANXA1;SERPING1;PDPN;ANXA2
16882,GO:0072358,2.25465880632375e-07,0.999999957877659,18,618,cardiovascular system development,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;COL1A1;LOX;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;PDPN;COL3A1;CXCL10;ANXA2;SOCS3;COL4A1
12947,GO:0048167,2.39100884613023e-07,0.999999978484683,10,164,regulation of synaptic plasticity,BP,TNR;SLC8A2;SNAP25;CPLX2;JPH3;KCNB1;SHANK2;RIMS2;GRIN1;SHISA7
515,GO:0001568,5.90281756407782e-07,0.99999988786937,17,586,blood vessel development,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;COL1A1;LOX;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;COL3A1;CXCL10;ANXA2;SOCS3;COL4A1
8207,GO:0032101,5.92414274763255e-07,0.999999887302949,17,646,regulation of response to external stimulus,BP,LTF;SERPINE1;CCL2;TNR;SPP1;PLAU;ANXA1;GPR17;SERPING1;C1R;PDPN;CXCL10;GRIN1;ANXA2;SOCS3;PLA2G2A;CFI
8208,GO:0032102,8.40105832609803e-07,0.999999899676829,11,259,negative regulation of response to external stimulus,BP,LTF;SERPINE1;CCL2;TNR;SPP1;PLAU;GPR17;SERPING1;GRIN1;ANXA2;SOCS3
12700,GO:0046903,1.01440122513468e-06,0.999999722765191,26,1439,secretion,BP,LTF;FERMT1;TIMP1;SERPINE1;ABCC3;STEAP3;GBP1;SPP1;PLAU;LGALS3;SNAP25;CHI3L1;POSTN;ANXA1;CPLX2;ADM;SERPING1;KCNB1;S100A11;PTX3;FABP5;PCDH7;RIMS2;ANXA2;PLA2G2A;SERPINA3
13209,GO:0048731,1.31042632344794e-06,0.999999527993566,50,4025,system development,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;TNR;SPP1;KCNIP2;FMOD;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;CA10;AFF2;SHANK2;PDPN;CSMD3;GABRB3;NNMT;ATCAY;COL3A1;CXCL10;FUT9;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;COL4A1;SMOC1;DOK6
2640,GO:0005581,1.4090877363138e-06,0.999999915964565,7,78,collagen trimer,CC,COL1A1;LOX;EMILIN2;COL4A2;COL6A2;COL3A1;COL4A1
18241,GO:0099503,2.10867284738691e-06,0.999999514985389,19,879,secretory vesicle,CC,LTF;MOXD1;TIMP1;SERPINE1;COL1A1;PLAU;LGALS3;SNAP25;CHI3L1;SERPING1;S100A11;PTX3;FABP5;SVOP;PCDH7;GRIN1;ANXA2;PLA2G2A;SERPINA3
13086,GO:0048514,2.5636546492178e-06,0.999999513717857,15,515,blood vessel morphogenesis,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;LOX;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;COL3A1;CXCL10;ANXA2;COL4A1
12070,GO:0045595,2.84154457143819e-06,0.999999157672455,27,1545,regulation of cell differentiation,BP,TNFRSF12A;LTF;VIM;SERPINE1;COL1A1;CUX2;TNR;GBP1;SPP1;GDF15;LGALS3;SNAP25;POSTN;ANXA1;ADM;SHANK2;PDPN;CSMD3;COL3A1;CXCL10;VSTM2A;RIMS2;GRIN1;SLITRK1;SOCS3;PLA2G2A;SMOC1
11833,GO:0045055,2.86490258328199e-06,0.999999384915237,17,715,regulated exocytosis,BP,LTF;TIMP1;SERPINE1;PLAU;LGALS3;SNAP25;CHI3L1;CPLX2;SERPING1;KCNB1;S100A11;PTX3;FABP5;PCDH7;RIMS2;ANXA2;SERPINA3
3523,GO:0006954,2.93279839995043e-06,0.9999994364292,15,591,inflammatory response,BP,SERPINE1;CCL2;SPP1;CHI3L1;ANXA1;GPR17;SERPING1;C1R;PTX3;CXCL10;CD163;SOCS3;PLA2G2A;SERPINA3;CFI
1129,GO:0002548,2.97542607343265e-06,0.99999990635069,5,40,monocyte chemotaxis,BP,SERPINE1;CCL2;LGALS3;ANXA1;CXCL10
8750,GO:0032940,3.11846345913402e-06,0.999999132318529,24,1334,secretion by cell,BP,LTF;FERMT1;TIMP1;SERPINE1;STEAP3;GBP1;SPP1;PLAU;LGALS3;SNAP25;CHI3L1;POSTN;ANXA1;CPLX2;ADM;SERPING1;KCNB1;S100A11;PTX3;FABP5;PCDH7;RIMS2;ANXA2;SERPINA3
3751,GO:0007399,3.20664079150112e-06,0.999998943358503,33,2100,nervous system development,BP,TNFRSF12A;TYMP;VIM;CRTAC1;SRPX2;SH3GL2;CCL2;CUX2;TNR;SPP1;KCNIP2;FMOD;SNAP25;POSTN;ANXA1;MDGA2;CPLX2;CDHR1;INA;ADM;CA10;AFF2;SHANK2;CSMD3;GABRB3;ATCAY;COL3A1;FUT9;RIMS2;GRIN1;SLITRK1;COL4A1;DOK6
3524,GO:0006955,3.73344195953007e-06,0.999998875042191,27,1710,immune response,BP,LTF;VIM;CCL2;COL1A1;GBP1;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;GPR17;CPLX2;SERPING1;C1R;S100A11;PTX3;FABP5;COL3A1;CXCL10;HLA-DQB1;ANXA2;SOCS3;PLA2G2A;SERPINA3;HLA-DQA1;CFI;IFI30
7184,GO:0030141,3.97628511143005e-06,0.999999123889207,17,750,secretory granule,CC,LTF;MOXD1;TIMP1;SERPINE1;COL1A1;PLAU;LGALS3;SNAP25;CHI3L1;SERPING1;S100A11;PTX3;FABP5;PCDH7;ANXA2;PLA2G2A;SERPINA3
3480,GO:0006887,4.38314366839448e-06,0.999998980762469,18,817,exocytosis,BP,LTF;TIMP1;SERPINE1;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;CPLX2;SERPING1;KCNB1;S100A11;PTX3;FABP5;PCDH7;RIMS2;ANXA2;SERPINA3
4548,GO:0009611,4.49423729955119e-06,0.999999105030125,15,563,response to wounding,BP,TNFRSF12A;TIMP1;SERPINE1;COL1A1;LOX;TNR;SPP1;PLAU;POSTN;ANXA1;ADM;SERPING1;PDPN;COL3A1;ANXA2
11645,GO:0044420,4.67295833632563e-06,0.999999575499472,8,114,extracellular matrix component,CC,TIMP1;COL1A1;TNR;COL4A2;COL3A1;ANXA2;COL4A1;SMOC1
7191,GO:0030154,4.94791530103095e-06,0.99999816080319,44,3484,cell differentiation,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;TNR;GBP1;SPP1;KCNIP2;FMOD;GDF15;LGALS3;SNAP25;POSTN;COL4A2;ANXA1;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;SHANK2;PDPN;CSMD3;GABRB3;ATCAY;COL3A1;CXCL10;VSTM2A;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;COL4A1;PLA2G2A;SMOC1;DOK6
13788,GO:0051239,4.96207470070389e-06,0.999998267711562,36,2566,regulation of multicellular organismal process,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SRPX2;SERPINE1;COL1A1;CUX2;KCNIP3;TNR;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;ADAM12;ADM;SERPING1;SHANK2;PDPN;CSMD3;COL3A1;CXCL10;RIMS2;GRIN1;SLITRK1;ANXA2;SMOC1
10624,GO:0042221,5.19700663049573e-06,0.999998053135643,45,3764,response to chemical,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SERPINE1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;LOX;IGFBP2;TNR;GBP1;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GPR17;INA;ADM;KCNB1;GABRB3;NNMT;COL3A1;CXCL10;VSTM2A;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;RTP5;HLA-DQA1;DOK6;IFI30
7040,GO:0022603,5.45130921987482e-06,0.999998606461483,20,945,regulation of anatomical structure morphogenesis,BP,TNFRSF12A;SRPX2;SERPINE1;CCL2;CUX2;TNR;GBP1;SPP1;GDF15;CHI3L1;POSTN;COL4A2;ANXA1;ADAM12;ADM;PDPN;CXCL10;RIMS2;GRIN1;SLITRK1
8468,GO:0032501,5.46883288624392e-06,0.999997890249105,62,5937,multicellular organismal process,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;KCNIP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;MDGA2;GNAL;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;JPH3;CA10;AFF2;SHANK2;PDPN;CSMD3;GABRB3;NNMT;ATCAY;COL3A1;CXCL10;FUT9;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;SERPINA3;SMOC1;DOK6
4544,GO:0009605,5.54705527646666e-06,0.999998225981361,29,1879,response to external stimulus,BP,LTF;TYMP;SERPINE1;CCL2;COL1A1;IGFBP2;TNR;GBP1;SPP1;PLAU;LGALS3;CHI3L1;POSTN;ANXA1;GPR17;ADM;SERPING1;KCNB1;C1R;PDPN;PTX3;COL3A1;CXCL10;GRIN1;ANXA2;SOCS3;PLA2G2A;CFI;DOK6
10883,GO:0042730,5.63317356135013e-06,0.999999894403556,4,21,fibrinolysis,BP,SERPINE1;PLAU;SERPING1;ANXA2
13163,GO:0048666,5.88125426077117e-06,0.999998436798044,21,1004,neuron development,BP,TNFRSF12A;VIM;CRTAC1;SH3GL2;CUX2;TNR;SPP1;KCNIP2;FMOD;SNAP25;POSTN;CDHR1;ADM;SHANK2;CSMD3;GABRB3;ATCAY;RIMS2;GRIN1;SLITRK1;DOK6
13506,GO:0050806,6.47166882646757e-06,0.999999380381475,8,141,positive regulation of synaptic transmission,BP,CUX2;TNR;SLC8A2;SNAP25;SHANK2;RIMS2;GRIN1;SHISA7
15150,GO:0061041,6.79225708769023e-06,0.999999476160184,7,109,regulation of wound healing,BP,TNFRSF12A;SERPINE1;PLAU;ANXA1;SERPING1;PDPN;ANXA2
19546,GO:1903035,7.60397824870197e-06,0.999999556144341,6,73,negative regulation of response to wounding,BP,SERPINE1;TNR;SPP1;PLAU;SERPING1;ANXA2
487,GO:0001525,7.90472821123846e-06,0.999998558121478,13,434,angiogenesis,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;CXCL10;ANXA2;COL4A1
13569,GO:0050896,9.90306663067022e-06,0.999996196088852,70,7420,response to stimulus,BP,TNFRSF12A;LTF;TYMP;VIM;APOL4;FERMT1;TIMP1;SHD;SERPINE1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;LOX;KCNIP3;IGFBP2;TNR;GBP1;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;GPR17;CPLX2;INA;ADM;SERPING1;SPHKAP;JPH3;KCNB1;C1R;SHANK2;PDPN;S100A11;PTX3;FABP5;GABRB3;NNMT;COL3A1;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;CD163;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;SMOC1;GABBR1;CFI;DOK6;IFI30
13504,GO:0050804,1.08344502004354e-05,0.999998294934511,11,317,modulation of chemical synaptic transmission,BP,CUX2;TNR;SLC8A2;SNAP25;CPLX2;JPH3;KCNB1;SHANK2;RIMS2;GRIN1;SHISA7
18230,GO:0099177,1.08344502004354e-05,0.999998294934511,11,317,regulation of trans-synaptic signaling,BP,CUX2;TNR;SLC8A2;SNAP25;CPLX2;JPH3;KCNB1;SHANK2;RIMS2;GRIN1;SHISA7
8469,GO:0032502,1.10097719331507e-05,0.999995604422875,57,5296,developmental process,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;IGFBP2;TNR;GBP1;SPP1;KCNIP2;FMOD;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;CA10;AFF2;SHANK2;PDPN;FABP5;CSMD3;GABRB3;NNMT;ATCAY;COL3A1;CXCL10;VSTM2A;FUT9;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;COL4A1;PLA2G2A;SMOC1;DOK6
4671,GO:0010033,1.134652065584e-05,0.999995827942337,37,2868,response to organic substance,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;LOX;IGFBP2;GBP1;SPP1;FMOD;GDF15;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GPR17;INA;ADM;KCNB1;GABRB3;NNMT;COL3A1;CXCL10;VSTM2A;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;HLA-DQA1;IFI30
2827,GO:0005886,1.16223600396778e-05,0.999995408075395,49,4280,plasma membrane,CC,TNFRSF12A;VIM;SNAP91;FERMT1;SRPX2;PLEKHA4;SERPINE1;SH3GL2;ABCC3;KCNIP3;STEAP3;IGFBP2;GBP1;SLC8A2;KCNIP2;PLAU;LGALS3;SNAP25;ANXA1;MDGA2;GNAL;COL6A2;EMP3;GPR17;CDHR1;ADAM12;JPH3;KCNB1;SHANK2;PDPN;FABP5;CSMD3;GABRB3;CXCL10;PCDH7;VSTM2A;KSR2;RIMS2;GRIN1;CD163;SLITRK1;HLA-DQB1;ANXA2;SHISA7;PLA2G2A;PTPRT;HLA-DQA1;FAM155A;GABBR1
9544,GO:0034774,1.21391255877684e-05,0.999998268115597,10,299,secretory granule lumen,CC,LTF;TIMP1;SERPINE1;CHI3L1;SERPING1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
3521,GO:0006952,1.3933629090927e-05,0.999995946947142,22,1317,defense response,BP,LTF;VIM;SERPINE1;CCL2;GBP1;SPP1;LGALS3;CHI3L1;ANXA1;GPR17;SERPING1;C1R;PTX3;CXCL10;CD163;HLA-DQB1;SOCS3;PLA2G2A;SERPINA3;HLA-DQA1;CFI;IFI30
7225,GO:0030199,1.46284693963306e-05,0.999999354733863,5,43,collagen fibril organization,BP,COL1A1;LOX;FMOD;COL3A1;ANXA2
7011,GO:0022008,1.57046254952982e-05,0.999995048707326,25,1446,neurogenesis,BP,TNFRSF12A;VIM;CRTAC1;SH3GL2;CCL2;CUX2;TNR;SPP1;KCNIP2;FMOD;SNAP25;POSTN;ANXA1;MDGA2;CDHR1;ADM;SHANK2;CSMD3;GABRB3;ATCAY;COL3A1;RIMS2;GRIN1;SLITRK1;DOK6
7858,GO:0031410,1.64507943791117e-05,0.999994312786189,30,2091,cytoplasmic vesicle,CC,LTF;VIM;SNAP91;MOXD1;TIMP1;SERPINE1;SH3GL2;COL1A1;STEAP3;IGFBP2;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;SERPING1;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;PCDH7;GRIN1;CD163;HLA-DQB1;ANXA2;PLA2G2A;SERPINA3;HLA-DQA1
16493,GO:0071674,1.68139830122942e-05,0.999999223486259,5,55,mononuclear cell migration,BP,SERPINE1;CCL2;LGALS3;ANXA1;CXCL10
2487,GO:0005201,1.69012788958156e-05,0.999998866787374,6,68,extracellular matrix structural constituent,MF,COL1A1;EMILIN2;CHI3L1;COL4A2;COL3A1;COL4A1
17897,GO:0097708,1.69430051244903e-05,0.999994132661213,30,2094,intracellular vesicle,CC,LTF;VIM;SNAP91;MOXD1;TIMP1;SERPINE1;SH3GL2;COL1A1;STEAP3;IGFBP2;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;SERPING1;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;PCDH7;GRIN1;CD163;HLA-DQB1;ANXA2;PLA2G2A;SERPINA3;HLA-DQA1
11656,GO:0044433,1.72396460093093e-05,0.999994777364762,23,1376,cytoplasmic vesicle part,CC,LTF;MOXD1;TIMP1;SERPINE1;SH3GL2;STEAP3;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;SERPING1;S100A11;PTX3;FABP5;SVOP;GABRB3;PCDH7;CD163;HLA-DQB1;ANXA2;SERPINA3;HLA-DQA1
13020,GO:0048306,1.78993144027816e-05,0.999999162438601,5,55,calcium-dependent protein binding,MF,SNAP25;ANXA1;CPLX2;S100A11;ANXA2
633,GO:0001775,1.92636992594422e-05,0.999994431524383,21,1208,cell activation,BP,LTF;TIMP1;CCL2;COL1A1;IGFBP2;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;CPLX2;PDPN;S100A11;PTX3;FABP5;COL3A1;CXCL10;HLA-DQB1;ANXA2;SERPINA3;HLA-DQA1
14618,GO:0060205,1.95318245406324e-05,0.999997050218994,10,315,cytoplasmic vesicle lumen,CC,LTF;TIMP1;SERPINE1;CHI3L1;SERPING1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
13279,GO:0048869,1.96884781252626e-05,0.999992187699576,44,3667,cellular developmental process,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;TNR;GBP1;SPP1;KCNIP2;FMOD;GDF15;LGALS3;SNAP25;POSTN;COL4A2;ANXA1;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;SHANK2;PDPN;CSMD3;GABRB3;ATCAY;COL3A1;CXCL10;VSTM2A;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;COL4A1;PLA2G2A;SMOC1;DOK6
21182,GO:2000026,1.99881880746443e-05,0.999993343992712,27,1712,regulation of multicellular organismal development,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SRPX2;SERPINE1;COL1A1;CUX2;TNR;SPP1;LGALS3;SNAP25;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;SHANK2;PDPN;CSMD3;COL3A1;CXCL10;RIMS2;GRIN1;SLITRK1
8134,GO:0031983,2.00320873309679e-05,0.999996965437894,10,316,vesicle lumen,CC,LTF;TIMP1;SERPINE1;CHI3L1;SERPING1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
1066,GO:0002443,2.08127691695211e-05,0.99999525590369,15,688,leukocyte mediated immunity,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;CPLX2;SERPING1;C1R;S100A11;PTX3;FABP5;HLA-DQB1;ANXA2;SERPINA3;CFI
16633,GO:0071944,2.33027391975099e-05,0.999990491035827,49,4376,cell periphery,CC,TNFRSF12A;VIM;SNAP91;FERMT1;SRPX2;PLEKHA4;SERPINE1;SH3GL2;ABCC3;KCNIP3;STEAP3;IGFBP2;GBP1;SLC8A2;KCNIP2;PLAU;LGALS3;SNAP25;ANXA1;MDGA2;GNAL;COL6A2;EMP3;GPR17;CDHR1;ADAM12;JPH3;KCNB1;SHANK2;PDPN;FABP5;CSMD3;GABRB3;CXCL10;PCDH7;VSTM2A;KSR2;RIMS2;GRIN1;CD163;SLITRK1;HLA-DQB1;ANXA2;SHISA7;PLA2G2A;PTPRT;HLA-DQA1;FAM155A;GABBR1
4765,GO:0010469,2.57281306221408e-05,0.99999553252675,11,397,regulation of signaling receptor activity,BP,TYMP;TIMP1;SERPINE1;CCL2;SPP1;PLAU;GDF15;ADM;SHANK2;CXCL10;SHISA7
17987,GO:0098644,2.63954518562994e-05,0.999999270071519,4,20,complex of collagen trimers,CC,COL1A1;COL4A2;COL3A1;COL4A1
16245,GO:0071310,2.72427371250558e-05,0.999990042920937,32,2366,cellular response to organic substance,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;IGFBP2;GBP1;SPP1;FMOD;GDF15;CHI3L1;POSTN;COL4A2;ANXA1;GPR17;INA;KCNB1;GABRB3;COL3A1;CXCL10;VSTM2A;HLA-DQB1;ANXA2;SOCS3;COL4A1;HLA-DQA1;IFI30
4568,GO:0009653,2.93263929025474e-05,0.99998911143469,33,2350,anatomical structure morphogenesis,BP,TNFRSF12A;LTF;TYMP;SRPX2;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;LOX;TNR;GBP1;SPP1;FMOD;GDF15;CHI3L1;POSTN;COL4A2;ANXA1;CDHR1;ADAM12;ADM;SHANK2;PDPN;COL3A1;CXCL10;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;COL4A1;DOK6
7099,GO:0023051,2.97280803237711e-05,0.999988323723301,39,3168,regulation of signaling,BP,TNFRSF12A;LTF;TYMP;FERMT1;TIMP1;SHD;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SLC8A2;SPP1;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;ANXA1;GPR17;CPLX2;ADM;SPHKAP;JPH3;KCNB1;SHANK2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;SHISA7;PLA2G2A
16269,GO:0071346,3.06026523507658e-05,0.999996984286627,7,146,cellular response to interferon-gamma,BP,VIM;CCL2;GBP1;HLA-DQB1;SOCS3;HLA-DQA1;IFI30
3825,GO:0007611,3.22947381680058e-05,0.99999544449195,9,225,learning or memory,BP,CUX2;TNR;SLC8A2;SNAP25;JPH3;AFF2;SHANK2;GRIN1;SHISA7
7214,GO:0030182,3.37991500851153e-05,0.999989551216092,22,1230,neuron differentiation,BP,TNFRSF12A;VIM;CRTAC1;SH3GL2;CUX2;TNR;SPP1;KCNIP2;FMOD;SNAP25;POSTN;MDGA2;CDHR1;ADM;SHANK2;CSMD3;GABRB3;ATCAY;RIMS2;GRIN1;SLITRK1;DOK6
3636,GO:0007166,3.45823674599333e-05,0.999986897079074,34,2604,cell surface receptor signaling pathway,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;IGFBP2;GBP1;FMOD;GDF15;LGALS3;POSTN;COL4A2;ANXA1;GPR17;KCNB1;SHANK2;GABRB3;COL3A1;CXCL10;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PTPRT;HLA-DQA1;IFI30
7192,GO:0030155,3.47895554200785e-05,0.999992161539868,14,583,regulation of cell adhesion,BP,FERMT1;SERPINE1;CCL2;COL1A1;IGFBP2;TNR;GBP1;PLAU;LGALS3;POSTN;ANXA1;PDPN;HLA-DQB1;HLA-DQA1
21445,GO:2000463,3.55332223091563e-05,0.999998905369934,4,25,positive regulation of excitatory postsynaptic potential,BP,CUX2;SHANK2;RIMS2;GRIN1
3528,GO:0006959,3.8185576841009e-05,0.999996093442105,7,160,humoral immune response,BP,LTF;CCL2;SERPING1;C1R;HLA-DQB1;PLA2G2A;CFI
13122,GO:0048584,3.97494662988526e-05,0.99998595144803,28,1979,positive regulation of response to stimulus,BP,TNFRSF12A;LTF;FERMT1;SHD;SERPINE1;CCL2;COL1A1;CUX2;GBP1;GDF15;LGALS3;CHI3L1;ANXA1;GPR17;SERPING1;C1R;SHANK2;PDPN;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;SOCS3;PLA2G2A;HLA-DQA1;CFI
13269,GO:0048856,4.18198162242389e-05,0.999982308664199,53,4939,anatomical structure development,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;TNR;GBP1;SPP1;KCNIP2;FMOD;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;CA10;AFF2;SHANK2;PDPN;FABP5;CSMD3;GABRB3;NNMT;ATCAY;COL3A1;CXCL10;FUT9;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;COL4A1;SMOC1;DOK6
12178,GO:0045765,4.31827162549569e-05,0.999993662827587,9,246,regulation of angiogenesis,BP,TNFRSF12A;SRPX2;SERPINE1;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;CXCL10
15543,GO:0065008,4.5154864845969e-05,0.999981748042489,40,3342,regulation of biological quality,BP,TNFRSF12A;LTF;VIM;CP;MOXD1;SRPX2;SERPINE1;CCL2;COL1A1;CUX2;STEAP3;TNR;SLC8A2;SPP1;KCNIP2;PLAU;SNAP25;POSTN;ANXA1;GPR17;CPLX2;CDHR1;ADM;SERPING1;JPH3;KCNB1;SHANK2;PDPN;PTX3;GABRB3;COL3A1;CXCL10;VSTM2A;RIMS2;GRIN1;SLITRK1;ANXA2;SHISA7;SERPINA3;FAM155A
8133,GO:0031982,4.55096023313201e-05,0.999981269400534,43,3837,vesicle,CC,LTF;VIM;CP;SNAP91;MOXD1;CRTAC1;TIMP1;SERPINE1;AEBP1;SH3GL2;COL1A1;CUX2;STEAP3;IGFBP2;SPP1;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;COL4A2;ANXA1;GNAL;COL6A2;SERPING1;SPHKAP;C1R;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;PCDH7;RIMS2;GRIN1;CD163;HLA-DQB1;ANXA2;PLA2G2A;SERPINA3;HLA-DQA1;CFI
3711,GO:0007275,4.60080041935378e-05,0.999980556239638,50,4533,multicellular organism development,BP,TNFRSF12A;LTF;TYMP;VIM;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;TNR;SPP1;KCNIP2;FMOD;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;MDGA2;CPLX2;CDHR1;INA;ADAM12;ADM;CA10;AFF2;SHANK2;PDPN;CSMD3;GABRB3;NNMT;ATCAY;COL3A1;CXCL10;FUT9;RIMS2;GRIN1;SLITRK1;ANXA2;SOCS3;COL4A1;SMOC1;DOK6
953,GO:0002252,4.71021278951966e-05,0.999986810289978,18,1003,immune effector process,BP,LTF;GBP1;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;CPLX2;SERPING1;C1R;S100A11;PTX3;FABP5;CXCL10;HLA-DQB1;ANXA2;SERPINA3;CFI
10378,GO:0038063,4.84057331321279e-05,0.999999397769628,3,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,COL1A1;COL4A2;COL4A1
7730,GO:0031175,4.88284524429179e-05,0.999986299309531,18,886,neuron projection development,BP,TNFRSF12A;VIM;CRTAC1;SH3GL2;CUX2;TNR;SPP1;FMOD;SNAP25;POSTN;ADM;SHANK2;CSMD3;ATCAY;RIMS2;GRIN1;SLITRK1;DOK6
13192,GO:0048699,4.94494073211812e-05,0.999983907884052,23,1353,generation of neurons,BP,TNFRSF12A;VIM;CRTAC1;SH3GL2;CUX2;TNR;SPP1;KCNIP2;FMOD;SNAP25;POSTN;MDGA2;CDHR1;ADM;SHANK2;CSMD3;GABRB3;ATCAY;COL3A1;RIMS2;GRIN1;SLITRK1;DOK6
4862,GO:0010646,5.00197014032591e-05,0.999979957977469,38,3117,regulation of cell communication,BP,TNFRSF12A;LTF;TYMP;FERMT1;TIMP1;SHD;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SLC8A2;SPP1;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;ANXA1;GPR17;CPLX2;ADM;SPHKAP;JPH3;KCNB1;SHANK2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SOCS3;SHISA7;PLA2G2A
10550,GO:0042060,5.40182613235565e-05,0.999988911472107,12,460,wound healing,BP,TNFRSF12A;TIMP1;SERPINE1;COL1A1;LOX;PLAU;POSTN;ANXA1;SERPING1;PDPN;COL3A1;ANXA2
9185,GO:0034097,6.02842857858564e-05,0.999982776409846,18,1031,response to cytokine,BP,TNFRSF12A;VIM;TIMP1;CCL2;COL1A1;GBP1;CHI3L1;POSTN;ANXA1;GPR17;INA;COL3A1;CXCL10;HLA-DQB1;ANXA2;SOCS3;HLA-DQA1;IFI30
9303,GO:0034341,6.04642617446517e-05,0.999993339169124,7,164,response to interferon-gamma,BP,VIM;CCL2;GBP1;HLA-DQB1;SOCS3;HLA-DQA1;IFI30
11929,GO:0045202,6.27729498930063e-05,0.999982697676606,17,835,synapse,CC,SRPX2;SH3GL2;KCNIP3;SLC8A2;SNAP25;POSTN;CPLX2;KCNB1;SHANK2;SVOP;GABRB3;ATCAY;RIMS2;GRIN1;SLITRK1;SHISA7;GABBR1
7101,GO:0023056,6.29558092169448e-05,0.999978694596211,24,1574,positive regulation of signaling,BP,TNFRSF12A;LTF;FERMT1;SHD;CCL2;COL1A1;CUX2;TNR;SLC8A2;SPP1;GDF15;SNAP25;CHI3L1;GPR17;SHANK2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;SHISA7;PLA2G2A
7220,GO:0030193,6.46362174741748e-05,0.999995982896938,5,70,regulation of blood coagulation,BP,SERPINE1;PLAU;SERPING1;PDPN;ANXA2
18591,GO:1900046,6.46362174741748e-05,0.999995982896938,5,70,regulation of hemostasis,BP,SERPINE1;PLAU;SERPING1;PDPN;ANXA2
1074,GO:0002455,6.77551338876371e-05,0.999997438106536,4,37,humoral immune response mediated by circulating immunoglobulin,BP,SERPING1;C1R;HLA-DQB1;CFI
16883,GO:0072359,7.42654216514165e-05,0.999978435421389,18,921,circulatory system development,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;COL1A1;LOX;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;PDPN;COL3A1;CXCL10;ANXA2;SOCS3;COL4A1
7041,GO:0022604,7.43722502752632e-05,0.99998421102538,12,442,regulation of cell morphogenesis,BP,TNFRSF12A;CCL2;CUX2;TNR;GBP1;SPP1;POSTN;ANXA1;PDPN;RIMS2;GRIN1;SLITRK1
16268,GO:0071345,7.49146626425415e-05,0.999979020731604,17,952,cellular response to cytokine stimulus,BP,TNFRSF12A;VIM;TIMP1;CCL2;COL1A1;GBP1;CHI3L1;POSTN;ANXA1;GPR17;INA;CXCL10;HLA-DQB1;ANXA2;SOCS3;HLA-DQA1;IFI30
8764,GO:0032963,7.64384963448836e-05,0.999993142911557,6,104,collagen metabolic process,BP,VIM;COL1A1;COL4A2;COL6A2;COL3A1;COL4A1
6661,GO:0019834,8.1629776394896e-05,0.999999859471287,2,3,phospholipase A2 inhibitor activity,MF,ANXA1;ANXA2
13061,GO:0048407,8.18071820021511e-05,0.999998706091984,3,11,platelet-derived growth factor binding,MF,COL1A1;COL3A1;COL4A1
7424,GO:0030574,8.37971670833025e-05,0.999994531402879,5,61,collagen catabolic process,BP,COL1A1;COL4A2;COL6A2;COL3A1;COL4A1
18907,GO:1901342,8.39537132227023e-05,0.999986531640273,9,269,regulation of vasculature development,BP,TNFRSF12A;SRPX2;SERPINE1;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;CXCL10
13564,GO:0050890,8.40836233438696e-05,0.999986520107373,9,255,cognition,BP,CUX2;TNR;SLC8A2;SNAP25;JPH3;AFF2;SHANK2;GRIN1;SHISA7
13515,GO:0050818,8.51006041081798e-05,0.999994377881873,5,74,regulation of coagulation,BP,SERPINE1;PLAU;SERPING1;PDPN;ANXA2
7100,GO:0023052,9.13180270492194e-05,0.999959819603683,55,5462,signaling,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SHD;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;GPR17;CPLX2;ADM;SPHKAP;JPH3;KCNB1;SHANK2;PDPN;S100A11;GABRB3;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;HLA-DQA1;SMOC1;GABBR1;IFI30
21219,GO:2000097,9.15723742778902e-05,0.999999832977153,2,3,regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1;PLAU
1031,GO:0002376,9.51219896431121e-05,0.999963034910451,31,2481,immune system process,BP,LTF;VIM;SERPINE1;SH3GL2;CCL2;COL1A1;IGFBP2;GBP1;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;GPR17;CPLX2;SERPING1;C1R;PDPN;S100A11;PTX3;FABP5;COL3A1;CXCL10;HLA-DQB1;ANXA2;SOCS3;PLA2G2A;SERPINA3;HLA-DQA1;CFI;IFI30
3624,GO:0007154,9.61774111513627e-05,0.999957574150371,55,5474,cell communication,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SHD;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;GPR17;CPLX2;ADM;SPHKAP;JPH3;KCNB1;SHANK2;PDPN;S100A11;GABRB3;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;HLA-DQA1;SMOC1;GABBR1;IFI30
10380,GO:0038065,9.78098947847611e-05,0.999998356036025,3,11,collagen-activated signaling pathway,BP,COL1A1;COL4A2;COL4A1
13121,GO:0048583,0.000107168915674447,0.999954373650653,41,3641,regulation of response to stimulus,BP,TNFRSF12A;LTF;TYMP;FERMT1;TIMP1;SHD;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SPP1;PLAU;GDF15;LGALS3;CHI3L1;POSTN;ANXA1;GPR17;ADM;SERPING1;SPHKAP;JPH3;C1R;SHANK2;PDPN;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;SHISA7;PLA2G2A;HLA-DQA1;CFI
17970,GO:0098609,0.000108458898772988,0.999972725248394,14,650,cell-cell adhesion,BP,SRPX2;CCL2;IGFBP2;TNR;LGALS3;ANXA1;CDHR1;PDPN;S100A11;PCDH7;HLA-DQB1;ANXA2;PTPRT;HLA-DQA1
14666,GO:0060284,0.000110498921609519,0.999969313736234,16,785,regulation of cell development,BP,TNFRSF12A;LTF;VIM;CUX2;TNR;GBP1;SPP1;SNAP25;POSTN;SHANK2;PDPN;CSMD3;COL3A1;RIMS2;GRIN1;SLITRK1
16496,GO:0071677,0.000112317099701327,0.999997843112308,3,17,positive regulation of mononuclear cell migration,BP,SERPINE1;LGALS3;CXCL10
16035,GO:0070887,0.000112864334798773,0.999954254873133,34,2805,cellular response to chemical stimulus,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;IGFBP2;GBP1;SPP1;FMOD;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;GPR17;INA;KCNB1;GABRB3;COL3A1;CXCL10;VSTM2A;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;HLA-DQA1;IFI30
13063,GO:0048468,0.000116477194169708,0.999956622624458,27,1852,cell development,BP,TNFRSF12A;LTF;VIM;CRTAC1;SH3GL2;CUX2;TNR;GBP1;SPP1;KCNIP2;FMOD;GDF15;SNAP25;POSTN;CDHR1;ADM;SHANK2;PDPN;CSMD3;GABRB3;ATCAY;COL3A1;RIMS2;GRIN1;SLITRK1;ANXA2;DOK6
4945,GO:0010769,0.000116996197784551,0.999980392890943,9,260,regulation of cell morphogenesis involved in differentiation,BP,TNFRSF12A;CUX2;TNR;GBP1;SPP1;POSTN;PDPN;GRIN1;SLITRK1
8707,GO:0032879,0.000120197044073391,0.999952629236983,31,2369,regulation of localization,BP,SNAP91;FERMT1;TIMP1;SRPX2;SERPINE1;SH3GL2;CCL2;COL1A1;KCNIP3;GBP1;SPP1;KCNIP2;PLAU;LGALS3;SNAP25;POSTN;ANXA1;CPLX2;JPH3;KCNB1;SHANK2;PDPN;PTX3;ATCAY;COL3A1;CXCL10;VSTM2A;RIMS2;GRIN1;ANXA2;SHISA7
3432,GO:0006810,0.000122844789988727,0.999945927061791,47,4455,transport,BP,LTF;CP;SNAP91;APOL4;FERMT1;TIMP1;SERPINE1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;KCNIP3;STEAP3;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;LGALS3;SNAP25;CHI3L1;POSTN;ANXA1;CPLX2;ADM;SERPING1;JPH3;KCNB1;SHANK2;S100A11;PTX3;FABP5;SVOP;GABRB3;CXCL10;PCDH7;RIMS2;GRIN1;CD163;ANXA2;SHISA7;RTP5;PLA2G2A;SERPINA3;FAM155A;CFI
7222,GO:0030195,0.000132385927112506,0.999993968535472,4,44,negative regulation of blood coagulation,BP,SERPINE1;PLAU;SERPING1;ANXA2
18592,GO:1900047,0.000132385927112506,0.999993968535472,4,44,negative regulation of hemostasis,BP,SERPINE1;PLAU;SERPING1;ANXA2
14705,GO:0060333,0.000156086319115243,0.999988195757656,5,84,interferon-gamma-mediated signaling pathway,BP,GBP1;HLA-DQB1;SOCS3;HLA-DQA1;IFI30
14670,GO:0060291,0.000159516432792451,0.999987967010852,5,70,long-term synaptic potentiation,BP,TNR;SLC8A2;SNAP25;SHANK2;SHISA7
17984,GO:0098641,0.000161489285034303,0.999996436693259,3,19,cadherin binding involved in cell-cell adhesion,MF,ANXA1;S100A11;ANXA2
4863,GO:0010647,0.0001664707817537,0.999940911688353,23,1567,positive regulation of cell communication,BP,TNFRSF12A;LTF;FERMT1;SHD;CCL2;COL1A1;CUX2;TNR;SLC8A2;SPP1;GDF15;SNAP25;CHI3L1;GPR17;SHANK2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SOCS3;SHISA7;PLA2G2A
18068,GO:0098815,0.000167519806810588,0.999991961168918,4,38,modulation of excitatory postsynaptic potential,BP,CUX2;SHANK2;RIMS2;GRIN1
13516,GO:0050819,0.000167749496294269,0.999991836554233,4,47,negative regulation of coagulation,BP,SERPINE1;PLAU;SERPING1;ANXA2
3635,GO:0007165,0.000168676769975847,0.999923803926324,51,5032,signal transduction,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SHD;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;GBP1;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;GPR17;ADM;SPHKAP;JPH3;KCNB1;SHANK2;PDPN;S100A11;GABRB3;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;HLA-DQA1;SMOC1;GABBR1;IFI30
9647,GO:0035239,0.000193527083521727,0.999945868477317,15,736,tube morphogenesis,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;LOX;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;COL3A1;CXCL10;ANXA2;COL4A1
2278,GO:0004857,0.000198209967829033,0.999964229772337,9,317,enzyme inhibitor activity,MF,LTF;TIMP1;SERPINE1;ANXA1;SERPING1;ELFN2;ANXA2;SOCS3;SERPINA3
7687,GO:0031091,0.000201573683759675,0.999983888881287,5,84,platelet alpha granule,CC,TIMP1;SERPINE1;SERPING1;PCDH7;SERPINA3
14914,GO:0060627,0.000204605045064303,0.999954927395316,11,452,regulation of vesicle-mediated transport,BP,SNAP91;SERPINE1;SH3GL2;CCL2;LGALS3;ANXA1;CPLX2;KCNB1;PTX3;RIMS2;ANXA2
3705,GO:0007268,0.000211036007587878,0.999946383237501,13,603,chemical synaptic transmission,BP,CUX2;TNR;SLC8A2;KCNIP2;SNAP25;CPLX2;JPH3;KCNB1;SHANK2;GABRB3;RIMS2;GRIN1;SHISA7
18128,GO:0098916,0.000211036007587878,0.999946383237501,13,603,anterograde trans-synaptic signaling,BP,CUX2;TNR;SLC8A2;KCNIP2;SNAP25;CPLX2;JPH3;KCNB1;SHANK2;GABRB3;RIMS2;GRIN1;SHISA7
13784,GO:0051234,0.000211340142797427,0.999904297881912,47,4549,establishment of localization,BP,LTF;CP;SNAP91;APOL4;FERMT1;TIMP1;SERPINE1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;KCNIP3;STEAP3;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;LGALS3;SNAP25;CHI3L1;POSTN;ANXA1;CPLX2;ADM;SERPING1;JPH3;KCNB1;SHANK2;S100A11;PTX3;FABP5;SVOP;GABRB3;CXCL10;PCDH7;RIMS2;GRIN1;CD163;ANXA2;SHISA7;RTP5;PLA2G2A;SERPINA3;FAM155A;CFI
11862,GO:0045087,0.000212518360971843,0.999942828706244,14,750,innate immune response,BP,LTF;VIM;CCL2;GBP1;LGALS3;ANXA1;SERPING1;C1R;PTX3;HLA-DQB1;SOCS3;HLA-DQA1;CFI;IFI30
18264,GO:0099537,0.000223438372830401,0.999942888664184,13,606,trans-synaptic signaling,BP,CUX2;TNR;SLC8A2;KCNIP2;SNAP25;CPLX2;JPH3;KCNB1;SHANK2;GABRB3;RIMS2;GRIN1;SHISA7
18263,GO:0099536,0.00022861864728295,0.999941422865971,13,607,synaptic signaling,BP,CUX2;TNR;SLC8A2;KCNIP2;SNAP25;CPLX2;JPH3;KCNB1;SHANK2;GABRB3;RIMS2;GRIN1;SHISA7
5097,GO:0010975,0.000243630107105445,0.999945247333969,11,428,regulation of neuron projection development,BP,TNFRSF12A;VIM;CUX2;TNR;SPP1;SNAP25;SHANK2;CSMD3;RIMS2;GRIN1;SLITRK1
4961,GO:0010810,0.00024582938187748,0.999965927676717,7,174,regulation of cell-substrate adhesion,BP,FERMT1;SERPINE1;COL1A1;GBP1;PLAU;POSTN;PDPN
17996,GO:0098657,0.000246346145904888,0.999932770574255,14,709,import into cell,BP,SNAP91;SERPINE1;SH3GL2;CCL2;STEAP3;LGALS3;SNAP25;ANXA1;ADM;PTX3;CD163;ANXA2;FAM155A;CFI
7952,GO:0031589,0.000246384746243728,0.999954244150144,9,295,cell-substrate adhesion,BP,TNFRSF12A;FERMT1;SERPINE1;COL1A1;GBP1;PLAU;POSTN;PDPN;COL3A1
1370,GO:0003008,0.000251959392567899,0.999909742666166,22,1463,system process,BP,TYMP;VIM;COL1A1;CUX2;KCNIP3;TNR;SLC8A2;KCNIP2;SNAP25;POSTN;GNAL;ADM;SERPING1;JPH3;AFF2;SHANK2;GABRB3;CXCL10;GRIN1;SHISA7;RTP5;SERPINA3
5746,GO:0016192,0.000258695856026337,0.999901539630719,25,1818,vesicle-mediated transport,BP,LTF;SNAP91;TIMP1;SERPINE1;SH3GL2;CCL2;CUX2;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;CPLX2;ADM;SERPING1;KCNB1;S100A11;PTX3;FABP5;PCDH7;RIMS2;CD163;ANXA2;SERPINA3;CFI
14265,GO:0052405,0.000270863330667095,0.999998600560439,2,5,negative regulation by host of symbiont molecular function,BP,PTX3;ANXA2
6474,GO:0019221,0.000275896415741166,0.999927821905339,13,687,cytokine-mediated signaling pathway,BP,TNFRSF12A;VIM;TIMP1;CCL2;GBP1;ANXA1;GPR17;CXCL10;HLA-DQB1;ANXA2;SOCS3;HLA-DQA1;IFI30
3489,GO:0006898,0.000296572860697886,0.99995015620495,8,254,receptor-mediated endocytosis,BP,SNAP91;SERPINE1;SH3GL2;SNAP25;ADM;CD163;ANXA2;CFI
5118,GO:0012505,0.000303966080731224,0.999862252837699,42,3974,endomembrane system,CC,LTF;CP;SNAP91;MOXD1;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;KCNIP3;STEAP3;GBP1;SPP1;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GALNT13;INA;SERPING1;JPH3;S100A11;PTX3;FABP5;SVOP;COL3A1;PCDH7;FUT9;GRIN1;ST8SIA3;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;HLA-DQA1
11188,GO:0043299,0.000307010596355581,0.99992896445273,11,505,leukocyte degranulation,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
15255,GO:0061302,0.000317270585420792,0.99999822474677,2,5,smooth muscle cell-matrix adhesion,BP,SERPINE1;PLAU
326,GO:0000902,0.000332970524417341,0.999893834935893,17,941,cell morphogenesis,BP,TNFRSF12A;SH3GL2;CCL2;CUX2;TNR;GBP1;SPP1;FMOD;POSTN;ANXA1;CDHR1;SHANK2;PDPN;RIMS2;GRIN1;SLITRK1;DOK6
17582,GO:0097060,0.00034452142354923,0.999932978490844,9,303,synaptic membrane,CC,SRPX2;SNAP25;KCNB1;SHANK2;GABRB3;RIMS2;GRIN1;SHISA7;GABBR1
963,GO:0002275,0.000346597634286657,0.999918623803941,11,513,myeloid cell activation involved in immune response,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
3826,GO:0007612,0.00034761327037233,0.99995843511832,6,129,learning,BP,TNR;SLC8A2;SNAP25;JPH3;SHANK2;GRIN1
13526,GO:0050840,0.000348845065796348,0.999979384078961,4,48,extracellular matrix binding,MF,SPP1;LGALS3;ANXA2;SMOC1
1067,GO:0002444,0.000360556178304903,0.999914941028729,11,516,myeloid leukocyte mediated immunity,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
13453,GO:0050727,0.000379753454701773,0.999933648888996,8,284,regulation of inflammatory response,BP,SERPINE1;ANXA1;GPR17;SERPING1;C1R;SOCS3;PLA2G2A;CFI
13664,GO:0051049,0.000381035199642379,0.999856175952311,23,1637,regulation of transport,BP,SNAP91;FERMT1;SERPINE1;SH3GL2;CCL2;KCNIP3;GBP1;SPP1;KCNIP2;LGALS3;SNAP25;POSTN;ANXA1;CPLX2;JPH3;KCNB1;SHANK2;PTX3;CXCL10;RIMS2;GRIN1;ANXA2;SHISA7
12179,GO:0045766,0.000409791371778907,0.999949318944172,6,144,positive regulation of angiogenesis,BP,SRPX2;SERPINE1;CHI3L1;ANXA1;ADAM12;ADM
17961,GO:0098590,0.000410927596662821,0.999866442164855,17,977,plasma membrane region,CC,FERMT1;SRPX2;ABCC3;IGFBP2;SLC8A2;SNAP25;ANXA1;CDHR1;KCNB1;SHANK2;PDPN;GABRB3;RIMS2;GRIN1;ANXA2;SHISA7;GABBR1
7139,GO:0030054,0.000424879827639313,0.999852668534045,19,1176,cell junction,CC,VIM;FERMT1;SRPX2;PLAU;SNAP25;ANXA1;KCNB1;SHANK2;PDPN;S100A11;SVOP;GABRB3;ATCAY;RIMS2;GRIN1;SLITRK1;ANXA2;GABBR1;IFI30
15575,GO:0070062,0.00042910453512255,0.999820776551395,29,2442,extracellular exosome,CC,LTF;VIM;CP;CRTAC1;TIMP1;SERPINE1;AEBP1;SH3GL2;CUX2;IGFBP2;SPP1;PLAU;GDF15;LGALS3;CHI3L1;COL4A2;ANXA1;GNAL;COL6A2;SERPING1;SPHKAP;C1R;S100A11;FABP5;RIMS2;ANXA2;PLA2G2A;SERPINA3;CFI
2767,GO:0005788,0.000430779369017855,0.999923349626348,8,267,endoplasmic reticulum lumen,CC,CP;TIMP1;COL1A1;SPP1;COL4A2;COL6A2;COL3A1;COL4A1
12072,GO:0045597,0.00044933062120632,0.99986354405529,15,834,positive regulation of cell differentiation,BP,TNFRSF12A;LTF;SERPINE1;COL1A1;CUX2;GDF15;ANXA1;ADM;SHANK2;PDPN;VSTM2A;RIMS2;SLITRK1;SOCS3;PLA2G2A
13790,GO:0051241,0.00045351446270352,0.999856462334157,16,950,negative regulation of multicellular organismal process,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;TNR;GBP1;SPP1;PLAU;COL4A2;ANXA1;ADM;SERPING1;COL3A1;CXCL10;ANXA2
2063,GO:0004568,0.0004555992838409,0.999996670193485,2,6,chitinase activity,MF,CHI3L2;CHI3L1
2915,GO:0006030,0.0004555992838409,0.999996670193485,2,6,chitin metabolic process,BP,CHI3L2;CHI3L1
2916,GO:0006032,0.0004555992838409,0.999996670193485,2,6,chitin catabolic process,BP,CHI3L2;CHI3L1
9684,GO:0035295,0.000462682740321959,0.999853333676291,16,899,tube development,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;LOX;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;PDPN;COL3A1;CXCL10;ANXA2;COL4A1
4963,GO:0010812,0.000478254417706609,0.99996916506355,4,51,negative regulation of cell-substrate adhesion,BP,SERPINE1;COL1A1;GBP1;POSTN
18475,GO:0120039,0.000479587426203739,0.999867013582019,13,612,plasma membrane bounded cell projection morphogenesis,BP,TNFRSF12A;SH3GL2;CUX2;TNR;SPP1;FMOD;POSTN;SHANK2;PDPN;RIMS2;GRIN1;SLITRK1;DOK6
19797,GO:1903561,0.000484177814974235,0.999796118673022,29,2458,extracellular vesicle,CC,LTF;VIM;CP;CRTAC1;TIMP1;SERPINE1;AEBP1;SH3GL2;CUX2;IGFBP2;SPP1;PLAU;GDF15;LGALS3;CHI3L1;COL4A2;ANXA1;GNAL;COL6A2;SERPING1;SPHKAP;C1R;S100A11;FABP5;RIMS2;ANXA2;PLA2G2A;SERPINA3;CFI
13271,GO:0048858,0.000485118682339031,0.999865311014186,13,613,cell projection morphogenesis,BP,TNFRSF12A;SH3GL2;CUX2;TNR;SPP1;FMOD;POSTN;SHANK2;PDPN;RIMS2;GRIN1;SLITRK1;DOK6
11143,GO:0043230,0.000489722239325846,0.999793624711661,29,2460,extracellular organelle,CC,LTF;VIM;CP;CRTAC1;TIMP1;SERPINE1;AEBP1;SH3GL2;CUX2;IGFBP2;SPP1;PLAU;GDF15;LGALS3;CHI3L1;COL4A2;ANXA1;GNAL;COL6A2;SERPING1;SPHKAP;C1R;S100A11;FABP5;RIMS2;ANXA2;PLA2G2A;SERPINA3;CFI
3704,GO:0007267,0.000505968647175131,0.999812786131288,21,1447,cell-cell signaling,BP,FERMT1;COL1A1;CUX2;IGFBP2;TNR;SLC8A2;SPP1;KCNIP2;GDF15;SNAP25;ANXA1;CPLX2;ADM;JPH3;KCNB1;SHANK2;GABRB3;CXCL10;RIMS2;GRIN1;SHISA7
12948,GO:0048168,0.000509883449418561,0.999966526896332,4,52,regulation of neuronal synaptic plasticity,BP,SLC8A2;JPH3;GRIN1;SHISA7
14271,GO:0052428,0.000511121465517989,0.999996040992533,2,6,modulation by host of symbiont molecular function,BP,PTX3;ANXA2
3527,GO:0006958,0.000547184168956014,0.999981035311313,3,26,complement activation, classical pathway,BP,SERPING1;C1R;CFI
1023,GO:0002366,0.000578160225431879,0.999845433122048,12,630,leukocyte activation involved in immune response,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
7154,GO:0030100,0.000579612599119823,0.999906900068346,7,215,regulation of endocytosis,BP,SNAP91;SERPINE1;SH3GL2;CCL2;LGALS3;PTX3;ANXA2
18472,GO:0120035,0.000591722598615014,0.999841531706528,12,562,regulation of plasma membrane bounded cell projection organization,BP,TNFRSF12A;VIM;CUX2;TNR;SPP1;SNAP25;SHANK2;PDPN;CSMD3;RIMS2;GRIN1;SLITRK1
13750,GO:0051179,0.000596515083368043,0.999711045906906,54,5679,localization,BP,TNFRSF12A;LTF;CP;SNAP91;APOL4;FERMT1;TIMP1;SRPX2;SERPINE1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;KCNIP3;STEAP3;TNR;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;LGALS3;SNAP25;CHI3L1;POSTN;ANXA1;CPLX2;ADM;SERPING1;JPH3;KCNB1;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;ATCAY;COL3A1;CXCL10;PCDH7;VSTM2A;RIMS2;GRIN1;CD163;ANXA2;SHISA7;RTP5;PLA2G2A;SERPINA3;FAM155A;CFI
7693,GO:0031099,0.000600024113312767,0.999920020446171,6,161,regeneration,BP,TNR;SPP1;POSTN;ANXA1;ADM;NNMT
11201,GO:0043312,0.000604332898816685,0.99985975454495,10,462,neutrophil degranulation,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
8785,GO:0032990,0.000609200236625419,0.999826580360069,13,631,cell part morphogenesis,BP,TNFRSF12A;SH3GL2;CUX2;TNR;SPP1;FMOD;POSTN;SHANK2;PDPN;RIMS2;GRIN1;SLITRK1;DOK6
12902,GO:0048018,0.000611346017227129,0.999884965717869,8,324,receptor ligand activity,MF,TYMP;TIMP1;CCL2;SPP1;GDF15;LGALS3;ADM;CXCL10
16415,GO:0071560,0.000614641601789091,0.999900341634867,7,208,cellular response to transforming growth factor beta stimulus,BP,FERMT1;COL1A1;FMOD;GDF15;POSTN;COL4A2;COL3A1
958,GO:0002263,0.000621211150014211,0.999832539542744,12,633,cell activation involved in immune response,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
970,GO:0002283,0.000631517926068019,0.999852592331933,10,465,neutrophil activation involved in immune response,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
7689,GO:0031093,0.000637635552691219,0.999955177792936,4,63,platelet alpha granule lumen,CC,TIMP1;SERPINE1;SERPING1;SERPINA3
11762,GO:0044793,0.000642957742822342,0.999994407178532,2,6,negative regulation by host of viral process,BP,LTF;PTX3
15154,GO:0061045,0.000647073816444072,0.999954395539356,4,61,negative regulation of wound healing,BP,SERPINE1;PLAU;SERPING1;ANXA2
3872,GO:0008061,0.000647875944691339,0.99999402571655,2,7,chitin binding,MF,CHI3L2;CHI3L1
13690,GO:0051094,0.000657603486283597,0.99976973910257,18,1161,positive regulation of developmental process,BP,TNFRSF12A;LTF;SRPX2;SERPINE1;COL1A1;CUX2;GDF15;CHI3L1;ANXA1;ADAM12;ADM;SHANK2;PDPN;VSTM2A;RIMS2;SLITRK1;SOCS3;PLA2G2A
11622,GO:0044362,0.000661216906201641,0.999993839512684,2,7,negative regulation of molecular function in other organism,BP,PTX3;ANXA2
14237,GO:0052204,0.000661216906201641,0.999993839512684,2,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,PTX3;ANXA2
2424,GO:0005102,0.000662972195111316,0.999761057205934,19,1311,signaling receptor binding,MF,TYMP;TIMP1;SRPX2;SERPINE1;CCL2;IGFBP2;SPP1;GDF15;LGALS3;ANXA1;GNAL;ADM;SHANK2;PDPN;COL3A1;CXCL10;GRIN1;SHISA7;RTP5
2608,GO:0005509,0.000671184506908333,0.999817625007065,12,560,calcium ion binding,MF,CRTAC1;KCNIP3;KCNIP2;ANXA1;CDHR1;C1R;S100A11;PCDH7;GRIN1;ANXA2;PLA2G2A;SMOC1
11649,GO:0044425,0.000672394444318021,0.999673022839963,51,5383,membrane part,CC,TNFRSF12A;LTF;SNAP91;MOXD1;FERMT1;SRPX2;ABCC3;KCNIP3;STEAP3;IGFBP2;TNR;SLC8A2;KCNIP2;LGALS3;SNAP25;ANXA1;MDGA2;GNAL;EMP3;GPR17;GALNT13;CPLX2;CDHR1;ADAM12;JPH3;KCNB1;SHANK2;PDPN;CSMD3;SVOP;GABRB3;ELFN2;CXCL10;PCDH7;VSTM2A;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;TMEM151B;SLITRK1;HLA-DQB1;ANXA2;SHISA7;RTP5;PLA2G2A;PTPRT;HLA-DQA1;FAM155A;GABBR1
7826,GO:0031344,0.000675345374083534,0.999816332891795,12,571,regulation of cell projection organization,BP,TNFRSF12A;VIM;CUX2;TNR;SPP1;SNAP25;SHANK2;PDPN;CSMD3;RIMS2;GRIN1;SLITRK1
13855,GO:0051346,0.00070003344233003,0.999849281937243,9,367,negative regulation of hydrolase activity,BP,LTF;TIMP1;SERPINE1;SPOCD1;ANXA1;SERPING1;PTX3;ELFN2;SERPINA3
10581,GO:0042119,0.000716590555435359,0.999829915554215,10,473,neutrophil activation,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
16414,GO:0071559,0.000725629408632356,0.999878937674589,7,212,response to transforming growth factor beta,BP,FERMT1;COL1A1;FMOD;GDF15;POSTN;COL4A2;COL3A1
1069,GO:0002446,0.000735140903405777,0.999824918918021,10,475,neutrophil mediated immunity,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
13689,GO:0051093,0.00074362026802992,0.999772567498028,14,778,negative regulation of developmental process,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;TNR;GBP1;SPP1;POSTN;COL4A2;ANXA1;COL3A1;CXCL10;ANXA2
3632,GO:0007162,0.000744101980861434,0.999875229455185,7,222,negative regulation of cell adhesion,BP,SERPINE1;COL1A1;TNR;GBP1;LGALS3;POSTN;ANXA1
5662,GO:0016020,0.000751873378972924,0.999637337475294,66,7647,membrane,CC,TNFRSF12A;LTF;VIM;CP;SNAP91;MOXD1;APOL4;FERMT1;SRPX2;PLEKHA4;SERPINE1;SH3GL2;ABCC3;CUX2;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;KCNIP2;PLAU;LGALS3;SNAP25;ANXA1;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;JPH3;KCNB1;SHANK2;PDPN;FABP5;CSMD3;SVOP;GABRB3;ELFN2;ATCAY;CXCL10;PCDH7;VSTM2A;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;TMEM151B;SLITRK1;HLA-DQB1;ANXA2;SHISA7;RTP5;PLA2G2A;PTPRT;HLA-DQA1;FAM155A;GABBR1;CFI
20032,GO:1904018,0.000753037264114264,0.999895156721331,6,161,positive regulation of vasculature development,BP,SRPX2;SERPINE1;CHI3L1;ANXA1;ADAM12;ADM
2279,GO:0004859,0.00076563237672303,0.99999201846307,2,8,phospholipase inhibitor activity,MF,ANXA1;ANXA2
10201,GO:0036230,0.000771394392598673,0.999815106868614,10,478,granulocyte activation,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;S100A11;PTX3;FABP5;ANXA2;SERPINA3
13508,GO:0050808,0.000788914489407957,0.999846006707945,8,265,synapse organization,BP,SRPX2;CUX2;TNR;SHANK2;GRIN1;SLITRK1;COL4A1;SHISA7
9501,GO:0034702,0.000804243800026498,0.999842456510343,8,276,ion channel complex,CC,KCNIP3;KCNIP2;SNAP25;KCNB1;SHANK2;GABRB3;GRIN1;SHISA7
13155,GO:0048646,0.0008072724531264,0.999730034305643,16,942,anatomical structure formation involved in morphogenesis,BP,TNFRSF12A;TYMP;SRPX2;SERPINE1;CCL2;COL1A1;GDF15;CHI3L1;COL4A2;ANXA1;ADAM12;ADM;PDPN;CXCL10;ANXA2;COL4A1
13485,GO:0050777,0.000848085292296178,0.999906104510241,5,118,negative regulation of immune response,BP,LGALS3;ANXA1;GPR17;SERPING1;COL3A1
7822,GO:0031340,0.000855487870912643,0.99999091941847,2,7,positive regulation of vesicle fusion,BP,ANXA1;ANXA2
2660,GO:0005604,0.000866290758092111,0.999904429420901,5,88,basement membrane,CC,TIMP1;COL4A2;ANXA2;COL4A1;SMOC1
7459,GO:0030659,0.000904800348907521,0.999730714655585,13,714,cytoplasmic vesicle membrane,CC,MOXD1;SH3GL2;PLAU;LGALS3;SNAP25;ANXA1;FABP5;SVOP;GABRB3;PCDH7;CD163;HLA-DQB1;HLA-DQA1
327,GO:0000904,0.000929695621543357,0.999722622677204,13,661,cell morphogenesis involved in differentiation,BP,TNFRSF12A;CUX2;TNR;GBP1;SPP1;FMOD;POSTN;CDHR1;SHANK2;PDPN;GRIN1;SLITRK1;DOK6
17959,GO:0098588,0.000940155235511133,0.999612810654789,24,1891,bounding membrane of organelle,CC,LTF;CP;MOXD1;SH3GL2;CUX2;STEAP3;GBP1;PLAU;LGALS3;SNAP25;ANXA1;GALNT13;CDHR1;JPH3;SHANK2;FABP5;SVOP;PCDH7;FUT9;ST8SIA3;CD163;HLA-DQB1;ANXA2;HLA-DQA1
3433,GO:0006811,0.000944618523746162,0.999640176344867,20,1419,ion transport,BP,LTF;CP;CCL2;ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;LGALS3;SNAP25;ANXA1;JPH3;KCNB1;SHANK2;GABRB3;CXCL10;GRIN1;SHISA7;PLA2G2A;FAM155A
14178,GO:0051960,0.000958025301102689,0.999699074768951,14,768,regulation of nervous system development,BP,TNFRSF12A;TYMP;VIM;SRPX2;CUX2;TNR;SPP1;SNAP25;SHANK2;CSMD3;COL3A1;RIMS2;GRIN1;SLITRK1
7412,GO:0030545,0.000965159108346944,0.999804960720218,8,347,receptor regulator activity,MF,TYMP;TIMP1;CCL2;SPP1;GDF15;LGALS3;ADM;CXCL10
3488,GO:0006897,0.000967540613610621,0.999725385498282,12,632,endocytosis,BP,SNAP91;SERPINE1;SH3GL2;CCL2;LGALS3;SNAP25;ANXA1;ADM;PTX3;CD163;ANXA2;CFI
4650,GO:0009966,0.000970457502369576,0.999558265996776,32,2831,regulation of signal transduction,BP,TNFRSF12A;LTF;TYMP;FERMT1;TIMP1;SHD;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;IGFBP2;GBP1;SPP1;PLAU;GDF15;LGALS3;CHI3L1;POSTN;GPR17;ADM;SPHKAP;JPH3;SHANK2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SOCS3;SHISA7;PLA2G2A
7120,GO:0030023,0.000980614050493213,0.999990289580904,2,5,extracellular matrix constituent conferring elasticity,MF,EMILIN2;COL4A1
8377,GO:0032395,0.000988931934955373,0.999987927881505,2,9,MHC class II receptor activity,MF,HLA-DQB1;HLA-DQA1
1116,GO:0002526,0.000996752382619217,0.999885409350105,5,126,acute inflammatory response,BP,SERPING1;C1R;CD163;SERPINA3;CFI
8784,GO:0032989,0.00100184684689713,0.999646336684322,17,1033,cellular component morphogenesis,BP,TNFRSF12A;SH3GL2;CCL2;CUX2;TNR;GBP1;SPP1;FMOD;POSTN;ANXA1;CDHR1;SHANK2;PDPN;RIMS2;GRIN1;SLITRK1;DOK6
11621,GO:0044359,0.00101647826472807,0.999987767648366,2,8,modulation of molecular function in other organism,BP,PTX3;ANXA2
14238,GO:0052205,0.00101647826472807,0.999987767648366,2,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,PTX3;ANXA2
815,GO:0002020,0.00102093308975893,0.999882354777099,5,111,protease binding,MF,TIMP1;SERPINE1;COL1A1;COL3A1;ANXA2
3827,GO:0007613,0.00102676376565058,0.999881705117152,5,105,memory,BP,CUX2;SLC8A2;JPH3;GRIN1;SHISA7
3789,GO:0007520,0.00104178804027361,0.999954471389959,3,29,myoblast fusion,BP,GDF15;ADAM12;CXCL10
6712,GO:0019932,0.00104184081680022,0.999787295597537,8,300,second-messenger-mediated signaling,BP,GBP1;GNAL;ADM;JPH3;CXCL10;KSR2;RIMS2;GRIN1
4656,GO:0009986,0.00104661518471579,0.999700162114897,12,638,cell surface,CC,TNFRSF12A;LTF;SRPX2;TNR;PLAU;ANXA1;CXCL10;GRIN1;CD163;ANXA2;RTP5;PTPRT
2285,GO:0004866,0.00105120409646273,0.999877788449561,5,122,endopeptidase inhibitor activity,MF,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
18805,GO:1901072,0.00105447864512368,0.99998670209252,2,9,glucosamine-containing compound catabolic process,BP,CHI3L2;CHI3L1
18473,GO:0120036,0.00106753190224354,0.999589150512612,20,1355,plasma membrane bounded cell projection organization,BP,TNFRSF12A;VIM;CRTAC1;SH3GL2;CUX2;TNR;SPP1;FMOD;SNAP25;POSTN;EMP3;ADM;SHANK2;PDPN;CSMD3;ATCAY;RIMS2;GRIN1;SLITRK1;DOK6
3824,GO:0007610,0.0010688552572543,0.999711935098175,11,529,behavior,BP,SRPX2;CUX2;TNR;SLC8A2;SNAP25;JPH3;AFF2;SHANK2;GRIN1;SLITRK1;SHISA7
18055,GO:0098797,0.00107003426522309,0.999711545807816,11,536,plasma membrane protein complex,CC,KCNIP3;KCNIP2;SNAP25;GNAL;KCNB1;SHANK2;GRIN1;HLA-DQB1;SHISA7;HLA-DQA1;GABBR1
13554,GO:0050877,0.00108136352291137,0.999655804087807,14,810,nervous system process,BP,TYMP;COL1A1;CUX2;TNR;SLC8A2;SNAP25;GNAL;JPH3;AFF2;SHANK2;GABRB3;GRIN1;SHISA7;RTP5
11976,GO:0045321,0.00109088456788121,0.999624042364552,16,1074,leukocyte activation,BP,LTF;CCL2;IGFBP2;PLAU;LGALS3;SNAP25;CHI3L1;ANXA1;CPLX2;S100A11;PTX3;FABP5;HLA-DQB1;ANXA2;SERPINA3;HLA-DQA1
16494,GO:0071675,0.00109345435588803,0.999950862760376,3,34,regulation of mononuclear cell migration,BP,SERPINE1;LGALS3;CXCL10
17977,GO:0098632,0.00110233417806288,0.999950629341687,3,31,cell-cell adhesion mediator activity,MF,ANXA1;S100A11;ANXA2
962,GO:0002274,0.00113013189009813,0.999693024021266,11,589,myeloid leukocyte activation,BP,LTF;PLAU;LGALS3;SNAP25;CHI3L1;CPLX2;S100A11;PTX3;FABP5;ANXA2;SERPINA3
1140,GO:0002576,0.00113646632178358,0.999865617983128,5,119,platelet degranulation,BP,TIMP1;SERPINE1;SERPING1;PCDH7;SERPINA3
11674,GO:0044456,0.00114016168535118,0.999651821816967,13,704,synapse part,CC,SRPX2;KCNIP3;SLC8A2;SNAP25;CPLX2;KCNB1;SHANK2;SVOP;GABRB3;RIMS2;GRIN1;SHISA7;GABBR1
5119,GO:0012506,0.00116346875446224,0.999643798059573,13,733,vesicle membrane,CC,MOXD1;SH3GL2;PLAU;LGALS3;SNAP25;ANXA1;FABP5;SVOP;GABRB3;PCDH7;CD163;HLA-DQB1;HLA-DQA1
2824,GO:0005883,0.00123334869463504,0.999984239215265,2,7,neurofilament,CC,INA;SHANK2
15204,GO:0061135,0.0012624740687979,0.999846884698583,5,128,endopeptidase regulator activity,MF,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
14538,GO:0060076,0.00127592436359637,0.999940158765416,3,29,excitatory synapse,CC,SRPX2;GRIN1;SHISA7
19318,GO:1902495,0.00128339000718452,0.999729275297195,8,299,transmembrane transporter complex,CC,KCNIP3;KCNIP2;SNAP25;KCNB1;SHANK2;GABRB3;GRIN1;SHISA7
13246,GO:0048812,0.00131888152921039,0.999611853088751,12,598,neuron projection morphogenesis,BP,TNFRSF12A;SH3GL2;CUX2;TNR;SPP1;FMOD;POSTN;SHANK2;RIMS2;GRIN1;SLITRK1;DOK6
7030,GO:0022407,0.00131919874507427,0.999720123155989,8,337,regulation of cell-cell adhesion,BP,CCL2;IGFBP2;TNR;LGALS3;ANXA1;PDPN;HLA-DQB1;HLA-DQA1
7358,GO:0030414,0.00135808317854698,0.999832579502907,5,127,peptidase inhibitor activity,MF,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
12991,GO:0048259,0.00136545501110592,0.999881546522929,4,72,regulation of receptor-mediated endocytosis,BP,SNAP91;SERPINE1;SH3GL2;ANXA2
7123,GO:0030030,0.00137338342883894,0.999459718394323,20,1386,cell projection organization,BP,TNFRSF12A;VIM;CRTAC1;SH3GL2;CUX2;TNR;SPP1;FMOD;SNAP25;POSTN;EMP3;ADM;SHANK2;PDPN;CSMD3;ATCAY;RIMS2;GRIN1;SLITRK1;DOK6
4576,GO:0009719,0.00142092753171075,0.999439243312534,20,1450,response to endogenous stimulus,BP,FERMT1;TIMP1;SH3GL2;CCL2;COL1A1;LOX;IGFBP2;SPP1;FMOD;GDF15;POSTN;COL4A2;ANXA1;ADM;GABRB3;COL3A1;VSTM2A;ANXA2;SOCS3;COL4A1
13713,GO:0051128,0.00144133512553239,0.999360009544684,27,2217,regulation of cellular component organization,BP,TNFRSF12A;VIM;SNAP91;SRPX2;SERPINE1;SH3GL2;CCL2;CUX2;IGFBP2;TNR;GBP1;SPP1;GDF15;LGALS3;SNAP25;POSTN;ANXA1;SHANK2;PDPN;PTX3;CSMD3;CXCL10;RIMS2;GRIN1;SLITRK1;ANXA2;SHISA7
3807,GO:0007584,0.00145618260793011,0.999768785775936,6,194,response to nutrient,BP,COL1A1;IGFBP2;SPP1;POSTN;CXCL10;GRIN1
20965,GO:1990351,0.00146540755368457,0.999684232727197,8,307,transporter complex,CC,KCNIP3;KCNIP2;SNAP25;KCNB1;SHANK2;GABRB3;GRIN1;SHISA7
2646,GO:0005587,0.00147191379201244,0.999980509038458,2,6,collagen type IV trimer,CC,COL4A2;COL4A1
7371,GO:0030449,0.00153311392815434,0.999922090112854,3,37,regulation of complement activation,BP,SERPING1;C1R;CFI
21305,GO:2000257,0.00153311392815434,0.999922090112854,3,37,regulation of protein activation cascade,BP,SERPING1;C1R;CFI
18281,GO:0099565,0.00156573292541535,0.999800912574682,5,120,chemical synaptic transmission, postsynaptic,BP,CUX2;SHANK2;GABRB3;RIMS2;GRIN1
14457,GO:0055102,0.00156825666630705,0.999974846708314,2,11,lipase inhibitor activity,MF,ANXA1;ANXA2
2436,GO:0005125,0.00157379412681339,0.999798748575792,5,149,cytokine activity,MF,TIMP1;CCL2;SPP1;GDF15;CXCL10
14931,GO:0060670,0.00157713094409929,0.999975064938003,2,10,branching involved in labyrinthine layer morphogenesis,BP,ADM;SOCS3
12981,GO:0048245,0.00159268383765478,0.999974253402566,2,11,eosinophil chemotaxis,BP,CCL2;LGALS3
9066,GO:0033628,0.001629125053899,0.999915432573742,3,37,regulation of cell adhesion mediated by integrin,BP,FERMT1;SERPINE1;PLAU
11052,GO:0043086,0.00163110535132969,0.999507095127658,12,688,negative regulation of catalytic activity,BP,LTF;TIMP1;SERPINE1;SPOCD1;ANXA1;SERPING1;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3;GABBR1
8098,GO:0031915,0.00165155945806007,0.99997384178939,2,9,positive regulation of synaptic plasticity,BP,SNAP25;CPLX2
17832,GO:0097529,0.00169820054393378,0.999779224326843,5,143,myeloid leukocyte migration,BP,SERPINE1;CCL2;LGALS3;ANXA1;CXCL10
17985,GO:0098642,0.00179973293446242,0.9999721255287,2,7,network-forming collagen trimer,CC,COL4A2;COL4A1
17988,GO:0098645,0.00179973293446242,0.9999721255287,2,7,collagen network,CC,COL4A2;COL4A1
7328,GO:0030335,0.00184116444119394,0.999543785935113,9,410,positive regulation of cell migration,BP,SRPX2;SERPINE1;COL1A1;PLAU;LGALS3;POSTN;ANXA1;PDPN;CXCL10
13789,GO:0051240,0.00189807141659939,0.999248639921459,19,1393,positive regulation of multicellular organismal process,BP,TNFRSF12A;LTF;FERMT1;SRPX2;SERPINE1;COL1A1;CUX2;TNR;SPP1;CHI3L1;POSTN;ANXA1;ADAM12;ADM;SHANK2;PDPN;RIMS2;SLITRK1;ANXA2
3803,GO:0007568,0.00189887548135924,0.999624454199638,7,267,aging,BP,TIMP1;SERPINE1;IGFBP2;COL4A2;ADM;SERPING1;COL3A1
14540,GO:0060078,0.00190970420657591,0.99974570330435,5,125,regulation of postsynaptic membrane potential,BP,CUX2;SHANK2;GABRB3;RIMS2;GRIN1
8943,GO:0033273,0.00192569392716354,0.999815614561554,4,84,response to vitamin,BP,COL1A1;SPP1;POSTN;CXCL10
7973,GO:0031638,0.00195885357568294,0.999890924395234,3,41,zymogen activation,BP,SERPINE1;PLAU;C1R
13484,GO:0050776,0.00197142776371941,0.999358558822472,13,836,regulation of immune response,BP,LTF;COL1A1;GBP1;LGALS3;ANXA1;GPR17;SERPING1;C1R;COL3A1;HLA-DQB1;SOCS3;HLA-DQA1;CFI
11676,GO:0044459,0.00200022777060489,0.999079027897513,28,2421,plasma membrane part,CC,FERMT1;SRPX2;ABCC3;KCNIP3;STEAP3;IGFBP2;SLC8A2;KCNIP2;LGALS3;SNAP25;ANXA1;GNAL;GPR17;CDHR1;KCNB1;SHANK2;PDPN;GABRB3;CXCL10;PCDH7;RIMS2;GRIN1;CD163;HLA-DQB1;ANXA2;SHISA7;HLA-DQA1;GABBR1
5214,GO:0014812,0.00204180874596503,0.999802109407928,4,74,muscle cell migration,BP,SERPINE1;PLAU;POSTN;ANXA1
12126,GO:0045664,0.00212395448332538,0.999375019705309,11,568,regulation of neuron differentiation,BP,TNFRSF12A;VIM;CUX2;TNR;SPP1;SNAP25;SHANK2;CSMD3;RIMS2;GRIN1;SLITRK1
16967,GO:0072562,0.00213395075314888,0.999789247693012,4,93,blood microparticle,CC,CP;SERPING1;C1R;SERPINA3
6664,GO:0019838,0.002145255043589,0.999706478082497,5,128,growth factor binding,MF,SRPX2;COL1A1;IGFBP2;COL3A1;COL4A1
21249,GO:2000147,0.00216852303738774,0.999449383309261,9,422,positive regulation of cell motility,BP,SRPX2;SERPINE1;COL1A1;PLAU;LGALS3;POSTN;ANXA1;PDPN;CXCL10
15669,GO:0070208,0.00216985525617061,0.999958941869384,2,11,protein heterotrimerization,BP,COL1A1;COL6A2
12439,GO:0046348,0.00222040120921856,0.99995638763407,2,13,amino sugar catabolic process,BP,CHI3L2;CHI3L1
5687,GO:0016064,0.00224468627771103,0.999775400367032,4,90,immunoglobulin mediated immune response,BP,SERPING1;C1R;HLA-DQB1;CFI
17992,GO:0098651,0.00229471914810761,0.999958212319381,2,8,basement membrane collagen trimer,CC,COL4A2;COL4A1
6613,GO:0019724,0.00232825146690617,0.999764613951058,4,91,B cell mediated immunity,BP,SERPING1;C1R;HLA-DQB1;CFI
17200,GO:0090026,0.00236918515986436,0.999951900365438,2,13,positive regulation of monocyte chemotaxis,BP,SERPINE1;CXCL10
13123,GO:0048585,0.00237040542409034,0.999042123602169,19,1437,negative regulation of response to stimulus,BP,LTF;FERMT1;SERPINE1;SH3GL2;CCL2;IGFBP2;TNR;GBP1;SPP1;PLAU;LGALS3;ANXA1;GPR17;ADM;SERPING1;COL3A1;GRIN1;ANXA2;SOCS3
1195,GO:0002683,0.00237328013394506,0.999446515768574,8,368,negative regulation of immune system process,BP,LTF;CCL2;GBP1;LGALS3;ANXA1;GPR17;SERPING1;COL3A1
4549,GO:0009612,0.00238009416058752,0.999583380630036,6,197,response to mechanical stimulus,BP,COL1A1;IGFBP2;CHI3L1;POSTN;COL3A1;CXCL10
271,GO:0000768,0.00238983542380337,0.999858067665451,3,37,syncytium formation by plasma membrane fusion,BP,GDF15;ADAM12;CXCL10
3761,GO:0007416,0.00239143053825429,0.999664820035936,5,123,synapse assembly,BP,SRPX2;CUX2;SHANK2;GRIN1;SLITRK1
17976,GO:0098631,0.0023985257772747,0.99985676160126,3,40,cell adhesion mediator activity,MF,ANXA1;S100A11;ANXA2
10833,GO:0042613,0.00241433493971927,0.999950023287572,2,14,MHC class II protein complex,CC,HLA-DQB1;HLA-DQA1
14181,GO:0051963,0.00241589061984587,0.999754343929851,4,78,regulation of synapse assembly,BP,SRPX2;CUX2;GRIN1;SLITRK1
18575,GO:1900025,0.0024573222412262,0.999949758207232,2,12,negative regulation of substrate adhesion-dependent cell spreading,BP,GBP1;POSTN
17391,GO:0090303,0.00250681868853733,0.999847567072159,3,42,positive regulation of wound healing,BP,SERPINE1;ANXA1;PDPN
15905,GO:0070613,0.00254606137251793,0.99973648718958,4,87,regulation of protein processing,BP,SERPINE1;SERPING1;C1R;CFI
3519,GO:0006949,0.00255006704605272,0.99984481199459,3,38,syncytium formation,BP,GDF15;ADAM12;CXCL10
1194,GO:0002682,0.00256122145677893,0.999008822075664,17,1285,regulation of immune system process,BP,LTF;SERPINE1;CCL2;COL1A1;IGFBP2;GBP1;LGALS3;ANXA1;GPR17;SERPING1;C1R;COL3A1;CXCL10;HLA-DQB1;SOCS3;HLA-DQA1;CFI
13813,GO:0051272,0.00259582492691875,0.999322848551788,9,433,positive regulation of cellular component movement,BP,SRPX2;SERPINE1;COL1A1;PLAU;LGALS3;POSTN;ANXA1;PDPN;CXCL10
1197,GO:0002685,0.00259636079300497,0.999627266818295,5,159,regulation of leukocyte migration,BP,SERPINE1;CCL2;LGALS3;ANXA1;CXCL10
16285,GO:0071363,0.00260347757503315,0.999213057871925,11,602,cellular response to growth factor stimulus,BP,FERMT1;SH3GL2;CCL2;COL1A1;FMOD;GDF15;POSTN;COL4A2;ANXA1;COL3A1;VSTM2A
7466,GO:0030669,0.00260733949485271,0.999839432942571,3,41,clathrin-coated endocytic vesicle membrane,CC,SH3GL2;HLA-DQB1;HLA-DQA1
3880,GO:0008076,0.00262109107417153,0.999726536568442,4,87,voltage-gated potassium channel complex,CC,KCNIP3;KCNIP2;SNAP25;KCNB1
13124,GO:0048588,0.00265999295019402,0.999524175905181,6,190,developmental cell growth,BP,TNFRSF12A;SH3GL2;TNR;SPP1;POSTN;RIMS2
17024,GO:0072677,0.0026670076297179,0.999941915769905,2,14,eosinophil migration,BP,CCL2;LGALS3
19672,GO:1903317,0.00276827257503945,0.999706601806082,4,89,regulation of protein maturation,BP,SERPINE1;SERPING1;C1R;CFI
7032,GO:0022409,0.00277332753387586,0.999498491097023,6,225,positive regulation of cell-cell adhesion,BP,CCL2;IGFBP2;ANXA1;PDPN;HLA-DQB1;HLA-DQA1
13177,GO:0048681,0.00283677606086222,0.999937585602394,2,12,negative regulation of axon regeneration,BP,TNR;SPP1
14187,GO:0051969,0.00288137265420202,0.999935352857589,2,13,regulation of transmission of nerve impulse,BP,TYMP;TNR
10810,GO:0042581,0.00291263808361752,0.999570841940815,5,154,specific granule,CC,LTF;PLAU;SNAP25;CHI3L1;PTX3
3813,GO:0007596,0.00292401299193543,0.999374840370293,7,293,blood coagulation,BP,SERPINE1;COL1A1;PLAU;SERPING1;PDPN;COL3A1;ANXA2
6691,GO:0019886,0.00293704795715478,0.999683202724148,4,93,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,SH3GL2;HLA-DQB1;HLA-DQA1;IFI30
3978,GO:0008236,0.00297713785904694,0.999558679528578,5,163,serine-type peptidase activity,MF,LTF;AEBP1;PLAU;C1R;CFI
18574,GO:1900024,0.00298705155261733,0.999806324040375,3,44,regulation of substrate adhesion-dependent cell spreading,BP,GBP1;POSTN;PDPN
15991,GO:0070820,0.00298997090231087,0.999556714166749,5,155,tertiary granule,CC,LTF;PLAU;LGALS3;SNAP25;PTX3
13514,GO:0050817,0.00304963388498316,0.999342983422135,7,295,coagulation,BP,SERPINE1;COL1A1;PLAU;SERPING1;PDPN;COL3A1;ANXA2
7327,GO:0030334,0.00306813823878737,0.99899820055814,12,698,regulation of cell migration,BP,TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;PLAU;LGALS3;POSTN;ANXA1;PDPN;COL3A1;CXCL10
4947,GO:0010771,0.00309185183058114,0.999662425761456,4,86,negative regulation of cell morphogenesis involved in differentiation,BP,TNR;GBP1;SPP1;POSTN
19783,GO:1903539,0.00310982773438288,0.99992828482921,2,12,protein localization to postsynaptic membrane,BP,SNAP25;GRIN1
19049,GO:1901739,0.00312439895065035,0.999925602822414,2,15,regulation of myoblast fusion,BP,GDF15;CXCL10
14429,GO:0055065,0.00312800042048548,0.999092305759266,10,543,metal ion homeostasis,BP,LTF;CP;STEAP3;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
5885,GO:0016485,0.00313658934385932,0.99941853144918,6,226,protein processing,BP,SERPINE1;AEBP1;PLAU;SERPING1;C1R;CFI
2756,GO:0005775,0.00316149135025299,0.999525021769446,5,158,vacuolar lumen,CC,FMOD;FABP5;ANXA2;SERPINA3;IFI30
3816,GO:0007599,0.00317258779289671,0.99931153449564,7,298,hemostasis,BP,SERPINE1;COL1A1;PLAU;SERPING1;PDPN;COL3A1;ANXA2
3525,GO:0006956,0.00319889514709911,0.999786479120567,3,49,complement activation,BP,SERPING1;C1R;CFI
1094,GO:0002495,0.00328149671555499,0.999634688808741,4,96,antigen processing and presentation of peptide antigen via MHC class II,BP,SH3GL2;HLA-DQB1;HLA-DQA1;IFI30
6253,GO:0017171,0.00331701254861686,0.999495599941978,5,167,serine hydrolase activity,MF,LTF;AEBP1;PLAU;C1R;CFI
2607,GO:0005507,0.00333873998269069,0.999773736661318,3,49,copper ion binding,MF,CP;MOXD1;LOX
13475,GO:0050767,0.00337913907484271,0.99888336324278,12,689,regulation of neurogenesis,BP,TNFRSF12A;VIM;CUX2;TNR;SPP1;SNAP25;SHANK2;CSMD3;COL3A1;RIMS2;GRIN1;SLITRK1
3493,GO:0006904,0.00338257435496893,0.999769901783547,3,48,vesicle docking involved in exocytosis,BP,SNAP25;CPLX2;KCNB1
4903,GO:0010721,0.00338915402422008,0.99925633559395,7,277,negative regulation of cell development,BP,LTF;VIM;TNR;GBP1;SPP1;POSTN;COL3A1
10510,GO:0040017,0.0034173021133592,0.999070556248418,9,452,positive regulation of locomotion,BP,SRPX2;SERPINE1;COL1A1;PLAU;LGALS3;POSTN;ANXA1;PDPN;CXCL10
1098,GO:0002504,0.00344821085581316,0.999610698708893,4,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,SH3GL2;HLA-DQB1;HLA-DQA1;IFI30
9504,GO:0034705,0.00351363859132595,0.999601540040512,4,94,potassium channel complex,CC,KCNIP3;KCNIP2;SNAP25;KCNB1
14155,GO:0051928,0.00353218791978941,0.999598741492209,4,95,positive regulation of calcium ion transport,BP,CCL2;LGALS3;CXCL10;GRIN1
16012,GO:0070848,0.00354270692714928,0.998884536542893,11,626,response to growth factor,BP,FERMT1;SH3GL2;CCL2;COL1A1;FMOD;GDF15;POSTN;COL4A2;ANXA1;COL3A1;VSTM2A
1196,GO:0002684,0.00360202045776829,0.998741683268234,13,888,positive regulation of immune system process,BP,LTF;SERPINE1;CCL2;IGFBP2;GBP1;LGALS3;ANXA1;SERPING1;C1R;CXCL10;HLA-DQB1;HLA-DQA1;CFI
7434,GO:0030595,0.00363337670398187,0.999435425666498,5,171,leukocyte chemotaxis,BP,SERPINE1;CCL2;LGALS3;ANXA1;CXCL10
3676,GO:0007215,0.00366212645530611,0.999581002580433,4,85,glutamate receptor signaling pathway,BP,KCNB1;SHANK2;GRIN1;SHISA7
12629,GO:0046717,0.0036809024536116,0.999576583161138,4,99,acid secretion,BP,ABCC3;SNAP25;ANXA1;PLA2G2A
1348,GO:0002920,0.00372097480334806,0.999737305613487,3,52,regulation of humoral immune response,BP,SERPING1;C1R;CFI
15203,GO:0061134,0.00376584238247289,0.999410499379596,5,161,peptidase regulator activity,MF,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
11696,GO:0044548,0.00395051585863392,0.999894797338036,2,14,S100 protein binding,MF,S100A11;ANXA2
13825,GO:0051291,0.00397448484293071,0.999532790971188,4,100,protein heterooligomerization,BP,COL1A1;COL6A2;GRIN1;ANXA2
9502,GO:0034703,0.00400251793748347,0.999221362864937,6,206,cation channel complex,CC,KCNIP3;KCNIP2;SNAP25;KCNB1;GRIN1;SHISA7
4480,GO:0009306,0.00401162442479594,0.998881477322115,9,477,protein secretion,BP,FERMT1;STEAP3;GBP1;SNAP25;CHI3L1;POSTN;ANXA1;KCNB1;RIMS2
15885,GO:0070571,0.0040333110359418,0.999891443104125,2,14,negative regulation of neuron projection regeneration,BP,TNR;SPP1
19547,GO:1903036,0.00407828410165804,0.999702986251917,3,50,positive regulation of response to wounding,BP,SERPINE1;ANXA1;PDPN
17371,GO:0090280,0.00416484017928696,0.999885090322464,2,15,positive regulation of calcium ion import,BP,CCL2;LGALS3
13396,GO:0050663,0.00417224827310717,0.999330487954268,5,169,cytokine secretion,BP,FERMT1;GBP1;CHI3L1;POSTN;ANXA1
13507,GO:0050807,0.0042506720102535,0.999316280673935,5,150,regulation of synapse organization,BP,SRPX2;CUX2;GRIN1;SLITRK1;SHISA7
14965,GO:0060712,0.00427121038137589,0.999881606895217,2,14,spongiotrophoblast layer development,BP,ADM;SOCS3
14871,GO:0060560,0.00427664842781881,0.999156635574253,6,207,developmental growth involved in morphogenesis,BP,TNFRSF12A;SH3GL2;TNR;SPP1;POSTN;RIMS2
3470,GO:0006875,0.00429957909367809,0.998788358847347,9,479,cellular metal ion homeostasis,BP,LTF;CP;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
18996,GO:1901623,0.0043473665985386,0.999875723284547,2,17,regulation of lymphocyte chemotaxis,BP,CCL2;CXCL10
7695,GO:0031102,0.00435510187464114,0.999675573937012,3,49,neuron projection regeneration,BP,TNR;SPP1;ADM
11171,GO:0043269,0.00437006489118652,0.998670050466602,10,559,regulation of ion transport,BP,CCL2;KCNIP3;KCNIP2;LGALS3;JPH3;KCNB1;SHANK2;CXCL10;GRIN1;SHISA7
2642,GO:0005583,0.00439568692778315,0.999878943517842,2,12,fibrillar collagen trimer,CC,COL1A1;COL3A1
17986,GO:0098643,0.00439568692778315,0.999878943517842,2,12,banded collagen fibril,CC,COL1A1;COL3A1
2828,GO:0005887,0.00443750133945545,0.998138846615143,18,1405,integral component of plasma membrane,CC,ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;SNAP25;GPR17;CDHR1;KCNB1;SHANK2;PDPN;GABRB3;PCDH7;GRIN1;CD163;SHISA7;HLA-DQA1;GABBR1
20917,GO:1990138,0.00464906987634223,0.999236632902092,5,146,neuron projection extension,BP,TNFRSF12A;SH3GL2;TNR;POSTN;RIMS2
14048,GO:0051716,0.00469957323132783,0.997429793251854,54,6193,cellular response to stimulus,BP,TNFRSF12A;LTF;TYMP;VIM;FERMT1;TIMP1;SHD;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;GPR17;INA;ADM;SPHKAP;JPH3;KCNB1;SHANK2;PDPN;S100A11;GABRB3;COL3A1;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;HLA-DQA1;SMOC1;GABBR1;IFI30
13085,GO:0048513,0.00470564203016742,0.997622767006842,31,2913,animal organ development,BP,LTF;VIM;CRTAC1;FERMT1;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;LOX;TNR;SPP1;LGALS3;CHI3L1;ANXA1;MDGA2;INA;ADM;CA10;AFF2;SHANK2;PDPN;GABRB3;NNMT;COL3A1;CXCL10;GRIN1;ANXA2;SOCS3;COL4A1;SMOC1
21247,GO:2000145,0.00475509601637523,0.998358570994021,12,741,regulation of cell motility,BP,TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;PLAU;LGALS3;POSTN;ANXA1;PDPN;COL3A1;CXCL10
13540,GO:0050860,0.00477280527813258,0.999856064535833,2,18,negative regulation of T cell receptor signaling pathway,BP,GBP1;LGALS3
3520,GO:0006950,0.00477505002777058,0.997548924459761,33,3332,response to stress,BP,TNFRSF12A;LTF;VIM;TIMP1;SERPINE1;CCL2;COL1A1;LOX;TNR;GBP1;SPP1;PLAU;LGALS3;CHI3L1;POSTN;ANXA1;GPR17;ADM;SERPING1;C1R;PDPN;PTX3;COL3A1;CXCL10;CD163;HLA-DQB1;ANXA2;SOCS3;PLA2G2A;SERPINA3;HLA-DQA1;CFI;IFI30
17199,GO:0090025,0.00482556427121649,0.999853648510434,2,18,regulation of monocyte chemotaxis,BP,SERPINE1;CXCL10
14575,GO:0060142,0.00483298119547295,0.999853307758397,2,18,regulation of syncytium formation by plasma membrane fusion,BP,GDF15;CXCL10
18041,GO:0098772,0.00499176660223278,0.997834192751869,19,1545,molecular function regulator,MF,LTF;TYMP;TIMP1;SERPINE1;CCL2;KCNIP3;SPP1;KCNIP2;GDF15;LGALS3;ANXA1;ADM;SERPING1;ELFN2;CXCL10;GRIN1;ANXA2;SOCS3;SERPINA3
6013,GO:0016722,0.00507258642995156,0.999844000591765,2,16,oxidoreductase activity, oxidizing metal ions,MF,CP;STEAP3
4651,GO:0009967,0.0051057628128499,0.997828116327181,18,1428,positive regulation of signal transduction,BP,TNFRSF12A;LTF;FERMT1;SHD;CCL2;COL1A1;CUX2;GDF15;CHI3L1;GPR17;SHANK2;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SOCS3;PLA2G2A
9065,GO:0033627,0.00514010523878768,0.999592735194257,3,52,cell adhesion mediated by integrin,BP,FERMT1;SERPINE1;PLAU
3434,GO:0006812,0.00515694921945071,0.998044362055132,14,976,cation transport,BP,CP;CCL2;KCNIP3;STEAP3;SLC8A2;KCNIP2;LGALS3;JPH3;KCNB1;SHANK2;CXCL10;GRIN1;SHISA7;FAM155A
9904,GO:0035684,0.00516713274877249,1,1,1,helper T cell extravasation,BP,CCL2
9831,GO:0035580,0.0051903153103965,0.999585436134243,3,59,specific granule lumen,CC,LTF;CHI3L1;PTX3
14542,GO:0060080,0.00521394180366741,0.999838528730142,2,15,inhibitory postsynaptic potential,BP,GABRB3;RIMS2
9083,GO:0033676,0.00522599661366467,1,1,1,double-stranded DNA-dependent ATPase activity,MF,ANXA1
8017,GO:0031700,0.00523219605779114,1,1,1,adrenomedullin receptor binding,MF,ADM
3900,GO:0008112,0.00525391219968502,1,1,1,nicotinamide N-methyltransferase activity,MF,NNMT
7498,GO:0030760,0.00525391219968502,1,1,1,pyridine N-methyltransferase activity,MF,NNMT
13170,GO:0048673,0.00525520705789035,1,1,1,collateral sprouting of intact axon in response to injury,BP,SPP1
13179,GO:0048683,0.00525520705789035,1,1,1,regulation of collateral sprouting of intact axon in response to injury,BP,SPP1
13180,GO:0048685,0.00525520705789035,1,1,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,SPP1
11477,GO:0044035,0.00526568446060697,1,1,1,multi-organism catabolic process,BP,ANXA2
11504,GO:0044115,0.00526568446060697,1,1,1,development of symbiont involved in interaction with host,BP,ANXA2
11514,GO:0044145,0.00526568446060697,1,1,1,modulation of development of symbiont involved in interaction with host,BP,ANXA2
11516,GO:0044147,0.00526568446060697,1,1,1,negative regulation of development of symbiont involved in interaction with host,BP,ANXA2
11737,GO:0044730,0.00526568446060697,1,1,1,bone sialoprotein binding,MF,ANXA2
14241,GO:0052214,0.00526568446060697,1,1,1,metabolism of substance in other organism involved in symbiotic interaction,BP,ANXA2
14242,GO:0052227,0.00526568446060697,1,1,1,catabolism of substance in other organism involved in symbiotic interaction,BP,ANXA2
14243,GO:0052229,0.00526568446060697,1,1,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,ANXA2
14257,GO:0052360,0.00526568446060697,1,1,1,catabolism by host of symbiont macromolecule,BP,ANXA2
14258,GO:0052361,0.00526568446060697,1,1,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,ANXA2
14259,GO:0052362,0.00526568446060697,1,1,1,catabolism by host of symbiont protein,BP,ANXA2
14260,GO:0052363,0.00526568446060697,1,1,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,ANXA2
14261,GO:0052364,0.00526568446060697,1,1,1,catabolism by host of substance in symbiont,BP,ANXA2
14266,GO:0052416,0.00526568446060697,1,1,1,metabolism by host of symbiont macromolecule,BP,ANXA2
14267,GO:0052417,0.00526568446060697,1,1,1,metabolism by host of symbiont protein,BP,ANXA2
14268,GO:0052418,0.00526568446060697,1,1,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,ANXA2
14269,GO:0052419,0.00526568446060697,1,1,1,metabolism by host of substance in symbiont,BP,ANXA2
20754,GO:1905581,0.00526568446060697,1,1,1,positive regulation of low-density lipoprotein particle clearance,BP,ANXA2
20760,GO:1905597,0.00526568446060697,1,1,1,positive regulation of low-density lipoprotein particle receptor binding,BP,ANXA2
20762,GO:1905599,0.00526568446060697,1,1,1,positive regulation of low-density lipoprotein receptor activity,BP,ANXA2
4297,GO:0009032,0.00527042263017907,1,1,1,thymidine phosphorylase activity,MF,TYMP
5732,GO:0016154,0.00527042263017907,1,1,1,pyrimidine-nucleoside phosphorylase activity,MF,TYMP
11122,GO:0043200,0.00531641257196825,0.999321024989006,4,105,response to amino acid,BP,COL1A1;COL3A1;GRIN1;COL4A1
709,GO:0001872,0.00533618538458916,1,1,1,(1->3)-beta-D-glucan binding,MF,PTX3
11794,GO:0044866,0.00533618538458916,1,1,1,modulation by host of viral exo-alpha-sialidase activity,BP,PTX3
11795,GO:0044867,0.00533618538458916,1,1,1,modulation by host of viral catalytic activity,BP,PTX3
11797,GO:0044869,0.00533618538458916,1,1,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,PTX3
11798,GO:0044870,0.00533618538458916,1,1,1,modulation by host of viral glycoprotein metabolic process,BP,PTX3
11799,GO:0044871,0.00533618538458916,1,1,1,negative regulation by host of viral glycoprotein metabolic process,BP,PTX3
14264,GO:0052403,0.00533618538458916,1,1,1,negative regulation by host of symbiont catalytic activity,BP,PTX3
19534,GO:1903016,0.00533618538458916,1,1,1,negative regulation of exo-alpha-sialidase activity,BP,PTX3
10286,GO:0036458,0.00541818486680586,1,1,1,hepatocyte growth factor binding,MF,SRPX2
13503,GO:0050803,0.00545086794758924,0.999069170612976,5,160,regulation of synapse structure or activity,BP,SRPX2;CUX2;GRIN1;SLITRK1;SHISA7
4037,GO:0008328,0.0054594854960624,0.99955901276678,3,49,ionotropic glutamate receptor complex,CC,SHANK2;GRIN1;SHISA7
8917,GO:0033212,0.00548719514175464,1,1,1,iron assimilation,BP,LTF
8918,GO:0033214,0.00548719514175464,1,1,1,iron assimilation by chelation and transport,BP,LTF
10873,GO:0042710,0.00548719514175464,1,1,1,biofilm formation,BP,LTF
11469,GO:0044010,0.00548719514175464,1,1,1,single-species biofilm formation,BP,LTF
11637,GO:0044407,0.00548719514175464,1,1,1,single-species biofilm formation in or on host organism,BP,LTF
18660,GO:1900159,0.00548719514175464,1,1,1,positive regulation of bone mineralization involved in bone maturation,BP,LTF
18675,GO:1900190,0.00548719514175464,1,1,1,regulation of single-species biofilm formation,BP,LTF
18676,GO:1900191,0.00548719514175464,1,1,1,negative regulation of single-species biofilm formation,BP,LTF
18699,GO:1900228,0.00548719514175464,1,1,1,regulation of single-species biofilm formation in or on host organism,BP,LTF
18700,GO:1900229,0.00548719514175464,1,1,1,negative regulation of single-species biofilm formation in or on host organism,BP,LTF
21338,GO:2000308,0.00548719514175464,1,1,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
601,GO:0001726,0.00550165449409138,0.999058723453667,5,157,ruffle,CC,TNFRSF12A;FERMT1;PDPN;S100A11;ANXA2
12951,GO:0048172,0.00551993267157231,0.99982395422853,2,15,regulation of short-term neuronal synaptic plasticity,BP,SLC8A2;SHISA7
15600,GO:0070098,0.0055545301482813,0.999544443790994,3,63,chemokine-mediated signaling pathway,BP,CCL2;GPR17;CXCL10
19548,GO:1903037,0.0056198990831245,0.998824193351635,6,261,regulation of leukocyte cell-cell adhesion,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1;HLA-DQA1
15497,GO:0061851,0.00565573394410298,1,1,1,leading edge of lamellipodium,CC,PDPN
20167,GO:1904328,0.00565573394410298,1,1,1,regulation of myofibroblast contraction,BP,PDPN
21090,GO:1990764,0.00565573394410298,1,1,1,myofibroblast contraction,BP,PDPN
13088,GO:0048518,0.00565948115632564,0.996894739234687,46,5067,positive regulation of biological process,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SRPX2;SHD;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;TNR;GBP1;SLC8A2;SPP1;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;ANXA1;GPR17;ADAM12;ADM;SERPING1;KCNB1;C1R;SHANK2;PDPN;PTX3;COL3A1;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;SLITRK1;HLA-DQB1;ANXA2;SOCS3;SHISA7;PLA2G2A;HLA-DQA1;CFI
18184,GO:0099050,0.00566128576137726,1,1,1,vesicle scission,BP,SH3GL2
13125,GO:0048589,0.00567331720579375,0.998207532766957,10,545,developmental growth,BP,TNFRSF12A;SH3GL2;TNR;SPP1;POSTN;ANXA1;ADM;SHANK2;RIMS2;SLITRK1
5017,GO:0010876,0.00572605470280552,0.998614891204938,7,317,lipid localization,BP,APOL4;ABCC3;SPP1;ANXA1;VSTM2A;ANXA2;PLA2G2A
13550,GO:0050870,0.00572618774322357,0.999008296963605,5,187,positive regulation of T cell activation,BP,CCL2;IGFBP2;ANXA1;HLA-DQB1;HLA-DQA1
7995,GO:0031667,0.00573916187225035,0.998449551556361,8,422,response to nutrient levels,BP,COL1A1;IGFBP2;SPP1;POSTN;ADM;KCNB1;CXCL10;GRIN1
13360,GO:0050482,0.00574595051064841,0.999808412391103,2,19,arachidonic acid secretion,BP,ANXA1;PLA2G2A
20004,GO:1903963,0.00574595051064841,0.999808412391103,2,19,arachidonate transport,BP,ANXA1;PLA2G2A
8342,GO:0032355,0.00576956871411994,0.999244448229332,4,115,response to estradiol,BP,COL1A1;IGFBP2;POSTN;ANXA1
7758,GO:0031252,0.00576978585973363,0.998441759017084,8,367,cell leading edge,CC,TNFRSF12A;VIM;FERMT1;KCNB1;PDPN;S100A11;ANXA2;SHISA7
7974,GO:0031639,0.00580620195647513,0.99980450902113,2,20,plasminogen activation,BP,SERPINE1;PLAU
7067,GO:0022839,0.00587075874387072,0.998573567068084,7,311,ion gated channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRB3;GRIN1;FAM155A
1273,GO:0002790,0.0059115618816913,0.998249177936713,9,508,peptide secretion,BP,FERMT1;STEAP3;GBP1;SNAP25;CHI3L1;POSTN;ANXA1;KCNB1;RIMS2
13164,GO:0048667,0.00591677084206686,0.998119320842391,10,538,cell morphogenesis involved in neuron differentiation,BP,TNFRSF12A;CUX2;TNR;SPP1;FMOD;CDHR1;SHANK2;GRIN1;SLITRK1;DOK6
10831,GO:0042611,0.00592211894712061,0.99979705547651,2,22,MHC protein complex,CC,HLA-DQB1;HLA-DQA1
18103,GO:0098878,0.00593401136817891,0.999505303380021,3,51,neurotransmitter receptor complex,CC,SHANK2;GRIN1;SHISA7
9772,GO:0035490,0.00594055189356507,1,1,1,regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
9773,GO:0035491,0.00594055189356507,1,1,1,positive regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
15153,GO:0061044,0.00594055189356507,1,1,1,negative regulation of vascular wound healing,BP,SERPINE1
18901,GO:1901331,0.00594055189356507,1,1,1,positive regulation of odontoblast differentiation,BP,SERPINE1
19476,GO:1902913,0.00594055189356507,1,1,1,positive regulation of neuroepithelial cell differentiation,BP,SERPINE1
3924,GO:0008150,0.00595122957702996,0.999305402649304,99,14380,biological_process,BP,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;MOXD1;CRTAC1;APOL4;FERMT1;TIMP1;SRPX2;SHD;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;EMILIN2;SNAP25;CHI3L1;POSTN;SPOCD1;COL4A2;ANXA1;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;CA10;AFF2;KCNB1;C1R;SHANK2;PDPN;S100A11;PTX3;FABP5;CSMD3;SVOP;GABRB3;NNMT;ELFN2;ATCAY;COL3A1;CXCL10;PCDH7;VSTM2A;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;SMOC1;FAM155A;GABBR1;CFI;C21ORF62;DOK6;IFI30
14966,GO:0060713,0.00597955492175995,0.999796483510765,2,19,labyrinthine layer morphogenesis,BP,ADM;SOCS3
14111,GO:0051851,0.0060395578446949,0.99949032406312,3,60,modification by host of symbiont morphology or physiology,BP,LTF;PTX3;ANXA2
766,GO:0001952,0.00607537413793126,0.999195476734973,4,98,regulation of cell-matrix adhesion,BP,FERMT1;SERPINE1;PLAU;POSTN
7065,GO:0022836,0.00611741693732946,0.998502070037254,7,314,gated channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRB3;GRIN1;FAM155A
5085,GO:0010959,0.00611961729509603,0.998500922365129,7,325,regulation of metal ion transport,BP,CCL2;KCNIP3;KCNIP2;LGALS3;JPH3;CXCL10;GRIN1
14541,GO:0060079,0.00620049532766006,0.999172834418672,4,105,excitatory postsynaptic potential,BP,CUX2;SHANK2;RIMS2;GRIN1
8549,GO:0032637,0.00621854022225555,0.999469383510386,3,61,interleukin-8 production,BP,SERPINE1;CHI3L1;ANXA1
17215,GO:0090050,0.00636108057424128,0.999777561740899,2,18,positive regulation of cell migration involved in sprouting angiogenesis,BP,SRPX2;ANXA1
2484,GO:0005198,0.00642131393813399,0.997932977324948,10,596,structural molecule activity,MF,VIM;COL1A1;EMILIN2;CHI3L1;COL4A2;ANXA1;INA;SHANK2;COL3A1;COL4A1
10827,GO:0042605,0.00642943936496932,0.999770936768103,2,21,peptide antigen binding,MF,HLA-DQB1;HLA-DQA1
2286,GO:0004867,0.00644185469213529,0.999443291529005,3,61,serine-type endopeptidase inhibitor activity,MF,SERPINE1;SERPING1;SERPINA3
7105,GO:0030001,0.00645203207585429,0.997682645882083,12,781,metal ion transport,BP,CP;CCL2;KCNIP3;STEAP3;SLC8A2;KCNIP2;LGALS3;JPH3;KCNB1;CXCL10;GRIN1;FAM155A
11983,GO:0045334,0.00646759723645323,0.999441198639577,3,58,clathrin-coated endocytic vesicle,CC,SH3GL2;HLA-DQB1;HLA-DQA1
10114,GO:0036035,0.00655877846284023,0.999768268869343,2,17,osteoclast development,BP,LTF;ANXA2
18632,GO:1900120,0.00663546103213126,0.999760651929673,2,20,regulation of receptor binding,BP,CRTAC1;ANXA2
7745,GO:0031226,0.00670720218315075,0.997066362587586,18,1460,intrinsic component of plasma membrane,CC,ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;SNAP25;GPR17;CDHR1;KCNB1;SHANK2;PDPN;GABRB3;PCDH7;GRIN1;CD163;SHISA7;HLA-DQA1;GABBR1
7516,GO:0030814,0.00672078585117381,0.999410230860796,3,61,regulation of cAMP metabolic process,BP,ADM;CXCL10;GABBR1
11934,GO:0045211,0.00673062094281788,0.998539886522517,6,233,postsynaptic membrane,CC,KCNB1;SHANK2;GABRB3;GRIN1;SHISA7;GABBR1
13478,GO:0050770,0.00685334460917257,0.998763725314621,5,162,regulation of axonogenesis,BP,TNFRSF12A;TNR;SPP1;GRIN1;SLITRK1
6389,GO:0018964,0.00692062476162535,1,1,1,propylene metabolic process,BP,GRIN1
5078,GO:0010951,0.00698989264916115,0.99873020906137,5,189,negative regulation of endopeptidase activity,BP,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
13555,GO:0050878,0.00699055272895065,0.998046973900008,8,426,regulation of body fluid levels,BP,SERPINE1;COL1A1;PLAU;ADM;SERPING1;PDPN;COL3A1;ANXA2
5674,GO:0016043,0.00708512185256521,0.996028975031424,50,5585,cellular component organization,BP,TNFRSF12A;TYMP;VIM;SNAP91;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;LOX;IGFBP2;TNR;GBP1;SPP1;KCNIP2;FMOD;GDF15;LGALS3;SNAP25;POSTN;COL4A2;ANXA1;COL6A2;EMP3;CDHR1;INA;ADAM12;ADM;AFF2;KCNB1;SHANK2;PDPN;PTX3;CSMD3;ATCAY;COL3A1;CXCL10;RIMS2;GRIN1;SLITRK1;ANXA2;COL4A1;SHISA7;RTP5;PLA2G2A;DOK6
13538,GO:0050858,0.00710436199853222,0.999732548400578,2,22,negative regulation of antigen receptor-mediated signaling pathway,BP,GBP1;LGALS3
19550,GO:1903039,0.00711842372360128,0.998700558589733,5,196,positive regulation of leukocyte cell-cell adhesion,BP,CCL2;IGFBP2;ANXA1;HLA-DQB1;HLA-DQA1
13089,GO:0048519,0.0071460057414356,0.996057183743792,42,4564,negative regulation of biological process,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SPP1;PLAU;LGALS3;POSTN;SPOCD1;COL4A2;ANXA1;EMP3;GPR17;ADM;SERPING1;JPH3;AFF2;KCNB1;SHANK2;PDPN;S100A11;PTX3;GABRB3;ELFN2;ATCAY;COL3A1;CXCL10;GRIN1;ANXA2;SOCS3;SERPINA3;GABBR1
6243,GO:0017156,0.00723029164134926,0.998991273030647,4,110,calcium ion regulated exocytosis,BP,SNAP25;CPLX2;KCNB1;RIMS2
11759,GO:0044788,0.00736607530763341,0.999719549335673,2,20,modulation by host of viral process,BP,LTF;PTX3
162,GO:0000323,0.00738314199538484,0.997573171463071,10,633,lytic vacuole,CC,CP;FMOD;ANXA1;CPLX2;FABP5;HLA-DQB1;ANXA2;SERPINA3;HLA-DQA1;IFI30
2746,GO:0005764,0.00738314199538484,0.997573171463071,10,633,lysosome,CC,CP;FMOD;ANXA1;CPLX2;FABP5;HLA-DQB1;ANXA2;SERPINA3;HLA-DQA1;IFI30
2912,GO:0006026,0.00738534661513012,0.999329788420021,3,60,aminoglycan catabolic process,BP,CHI3L2;FMOD;CHI3L1
14037,GO:0051702,0.00743217090672557,0.999322610352032,3,64,interaction with symbiont,BP,LTF;PTX3;ANXA2
21283,GO:2000212,0.00769726348921143,1,1,1,negative regulation of glutamate metabolic process,BP,ATCAY
16893,GO:0072376,0.00770314176104859,0.99928776862746,3,67,protein activation cascade,BP,SERPING1;C1R;CFI
3667,GO:0007204,0.00773960177296804,0.998269074897613,6,257,positive regulation of cytosolic calcium ion concentration,BP,GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
12187,GO:0045785,0.00777044355157384,0.998007895597328,7,353,positive regulation of cell adhesion,BP,FERMT1;CCL2;IGFBP2;ANXA1;PDPN;HLA-DQB1;HLA-DQA1
3962,GO:0008209,0.00777753269012117,0.999694239057029,2,21,androgen metabolic process,BP,SPP1;ADM
21100,GO:1990778,0.00778059212304399,0.998258432351463,6,251,protein localization to cell periphery,BP,KCNIP3;GBP1;SNAP25;KCNB1;GRIN1;ANXA2
14440,GO:0055080,0.00778223422434861,0.997422303146735,10,620,cation homeostasis,BP,LTF;CP;STEAP3;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
14129,GO:0051886,0.00782073190655957,1,1,1,negative regulation of timing of anagen,BP,FERMT1
21822,GO:2001203,0.00782073190655957,1,1,1,positive regulation of transforming growth factor-beta secretion,BP,FERMT1
3442,GO:0006825,0.00786958209833135,0.999689940051963,2,20,copper ion transport,BP,CP;STEAP3
13187,GO:0048692,0.00787110889411273,1,1,1,negative regulation of axon extension involved in regeneration,BP,TNR
18804,GO:1901071,0.00790423103919421,0.999685538880924,2,22,glucosamine-containing compound metabolic process,BP,CHI3L2;CHI3L1
16378,GO:0071495,0.007968412785277,0.996619302792924,16,1217,cellular response to endogenous stimulus,BP,FERMT1;SH3GL2;CCL2;COL1A1;IGFBP2;SPP1;FMOD;GDF15;POSTN;COL4A2;ANXA1;GABRB3;COL3A1;VSTM2A;SOCS3;COL4A1
18054,GO:0098796,0.00808677826427518,0.996764121021884,14,1052,membrane protein complex,CC,LTF;KCNIP3;KCNIP2;SNAP25;GNAL;CPLX2;KCNB1;SHANK2;GABRB3;GRIN1;HLA-DQB1;SHISA7;HLA-DQA1;GABBR1
5274,GO:0014910,0.00809266742655761,0.999243083264351,3,55,regulation of smooth muscle cell migration,BP,SERPINE1;PLAU;POSTN
10841,GO:0042629,0.00812607776675958,0.999673194399376,2,21,mast cell granule,CC,ANXA1;CPLX2
1078,GO:0002460,0.00814438302470573,0.998463871751658,5,200,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ANXA1;SERPING1;C1R;HLA-DQB1;CFI
13543,GO:0050863,0.00820694174932686,0.998139834167651,6,283,regulation of T cell activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1;HLA-DQA1
3653,GO:0007187,0.00821630320625048,0.99844731373514,5,197,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,CCL2;ANXA1;GNAL;ADM;GABBR1
2645,GO:0005586,0.00821675480818502,1,1,1,collagen type III trimer,CC,COL3A1
14183,GO:0051965,0.00827947013095243,0.99921726575771,3,59,positive regulation of synapse assembly,BP,SRPX2;CUX2;SLITRK1
4659,GO:0009991,0.00832405626816214,0.997602613939332,8,450,response to extracellular stimulus,BP,COL1A1;IGFBP2;SPP1;POSTN;ADM;KCNB1;CXCL10;GRIN1
6133,GO:0016917,0.00839767319964177,0.999657798870855,2,20,GABA receptor activity,MF,GABRB3;GABBR1
7221,GO:0030194,0.00840390563646087,0.999653757408399,2,23,positive regulation of blood coagulation,BP,SERPINE1;PDPN
18593,GO:1900048,0.00840390563646087,0.999653757408399,2,23,positive regulation of hemostasis,BP,SERPINE1;PDPN
4762,GO:0010466,0.00843855978224706,0.998395090308806,5,196,negative regulation of peptidase activity,BP,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
16411,GO:0071556,0.00844665934273693,0.999649123642558,2,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,HLA-DQB1;HLA-DQA1
17943,GO:0098553,0.00844665934273693,0.999649123642558,2,25,lumenal side of endoplasmic reticulum membrane,CC,HLA-DQB1;HLA-DQA1
13547,GO:0050867,0.00853971945743536,0.998047936658856,6,285,positive regulation of cell activation,BP,CCL2;IGFBP2;ANXA1;PDPN;HLA-DQB1;HLA-DQA1
16202,GO:0071230,0.00861278975964302,0.999173078802535,3,61,cellular response to amino acid stimulus,BP,COL1A1;COL3A1;COL4A1
19371,GO:1902618,0.00867473638825879,1,1,1,cellular response to fluoride,BP,COL1A1
16459,GO:0071625,0.00880089381240071,0.999637869798067,2,17,vocalization behavior,BP,SRPX2;SHANK2
10505,GO:0040012,0.00882287738640752,0.996697169657811,12,805,regulation of locomotion,BP,TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;PLAU;LGALS3;POSTN;ANXA1;PDPN;COL3A1;CXCL10
16519,GO:0071711,0.00882353301112501,0.999632685555211,2,19,basement membrane organization,BP,FERMT1;COL4A1
18040,GO:0098771,0.00883273440434029,0.997018354233361,10,631,inorganic ion homeostasis,BP,LTF;CP;STEAP3;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
1873,GO:0004252,0.00886306887495748,0.998683565178251,4,138,serine-type endopeptidase activity,MF,LTF;PLAU;C1R;CFI
18561,GO:0150034,0.00890279073213336,0.997949300802835,6,255,distal axon,CC,CRTAC1;KCNIP3;SNAP25;CPLX2;SHANK2;GRIN1
13175,GO:0048679,0.00894942430509363,0.999620260917659,2,22,regulation of axon regeneration,BP,TNR;SPP1
7686,GO:0031090,0.00918590661617379,0.995270737002836,27,2684,organelle membrane,CC,LTF;CP;MOXD1;SH3GL2;CUX2;STEAP3;GBP1;PLAU;LGALS3;SNAP25;ANXA1;GALNT13;CDHR1;INA;JPH3;SHANK2;FABP5;SVOP;GABRB3;ATCAY;PCDH7;FUT9;ST8SIA3;CD163;HLA-DQB1;ANXA2;HLA-DQA1
3629,GO:0007159,0.00928767687163666,0.997838443632696,6,290,leukocyte cell-cell adhesion,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1;HLA-DQA1
13990,GO:0051604,0.0092928601095787,0.997837273804904,6,286,protein maturation,BP,SERPINE1;AEBP1;PLAU;SERPING1;C1R;CFI
11597,GO:0044325,0.00936271732419089,0.998591552012742,4,116,ion channel binding,MF,KCNIP3;KCNIP2;KCNB1;RIMS2
14930,GO:0060669,0.00942450924040374,0.999587893360755,2,23,embryonic placenta morphogenesis,BP,ADM;SOCS3
12197,GO:0045807,0.00943712232621257,0.998575529211075,4,123,positive regulation of endocytosis,BP,SERPINE1;CCL2;PTX3;ANXA2
13517,GO:0050820,0.0094685509089036,0.999583752996769,2,24,positive regulation of coagulation,BP,SERPINE1;PDPN
3511,GO:0006935,0.00952182521687893,0.996957657921598,9,530,chemotaxis,BP,TYMP;SERPINE1;CCL2;TNR;PLAU;LGALS3;ANXA1;CXCL10;DOK6
10683,GO:0042330,0.00960773490948857,0.996925726527411,9,531,taxis,BP,TYMP;SERPINE1;CCL2;TNR;PLAU;LGALS3;ANXA1;CXCL10;DOK6
9578,GO:0035025,0.00965158735002879,0.99957270567015,2,23,positive regulation of Rho protein signal transduction,BP,GPR17;COL3A1
13003,GO:0048278,0.00978966284220569,0.99901149204604,3,69,vesicle docking,BP,SNAP25;CPLX2;KCNB1
565,GO:0001664,0.00982583972933833,0.998058950500324,5,212,G-protein coupled receptor binding,MF,CCL2;GNAL;ADM;CXCL10;RTP5
17994,GO:0098655,0.00985161176948925,0.996428110098083,11,727,cation transmembrane transport,BP,KCNIP3;STEAP3;SLC8A2;KCNIP2;JPH3;KCNB1;SHANK2;CXCL10;GRIN1;SHISA7;FAM155A
11495,GO:0044092,0.00986527420420833,0.996095583441048,13,967,negative regulation of molecular function,BP,LTF;CRTAC1;TIMP1;SERPINE1;SPOCD1;ANXA1;SERPING1;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3;GABBR1
20871,GO:1905954,0.00992517691830782,0.998994041225937,3,66,positive regulation of lipid localization,BP,SPP1;VSTM2A;ANXA2
1186,GO:0002673,0.0100255770399689,0.998977254418941,3,73,regulation of acute inflammatory response,BP,SERPING1;C1R;CFI
7182,GO:0030139,0.01002801663871,0.997628846744325,6,276,endocytic vesicle,CC,LTF;VIM;SH3GL2;CD163;HLA-DQB1;HLA-DQA1
19037,GO:1901700,0.0100556229783342,0.995510952728286,17,1422,response to oxygen-containing compound,BP,LTF;TIMP1;SERPINE1;CCL2;COL1A1;IGFBP2;SPP1;POSTN;ANXA1;COL6A2;ADM;KCNB1;COL3A1;CXCL10;GRIN1;SOCS3;COL4A1
18051,GO:0098793,0.0101343829919576,0.997267020516694,7,357,presynapse,CC,KCNIP3;SNAP25;CPLX2;SVOP;RIMS2;GRIN1;GABBR1
15757,GO:0070352,0.0103459446380906,0.999973370354882,1,2,positive regulation of white fat cell proliferation,BP,VSTM2A
13811,GO:0051270,0.010346128996971,0.996043171301377,12,813,regulation of cellular component movement,BP,TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;PLAU;LGALS3;POSTN;ANXA1;PDPN;COL3A1;CXCL10
6713,GO:0019933,0.0103797629902665,0.998388744761705,4,126,cAMP-mediated signaling,BP,GNAL;ADM;CXCL10;RIMS2
21471,GO:2000502,0.0103945346782095,0.999973118968849,1,2,negative regulation of natural killer cell chemotaxis,BP,CCL2
7518,GO:0030816,0.0104366678535833,0.999514877341222,2,26,positive regulation of cAMP metabolic process,BP,ADM;CXCL10
5232,GO:0014839,0.0105118756392286,0.999972506996504,1,2,myoblast migration involved in skeletal muscle regeneration,BP,ANXA1
19050,GO:1901740,0.0105126229930054,0.999972503076612,1,2,negative regulation of myoblast fusion,BP,CXCL10
12683,GO:0046879,0.0105141937053337,0.997488494672178,6,277,hormone secretion,BP,SPP1;SNAP25;ANXA1;ADM;KCNB1;RIMS2
19533,GO:1903015,0.010583612180503,0.999972129455546,1,2,regulation of exo-alpha-sialidase activity,BP,PTX3
14270,GO:0052422,0.0105970637979228,0.999972058373073,1,2,modulation by host of symbiont catalytic activity,BP,PTX3
21484,GO:2000521,0.0106642689837583,0.99997170187689,1,2,negative regulation of immunological synapse formation,BP,LGALS3
3637,GO:0007167,0.0106865540316622,0.995727667018756,13,929,enzyme linked receptor protein signaling pathway,BP,VIM;FERMT1;SH3GL2;COL1A1;IGFBP2;FMOD;GDF15;COL4A2;COL3A1;GRIN1;SOCS3;COL4A1;PTPRT
7107,GO:0030003,0.010730945890442,0.996503428643316,9,554,cellular cation homeostasis,BP,LTF;CP;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
16997,GO:0072606,0.0107631593509242,0.999491605948227,2,26,interleukin-8 secretion,BP,CHI3L1;ANXA1
14153,GO:0051924,0.0108430154683651,0.997807226808986,5,201,regulation of calcium ion transport,BP,CCL2;LGALS3;JPH3;CXCL10;GRIN1
13505,GO:0050805,0.0109333403941948,0.998851884230953,3,66,negative regulation of synaptic transmission,BP,TNR;KCNB1;SHANK2
17846,GO:0097553,0.0109515445191258,0.998275941944813,4,116,calcium ion transmembrane import into cytosol,BP,JPH3;CXCL10;GRIN1;FAM155A
7465,GO:0030667,0.0109553500051516,0.997359479240802,6,282,secretory granule membrane,CC,MOXD1;PLAU;LGALS3;SNAP25;FABP5;PCDH7
14234,GO:0052199,0.0109849453781415,0.9999699695277,1,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,PTX3
20765,GO:1905602,0.0110212215866469,0.999969770299117,1,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
21220,GO:2000098,0.0111027765874106,0.999969319981273,1,2,negative regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1
5273,GO:0014909,0.0111445465720636,0.998823097257173,3,63,smooth muscle cell migration,BP,SERPINE1;PLAU;POSTN
3469,GO:0006874,0.0111691557787311,0.996930504717297,7,366,cellular calcium ion homeostasis,BP,SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
6196,GO:0017075,0.0112220161554225,0.999464287408666,2,22,syntaxin-1 binding,MF,SNAP25;CPLX2
2823,GO:0005882,0.0112330130353243,0.998806199340318,3,71,intermediate filament,CC,VIM;INA;SHANK2
5818,GO:0016323,0.0113100912948702,0.997690016467173,5,194,basolateral plasma membrane,CC,ABCC3;SLC8A2;ANXA1;PDPN;ANXA2
19048,GO:1901731,0.0113106766321525,0.999968156882768,1,2,positive regulation of platelet aggregation,BP,PDPN
3675,GO:0007214,0.0113627706628611,0.999452288441724,2,23,gamma-aminobutyric acid signaling pathway,BP,GABRB3;GABBR1
20060,GO:1904062,0.0113831158940942,0.997234491536646,6,274,regulation of cation transmembrane transport,BP,KCNIP3;KCNIP2;JPH3;SHANK2;CXCL10;SHISA7
16950,GO:0072535,0.0113867876258163,0.99996772563686,1,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
21337,GO:2000307,0.0113867876258163,0.99996772563686,1,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
20108,GO:1904207,0.011400106734445,0.999967649870677,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
20109,GO:1904209,0.011400106734445,0.999967649870677,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
9880,GO:0035640,0.0114184728757628,0.999448196458769,2,23,exploration behavior,BP,TNR;JPH3
1122,GO:0002538,0.0114797183664672,0.999967195134196,1,2,arachidonic acid metabolite production involved in inflammatory response,BP,SERPINE1
1123,GO:0002540,0.0114797183664672,0.999967195134196,1,2,leukotriene production involved in inflammatory response,BP,SERPINE1
4025,GO:0008306,0.0114976876264975,0.998769559395239,3,67,associative learning,BP,TNR;SNAP25;GRIN1
16244,GO:0071307,0.0115029020204508,0.999967062110481,1,2,cellular response to vitamin K,BP,POSTN
2017,GO:0004500,0.0115074323246959,0.999967036084773,1,2,dopamine beta-monooxygenase activity,MF,MOXD1
3281,GO:0006589,0.0115074323246959,0.999967036084773,1,2,octopamine biosynthetic process,BP,MOXD1
12433,GO:0046333,0.0115074323246959,0.999967036084773,1,2,octopamine metabolic process,BP,MOXD1
20758,GO:1905595,0.0115608491671726,0.999966728435888,1,2,regulation of low-density lipoprotein particle receptor binding,BP,ANXA2
21055,GO:1990667,0.0115608491671726,0.999966728435888,1,2,PCSK9-AnxA2 complex,CC,ANXA2
10216,GO:0036292,0.0115792072386211,0.999966622372551,1,2,DNA rewinding,BP,ANXA1
13665,GO:0051050,0.0116834315718795,0.995456260606361,12,862,positive regulation of transport,BP,FERMT1;SERPINE1;CCL2;SPP1;LGALS3;POSTN;ANXA1;KCNB1;PTX3;CXCL10;GRIN1;ANXA2
13092,GO:0048522,0.011754810766674,0.993297813791453,41,4532,positive regulation of cellular process,BP,TNFRSF12A;LTF;VIM;FERMT1;TIMP1;SRPX2;SHD;SERPINE1;CCL2;COL1A1;CUX2;IGFBP2;TNR;SLC8A2;SPP1;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;ANXA1;GPR17;ADM;KCNB1;SHANK2;PDPN;PTX3;COL3A1;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;SLITRK1;HLA-DQB1;ANXA2;SOCS3;SHISA7;PLA2G2A;HLA-DQA1
462,GO:0001300,0.0118277744191957,0.999965169566814,1,2,chronological cell aging,BP,SERPINE1
4622,GO:0009888,0.0119097370085034,0.994357750409693,19,1618,tissue development,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;COL1A1;SPP1;LGALS3;CHI3L1;POSTN;COL4A2;ANXA1;ADM;PDPN;FABP5;COL3A1;CXCL10;SOCS3;COL4A1
11426,GO:0043901,0.0119617508724261,0.99806060092623,4,144,negative regulation of multi-organism process,BP,LTF;TIMP1;PTX3;ANXA2
17812,GO:0097493,0.0120400328480444,0.999416646438502,2,17,structural molecule activity conferring elasticity,MF,EMILIN2;COL4A1
8665,GO:0032804,0.0120658647745889,0.999963748798169,1,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,ANXA2
17918,GO:0097753,0.0120929754610723,0.999963585207009,1,2,membrane bending,BP,SH3GL2
8320,GO:0032309,0.0121348402290245,0.99938713275879,2,28,icosanoid secretion,BP,ANXA1;PLA2G2A
4635,GO:0009914,0.0121723938957216,0.99699830445316,6,287,hormone transport,BP,SPP1;SNAP25;ANXA1;ADM;KCNB1;RIMS2
18658,GO:1900157,0.0122282626574482,0.999962763318954,1,2,regulation of bone mineralization involved in bone maturation,BP,LTF
3468,GO:0006873,0.0122339253652152,0.995927075220685,9,565,cellular ion homeostasis,BP,LTF;CP;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
20688,GO:1905429,0.0122623424310449,0.999962554824435,1,2,response to glycine,BP,GRIN1
15844,GO:0070509,0.0122771833899337,0.998655218716416,3,65,calcium ion import,BP,CCL2;LGALS3;FAM155A
13925,GO:0051480,0.0122869764713832,0.996964215888127,6,284,regulation of cytosolic calcium ion concentration,BP,GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
21712,GO:2000866,0.0123231311549661,0.999962181474722,1,2,positive regulation of estradiol secretion,BP,SPP1
18506,GO:0140029,0.0124237206224317,0.998627366135575,3,76,exocytic process,BP,SNAP25;CPLX2;KCNB1
7263,GO:0030246,0.0124586435166634,0.997389689965468,5,223,carbohydrate binding,MF,CHI3L2;LGALS3;CHI3L1;GALNT13;PTX3
11273,GO:0043449,0.0124791287757554,0.999961214846302,1,2,cellular alkene metabolic process,BP,GRIN1
15884,GO:0070570,0.0125657980955911,0.999356472547179,2,26,regulation of neuron projection regeneration,BP,TNR;SPP1
706,GO:0001868,0.0126133631918429,0.999960373245228,1,2,regulation of complement activation, lectin pathway,BP,SERPING1
707,GO:0001869,0.0126133631918429,0.999960373245228,1,2,negative regulation of complement activation, lectin pathway,BP,SERPING1
15872,GO:0070554,0.0127036169374057,0.999959802275503,1,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,CPLX2
14435,GO:0055074,0.0127521501547312,0.996403564744949,7,376,calcium ion homeostasis,BP,SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
3846,GO:0008009,0.0127680252839284,0.999333145492234,2,32,chemokine activity,MF,CCL2;CXCL10
18052,GO:0098794,0.0127813497690251,0.996032755260375,8,435,postsynapse,CC,SLC8A2;SNAP25;KCNB1;SHANK2;GABRB3;GRIN1;SHISA7;GABBR1
12982,GO:0048246,0.0127816668027975,0.999335414350557,2,29,macrophage chemotaxis,BP,CCL2;LGALS3
13093,GO:0048523,0.0128067307484203,0.992728688182917,38,4134,negative regulation of cellular process,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;IGFBP2;TNR;GBP1;SPP1;LGALS3;POSTN;SPOCD1;ANXA1;EMP3;ADM;SERPING1;JPH3;KCNB1;SHANK2;PDPN;S100A11;PTX3;GABRB3;ELFN2;ATCAY;COL3A1;CXCL10;GRIN1;ANXA2;SOCS3;SERPINA3;GABBR1
18242,GO:0099504,0.0128190291930044,0.997883174170107,4,128,synaptic vesicle cycle,BP,SH3GL2;SNAP25;CPLX2;RIMS2
469,GO:0001501,0.0128682755724372,0.995999974767902,8,450,skeletal system development,BP,LTF;TIMP1;AEBP1;COL1A1;CHI3L1;POSTN;COL3A1;ANXA2
15542,GO:0065007,0.0128772069275873,0.993063959441229,78,10285,biological regulation,BP,TNFRSF12A;LTF;TYMP;VIM;CP;SNAP91;MOXD1;CRTAC1;FERMT1;TIMP1;SRPX2;SHD;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;SPOCD1;COL4A2;ANXA1;GNAL;EMP3;GPR17;CPLX2;CDHR1;ADAM12;ADM;SERPING1;SPHKAP;JPH3;AFF2;KCNB1;C1R;SHANK2;PDPN;S100A11;PTX3;CSMD3;GABRB3;ELFN2;ATCAY;COL3A1;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;SMOC1;FAM155A;GABBR1;CFI;IFI30
18643,GO:1900138,0.0128823956528989,0.999958659136097,1,2,negative regulation of phospholipase A2 activity,BP,ANXA1
13435,GO:0050707,0.0129482359660646,0.997850963526093,4,146,regulation of cytokine secretion,BP,FERMT1;GBP1;POSTN;ANXA1
17100,GO:0080134,0.0129966177499005,0.994320172266688,15,1237,regulation of response to stress,BP,TNFRSF12A;LTF;SERPINE1;TNR;SPP1;PLAU;ANXA1;GPR17;SERPING1;C1R;PDPN;ANXA2;SOCS3;PLA2G2A;CFI
6715,GO:0019935,0.0129997525941659,0.997842564510506,4,135,cyclic-nucleotide-mediated signaling,BP,GNAL;ADM;CXCL10;RIMS2
21282,GO:2000211,0.0130585212521002,0.999957517184611,1,2,regulation of glutamate metabolic process,BP,ATCAY
16455,GO:0071621,0.0131932057248505,0.998506525072787,3,83,granulocyte chemotaxis,BP,CCL2;LGALS3;ANXA1
14700,GO:0060326,0.0132809630776103,0.997172488891336,5,227,cell chemotaxis,BP,SERPINE1;CCL2;LGALS3;ANXA1;CXCL10
4196,GO:0008594,0.0133442729325905,0.999955631124473,1,2,photoreceptor cell morphogenesis,BP,CDHR1
13183,GO:0048688,0.0133459468023347,0.999955619954854,1,2,negative regulation of sprouting of injured axon,BP,TNR
21341,GO:2000311,0.013393852972209,0.999294354932347,2,24,regulation of AMPA receptor activity,BP,SHANK2;SHISA7
13824,GO:0051290,0.0134951097294773,0.999279468585648,2,28,protein heterotetramerization,BP,GRIN1;ANXA2
13185,GO:0048690,0.0135722452121618,0.999954096849294,1,2,regulation of axon extension involved in regeneration,BP,TNR
5453,GO:0015432,0.0136382459488356,0.999953647756212,1,2,bile acid-exporting ATPase activity,MF,ABCC3
8950,GO:0033283,0.0136382459488356,0.999953647756212,1,2,organic acid-transporting ATPase activity,MF,ABCC3
8951,GO:0033284,0.0136382459488356,0.999953647756212,1,2,carboxylic acid-transporting ATPase activity,MF,ABCC3
8952,GO:0033285,0.0136382459488356,0.999953647756212,1,2,monocarboxylic acid-transporting ATPase activity,MF,ABCC3
3467,GO:0006869,0.0136927344430389,0.996536105731642,6,287,lipid transport,BP,APOL4;ABCC3;SPP1;ANXA1;ANXA2;PLA2G2A
14433,GO:0055072,0.013694610684041,0.99843053986669,3,78,iron ion homeostasis,BP,LTF;CP;STEAP3
16572,GO:0071840,0.0137597137381637,0.99192407620801,50,5788,cellular component organization or biogenesis,BP,TNFRSF12A;TYMP;VIM;SNAP91;CRTAC1;FERMT1;TIMP1;SRPX2;SERPINE1;SH3GL2;CCL2;COL1A1;CUX2;LOX;IGFBP2;TNR;GBP1;SPP1;KCNIP2;FMOD;GDF15;LGALS3;SNAP25;POSTN;COL4A2;ANXA1;COL6A2;EMP3;CDHR1;INA;ADAM12;ADM;AFF2;KCNB1;SHANK2;PDPN;PTX3;CSMD3;ATCAY;COL3A1;CXCL10;RIMS2;GRIN1;SLITRK1;ANXA2;COL4A1;SHISA7;RTP5;PLA2G2A;DOK6
9877,GO:0035637,0.0138426790100839,0.997028792080075,5,190,multicellular organismal signaling,BP,TYMP;KCNIP3;TNR;SLC8A2;KCNIP2
17370,GO:0090279,0.0138672832768126,0.999248964904469,2,28,regulation of calcium ion import,BP,CCL2;LGALS3
4054,GO:0008355,0.0139233157536598,0.999951682745682,1,2,olfactory learning,BP,GRIN1
9829,GO:0035578,0.0139383147916831,0.998388936520701,3,85,azurophil granule lumen,CC,FABP5;ANXA2;SERPINA3
16243,GO:0071306,0.0139446164124222,0.999951534268915,1,2,cellular response to vitamin E,BP,COL1A1
6300,GO:0018149,0.0139843401009458,0.999239279724904,2,28,peptide cross-linking,BP,ANXA1;COL3A1
8123,GO:0031960,0.0139905671426495,0.997624315276263,4,147,response to corticosteroid,BP,COL1A1;IGFBP2;ANXA1;ADM
3630,GO:0007160,0.0141048428371168,0.996957538450119,5,194,cell-matrix adhesion,BP,FERMT1;SERPINE1;PLAU;POSTN;COL3A1
7363,GO:0030425,0.014255211914694,0.99513423472809,9,543,dendrite,CC,KCNIP3;SLC8A2;CPLX2;KCNB1;SHANK2;ATCAY;GRIN1;SHISA7;GABBR1
10500,GO:0040007,0.0142834983388266,0.994289921536886,12,858,growth,BP,TNFRSF12A;SH3GL2;IGFBP2;TNR;SPP1;POSTN;ANXA1;ADM;SHANK2;RIMS2;SLITRK1;SOCS3
11503,GO:0044111,0.0143386891074687,0.999948745986533,1,2,development involved in symbiotic interaction,BP,ANXA2
17785,GO:0097447,0.0143709285670341,0.995088101279041,9,544,dendritic tree,CC,KCNIP3;SLC8A2;CPLX2;KCNB1;SHANK2;ATCAY;GRIN1;SHISA7;GABBR1
11796,GO:0044868,0.0144661947832773,0.999947826992802,1,2,modulation by host of viral molecular function,BP,PTX3
3437,GO:0006816,0.0145363128477639,0.995794598907153,7,371,calcium ion transport,BP,CCL2;SLC8A2;LGALS3;JPH3;CXCL10;GRIN1;FAM155A
14442,GO:0055082,0.0145641544106319,0.994692354875954,10,682,cellular chemical homeostasis,BP,LTF;CP;SLC8A2;GPR17;ADM;JPH3;KCNB1;CXCL10;GRIN1;FAM155A
13249,GO:0048817,0.0146965266731162,0.999946146027503,1,2,negative regulation of hair follicle maturation,BP,FERMT1
17916,GO:0097749,0.0147111472831509,0.999946038419757,1,2,membrane tubulation,BP,SH3GL2
7501,GO:0030799,0.0148167829624356,0.998250079915078,3,81,regulation of cyclic nucleotide metabolic process,BP,ADM;CXCL10;GABBR1
10710,GO:0042383,0.0148722433830687,0.997435827965869,4,124,sarcolemma,CC,ANXA1;COL6A2;KCNB1;ANXA2
18172,GO:0099003,0.0149088473515161,0.997423923355387,4,135,vesicle-mediated transport in synapse,BP,SH3GL2;SNAP25;CPLX2;RIMS2
13501,GO:0050801,0.0149714865109969,0.994520443322542,10,683,ion homeostasis,BP,LTF;CP;STEAP3;SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
16238,GO:0071295,0.015017725164306,0.999151916397655,2,28,cellular response to vitamin,BP,COL1A1;POSTN
954,GO:0002253,0.0151640756751725,0.995141948818225,8,509,activation of immune response,BP,LTF;GBP1;LGALS3;SERPING1;C1R;HLA-DQB1;HLA-DQA1;CFI
16523,GO:0071715,0.0152505520998951,0.99912709779425,2,31,icosanoid transport,BP,ANXA1;PLA2G2A
18973,GO:1901571,0.0152505520998951,0.99912709779425,2,31,fatty acid derivative transport,BP,ANXA1;PLA2G2A
14763,GO:0060402,0.0154239728968793,0.997309018286557,4,132,calcium ion transport into cytosol,BP,JPH3;CXCL10;GRIN1;FAM155A
10365,GO:0038039,0.0154445343993954,0.999940501789234,1,2,G-protein coupled receptor heterodimeric complex,CC,GABBR1
20649,GO:1905333,0.0155264731536339,0.999919892055799,1,3,regulation of gastric motility,BP,TYMP
13481,GO:0050773,0.0156948578955959,0.997249041117417,4,128,regulation of dendrite development,BP,CUX2;SHANK2;CSMD3;GRIN1
17552,GO:0097013,0.0157558848965565,0.999917498700449,1,3,phagocytic vesicle lumen,CC,LTF
10504,GO:0040011,0.0157695032533989,0.992444232010797,18,1527,locomotion,BP,TNFRSF12A;TYMP;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;TNR;PLAU;LGALS3;POSTN;ANXA1;JPH3;PDPN;COL3A1;CXCL10;DOK6
8033,GO:0031727,0.0157976413511902,0.99991705925628,1,3,CCR2 chemokine receptor binding,MF,CCL2
15755,GO:0070346,0.015940468592361,0.999915547256599,1,3,positive regulation of fat cell proliferation,BP,VSTM2A
21483,GO:2000520,0.0160165050552507,0.999914736707028,1,3,regulation of immunological synapse formation,BP,LGALS3
19408,GO:1902732,0.0160697780644612,0.999914166493067,1,3,positive regulation of chondrocyte proliferation,BP,LTF
12071,GO:0045596,0.0161524989168768,0.994368705837102,9,576,negative regulation of cell differentiation,BP,LTF;VIM;TNR;GBP1;SPP1;POSTN;ANXA1;COL3A1;CXCL10
8362,GO:0032379,0.0161922477808451,0.999912848364898,1,3,positive regulation of intracellular lipid transport,BP,ANXA2
8365,GO:0032382,0.0161922477808451,0.999912848364898,1,3,positive regulation of intracellular sterol transport,BP,ANXA2
8368,GO:0032385,0.0161922477808451,0.999912848364898,1,3,positive regulation of intracellular cholesterol transport,BP,ANXA2
14236,GO:0052203,0.0162162444057954,0.999912588906346,1,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,PTX3
21859,GO:2001257,0.0162224352594693,0.997124032718596,4,141,regulation of cation channel activity,BP,KCNIP2;JPH3;SHANK2;SHISA7
16926,GO:0072503,0.0162477140421978,0.995192776648327,7,397,cellular divalent inorganic cation homeostasis,BP,SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
5881,GO:0016477,0.0163261925070743,0.992665473741187,15,1198,cell migration,BP,TNFRSF12A;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;TNR;PLAU;LGALS3;POSTN;ANXA1;PDPN;COL3A1;CXCL10
21812,GO:2001189,0.0163434175807368,0.999911207387373,1,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
20725,GO:1905517,0.0164195828495716,0.999020007773422,2,33,macrophage migration,BP,CCL2;LGALS3
16507,GO:0071695,0.0164688367292725,0.997068248689974,4,138,anatomical structure maturation,BP,LTF;FERMT1;KCNIP2;GRIN1
16195,GO:0071222,0.0165668976869018,0.997039937048002,4,157,cellular response to lipopolysaccharide,BP,LTF;SERPINE1;CCL2;CXCL10
2519,GO:0005261,0.0166034813973399,0.995618507016506,6,288,cation channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GRIN1;FAM155A
14671,GO:0060292,0.0166304057070573,0.999009070823772,2,28,long term synaptic depression,BP,KCNB1;SHANK2
9378,GO:0034446,0.0166660705177563,0.997944838805848,3,79,substrate adhesion-dependent cell spreading,BP,GBP1;POSTN;PDPN
2643,GO:0005584,0.0167392990833746,0.999930061509841,1,2,collagen type I trimer,CC,COL1A1
6614,GO:0019725,0.01674700662956,0.993439772374209,11,813,cellular homeostasis,BP,LTF;CP;CCL2;SLC8A2;GPR17;ADM;JPH3;KCNB1;CXCL10;GRIN1;FAM155A
9153,GO:0033993,0.0169016161382146,0.993369659173316,11,828,response to lipid,BP,LTF;SERPINE1;CCL2;COL1A1;LOX;IGFBP2;SPP1;POSTN;ANXA1;ADM;CXCL10
17655,GO:0097187,0.0169151842266434,0.999904861265042,1,3,dentinogenesis,BP,SERPINE1
16279,GO:0071356,0.0170058448077119,0.996145119362703,5,250,cellular response to tumor necrosis factor,BP,TNFRSF12A;CCL2;COL1A1;CHI3L1;POSTN
1087,GO:0002478,0.0170430222313191,0.996927563457943,4,163,antigen processing and presentation of exogenous peptide antigen,BP,SH3GL2;HLA-DQB1;HLA-DQA1;IFI30
9661,GO:0035255,0.0170660743639776,0.998971283037522,2,27,ionotropic glutamate receptor binding,MF,SHANK2;SHISA7
13796,GO:0051251,0.0171673411390013,0.996100343587064,5,243,positive regulation of lymphocyte activation,BP,CCL2;IGFBP2;ANXA1;HLA-DQB1;HLA-DQA1
15752,GO:0070343,0.017212187493151,0.999901477670605,1,3,white fat cell proliferation,BP,VSTM2A
15756,GO:0070350,0.017212187493151,0.999901477670605,1,3,regulation of white fat cell proliferation,BP,VSTM2A
4552,GO:0009620,0.0172154523720189,0.998942484773199,2,36,response to fungus,BP,LTF;PTX3
10995,GO:0042995,0.0172167096964784,0.99124475164637,21,1877,cell projection,CC,TNFRSF12A;VIM;CRTAC1;FERMT1;KCNIP3;SLC8A2;SPP1;SNAP25;ANXA1;CPLX2;CDHR1;KCNB1;SHANK2;PDPN;S100A11;GABRB3;ATCAY;GRIN1;ANXA2;SHISA7;GABBR1
20763,GO:1905600,0.017280324649112,0.999900693018479,1,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
18997,GO:1901624,0.0173366087920125,0.999900042497282,1,3,negative regulation of lymphocyte chemotaxis,BP,CCL2
11655,GO:0044432,0.0173409412901755,0.992367819941796,14,1174,endoplasmic reticulum part,CC,LTF;CP;MOXD1;TIMP1;COL1A1;SPP1;COL4A2;COL6A2;JPH3;COL3A1;HLA-DQB1;COL4A1;PLA2G2A;HLA-DQA1
14961,GO:0060708,0.0173463195042302,0.999899930046252,1,3,spongiotrophoblast differentiation,BP,SOCS3
7829,GO:0031347,0.0174395855805865,0.993838406951296,9,626,regulation of defense response,BP,LTF;SERPINE1;ANXA1;GPR17;SERPING1;C1R;SOCS3;PLA2G2A;CFI
7464,GO:0030666,0.0175088400696904,0.996821225487291,4,152,endocytic vesicle membrane,CC,SH3GL2;CD163;HLA-DQB1;HLA-DQA1
2754,GO:0005773,0.0175417941844224,0.993416673465137,10,723,vacuole,CC,CP;FMOD;ANXA1;CPLX2;FABP5;HLA-DQB1;ANXA2;SERPINA3;HLA-DQA1;IFI30
7964,GO:0031623,0.0177482472549088,0.997755605561929,3,85,receptor internalization,BP,SH3GL2;SNAP25;ADM
14186,GO:0051968,0.0177796813649507,0.998902593572395,2,28,positive regulation of synaptic transmission, glutamatergic,BP,TNR;SHANK2
19855,GO:1903672,0.0177894247241142,0.998895778220556,2,31,positive regulation of sprouting angiogenesis,BP,SRPX2;ANXA1
18765,GO:1900673,0.0178353452575089,0.999894184661321,1,3,olefin metabolic process,BP,GRIN1
17805,GO:0097484,0.0178534022164982,0.998893519052027,2,29,dendrite extension,BP,SH3GL2;RIMS2
15040,GO:0060838,0.0179925741968207,0.99989230308954,1,3,lymphatic endothelial cell fate commitment,BP,PDPN
21146,GO:1990926,0.0180137751147083,0.999892048097308,1,3,short-term synaptic potentiation,BP,SNAP25
15559,GO:0070033,0.0180298981550629,0.999891853975321,1,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,CPLX2
20832,GO:1905863,0.0180584568930963,0.999918549051795,1,2,invadopodium organization,BP,PDPN
18900,GO:1901329,0.0181120137677559,0.999890862572362,1,3,regulation of odontoblast differentiation,BP,SERPINE1
2490,GO:0005216,0.0181379983497523,0.994516073317346,7,386,ion channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRB3;GRIN1;FAM155A
17833,GO:0097530,0.0183681824744131,0.997642237152301,3,94,granulocyte migration,BP,CCL2;LGALS3;ANXA1
19777,GO:1903530,0.0184195441980904,0.993432732101888,9,611,regulation of secretion by cell,BP,FERMT1;GBP1;SPP1;SNAP25;POSTN;ANXA1;CPLX2;KCNB1;RIMS2
13486,GO:0050778,0.0184878871799901,0.993402782048434,9,637,positive regulation of immune response,BP,LTF;GBP1;LGALS3;ANXA1;SERPING1;C1R;HLA-DQB1;HLA-DQA1;CFI
7104,GO:0023061,0.0185802541541679,0.994353697961535,7,401,signal release,BP,SPP1;SNAP25;ANXA1;CPLX2;ADM;KCNB1;RIMS2
4890,GO:0010701,0.0186963615464367,0.999883675849322,1,3,positive regulation of norepinephrine secretion,BP,KCNB1
16949,GO:0072534,0.0187084628773993,0.9999125508398,1,2,perineuronal net,CC,TNR
6810,GO:0021586,0.0188484600315547,0.999881767328722,1,3,pons maturation,BP,GRIN1
6689,GO:0019884,0.0189078499636719,0.996482825286972,4,168,antigen processing and presentation of exogenous antigen,BP,SH3GL2;HLA-DQB1;HLA-DQA1;IFI30
5399,GO:0015275,0.019003309782719,0.999879808194151,1,3,stretch-activated, cation-selective, calcium channel activity,MF,FAM155A
13181,GO:0048686,0.0190159358341205,0.999879647735369,1,3,regulation of sprouting of injured axon,BP,TNR
7845,GO:0031394,0.0190412205332323,0.999879326078963,1,3,positive regulation of prostaglandin biosynthetic process,BP,ANXA1
21874,GO:2001280,0.0190412205332323,0.999879326078963,1,3,positive regulation of unsaturated fatty acid biosynthetic process,BP,ANXA1
9269,GO:0034242,0.0191302314388642,0.999878190291707,1,3,negative regulation of syncytium formation by plasma membrane fusion,BP,CXCL10
12176,GO:0045763,0.0191671812945641,0.999908188307757,1,2,negative regulation of cellular amino acid metabolic process,BP,ATCAY
14762,GO:0060401,0.0192348517575922,0.996412043650952,4,142,cytosolic calcium ion transport,BP,JPH3;CXCL10;GRIN1;FAM155A
21570,GO:2000645,0.0193592370576149,0.999875243492748,1,3,negative regulation of receptor catabolic process,BP,ANXA2
18062,GO:0098805,0.019384558654318,0.99067921656372,17,1523,whole membrane,CC,CP;MOXD1;SH3GL2;STEAP3;TNR;PLAU;LGALS3;SNAP25;ANXA1;PDPN;FABP5;SVOP;PCDH7;CD163;HLA-DQB1;ANXA2;HLA-DQA1
3762,GO:0007417,0.0194771692521614,0.991866804196926,12,878,central nervous system development,BP,VIM;CRTAC1;SH3GL2;TNR;MDGA2;INA;CA10;AFF2;SHANK2;COL3A1;GRIN1;COL4A1
7050,GO:0022617,0.0195698373255775,0.997435724423157,3,81,extracellular matrix disassembly,BP,TIMP1;SPP1;PDPN
3522,GO:0006953,0.0196326936602063,0.998707358693998,2,36,acute-phase response,BP,CD163;SERPINA3
16192,GO:0071219,0.0196400536538523,0.996305698810619,4,165,cellular response to molecule of bacterial origin,BP,LTF;SERPINE1;CCL2;CXCL10
7759,GO:0031253,0.0196553287289444,0.994613744806336,6,298,cell projection membrane,CC,FERMT1;CDHR1;KCNB1;SHANK2;PDPN;SHISA7
17942,GO:0098552,0.0197627566524625,0.993917139106873,7,426,side of membrane,CC,SNAP25;ANXA1;GNAL;CXCL10;CD163;HLA-DQB1;HLA-DQA1
14281,GO:0052548,0.0198115184405507,0.994555720798663,6,337,regulation of endopeptidase activity,BP,LTF;TIMP1;SERPINE1;SERPING1;GRIN1;SERPINA3
1200,GO:0002688,0.019814230972047,0.997380200170584,3,100,regulation of leukocyte chemotaxis,BP,SERPINE1;CCL2;CXCL10
8949,GO:0033280,0.0198618909000088,0.998689268995632,2,33,response to vitamin D,BP,SPP1;CXCL10
13536,GO:0050856,0.0198870662139207,0.998683251411257,2,35,regulation of T cell receptor signaling pathway,BP,GBP1;LGALS3
7066,GO:0022838,0.019924160833266,0.993860702336484,7,395,substrate-specific channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRB3;GRIN1;FAM155A
10820,GO:0042592,0.0199380699581842,0.990381750281842,17,1514,homeostatic process,BP,LTF;CP;CCL2;STEAP3;SLC8A2;SPP1;ANXA1;GPR17;CDHR1;ADM;JPH3;KCNB1;CXCL10;GRIN1;SLITRK1;SERPINA3;FAM155A
16929,GO:0072507,0.020032335311424,0.993818687500443,7,413,divalent inorganic cation homeostasis,BP,SLC8A2;GPR17;ADM;JPH3;CXCL10;GRIN1;FAM155A
3648,GO:0007181,0.0200594912512607,0.99986601226191,1,3,transforming growth factor beta receptor complex assembly,BP,FMOD
12330,GO:0046058,0.0200920968088874,0.997337548212003,3,86,cAMP metabolic process,BP,ADM;CXCL10;GABBR1
10887,GO:0042734,0.0202214330556463,0.997320714807216,3,77,presynaptic membrane,CC,SNAP25;RIMS2;GABBR1
15360,GO:0061564,0.0204462461615575,0.9930870962622,8,471,axon development,BP,TNFRSF12A;CRTAC1;TNR;SPP1;FMOD;GRIN1;SLITRK1;DOK6
9769,GO:0035482,0.0206097330683186,0.999840933832571,1,4,gastric motility,BP,TYMP
6678,GO:0019863,0.0206857404275661,0.999839753215571,1,4,IgE binding,MF,LGALS3
7433,GO:0030594,0.020686978564879,0.997226438434899,3,89,neurotransmitter receptor activity,MF,GABRB3;GRIN1;GABBR1
17009,GO:0072657,0.0207501143703612,0.992960143481111,8,530,protein localization to membrane,BP,KCNIP3;GBP1;SNAP25;KCNB1;GRIN1;ANXA2;SHISA7;RTP5
1210,GO:0002698,0.0207881811879468,0.997205248155246,3,93,negative regulation of immune effector process,BP,LGALS3;ANXA1;SERPING1
14094,GO:0051799,0.0210188430893547,0.999852825456093,1,3,negative regulation of hair follicle development,BP,FERMT1
11064,GO:0043112,0.0210326105799101,0.995963519318972,4,159,receptor metabolic process,BP,SH3GL2;SNAP25;ADM;ANXA2
2917,GO:0006040,0.0210608353304008,0.998560786384383,2,36,amino sugar metabolic process,BP,CHI3L2;CHI3L1
18824,GO:1901136,0.021120208374886,0.995939016699901,4,167,carbohydrate derivative catabolic process,BP,TYMP;CHI3L2;FMOD;CHI3L1
767,GO:0001953,0.0211404868043066,0.998562311663884,2,31,negative regulation of cell-matrix adhesion,BP,SERPINE1;POSTN
11657,GO:0044437,0.021175407823502,0.9927886859816,8,533,vacuolar part,CC,CP;FMOD;FABP5;HLA-DQB1;ANXA2;SERPINA3;HLA-DQA1;IFI30
17030,GO:0072683,0.0211892336562189,0.999831821259229,1,4,T cell extravasation,BP,CCL2
8765,GO:0032964,0.0212807094798191,0.998539490761138,2,35,collagen biosynthetic process,BP,VIM;COL1A1
11119,GO:0043197,0.0213371500436428,0.99589103446846,4,149,dendritic spine,CC,SLC8A2;SHANK2;GRIN1;SHISA7
10056,GO:0035938,0.0213375166666628,0.999848306865949,1,3,estradiol secretion,BP,SPP1
21711,GO:2000864,0.0213375166666628,0.999848306865949,1,3,regulation of estradiol secretion,BP,SPP1
6696,GO:0019897,0.021369482154934,0.995878857335537,4,160,extrinsic component of plasma membrane,CC,SNAP25;ANXA1;GNAL;ANXA2
15558,GO:0070032,0.0213913751231622,0.99982858235789,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,SNAP25
6617,GO:0019732,0.0214225924665713,0.999828079385191,1,4,antifungal humoral response,BP,LTF
10711,GO:0042391,0.0214275383537539,0.993299300899082,7,401,regulation of membrane potential,BP,CUX2;KCNIP2;KCNB1;SHANK2;GABRB3;RIMS2;GRIN1
5307,GO:0015085,0.0215347734677393,0.995848653553425,4,133,calcium ion transmembrane transporter activity,MF,SLC8A2;JPH3;GRIN1;FAM155A
12888,GO:0048002,0.0216914489367258,0.995793063723683,4,175,antigen processing and presentation of peptide antigen,BP,SH3GL2;HLA-DQB1;HLA-DQA1;IFI30
711,GO:0001878,0.0217805081124291,0.999822259517666,1,4,response to yeast,BP,PTX3
3800,GO:0007565,0.0219393489811692,0.995735260791222,4,160,female pregnancy,BP,TIMP1;IGFBP2;SPP1;ADM
13173,GO:0048677,0.0219885392388879,0.999838861291327,1,3,axon extension involved in regeneration,BP,TNR
2349,GO:0004965,0.0221758193029474,0.999836090708044,1,3,G-protein coupled GABA receptor activity,MF,GABBR1
9538,GO:0034765,0.0221808377778082,0.993014729118066,7,404,regulation of ion transmembrane transport,BP,KCNIP3;KCNIP2;JPH3;KCNB1;SHANK2;CXCL10;SHISA7
9592,GO:0035063,0.0221897511802878,0.999876757714017,1,2,nuclear speck organization,BP,AFF2
18467,GO:0120025,0.0223407764691385,0.988492178824602,20,1807,plasma membrane bounded cell projection,CC,TNFRSF12A;VIM;CRTAC1;FERMT1;KCNIP3;SLC8A2;SNAP25;ANXA1;CPLX2;CDHR1;KCNB1;SHANK2;PDPN;S100A11;GABRB3;ATCAY;GRIN1;ANXA2;SHISA7;GABBR1
18031,GO:0098751,0.0223446644573998,0.998432643369745,2,32,bone cell development,BP,LTF;ANXA2
17214,GO:0090049,0.0223555232341499,0.99842707480598,2,34,regulation of cell migration involved in sprouting angiogenesis,BP,SRPX2;ANXA1
14101,GO:0051817,0.0223864022552047,0.996905088017875,3,93,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,LTF;PTX3;ANXA2
8508,GO:0032571,0.0224000331671361,0.999811954605859,1,4,response to vitamin K,BP,POSTN
5911,GO:0016525,0.0224179430872225,0.996904073168455,3,86,negative regulation of angiogenesis,BP,SERPINE1;COL4A2;CXCL10
5697,GO:0016079,0.0224786447956014,0.99689251448399,3,86,synaptic vesicle exocytosis,BP,SNAP25;CPLX2;RIMS2
8076,GO:0031849,0.0225331429701633,0.999809702253345,1,4,olfactory receptor binding,MF,RTP5
11586,GO:0044309,0.0225475421052178,0.99558421693544,4,151,neuron spine,CC,SLC8A2;SHANK2;GRIN1;SHISA7
7743,GO:0031224,0.0226358566976735,0.986603690730826,37,4249,intrinsic component of membrane,CC,TNFRSF12A;MOXD1;ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;SNAP25;MDGA2;EMP3;GPR17;GALNT13;CDHR1;ADAM12;JPH3;KCNB1;SHANK2;PDPN;CSMD3;SVOP;GABRB3;ELFN2;PCDH7;VSTM2A;FUT9;GRIN1;ST8SIA3;CD163;TMEM151B;SLITRK1;HLA-DQB1;SHISA7;RTP5;PTPRT;HLA-DQA1;FAM155A;GABBR1
9439,GO:0034612,0.0226800530733282,0.994465479358166,5,268,response to tumor necrosis factor,BP,TNFRSF12A;CCL2;COL1A1;CHI3L1;POSTN
15544,GO:0065009,0.0227110661624714,0.987217642061208,28,2938,regulation of molecular function,BP,LTF;TYMP;CRTAC1;TIMP1;SERPINE1;CCL2;KCNIP3;SPP1;KCNIP2;PLAU;GDF15;CHI3L1;SPOCD1;ANXA1;GNAL;ADM;SERPING1;JPH3;SHANK2;PTX3;ELFN2;CXCL10;GRIN1;ANXA2;SOCS3;SHISA7;SERPINA3;GABBR1
3374,GO:0006710,0.02272962356871,0.999806352860532,1,4,androgen catabolic process,BP,SPP1
12983,GO:0048247,0.0227696535752474,0.998369914310085,2,41,lymphocyte chemotaxis,BP,CCL2;CXCL10
11870,GO:0045104,0.0228446114684183,0.998376270785843,2,33,intermediate filament cytoskeleton organization,BP,VIM;INA
4790,GO:0010522,0.0229021028140173,0.996809988250669,3,88,regulation of calcium ion transport into cytosol,BP,JPH3;CXCL10;GRIN1
21021,GO:1990523,0.0229456385913936,0.999802636412864,1,4,bone regeneration,BP,POSTN
18587,GO:1900041,0.0230511374534351,0.999800808383679,1,4,negative regulation of interleukin-2 secretion,BP,GBP1
10708,GO:0042379,0.0230669466303637,0.998335757508748,2,42,chemokine receptor binding,MF,CCL2;CXCL10
20986,GO:1990410,0.023077375199272,0.999800352428294,1,4,adrenomedullin receptor signaling pathway,BP,ADM
15968,GO:0070741,0.023130422751577,0.998340688338322,2,35,response to interleukin-6,BP,CHI3L1;SOCS3
15152,GO:0061043,0.0233848683141146,0.999794969622147,1,4,regulation of vascular wound healing,BP,SERPINE1
16002,GO:0070838,0.0234064784602111,0.992546831115649,7,412,divalent metal ion transport,BP,CCL2;SLC8A2;LGALS3;JPH3;CXCL10;GRIN1;FAM155A
4012,GO:0008289,0.0236196371074108,0.991212059505715,9,626,lipid binding,MF,LTF;SNAP91;APOL4;PLEKHA4;SH3GL2;ANXA1;FABP5;ANXA2;PLA2G2A
18104,GO:0098881,0.0236290775365307,0.999790643098289,1,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,SNAP25
18153,GO:0098967,0.0236290775365307,0.999790643098289,1,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,SNAP25
5395,GO:0015267,0.0237964367681766,0.992397010731703,7,413,channel activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRB3;GRIN1;FAM155A
7057,GO:0022803,0.0237964367681766,0.992397010731703,7,413,passive transmembrane transporter activity,MF,KCNIP3;KCNIP2;JPH3;KCNB1;GABRB3;GRIN1;FAM155A
12097,GO:0045629,0.0237994894449924,0.999787596969316,1,4,negative regulation of T-helper 2 cell differentiation,BP,ANXA1
5175,GO:0014070,0.0238660109318559,0.990138527242859,11,847,response to organic cyclic compound,BP,CCL2;COL1A1;LOX;IGFBP2;SPP1;POSTN;ANXA1;ADM;GABRB3;CXCL10;GRIN1
5270,GO:0014902,0.0238912873056121,0.996617666911974,3,89,myotube differentiation,BP,GDF15;ADAM12;CXCL10
21265,GO:2000181,0.0238998823556221,0.99661678206692,3,88,negative regulation of blood vessel morphogenesis,BP,SERPINE1;COL4A2;CXCL10
11869,GO:0045103,0.0239887460822237,0.998247652119899,2,34,intermediate filament-based process,BP,VIM;INA
13532,GO:0050852,0.0240833921721849,0.995176527621187,4,183,T cell receptor signaling pathway,BP,GBP1;LGALS3;HLA-DQB1;HLA-DQA1
16932,GO:0072511,0.0241408057702489,0.992264114946239,7,415,divalent inorganic cation transport,BP,CCL2;SLC8A2;LGALS3;JPH3;CXCL10;GRIN1;FAM155A
6612,GO:0019722,0.02416511412189,0.995165315261344,4,155,calcium-mediated signaling,BP,GBP1;JPH3;KSR2;GRIN1
18442,GO:0106104,0.0241687070973609,0.999805129445671,1,3,regulation of glutamate receptor clustering,BP,SHISA7
20357,GO:1904717,0.0241687070973609,0.999805129445671,1,3,regulation of AMPA glutamate receptor clustering,BP,SHISA7
18541,GO:0140135,0.0242074551493996,0.999780214236044,1,4,mechanosensitive cation channel activity,MF,FAM155A
14771,GO:0060414,0.0242216386624332,0.999804270210478,1,3,aorta smooth muscle tissue morphogenesis,BP,COL3A1
17998,GO:0098660,0.0242573841909429,0.990412882922772,10,719,inorganic ion transmembrane transport,BP,KCNIP3;STEAP3;SLC8A2;KCNIP2;JPH3;KCNB1;GABRB3;CXCL10;GRIN1;FAM155A
6010,GO:0016715,0.0244126707185978,0.999776452385042,1,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,MOXD1
21820,GO:2001201,0.0245008465384794,0.999799706212866,1,3,regulation of transforming growth factor-beta secretion,BP,FERMT1
13575,GO:0050905,0.0245136130379051,0.996496347423087,3,88,neuromuscular process,BP,TNR;JPH3;GRIN1
8813,GO:0033031,0.0247772718006221,0.999769689229419,1,4,positive regulation of neutrophil apoptotic process,BP,ANXA1
18295,GO:0099604,0.0247953263778952,0.998177924172768,2,27,ligand-gated calcium channel activity,MF,JPH3;GRIN1
21412,GO:2000401,0.025046238017889,0.998115362067083,2,40,regulation of lymphocyte migration,BP,CCL2;CXCL10
5106,GO:0010986,0.0252142808213964,0.999761448711322,1,4,positive regulation of lipoprotein particle clearance,BP,ANXA2
18943,GO:1901509,0.0253263134118199,0.99975931257483,1,4,regulation of endothelial tube morphogenesis,BP,CXCL10
5663,GO:0016021,0.0253620320545449,0.984907467853429,36,4139,integral component of membrane,CC,TNFRSF12A;MOXD1;ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;SNAP25;EMP3;GPR17;GALNT13;CDHR1;ADAM12;JPH3;KCNB1;SHANK2;PDPN;CSMD3;SVOP;GABRB3;ELFN2;PCDH7;VSTM2A;FUT9;GRIN1;ST8SIA3;CD163;TMEM151B;SLITRK1;HLA-DQB1;SHISA7;RTP5;PTPRT;HLA-DQA1;FAM155A;GABBR1
11004,GO:0043005,0.0254571160281425,0.988220117788282,14,1140,neuron projection,CC,VIM;CRTAC1;KCNIP3;SLC8A2;SNAP25;CPLX2;CDHR1;KCNB1;SHANK2;GABRB3;ATCAY;GRIN1;SHISA7;GABBR1
13571,GO:0050900,0.025533890756146,0.992566736956138,6,361,leukocyte migration,BP,SERPINE1;CCL2;COL1A1;LGALS3;ANXA1;CXCL10
14604,GO:0060179,0.0256925416254619,0.999752262496391,1,4,male mating behavior,BP,GRIN1
21470,GO:2000501,0.0258700669159611,0.999732179924349,1,5,regulation of natural killer cell chemotaxis,BP,CCL2
14696,GO:0060322,0.0259314708189933,0.989641126040157,10,695,head development,BP,CRTAC1;COL1A1;TNR;INA;CA10;AFF2;SHANK2;COL3A1;GRIN1;COL4A1
8518,GO:0032590,0.0259777679239415,0.998012865469029,2,37,dendrite membrane,CC,KCNB1;SHISA7
5081,GO:0010955,0.0260219012273696,0.998012316922672,2,35,negative regulation of protein processing,BP,SERPINE1;SERPING1
19673,GO:1903318,0.0260219012273696,0.998012316922672,2,35,negative regulation of protein maturation,BP,SERPINE1;SERPING1
12984,GO:0048248,0.0260848215544344,0.999727690905411,1,5,CXCR3 chemokine receptor binding,MF,CXCL10
2513,GO:0005250,0.0262448827079051,0.99974143499683,1,4,A-type (transient outward) potassium channel activity,MF,KCNIP2
21811,GO:2001188,0.0266385699224526,0.99971594187643,1,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
17877,GO:0097647,0.0268108715147351,0.99971223493096,1,5,amylin receptor signaling pathway,BP,ADM
9655,GO:0035249,0.0268384831369378,0.996029428900282,3,88,synaptic transmission, glutamatergic,BP,TNR;SHANK2;GRIN1
14280,GO:0052547,0.0268525631821415,0.992092820930483,6,360,regulation of peptidase activity,BP,LTF;TIMP1;SERPINE1;SERPING1;GRIN1;SERPINA3
726,GO:0001894,0.0268617967243527,0.994441976598238,4,173,tissue homeostasis,BP,LTF;SPP1;CDHR1;SERPINA3
11654,GO:0044431,0.0268680285087055,0.988693765169414,11,858,Golgi apparatus part,CC,SH3GL2;CUX2;GBP1;FMOD;SNAP25;POSTN;GALNT13;FUT9;ST8SIA3;HLA-DQB1;HLA-DQA1
13437,GO:0050709,0.0268884642704592,0.996007890691618,3,102,negative regulation of protein secretion,BP,GBP1;ANXA1;KCNB1
13545,GO:0050865,0.0269490896244552,0.991161046259325,7,464,regulation of cell activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;PDPN;HLA-DQB1;HLA-DQA1
5515,GO:0015722,0.0269875693151046,0.999726506901284,1,4,canalicular bile acid transport,BP,ABCC3
12711,GO:0046923,0.0270254341980809,0.999707584798589,1,5,ER retention sequence binding,MF,KCNIP2
10847,GO:0042636,0.0270414069031044,0.999725408285087,1,4,negative regulation of hair cycle,BP,FERMT1
11617,GO:0044352,0.0273683786785689,0.999718688204094,1,4,pinosome,CC,ANXA2
11618,GO:0044354,0.0273683786785689,0.999718688204094,1,4,macropinosome,CC,ANXA2
13178,GO:0048682,0.0273862448968424,0.999718318640659,1,4,sprouting of injured axon,BP,TNR
11725,GO:0044691,0.02743247831837,0.999748569543378,1,3,tooth eruption,BP,COL1A1
3647,GO:0007179,0.0274682284898543,0.994282298045935,4,162,transforming growth factor beta receptor signaling pathway,BP,FERMT1;FMOD;GDF15;COL3A1
7503,GO:0030801,0.0275462467615169,0.997813526356188,2,43,positive regulation of cyclic nucleotide metabolic process,BP,ADM;CXCL10
13661,GO:0051046,0.0275899331082856,0.989451158385723,9,657,regulation of secretion,BP,FERMT1;GBP1;SPP1;SNAP25;POSTN;ANXA1;CPLX2;KCNB1;RIMS2
18908,GO:1901343,0.0276204539621683,0.995863213081269,3,94,negative regulation of vasculature development,BP,SERPINE1;COL4A2;CXCL10
13497,GO:0050794,0.0276557543754956,0.983395224711347,70,9170,regulation of cellular process,BP,TNFRSF12A;LTF;TYMP;VIM;SNAP91;FERMT1;TIMP1;SRPX2;SHD;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;SPOCD1;COL4A2;ANXA1;GNAL;EMP3;GPR17;CPLX2;ADM;SERPING1;SPHKAP;JPH3;AFF2;KCNB1;SHANK2;PDPN;S100A11;PTX3;CSMD3;GABRB3;ELFN2;ATCAY;COL3A1;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;SMOC1;GABBR1;IFI30
15416,GO:0061669,0.0277995201703022,0.999741752924168,1,3,spontaneous neurotransmitter secretion,BP,RIMS2
1208,GO:0002696,0.0280139964712036,0.992779040633634,5,275,positive regulation of leukocyte activation,BP,CCL2;IGFBP2;ANXA1;HLA-DQB1;HLA-DQA1
13794,GO:0051249,0.0280216141405755,0.99166616109151,6,370,regulation of lymphocyte activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1;HLA-DQA1
7761,GO:0031256,0.0280822999194847,0.994116698972295,4,158,leading edge membrane,CC,FERMT1;KCNB1;PDPN;SHISA7
7463,GO:0030665,0.0281557276822284,0.995747838354615,3,99,clathrin-coated vesicle membrane,CC,SH3GL2;HLA-DQB1;HLA-DQA1
11904,GO:0045163,0.0282338512935173,0.999733567322819,1,3,clustering of voltage-gated potassium channels,BP,KCNIP2
7180,GO:0030136,0.0282734444521499,0.994059187162728,4,169,clathrin-coated vesicle,CC,SNAP91;SH3GL2;HLA-DQB1;HLA-DQA1
3688,GO:0007229,0.0284853709125597,0.99568305882737,3,94,integrin-mediated signaling pathway,BP,FERMT1;TIMP1;COL3A1
10888,GO:0042737,0.0285805527898396,0.995647843490719,3,115,drug catabolic process,BP,CHI3L2;MOXD1;CHI3L1
11536,GO:0044218,0.0286552643135104,0.999671030903284,1,5,other organism cell membrane,CC,LTF
11566,GO:0044279,0.0286552643135104,0.999671030903284,1,5,other organism membrane,CC,LTF
12678,GO:0046873,0.0287065661601507,0.990467422286835,7,418,metal ion transmembrane transporter activity,MF,KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;GRIN1;FAM155A
17025,GO:0072678,0.0287976329497818,0.997657345673848,2,44,T cell migration,BP,CCL2;CXCL10
9194,GO:0034112,0.0288300342532867,0.999687641941653,1,4,positive regulation of homotypic cell-cell adhesion,BP,PDPN
18011,GO:0098706,0.0288809270265407,0.999686531321678,1,4,ferric iron import across plasma membrane,BP,STEAP3
6244,GO:0017157,0.0288856729614013,0.993887933122463,4,175,regulation of exocytosis,BP,ANXA1;CPLX2;KCNB1;RIMS2
16189,GO:0071216,0.0289462442533085,0.993867595141675,4,184,cellular response to biotic stimulus,BP,LTF;SERPINE1;CCL2;CXCL10
10045,GO:0035926,0.0289663013336811,0.999663807472307,1,5,chemokine (C-C motif) ligand 2 secretion,BP,POSTN
5678,GO:0016049,0.0289951833720838,0.990348827041247,7,437,cell growth,BP,TNFRSF12A;SH3GL2;IGFBP2;TNR;SPP1;POSTN;RIMS2
10300,GO:0036477,0.0290884637564998,0.988156655840721,10,725,somatodendritic compartment,CC,KCNIP3;SLC8A2;SNAP25;CPLX2;KCNB1;SHANK2;ATCAY;GRIN1;SHISA7;GABBR1
1199,GO:0002687,0.0291261871012231,0.99553376132965,3,113,positive regulation of leukocyte migration,BP,SERPINE1;LGALS3;CXCL10
13521,GO:0050829,0.0291433859207817,0.997608882002566,2,47,defense response to Gram-negative bacterium,BP,LTF;SERPINE1
8664,GO:0032803,0.0291610270731532,0.999659244809867,1,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,ANXA2
21594,GO:2000671,0.0295865342806197,0.999649166325264,1,5,regulation of motor neuron apoptotic process,BP,KCNB1
1637,GO:0003823,0.0300123349089809,0.997500193217487,2,46,antigen binding,MF,HLA-DQB1;HLA-DQA1
7696,GO:0031103,0.0301452525602827,0.997495299337478,2,40,axon regeneration,BP,TNR;SPP1
4933,GO:0010757,0.0302067129880158,0.999634210552374,1,5,negative regulation of plasminogen activation,BP,SERPINE1
17736,GO:0097350,0.0302523590318593,0.999633097298629,1,5,neutrophil clearance,BP,ANXA1
21079,GO:1990743,0.0302534185773885,0.999655826802647,1,4,protein sialylation,BP,ST8SIA3
18060,GO:0098802,0.0305235204153282,0.993431343169708,4,174,plasma membrane receptor complex,CC,SHANK2;GRIN1;SHISA7;GABBR1
18049,GO:0098791,0.0306110162487048,0.98742791862588,10,769,Golgi subcompartment,CC,SH3GL2;CUX2;GBP1;SNAP25;POSTN;GALNT13;FUT9;ST8SIA3;HLA-DQB1;HLA-DQA1
3509,GO:0006931,0.0307097802999984,0.999645295407916,1,4,substrate-dependent cell migration, cell attachment to substrate,BP,TNFRSF12A
20947,GO:1990254,0.0307706901756297,0.999620335638242,1,5,keratin filament binding,MF,VIM
1275,GO:0002792,0.0308881931716951,0.995159164560825,3,108,negative regulation of peptide secretion,BP,GBP1;ANXA1;KCNB1
18000,GO:0098662,0.0309108598574147,0.987943647307547,9,644,inorganic cation transmembrane transport,BP,KCNIP3;STEAP3;SLC8A2;KCNIP2;JPH3;KCNB1;CXCL10;GRIN1;FAM155A
4512,GO:0009409,0.0309290006115941,0.997387754908222,2,43,response to cold,BP,ADM;CXCL10
4812,GO:0010572,0.0309805524197905,0.999615105848007,1,5,positive regulation of platelet activation,BP,PDPN
1072,GO:0002449,0.0311016431033967,0.993259805290235,4,194,lymphocyte mediated immunity,BP,SERPING1;C1R;HLA-DQB1;CFI
7362,GO:0030424,0.0311191861818569,0.988610267106833,8,516,axon,CC,CRTAC1;KCNIP3;SNAP25;CPLX2;KCNB1;SHANK2;ATCAY;GRIN1
7843,GO:0031392,0.0311903296899249,0.999609841962134,1,5,regulation of prostaglandin biosynthetic process,BP,ANXA1
21873,GO:2001279,0.0311903296899249,0.999609841962134,1,5,regulation of unsaturated fatty acid biosynthetic process,BP,ANXA1
13105,GO:0048545,0.0311929326345901,0.990492757229267,6,362,response to steroid hormone,BP,COL1A1;LOX;IGFBP2;SPP1;ANXA1;ADM
14964,GO:0060711,0.0312980837657837,0.9973396767947,2,43,labyrinthine layer development,BP,ADM;SOCS3
19730,GO:1903428,0.0314746732486977,0.997318761786539,2,42,positive regulation of reactive oxygen species biosynthetic process,BP,PTX3;GRIN1
9747,GO:0035418,0.0316730506233504,0.997311876889168,2,35,protein localization to synapse,BP,SNAP25;GRIN1
3801,GO:0007566,0.031717591212347,0.997284649394817,2,43,embryo implantation,BP,TIMP1;SPP1
18834,GO:1901164,0.0321183212896058,0.999586121528414,1,5,negative regulation of trophoblast cell migration,BP,TIMP1
4787,GO:0010519,0.032205850214322,0.999583847592912,1,5,negative regulation of phospholipase activity,BP,ANXA1
5098,GO:0010976,0.0323523793651331,0.991349890346176,5,244,positive regulation of neuron projection development,BP,TNFRSF12A;CUX2;SHANK2;RIMS2;SLITRK1
563,GO:0001661,0.0323701993488484,0.999579560870555,1,5,conditioned taste aversion,BP,GRIN1
3501,GO:0006915,0.032416167770254,0.983124212077072,18,1756,apoptotic process,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;KCNIP3;STEAP3;GDF15;LGALS3;CHI3L1;ANXA1;ADM;KCNB1;PDPN;GABRB3;ATCAY;GRIN1;SOCS3
13493,GO:0050789,0.0327617474573234,0.980332026953579,73,9735,regulation of biological process,BP,TNFRSF12A;LTF;TYMP;VIM;SNAP91;FERMT1;TIMP1;SRPX2;SHD;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;SPOCD1;COL4A2;ANXA1;GNAL;EMP3;GPR17;CPLX2;ADAM12;ADM;SERPING1;SPHKAP;JPH3;AFF2;KCNB1;C1R;SHANK2;PDPN;S100A11;PTX3;CSMD3;GABRB3;ELFN2;ATCAY;COL3A1;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;SMOC1;GABBR1;CFI;IFI30
2762,GO:0005783,0.0327639074800644,0.983222475404867,17,1648,endoplasmic reticulum,CC,LTF;CP;MOXD1;TIMP1;COL1A1;KCNIP3;SPP1;CHI3L1;COL4A2;COL6A2;JPH3;COL3A1;GRIN1;HLA-DQB1;COL4A1;PLA2G2A;HLA-DQA1
3367,GO:0006701,0.0327893180255883,0.999568528205144,1,5,progesterone biosynthetic process,BP,ADM
11317,GO:0043523,0.0333068272016365,0.992631218518214,4,185,regulation of neuron apoptotic process,BP,CCL2;KCNB1;GABRB3;GRIN1
12227,GO:0045861,0.0333162489726701,0.9910133751782,5,275,negative regulation of proteolysis,BP,LTF;TIMP1;SERPINE1;SERPING1;SERPINA3
1883,GO:0004309,0.0333293061058982,0.999581730817183,1,4,exopolyphosphatase activity,MF,ATCAY
3426,GO:0006798,0.0333293061058982,0.999581730817183,1,4,polyphosphate catabolic process,BP,ATCAY
10730,GO:0042421,0.0334688384393662,0.999531775464582,1,6,norepinephrine biosynthetic process,BP,MOXD1
20363,GO:1904724,0.0334948816716287,0.99702956543709,2,52,tertiary granule lumen,CC,LTF;PTX3
4259,GO:0008823,0.0335588450721836,0.999547894383377,1,5,cupric reductase activity,MF,STEAP3
14365,GO:0052851,0.0335588450721836,0.999547894383377,1,5,ferric-chelate reductase (NADPH) activity,MF,STEAP3
12992,GO:0048260,0.0336754494961548,0.997020214203083,2,44,positive regulation of receptor-mediated endocytosis,BP,SERPINE1;ANXA2
12095,GO:0045627,0.0337278193765513,0.999524451678092,1,6,positive regulation of T-helper 1 cell differentiation,BP,ANXA1
2401,GO:0005047,0.0337833030402412,0.999522875148751,1,6,signal recognition particle binding,MF,LTF
10849,GO:0042640,0.0338356391832479,0.999540353025814,1,5,anagen,BP,FERMT1
14127,GO:0051884,0.0338356391832479,0.999540353025814,1,5,regulation of timing of anagen,BP,FERMT1
15300,GO:0061387,0.0340442969830342,0.994472077677023,3,96,regulation of extent of cell growth,BP,TNFRSF12A;TNR;SPP1
14189,GO:0051971,0.0342414608630874,0.999529181892456,1,5,positive regulation of transmission of nerve impulse,BP,TNR
17876,GO:0097646,0.0342652167170639,0.999509070654117,1,6,calcitonin family receptor signaling pathway,BP,ADM
15257,GO:0061304,0.0345891906978344,0.999549266231393,1,4,retinal blood vessel morphogenesis,BP,COL4A1
3506,GO:0006928,0.0346788605041732,0.981511228453067,19,1753,movement of cell or subcellular component,BP,TNFRSF12A;VIM;FERMT1;TIMP1;SRPX2;SERPINE1;SH3GL2;CCL2;COL1A1;TNR;PLAU;LGALS3;POSTN;ANXA1;SPHKAP;PDPN;COL3A1;CXCL10;DOK6
19370,GO:1902617,0.0347049130989043,0.999516257941813,1,5,response to fluoride,BP,COL1A1
7733,GO:0031201,0.0347448491829951,0.996862639240713,2,49,SNARE complex,CC,SNAP25;CPLX2
311,GO:0000820,0.0348244424776405,0.999512895918607,1,5,regulation of glutamine family amino acid metabolic process,BP,ATCAY
8939,GO:0033267,0.0348906997351508,0.989090344950443,6,340,axon part,CC,CRTAC1;KCNIP3;SNAP25;CPLX2;SHANK2;GRIN1
18227,GO:0099173,0.0350377743303978,0.994245950686569,3,97,postsynapse organization,BP,CUX2;SHANK2;SHISA7
4981,GO:0010830,0.0351014503141646,0.996819129431091,2,46,regulation of myotube differentiation,BP,GDF15;CXCL10
16605,GO:0071895,0.0351731395914915,0.99948252064923,1,6,odontoblast differentiation,BP,SERPINE1
11727,GO:0044706,0.0353168372467496,0.992042048086226,4,187,multi-multicellular organism process,BP,TIMP1;IGFBP2;SPP1;ADM
17793,GO:0097458,0.0353503315630362,0.982083264294877,16,1425,neuron part,CC,VIM;CRTAC1;KCNIP3;SLC8A2;SNAP25;CPLX2;CDHR1;KCNB1;SHANK2;SVOP;GABRB3;ATCAY;RIMS2;GRIN1;SHISA7;GABBR1
13280,GO:0048870,0.0353612322700026,0.982463305500535,15,1317,cell motility,BP,TNFRSF12A;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;TNR;PLAU;LGALS3;POSTN;ANXA1;PDPN;COL3A1;CXCL10
14025,GO:0051674,0.0353612322700026,0.982463305500535,15,1317,localization of cell,BP,TNFRSF12A;FERMT1;TIMP1;SRPX2;SERPINE1;CCL2;COL1A1;TNR;PLAU;LGALS3;POSTN;ANXA1;PDPN;COL3A1;CXCL10
10740,GO:0042439,0.035608525325851,0.999469537262373,1,6,ethanolamine-containing compound metabolic process,BP,MOXD1
9258,GO:0034220,0.0356355636104266,0.983736291758742,12,990,ion transmembrane transport,BP,KCNIP3;STEAP3;SLC8A2;KCNIP2;JPH3;KCNB1;SHANK2;GABRB3;CXCL10;GRIN1;SHISA7;FAM155A
10985,GO:0042981,0.0357850322033932,0.982221917375134,15,1399,regulation of apoptotic process,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;STEAP3;GDF15;LGALS3;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
18750,GO:1900454,0.0358695770735984,0.999482995895224,1,5,positive regulation of long term synaptic depression,BP,KCNB1
5458,GO:0015459,0.0358969520483046,0.996707418504245,2,46,potassium channel regulator activity,MF,KCNIP3;KCNIP2
2176,GO:0004720,0.0359428127229068,0.999459457916778,1,6,protein-lysine 6-oxidase activity,MF,LOX
2844,GO:0005913,0.0359972454281416,0.994017747516043,3,105,cell-cell adherens junction,CC,ANXA1;S100A11;ANXA2
13436,GO:0050708,0.0360738671832913,0.988624446746637,6,374,regulation of protein secretion,BP,FERMT1;GBP1;SNAP25;POSTN;ANXA1;KCNB1
5745,GO:0016191,0.0361439731712728,0.999474995944519,1,5,synaptic vesicle uncoating,BP,SH3GL2
14024,GO:0051673,0.0361672140668279,0.999437164768854,1,7,membrane disruption in other organism,BP,LTF
9660,GO:0035254,0.0361685299829871,0.996681925855578,2,41,glutamate receptor binding,MF,SHANK2;SHISA7
10759,GO:0042476,0.0362811361637038,0.993952158203066,3,105,odontogenesis,BP,SERPINE1;COL1A1;ADM
13438,GO:0050710,0.0363593798286107,0.996635298430855,2,49,negative regulation of cytokine secretion,BP,GBP1;ANXA1
7197,GO:0030160,0.0364758971650228,0.999498345122444,1,4,GKAP/Homer scaffold activity,MF,SHANK2
5581,GO:0015850,0.0365741486041554,0.991666939068403,4,190,organic hydroxy compound transport,BP,ABCC3;SPP1;KCNB1;ANXA2
2121,GO:0004645,0.0366652584831569,0.999437346095487,1,6,phosphorylase activity,MF,TYMP
14517,GO:0060052,0.0368222619640711,0.999432481204468,1,6,neurofilament cytoskeleton organization,BP,INA
6687,GO:0019882,0.0368621777754258,0.991573269354214,4,207,antigen processing and presentation,BP,SH3GL2;HLA-DQB1;HLA-DQA1;IFI30
18745,GO:1900449,0.0370041590103875,0.996560105654399,2,42,regulation of glutamate receptor signaling pathway,BP,SHANK2;SHISA7
11044,GO:0043066,0.0370963229249149,0.984263017710788,10,812,negative regulation of apoptotic process,BP,LTF;TIMP1;SERPINE1;CCL2;LGALS3;ANXA1;PDPN;GABRB3;GRIN1;SOCS3
7991,GO:0031663,0.0372055370025144,0.996513875402107,2,49,lipopolysaccharide-mediated signaling pathway,BP,LTF;CCL2
15119,GO:0060999,0.0373378820899351,0.996521577092673,2,39,positive regulation of dendritic spine development,BP,CUX2;SHANK2
15667,GO:0070206,0.0373712046246847,0.99649209815548,2,48,protein trimerization,BP,COL1A1;COL6A2
20869,GO:1905952,0.0374635342478864,0.993672820736337,3,109,regulation of lipid localization,BP,SPP1;VSTM2A;ANXA2
17242,GO:0090091,0.0374829092116554,0.999435064802545,1,5,positive regulation of extracellular matrix disassembly,BP,PDPN
11876,GO:0045111,0.0374935055161513,0.99366870829657,3,106,intermediate filament cytoskeleton,CC,VIM;INA;SHANK2
8929,GO:0033239,0.0375003399568529,0.999434535164701,1,5,negative regulation of cellular amine metabolic process,BP,ATCAY
17258,GO:0090118,0.0375314225976799,0.999433590084951,1,5,receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
1895,GO:0004322,0.0376225614439358,0.999430814352744,1,5,ferroxidase activity,MF,CP
6015,GO:0016724,0.0376225614439358,0.999430814352744,1,5,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,CP
835,GO:0002042,0.0376907780812235,0.996452961613137,2,45,cell migration involved in sprouting angiogenesis,BP,SRPX2;ANXA1
9992,GO:0035821,0.0381027869337719,0.993513502183345,3,119,modification of morphology or physiology of other organism,BP,LTF;PTX3;ANXA2
11045,GO:0043067,0.0381467269603667,0.980885802604921,15,1411,regulation of programmed cell death,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;STEAP3;GDF15;LGALS3;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
2778,GO:0005802,0.0382072561866,0.99117565697374,4,189,trans-Golgi network,CC,SNAP25;POSTN;HLA-DQB1;HLA-DQA1
4792,GO:0010524,0.0382116031819184,0.996367492803199,2,49,positive regulation of calcium ion transport into cytosol,BP,CXCL10;GRIN1
3848,GO:0008015,0.0382375511780127,0.986507374549426,7,464,blood circulation,BP,KCNIP3;SLC8A2;KCNIP2;POSTN;ADM;SERPING1;CXCL10
18293,GO:0099601,0.0382794783957449,0.99636986369351,2,44,regulation of neurotransmitter receptor activity,BP,SHANK2;SHISA7
7741,GO:0031214,0.0382882388775015,0.993475660877345,3,112,biomineral tissue development,BP,LTF;COL1A1;SPP1
10632,GO:0042246,0.0384228967121311,0.99633429553895,2,50,tissue regeneration,BP,POSTN;ANXA1
8463,GO:0032496,0.038444038417018,0.98922077711702,5,302,response to lipopolysaccharide,BP,LTF;SERPINE1;CCL2;ADM;CXCL10
21824,GO:2001205,0.0384785321030732,0.999404408443891,1,5,negative regulation of osteoclast development,BP,LTF
8570,GO:0032663,0.0385413344790475,0.996319044674354,2,49,regulation of interleukin-2 production,BP,GBP1;ANXA1
7149,GO:0030073,0.038711660156814,0.991023909832317,4,186,insulin secretion,BP,SNAP25;ANXA1;KCNB1;RIMS2
11476,GO:0044033,0.0387492208580805,0.999353274331794,1,7,multi-organism metabolic process,BP,ANXA2
18067,GO:0098814,0.0388572773880678,0.999392530344964,1,5,spontaneous synaptic transmission,BP,RIMS2
3425,GO:0006797,0.038869593524831,0.99939214208919,1,5,polyphosphate metabolic process,BP,ATCAY
8811,GO:0033029,0.0389280417249202,0.999365175891866,1,6,regulation of neutrophil apoptotic process,BP,ANXA1
3757,GO:0007409,0.0392126092330354,0.986094420378672,7,435,axonogenesis,BP,TNFRSF12A;TNR;SPP1;FMOD;GRIN1;SLITRK1;DOK6
8353,GO:0032370,0.039256146027991,0.996218009852299,2,47,positive regulation of lipid transport,BP,SPP1;ANXA2
10368,GO:0038044,0.0392658467291707,0.999379583269318,1,5,transforming growth factor-beta secretion,BP,FERMT1
4900,GO:0010718,0.0394014177728587,0.996204451567215,2,44,positive regulation of epithelial to mesenchymal transition,BP,COL1A1;PDPN
2521,GO:0005267,0.0394182214773726,0.99320021885495,3,119,potassium channel activity,MF,KCNIP3;KCNIP2;KCNB1
4199,GO:0008603,0.0394576474594498,0.999329222924476,1,7,cAMP-dependent protein kinase regulator activity,MF,CXCL10
8919,GO:0033216,0.0394827051190716,0.999346810223517,1,6,ferric iron import,BP,STEAP3
9952,GO:0035749,0.0394922972600798,0.999346490274046,1,6,myelin sheath adaxonal region,CC,ANXA2
12646,GO:0046790,0.0395045953986486,0.999371953372292,1,5,virion binding,MF,PTX3
15814,GO:0070459,0.0396105254802123,0.999323974137524,1,7,prolactin secretion,BP,ANXA1
19532,GO:1903012,0.0396340177500697,0.999323165731749,1,7,positive regulation of bone development,BP,LTF
2629,GO:0005544,0.0398452923930017,0.996127584112831,2,48,calcium-dependent phospholipid binding,MF,ANXA1;ANXA2
1209,GO:0002697,0.0399039881996915,0.988699687794496,5,301,regulation of immune effector process,BP,LGALS3;ANXA1;SERPING1;C1R;CFI
11047,GO:0043069,0.0399562352741084,0.982833939708265,10,823,negative regulation of programmed cell death,BP,LTF;TIMP1;SERPINE1;CCL2;LGALS3;ANXA1;PDPN;GABRB3;GRIN1;SOCS3
12548,GO:0046579,0.0400351975487276,0.996104215367289,2,46,positive regulation of Ras protein signal transduction,BP,GPR17;COL3A1
13474,GO:0050766,0.040091776607106,0.996088138927802,2,49,positive regulation of phagocytosis,BP,CCL2;PTX3
15041,GO:0060839,0.0402698595601989,0.999301099011846,1,7,endothelial cell fate commitment,BP,PDPN
2583,GO:0005432,0.040290979536422,0.999319570614905,1,6,calcium:sodium antiporter activity,MF,SLC8A2
18012,GO:0098711,0.0403172500614506,0.999318675784477,1,6,iron ion import across plasma membrane,BP,STEAP3
11374,GO:0043615,0.040321266641853,0.999299299229415,1,7,astrocyte cell migration,BP,CCL2
1375,GO:0003013,0.040374897101511,0.985586501212505,7,468,circulatory system process,BP,KCNIP3;SLC8A2;KCNIP2;POSTN;ADM;SERPING1;CXCL10
10729,GO:0042420,0.040443172959533,0.999295021840495,1,7,dopamine catabolic process,BP,MOXD1
17663,GO:0097197,0.0405969248504407,0.999289608210596,1,7,tetraspanin-enriched microdomain,CC,PDPN
13715,GO:0051130,0.040657612763388,0.980472641361289,13,1122,positive regulation of cellular component organization,BP,TNFRSF12A;SRPX2;SERPINE1;CCL2;CUX2;GDF15;ANXA1;SHANK2;PDPN;PTX3;RIMS2;SLITRK1;ANXA2
6809,GO:0021578,0.0408506521886445,0.999300377683086,1,6,hindbrain maturation,BP,GRIN1
6829,GO:0021626,0.0408506521886445,0.999300377683086,1,6,central nervous system maturation,BP,GRIN1
17416,GO:0090336,0.0409251642314439,0.999297801962318,1,6,positive regulation of brown fat cell differentiation,BP,VSTM2A
12828,GO:0047498,0.0409955375974713,0.999275474988847,1,7,calcium-dependent phospholipase A2 activity,MF,PLA2G2A
17859,GO:0097623,0.041010427415116,0.999274944314128,1,7,potassium ion export across plasma membrane,BP,KCNIP2
17997,GO:0098659,0.0411486849916371,0.995930350599786,2,48,inorganic cation import across plasma membrane,BP,STEAP3;FAM155A
18290,GO:0099587,0.0411486849916371,0.995930350599786,2,48,inorganic ion import across plasma membrane,BP,STEAP3;FAM155A
13562,GO:0050885,0.0412932888770051,0.995919528219736,2,44,neuromuscular process controlling balance,BP,TNR;JPH3
2507,GO:0005244,0.041314464644606,0.990223635570079,4,184,voltage-gated ion channel activity,MF,KCNIP3;KCNIP2;KCNB1;GRIN1
7062,GO:0022832,0.041314464644606,0.990223635570079,4,184,voltage-gated channel activity,MF,KCNIP3;KCNIP2;KCNB1;GRIN1
16858,GO:0072318,0.0413170516229589,0.999284176054104,1,6,clathrin coat disassembly,BP,SH3GL2
5612,GO:0015909,0.0413889563519321,0.995886294556167,2,51,long-chain fatty acid transport,BP,ANXA1;PLA2G2A
9950,GO:0035747,0.0415471927033345,0.99925568206502,1,7,natural killer cell chemotaxis,BP,CCL2
551,GO:0001649,0.0417919917682808,0.990070734123229,4,191,osteoblast differentiation,BP,LTF;COL1A1;SPP1;SMOC1
14149,GO:0051918,0.0417950050274856,0.999246702504069,1,7,negative regulation of fibrinolysis,BP,SERPINE1
771,GO:0001957,0.0418142938945886,0.999266695297092,1,6,intramembranous ossification,BP,COL1A1
10134,GO:0036072,0.0418142938945886,0.999266695297092,1,6,direct ossification,BP,COL1A1
17572,GO:0097049,0.0420794012377476,0.999236329854285,1,7,motor neuron apoptotic process,BP,KCNB1
9164,GO:0034040,0.0421628665453995,0.999254313203719,1,6,lipid-transporting ATPase activity,MF,ABCC3
11326,GO:0043536,0.0422134283755632,0.995766606682125,2,48,positive regulation of blood vessel endothelial cell migration,BP,SRPX2;ANXA1
11403,GO:0043679,0.0425801388264418,0.992431631210522,3,117,axon terminus,CC,KCNIP3;CPLX2;GRIN1
2399,GO:0005044,0.0426080288382292,0.995700134825794,2,50,scavenger receptor activity,MF,CD163;CFI
13534,GO:0050854,0.0426278403767583,0.995692253314804,2,52,regulation of antigen receptor-mediated signaling pathway,BP,GBP1;LGALS3
21413,GO:2000402,0.0427538634439532,0.999211442132443,1,7,negative regulation of lymphocyte migration,BP,CCL2
21366,GO:2000343,0.0428088826608832,0.999193134721204,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
3626,GO:0007156,0.0428817647210623,0.99238348093686,3,95,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDHR1;PCDH7;PTPRT
473,GO:0001505,0.0429566199715773,0.987597199960667,5,285,regulation of neurotransmitter levels,BP,MOXD1;SNAP25;CPLX2;PTX3;RIMS2
4409,GO:0009187,0.0429612186145893,0.992338150991395,3,116,cyclic nucleotide metabolic process,BP,ADM;CXCL10;GABBR1
10576,GO:0042110,0.0429976087030427,0.985860853643223,6,403,T cell activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1;HLA-DQA1
697,GO:0001849,0.0431040507712285,0.999220353299005,1,6,complement component C1q binding,MF,PTX3
951,GO:0002250,0.0432124014717043,0.98749509473379,5,311,adaptive immune response,BP,ANXA1;SERPING1;C1R;HLA-DQB1;CFI
2772,GO:0005794,0.0432628182100779,0.977951661874118,15,1391,Golgi apparatus,CC,SH3GL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;FMOD;GDF15;SNAP25;POSTN;GALNT13;FUT9;ST8SIA3;HLA-DQB1;HLA-DQA1
3885,GO:0008083,0.0435069647818804,0.992187232517801,3,133,growth factor activity,MF,TYMP;TIMP1;GDF15
2764,GO:0005785,0.0435156189805641,0.999166043486663,1,8,signal recognition particle receptor complex,CC,LTF
10366,GO:0038042,0.043575093954479,0.999180590535853,1,7,dimeric G-protein coupled receptor signaling pathway,BP,ADM
14437,GO:0055076,0.0437144495256264,0.992142786406269,3,124,transition metal ion homeostasis,BP,LTF;CP;STEAP3
639,GO:0001781,0.0439256075561968,0.999167239199031,1,7,neutrophil apoptotic process,BP,ANXA1
3972,GO:0008219,0.044222122307072,0.975727810994865,19,1956,cell death,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;KCNIP3;STEAP3;GDF15;LGALS3;CHI3L1;ANXA1;EMP3;ADM;KCNB1;PDPN;GABRB3;ATCAY;GRIN1;SOCS3
4183,GO:0008559,0.0442580494995505,0.99917766406912,1,6,xenobiotic transmembrane transporting ATPase activity,MF,ABCC3
13531,GO:0050851,0.0447080229738097,0.989133418909712,4,221,antigen receptor-mediated signaling pathway,BP,GBP1;LGALS3;HLA-DQB1;HLA-DQA1
3764,GO:0007420,0.0448199009183782,0.981304635538697,9,656,brain development,BP,CRTAC1;TNR;INA;CA10;AFF2;SHANK2;COL3A1;GRIN1;COL4A1
8816,GO:0033034,0.0448559728029562,0.999131268247693,1,7,positive regulation of myeloid cell apoptotic process,BP,ANXA1
727,GO:0001895,0.0448756383247026,0.995336232850422,2,52,retina homeostasis,BP,LTF;CDHR1
8576,GO:0032677,0.0448844446257912,0.995327764329506,2,55,regulation of interleukin-8 production,BP,SERPINE1;ANXA1
8360,GO:0032377,0.0453432793087061,0.999112118405982,1,7,regulation of intracellular lipid transport,BP,ANXA2
8363,GO:0032380,0.0453432793087061,0.999112118405982,1,7,regulation of intracellular sterol transport,BP,ANXA2
8366,GO:0032383,0.0453432793087061,0.999112118405982,1,7,regulation of intracellular cholesterol transport,BP,ANXA2
975,GO:0002291,0.0453932108790717,0.999091858474327,1,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
12253,GO:0045916,0.0454159719359175,0.99913366499128,1,6,negative regulation of complement activation,BP,SERPING1
21306,GO:2000258,0.0454159719359175,0.99913366499128,1,6,negative regulation of protein activation cascade,BP,SERPING1
5117,GO:0012501,0.0456248847588222,0.97523692289916,18,1832,programmed cell death,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;KCNIP3;STEAP3;GDF15;LGALS3;CHI3L1;ANXA1;ADM;KCNB1;PDPN;GABRB3;ATCAY;GRIN1;SOCS3
13076,GO:0048489,0.0458864537536364,0.991601672628124,3,116,synaptic vesicle transport,BP,SNAP25;CPLX2;RIMS2
17804,GO:0097480,0.0458864537536364,0.991601672628124,3,116,establishment of synaptic vesicle localization,BP,SNAP25;CPLX2;RIMS2
20533,GO:1905049,0.0459012989803915,0.999114876015813,1,6,negative regulation of metallopeptidase activity,BP,TIMP1
7073,GO:0022849,0.0459993124278911,0.99914616441362,1,5,glutamate-gated calcium ion channel activity,MF,GRIN1
6594,GO:0019614,0.0460728264955133,0.999064213261563,1,8,catechol-containing compound catabolic process,BP,MOXD1
10732,GO:0042424,0.0460728264955133,0.999064213261563,1,8,catecholamine catabolic process,BP,MOXD1
9872,GO:0035630,0.0462370440235131,0.999076443254561,1,7,bone mineralization involved in bone maturation,BP,LTF
16859,GO:0072319,0.0465091293835837,0.999065440703007,1,7,vesicle uncoating,BP,SH3GL2
6615,GO:0019730,0.0467337272663852,0.995010276503062,2,63,antimicrobial humoral response,BP,LTF;PLA2G2A
20556,GO:1905114,0.0467503147363332,0.981464851163062,8,584,cell surface receptor signaling pathway involved in cell-cell signaling,BP,FERMT1;COL1A1;CUX2;IGFBP2;SHANK2;GABRB3;RIMS2;GRIN1
1274,GO:0002791,0.0468138329619784,0.98429078505329,6,400,regulation of peptide secretion,BP,FERMT1;GBP1;SNAP25;POSTN;ANXA1;KCNB1
21460,GO:2000483,0.0468267205180443,0.99905251404996,1,7,negative regulation of interleukin-8 secretion,BP,ANXA1
9535,GO:0034762,0.0468953885779804,0.982709101907531,7,476,regulation of transmembrane transport,BP,KCNIP3;KCNIP2;JPH3;KCNB1;SHANK2;CXCL10;SHISA7
3974,GO:0008228,0.046903738122208,0.999049365638641,1,7,opsonization,BP,PTX3
7750,GO:0031232,0.0469527755874465,0.999047358258558,1,7,extrinsic component of external side of plasma membrane,CC,ANXA1
10585,GO:0042129,0.0470560918824465,0.991284960866206,3,133,regulation of T cell proliferation,BP,IGFBP2;LGALS3;ANXA1
945,GO:0002237,0.0471625013631472,0.986022823563782,5,318,response to molecule of bacterial origin,BP,LTF;SERPINE1;CCL2;ADM;CXCL10
1312,GO:0002862,0.0476362552157908,0.998983356181148,1,9,negative regulation of inflammatory response to antigenic stimulus,BP,GPR17
15599,GO:0070097,0.0478030805724675,0.999039270062957,1,6,delta-catenin binding,MF,PTPRT
19146,GO:1902041,0.0478311783164959,0.994844871500185,2,55,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1;LGALS3
18162,GO:0098978,0.0482767214186234,0.999019948958626,1,6,glutamatergic synapse,CC,SHISA7
18166,GO:0098985,0.0482767214186234,0.999019948958626,1,6,asymmetric, glutamatergic, excitatory synapse,CC,SHISA7
18634,GO:1900122,0.0484628924684009,0.998963636085267,1,8,positive regulation of receptor binding,BP,ANXA2
18586,GO:1900040,0.0485233787772365,0.99898192307229,1,7,regulation of interleukin-2 secretion,BP,GBP1
13884,GO:0051402,0.0486006459512483,0.987876280810646,4,208,neuron apoptotic process,BP,CCL2;KCNB1;GABRB3;GRIN1
21433,GO:2000427,0.0487141554782833,0.998973823942248,1,7,positive regulation of apoptotic cell clearance,BP,CCL2
8542,GO:0032623,0.0488181616350765,0.994676805870456,2,56,interleukin-2 production,BP,GBP1;ANXA1
10228,GO:0036310,0.0490225024776158,0.998939331084536,1,8,annealing helicase activity,MF,ANXA1
13874,GO:0051384,0.0490423392104579,0.99077018915441,3,130,response to glucocorticoid,BP,IGFBP2;ANXA1;ADM
7060,GO:0022824,0.0491027834697959,0.994642143455894,2,51,transmitter-gated ion channel activity,MF,GABRB3;GRIN1
7064,GO:0022835,0.0491027834697959,0.994642143455894,2,51,transmitter-gated channel activity,MF,GABRB3;GRIN1
15897,GO:0070588,0.0493311527439826,0.985215362627179,5,277,calcium ion transmembrane transport,BP,SLC8A2;JPH3;CXCL10;GRIN1;FAM155A
11612,GO:0044344,0.0495115921805901,0.990651641742647,3,125,cellular response to fibroblast growth factor stimulus,BP,CCL2;COL1A1;POSTN
10033,GO:0035904,0.0495669920024728,0.994576540439283,2,47,aorta development,BP,LOX;COL3A1
14489,GO:0060020,0.0497072299012112,0.998909201258997,1,8,Bergmann glial cell differentiation,BP,VIM
7802,GO:0031313,0.0498348109263426,0.998903539804471,1,8,extrinsic component of endosome membrane,CC,ANXA1
1641,GO:0003828,0.0500430044136205,0.998946166666581,1,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,ST8SIA3
19531,GO:1903011,0.0500945926313782,0.99891424434261,1,7,negative regulation of bone development,BP,LTF
420,GO:0001101,0.050175098217624,0.984880014881886,5,309,response to acid chemical,BP,COL1A1;IGFBP2;COL3A1;GRIN1;COL4A1
705,GO:0001867,0.0503455302143192,0.998863234220614,1,9,complement activation, lectin pathway,BP,SERPING1
4551,GO:0009617,0.0505589507432503,0.982708923631678,6,432,response to bacterium,BP,LTF;SERPINE1;CCL2;ADM;CXCL10;PLA2G2A
5120,GO:0012507,0.0508423897262646,0.994328542991484,2,57,ER to Golgi transport vesicle membrane,CC,HLA-DQB1;HLA-DQA1
624,GO:0001765,0.0508632181425685,0.998839503136053,1,9,membrane raft assembly,BP,ANXA2
5107,GO:0010988,0.051064214592275,0.998830221972741,1,9,regulation of low-density lipoprotein particle clearance,BP,ANXA2
2997,GO:0006171,0.0510955429213215,0.994289931172587,2,55,cAMP biosynthetic process,BP,ADM;GABBR1
17592,GO:0097084,0.0512055359653558,0.998841770238825,1,8,vascular smooth muscle cell development,BP,ADM
6508,GO:0019336,0.0512124872276134,0.998823351206751,1,9,phenol-containing compound catabolic process,BP,MOXD1
9221,GO:0034145,0.0512448159818575,0.998821850408444,1,9,positive regulation of toll-like receptor 4 signaling pathway,BP,LTF
7198,GO:0030162,0.0512993991651617,0.979271915226025,8,636,regulation of proteolysis,BP,LTF;TIMP1;SERPINE1;SERPING1;C1R;GRIN1;SERPINA3;CFI
15151,GO:0061042,0.051708295146186,0.998800227036777,1,9,vascular wound healing,BP,SERPINE1
3793,GO:0007528,0.0517872364454934,0.994199363479317,2,46,neuromuscular junction development,BP,SHANK2;COL4A1
16323,GO:0071420,0.0518042752792882,0.998838075809063,1,7,cellular response to histamine,BP,GABRB3
3657,GO:0007191,0.0518111784877697,0.998795399862825,1,9,adenylate cyclase-activating dopamine receptor signaling pathway,BP,GNAL
4067,GO:0008381,0.0518438613944178,0.998793864347307,1,9,mechanosensitive ion channel activity,MF,FAM155A
902,GO:0002151,0.0519018597824193,0.998865564441938,1,6,G-quadruplex RNA binding,MF,AFF2
9309,GO:0034350,0.0519930022685694,0.99880550314217,1,8,regulation of glial cell apoptotic process,BP,CCL2
9310,GO:0034351,0.0519930022685694,0.99880550314217,1,8,negative regulation of glial cell apoptotic process,BP,CCL2
3473,GO:0006879,0.0519994600238205,0.994124741145871,2,58,cellular iron ion homeostasis,BP,LTF;CP
12712,GO:0046928,0.0521683313765703,0.994111884265421,2,52,regulation of neurotransmitter secretion,BP,CPLX2;RIMS2
17610,GO:0097113,0.0523953258284436,0.998811130573088,1,7,AMPA glutamate receptor clustering,BP,SHISA7
17888,GO:0097688,0.0523953258284436,0.998811130573088,1,7,glutamate receptor clustering,BP,SHISA7
18155,GO:0098969,0.052969519328035,0.99874036918103,1,9,neurotransmitter receptor transport to postsynaptic membrane,BP,SNAP25
19784,GO:1903540,0.052969519328035,0.99874036918103,1,9,establishment of protein localization to postsynaptic membrane,BP,SNAP25
19038,GO:1901701,0.0533177920238654,0.974951393080833,11,959,cellular response to oxygen-containing compound,BP,LTF;SERPINE1;CCL2;COL1A1;SPP1;ANXA1;KCNB1;COL3A1;CXCL10;SOCS3;COL4A1
9632,GO:0035176,0.0533657218176824,0.993911273873132,2,49,social behavior,BP,SHANK2;GRIN1
14038,GO:0051703,0.0533657218176824,0.993911273873132,2,49,intraspecies interaction between organisms,BP,SHANK2;GRIN1
10363,GO:0038037,0.0533976378722277,0.998739394740848,1,8,G-protein coupled receptor dimeric complex,CC,GABBR1
17878,GO:0097648,0.0533976378722277,0.998739394740848,1,8,G-protein coupled receptor complex,CC,GABBR1
15117,GO:0060997,0.0535428969059185,0.993883620671066,2,48,dendritic spine morphogenesis,BP,CUX2;SHANK2
21364,GO:2000341,0.0535671425169936,0.99869564772176,1,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
1206,GO:0002694,0.0537843423025862,0.981328173281201,6,431,regulation of leukocyte activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1;HLA-DQA1
7031,GO:0022408,0.0540100328394056,0.989432801314086,3,135,negative regulation of cell-cell adhesion,BP,TNR;LGALS3;ANXA1
17803,GO:0097479,0.0540305502331329,0.9894403099262,3,123,synaptic vesicle localization,BP,SNAP25;CPLX2;RIMS2
9067,GO:0033629,0.054067576014426,0.998707223998278,1,8,negative regulation of cell adhesion mediated by integrin,BP,SERPINE1
3828,GO:0007614,0.0541075908964909,0.998685079189919,1,9,short-term memory,BP,CUX2
13660,GO:0051045,0.0542703704863967,0.998697404079185,1,8,negative regulation of membrane protein ectodomain proteolysis,BP,TIMP1
267,GO:0000733,0.0543380592984349,0.998673734878737,1,9,DNA strand renaturation,BP,ANXA1
16306,GO:0071394,0.0545069001704564,0.998665392468759,1,9,cellular response to testosterone stimulus,BP,SPP1
19853,GO:1903670,0.0548447911976945,0.993627243002688,2,55,regulation of sprouting angiogenesis,BP,SRPX2;ANXA1
5513,GO:0015718,0.0549335301246279,0.989180181965671,3,134,monocarboxylic acid transport,BP,ABCC3;ANXA1;PLA2G2A
16536,GO:0071774,0.0550449666190651,0.989153727494368,3,130,response to fibroblast growth factor,BP,CCL2;COL1A1;POSTN
11318,GO:0043524,0.0550572983672605,0.989149233995813,3,131,negative regulation of neuron apoptotic process,BP,CCL2;GABRB3;GRIN1
13672,GO:0051057,0.0551797173926603,0.993573031781098,2,53,positive regulation of small GTPase mediated signal transduction,BP,GPR17;COL3A1
6786,GO:0021548,0.0552802955623656,0.998626837570096,1,9,pons development,BP,GRIN1
17629,GO:0097151,0.055517678145669,0.998663546797103,1,7,positive regulation of inhibitory postsynaptic potential,BP,RIMS2
18074,GO:0098828,0.055517678145669,0.998663546797103,1,7,modulation of inhibitory postsynaptic potential,BP,RIMS2
19975,GO:1903909,0.0555535242373511,0.998634389692226,1,8,regulation of receptor clustering,BP,SHISA7
15751,GO:0070341,0.0556127798394683,0.998610090337087,1,9,fat cell proliferation,BP,VSTM2A
15753,GO:0070344,0.0556127798394683,0.998610090337087,1,9,regulation of fat cell proliferation,BP,VSTM2A
13286,GO:0048878,0.0557363660948653,0.973619426547912,11,971,chemical homeostasis,BP,LTF;CP;STEAP3;SLC8A2;GPR17;ADM;JPH3;KCNB1;CXCL10;GRIN1;FAM155A
7309,GO:0030314,0.0558274941061771,0.998648421445523,1,7,junctional membrane complex,CC,JPH3
4931,GO:0010755,0.0560421088516009,0.998570972588285,1,10,regulation of plasminogen activation,BP,SERPINE1
10178,GO:0036149,0.0562323329662194,0.998561149572059,1,10,phosphatidylinositol acyl-chain remodeling,BP,PLA2G2A
20989,GO:1990416,0.0562606997073785,0.998599010676223,1,8,cellular response to brain-derived neurotrophic factor stimulus,BP,SH3GL2
11677,GO:0044463,0.0562799060210067,0.97090449372113,14,1261,cell projection part,CC,CRTAC1;FERMT1;KCNIP3;SLC8A2;SNAP25;CPLX2;CDHR1;KCNB1;SHANK2;PDPN;ATCAY;GRIN1;SHISA7;GABBR1
18474,GO:0120038,0.0562799060210067,0.97090449372113,14,1261,plasma membrane bounded cell projection part,CC,CRTAC1;FERMT1;KCNIP3;SLC8A2;SNAP25;CPLX2;CDHR1;KCNB1;SHANK2;PDPN;ATCAY;GRIN1;SHISA7;GABBR1
12708,GO:0046920,0.0563194324052434,0.99859605155824,1,8,alpha-(1->3)-fucosyltransferase activity,MF,FUT9
7820,GO:0031338,0.0564776610546683,0.993324286597623,2,57,regulation of vesicle fusion,BP,ANXA1;ANXA2
16308,GO:0071396,0.0571830297727392,0.977968592491346,7,523,cellular response to lipid,BP,LTF;SERPINE1;CCL2;COL1A1;SPP1;ANXA1;CXCL10
4970,GO:0010819,0.0572543343825435,0.998507785525817,1,10,regulation of T cell chemotaxis,BP,CXCL10
11172,GO:0043270,0.0573384080745543,0.984909690987197,4,217,positive regulation of ion transport,BP,CCL2;LGALS3;CXCL10;GRIN1
14148,GO:0051917,0.0575402317670937,0.998492679528389,1,10,regulation of fibrinolysis,BP,SERPINE1
12245,GO:0045906,0.0576455003662759,0.998557910787922,1,7,negative regulation of vasoconstriction,BP,ADM
12093,GO:0045625,0.0576758282947441,0.998485487805784,1,10,regulation of T-helper 1 cell differentiation,BP,ANXA1
5221,GO:0014823,0.0576872319065021,0.993104012047909,2,56,response to activity,BP,POSTN;COL4A2
8406,GO:0032429,0.0576970596412199,0.998525727005374,1,8,regulation of phospholipase A2 activity,BP,ANXA1
8141,GO:0031995,0.0578126167195536,0.998519748184889,1,8,insulin-like growth factor II binding,MF,IGFBP2
1868,GO:0004185,0.057826813488928,0.99849592238515,1,9,serine-type carboxypeptidase activity,MF,AEBP1
3646,GO:0007178,0.0578326727654721,0.981881418145061,5,300,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,VIM;FERMT1;FMOD;GDF15;COL3A1
1863,GO:0004175,0.0578758053410399,0.981850351967473,5,335,endopeptidase activity,MF,LTF;PLAU;ADAM12;C1R;CFI
10544,GO:0042048,0.0579499384283691,0.998542460734823,1,7,olfactory behavior,BP,GRIN1
11783,GO:0044848,0.0581373010157309,0.998479543486104,1,9,biological phase,BP,FERMT1
11785,GO:0044851,0.0581373010157309,0.998479543486104,1,9,hair cycle phase,BP,FERMT1
13251,GO:0048819,0.0581373010157309,0.998479543486104,1,9,regulation of hair follicle maturation,BP,FERMT1
3956,GO:0008201,0.0583365842111914,0.988227936005472,3,136,heparin binding,MF,LTF;POSTN;CXCL10
6501,GO:0019317,0.0583384538835054,0.998492385515819,1,8,fucose catabolic process,BP,FUT9
10690,GO:0042354,0.0583384538835054,0.998492385515819,1,8,L-fucose metabolic process,BP,FUT9
10691,GO:0042355,0.0583384538835054,0.998492385515819,1,8,L-fucose catabolic process,BP,FUT9
7998,GO:0031670,0.0583859862968215,0.992964778027373,2,59,cellular response to nutrient,BP,COL1A1;POSTN
11583,GO:0044306,0.058448145858757,0.988200864053836,3,132,neuron projection terminus,CC,KCNIP3;CPLX2;GRIN1
17313,GO:0090197,0.0584567678429081,0.998443727908369,1,10,positive regulation of chemokine secretion,BP,POSTN
18102,GO:0098877,0.0586933260396307,0.998430963594415,1,10,neurotransmitter receptor transport to plasma membrane,BP,SNAP25
17939,GO:0098542,0.0587625643357219,0.981491566053189,5,343,defense response to other organism,BP,LTF;SERPINE1;GBP1;CXCL10;PLA2G2A
21569,GO:2000644,0.0589423738988782,0.998436651425444,1,9,regulation of receptor catabolic process,BP,ANXA2
5821,GO:0016328,0.0589664446551387,0.992864975449693,2,56,lateral plasma membrane,CC,ANXA1;KCNB1
18229,GO:0099175,0.0590690620725857,0.992855916789325,2,53,regulation of postsynapse organization,BP,CUX2;SHISA7
10963,GO:0042910,0.0591126025556784,0.998451634895011,1,8,xenobiotic transmembrane transporter activity,MF,ABCC3
7993,GO:0031665,0.0593606348051535,0.998394669231861,1,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,LTF
7787,GO:0031295,0.0593990975452628,0.992753545025185,2,67,T cell costimulation,BP,HLA-DQB1;HLA-DQA1
8517,GO:0032589,0.0594220126186717,0.992789459813671,2,53,neuron projection membrane,CC,KCNB1;SHISA7
9098,GO:0033691,0.0595810479183643,0.99842670613405,1,8,sialic acid binding,MF,ST8SIA3
15321,GO:0061450,0.0596234059547903,0.99838026081677,1,10,trophoblast cell migration,BP,TIMP1
18833,GO:1901163,0.0596234059547903,0.99838026081677,1,10,regulation of trophoblast cell migration,BP,TIMP1
11058,GO:0043097,0.0596331382904416,0.998363666117427,1,11,pyrimidine nucleoside salvage,BP,TYMP
21431,GO:2000425,0.0598936084010121,0.998385185328618,1,9,regulation of apoptotic cell clearance,BP,CCL2
10580,GO:0042118,0.0601177794170129,0.998372932447783,1,9,endothelial cell activation,BP,CXCL10
5490,GO:0015677,0.0601225109573549,0.998397637710666,1,8,copper ion import,BP,STEAP3
2520,GO:0005262,0.0602238691490932,0.987723703735327,3,112,calcium channel activity,MF,JPH3;GRIN1;FAM155A
11364,GO:0043589,0.060277072703318,0.99838929008376,1,8,skin morphogenesis,BP,COL1A1
21832,GO:2001223,0.0603562074234448,0.998385007551595,1,8,negative regulation of neuron migration,BP,COL3A1
13174,GO:0048678,0.0604189804647455,0.992571820874248,2,62,response to axon injury,BP,TNR;SPP1
9052,GO:0033605,0.0607349631778062,0.998318582419405,1,10,positive regulation of catecholamine secretion,BP,KCNB1
7786,GO:0031294,0.0607849401680078,0.99248674124301,2,68,lymphocyte costimulation,BP,HLA-DQB1;HLA-DQA1
2748,GO:0005766,0.0614407403730761,0.987328588217042,3,147,primary lysosome,CC,FABP5;ANXA2;SERPINA3
10811,GO:0042582,0.0614407403730761,0.987328588217042,3,147,azurophil granule,CC,FABP5;ANXA2;SERPINA3
8645,GO:0032783,0.0618540846458209,0.998382222441406,1,6,ELL-EAF complex,CC,AFF2
13777,GO:0051224,0.0618767664298988,0.987205322641446,3,144,negative regulation of protein transport,BP,GBP1;ANXA1;KCNB1
9546,GO:0034776,0.0620614389237115,0.998264705908132,1,9,response to histamine,BP,GABRB3
10778,GO:0042532,0.0620634654418011,0.998243317826222,1,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,SOCS3
14756,GO:0060395,0.062189964366432,0.992236342434745,2,60,SMAD protein signal transduction,BP,VIM;GDF15
15038,GO:0060836,0.0623134744329115,0.998277232006875,1,8,lymphatic endothelial cell differentiation,BP,PDPN
6014,GO:0016723,0.0623343886215784,0.998227761833028,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,STEAP3
14041,GO:0051707,0.062388740415784,0.973759385188258,8,688,response to other organism,BP,LTF;SERPINE1;CCL2;GBP1;ADM;PTX3;CXCL10;PLA2G2A
10725,GO:0042415,0.0624192918829811,0.998222872363506,1,10,norepinephrine metabolic process,BP,MOXD1
8390,GO:0032412,0.0624254995100316,0.983113215838396,4,213,regulation of ion transmembrane transporter activity,BP,KCNIP2;JPH3;SHANK2;SHISA7
9998,GO:0035845,0.0624512015462668,0.998242573497729,1,9,photoreceptor cell outer segment organization,BP,CDHR1
7432,GO:0030593,0.0625418875759478,0.992143956060322,2,69,neutrophil chemotaxis,BP,CCL2;LGALS3
722,GO:0001890,0.0626302036209876,0.986995170868666,3,136,placenta development,BP,SPP1;ADM;SOCS3
2356,GO:0004972,0.0626416224281862,0.998293687261788,1,7,NMDA glutamate receptor activity,MF,GRIN1
7148,GO:0030072,0.0627455189069335,0.982991978485296,4,222,peptide hormone secretion,BP,SNAP25;ANXA1;KCNB1;RIMS2
1290,GO:0002829,0.0628210261485639,0.998181817444354,1,11,negative regulation of type 2 immune response,BP,ANXA1
12096,GO:0045628,0.0630708004310415,0.998167154897208,1,11,regulation of T-helper 2 cell differentiation,BP,ANXA1
11127,GO:0043207,0.063129020896405,0.973383179673202,8,690,response to external biotic stimulus,BP,LTF;SERPINE1;CCL2;GBP1;ADM;PTX3;CXCL10;PLA2G2A
7329,GO:0030336,0.0631755586583238,0.982841319684917,4,216,negative regulation of cell migration,BP,TIMP1;SERPINE1;CCL2;COL3A1
15252,GO:0061299,0.063330020602835,0.998192142924628,1,9,retina vasculature morphogenesis in camera-type eye,BP,COL4A1
13168,GO:0048671,0.063368069913155,0.998217682001935,1,8,negative regulation of collateral sprouting,BP,SPP1
4716,GO:0010243,0.0634355861809127,0.970445250675988,10,863,response to organonitrogen compound,BP,TIMP1;COL1A1;ANXA1;ADM;GABRB3;NNMT;COL3A1;GRIN1;SOCS3;COL4A1
17312,GO:0090196,0.0638729645613613,0.998119657260765,1,11,regulation of chemokine secretion,BP,POSTN
14866,GO:0060548,0.0641085417711808,0.970071060056844,10,896,negative regulation of cell death,BP,LTF;TIMP1;SERPINE1;CCL2;LGALS3;ANXA1;PDPN;GABRB3;GRIN1;SOCS3
21830,GO:2001214,0.0642403557468125,0.998116337542228,1,10,positive regulation of vasculogenesis,BP,ADM
520,GO:0001574,0.0642444492972381,0.998116094483211,1,10,ganglioside biosynthetic process,BP,ST8SIA3
10890,GO:0042742,0.0643257335900132,0.986479558882987,3,153,defense response to bacterium,BP,LTF;SERPINE1;PLA2G2A
11636,GO:0044406,0.0644167983125773,0.998087101659683,1,11,adhesion of symbiont to host,BP,LTF
4227,GO:0008655,0.0645838859850981,0.998061345658633,1,12,pyrimidine-containing compound salvage,BP,TYMP
5419,GO:0015318,0.0647348200081879,0.971048792798682,9,750,inorganic molecular entity transmembrane transporter activity,MF,ABCC3;KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;GABRB3;GRIN1;FAM155A
16971,GO:0072567,0.0649057444711531,0.998041734097034,1,12,chemokine (C-X-C motif) ligand 2 production,BP,POSTN
18633,GO:1900121,0.0649627007733368,0.99805413415898,1,11,negative regulation of receptor binding,BP,CRTAC1
5952,GO:0016595,0.0649951992730469,0.998071246029404,1,10,glutamate binding,MF,GRIN1
6033,GO:0016757,0.0650288288675487,0.98215400551084,4,240,transferase activity, transferring glycosyl groups,MF,TYMP;GALNT13;FUT9;ST8SIA3
12986,GO:0048251,0.0651186872116777,0.998087241268438,1,9,elastic fiber assembly,BP,LOX
17011,GO:0072659,0.0653487076651435,0.982050507706036,4,220,protein localization to plasma membrane,BP,KCNIP3;GBP1;KCNB1;ANXA2
11135,GO:0043220,0.0654255252001924,0.998045295202018,1,10,Schmidt-Lanterman incisure,CC,ANXA2
10962,GO:0042908,0.0656567418127863,0.99805509172214,1,9,xenobiotic transport,BP,ABCC3
5072,GO:0010941,0.0656978100906512,0.964496088318411,15,1524,regulation of cell death,BP,TNFRSF12A;LTF;TIMP1;SERPINE1;CCL2;STEAP3;GDF15;LGALS3;ANXA1;ADM;KCNB1;PDPN;GABRB3;GRIN1;SOCS3
15534,GO:0062013,0.0658852179729055,0.986027628955868,3,143,positive regulation of small molecule metabolic process,BP,ANXA1;ADM;CXCL10
7084,GO:0022898,0.0659496070151163,0.98183243603655,4,218,regulation of transmembrane transporter activity,BP,KCNIP2;JPH3;SHANK2;SHISA7
18161,GO:0098976,0.0659589440265494,0.998066973519206,1,8,excitatory chemical synaptic transmission,BP,GRIN1
1288,GO:0002827,0.0659694197821285,0.997976202137822,1,12,positive regulation of T-helper 1 type immune response,BP,ANXA1
14444,GO:0055085,0.0660127994588968,0.965051825433566,14,1359,transmembrane transport,BP,ABCC3;KCNIP3;STEAP3;SLC8A2;KCNIP2;JPH3;KCNB1;SHANK2;SVOP;GABRB3;CXCL10;GRIN1;SHISA7;FAM155A
15341,GO:0061515,0.0660613100837457,0.99146158146563,2,63,myeloid cell development,BP,LTF;ANXA2
20482,GO:1904950,0.0661790446362964,0.985934392229911,3,148,negative regulation of establishment of protein localization,BP,GBP1;ANXA1;KCNB1
7407,GO:0030534,0.0662461597561761,0.985936538521946,3,130,adult behavior,BP,SHANK2;GRIN1;SLITRK1
19728,GO:1903426,0.066278119634946,0.99141202558069,2,65,regulation of reactive oxygen species biosynthetic process,BP,PTX3;GRIN1
2488,GO:0005212,0.066303700903629,0.997941384245821,1,13,structural constituent of eye lens,MF,VIM
21572,GO:2000647,0.0664146050053157,0.997984974317847,1,10,negative regulation of stem cell proliferation,BP,FERMT1
17604,GO:0097107,0.0664180108952736,0.998078833095649,1,7,postsynaptic density assembly,BP,SHANK2
18006,GO:0098698,0.0664180108952736,0.998078833095649,1,7,postsynaptic specialization assembly,BP,SHANK2
4578,GO:0009725,0.0664304574750377,0.968788000934415,10,888,response to hormone,BP,TIMP1;COL1A1;LOX;IGFBP2;SPP1;POSTN;ANXA1;ADM;ANXA2;SOCS3
11049,GO:0043083,0.0664340650124368,0.998008159998192,1,9,synaptic cleft,CC,GRIN1
15731,GO:0070307,0.0665267044971513,0.997958083122036,1,11,lens fiber cell development,BP,VIM
5400,GO:0015276,0.0667095654725254,0.985793906481067,3,133,ligand-gated ion channel activity,MF,JPH3;GABRB3;GRIN1
7063,GO:0022834,0.0667095654725254,0.985793906481067,3,133,ligand-gated channel activity,MF,JPH3;GABRB3;GRIN1
1349,GO:0002921,0.0668763749207953,0.997956490355682,1,10,negative regulation of humoral immune response,BP,SERPING1
5166,GO:0014061,0.066962802292826,0.997914001836906,1,12,regulation of norepinephrine secretion,BP,KCNB1
14610,GO:0060192,0.0670065132806903,0.997928140527419,1,11,negative regulation of lipase activity,BP,ANXA1
17023,GO:0072676,0.067014479669169,0.991247061534148,2,71,lymphocyte migration,BP,CCL2;CXCL10
4968,GO:0010817,0.0670683852435653,0.97541233706473,6,443,regulation of hormone levels,BP,SPP1;SNAP25;ANXA1;ADM;KCNB1;RIMS2
7979,GO:0031644,0.067089542882994,0.991250596363706,2,64,regulation of neurological system process,BP,TYMP;TNR
18292,GO:0099590,0.0671120534275389,0.997921524265138,1,11,neurotransmitter receptor internalization,BP,SNAP25
3849,GO:0008016,0.0671676620616495,0.981384536285231,4,219,regulation of heart contraction,BP,KCNIP3;SLC8A2;KCNIP2;ADM
14960,GO:0060707,0.0672961255886071,0.997909958970979,1,11,trophoblast giant cell differentiation,BP,SOCS3
5699,GO:0016081,0.0675843197851218,0.997937658230175,1,9,synaptic vesicle docking,BP,SNAP25
9097,GO:0033690,0.0677649351615119,0.997880354832106,1,11,positive regulation of osteoblast proliferation,BP,LTF
7071,GO:0022843,0.0681502320640321,0.985359265680043,3,134,voltage-gated cation channel activity,MF,KCNIP2;KCNB1;GRIN1
7082,GO:0022890,0.0682292160374837,0.972652787452504,7,523,inorganic cation transmembrane transporter activity,MF,KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;GRIN1;FAM155A
17121,GO:0086008,0.0684552928836506,0.997818733706155,1,12,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,KCNIP2
13479,GO:0050771,0.0685116837942663,0.990972964175478,2,60,negative regulation of axonogenesis,BP,TNR;SPP1
21841,GO:2001236,0.0685361444744057,0.985227306763325,3,146,regulation of extrinsic apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1;LGALS3
11067,GO:0043116,0.0687325514311368,0.997818576487815,1,11,negative regulation of vascular permeability,BP,ADM
5099,GO:0010977,0.0687331963492727,0.985182801981141,3,134,negative regulation of neuron projection development,BP,VIM;TNR;SPP1
19970,GO:1903901,0.0687933664487511,0.990887441804615,2,69,negative regulation of viral life cycle,BP,LTF;PTX3
5831,GO:0016358,0.068924704946523,0.980744268468074,4,207,dendrite development,BP,CUX2;SHANK2;CSMD3;GRIN1
16088,GO:0070970,0.0689866665206892,0.997823705543483,1,10,interleukin-2 secretion,BP,GBP1
8909,GO:0033197,0.0691625733669537,0.997772824186848,1,12,response to vitamin E,BP,COL1A1
19537,GO:1903019,0.0693315853262688,0.997761780969905,1,12,negative regulation of glycoprotein metabolic process,BP,PTX3
13236,GO:0048788,0.0694685631512291,0.997952989036261,1,6,cytoskeleton of presynaptic active zone,CC,RIMS2
16333,GO:0071435,0.0694820840383061,0.997751923803948,1,12,potassium ion export,BP,KCNIP2
13472,GO:0050764,0.0694857175489111,0.99074678395196,2,68,regulation of phagocytosis,BP,CCL2;PTX3
14713,GO:0060341,0.0695254769699456,0.968472786751756,9,761,regulation of cellular localization,BP,GBP1;CPLX2;JPH3;KCNB1;CXCL10;RIMS2;GRIN1;ANXA2;SHISA7
7830,GO:0031348,0.0697220952017418,0.984860670099023,3,151,negative regulation of defense response,BP,GPR17;SERPING1;SOCS3
12687,GO:0046883,0.0698774862942943,0.980367720596471,4,235,regulation of hormone secretion,BP,SPP1;SNAP25;ANXA1;KCNB1
10686,GO:0042340,0.0698818483751228,0.997744014374329,1,11,keratan sulfate catabolic process,BP,FMOD
825,GO:0002031,0.0703492221764378,0.997678938275386,1,13,G-protein coupled receptor internalization,BP,ADM
780,GO:0001967,0.07110314270319,0.997663370298929,1,11,suckling behavior,BP,GRIN1
10583,GO:0042127,0.0711905628753837,0.961877214185329,14,1410,regulation of cell proliferation,BP,LTF;FERMT1;TIMP1;IGFBP2;PLAU;LGALS3;ANXA1;EMP3;ADM;PDPN;S100A11;CXCL10;VSTM2A;ANXA2
19051,GO:1901741,0.0712462897102359,0.997618552233768,1,13,positive regulation of myoblast fusion,BP,GDF15
13910,GO:0051451,0.0716159789536303,0.997629072949269,1,11,myoblast migration,BP,ANXA1
9314,GO:0034356,0.0716764409249853,0.997605672693151,1,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NNMT
21248,GO:2000146,0.0718408207572904,0.979635462758695,4,228,negative regulation of cell motility,BP,TIMP1;SERPINE1;CCL2;COL3A1
7255,GO:0030234,0.0719906345138104,0.96567493574706,10,903,enzyme regulator activity,MF,LTF;TIMP1;SERPINE1;ANXA1;SERPING1;ELFN2;CXCL10;ANXA2;SOCS3;SERPINA3
3706,GO:0007269,0.0720377164924347,0.984163237117504,3,139,neurotransmitter secretion,BP,SNAP25;CPLX2;RIMS2
18314,GO:0099643,0.0720377164924347,0.984163237117504,3,139,signal release from synapse,BP,SNAP25;CPLX2;RIMS2
9331,GO:0034374,0.0722443875568,0.997586696123104,1,11,low-density lipoprotein particle remodeling,BP,PLA2G2A
8642,GO:0032780,0.0722835683928051,0.997547734353221,1,13,negative regulation of ATPase activity,BP,LTF
10567,GO:0042098,0.0728054285058359,0.983901776158363,3,158,T cell proliferation,BP,IGFBP2;LGALS3;ANXA1
13247,GO:0048813,0.0729521749603004,0.983894353441877,3,129,dendrite morphogenesis,BP,CUX2;SHANK2;GRIN1
8183,GO:0032060,0.0732169050445426,0.997520353246699,1,11,bleb assembly,BP,EMP3
11129,GO:0043209,0.0733084781247226,0.98374485726459,3,158,myelin sheath,CC,SNAP25;INA;ANXA2
18998,GO:1901626,0.0733449750481877,0.997511547665762,1,11,regulation of postsynaptic membrane organization,BP,SHISA7
3639,GO:0007169,0.0737037573871253,0.967915214655216,8,648,transmembrane receptor protein tyrosine kinase signaling pathway,BP,SH3GL2;COL1A1;IGFBP2;COL4A2;GRIN1;SOCS3;COL4A1;PTPRT
21407,GO:2000392,0.0737706565434169,0.997482164141638,1,11,regulation of lamellipodium morphogenesis,BP,PDPN
3494,GO:0006906,0.0739588571224588,0.983551751673254,3,149,vesicle fusion,BP,SNAP25;ANXA1;ANXA2
5433,GO:0015368,0.0740601026925662,0.997462083196851,1,11,calcium:cation antiporter activity,MF,SLC8A2
1202,GO:0002690,0.0741013417110112,0.989740874787209,2,79,positive regulation of leukocyte chemotaxis,BP,SERPINE1;CXCL10
12979,GO:0048243,0.0743570505487485,0.997402973101363,1,13,norepinephrine secretion,BP,KCNB1
14717,GO:0060346,0.0748140036838314,0.99743469334092,1,10,bone trabecula formation,BP,COL1A1
17311,GO:0090195,0.0751949164993337,0.997343265409087,1,13,chemokine secretion,BP,POSTN
4484,GO:0009311,0.0752550027754286,0.989505363243824,2,73,oligosaccharide metabolic process,BP,GALNT13;ST8SIA3
10746,GO:0042448,0.0752578941813478,0.997338749304048,1,13,progesterone metabolic process,BP,ADM
18284,GO:0099569,0.0752994472651328,0.997521789916521,1,7,presynaptic cytoskeleton,CC,RIMS2
7679,GO:0031083,0.0753070568271947,0.997319745295386,1,14,BLOC-1 complex,CC,SNAP25
5305,GO:0015079,0.0756932996225379,0.983000421897403,3,153,potassium ion transmembrane transporter activity,MF,KCNIP3;KCNIP2;KCNB1
6867,GO:0021700,0.0760989858423634,0.978008767111202,4,232,developmental maturation,BP,LTF;FERMT1;KCNIP2;GRIN1
7075,GO:0022851,0.0761798291186293,0.997312519612331,1,11,GABA-gated chloride ion channel activity,MF,GABRB3
20714,GO:1905475,0.0761816246559273,0.982845555532422,3,153,regulation of protein localization to membrane,BP,GBP1;KCNB1;SHISA7
4946,GO:0010770,0.0761820334375257,0.982873433518112,3,133,positive regulation of cell morphogenesis involved in differentiation,BP,TNFRSF12A;CUX2;SLITRK1
4541,GO:0009593,0.0761881303517469,0.989290825539304,2,77,detection of chemical stimulus,BP,KCNIP2;RTP5
11493,GO:0044090,0.0762066331782604,0.997310600144567,1,11,positive regulation of vacuole organization,BP,ANXA2
7694,GO:0031100,0.0762138478413312,0.989301366782386,2,71,animal organ regeneration,BP,ADM;NNMT
2501,GO:0005230,0.0762323445043053,0.989306487949391,2,68,extracellular ligand-gated ion channel activity,MF,GABRB3;GRIN1
12136,GO:0045683,0.0762863594917751,0.997282974214315,1,12,negative regulation of epidermis development,BP,FERMT1
12128,GO:0045666,0.0763983323193456,0.974102229791408,5,321,positive regulation of neuron differentiation,BP,TNFRSF12A;CUX2;SHANK2;RIMS2;SLITRK1
12295,GO:0045981,0.0764353427497633,0.989249830814247,2,72,positive regulation of nucleotide metabolic process,BP,ADM;CXCL10
18756,GO:1900544,0.0764353427497633,0.989249830814247,2,72,positive regulation of purine nucleotide metabolic process,BP,ADM;CXCL10
15550,GO:0070008,0.0764505202214277,0.997271095651061,1,12,serine-type exopeptidase activity,MF,AEBP1
8387,GO:0032409,0.076474882851404,0.977864613246726,4,231,regulation of transporter activity,BP,KCNIP2;JPH3;SHANK2;SHISA7
12151,GO:0045723,0.0764779593106704,0.997250479805776,1,13,positive regulation of fatty acid biosynthetic process,BP,ANXA1
7203,GO:0030168,0.0768014504852309,0.982653408013461,3,149,platelet activation,BP,COL1A1;PDPN;COL3A1
11970,GO:0045294,0.0768192520026961,0.997266537452265,1,11,alpha-catenin binding,MF,PTPRT
7177,GO:0030133,0.0773347110344129,0.973676344109087,5,356,transport vesicle,CC,SNAP25;SVOP;GRIN1;HLA-DQB1;HLA-DQA1
941,GO:0002227,0.0773425814084585,0.997156558578418,1,15,innate immune response in mucosa,BP,LTF
21823,GO:2001204,0.0774564416297098,0.997220316167035,1,11,regulation of osteoclast development,BP,LTF
14040,GO:0051705,0.0775289278300018,0.989038499083624,2,63,multi-organism behavior,BP,SHANK2;GRIN1
20954,GO:1990266,0.0776038121125973,0.9889756304676,2,78,neutrophil migration,BP,CCL2;LGALS3
5326,GO:0015125,0.0776282171110817,0.997165902462745,1,13,bile acid transmembrane transporter activity,MF,ABCC3
16979,GO:0072578,0.0777174332490393,0.997228573840186,1,10,neurotransmitter-gated ion channel clustering,BP,SHISA7
615,GO:0001750,0.0778580408314482,0.988954630002521,2,66,photoreceptor outer segment,CC,CDHR1;SHANK2
5611,GO:0015908,0.0782457260877132,0.988849098412997,2,72,fatty acid transport,BP,ANXA1;PLA2G2A
11117,GO:0043195,0.0782500849814447,0.988864047646378,2,67,terminal bouton,CC,CPLX2;GRIN1
11841,GO:0045064,0.0783338977168606,0.997096614300773,1,14,T-helper 2 cell differentiation,BP,ANXA1
972,GO:0002286,0.0784576376849933,0.988798898788405,2,73,T cell activation involved in immune response,BP,LGALS3;ANXA1
14184,GO:0051966,0.0790025101499852,0.988710881212356,2,63,regulation of synaptic transmission, glutamatergic,BP,TNR;SHANK2
15272,GO:0061337,0.0791236504614121,0.981926226583552,3,137,cardiac conduction,BP,KCNIP3;SLC8A2;KCNIP2
6775,GO:0021537,0.0794068940375995,0.97672871865701,4,227,telencephalon development,BP,CRTAC1;TNR;COL3A1;GRIN1
10745,GO:0042447,0.0795220203254715,0.997006516627096,1,14,hormone catabolic process,BP,SPP1
15759,GO:0070365,0.079586478289476,0.997018875685556,1,13,hepatocyte differentiation,BP,ANXA1
4088,GO:0008417,0.0796129483877818,0.997037051080566,1,12,fucosyltransferase activity,MF,FUT9
1400,GO:0003073,0.0796242182562736,0.988534360101223,2,74,regulation of systemic arterial blood pressure,BP,POSTN;ADM
2052,GO:0004553,0.0796482025801032,0.988523354423211,2,76,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,CHI3L2;CHI3L1
17710,GO:0097286,0.0798001856350085,0.997002598546032,1,13,iron ion import,BP,STEAP3
10177,GO:0036148,0.0798417579342977,0.99699942686109,1,13,phosphatidylglycerol acyl-chain remodeling,BP,PLA2G2A
19778,GO:1903531,0.079965390723847,0.98162345851368,3,159,negative regulation of secretion by cell,BP,GBP1;ANXA1;KCNB1
21225,GO:2000106,0.0799775343080888,0.988451799343575,2,75,regulation of leukocyte apoptotic process,BP,LGALS3;ANXA1
4545,GO:0009607,0.0800136422130686,0.964543247409922,8,726,response to biotic stimulus,BP,LTF;SERPINE1;CCL2;GBP1;ADM;PTX3;CXCL10;PLA2G2A
17857,GO:0097617,0.0800318951466294,0.996984898641969,1,13,annealing activity,MF,ANXA1
17291,GO:0090174,0.0800526177284731,0.981601344378637,3,154,organelle membrane fusion,BP,SNAP25;ANXA1;ANXA2
11133,GO:0043218,0.0802952792190098,0.996964713932813,1,13,compact myelin,CC,ANXA2
15992,GO:0070821,0.0804519208070435,0.988359665874534,2,70,tertiary granule membrane,CC,PLAU;SNAP25
7038,GO:0022600,0.0808733349535574,0.988248734324469,2,75,digestive system process,BP,TYMP;SERPINA3
17415,GO:0090335,0.0809743085438256,0.996933242144477,1,12,regulation of brown fat cell differentiation,BP,VSTM2A
17273,GO:0090148,0.0809971301198709,0.996931486200065,1,12,membrane fission,BP,SH3GL2
68,GO:0000139,0.0810266914239161,0.964005891161199,8,685,Golgi membrane,CC,SH3GL2;CUX2;GBP1;GALNT13;FUT9;ST8SIA3;HLA-DQB1;HLA-DQA1
629,GO:0001771,0.0810648210237986,0.996905341434404,1,13,immunological synapse formation,BP,LGALS3
21756,GO:2001044,0.0810937498164001,0.996903097923013,1,13,regulation of integrin-mediated signaling pathway,BP,TIMP1
11784,GO:0044849,0.0813164625823756,0.996867749267462,1,14,estrous cycle,BP,ANXA1
1201,GO:0002689,0.0813885634381615,0.996862105827776,1,14,negative regulation of leukocyte chemotaxis,BP,CCL2
13709,GO:0051124,0.0815290408238424,0.996945502452563,1,10,synaptic growth at neuromuscular junction,BP,SHANK2
8663,GO:0032802,0.0815635285692949,0.996866547848165,1,13,low-density lipoprotein particle receptor catabolic process,BP,ANXA2
14570,GO:0060134,0.0820295683562069,0.996851505629251,1,12,prepulse inhibition,BP,GRIN1
18261,GO:0099531,0.0825272543028397,0.980799564814543,3,149,presynaptic process involved in chemical synaptic transmission,BP,SNAP25;CPLX2;RIMS2
15873,GO:0070555,0.0827035364274106,0.980719784948654,3,166,response to interleukin-1,BP,CCL2;CHI3L1;ANXA1
10834,GO:0042622,0.0831624866136638,0.996740485927344,1,13,photoreceptor outer segment membrane,CC,CDHR1
12091,GO:0045623,0.0832699466603207,0.996731921747646,1,13,negative regulation of T-helper cell differentiation,BP,ANXA1
18024,GO:0098739,0.0833904298069642,0.987690585854453,2,69,import across plasma membrane,BP,STEAP3;FAM155A
743,GO:0001921,0.0834914704609446,0.996714230495077,1,13,positive regulation of receptor recycling,BP,ANXA2
5302,GO:0015075,0.0837754970259691,0.960587208136855,9,793,ion transmembrane transporter activity,MF,ABCC3;KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;GABRB3;GRIN1;FAM155A
18921,GO:1901379,0.0838060651938667,0.987594328645276,2,69,regulation of potassium ion transmembrane transport,BP,KCNIP3;KCNIP2
13804,GO:0051259,0.0841807996947333,0.967304630414512,6,470,protein complex oligomerization,BP,COL1A1;GBP1;COL6A2;KCNB1;GRIN1;ANXA2
17547,GO:0097006,0.0842619364409502,0.987471637494889,2,74,regulation of plasma lipoprotein particle levels,BP,ANXA2;PLA2G2A
11363,GO:0043588,0.0844949658782245,0.974703586798383,4,241,skin development,BP,FERMT1;COL1A1;ANXA1;COL3A1
5104,GO:0010984,0.084526029965679,0.996594553831992,1,15,regulation of lipoprotein particle clearance,BP,ANXA2
20532,GO:1905048,0.0847514817614344,0.99661266580314,1,13,regulation of metallopeptidase activity,BP,TIMP1
4212,GO:0008625,0.0847729022605973,0.987343278906721,2,77,extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1;LGALS3
18008,GO:0098703,0.0849710090032844,0.996594807214875,1,13,calcium ion import across plasma membrane,BP,FAM155A
19382,GO:1902656,0.0849710090032844,0.996594807214875,1,13,calcium ion import into cytosol,BP,FAM155A
5179,GO:0014701,0.0851035996803702,0.996707168043201,1,9,junctional sarcoplasmic reticulum membrane,CC,JPH3
15118,GO:0060998,0.0851421392873812,0.987307053485583,2,63,regulation of dendritic spine development,BP,CUX2;SHANK2
18748,GO:1900452,0.0851671815708465,0.99660191732602,1,12,regulation of long term synaptic depression,BP,KCNB1
18377,GO:0102567,0.0853093235766727,0.996530109363913,1,15,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,PLA2G2A
18378,GO:0102568,0.0853093235766727,0.996530109363913,1,15,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,PLA2G2A
11949,GO:0045236,0.0855363627444194,0.996496175424206,1,16,CXCR chemokine receptor binding,MF,CXCL10
9219,GO:0034143,0.0855839633599302,0.996507366000832,1,15,regulation of toll-like receptor 4 signaling pathway,BP,LTF
823,GO:0002029,0.0856120075463223,0.996489874518862,1,16,desensitization of G-protein coupled receptor protein signaling pathway,BP,ADM
7025,GO:0022401,0.0856120075463223,0.996489874518862,1,16,negative adaptation of signaling pathway,BP,ADM
7828,GO:0031346,0.0856308913686115,0.970000951284438,5,326,positive regulation of cell projection organization,BP,TNFRSF12A;CUX2;SHANK2;RIMS2;SLITRK1
2909,GO:0006022,0.0857453260005583,0.979719488680023,3,158,aminoglycan metabolic process,BP,CHI3L2;FMOD;CHI3L1
694,GO:0001846,0.0858551908905656,0.996545873017717,1,12,opsonin binding,MF,PTX3
11138,GO:0043225,0.0859623705270424,0.996537099658844,1,12,ATPase-coupled anion transmembrane transporter activity,MF,ABCC3
18220,GO:0099133,0.0859623705270424,0.996537099658844,1,12,ATP hydrolysis coupled anion transmembrane transport,BP,ABCC3
13528,GO:0050848,0.0859681598992611,0.987081823565829,2,71,regulation of calcium-mediated signaling,BP,GBP1;JPH3
638,GO:0001780,0.0860116836836335,0.996489291282553,1,14,neutrophil homeostasis,BP,ANXA1
11103,GO:0043174,0.0863101237016145,0.996431448278438,1,16,nucleoside salvage,BP,TYMP
7425,GO:0030575,0.0863210703476276,0.996535724060858,1,11,nuclear body organization,BP,AFF2
2609,GO:0005513,0.0863965881994699,0.996477655299516,1,13,detection of calcium ion,BP,KCNIP2
6468,GO:0019215,0.0865340959369515,0.996466246834586,1,13,intermediate filament binding,MF,VIM
7281,GO:0030277,0.0867121566475724,0.996430918024213,1,14,maintenance of gastrointestinal epithelium,BP,SERPINA3
18566,GO:1900006,0.0867774653489937,0.986913929919399,2,65,positive regulation of dendrite development,BP,CUX2;SHANK2
14597,GO:0060170,0.0875045268064211,0.986714389742801,2,72,ciliary membrane,CC,CDHR1;SHANK2
1437,GO:0003159,0.0876020942570668,0.99633788583152,1,15,morphogenesis of an endothelium,BP,CXCL10
15218,GO:0061154,0.0876020942570668,0.99633788583152,1,15,endothelial tube morphogenesis,BP,CXCL10
13095,GO:0048525,0.08781791772972,0.986614371697633,2,80,negative regulation of viral process,BP,LTF;PTX3
6680,GO:0019865,0.0878709866021824,0.996299014466666,1,16,immunoglobulin binding,MF,LGALS3
12092,GO:0045624,0.0879224626718677,0.996294604417139,1,16,positive regulation of T-helper cell differentiation,BP,ANXA1
4412,GO:0009190,0.0880585641056087,0.986565690763908,2,77,cyclic nucleotide biosynthetic process,BP,ADM;GABBR1
14301,GO:0052652,0.0880585641056087,0.986565690763908,2,77,cyclic purine nucleotide metabolic process,BP,ADM;GABBR1
4922,GO:0010744,0.0882977103896121,0.996296949010442,1,14,positive regulation of macrophage derived foam cell differentiation,BP,PLA2G2A
17443,GO:0090399,0.088306702870277,0.996317472614788,1,13,replicative senescence,BP,SERPINE1
3814,GO:0007597,0.0883372874374888,0.996275113517192,1,15,blood coagulation, intrinsic pathway,BP,SERPING1
10179,GO:0036150,0.0883741237778441,0.996271953843953,1,15,phosphatidylserine acyl-chain remodeling,BP,PLA2G2A
13099,GO:0048535,0.0883923089297347,0.996270393484024,1,15,lymph node development,BP,PDPN
16334,GO:0071437,0.0884337135667532,0.996285338757285,1,14,invadopodium,CC,PDPN
21396,GO:2000379,0.088443405697581,0.986470400025959,2,78,positive regulation of reactive oxygen species metabolic process,BP,PTX3;GRIN1
6473,GO:0019220,0.0885389160128206,0.950003745386141,15,1554,regulation of phosphate metabolic process,BP,LTF;SRPX2;CCL2;GBP1;GDF15;CHI3L1;SPOCD1;ADM;ELFN2;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A;GABBR1
10570,GO:0042102,0.0886406132739652,0.986406137288375,2,84,positive regulation of T cell proliferation,BP,IGFBP2;ANXA1
13950,GO:0051546,0.0887041149708826,0.996262199427647,1,14,keratinocyte migration,BP,FERMT1
19170,GO:1902106,0.0887844518390572,0.986394696756917,2,76,negative regulation of leukocyte differentiation,BP,LTF;ANXA1
13815,GO:0051279,0.0888093483529156,0.986413456132636,2,69,regulation of release of sequestered calcium ion into cytosol,BP,JPH3;CXCL10
11226,GO:0043371,0.0889065092217231,0.996244831111894,1,14,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
9308,GO:0034349,0.0893563592583973,0.996206078390813,1,14,glial cell apoptotic process,BP,CCL2
10080,GO:0035988,0.0894531229217843,0.996197715703521,1,14,chondrocyte proliferation,BP,LTF
12186,GO:0045780,0.0895622574243763,0.99621017391093,1,13,positive regulation of bone resorption,BP,SPP1
12670,GO:0046852,0.0895622574243763,0.99621017391093,1,13,positive regulation of bone remodeling,BP,SPP1
21828,GO:2001212,0.0896113301699447,0.996184022306467,1,14,regulation of vasculogenesis,BP,ADM
8516,GO:0032588,0.0898588386231295,0.986126002337996,2,79,trans-Golgi network membrane,CC,HLA-DQB1;HLA-DQA1
6245,GO:0017158,0.0899672808693409,0.986119360292206,2,73,regulation of calcium ion-dependent exocytosis,BP,KCNB1;RIMS2
16746,GO:0072148,0.0899799805225316,0.996132862691728,1,15,epithelial cell fate commitment,BP,PDPN
17583,GO:0097061,0.0900083248776601,0.98613691596696,2,66,dendritic spine organization,BP,CUX2;SHANK2
7461,GO:0030662,0.090067121136639,0.978251473622984,3,162,coated vesicle membrane,CC,SH3GL2;HLA-DQB1;HLA-DQA1
6236,GO:0017146,0.090213261543057,0.996210510801651,1,11,NMDA selective glutamate receptor complex,CC,GRIN1
10758,GO:0042475,0.0902176315822064,0.986065999000375,2,71,odontogenesis of dentin-containing tooth,BP,SERPINE1;ADM
14576,GO:0060143,0.090255127145204,0.996091909662337,1,16,positive regulation of syncytium formation by plasma membrane fusion,BP,GDF15
7078,GO:0022857,0.0902658979189813,0.955106595775743,10,931,transmembrane transporter activity,MF,ABCC3;KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;SVOP;GABRB3;GRIN1;FAM155A
8519,GO:0032591,0.0903812731715369,0.996139321896667,1,13,dendritic spine membrane,CC,SHISA7
5977,GO:0016641,0.0903954036913165,0.996079542444172,1,16,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,LOX
2899,GO:0006004,0.0904618636494289,0.996109969003776,1,14,fucose metabolic process,BP,FUT9
3948,GO:0008191,0.0904653194114526,0.996090306329792,1,15,metalloendopeptidase inhibitor activity,MF,TIMP1
5951,GO:0016594,0.0905097080105605,0.996086402139448,1,15,glycine binding,MF,GRIN1
7103,GO:0023058,0.0907146126707315,0.996036302805298,1,17,adaptation of signaling pathway,BP,ADM
7364,GO:0030426,0.0908880340813357,0.977994274734411,3,146,growth cone,CC,CRTAC1;SNAP25;SHANK2
7970,GO:0031629,0.0910157704386706,0.996024606528555,1,16,synaptic vesicle fusion to presynaptic active zone membrane,BP,SNAP25
18239,GO:0099500,0.0910157704386706,0.996024606528555,1,16,vesicle fusion to plasma membrane,BP,SNAP25
9881,GO:0035641,0.0912317398639824,0.996065029970543,1,13,locomotory exploration behavior,BP,TNR
3852,GO:0008021,0.0913827113124941,0.977793180631397,3,167,synaptic vesicle,CC,SNAP25;SVOP;GRIN1
3822,GO:0007606,0.0919203257593067,0.985600315041695,2,87,sensory perception of chemical stimulus,BP,GNAL;RTP5
15766,GO:0070372,0.0919308999621507,0.971662710985938,4,262,regulation of ERK1 and ERK2 cascade,BP,CCL2;GBP1;CHI3L1;PLA2G2A
3658,GO:0007193,0.0921770893144645,0.985566286582217,2,77,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,GNAL;GABBR1
6476,GO:0019226,0.092434956910715,0.985540953439939,2,67,transmission of nerve impulse,BP,TYMP;TNR
12556,GO:0046597,0.0925772025799826,0.995884583621181,1,16,negative regulation of viral entry into host cell,BP,PTX3
13525,GO:0050839,0.0927508531236804,0.96306751297702,6,460,cell adhesion molecule binding,MF,POSTN;ANXA1;S100A11;COL3A1;ANXA2;PTPRT
4983,GO:0010832,0.0928192005806307,0.995900869542199,1,14,negative regulation of myotube differentiation,BP,CXCL10
14073,GO:0051770,0.0934389866198066,0.995844951854616,1,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL2
8600,GO:0032717,0.0934492830478165,0.995805286290205,1,16,negative regulation of interleukin-8 production,BP,ANXA1
4897,GO:0010715,0.0938545946496882,0.995831290299178,1,13,regulation of extracellular matrix disassembly,BP,PDPN
13747,GO:0051174,0.0939500814306046,0.946468939765868,15,1568,regulation of phosphorus metabolic process,BP,LTF;SRPX2;CCL2;GBP1;GDF15;CHI3L1;SPOCD1;ADM;ELFN2;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A;GABBR1
11902,GO:0045161,0.0940583376049316,0.9958410382396,1,12,neuronal ion channel clustering,BP,KCNIP2
7856,GO:0031406,0.0947221239589161,0.976628108407151,3,171,carboxylic acid binding,MF,FABP5;GRIN1;ST8SIA3
15551,GO:0070011,0.0947924089302526,0.962027616751495,6,494,peptidase activity, acting on L-amino acid peptides,MF,LTF;AEBP1;PLAU;ADAM12;C1R;CFI
5596,GO:0015874,0.0953929894102181,0.99560911102319,1,17,norepinephrine transport,BP,KCNB1
18754,GO:1900542,0.0957657240090315,0.976271345942543,3,164,regulation of purine nucleotide metabolic process,BP,ADM;CXCL10;GABBR1
11971,GO:0045295,0.095976361191806,0.99570116475928,1,11,gamma-catenin binding,MF,PTPRT
7827,GO:0031345,0.0959765118425213,0.976206073516821,3,158,negative regulation of cell projection organization,BP,VIM;TNR;SPP1
9068,GO:0033630,0.0961138801619426,0.995558135457646,1,16,positive regulation of cell adhesion mediated by integrin,BP,FERMT1
4057,GO:0008360,0.0962670801345537,0.976110080907415,3,154,regulation of cell shape,BP,CCL2;ANXA1;PDPN
11482,GO:0044057,0.0962685577062823,0.96129148609938,6,465,regulation of system process,BP,TYMP;KCNIP3;TNR;SLC8A2;KCNIP2;ADM
7179,GO:0030135,0.0964706632453431,0.969772032819128,4,260,coated vesicle,CC,SNAP91;SH3GL2;HLA-DQB1;HLA-DQA1
18416,GO:0106027,0.0965432889505988,0.984508747300402,2,69,neuron projection organization,BP,CUX2;SHANK2
13476,GO:0050768,0.0966218187351511,0.969721592368577,4,245,negative regulation of neurogenesis,BP,VIM;TNR;SPP1;COL3A1
5397,GO:0015271,0.0967184010188186,0.99552040391004,1,15,outward rectifier potassium channel activity,MF,KCNIP2
4035,GO:0008324,0.0969686837747881,0.957820873121995,7,578,cation transmembrane transporter activity,MF,KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;GRIN1;FAM155A
6034,GO:0016758,0.0973527873382149,0.975695970040913,3,175,transferase activity, transferring hexosyl groups,MF,TYMP;GALNT13;FUT9
15309,GO:0061430,0.0974090202473602,0.995503361091257,1,13,bone trabecula morphogenesis,BP,COL1A1
665,GO:0001816,0.0974450878552519,0.957552284239895,7,621,cytokine production,BP,LTF;FERMT1;SERPINE1;GBP1;CHI3L1;POSTN;ANXA1
8140,GO:0031994,0.097599979455797,0.995485378488266,1,13,insulin-like growth factor I binding,MF,IGFBP2
3654,GO:0007188,0.0980724715694942,0.975445638745567,3,171,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,GNAL;ADM;GABBR1
510,GO:0001558,0.0982010384663286,0.964168391437581,5,365,regulation of cell growth,BP,TNFRSF12A;IGFBP2;TNR;SPP1;RIMS2
4899,GO:0010717,0.098507095721619,0.983973827864805,2,78,regulation of epithelial to mesenchymal transition,BP,COL1A1;PDPN
18200,GO:0099081,0.0994004570966704,0.95160278784056,9,759,supramolecular polymer,CC,VIM;FERMT1;COL1A1;COL4A2;ANXA1;INA;SHANK2;COL3A1;COL4A1
18077,GO:0098831,0.099486166413621,0.995474199796457,1,9,presynaptic active zone cytoplasmic component,CC,RIMS2
18823,GO:1901135,0.0995042724964814,0.947877712034822,11,1121,carbohydrate derivative metabolic process,BP,TYMP;CHI3L2;FMOD;CHI3L1;GALNT13;ADM;PTX3;CXCL10;FUT9;ST8SIA3;GABBR1
11106,GO:0043177,0.0996103488833481,0.974893948085682,3,173,organic acid binding,MF,FABP5;GRIN1;ST8SIA3
3844,GO:0007635,0.0997270679921113,0.995255384710282,1,14,chemosensory behavior,BP,GRIN1
7178,GO:0030134,0.0998802616026341,0.983603707434475,2,83,COPII-coated ER to Golgi transport vesicle,CC,HLA-DQB1;HLA-DQA1
11325,GO:0043535,0.100167827680698,0.983546415608581,2,78,regulation of blood vessel endothelial cell migration,BP,SRPX2;ANXA1
9530,GO:0034755,0.100299538531636,0.995155062740502,1,16,iron ion transmembrane transport,BP,STEAP3
7318,GO:0030324,0.100359971478273,0.974645693206522,3,159,lung development,BP,LOX;CHI3L1;PDPN
18199,GO:0099080,0.100405045327171,0.951012819182497,9,760,supramolecular complex,CC,VIM;FERMT1;COL1A1;COL4A2;ANXA1;INA;SHANK2;COL3A1;COL4A1
7311,GO:0030316,0.100461161702866,0.983474177876067,2,77,osteoclast differentiation,BP,LTF;ANXA2
11840,GO:0045063,0.100475394956733,0.995119296798528,1,17,T-helper 1 cell differentiation,BP,ANXA1
5580,GO:0015849,0.100514603970879,0.968049898403328,4,270,organic acid transport,BP,ABCC3;SNAP25;ANXA1;PLA2G2A
12721,GO:0046942,0.100514603970879,0.968049898403328,4,270,carboxylic acid transport,BP,ABCC3;SNAP25;ANXA1;PLA2G2A
14512,GO:0060047,0.10068846798023,0.967992985130032,4,250,heart contraction,BP,KCNIP3;SLC8A2;KCNIP2;ADM
13812,GO:0051271,0.100902333473075,0.967896970134258,4,255,negative regulation of cellular component movement,BP,TIMP1;SERPINE1;CCL2;COL3A1
3505,GO:0006925,0.100903831621977,0.995076776923632,1,17,inflammatory cell apoptotic process,BP,ANXA1
8135,GO:0031984,0.100996173811676,0.942892323342674,14,1497,organelle subcompartment,CC,LTF;MOXD1;SH3GL2;CUX2;GBP1;SNAP25;POSTN;GALNT13;JPH3;FUT9;ST8SIA3;HLA-DQB1;PLA2G2A;HLA-DQA1
7365,GO:0030427,0.101141443439765,0.974378231764541,3,151,site of polarized growth,CC,CRTAC1;SNAP25;SHANK2
19560,GO:1903055,0.101155866078185,0.995091539720721,1,15,positive regulation of extracellular matrix organization,BP,PDPN
10592,GO:0042136,0.10161130522635,0.98315070252037,2,84,neurotransmitter biosynthetic process,BP,MOXD1;PTX3
9529,GO:0034754,0.101830467317643,0.983072662445555,2,91,cellular hormone metabolic process,BP,SPP1;ADM
20430,GO:1904861,0.10187664325667,0.995072868262261,1,13,excitatory synapse assembly,BP,SHANK2
13402,GO:0050670,0.1018771880629,0.974065790686374,3,182,regulation of lymphocyte proliferation,BP,IGFBP2;LGALS3;ANXA1
18852,GO:1901214,0.101911329287916,0.967455058949895,4,266,regulation of neuron death,BP,CCL2;KCNB1;GABRB3;GRIN1
14180,GO:0051962,0.102064596628761,0.958329458891559,6,460,positive regulation of nervous system development,BP,TNFRSF12A;SRPX2;CUX2;SHANK2;RIMS2;SLITRK1
14720,GO:0060349,0.102137032327378,0.983026718741355,2,80,bone morphogenesis,BP,LTF;COL1A1
3655,GO:0007189,0.102405250273262,0.982949457002422,2,82,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,GNAL;ADM
2982,GO:0006140,0.102684361933388,0.973789281587029,3,170,regulation of nucleotide metabolic process,BP,ADM;CXCL10;GABBR1
8753,GO:0032944,0.103004958264175,0.973655148478399,3,183,regulation of mononuclear cell proliferation,BP,IGFBP2;LGALS3;ANXA1
13548,GO:0050868,0.103090433848089,0.982753142414728,2,87,negative regulation of T cell activation,BP,LGALS3;ANXA1
1311,GO:0002861,0.10317460457387,0.994815487860777,1,19,regulation of inflammatory response to antigenic stimulus,BP,GPR17
9985,GO:0035809,0.103191455007906,0.994829218192176,1,18,regulation of urine volume,BP,ADM
13772,GO:0051216,0.103224417954313,0.973598903628779,3,166,cartilage development,BP,TIMP1;COL1A1;CHI3L1
9413,GO:0034505,0.103264171283893,0.994880635007142,1,15,tooth mineralization,BP,COL1A1
2630,GO:0005545,0.103319864496833,0.994875001163748,1,15,1-phosphatidylinositol binding,MF,SNAP91
13734,GO:0051153,0.103499895767688,0.982661333834481,2,82,regulation of striated muscle cell differentiation,BP,GDF15;CXCL10
11406,GO:0043687,0.103580243424903,0.96158910495424,5,394,post-translational protein modification,BP,CP;TIMP1;SPP1;MDGA2;SOCS3
12587,GO:0046639,0.103641930074226,0.994820121550741,1,16,negative regulation of alpha-beta T cell differentiation,BP,ANXA1
13005,GO:0048284,0.103984025853487,0.97330873215844,3,175,organelle fusion,BP,SNAP25;ANXA1;ANXA2
696,GO:0001848,0.103996520782593,0.99480629407727,1,15,complement binding,MF,PTX3
1286,GO:0002825,0.104119385112853,0.994718199749881,1,19,regulation of T-helper 1 type immune response,BP,ANXA1
3691,GO:0007250,0.104158711385051,0.994729878463838,1,18,activation of NF-kappaB-inducing kinase activity,BP,CHI3L1
6697,GO:0019898,0.104320474530127,0.966416170926353,4,266,extrinsic component of membrane,CC,SNAP25;ANXA1;GNAL;ANXA2
10715,GO:0042401,0.104388522322249,0.994676079812033,1,20,cellular biogenic amine biosynthetic process,BP,MOXD1
4575,GO:0009713,0.104409475561868,0.994688139132498,1,19,catechol-containing compound biosynthetic process,BP,MOXD1
10731,GO:0042423,0.104409475561868,0.994688139132498,1,19,catecholamine biosynthetic process,BP,MOXD1
12378,GO:0046135,0.104630542266149,0.994650871811338,1,20,pyrimidine nucleoside catabolic process,BP,TYMP
724,GO:0001892,0.104724776897587,0.982340288805172,2,81,embryonic placenta development,BP,ADM;SOCS3
18307,GO:0099632,0.104919696654898,0.994651032075855,1,18,protein transport within plasma membrane,BP,SNAP25
18309,GO:0099637,0.104919696654898,0.994651032075855,1,18,neurotransmitter receptor transport,BP,SNAP25
1377,GO:0003015,0.105036461170785,0.966117579678179,4,253,heart process,BP,KCNIP3;SLC8A2;KCNIP2;ADM
3830,GO:0007617,0.10516767449606,0.994625207256832,1,18,mating behavior,BP,GRIN1
7678,GO:0031082,0.105167954177812,0.994609122396164,1,19,BLOC complex,CC,SNAP25
8004,GO:0031683,0.105255714522306,0.994616023056683,1,18,G-protein beta/gamma-subunit complex binding,MF,GNAL
13663,GO:0051048,0.105283556967224,0.97282704216727,3,179,negative regulation of secretion,BP,GBP1;ANXA1;KCNB1
2512,GO:0005249,0.105307849831659,0.982167872141779,2,86,voltage-gated potassium channel activity,MF,KCNIP2;KCNB1
19771,GO:1903522,0.105324161966219,0.965986031700814,4,260,regulation of blood circulation,BP,KCNIP3;SLC8A2;KCNIP2;ADM
4058,GO:0008361,0.105343877230811,0.972838877603376,3,157,regulation of cell size,BP,TNFRSF12A;TNR;SPP1
19719,GO:1903409,0.105366656082531,0.982162190737739,2,83,reactive oxygen species biosynthetic process,BP,PTX3;GRIN1
7317,GO:0030323,0.10563982856673,0.97271990950712,3,163,respiratory tube development,BP,LOX;CHI3L1;PDPN
519,GO:0001573,0.1056624829772,0.994591601810169,1,17,ganglioside metabolic process,BP,ST8SIA3
8351,GO:0032368,0.106853811760353,0.981766996269001,2,82,regulation of lipid transport,BP,SPP1;ANXA2
18518,GO:0140056,0.106866094452831,0.972256531105399,3,170,organelle localization by membrane tethering,BP,SNAP25;CPLX2;KCNB1
762,GO:0001946,0.106914667030968,0.994504528416835,1,15,lymphangiogenesis,BP,PDPN
525,GO:0001580,0.107055536543956,0.9943813276345,1,21,detection of chemical stimulus involved in sensory perception of bitter taste,BP,RTP5
3015,GO:0006206,0.107094703549795,0.99442231609414,1,18,pyrimidine nucleobase metabolic process,BP,TYMP
6692,GO:0019887,0.107409820299548,0.972036585334375,3,183,protein kinase regulator activity,MF,LTF;CXCL10;SOCS3
5700,GO:0016082,0.107730328852531,0.994418592919232,1,15,synaptic vesicle priming,BP,SNAP25
10353,GO:0038024,0.107920239364089,0.981482719979113,2,81,cargo receptor activity,MF,CD163;CFI
14071,GO:0051767,0.108083925141261,0.994335601901036,1,17,nitric-oxide synthase biosynthetic process,BP,CCL2
14072,GO:0051769,0.108083925141261,0.994335601901036,1,17,regulation of nitric-oxide synthase biosynthetic process,BP,CCL2
1037,GO:0002385,0.108107884479072,0.994268026436064,1,21,mucosal immune response,BP,LTF
7688,GO:0031092,0.108334477727854,0.994330194668984,1,16,platelet alpha granule membrane,CC,PCDH7
10181,GO:0036152,0.108793342956513,0.994207578850123,1,20,phosphatidylethanolamine acyl-chain remodeling,BP,PLA2G2A
4805,GO:0010562,0.108813531525612,0.943897785447005,10,974,positive regulation of phosphorus metabolic process,BP,LTF;CCL2;GDF15;CHI3L1;ADM;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
12272,GO:0045937,0.108813531525612,0.943897785447005,10,974,positive regulation of phosphate metabolic process,BP,LTF;CCL2;GDF15;CHI3L1;ADM;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
11874,GO:0045109,0.109004682493924,0.99423663835656,1,17,intermediate filament organization,BP,VIM
8594,GO:0032703,0.109017666404645,0.99419869399389,1,19,negative regulation of interleukin-2 production,BP,GBP1
21479,GO:2000515,0.109031610462839,0.994214437247526,1,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,ANXA1
4482,GO:0009309,0.109049586038733,0.994165638933261,1,21,amine biosynthetic process,BP,MOXD1
13975,GO:0051588,0.109321283021966,0.981090661277735,2,84,regulation of neurotransmitter transport,BP,CPLX2;RIMS2
15765,GO:0070371,0.109396393728011,0.964187092150649,4,278,ERK1 and ERK2 cascade,BP,CCL2;GBP1;CHI3L1;PLA2G2A
16501,GO:0071682,0.109642403330635,0.9941306090316,1,19,endocytic vesicle lumen,CC,LTF
18212,GO:0099106,0.109784934222454,0.980956843427186,2,86,ion channel regulator activity,MF,KCNIP3;KCNIP2
15773,GO:0070382,0.109847847539974,0.971130253239268,3,181,exocytic vesicle,CC,SNAP25;SVOP;GRIN1
10571,GO:0042104,0.109872041061488,0.994105478622027,1,19,positive regulation of activated T cell proliferation,BP,IGFBP2
11147,GO:0043235,0.110125895567982,0.958432901757359,5,354,receptor complex,CC,SHANK2;GABRB3;GRIN1;SHISA7;GABBR1
12904,GO:0048020,0.110444961238432,0.99401218792079,1,21,CCR chemokine receptor binding,MF,CCL2
2301,GO:0004890,0.110705338154081,0.994051500494411,1,17,GABA-A receptor activity,MF,GABRB3
19397,GO:1902711,0.110705338154081,0.994051500494411,1,17,GABA-A receptor complex,CC,GABRB3
17020,GO:0072673,0.110748530766493,0.994046758679761,1,17,lamellipodium morphogenesis,BP,PDPN
11124,GO:0043202,0.110802698400106,0.980673824432157,2,87,lysosomal lumen,CC,FMOD;IFI30
15929,GO:0070663,0.110804602726817,0.970760136891346,3,189,regulation of leukocyte proliferation,BP,IGFBP2;LGALS3;ANXA1
4969,GO:0010818,0.110886630995919,0.993977714208441,1,20,T cell chemotaxis,BP,CXCL10
11442,GO:0043950,0.110925927757345,0.993989428424188,1,19,positive regulation of cAMP-mediated signaling,BP,CXCL10
9204,GO:0034123,0.111159105562565,0.993947450592082,1,20,positive regulation of toll-like receptor signaling pathway,BP,LTF
13589,GO:0050920,0.111325010302346,0.970574945608473,3,181,regulation of chemotaxis,BP,SERPINE1;CCL2;CXCL10
11168,GO:0043266,0.11153271579137,0.980486656982005,2,83,regulation of potassium ion transport,BP,KCNIP3;KCNIP2
12999,GO:0048268,0.111542169926441,0.993982003400413,1,16,clathrin coat assembly,BP,SNAP91
19035,GO:1901698,0.111644781168172,0.942150055478477,10,965,response to nitrogen compound,BP,TIMP1;COL1A1;ANXA1;ADM;GABRB3;NNMT;COL3A1;GRIN1;SOCS3;COL4A1
4824,GO:0010595,0.111871795497693,0.980392831856368,2,83,positive regulation of endothelial cell migration,BP,SRPX2;ANXA1
13714,GO:0051129,0.11197601541148,0.949577099776931,7,600,negative regulation of cellular component organization,BP,VIM;TNR;GBP1;SPP1;LGALS3;POSTN;CXCL10
10506,GO:0040013,0.11210000919525,0.962998765547025,4,267,negative regulation of locomotion,BP,TIMP1;SERPINE1;CCL2;COL3A1
18853,GO:1901215,0.11216245480247,0.970266002349189,3,176,negative regulation of neuron death,BP,CCL2;GABRB3;GRIN1
708,GO:0001871,0.112304437719102,0.993835849982455,1,19,pattern binding,MF,PTX3
7264,GO:0030247,0.112304437719102,0.993835849982455,1,19,polysaccharide binding,MF,PTX3
3372,GO:0006706,0.112317329920067,0.993817923964801,1,20,steroid catabolic process,BP,SPP1
14520,GO:0060055,0.112539458290057,0.993809464834856,1,19,angiogenesis involved in wound healing,BP,SERPINE1
3975,GO:0008233,0.112560232305372,0.952811614355793,6,518,peptidase activity,MF,LTF;AEBP1;PLAU;ADAM12;C1R;CFI
17413,GO:0090330,0.11292634644376,0.993784416558284,1,18,regulation of platelet aggregation,BP,PDPN
2127,GO:0004653,0.11295525678005,0.993762640143323,1,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT13
6331,GO:0018243,0.11295525678005,0.993762640143323,1,19,protein O-linked glycosylation via threonine,BP,GALNT13
14092,GO:0051797,0.112979834097605,0.993778398945674,1,18,regulation of hair follicle development,BP,FERMT1
3628,GO:0007158,0.113157438114483,0.993802566365546,1,16,neuron cell-cell adhesion,BP,TNR
16599,GO:0071887,0.11353586512679,0.979895333149326,2,93,leukocyte apoptotic process,BP,LGALS3;ANXA1
3809,GO:0007586,0.113562806887495,0.979887790547773,2,93,digestion,BP,TYMP;SERPINA3
11227,GO:0043372,0.113643406921394,0.993652606188161,1,21,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
13281,GO:0048871,0.113792129794076,0.962230685296456,4,281,multicellular organismal homeostasis,BP,LTF;SPP1;CDHR1;SERPINA3
2625,GO:0005539,0.113951747254905,0.969580542964307,3,180,glycosaminoglycan binding,MF,LTF;POSTN;CXCL10
10319,GO:0036499,0.114225495938193,0.993601406988139,1,20,PERK-mediated unfolded protein response,BP,CCL2
13252,GO:0048820,0.114235457106373,0.993681279058071,1,16,hair follicle maturation,BP,FERMT1
3652,GO:0007186,0.114365307556059,0.945205902973287,8,771,G-protein coupled receptor signaling pathway,BP,CCL2;ANXA1;GNAL;GPR17;ADM;GABRB3;CXCL10;GABBR1
5819,GO:0016324,0.114754636204732,0.961811736114167,4,267,apical plasma membrane,CC,IGFBP2;ANXA1;SHANK2;PDPN
13248,GO:0048814,0.114790997122384,0.979598798486765,2,78,regulation of dendrite morphogenesis,BP,CUX2;GRIN1
4864,GO:0010648,0.114881738928195,0.936519385886315,12,1238,negative regulation of cell communication,BP,LTF;FERMT1;SERPINE1;SH3GL2;IGFBP2;TNR;GBP1;LGALS3;ADM;KCNB1;SHANK2;SOCS3
13022,GO:0048311,0.1150988701677,0.993583251041765,1,16,mitochondrion distribution,BP,ATCAY
9830,GO:0035579,0.115127423943989,0.979464483679054,2,88,specific granule membrane,CC,PLAU;SNAP25
10025,GO:0035886,0.115602706455014,0.993460176996092,1,19,vascular smooth muscle cell differentiation,BP,ADM
18208,GO:0099095,0.115664118638159,0.993472496386461,1,18,ligand-gated anion channel activity,MF,GABRB3
13683,GO:0051087,0.116009603024811,0.979208059597223,2,90,chaperone binding,MF,CP;PDPN
5975,GO:0016638,0.116100667247174,0.993368910355149,1,21,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,LOX
11269,GO:0043434,0.116143447352217,0.95543487389557,5,385,response to peptide hormone,BP,TIMP1;COL1A1;ANXA1;ADM;SOCS3
3366,GO:0006700,0.116149155110249,0.99337919016161,1,20,C21-steroid hormone biosynthetic process,BP,ADM
18193,GO:0099072,0.116244444671024,0.993368079480452,1,20,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,SNAP25
11351,GO:0043567,0.116408712665874,0.993386282475445,1,18,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP2
14719,GO:0060348,0.116581588702364,0.96859073763733,3,169,bone development,BP,LTF;COL1A1;ANXA2
7102,GO:0023057,0.116632113131254,0.935378254181398,12,1242,negative regulation of signaling,BP,LTF;FERMT1;SERPINE1;SH3GL2;IGFBP2;TNR;GBP1;LGALS3;ADM;KCNB1;SHANK2;SOCS3
13480,GO:0050772,0.116669877285877,0.979072584994175,2,77,positive regulation of axonogenesis,BP,TNFRSF12A;SLITRK1
14179,GO:0051961,0.116997476445689,0.960803561057351,4,264,negative regulation of nervous system development,BP,VIM;TNR;SPP1;COL3A1
21388,GO:2000369,0.117237654226313,0.993337024046289,1,16,regulation of clathrin-dependent endocytosis,BP,SNAP91
13582,GO:0050912,0.117254556066037,0.993205204423363,1,23,detection of chemical stimulus involved in sensory perception of taste,BP,RTP5
4896,GO:0010714,0.117459865323441,0.993225508108332,1,20,positive regulation of collagen metabolic process,BP,VIM
8768,GO:0032967,0.117459865323441,0.993225508108332,1,20,positive regulation of collagen biosynthetic process,BP,VIM
19549,GO:1903038,0.117467217671356,0.978779908619601,2,94,negative regulation of leukocyte cell-cell adhesion,BP,LGALS3;ANXA1
11436,GO:0043931,0.117569412233846,0.993359748430106,1,14,ossification involved in bone maturation,BP,LTF
6330,GO:0018242,0.11800572585567,0.993160961539351,1,20,protein O-linked glycosylation via serine,BP,GALNT13
15042,GO:0060840,0.1180846842934,0.978674275419804,2,76,artery development,BP,LOX;COL3A1
19396,GO:1902710,0.118268865250026,0.993168316363947,1,18,GABA receptor complex,CC,GABRB3
15604,GO:0070102,0.11847364647402,0.993166879082026,1,17,interleukin-6-mediated signaling pathway,BP,SOCS3
12619,GO:0046697,0.118487127256138,0.993122113718253,1,19,decidualization,BP,SPP1
7029,GO:0022406,0.11864756754863,0.967775286170188,3,179,membrane docking,BP,SNAP25;CPLX2;KCNB1
10180,GO:0036151,0.118658014162578,0.993066770517029,1,21,phosphatidylcholine acyl-chain remodeling,BP,PLA2G2A
952,GO:0002251,0.118772179572097,0.993024131710906,1,23,organ or tissue specific immune response,BP,LTF
13149,GO:0048640,0.119064177084254,0.978353592861572,2,85,negative regulation of developmental growth,BP,TNR;SPP1
16894,GO:0072378,0.119223353423518,0.992999027614371,1,21,blood coagulation, fibrin clot formation,BP,SERPING1
7458,GO:0030658,0.119309881104488,0.967507010643005,3,186,transport vesicle membrane,CC,SVOP;HLA-DQB1;HLA-DQA1
8349,GO:0032366,0.119490162320664,0.993023197698182,1,18,intracellular sterol transport,BP,ANXA2
8350,GO:0032367,0.119490162320664,0.993023197698182,1,18,intracellular cholesterol transport,BP,ANXA2
14452,GO:0055093,0.119863124085694,0.99293892988419,1,20,response to hyperoxia,BP,COL1A1
10547,GO:0042056,0.120184292549172,0.992867574255432,1,22,chemoattractant activity,MF,LGALS3
480,GO:0001516,0.120330087884605,0.992849859277584,1,22,prostaglandin biosynthetic process,BP,ANXA1
12480,GO:0046457,0.120330087884605,0.992849859277584,1,22,prostanoid biosynthetic process,BP,ANXA1
13455,GO:0050729,0.120524476651786,0.977883162069679,2,99,positive regulation of inflammatory response,BP,SERPINE1;PLA2G2A
6704,GO:0019905,0.120653271615887,0.977882492194775,2,88,syntaxin binding,MF,SNAP25;CPLX2
2628,GO:0005543,0.120937872993085,0.953027010387374,5,380,phospholipid binding,MF,SNAP91;PLEKHA4;ANXA1;ANXA2;PLA2G2A
17603,GO:0097106,0.120992489648076,0.992923321811728,1,15,postsynaptic density organization,BP,SHANK2
18203,GO:0099084,0.120992489648076,0.992923321811728,1,15,postsynaptic specialization organization,BP,SHANK2
19950,GO:1903861,0.12105285524748,0.992858971865841,1,17,positive regulation of dendrite extension,BP,RIMS2
21111,GO:1990823,0.121062279036165,0.977749107348137,2,92,response to leukemia inhibitory factor,BP,INA;SOCS3
21115,GO:1990830,0.121062279036165,0.977749107348137,2,92,cellular response to leukemia inhibitory factor,BP,INA;SOCS3
4881,GO:0010669,0.121296300545493,0.992765070654042,1,20,epithelial structure maintenance,BP,SERPINA3
8515,GO:0032587,0.122193042559766,0.977445448106669,2,85,ruffle membrane,CC,FERMT1;PDPN
18025,GO:0098742,0.122196594040445,0.966410460377974,3,166,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CDHR1;PCDH7;PTPRT
6059,GO:0016798,0.122481651299446,0.977305420825624,2,101,hydrolase activity, acting on glycosyl bonds,MF,CHI3L2;CHI3L1
17908,GO:0097731,0.122629220089654,0.977309610126234,2,87,9+0 non-motile cilium,CC,CDHR1;SHANK2
17910,GO:0097733,0.122629220089654,0.977309610126234,2,87,photoreceptor cell cilium,CC,CDHR1;SHANK2
15251,GO:0061298,0.122680245563644,0.992688529033537,1,16,retina vasculature development in camera-type eye,BP,COL4A1
489,GO:0001530,0.123199866689893,0.992481593506361,1,23,lipopolysaccharide binding,MF,LTF
13167,GO:0048670,0.12334693676088,0.99253233237096,1,19,regulation of collateral sprouting,BP,SPP1
6719,GO:0019955,0.123347182362677,0.977066184417213,2,96,cytokine binding,MF,GBP1;PDPN
7944,GO:0031579,0.12366488674609,0.992438374871994,1,22,membrane raft organization,BP,ANXA2
16095,GO:0070977,0.123703067924957,0.992594827775006,1,15,bone maturation,BP,LTF
2437,GO:0005126,0.123779968521669,0.965725466043761,3,204,cytokine receptor binding,MF,CCL2;GDF15;CXCL10
4008,GO:0008284,0.123796731316937,0.939620324807694,8,761,positive regulation of cell proliferation,BP,LTF;TIMP1;IGFBP2;ANXA1;ADM;CXCL10;VSTM2A;ANXA2
17126,GO:0086013,0.123806426259597,0.992437109266443,1,21,membrane repolarization during cardiac muscle cell action potential,BP,KCNIP2
13846,GO:0051336,0.124077907843407,0.932294302151578,11,1111,regulation of hydrolase activity,BP,LTF;TIMP1;SERPINE1;CCL2;SPOCD1;ANXA1;SERPING1;PTX3;ELFN2;GRIN1;SERPINA3
7398,GO:0030516,0.124422610996273,0.976802574862089,2,82,regulation of axon extension,BP,TNFRSF12A;TNR
19530,GO:1903010,0.124835026346722,0.992346651386087,1,19,regulation of bone development,BP,LTF
15206,GO:0061138,0.125084909487216,0.965252587828099,3,174,morphogenesis of a branching epithelium,BP,ADM;SOCS3;COL4A1
21459,GO:2000482,0.125656834148886,0.992186826440692,1,22,regulation of interleukin-8 secretion,BP,ANXA1
3659,GO:0007194,0.125890943406975,0.992174004488491,1,21,negative regulation of adenylate cyclase activity,BP,GABBR1
3198,GO:0006491,0.12606295630306,0.992214708900692,1,18,N-glycan processing,BP,ST8SIA3
723,GO:0001891,0.126109164706666,0.992146187989799,1,21,phagocytic cup,CC,ANXA1
10617,GO:0042180,0.126456891990559,0.964665419594242,3,199,cellular ketone metabolic process,BP,ANXA1;ADM;ATCAY
7992,GO:0031664,0.126620934960711,0.992080749904186,1,21,regulation of lipopolysaccharide-mediated signaling pathway,BP,LTF
21842,GO:2001237,0.126693139019976,0.976074986119654,2,95,negative regulation of extrinsic apoptotic signaling pathway,BP,SERPINE1;LGALS3
13658,GO:0051043,0.126816979420541,0.992055606978482,1,21,regulation of membrane protein ectodomain proteolysis,BP,TIMP1
547,GO:0001637,0.126942477054595,0.991991891948717,1,24,G-protein coupled chemoattractant receptor activity,MF,GPR17
2337,GO:0004950,0.126942477054595,0.991991891948717,1,24,chemokine receptor activity,MF,GPR17
5025,GO:0010884,0.126959525540496,0.992056350535746,1,20,positive regulation of lipid storage,BP,VSTM2A
15123,GO:0061003,0.127146475499979,0.992103209503653,1,17,positive regulation of dendritic spine morphogenesis,BP,CUX2
8356,GO:0032373,0.127169230954923,0.992074056631368,1,18,positive regulation of sterol transport,BP,ANXA2
8359,GO:0032376,0.127169230954923,0.992074056631368,1,18,positive regulation of cholesterol transport,BP,ANXA2
13454,GO:0050728,0.127258979079631,0.975888584319548,2,100,negative regulation of inflammatory response,BP,GPR17;SOCS3
13218,GO:0048745,0.127643752535885,0.991989659306955,1,19,smooth muscle tissue development,BP,COL3A1
5059,GO:0010923,0.127766787727242,0.975774873607838,2,89,negative regulation of phosphatase activity,BP,SPOCD1;ELFN2
21417,GO:2000406,0.127810587949711,0.991909983110311,1,22,positive regulation of T cell migration,BP,CXCL10
18717,GO:1900273,0.127832831814785,0.992045439169917,1,16,positive regulation of long-term synaptic potentiation,BP,SHISA7
12707,GO:0046916,0.128047975979481,0.975650851897171,2,100,cellular transition metal ion homeostasis,BP,LTF;CP
16551,GO:0071804,0.128092860406974,0.964026319014431,3,187,cellular potassium ion transport,BP,KCNIP3;KCNIP2;KCNB1
16552,GO:0071805,0.128092860406974,0.964026319014431,3,187,potassium ion transmembrane transport,BP,KCNIP3;KCNIP2;KCNB1
13443,GO:0050715,0.128167645961772,0.975614714006166,2,100,positive regulation of cytokine secretion,BP,FERMT1;POSTN
14959,GO:0060706,0.129195672829271,0.991729269649195,1,22,cell differentiation involved in embryonic placenta development,BP,SOCS3
7922,GO:0031527,0.129275059706171,0.99182979725606,1,17,filopodium membrane,CC,PDPN
13523,GO:0050832,0.129653156783525,0.991610801049708,1,26,defense response to fungus,BP,LTF
4060,GO:0008373,0.129705234984123,0.9917002174667,1,20,sialyltransferase activity,MF,ST8SIA3
17820,GO:0097503,0.129705234984123,0.9917002174667,1,20,sialylation,BP,ST8SIA3
8480,GO:0032526,0.1297653079419,0.97514026238583,2,97,response to retinoic acid,BP,COL1A1;IGFBP2
11428,GO:0043903,0.129952758727643,0.963252141249318,3,202,regulation of symbiosis, encompassing mutualism through parasitism,BP,LTF;PTX3;ANXA2
19571,GO:1903077,0.130065627019611,0.991614693385052,1,22,negative regulation of protein localization to plasma membrane,BP,GBP1
7777,GO:0031280,0.130464788793419,0.991561845037949,1,22,negative regulation of cyclase activity,BP,GABBR1
8660,GO:0032799,0.130734253827156,0.991544431264348,1,21,low-density lipoprotein receptor particle metabolic process,BP,ANXA2
7520,GO:0030818,0.130888440216954,0.99150556340715,1,22,negative regulation of cAMP biosynthetic process,BP,GABBR1
2486,GO:0005200,0.131127894944102,0.974742721800353,2,92,structural constituent of cytoskeleton,MF,VIM;INA
7923,GO:0031528,0.131143399288103,0.991490074363195,1,21,microvillus membrane,CC,PDPN
22,GO:0000041,0.131530885905157,0.974590470388495,2,100,transition metal ion transport,BP,CP;STEAP3
16201,GO:0071229,0.131767369779491,0.962534915498091,3,188,cellular response to acid chemical,BP,COL1A1;COL3A1;COL4A1
741,GO:0001919,0.131939422174161,0.991365092232545,1,22,regulation of receptor recycling,BP,ANXA2
10224,GO:0036303,0.132036944423899,0.991439434050755,1,18,lymph vessel morphogenesis,BP,PDPN
4714,GO:0010226,0.132462023464813,0.991294791820681,1,22,response to lithium ion,BP,IGFBP2
9325,GO:0034368,0.132557497070412,0.991281916307465,1,22,protein-lipid complex remodeling,BP,PLA2G2A
9326,GO:0034369,0.132557497070412,0.991281916307465,1,22,plasma lipoprotein particle remodeling,BP,PLA2G2A
19335,GO:1902533,0.133044324043121,0.931111154984489,9,901,positive regulation of intracellular signal transduction,BP,LTF;CCL2;CHI3L1;GPR17;COL3A1;CXCL10;KSR2;SOCS3;PLA2G2A
12377,GO:0046134,0.133051150844649,0.991167273499752,1,25,pyrimidine nucleoside biosynthetic process,BP,TYMP
3330,GO:0006658,0.133062529216076,0.991180362762084,1,24,phosphatidylserine metabolic process,BP,PLA2G2A
18539,GO:0140115,0.133162089156565,0.991182758648538,1,23,export across plasma membrane,BP,KCNIP2
15535,GO:0062014,0.133232311932005,0.974065999107565,2,100,negative regulation of small molecule metabolic process,BP,ATCAY;GABBR1
6616,GO:0019731,0.133438157442284,0.991100903350961,1,26,antibacterial humoral response,BP,LTF
15116,GO:0060996,0.133898113450402,0.973924382191185,2,84,dendritic spine development,BP,CUX2;SHANK2
13583,GO:0050913,0.133928661558708,0.99104735370206,1,25,sensory perception of bitter taste,BP,RTP5
3356,GO:0006688,0.134162023112429,0.991064032418943,1,22,glycosphingolipid biosynthetic process,BP,ST8SIA3
3839,GO:0007626,0.134483024555225,0.961440789415143,3,177,locomotory behavior,BP,TNR;SNAP25;GRIN1
21480,GO:2000516,0.134989621519365,0.99090122723499,1,25,positive regulation of CD4-positive, alpha-beta T cell activation,BP,ANXA1
4918,GO:0010738,0.135024899332175,0.991037131913461,1,18,regulation of protein kinase A signaling,BP,SPHKAP
12124,GO:0045662,0.135303602459548,0.990889335020124,1,23,negative regulation of myoblast differentiation,BP,CXCL10
14702,GO:0060330,0.135408085701329,0.990874889652236,1,23,regulation of response to interferon-gamma,BP,SOCS3
14706,GO:0060334,0.135408085701329,0.990874889652236,1,23,regulation of interferon-gamma-mediated signaling pathway,BP,SOCS3
7505,GO:0030803,0.135436396184812,0.990870973501425,1,23,negative regulation of cyclic nucleotide biosynthetic process,BP,GABBR1
2605,GO:0005504,0.135528836499846,0.990841670188569,1,24,fatty acid binding,MF,FABP5
18192,GO:0099068,0.136066388756168,0.990924679202504,1,17,postsynapse assembly,BP,SHANK2
19948,GO:1903859,0.136182281565024,0.990827512794498,1,20,regulation of dendrite extension,BP,RIMS2
1867,GO:0004181,0.136637760271072,0.990687193307746,1,24,metallocarboxypeptidase activity,MF,AEBP1
6461,GO:0019207,0.136641639871812,0.96050416598911,3,203,kinase regulator activity,MF,LTF;CXCL10;SOCS3
16111,GO:0070997,0.137326715753548,0.951267787321672,4,297,neuron death,BP,CCL2;KCNB1;GABRB3;GRIN1
9324,GO:0034367,0.137638132361228,0.99056369797087,1,23,protein-containing complex remodeling,BP,PLA2G2A
15768,GO:0070374,0.137767868982221,0.960042925768273,3,198,positive regulation of ERK1 and ERK2 cascade,BP,CCL2;CHI3L1;PLA2G2A
833,GO:0002040,0.138662000710425,0.972386892723629,2,94,sprouting angiogenesis,BP,SRPX2;ANXA1
7997,GO:0031669,0.138881105630228,0.959580928408167,3,196,cellular response to nutrient levels,BP,COL1A1;POSTN;KCNB1
9190,GO:0034105,0.138886947731235,0.990405947239867,1,22,positive regulation of tissue remodeling,BP,SPP1
17124,GO:0086011,0.139328735593547,0.990306666414126,1,24,membrane repolarization during action potential,BP,KCNIP2
17247,GO:0090100,0.139358351317654,0.97215770232169,2,96,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,FERMT1;GDF15
14860,GO:0060541,0.139452687455652,0.959362165991733,3,184,respiratory system development,BP,LOX;CHI3L1;PDPN
5239,GO:0014850,0.139460226299212,0.990345319664096,1,21,response to muscle activity,BP,POSTN
4390,GO:0009164,0.139551329216658,0.990230109712523,1,27,nucleoside catabolic process,BP,TYMP
4758,GO:0010460,0.139616962330061,0.990302071493622,1,22,positive regulation of heart rate,BP,ADM
11499,GO:0044106,0.139760537627837,0.971972910565606,2,113,cellular amine metabolic process,BP,MOXD1;ATCAY
5276,GO:0014912,0.139914890863594,0.990280541452223,1,21,negative regulation of smooth muscle cell migration,BP,SERPINE1
1053,GO:0002429,0.139942331119025,0.949980134781819,4,321,immune response-activating cell surface receptor signaling pathway,BP,GBP1;LGALS3;HLA-DQB1;HLA-DQA1
8670,GO:0032809,0.140077693170068,0.990216964739899,1,23,neuronal cell body membrane,CC,KCNB1
11576,GO:0044298,0.140077693170068,0.990216964739899,1,23,cell body membrane,CC,KCNB1
11356,GO:0043576,0.140121497715562,0.990229934892851,1,22,regulation of respiratory gaseous exchange,BP,GRIN1
13859,GO:0051350,0.140225866255472,0.990178017764953,1,24,negative regulation of lyase activity,BP,GABBR1
13147,GO:0048638,0.140230808641461,0.94987961987212,4,280,regulation of developmental growth,BP,TNFRSF12A;TNR;SPP1;RIMS2
20188,GO:1904376,0.14032634035239,0.99016355404852,1,24,negative regulation of protein localization to cell periphery,BP,GBP1
2107,GO:0004623,0.140978258525612,0.990037835648763,1,26,phospholipase A2 activity,MF,PLA2G2A
8814,GO:0033032,0.141049399314376,0.990059135085244,1,24,regulation of myeloid cell apoptotic process,BP,ANXA1
9095,GO:0033688,0.141200004599719,0.990055233618828,1,23,regulation of osteoblast proliferation,BP,LTF
21227,GO:2000108,0.14137849908101,0.99001141615947,1,24,positive regulation of leukocyte apoptotic process,BP,ANXA1
6720,GO:0019956,0.141615763942212,0.989960356624082,1,25,chemokine binding,MF,PDPN
2843,GO:0005912,0.14169968511581,0.93676434333417,6,509,adherens junction,CC,VIM;FERMT1;PLAU;ANXA1;S100A11;ANXA2
2503,GO:0005234,0.142505766272493,0.989957587892203,1,19,extracellularly glutamate-gated ion channel activity,MF,GRIN1
9689,GO:0035305,0.142531667198102,0.971144634652353,2,95,negative regulation of dephosphorylation,BP,SPOCD1;ELFN2
18258,GO:0099528,0.142641595729917,0.989794799890103,1,26,G-protein coupled neurotransmitter receptor activity,MF,GABBR1
12555,GO:0046596,0.142755154239653,0.989778094691052,1,26,regulation of viral entry into host cell,BP,PTX3
4665,GO:0010008,0.142799750833295,0.941597247369075,5,427,endosome membrane,CC,STEAP3;ANXA1;HLA-DQB1;ANXA2;HLA-DQA1
12285,GO:0045956,0.142804722179859,0.989841553532553,1,22,positive regulation of calcium ion-dependent exocytosis,BP,KCNB1
666,GO:0001817,0.142844121403291,0.936086471986343,6,563,regulation of cytokine production,BP,LTF;FERMT1;SERPINE1;GBP1;POSTN;ANXA1
17587,GO:0097066,0.143044409496898,0.989768010170722,1,24,response to thyroid hormone,BP,ANXA2
15533,GO:0062012,0.143055289951402,0.941461386937498,5,425,regulation of small molecule metabolic process,BP,ANXA1;ADM;ATCAY;CXCL10;GABBR1
14722,GO:0060351,0.14331861339255,0.989727649594568,1,24,cartilage development involved in endochondral bone morphogenesis,BP,COL1A1
667,GO:0001818,0.143376151425113,0.957658203813118,3,213,negative regulation of cytokine production,BP,LTF;GBP1;ANXA1
2354,GO:0004970,0.143521906932707,0.989809793189832,1,19,ionotropic glutamate receptor activity,MF,GRIN1
9192,GO:0034110,0.144477546205809,0.989574899647551,1,23,regulation of homotypic cell-cell adhesion,BP,PDPN
13793,GO:0051248,0.144647047566268,0.921046360520233,10,1031,negative regulation of protein metabolic process,BP,LTF;TIMP1;SERPINE1;GBP1;SERPING1;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3
4982,GO:0010831,0.144754806620032,0.989497556823212,1,25,positive regulation of myotube differentiation,BP,GDF15
7981,GO:0031646,0.144878888818089,0.989515258607498,1,23,positive regulation of neurological system process,BP,TNR
11324,GO:0043534,0.145221267626357,0.970258943303019,2,98,blood vessel endothelial cell migration,BP,SRPX2;ANXA1
1289,GO:0002828,0.145483446421127,0.98935745103827,1,27,regulation of type 2 immune response,BP,ANXA1
7752,GO:0031234,0.146048404451783,0.96996190348181,2,105,extrinsic component of cytoplasmic side of plasma membrane,CC,SNAP25;GNAL
8522,GO:0032594,0.146231041740352,0.989259780222148,1,26,protein transport within lipid bilayer,BP,SNAP25
13927,GO:0051482,0.146241245302799,0.989243130266698,1,27,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,GPR17
7460,GO:0030660,0.146455650797974,0.96982463664783,2,106,Golgi-associated vesicle membrane,CC,HLA-DQB1;HLA-DQA1
13242,GO:0048799,0.146477072529339,0.989373479251162,1,19,animal organ maturation,BP,LTF
622,GO:0001763,0.147336576770917,0.956006154501691,3,187,morphogenesis of a branching structure,BP,ADM;SOCS3;COL4A1
14783,GO:0060429,0.147337159989089,0.919277578215807,10,1008,epithelium development,BP,VIM;FERMT1;SERPINE1;LGALS3;ANXA1;ADM;PDPN;CXCL10;SOCS3;COL4A1
21414,GO:2000403,0.147498976816659,0.989067333434633,1,26,positive regulation of lymphocyte migration,BP,CXCL10
2825,GO:0005884,0.14751346110036,0.969506164173188,2,98,actin filament,CC,FERMT1;ANXA1
5113,GO:0010996,0.147516843970182,0.989163492430707,1,21,response to auditory stimulus,BP,CXCL10
17657,GO:0097191,0.148523943947528,0.955460487341524,3,206,extrinsic apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1;LGALS3
6421,GO:0019079,0.148724311947311,0.969074931296472,2,106,viral genome replication,BP,LTF;CCL2
2610,GO:0005515,0.149316120328974,0.895917966453218,72,10245,protein binding,MF,TNFRSF12A;LTF;TYMP;VIM;CP;SNAP91;MOXD1;CRTAC1;TIMP1;SRPX2;SHD;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;LOX;KCNIP3;STEAP3;IGFBP2;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;GDF15;LGALS3;EMILIN2;SNAP25;POSTN;COL4A2;ANXA1;GNAL;COL6A2;EMP3;CPLX2;ADAM12;ADM;SERPING1;SPHKAP;KCNB1;C1R;SHANK2;PDPN;S100A11;PTX3;FABP5;GABRB3;ATCAY;COL3A1;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PTPRT;SERPINA3;HLA-DQA1;SMOC1;GABBR1;CFI;DOK6;IFI30
5514,GO:0015721,0.149533881136997,0.988771756457198,1,25,bile acid and bile salt transport,BP,ABCC3
3760,GO:0007413,0.149621502399637,0.988869318270784,1,20,axonal fasciculation,BP,CRTAC1
18418,GO:0106030,0.149621502399637,0.988869318270784,1,20,neuron projection fasciculation,BP,CRTAC1
14715,GO:0060343,0.1497557320614,0.988776142140817,1,23,trabecula formation,BP,COL1A1
12090,GO:0045622,0.150140330672389,0.988660616530651,1,26,regulation of T-helper cell differentiation,BP,ANXA1
11818,GO:0045026,0.150282955860503,0.988607662950389,1,28,plasma membrane fusion,BP,SNAP25
12584,GO:0046636,0.150408975132222,0.98863607282571,1,25,negative regulation of alpha-beta T cell activation,BP,ANXA1
6551,GO:0019433,0.151647609200327,0.988424996950385,1,26,triglyceride catabolic process,BP,FABP5
14727,GO:0060359,0.151842370714491,0.96803254149457,2,106,response to ammonium ion,BP,GABRB3;GRIN1
7548,GO:0030855,0.152100151337491,0.930755920341526,6,536,epithelial cell differentiation,BP,VIM;SERPINE1;LGALS3;ANXA1;PDPN;COL4A1
7559,GO:0030867,0.152411694368947,0.988272927234232,1,28,rough endoplasmic reticulum membrane,CC,LTF
7763,GO:0031258,0.152657208479916,0.988346595067447,1,22,lamellipodium membrane,CC,PDPN
8766,GO:0032965,0.152737871070969,0.988236484148744,1,27,regulation of collagen biosynthetic process,BP,VIM
10930,GO:0042802,0.15307656170992,0.908948511231506,13,1494,identical protein binding,MF,TYMP;VIM;SRPX2;SH3GL2;COL1A1;GBP1;ANXA1;S100A11;PTX3;GABRB3;VSTM2A;ST8SIA3;ANXA2
7517,GO:0030815,0.153449062824042,0.988140020294687,1,26,negative regulation of cAMP metabolic process,BP,GABBR1
1,GO:0000002,0.153820025243763,0.988080880279811,1,26,mitochondrial genome maintenance,BP,TYMP
17402,GO:0090314,0.154075903791512,0.988023225948799,1,27,positive regulation of protein targeting to membrane,BP,KCNB1
18207,GO:0099094,0.154187602101324,0.967271611469563,2,98,ligand-gated cation channel activity,MF,JPH3;GRIN1
11250,GO:0043403,0.154344015276295,0.987980249369907,1,27,skeletal muscle tissue regeneration,BP,ANXA1
11972,GO:0045296,0.154495617933852,0.942774907978112,4,309,cadherin binding,MF,ANXA1;S100A11;ANXA2;PTPRT
772,GO:0001958,0.154514781783025,0.987987918458318,1,25,endochondral ossification,BP,COL1A1
10135,GO:0036075,0.154514781783025,0.987987918458318,1,25,replacement ossification,BP,COL1A1
788,GO:0001975,0.154724660601579,0.987974067676952,1,24,response to amphetamine,BP,GRIN1
12593,GO:0046649,0.154766608282664,0.929182201557905,6,568,lymphocyte activation,BP,CCL2;IGFBP2;LGALS3;ANXA1;HLA-DQB1;HLA-DQA1
2514,GO:0005251,0.155187106552136,0.987861587906181,1,26,delayed rectifier potassium channel activity,MF,KCNB1
12492,GO:0046471,0.155267584690386,0.987831581572716,1,27,phosphatidylglycerol metabolic process,BP,PLA2G2A
4481,GO:0009308,0.155430416711828,0.966766477667862,2,121,amine metabolic process,BP,MOXD1;ATCAY
9094,GO:0033687,0.155602508002525,0.987794533285987,1,26,osteoblast proliferation,BP,LTF
6299,GO:0018146,0.155638225222995,0.987788758612155,1,26,keratan sulfate biosynthetic process,BP,FMOD
13403,GO:0050671,0.155896684603495,0.96661880808305,2,117,positive regulation of lymphocyte proliferation,BP,IGFBP2;ANXA1
3703,GO:0007266,0.155900367226542,0.952262752910688,3,189,Rho protein signal transduction,BP,GPR17;PDPN;COL3A1
1252,GO:0002757,0.156028728487578,0.934373467773134,5,451,immune response-activating signal transduction,BP,LTF;GBP1;LGALS3;HLA-DQB1;HLA-DQA1
14690,GO:0060314,0.156155211441332,0.987723618329316,1,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,JPH3
13477,GO:0050769,0.156574422831965,0.934101585534434,5,406,positive regulation of neurogenesis,BP,TNFRSF12A;CUX2;SHANK2;RIMS2;SLITRK1
12594,GO:0046651,0.156808980723396,0.951802913167753,3,222,lymphocyte proliferation,BP,IGFBP2;LGALS3;ANXA1
9218,GO:0034142,0.156838778576972,0.98756030169443,1,28,toll-like receptor 4 signaling pathway,BP,LTF
15633,GO:0070161,0.156896425505208,0.927952419895108,6,524,anchoring junction,CC,VIM;FERMT1;PLAU;ANXA1;S100A11;ANXA2
12257,GO:0045920,0.15694145195471,0.987559663983128,1,27,negative regulation of exocytosis,BP,ANXA1
10220,GO:0036296,0.156991923345935,0.987551415400262,1,27,response to increased oxygen levels,BP,COL1A1
12133,GO:0045671,0.157493864756449,0.987526183334317,1,24,negative regulation of osteoclast differentiation,BP,LTF
19779,GO:1903532,0.15777592055325,0.941094044987887,4,324,positive regulation of secretion by cell,BP,FERMT1;SPP1;POSTN;KCNB1
10615,GO:0042177,0.157809755025507,0.966002967235666,2,105,negative regulation of protein catabolic process,BP,TIMP1;ANXA2
8755,GO:0032946,0.157824980418042,0.965952337549291,2,118,positive regulation of mononuclear cell proliferation,BP,IGFBP2;ANXA1
7502,GO:0030800,0.157880124830913,0.987405780480379,1,27,negative regulation of cyclic nucleotide metabolic process,BP,GABBR1
10131,GO:0036065,0.158070652836208,0.987411140584007,1,25,fucosylation,BP,FUT9
21415,GO:2000404,0.15837134389518,0.987308400582549,1,28,regulation of T cell migration,BP,CXCL10
4631,GO:0009897,0.15837172498672,0.951117483931444,3,215,external side of plasma membrane,CC,ANXA1;CXCL10;CD163
14172,GO:0051954,0.158460201430572,0.987293713146773,1,28,positive regulation of amine transport,BP,KCNB1
21375,GO:2000352,0.158534339048464,0.9873156905273,1,26,negative regulation of endothelial cell apoptotic process,BP,SERPINE1
10845,GO:0042634,0.15878589645704,0.987293387846201,1,25,regulation of hair cycle,BP,FERMT1
12127,GO:0045665,0.158868403430697,0.950928802813693,3,196,negative regulation of neuron differentiation,BP,VIM;TNR;SPP1
8301,GO:0032281,0.15888309110604,0.987240245627272,1,27,AMPA glutamate receptor complex,CC,SHISA7
3961,GO:0008207,0.159456779716963,0.987112844327687,1,29,C21-steroid hormone metabolic process,BP,ADM
8752,GO:0032943,0.159589712067774,0.950558783864057,3,224,mononuclear cell proliferation,BP,IGFBP2;LGALS3;ANXA1
18825,GO:1901137,0.15981060050609,0.921321414842001,7,688,carbohydrate derivative biosynthetic process,BP,TYMP;FMOD;GALNT13;ADM;FUT9;ST8SIA3;GABBR1
19031,GO:1901681,0.160424233894715,0.95020640422453,3,210,sulfur compound binding,MF,LTF;POSTN;CXCL10
8810,GO:0033028,0.160445917951249,0.986963133242572,1,28,myeloid cell apoptotic process,BP,ANXA1
6431,GO:0019098,0.161155300272974,0.986843940941183,1,28,reproductive behavior,BP,GRIN1
15135,GO:0061025,0.161338454415277,0.949785152267811,3,216,membrane fusion,BP,SNAP25;ANXA1;ANXA2
7393,GO:0030511,0.161983605817597,0.986759802149093,1,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,FERMT1
19943,GO:1903846,0.161983605817597,0.986759802149093,1,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,FERMT1
12129,GO:0045667,0.162598147535996,0.964335043453184,2,105,regulation of osteoblast differentiation,BP,LTF;SMOC1
15679,GO:0070232,0.16268405175075,0.986568954558984,1,29,regulation of T cell apoptotic process,BP,LGALS3
7196,GO:0030159,0.163108146582161,0.986591374065033,1,24,receptor signaling complex scaffold activity,MF,SHANK2
11425,GO:0043900,0.163605830488873,0.938082421672354,4,340,regulation of multi-organism process,BP,LTF;TIMP1;PTX3;ANXA2
3435,GO:0006813,0.16366055208054,0.948743483469836,3,211,potassium ion transport,BP,KCNIP3;KCNIP2;KCNB1
13165,GO:0048668,0.163768020363351,0.98645696288265,1,25,collateral sprouting,BP,SPP1
15730,GO:0070306,0.163801353424396,0.986430797538738,1,26,lens fiber cell differentiation,BP,VIM
3496,GO:0006909,0.163853968592323,0.948642420304909,3,219,phagocytosis,BP,CCL2;ANXA1;PTX3
20715,GO:1905476,0.164429124203948,0.986269869802366,1,29,negative regulation of protein localization to membrane,BP,GBP1
15491,GO:0061844,0.164436387361369,0.986200669695083,1,34,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,LTF
4921,GO:0010743,0.164507707047322,0.986330358013276,1,25,regulation of macrophage derived foam cell differentiation,BP,PLA2G2A
15931,GO:0070665,0.164549627921039,0.963588130030855,2,121,positive regulation of leukocyte proliferation,BP,IGFBP2;ANXA1
777,GO:0001964,0.164650887399391,0.98632819333999,1,24,startle response,BP,GRIN1
19869,GO:1903707,0.165638053836406,0.963224509834129,2,114,negative regulation of hemopoiesis,BP,LTF;ANXA1
21332,GO:2000300,0.166057774909348,0.986063010559589,1,25,regulation of synaptic vesicle exocytosis,BP,RIMS2
18609,GO:1900087,0.166694190198265,0.985911613694442,1,27,positive regulation of G1/S transition of mitotic cell cycle,BP,ANXA1
3507,GO:0006929,0.166836377579122,0.985927679070588,1,25,substrate-dependent cell migration,BP,TNFRSF12A
13795,GO:0051250,0.166995748566288,0.962728944074645,2,117,negative regulation of lymphocyte activation,BP,LGALS3;ANXA1
11148,GO:0043236,0.167018960731376,0.985874557212445,1,26,laminin binding,MF,LGALS3
820,GO:0002026,0.167042753415238,0.985891691233051,1,25,regulation of the force of heart contraction,BP,ADM
3231,GO:0006536,0.167161506852069,0.985763704859929,1,31,glutamate metabolic process,BP,ATCAY
1436,GO:0003158,0.167247293665575,0.962680560841008,2,106,endothelium development,BP,PDPN;CXCL10
12949,GO:0048169,0.167385744857093,0.985810392816859,1,26,regulation of long-term neuronal synaptic plasticity,BP,GRIN1
12061,GO:0045581,0.167805870968055,0.985698347724217,1,28,negative regulation of T cell differentiation,BP,ANXA1
761,GO:0001945,0.169206060355916,0.985535171326694,1,24,lymph vessel development,BP,PDPN
4955,GO:0010800,0.169342725967983,0.985426354457994,1,28,positive regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
13770,GO:0051209,0.170275262550837,0.961616790309772,2,100,release of sequestered calcium ion into cytosol,BP,JPH3;CXCL10
13819,GO:0051283,0.170275262550837,0.961616790309772,2,100,negative regulation of sequestering of calcium ion,BP,JPH3;CXCL10
13494,GO:0050790,0.171119620852751,0.889748398070378,17,2016,regulation of catalytic activity,BP,LTF;TIMP1;SERPINE1;CCL2;CHI3L1;SPOCD1;ANXA1;GNAL;SERPING1;PTX3;ELFN2;CXCL10;GRIN1;ANXA2;SOCS3;SERPINA3;GABBR1
10864,GO:0042692,0.171254283932206,0.934116717287354,4,308,muscle cell differentiation,BP,GDF15;ADAM12;ADM;CXCL10
15694,GO:0070252,0.171455647145619,0.961198221920468,2,98,actin-mediated cell contraction,BP,VIM;PDPN
5463,GO:0015491,0.171653445514094,0.985012248254258,1,28,cation:cation antiporter activity,MF,SLC8A2
4894,GO:0010712,0.171766036666009,0.984941371569179,1,31,regulation of collagen metabolic process,BP,VIM
13818,GO:0051282,0.172473743921583,0.960812155959509,2,101,regulation of sequestering of calcium ion,BP,JPH3;CXCL10
14747,GO:0060384,0.172707074405839,0.984884756997638,1,25,innervation,BP,GABRB3
10562,GO:0042092,0.17338400333526,0.984617433897648,1,33,type 2 immune response,BP,ANXA1
17401,GO:0090313,0.173575301776438,0.984611493480338,1,31,regulation of protein targeting to membrane,BP,KCNB1
13590,GO:0050921,0.173714480222699,0.960276261129745,2,121,positive regulation of chemotaxis,BP,SERPINE1;CXCL10
8618,GO:0032743,0.1737732210969,0.984608468791311,1,29,positive regulation of interleukin-2 production,BP,ANXA1
5176,GO:0014072,0.174084306938378,0.98453414709164,1,30,response to isoquinoline alkaloid,BP,GRIN1
11178,GO:0043278,0.174084306938378,0.98453414709164,1,30,response to morphine,BP,GRIN1
460,GO:0001227,0.174886487816374,0.943545964393829,3,221,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,AEBP1;CUX2;KCNIP3
11984,GO:0045335,0.175054489197761,0.959789201619127,2,119,phagocytic vesicle,CC,LTF;VIM
19429,GO:1902803,0.175089597947631,0.984405073364847,1,27,regulation of synaptic vesicle transport,BP,RIMS2
13427,GO:0050699,0.175529597731805,0.984267291403986,1,30,WW domain binding,MF,ATCAY
17907,GO:0097730,0.175831520718071,0.959532317151407,2,111,non-motile cilium,CC,CDHR1;SHANK2
6762,GO:0021522,0.176002492648659,0.984197092864159,1,29,spinal cord motor neuron differentiation,BP,MDGA2
15927,GO:0070661,0.176188300530794,0.94291141558293,3,235,leukocyte proliferation,BP,IGFBP2;LGALS3;ANXA1
7004,GO:0021987,0.176364825654994,0.959370247616686,2,103,cerebral cortex development,BP,COL3A1;GRIN1
1262,GO:0002768,0.176375266855444,0.931352557552634,4,351,immune response-regulating cell surface receptor signaling pathway,BP,GBP1;LGALS3;HLA-DQB1;HLA-DQA1
13735,GO:0051154,0.176426900589796,0.984137118018578,1,28,negative regulation of striated muscle cell differentiation,BP,CXCL10
5402,GO:0015278,0.176666280282749,0.984276866179325,1,21,calcium-release channel activity,MF,JPH3
11126,GO:0043204,0.17667765194617,0.959206318980312,2,114,perikaryon,CC,SLC8A2;KCNB1
12174,GO:0045761,0.176728780831473,0.984044020815301,1,30,regulation of adenylate cyclase activity,BP,GABBR1
11591,GO:0044319,0.176828795282028,0.984082728679875,1,27,wound healing, spreading of cells,BP,PDPN
17469,GO:0090505,0.176828795282028,0.984082728679875,1,27,epiboly involved in wound healing,BP,PDPN
19014,GO:1901658,0.177671436761152,0.983792859017949,1,35,glycosyl compound catabolic process,BP,TYMP
4797,GO:0010543,0.177681298877701,0.983865474518181,1,30,regulation of platelet activation,BP,PDPN
8817,GO:0033036,0.178040494345939,0.879137805708048,22,2703,macromolecule localization,BP,SNAP91;APOL4;FERMT1;COL1A1;ABCC3;KCNIP3;STEAP3;GBP1;SPP1;SNAP25;CHI3L1;POSTN;ANXA1;KCNB1;ATCAY;VSTM2A;RIMS2;GRIN1;ANXA2;SHISA7;RTP5;PLA2G2A
491,GO:0001533,0.17821101047648,0.983783812878619,1,29,cornified envelope,CC,ANXA1
10618,GO:0042181,0.178276596406568,0.983705629199118,1,33,ketone biosynthetic process,BP,ADM
11055,GO:0043094,0.178411633336241,0.98366601186263,1,34,cellular metabolic compound salvage,BP,TYMP
19772,GO:1903523,0.178629856457773,0.983745191788156,1,27,negative regulation of blood circulation,BP,ADM
11329,GO:0043539,0.179406100563302,0.983506230579959,1,32,protein serine/threonine kinase activator activity,MF,LTF
11066,GO:0043114,0.179422659648798,0.983536308491539,1,30,regulation of vascular permeability,BP,ADM
13791,GO:0051246,0.179453289787231,0.879944424196265,20,2458,regulation of protein metabolic process,BP,LTF;VIM;TIMP1;SERPINE1;CCL2;GBP1;GDF15;CHI3L1;SERPING1;C1R;PTX3;ELFN2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;CFI
7390,GO:0030507,0.179526240589655,0.983623140338987,1,25,spectrin binding,MF,GBP1
11225,GO:0043370,0.179538420172872,0.983481026356402,1,32,regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
19008,GO:1901652,0.179538960060211,0.921020244954861,5,446,response to peptide,BP,TIMP1;COL1A1;ANXA1;ADM;SOCS3
11483,GO:0044058,0.179562724812807,0.983476394568457,1,32,regulation of digestive system process,BP,TYMP
9339,GO:0034383,0.179634386315042,0.983496043160719,1,30,low-density lipoprotein particle clearance,BP,ANXA2
10787,GO:0042542,0.179650610878651,0.958061691236225,2,123,response to hydrogen peroxide,BP,COL1A1;ANXA1
13769,GO:0051208,0.17965696438788,0.958137024821487,2,104,sequestering of calcium ion,BP,JPH3;CXCL10
12307,GO:0046006,0.179819059805705,0.983427501857816,1,32,regulation of activated T cell proliferation,BP,IGFBP2
14023,GO:0051668,0.179959879471103,0.957978972959757,2,114,localization within membrane,BP,SNAP25;SHISA7
2614,GO:0005520,0.180096032839887,0.983426542193412,1,29,insulin-like growth factor binding,MF,IGFBP2
10685,GO:0042339,0.180447302100829,0.983323607091204,1,31,keratan sulfate metabolic process,BP,FMOD
12260,GO:0045923,0.180498835476366,0.983369544357988,1,28,positive regulation of fatty acid metabolic process,BP,ANXA1
19665,GO:1903305,0.180578053095698,0.957734290891702,2,117,regulation of regulated secretory pathway,BP,KCNB1;RIMS2
2747,GO:0005765,0.180773150187754,0.929001457413769,4,339,lysosomal membrane,CC,CP;HLA-DQB1;ANXA2;HLA-DQA1
18090,GO:0098852,0.180773150187754,0.929001457413769,4,339,lytic vacuole membrane,CC,CP;HLA-DQB1;ANXA2;HLA-DQA1
14642,GO:0060249,0.180804646973806,0.928987540371998,4,336,anatomical structure homeostasis,BP,LTF;SPP1;CDHR1;SERPINA3
2792,GO:0005834,0.180868861389934,0.983211110704597,1,33,heterotrimeric G-protein complex,CC,GNAL
20661,GO:1905360,0.180868861389934,0.983211110704597,1,33,GTPase complex,CC,GNAL
14934,GO:0060674,0.180928695361147,0.98326739641676,1,29,placenta blood vessel development,BP,SOCS3
5303,GO:0015077,0.181194814841866,0.928777790128012,4,335,monovalent inorganic cation transmembrane transporter activity,MF,KCNIP3;SLC8A2;KCNIP2;KCNB1
3831,GO:0007618,0.181556541406569,0.983094055544338,1,32,mating,BP,GRIN1
713,GO:0001881,0.181658432385847,0.983108453870501,1,30,receptor recycling,BP,ANXA2
7975,GO:0031640,0.181712314144973,0.982994927986874,1,37,killing of cells of other organism,BP,LTF
11623,GO:0044364,0.181712314144973,0.982994927986874,1,37,disruption of cells of other organism,BP,LTF
7996,GO:0031668,0.181997908853394,0.940170396709729,3,224,cellular response to extracellular stimulus,BP,COL1A1;POSTN;KCNB1
2611,GO:0005516,0.182272102723832,0.940119299520585,3,186,calmodulin binding,MF,AEBP1;SLC8A2;GRIN1
13662,GO:0051047,0.182405992345273,0.928111947760846,4,345,positive regulation of secretion,BP,FERMT1;SPP1;POSTN;KCNB1
7801,GO:0031312,0.182598619626592,0.982892355917257,1,32,extrinsic component of organelle membrane,CC,ANXA1
3860,GO:0008037,0.182689270559281,0.956938891002569,2,116,cell recognition,BP,CRTAC1;LGALS3
3817,GO:0007600,0.182831441719911,0.919088042066214,5,457,sensory perception,BP,COL1A1;GNAL;GABRB3;GRIN1;RTP5
11660,GO:0044440,0.183158450014641,0.918891351832064,5,464,endosomal part,CC,STEAP3;ANXA1;HLA-DQB1;ANXA2;HLA-DQA1
4554,GO:0009628,0.183310608021748,0.894823156422901,10,1099,response to abiotic stimulus,BP,COL1A1;IGFBP2;PLAU;CHI3L1;POSTN;ANXA1;ADM;COL3A1;CXCL10;GRIN1
17284,GO:0090162,0.183503993751328,0.982790566568679,1,28,establishment of epithelial cell polarity,BP,FERMT1
19147,GO:1902042,0.183778041985103,0.982631770545818,1,34,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1
725,GO:0001893,0.183855498410469,0.982682262133564,1,30,maternal placenta development,BP,SPP1
12576,GO:0046627,0.183883267985661,0.982658823856962,1,31,negative regulation of insulin receptor signaling pathway,BP,SOCS3
472,GO:0001504,0.184128417548701,0.982628922281188,1,30,neurotransmitter uptake,BP,SNAP25
1198,GO:0002686,0.184165387387823,0.982570771738142,1,33,negative regulation of leukocyte migration,BP,CCL2
15320,GO:0061448,0.184205530249251,0.939117544535048,3,220,connective tissue development,BP,TIMP1;COL1A1;CHI3L1
630,GO:0001772,0.184555966710228,0.982510026964634,1,32,immunological synapse,CC,LGALS3
19969,GO:1903900,0.184637262153458,0.956162160078169,2,125,regulation of viral life cycle,BP,LTF;PTX3
4657,GO:0009987,0.184748028054414,0.887950865808766,90,13331,cellular process,BP,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;MOXD1;CRTAC1;FERMT1;TIMP1;SRPX2;SHD;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;SPOCD1;COL4A2;ANXA1;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;AFF2;KCNB1;SHANK2;PDPN;S100A11;PTX3;FABP5;CSMD3;GABRB3;NNMT;ELFN2;ATCAY;COL3A1;CXCL10;PCDH7;VSTM2A;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;SMOC1;FAM155A;GABBR1;DOK6;IFI30
3360,GO:0006692,0.184895040106028,0.9824122078012,1,34,prostanoid metabolic process,BP,ANXA1
3361,GO:0006693,0.184895040106028,0.9824122078012,1,34,prostaglandin metabolic process,BP,ANXA1
19558,GO:1903053,0.184912624737055,0.982515511803826,1,28,regulation of extracellular matrix organization,BP,PDPN
14122,GO:0051879,0.185198152640209,0.98238359923063,1,32,Hsp90 protein binding,MF,GBP1
5413,GO:0015298,0.185355655504402,0.982369674495637,1,31,solute:cation antiporter activity,MF,SLC8A2
9645,GO:0035235,0.185532479339952,0.982440616850447,1,26,ionotropic glutamate receptor signaling pathway,BP,GRIN1
3656,GO:0007190,0.185665659111931,0.982308468009615,1,31,activation of adenylate cyclase activity,BP,GNAL
16518,GO:0071709,0.186270535122833,0.982270891284984,1,27,membrane assembly,BP,ANXA2
2283,GO:0004864,0.186284229354576,0.982168668050754,1,32,protein phosphatase inhibitor activity,MF,ELFN2
516,GO:0001569,0.186325508543103,0.982177808877489,1,31,branching involved in blood vessel morphogenesis,BP,COL4A1
12483,GO:0046461,0.186951563301211,0.982035909430465,1,32,neutral lipid catabolic process,BP,FABP5
12486,GO:0046464,0.186951563301211,0.982035909430465,1,32,acylglycerol catabolic process,BP,FABP5
1259,GO:0002764,0.187071656226686,0.916574179414066,5,481,immune response-regulating signaling pathway,BP,LTF;GBP1;LGALS3;HLA-DQB1;HLA-DQA1
12586,GO:0046638,0.187347904971064,0.981924854490233,1,34,positive regulation of alpha-beta T cell differentiation,BP,ANXA1
5775,GO:0016247,0.187643303063718,0.955011855310595,2,123,channel regulator activity,MF,KCNIP3;KCNIP2
8348,GO:0032365,0.187836274727546,0.981915601394034,1,29,intracellular lipid transport,BP,ANXA2
17468,GO:0090504,0.188040712190831,0.981896314494559,1,28,epiboly,BP,PDPN
16946,GO:0072529,0.188126449800757,0.981768668971914,1,34,pyrimidine-containing compound catabolic process,BP,TYMP
10589,GO:0042133,0.188682970515297,0.954608667652369,2,123,neurotransmitter metabolic process,BP,MOXD1;PTX3
4920,GO:0010742,0.188797033501,0.981723104898603,1,29,macrophage derived foam cell differentiation,BP,PLA2G2A
17229,GO:0090077,0.188797033501,0.981723104898603,1,29,foam cell differentiation,BP,PLA2G2A
14699,GO:0060325,0.190584743071153,0.981361998558863,1,29,face morphogenesis,BP,COL1A1
11911,GO:0045177,0.190661457237945,0.923617270878794,4,324,apical part of cell,CC,IGFBP2;ANXA1;SHANK2;PDPN
13553,GO:0050873,0.191493206585462,0.981101105605477,1,33,brown fat cell differentiation,BP,VSTM2A
2753,GO:0005771,0.192459499626984,0.980870759286458,1,35,multivesicular body,CC,STEAP3
11744,GO:0044764,0.193115070183207,0.980767154493319,1,33,multi-organism cellular process,BP,LTF
17617,GO:0097120,0.193268094327205,0.980753001586416,1,32,receptor localization to synapse,BP,SNAP25
668,GO:0001819,0.193392883508435,0.922062902730212,4,362,positive regulation of cytokine production,BP,FERMT1;SERPINE1;POSTN;ANXA1
16277,GO:0071354,0.193510979540802,0.980721416081929,1,31,cellular response to interleukin-6,BP,SOCS3
17112,GO:0085029,0.193744427802975,0.980693060273315,1,30,extracellular matrix assembly,BP,LOX
3698,GO:0007259,0.194132444474758,0.952459706307722,2,126,JAK-STAT cascade,BP,CCL2;SOCS3
10652,GO:0042277,0.194176436613279,0.934211927187651,3,241,peptide binding,MF,KCNIP2;HLA-DQB1;HLA-DQA1
11884,GO:0045124,0.194280693620822,0.98056174584228,1,31,regulation of bone resorption,BP,SPP1
10558,GO:0042088,0.194429359789864,0.980446953259073,1,36,T-helper 1 type immune response,BP,ANXA1
2597,GO:0005484,0.194693898538987,0.980391637807188,1,36,SNAP receptor activity,MF,SNAP25
3876,GO:0008066,0.194781555931834,0.980547311857096,1,27,glutamate receptor activity,MF,GRIN1
18602,GO:1900077,0.194851490951589,0.980406116108282,1,33,negative regulation of cellular response to insulin stimulus,BP,SOCS3
72,GO:0000149,0.19506273966428,0.952105981165863,2,122,SNARE binding,MF,SNAP25;CPLX2
10666,GO:0042304,0.195079964279409,0.980341546111823,1,34,regulation of fatty acid biosynthetic process,BP,ANXA1
6466,GO:0019212,0.195432988620808,0.980267543815992,1,34,phosphatase inhibitor activity,MF,ELFN2
9032,GO:0033572,0.195839296867856,0.980166228854325,1,35,transferrin transport,BP,STEAP3
13172,GO:0048675,0.195902202289208,0.95184028569257,2,107,axon extension,BP,TNFRSF12A;TNR
8209,GO:0032103,0.195974675729732,0.933309919288985,3,247,positive regulation of response to external stimulus,BP,SERPINE1;CXCL10;PLA2G2A
17893,GO:0097696,0.19605611245982,0.951691518803672,2,127,STAT cascade,BP,CCL2;SOCS3
13350,GO:0050433,0.196939459729664,0.979918688607797,1,36,regulation of catecholamine secretion,BP,KCNB1
12036,GO:0045494,0.197016558564618,0.979988456040244,1,31,photoreceptor cell maintenance,BP,CDHR1
2489,GO:0005215,0.197063972425186,0.885142320814845,10,1100,transporter activity,MF,ABCC3;KCNIP3;SLC8A2;KCNIP2;JPH3;KCNB1;SVOP;GABRB3;GRIN1;FAM155A
12479,GO:0046456,0.197122608371315,0.979851728097978,1,38,icosanoid biosynthetic process,BP,ANXA1
13807,GO:0051262,0.197460929160971,0.951137559547605,2,125,protein tetramerization,BP,GRIN1;ANXA2
7211,GO:0030176,0.197508618366792,0.951076391900443,2,137,integral component of endoplasmic reticulum membrane,CC,HLA-DQB1;HLA-DQA1
10727,GO:0042417,0.197862745184335,0.979754133103594,1,34,dopamine metabolic process,BP,MOXD1
18301,GO:0099622,0.198607117549422,0.979631325027575,1,32,cardiac muscle cell membrane repolarization,BP,KCNIP2
1866,GO:0004180,0.198821957062189,0.979502821943984,1,37,carboxypeptidase activity,MF,AEBP1
3927,GO:0008156,0.198946991828988,0.979558757756229,1,32,negative regulation of DNA replication,BP,S100A11
8289,GO:0032269,0.199199477276909,0.88711415731274,9,978,negative regulation of cellular protein metabolic process,BP,LTF;TIMP1;SERPINE1;GBP1;SERPING1;ELFN2;ANXA2;SOCS3;SERPINA3
685,GO:0001837,0.199561692108697,0.950296874352399,2,124,epithelial to mesenchymal transition,BP,COL1A1;PDPN
12205,GO:0045823,0.199837066641733,0.979331704074487,1,34,positive regulation of heart contraction,BP,ADM
568,GO:0001667,0.200029806234149,0.918377657482939,4,333,ameboidal-type cell migration,BP,FERMT1;TIMP1;SRPX2;ANXA1
12677,GO:0046872,0.200135501378824,0.856662102012249,29,3677,metal ion binding,MF,LTF;CP;MOXD1;CRTAC1;TIMP1;AEBP1;COL1A1;LOX;KCNIP3;STEAP3;SLC8A2;KCNIP2;POSTN;ANXA1;GNAL;GALNT13;CDHR1;ADAM12;C1R;S100A11;COL3A1;PCDH7;KSR2;RIMS2;GRIN1;ANXA2;PLA2G2A;SMOC1;CFI
12088,GO:0045620,0.20038121691129,0.979197742819158,1,35,negative regulation of lymphocyte differentiation,BP,ANXA1
4917,GO:0010737,0.201253522334276,0.979207323873526,1,26,protein kinase A signaling,BP,SPHKAP
872,GO:0002090,0.201667827819865,0.978918852970783,1,35,regulation of receptor internalization,BP,SH3GL2
8662,GO:0032801,0.201670633379009,0.978972181290402,1,32,receptor catabolic process,BP,ANXA2
15166,GO:0061061,0.201856343813244,0.900284545261734,6,559,muscle structure development,BP,AEBP1;GDF15;ADAM12;ADM;COL3A1;CXCL10
3326,GO:0006654,0.201899034325242,0.978903468568885,1,33,phosphatidic acid biosynthetic process,BP,PLA2G2A
13500,GO:0050798,0.202024684436688,0.978825109782122,1,36,activated T cell proliferation,BP,IGFBP2
751,GO:0001934,0.202477420263734,0.888957142519924,8,855,positive regulation of protein phosphorylation,BP,LTF;CCL2;GDF15;CHI3L1;KSR2;ANXA2;SOCS3;PLA2G2A
3448,GO:0006836,0.202685079815983,0.929972429540585,3,230,neurotransmitter transport,BP,SNAP25;CPLX2;RIMS2
10036,GO:0035909,0.20296904985102,0.978731892399529,1,30,aorta morphogenesis,BP,COL3A1
19434,GO:1902808,0.203520105781397,0.978531044529701,1,34,positive regulation of cell cycle G1/S phase transition,BP,ANXA1
4850,GO:0010634,0.203806631951273,0.948588814482274,2,120,positive regulation of epithelial cell migration,BP,SRPX2;ANXA1
15829,GO:0070482,0.204102725670494,0.916046488365304,4,354,response to oxygen levels,BP,COL1A1;PLAU;POSTN;ADM
5275,GO:0014911,0.204240647851889,0.97845348463656,1,30,positive regulation of smooth muscle cell migration,BP,POSTN
16945,GO:0072528,0.204242614565381,0.9782941949555,1,39,pyrimidine-containing compound biosynthetic process,BP,TYMP
4485,GO:0009312,0.204568844426479,0.978235916987555,1,38,oligosaccharide biosynthetic process,BP,GALNT13
12025,GO:0045429,0.204636131001977,0.978267754887735,1,35,positive regulation of nitric oxide biosynthetic process,BP,PTX3
20211,GO:1904407,0.204636131001977,0.978267754887735,1,35,positive regulation of nitric oxide metabolic process,BP,PTX3
18966,GO:1901564,0.205130782792965,0.847774930099062,43,5974,organonitrogen compound metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;MOXD1;APOL4;TIMP1;SERPINE1;AEBP1;CCL2;LOX;IGFBP2;GBP1;SPP1;FMOD;PLAU;GDF15;CHI3L1;ANXA1;MDGA2;GALNT13;ADAM12;ADM;SERPING1;C1R;PTX3;NNMT;ELFN2;ATCAY;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;GABBR1;CFI
10501,GO:0040008,0.205335068915378,0.898030975815901,6,592,regulation of growth,BP,TNFRSF12A;IGFBP2;TNR;SPP1;RIMS2;SOCS3
9603,GO:0035091,0.206019742936261,0.928289731010574,3,224,phosphatidylinositol binding,MF,SNAP91;PLEKHA4;ANXA2
12397,GO:0046189,0.206058829865358,0.977935198997586,1,36,phenol-containing compound biosynthetic process,BP,MOXD1
7976,GO:0031641,0.206126839988235,0.977954389498342,1,34,regulation of myelination,BP,TYMP
5122,GO:0014002,0.206325204176177,0.977970163270685,1,31,astrocyte development,BP,VIM
6890,GO:0021772,0.206493324110245,0.977932744450974,1,31,olfactory bulb development,BP,CRTAC1
20044,GO:1904036,0.206963685126891,0.977749689023866,1,35,negative regulation of epithelial cell apoptotic process,BP,SERPINE1
3193,GO:0006486,0.20710736586104,0.927710528164167,3,236,protein glycosylation,BP,GALNT13;FUT9;ST8SIA3
11258,GO:0043413,0.20710736586104,0.927710528164167,3,236,macromolecule glycosylation,BP,GALNT13;FUT9;ST8SIA3
7746,GO:0031227,0.207233220484797,0.947098956277094,2,141,intrinsic component of endoplasmic reticulum membrane,CC,HLA-DQB1;HLA-DQA1
12493,GO:0046473,0.207379397293298,0.977674351532754,1,34,phosphatidic acid metabolic process,BP,PLA2G2A
4389,GO:0009163,0.207894043731681,0.977451344230628,1,41,nucleoside biosynthetic process,BP,TYMP
1060,GO:0002437,0.207957326171596,0.977463797489051,1,39,inflammatory response to antigenic stimulus,BP,GPR17
471,GO:0001503,0.208108139645518,0.913768697058077,4,344,ossification,BP,LTF;COL1A1;SPP1;SMOC1
8287,GO:0032266,0.208206218843578,0.977507571666188,1,33,phosphatidylinositol-3-phosphate binding,MF,PLEKHA4
13577,GO:0050907,0.208238048301746,0.977349197606348,1,43,detection of chemical stimulus involved in sensory perception,BP,RTP5
3314,GO:0006636,0.208452647773698,0.977338014130403,1,40,unsaturated fatty acid biosynthetic process,BP,ANXA1
13728,GO:0051147,0.208488444410689,0.946628543404942,2,127,regulation of muscle cell differentiation,BP,GDF15;CXCL10
11494,GO:0044091,0.209013529464996,0.977345874983058,1,32,membrane biogenesis,BP,ANXA2
19602,GO:1903169,0.209098824000274,0.946382767872236,2,125,regulation of calcium ion transmembrane transport,BP,JPH3;CXCL10
971,GO:0002285,0.209589145609484,0.946150611169361,2,132,lymphocyte activation involved in immune response,BP,LGALS3;ANXA1
3823,GO:0007608,0.209820742857196,0.977040866664395,1,39,sensory perception of smell,BP,GNAL
1293,GO:0002832,0.210227306799337,0.976962776215836,1,38,negative regulation of response to biotic stimulus,BP,LTF
13817,GO:0051281,0.210229625464047,0.976994217728439,1,36,positive regulation of release of sequestered calcium ion into cytosol,BP,CXCL10
7005,GO:0021988,0.211326318211233,0.976819997964149,1,32,olfactory lobe development,BP,CRTAC1
7385,GO:0030501,0.211724592760796,0.976687983951436,1,34,positive regulation of bone mineralization,BP,LTF
7511,GO:0030809,0.212013233527894,0.976585291763712,1,36,negative regulation of nucleotide biosynthetic process,BP,GABBR1
18730,GO:1900372,0.212013233527894,0.976585291763712,1,36,negative regulation of purine nucleotide biosynthetic process,BP,GABBR1
1207,GO:0002695,0.212814706034256,0.944775308580984,2,138,negative regulation of leukocyte activation,BP,LGALS3;ANXA1
6222,GO:0017124,0.212851517387995,0.944827958108721,2,121,SH3 domain binding,MF,ADAM12;SHANK2
21478,GO:2000514,0.21287316486283,0.976338832128004,1,39,regulation of CD4-positive, alpha-beta T cell activation,BP,ANXA1
4343,GO:0009112,0.212895729179839,0.976333599679077,1,39,nucleobase metabolic process,BP,TYMP
14697,GO:0060323,0.212997378068481,0.976394666028089,1,34,head morphogenesis,BP,COL1A1
5493,GO:0015682,0.213203060973574,0.976277442196477,1,38,ferric iron transport,BP,STEAP3
16933,GO:0072512,0.213203060973574,0.976277442196477,1,38,trivalent inorganic cation transport,BP,STEAP3
18259,GO:0099529,0.213337580975827,0.976296998533335,1,35,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,GRIN1
20159,GO:1904315,0.213337580975827,0.976296998533335,1,35,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,GRIN1
3673,GO:0007212,0.213671010276801,0.976168675975122,1,38,dopamine receptor signaling pathway,BP,GNAL
13483,GO:0050775,0.213954248563441,0.976214491366106,1,32,positive regulation of dendrite morphogenesis,BP,CUX2
7399,GO:0030517,0.214124071459822,0.976133349564233,1,34,negative regulation of axon extension,BP,TNR
8708,GO:0032880,0.214435677562254,0.880685158579525,8,867,regulation of protein localization,BP,FERMT1;GBP1;SNAP25;POSTN;ANXA1;KCNB1;ATCAY;SHISA7
12605,GO:0046676,0.214527183812555,0.976002260911312,1,36,negative regulation of insulin secretion,BP,KCNB1
8354,GO:0032371,0.214738758689039,0.975970946085157,1,35,regulation of sterol transport,BP,ANXA2
8357,GO:0032374,0.214738758689039,0.975970946085157,1,35,regulation of cholesterol transport,BP,ANXA2
11375,GO:0043616,0.215596734913824,0.975789428590479,1,34,keratinocyte proliferation,BP,FERMT1
13776,GO:0051223,0.215651710923323,0.891314463209692,6,614,regulation of protein transport,BP,FERMT1;GBP1;SNAP25;POSTN;ANXA1;KCNB1
3021,GO:0006213,0.215669657513263,0.975630688952579,1,43,pyrimidine nucleoside metabolic process,BP,TYMP
15641,GO:0070169,0.215895292901614,0.975699993730645,1,35,positive regulation of biomineral tissue development,BP,LTF
12893,GO:0048009,0.216071773567372,0.975743699402255,1,31,insulin-like growth factor receptor signaling pathway,BP,IGFBP2
18715,GO:1900271,0.216422716457434,0.975661352771787,1,31,regulation of long-term synaptic potentiation,BP,SHISA7
12167,GO:0045744,0.216533263169646,0.975466984672539,1,40,negative regulation of G-protein coupled receptor protein signaling pathway,BP,ADM
13349,GO:0050432,0.216616200620194,0.975462237668449,1,39,catecholamine secretion,BP,KCNB1
19015,GO:1901659,0.216964086772453,0.975324360681799,1,43,glycosyl compound biosynthetic process,BP,TYMP
15590,GO:0070085,0.217533431879656,0.922290626049062,3,243,glycosylation,BP,GALNT13;FUT9;ST8SIA3
4702,GO:0010165,0.218239620946285,0.975145682306298,1,35,response to X-ray,BP,ANXA1
16567,GO:0071827,0.218298792006273,0.975095190967188,1,37,plasma lipoprotein particle organization,BP,PLA2G2A
405,GO:0001078,0.218765313360548,0.942252013658035,2,135,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,CUX2;KCNIP3
8624,GO:0032757,0.218792246652642,0.974929452837566,1,40,positive regulation of interleukin-8 production,BP,SERPINE1
21831,GO:2001222,0.219557931426778,0.974972039780468,1,29,regulation of neuron migration,BP,COL3A1
4902,GO:0010720,0.220884797486629,0.895920237044088,5,463,positive regulation of cell development,BP,TNFRSF12A;CUX2;SHANK2;RIMS2;SLITRK1
6882,GO:0021762,0.221159343007383,0.974374875446741,1,39,substantia nigra development,BP,INA
16270,GO:0071347,0.221658365608649,0.940963044842825,2,146,cellular response to interleukin-1,BP,CCL2;CHI3L1
18082,GO:0098839,0.221909017165391,0.974329625562599,1,32,postsynaptic density membrane,CC,GRIN1
15034,GO:0060828,0.222401200995831,0.919716358436602,3,244,regulation of canonical Wnt signaling pathway,BP,FERMT1;COL1A1;IGFBP2
13579,GO:0050909,0.222819944169095,0.973899477352229,1,44,sensory perception of taste,BP,RTP5
758,GO:0001941,0.223021181158052,0.973993911404633,1,35,postsynaptic membrane organization,BP,SHISA7
8109,GO:0031941,0.223800264338029,0.973783880199961,1,36,filamentous actin,CC,FERMT1
5178,GO:0014075,0.224010016723611,0.973732461461724,1,36,response to amine,BP,GRIN1
12206,GO:0045824,0.224066882813807,0.973665455209464,1,39,negative regulation of innate immune response,BP,SERPING1
642,GO:0001784,0.224379522473004,0.973661513262153,1,35,phosphotyrosine residue binding,MF,SOCS3
13239,GO:0048791,0.224903970880172,0.97349391659488,1,37,calcium ion-regulated exocytosis of neurotransmitter,BP,RIMS2
13727,GO:0051146,0.225001040954215,0.918352228789177,3,233,striated muscle cell differentiation,BP,GDF15;ADAM12;CXCL10
3829,GO:0007616,0.225440992534315,0.97342128430619,1,34,long-term memory,BP,GRIN1
18992,GO:1901618,0.22557074780086,0.973278236947937,1,40,organic hydroxy compound transmembrane transporter activity,MF,ABCC3
740,GO:0001917,0.2256153757379,0.973337097785368,1,36,photoreceptor inner segment,CC,SHANK2
9471,GO:0034656,0.226284815672276,0.973056789902846,1,43,nucleobase-containing small molecule catabolic process,BP,TYMP
9033,GO:0033574,0.227119701561003,0.972877277015591,1,41,response to testosterone,BP,SPP1
4823,GO:0010594,0.227274210489724,0.938566112883303,2,130,regulation of endothelial cell migration,BP,SRPX2;ANXA1
4954,GO:0010799,0.227681241581009,0.972768785817813,1,39,regulation of peptidyl-threonine phosphorylation,BP,CHI3L1
16565,GO:0071825,0.227926597940658,0.972707320530962,1,39,protein-lipid complex subunit organization,BP,PLA2G2A
3861,GO:0008038,0.228346627635434,0.972746589691889,1,32,neuron recognition,BP,CRTAC1
19536,GO:1903018,0.228437824278558,0.972562469412327,1,40,regulation of glycoprotein metabolic process,BP,PTX3
14011,GO:0051650,0.2286541055546,0.91637763602865,3,239,establishment of vesicle localization,BP,SNAP25;CPLX2;RIMS2
18149,GO:0098960,0.229244421941008,0.972411902888388,1,37,postsynaptic neurotransmitter receptor activity,MF,GRIN1
11441,GO:0043949,0.229252172490139,0.972357276203513,1,40,regulation of cAMP-mediated signaling,BP,CXCL10
14559,GO:0060119,0.229262190293942,0.972426939834265,1,36,inner ear receptor cell development,BP,GABRB3
9931,GO:0035722,0.229298010694699,0.972286642123763,1,44,interleukin-12-mediated signaling pathway,BP,ANXA2
16272,GO:0071349,0.229298010694699,0.972286642123763,1,44,cellular response to interleukin-12,BP,ANXA2
2402,GO:0005048,0.229607492868781,0.972284189555427,1,39,signal sequence binding,MF,KCNIP2
4626,GO:0009892,0.230092767503505,0.840021002060192,20,2559,negative regulation of metabolic process,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;AEBP1;CUX2;KCNIP3;GBP1;SPOCD1;SERPING1;AFF2;S100A11;PTX3;ELFN2;ATCAY;ANXA2;SOCS3;SERPINA3;GABBR1
4303,GO:0009056,0.230372489889016,0.842492550729275,18,2313,catabolic process,BP,TYMP;VIM;CHI3L2;MOXD1;TIMP1;COL1A1;SPP1;FMOD;CHI3L1;COL4A2;COL6A2;FABP5;ATCAY;COL3A1;FUT9;ANXA2;COL4A1;PLA2G2A
5174,GO:0014069,0.231312917203171,0.914979250016265,3,221,postsynaptic density,CC,SHANK2;GRIN1;SHISA7
18308,GO:0099634,0.231454197983867,0.971915097838025,1,34,postsynaptic specialization membrane,CC,GRIN1
2491,GO:0005217,0.231550911800416,0.971966012765354,1,31,intracellular ligand-gated ion channel activity,MF,JPH3
15678,GO:0070231,0.231611141573604,0.971711905753866,1,43,T cell apoptotic process,BP,LGALS3
11491,GO:0044088,0.231730063601925,0.971744773266582,1,39,regulation of vacuole organization,BP,ANXA2
4048,GO:0008347,0.231930722925576,0.971711428320169,1,38,glial cell migration,BP,CCL2
3209,GO:0006509,0.232123818778362,0.971627005956732,1,40,membrane protein ectodomain proteolysis,BP,TIMP1
21394,GO:2000377,0.232212636772934,0.936310000773727,2,145,regulation of reactive oxygen species metabolic process,BP,PTX3;GRIN1
6694,GO:0019894,0.232268568132524,0.971643982064096,1,37,kinesin binding,MF,ATCAY
6322,GO:0018210,0.232428857924941,0.936264695058054,2,132,peptidyl-threonine modification,BP,CHI3L1;GALNT13
2287,GO:0004869,0.232433085282331,0.971515948019937,1,42,cysteine-type endopeptidase inhibitor activity,MF,LTF
11099,GO:0043169,0.232491210063533,0.830095799152804,29,3756,cation binding,MF,LTF;CP;MOXD1;CRTAC1;TIMP1;AEBP1;COL1A1;LOX;KCNIP3;STEAP3;SLC8A2;KCNIP2;POSTN;ANXA1;GNAL;GALNT13;CDHR1;ADAM12;C1R;S100A11;COL3A1;PCDH7;KSR2;RIMS2;GRIN1;ANXA2;PLA2G2A;SMOC1;CFI
3540,GO:0006984,0.232533744759129,0.971490093456311,1,42,ER-nucleus signaling pathway,BP,CCL2
21374,GO:2000351,0.232646316144013,0.971493009145358,1,40,regulation of endothelial cell apoptotic process,BP,SERPINE1
19413,GO:1902743,0.23278755225917,0.971491976685886,1,38,regulation of lamellipodium organization,BP,PDPN
13267,GO:0048854,0.232798786026714,0.97154954299821,1,35,brain morphogenesis,BP,SHANK2
19795,GO:1903556,0.232895062932439,0.971354642179657,1,45,negative regulation of tumor necrosis factor superfamily cytokine production,BP,LTF
10551,GO:0042063,0.233087958659564,0.91396296843937,3,244,gliogenesis,BP,VIM;CCL2;ANXA1
10751,GO:0042461,0.233740631231684,0.971246779346845,1,38,photoreceptor cell development,BP,CDHR1
13233,GO:0048771,0.233805038339246,0.935629388621696,2,136,tissue remodeling,BP,SPP1;ANXA1
7519,GO:0030817,0.233974030398966,0.971103764619778,1,43,regulation of cAMP biosynthetic process,BP,GABBR1
4847,GO:0010631,0.234235097449907,0.913347110581379,3,239,epithelial cell migration,BP,FERMT1;SRPX2;ANXA1
967,GO:0002279,0.234241998019934,0.971049361113088,1,42,mast cell activation involved in immune response,BP,CPLX2
11192,GO:0043303,0.234241998019934,0.971049361113088,1,42,mast cell degranulation,BP,CPLX2
18286,GO:0099572,0.234536140051722,0.91321877469196,3,223,postsynaptic specialization,CC,SHANK2;GRIN1;SHISA7
10549,GO:0042059,0.234880489840159,0.970899507298716,1,41,negative regulation of epidermal growth factor receptor signaling pathway,BP,SH3GL2
18859,GO:1901224,0.235045979638699,0.970825531773651,1,43,positive regulation of NIK/NF-kappaB signaling,BP,CHI3L1
13207,GO:0048729,0.23506528969404,0.8784025859738,6,593,tissue morphogenesis,BP,ADM;PDPN;COL3A1;CXCL10;SOCS3;COL4A1
7776,GO:0031279,0.235186421786648,0.970804103458902,1,42,regulation of cyclase activity,BP,GABBR1
21296,GO:2000242,0.235539138778779,0.970682549398414,1,44,negative regulation of reproductive process,BP,TIMP1
17265,GO:0090132,0.235611039821071,0.912591789001195,3,240,epithelium migration,BP,FERMT1;SRPX2;ANXA1
12668,GO:0046850,0.236499312802635,0.970511893141704,1,39,regulation of bone remodeling,BP,SPP1
15121,GO:0061001,0.236542236730024,0.970604983319386,1,34,regulation of dendritic spine morphogenesis,BP,CUX2
12583,GO:0046635,0.236699330791113,0.970364910073268,1,45,positive regulation of alpha-beta T cell activation,BP,ANXA1
13848,GO:0051339,0.236713013431723,0.970405256822238,1,42,regulation of lyase activity,BP,GABBR1
17779,GO:0097435,0.236739062490536,0.877270444284043,6,592,supramolecular fiber organization,BP,VIM;COL1A1;LOX;FMOD;COL3A1;ANXA2
4063,GO:0008376,0.237109702730872,0.97027106777975,1,44,acetylgalactosaminyltransferase activity,MF,GALNT13
7137,GO:0030049,0.237448550534583,0.97034473653168,1,35,muscle filament sliding,BP,VIM
8945,GO:0033275,0.237448550534583,0.97034473653168,1,35,actin-myosin filament sliding,BP,VIM
11563,GO:0044273,0.23753198319494,0.970174625869546,1,43,sulfur compound catabolic process,BP,FMOD
12196,GO:0045806,0.238015107009023,0.9700182887146,1,45,negative regulation of endocytosis,BP,LGALS3
15937,GO:0070671,0.23808583443441,0.969986068579833,1,46,response to interleukin-12,BP,ANXA2
6758,GO:0021517,0.238375527946151,0.969983814992109,1,41,ventral spinal cord development,BP,MDGA2
17369,GO:0090278,0.238415114782211,0.969973353910305,1,41,negative regulation of peptide hormone secretion,BP,KCNB1
13768,GO:0051205,0.238470575941928,0.969884216768074,1,46,protein insertion into membrane,BP,RTP5
4710,GO:0010212,0.238506861490763,0.93347292079457,2,142,response to ionizing radiation,BP,ANXA1;CXCL10
4808,GO:0010565,0.238648123272681,0.933389463911355,2,147,regulation of cellular ketone metabolic process,BP,ANXA1;ATCAY
13666,GO:0051051,0.239055822027832,0.895376654916897,4,392,negative regulation of transport,BP,GBP1;LGALS3;ANXA1;KCNB1
13729,GO:0051148,0.239375457513328,0.969736226844849,1,40,negative regulation of muscle cell differentiation,BP,CXCL10
19117,GO:1901981,0.239516507455689,0.933027294260272,2,138,phosphatidylinositol phosphate binding,MF,PLEKHA4;ANXA2
17275,GO:0090150,0.239942592518568,0.91012337707316,3,285,establishment of protein localization to membrane,BP,SNAP25;KCNB1;RTP5
10681,GO:0042327,0.240008747981859,0.862527483999995,8,894,positive regulation of phosphorylation,BP,LTF;CCL2;GDF15;CHI3L1;KSR2;ANXA2;SOCS3;PLA2G2A
16286,GO:0071364,0.240343971758596,0.969496911192641,1,39,cellular response to epidermal growth factor stimulus,BP,COL1A1
13234,GO:0048786,0.240348289976227,0.969603447895394,1,34,presynaptic active zone,CC,RIMS2
4335,GO:0009100,0.240563075075654,0.894474341394611,4,374,glycoprotein metabolic process,BP,GALNT13;PTX3;FUT9;ST8SIA3
8299,GO:0032279,0.240980078436332,0.909662052815555,3,226,asymmetric synapse,CC,SHANK2;GRIN1;SHISA7
3270,GO:0006576,0.241015636034365,0.969192413444097,1,47,cellular biogenic amine metabolic process,BP,MOXD1
9576,GO:0035023,0.241724608431357,0.932073381164692,2,125,regulation of Rho protein signal transduction,BP,GPR17;COL3A1
5024,GO:0010883,0.242010603610465,0.969032488270565,1,40,regulation of lipid storage,BP,VSTM2A
5673,GO:0016042,0.242360722940624,0.908798982637662,3,273,lipid catabolic process,BP,SPP1;FABP5;PLA2G2A
7136,GO:0030048,0.242406001893941,0.93178060923625,2,121,actin filament-based movement,BP,VIM;PDPN
11177,GO:0043277,0.242898944946471,0.968775463931591,1,41,apoptotic cell clearance,BP,CCL2
17263,GO:0090130,0.242972618092263,0.90851061075838,3,245,tissue migration,BP,FERMT1;SRPX2;ANXA1
1035,GO:0002381,0.243050387491356,0.968686028519187,1,44,immunoglobulin production involved in immunoglobulin mediated immune response,BP,HLA-DQB1
3970,GO:0008217,0.24342425449762,0.931183704251293,2,149,regulation of blood pressure,BP,POSTN;ADM
14007,GO:0051646,0.243436228087624,0.968666813356155,1,39,mitochondrion localization,BP,ATCAY
1257,GO:0002762,0.243469754749816,0.968621112883778,1,41,negative regulation of myeloid leukocyte differentiation,BP,LTF
1071,GO:0002448,0.243502605598391,0.968563511970939,1,44,mast cell mediated immunity,BP,CPLX2
17238,GO:0090087,0.243836807827488,0.872404129142525,6,642,regulation of peptide transport,BP,FERMT1;GBP1;SNAP25;POSTN;ANXA1;KCNB1
18316,GO:0099738,0.244002417614245,0.968624462870379,1,34,cell cortex region,CC,RIMS2
3821,GO:0007605,0.2441034174266,0.930934496667759,2,133,sensory perception of sound,BP,COL1A1;GABRB3
9506,GO:0034707,0.244507888400386,0.968305817044944,1,43,chloride channel complex,CC,GABRB3
13458,GO:0050732,0.245473232635393,0.968026539381899,1,44,negative regulation of peptidyl-tyrosine phosphorylation,BP,SOCS3
6035,GO:0016763,0.24549482673559,0.968020627432431,1,44,transferase activity, transferring pentosyl groups,MF,TYMP
7585,GO:0030900,0.245704954829271,0.89133764895423,4,351,forebrain development,BP,CRTAC1;TNR;COL3A1;GRIN1
5005,GO:0010862,0.245868151010429,0.96791832473534,1,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,GDF15
8920,GO:0033218,0.245917886530297,0.906809256744926,3,273,amide binding,MF,KCNIP2;HLA-DQB1;HLA-DQA1
16981,GO:0072583,0.245929361350891,0.96800874861379,1,38,clathrin-dependent endocytosis,BP,SNAP91
17122,GO:0086009,0.246077796670293,0.96792877173741,1,40,membrane repolarization,BP,KCNIP2
10790,GO:0042551,0.246112112075132,0.967938551996763,1,39,neuron maturation,BP,KCNIP2
18165,GO:0098984,0.246126444246477,0.906782288325264,3,229,neuron to neuron synapse,CC,SHANK2;GRIN1;SHISA7
17744,GO:0097366,0.246367754334964,0.967813576832929,1,42,response to bronchodilator,BP,GRIN1
7643,GO:0031018,0.246647261633783,0.967736757196784,1,42,endocrine pancreas development,BP,ANXA1
5153,GO:0014047,0.247003298637277,0.967656257589137,1,41,glutamate secretion,BP,SNAP25
4518,GO:0009435,0.247042764969295,0.967551553297465,1,47,NAD biosynthetic process,BP,NNMT
2464,GO:0005160,0.247630477690562,0.967417661191089,1,45,transforming growth factor beta receptor binding,MF,GDF15
10043,GO:0035924,0.24819211924044,0.967328011084298,1,41,cellular response to vascular endothelial growth factor stimulus,BP,ANXA1
12467,GO:0046426,0.248372483246158,0.967212004847353,1,45,negative regulation of JAK-STAT cascade,BP,SOCS3
20456,GO:1904893,0.248372483246158,0.967212004847353,1,45,negative regulation of STAT cascade,BP,SOCS3
2755,GO:0005774,0.248780477453967,0.889379165616243,4,392,vacuolar membrane,CC,CP;HLA-DQB1;ANXA2;HLA-DQA1
8804,GO:0033017,0.250775542624425,0.966713622580286,1,36,sarcoplasmic reticulum membrane,CC,JPH3
14009,GO:0051648,0.251674563129321,0.903597858735725,3,251,vesicle localization,BP,SNAP25;CPLX2;RIMS2
1118,GO:0002532,0.252253996049407,0.966094813507058,1,47,production of molecular mediator involved in inflammatory response,BP,SERPINE1
6504,GO:0019320,0.253232239055003,0.965817405828189,1,47,hexose catabolic process,BP,FUT9
13075,GO:0048488,0.254409939158485,0.965600748522512,1,40,synaptic vesicle endocytosis,BP,SH3GL2
12181,GO:0045773,0.254790075422218,0.965557378923919,1,37,positive regulation of axon extension,BP,TNFRSF12A
10607,GO:0042165,0.255156721066101,0.965240108555244,1,49,neurotransmitter binding,MF,GRIN1
13546,GO:0050866,0.25525412690234,0.925579538050866,2,156,negative regulation of cell activation,BP,LGALS3;ANXA1
3278,GO:0006584,0.256122711349229,0.964990405367633,1,47,catecholamine metabolic process,BP,MOXD1
4574,GO:0009712,0.256122711349229,0.964990405367633,1,47,catechol-containing compound metabolic process,BP,MOXD1
17249,GO:0090102,0.256229233655087,0.965023851923066,1,43,cochlea development,BP,GABRB3
13522,GO:0050830,0.256268664433889,0.964870316542833,1,53,defense response to Gram-positive bacterium,BP,PLA2G2A
15675,GO:0070228,0.25691436841532,0.964747551899254,1,48,regulation of lymphocyte apoptotic process,BP,LGALS3
5316,GO:0015103,0.257097711566053,0.924731612341352,2,146,inorganic anion transmembrane transporter activity,MF,ABCC3;GABRB3
3857,GO:0008028,0.257121691029749,0.9646737056004,1,49,monocarboxylic acid transmembrane transporter activity,MF,ABCC3
12585,GO:0046637,0.257467653678504,0.96460185873013,1,47,regulation of alpha-beta T cell differentiation,BP,ANXA1
15664,GO:0070201,0.257736053921967,0.862773975500222,6,656,regulation of establishment of protein localization,BP,FERMT1;GBP1;SNAP25;POSTN;ANXA1;KCNB1
8477,GO:0032515,0.258204410790433,0.964403219755532,1,46,negative regulation of phosphoprotein phosphatase activity,BP,ELFN2
7304,GO:0030307,0.258364702513631,0.924137061319949,2,142,positive regulation of cell growth,BP,TNFRSF12A;RIMS2
18755,GO:1900543,0.25867649563005,0.964265869153008,1,46,negative regulation of purine nucleotide metabolic process,BP,GABBR1
10777,GO:0042531,0.258717549586427,0.964223996429143,1,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,SOCS3
19667,GO:1903307,0.260019073016434,0.963873646050091,1,46,positive regulation of regulated secretory pathway,BP,KCNB1
7921,GO:0031526,0.260127073221707,0.963911130305002,1,42,brush border membrane,CC,SHANK2
475,GO:0001508,0.260434164428714,0.923197219658293,2,129,action potential,BP,KCNIP2;KCNB1
7305,GO:0030308,0.261379284440439,0.922623916775332,2,154,negative regulation of cell growth,BP,TNR;SPP1
12123,GO:0045661,0.261388148866052,0.963471228861849,1,46,regulation of myoblast differentiation,BP,CXCL10
11254,GO:0043408,0.261479181839255,0.860150050299582,6,654,regulation of MAPK cascade,BP,CCL2;GBP1;GDF15;CHI3L1;KSR2;PLA2G2A
4007,GO:0008283,0.261518867193002,0.825121446549902,14,1774,cell proliferation,BP,LTF;FERMT1;TIMP1;IGFBP2;PLAU;LGALS3;ANXA1;EMP3;ADM;PDPN;S100A11;CXCL10;VSTM2A;ANXA2
13132,GO:0048608,0.261668104196451,0.881274835648448,4,381,reproductive structure development,BP,SPP1;ANXA1;ADM;SOCS3
11846,GO:0045071,0.262213551492656,0.963182274540831,1,49,negative regulation of viral genome replication,BP,LTF
6756,GO:0021515,0.26238196988054,0.963177557455754,1,46,cell differentiation in spinal cord,BP,MDGA2
12294,GO:0045980,0.262527039418734,0.963118853923249,1,47,negative regulation of nucleotide metabolic process,BP,GABBR1
16013,GO:0070849,0.262711346926453,0.963131589089635,1,43,response to epidermal growth factor,BP,COL1A1
9337,GO:0034381,0.263035476835685,0.962967947458972,1,47,plasma lipoprotein particle clearance,BP,ANXA2
13736,GO:0051155,0.263331681724257,0.962879874376462,1,47,positive regulation of striated muscle cell differentiation,BP,GDF15
2852,GO:0005925,0.2633824162451,0.880180681549414,4,381,focal adhesion,CC,VIM;FERMT1;PLAU;ANXA1
8602,GO:0032722,0.263392202133531,0.962818183296892,1,50,positive regulation of chemokine production,BP,POSTN
11883,GO:0045123,0.263403913024455,0.962843209659383,1,48,cellular extravasation,BP,CCL2
809,GO:0002009,0.263725119645329,0.86786326206974,5,498,morphogenesis of an epithelium,BP,ADM;PDPN;CXCL10;SOCS3;COL4A1
5990,GO:0016667,0.264043745067541,0.962584859675332,1,53,oxidoreductase activity, acting on a sulfur group of donors,MF,IFI30
19581,GO:1903115,0.264113071664106,0.962820458044766,1,38,regulation of actin filament-based movement,BP,PDPN
12024,GO:0045428,0.265219962078536,0.962315675313359,1,47,regulation of nitric oxide biosynthetic process,BP,PTX3
16321,GO:0071417,0.265555446077271,0.866620364999751,5,499,cellular response to organonitrogen compound,BP,COL1A1;GABRB3;COL3A1;SOCS3;COL4A1
15322,GO:0061458,0.265670132856998,0.878711547060431,4,384,reproductive system development,BP,SPP1;ANXA1;ADM;SOCS3
21843,GO:2001238,0.266132950606951,0.962010847580128,1,49,positive regulation of extrinsic apoptotic signaling pathway,BP,TNFRSF12A
3217,GO:0006521,0.266210696292643,0.96190961841011,1,55,regulation of cellular amino acid metabolic process,BP,ATCAY
10563,GO:0042093,0.267145098187299,0.961719975778644,1,48,T-helper cell differentiation,BP,ANXA1
4658,GO:0009988,0.267145205305127,0.961650786808717,1,53,cell-cell recognition,BP,LGALS3
2851,GO:0005924,0.267492220048441,0.877540079264084,4,384,cell-substrate adherens junction,CC,VIM;FERMT1;PLAU;ANXA1
2502,GO:0005231,0.267902217836103,0.961522452624735,1,46,excitatory extracellular ligand-gated ion channel activity,MF,GRIN1
18005,GO:0098693,0.268334425900727,0.961464693046877,1,42,regulation of synaptic vesicle cycle,BP,RIMS2
12516,GO:0046503,0.268869160242202,0.961180911418337,1,49,glycerolipid catabolic process,BP,FABP5
2876,GO:0005975,0.269023729821474,0.864220255467946,5,544,carbohydrate metabolic process,BP,CHI3L2;CHI3L1;GALNT13;FUT9;ST8SIA3
11975,GO:0045309,0.269228123355029,0.96115418976926,1,44,protein phosphorylated amino acid binding,MF,SOCS3
13591,GO:0050922,0.2697579351772,0.960974273406322,1,45,negative regulation of chemotaxis,BP,CCL2
4487,GO:0009314,0.269960261135804,0.875925591838879,4,402,response to radiation,BP,ANXA1;COL3A1;CXCL10;GRIN1
978,GO:0002294,0.271021218335192,0.960521116005538,1,49,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,ANXA1
3439,GO:0006820,0.27142441334922,0.862588159203272,5,529,anion transport,BP,ABCC3;SNAP25;ANXA1;GABRB3;PLA2G2A
5511,GO:0015711,0.272203275485431,0.874470564950236,4,403,organic anion transport,BP,ABCC3;SNAP25;ANXA1;PLA2G2A
3297,GO:0006612,0.272991950460618,0.916786998024022,2,177,protein targeting to membrane,BP,KCNB1;RTP5
7140,GO:0030055,0.273462052546592,0.873671442272252,4,387,cell-substrate junction,CC,VIM;FERMT1;PLAU;ANXA1
12939,GO:0048146,0.274569944297867,0.959435322932933,1,48,positive regulation of fibroblast proliferation,BP,ANXA2
8956,GO:0033293,0.275081698598262,0.959229416993671,1,51,monocarboxylic acid binding,MF,FABP5
973,GO:0002287,0.275163252368023,0.959218460725091,1,50,alpha-beta T cell activation involved in immune response,BP,ANXA1
977,GO:0002293,0.275163252368023,0.959218460725091,1,50,alpha-beta T cell differentiation involved in immune response,BP,ANXA1
14162,GO:0051937,0.275267679324715,0.959156968639985,1,52,catecholamine transport,BP,KCNB1
17919,GO:0097755,0.275452025974015,0.959113146274804,1,51,positive regulation of blood vessel diameter,BP,ADM
4175,GO:0008542,0.275495760213469,0.959216116012309,1,44,visual learning,BP,GRIN1
14721,GO:0060350,0.276487293462015,0.958833291890718,1,48,endochondral bone morphogenesis,BP,COL1A1
15525,GO:0061971,0.276487293462015,0.958833291890718,1,48,replacement bone morphogenesis,BP,COL1A1
17241,GO:0090090,0.276565875220876,0.915032165570087,2,161,negative regulation of canonical Wnt signaling pathway,BP,FERMT1;IGFBP2
12575,GO:0046626,0.276891499065837,0.958705740347297,1,48,regulation of insulin receptor signaling pathway,BP,SOCS3
10079,GO:0035987,0.276944542586872,0.958741498565339,1,45,endodermal cell differentiation,BP,COL4A2
12056,GO:0045576,0.277456362998016,0.958466326146322,1,52,mast cell activation,BP,CPLX2
14698,GO:0060324,0.277571954840817,0.958524915285081,1,46,face development,BP,COL1A1
12030,GO:0045453,0.277642540854127,0.958452000571525,1,49,bone resorption,BP,SPP1
16978,GO:0072577,0.27789754374653,0.95840418343182,1,47,endothelial cell apoptotic process,BP,SERPINE1
10679,GO:0042325,0.27829888525879,0.820583338630552,11,1343,regulation of phosphorylation,BP,LTF;SRPX2;CCL2;GBP1;GDF15;CHI3L1;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
9692,GO:0035308,0.278519318830737,0.958157966486866,1,50,negative regulation of protein dephosphorylation,BP,ELFN2
13605,GO:0050954,0.278912301416139,0.913893846813832,2,147,sensory perception of mechanical stimulus,BP,COL1A1;GABRB3
3979,GO:0008237,0.280348300366351,0.913095460825103,2,162,metallopeptidase activity,MF,AEBP1;ADAM12
18990,GO:1901616,0.2812581147577,0.957223465404557,1,54,organic hydroxy compound catabolic process,BP,MOXD1
768,GO:0001954,0.283011028347453,0.956802373860184,1,45,positive regulation of cell-matrix adhesion,BP,FERMT1
12606,GO:0046677,0.283500616851447,0.884789584173107,3,290,response to antibiotic,BP,COL1A1;ANXA1;GRIN1
14874,GO:0060563,0.283880987114467,0.956431948316988,1,50,neuroepithelial cell differentiation,BP,SERPINE1
12520,GO:0046513,0.284018779616946,0.956328214527262,1,54,ceramide biosynthetic process,BP,ST8SIA3
7543,GO:0030850,0.284712197458423,0.956211832581792,1,47,prostate gland development,BP,ANXA1
12271,GO:0045936,0.285169010207974,0.853050577820165,5,540,negative regulation of phosphate metabolic process,BP,GBP1;SPOCD1;ELFN2;SOCS3;GABBR1
13726,GO:0051145,0.285341705941241,0.955939184063703,1,51,smooth muscle cell differentiation,BP,ADM
13587,GO:0050918,0.285581794903274,0.955860470349123,1,51,positive chemotaxis,BP,LGALS3
7551,GO:0030858,0.285852833828626,0.955787296902337,1,50,positive regulation of epithelial cell differentiation,BP,SERPINE1
4806,GO:0010563,0.286219642094211,0.852313132241443,5,541,negative regulation of phosphorus metabolic process,BP,GBP1;SPOCD1;ELFN2;SOCS3;GABBR1
4704,GO:0010171,0.287050704637921,0.955444889497933,1,47,body morphogenesis,BP,COL1A1
6479,GO:0019229,0.287790373724435,0.955102493235846,1,53,regulation of vasoconstriction,BP,ADM
2776,GO:0005798,0.288149120515366,0.909044011427006,2,163,Golgi-associated vesicle,CC,HLA-DQB1;HLA-DQA1
12448,GO:0046365,0.288880447965154,0.954699052581374,1,56,monosaccharide catabolic process,BP,FUT9
4177,GO:0008544,0.28904047150537,0.881418905902869,3,280,epidermis development,BP,FERMT1;ANXA1;FABP5
15297,GO:0061383,0.289241518236405,0.95473863245739,1,46,trabecula morphogenesis,BP,COL1A1
3854,GO:0008023,0.289450972627651,0.95463158720659,1,48,transcription elongation factor complex,CC,AFF2
3977,GO:0008235,0.289579309418848,0.954479362146617,1,55,metalloexopeptidase activity,MF,AEBP1
6410,GO:0019058,0.290283695178683,0.880631891926894,3,291,viral life cycle,BP,LTF;CCL2;PTX3
13499,GO:0050796,0.290428155417787,0.907862101118517,2,159,regulation of insulin secretion,BP,SNAP25;KCNB1
3443,GO:0006826,0.291584007829362,0.953821262177522,1,54,iron ion transport,BP,STEAP3
12075,GO:0045600,0.291626261008035,0.953807038575723,1,54,positive regulation of fat cell differentiation,BP,VSTM2A
11662,GO:0044444,0.291981425755931,0.773573412571904,59,8623,cytoplasmic part,CC,LTF;TYMP;VIM;CP;SNAP91;MOXD1;FERMT1;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GALNT13;CPLX2;INA;SERPING1;SPHKAP;JPH3;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;NNMT;ATCAY;COL3A1;PCDH7;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;SOCS3;COL4A1;PLA2G2A;SERPINA3;HLA-DQA1;DOK6;IFI30
15851,GO:0070527,0.292618895347757,0.953502196821422,1,52,platelet aggregation,BP,PDPN
6396,GO:0019003,0.292625540409252,0.953416115706579,1,58,GDP binding,MF,GBP1
10776,GO:0042509,0.293141405973331,0.953267394290749,1,56,regulation of tyrosine phosphorylation of STAT protein,BP,SOCS3
18857,GO:1901222,0.293534613671323,0.953147776163507,1,55,regulation of NIK/NF-kappaB signaling,BP,CHI3L1
5786,GO:0016266,0.293725137859684,0.953160295058736,1,50,O-glycan processing,BP,GALNT13
18838,GO:1901185,0.294144399127448,0.952969769824308,1,53,negative regulation of ERBB signaling pathway,BP,SH3GL2
16207,GO:0071242,0.294381458203843,0.952889118433421,1,53,cellular response to ammonium ion,BP,GABRB3
14557,GO:0060113,0.294727998215598,0.952855119861209,1,48,inner ear receptor cell differentiation,BP,GABRB3
15134,GO:0061024,0.295219808389235,0.827810729891524,7,806,membrane organization,BP,SH3GL2;KCNIP2;SNAP25;ANXA1;ANXA2;SHISA7;RTP5
16379,GO:0071496,0.295581389439641,0.877344695125625,3,292,cellular response to external stimulus,BP,COL1A1;POSTN;KCNB1
17640,GO:0097164,0.295772280641102,0.904946797627271,2,180,ammonium ion metabolic process,BP,MOXD1;PLA2G2A
7020,GO:0022029,0.29580979156076,0.952467858096307,1,49,telencephalon cell migration,BP,TNR
749,GO:0001932,0.29591001433679,0.810546377298915,10,1230,regulation of protein phosphorylation,BP,LTF;CCL2;GBP1;GDF15;CHI3L1;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
5504,GO:0015698,0.296056568289081,0.904869400133669,2,160,inorganic anion transport,BP,ABCC3;GABRB3
16534,GO:0071772,0.2961783009527,0.904835083384827,2,153,response to BMP,BP,GDF15;VSTM2A
16535,GO:0071773,0.2961783009527,0.904835083384827,2,153,cellular response to BMP stimulus,BP,GDF15;VSTM2A
10291,GO:0036465,0.296275222819396,0.952308564668627,1,49,synaptic vesicle recycling,BP,SH3GL2
14754,GO:0060393,0.297053112685031,0.951930885076915,1,56,regulation of pathway-restricted SMAD protein phosphorylation,BP,GDF15
18114,GO:0098900,0.297131794153284,0.952115429858491,1,44,regulation of action potential,BP,KCNB1
11882,GO:0045121,0.297163015765353,0.876368734241682,3,286,membrane raft,CC,TNR;PDPN;ANXA2
5057,GO:0010921,0.297599128482955,0.904060214068971,2,156,regulation of phosphatase activity,BP,SPOCD1;ELFN2
10743,GO:0042445,0.298666974587291,0.903393133769144,2,180,hormone metabolic process,BP,SPP1;ADM
18093,GO:0098857,0.299002257754519,0.875214560234265,3,287,membrane microdomain,CC,TNR;PDPN;ANXA2
976,GO:0002292,0.299045984770587,0.951256054132253,1,55,T cell differentiation involved in immune response,BP,ANXA1
4587,GO:0009749,0.299595329384199,0.902947688701248,2,165,response to glucose,BP,COL6A2;KCNB1
10600,GO:0042157,0.299621303377069,0.902917975834223,2,169,lipoprotein metabolic process,BP,APOL4;MDGA2
11065,GO:0043113,0.299941761536546,0.951043127345028,1,49,receptor clustering,BP,SHISA7
4785,GO:0010517,0.30012308865687,0.950927871265106,1,52,regulation of phospholipase activity,BP,ANXA1
16316,GO:0071407,0.301021881202651,0.841815222505202,5,536,cellular response to organic cyclic compound,BP,CCL2;COL1A1;SPP1;ANXA1;GABRB3
18244,GO:0099512,0.301773887688639,0.822859420797602,7,752,supramolecular fiber,CC,VIM;FERMT1;COL1A1;ANXA1;INA;SHANK2;COL3A1
4391,GO:0009165,0.302227931667934,0.873146378483297,3,307,nucleotide biosynthetic process,BP,ADM;NNMT;GABBR1
20904,GO:1990090,0.30281168336814,0.950039497228142,1,49,cellular response to nerve growth factor stimulus,BP,SH3GL2
7470,GO:0030674,0.302868817623124,0.901182026105724,2,163,protein binding, bridging,MF,SHD;ANXA1
16513,GO:0071702,0.302959307042891,0.782685396471274,18,2410,organic substance transport,BP,SNAP91;APOL4;FERMT1;COL1A1;ABCC3;KCNIP3;STEAP3;GBP1;SPP1;SNAP25;CHI3L1;POSTN;ANXA1;KCNB1;RIMS2;ANXA2;RTP5;PLA2G2A
3699,GO:0007260,0.302989471112427,0.94983394691865,1,58,tyrosine phosphorylation of STAT protein,BP,SOCS3
13148,GO:0048639,0.303019325390822,0.90115436137698,2,151,positive regulation of developmental growth,BP,TNFRSF12A;RIMS2
3842,GO:0007632,0.303072990232061,0.949947541926244,1,49,visual behavior,BP,GRIN1
3204,GO:0006501,0.3036198157294,0.949624924453245,1,57,C-terminal protein lipidation,BP,MDGA2
13495,GO:0050792,0.304313345888523,0.900336839550098,2,178,regulation of viral process,BP,LTF;PTX3
5954,GO:0016597,0.304864051177983,0.949169917463031,1,58,amino acid binding,MF,GRIN1
7504,GO:0030802,0.304866522660148,0.949155686596855,1,59,regulation of cyclic nucleotide biosynthetic process,BP,GABBR1
82,GO:0000165,0.305436448891469,0.820021030694124,7,827,MAPK cascade,BP,CCL2;GBP1;GDF15;CHI3L1;KSR2;GRIN1;PLA2G2A
12693,GO:0046889,0.306023005708347,0.948756898907786,1,58,positive regulation of lipid biosynthetic process,BP,ANXA1
2913,GO:0006027,0.306968471455225,0.948477717041816,1,54,glycosaminoglycan catabolic process,BP,FMOD
12132,GO:0045670,0.307991262474746,0.948126959367758,1,53,regulation of osteoclast differentiation,BP,LTF
18883,GO:1901293,0.308074663632822,0.869424795814015,3,311,nucleoside phosphate biosynthetic process,BP,ADM;NNMT;GABBR1
12529,GO:0046530,0.308134243279124,0.948092484224239,1,52,photoreceptor cell differentiation,BP,CDHR1
13270,GO:0048857,0.308275343120092,0.947962915989988,1,57,neural nucleus development,BP,INA
4586,GO:0009746,0.308328628635579,0.898166338131737,2,169,response to hexose,BP,COL6A2;KCNB1
16299,GO:0071385,0.308908556989973,0.947734486910024,1,57,cellular response to glucocorticoid stimulus,BP,ANXA1
9202,GO:0034121,0.30904292747351,0.947685940053874,1,57,regulation of toll-like receptor signaling pathway,BP,LTF
12692,GO:0046888,0.309265911557228,0.947605321234385,1,57,negative regulation of hormone secretion,BP,KCNB1
4732,GO:0010332,0.309281558101167,0.947678987396019,1,52,response to gamma radiation,BP,CXCL10
2409,GO:0005070,0.309456103028175,0.947536502533499,1,57,SH3/SH2 adaptor activity,MF,SHD
11222,GO:0043367,0.309520002908312,0.947499127434019,1,58,CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
6950,GO:0021885,0.309641607280946,0.947548838778073,1,52,forebrain cell migration,BP,TNR
6781,GO:0021543,0.310497979507714,0.897028013919684,2,155,pallium development,BP,COL3A1;GRIN1
13639,GO:0051018,0.310558609736254,0.947313569298586,1,47,protein kinase A binding,MF,SPHKAP
4632,GO:0009898,0.310937458056201,0.896718612337249,2,170,cytoplasmic side of plasma membrane,CC,SNAP25;GNAL
1139,GO:0002573,0.311019803749324,0.896668922428497,2,171,myeloid leukocyte differentiation,BP,LTF;ANXA2
14532,GO:0060070,0.311976485218699,0.866956155513364,3,293,canonical Wnt signaling pathway,BP,FERMT1;COL1A1;IGFBP2
15767,GO:0070373,0.313408669804592,0.946080039708623,1,58,negative regulation of ERK1 and ERK2 cascade,BP,GBP1
590,GO:0001706,0.313583608664459,0.946094290257103,1,53,endoderm formation,BP,COL4A2
14750,GO:0060389,0.313661459335064,0.945972916793571,1,59,pathway-restricted SMAD protein phosphorylation,BP,GDF15
7282,GO:0030278,0.314143329390059,0.894939948701714,2,168,regulation of ossification,BP,LTF;SMOC1
18248,GO:0099516,0.314174446617476,0.945827900387982,1,56,ion antiporter activity,MF,SLC8A2
12468,GO:0046427,0.315337590373425,0.945353821424777,1,59,positive regulation of JAK-STAT cascade,BP,SOCS3
20903,GO:1990089,0.315981441886906,0.945226863779103,1,52,response to nerve growth factor,BP,SH3GL2
810,GO:0002011,0.316818355624682,0.944953992123173,1,50,morphogenesis of an epithelial sheet,BP,PDPN
7807,GO:0031324,0.31686362562034,0.772723945960287,17,2250,negative regulation of cellular metabolic process,BP,LTF;TIMP1;SERPINE1;AEBP1;CUX2;KCNIP3;GBP1;SPOCD1;SERPING1;S100A11;PTX3;ELFN2;ATCAY;ANXA2;SOCS3;SERPINA3;GABBR1
10766,GO:0042490,0.317107851130109,0.944790364750025,1,53,mechanoreceptor differentiation,BP,GABRB3
18322,GO:0101003,0.317489659301515,0.944597972487337,1,56,ficolin-1-rich granule membrane,CC,LGALS3
17960,GO:0098589,0.317892998261908,0.863120577549747,3,296,membrane region,CC,TNR;PDPN;ANXA2
19773,GO:1903524,0.318093903536687,0.944299361107655,1,61,positive regulation of blood circulation,BP,ADM
8563,GO:0032652,0.318144777023214,0.944254433386117,1,63,regulation of interleukin-1 production,BP,ANXA1
20457,GO:1904894,0.31898175744309,0.943979763740223,1,60,positive regulation of STAT cascade,BP,SOCS3
6601,GO:0019674,0.31936048179999,0.943785139574051,1,64,NAD metabolic process,BP,NNMT
13745,GO:0051172,0.319563403932279,0.772513446387779,16,2109,negative regulation of nitrogen compound metabolic process,BP,LTF;TIMP1;SERPINE1;AEBP1;CUX2;KCNIP3;GBP1;SERPING1;S100A11;PTX3;ELFN2;ATCAY;ANXA2;SOCS3;SERPINA3;GABBR1
9284,GO:0034284,0.320610686821271,0.891268119421614,2,174,response to monosaccharide,BP,COL6A2;KCNB1
2631,GO:0005546,0.321533075804692,0.943016023952462,1,60,phosphatidylinositol-4,5-bisphosphate binding,MF,ANXA2
12131,GO:0045669,0.322202286934084,0.942822354396839,1,56,positive regulation of osteoblast differentiation,BP,LTF
3431,GO:0006809,0.322501525834327,0.942677076169765,1,58,nitric oxide biosynthetic process,BP,PTX3
11332,GO:0043542,0.322530600863072,0.890194874935506,2,169,endothelial cell migration,BP,SRPX2;ANXA1
5577,GO:0015844,0.322670227299631,0.942542876916952,1,63,monoamine transport,BP,KCNB1
15674,GO:0070227,0.322758491482192,0.942509199607961,1,63,lymphocyte apoptotic process,BP,LGALS3
19333,GO:1902531,0.32289372639586,0.777508107013843,13,1671,regulation of intracellular signal transduction,BP,LTF;CCL2;GBP1;GDF15;CHI3L1;GPR17;SPHKAP;JPH3;COL3A1;CXCL10;KSR2;SOCS3;PLA2G2A
16298,GO:0071384,0.323703738115012,0.942174593003291,1,61,cellular response to corticosteroid stimulus,BP,ANXA1
4455,GO:0009247,0.323903356844507,0.942058579733854,1,64,glycolipid biosynthetic process,BP,ST8SIA3
20220,GO:1904427,0.324024370503861,0.942080409581672,1,59,positive regulation of calcium ion transmembrane transport,BP,CXCL10
14170,GO:0051952,0.324485973597626,0.941834981567143,1,64,regulation of amine transport,BP,KCNB1
8396,GO:0032418,0.325074123650548,0.941634893824033,1,62,lysosome localization,BP,CPLX2
14571,GO:0060135,0.326314866756545,0.941246513049013,1,56,maternal process involved in female pregnancy,BP,SPP1
16706,GO:0072091,0.326776509087862,0.94105166387851,1,57,regulation of stem cell proliferation,BP,FERMT1
2300,GO:0004888,0.326842864003377,0.812008396495215,6,729,transmembrane signaling receptor activity,MF,GPR17;GABRB3;GRIN1;HLA-DQB1;HLA-DQA1;GABBR1
9188,GO:0034103,0.327171786678331,0.940867356802405,1,59,regulation of tissue remodeling,BP,SPP1
14039,GO:0051704,0.327608103508235,0.767982736411526,15,2043,multi-organism process,BP,LTF;VIM;TIMP1;SERPINE1;CCL2;IGFBP2;GBP1;SPP1;ADM;SHANK2;PTX3;CXCL10;GRIN1;ANXA2;PLA2G2A
19127,GO:1901992,0.328470757938526,0.94033308045383,1,61,positive regulation of mitotic cell cycle phase transition,BP,ANXA1
3808,GO:0007585,0.328652915129821,0.940276533162973,1,60,respiratory gaseous exchange,BP,GRIN1
12062,GO:0045582,0.329427842479108,0.939918442246455,1,64,positive regulation of T cell differentiation,BP,ANXA1
10867,GO:0042698,0.330207936783149,0.939668352586572,1,60,ovulation cycle,BP,ANXA1
6709,GO:0019915,0.330959070405502,0.939388486221762,1,59,lipid storage,BP,VSTM2A
2481,GO:0005179,0.331155651469529,0.939179039090822,1,69,hormone activity,MF,ADM
8553,GO:0032642,0.331300321498877,0.939145255637374,1,67,regulation of chemokine production,BP,POSTN
10819,GO:0042590,0.331705768360183,0.938929313898169,1,72,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,IFI30
7384,GO:0030500,0.333010520460022,0.938563264999754,1,60,regulation of bone mineralization,BP,LTF
13992,GO:0051607,0.333068110858773,0.884026167095747,2,188,defense response to virus,BP,GBP1;CXCL10
7957,GO:0031594,0.334565780892229,0.938010374014255,1,56,neuromuscular junction,CC,POSTN
9059,GO:0033619,0.335312081058059,0.937617431409851,1,62,membrane protein proteolysis,BP,TIMP1
10769,GO:0042493,0.335601592243614,0.796462892605715,7,876,response to drug,BP,COL1A1;ABCC3;LOX;IGFBP2;ANXA1;NNMT;GRIN1
5548,GO:0015800,0.336018420669704,0.937379965032636,1,59,acidic amino acid transport,BP,SNAP25
12401,GO:0046209,0.336094239339842,0.937318797292574,1,61,nitric oxide metabolic process,BP,PTX3
5489,GO:0015672,0.33741771039016,0.829651647621795,4,443,monovalent inorganic cation transport,BP,KCNIP3;SLC8A2;KCNIP2;KCNB1
18245,GO:0099513,0.33773031836762,0.814772897337117,5,545,polymeric cytoskeletal fiber,CC,VIM;FERMT1;ANXA1;INA;SHANK2
6362,GO:0018410,0.337889772504731,0.936539896874641,1,65,C-terminal protein amino acid modification,BP,MDGA2
8928,GO:0033238,0.339019988771348,0.935998090014864,1,72,regulation of cellular amine metabolic process,BP,ATCAY
8288,GO:0032268,0.339733794182451,0.753017665925187,17,2295,regulation of cellular protein metabolic process,BP,LTF;VIM;TIMP1;SERPINE1;CCL2;GBP1;GDF15;CHI3L1;SERPING1;ELFN2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3
12582,GO:0046634,0.339741476571032,0.935763246850309,1,67,regulation of alpha-beta T cell activation,BP,ANXA1
16874,GO:0072347,0.340419008705708,0.935526922290715,1,64,response to anesthetic,BP,GRIN1
7087,GO:0023014,0.340660190003657,0.792443874488765,7,855,signal transduction by protein phosphorylation,BP,CCL2;GBP1;GDF15;CHI3L1;KSR2;GRIN1;PLA2G2A
11020,GO:0043025,0.340733456033905,0.82726595275274,4,428,neuronal cell body,CC,SLC8A2;CPLX2;KCNB1;SHANK2
10744,GO:0042446,0.340751836430909,0.935351340457731,1,67,hormone biosynthetic process,BP,ADM
13785,GO:0051235,0.34078454813164,0.847917337367388,3,287,maintenance of location,BP,JPH3;CXCL10;VSTM2A
1285,GO:0002824,0.34079310419689,0.935309870210977,1,69,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ANXA1
9921,GO:0035710,0.341085508060595,0.93522786238993,1,66,CD4-positive, alpha-beta T cell activation,BP,ANXA1
12491,GO:0046470,0.342096330514183,0.934764180085276,1,70,phosphatidylcholine metabolic process,BP,PLA2G2A
2751,GO:0005769,0.342329081271521,0.846821637229248,3,308,early endosome,CC,SH3GL2;ANXA1;ANXA2
4652,GO:0009968,0.342360770073733,0.777791281680538,9,1145,negative regulation of signal transduction,BP,LTF;FERMT1;SERPINE1;SH3GL2;IGFBP2;GBP1;LGALS3;ADM;SOCS3
5889,GO:0016491,0.342849747518584,0.810809995137027,5,646,oxidoreductase activity,MF,CP;MOXD1;LOX;STEAP3;IFI30
20043,GO:1904035,0.343531722871136,0.934250590282896,1,64,regulation of epithelial cell apoptotic process,BP,SERPINE1
15639,GO:0070167,0.343904634898483,0.934111077985182,1,63,regulation of biomineral tissue development,BP,LTF
6232,GO:0017137,0.343994870361712,0.877618570615897,2,170,Rab GTPase binding,MF,RIMS2;ANXA2
16240,GO:0071300,0.345516359433587,0.933429227381062,1,64,cellular response to retinoic acid,BP,COL1A1
11278,GO:0043462,0.346097609864274,0.933097193836122,1,71,regulation of ATPase activity,BP,LTF
21765,GO:2001057,0.347261041907227,0.932702275626112,1,64,reactive nitrogen species metabolic process,BP,PTX3
4311,GO:0009064,0.347456878103607,0.932553462252648,1,69,glutamine family amino acid metabolic process,BP,ATCAY
17367,GO:0090276,0.347740414759289,0.875299311186011,2,184,regulation of peptide hormone secretion,BP,SNAP25;KCNB1
21839,GO:2001234,0.347956496200109,0.875119950868489,2,197,negative regulation of apoptotic signaling pathway,BP,SERPINE1;LGALS3
870,GO:0002088,0.348479933780244,0.932270432308687,1,59,lens development in camera-type eye,BP,VIM
17607,GO:0097110,0.349243207940935,0.931949890459623,1,59,scaffold protein binding,MF,VIM
2796,GO:0005844,0.349800793171256,0.931568009832362,1,69,polysome,CC,VIM
5573,GO:0015837,0.35002463087828,0.931448987936191,1,71,amine transport,BP,KCNB1
3355,GO:0006687,0.350901563943189,0.931115182926684,1,68,glycosphingolipid metabolic process,BP,ST8SIA3
11384,GO:0043627,0.351507657927197,0.930845151820607,1,69,response to estrogen,BP,IGFBP2
17447,GO:0090407,0.35186504404833,0.803931958046709,5,611,organophosphate biosynthetic process,BP,PLEKHA4;ADM;NNMT;PLA2G2A;GABBR1
4336,GO:0009101,0.351938159690142,0.840211475534356,3,312,glycoprotein biosynthetic process,BP,GALNT13;FUT9;ST8SIA3
5288,GO:0015031,0.352823552884635,0.752035493402381,13,1754,protein transport,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;SNAP25;CHI3L1;POSTN;ANXA1;KCNB1;RIMS2;RTP5
14550,GO:0060090,0.353388548976071,0.871863158294859,2,182,molecular adaptor activity,MF,SHD;ANXA1
10671,GO:0042310,0.353887571937559,0.929842919172237,1,68,vasoconstriction,BP,ADM
13226,GO:0048762,0.354598275154183,0.871103337767146,2,186,mesenchymal cell differentiation,BP,COL1A1;PDPN
567,GO:0001666,0.355295377003011,0.837854214280788,3,324,response to hypoxia,BP,PLAU;POSTN;ADM
1620,GO:0003725,0.355519187954104,0.929169539570677,1,66,double-stranded RNA binding,MF,VIM
8525,GO:0032602,0.356818596911552,0.928506605406732,1,74,chemokine production,BP,POSTN
4673,GO:0010035,0.356978061257171,0.815260006283111,4,466,response to inorganic substance,BP,COL1A1;IGFBP2;KCNIP2;ANXA1
19692,GO:1903363,0.357597314510966,0.928257057475536,1,67,negative regulation of cellular protein catabolic process,BP,ANXA2
1282,GO:0002821,0.357758790528581,0.928110179819563,1,73,positive regulation of adaptive immune response,BP,ANXA1
17948,GO:0098562,0.357844294369135,0.869078465538971,2,191,cytoplasmic side of membrane,CC,SNAP25;GNAL
7213,GO:0030178,0.358486729352869,0.868668445864583,2,194,negative regulation of Wnt signaling pathway,BP,FERMT1;IGFBP2
8535,GO:0032612,0.358908146440441,0.927621610947598,1,72,interleukin-1 production,BP,ANXA1
14873,GO:0060562,0.35893556990967,0.835355526596863,3,301,epithelial tube morphogenesis,BP,ADM;CXCL10;COL4A1
18972,GO:1901570,0.360382573784871,0.926941339891937,1,75,fatty acid derivative biosynthetic process,BP,ANXA1
7295,GO:0030295,0.360513619112633,0.926957488961596,1,69,protein kinase activator activity,MF,LTF
18601,GO:1900076,0.360514599451074,0.926998925002717,1,66,regulation of cellular response to insulin stimulus,BP,SOCS3
17219,GO:0090066,0.36086739956806,0.81237307659258,4,449,regulation of anatomical structure size,BP,TNFRSF12A;TNR;SPP1;ADM
3853,GO:0008022,0.361117087918157,0.867074232897556,2,183,protein C-terminus binding,MF,VIM;SH3GL2
12135,GO:0045682,0.361450514922442,0.926559512360067,1,68,regulation of epidermis development,BP,FERMT1
6693,GO:0019888,0.361595626807965,0.926455934749278,1,71,protein phosphatase regulator activity,MF,ELFN2
4009,GO:0008285,0.363486317134618,0.794910013230255,5,610,negative regulation of cell proliferation,BP,FERMT1;EMP3;ADM;PDPN;S100A11
13261,GO:0048844,0.365002148689243,0.925152326771967,1,58,artery morphogenesis,BP,COL3A1
2779,GO:0005811,0.365455513144393,0.924744498880338,1,71,lipid droplet,CC,ANXA2
3702,GO:0007265,0.365541374405252,0.808867146499277,4,441,Ras protein signal transduction,BP,GPR17;PDPN;COL3A1;KSR2
9687,GO:0035303,0.366156751086535,0.863904969827231,2,184,regulation of dephosphorylation,BP,SPOCD1;ELFN2
7161,GO:0030111,0.366652283166517,0.829863743143091,3,320,regulation of Wnt signaling pathway,BP,FERMT1;COL1A1;IGFBP2
150,GO:0000302,0.367569383102458,0.862926900205687,2,206,response to reactive oxygen species,BP,COL1A1;ANXA1
5913,GO:0016529,0.367577924674471,0.923982741894886,1,59,sarcoplasmic reticulum,CC,JPH3
4203,GO:0008610,0.368188196398426,0.791207824247762,5,625,lipid biosynthetic process,BP,PLEKHA4;ANXA1;ADM;ST8SIA3;PLA2G2A
7300,GO:0030301,0.369105587032976,0.923160740753036,1,67,cholesterol transport,BP,ANXA2
4584,GO:0009743,0.370236452235583,0.861271665371516,2,195,response to carbohydrate,BP,COL6A2;KCNB1
9191,GO:0034109,0.370600216651413,0.922483747245694,1,67,homotypic cell-cell adhesion,BP,PDPN
16944,GO:0072527,0.370883676288502,0.922224758579363,1,77,pyrimidine-containing compound metabolic process,BP,TYMP
4848,GO:0010632,0.371186782919593,0.860710520045766,2,184,regulation of epithelial cell migration,BP,SRPX2;ANXA1
2014,GO:0004497,0.371241700932051,0.922073162669993,1,76,monooxygenase activity,MF,MOXD1
11533,GO:0044215,0.371550244800738,0.922008485160469,1,70,other organism,CC,LTF
11534,GO:0044216,0.371550244800738,0.922008485160469,1,70,other organism cell,CC,LTF
11535,GO:0044217,0.371550244800738,0.922008485160469,1,70,other organism part,CC,LTF
14609,GO:0060191,0.371718222499032,0.921931892234757,1,70,regulation of lipase activity,BP,ANXA1
17920,GO:0097756,0.371830612504546,0.921853831289207,1,72,negative regulation of blood vessel diameter,BP,ADM
18101,GO:0098876,0.37246269031642,0.921620366701455,1,68,vesicle-mediated transport to the plasma membrane,BP,SNAP25
19124,GO:1901989,0.373285017424742,0.921188347693445,1,72,positive regulation of cell cycle phase transition,BP,ANXA1
7641,GO:0031016,0.373970684831097,0.920914684859498,1,69,pancreas development,BP,ANXA1
10217,GO:0036293,0.374199150907635,0.824436358146607,3,332,response to decreased oxygen levels,BP,PLAU;POSTN;ADM
12089,GO:0045621,0.374907375476092,0.920403972773378,1,75,positive regulation of lymphocyte differentiation,BP,ANXA1
13199,GO:0048708,0.375936827098359,0.92003789502186,1,67,astrocyte differentiation,BP,VIM
7851,GO:0031401,0.37674225416394,0.75532590623645,8,1039,positive regulation of protein modification process,BP,LTF;CCL2;GDF15;CHI3L1;KSR2;ANXA2;SOCS3;PLA2G2A
12104,GO:0045638,0.377548112355129,0.919205248534983,1,73,negative regulation of myeloid cell differentiation,BP,LTF
21838,GO:2001233,0.3781014317275,0.821572472096661,3,355,regulation of apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1;LGALS3
8473,GO:0032508,0.378273976691257,0.918907918111516,1,70,DNA duplex unwinding,BP,ANXA1
4828,GO:0010605,0.378510767114235,0.718826804339362,17,2356,negative regulation of macromolecule metabolic process,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;AEBP1;CUX2;KCNIP3;GBP1;SERPING1;AFF2;S100A11;PTX3;ELFN2;ANXA2;SOCS3;SERPINA3
13730,GO:0051149,0.378671785191178,0.918681158509856,1,73,positive regulation of muscle cell differentiation,BP,GDF15
5572,GO:0015833,0.378819610688413,0.729394385816202,13,1788,peptide transport,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;SNAP25;CHI3L1;POSTN;ANXA1;KCNB1;RIMS2;RTP5
11241,GO:0043393,0.379996747546066,0.854979063621992,2,196,regulation of protein binding,BP,CRTAC1;ANXA2
7280,GO:0030276,0.380584364172503,0.917840610615776,1,69,clathrin binding,MF,SNAP91
3318,GO:0006641,0.38288436083022,0.916672372954243,1,75,triglyceride metabolic process,BP,FABP5
16218,GO:0071260,0.383338067351362,0.916444513400622,1,76,cellular response to mechanical stimulus,BP,COL1A1
2288,GO:0004871,0.384115296140472,0.742614616511938,9,1194,signal transducer activity,MF,GNAL;GPR17;JPH3;GABRB3;KSR2;GRIN1;HLA-DQB1;HLA-DQA1;GABBR1
2517,GO:0005254,0.384363485588533,0.9159955996279,1,73,chloride channel activity,MF,GABRB3
1622,GO:0003727,0.385185417228331,0.915552033522973,1,77,single-stranded RNA binding,MF,ANXA1
6463,GO:0019209,0.38530384226913,0.91552047822695,1,75,kinase activator activity,MF,LTF
13197,GO:0048705,0.38569189055688,0.851255596856372,2,194,skeletal system morphogenesis,BP,LTF;COL1A1
19036,GO:1901699,0.38570418541331,0.777289334213361,5,589,cellular response to nitrogen compound,BP,COL1A1;GABRB3;COL3A1;SOCS3;COL4A1
6579,GO:0019538,0.385963278866826,0.691772380903046,35,5080,protein metabolic process,BP,LTF;VIM;CP;APOL4;TIMP1;SERPINE1;AEBP1;CCL2;LOX;IGFBP2;GBP1;SPP1;PLAU;GDF15;CHI3L1;ANXA1;MDGA2;GALNT13;ADAM12;SERPING1;C1R;PTX3;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;CFI
12103,GO:0045637,0.387238061884818,0.85020651297592,2,201,regulation of myeloid cell differentiation,BP,LTF;LGALS3
12667,GO:0046849,0.388012709916061,0.914246443878979,1,73,bone remodeling,BP,SPP1
13442,GO:0050714,0.388060151043948,0.849632318983801,2,209,positive regulation of protein secretion,BP,FERMT1;POSTN
2841,GO:0005905,0.388805331576844,0.91397073594084,1,66,clathrin-coated pit,CC,SNAP91
17852,GO:0097581,0.389327119244078,0.913639660352388,1,71,lamellipodium organization,BP,PDPN
10548,GO:0042058,0.389722898351192,0.913366666389593,1,77,regulation of epidermal growth factor receptor signaling pathway,BP,SH3GL2
556,GO:0001654,0.390847724201721,0.812291309360535,3,319,eye development,BP,VIM;COL4A1;SMOC1
12027,GO:0045445,0.391126706295549,0.912696547247671,1,76,myoblast differentiation,BP,CXCL10
17114,GO:0086001,0.391434912930535,0.912748930496944,1,63,cardiac muscle cell action potential,BP,KCNIP2
10955,GO:0042886,0.394969293187843,0.715086066995558,13,1809,amide transport,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;SNAP25;CHI3L1;POSTN;ANXA1;KCNB1;RIMS2;RTP5
3458,GO:0006855,0.395034605136185,0.910806033020775,1,74,drug transmembrane transport,BP,ABCC3
8511,GO:0032580,0.396193016919587,0.910180039600293,1,78,Golgi cisterna membrane,CC,FUT9
12258,GO:0045921,0.39640064376759,0.910102847818167,1,76,positive regulation of exocytosis,BP,KCNB1
9023,GO:0033559,0.397150630834813,0.909612894973818,1,86,unsaturated fatty acid metabolic process,BP,ANXA1
11256,GO:0043410,0.397378961978813,0.78420513758792,4,484,positive regulation of MAPK cascade,BP,CCL2;CHI3L1;KSR2;PLA2G2A
6470,GO:0019217,0.397456854928327,0.909619523548815,1,73,regulation of fatty acid metabolic process,BP,ANXA1
3358,GO:0006690,0.397478913703217,0.909449352287455,1,86,icosanoid metabolic process,BP,ANXA1
5412,GO:0015297,0.398198320298161,0.909208369624838,1,76,antiporter activity,MF,SLC8A2
3310,GO:0006629,0.398460666499284,0.730186718244137,9,1245,lipid metabolic process,BP,APOL4;PLEKHA4;SPP1;ANXA1;ADM;FABP5;ST8SIA3;PLA2G2A;SERPINA3
5620,GO:0015918,0.399265278124287,0.908702555150127,1,74,sterol transport,BP,ANXA2
12504,GO:0046488,0.399661324722375,0.841878014885178,2,201,phosphatidylinositol metabolic process,BP,PLEKHA4;PLA2G2A
12938,GO:0048145,0.399848587892691,0.908382565478643,1,76,regulation of fibroblast proliferation,BP,ANXA2
2302,GO:0004896,0.400008629594577,0.908227303248894,1,82,cytokine receptor activity,MF,GPR17
2839,GO:0005902,0.400584226037105,0.908040766578004,1,74,microvillus,CC,PDPN
7153,GO:0030099,0.400930501416765,0.804695375471238,3,346,myeloid cell differentiation,BP,LTF;LGALS3;ANXA2
2770,GO:0005791,0.401227352683506,0.907602298183664,1,83,rough endoplasmic reticulum,CC,LTF
1083,GO:0002474,0.401331298861604,0.907496244029491,1,88,antigen processing and presentation of peptide antigen via MHC class I,BP,IFI30
16990,GO:0072593,0.401398063184877,0.840639369273145,2,216,reactive oxygen species metabolic process,BP,PTX3;GRIN1
6846,GO:0021675,0.40147336819109,0.907637795611575,1,71,nerve development,BP,GABRB3
3208,GO:0006508,0.4021594476497,0.716532676547821,11,1529,proteolysis,BP,LTF;TIMP1;SERPINE1;AEBP1;PLAU;ADAM12;SERPING1;C1R;GRIN1;SERPINA3;CFI
14002,GO:0051640,0.402362152788215,0.763706352278608,5,614,organelle localization,BP,SNAP25;CPLX2;KCNB1;ATCAY;RIMS2
12937,GO:0048144,0.403811597246098,0.906367554924926,1,77,fibroblast proliferation,BP,ANXA2
634,GO:0001776,0.404010839417954,0.906227581025947,1,80,leukocyte homeostasis,BP,ANXA1
3344,GO:0006672,0.405321451858435,0.905511659500793,1,84,ceramide metabolic process,BP,ST8SIA3
8290,GO:0032270,0.405889200378139,0.718064753963443,10,1366,positive regulation of cellular protein metabolic process,BP,LTF;VIM;CCL2;GDF15;CHI3L1;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
19910,GO:1903779,0.406619545821369,0.905054549996333,1,69,regulation of cardiac conduction,BP,SLC8A2
11844,GO:0045069,0.406634495458443,0.904874290058209,1,81,regulation of viral genome replication,BP,LTF
17243,GO:0090092,0.406634629745165,0.837098004818956,2,203,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,FERMT1;GDF15
1615,GO:0003714,0.407000573049094,0.836818161997484,2,210,transcription corepressor activity,MF,AEBP1;KCNIP3
15271,GO:0061333,0.407032903913612,0.90479392538262,1,72,renal tubule morphogenesis,BP,COL4A1
19312,GO:1902476,0.407529373827444,0.904466026032035,1,77,chloride transmembrane transport,BP,GABRB3
13773,GO:0051219,0.407746423721451,0.904396847512273,1,74,phosphoprotein binding,MF,SOCS3
2752,GO:0005770,0.407858465561337,0.836192873869116,2,219,late endosome,CC,STEAP3;ANXA2
517,GO:0001570,0.407994088229659,0.904284296314017,1,73,vasculogenesis,BP,ADM
13576,GO:0050906,0.409225519381964,0.903469403136635,1,87,detection of stimulus involved in sensory perception,BP,RTP5
3811,GO:0007589,0.409687305632541,0.903338158666431,1,78,body fluid secretion,BP,ANXA2
15725,GO:0070301,0.410488749218028,0.902871092464478,1,82,cellular response to hydrogen peroxide,BP,ANXA1
14445,GO:0055086,0.410829406404795,0.756653943375439,5,674,nucleobase-containing small molecule metabolic process,BP,TYMP;ADM;NNMT;CXCL10;GABBR1
7813,GO:0031330,0.410833710299994,0.834170550385698,2,208,negative regulation of cellular catabolic process,BP,TIMP1;ANXA2
4047,GO:0008344,0.411041132356565,0.902662708071341,1,76,adult locomotory behavior,BP,GRIN1
3933,GO:0008170,0.411143768830428,0.90254259683265,1,81,N-methyltransferase activity,MF,NNMT
2774,GO:0005796,0.411319730084485,0.902503621737527,1,77,Golgi lumen,CC,FMOD
8486,GO:0032535,0.41216378644434,0.796164978529087,3,335,regulation of cellular component size,BP,TNFRSF12A;TNR;SPP1
18789,GO:1901019,0.412751391866043,0.901756126444656,1,77,regulation of calcium ion transmembrane transporter activity,BP,JPH3
5912,GO:0016528,0.41360763111383,0.901450264986345,1,68,sarcoplasm,CC,JPH3
11293,GO:0043491,0.413903606505331,0.832032607952527,2,207,protein kinase B signaling,BP,CCL2;CHI3L1
3841,GO:0007631,0.413916731484625,0.901043461936395,1,85,feeding behavior,BP,GRIN1
8374,GO:0032392,0.414817435632328,0.900630634057227,1,80,DNA geometric change,BP,ANXA1
12184,GO:0045778,0.415178413961414,0.900467110001272,1,78,positive regulation of ossification,BP,LTF
19570,GO:1903076,0.415187795495912,0.900435338806153,1,80,regulation of protein localization to plasma membrane,BP,GBP1
12580,GO:0046632,0.415517478834011,0.90022343447872,1,83,alpha-beta T cell differentiation,BP,ANXA1
4470,GO:0009266,0.415728253814425,0.830718393062837,2,216,response to temperature stimulus,BP,ADM;CXCL10
11863,GO:0045088,0.416005208577973,0.793146966347711,3,364,regulation of innate immune response,BP,LTF;SERPING1;SOCS3
13065,GO:0048471,0.416897821285944,0.751622986935266,5,630,perinuclear region of cytoplasm,CC,SPP1;SNAP25;CHI3L1;ANXA2;PLA2G2A
2104,GO:0004620,0.417095254779485,0.899375583065135,1,84,phospholipase activity,MF,PLA2G2A
12263,GO:0045926,0.417247397885461,0.829638238452722,2,219,negative regulation of growth,BP,TNR;SPP1
7586,GO:0030901,0.417905305501327,0.898956967284711,1,83,midbrain development,BP,INA
1032,GO:0002377,0.418872384004858,0.898405517261944,1,86,immunoglobulin production,BP,HLA-DQB1
6234,GO:0017144,0.420043510266035,0.748934677216904,5,690,drug metabolic process,BP,CHI3L2;MOXD1;CHI3L1;ADM;PTX3
3773,GO:0007492,0.420386179602746,0.897726014921119,1,76,endoderm development,BP,COL4A2
13991,GO:0051606,0.420534801698196,0.827295086424039,2,224,detection of stimulus,BP,KCNIP2;RTP5
21234,GO:2000116,0.421393788731976,0.826674492817358,2,227,regulation of cysteine-type endopeptidase activity,BP,LTF;GRIN1
9842,GO:0035591,0.42260485542649,0.896475166560745,1,80,signaling adaptor activity,MF,SHD
3892,GO:0008094,0.424029995465676,0.895731424628136,1,78,DNA-dependent ATPase activity,MF,ANXA1
1276,GO:0002793,0.424180180366836,0.824687420972131,2,227,positive regulation of peptide secretion,BP,FERMT1;POSTN
3428,GO:0006805,0.425240589193132,0.894892113640092,1,93,xenobiotic metabolic process,BP,GRIN1
6462,GO:0019208,0.426056504217171,0.894547790794271,1,84,phosphatase regulator activity,MF,ELFN2
19169,GO:1902105,0.426089368505425,0.823329834387636,2,224,regulation of leukocyte differentiation,BP,LTF;ANXA1
11575,GO:0044297,0.42641280190829,0.76075379445065,4,490,cell body,CC,SLC8A2;CPLX2;KCNB1;SHANK2
2280,GO:0004860,0.427790247269179,0.893538537149107,1,89,protein kinase inhibitor activity,MF,SOCS3
6387,GO:0018958,0.427966591051732,0.893500910725631,1,84,phenol-containing compound metabolic process,BP,MOXD1
12432,GO:0046332,0.428151538520257,0.893542117427441,1,74,SMAD binding,MF,COL3A1
3766,GO:0007423,0.428398151656592,0.759128339875525,4,480,sensory organ development,BP,VIM;GABRB3;COL4A1;SMOC1
19011,GO:1901655,0.429017241249576,0.892935166969437,1,83,cellular response to ketone,BP,SPP1
11917,GO:0045184,0.429296712442264,0.684057636412818,13,1847,establishment of protein localization,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;SNAP25;CHI3L1;POSTN;ANXA1;KCNB1;RIMS2;RTP5
759,GO:0001942,0.430806496562428,0.891972363418856,1,81,hair follicle development,BP,FERMT1
6481,GO:0019233,0.431178307974811,0.891726384111542,1,84,sensory perception of pain,BP,GRIN1
2516,GO:0005253,0.433755260765179,0.890264382769824,1,86,anion channel activity,MF,GABRB3
18042,GO:0098773,0.434272640016485,0.890026233424128,1,82,skin epidermis development,BP,FERMT1
3665,GO:0007200,0.43441508657562,0.889774160550919,1,97,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,GPR17
12897,GO:0048013,0.435326292126277,0.889370319876927,1,87,ephrin receptor signaling pathway,BP,GRIN1
5319,GO:0015108,0.435359341411083,0.889389370070595,1,84,chloride transmembrane transporter activity,MF,GABRB3
3447,GO:0006835,0.436119167972603,0.888974574427363,1,83,dicarboxylic acid transport,BP,SNAP25
14772,GO:0060415,0.436281275906297,0.889035195572292,1,73,muscle tissue morphogenesis,BP,COL3A1
12494,GO:0046474,0.436747040188766,0.815598095327461,2,223,glycerophospholipid biosynthetic process,BP,PLEKHA4;PLA2G2A
7027,GO:0022404,0.438844287628553,0.887431374608923,1,83,molting cycle process,BP,FERMT1
7028,GO:0022405,0.438844287628553,0.887431374608923,1,83,hair cycle process,BP,FERMT1
7187,GO:0030148,0.438894099642655,0.887293258444788,1,92,sphingolipid biosynthetic process,BP,ST8SIA3
3317,GO:0006639,0.441744244927283,0.885698151669702,1,89,acylglycerol metabolic process,BP,FABP5
3894,GO:0008104,0.443543942298734,0.65931644768353,17,2423,protein localization,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;SNAP25;CHI3L1;POSTN;ANXA1;KCNB1;ATCAY;RIMS2;GRIN1;ANXA2;SHISA7;RTP5
6464,GO:0019210,0.444314045626513,0.884170728686985,1,93,kinase inhibitor activity,MF,SOCS3
2840,GO:0005903,0.444785628143016,0.884035379684362,1,82,brush border,CC,SHANK2
11393,GO:0043648,0.444910391315631,0.883772728584841,1,98,dicarboxylic acid metabolic process,BP,ATCAY
3316,GO:0006638,0.445082596509563,0.883759558578632,1,90,neutral lipid metabolic process,BP,FABP5
3980,GO:0008238,0.445857380390076,0.883253391882134,1,95,exopeptidase activity,MF,AEBP1
20187,GO:1904375,0.446120062722672,0.883180980949474,1,88,regulation of protein localization to cell periphery,BP,GBP1
8371,GO:0032388,0.446277111323728,0.808534569416485,2,224,positive regulation of intracellular transport,BP,KCNB1;ANXA2
4379,GO:0009152,0.446304760556173,0.808470943495079,2,236,purine ribonucleotide biosynthetic process,BP,ADM;GABBR1
7468,GO:0030672,0.446423029967659,0.882968545973316,1,91,synaptic vesicle membrane,CC,SVOP
18240,GO:0099501,0.446423029967659,0.882968545973316,1,91,exocytic vesicle membrane,CC,SVOP
5387,GO:0015238,0.447007199602859,0.88260510357047,1,93,drug transmembrane transporter activity,MF,ABCC3
4621,GO:0009887,0.44702020802449,0.702302219619681,7,913,animal organ morphogenesis,BP,LTF;SERPINE1;CCL2;COL1A1;ADM;SHANK2;COL3A1
18974,GO:1901575,0.447028321633591,0.667697092831286,13,1894,organic substance catabolic process,BP,TYMP;VIM;CHI3L2;MOXD1;TIMP1;SPP1;FMOD;CHI3L1;FABP5;ATCAY;FUT9;ANXA2;PLA2G2A
8197,GO:0032091,0.447244577205624,0.882489307483445,1,91,negative regulation of protein binding,BP,CRTAC1
2750,GO:0005768,0.447865725738364,0.711902983702555,6,813,endosome,CC,SH3GL2;STEAP3;ANXA1;HLA-DQB1;ANXA2;HLA-DQA1
8198,GO:0032092,0.44811995498381,0.882066127308088,1,84,positive regulation of protein binding,BP,ANXA2
8756,GO:0032947,0.449482804928913,0.881324904307736,1,80,protein-containing complex scaffold activity,MF,SHANK2
8369,GO:0032386,0.449895117277098,0.766186214967849,3,371,regulation of intracellular transport,BP,KCNB1;RIMS2;ANXA2
18837,GO:1901184,0.449952168802837,0.880913221889319,1,90,regulation of ERBB signaling pathway,BP,SH3GL2
9815,GO:0035556,0.450173791255872,0.650860140236769,18,2556,intracellular signal transduction,BP,LTF;CCL2;GBP1;GDF15;CHI3L1;GNAL;GPR17;ADM;SPHKAP;JPH3;PDPN;COL3A1;CXCL10;KSR2;RIMS2;GRIN1;SOCS3;PLA2G2A
10352,GO:0038023,0.450479036694343,0.709575641330361,6,829,signaling receptor activity,MF,GPR17;GABRB3;GRIN1;HLA-DQB1;HLA-DQA1;GABBR1
14549,GO:0060089,0.450479036694343,0.709575641330361,6,829,molecular transducer activity,MF,GPR17;GABRB3;GRIN1;HLA-DQB1;HLA-DQA1;GABBR1
19483,GO:1902936,0.450656114954542,0.880498228159952,1,90,phosphatidylinositol bisphosphate binding,MF,ANXA2
20033,GO:1904019,0.451235944199756,0.880193379178149,1,87,epithelial cell apoptotic process,BP,SERPINE1
21235,GO:2000117,0.451289264868796,0.880066744637425,1,95,negative regulation of cysteine-type endopeptidase activity,BP,LTF
3786,GO:0007517,0.451421859602449,0.764985987326176,3,347,muscle organ development,BP,AEBP1;COL3A1;CXCL10
3847,GO:0008013,0.452044742103374,0.879829551059527,1,79,beta-catenin binding,MF,PTPRT
19868,GO:1903706,0.452821231097737,0.763758979029293,3,388,regulation of hemopoiesis,BP,LTF;LGALS3;ANXA1
2991,GO:0006164,0.45381447694025,0.802796929798152,2,240,purine nucleotide biosynthetic process,BP,ADM;GABBR1
2635,GO:0005575,0.454378995212203,0.782452222180168,98,15065,cellular_component,CC,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;MOXD1;CRTAC1;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;EMILIN2;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;CA10;AFF2;KCNB1;C1R;SHANK2;PDPN;S100A11;PTX3;FABP5;CSMD3;SVOP;GABRB3;NNMT;ELFN2;ATCAY;COL3A1;CXCL10;PCDH7;VSTM2A;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;TMEM151B;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;SMOC1;FAM155A;GABBR1;CFI;C21ORF62;DOK6;IFI30
1608,GO:0003697,0.45450890615875,0.87814186439594,1,96,single-stranded DNA binding,MF,ANXA1
4195,GO:0008593,0.455284088948773,0.877747600539102,1,90,regulation of Notch signaling pathway,BP,POSTN
14490,GO:0060021,0.456392928120232,0.877176906660132,1,83,roof of mouth development,BP,GABRB3
5679,GO:0016050,0.456489216351761,0.760770279778938,3,371,vesicle organization,BP,SNAP25;ANXA1;ANXA2
13153,GO:0048644,0.457768723720339,0.876411110976698,1,79,muscle organ morphogenesis,BP,COL3A1
19935,GO:1903828,0.458232341645867,0.875915828257016,1,95,negative regulation of cellular protein localization,BP,GBP1
13775,GO:0051222,0.458770743265388,0.758858929205402,3,384,positive regulation of protein transport,BP,FERMT1;POSTN;KCNB1
821,GO:0002027,0.459111928792162,0.875495581410934,1,86,regulation of heart rate,BP,ADM
7285,GO:0030282,0.459930679631861,0.874910152743692,1,93,bone mineralization,BP,LTF
691,GO:0001843,0.460184927130428,0.874858976100068,1,85,neural tube closure,BP,ADM
14825,GO:0060485,0.461584211792988,0.796878895810906,2,232,mesenchyme development,BP,COL1A1;PDPN
7831,GO:0031349,0.462458745408848,0.755771005894416,3,397,positive regulation of defense response,BP,LTF;SERPINE1;PLA2G2A
14907,GO:0060606,0.462989189260373,0.873134774735058,1,86,tube closure,BP,ADM
13978,GO:0051591,0.46458188594051,0.872090581273985,1,91,response to cAMP,BP,COL1A1
1376,GO:0003014,0.465326631184758,0.871571902364177,1,96,renal system process,BP,ADM
730,GO:0001906,0.466025108023921,0.871019364625836,1,108,cell killing,BP,LTF
15270,GO:0061326,0.466725699995686,0.870819387955435,1,87,renal tubule development,BP,COL4A1
3490,GO:0006900,0.467005512340335,0.870568162522833,1,93,vesicle budding from membrane,BP,ANXA2
12264,GO:0045927,0.468538488458304,0.791510069733336,2,224,positive regulation of growth,BP,TNFRSF12A;RIMS2
10753,GO:0042470,0.469246960434029,0.869082979669,1,101,melanosome,CC,ANXA2
13232,GO:0048770,0.469246960434029,0.869082979669,1,101,pigment granule,CC,ANXA2
7034,GO:0022411,0.470139459751917,0.723565231360509,4,530,cellular component disassembly,BP,TIMP1;SH3GL2;SPP1;PDPN
4464,GO:0009260,0.471921292212677,0.788765621484472,2,249,ribonucleotide biosynthetic process,BP,ADM;GABBR1
1872,GO:0004222,0.47216865412341,0.867316420391367,1,95,metalloendopeptidase activity,MF,ADAM12
3423,GO:0006793,0.472385417632804,0.625822078151141,20,2947,phosphorus metabolic process,BP,LTF;SRPX2;PLEKHA4;CCL2;GBP1;GDF15;CHI3L1;SPOCD1;ADM;NNMT;ELFN2;ATCAY;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;PTPRT;GABBR1
12028,GO:0045446,0.472518252031262,0.867158804513895,1,90,endothelial cell differentiation,BP,PDPN
17999,GO:0098661,0.473168682152556,0.866709780678189,1,93,inorganic anion transmembrane transport,BP,GABRB3
16939,GO:0072522,0.475210919754954,0.786161121734352,2,251,purine-containing compound biosynthetic process,BP,ADM;GABBR1
6751,GO:0021510,0.476292412545061,0.86472693326555,1,93,spinal cord development,BP,MDGA2
3804,GO:0007569,0.476533937348033,0.864536207120411,1,96,cell aging,BP,SERPINE1
8136,GO:0031985,0.477179157188964,0.864089442332407,1,99,Golgi cisterna,CC,FUT9
7849,GO:0031399,0.477220023118797,0.647781263997445,11,1579,regulation of protein modification process,BP,LTF;CCL2;GBP1;GDF15;CHI3L1;ELFN2;CXCL10;KSR2;ANXA2;SOCS3;PLA2G2A
12457,GO:0046390,0.477357673823318,0.784453413054261,2,252,ribose phosphate biosynthetic process,BP,ADM;GABBR1
1256,GO:0002761,0.477667493788931,0.86379964371102,1,97,regulation of myeloid leukocyte differentiation,BP,LTF
8697,GO:0032868,0.47820763362987,0.7838248896816,2,238,response to insulin,BP,ADM;SOCS3
11179,GO:0043279,0.479539598152932,0.862609026772778,1,96,response to alkaloid,BP,GRIN1
3440,GO:0006821,0.480019857778326,0.862287623948403,1,97,chloride transport,BP,GABRB3
6898,GO:0021782,0.481019585587527,0.861704040210722,1,92,glial cell development,BP,VIM
7022,GO:0022037,0.481204780624392,0.861571260078995,1,93,metencephalon development,BP,GRIN1
850,GO:0002065,0.481457051843156,0.861335489194681,1,99,columnar/cuboidal epithelial cell differentiation,BP,SERPINE1
9704,GO:0035335,0.482739198068824,0.860576116280503,1,93,peptidyl-tyrosine dephosphorylation,BP,PTPRT
11813,GO:0045017,0.484256012268864,0.778948088763643,2,246,glycerolipid biosynthetic process,BP,PLEKHA4;PLA2G2A
5135,GO:0014020,0.484575110719855,0.859392659257271,1,92,primary neural tube formation,BP,ADM
2180,GO:0004725,0.485648599658521,0.858663875370697,1,94,protein tyrosine phosphatase activity,MF,PTPRT
13792,GO:0051247,0.486118819815629,0.644549923211134,10,1455,positive regulation of protein metabolic process,BP,LTF;VIM;CCL2;GDF15;CHI3L1;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
12502,GO:0046486,0.488344061793923,0.733749929015951,3,397,glycerolipid metabolic process,BP,PLEKHA4;FABP5;PLA2G2A
11801,GO:0044877,0.488471739315988,0.675128187127378,6,810,protein-containing complex binding,MF,LTF;VIM;LGALS3;GNAL;COL3A1;GRIN1
1283,GO:0002822,0.488891738320974,0.856359687925024,1,109,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ANXA1
12630,GO:0046718,0.490461726070288,0.855357251356011,1,105,viral entry into host cell,BP,PTX3
12579,GO:0046631,0.490752631394379,0.855153212804937,1,106,alpha-beta T cell activation,BP,ANXA1
4166,GO:0008528,0.49096766354179,0.854907625844038,1,117,G-protein coupled peptide receptor activity,MF,GPR17
5803,GO:0016298,0.491458804136693,0.854682335983035,1,106,lipase activity,MF,PLA2G2A
1695,GO:0003924,0.491765615147683,0.772765073813745,2,272,GTPase activity,MF,GBP1;GNAL
10665,GO:0042303,0.49212190198014,0.854328555695705,1,98,molting cycle,BP,FERMT1
10844,GO:0042633,0.49212190198014,0.854328555695705,1,98,hair cycle,BP,FERMT1
8578,GO:0032680,0.492348577133076,0.854077420790114,1,107,regulation of tumor necrosis factor production,BP,LTF
4629,GO:0009895,0.494071277433885,0.770968537455953,2,243,negative regulation of catabolic process,BP,TIMP1;ANXA2
555,GO:0001653,0.494125115156163,0.852783627199601,1,118,peptide receptor activity,MF,GPR17
11402,GO:0043666,0.494451954306862,0.852730280473857,1,101,regulation of phosphoprotein phosphatase activity,BP,ELFN2
7927,GO:0031532,0.494462716528811,0.852734616081181,1,100,actin cytoskeleton reorganization,BP,ANXA1
7210,GO:0030175,0.496934880357669,0.851181331560326,1,91,filopodium,CC,PDPN
8091,GO:0031902,0.497180349006613,0.85075294428293,1,114,late endosome membrane,CC,ANXA2
11438,GO:0043933,0.497615246501567,0.619799222317677,13,1936,protein-containing complex subunit organization,BP,SNAP91;SH3GL2;COL1A1;LOX;GBP1;FMOD;SNAP25;COL6A2;KCNB1;COL3A1;GRIN1;ANXA2;PLA2G2A
4346,GO:0009116,0.499489994967003,0.849188588404633,1,113,nucleoside metabolic process,BP,TYMP
19794,GO:1903555,0.500903651639312,0.848249178096957,1,110,regulation of tumor necrosis factor superfamily cytokine production,BP,LTF
12691,GO:0046887,0.501261471471507,0.847984011202332,1,112,positive regulation of hormone secretion,BP,SPP1
8551,GO:0032640,0.501271928841548,0.847996302811614,1,110,tumor necrosis factor production,BP,LTF
3199,GO:0006493,0.501969292103977,0.847614190334815,1,101,protein O-linked glycosylation,BP,GALNT13
3957,GO:0008202,0.502117999784707,0.764235242788365,2,263,steroid metabolic process,BP,SPP1;ADM
1292,GO:0002831,0.503591349489013,0.846407560120092,1,109,regulation of response to biotic stimulus,BP,LTF
11043,GO:0043065,0.504052879750899,0.693171139047851,4,563,positive regulation of apoptotic process,BP,TNFRSF12A;ANXA1;ADM;GRIN1
12466,GO:0046425,0.504231204664397,0.845954502653538,1,110,regulation of JAK-STAT cascade,BP,SOCS3
10376,GO:0038061,0.504446858390964,0.84573899175272,1,117,NIK/NF-kappaB signaling,BP,CHI3L1
4550,GO:0009615,0.504863098535052,0.761924913003021,2,267,response to virus,BP,GBP1;CXCL10
6052,GO:0016787,0.504958582745987,0.605994079484678,15,2236,hydrolase activity,MF,LTF;CHI3L2;AEBP1;ABCC3;GBP1;PLAU;CHI3L1;ANXA1;GNAL;ADAM12;C1R;ATCAY;PLA2G2A;PTPRT;CFI
13806,GO:0051261,0.505022096927195,0.845567216263947,1,96,protein depolymerization,BP,SH3GL2
4347,GO:0009117,0.50520303163862,0.692087884868494,4,591,nucleotide metabolic process,BP,ADM;NNMT;CXCL10;GABBR1
20455,GO:1904892,0.506878487488273,0.844103052994763,1,111,regulation of STAT cascade,BP,SOCS3
2911,GO:0006024,0.507310168459421,0.843887312048087,1,103,glycosaminoglycan biosynthetic process,BP,FMOD
7671,GO:0031072,0.507401112464446,0.843747888947507,1,110,heat shock protein binding,MF,GBP1
12824,GO:0047485,0.507665188880829,0.8436053084823,1,106,protein N-terminus binding,MF,KCNIP2
4962,GO:0010811,0.507794632147608,0.843572157346514,1,101,positive regulation of cell-substrate adhesion,BP,FERMT1
9685,GO:0035296,0.508360337931281,0.843046434637097,1,113,regulation of tube diameter,BP,ADM
17914,GO:0097746,0.508360337931281,0.843046434637097,1,113,regulation of blood vessel diameter,BP,ADM
11016,GO:0043021,0.508559278272533,0.842946905895365,1,109,ribonucleoprotein complex binding,MF,LTF
6166,GO:0017015,0.508631313180068,0.843023396104584,1,98,regulation of transforming growth factor beta receptor signaling pathway,BP,FERMT1
12155,GO:0045727,0.509861336322605,0.842001210894423,1,112,positive regulation of translation,BP,VIM
4627,GO:0009893,0.510632357702543,0.588728383233396,20,2964,positive regulation of metabolic process,BP,LTF;VIM;SERPINE1;CCL2;COL1A1;CUX2;SPP1;GDF15;CHI3L1;ANXA1;ADM;PTX3;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;PLA2G2A
20716,GO:1905477,0.511011817516977,0.84120971263341,1,110,positive regulation of protein localization to membrane,BP,KCNB1
20483,GO:1904951,0.511133283763169,0.713577135411249,3,419,positive regulation of establishment of protein localization,BP,FERMT1;POSTN;KCNB1
10838,GO:0042626,0.511373752546178,0.841105661711796,1,97,ATPase activity, coupled to transmembrane movement of substances,MF,ABCC3
12060,GO:0045580,0.512015384070685,0.840479274962379,1,112,regulation of T cell differentiation,BP,ANXA1
19780,GO:1903533,0.512062979836865,0.840425977621774,1,114,regulation of protein targeting,BP,KCNB1
16516,GO:0071706,0.512590006592401,0.840052081092724,1,114,tumor necrosis factor superfamily cytokine production,BP,LTF
11046,GO:0043068,0.513302903758769,0.68464396406754,4,569,positive regulation of programmed cell death,BP,TNFRSF12A;ANXA1;ADM;GRIN1
3400,GO:0006753,0.513390928714593,0.684532118865484,4,598,nucleoside phosphate metabolic process,BP,ADM;NNMT;CXCL10;GABBR1
19941,GO:1903844,0.513957725705469,0.839233590570194,1,100,regulation of cellular response to transforming growth factor beta stimulus,BP,FERMT1
16705,GO:0072089,0.515531007139099,0.838061876225345,1,104,stem cell proliferation,BP,FERMT1
689,GO:0001841,0.515774638488055,0.837936181643795,1,100,neural tube formation,BP,ADM
3336,GO:0006664,0.515890197855729,0.837660210245237,1,118,glycolipid metabolic process,BP,ST8SIA3
19761,GO:1903509,0.515890197855729,0.837660210245237,1,118,liposaccharide metabolic process,BP,ST8SIA3
4226,GO:0008654,0.516429238145304,0.752122611316215,2,263,phospholipid biosynthetic process,BP,PLEKHA4;PLA2G2A
19762,GO:1903510,0.518451616032008,0.835906678075793,1,109,mucopolysaccharide metabolic process,BP,FMOD
12211,GO:0045834,0.518517151804873,0.835838229882086,1,111,positive regulation of lipid metabolic process,BP,ANXA1
12547,GO:0046578,0.518539075258128,0.750416713060883,2,234,regulation of Ras protein signal transduction,BP,GPR17;COL3A1
2910,GO:0006023,0.518627557028967,0.83580158503727,1,107,aminoglycan biosynthetic process,BP,FMOD
16261,GO:0071333,0.518842886031508,0.835613410885637,1,110,cellular response to glucose stimulus,BP,KCNB1
3424,GO:0006796,0.519313334390904,0.582105668541578,19,2861,phosphate-containing compound metabolic process,BP,LTF;SRPX2;PLEKHA4;CCL2;GBP1;GDF15;CHI3L1;SPOCD1;ADM;NNMT;ELFN2;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;PTPRT;GABBR1
12073,GO:0045598,0.51936618301699,0.835224447020313,1,111,regulation of fat cell differentiation,BP,VSTM2A
1368,GO:0003006,0.520283970614118,0.678155388503595,4,559,developmental process involved in reproduction,BP,SPP1;ANXA1;ADM;SOCS3
1280,GO:0002819,0.521308829045393,0.833727192378089,1,120,regulation of adaptive immune response,BP,ANXA1
21295,GO:2000241,0.521518318547775,0.833621430139771,1,115,regulation of reproductive process,BP,TIMP1
13083,GO:0048511,0.522398400785099,0.746988856802987,2,258,rhythmic process,BP,SERPINE1;ANXA1
3053,GO:0006275,0.523079984410178,0.832554618568538,1,108,regulation of DNA replication,BP,S100A11
3951,GO:0008194,0.523514278706907,0.832134629619323,1,118,UDP-glycosyltransferase activity,MF,GALNT13
14309,GO:0052689,0.523647240830995,0.832009835134272,1,121,carboxylic ester hydrolase activity,MF,PLA2G2A
16259,GO:0071331,0.524201804751365,0.831689645388403,1,112,cellular response to hexose stimulus,BP,KCNB1
12032,GO:0045471,0.525972005801099,0.83034678745684,1,116,response to ethanol,BP,GRIN1
16257,GO:0071326,0.527146856762749,0.829508769870413,1,113,cellular response to monosaccharide stimulus,BP,KCNB1
5447,GO:0015399,0.527187769160168,0.829591831784618,1,103,primary active transmembrane transporter activity,MF,ABCC3
5448,GO:0015405,0.527187769160168,0.829591831784618,1,103,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCC3
19171,GO:1902107,0.527682202325836,0.829062713113371,1,118,positive regulation of leukocyte differentiation,BP,ANXA1
3312,GO:0006633,0.528096905274289,0.828736379967055,1,120,fatty acid biosynthetic process,BP,ANXA1
1111,GO:0002521,0.529005284353203,0.697277207162228,3,424,leukocyte differentiation,BP,LTF;ANXA1;ANXA2
13557,GO:0050880,0.530001862259979,0.827309219100637,1,121,regulation of blood vessel size,BP,ADM
11286,GO:0043484,0.530207020091433,0.827244559233653,1,112,regulation of RNA splicing,BP,AFF2
2758,GO:0005777,0.532092001124652,0.825735387422082,1,122,peroxisome,CC,VIM
10809,GO:0042579,0.532092001124652,0.825735387422082,1,122,microbody,CC,VIM
9626,GO:0035150,0.532480705904196,0.825443354540673,1,122,regulation of tube size,BP,ADM
4558,GO:0009636,0.533077174842596,0.6934731067489,3,442,response to toxic substance,BP,COL1A1;ANXA1;GRIN1
3758,GO:0007411,0.534716392479,0.736259668774697,2,236,axon guidance,BP,TNR;DOK6
5811,GO:0016311,0.536563486460602,0.690270189970144,3,414,dephosphorylation,BP,SPOCD1;ELFN2;PTPRT
2598,GO:0005488,0.53704840262042,0.568699603893272,83,12745,binding,MF,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;MOXD1;CRTAC1;APOL4;TIMP1;SRPX2;SHD;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;GDF15;LGALS3;EMILIN2;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;EMP3;GALNT13;CPLX2;CDHR1;ADAM12;ADM;SERPING1;SPHKAP;AFF2;KCNB1;C1R;SHANK2;PDPN;S100A11;PTX3;FABP5;GABRB3;ATCAY;COL3A1;CXCL10;PCDH7;VSTM2A;KSR2;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;SMOC1;GABBR1;CFI;DOK6;IFI30
588,GO:0001704,0.538064661961039,0.821334995758914,1,110,formation of primary germ layer,BP,COL4A2
2842,GO:0005911,0.53852993574705,0.688451803268085,3,402,cell-cell junction,CC,ANXA1;S100A11;ANXA2
17806,GO:0097485,0.538660679112235,0.732735121623098,2,238,neuron projection guidance,BP,TNR;DOK6
7555,GO:0030863,0.540722446267761,0.819410856673302,1,101,cortical cytoskeleton,CC,RIMS2
13198,GO:0048706,0.542001307576932,0.818258703134497,1,115,embryonic skeletal system development,BP,COL1A1
2768,GO:0005789,0.542736858480048,0.623304682988439,6,932,endoplasmic reticulum membrane,CC,LTF;MOXD1;JPH3;HLA-DQB1;PLA2G2A;HLA-DQA1
2480,GO:0005178,0.543435430453641,0.817181882692464,1,112,integrin binding,MF,COL3A1
7744,GO:0031225,0.543493473396748,0.816998451954757,1,126,anchored component of membrane,CC,MDGA2
9673,GO:0035270,0.544263422314491,0.816465966627054,1,119,endocrine system development,BP,ANXA1
18970,GO:1901568,0.544568995353096,0.816112534534552,1,132,fatty acid derivative metabolic process,BP,ANXA1
7270,GO:0030260,0.545166775565872,0.81574364745525,1,121,entry into host cell,BP,PTX3
11638,GO:0044409,0.545166775565872,0.81574364745525,1,121,entry into host,BP,PTX3
14098,GO:0051806,0.545166775565872,0.81574364745525,1,121,entry into cell of other organism involved in symbiotic interaction,BP,PTX3
14105,GO:0051828,0.545166775565872,0.81574364745525,1,121,entry into other organism involved in symbiotic interaction,BP,PTX3
4003,GO:0008277,0.545469314906614,0.81548896947986,1,123,regulation of G-protein coupled receptor protein signaling pathway,BP,ADM
9688,GO:0035304,0.546594991150122,0.814648314605727,1,119,regulation of protein dephosphorylation,BP,ELFN2
18073,GO:0098827,0.546782564417958,0.619321691485855,6,936,endoplasmic reticulum subcompartment,CC,LTF;MOXD1;JPH3;HLA-DQB1;PLA2G2A;HLA-DQA1
6518,GO:0019359,0.548255681913512,0.813346388979804,1,119,nicotinamide nucleotide biosynthetic process,BP,NNMT
6520,GO:0019363,0.548255681913512,0.813346388979804,1,119,pyridine nucleotide biosynthetic process,BP,NNMT
939,GO:0002224,0.54839565530727,0.813179150963078,1,125,toll-like receptor signaling pathway,BP,LTF
3701,GO:0007264,0.548720090141811,0.651061515704643,4,553,small GTPase mediated signal transduction,BP,GPR17;PDPN;COL3A1;KSR2
16255,GO:0071322,0.550472734307302,0.81157896636359,1,121,cellular response to carbohydrate stimulus,BP,KCNB1
7618,GO:0030968,0.550654614155607,0.811406523380075,1,124,endoplasmic reticulum unfolded protein response,BP,CCL2
2725,GO:0005737,0.550758229538062,0.53348224839404,66,10204,cytoplasm,CC,LTF;TYMP;VIM;CP;CHI3L2;SNAP91;MOXD1;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;SH3GL2;COL1A1;CUX2;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GALNT13;CPLX2;INA;ADM;SERPING1;SPHKAP;JPH3;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;NNMT;ATCAY;COL3A1;PCDH7;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;SOCS3;COL4A1;PLA2G2A;SERPINA3;HLA-DQA1;GABBR1;DOK6;IFI30
6291,GO:0018107,0.550988484154862,0.811254587230704,1,113,peptidyl-threonine phosphorylation,BP,CHI3L1
14015,GO:0051656,0.551651138106279,0.67598761144045,3,423,establishment of organelle localization,BP,SNAP25;CPLX2;RIMS2
4377,GO:0009150,0.552650800352599,0.67497918792126,3,454,purine ribonucleotide metabolic process,BP,ADM;CXCL10;GABBR1
10791,GO:0042552,0.553961492475192,0.808914306487147,1,111,myelination,BP,TYMP
20062,GO:1904064,0.554340342308788,0.808544877384592,1,117,positive regulation of cation transmembrane transport,BP,CXCL10
13979,GO:0051592,0.554376423269454,0.808548602032944,1,114,response to calcium ion,BP,KCNIP2
2542,GO:0005319,0.55445437633943,0.808453722728998,1,117,lipid transporter activity,MF,ABCC3
3642,GO:0007173,0.554618926696289,0.808301324544051,1,119,epidermal growth factor receptor signaling pathway,BP,SH3GL2
2606,GO:0005506,0.554806693438873,0.808048029346886,1,130,iron ion binding,MF,LTF
12387,GO:0046165,0.554863853612646,0.808037653092198,1,126,alcohol biosynthetic process,BP,MOXD1
18968,GO:1901566,0.555373133572949,0.571526777449513,11,1765,organonitrogen compound biosynthetic process,BP,TYMP;VIM;MOXD1;FMOD;MDGA2;GALNT13;ADM;NNMT;FUT9;ST8SIA3;GABBR1
19013,GO:1901657,0.555601431411857,0.807377624174267,1,134,glycosyl compound metabolic process,BP,TYMP
7917,GO:0031514,0.556906844995573,0.806425399777764,1,123,motile cilium,CC,ANXA1
4010,GO:0008286,0.557301164484072,0.806158071897192,1,118,insulin receptor signaling pathway,BP,SOCS3
16942,GO:0072525,0.558067905261281,0.805498769881966,1,122,pyridine-containing compound biosynthetic process,BP,NNMT
3709,GO:0007272,0.559294784849374,0.80460208452489,1,113,ensheathment of neurons,BP,TYMP
4059,GO:0008366,0.559294784849374,0.80460208452489,1,113,axon ensheathment,BP,TYMP
13668,GO:0051053,0.561076276289697,0.80311029318397,1,117,negative regulation of DNA metabolic process,BP,S100A11
576,GO:0001678,0.561413257802388,0.80277395676393,1,123,cellular glucose homeostasis,BP,KCNB1
12489,GO:0046467,0.562327601369433,0.801928333309732,1,134,membrane lipid biosynthetic process,BP,ST8SIA3
7549,GO:0030856,0.562358878868472,0.802032101282459,1,120,regulation of epithelial cell differentiation,BP,SERPINE1
6002,GO:0016705,0.562413547492538,0.801892153001637,1,130,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,MOXD1
9438,GO:0034605,0.562766586369288,0.801688390722635,1,121,cellular response to heat,BP,CXCL10
11294,GO:0043492,0.564667046123262,0.800252700418781,1,110,ATPase activity, coupled to movement of substances,MF,ABCC3
17356,GO:0090263,0.565496125805774,0.799396811214783,1,126,positive regulation of canonical Wnt signaling pathway,BP,COL1A1
9276,GO:0034250,0.565769863591636,0.799125446154525,1,131,positive regulation of cellular amide metabolic process,BP,VIM
10613,GO:0042175,0.565796669851619,0.600372030284209,6,949,nuclear outer membrane-endoplasmic reticulum membrane network,CC,LTF;MOXD1;JPH3;HLA-DQB1;PLA2G2A;HLA-DQA1
686,GO:0001838,0.566327291536512,0.798791462596159,1,118,embryonic epithelial tube formation,BP,ADM
13805,GO:0051260,0.567466304183861,0.706041151018528,2,295,protein homooligomerization,BP,GBP1;KCNB1
12608,GO:0046683,0.568367176417474,0.797028918040664,1,125,response to organophosphorus,BP,COL1A1
3464,GO:0006865,0.56861517978833,0.796813037216503,1,126,amino acid transport,BP,SNAP25
11635,GO:0044403,0.568714170051902,0.611866337627261,5,790,symbiont process,BP,LTF;VIM;CCL2;PTX3;ANXA2
8787,GO:0032993,0.569001156877454,0.796395030709491,1,137,protein-DNA complex,CC,KCNIP3
4242,GO:0008757,0.569825155498255,0.795749770861247,1,132,S-adenosylmethionine-dependent methyltransferase activity,MF,NNMT
13688,GO:0051092,0.570898643788354,0.794826415796301,1,135,positive regulation of NF-kappaB transcription factor activity,BP,LTF
4463,GO:0009259,0.573196718385577,0.654963168340324,3,469,ribonucleotide metabolic process,BP,ADM;CXCL10;GABBR1
3181,GO:0006470,0.573796886218904,0.700059897101206,2,283,protein dephosphorylation,BP,ELFN2;PTPRT
7510,GO:0030808,0.574209072771257,0.792103572209932,1,128,regulation of nucleotide biosynthetic process,BP,GABBR1
18729,GO:1900371,0.574209072771257,0.792103572209932,1,128,regulation of purine nucleotide biosynthetic process,BP,GABBR1
5073,GO:0010942,0.574839357283647,0.625190335059593,4,616,positive regulation of cell death,BP,TNFRSF12A;ANXA1;ADM;GRIN1
2990,GO:0006163,0.575564538997204,0.652615746255264,3,471,purine nucleotide metabolic process,BP,ADM;CXCL10;GABBR1
18095,GO:0098862,0.576257390631496,0.790448616807764,1,120,cluster of actin-based cell projections,CC,SHANK2
13115,GO:0048565,0.576472744096037,0.790244356990993,1,122,digestive tract development,BP,COL3A1
3200,GO:0006497,0.576601514763855,0.790003663261454,1,136,protein lipidation,BP,MDGA2
8090,GO:0031901,0.577411436657585,0.789385356003774,1,128,early endosome membrane,CC,ANXA1
11008,GO:0043010,0.577625529181656,0.696412309635027,2,275,camera-type eye development,BP,VIM;COL4A1
1595,GO:0003674,0.579369648289678,0.575423271925995,93,14390,molecular_function,MF,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;MOXD1;CRTAC1;APOL4;TIMP1;SRPX2;SHD;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;GBP1;SLC8A2;SPP1;KCNIP2;PLAU;GDF15;LGALS3;EMILIN2;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;CA10;AFF2;KCNB1;C1R;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;NNMT;ELFN2;ATCAY;COL3A1;CXCL10;PCDH7;VSTM2A;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;SMOC1;FAM155A;GABBR1;CFI;C21ORF62;DOK6;IFI30
16205,GO:0071236,0.579739333194751,0.787394218452516,1,128,cellular response to antibiotic,BP,ANXA1
2773,GO:0005795,0.580304739465239,0.786889760474096,1,130,Golgi stack,CC,FUT9
957,GO:0002262,0.580513765050393,0.786682743454475,1,133,myeloid cell homeostasis,BP,ANXA1
12087,GO:0045619,0.58181535748923,0.785526567529766,1,137,regulation of lymphocyte differentiation,BP,ANXA1
21764,GO:2001056,0.582679464910187,0.784779703138029,1,137,positive regulation of cysteine-type endopeptidase activity,BP,GRIN1
13098,GO:0048534,0.583698768176821,0.596678827899713,5,785,hematopoietic or lymphoid organ development,BP,LTF;LGALS3;ANXA1;PDPN;ANXA2
7111,GO:0030010,0.583931811501835,0.783869754710071,1,119,establishment of cell polarity,BP,FERMT1
2554,GO:0005342,0.58481906588633,0.782922714919667,1,137,organic acid transmembrane transporter activity,MF,ABCC3
12722,GO:0046943,0.58481906588633,0.782922714919667,1,137,carboxylic acid transmembrane transporter activity,MF,ABCC3
7241,GO:0030216,0.585286483942217,0.782550635216222,1,133,keratinocyte differentiation,BP,ANXA1
12705,GO:0046914,0.587509735596414,0.578271369639278,6,931,transition metal ion binding,MF,LTF;CP;MOXD1;TIMP1;AEBP1;LOX
9540,GO:0034767,0.588513330752358,0.77977327323164,1,128,positive regulation of ion transmembrane transport,BP,CXCL10
11726,GO:0044703,0.588655226705558,0.591593489579267,5,787,multi-organism reproductive process,BP,TIMP1;IGFBP2;SPP1;ADM;GRIN1
16763,GO:0072175,0.588867763151961,0.779481552939749,1,126,epithelial tube formation,BP,ADM
4151,GO:0008509,0.58941951699774,0.684840645691082,2,302,anion transmembrane transporter activity,MF,ABCC3;GABRB3
721,GO:0001889,0.589561634809407,0.778821370406222,1,131,liver development,BP,ANXA1
10601,GO:0042158,0.590089103560662,0.778276385288241,1,140,lipoprotein biosynthetic process,BP,MDGA2
16515,GO:0071705,0.591024750165321,0.526392498456336,13,2063,nitrogen compound transport,BP,SNAP91;FERMT1;COL1A1;KCNIP3;STEAP3;GBP1;SNAP25;CHI3L1;POSTN;ANXA1;KCNB1;RIMS2;RTP5
6606,GO:0019693,0.5921357013952,0.635952742922802,3,483,ribose phosphate metabolic process,BP,ADM;CXCL10;GABBR1
11644,GO:0044419,0.592622180323463,0.587484439944903,5,814,interspecies interaction between organisms,BP,LTF;VIM;CCL2;PTX3;ANXA2
14137,GO:0051897,0.59278413293345,0.77596717724978,1,131,positive regulation of protein kinase B signaling,BP,CHI3L1
9445,GO:0034620,0.594341875336715,0.774489477080738,1,141,cellular response to unfolded protein,BP,CCL2
4675,GO:0010038,0.595683707079327,0.678623902489726,2,306,response to metal ion,BP,IGFBP2;KCNIP2
12266,GO:0045931,0.596200948426546,0.772922764737883,1,130,positive regulation of mitotic cell cycle,BP,ANXA1
1380,GO:0003018,0.597907517213133,0.771262516384469,1,144,vascular process in circulatory system,BP,ADM
18913,GO:1901361,0.598492960693835,0.601009023020511,4,657,organic cyclic compound catabolic process,BP,TYMP;VIM;MOXD1;SPP1
14469,GO:0055123,0.598607494526259,0.770754443402942,1,130,digestive system development,BP,COL3A1
15126,GO:0061008,0.599343588177812,0.77005007169704,1,134,hepaticobiliary system development,BP,ANXA1
7587,GO:0030902,0.600030671928937,0.769455566572408,1,131,hindbrain development,BP,GRIN1
586,GO:0001701,0.601278558260761,0.673059300463966,2,293,in utero embryonic development,BP,ADM;SOCS3
773,GO:0001959,0.602449083504685,0.767145633707559,1,143,regulation of cytokine-mediated signaling pathway,BP,SOCS3
16355,GO:0071466,0.603623585816248,0.766046223964797,1,146,cellular response to xenobiotic stimulus,BP,GRIN1
14506,GO:0060041,0.604387016152242,0.765508366195839,1,128,retina development in camera-type eye,BP,COL4A1
3547,GO:0006997,0.604829307316333,0.76506180493494,1,132,nucleus organization,BP,AFF2
18967,GO:1901565,0.606114799360716,0.547597898563575,7,1130,organonitrogen compound catabolic process,BP,TYMP;CHI3L2;MOXD1;TIMP1;FMOD;CHI3L1;ANXA2
9441,GO:0034614,0.606276525834581,0.763596744672708,1,147,cellular response to reactive oxygen species,BP,ANXA1
3337,GO:0006665,0.606716212507895,0.763167198260391,1,150,sphingolipid metabolic process,BP,ST8SIA3
8914,GO:0033209,0.607144581571295,0.762693149327975,1,161,tumor necrosis factor-mediated signaling pathway,BP,TNFRSF12A
2856,GO:0005938,0.610441448991393,0.663798032103976,2,280,cell cortex,CC,RIMS2;ANXA2
3333,GO:0006661,0.610465890469152,0.759799396175403,1,136,phosphatidylinositol biosynthetic process,BP,PLEKHA4
11255,GO:0043409,0.610990081553434,0.759247332225604,1,143,negative regulation of MAPK cascade,BP,GBP1
3179,GO:0006468,0.611799914724322,0.51342312007674,11,1717,protein phosphorylation,BP,LTF;CCL2;GBP1;GDF15;CHI3L1;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
11569,GO:0044283,0.612259394518722,0.58659323395417,4,674,small molecule biosynthetic process,BP,TYMP;MOXD1;ANXA1;ADM
8699,GO:0032870,0.613352562408252,0.585480335783585,4,630,cellular response to hormone stimulus,BP,IGFBP2;SPP1;ANXA1;SOCS3
2619,GO:0005525,0.613430720568429,0.660559994455437,2,337,GTP binding,MF,GBP1;GNAL
16938,GO:0072521,0.613547123034401,0.613792728754822,3,499,purine-containing compound metabolic process,BP,ADM;CXCL10;GABBR1
11492,GO:0044089,0.614049317609889,0.613317535277346,3,464,positive regulation of cellular component biogenesis,BP,SRPX2;CUX2;SLITRK1
13064,GO:0048469,0.614239416592873,0.756168534476547,1,146,cell maturation,BP,KCNIP2
9668,GO:0035264,0.616163006783113,0.754474818505378,1,132,multicellular organism growth,BP,SLITRK1
1063,GO:0002440,0.616305457443557,0.754157629106642,1,153,production of molecular mediator of immune response,BP,HLA-DQB1
13696,GO:0051100,0.617745610232779,0.752834217971732,1,147,negative regulation of binding,BP,CRTAC1
8493,GO:0032550,0.617871900098599,0.655958101658804,2,340,purine ribonucleoside binding,MF,GBP1;GNAL
21190,GO:2000045,0.618005421992178,0.752602970066293,1,145,regulation of G1/S transition of mitotic cell cycle,BP,ANXA1
19870,GO:1903708,0.61927899503125,0.75133765922194,1,151,positive regulation of hemopoiesis,BP,ANXA1
15000,GO:0060759,0.619438349541337,0.751192864320645,1,150,regulation of response to cytokine stimulus,BP,SOCS3
13457,GO:0050731,0.619592863634132,0.7510607629952,1,148,positive regulation of peptidyl-tyrosine phosphorylation,BP,SOCS3
3269,GO:0006575,0.619915370477934,0.750668994853229,1,159,cellular modified amino acid metabolic process,BP,PLA2G2A
19934,GO:1903827,0.619968764155999,0.607045503086538,3,476,regulation of cellular protein localization,BP,GBP1;KCNB1;SHISA7
12694,GO:0046890,0.619972604755456,0.75067300560651,1,151,regulation of lipid biosynthetic process,BP,ANXA1
14464,GO:0055114,0.620478714901859,0.558176120105688,5,874,oxidation-reduction process,BP,CP;MOXD1;LOX;STEAP3;IFI30
11290,GO:0043488,0.621014533936999,0.749687960529961,1,149,regulation of mRNA stability,BP,VIM
715,GO:0001883,0.622240813430859,0.651393481197152,2,343,purine nucleoside binding,MF,GBP1;GNAL
1211,GO:0002699,0.622748977803342,0.747947564444487,1,158,positive regulation of immune effector process,BP,ANXA1
9934,GO:0035725,0.62325761453918,0.747667912327677,1,133,sodium ion transmembrane transport,BP,SLC8A2
10412,GO:0038127,0.623546953143845,0.747311667369735,1,141,ERBB signaling pathway,BP,SH3GL2
2323,GO:0004930,0.624171540243886,0.649339647707987,2,355,G-protein coupled receptor activity,MF,GPR17;GABBR1
7058,GO:0022804,0.625139418229763,0.648442962250248,2,308,active transmembrane transporter activity,MF,ABCC3;SLC8A2
8492,GO:0032549,0.625616027211219,0.647844542670934,2,344,ribonucleoside binding,MF,GBP1;GNAL
7229,GO:0030203,0.625787341336582,0.745083416090598,1,147,glycosaminoglycan metabolic process,BP,FMOD
623,GO:0001764,0.625791098961624,0.745239706497749,1,130,neuron migration,BP,COL3A1
5077,GO:0010950,0.626272001037149,0.744555158269897,1,154,positive regulation of endopeptidase activity,BP,GRIN1
5177,GO:0014074,0.626785854591165,0.744161228508638,1,141,response to purine-containing compound,BP,COL1A1
5684,GO:0016055,0.626977598253763,0.599574496267325,3,472,Wnt signaling pathway,BP,FERMT1;COL1A1;IGFBP2
557,GO:0001655,0.627795767822488,0.645679570257143,2,295,urogenital system development,BP,ANXA1;COL4A1
9625,GO:0035148,0.627811332659769,0.743167072817327,1,140,tube formation,BP,ADM
18562,GO:0198738,0.629776916730794,0.596562431773964,3,474,cell-cell signaling by wnt,BP,FERMT1;COL1A1;IGFBP2
1110,GO:0002520,0.630201683883759,0.547761084614693,5,824,immune system development,BP,LTF;LGALS3;ANXA1;PDPN;ANXA2
11072,GO:0043123,0.634418522694828,0.736470445923441,1,160,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,LTF
5822,GO:0016331,0.634850817679436,0.736175619574299,1,143,morphogenesis of embryonic epithelium,BP,ADM
10067,GO:0035967,0.63514707135457,0.735764577245114,1,157,cellular response to topologically incorrect protein,BP,CCL2
21840,GO:2001235,0.635629885631363,0.735231245863426,1,164,positive regulation of apoptotic signaling pathway,BP,TNFRSF12A
11097,GO:0043167,0.635719644743365,0.444837690593233,36,5527,ion binding,MF,LTF;CP;SNAP91;MOXD1;CRTAC1;TIMP1;PLEKHA4;AEBP1;COL1A1;ABCC3;LOX;KCNIP3;STEAP3;GBP1;SLC8A2;KCNIP2;POSTN;ANXA1;GNAL;GALNT13;CDHR1;ADAM12;C1R;S100A11;FABP5;COL3A1;CXCL10;PCDH7;KSR2;RIMS2;GRIN1;ST8SIA3;ANXA2;PLA2G2A;SMOC1;CFI
714,GO:0001882,0.636403646697028,0.636340450673038,2,351,nucleoside binding,MF,GBP1;GNAL
6469,GO:0019216,0.637526672480926,0.635199661778807,2,324,regulation of lipid metabolic process,BP,ANXA1;SERPINA3
7036,GO:0022414,0.637742090523235,0.513797581544793,7,1156,reproductive process,BP,TIMP1;IGFBP2;SPP1;ANXA1;ADM;GRIN1;SOCS3
16612,GO:0071902,0.639371292471601,0.633196939411512,2,328,positive regulation of protein serine/threonine kinase activity,BP,LTF;CHI3L1
2,GO:0000003,0.640045587512656,0.511292507843964,7,1159,reproduction,BP,TIMP1;IGFBP2;SPP1;ANXA1;ADM;GRIN1;SOCS3
6519,GO:0019362,0.640980894058605,0.729883689435151,1,157,pyridine nucleotide metabolic process,BP,NNMT
12509,GO:0046496,0.640980894058605,0.729883689435151,1,157,nicotinamide nucleotide metabolic process,BP,NNMT
3362,GO:0006694,0.641054360394648,0.729779388748237,1,161,steroid biosynthetic process,BP,ADM
11289,GO:0043487,0.641158782338924,0.729702884063064,1,157,regulation of RNA stability,BP,VIM
7391,GO:0030509,0.641386607612338,0.72959736665601,1,142,BMP signaling pathway,BP,GDF15
3573,GO:0007033,0.642099324637188,0.728776731665126,1,153,vacuole organization,BP,ANXA2
8504,GO:0032561,0.642684782623806,0.629536326514192,2,354,guanyl ribonucleotide binding,MF,GBP1;GNAL
6394,GO:0019001,0.644175729301547,0.627908696317117,2,355,guanyl nucleotide binding,MF,GBP1;GNAL
13223,GO:0048754,0.644820816842491,0.72606994574728,1,144,branching morphogenesis of an epithelial tube,BP,COL4A1
5306,GO:0015081,0.645945537071109,0.724922719360591,1,143,sodium ion transmembrane transporter activity,MF,SLC8A2
1947,GO:0004386,0.646079008642569,0.724785249101788,1,143,helicase activity,MF,ANXA1
3324,GO:0006650,0.646199397926608,0.625755085932319,2,331,glycerophospholipid metabolic process,BP,PLEKHA4;PLA2G2A
19432,GO:1902806,0.646463904526415,0.724277782533389,1,156,regulation of cell cycle G1/S phase transition,BP,ANXA1
2854,GO:0005929,0.646472669571094,0.578328309079894,3,485,cilium,CC,ANXA1;CDHR1;SHANK2
937,GO:0002221,0.648940479657376,0.721676356330473,1,161,pattern recognition receptor signaling pathway,BP,LTF
14003,GO:0051641,0.649383820483855,0.455101124234498,16,2548,cellular localization,BP,SH3GL2;COL1A1;KCNIP3;GBP1;SNAP25;CPLX2;JPH3;KCNB1;ATCAY;CXCL10;RIMS2;GRIN1;ANXA2;SHISA7;RTP5;FAM155A
13694,GO:0051098,0.649920335290913,0.621658112810262,2,333,regulation of binding,BP,CRTAC1;ANXA2
14010,GO:0051649,0.651486916892878,0.46630483591237,12,1941,establishment of localization in cell,BP,SH3GL2;KCNIP3;SNAP25;CPLX2;JPH3;KCNB1;CXCL10;RIMS2;GRIN1;ANXA2;RTP5;FAM155A
3925,GO:0008152,0.652445715759724,0.427089385970986,63,10000,metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;MOXD1;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;SPOCD1;COL4A2;ANXA1;MDGA2;COL6A2;GALNT13;ADAM12;ADM;SERPING1;AFF2;C1R;S100A11;PTX3;FABP5;NNMT;ELFN2;ATCAY;COL3A1;CXCL10;VSTM2A;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;ANXA2;SOCS3;COL4A1;PLA2G2A;PTPRT;SERPINA3;GABBR1;CFI;IFI30
10614,GO:0042176,0.653149977028998,0.618083231086649,2,333,regulation of protein catabolic process,BP,TIMP1;ANXA2
4511,GO:0009408,0.653296253112445,0.717140140368647,1,159,response to heat,BP,CXCL10
16941,GO:0072524,0.653384580014701,0.71702475724094,1,162,pyridine-containing compound metabolic process,BP,NNMT
3512,GO:0006936,0.654888520451948,0.616183040999221,2,321,muscle contraction,BP,VIM;KCNIP2
10822,GO:0042594,0.655767913077781,0.714510629346404,1,162,response to starvation,BP,ADM
6597,GO:0019637,0.657556044890303,0.503226587273476,6,1043,organophosphate metabolic process,BP,PLEKHA4;ADM;NNMT;CXCL10;PLA2G2A;GABBR1
3541,GO:0006986,0.659899950528337,0.710048730130083,1,171,response to unfolded protein,BP,CCL2
7212,GO:0030177,0.66042131832194,0.709569328493955,1,160,positive regulation of Wnt signaling pathway,BP,COL1A1
11562,GO:0044272,0.661958801807249,0.707865984577561,1,167,sulfur compound biosynthetic process,BP,FMOD
5681,GO:0016052,0.663805091041413,0.705902399556133,1,163,carbohydrate catabolic process,BP,FUT9
13695,GO:0051099,0.663908829226578,0.705790137959673,1,163,positive regulation of binding,BP,ANXA2
9440,GO:0034613,0.663915489360265,0.462530361909107,10,1648,cellular protein localization,BP,COL1A1;KCNIP3;GBP1;SNAP25;KCNB1;RIMS2;GRIN1;ANXA2;SHISA7;RTP5
5079,GO:0010952,0.664086060447945,0.705541234489697,1,171,positive regulation of peptidase activity,BP,GRIN1
6703,GO:0019904,0.664269445341723,0.529763382707883,4,657,protein domain specific binding,MF,VIM;ADAM12;SHANK2;ATCAY
14396,GO:0055001,0.664698405134027,0.705040491057181,1,150,muscle cell development,BP,ADM
3818,GO:0007601,0.665443175988241,0.704118515638863,1,164,visual perception,BP,COL1A1
6970,GO:0021915,0.665453578962039,0.704220721349115,1,150,neural tube development,BP,ADM
7382,GO:0030496,0.666338800536501,0.703174310748635,1,160,midbody,CC,ANXA2
3386,GO:0006733,0.670015001703707,0.699060697813675,1,172,oxidoreduction coenzyme metabolic process,BP,NNMT
2700,GO:0005681,0.670602269343534,0.698361517573912,1,180,spliceosomal complex,CC,LGALS3
15960,GO:0070727,0.67121180411282,0.454445753589238,10,1658,cellular macromolecule localization,BP,COL1A1;KCNIP3;GBP1;SNAP25;KCNB1;RIMS2;GRIN1;ANXA2;SHISA7;RTP5
13604,GO:0050953,0.672726514269593,0.696099900833532,1,167,sensory perception of light stimulus,BP,COL1A1
18321,GO:0101002,0.673815332703098,0.694808875052682,1,179,ficolin-1-rich granule,CC,LGALS3
5877,GO:0016462,0.67411404324482,0.499036438259894,5,811,pyrophosphatase activity,MF,ABCC3;GBP1;ANXA1;GNAL;ATCAY
6072,GO:0016817,0.675696854440641,0.497229240674063,5,813,hydrolase activity, acting on acid anhydrides,MF,ABCC3;GBP1;ANXA1;GNAL;ATCAY
6073,GO:0016818,0.675696854440641,0.497229240674063,5,813,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,ABCC3;GBP1;ANXA1;GNAL;ATCAY
19010,GO:1901654,0.676178662911597,0.692210592408485,1,173,response to ketone,BP,SPP1
15130,GO:0061013,0.677183515869628,0.691104777023082,1,170,regulation of mRNA catabolic process,BP,VIM
7808,GO:0031325,0.677224552318535,0.422290994525485,17,2766,positive regulation of cellular metabolic process,BP,LTF;VIM;SERPINE1;CCL2;COL1A1;SPP1;GDF15;CHI3L1;ANXA1;ADM;PTX3;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
20646,GO:1905330,0.677425022302571,0.690826459238232,1,171,regulation of morphogenesis of an epithelium,BP,CXCL10
5609,GO:0015893,0.679374597964993,0.68858262298613,1,178,drug transport,BP,ABCC3
17715,GO:0097305,0.680830779771084,0.686981752749602,1,171,response to alcohol,BP,GRIN1
17656,GO:0097190,0.682656439466296,0.537097463985469,3,552,apoptotic signaling pathway,BP,TNFRSF12A;SERPINE1;LGALS3
3931,GO:0008168,0.682686242291699,0.684798392543271,1,182,methyltransferase activity,MF,NNMT
3177,GO:0006464,0.682836125482277,0.40538651888884,23,3694,cellular protein modification process,BP,LTF;CP;TIMP1;CCL2;LOX;GBP1;SPP1;GDF15;CHI3L1;ANXA1;MDGA2;GALNT13;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT
10193,GO:0036211,0.682836125482277,0.40538651888884,23,3694,protein modification process,BP,LTF;CP;TIMP1;CCL2;LOX;GBP1;SPP1;GDF15;CHI3L1;ANXA1;MDGA2;GALNT13;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT
2177,GO:0004721,0.683565566201962,0.683897324997921,1,167,phosphoprotein phosphatase activity,MF,PTPRT
11666,GO:0044448,0.684991525463505,0.682344286585247,1,157,cell cortex part,CC,RIMS2
3680,GO:0007219,0.685110779574347,0.682091326330167,1,172,Notch signaling pathway,BP,POSTN
6475,GO:0019222,0.685123025430822,0.39159685769611,37,5923,regulation of metabolic process,BP,LTF;VIM;FERMT1;TIMP1;SRPX2;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;GDF15;CHI3L1;SPOCD1;ANXA1;ADM;SERPING1;AFF2;C1R;S100A11;PTX3;ELFN2;ATCAY;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;GABBR1;CFI
4827,GO:0010604,0.685156429085899,0.413552219776926,17,2772,positive regulation of macromolecule metabolic process,BP,LTF;VIM;SERPINE1;CCL2;COL1A1;CUX2;SPP1;GDF15;CHI3L1;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;PLA2G2A
3743,GO:0007369,0.685664855939403,0.6815065216353,1,165,gastrulation,BP,COL4A2
11547,GO:0044242,0.685847527079388,0.681153235440147,1,186,cellular lipid catabolic process,BP,FABP5
10931,GO:0042803,0.686276854557812,0.504415909012879,4,731,protein homodimerization activity,MF,TYMP;GBP1;ANXA1;S100A11
6989,GO:0021953,0.68736972160474,0.679542296595783,1,165,central nervous system neuron differentiation,BP,MDGA2
11568,GO:0044282,0.688015467566503,0.577918644531977,2,390,small molecule catabolic process,BP,TYMP;FUT9
13256,GO:0048839,0.69150548789658,0.674715563642712,1,168,inner ear development,BP,GABRB3
7850,GO:0031400,0.691537482951195,0.526656315783499,3,537,negative regulation of protein modification process,BP,GBP1;ELFN2;SOCS3
18531,GO:0140097,0.692871825792338,0.673025310738769,1,181,catalytic activity, acting on DNA,MF,ANXA1
5667,GO:0016032,0.695882567744236,0.493133885779106,4,736,viral process,BP,LTF;VIM;CCL2;PTX3
13671,GO:0051056,0.69700827780852,0.567306213692785,2,326,regulation of small GTPase mediated signal transduction,BP,GPR17;COL3A1
14136,GO:0051896,0.697211239452383,0.667952393085654,1,174,regulation of protein kinase B signaling,BP,CHI3L1
10066,GO:0035966,0.697593878037264,0.667399846663631,1,189,response to topologically incorrect protein,BP,CCL2
4634,GO:0009913,0.698212910439635,0.666720406781792,1,180,epidermal cell differentiation,BP,ANXA1
13212,GO:0048736,0.69963910277126,0.665128263542749,1,165,appendage development,BP,SMOC1
14599,GO:0060173,0.69963910277126,0.665128263542749,1,165,limb development,BP,SMOC1
9537,GO:0034764,0.700133131623451,0.664491483945806,1,171,positive regulation of transmembrane transport,BP,CXCL10
10290,GO:0036464,0.700634130036903,0.663828177263299,1,180,cytoplasmic ribonucleoprotein granule,CC,INA
3783,GO:0007507,0.70078696694597,0.515666544895618,3,493,heart development,BP,LOX;ADM;COL3A1
3292,GO:0006605,0.701488196398154,0.561704598221112,2,394,protein targeting,BP,KCNB1;RTP5
8786,GO:0032991,0.701931950916388,0.378924185666358,28,4556,protein-containing complex,CC,LTF;VIM;FERMT1;COL1A1;LOX;KCNIP3;KCNIP2;LGALS3;EMILIN2;SNAP25;COL4A2;GNAL;COL6A2;CPLX2;INA;JPH3;AFF2;KCNB1;SHANK2;GABRB3;COL3A1;GRIN1;HLA-DQB1;ANXA2;COL4A1;SHISA7;HLA-DQA1;GABBR1
17404,GO:0090316,0.702214576005783,0.661936437141514,1,179,positive regulation of intracellular protein transport,BP,KCNB1
6167,GO:0017016,0.702305085796476,0.513846275641269,3,487,Ras GTPase binding,MF,RIMS2;GRIN1;ANXA2
3537,GO:0006979,0.705850859763405,0.556372961483549,2,390,response to oxidative stress,BP,COL1A1;ANXA1
18982,GO:1901605,0.705962976675475,0.657266160001809,1,201,alpha-amino acid metabolic process,BP,ATCAY
12225,GO:0045859,0.706380224582396,0.480647156472276,4,720,regulation of protein kinase activity,BP,LTF;CHI3L1;CXCL10;SOCS3
6023,GO:0016741,0.707116988422892,0.655898998416073,1,194,transferase activity, transferring one-carbon groups,MF,NNMT
14036,GO:0051701,0.709599743654636,0.652881570750206,1,190,interaction with host,BP,PTX3
13746,GO:0051173,0.710090781702665,0.388142557232826,16,2668,positive regulation of nitrogen compound metabolic process,BP,LTF;VIM;SERPINE1;CCL2;COL1A1;SPP1;GDF15;CHI3L1;ADM;PTX3;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
11007,GO:0043009,0.710619710954916,0.503684391883189,3,528,chordate embryonic development,BP,COL1A1;ADM;SOCS3
3836,GO:0007623,0.710635769784519,0.651657379916488,1,182,circadian rhythm,BP,SERPINE1
11678,GO:0044464,0.711166986614327,0.413634991049971,90,14059,cell part,CC,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;MOXD1;CRTAC1;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;AFF2;KCNB1;SHANK2;PDPN;S100A11;PTX3;FABP5;CSMD3;SVOP;GABRB3;NNMT;ATCAY;COL3A1;CXCL10;PCDH7;VSTM2A;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;FAM155A;GABBR1;DOK6;IFI30
8126,GO:0031966,0.711812869981896,0.502117782725375,3,619,mitochondrial membrane,CC,LGALS3;ANXA1;ATCAY
3320,GO:0006643,0.71420326909449,0.647105491956665,1,204,membrane lipid metabolic process,BP,ST8SIA3
9964,GO:0035770,0.718305558214152,0.642054102116368,1,189,ribonucleoprotein granule,CC,INA
11100,GO:0043170,0.720565850344844,0.350527039584832,51,8205,macromolecule metabolic process,BP,LTF;VIM;CP;CHI3L2;APOL4;FERMT1;TIMP1;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;KCNIP3;IGFBP2;GBP1;SPP1;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;SPOCD1;COL4A2;ANXA1;MDGA2;GALNT13;ADAM12;ADM;SERPING1;AFF2;C1R;S100A11;PTX3;ELFN2;COL3A1;CXCL10;VSTM2A;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;CFI
12026,GO:0045444,0.722327201979482,0.636933954699444,1,193,fat cell differentiation,BP,VSTM2A
11381,GO:0043624,0.723356838674994,0.635584539790985,1,199,cellular protein complex disassembly,BP,SH3GL2
2669,GO:0005623,0.723552634855514,0.399642217450038,90,14077,cell,CC,TNFRSF12A;LTF;TYMP;VIM;CP;CHI3L2;SNAP91;MOXD1;CRTAC1;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;ABCC3;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;TNR;GBP1;SLC8A2;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;MDGA2;GNAL;COL6A2;EMP3;GPR17;GALNT13;CPLX2;CDHR1;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;AFF2;KCNB1;SHANK2;PDPN;S100A11;PTX3;FABP5;CSMD3;SVOP;GABRB3;NNMT;ATCAY;COL3A1;CXCL10;PCDH7;VSTM2A;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;SLITRK1;HLA-DQB1;ANXA2;SOCS3;COL4A1;SHISA7;RTP5;PLA2G2A;PTPRT;SERPINA3;HLA-DQA1;FAM155A;GABBR1;DOK6;IFI30
9355,GO:0034404,0.723865201844361,0.634940121374948,1,198,nucleobase-containing small molecule biosynthetic process,BP,TYMP
7151,GO:0030097,0.72426643887392,0.458895280880239,4,747,hemopoiesis,BP,LTF;LGALS3;ANXA1;ANXA2
8698,GO:0032869,0.724719667771194,0.633912821471633,1,187,cellular response to insulin stimulus,BP,SOCS3
750,GO:0001933,0.724722869957579,0.532742557763314,2,387,negative regulation of protein phosphorylation,BP,GBP1;SOCS3
11559,GO:0044267,0.725460327294105,0.352818763485206,28,4620,cellular protein metabolic process,BP,LTF;VIM;CP;TIMP1;SERPINE1;CCL2;LOX;IGFBP2;GBP1;SPP1;GDF15;CHI3L1;ANXA1;MDGA2;GALNT13;SERPING1;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3
5680,GO:0016051,0.725793617406415,0.632436791832414,1,203,carbohydrate biosynthetic process,BP,GALNT13
4066,GO:0008380,0.726064669599531,0.530989006645252,2,406,RNA splicing,BP,LGALS3;AFF2
17688,GO:0097237,0.72651729900999,0.631498944164308,1,204,cellular response to toxic substance,BP,ANXA1
4155,GO:0008514,0.726731225488961,0.631239693397614,1,201,organic anion transmembrane transporter activity,MF,ABCC3
18094,GO:0098858,0.727725565223967,0.630109336135564,1,177,actin-based cell projection,CC,PDPN
849,GO:0002064,0.727983597083124,0.629739792217477,1,182,epithelial cell development,BP,VIM
13130,GO:0048598,0.728177775497162,0.481878586169069,3,542,embryonic morphogenesis,BP,COL4A2;ADM;SOCS3
13456,GO:0050730,0.729824226962292,0.627225149590722,1,202,regulation of peptidyl-tyrosine phosphorylation,BP,SOCS3
4663,GO:0010001,0.730486852866113,0.626433707772344,1,190,glial cell differentiation,BP,VIM
9005,GO:0033500,0.730516471166156,0.626351997961769,1,197,carbohydrate homeostasis,BP,KCNB1
10821,GO:0042593,0.730516471166156,0.626351997961769,1,197,glucose homeostasis,BP,KCNB1
4600,GO:0009792,0.731846770341748,0.477240361541691,3,546,embryo development ending in birth or egg hatching,BP,COL1A1;ADM;SOCS3
10835,GO:0042623,0.732032900175401,0.523435807232201,2,349,ATPase activity, coupled,MF,ABCC3;ANXA1
7121,GO:0030027,0.732052847410961,0.624476132017475,1,177,lamellipodium,CC,PDPN
11552,GO:0044255,0.732279613915032,0.430170025224733,5,953,cellular lipid metabolic process,BP,PLEKHA4;ANXA1;FABP5;ST8SIA3;PLA2G2A
11661,GO:0044441,0.733516516182903,0.521449581929283,2,374,ciliary part,CC,CDHR1;SHANK2
367,GO:0000982,0.735517091499435,0.518810053806866,2,390,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,CUX2;KCNIP3
7242,GO:0030217,0.737658129998191,0.616900005364572,1,204,T cell differentiation,BP,ANXA1
11071,GO:0043122,0.738024049225867,0.616390524174278,1,208,regulation of I-kappaB kinase/NF-kappaB signaling,BP,LTF
11358,GO:0043583,0.73959516128445,0.614372985341921,1,194,ear development,BP,GABRB3
11663,GO:0044445,0.740468005284267,0.613027091672157,1,227,cytosolic part,CC,SNAP25
5406,GO:0015291,0.742368110950216,0.610597636444155,1,202,secondary active transmembrane transporter activity,MF,SLC8A2
11567,GO:0044281,0.743299456085056,0.371553305992937,10,1880,small molecule metabolic process,BP,TYMP;MOXD1;FMOD;ANXA1;ADM;NNMT;ATCAY;CXCL10;FUT9;GABBR1
5810,GO:0016310,0.743831794248664,0.361865868834501,12,2081,phosphorylation,BP,LTF;SRPX2;CCL2;GBP1;GDF15;CHI3L1;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A
2727,GO:0005740,0.745099317791485,0.460149170127627,3,655,mitochondrial envelope,CC,LGALS3;ANXA1;ATCAY
18991,GO:1901617,0.746159954092683,0.605380871027398,1,215,organic hydroxy compound biosynthetic process,BP,MOXD1
6502,GO:0019318,0.749030309922574,0.601473823670507,1,210,hexose metabolic process,BP,FUT9
7769,GO:0031267,0.751631694898536,0.451780946503494,3,529,small GTPase binding,MF,RIMS2;GRIN1;ANXA2
363,GO:0000978,0.751842083896266,0.49713084836291,2,403,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,CUX2;KCNIP3
13118,GO:0048568,0.755744368781176,0.491856337652212,2,398,embryonic organ development,BP,ADM;SOCS3
3321,GO:0006644,0.75655095454505,0.490726717939528,2,414,phospholipid metabolic process,BP,PLEKHA4;PLA2G2A
4339,GO:0009108,0.757650492159455,0.589404025628602,1,221,coenzyme biosynthetic process,BP,NNMT
11257,GO:0043412,0.757750448760557,0.321342501843307,23,3860,macromolecule modification,BP,LTF;CP;TIMP1;CCL2;LOX;GBP1;SPP1;GDF15;CHI3L1;ANXA1;MDGA2;GALNT13;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT
3633,GO:0007163,0.758842305653415,0.587859048465976,1,196,establishment or maintenance of cell polarity,BP,FERMT1
1374,GO:0003012,0.760015312863364,0.486031128618059,2,394,muscle system process,BP,VIM;KCNIP2
3436,GO:0006814,0.762493393117729,0.582624062935894,1,202,sodium ion transport,BP,SLC8A2
15538,GO:0065003,0.764746733676315,0.351325877308241,9,1656,protein-containing complex assembly,BP,SNAP91;COL1A1;GBP1;FMOD;SNAP25;COL6A2;KCNB1;GRIN1;ANXA2
10680,GO:0042326,0.765975976236352,0.4777494994109,2,420,negative regulation of phosphorylation,BP,GBP1;SOCS3
11098,GO:0043168,0.766930283695594,0.324980900372603,15,2541,anion binding,MF,LTF;SNAP91;PLEKHA4;ABCC3;GBP1;POSTN;ANXA1;GNAL;FABP5;CXCL10;KSR2;GRIN1;ST8SIA3;ANXA2;PLA2G2A
16153,GO:0071103,0.76839952795582,0.57399036934366,1,221,DNA conformation change,BP,ANXA1
6553,GO:0019439,0.768521687392716,0.429212745797795,3,633,aromatic compound catabolic process,BP,TYMP;VIM;MOXD1
19691,GO:1903362,0.768813927474315,0.573391302210252,1,220,regulation of cellular protein catabolic process,BP,ANXA2
369,GO:0000987,0.769584145863503,0.472724474720544,2,416,proximal promoter sequence-specific DNA binding,MF,CUX2;KCNIP3
13282,GO:0048872,0.772698897953019,0.567665983506555,1,225,homeostasis of number of cells,BP,ANXA1
362,GO:0000977,0.776906884503798,0.417836527219281,3,614,RNA polymerase II regulatory region sequence-specific DNA binding,MF,AEBP1;CUX2;KCNIP3
13687,GO:0051091,0.778881842398796,0.558440740445993,1,228,positive regulation of DNA binding transcription factor activity,BP,LTF
3479,GO:0006886,0.779083671639983,0.37084581648088,5,1002,intracellular protein transport,BP,KCNIP3;SNAP25;KCNB1;RIMS2;RTP5
383,GO:0001012,0.779972523361182,0.413624565934037,3,617,RNA polymerase II regulatory region DNA binding,MF,AEBP1;CUX2;KCNIP3
11905,GO:0045165,0.782461657499799,0.553043304811249,1,225,cell fate commitment,BP,PDPN
2891,GO:0005996,0.783764166217928,0.551011782356917,1,235,monosaccharide metabolic process,BP,FUT9
4513,GO:0009410,0.784007853531765,0.550635183483428,1,236,response to xenobiotic stimulus,BP,GRIN1
3128,GO:0006397,0.784254568094684,0.451783840338517,2,457,mRNA processing,BP,LGALS3;AFF2
3180,GO:0006469,0.785765338587398,0.547943687889568,1,236,negative regulation of protein kinase activity,BP,SOCS3
1604,GO:0003690,0.78597284316459,0.379320891816864,4,799,double-stranded DNA binding,MF,AEBP1;CUX2;KCNIP3;AFF2
9412,GO:0034504,0.786239178983762,0.547262972225857,1,226,protein localization to nucleus,BP,COL1A1
7043,GO:0022607,0.787238569205099,0.300657502018332,15,2631,cellular component assembly,BP,SNAP91;SRPX2;COL1A1;CUX2;LOX;GBP1;FMOD;SNAP25;COL6A2;EMP3;KCNB1;SHANK2;GRIN1;SLITRK1;ANXA2
3690,GO:0007249,0.787738505912084,0.544882287571255,1,241,I-kappaB kinase/NF-kappaB signaling,BP,LTF
11339,GO:0043549,0.789498497766409,0.374540116804599,4,803,regulation of kinase activity,BP,LTF;CHI3L1;CXCL10;SOCS3
7911,GO:0031503,0.791299245742361,0.539387228528678,1,233,protein-containing complex localization,BP,SNAP25
40,GO:0000082,0.79426587429117,0.534700208083595,1,240,G1/S transition of mitotic cell cycle,BP,ANXA1
6216,GO:0017111,0.794819887355473,0.367299502892717,4,769,nucleoside-triphosphatase activity,MF,ABCC3;GBP1;ANXA1;GNAL
4625,GO:0009891,0.797149722932177,0.31092035849767,9,1684,positive regulation of biosynthetic process,BP,VIM;SERPINE1;CCL2;COL1A1;SPP1;ANXA1;PTX3;CXCL10;GRIN1
6055,GO:0016791,0.799055099730805,0.527107382468598,1,237,phosphatase activity,MF,PTPRT
1253,GO:0002758,0.799726133464108,0.525984327450243,1,248,innate immune response-activating signal transduction,BP,LTF
16514,GO:0071704,0.799758013136936,0.262140393468515,58,9561,organic substance metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;MOXD1;APOL4;FERMT1;TIMP1;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;KCNIP3;IGFBP2;GBP1;SPP1;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;SPOCD1;COL4A2;ANXA1;MDGA2;GALNT13;ADAM12;ADM;SERPING1;AFF2;C1R;S100A11;PTX3;FABP5;NNMT;ELFN2;ATCAY;COL3A1;CXCL10;VSTM2A;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;GABBR1;CFI
8882,GO:0033157,0.802425298609312,0.521672314170289,1,240,regulation of intracellular protein transport,BP,KCNB1
17995,GO:0098656,0.804319539347373,0.518618014251099,1,236,anion transmembrane transport,BP,GABRB3
9081,GO:0033673,0.804474207312679,0.518304888240951,1,250,negative regulation of kinase activity,BP,SOCS3
17378,GO:0090287,0.805136230607203,0.517306540311425,1,232,regulation of cellular response to growth factor stimulus,BP,FERMT1
16297,GO:0071383,0.806940058655163,0.51430518343715,1,243,cellular response to steroid hormone stimulus,BP,ANXA1
9434,GO:0034599,0.806981830920326,0.514174536755766,1,258,cellular response to oxidative stress,BP,ANXA1
19334,GO:1902532,0.807298072940219,0.417605557293786,2,458,negative regulation of intracellular signal transduction,BP,GBP1;SOCS3
17221,GO:0090068,0.809712028432364,0.50973305226975,1,244,positive regulation of cell cycle process,BP,ANXA1
4845,GO:0010628,0.80994917428251,0.294542430429341,9,1691,positive regulation of gene expression,BP,VIM;SERPINE1;COL1A1;CUX2;SPP1;CXCL10;VSTM2A;RIMS2;GRIN1
13133,GO:0048609,0.810702431328702,0.370055861571621,3,657,multicellular organismal reproductive process,BP,SPP1;ANXA1;GRIN1
11782,GO:0044843,0.810787661740517,0.507915721575968,1,252,cell cycle G1/S phase transition,BP,ANXA1
11490,GO:0044087,0.812358424765845,0.342873157613929,4,809,regulation of cellular component biogenesis,BP,SRPX2;CUX2;GRIN1;SLITRK1
6116,GO:0016887,0.813523313937166,0.408145602694589,2,410,ATPase activity,MF,ABCC3;ANXA1
16610,GO:0071900,0.813728237977603,0.407731571091012,2,466,regulation of protein serine/threonine kinase activity,BP,LTF;CHI3L1
9558,GO:0034976,0.815653353226852,0.499734699733091,1,261,response to endoplasmic reticulum stress,BP,CCL2
8470,GO:0032504,0.81621874507273,0.361961963414183,3,665,multicellular organism reproduction,BP,SPP1;ANXA1;GRIN1
935,GO:0002218,0.823351510723254,0.486566162293304,1,265,activation of innate immune response,BP,LTF
21136,GO:1990904,0.823455335868473,0.351176423827243,3,719,ribonucleoprotein complex,CC,VIM;LGALS3;INA
16863,GO:0072330,0.82465276846336,0.484294876924487,1,269,monocarboxylic acid biosynthetic process,BP,ANXA1
4304,GO:0009057,0.826586750091474,0.294715090389215,6,1231,macromolecule catabolic process,BP,VIM;CHI3L2;TIMP1;FMOD;CHI3L1;ANXA2
13758,GO:0051188,0.826720997239857,0.480670358270195,1,274,cofactor biosynthetic process,BP,NNMT
3552,GO:0007005,0.827438417927888,0.386133745973185,2,513,mitochondrion organization,BP,TYMP;ATCAY
13857,GO:0051348,0.831879725509944,0.471561633976123,1,275,negative regulation of transferase activity,BP,SOCS3
2416,GO:0005088,0.832476543015173,0.470662579256409,1,235,Ras guanyl-nucleotide exchange factor activity,MF,GRIN1
12226,GO:0045860,0.832772616866423,0.377607294745551,2,479,positive regulation of protein kinase activity,BP,LTF;CHI3L1
19668,GO:1903311,0.832987771668821,0.469592298089458,1,273,regulation of mRNA metabolic process,BP,VIM
18530,GO:0140096,0.833286211121146,0.255231922941636,11,2058,catalytic activity, acting on a protein,MF,LTF;AEBP1;CCL2;LOX;PLAU;GALNT13;ADAM12;C1R;KSR2;PTPRT;CFI
18283,GO:0099568,0.835057466496098,0.373960165084572,2,441,cytoplasmic region,CC,RIMS2;ANXA2
13641,GO:0051020,0.838393171633862,0.328575423330406,3,623,GTPase binding,MF,RIMS2;GRIN1;ANXA2
3041,GO:0006260,0.839278664755295,0.458221811749042,1,275,DNA replication,BP,S100A11
4517,GO:0009416,0.840760950942379,0.45550842875045,1,275,response to light stimulus,BP,GRIN1
12750,GO:0046983,0.840883312916968,0.286029587254954,5,1108,protein dimerization activity,MF,TYMP;GBP1;ANXA1;KCNB1;S100A11
2939,GO:0006066,0.841607996852938,0.453924142114888,1,283,alcohol metabolic process,BP,MOXD1
361,GO:0000976,0.841805082206583,0.323241780093128,3,685,transcription regulatory region sequence-specific DNA binding,MF,AEBP1;CUX2;KCNIP3
5474,GO:0015629,0.845020626812754,0.357517916353118,2,459,actin cytoskeleton,CC,FERMT1;ANXA1
16187,GO:0071214,0.848066795652122,0.441884295884295,1,288,cellular response to abiotic stimulus,BP,COL1A1
18403,GO:0104004,0.848066795652122,0.441884295884295,1,288,cellular response to environmental stimulus,BP,COL1A1
7152,GO:0030098,0.849005492962182,0.440120519077063,1,286,lymphocyte differentiation,BP,ANXA1
13847,GO:0051338,0.851905594083506,0.284967001692808,4,898,regulation of transferase activity,BP,LTF;CHI3L1;CXCL10;SOCS3
16650,GO:0072001,0.852261133623661,0.434020743627814,1,262,renal system development,BP,COL4A1
8125,GO:0031965,0.852419189715676,0.43365958934727,1,278,nuclear membrane,CC,INA
7806,GO:0031323,0.855002811505017,0.19884632513207,32,5557,regulation of cellular metabolic process,BP,LTF;VIM;TIMP1;SRPX2;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;GDF15;CHI3L1;SPOCD1;ANXA1;ADM;SERPING1;AFF2;S100A11;PTX3;ELFN2;ATCAY;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;GABBR1
16291,GO:0071375,0.856691008677528,0.425410822004117,1,283,cellular response to peptide hormone stimulus,BP,SOCS3
8781,GO:0032984,0.85695356233565,0.42486207254799,1,295,protein-containing complex disassembly,BP,SH3GL2
4846,GO:0010629,0.857260552395212,0.236905745305758,8,1637,negative regulation of gene expression,BP,VIM;FERMT1;SERPINE1;AEBP1;CUX2;KCNIP3;SERPING1;AFF2
6321,GO:0018209,0.862802196589304,0.413399486395273,1,286,peptidyl-serine modification,BP,GALNT13
8282,GO:0032259,0.864347714644424,0.410259628263023,1,306,methylation,BP,NNMT
21119,GO:1990837,0.866059352684986,0.284524602600629,3,721,sequence-specific double-stranded DNA binding,MF,AEBP1;CUX2;KCNIP3
11864,GO:0045089,0.867110273245265,0.404704030414186,1,309,positive regulation of innate immune response,BP,LTF
5690,GO:0016071,0.867155263098634,0.282692220965598,3,774,mRNA metabolic process,BP,VIM;LGALS3;AFF2
17092,GO:0080090,0.867211823392661,0.184217573933215,31,5437,regulation of primary metabolic process,BP,LTF;VIM;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;GDF15;CHI3L1;ANXA1;ADM;SERPING1;AFF2;C1R;S100A11;PTX3;ELFN2;ATCAY;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;GABBR1;CFI
11550,GO:0044248,0.867477446193415,0.213330213070925,10,2061,cellular catabolic process,BP,TYMP;VIM;CHI3L2;MOXD1;TIMP1;FMOD;CHI3L1;FABP5;ATCAY;ANXA2
7122,GO:0030029,0.871325672368926,0.275866119093232,3,680,actin filament-based process,BP,VIM;ANXA1;PDPN
3311,GO:0006631,0.871847726136175,0.395007409196792,1,327,fatty acid metabolic process,BP,ANXA1
8229,GO:0032147,0.871863509065171,0.395040088842912,1,303,activation of protein kinase activity,BP,CHI3L1
4598,GO:0009790,0.872891548848242,0.252439281874793,4,892,embryo development,BP,COL1A1;COL4A2;ADM;SOCS3
7811,GO:0031328,0.873086528753353,0.214613913141435,8,1662,positive regulation of cellular biosynthetic process,BP,VIM;SERPINE1;COL1A1;SPP1;ANXA1;PTX3;CXCL10;GRIN1
3216,GO:0006520,0.873621956428703,0.391314779401346,1,341,cellular amino acid metabolic process,BP,ATCAY
13744,GO:0051171,0.874056795046798,0.176138375190901,30,5304,regulation of nitrogen compound metabolic process,BP,LTF;VIM;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;GDF15;CHI3L1;ADM;SERPING1;AFF2;C1R;S100A11;PTX3;ELFN2;ATCAY;CXCL10;KSR2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;GABBR1;CFI
11647,GO:0044422,0.874947329501264,0.171176497730213,49,8352,organelle part,CC,LTF;VIM;CP;MOXD1;FERMT1;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;STEAP3;GBP1;SPP1;FMOD;PLAU;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GALNT13;CDHR1;INA;ADAM12;SERPING1;JPH3;AFF2;SHANK2;S100A11;PTX3;FABP5;SVOP;GABRB3;ATCAY;COL3A1;PCDH7;FUT9;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;HLA-DQA1;IFI30
1613,GO:0003712,0.875149039503666,0.305084410030093,2,531,transcription cofactor activity,MF,AEBP1;KCNIP3
12228,GO:0045862,0.875535289540231,0.387392391263623,1,320,positive regulation of proteolysis,BP,GRIN1
3422,GO:0006790,0.875876115483508,0.386648604286679,1,333,sulfur compound metabolic process,BP,FMOD
9906,GO:0035690,0.878255000253446,0.381707977600102,1,314,cellular response to drug,BP,ANXA1
3133,GO:0006402,0.879714595592715,0.378574645820586,1,333,mRNA catabolic process,BP,VIM
11489,GO:0044085,0.881117482366818,0.181566533170126,15,2889,cellular component biogenesis,BP,SNAP91;SRPX2;COL1A1;CUX2;LOX;GBP1;FMOD;SNAP25;COL6A2;EMP3;KCNB1;SHANK2;GRIN1;SLITRK1;ANXA2
14647,GO:0060255,0.882399048684566,0.165189231658408,31,5491,regulation of macromolecule metabolic process,BP,LTF;VIM;FERMT1;TIMP1;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;KCNIP3;GBP1;SPP1;GDF15;CHI3L1;SERPING1;AFF2;C1R;S100A11;PTX3;ELFN2;CXCL10;VSTM2A;KSR2;RIMS2;GRIN1;ANXA2;SOCS3;PLA2G2A;SERPINA3;CFI
59,GO:0000122,0.883848494279065,0.254707825821551,3,752,negative regulation of transcription by RNA polymerase II,BP,AEBP1;CUX2;KCNIP3
9082,GO:0033674,0.885832196195503,0.285418903895961,2,543,positive regulation of kinase activity,BP,LTF;CHI3L1
9470,GO:0034655,0.885867071794265,0.285319314295954,2,578,nucleobase-containing compound catabolic process,BP,TYMP;VIM
3385,GO:0006732,0.88878548648854,0.358958706004943,1,348,coenzyme metabolic process,BP,NNMT
10808,GO:0042578,0.889782834321384,0.356820223167527,1,323,phosphoric ester hydrolase activity,MF,PTPRT
7812,GO:0031329,0.889859847256589,0.244328959776703,3,763,regulation of cellular catabolic process,BP,VIM;TIMP1;ANXA2
19936,GO:1903829,0.89192184699806,0.35206804705366,1,326,positive regulation of cellular protein localization,BP,KCNB1
13405,GO:0050673,0.892087660991103,0.351700975875909,1,325,epithelial cell proliferation,BP,FERMT1
3562,GO:0007018,0.892761203181177,0.350289487320442,1,292,microtubule-based movement,BP,SH3GL2
19009,GO:1901653,0.89297051161484,0.349731353588942,1,324,cellular response to peptide,BP,SOCS3
17745,GO:0097367,0.89319225741154,0.177306038187972,10,1994,carbohydrate derivative binding,MF,LTF;CHI3L2;ABCC3;GBP1;CHI3L1;POSTN;GNAL;CXCL10;KSR2;ST8SIA3
6292,GO:0018108,0.895350362772725,0.344351249809411,1,335,peptidyl-tyrosine phosphorylation,BP,SOCS3
6324,GO:0018212,0.897321692151843,0.339868379621367,1,338,peptidyl-tyrosine modification,BP,SOCS3
12189,GO:0045787,0.897589601103908,0.339259466645198,1,337,positive regulation of cell cycle,BP,ANXA1
11664,GO:0044446,0.899135257169542,0.14095540835886,47,8154,intracellular organelle part,CC,LTF;VIM;CP;MOXD1;FERMT1;TIMP1;SERPINE1;SH3GL2;COL1A1;CUX2;STEAP3;GBP1;SPP1;FMOD;PLAU;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GALNT13;INA;ADAM12;SERPING1;JPH3;AFF2;SHANK2;S100A11;PTX3;FABP5;SVOP;GABRB3;ATCAY;COL3A1;PCDH7;FUT9;ST8SIA3;CD163;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;HLA-DQA1;IFI30
3132,GO:0006401,0.899361714120511,0.335144320676584,1,362,RNA catabolic process,BP,VIM
8127,GO:0031967,0.899528939728844,0.208897618678098,4,1054,organelle envelope,CC,LGALS3;ANXA1;INA;ATCAY
8131,GO:0031975,0.899528939728844,0.208897618678098,4,1054,envelope,CC,LGALS3;ANXA1;INA;ATCAY
2413,GO:0005085,0.901649593194798,0.329987333706129,1,306,guanyl-nucleotide exchange factor activity,MF,GRIN1
12960,GO:0048193,0.904610970597714,0.322984950624705,1,335,Golgi vesicle transport,BP,CUX2
12620,GO:0046700,0.906311159724066,0.245805867653846,2,616,heterocycle catabolic process,BP,TYMP;VIM
11560,GO:0044270,0.90712074457867,0.244185308310195,2,618,cellular nitrogen compound catabolic process,BP,TYMP;VIM
4854,GO:0010638,0.907319441441981,0.243811277767809,2,588,positive regulation of organelle organization,BP,ANXA1;ANXA2
4800,GO:0010557,0.909206836322514,0.166413616001243,7,1569,positive regulation of macromolecule biosynthetic process,BP,VIM;SERPINE1;CCL2;COL1A1;SPP1;CXCL10;GRIN1
11652,GO:0044429,0.90990653356825,0.208424956183704,3,910,mitochondrial part,CC,LGALS3;ANXA1;ATCAY
5962,GO:0016607,0.910171961642949,0.309664345818984,1,361,nuclear speck,CC,AFF2
17101,GO:0080135,0.91068845697598,0.237008230883643,2,602,regulation of cellular response to stress,BP,TNR;SPP1
12459,GO:0046394,0.910714220868153,0.30832573263203,1,375,carboxylic acid biosynthetic process,BP,ANXA1
5682,GO:0016053,0.911230812209148,0.307071068488572,1,376,organic acid biosynthetic process,BP,ANXA1
13667,GO:0051052,0.912301231355492,0.304497856798777,1,359,regulation of DNA metabolic process,BP,S100A11
3429,GO:0006807,0.912547267974595,0.123912018135378,51,8864,nitrogen compound metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;MOXD1;APOL4;TIMP1;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;LOX;KCNIP3;IGFBP2;GBP1;SPP1;FMOD;PLAU;GDF15;LGALS3;CHI3L1;SPOCD1;COL4A2;ANXA1;MDGA2;GALNT13;ADAM12;ADM;SERPING1;AFF2;C1R;S100A11;PTX3;NNMT;ELFN2;ATCAY;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;GABBR1;CFI
19125,GO:1901990,0.916417687252744,0.294319201996917,1,376,regulation of mitotic cell cycle phase transition,BP,ANXA1
11530,GO:0044212,0.91712289469916,0.195042006738895,3,817,transcription regulatory region DNA binding,MF,AEBP1;CUX2;KCNIP3
8770,GO:0032970,0.917156095851847,0.292534410839441,1,347,regulation of actin filament-based process,BP,PDPN
399,GO:0001067,0.917607299321248,0.194129788930279,3,818,regulatory region nucleic acid binding,MF,AEBP1;CUX2;KCNIP3
14857,GO:0060537,0.917822414831054,0.290868908891511,1,346,muscle tissue development,BP,COL3A1
371,GO:0000989,0.918004474522267,0.221973753042994,2,603,transcription factor activity, transcription factor binding,MF,AEBP1;KCNIP3
2730,GO:0005743,0.918336944709144,0.289425488907598,1,436,mitochondrial inner membrane,CC,LGALS3
13686,GO:0051090,0.918931992921939,0.28801565784471,1,379,regulation of DNA binding transcription factor activity,BP,LTF
370,GO:0000988,0.919777535777605,0.218265630625994,2,607,transcription factor activity, protein binding,MF,AEBP1;KCNIP3
12702,GO:0046907,0.919875961641773,0.14962189354855,7,1616,intracellular transport,BP,KCNIP3;SNAP25;CPLX2;KCNB1;RIMS2;ANXA2;RTP5
13856,GO:0051347,0.920831445431661,0.216046301882589,2,614,positive regulation of transferase activity,BP,LTF;CHI3L1
11337,GO:0043547,0.92511135712837,0.272222736437811,1,363,positive regulation of GTPase activity,BP,CCL2
3145,GO:0006417,0.926192838171419,0.269358670622963,1,387,regulation of translation,BP,VIM
12749,GO:0046982,0.926702544183532,0.267996322531057,1,404,protein heterodimerization activity,MF,KCNB1
19122,GO:1901987,0.92855207384416,0.26312672308042,1,400,regulation of cell cycle phase transition,BP,ANXA1
2142,GO:0004672,0.928736437803524,0.199157116985003,2,597,protein kinase activity,MF,CCL2;KSR2
4628,GO:0009894,0.930413794765683,0.169474913758338,3,855,regulation of catabolic process,BP,VIM;TIMP1;ANXA2
6053,GO:0016788,0.931806404059132,0.192402662080746,2,662,hydrolase activity, acting on ester bonds,MF,PLA2G2A;PTPRT
6700,GO:0019901,0.931877586095378,0.192269405066244,2,625,protein kinase binding,MF,SNAP91;SH3GL2
6698,GO:0019899,0.932729156759921,0.118676463589276,10,2133,enzyme binding,MF,SNAP91;TIMP1;SERPINE1;SH3GL2;COL1A1;GBP1;COL3A1;RIMS2;GRIN1;ANXA2
12269,GO:0045934,0.937285411825499,0.132785888938079,5,1290,negative regulation of nucleobase-containing compound metabolic process,BP,AEBP1;CUX2;KCNIP3;S100A11;GABBR1
13210,GO:0048732,0.937433044347614,0.239012705318318,1,398,gland development,BP,ANXA1
1638,GO:0003824,0.941524281864889,0.0889591131505814,27,5217,catalytic activity,MF,LTF;TYMP;CP;CHI3L2;MOXD1;AEBP1;CCL2;ABCC3;LOX;STEAP3;GBP1;PLAU;CHI3L1;ANXA1;GNAL;GALNT13;ADAM12;C1R;NNMT;ATCAY;KSR2;FUT9;ST8SIA3;PLA2G2A;PTPRT;CFI;IFI30
11368,GO:0043603,0.941557815293005,0.147067612776803,3,965,cellular amide metabolic process,BP,VIM;AEBP1;ST8SIA3
6681,GO:0019866,0.942008620943538,0.225988454810938,1,486,organelle inner membrane,CC,LGALS3
18989,GO:1901615,0.942848121109094,0.223634388250618,1,436,organic hydroxy compound metabolic process,BP,MOXD1
2671,GO:0005635,0.943679942947348,0.221255046791082,1,420,nuclear envelope,CC,INA
9274,GO:0034248,0.944231057123866,0.219645477888484,1,430,regulation of cellular amide metabolic process,BP,VIM
13854,GO:0051345,0.947456005894334,0.156727076523177,2,682,positive regulation of hydrolase activity,BP,CCL2;GRIN1
3890,GO:0008092,0.947724191212957,0.134294192424608,3,846,cytoskeletal protein binding,MF,GBP1;ATCAY;ANXA2
11369,GO:0043604,0.948479184275669,0.154270262440633,2,750,amide biosynthetic process,BP,VIM;ST8SIA3
1633,GO:0003779,0.948849576864286,0.206099075245738,1,386,actin binding,MF,GBP1
12238,GO:0045893,0.952755839725427,0.1044492928049,5,1339,positive regulation of transcription, DNA-templated,BP,SERPINE1;COL1A1;SPP1;CXCL10;GRIN1
19760,GO:1903508,0.952755839725427,0.1044492928049,5,1339,positive regulation of nucleic acid-templated transcription,BP,SERPINE1;COL1A1;SPP1;CXCL10;GRIN1
19389,GO:1902680,0.952935449636273,0.104110917452958,5,1340,positive regulation of RNA biosynthetic process,BP,SERPINE1;COL1A1;SPP1;CXCL10;GRIN1
9446,GO:0034622,0.954344058627324,0.120116935176143,3,969,cellular protein-containing complex assembly,BP,SNAP91;FMOD;SNAP25
11271,GO:0043436,0.955885656368342,0.116748953103624,3,1020,oxoacid metabolic process,BP,FMOD;ANXA1;ATCAY
6699,GO:0019900,0.956534425433226,0.134726893055349,2,700,kinase binding,MF,SNAP91;SH3GL2
11053,GO:0043087,0.957151301836916,0.180471924336232,1,436,regulation of GTPase activity,BP,CCL2
2947,GO:0006082,0.958256388964922,0.111534744542353,3,1032,organic acid metabolic process,BP,FMOD;ANXA1;ATCAY
3996,GO:0008270,0.958358852437794,0.130163280059778,2,719,zinc ion binding,MF,TIMP1;AEBP1
13756,GO:0051186,0.959424912187811,0.173124669261207,1,513,cofactor metabolic process,BP,NNMT
3865,GO:0008047,0.960971048197697,0.168140723621725,1,469,enzyme activator activity,MF,LTF
3215,GO:0006518,0.962088951030421,0.120661550266585,2,805,peptide metabolic process,BP,VIM;AEBP1
12270,GO:0045935,0.962914744036949,0.0803500517761895,6,1600,positive regulation of nucleobase-containing compound metabolic process,BP,SERPINE1;COL1A1;SPP1;ADM;CXCL10;GRIN1
7810,GO:0031327,0.963830937440702,0.0831087195582108,5,1410,negative regulation of cellular biosynthetic process,BP,AEBP1;CUX2;KCNIP3;S100A11;GABBR1
4831,GO:0010608,0.965547015423213,0.152866461665642,1,509,posttranscriptional regulation of gene expression,BP,VIM
6040,GO:0016773,0.96555352480234,0.111688458383026,2,721,phosphotransferase activity, alcohol group as acceptor,MF,CCL2;KSR2
13799,GO:0051254,0.966108481629331,0.0785893673217928,5,1409,positive regulation of RNA metabolic process,BP,SERPINE1;COL1A1;SPP1;CXCL10;GRIN1
8649,GO:0032787,0.966421530655067,0.149868860014814,1,532,monocarboxylic acid metabolic process,BP,ANXA1
366,GO:0000981,0.966603185668034,0.0926551632672805,3,1013,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,AEBP1;CUX2;KCNIP3
4624,GO:0009890,0.966618269445463,0.0775687538575007,5,1430,negative regulation of biosynthetic process,BP,AEBP1;CUX2;KCNIP3;S100A11;GABBR1
11749,GO:0044772,0.967135859685977,0.147428251438075,1,515,mitotic cell cycle phase transition,BP,ANXA1
8130,GO:0031974,0.969231204446898,0.050539769926274,23,4779,membrane-enclosed lumen,CC,LTF;CP;TIMP1;SERPINE1;COL1A1;SPP1;FMOD;CHI3L1;COL4A2;ANXA1;COL6A2;INA;ADAM12;SERPING1;AFF2;S100A11;PTX3;FABP5;COL3A1;ANXA2;COL4A1;SERPINA3;IFI30
11146,GO:0043233,0.969231204446898,0.050539769926274,23,4779,organelle lumen,CC,LTF;CP;TIMP1;SERPINE1;COL1A1;SPP1;FMOD;CHI3L1;COL4A2;ANXA1;COL6A2;INA;ADAM12;SERPING1;AFF2;S100A11;PTX3;FABP5;COL3A1;ANXA2;COL4A1;SERPINA3;IFI30
15553,GO:0070013,0.969231204446898,0.050539769926274,23,4779,intracellular organelle lumen,CC,LTF;CP;TIMP1;SERPINE1;COL1A1;SPP1;FMOD;CHI3L1;COL4A2;ANXA1;COL6A2;INA;ADAM12;SERPING1;AFF2;S100A11;PTX3;FABP5;COL3A1;ANXA2;COL4A1;SERPINA3;IFI30
11545,GO:0044238,0.969976863938611,0.0465610721691568,51,9272,primary metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;APOL4;TIMP1;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;LOX;KCNIP3;IGFBP2;GBP1;SPP1;PLAU;GDF15;LGALS3;CHI3L1;SPOCD1;COL4A2;ANXA1;MDGA2;GALNT13;ADAM12;ADM;SERPING1;AFF2;C1R;S100A11;PTX3;FABP5;NNMT;ELFN2;ATCAY;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;GABBR1;CFI
11350,GO:0043565,0.970036010929385,0.0846131445485761,3,1030,sequence-specific DNA binding,MF,AEBP1;CUX2;KCNIP3
11653,GO:0044430,0.97014227260455,0.0704576829222856,5,1393,cytoskeletal part,CC,VIM;FERMT1;ANXA1;INA;SHANK2
2144,GO:0004674,0.970503111837145,0.135675716224599,1,475,protein serine/threonine kinase activity,MF,KSR2
18468,GO:0120031,0.972220366481919,0.129491320751863,1,509,plasma membrane bounded cell projection assembly,BP,EMP3
7199,GO:0030163,0.972422338161948,0.0931507296567941,2,806,protein catabolic process,BP,TIMP1;ANXA2
11747,GO:0044770,0.973057206759715,0.126428100948375,1,545,cell cycle phase transition,BP,ANXA1
4305,GO:0009058,0.973376390696323,0.0429389835201982,29,5840,biosynthetic process,BP,LTF;TYMP;VIM;MOXD1;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;SPP1;FMOD;GDF15;SPOCD1;COL4A2;ANXA1;MDGA2;GALNT13;ADM;S100A11;PTX3;NNMT;CXCL10;FUT9;GRIN1;ST8SIA3;PLA2G2A;GABBR1
1618,GO:0003723,0.973615995752231,0.0632969294519581,5,1533,RNA binding,MF,VIM;LGALS3;ANXA1;AFF2;ANXA2
12237,GO:0045892,0.973851634862731,0.0754575722051039,3,1050,negative regulation of transcription, DNA-templated,BP,AEBP1;CUX2;KCNIP3
12277,GO:0045944,0.973934766931177,0.0752573956435203,3,1037,positive regulation of transcription by RNA polymerase II,BP,SERPINE1;CXCL10;GRIN1
3557,GO:0007010,0.974205767474328,0.0670181204512798,4,1189,cytoskeleton organization,BP,VIM;CCL2;ANXA1;INA
7124,GO:0030031,0.974686241324105,0.120445279402701,1,523,cell projection assembly,BP,EMP3
11555,GO:0044260,0.974868119384755,0.0396757372767214,39,7383,cellular macromolecule metabolic process,BP,LTF;VIM;CP;TIMP1;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;KCNIP3;IGFBP2;GBP1;SPP1;GDF15;SNAP25;CHI3L1;SPOCD1;COL4A2;ANXA1;MDGA2;GALNT13;ADM;SERPING1;S100A11;PTX3;ELFN2;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3
11551,GO:0044249,0.975647086982867,0.0397168145330087,28,5703,cellular biosynthetic process,BP,LTF;TYMP;VIM;MOXD1;PLEKHA4;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;FMOD;GDF15;SPOCD1;COL4A2;ANXA1;MDGA2;GALNT13;ADM;S100A11;PTX3;NNMT;CXCL10;FUT9;GRIN1;ST8SIA3;PLA2G2A;GABBR1
11051,GO:0043085,0.975679528687329,0.0637111815948184,4,1279,positive regulation of catalytic activity,BP,LTF;CCL2;CHI3L1;GRIN1
11140,GO:0043227,0.975871621516221,0.0389221780711333,63,11108,membrane-bounded organelle,CC,LTF;VIM;CP;SNAP91;MOXD1;CRTAC1;APOL4;TIMP1;SERPINE1;AEBP1;SH3GL2;COL1A1;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;GALNT13;CPLX2;CDHR1;INA;ADAM12;SERPING1;SPHKAP;JPH3;AFF2;C1R;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;ATCAY;COL3A1;PCDH7;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;HLA-DQA1;CFI;IFI30
5805,GO:0016301,0.975886047413816,0.0834343014205414,2,785,kinase activity,MF,CCL2;KSR2
21232,GO:2000113,0.976774260135994,0.061239516708407,4,1285,negative regulation of cellular macromolecule biosynthetic process,BP,AEBP1;CUX2;KCNIP3;S100A11
3127,GO:0006396,0.976946287370689,0.0803749074464946,2,893,RNA processing,BP,LGALS3;AFF2
19759,GO:1903507,0.978387723520073,0.0642309797733147,3,1087,negative regulation of nucleic acid-templated transcription,BP,AEBP1;CUX2;KCNIP3
19388,GO:1902679,0.978573170809342,0.0637631683789576,3,1089,negative regulation of RNA biosynthetic process,BP,AEBP1;CUX2;KCNIP3
9019,GO:0033554,0.980099722302608,0.0466365814908459,6,1785,cellular response to stress,BP,CCL2;TNR;SPP1;ANXA1;ADM;CXCL10
2806,GO:0005856,0.980340824916236,0.0439902766851106,7,1863,cytoskeleton,CC,VIM;FERMT1;SNAP25;ANXA1;INA;SHANK2;RIMS2
18975,GO:1901576,0.98092164387181,0.0317074390340422,28,5780,organic substance biosynthetic process,BP,LTF;TYMP;VIM;MOXD1;PLEKHA4;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;SPP1;FMOD;GDF15;SPOCD1;COL4A2;ANXA1;MDGA2;GALNT13;ADM;S100A11;NNMT;CXCL10;FUT9;GRIN1;ST8SIA3;PLA2G2A;GABBR1
6623,GO:0019752,0.980991784529691,0.0684994353297484,2,932,carboxylic acid metabolic process,BP,ANXA1;ATCAY
11544,GO:0044237,0.981782798602418,0.0293401591653492,51,9434,cellular metabolic process,BP,LTF;TYMP;VIM;CP;CHI3L2;MOXD1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;KCNIP3;IGFBP2;GBP1;SPP1;FMOD;GDF15;LGALS3;SNAP25;CHI3L1;SPOCD1;COL4A2;ANXA1;MDGA2;GALNT13;ADM;SERPING1;AFF2;S100A11;PTX3;FABP5;NNMT;ELFN2;ATCAY;COL3A1;CXCL10;KSR2;FUT9;GRIN1;ST8SIA3;ANXA2;SOCS3;PLA2G2A;PTPRT;SERPINA3;GABBR1
3040,GO:0006259,0.982648110985654,0.0634986280305873,2,898,DNA metabolic process,BP,ANXA1;S100A11
4801,GO:0010558,0.982709082891745,0.0474697318545218,4,1346,negative regulation of macromolecule biosynthetic process,BP,AEBP1;CUX2;KCNIP3;S100A11
3141,GO:0006412,0.983584252934452,0.0855020637787879,1,652,translation,BP,VIM
6308,GO:0018193,0.984381600608834,0.0487007301497658,3,1147,peptidyl-amino acid modification,BP,CHI3L1;GALNT13;SOCS3
11496,GO:0044093,0.984542043558364,0.0397042849507091,5,1584,positive regulation of molecular function,BP,LTF;CCL2;CHI3L1;GRIN1;ANXA2
3735,GO:0007346,0.984727330579431,0.0807167809818465,1,615,regulation of mitotic cell cycle,BP,ANXA1
11033,GO:0043043,0.985579951775309,0.0770627556702426,1,672,peptide biosynthetic process,BP,VIM
13798,GO:0051253,0.985619188526391,0.0453739154789732,3,1163,negative regulation of RNA metabolic process,BP,AEBP1;CUX2;KCNIP3
6718,GO:0019953,0.98609641552982,0.0748442732860385,1,641,sexual reproduction,BP,GRIN1
3104,GO:0006357,0.986482041409396,0.0315252085498329,7,2033,regulation of transcription by RNA polymerase II,BP,SERPINE1;AEBP1;CUX2;KCNIP3;GDF15;CXCL10;GRIN1
1609,GO:0003700,0.98661325284688,0.0380028913314837,4,1412,DNA binding transcription factor activity,MF,AEBP1;CUX2;KCNIP3;AFF2
2726,GO:0005739,0.987217932255817,0.0364949806358641,4,1557,mitochondrion,CC,LGALS3;ANXA1;SPHKAP;ATCAY
7128,GO:0030036,0.987248748280537,0.0698142735541515,1,598,actin cytoskeleton organization,BP,ANXA1
4764,GO:0010468,0.98958573460127,0.019487446816181,18,4149,regulation of gene expression,BP,LTF;VIM;FERMT1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;SERPING1;AFF2;C1R;CXCL10;VSTM2A;RIMS2;GRIN1;CFI
11553,GO:0044257,0.989700943294082,0.0586847903971597,1,676,cellular protein catabolic process,BP,ANXA2
4807,GO:0010564,0.989739392021594,0.0585075659443297,1,670,regulation of cell cycle process,BP,ANXA1
6039,GO:0016772,0.989844981824212,0.0404615823146335,2,936,transferase activity, transferring phosphorus-containing groups,MF,CCL2;KSR2
3921,GO:0008144,0.990226523775521,0.0265041474985561,5,1592,drug binding,MF,CHI3L2;ABCC3;CHI3L1;KSR2;GRIN1
11561,GO:0044271,0.990250379238384,0.0179657478519135,20,4604,cellular nitrogen compound biosynthetic process,BP,LTF;TYMP;VIM;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;SPOCD1;COL4A2;ADM;PTX3;NNMT;CXCL10;GRIN1;ST8SIA3;GABBR1
6552,GO:0019438,0.990879151585433,0.0174489132768936,17,4053,aromatic compound biosynthetic process,BP,LTF;TYMP;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;SPOCD1;COL4A2;ADM;NNMT;CXCL10;GRIN1;GABBR1
4763,GO:0010467,0.990882658889646,0.0165968037481615,22,4942,gene expression,BP,LTF;VIM;FERMT1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;PLAU;GDF15;LGALS3;SPOCD1;COL4A2;SERPING1;AFF2;C1R;CXCL10;VSTM2A;RIMS2;GRIN1;CFI
11558,GO:0044265,0.992052217311885,0.0328395916097088,2,1025,cellular macromolecule catabolic process,BP,VIM;ANXA2
5960,GO:0016604,0.992098046120251,0.0472301542750013,1,704,nuclear body,CC,AFF2
3111,GO:0006366,0.993633892167153,0.0160354887508068,7,2202,transcription by RNA polymerase II,BP,SERPINE1;AEBP1;CUX2;KCNIP3;GDF15;CXCL10;GRIN1
6022,GO:0016740,0.993827504130007,0.015594607215939,7,2206,transferase activity,MF,TYMP;CCL2;GALNT13;NNMT;KSR2;FUT9;ST8SIA3
18914,GO:1901362,0.994159334623196,0.0115600096918024,17,4175,organic cyclic compound biosynthetic process,BP,LTF;TYMP;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;SPOCD1;COL4A2;ADM;NNMT;CXCL10;GRIN1;GABBR1
9469,GO:0034654,0.994283868034081,0.0114872381881247,16,3989,nucleobase-containing compound biosynthetic process,BP,LTF;TYMP;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;SPOCD1;COL4A2;ADM;NNMT;CXCL10;GRIN1;GABBR1
5930,GO:0016567,0.9944088808193,0.0354579716634304,1,763,protein ubiquitination,BP,SOCS3
8977,GO:0033365,0.994592623833277,0.0344822447552198,1,780,protein localization to organelle,BP,COL1A1
3561,GO:0007017,0.994629151047932,0.0342974175785342,1,708,microtubule-based process,BP,SH3GL2
16059,GO:0070925,0.995119493072038,0.031656554583001,1,753,organelle assembly,BP,SHANK2
1597,GO:0003677,0.99515028281015,0.0125387644857858,7,2247,DNA binding,MF,LTF;AEBP1;CUX2;KCNIP3;ANXA1;AFF2;SERPINA3
6298,GO:0018130,0.995393845829696,0.00940682529801397,16,4046,heterocycle biosynthetic process,BP,LTF;TYMP;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;SPOCD1;COL4A2;ADM;NNMT;CXCL10;GRIN1;GABBR1
4306,GO:0009059,0.9958206456897,0.0081866577961916,20,4792,macromolecule biosynthetic process,BP,LTF;VIM;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;SPP1;FMOD;GDF15;SPOCD1;COL4A2;MDGA2;GALNT13;S100A11;CXCL10;FUT9;GRIN1;ST8SIA3
4623,GO:0009889,0.995870855692134,0.00850059864208526,16,4038,regulation of biosynthetic process,BP,LTF;VIM;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;SPP1;GDF15;ANXA1;S100A11;PTX3;CXCL10;GRIN1;GABBR1
19554,GO:1903047,0.995874692281001,0.0274903098344214,1,802,mitotic cell cycle process,BP,ANXA1
6472,GO:0019219,0.996113217617731,0.00816319949232215,15,3857,regulation of nucleobase-containing compound metabolic process,BP,LTF;VIM;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;ADM;AFF2;S100A11;CXCL10;GRIN1;GABBR1
10144,GO:0036094,0.996156189752571,0.0101556813946881,7,2253,small molecule binding,MF,ABCC3;GBP1;GNAL;FABP5;KSR2;GRIN1;ST8SIA3
2668,GO:0005622,0.996266506115853,0.00738692993296942,73,12823,intracellular,CC,LTF;TYMP;VIM;CP;CHI3L2;SNAP91;MOXD1;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;SH3GL2;CCL2;COL1A1;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;GALNT13;CPLX2;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;AFF2;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;NNMT;ATCAY;COL3A1;PCDH7;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;SOCS3;COL4A1;RTP5;PLA2G2A;SERPINA3;HLA-DQA1;GABBR1;DOK6;IFI30
8419,GO:0032446,0.996856674243934,0.0218535610862916,1,845,protein modification by small protein conjugation,BP,SOCS3
11648,GO:0044424,0.997236316594383,0.00549626869380724,71,12617,intracellular part,CC,LTF;TYMP;VIM;CP;CHI3L2;SNAP91;MOXD1;APOL4;FERMT1;TIMP1;SRPX2;PLEKHA4;SERPINE1;AEBP1;SH3GL2;COL1A1;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;KCNIP2;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;GALNT13;CPLX2;INA;ADAM12;ADM;SERPING1;SPHKAP;JPH3;AFF2;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;NNMT;ATCAY;COL3A1;PCDH7;KSR2;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;SOCS3;COL4A1;PLA2G2A;SERPINA3;HLA-DQA1;GABBR1;DOK6;IFI30
8822,GO:0033043,0.997465133614268,0.0122203800078126,2,1159,regulation of organelle organization,BP,ANXA1;ANXA2
7809,GO:0031326,0.997559464254982,0.00530039384993159,15,3977,regulation of cellular biosynthetic process,BP,LTF;VIM;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;ANXA1;S100A11;PTX3;CXCL10;GRIN1;GABBR1
11139,GO:0043226,0.997807252991244,0.00425306122994351,65,11884,organelle,CC,LTF;VIM;CP;SNAP91;MOXD1;CRTAC1;APOL4;FERMT1;TIMP1;SERPINE1;AEBP1;SH3GL2;COL1A1;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;GNAL;COL6A2;GALNT13;CPLX2;CDHR1;INA;ADAM12;SERPING1;SPHKAP;JPH3;AFF2;C1R;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;ATCAY;COL3A1;PCDH7;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;COL4A1;SHISA7;PLA2G2A;SERPINA3;HLA-DQA1;CFI;IFI30
18537,GO:0140110,0.998015460370524,0.00699119112954202,4,1754,transcription regulator activity,MF,AEBP1;CUX2;KCNIP3;AFF2
9879,GO:0035639,0.998135329354601,0.00661071212517614,4,1684,purine ribonucleoside triphosphate binding,MF,ABCC3;GBP1;GNAL;KSR2
2789,GO:0005829,0.998157334978202,0.00390169407857162,18,4614,cytosol,CC,TYMP;VIM;FERMT1;SH3GL2;KCNIP3;GBP1;SNAP25;ANXA1;CPLX2;SHANK2;PDPN;FABP5;NNMT;KSR2;ANXA2;SOCS3;DOK6;IFI30
9459,GO:0034641,0.998194922968754,0.00357885875938878,25,5944,cellular nitrogen compound metabolic process,BP,LTF;TYMP;VIM;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;ADM;AFF2;S100A11;PTX3;NNMT;ATCAY;CXCL10;GRIN1;ST8SIA3;GABBR1
11142,GO:0043229,0.998299813877994,0.00326179841510832,59,11114,intracellular organelle,CC,LTF;VIM;CP;SNAP91;MOXD1;APOL4;FERMT1;TIMP1;SERPINE1;AEBP1;SH3GL2;COL1A1;CUX2;LOX;KCNIP3;STEAP3;IGFBP2;GBP1;SPP1;FMOD;PLAU;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GALNT13;CPLX2;INA;ADAM12;SERPING1;SPHKAP;JPH3;AFF2;SHANK2;PDPN;S100A11;PTX3;FABP5;SVOP;GABRB3;ATCAY;COL3A1;PCDH7;FUT9;RIMS2;GRIN1;ST8SIA3;CD163;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;HLA-DQA1;IFI30
3098,GO:0006351,0.998306811778799,0.00401355881713421,12,3495,transcription, DNA-templated,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;SPOCD1;COL4A2;CXCL10;GRIN1
17881,GO:0097659,0.998404438422372,0.00379835829116463,12,3509,nucleic acid-templated transcription,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;SPOCD1;COL4A2;CXCL10;GRIN1
8638,GO:0032774,0.998487444243124,0.00361456827144653,12,3522,RNA biosynthetic process,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;SPOCD1;COL4A2;CXCL10;GRIN1
9462,GO:0034645,0.998523492713622,0.00317161775715089,18,4682,cellular macromolecule biosynthetic process,BP,LTF;VIM;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;SPOCD1;COL4A2;MDGA2;GALNT13;S100A11;CXCL10;FUT9;GRIN1;ST8SIA3
8498,GO:0032555,0.998530063507551,0.00533477110161534,4,1724,purine ribonucleotide binding,MF,ABCC3;GBP1;GNAL;KSR2
8496,GO:0032553,0.998623708930241,0.00502685608570072,4,1736,ribonucleotide binding,MF,ABCC3;GBP1;GNAL;KSR2
6197,GO:0017076,0.998631404350886,0.0050014473859445,4,1738,purine nucleotide binding,MF,ABCC3;GBP1;GNAL;KSR2
135,GO:0000278,0.99875750593206,0.00987022150269466,1,974,mitotic cell cycle,BP,ANXA1
3381,GO:0006725,0.998788754166297,0.00252048847215597,22,5492,cellular aromatic compound metabolic process,BP,LTF;TYMP;VIM;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;ADM;AFF2;S100A11;NNMT;CXCL10;GRIN1;GABBR1
2981,GO:0006139,0.998810158850629,0.0025026962126316,21,5311,nucleobase-containing compound metabolic process,BP,LTF;TYMP;VIM;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;ADM;AFF2;S100A11;NNMT;CXCL10;GRIN1;GABBR1
13797,GO:0051252,0.998888039898164,0.00271556949818422,12,3566,regulation of RNA metabolic process,BP,LTF;VIM;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;AFF2;CXCL10;GRIN1
15922,GO:0070647,0.999108082115146,0.00740333333391295,1,1011,protein modification by small protein conjugation or removal,BP,SOCS3
4799,GO:0010556,0.999226264401698,0.00189052323972722,13,3837,regulation of macromolecule biosynthetic process,BP,LTF;VIM;SERPINE1;AEBP1;CCL2;COL1A1;CUX2;KCNIP3;SPP1;GDF15;S100A11;CXCL10;GRIN1
11669,GO:0044451,0.999245373146294,0.0063997338142036,1,1032,nucleoplasm part,CC,AFF2
12500,GO:0046483,0.999347525423487,0.00142233896808245,21,5453,heterocycle metabolic process,BP,LTF;TYMP;VIM;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;ADM;AFF2;S100A11;NNMT;CXCL10;GRIN1;GABBR1
5689,GO:0016070,0.999388618702904,0.00145526744697134,15,4325,RNA metabolic process,BP,LTF;VIM;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;LGALS3;SPOCD1;COL4A2;AFF2;CXCL10;GRIN1
18912,GO:1901360,0.999424657093981,0.00125068854160628,22,5667,organic cyclic compound metabolic process,BP,LTF;TYMP;VIM;MOXD1;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;ADM;AFF2;S100A11;NNMT;CXCL10;GRIN1;GABBR1
14055,GO:0051726,0.999462603742446,0.00475444279539857,1,1091,regulation of cell cycle,BP,ANXA1
13814,GO:0051276,0.999512787901895,0.0043623811783813,1,1087,chromosome organization,BP,ANXA1
3102,GO:0006355,0.999526641219934,0.00130086271462274,10,3344,regulation of transcription, DNA-templated,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;CXCL10;GRIN1
17392,GO:0090304,0.999545964686693,0.00106384885645951,17,4768,nucleic acid metabolic process,BP,LTF;VIM;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;LGALS3;SPOCD1;COL4A2;ANXA1;AFF2;S100A11;CXCL10;GRIN1
19758,GO:1903506,0.9995682612462,0.00119390512427488,10,3363,regulation of nucleic acid-templated transcription,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;CXCL10;GRIN1
21231,GO:2000112,0.999568757485673,0.00112201729391007,12,3756,regulation of cellular macromolecule biosynthetic process,BP,LTF;VIM;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;S100A11;CXCL10;GRIN1
21782,GO:2001141,0.999577521146463,0.00117000760084324,10,3368,regulation of RNA biosynthetic process,BP,LTF;SERPINE1;AEBP1;COL1A1;CUX2;KCNIP3;SPP1;GDF15;CXCL10;GRIN1
83,GO:0000166,0.99958407678231,0.0016938977671581,4,1956,nucleotide binding,MF,ABCC3;GBP1;GNAL;KSR2
18878,GO:1901265,0.999586048182088,0.00168655704060142,4,1957,nucleoside phosphate binding,MF,ABCC3;GBP1;GNAL;KSR2
2618,GO:0005524,0.999629775819722,0.00221413979901653,2,1377,ATP binding,MF,ABCC3;KSR2
8502,GO:0032559,0.999709589758762,0.00177938578326549,2,1413,adenyl ribonucleotide binding,MF,ABCC3;KSR2
7421,GO:0030554,0.999729403871854,0.00166952847603731,2,1425,adenyl nucleotide binding,MF,ABCC3;KSR2
3546,GO:0006996,0.999832901733108,0.000491558511216722,10,3478,organelle organization,BP,TYMP;VIM;CCL2;SNAP25;ANXA1;INA;AFF2;SHANK2;ATCAY;ANXA2
7026,GO:0022402,0.999839018133341,0.00163553599307689,1,1259,cell cycle process,BP,ANXA1
19317,GO:1902494,0.999879276402147,0.0012645831999633,1,1318,catalytic complex,CC,GNAL
1596,GO:0003676,0.999885043129042,0.000346093249508989,10,3641,nucleic acid binding,MF,LTF;VIM;AEBP1;CUX2;KCNIP3;LGALS3;ANXA1;AFF2;ANXA2;SERPINA3
3583,GO:0007049,0.99991817413347,0.000564016719163317,2,1712,cell cycle,BP,STEAP3;ANXA1
11144,GO:0043231,0.999929995416801,0.000154953135246733,44,9668,intracellular membrane-bounded organelle,CC,LTF;VIM;CP;MOXD1;APOL4;TIMP1;AEBP1;SH3GL2;COL1A1;CUX2;LOX;KCNIP3;GBP1;SPP1;FMOD;GDF15;LGALS3;SNAP25;CHI3L1;POSTN;COL4A2;ANXA1;COL6A2;GALNT13;CPLX2;INA;ADAM12;SPHKAP;JPH3;AFF2;S100A11;FABP5;ATCAY;COL3A1;FUT9;GRIN1;ST8SIA3;HLA-DQB1;ANXA2;COL4A1;PLA2G2A;SERPINA3;HLA-DQA1;IFI30
11141,GO:0043228,0.999995745369131,1.69415095383915e-05,8,3670,non-membrane-bounded organelle,CC,VIM;FERMT1;SNAP25;ANXA1;INA;SHANK2;RIMS2;ANXA2
11145,GO:0043232,0.999995745369131,1.69415095383915e-05,8,3670,intracellular non-membrane-bounded organelle,CC,VIM;FERMT1;SNAP25;ANXA1;INA;SHANK2;RIMS2;ANXA2
2680,GO:0005654,0.999999155130712,4.64663086983878e-06,5,3247,nucleoplasm,CC,ANXA1;INA;ADAM12;AFF2;FABP5
18915,GO:1901363,0.999999606220729,1.3914473774367e-06,14,5362,heterocyclic compound binding,MF,LTF;VIM;AEBP1;ABCC3;CUX2;KCNIP3;GBP1;LGALS3;ANXA1;GNAL;AFF2;KSR2;ANXA2;SERPINA3
17637,GO:0097159,0.999999737630483,9.43038434601782e-07,14,5427,organic cyclic compound binding,MF,LTF;VIM;AEBP1;ABCC3;CUX2;KCNIP3;GBP1;LGALS3;ANXA1;GNAL;AFF2;KSR2;ANXA2;SERPINA3
8132,GO:0031981,0.999999979202477,1.4039424473729e-07,5,3776,nuclear lumen,CC,ANXA1;INA;ADAM12;AFF2;FABP5
11651,GO:0044428,0.999999986646277,8.41947179318709e-08,6,4097,nuclear part,CC,LGALS3;ANXA1;INA;ADAM12;AFF2;FABP5
2670,GO:0005634,0.999999999002981,4.32129820717154e-09,15,6483,nucleus,CC,LTF;AEBP1;CUX2;LOX;KCNIP3;GDF15;LGALS3;ANXA1;INA;ADAM12;AFF2;S100A11;FABP5;ANXA2;SERPINA3
14417,GO:0055025,0.999999999999994,0.755159433538279,0,38,positive regulation of cardiac muscle tissue development,BP,
14144,GO:0051904,0.999999999999995,0.859920078177692,0,24,pigment granule transport,BP,
3820,GO:0007603,0.999999999999999,0.85249748868052,0,26,phototransduction, visible light,BP,
5021,GO:0010880,0.999999999999999,0.817766400152657,0,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
774,GO:0001960,1,0.751873041595852,0,44,negative regulation of cytokine-mediated signaling pathway,BP,
20045,GO:1904037,1,0.842180920241437,0,26,positive regulation of epithelial cell apoptotic process,BP,
21121,GO:1990841,1,0.766742114956268,0,38,promoter-specific chromatin binding,MF,
3,GO:0000009,1,0.994511127043614,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.988517424220207,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.994313214468247,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.951808774616681,0,8,single strand break repair,BP,
7,GO:0000014,1,0.953604402805497,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.978428372026593,0,4,phosphopyruvate hydratase complex,CC,
9,GO:0000018,1,0.644092763849527,0,66,regulation of DNA recombination,BP,
10,GO:0000019,1,0.974956793890518,0,4,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.93679693424324,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.977375830895706,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.97991356509618,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.853746771309927,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.91438202889446,0,17,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.867852014071495,0,23,mannosyltransferase activity,MF,
17,GO:0000032,1,0.994704866976516,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.983796118665871,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.98390681553113,0,3,acyl binding,MF,
20,GO:0000036,1,0.989698593754242,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.836234128112902,0,30,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.552896165210077,0,88,autophagosome assembly,BP,
24,GO:0000048,1,0.989001836857169,0,2,peptidyltransferase activity,MF,
25,GO:0000049,1,0.715724751686627,0,55,tRNA binding,MF,
26,GO:0000050,1,0.929428041141399,0,12,urea cycle,BP,
27,GO:0000052,1,0.942922453609094,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.994692260020404,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.928683779732961,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.955529568263265,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.9609099738493,0,7,ribosomal small subunit export from nucleus,BP,
32,GO:0000060,1,0.747128138164921,0,43,protein import into nucleus, translocation,BP,
33,GO:0000062,1,0.903620369907371,0,18,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.957682301357019,0,6,L-ornithine transmembrane transporter activity,MF,
35,GO:0000070,1,0.370629250776621,0,143,mitotic sister chromatid segregation,BP,
36,GO:0000075,1,0.249187636270945,0,211,cell cycle checkpoint,BP,
37,GO:0000076,1,0.908415694966609,0,16,DNA replication checkpoint,BP,
38,GO:0000077,1,0.378832406750248,0,147,DNA damage checkpoint,BP,
39,GO:0000079,1,0.590999610853722,0,83,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
41,GO:0000083,1,0.840839633099466,0,28,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
42,GO:0000086,1,0.210104865041098,0,237,G2/M transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.994569468293183,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.793615537482578,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.906117040555383,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.942436858800347,0,10,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.957200771189939,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.969168993302135,0,5,sulfur amino acid transport,BP,
49,GO:0000103,1,0.982809572065692,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.978605012937881,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.988367888872787,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.939949618963346,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.97932683536089,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.993693582881017,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.985883448970642,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
56,GO:0000118,1,0.634546918685574,0,60,histone deacetylase complex,CC,
57,GO:0000120,1,0.971838768426047,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.99408046807447,0,1,glycerol-1-phosphatase activity,MF,
60,GO:0000123,1,0.611614689620836,0,75,histone acetyltransferase complex,CC,
61,GO:0000124,1,0.938702422506118,0,11,SAGA complex,CC,
62,GO:0000125,1,0.972513017683885,0,3,PCAF complex,CC,
63,GO:0000126,1,0.980080368876504,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.961185256183377,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.869427744942057,0,20,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.899639279374202,0,17,Golgi cis cisterna,CC,
67,GO:0000138,1,0.960686975817891,0,7,Golgi trans cisterna,CC,
69,GO:0000145,1,0.888464865580262,0,18,exocyst,CC,
70,GO:0000146,1,0.829616430797247,0,19,microfilament motor activity,MF,
71,GO:0000147,1,0.966603074182044,0,5,actin cortical patch assembly,BP,
73,GO:0000150,1,0.956460096059703,0,8,recombinase activity,MF,
74,GO:0000151,1,0.147183653691976,0,289,ubiquitin ligase complex,CC,
75,GO:0000152,1,0.787444963876294,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.931671686764826,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.838456086393136,0,31,rRNA modification,BP,
78,GO:0000155,1,0.957241181593253,0,6,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.889571283636105,0,19,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.951124484115507,0,7,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.932109552548179,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.994774589322036,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.987165501017301,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.96574555512251,0,6,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.994731711062424,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.822664942526446,0,30,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.928845071897869,0,13,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.912582344715747,0,15,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.87407741101552,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.97829627150313,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.92375466865954,0,10,rDNA binding,MF,
94,GO:0000183,1,0.891545817733401,0,18,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.507639890500533,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
96,GO:0000185,1,0.886194021927392,0,18,activation of MAPKKK activity,BP,
97,GO:0000186,1,0.682672300056012,0,53,activation of MAPKK activity,BP,
98,GO:0000187,1,0.41686308141733,0,133,activation of MAPK activity,BP,
99,GO:0000188,1,0.866776735382458,0,24,inactivation of MAPK activity,BP,
100,GO:0000209,1,0.145016535709383,0,290,protein polyubiquitination,BP,
101,GO:0000210,1,0.993803232849097,0,1,NAD+ diphosphatase activity,MF,
102,GO:0000212,1,0.921990326748777,0,10,meiotic spindle organization,BP,
103,GO:0000213,1,0.978648896941998,0,4,tRNA-intron endonuclease activity,MF,
104,GO:0000214,1,0.978700915093065,0,4,tRNA-intron endonuclease complex,CC,
105,GO:0000215,1,0.989160119364058,0,2,tRNA 2'-phosphotransferase activity,MF,
106,GO:0000217,1,0.860946459173563,0,24,DNA secondary structure binding,MF,
107,GO:0000220,1,0.962645629117717,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
108,GO:0000221,1,0.980388859085079,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
109,GO:0000224,1,0.994438236335319,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
110,GO:0000225,1,0.994805006816744,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
111,GO:0000226,1,0.0290307953332329,0,491,microtubule cytoskeleton organization,BP,
112,GO:0000228,1,0.0301261713857451,0,513,nuclear chromosome,CC,
113,GO:0000229,1,0.989579299051809,0,2,cytoplasmic chromosome,CC,
114,GO:0000235,1,0.943774503419961,0,8,astral microtubule,CC,
115,GO:0000242,1,0.853461470621107,0,20,pericentriolar material,CC,
116,GO:0000243,1,0.957193289818244,0,8,commitment complex,CC,
117,GO:0000244,1,0.926931889373618,0,12,spliceosomal tri-snRNP complex assembly,BP,
118,GO:0000245,1,0.703288291317854,0,57,spliceosomal complex assembly,BP,
119,GO:0000246,1,0.993067605326437,0,1,delta24(24-1) sterol reductase activity,MF,
120,GO:0000247,1,0.994804808863941,0,1,C-8 sterol isomerase activity,MF,
121,GO:0000248,1,0.987291019116353,0,2,C-5 sterol desaturase activity,MF,
122,GO:0000250,1,0.99309846458083,0,1,lanosterol synthase activity,MF,
123,GO:0000252,1,0.994741600457001,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
124,GO:0000253,1,0.984436758809344,0,3,3-keto sterol reductase activity,MF,
125,GO:0000254,1,0.983496091181878,0,3,C-4 methylsterol oxidase activity,MF,
126,GO:0000255,1,0.97330904741195,0,4,allantoin metabolic process,BP,
127,GO:0000256,1,0.994767648281609,0,1,allantoin catabolic process,BP,
128,GO:0000257,1,0.994780129678445,0,1,nitrilase activity,MF,
129,GO:0000262,1,0.994742546484928,0,1,mitochondrial chromosome,CC,
130,GO:0000266,1,0.785887032177022,0,34,mitochondrial fission,BP,
131,GO:0000268,1,0.976431187785381,0,4,peroxisome targeting sequence binding,MF,
132,GO:0000270,1,0.989667194221867,0,2,peptidoglycan metabolic process,BP,
133,GO:0000271,1,0.616925696261887,0,69,polysaccharide biosynthetic process,BP,
134,GO:0000272,1,0.83443631512845,0,26,polysaccharide catabolic process,BP,
136,GO:0000280,1,0.0815020820812136,0,367,nuclear division,BP,
137,GO:0000281,1,0.635755139039741,0,64,mitotic cytokinesis,BP,
138,GO:0000285,1,0.974294009547707,0,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
139,GO:0000287,1,0.285254944317866,0,186,magnesium ion binding,MF,
140,GO:0000288,1,0.602554099098387,0,74,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
141,GO:0000289,1,0.769096570741328,0,36,nuclear-transcribed mRNA poly(A) tail shortening,BP,
142,GO:0000290,1,0.947811523222575,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
143,GO:0000291,1,0.80773489568235,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
144,GO:0000293,1,0.981757548207322,0,3,ferric-chelate reductase activity,MF,
145,GO:0000294,1,0.986357764562021,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
146,GO:0000295,1,0.938250740532886,0,11,adenine nucleotide transmembrane transporter activity,MF,
147,GO:0000296,1,0.994545951534136,0,1,spermine transport,BP,
148,GO:0000298,1,0.97668461576008,0,4,endopolyphosphatase activity,MF,
149,GO:0000301,1,0.977625234068914,0,4,retrograde transport, vesicle recycling within Golgi,BP,
151,GO:0000303,1,0.852007888442074,0,27,response to superoxide,BP,
152,GO:0000305,1,0.837105284839781,0,30,response to oxygen radical,BP,
153,GO:0000306,1,0.973715677534586,0,4,extrinsic component of vacuolar membrane,CC,
154,GO:0000307,1,0.77837511212824,0,39,cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000308,1,0.985830639370991,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
156,GO:0000309,1,0.980128584109915,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
157,GO:0000313,1,0.643740448120203,0,82,organellar ribosome,CC,
158,GO:0000314,1,0.867374407960597,0,27,organellar small ribosomal subunit,CC,
159,GO:0000315,1,0.762747327489248,0,50,organellar large ribosomal subunit,CC,
160,GO:0000320,1,0.986175963076235,0,2,re-entry into mitotic cell cycle,BP,
161,GO:0000322,1,0.98141934813289,0,3,storage vacuole,CC,
163,GO:0000333,1,0.98452384760754,0,2,telomerase catalytic core complex,CC,
164,GO:0000334,1,0.994790052697,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
165,GO:0000338,1,0.946630436050141,0,10,protein deneddylation,BP,
166,GO:0000339,1,0.904050162985458,0,15,RNA cap binding,MF,
167,GO:0000340,1,0.951768235303127,0,7,RNA 7-methylguanosine cap binding,MF,
168,GO:0000346,1,0.925795831640474,0,13,transcription export complex,CC,
169,GO:0000347,1,0.965485132483242,0,6,THO complex,CC,
170,GO:0000349,1,0.988924923518556,0,2,generation of catalytic spliceosome for first transesterification step,BP,
171,GO:0000350,1,0.984114031221633,0,3,generation of catalytic spliceosome for second transesterification step,BP,
172,GO:0000354,1,0.984042456708051,0,2,cis assembly of pre-catalytic spliceosome,BP,
173,GO:0000375,1,0.140932372400932,0,315,RNA splicing, via transesterification reactions,BP,
174,GO:0000377,1,0.143364192848209,0,312,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
175,GO:0000379,1,0.983905568494126,0,3,tRNA-type intron splice site recognition and cleavage,BP,
176,GO:0000380,1,0.702164531440169,0,54,alternative mRNA splicing, via spliceosome,BP,
177,GO:0000381,1,0.757374851293821,0,42,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000384,1,0.98948933364883,0,2,first spliceosomal transesterification activity,MF,
179,GO:0000386,1,0.978527455516942,0,3,second spliceosomal transesterification activity,MF,
180,GO:0000387,1,0.801812382550398,0,38,spliceosomal snRNP assembly,BP,
181,GO:0000389,1,0.964472619888457,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.989069059289658,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.973213155126315,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.909288759434417,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.966360118367049,0,6,mRNA 5'-splice site recognition,BP,
186,GO:0000398,1,0.143364192848209,0,312,mRNA splicing, via spliceosome,BP,
187,GO:0000400,1,0.907825729946418,0,16,four-way junction DNA binding,MF,
188,GO:0000403,1,0.957759397154385,0,6,Y-form DNA binding,MF,
189,GO:0000404,1,0.980601980117945,0,3,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.954060403625281,0,7,bubble DNA binding,MF,
191,GO:0000406,1,0.986826140148448,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.803225842225583,0,33,phagophore assembly site,CC,
193,GO:0000408,1,0.973006490684115,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.990355991938452,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.990355991938452,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000412,1,0.994245387377219,0,1,histone peptidyl-prolyl isomerization,BP,
197,GO:0000413,1,0.831318594223493,0,31,protein peptidyl-prolyl isomerization,BP,
198,GO:0000414,1,0.964110226033157,0,4,regulation of histone H3-K36 methylation,BP,
199,GO:0000415,1,0.990906898634181,0,1,negative regulation of histone H3-K36 methylation,BP,
200,GO:0000416,1,0.993597729982813,0,1,positive regulation of histone H3-K36 methylation,BP,
201,GO:0000417,1,0.993315684100996,0,1,HIR complex,CC,
202,GO:0000421,1,0.827053135344635,0,31,autophagosome membrane,CC,
203,GO:0000422,1,0.588475035867723,0,80,autophagy of mitochondrion,BP,
204,GO:0000423,1,0.881471955878232,0,18,mitophagy,BP,
205,GO:0000428,1,0.423455004484101,0,132,DNA-directed RNA polymerase complex,CC,
206,GO:0000429,1,0.974529938415585,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
207,GO:0000430,1,0.984021369211432,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000431,1,0.990355991938452,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000432,1,0.984021369211432,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
210,GO:0000435,1,0.990355991938452,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
211,GO:0000436,1,0.974529938415585,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
212,GO:0000438,1,0.984213189408007,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
213,GO:0000439,1,0.95230071595975,0,8,core TFIIH complex,CC,
214,GO:0000444,1,0.968648287419433,0,4,MIS12/MIND type complex,CC,
215,GO:0000445,1,0.965485132483242,0,6,THO complex part of transcription export complex,CC,
216,GO:0000447,1,0.945927839052066,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000448,1,0.990551561395983,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
218,GO:0000451,1,0.992185559584738,0,1,rRNA 2'-O-methylation,BP,
219,GO:0000453,1,0.992185559584738,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
220,GO:0000454,1,0.984431866298585,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
221,GO:0000455,1,0.989347839863138,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
222,GO:0000459,1,0.961542174346094,0,7,exonucleolytic trimming involved in rRNA processing,BP,
223,GO:0000460,1,0.820644611824554,0,32,maturation of 5.8S rRNA,BP,
224,GO:0000461,1,0.989676252966412,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000462,1,0.798721503244083,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000463,1,0.948316994042231,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000466,1,0.877401399874909,0,21,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000467,1,0.961542174346094,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000469,1,0.855426500766971,0,25,cleavage involved in rRNA processing,BP,
230,GO:0000470,1,0.875581132824475,0,22,maturation of LSU-rRNA,BP,
231,GO:0000472,1,0.977156844986389,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000478,1,0.908960182636233,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
233,GO:0000479,1,0.914008875476615,0,13,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000480,1,0.960364376907343,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
235,GO:0000481,1,0.993696181220172,0,1,maturation of 5S rRNA,BP,
236,GO:0000491,1,0.953915439561693,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
237,GO:0000492,1,0.964526176478236,0,6,box C/D snoRNP assembly,BP,
238,GO:0000493,1,0.98900297014421,0,2,box H/ACA snoRNP assembly,BP,
239,GO:0000494,1,0.994803505452008,0,1,box C/D snoRNA 3'-end processing,BP,
240,GO:0000495,1,0.994418462131223,0,1,box H/ACA snoRNA 3'-end processing,BP,
241,GO:0000502,1,0.700599964702815,0,62,proteasome complex,CC,
242,GO:0000506,1,0.952254428225992,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
243,GO:0000578,1,0.804333339791529,0,31,embryonic axis specification,BP,
244,GO:0000700,1,0.978115694829573,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000701,1,0.989499170368855,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.97401751609326,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.98958715013975,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.981519908564414,0,3,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.956262661521383,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.974014951133927,0,4,meiotic mismatch repair,BP,
251,GO:0000711,1,0.99477230024578,0,1,meiotic DNA repair synthesis,BP,
252,GO:0000712,1,0.915925290911992,0,13,resolution of meiotic recombination intermediates,BP,
253,GO:0000715,1,0.87507709195086,0,23,nucleotide-excision repair, DNA damage recognition,BP,
254,GO:0000717,1,0.875173819786693,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
255,GO:0000718,1,0.994715539073901,0,1,nucleotide-excision repair, DNA damage removal,BP,
256,GO:0000720,1,0.982329273099223,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
257,GO:0000722,1,0.899106996527074,0,14,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.37716914505128,0,144,telomere maintenance,BP,
259,GO:0000724,1,0.497182317877819,0,104,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.494335171873816,0,105,recombinational repair,BP,
261,GO:0000726,1,0.642666459112481,0,64,non-recombinational repair,BP,
262,GO:0000727,1,0.971793028207136,0,5,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.86206278780106,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.945462601623747,0,10,DNA recombinase assembly,BP,
265,GO:0000731,1,0.632606484868886,0,68,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.836419206419907,0,25,strand displacement,BP,
268,GO:0000737,1,0.848873166110415,0,26,DNA catabolic process, endonucleolytic,BP,
269,GO:0000738,1,0.976062359014812,0,4,DNA catabolic process, exonucleolytic,BP,
270,GO:0000741,1,0.994711067543834,0,1,karyogamy,BP,
272,GO:0000773,1,0.994818732113291,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
273,GO:0000774,1,0.937281110687815,0,11,adenyl-nucleotide exchange factor activity,MF,
274,GO:0000775,1,0.294141270380683,0,181,chromosome, centromeric region,CC,
275,GO:0000776,1,0.434805972744803,0,125,kinetochore,CC,
276,GO:0000777,1,0.538790183960281,0,96,condensed chromosome kinetochore,CC,
277,GO:0000778,1,0.934783663403293,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000779,1,0.499490371731249,0,107,condensed chromosome, centromeric region,CC,
279,GO:0000780,1,0.885322347536055,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000781,1,0.402243860591711,0,135,chromosome, telomeric region,CC,
281,GO:0000782,1,0.937806853299092,0,11,telomere cap complex,CC,
282,GO:0000783,1,0.937806853299092,0,11,nuclear telomere cap complex,CC,
283,GO:0000784,1,0.497389934502547,0,105,nuclear chromosome, telomeric region,CC,
284,GO:0000785,1,0.0456324515575828,0,452,chromatin,CC,
285,GO:0000786,1,0.76978156198139,0,47,nucleosome,CC,
286,GO:0000788,1,0.924981936655841,0,14,nuclear nucleosome,CC,
287,GO:0000789,1,0.994809736870213,0,1,cytoplasmic chromatin,CC,
288,GO:0000790,1,0.123007700464713,0,306,nuclear chromatin,CC,
289,GO:0000791,1,0.833487882699852,0,30,euchromatin,CC,
290,GO:0000792,1,0.632175833356348,0,68,heterochromatin,CC,
291,GO:0000793,1,0.271360269973905,0,194,condensed chromosome,CC,
292,GO:0000794,1,0.572838959350764,0,82,condensed nuclear chromosome,CC,
293,GO:0000795,1,0.819970752117944,0,31,synaptonemal complex,CC,
294,GO:0000796,1,0.947729267887614,0,7,condensin complex,CC,
295,GO:0000797,1,0.992519710413575,0,1,condensin core heterodimer,CC,
296,GO:0000798,1,0.969489778833443,0,5,nuclear cohesin complex,CC,
297,GO:0000799,1,0.97722248765486,0,3,nuclear condensin complex,CC,
298,GO:0000800,1,0.911710697187001,0,13,lateral element,CC,
299,GO:0000801,1,0.966014233952962,0,6,central element,CC,
300,GO:0000803,1,0.843113279346962,0,25,sex chromosome,CC,
301,GO:0000805,1,0.947532105551233,0,7,X chromosome,CC,
302,GO:0000806,1,0.986802127899317,0,2,Y chromosome,CC,
303,GO:0000808,1,0.949582849192699,0,9,origin recognition complex,CC,
304,GO:0000811,1,0.982361826107665,0,3,GINS complex,CC,
305,GO:0000812,1,0.928737458209723,0,10,Swr1 complex,CC,
306,GO:0000813,1,0.944467295020667,0,10,ESCRT I complex,CC,
307,GO:0000814,1,0.982636935245744,0,3,ESCRT II complex,CC,
308,GO:0000815,1,0.933786422593791,0,12,ESCRT III complex,CC,
309,GO:0000818,1,0.989047228889805,0,2,nuclear MIS12/MIND complex,CC,
310,GO:0000819,1,0.216799033909434,0,223,sister chromatid segregation,BP,
312,GO:0000821,1,0.983058380733936,0,2,regulation of arginine metabolic process,BP,
313,GO:0000822,1,0.97161642248798,0,3,inositol hexakisphosphate binding,MF,
314,GO:0000823,1,0.994700150844296,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
315,GO:0000824,1,0.994700150844296,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
316,GO:0000825,1,0.994700150844296,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
317,GO:0000827,1,0.966324614193425,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
318,GO:0000828,1,0.966324614193425,0,5,inositol hexakisphosphate kinase activity,MF,
319,GO:0000829,1,0.966324614193425,0,5,inositol heptakisphosphate kinase activity,MF,
320,GO:0000831,1,0.994321808797535,0,1,inositol hexakisphosphate 6-kinase activity,MF,
321,GO:0000832,1,0.966324614193425,0,5,inositol hexakisphosphate 5-kinase activity,MF,
322,GO:0000835,1,0.959048995252895,0,6,ER ubiquitin ligase complex,CC,
323,GO:0000836,1,0.966079027006958,0,5,Hrd1p ubiquitin ligase complex,CC,
324,GO:0000839,1,0.979683965642342,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
325,GO:0000900,1,0.912420969854909,0,13,translation repressor activity, mRNA regulatory element binding,MF,
328,GO:0000910,1,0.333862706459719,0,157,cytokinesis,BP,
329,GO:0000912,1,0.95795711484427,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
330,GO:0000915,1,0.95795711484427,0,6,actomyosin contractile ring assembly,BP,
331,GO:0000916,1,0.994586434910566,0,1,actomyosin contractile ring contraction,BP,
332,GO:0000917,1,0.994686629942592,0,1,division septum assembly,BP,
333,GO:0000920,1,0.907204203380195,0,17,cell separation after cytokinesis,BP,
334,GO:0000921,1,0.920879778277033,0,13,septin ring assembly,BP,
335,GO:0000922,1,0.381906530540599,0,142,spindle pole,CC,
336,GO:0000923,1,0.967564261759812,0,5,equatorial microtubule organizing center,CC,
337,GO:0000928,1,0.994313214468247,0,1,gamma-tubulin small complex, spindle pole body,CC,
338,GO:0000930,1,0.873668357453382,0,19,gamma-tubulin complex,CC,
339,GO:0000931,1,0.950643572325559,0,7,gamma-tubulin large complex,CC,
340,GO:0000932,1,0.583366703933575,0,79,P-body,CC,
341,GO:0000938,1,0.972906489978062,0,4,GARP complex,CC,
342,GO:0000939,1,0.983737891334588,0,3,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.915106693633244,0,13,condensed chromosome outer kinetochore,CC,
344,GO:0000941,1,0.994559765489272,0,1,condensed nuclear chromosome inner kinetochore,CC,
345,GO:0000942,1,0.977754703687699,0,4,condensed nuclear chromosome outer kinetochore,CC,
346,GO:0000956,1,0.284416355468503,0,200,nuclear-transcribed mRNA catabolic process,BP,
347,GO:0000957,1,0.965970873429056,0,5,mitochondrial RNA catabolic process,BP,
348,GO:0000958,1,0.980699525487447,0,3,mitochondrial mRNA catabolic process,BP,
349,GO:0000959,1,0.77409271124398,0,41,mitochondrial RNA metabolic process,BP,
350,GO:0000960,1,0.972433222077548,0,4,regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000961,1,0.984984386887675,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000962,1,0.987259413403358,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000963,1,0.911171201824973,0,16,mitochondrial RNA processing,BP,
354,GO:0000964,1,0.976499797681759,0,4,mitochondrial RNA 5'-end processing,BP,
355,GO:0000965,1,0.9712380243357,0,5,mitochondrial RNA 3'-end processing,BP,
356,GO:0000966,1,0.880417233013122,0,21,RNA 5'-end processing,BP,
357,GO:0000967,1,0.977156844986389,0,3,rRNA 5'-end processing,BP,
358,GO:0000972,1,0.957166016361152,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000973,1,0.981002931839788,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000974,1,0.926110050928823,0,13,Prp19 complex,CC,
364,GO:0000979,1,0.78514979088655,0,36,RNA polymerase II core promoter sequence-specific DNA binding,MF,
365,GO:0000980,1,0.639199318515419,0,67,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
368,GO:0000983,1,0.863202835428593,0,21,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
372,GO:0000990,1,0.940054923995187,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.986202795118762,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.984661483912159,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.834811928108266,0,28,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.994703932185688,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.964775296910811,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0001002,1,0.984661483912159,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
379,GO:0001003,1,0.984661483912159,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
380,GO:0001007,1,0.965206280554683,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
381,GO:0001010,1,0.875124518752963,0,19,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
382,GO:0001011,1,0.988921114894211,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
384,GO:0001013,1,0.945536942810825,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001016,1,0.949032905456508,0,7,RNA polymerase III regulatory region DNA binding,MF,
386,GO:0001018,1,0.988782144084186,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
387,GO:0001025,1,0.96581643161612,0,3,RNA polymerase III transcription factor binding,MF,
388,GO:0001026,1,0.980080368876504,0,2,TFIIIB-type transcription factor activity,MF,
389,GO:0001030,1,0.959095722062837,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
390,GO:0001031,1,0.959095722062837,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
391,GO:0001032,1,0.968829882721025,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
392,GO:0001034,1,0.994697632436769,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
393,GO:0001042,1,0.964082054413771,0,5,RNA polymerase I core binding,MF,
394,GO:0001046,1,0.548639810141127,0,85,core promoter sequence-specific DNA binding,MF,
395,GO:0001047,1,0.379676443321259,0,139,core promoter binding,MF,
396,GO:0001054,1,0.935645336026447,0,11,RNA polymerase I activity,MF,
397,GO:0001055,1,0.93831073050312,0,11,RNA polymerase II activity,MF,
398,GO:0001056,1,0.916848168827856,0,15,RNA polymerase III activity,MF,
400,GO:0001069,1,0.98486404131936,0,2,regulatory region RNA binding,MF,
401,GO:0001074,1,0.994413231134376,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
402,GO:0001075,1,0.94827326800327,0,7,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
403,GO:0001076,1,0.270782041211787,0,184,transcription factor activity, RNA polymerase II transcription factor binding,MF,
404,GO:0001077,1,0.173347661685859,0,259,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,
406,GO:0001079,1,0.99459757150219,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
407,GO:0001080,1,0.99459757150219,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
408,GO:0001083,1,0.951940813921823,0,6,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
409,GO:0001084,1,0.994413231134376,0,1,transcription factor activity, TFIID-class binding,MF,
410,GO:0001085,1,0.386104675418972,0,138,RNA polymerase II transcription factor binding,MF,
411,GO:0001087,1,0.988921114894211,0,1,transcription factor activity, TFIIB-class binding,MF,
412,GO:0001091,1,0.89315814542938,0,16,RNA polymerase II basal transcription factor binding,MF,
413,GO:0001093,1,0.974759841296163,0,3,TFIIB-class transcription factor binding,MF,
414,GO:0001094,1,0.941505359134466,0,9,TFIID-class transcription factor binding,MF,
415,GO:0001096,1,0.993642921974472,0,1,TFIIF-class transcription factor binding,MF,
416,GO:0001097,1,0.979478638730768,0,3,TFIIH-class transcription factor binding,MF,
417,GO:0001098,1,0.753174818558628,0,43,basal transcription machinery binding,MF,
418,GO:0001099,1,0.753174818558628,0,43,basal RNA polymerase II transcription machinery binding,MF,
419,GO:0001100,1,0.994313214468247,0,1,negative regulation of exit from mitosis,BP,
421,GO:0001102,1,0.721693408872066,0,47,RNA polymerase II activating transcription factor binding,MF,
422,GO:0001103,1,0.812725113675813,0,32,RNA polymerase II repressing transcription factor binding,MF,
423,GO:0001104,1,0.486230876028929,0,101,RNA polymerase II transcription cofactor activity,MF,
424,GO:0001105,1,0.72391022805741,0,43,RNA polymerase II transcription coactivator activity,MF,
425,GO:0001106,1,0.834690310026943,0,28,RNA polymerase II transcription corepressor activity,MF,
426,GO:0001112,1,0.994151273416306,0,1,DNA-templated transcriptional open complex formation,BP,
427,GO:0001113,1,0.994151273416306,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
428,GO:0001120,1,0.994151273416306,0,1,protein-DNA complex remodeling,BP,
429,GO:0001128,1,0.994782582755355,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
430,GO:0001129,1,0.968019342148224,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
431,GO:0001132,1,0.968019342148224,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
432,GO:0001133,1,0.880220290691457,0,18,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
433,GO:0001134,1,0.821630576444102,0,28,transcription factor activity, transcription factor recruiting,MF,
434,GO:0001135,1,0.955666666315546,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
435,GO:0001147,1,0.980284558913768,0,2,transcription termination site sequence-specific DNA binding,MF,
436,GO:0001156,1,0.96581643161612,0,3,TFIIIC-class transcription factor binding,MF,
437,GO:0001158,1,0.565498608334414,0,86,enhancer sequence-specific DNA binding,MF,
438,GO:0001160,1,0.980284558913768,0,2,transcription termination site DNA binding,MF,
439,GO:0001161,1,0.92123614973313,0,12,intronic transcription regulatory region sequence-specific DNA binding,MF,
440,GO:0001162,1,0.932094414595611,0,10,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
441,GO:0001163,1,0.945536942810825,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
442,GO:0001164,1,0.945536942810825,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
443,GO:0001165,1,0.992772295280378,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
444,GO:0001172,1,0.984070496792634,0,2,transcription, RNA-templated,BP,
445,GO:0001179,1,0.994683570556396,0,1,RNA polymerase I transcription factor binding,MF,
446,GO:0001181,1,0.993570877687035,0,1,transcription factor activity, core RNA polymerase I binding,MF,
447,GO:0001188,1,0.945536942810825,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
448,GO:0001190,1,0.621660648426204,0,64,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,
449,GO:0001191,1,0.740467861333059,0,46,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
450,GO:0001192,1,0.994826579096813,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
451,GO:0001193,1,0.994826579096813,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
452,GO:0001205,1,0.820157873503437,0,30,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
453,GO:0001206,1,0.92177583611555,0,10,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
454,GO:0001221,1,0.746802041159216,0,40,transcription cofactor binding,MF,
455,GO:0001222,1,0.908964204645134,0,14,transcription corepressor binding,MF,
456,GO:0001223,1,0.854388210173133,0,20,transcription coactivator binding,MF,
457,GO:0001224,1,0.97477613563232,0,3,RNA polymerase II transcription cofactor binding,MF,
458,GO:0001225,1,0.980697561756746,0,2,RNA polymerase II transcription coactivator binding,MF,
459,GO:0001226,1,0.993963198486243,0,1,RNA polymerase II transcription corepressor binding,MF,
461,GO:0001228,1,0.0762756276961094,0,383,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,
463,GO:0001302,1,0.961932800487562,0,6,replicative cell aging,BP,
464,GO:0001306,1,0.994816463596202,0,1,age-dependent response to oxidative stress,BP,
465,GO:0001315,1,0.994816463596202,0,1,age-dependent response to reactive oxygen species,BP,
466,GO:0001325,1,0.913739601252945,0,14,formation of extrachromosomal circular DNA,BP,
467,GO:0001401,1,0.98869098801492,0,2,mitochondrial sorting and assembly machinery complex,CC,
468,GO:0001405,1,0.971728069029603,0,5,presequence translocase-associated import motor,CC,
470,GO:0001502,1,0.889549074181786,0,17,cartilage condensation,BP,
474,GO:0001507,1,0.988612365486382,0,2,acetylcholine catabolic process in synaptic cleft,BP,
476,GO:0001510,1,0.712492632290155,0,57,RNA methylation,BP,
477,GO:0001512,1,0.994806180241139,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
478,GO:0001514,1,0.946770271849025,0,8,selenocysteine incorporation,BP,
479,GO:0001515,1,0.978843569587826,0,4,opioid peptide activity,MF,
481,GO:0001517,1,0.958425822969528,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
482,GO:0001518,1,0.874766621423357,0,14,voltage-gated sodium channel complex,CC,
483,GO:0001519,1,0.99359549975056,0,1,peptide amidation,BP,
484,GO:0001520,1,0.980123265107339,0,3,outer dense fiber,CC,
485,GO:0001522,1,0.905014151745679,0,18,pseudouridine synthesis,BP,
486,GO:0001523,1,0.62604976238732,0,70,retinoid metabolic process,BP,
488,GO:0001527,1,0.921201136615771,0,10,microfibril,CC,
490,GO:0001532,1,0.993980897783266,0,1,interleukin-21 receptor activity,MF,
492,GO:0001534,1,0.976705184198514,0,4,radial spoke,CC,
493,GO:0001536,1,0.982290843892888,0,3,radial spoke stalk,CC,
494,GO:0001537,1,0.970338794569613,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
495,GO:0001539,1,0.78390193072267,0,31,cilium or flagellum-dependent cell motility,BP,
496,GO:0001540,1,0.692217293918201,0,55,amyloid-beta binding,MF,
497,GO:0001541,1,0.727778065731782,0,49,ovarian follicle development,BP,
498,GO:0001542,1,0.929619713950354,0,9,ovulation from ovarian follicle,BP,
499,GO:0001543,1,0.98970109421946,0,1,ovarian follicle rupture,BP,
500,GO:0001544,1,0.989931555402469,0,1,initiation of primordial ovarian follicle growth,BP,
501,GO:0001545,1,0.993294318928742,0,1,primary ovarian follicle growth,BP,
502,GO:0001546,1,0.983990412609033,0,3,preantral ovarian follicle growth,BP,
503,GO:0001547,1,0.955497067211344,0,6,antral ovarian follicle growth,BP,
504,GO:0001550,1,0.98454798274091,0,2,ovarian cumulus expansion,BP,
505,GO:0001552,1,0.994662144494123,0,1,ovarian follicle atresia,BP,
506,GO:0001553,1,0.93743685577512,0,9,luteinization,BP,
507,GO:0001554,1,0.963527031738458,0,5,luteolysis,BP,
508,GO:0001555,1,0.983276684999238,0,3,oocyte growth,BP,
509,GO:0001556,1,0.879219073735855,0,20,oocyte maturation,BP,
511,GO:0001560,1,0.974466649753899,0,3,regulation of cell growth by extracellular stimulus,BP,
512,GO:0001561,1,0.955146085237791,0,8,fatty acid alpha-oxidation,BP,
513,GO:0001562,1,0.883898036946483,0,20,response to protozoan,BP,
514,GO:0001567,1,0.994779018494324,0,1,cholesterol 25-hydroxylase activity,MF,
518,GO:0001572,1,0.99253621125495,0,1,lactosylceramide biosynthetic process,BP,
521,GO:0001575,1,0.989318102558072,0,2,globoside metabolic process,BP,
522,GO:0001576,1,0.994617566626888,0,1,globoside biosynthetic process,BP,
523,GO:0001578,1,0.565992420036951,0,78,microtubule bundle formation,BP,
524,GO:0001579,1,0.987987040709975,0,2,medium-chain fatty acid transport,BP,
526,GO:0001581,1,0.994130640221456,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
527,GO:0001582,1,0.994428062514543,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
528,GO:0001587,1,0.992603061587419,0,1,Gq/11-coupled serotonin receptor activity,MF,
529,GO:0001588,1,0.978172600177977,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
530,GO:0001591,1,0.983623500244682,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
531,GO:0001595,1,0.98422401450165,0,3,angiotensin receptor activity,MF,
532,GO:0001596,1,0.994531690310349,0,1,angiotensin type I receptor activity,MF,
533,GO:0001601,1,0.98280169209012,0,3,peptide YY receptor activity,MF,
534,GO:0001602,1,0.973221884621863,0,5,pancreatic polypeptide receptor activity,MF,
535,GO:0001604,1,0.989591511978446,0,2,urotensin II receptor activity,MF,
536,GO:0001605,1,0.982061893830096,0,3,adrenomedullin receptor activity,MF,
537,GO:0001607,1,0.98863575315942,0,2,neuromedin U receptor activity,MF,
538,GO:0001608,1,0.930491997285683,0,13,G-protein coupled nucleotide receptor activity,MF,
539,GO:0001609,1,0.967345778897564,0,6,G-protein coupled adenosine receptor activity,MF,
540,GO:0001614,1,0.89516087890028,0,20,purinergic nucleotide receptor activity,MF,
541,GO:0001618,1,0.657303284578201,0,64,virus receptor activity,MF,
542,GO:0001621,1,0.994761818858827,0,1,ADP receptor activity,MF,
543,GO:0001626,1,0.993972454403759,0,1,nociceptin receptor activity,MF,
544,GO:0001631,1,0.967481502696901,0,6,cysteinyl leukotriene receptor activity,MF,
545,GO:0001632,1,0.988580515946865,0,2,leukotriene B4 receptor activity,MF,
546,GO:0001635,1,0.981632987173754,0,3,calcitonin gene-related peptide receptor activity,MF,
548,GO:0001640,1,0.95439152377542,0,6,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
549,GO:0001641,1,0.987522044347186,0,2,group II metabotropic glutamate receptor activity,MF,
550,GO:0001642,1,0.978137181326922,0,3,group III metabotropic glutamate receptor activity,MF,
552,GO:0001650,1,0.434163639025161,0,127,fibrillar center,CC,
553,GO:0001651,1,0.994803505452008,0,1,dense fibrillar component,CC,
554,GO:0001652,1,0.971256680877476,0,5,granular component,CC,
558,GO:0001656,1,0.554769367378364,0,81,metanephros development,BP,
559,GO:0001657,1,0.526150107593493,0,92,ureteric bud development,BP,
560,GO:0001658,1,0.683603549839983,0,54,branching involved in ureteric bud morphogenesis,BP,
561,GO:0001659,1,0.797866651724753,0,36,temperature homeostasis,BP,
562,GO:0001660,1,0.939473014382052,0,10,fever generation,BP,
564,GO:0001662,1,0.795642173430662,0,35,behavioral fear response,BP,
566,GO:0001665,1,0.967926946533318,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
569,GO:0001669,1,0.592206094831236,0,83,acrosomal vesicle,CC,
570,GO:0001671,1,0.860939533243289,0,26,ATPase activator activity,MF,
571,GO:0001672,1,0.932948370714901,0,9,regulation of chromatin assembly or disassembly,BP,
572,GO:0001673,1,0.93313637739665,0,11,male germ cell nucleus,CC,
573,GO:0001674,1,0.989107160907758,0,2,female germ cell nucleus,CC,
574,GO:0001675,1,0.94077914383502,0,8,acrosome assembly,BP,
575,GO:0001676,1,0.589730176686527,0,86,long-chain fatty acid metabolic process,BP,
577,GO:0001680,1,0.994551376364011,0,1,tRNA 3'-terminal CCA addition,BP,
578,GO:0001681,1,0.994273052560318,0,1,sialate O-acetylesterase activity,MF,
579,GO:0001682,1,0.934726851530465,0,12,tRNA 5'-leader removal,BP,
580,GO:0001692,1,0.984049257024573,0,3,histamine metabolic process,BP,
581,GO:0001694,1,0.994496200087079,0,1,histamine biosynthetic process,BP,
582,GO:0001695,1,0.994824698598226,0,1,histamine catabolic process,BP,
583,GO:0001696,1,0.909218835057231,0,16,gastric acid secretion,BP,
584,GO:0001697,1,0.99428656086018,0,1,histamine-induced gastric acid secretion,BP,
585,GO:0001698,1,0.989155482783808,0,2,gastrin-induced gastric acid secretion,BP,
587,GO:0001702,1,0.825534716424634,0,25,gastrulation with mouth forming second,BP,
589,GO:0001705,1,0.987174848286786,0,2,ectoderm formation,BP,
591,GO:0001707,1,0.65959249207055,0,62,mesoderm formation,BP,
592,GO:0001708,1,0.60581496549902,0,76,cell fate specification,BP,
593,GO:0001709,1,0.782497131145427,0,37,cell fate determination,BP,
594,GO:0001710,1,0.905711188425649,0,17,mesodermal cell fate commitment,BP,
595,GO:0001711,1,0.913787772734754,0,15,endodermal cell fate commitment,BP,
596,GO:0001712,1,0.987174848286786,0,2,ectodermal cell fate commitment,BP,
597,GO:0001714,1,0.957426041153106,0,8,endodermal cell fate specification,BP,
598,GO:0001715,1,0.993489199089586,0,1,ectodermal cell fate specification,BP,
599,GO:0001716,1,0.994628238340281,0,1,L-amino-acid oxidase activity,MF,
600,GO:0001725,1,0.681647400374916,0,52,stress fiber,CC,
602,GO:0001727,1,0.966079847712834,0,5,lipid kinase activity,MF,
603,GO:0001729,1,0.987162680280839,0,2,ceramide kinase activity,MF,
604,GO:0001730,1,0.974108488328847,0,4,2'-5'-oligoadenylate synthetase activity,MF,
605,GO:0001731,1,0.94795501750239,0,8,formation of translation preinitiation complex,BP,
606,GO:0001732,1,0.986709646158129,0,2,formation of cytoplasmic translation initiation complex,BP,
607,GO:0001733,1,0.978030643945505,0,4,galactosylceramide sulfotransferase activity,MF,
608,GO:0001735,1,0.986426861842812,0,2,prenylcysteine oxidase activity,MF,
609,GO:0001736,1,0.462449056496965,0,117,establishment of planar polarity,BP,
610,GO:0001738,1,0.412572530689063,0,132,morphogenesis of a polarized epithelium,BP,
611,GO:0001739,1,0.970918507624746,0,5,sex chromatin,CC,
612,GO:0001740,1,0.977960404744914,0,3,Barr body,CC,
613,GO:0001741,1,0.928613478034443,0,12,XY body,CC,
614,GO:0001743,1,0.978552166782765,0,3,optic placode formation,BP,
616,GO:0001754,1,0.767493648720737,0,38,eye photoreceptor cell differentiation,BP,
617,GO:0001755,1,0.730427695385598,0,46,neural crest cell migration,BP,
618,GO:0001756,1,0.657653402841585,0,57,somitogenesis,BP,
619,GO:0001757,1,0.970231807884994,0,5,somite specification,BP,
620,GO:0001758,1,0.961827093042407,0,7,retinal dehydrogenase activity,MF,
621,GO:0001759,1,0.898221503728557,0,18,organ induction,BP,
625,GO:0001766,1,0.948267452687395,0,9,membrane raft polarization,BP,
626,GO:0001767,1,0.928933213682467,0,10,establishment of lymphocyte polarity,BP,
627,GO:0001768,1,0.938162557853133,0,9,establishment of T cell polarity,BP,
628,GO:0001770,1,0.990168557069528,0,1,establishment of natural killer cell polarity,BP,
631,GO:0001773,1,0.868794768766354,0,24,myeloid dendritic cell activation,BP,
632,GO:0001774,1,0.840274235094947,0,25,microglial cell activation,BP,
635,GO:0001777,1,0.98372697615639,0,3,T cell homeostatic proliferation,BP,
636,GO:0001778,1,0.960921428892496,0,5,plasma membrane repair,BP,
637,GO:0001779,1,0.895404855725682,0,17,natural killer cell differentiation,BP,
640,GO:0001782,1,0.825631634596897,0,28,B cell homeostasis,BP,
641,GO:0001783,1,0.87027519656374,0,22,B cell apoptotic process,BP,
643,GO:0001785,1,0.988559448556813,0,2,prostaglandin J receptor activity,MF,
644,GO:0001786,1,0.785342886426322,0,37,phosphatidylserine binding,MF,
645,GO:0001787,1,0.958557460312911,0,7,natural killer cell proliferation,BP,
646,GO:0001788,1,0.994740552997493,0,1,antibody-dependent cellular cytotoxicity,BP,
647,GO:0001791,1,0.994714874879879,0,1,IgM binding,MF,
648,GO:0001792,1,0.993078395067198,0,1,polymeric immunoglobulin receptor activity,MF,
649,GO:0001794,1,0.981890033554059,0,3,type IIa hypersensitivity,BP,
650,GO:0001796,1,0.981890033554059,0,3,regulation of type IIa hypersensitivity,BP,
651,GO:0001797,1,0.994740552997493,0,1,negative regulation of type IIa hypersensitivity,BP,
652,GO:0001798,1,0.987082213899801,0,2,positive regulation of type IIa hypersensitivity,BP,
653,GO:0001802,1,0.989261558114773,0,2,type III hypersensitivity,BP,
654,GO:0001803,1,0.989261558114773,0,2,regulation of type III hypersensitivity,BP,
655,GO:0001805,1,0.989261558114773,0,2,positive regulation of type III hypersensitivity,BP,
656,GO:0001806,1,0.983624772971921,0,3,type IV hypersensitivity,BP,
657,GO:0001807,1,0.989436527306266,0,2,regulation of type IV hypersensitivity,BP,
658,GO:0001808,1,0.994632440985383,0,1,negative regulation of type IV hypersensitivity,BP,
659,GO:0001809,1,0.994776327250428,0,1,positive regulation of type IV hypersensitivity,BP,
660,GO:0001810,1,0.98405802831529,0,3,regulation of type I hypersensitivity,BP,
661,GO:0001811,1,0.994740552997493,0,1,negative regulation of type I hypersensitivity,BP,
662,GO:0001812,1,0.989261558114773,0,2,positive regulation of type I hypersensitivity,BP,
663,GO:0001813,1,0.994740552997493,0,1,regulation of antibody-dependent cellular cytotoxicity,BP,
664,GO:0001814,1,0.994740552997493,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
669,GO:0001820,1,0.943136497398664,0,10,serotonin secretion,BP,
670,GO:0001821,1,0.95167495527145,0,9,histamine secretion,BP,
671,GO:0001822,1,0.167169411294141,0,246,kidney development,BP,
672,GO:0001823,1,0.509230843510019,0,96,mesonephros development,BP,
673,GO:0001824,1,0.704674508184397,0,54,blastocyst development,BP,
674,GO:0001825,1,0.84960079775196,0,25,blastocyst formation,BP,
675,GO:0001826,1,0.954871861615572,0,6,inner cell mass cell differentiation,BP,
676,GO:0001827,1,0.984433040308074,0,2,inner cell mass cell fate commitment,BP,
677,GO:0001828,1,0.979041019426536,0,3,inner cell mass cellular morphogenesis,BP,
678,GO:0001829,1,0.926102599895627,0,12,trophectodermal cell differentiation,BP,
679,GO:0001831,1,0.985141515198294,0,2,trophectodermal cellular morphogenesis,BP,
680,GO:0001832,1,0.893503939839646,0,16,blastocyst growth,BP,
681,GO:0001833,1,0.927539160039478,0,11,inner cell mass cell proliferation,BP,
682,GO:0001834,1,0.984366267198461,0,2,trophectodermal cell proliferation,BP,
683,GO:0001835,1,0.993993108028265,0,1,blastocyst hatching,BP,
684,GO:0001836,1,0.728666257986555,0,54,release of cytochrome c from mitochondria,BP,
687,GO:0001839,1,0.961188656298291,0,6,neural plate morphogenesis,BP,
688,GO:0001840,1,0.936634598090953,0,9,neural plate development,BP,
690,GO:0001842,1,0.955088851554017,0,7,neural fold formation,BP,
692,GO:0001844,1,0.82826399173961,0,32,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
693,GO:0001845,1,0.924618519965263,0,12,phagolysosome assembly,BP,
695,GO:0001847,1,0.971832640844108,0,4,opsonin receptor activity,MF,
698,GO:0001850,1,0.994691888966527,0,1,complement component C3a binding,MF,
699,GO:0001851,1,0.969784777523377,0,4,complement component C3b binding,MF,
700,GO:0001855,1,0.982772761926021,0,2,complement component C4b binding,MF,
701,GO:0001856,1,0.994526835883411,0,1,complement component C5a binding,MF,
702,GO:0001861,1,0.987965628034237,0,1,complement component C4b receptor activity,MF,
703,GO:0001865,1,0.948825338459233,0,8,NK T cell differentiation,BP,
704,GO:0001866,1,0.97182560690588,0,5,NK T cell proliferation,BP,
710,GO:0001875,1,0.968358931266403,0,5,lipopolysaccharide receptor activity,MF,
712,GO:0001880,1,0.978722778500282,0,3,Mullerian duct regression,BP,
716,GO:0001884,1,0.986172059899896,0,2,pyrimidine nucleoside binding,MF,
717,GO:0001885,1,0.692113792546918,0,53,endothelial cell development,BP,
718,GO:0001886,1,0.927496080341611,0,10,endothelial cell morphogenesis,BP,
719,GO:0001887,1,0.971171103129345,0,5,selenium compound metabolic process,BP,
720,GO:0001888,1,0.985420867235021,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
728,GO:0001897,1,0.988946662515827,0,2,cytolysis by symbiont of host cells,BP,
729,GO:0001905,1,0.975654632408203,0,3,activation of membrane attack complex,BP,
731,GO:0001907,1,0.971274772481658,0,5,killing by symbiont of host cells,BP,
732,GO:0001909,1,0.631244665500869,0,77,leukocyte mediated cytotoxicity,BP,
733,GO:0001910,1,0.736626124479244,0,52,regulation of leukocyte mediated cytotoxicity,BP,
734,GO:0001911,1,0.922560611431734,0,14,negative regulation of leukocyte mediated cytotoxicity,BP,
735,GO:0001912,1,0.826150207292815,0,32,positive regulation of leukocyte mediated cytotoxicity,BP,
736,GO:0001913,1,0.852636756804576,0,27,T cell mediated cytotoxicity,BP,
737,GO:0001914,1,0.89073157742568,0,20,regulation of T cell mediated cytotoxicity,BP,
738,GO:0001915,1,0.964413593350185,0,6,negative regulation of T cell mediated cytotoxicity,BP,
739,GO:0001916,1,0.933454910378753,0,12,positive regulation of T cell mediated cytotoxicity,BP,
742,GO:0001920,1,0.976600651119355,0,4,negative regulation of receptor recycling,BP,
744,GO:0001922,1,0.978104764640257,0,3,B-1 B cell homeostasis,BP,
745,GO:0001923,1,0.980532024230565,0,3,B-1 B cell differentiation,BP,
746,GO:0001927,1,0.97983810578157,0,3,exocyst assembly,BP,
747,GO:0001928,1,0.994558252460162,0,1,regulation of exocyst assembly,BP,
748,GO:0001931,1,0.919391279463634,0,13,uropod,CC,
752,GO:0001935,1,0.440980299700961,0,120,endothelial cell proliferation,BP,
753,GO:0001936,1,0.48105354011408,0,106,regulation of endothelial cell proliferation,BP,
754,GO:0001937,1,0.79975998740878,0,32,negative regulation of endothelial cell proliferation,BP,
755,GO:0001938,1,0.581095085234268,0,78,positive regulation of endothelial cell proliferation,BP,
756,GO:0001939,1,0.96043716651774,0,6,female pronucleus,CC,
757,GO:0001940,1,0.959437807781929,0,5,male pronucleus,CC,
763,GO:0001947,1,0.690789687480899,0,55,heart looping,BP,
764,GO:0001949,1,0.994489228030668,0,1,sebaceous gland cell differentiation,BP,
765,GO:0001951,1,0.974665650733245,0,4,intestinal D-glucose absorption,BP,
769,GO:0001955,1,0.946391756594922,0,8,blood vessel maturation,BP,
770,GO:0001956,1,0.912547574613825,0,13,positive regulation of neurotransmitter secretion,BP,
775,GO:0001961,1,0.753876431436137,0,44,positive regulation of cytokine-mediated signaling pathway,BP,
776,GO:0001963,1,0.85836826926054,0,26,synaptic transmission, dopaminergic,BP,
778,GO:0001965,1,0.881308751091224,0,21,G-protein alpha-subunit binding,MF,
779,GO:0001966,1,0.99478068042453,0,1,thigmotaxis,BP,
781,GO:0001968,1,0.841226020562892,0,25,fibronectin binding,MF,
782,GO:0001969,1,0.975654632408203,0,3,regulation of activation of membrane attack complex,BP,
783,GO:0001970,1,0.985922081053768,0,2,positive regulation of activation of membrane attack complex,BP,
784,GO:0001971,1,0.989587409658653,0,1,negative regulation of activation of membrane attack complex,BP,
785,GO:0001972,1,0.921790788682326,0,12,retinoic acid binding,MF,
786,GO:0001973,1,0.930767324018006,0,12,adenosine receptor signaling pathway,BP,
787,GO:0001974,1,0.755556767066433,0,39,blood vessel remodeling,BP,
789,GO:0001976,1,0.929970009924824,0,11,neurological system process involved in regulation of systemic arterial blood pressure,BP,
790,GO:0001977,1,0.931569026202057,0,12,renal system process involved in regulation of blood volume,BP,
791,GO:0001978,1,0.994585904691897,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
792,GO:0001979,1,0.994721521013411,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
793,GO:0001980,1,0.994828221780802,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
794,GO:0001983,1,0.994585904691897,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
795,GO:0001985,1,0.994585904691897,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
796,GO:0001990,1,0.835432446849108,0,30,regulation of systemic arterial blood pressure by hormone,BP,
797,GO:0001991,1,0.918506572718954,0,14,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
798,GO:0001992,1,0.975676648413684,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
799,GO:0001993,1,0.946444102955438,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
800,GO:0001994,1,0.978213614812558,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
801,GO:0001996,1,0.972946138461157,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
802,GO:0001997,1,0.988881793298068,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
803,GO:0001998,1,0.994668217648025,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
804,GO:0001999,1,0.976203280186784,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
805,GO:0002001,1,0.976203280186784,0,4,renin secretion into blood stream,BP,
806,GO:0002002,1,0.940910645081678,0,10,regulation of angiotensin levels in blood,BP,
807,GO:0002003,1,0.940910645081678,0,10,angiotensin maturation,BP,
808,GO:0002007,1,0.994721521013411,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
811,GO:0002016,1,0.965945754429635,0,6,regulation of blood volume by renin-angiotensin,BP,
812,GO:0002017,1,0.994678645049058,0,1,regulation of blood volume by renal aldosterone,BP,
813,GO:0002018,1,0.988980123377657,0,2,renin-angiotensin regulation of aldosterone production,BP,
814,GO:0002019,1,0.983251909451366,0,3,regulation of renal output by angiotensin,BP,
816,GO:0002021,1,0.882825532617532,0,19,response to dietary excess,BP,
817,GO:0002023,1,0.994625879346492,0,1,reduction of food intake in response to dietary excess,BP,
818,GO:0002024,1,0.952690039770315,0,8,diet induced thermogenesis,BP,
819,GO:0002025,1,0.983377806762913,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
822,GO:0002028,1,0.566108469574739,0,81,regulation of sodium ion transport,BP,
824,GO:0002030,1,0.994235345635034,0,1,inhibitory G-protein coupled receptor phosphorylation,BP,
826,GO:0002032,1,0.989334299000158,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
827,GO:0002034,1,0.978349183529716,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
828,GO:0002035,1,0.982289905635371,0,3,brain renin-angiotensin system,BP,
829,GO:0002036,1,0.966222503372074,0,5,regulation of L-glutamate import across plasma membrane,BP,
830,GO:0002037,1,0.994606041912281,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
831,GO:0002038,1,0.994555591563614,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
832,GO:0002039,1,0.619919686283085,0,68,p53 binding,MF,
834,GO:0002041,1,0.994545561463139,0,1,intussusceptive angiogenesis,BP,
836,GO:0002043,1,0.903469091225759,0,15,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
837,GO:0002046,1,0.994820029435987,0,1,opsin binding,MF,
838,GO:0002051,1,0.966107794043726,0,4,osteoblast fate commitment,BP,
839,GO:0002052,1,0.867817367765605,0,20,positive regulation of neuroblast proliferation,BP,
840,GO:0002053,1,0.838274757944297,0,27,positive regulation of mesenchymal cell proliferation,BP,
841,GO:0002054,1,0.978401993417896,0,4,nucleobase binding,MF,
842,GO:0002055,1,0.994833072010578,0,1,adenine binding,MF,
843,GO:0002058,1,0.994605036022853,0,1,uracil binding,MF,
844,GO:0002059,1,0.994605036022853,0,1,thymine binding,MF,
845,GO:0002060,1,0.983709943556727,0,3,purine nucleobase binding,MF,
846,GO:0002061,1,0.994605036022853,0,1,pyrimidine nucleobase binding,MF,
847,GO:0002062,1,0.534100975392737,0,89,chondrocyte differentiation,BP,
848,GO:0002063,1,0.842906835910358,0,23,chondrocyte development,BP,
851,GO:0002066,1,0.705137970583322,0,51,columnar/cuboidal epithelial cell development,BP,
852,GO:0002067,1,0.753272440240314,0,43,glandular epithelial cell differentiation,BP,
853,GO:0002068,1,0.853559799647032,0,23,glandular epithelial cell development,BP,
854,GO:0002069,1,0.966806757219797,0,6,columnar/cuboidal epithelial cell maturation,BP,
855,GO:0002070,1,0.90392032993115,0,15,epithelial cell maturation,BP,
856,GO:0002071,1,0.988923913110916,0,2,glandular epithelial cell maturation,BP,
857,GO:0002072,1,0.937021591881041,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
858,GO:0002074,1,0.963359752288355,0,5,extraocular skeletal muscle development,BP,
859,GO:0002076,1,0.886590670847803,0,17,osteoblast development,BP,
860,GO:0002077,1,0.994779436706047,0,1,acrosome matrix dispersal,BP,
861,GO:0002079,1,0.972578083795088,0,4,inner acrosomal membrane,CC,
862,GO:0002080,1,0.895179029355743,0,18,acrosomal membrane,CC,
863,GO:0002081,1,0.983528786292182,0,2,outer acrosomal membrane,CC,
864,GO:0002082,1,0.912729740800552,0,15,regulation of oxidative phosphorylation,BP,
865,GO:0002083,1,0.994733618370611,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
866,GO:0002084,1,0.949199561996389,0,9,protein depalmitoylation,BP,
867,GO:0002085,1,0.971590112199909,0,4,inhibition of neuroepithelial cell differentiation,BP,
868,GO:0002086,1,0.988571704982937,0,2,diaphragm contraction,BP,
869,GO:0002087,1,0.922899966251865,0,12,regulation of respiratory gaseous exchange by neurological system process,BP,
871,GO:0002089,1,0.882964524511863,0,16,lens morphogenesis in camera-type eye,BP,
873,GO:0002091,1,0.944313688151019,0,9,negative regulation of receptor internalization,BP,
874,GO:0002092,1,0.864051073844441,0,22,positive regulation of receptor internalization,BP,
875,GO:0002093,1,0.919845322239453,0,12,auditory receptor cell morphogenesis,BP,
876,GO:0002094,1,0.988720970291632,0,2,polyprenyltransferase activity,MF,
877,GO:0002097,1,0.910456201679644,0,16,tRNA wobble base modification,BP,
879,GO:0002100,1,0.991030940628369,0,1,tRNA wobble adenosine to inosine editing,BP,
880,GO:0002101,1,0.982672602242027,0,3,tRNA wobble cytosine modification,BP,
881,GO:0002102,1,0.801984583952307,0,32,podosome,CC,
882,GO:0002113,1,0.99454750836859,0,1,interleukin-33 binding,MF,
883,GO:0002114,1,0.988105900478056,0,2,interleukin-33 receptor activity,MF,
884,GO:0002115,1,0.899945231798615,0,16,store-operated calcium entry,BP,
885,GO:0002116,1,0.903686868885401,0,11,semaphorin receptor complex,CC,
886,GO:0002118,1,0.959289327026224,0,7,aggressive behavior,BP,
887,GO:0002121,1,0.987944138444772,0,2,inter-male aggressive behavior,BP,
888,GO:0002125,1,0.987927742471035,0,2,maternal aggressive behavior,BP,
889,GO:0002127,1,0.994769655212555,0,1,tRNA wobble base cytosine methylation,BP,
890,GO:0002133,1,0.976048713732703,0,2,polycystin complex,CC,
891,GO:0002134,1,0.986172059899896,0,2,UTP binding,MF,
892,GO:0002135,1,0.994434863992636,0,1,CTP binding,MF,
893,GO:0002138,1,0.955604446073428,0,8,retinoic acid biosynthetic process,BP,
894,GO:0002139,1,0.964236454842585,0,4,stereocilia coupling link,CC,
895,GO:0002140,1,0.989874055397202,0,1,stereocilia tip link,CC,
896,GO:0002141,1,0.974102735440998,0,3,stereocilia ankle link,CC,
897,GO:0002142,1,0.974102735440998,0,3,stereocilia ankle link complex,CC,
898,GO:0002143,1,0.97863688691346,0,4,tRNA wobble position uridine thiolation,BP,
899,GO:0002144,1,0.994612674796797,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
900,GO:0002148,1,0.994015021629261,0,1,hypochlorous acid metabolic process,BP,
901,GO:0002149,1,0.994015021629261,0,1,hypochlorous acid biosynthetic process,BP,
903,GO:0002152,1,0.993855553218095,0,1,bile acid conjugation,BP,
904,GO:0002153,1,0.994492071724798,0,1,steroid receptor RNA activator RNA binding,MF,
905,GO:0002154,1,0.958992811970208,0,5,thyroid hormone mediated signaling pathway,BP,
906,GO:0002155,1,0.979569064645514,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
907,GO:0002158,1,0.970194142958701,0,5,osteoclast proliferation,BP,
908,GO:0002159,1,0.969990169853729,0,4,desmosome assembly,BP,
909,GO:0002161,1,0.933228328337,0,11,aminoacyl-tRNA editing activity,MF,
910,GO:0002162,1,0.931202468328758,0,8,dystroglycan binding,MF,
911,GO:0002169,1,0.98810571730964,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
912,GO:0002174,1,0.994214944803451,0,1,mammary stem cell proliferation,BP,
913,GO:0002175,1,0.966669685051814,0,4,protein localization to paranode region of axon,BP,
914,GO:0002176,1,0.968106096225629,0,6,male germ cell proliferation,BP,
915,GO:0002177,1,0.962101302251694,0,7,manchette,CC,
916,GO:0002178,1,0.935870365993204,0,11,palmitoyltransferase complex,CC,
917,GO:0002181,1,0.609263719126188,0,84,cytoplasmic translation,BP,
918,GO:0002182,1,0.93896126745968,0,10,cytoplasmic translational elongation,BP,
919,GO:0002183,1,0.888250964866151,0,18,cytoplasmic translational initiation,BP,
920,GO:0002184,1,0.984429504624133,0,2,cytoplasmic translational termination,BP,
921,GO:0002188,1,0.973974711016233,0,3,translation reinitiation,BP,
922,GO:0002189,1,0.994438476494689,0,1,ribose phosphate diphosphokinase complex,CC,
923,GO:0002190,1,0.97345434908139,0,5,cap-independent translational initiation,BP,
924,GO:0002191,1,0.981540481757063,0,3,cap-dependent translational initiation,BP,
925,GO:0002192,1,0.989587659234027,0,2,IRES-dependent translational initiation of linear mRNA,BP,
926,GO:0002193,1,0.974287471853312,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
927,GO:0002194,1,0.994125776747889,0,1,hepatocyte cell migration,BP,
928,GO:0002196,1,0.994673752271903,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
929,GO:0002199,1,0.956791098453681,0,8,zona pellucida receptor complex,CC,
930,GO:0002200,1,0.675519119759957,0,57,somatic diversification of immune receptors,BP,
931,GO:0002204,1,0.779014640920098,0,39,somatic recombination of immunoglobulin genes involved in immune response,BP,
932,GO:0002208,1,0.779014640920098,0,39,somatic diversification of immunoglobulins involved in immune response,BP,
933,GO:0002209,1,0.795642173430662,0,35,behavioral defense response,BP,
934,GO:0002215,1,0.988661553131677,0,2,defense response to nematode,BP,
936,GO:0002220,1,0.499026637083086,0,110,innate immune response activating cell surface receptor signaling pathway,BP,
938,GO:0002223,1,0.507082818198796,0,107,stimulatory C-type lectin receptor signaling pathway,BP,
940,GO:0002225,1,0.989464511884667,0,2,positive regulation of antimicrobial peptide production,BP,
942,GO:0002228,1,0.729473755386849,0,52,natural killer cell mediated immunity,BP,
943,GO:0002230,1,0.870853217036393,0,21,positive regulation of defense response to virus by host,BP,
944,GO:0002232,1,0.989349761230899,0,2,leukocyte chemotaxis involved in inflammatory response,BP,
946,GO:0002238,1,0.986748201095745,0,2,response to molecule of fungal origin,BP,
947,GO:0002244,1,0.366271281365612,0,159,hematopoietic progenitor cell differentiation,BP,
948,GO:0002246,1,0.965696383822334,0,6,wound healing involved in inflammatory response,BP,
949,GO:0002248,1,0.970793785060858,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
950,GO:0002249,1,0.96631685573279,0,5,lymphocyte anergy,BP,
955,GO:0002254,1,0.983860689540801,0,3,kinin cascade,BP,
956,GO:0002260,1,0.677503608249306,0,60,lymphocyte homeostasis,BP,
959,GO:0002265,1,0.968315987079513,0,3,astrocyte activation involved in immune response,BP,
960,GO:0002266,1,0.983639467671962,0,3,follicular dendritic cell activation,BP,
961,GO:0002268,1,0.988840806325752,0,2,follicular dendritic cell differentiation,BP,
964,GO:0002276,1,0.987813118604871,0,2,basophil activation involved in immune response,BP,
965,GO:0002277,1,0.980735891918463,0,3,myeloid dendritic cell activation involved in immune response,BP,
966,GO:0002278,1,0.978256734112049,0,4,eosinophil activation involved in immune response,BP,
968,GO:0002281,1,0.9448993575197,0,9,macrophage activation involved in immune response,BP,
969,GO:0002282,1,0.988463427981363,0,2,microglial cell activation involved in immune response,BP,
974,GO:0002290,1,0.994260248918568,0,1,gamma-delta T cell activation involved in immune response,BP,
979,GO:0002295,1,0.921663391156517,0,13,T-helper cell lineage commitment,BP,
980,GO:0002296,1,0.983799241459852,0,2,T-helper 1 cell lineage commitment,BP,
981,GO:0002298,1,0.994727313045411,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
982,GO:0002299,1,0.994748733754935,0,1,alpha-beta intraepithelial T cell differentiation,BP,
983,GO:0002300,1,0.994748733754935,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
984,GO:0002302,1,0.99433592275565,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
985,GO:0002304,1,0.994748733754935,0,1,gamma-delta intraepithelial T cell differentiation,BP,
986,GO:0002305,1,0.994748733754935,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
987,GO:0002309,1,0.977586544893065,0,4,T cell proliferation involved in immune response,BP,
988,GO:0002312,1,0.671440291310231,0,61,B cell activation involved in immune response,BP,
989,GO:0002313,1,0.89258921095491,0,17,mature B cell differentiation involved in immune response,BP,
990,GO:0002314,1,0.982975123489473,0,3,germinal center B cell differentiation,BP,
991,GO:0002315,1,0.932850626606524,0,9,marginal zone B cell differentiation,BP,
992,GO:0002316,1,0.987865709040262,0,2,follicular B cell differentiation,BP,
993,GO:0002317,1,0.984324384887301,0,3,plasma cell differentiation,BP,
994,GO:0002318,1,0.968442938132813,0,5,myeloid progenitor cell differentiation,BP,
995,GO:0002320,1,0.87498601580447,0,18,lymphoid progenitor cell differentiation,BP,
996,GO:0002322,1,0.966024814379147,0,5,B cell proliferation involved in immune response,BP,
997,GO:0002323,1,0.9518479904694,0,8,natural killer cell activation involved in immune response,BP,
998,GO:0002325,1,0.989580071327517,0,2,natural killer cell differentiation involved in immune response,BP,
999,GO:0002326,1,0.971005277602689,0,3,B cell lineage commitment,BP,
1000,GO:0002327,1,0.937447811949741,0,7,immature B cell differentiation,BP,
1001,GO:0002328,1,0.918019288206448,0,10,pro-B cell differentiation,BP,
1002,GO:0002329,1,0.961759669672691,0,4,pre-B cell differentiation,BP,
1003,GO:0002331,1,0.977133243707279,0,2,pre-B cell allelic exclusion,BP,
1004,GO:0002332,1,0.991676115748014,0,1,transitional stage B cell differentiation,BP,
1005,GO:0002333,1,0.991676115748014,0,1,transitional one stage B cell differentiation,BP,
1006,GO:0002335,1,0.868935585439052,0,21,mature B cell differentiation,BP,
1007,GO:0002337,1,0.988120191717056,0,2,B-1a B cell differentiation,BP,
1008,GO:0002339,1,0.983893323550612,0,3,B cell selection,BP,
1009,GO:0002343,1,0.994394966194328,0,1,peripheral B cell selection,BP,
1010,GO:0002344,1,0.994394966194328,0,1,B cell affinity maturation,BP,
1011,GO:0002347,1,0.906484931272592,0,17,response to tumor cell,BP,
1012,GO:0002349,1,0.967635152437168,0,6,histamine production involved in inflammatory response,BP,
1013,GO:0002351,1,0.981519046635611,0,3,serotonin production involved in inflammatory response,BP,
1014,GO:0002352,1,0.98943975467848,0,2,B cell negative selection,BP,
1015,GO:0002353,1,0.983860689540801,0,3,plasma kallikrein-kinin cascade,BP,
1016,GO:0002355,1,0.994490104663249,0,1,detection of tumor cell,BP,
1017,GO:0002357,1,0.98317423679804,0,3,defense response to tumor cell,BP,
1018,GO:0002358,1,0.994829850254701,0,1,B cell homeostatic proliferation,BP,
1019,GO:0002360,1,0.866899946046452,0,21,T cell lineage commitment,BP,
1020,GO:0002361,1,0.978325706437255,0,4,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1021,GO:0002362,1,0.994528054242239,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1022,GO:0002363,1,0.905783435395179,0,16,alpha-beta T cell lineage commitment,BP,
1024,GO:0002367,1,0.629298831942305,0,76,cytokine production involved in immune response,BP,
1025,GO:0002368,1,0.98896098593572,0,2,B cell cytokine production,BP,
1026,GO:0002369,1,0.836996459678408,0,30,T cell cytokine production,BP,
1027,GO:0002370,1,0.987321851056041,0,2,natural killer cell cytokine production,BP,
1028,GO:0002371,1,0.958262459892193,0,6,dendritic cell cytokine production,BP,
1029,GO:0002373,1,0.994822550162066,0,1,plasmacytoid dendritic cell cytokine production,BP,
1030,GO:0002374,1,0.905301970932267,0,16,cytokine secretion involved in immune response,BP,
1033,GO:0002378,1,0.979641802846506,0,3,immunoglobulin biosynthetic process,BP,
1034,GO:0002380,1,0.992860023444358,0,1,immunoglobulin secretion involved in immune response,BP,
1036,GO:0002384,1,0.988056668495204,0,2,hepatic immune response,BP,
1038,GO:0002386,1,0.987781927738157,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1039,GO:0002396,1,0.974128168425038,0,5,MHC protein complex assembly,BP,
1040,GO:0002397,1,0.994669306956329,0,1,MHC class I protein complex assembly,BP,
1041,GO:0002399,1,0.979349870107715,0,4,MHC class II protein complex assembly,BP,
1042,GO:0002407,1,0.87524939628087,0,22,dendritic cell chemotaxis,BP,
1043,GO:0002408,1,0.976285182010308,0,4,myeloid dendritic cell chemotaxis,BP,
1044,GO:0002414,1,0.98255348108359,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1045,GO:0002415,1,0.987781927738157,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1046,GO:0002416,1,0.994707531155888,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1047,GO:0002418,1,0.921674327788417,0,14,immune response to tumor cell,BP,
1048,GO:0002420,1,0.948080300317891,0,9,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1049,GO:0002423,1,0.948080300317891,0,9,natural killer cell mediated immune response to tumor cell,BP,
1050,GO:0002424,1,0.988425706687646,0,2,T cell mediated immune response to tumor cell,BP,
1051,GO:0002426,1,0.994797996453385,0,1,immunoglobulin production in mucosal tissue,BP,
1052,GO:0002428,1,0.982961606524364,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1054,GO:0002430,1,0.950960549248272,0,8,complement receptor mediated signaling pathway,BP,
1055,GO:0002431,1,0.618390197652618,0,75,Fc receptor mediated stimulatory signaling pathway,BP,
1056,GO:0002432,1,0.992943023750549,0,1,granuloma formation,BP,
1057,GO:0002433,1,0.637188260892889,0,70,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1058,GO:0002434,1,0.989225635570567,0,2,immune complex clearance,BP,
1059,GO:0002436,1,0.989225635570567,0,2,immune complex clearance by monocytes and macrophages,BP,
1061,GO:0002438,1,0.895922243587206,0,19,acute inflammatory response to antigenic stimulus,BP,
1062,GO:0002439,1,0.978948128123928,0,4,chronic inflammatory response to antigenic stimulus,BP,
1064,GO:0002441,1,0.967635152437168,0,6,histamine secretion involved in inflammatory response,BP,
1065,GO:0002442,1,0.981519046635611,0,3,serotonin secretion involved in inflammatory response,BP,
1068,GO:0002445,1,0.981890033554059,0,3,type II hypersensitivity,BP,
1070,GO:0002447,1,0.978256734112049,0,4,eosinophil mediated immunity,BP,
1073,GO:0002450,1,0.994740552997493,0,1,B cell antigen processing and presentation,BP,
1075,GO:0002456,1,0.639221290075984,0,74,T cell mediated immunity,BP,
1076,GO:0002457,1,0.969695552609949,0,5,T cell antigen processing and presentation,BP,
1077,GO:0002458,1,0.989166466955362,0,2,peripheral T cell tolerance induction,BP,
1079,GO:0002461,1,0.98375839973087,0,3,tolerance induction dependent upon immune response,BP,
1080,GO:0002465,1,0.989166466955362,0,2,peripheral tolerance induction,BP,
1081,GO:0002467,1,0.902863548698343,0,15,germinal center formation,BP,
1082,GO:0002468,1,0.945808643407677,0,9,dendritic cell antigen processing and presentation,BP,
1084,GO:0002475,1,0.952319369576076,0,8,antigen processing and presentation via MHC class Ib,BP,
1085,GO:0002476,1,0.988081157090583,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1086,GO:0002477,1,0.994819314532757,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1088,GO:0002479,1,0.680083220640882,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1089,GO:0002480,1,0.957131024106652,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1090,GO:0002481,1,0.994819314532757,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1091,GO:0002483,1,0.950438427295111,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1092,GO:0002488,1,0.993320421893173,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1093,GO:0002489,1,0.993320421893173,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1095,GO:0002501,1,0.979214912173502,0,4,peptide antigen assembly with MHC protein complex,BP,
1096,GO:0002502,1,0.994669306956329,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1097,GO:0002503,1,0.984463606267413,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1099,GO:0002505,1,0.989627736475638,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1100,GO:0002506,1,0.989627736475638,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1101,GO:0002507,1,0.865904539286801,0,23,tolerance induction,BP,
1102,GO:0002508,1,0.989028435902785,0,2,central tolerance induction,BP,
1103,GO:0002509,1,0.99460920833876,0,1,central tolerance induction to self antigen,BP,
1104,GO:0002510,1,0.994389282500765,0,1,central B cell tolerance induction,BP,
1105,GO:0002513,1,0.97087700479031,0,5,tolerance induction to self antigen,BP,
1106,GO:0002514,1,0.987120904512393,0,2,B cell tolerance induction,BP,
1107,GO:0002517,1,0.927752560269162,0,12,T cell tolerance induction,BP,
1108,GO:0002518,1,0.994800064853307,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1109,GO:0002519,1,0.989289147390898,0,2,natural killer cell tolerance induction,BP,
1112,GO:0002522,1,0.989119783704943,0,2,leukocyte migration involved in immune response,BP,
1113,GO:0002523,1,0.93885645956963,0,11,leukocyte migration involved in inflammatory response,BP,
1114,GO:0002524,1,0.955195976313545,0,8,hypersensitivity,BP,
1115,GO:0002525,1,0.983502974597504,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1117,GO:0002528,1,0.983502503465096,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1119,GO:0002534,1,0.828538931650498,0,30,cytokine production involved in inflammatory response,BP,
1120,GO:0002536,1,0.984166271008039,0,3,respiratory burst involved in inflammatory response,BP,
1121,GO:0002537,1,0.981437246927539,0,2,nitric oxide production involved in inflammatory response,BP,
1124,GO:0002541,1,0.983795013429699,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1125,GO:0002542,1,0.989215404447577,0,2,Factor XII activation,BP,
1126,GO:0002543,1,0.987129553326251,0,2,activation of blood coagulation via clotting cascade,BP,
1127,GO:0002544,1,0.903714571749202,0,17,chronic inflammatory response,BP,
1128,GO:0002545,1,0.994678120727467,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1130,GO:0002551,1,0.940039322954169,0,10,mast cell chemotaxis,BP,
1131,GO:0002553,1,0.967635152437168,0,6,histamine secretion by mast cell,BP,
1132,GO:0002554,1,0.981519046635611,0,3,serotonin secretion by platelet,BP,
1133,GO:0002560,1,0.993166120876802,0,1,basophil mediated immunity,BP,
1134,GO:0002561,1,0.993166120876802,0,1,basophil degranulation,BP,
1135,GO:0002562,1,0.705467967584233,0,51,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1136,GO:0002566,1,0.924311255346808,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1137,GO:0002568,1,0.95584595352159,0,5,somatic diversification of T cell receptor genes,BP,
1138,GO:0002572,1,0.987535778852267,0,2,pro-T cell differentiation,BP,
1141,GO:0002577,1,0.905402021547126,0,17,regulation of antigen processing and presentation,BP,
1142,GO:0002578,1,0.959123246199482,0,7,negative regulation of antigen processing and presentation,BP,
1143,GO:0002579,1,0.949053929749906,0,9,positive regulation of antigen processing and presentation,BP,
1144,GO:0002580,1,0.970082924452595,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1145,GO:0002581,1,0.98021438559323,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1146,GO:0002582,1,0.989666091593096,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1147,GO:0002583,1,0.968012781015357,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1148,GO:0002584,1,0.978122840423267,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1149,GO:0002585,1,0.989666091593096,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1150,GO:0002586,1,0.978402601677297,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1151,GO:0002587,1,0.988620075719689,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1152,GO:0002588,1,0.989666091593096,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1153,GO:0002589,1,0.989383141988122,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1154,GO:0002590,1,0.989383141988122,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1155,GO:0002604,1,0.945808643407677,0,9,regulation of dendritic cell antigen processing and presentation,BP,
1156,GO:0002605,1,0.986283343290208,0,2,negative regulation of dendritic cell antigen processing and presentation,BP,
1157,GO:0002606,1,0.958967952583251,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1158,GO:0002622,1,0.994740552997493,0,1,regulation of B cell antigen processing and presentation,BP,
1159,GO:0002625,1,0.989378962343985,0,2,regulation of T cell antigen processing and presentation,BP,
1160,GO:0002626,1,0.994660744776641,0,1,negative regulation of T cell antigen processing and presentation,BP,
1161,GO:0002634,1,0.938684732270673,0,9,regulation of germinal center formation,BP,
1162,GO:0002635,1,0.980864317287055,0,2,negative regulation of germinal center formation,BP,
1163,GO:0002636,1,0.984459044955453,0,3,positive regulation of germinal center formation,BP,
1164,GO:0002637,1,0.724611219851546,0,52,regulation of immunoglobulin production,BP,
1165,GO:0002638,1,0.934887180089038,0,10,negative regulation of immunoglobulin production,BP,
1166,GO:0002639,1,0.81372695557316,0,34,positive regulation of immunoglobulin production,BP,
1167,GO:0002640,1,0.994313214468247,0,1,regulation of immunoglobulin biosynthetic process,BP,
1168,GO:0002642,1,0.994313214468247,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1169,GO:0002643,1,0.901309886875377,0,16,regulation of tolerance induction,BP,
1170,GO:0002644,1,0.994610367698507,0,1,negative regulation of tolerance induction,BP,
1171,GO:0002645,1,0.941511525529673,0,9,positive regulation of tolerance induction,BP,
1172,GO:0002646,1,0.994389282500765,0,1,regulation of central tolerance induction,BP,
1173,GO:0002648,1,0.994389282500765,0,1,positive regulation of central tolerance induction,BP,
1174,GO:0002649,1,0.992691020896154,0,1,regulation of tolerance induction to self antigen,BP,
1175,GO:0002651,1,0.992691020896154,0,1,positive regulation of tolerance induction to self antigen,BP,
1176,GO:0002652,1,0.989090967099511,0,2,regulation of tolerance induction dependent upon immune response,BP,
1177,GO:0002654,1,0.994528054242239,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1178,GO:0002658,1,0.994528054242239,0,1,regulation of peripheral tolerance induction,BP,
1179,GO:0002660,1,0.994528054242239,0,1,positive regulation of peripheral tolerance induction,BP,
1180,GO:0002661,1,0.987120904512393,0,2,regulation of B cell tolerance induction,BP,
1181,GO:0002663,1,0.987120904512393,0,2,positive regulation of B cell tolerance induction,BP,
1182,GO:0002664,1,0.938053452381864,0,10,regulation of T cell tolerance induction,BP,
1183,GO:0002666,1,0.957351178487365,0,7,positive regulation of T cell tolerance induction,BP,
1184,GO:0002667,1,0.96631685573279,0,5,regulation of T cell anergy,BP,
1185,GO:0002669,1,0.980289133980713,0,3,positive regulation of T cell anergy,BP,
1187,GO:0002674,1,0.942150213556467,0,9,negative regulation of acute inflammatory response,BP,
1188,GO:0002675,1,0.863566652097317,0,25,positive regulation of acute inflammatory response,BP,
1189,GO:0002676,1,0.954915098776394,0,8,regulation of chronic inflammatory response,BP,
1190,GO:0002677,1,0.975314290757347,0,4,negative regulation of chronic inflammatory response,BP,
1191,GO:0002678,1,0.979089670986762,0,4,positive regulation of chronic inflammatory response,BP,
1192,GO:0002679,1,0.957326637700164,0,7,respiratory burst involved in defense response,BP,
1193,GO:0002681,1,0.95584595352159,0,5,somatic recombination of T cell receptor gene segments,BP,
1203,GO:0002691,1,0.869639363121335,0,22,regulation of cellular extravasation,BP,
1204,GO:0002692,1,0.947179736573436,0,8,negative regulation of cellular extravasation,BP,
1205,GO:0002693,1,0.927969455783505,0,12,positive regulation of cellular extravasation,BP,
1212,GO:0002700,1,0.523625734760511,0,104,regulation of production of molecular mediator of immune response,BP,
1213,GO:0002701,1,0.826138830652818,0,30,negative regulation of production of molecular mediator of immune response,BP,
1214,GO:0002702,1,0.660355619974451,0,68,positive regulation of production of molecular mediator of immune response,BP,
1215,GO:0002703,1,0.392737079915602,0,152,regulation of leukocyte mediated immunity,BP,
1216,GO:0002704,1,0.780923031343527,0,41,negative regulation of leukocyte mediated immunity,BP,
1217,GO:0002705,1,0.575892586866469,0,90,positive regulation of leukocyte mediated immunity,BP,
1218,GO:0002706,1,0.511702927979472,0,110,regulation of lymphocyte mediated immunity,BP,
1219,GO:0002707,1,0.832645308466142,0,31,negative regulation of lymphocyte mediated immunity,BP,
1220,GO:0002708,1,0.646957902522306,0,71,positive regulation of lymphocyte mediated immunity,BP,
1221,GO:0002709,1,0.755081439080719,0,48,regulation of T cell mediated immunity,BP,
1222,GO:0002710,1,0.918576931279706,0,15,negative regulation of T cell mediated immunity,BP,
1223,GO:0002711,1,0.841551649368517,0,29,positive regulation of T cell mediated immunity,BP,
1224,GO:0002712,1,0.771774479260907,0,41,regulation of B cell mediated immunity,BP,
1225,GO:0002713,1,0.944225734354382,0,9,negative regulation of B cell mediated immunity,BP,
1226,GO:0002714,1,0.839448613322963,0,28,positive regulation of B cell mediated immunity,BP,
1227,GO:0002715,1,0.820129780354151,0,33,regulation of natural killer cell mediated immunity,BP,
1228,GO:0002716,1,0.938519652384402,0,11,negative regulation of natural killer cell mediated immunity,BP,
1229,GO:0002717,1,0.879264899030714,0,21,positive regulation of natural killer cell mediated immunity,BP,
1230,GO:0002718,1,0.692039469675142,0,60,regulation of cytokine production involved in immune response,BP,
1231,GO:0002719,1,0.879010893428425,0,21,negative regulation of cytokine production involved in immune response,BP,
1232,GO:0002720,1,0.806885496174148,0,35,positive regulation of cytokine production involved in immune response,BP,
1233,GO:0002721,1,0.994394966194328,0,1,regulation of B cell cytokine production,BP,
1234,GO:0002724,1,0.882140585292089,0,21,regulation of T cell cytokine production,BP,
1235,GO:0002725,1,0.967728142538553,0,6,negative regulation of T cell cytokine production,BP,
1236,GO:0002726,1,0.917724835818362,0,14,positive regulation of T cell cytokine production,BP,
1237,GO:0002727,1,0.987321851056041,0,2,regulation of natural killer cell cytokine production,BP,
1238,GO:0002728,1,0.992893608324605,0,1,negative regulation of natural killer cell cytokine production,BP,
1239,GO:0002729,1,0.994388763401318,0,1,positive regulation of natural killer cell cytokine production,BP,
1240,GO:0002730,1,0.965842999516534,0,5,regulation of dendritic cell cytokine production,BP,
1241,GO:0002731,1,0.986737168061742,0,2,negative regulation of dendritic cell cytokine production,BP,
1242,GO:0002732,1,0.992867050439484,0,1,positive regulation of dendritic cell cytokine production,BP,
1243,GO:0002736,1,0.994822550162066,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1244,GO:0002737,1,0.994822550162066,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1245,GO:0002739,1,0.923840116833436,0,13,regulation of cytokine secretion involved in immune response,BP,
1246,GO:0002740,1,0.971884623839782,0,5,negative regulation of cytokine secretion involved in immune response,BP,
1247,GO:0002741,1,0.956322101715466,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1248,GO:0002752,1,0.989449369550417,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1249,GO:0002753,1,0.705565410074163,0,52,cytoplasmic pattern recognition receptor signaling pathway,BP,
1250,GO:0002755,1,0.798393102767828,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1251,GO:0002756,1,0.832710897314161,0,30,MyD88-independent toll-like receptor signaling pathway,BP,
1254,GO:0002759,1,0.97795866666876,0,4,regulation of antimicrobial humoral response,BP,
1255,GO:0002760,1,0.989464511884667,0,2,positive regulation of antimicrobial humoral response,BP,
1258,GO:0002763,1,0.762692036415832,0,42,positive regulation of myeloid leukocyte differentiation,BP,
1260,GO:0002765,1,0.961950722635006,0,7,immune response-inhibiting signal transduction,BP,
1261,GO:0002767,1,0.967143655244964,0,6,immune response-inhibiting cell surface receptor signaling pathway,BP,
1263,GO:0002769,1,0.989365398983859,0,2,natural killer cell inhibitory signaling pathway,BP,
1264,GO:0002774,1,0.982706635384106,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1265,GO:0002775,1,0.978091352909482,0,4,antimicrobial peptide production,BP,
1266,GO:0002777,1,0.994823580847966,0,1,antimicrobial peptide biosynthetic process,BP,
1267,GO:0002778,1,0.978091352909482,0,4,antibacterial peptide production,BP,
1268,GO:0002780,1,0.994823580847966,0,1,antibacterial peptide biosynthetic process,BP,
1269,GO:0002784,1,0.983181575002281,0,3,regulation of antimicrobial peptide production,BP,
1270,GO:0002785,1,0.993650835388071,0,1,negative regulation of antimicrobial peptide production,BP,
1271,GO:0002786,1,0.983181575002281,0,3,regulation of antibacterial peptide production,BP,
1272,GO:0002787,1,0.993650835388071,0,1,negative regulation of antibacterial peptide production,BP,
1277,GO:0002803,1,0.989464511884667,0,2,positive regulation of antibacterial peptide production,BP,
1278,GO:0002812,1,0.994823580847966,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1279,GO:0002818,1,0.994826944745365,0,1,intracellular defense response,BP,
1281,GO:0002820,1,0.809804700869788,0,34,negative regulation of adaptive immune response,BP,
1284,GO:0002823,1,0.823565527815212,0,31,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1287,GO:0002826,1,0.959166583190045,0,7,negative regulation of T-helper 1 type immune response,BP,
1291,GO:0002830,1,0.916753885224653,0,15,positive regulation of type 2 immune response,BP,
1294,GO:0002833,1,0.800108485204241,0,34,positive regulation of response to biotic stimulus,BP,
1295,GO:0002834,1,0.937101118625593,0,11,regulation of response to tumor cell,BP,
1296,GO:0002835,1,0.988383287277771,0,2,negative regulation of response to tumor cell,BP,
1297,GO:0002836,1,0.953984301245102,0,8,positive regulation of response to tumor cell,BP,
1298,GO:0002837,1,0.937101118625593,0,11,regulation of immune response to tumor cell,BP,
1299,GO:0002838,1,0.988383287277771,0,2,negative regulation of immune response to tumor cell,BP,
1300,GO:0002839,1,0.953984301245102,0,8,positive regulation of immune response to tumor cell,BP,
1301,GO:0002840,1,0.988425706687646,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1302,GO:0002842,1,0.994535697056988,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1303,GO:0002849,1,0.994528054242239,0,1,regulation of peripheral T cell tolerance induction,BP,
1304,GO:0002851,1,0.994528054242239,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1305,GO:0002855,1,0.948080300317891,0,9,regulation of natural killer cell mediated immune response to tumor cell,BP,
1306,GO:0002856,1,0.988383287277771,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1307,GO:0002857,1,0.959227991840054,0,7,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1308,GO:0002858,1,0.948080300317891,0,9,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1309,GO:0002859,1,0.988383287277771,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1310,GO:0002860,1,0.959227991840054,0,7,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1313,GO:0002863,1,0.94171132187401,0,10,positive regulation of inflammatory response to antigenic stimulus,BP,
1314,GO:0002864,1,0.93708262654431,0,11,regulation of acute inflammatory response to antigenic stimulus,BP,
1315,GO:0002865,1,0.978292154732724,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1316,GO:0002866,1,0.957885106725808,0,7,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1317,GO:0002870,1,0.96631685573279,0,5,T cell anergy,BP,
1318,GO:0002874,1,0.984318263433407,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1319,GO:0002875,1,0.99473599633455,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1320,GO:0002876,1,0.989527688568719,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1321,GO:0002877,1,0.983502974597504,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1322,GO:0002878,1,0.994053230509328,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1323,GO:0002879,1,0.989387259092226,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1324,GO:0002880,1,0.994678120727467,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1325,GO:0002882,1,0.994678120727467,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1326,GO:0002883,1,0.960841420235538,0,7,regulation of hypersensitivity,BP,
1327,GO:0002884,1,0.989400943173506,0,2,negative regulation of hypersensitivity,BP,
1328,GO:0002885,1,0.9711375646423,0,5,positive regulation of hypersensitivity,BP,
1329,GO:0002886,1,0.7691165055656,0,43,regulation of myeloid leukocyte mediated immunity,BP,
1330,GO:0002887,1,0.940615343715453,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1331,GO:0002888,1,0.880441836950128,0,21,positive regulation of myeloid leukocyte mediated immunity,BP,
1332,GO:0002889,1,0.771774479260907,0,41,regulation of immunoglobulin mediated immune response,BP,
1333,GO:0002890,1,0.944225734354382,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1334,GO:0002891,1,0.839448613322963,0,28,positive regulation of immunoglobulin mediated immune response,BP,
1335,GO:0002892,1,0.981890033554059,0,3,regulation of type II hypersensitivity,BP,
1336,GO:0002893,1,0.994740552997493,0,1,negative regulation of type II hypersensitivity,BP,
1337,GO:0002894,1,0.987082213899801,0,2,positive regulation of type II hypersensitivity,BP,
1338,GO:0002895,1,0.994389282500765,0,1,regulation of central B cell tolerance induction,BP,
1339,GO:0002897,1,0.994389282500765,0,1,positive regulation of central B cell tolerance induction,BP,
1340,GO:0002901,1,0.978653009786998,0,4,mature B cell apoptotic process,BP,
1341,GO:0002902,1,0.897599693889457,0,17,regulation of B cell apoptotic process,BP,
1342,GO:0002903,1,0.933881740375689,0,11,negative regulation of B cell apoptotic process,BP,
1343,GO:0002904,1,0.980376579027374,0,3,positive regulation of B cell apoptotic process,BP,
1344,GO:0002905,1,0.978653009786998,0,4,regulation of mature B cell apoptotic process,BP,
1345,GO:0002906,1,0.978653009786998,0,4,negative regulation of mature B cell apoptotic process,BP,
1346,GO:0002911,1,0.96631685573279,0,5,regulation of lymphocyte anergy,BP,
1347,GO:0002913,1,0.980289133980713,0,3,positive regulation of lymphocyte anergy,BP,
1350,GO:0002922,1,0.93507600714842,0,12,positive regulation of humoral immune response,BP,
1351,GO:0002923,1,0.94647741662996,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1352,GO:0002924,1,0.966650723182562,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1353,GO:0002925,1,0.979137725660521,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1354,GO:0002930,1,0.986882256633911,0,2,trabecular meshwork development,BP,
1355,GO:0002931,1,0.799304771650863,0,33,response to ischemia,BP,
1356,GO:0002933,1,0.983874123969251,0,3,lipid hydroxylation,BP,
1357,GO:0002934,1,0.933136124555007,0,9,desmosome organization,BP,
1358,GO:0002940,1,0.98892766197736,0,2,tRNA N2-guanine methylation,BP,
1359,GO:0002943,1,0.978439163542573,0,4,tRNA dihydrouridine synthesis,BP,
1360,GO:0002944,1,0.98358840933517,0,2,cyclin K-CDK12 complex,CC,
1361,GO:0002945,1,0.984976601376822,0,2,cyclin K-CDK13 complex,CC,
1362,GO:0002946,1,0.994769655212555,0,1,tRNA C5-cytosine methylation,BP,
1363,GO:0002947,1,0.993226916650415,0,1,tumor necrosis factor receptor superfamily complex,CC,
1364,GO:0002949,1,0.984059032595723,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1365,GO:0002950,1,0.979606678677528,0,3,ceramide phosphoethanolamine synthase activity,MF,
1366,GO:0002951,1,0.989001836857169,0,2,leukotriene-C(4) hydrolase,MF,
1367,GO:0003002,1,0.124592099503951,0,308,regionalization,BP,
1369,GO:0003007,1,0.193950267055451,0,224,heart morphogenesis,BP,
1371,GO:0003009,1,0.782327614510106,0,38,skeletal muscle contraction,BP,
1372,GO:0003010,1,0.965471079791807,0,5,voluntary skeletal muscle contraction,BP,
1373,GO:0003011,1,0.980966696103994,0,3,involuntary skeletal muscle contraction,BP,
1378,GO:0003016,1,0.82662240527783,0,29,respiratory system process,BP,
1379,GO:0003017,1,0.988119682827402,0,1,lymph circulation,BP,
1381,GO:0003025,1,0.975608029391401,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1382,GO:0003026,1,0.994313214468247,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1383,GO:0003027,1,0.994721521013411,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1384,GO:0003029,1,0.994721521013411,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1385,GO:0003032,1,0.988633666924083,0,2,detection of oxygen,BP,
1386,GO:0003044,1,0.786520175253577,0,40,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1387,GO:0003050,1,0.992391277140388,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1388,GO:0003051,1,0.982289905635371,0,3,angiotensin-mediated drinking behavior,BP,
1389,GO:0003056,1,0.951408701474901,0,7,regulation of vascular smooth muscle contraction,BP,
1390,GO:0003057,1,0.972787720775605,0,5,regulation of the force of heart contraction by chemical signal,BP,
1391,GO:0003058,1,0.994795748772704,0,1,hormonal regulation of the force of heart contraction,BP,
1392,GO:0003062,1,0.958540554067759,0,6,regulation of heart rate by chemical signal,BP,
1393,GO:0003064,1,0.988756155985356,0,2,regulation of heart rate by hormone,BP,
1394,GO:0003065,1,0.994701102526894,0,1,positive regulation of heart rate by epinephrine,BP,
1395,GO:0003068,1,0.994816463596202,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1396,GO:0003069,1,0.994816463596202,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1397,GO:0003070,1,0.994816463596202,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1398,GO:0003071,1,0.900664260114281,0,18,renal system process involved in regulation of systemic arterial blood pressure,BP,
1399,GO:0003072,1,0.978349183529716,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1401,GO:0003081,1,0.893572523831002,0,19,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1402,GO:0003083,1,0.994834972089459,0,1,negative regulation of renal output by angiotensin,BP,
1403,GO:0003084,1,0.94292761431536,0,9,positive regulation of systemic arterial blood pressure,BP,
1404,GO:0003085,1,0.921628675500124,0,13,negative regulation of systemic arterial blood pressure,BP,
1405,GO:0003091,1,0.810824620732,0,29,renal water homeostasis,BP,
1406,GO:0003093,1,0.941535791461717,0,10,regulation of glomerular filtration,BP,
1407,GO:0003094,1,0.908978952264788,0,15,glomerular filtration,BP,
1408,GO:0003095,1,0.994714208385392,0,1,pressure natriuresis,BP,
1409,GO:0003096,1,0.967735050115743,0,5,renal sodium ion transport,BP,
1410,GO:0003097,1,0.97190575466822,0,5,renal water transport,BP,
1411,GO:0003099,1,0.983734829348222,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1412,GO:0003100,1,0.965665532343567,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1413,GO:0003104,1,0.977235669534205,0,4,positive regulation of glomerular filtration,BP,
1414,GO:0003105,1,0.976687014049833,0,4,negative regulation of glomerular filtration,BP,
1415,GO:0003106,1,0.994834972089459,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1416,GO:0003127,1,0.980597893789682,0,2,detection of nodal flow,BP,
1417,GO:0003128,1,0.93096362635322,0,10,heart field specification,BP,
1418,GO:0003129,1,0.978449436317864,0,4,heart induction,BP,
1419,GO:0003130,1,0.988803492800882,0,2,BMP signaling pathway involved in heart induction,BP,
1420,GO:0003131,1,0.994281782907077,0,1,mesodermal-endodermal cell signaling,BP,
1421,GO:0003133,1,0.988803492800882,0,2,endodermal-mesodermal cell signaling,BP,
1422,GO:0003134,1,0.988803492800882,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1423,GO:0003137,1,0.994804610227398,0,1,Notch signaling pathway involved in heart induction,BP,
1424,GO:0003138,1,0.990981586846904,0,1,primary heart field specification,BP,
1425,GO:0003139,1,0.935929207868706,0,9,secondary heart field specification,BP,
1426,GO:0003140,1,0.949769220778177,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1427,GO:0003142,1,0.994523571391181,0,1,cardiogenic plate morphogenesis,BP,
1428,GO:0003143,1,0.652681380308548,0,61,embryonic heart tube morphogenesis,BP,
1429,GO:0003147,1,0.994814632277951,0,1,neural crest cell migration involved in heart formation,BP,
1430,GO:0003148,1,0.834815302320845,0,25,outflow tract septum morphogenesis,BP,
1431,GO:0003149,1,0.943349969923767,0,9,membranous septum morphogenesis,BP,
1432,GO:0003150,1,0.965347158040361,0,5,muscular septum morphogenesis,BP,
1433,GO:0003151,1,0.610432327918961,0,71,outflow tract morphogenesis,BP,
1434,GO:0003156,1,0.818828280857703,0,32,regulation of animal organ formation,BP,
1435,GO:0003157,1,0.925621602448351,0,11,endocardium development,BP,
1438,GO:0003160,1,0.961226830781101,0,6,endocardium morphogenesis,BP,
1439,GO:0003161,1,0.919448687012548,0,12,cardiac conduction system development,BP,
1440,GO:0003162,1,0.974433711801696,0,3,atrioventricular node development,BP,
1441,GO:0003163,1,0.979394268308562,0,3,sinoatrial node development,BP,
1442,GO:0003164,1,0.96777941931737,0,5,His-Purkinje system development,BP,
1443,GO:0003165,1,0.986362019580636,0,2,Purkinje myocyte development,BP,
1444,GO:0003166,1,0.975930151880569,0,4,bundle of His development,BP,
1445,GO:0003167,1,0.992599469753134,0,1,atrioventricular bundle cell differentiation,BP,
1446,GO:0003168,1,0.99466767128089,0,1,Purkinje myocyte differentiation,BP,
1447,GO:0003169,1,0.981821384907024,0,2,coronary vein morphogenesis,BP,
1448,GO:0003170,1,0.750634471907221,0,38,heart valve development,BP,
1449,GO:0003171,1,0.842710568793148,0,23,atrioventricular valve development,BP,
1450,GO:0003172,1,0.990981586846904,0,1,sinoatrial valve development,BP,
1451,GO:0003174,1,0.921002385685506,0,10,mitral valve development,BP,
1452,GO:0003175,1,0.955731947568386,0,6,tricuspid valve development,BP,
1453,GO:0003176,1,0.961628897453528,0,6,aortic valve development,BP,
1454,GO:0003177,1,0.920470092633914,0,11,pulmonary valve development,BP,
1455,GO:0003179,1,0.769456064258035,0,34,heart valve morphogenesis,BP,
1456,GO:0003180,1,0.961628897453528,0,6,aortic valve morphogenesis,BP,
1457,GO:0003181,1,0.851808023859198,0,21,atrioventricular valve morphogenesis,BP,
1458,GO:0003183,1,0.921002385685506,0,10,mitral valve morphogenesis,BP,
1459,GO:0003184,1,0.920470092633914,0,11,pulmonary valve morphogenesis,BP,
1460,GO:0003185,1,0.990981586846904,0,1,sinoatrial valve morphogenesis,BP,
1461,GO:0003186,1,0.960786069823812,0,5,tricuspid valve morphogenesis,BP,
1462,GO:0003188,1,0.914126217473266,0,12,heart valve formation,BP,
1463,GO:0003190,1,0.942073658882758,0,7,atrioventricular valve formation,BP,
1464,GO:0003192,1,0.968897965083831,0,3,mitral valve formation,BP,
1465,GO:0003193,1,0.994741695325515,0,1,pulmonary valve formation,BP,
1466,GO:0003195,1,0.988401991277753,0,2,tricuspid valve formation,BP,
1467,GO:0003197,1,0.760051550433151,0,39,endocardial cushion development,BP,
1468,GO:0003198,1,0.896286088494645,0,16,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1469,GO:0003199,1,0.976417961319695,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1470,GO:0003203,1,0.819578309680896,0,29,endocardial cushion morphogenesis,BP,
1471,GO:0003205,1,0.343866711265613,0,146,cardiac chamber development,BP,
1472,GO:0003206,1,0.447196603262269,0,113,cardiac chamber morphogenesis,BP,
1473,GO:0003207,1,0.923719780795631,0,11,cardiac chamber formation,BP,
1474,GO:0003208,1,0.606083952578109,0,68,cardiac ventricle morphogenesis,BP,
1475,GO:0003209,1,0.813475650012388,0,28,cardiac atrium morphogenesis,BP,
1476,GO:0003210,1,0.994804610227398,0,1,cardiac atrium formation,BP,
1477,GO:0003211,1,0.934316653592039,0,9,cardiac ventricle formation,BP,
1478,GO:0003213,1,0.979537961059613,0,2,cardiac right atrium morphogenesis,BP,
1479,GO:0003214,1,0.904413564136041,0,13,cardiac left ventricle morphogenesis,BP,
1480,GO:0003215,1,0.880690616112998,0,18,cardiac right ventricle morphogenesis,BP,
1481,GO:0003218,1,0.993665731148129,0,1,cardiac left ventricle formation,BP,
1482,GO:0003219,1,0.977366148841793,0,3,cardiac right ventricle formation,BP,
1483,GO:0003220,1,0.970517186988486,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1484,GO:0003221,1,0.974632789680434,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1485,GO:0003222,1,0.882246347575495,0,16,ventricular trabecula myocardium morphogenesis,BP,
1486,GO:0003223,1,0.92387377094889,0,8,ventricular compact myocardium morphogenesis,BP,
1487,GO:0003226,1,0.986888237407797,0,1,right ventricular compact myocardium morphogenesis,BP,
1488,GO:0003228,1,0.963579230226856,0,6,atrial cardiac muscle tissue development,BP,
1489,GO:0003229,1,0.674657091057555,0,51,ventricular cardiac muscle tissue development,BP,
1490,GO:0003230,1,0.785843773829216,0,32,cardiac atrium development,BP,
1491,GO:0003231,1,0.440576875133583,0,111,cardiac ventricle development,BP,
1492,GO:0003235,1,0.994804610227398,0,1,sinus venosus development,BP,
1493,GO:0003236,1,0.994804610227398,0,1,sinus venosus morphogenesis,BP,
1494,GO:0003241,1,0.97193118689895,0,4,growth involved in heart morphogenesis,BP,
1495,GO:0003245,1,0.988905760849593,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1496,GO:0003247,1,0.99473421612549,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1497,GO:0003249,1,0.974104194385005,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003250,1,0.974104194385005,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1499,GO:0003251,1,0.988496738198091,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1500,GO:0003252,1,0.98544163527816,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1501,GO:0003253,1,0.95950777400174,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1502,GO:0003254,1,0.758917787489718,0,39,regulation of membrane depolarization,BP,
1503,GO:0003256,1,0.953978017078908,0,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1504,GO:0003257,1,0.976889466537433,0,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1505,GO:0003259,1,0.994804610227398,0,1,cardioblast anterior-lateral migration,BP,
1506,GO:0003260,1,0.994804610227398,0,1,cardioblast migration,BP,
1507,GO:0003263,1,0.949278798101701,0,9,cardioblast proliferation,BP,
1508,GO:0003264,1,0.937853452046575,0,10,regulation of cardioblast proliferation,BP,
1509,GO:0003266,1,0.943184731950933,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1510,GO:0003270,1,0.987970401814337,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1511,GO:0003272,1,0.863513639055536,0,21,endocardial cushion formation,BP,
1512,GO:0003273,1,0.963756947127157,0,4,cell migration involved in endocardial cushion formation,BP,
1513,GO:0003274,1,0.979173659141675,0,3,endocardial cushion fusion,BP,
1514,GO:0003275,1,0.980828727374699,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1515,GO:0003278,1,0.964952110805368,0,6,apoptotic process involved in heart morphogenesis,BP,
1516,GO:0003279,1,0.501037345744774,0,93,cardiac septum development,BP,
1517,GO:0003281,1,0.629619389717194,0,61,ventricular septum development,BP,
1518,GO:0003283,1,0.872007847145176,0,18,atrial septum development,BP,
1519,GO:0003284,1,0.972960769956491,0,4,septum primum development,BP,
1520,GO:0003285,1,0.988568191475599,0,2,septum secundum development,BP,
1521,GO:0003289,1,0.972960769956491,0,4,atrial septum primum morphogenesis,BP,
1522,GO:0003290,1,0.993868148531475,0,1,atrial septum secundum morphogenesis,BP,
1523,GO:0003292,1,0.986300130337755,0,2,cardiac septum cell differentiation,BP,
1524,GO:0003294,1,0.994085496691891,0,1,atrial ventricular junction remodeling,BP,
1525,GO:0003298,1,0.887635444077276,0,17,physiological muscle hypertrophy,BP,
1526,GO:0003299,1,0.84936010875816,0,22,muscle hypertrophy in response to stress,BP,
1527,GO:0003300,1,0.581574167786187,0,69,cardiac muscle hypertrophy,BP,
1528,GO:0003301,1,0.887635444077276,0,17,physiological cardiac muscle hypertrophy,BP,
1529,GO:0003306,1,0.950984557894219,0,8,Wnt signaling pathway involved in heart development,BP,
1530,GO:0003307,1,0.972909495239557,0,5,regulation of Wnt signaling pathway involved in heart development,BP,
1531,GO:0003308,1,0.978273148851799,0,4,negative regulation of Wnt signaling pathway involved in heart development,BP,
1532,GO:0003309,1,0.853633998575504,0,23,type B pancreatic cell differentiation,BP,
1533,GO:0003310,1,0.962812420132522,0,6,pancreatic A cell differentiation,BP,
1534,GO:0003312,1,0.989047001044577,0,2,pancreatic PP cell differentiation,BP,
1535,GO:0003318,1,0.994804610227398,0,1,cell migration to the midline involved in heart development,BP,
1536,GO:0003321,1,0.956926574473547,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1537,GO:0003322,1,0.99036824888697,0,1,pancreatic A cell development,BP,
1538,GO:0003323,1,0.877200912989215,0,19,type B pancreatic cell development,BP,
1539,GO:0003326,1,0.989047001044577,0,2,pancreatic A cell fate commitment,BP,
1540,GO:0003327,1,0.994622706997525,0,1,type B pancreatic cell fate commitment,BP,
1541,GO:0003329,1,0.989047001044577,0,2,pancreatic PP cell fate commitment,BP,
1542,GO:0003330,1,0.988762854960084,0,2,regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003331,1,0.988762854960084,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1544,GO:0003333,1,0.622629963759369,0,71,amino acid transmembrane transport,BP,
1545,GO:0003334,1,0.925657071680098,0,10,keratinocyte development,BP,
1546,GO:0003335,1,0.994785102159228,0,1,corneocyte development,BP,
1547,GO:0003337,1,0.923222346450705,0,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1548,GO:0003338,1,0.799675488891369,0,31,metanephros morphogenesis,BP,
1549,GO:0003339,1,0.953124027310483,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1550,GO:0003340,1,0.982513848959132,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1551,GO:0003341,1,0.639191267685487,0,61,cilium movement,BP,
1552,GO:0003342,1,0.988858608992752,0,2,proepicardium development,BP,
1553,GO:0003343,1,0.988858608992752,0,2,septum transversum development,BP,
1554,GO:0003344,1,0.927958073342962,0,9,pericardium morphogenesis,BP,
1555,GO:0003345,1,0.993465767817386,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1556,GO:0003348,1,0.955243554797147,0,6,cardiac endothelial cell differentiation,BP,
1557,GO:0003350,1,0.981498649904463,0,3,pulmonary myocardium development,BP,
1558,GO:0003351,1,0.888043619543556,0,19,epithelial cilium movement,BP,
1559,GO:0003352,1,0.916402304037277,0,13,regulation of cilium movement,BP,
1560,GO:0003353,1,0.994169883619931,0,1,positive regulation of cilium movement,BP,
1561,GO:0003356,1,0.932004854882671,0,10,regulation of cilium beat frequency,BP,
1562,GO:0003357,1,0.959700594761217,0,6,noradrenergic neuron differentiation,BP,
1563,GO:0003358,1,0.98878516470613,0,2,noradrenergic neuron development,BP,
1564,GO:0003359,1,0.994468201715917,0,1,noradrenergic neuron fate commitment,BP,
1565,GO:0003360,1,0.952926893057397,0,6,brainstem development,BP,
1566,GO:0003365,1,0.971434950697304,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1567,GO:0003366,1,0.985552842766871,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1568,GO:0003373,1,0.950282716408675,0,7,dynamin family protein polymerization involved in membrane fission,BP,
1569,GO:0003374,1,0.950282716408675,0,7,dynamin family protein polymerization involved in mitochondrial fission,BP,
1570,GO:0003376,1,0.932429619954583,0,12,sphingosine-1-phosphate signaling pathway,BP,
1571,GO:0003382,1,0.817944571373691,0,27,epithelial cell morphogenesis,BP,
1572,GO:0003383,1,0.973946609446451,0,3,apical constriction,BP,
1573,GO:0003400,1,0.994590999317122,0,1,regulation of COPII vesicle coating,BP,
1574,GO:0003401,1,0.812820402175624,0,29,axis elongation,BP,
1575,GO:0003402,1,0.956807716487978,0,6,planar cell polarity pathway involved in axis elongation,BP,
1576,GO:0003404,1,0.988435201884575,0,2,optic vesicle morphogenesis,BP,
1577,GO:0003406,1,0.965630171309524,0,5,retinal pigment epithelium development,BP,
1578,GO:0003407,1,0.686182684894327,0,53,neural retina development,BP,
1579,GO:0003408,1,0.974835154018597,0,3,optic cup formation involved in camera-type eye development,BP,
1580,GO:0003409,1,0.99395467302324,0,1,optic cup structural organization,BP,
1581,GO:0003413,1,0.933862681423105,0,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1582,GO:0003414,1,0.993503837846473,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1583,GO:0003415,1,0.973860858975471,0,4,chondrocyte hypertrophy,BP,
1584,GO:0003416,1,0.864307318817848,0,22,endochondral bone growth,BP,
1585,GO:0003417,1,0.913200467902147,0,15,growth plate cartilage development,BP,
1586,GO:0003418,1,0.962170548622077,0,6,growth plate cartilage chondrocyte differentiation,BP,
1587,GO:0003419,1,0.978455846093646,0,4,growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003420,1,0.988671471378765,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1589,GO:0003421,1,0.993462542276915,0,1,growth plate cartilage axis specification,BP,
1590,GO:0003422,1,0.987008426596452,0,2,growth plate cartilage morphogenesis,BP,
1591,GO:0003429,1,0.993503837846473,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1592,GO:0003430,1,0.987010905912492,0,2,growth plate cartilage chondrocyte growth,BP,
1593,GO:0003431,1,0.973486675147464,0,4,growth plate cartilage chondrocyte development,BP,
1594,GO:0003433,1,0.961916273177235,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1598,GO:0003678,1,0.725337425743769,0,45,DNA helicase activity,MF,
1599,GO:0003680,1,0.940632011646694,0,10,AT DNA binding,MF,
1600,GO:0003682,1,0.0311558433548416,0,495,chromatin binding,MF,
1601,GO:0003684,1,0.64412681383449,0,66,damaged DNA binding,MF,
1602,GO:0003688,1,0.91989498283254,0,14,DNA replication origin binding,MF,
1603,GO:0003689,1,0.954988708398327,0,8,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.947320576902789,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.994585196585992,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.955784963560233,0,7,satellite DNA binding,MF,
1610,GO:0003705,1,0.542361683472839,0,92,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1611,GO:0003707,1,0.676746893462082,0,56,steroid hormone receptor activity,MF,
1612,GO:0003708,1,0.956139410052008,0,7,retinoic acid receptor activity,MF,
1614,GO:0003713,1,0.120576392539474,0,306,transcription coactivator activity,MF,
1616,GO:0003720,1,0.94749533986373,0,8,telomerase activity,MF,
1617,GO:0003721,1,0.993341223717095,0,1,telomerase RNA reverse transcriptase activity,MF,
1619,GO:0003724,1,0.657497787528579,0,65,RNA helicase activity,MF,
1621,GO:0003726,1,0.977878304068962,0,3,double-stranded RNA adenosine deaminase activity,MF,
1623,GO:0003729,1,0.287625067027769,0,190,mRNA binding,MF,
1624,GO:0003730,1,0.652960050527115,0,63,mRNA 3'-UTR binding,MF,
1625,GO:0003735,1,0.442868835205669,0,153,structural constituent of ribosome,MF,
1626,GO:0003743,1,0.735519056201163,0,50,translation initiation factor activity,MF,
1627,GO:0003746,1,0.895594827481947,0,18,translation elongation factor activity,MF,
1628,GO:0003747,1,0.961471168353941,0,6,translation release factor activity,MF,
1629,GO:0003755,1,0.831318594223493,0,31,peptidyl-prolyl cis-trans isomerase activity,MF,
1630,GO:0003756,1,0.899953906879261,0,17,protein disulfide isomerase activity,MF,
1631,GO:0003774,1,0.326192174126226,0,128,motor activity,MF,
1632,GO:0003777,1,0.363291673538223,0,112,microtubule motor activity,MF,
1634,GO:0003785,1,0.849520789160646,0,25,actin monomer binding,MF,
1635,GO:0003796,1,0.984489402778537,0,3,lysozyme activity,MF,
1636,GO:0003810,1,0.965704753239312,0,6,protein-glutamine gamma-glutamyltransferase activity,MF,
1639,GO:0003826,1,0.9891229568876,0,2,alpha-ketoacid dehydrogenase activity,MF,
1640,GO:0003827,1,0.988524623283748,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1642,GO:0003829,1,0.985624534596307,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003830,1,0.992322559608733,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1644,GO:0003831,1,0.95063425371455,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1645,GO:0003834,1,0.994313214468247,0,1,beta-carotene 15,15'-monooxygenase activity,MF,
1646,GO:0003835,1,0.983622480818472,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1647,GO:0003836,1,0.962324301585661,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1648,GO:0003837,1,0.994623343944697,0,1,beta-ureidopropionase activity,MF,
1649,GO:0003839,1,0.97883836128638,0,4,gamma-glutamylcyclotransferase activity,MF,
1650,GO:0003841,1,0.886350995431904,0,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1651,GO:0003842,1,0.993993108028265,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1652,GO:0003844,1,0.994096923959342,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1653,GO:0003845,1,0.989479668074791,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1654,GO:0003846,1,0.988118398162579,0,2,2-acylglycerol O-acyltransferase activity,MF,
1655,GO:0003847,1,0.973011869066358,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1656,GO:0003854,1,0.983727258507053,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.951098884552355,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.988137918714323,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.99466533644563,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.9891229568876,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.988963751499022,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.992431771564765,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.989455272265349,0,2,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.989192233409595,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.982564670679362,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.973758749119359,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.994822876044542,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.988578853554144,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.986640464723518,0,2,AMP deaminase activity,MF,
1670,GO:0003877,1,0.99461053300476,0,1,ATP adenylyltransferase activity,MF,
1671,GO:0003878,1,0.992999107928046,0,1,ATP citrate synthase activity,MF,
1672,GO:0003880,1,0.981670756102014,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1673,GO:0003881,1,0.99468021131471,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1674,GO:0003882,1,0.994478593547072,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1675,GO:0003883,1,0.987746100316896,0,2,CTP synthase activity,MF,
1676,GO:0003884,1,0.989506757309471,0,2,D-amino-acid oxidase activity,MF,
1677,GO:0003886,1,0.978530392639415,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1678,GO:0003887,1,0.826768159849974,0,27,DNA-directed DNA polymerase activity,MF,
1679,GO:0003896,1,0.983712355693517,0,3,DNA primase activity,MF,
1680,GO:0003899,1,0.783648750997982,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1681,GO:0003905,1,0.994811251181433,0,1,alkylbase DNA N-glycosylase activity,MF,
1682,GO:0003906,1,0.931374559070999,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1683,GO:0003908,1,0.994792835840374,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1684,GO:0003909,1,0.959151798982716,0,7,DNA ligase activity,MF,
1685,GO:0003910,1,0.964352144400061,0,6,DNA ligase (ATP) activity,MF,
1686,GO:0003912,1,0.994632286326657,0,1,DNA nucleotidylexotransferase activity,MF,
1687,GO:0003916,1,0.95993809187684,0,6,DNA topoisomerase activity,MF,
1688,GO:0003917,1,0.975782987490442,0,4,DNA topoisomerase type I activity,MF,
1689,GO:0003918,1,0.983765811461374,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1690,GO:0003919,1,0.994653204781261,0,1,FMN adenylyltransferase activity,MF,
1691,GO:0003920,1,0.989462300783792,0,2,GMP reductase activity,MF,
1692,GO:0003921,1,0.994472291576785,0,1,GMP synthase activity,MF,
1693,GO:0003922,1,0.994472291576785,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1694,GO:0003923,1,0.971191116161672,0,5,GPI-anchor transamidase activity,MF,
1696,GO:0003933,1,0.994658631603326,0,1,GTP cyclohydrolase activity,MF,
1697,GO:0003934,1,0.994658631603326,0,1,GTP cyclohydrolase I activity,MF,
1698,GO:0003937,1,0.994614640011293,0,1,IMP cyclohydrolase activity,MF,
1699,GO:0003938,1,0.989201606450066,0,2,IMP dehydrogenase activity,MF,
1700,GO:0003939,1,0.99444254450294,0,1,L-iditol 2-dehydrogenase activity,MF,
1701,GO:0003940,1,0.994581815133195,0,1,L-iduronidase activity,MF,
1702,GO:0003941,1,0.984065451000756,0,3,L-serine ammonia-lyase activity,MF,
1703,GO:0003943,1,0.987779799260057,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1704,GO:0003944,1,0.994577139632676,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1705,GO:0003945,1,0.977165340293846,0,4,N-acetyllactosamine synthase activity,MF,
1706,GO:0003947,1,0.994162136828555,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1707,GO:0003948,1,0.994617566626888,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1708,GO:0003950,1,0.879459986229834,0,19,NAD+ ADP-ribosyltransferase activity,MF,
1709,GO:0003951,1,0.894672747797075,0,16,NAD+ kinase activity,MF,
1710,GO:0003952,1,0.994481717242437,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1711,GO:0003953,1,0.98954981728533,0,2,NAD+ nucleosidase activity,MF,
1712,GO:0003954,1,0.808632331679379,0,40,NADH dehydrogenase activity,MF,
1713,GO:0003955,1,0.983194826283511,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1714,GO:0003956,1,0.98434707739798,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1715,GO:0003957,1,0.992679803161637,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1716,GO:0003958,1,0.959321908559208,0,6,NADPH-hemoprotein reductase activity,MF,
1717,GO:0003960,1,0.97888031767884,0,4,NADPH:quinone reductase activity,MF,
1718,GO:0003962,1,0.994711632107073,0,1,cystathionine gamma-synthase activity,MF,
1719,GO:0003963,1,0.988932928223108,0,2,RNA-3'-phosphate cyclase activity,MF,
1720,GO:0003964,1,0.94749533986373,0,8,RNA-directed DNA polymerase activity,MF,
1721,GO:0003968,1,0.984070496792634,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1722,GO:0003972,1,0.994313214468247,0,1,RNA ligase (ATP) activity,MF,
1723,GO:0003973,1,0.985949173317958,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1724,GO:0003974,1,0.994739113071435,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1725,GO:0003975,1,0.994598940247943,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1726,GO:0003976,1,0.981192502244509,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1727,GO:0003977,1,0.988464619870135,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1728,GO:0003978,1,0.994739113071435,0,1,UDP-glucose 4-epimerase activity,MF,
1729,GO:0003979,1,0.994034425998983,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1730,GO:0003980,1,0.978996318991696,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1731,GO:0003983,1,0.994599281629308,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1732,GO:0003985,1,0.983579190328665,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1733,GO:0003986,1,0.979147477382464,0,4,acetyl-CoA hydrolase activity,MF,
1734,GO:0003987,1,0.981315260765772,0,3,acetate-CoA ligase activity,MF,
1735,GO:0003988,1,0.967859995759769,0,6,acetyl-CoA C-acyltransferase activity,MF,
1736,GO:0003989,1,0.987998103041228,0,1,acetyl-CoA carboxylase activity,MF,
1737,GO:0003990,1,0.988930179632782,0,2,acetylcholinesterase activity,MF,
1738,GO:0003991,1,0.994622706997525,0,1,acetylglutamate kinase activity,MF,
1739,GO:0003993,1,0.968097859038403,0,6,acid phosphatase activity,MF,
1740,GO:0003994,1,0.98810265893406,0,2,aconitate hydratase activity,MF,
1741,GO:0003995,1,0.910169363624487,0,15,acyl-CoA dehydrogenase activity,MF,
1742,GO:0003996,1,0.972850985198778,0,5,acyl-CoA ligase activity,MF,
1743,GO:0003997,1,0.968090647057499,0,5,acyl-CoA oxidase activity,MF,
1744,GO:0003998,1,0.989661162799501,0,2,acylphosphatase activity,MF,
1745,GO:0003999,1,0.994833072010578,0,1,adenine phosphoribosyltransferase activity,MF,
1746,GO:0004000,1,0.942029889970158,0,9,adenosine deaminase activity,MF,
1747,GO:0004001,1,0.994628394990776,0,1,adenosine kinase activity,MF,
1748,GO:0004003,1,0.802378161157378,0,32,ATP-dependent DNA helicase activity,MF,
1749,GO:0004004,1,0.661390256355786,0,64,ATP-dependent RNA helicase activity,MF,
1750,GO:0004008,1,0.979797308921074,0,2,copper-exporting ATPase activity,MF,
1751,GO:0004012,1,0.833408843343453,0,20,phospholipid-translocating ATPase activity,MF,
1752,GO:0004013,1,0.980270778395442,0,3,adenosylhomocysteinase activity,MF,
1753,GO:0004014,1,0.99398281120159,0,1,adenosylmethionine decarboxylase activity,MF,
1754,GO:0004016,1,0.899306179048807,0,13,adenylate cyclase activity,MF,
1755,GO:0004017,1,0.952581790039249,0,8,adenylate kinase activity,MF,
1756,GO:0004018,1,0.994762715811139,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1757,GO:0004019,1,0.989050547314452,0,2,adenylosuccinate synthase activity,MF,
1758,GO:0004020,1,0.987950284148667,0,2,adenylylsulfate kinase activity,MF,
1759,GO:0004021,1,0.988130376259267,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1760,GO:0004022,1,0.973054484429261,0,5,alcohol dehydrogenase (NAD) activity,MF,
1761,GO:0004024,1,0.989043966689256,0,2,alcohol dehydrogenase activity, zinc-dependent,MF,
1762,GO:0004027,1,0.994797218038617,0,1,alcohol sulfotransferase activity,MF,
1763,GO:0004028,1,0.960079601177799,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1764,GO:0004029,1,0.911899898768477,0,15,aldehyde dehydrogenase (NAD) activity,MF,
1765,GO:0004030,1,0.965981733459035,0,6,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1766,GO:0004031,1,0.992387119019582,0,1,aldehyde oxidase activity,MF,
1767,GO:0004032,1,0.943796350727315,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1768,GO:0004033,1,0.873550180913987,0,25,aldo-keto reductase (NADP) activity,MF,
1769,GO:0004034,1,0.994463621833979,0,1,aldose 1-epimerase activity,MF,
1770,GO:0004035,1,0.98870391927184,0,2,alkaline phosphatase activity,MF,
1771,GO:0004037,1,0.994767648281609,0,1,allantoicase activity,MF,
1772,GO:0004040,1,0.982721298934819,0,3,amidase activity,MF,
1773,GO:0004042,1,0.994622706997525,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1774,GO:0004043,1,0.993740008944569,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1775,GO:0004044,1,0.993578057259104,0,1,amidophosphoribosyltransferase activity,MF,
1776,GO:0004045,1,0.97887902180368,0,4,aminoacyl-tRNA hydrolase activity,MF,
1777,GO:0004046,1,0.973683714035678,0,5,aminoacylase activity,MF,
1778,GO:0004047,1,0.989409429326845,0,2,aminomethyltransferase activity,MF,
1779,GO:0004051,1,0.994428062514543,0,1,arachidonate 5-lipoxygenase activity,MF,
1780,GO:0004052,1,0.983420290933545,0,3,arachidonate 12-lipoxygenase activity,MF,
1781,GO:0004053,1,0.989445946288088,0,2,arginase activity,MF,
1782,GO:0004055,1,0.994692260020404,0,1,argininosuccinate synthase activity,MF,
1783,GO:0004056,1,0.994647230383162,0,1,argininosuccinate lyase activity,MF,
1784,GO:0004057,1,0.994574234552225,0,1,arginyltransferase activity,MF,
1785,GO:0004058,1,0.994639019362965,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1786,GO:0004059,1,0.994764489884017,0,1,aralkylamine N-acetyltransferase activity,MF,
1787,GO:0004060,1,0.984273678404824,0,3,arylamine N-acetyltransferase activity,MF,
1788,GO:0004061,1,0.994722055363197,0,1,arylformamidase activity,MF,
1789,GO:0004062,1,0.952985091570681,0,9,aryl sulfotransferase activity,MF,
1790,GO:0004063,1,0.989537626518402,0,2,aryldialkylphosphatase activity,MF,
1791,GO:0004064,1,0.96849572175838,0,6,arylesterase activity,MF,
1792,GO:0004065,1,0.93261118517558,0,11,arylsulfatase activity,MF,
1793,GO:0004066,1,0.989030398542692,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1794,GO:0004067,1,0.989223230067923,0,2,asparaginase activity,MF,
1795,GO:0004069,1,0.989111672169772,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1796,GO:0004070,1,0.981749683174573,0,2,aspartate carbamoyltransferase activity,MF,
1797,GO:0004074,1,0.989665899000153,0,2,biliverdin reductase activity,MF,
1798,GO:0004075,1,0.982498142258693,0,2,biotin carboxylase activity,MF,
1799,GO:0004077,1,0.991278145749113,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1800,GO:0004078,1,0.991278145749113,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1801,GO:0004079,1,0.991278145749113,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1802,GO:0004080,1,0.991278145749113,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1803,GO:0004081,1,0.989170597887527,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1804,GO:0004082,1,0.979098321865469,0,4,bisphosphoglycerate mutase activity,MF,
1805,GO:0004084,1,0.983785891489177,0,2,branched-chain-amino-acid transaminase activity,MF,
1806,GO:0004085,1,0.99466767128089,0,1,butyryl-CoA dehydrogenase activity,MF,
1807,GO:0004087,1,0.981749683174573,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1808,GO:0004088,1,0.981749683174573,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1809,GO:0004089,1,0.92797754004561,0,13,carbonate dehydratase activity,MF,
1810,GO:0004090,1,0.974216925026667,0,5,carbonyl reductase (NADPH) activity,MF,
1811,GO:0004092,1,0.994285070710322,0,1,carnitine O-acetyltransferase activity,MF,
1812,GO:0004095,1,0.976376890524824,0,4,carnitine O-palmitoyltransferase activity,MF,
1813,GO:0004096,1,0.978357129477009,0,4,catalase activity,MF,
1814,GO:0004098,1,0.994672279075657,0,1,cerebroside-sulfatase activity,MF,
1815,GO:0004102,1,0.994470931654023,0,1,choline O-acetyltransferase activity,MF,
1816,GO:0004103,1,0.989122457044192,0,2,choline kinase activity,MF,
1817,GO:0004104,1,0.983350249167555,0,3,cholinesterase activity,MF,
1818,GO:0004105,1,0.986614892412283,0,2,choline-phosphate cytidylyltransferase activity,MF,
1819,GO:0004108,1,0.994184890625447,0,1,citrate (Si)-synthase activity,MF,
1820,GO:0004109,1,0.988836158162503,0,2,coproporphyrinogen oxidase activity,MF,
1821,GO:0004111,1,0.969405750564124,0,5,creatine kinase activity,MF,
1822,GO:0004112,1,0.844373032563711,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1823,GO:0004113,1,0.99211523438915,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1824,GO:0004114,1,0.851094488810706,0,22,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1825,GO:0004115,1,0.890794259388262,0,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1826,GO:0004117,1,0.982961397499908,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1827,GO:0004118,1,0.971608720220374,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1828,GO:0004119,1,0.984468799463856,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1829,GO:0004122,1,0.994406694608454,0,1,cystathionine beta-synthase activity,MF,
1830,GO:0004123,1,0.994711632107073,0,1,cystathionine gamma-lyase activity,MF,
1831,GO:0004126,1,0.946918084436642,0,10,cytidine deaminase activity,MF,
1832,GO:0004127,1,0.977329469824614,0,4,cytidylate kinase activity,MF,
1833,GO:0004128,1,0.961575494564935,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1834,GO:0004129,1,0.887422625962654,0,22,cytochrome-c oxidase activity,MF,
1835,GO:0004132,1,0.994635977108142,0,1,dCMP deaminase activity,MF,
1836,GO:0004133,1,0.990048852467886,0,1,glycogen debranching enzyme activity,MF,
1837,GO:0004134,1,0.990048852467886,0,1,4-alpha-glucanotransferase activity,MF,
1838,GO:0004135,1,0.990048852467886,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1839,GO:0004137,1,0.986739648752737,0,2,deoxycytidine kinase activity,MF,
1840,GO:0004138,1,0.994817387140874,0,1,deoxyguanosine kinase activity,MF,
1841,GO:0004139,1,0.994715539073901,0,1,deoxyribose-phosphate aldolase activity,MF,
1842,GO:0004140,1,0.989203954578272,0,2,dephospho-CoA kinase activity,MF,
1843,GO:0004142,1,0.982231512163132,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1844,GO:0004143,1,0.927439158043095,0,10,diacylglycerol kinase activity,MF,
1845,GO:0004144,1,0.988118398162579,0,2,diacylglycerol O-acyltransferase activity,MF,
1846,GO:0004145,1,0.984307956201011,0,3,diamine N-acetyltransferase activity,MF,
1847,GO:0004146,1,0.988269901518298,0,2,dihydrofolate reductase activity,MF,
1848,GO:0004148,1,0.993720324739055,0,1,dihydrolipoyl dehydrogenase activity,MF,
1849,GO:0004149,1,0.994267588319634,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1850,GO:0004151,1,0.981749683174573,0,2,dihydroorotase activity,MF,
1851,GO:0004152,1,0.994623979651904,0,1,dihydroorotate dehydrogenase activity,MF,
1852,GO:0004155,1,0.994731610069127,0,1,6,7-dihydropteridine reductase activity,MF,
1853,GO:0004157,1,0.987453133987556,0,2,dihydropyrimidinase activity,MF,
1854,GO:0004161,1,0.989083374199378,0,2,dimethylallyltranstransferase activity,MF,
1855,GO:0004163,1,0.994698715350984,0,1,diphosphomevalonate decarboxylase activity,MF,
1856,GO:0004164,1,0.994700627216033,0,1,diphthine synthase activity,MF,
1857,GO:0004165,1,0.982161925436174,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1858,GO:0004167,1,0.984279577004384,0,3,dopachrome isomerase activity,MF,
1859,GO:0004168,1,0.994580023477462,0,1,dolichol kinase activity,MF,
1860,GO:0004169,1,0.971350990730596,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1861,GO:0004170,1,0.994680471383707,0,1,dUTP diphosphatase activity,MF,
1862,GO:0004174,1,0.988551267231191,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1864,GO:0004176,1,0.975232857945823,0,4,ATP-dependent peptidase activity,MF,
1865,GO:0004177,1,0.768496565536012,0,43,aminopeptidase activity,MF,
1869,GO:0004190,1,0.898562252003396,0,18,aspartic-type endopeptidase activity,MF,
1870,GO:0004197,1,0.585816473786614,0,82,cysteine-type endopeptidase activity,MF,
1871,GO:0004198,1,0.889523743745671,0,20,calcium-dependent cysteine-type endopeptidase activity,MF,
1874,GO:0004298,1,0.910273711494247,0,18,threonine-type endopeptidase activity,MF,
1875,GO:0004300,1,0.956252005882433,0,8,enoyl-CoA hydratase activity,MF,
1876,GO:0004301,1,0.962767139918731,0,7,epoxide hydrolase activity,MF,
1877,GO:0004303,1,0.953308801911388,0,9,estradiol 17-beta-dehydrogenase activity,MF,
1878,GO:0004304,1,0.989379755748615,0,2,estrone sulfotransferase activity,MF,
1879,GO:0004305,1,0.977035213400697,0,4,ethanolamine kinase activity,MF,
1880,GO:0004306,1,0.994684339122084,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1881,GO:0004307,1,0.989406104620582,0,2,ethanolaminephosphotransferase activity,MF,
1882,GO:0004308,1,0.972787726947417,0,5,exo-alpha-sialidase activity,MF,
1884,GO:0004310,1,0.994611358350175,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1885,GO:0004311,1,0.983170751964058,0,3,farnesyltranstransferase activity,MF,
1886,GO:0004312,1,0.93848219460135,0,10,fatty acid synthase activity,MF,
1887,GO:0004313,1,0.988770284686703,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1888,GO:0004314,1,0.98348969877463,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1889,GO:0004315,1,0.983619711917634,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1890,GO:0004316,1,0.988770284686703,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1891,GO:0004317,1,0.988770284686703,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1892,GO:0004319,1,0.988770284686703,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1893,GO:0004320,1,0.983537681319841,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1894,GO:0004321,1,0.978172168901287,0,4,fatty-acyl-CoA synthase activity,MF,
1896,GO:0004324,1,0.994673885774967,0,1,ferredoxin-NADP+ reductase activity,MF,
1897,GO:0004325,1,0.98998409046604,0,1,ferrochelatase activity,MF,
1898,GO:0004326,1,0.994460393542134,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1899,GO:0004329,1,0.987548713999019,0,2,formate-tetrahydrofolate ligase activity,MF,
1900,GO:0004331,1,0.973758749119359,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1901,GO:0004332,1,0.984056617595152,0,3,fructose-bisphosphate aldolase activity,MF,
1902,GO:0004333,1,0.994700627216033,0,1,fumarate hydratase activity,MF,
1903,GO:0004334,1,0.994766552650522,0,1,fumarylacetoacetase activity,MF,
1904,GO:0004335,1,0.988864958732835,0,2,galactokinase activity,MF,
1905,GO:0004336,1,0.994231552574136,0,1,galactosylceramidase activity,MF,
1906,GO:0004337,1,0.989083374199378,0,2,geranyltranstransferase activity,MF,
1907,GO:0004339,1,0.990748156540811,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1908,GO:0004340,1,0.966283608778596,0,5,glucokinase activity,MF,
1909,GO:0004341,1,0.994665887682369,0,1,gluconolactonase activity,MF,
1910,GO:0004342,1,0.989241015879916,0,2,glucosamine-6-phosphate deaminase activity,MF,
1911,GO:0004343,1,0.993414359526987,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1912,GO:0004344,1,0.988171510293242,0,1,glucose dehydrogenase activity,MF,
1913,GO:0004345,1,0.982761438368589,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1914,GO:0004346,1,0.983094756786994,0,3,glucose-6-phosphatase activity,MF,
1915,GO:0004347,1,0.994617890239844,0,1,glucose-6-phosphate isomerase activity,MF,
1916,GO:0004348,1,0.983009910504257,0,3,glucosylceramidase activity,MF,
1917,GO:0004349,1,0.993817351434055,0,1,glutamate 5-kinase activity,MF,
1918,GO:0004350,1,0.993817351434055,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1919,GO:0004351,1,0.982005367300059,0,3,glutamate decarboxylase activity,MF,
1920,GO:0004352,1,0.988371408743556,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1921,GO:0004353,1,0.988371408743556,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1922,GO:0004356,1,0.984953383039074,0,2,glutamate-ammonia ligase activity,MF,
1923,GO:0004357,1,0.987755890252162,0,2,glutamate-cysteine ligase activity,MF,
1924,GO:0004359,1,0.981986515994248,0,3,glutaminase activity,MF,
1925,GO:0004360,1,0.982836181793336,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1926,GO:0004361,1,0.994718825676242,0,1,glutaryl-CoA dehydrogenase activity,MF,
1927,GO:0004362,1,0.994553680693229,0,1,glutathione-disulfide reductase activity,MF,
1928,GO:0004363,1,0.994671471904999,0,1,glutathione synthase activity,MF,
1929,GO:0004364,1,0.879527880391946,0,24,glutathione transferase activity,MF,
1930,GO:0004365,1,0.994786785076571,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1931,GO:0004366,1,0.979660551898762,0,3,glycerol-3-phosphate O-acyltransferase activity,MF,
1932,GO:0004367,1,0.987717933654758,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1933,GO:0004368,1,0.985672722189292,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1934,GO:0004370,1,0.980712619391335,0,2,glycerol kinase activity,MF,
1935,GO:0004372,1,0.989069378057645,0,2,glycine hydroxymethyltransferase activity,MF,
1936,GO:0004373,1,0.987950446984891,0,2,glycogen (starch) synthase activity,MF,
1937,GO:0004375,1,0.993507489775592,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1938,GO:0004376,1,0.977951691670713,0,4,glycolipid mannosyltransferase activity,MF,
1939,GO:0004377,1,0.994439675849075,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1940,GO:0004378,1,0.99423408293677,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1941,GO:0004379,1,0.984854102081143,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1942,GO:0004380,1,0.994745164069223,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1943,GO:0004381,1,0.994745164069223,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1944,GO:0004382,1,0.988472230549823,0,2,guanosine-diphosphatase activity,MF,
1945,GO:0004383,1,0.906459432229687,0,12,guanylate cyclase activity,MF,
1946,GO:0004385,1,0.906155455483352,0,13,guanylate kinase activity,MF,
1948,GO:0004392,1,0.989490473046599,0,2,heme oxygenase (decyclizing) activity,MF,
1949,GO:0004394,1,0.993186443707039,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1950,GO:0004395,1,0.99479271690561,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1951,GO:0004396,1,0.966283608778596,0,5,hexokinase activity,MF,
1952,GO:0004397,1,0.994064549318113,0,1,histidine ammonia-lyase activity,MF,
1953,GO:0004398,1,0.994496200087079,0,1,histidine decarboxylase activity,MF,
1954,GO:0004402,1,0.702038798733887,0,50,histone acetyltransferase activity,MF,
1955,GO:0004407,1,0.741949463432397,0,43,histone deacetylase activity,MF,
1956,GO:0004408,1,0.994546730640956,0,1,holocytochrome-c synthase activity,MF,
1957,GO:0004411,1,0.994665749980841,0,1,homogentisate 1,2-dioxygenase activity,MF,
1958,GO:0004415,1,0.965409785477378,0,6,hyalurononglucosaminidase activity,MF,
1959,GO:0004416,1,0.988958031364877,0,2,hydroxyacylglutathione hydrolase activity,MF,
1960,GO:0004418,1,0.994764489884017,0,1,hydroxymethylbilane synthase activity,MF,
1961,GO:0004419,1,0.989235179829537,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1962,GO:0004420,1,0.992843943660307,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1963,GO:0004421,1,0.988338442614443,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1964,GO:0004422,1,0.989465332158368,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1965,GO:0004423,1,0.991492207746203,0,1,iduronate-2-sulfatase activity,MF,
1966,GO:0004427,1,0.98434633674836,0,3,inorganic diphosphatase activity,MF,
1967,GO:0004430,1,0.973386950600433,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1968,GO:0004435,1,0.844483721692475,0,24,phosphatidylinositol phospholipase C activity,MF,
1969,GO:0004438,1,0.889666374776032,0,15,phosphatidylinositol-3-phosphatase activity,MF,
1970,GO:0004439,1,0.94402670708164,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1971,GO:0004441,1,0.994616756225274,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1972,GO:0004445,1,0.96955593442489,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1973,GO:0004446,1,0.994270628287957,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1974,GO:0004447,1,0.994200023896106,0,1,iodide peroxidase activity,MF,
1975,GO:0004448,1,0.973395172358188,0,5,isocitrate dehydrogenase activity,MF,
1976,GO:0004449,1,0.983953452871724,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1977,GO:0004450,1,0.989271261171851,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1978,GO:0004452,1,0.994602677775799,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1979,GO:0004454,1,0.994493161333069,0,1,ketohexokinase activity,MF,
1980,GO:0004457,1,0.968199293002806,0,6,lactate dehydrogenase activity,MF,
1981,GO:0004458,1,0.989075745694475,0,2,D-lactate dehydrogenase (cytochrome) activity,MF,
1982,GO:0004459,1,0.978895265540224,0,4,L-lactate dehydrogenase activity,MF,
1983,GO:0004461,1,0.982700893149728,0,3,lactose synthase activity,MF,
1984,GO:0004462,1,0.994631511887282,0,1,lactoylglutathione lyase activity,MF,
1985,GO:0004463,1,0.994622388058537,0,1,leukotriene-A4 hydrolase activity,MF,
1986,GO:0004464,1,0.979486709184727,0,4,leukotriene-C4 synthase activity,MF,
1987,GO:0004465,1,0.965506003299976,0,6,lipoprotein lipase activity,MF,
1988,GO:0004466,1,0.972275741832979,0,5,long-chain-acyl-CoA dehydrogenase activity,MF,
1989,GO:0004467,1,0.929218829064511,0,12,long-chain fatty acid-CoA ligase activity,MF,
1990,GO:0004468,1,0.969564130630482,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1991,GO:0004470,1,0.976283017279275,0,4,malic enzyme activity,MF,
1992,GO:0004471,1,0.981395081808658,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1993,GO:0004473,1,0.981395081808658,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1994,GO:0004474,1,0.991533261091361,0,1,malate synthase activity,MF,
1995,GO:0004475,1,0.99474064851731,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1996,GO:0004476,1,0.994704866976516,0,1,mannose-6-phosphate isomerase activity,MF,
1997,GO:0004477,1,0.976796174592312,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1998,GO:0004478,1,0.988191514770708,0,2,methionine adenosyltransferase activity,MF,
1999,GO:0004479,1,0.994328051160662,0,1,methionyl-tRNA formyltransferase activity,MF,
2000,GO:0004482,1,0.991075673892161,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2001,GO:0004483,1,0.988658446617857,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2002,GO:0004484,1,0.99288509745476,0,1,mRNA guanylyltransferase activity,MF,
2003,GO:0004485,1,0.98810571730964,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2004,GO:0004486,1,0.993816523157011,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2005,GO:0004487,1,0.982996420477056,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2006,GO:0004488,1,0.976796174592312,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2007,GO:0004489,1,0.99010256999547,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2008,GO:0004490,1,0.994743299063165,0,1,methylglutaconyl-CoA hydratase activity,MF,
2009,GO:0004491,1,0.994585019354448,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2010,GO:0004492,1,0.99460871028205,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2011,GO:0004493,1,0.994826804754926,0,1,methylmalonyl-CoA epimerase activity,MF,
2012,GO:0004494,1,0.994197407196737,0,1,methylmalonyl-CoA mutase activity,MF,
2013,GO:0004496,1,0.99462254756683,0,1,mevalonate kinase activity,MF,
2015,GO:0004498,1,0.994460393542134,0,1,calcidiol 1-monooxygenase activity,MF,
2016,GO:0004499,1,0.970774302356221,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2018,GO:0004502,1,0.992321516723306,0,1,kynurenine 3-monooxygenase activity,MF,
2019,GO:0004504,1,0.99359549975056,0,1,peptidylglycine monooxygenase activity,MF,
2020,GO:0004505,1,0.98377775998182,0,3,phenylalanine 4-monooxygenase activity,MF,
2021,GO:0004506,1,0.994177578746373,0,1,squalene monooxygenase activity,MF,
2022,GO:0004509,1,0.994636740510857,0,1,steroid 21-monooxygenase activity,MF,
2023,GO:0004510,1,0.989237984415806,0,2,tryptophan 5-monooxygenase activity,MF,
2024,GO:0004511,1,0.994671741245347,0,1,tyrosine 3-monooxygenase activity,MF,
2025,GO:0004512,1,0.994556353522904,0,1,inositol-3-phosphate synthase activity,MF,
2026,GO:0004513,1,0.994538084329157,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2027,GO:0004514,1,0.981945261208719,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2028,GO:0004515,1,0.971968477653087,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2029,GO:0004516,1,0.994313214468247,0,1,nicotinate phosphoribosyltransferase activity,MF,
2030,GO:0004517,1,0.977869813374965,0,3,nitric-oxide synthase activity,MF,
2031,GO:0004518,1,0.2926554312632,0,193,nuclease activity,MF,
2032,GO:0004519,1,0.485199010842566,0,118,endonuclease activity,MF,
2033,GO:0004520,1,0.751584816447566,0,47,endodeoxyribonuclease activity,MF,
2034,GO:0004521,1,0.740971363223527,0,51,endoribonuclease activity,MF,
2035,GO:0004522,1,0.984487285913723,0,3,ribonuclease A activity,MF,
2036,GO:0004523,1,0.968070877841425,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2037,GO:0004525,1,0.969349051541781,0,4,ribonuclease III activity,MF,
2038,GO:0004526,1,0.939679200354162,0,11,ribonuclease P activity,MF,
2039,GO:0004527,1,0.617438008433989,0,73,exonuclease activity,MF,
2040,GO:0004528,1,0.962181185349505,0,6,phosphodiesterase I activity,MF,
2041,GO:0004529,1,0.89089407207213,0,19,exodeoxyribonuclease activity,MF,
2042,GO:0004530,1,0.981255587050624,0,2,deoxyribonuclease I activity,MF,
2043,GO:0004531,1,0.989476879356079,0,2,deoxyribonuclease II activity,MF,
2044,GO:0004532,1,0.793902721786099,0,34,exoribonuclease activity,MF,
2045,GO:0004534,1,0.969679945633293,0,3,5'-3' exoribonuclease activity,MF,
2046,GO:0004535,1,0.9167116639228,0,12,poly(A)-specific ribonuclease activity,MF,
2047,GO:0004536,1,0.673833298251984,0,65,deoxyribonuclease activity,MF,
2048,GO:0004540,1,0.557342557377906,0,94,ribonuclease activity,MF,
2049,GO:0004549,1,0.913634830942707,0,16,tRNA-specific ribonuclease activity,MF,
2050,GO:0004550,1,0.910270230355884,0,17,nucleoside diphosphate kinase activity,MF,
2051,GO:0004551,1,0.908008192105044,0,16,nucleotide diphosphatase activity,MF,
2053,GO:0004556,1,0.989349393006347,0,2,alpha-amylase activity,MF,
2054,GO:0004557,1,0.988401168745847,0,2,alpha-galactosidase activity,MF,
2055,GO:0004558,1,0.977375830895706,0,3,alpha-1,4-glucosidase activity,MF,
2056,GO:0004559,1,0.910834253639047,0,13,alpha-mannosidase activity,MF,
2057,GO:0004560,1,0.989252082607952,0,2,alpha-L-fucosidase activity,MF,
2058,GO:0004561,1,0.99430975013158,0,1,alpha-N-acetylglucosaminidase activity,MF,
2059,GO:0004563,1,0.970016246403445,0,5,beta-N-acetylhexosaminidase activity,MF,
2060,GO:0004565,1,0.966630678468729,0,6,beta-galactosidase activity,MF,
2061,GO:0004566,1,0.981699053910653,0,3,beta-glucuronidase activity,MF,
2062,GO:0004567,1,0.993938289745582,0,1,beta-mannosidase activity,MF,
2064,GO:0004569,1,0.992784437765167,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2065,GO:0004571,1,0.950980358188636,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2066,GO:0004572,1,0.983262246449822,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2067,GO:0004573,1,0.99433843555818,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2068,GO:0004574,1,0.993704826320826,0,1,oligo-1,6-glucosidase activity,MF,
2069,GO:0004576,1,0.946194271661551,0,10,oligosaccharyl transferase activity,MF,
2070,GO:0004577,1,0.988984209156252,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2071,GO:0004578,1,0.993403173169431,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2072,GO:0004579,1,0.951139578380688,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2073,GO:0004581,1,0.994803251456914,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2074,GO:0004582,1,0.984486913233565,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2075,GO:0004583,1,0.970277442063251,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2076,GO:0004584,1,0.994516558998709,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2077,GO:0004585,1,0.994731610069127,0,1,ornithine carbamoyltransferase activity,MF,
2078,GO:0004586,1,0.982119038716112,0,3,ornithine decarboxylase activity,MF,
2079,GO:0004587,1,0.994650305971359,0,1,ornithine-oxo-acid transaminase activity,MF,
2080,GO:0004588,1,0.994378297052286,0,1,orotate phosphoribosyltransferase activity,MF,
2081,GO:0004590,1,0.994378297052286,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2082,GO:0004591,1,0.973923650171644,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2083,GO:0004594,1,0.97753623296347,0,4,pantothenate kinase activity,MF,
2084,GO:0004595,1,0.994542821289468,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2085,GO:0004596,1,0.933588645109659,0,11,peptide alpha-N-acetyltransferase activity,MF,
2086,GO:0004597,1,0.993680993227969,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2087,GO:0004598,1,0.99359549975056,0,1,peptidylamidoglycolate lyase activity,MF,
2088,GO:0004601,1,0.798042940910355,0,38,peroxidase activity,MF,
2089,GO:0004602,1,0.918428049482816,0,16,glutathione peroxidase activity,MF,
2090,GO:0004603,1,0.994804808863941,0,1,phenylethanolamine N-methyltransferase activity,MF,
2091,GO:0004605,1,0.98158896733978,0,3,phosphatidate cytidylyltransferase activity,MF,
2092,GO:0004607,1,0.994781364332826,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2093,GO:0004608,1,0.994818732113291,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2094,GO:0004609,1,0.988998582857049,0,2,phosphatidylserine decarboxylase activity,MF,
2095,GO:0004610,1,0.994645161781861,0,1,phosphoacetylglucosamine mutase activity,MF,
2096,GO:0004611,1,0.989048381054196,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2097,GO:0004613,1,0.989048381054196,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2098,GO:0004614,1,0.966234530120723,0,5,phosphoglucomutase activity,MF,
2099,GO:0004615,1,0.989350593677905,0,2,phosphomannomutase activity,MF,
2100,GO:0004616,1,0.982992934877376,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2101,GO:0004617,1,0.994638867968558,0,1,phosphoglycerate dehydrogenase activity,MF,
2102,GO:0004618,1,0.994489228030668,0,1,phosphoglycerate kinase activity,MF,
2103,GO:0004619,1,0.979098321865469,0,4,phosphoglycerate mutase activity,MF,
2105,GO:0004621,1,0.994546146440205,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2106,GO:0004622,1,0.896749550761475,0,18,lysophospholipase activity,MF,
2108,GO:0004629,1,0.830165392337147,0,27,phospholipase C activity,MF,
2109,GO:0004630,1,0.964593002801343,0,6,phospholipase D activity,MF,
2110,GO:0004631,1,0.994788811303326,0,1,phosphomevalonate kinase activity,MF,
2111,GO:0004632,1,0.994793013891674,0,1,phosphopantothenate--cysteine ligase activity,MF,
2112,GO:0004633,1,0.994572774022955,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2113,GO:0004634,1,0.978428372026593,0,4,phosphopyruvate hydratase activity,MF,
2114,GO:0004637,1,0.993838377268579,0,1,phosphoribosylamine-glycine ligase activity,MF,
2115,GO:0004638,1,0.993920977146251,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2116,GO:0004639,1,0.993920977146251,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2117,GO:0004641,1,0.993838377268579,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2118,GO:0004642,1,0.991919377612401,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2119,GO:0004643,1,0.994614640011293,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2120,GO:0004644,1,0.993838377268579,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2122,GO:0004647,1,0.98406998364309,0,3,phosphoserine phosphatase activity,MF,
2123,GO:0004648,1,0.994607211827369,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2124,GO:0004649,1,0.987852499526765,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2125,GO:0004651,1,0.987655614733499,0,2,polynucleotide 5'-phosphatase activity,MF,
2126,GO:0004652,1,0.937956486916094,0,9,polynucleotide adenylyltransferase activity,MF,
2128,GO:0004654,1,0.992756085097393,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2129,GO:0004655,1,0.994039610544966,0,1,porphobilinogen synthase activity,MF,
2130,GO:0004656,1,0.977979330795285,0,4,procollagen-proline 4-dioxygenase activity,MF,
2131,GO:0004657,1,0.994572774022955,0,1,proline dehydrogenase activity,MF,
2132,GO:0004658,1,0.989191730105108,0,2,propionyl-CoA carboxylase activity,MF,
2133,GO:0004659,1,0.909930408030294,0,15,prenyltransferase activity,MF,
2134,GO:0004660,1,0.989054668265066,0,2,protein farnesyltransferase activity,MF,
2135,GO:0004661,1,0.971984663563875,0,5,protein geranylgeranyltransferase activity,MF,
2136,GO:0004662,1,0.989109220313979,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2137,GO:0004663,1,0.977519939241974,0,4,Rab geranylgeranyltransferase activity,MF,
2138,GO:0004666,1,0.985217611398716,0,2,prostaglandin-endoperoxide synthase activity,MF,
2139,GO:0004667,1,0.989595168543473,0,2,prostaglandin-D synthase activity,MF,
2140,GO:0004668,1,0.975279410549987,0,4,protein-arginine deiminase activity,MF,
2141,GO:0004671,1,0.992540333741243,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2143,GO:0004673,1,0.952293336373609,0,7,protein histidine kinase activity,MF,
2145,GO:0004675,1,0.880358333132027,0,15,transmembrane receptor protein serine/threonine kinase activity,MF,
2146,GO:0004676,1,0.990209223188104,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2147,GO:0004677,1,0.96514928871003,0,3,DNA-dependent protein kinase activity,MF,
2148,GO:0004679,1,0.950875664476783,0,7,AMP-activated protein kinase activity,MF,
2149,GO:0004683,1,0.828507504822499,0,28,calmodulin-dependent protein kinase activity,MF,
2150,GO:0004686,1,0.989832751644873,0,1,elongation factor-2 kinase activity,MF,
2151,GO:0004687,1,0.965219660754393,0,4,myosin light chain kinase activity,MF,
2152,GO:0004689,1,0.963574686756227,0,5,phosphorylase kinase activity,MF,
2153,GO:0004690,1,0.938884759777542,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2154,GO:0004691,1,0.950799167854145,0,6,cAMP-dependent protein kinase activity,MF,
2155,GO:0004692,1,0.987475336312182,0,2,cGMP-dependent protein kinase activity,MF,
2156,GO:0004693,1,0.803216238949031,0,34,cyclin-dependent protein serine/threonine kinase activity,MF,
2157,GO:0004694,1,0.972004436589299,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2158,GO:0004697,1,0.898695083795048,0,15,protein kinase C activity,MF,
2159,GO:0004698,1,0.97472722302227,0,3,calcium-dependent protein kinase C activity,MF,
2160,GO:0004699,1,0.980010460647968,0,3,calcium-independent protein kinase C activity,MF,
2161,GO:0004702,1,0.418133054307454,0,118,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,
2162,GO:0004703,1,0.977989594553174,0,4,G-protein coupled receptor kinase activity,MF,
2163,GO:0004704,1,0.967595693417255,0,5,NF-kappaB-inducing kinase activity,MF,
2164,GO:0004705,1,0.981286714231871,0,3,JUN kinase activity,MF,
2165,GO:0004706,1,0.979421885587149,0,3,JUN kinase kinase kinase activity,MF,
2166,GO:0004707,1,0.918067906993947,0,14,MAP kinase activity,MF,
2167,GO:0004708,1,0.908029414544449,0,15,MAP kinase kinase activity,MF,
2168,GO:0004709,1,0.558457200638311,0,78,MAP kinase kinase kinase activity,MF,
2169,GO:0004711,1,0.946173854961415,0,7,ribosomal protein S6 kinase activity,MF,
2170,GO:0004712,1,0.760235040507052,0,41,protein serine/threonine/tyrosine kinase activity,MF,
2171,GO:0004713,1,0.305213540415486,0,170,protein tyrosine kinase activity,MF,
2172,GO:0004714,1,0.61417338655482,0,65,transmembrane receptor protein tyrosine kinase activity,MF,
2173,GO:0004715,1,0.731003527321026,0,49,non-membrane spanning protein tyrosine kinase activity,MF,
2174,GO:0004716,1,0.926490658184412,0,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
2175,GO:0004719,1,0.981463159910216,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2178,GO:0004722,1,0.643941537910746,0,67,protein serine/threonine phosphatase activity,MF,
2179,GO:0004723,1,0.951517840542528,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2181,GO:0004726,1,0.950824054185101,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2182,GO:0004727,1,0.989445416094642,0,2,prenylated protein tyrosine phosphatase activity,MF,
2183,GO:0004728,1,0.994412229846995,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2184,GO:0004729,1,0.994711406475216,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2185,GO:0004730,1,0.994728345978047,0,1,pseudouridylate synthase activity,MF,
2186,GO:0004731,1,0.986963794776748,0,2,purine-nucleoside phosphorylase activity,MF,
2187,GO:0004733,1,0.99382231520976,0,1,pyridoxamine-phosphate oxidase activity,MF,
2188,GO:0004735,1,0.989426523191245,0,2,pyrroline-5-carboxylate reductase activity,MF,
2189,GO:0004736,1,0.993327048564354,0,1,pyruvate carboxylase activity,MF,
2190,GO:0004738,1,0.970101285046887,0,5,pyruvate dehydrogenase activity,MF,
2191,GO:0004739,1,0.988672999098192,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2192,GO:0004740,1,0.971212002854868,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2193,GO:0004741,1,0.976064358413343,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2194,GO:0004742,1,0.993005537531851,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2195,GO:0004743,1,0.988493341280182,0,2,pyruvate kinase activity,MF,
2196,GO:0004744,1,0.994399069470243,0,1,retinal isomerase activity,MF,
2197,GO:0004745,1,0.936112820650883,0,12,retinol dehydrogenase activity,MF,
2198,GO:0004747,1,0.994800278830175,0,1,ribokinase activity,MF,
2199,GO:0004748,1,0.98049805936824,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2200,GO:0004749,1,0.978399009042965,0,4,ribose phosphate diphosphokinase activity,MF,
2201,GO:0004750,1,0.994542428451779,0,1,ribulose-phosphate 3-epimerase activity,MF,
2202,GO:0004751,1,0.994689649819694,0,1,ribose-5-phosphate isomerase activity,MF,
2203,GO:0004753,1,0.99141232102543,0,1,saccharopine dehydrogenase activity,MF,
2204,GO:0004756,1,0.988994073781482,0,2,selenide, water dikinase activity,MF,
2205,GO:0004757,1,0.994766395271907,0,1,sepiapterin reductase activity,MF,
2206,GO:0004758,1,0.967235594272168,0,5,serine C-palmitoyltransferase activity,MF,
2207,GO:0004760,1,0.99474103000378,0,1,serine-pyruvate transaminase activity,MF,
2208,GO:0004766,1,0.994791517233043,0,1,spermidine synthase activity,MF,
2209,GO:0004767,1,0.969023942624396,0,5,sphingomyelin phosphodiesterase activity,MF,
2210,GO:0004768,1,0.980456825762876,0,3,stearoyl-CoA 9-desaturase activity,MF,
2211,GO:0004769,1,0.994804808863941,0,1,steroid delta-isomerase activity,MF,
2212,GO:0004771,1,0.953077633563475,0,8,sterol esterase activity,MF,
2213,GO:0004772,1,0.9938738135908,0,1,sterol O-acyltransferase activity,MF,
2214,GO:0004773,1,0.990899127042202,0,1,steryl-sulfatase activity,MF,
2215,GO:0004774,1,0.983961505573415,0,3,succinate-CoA ligase activity,MF,
2216,GO:0004775,1,0.989384445557196,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2217,GO:0004776,1,0.989313623233073,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2218,GO:0004777,1,0.992184511093937,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2219,GO:0004778,1,0.994736192929894,0,1,succinyl-CoA hydrolase activity,MF,
2220,GO:0004779,1,0.987950284148667,0,2,sulfate adenylyltransferase activity,MF,
2221,GO:0004781,1,0.987950284148667,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2222,GO:0004782,1,0.994351969086881,0,1,sulfinoalanine decarboxylase activity,MF,
2223,GO:0004784,1,0.97394297689629,0,5,superoxide dismutase activity,MF,
2224,GO:0004788,1,0.994517803950429,0,1,thiamine diphosphokinase activity,MF,
2225,GO:0004790,1,0.994429038802581,0,1,thioether S-methyltransferase activity,MF,
2226,GO:0004791,1,0.956538486820536,0,8,thioredoxin-disulfide reductase activity,MF,
2227,GO:0004792,1,0.984132356136289,0,3,thiosulfate sulfurtransferase activity,MF,
2228,GO:0004793,1,0.989069378057645,0,2,threonine aldolase activity,MF,
2229,GO:0004794,1,0.989542691198702,0,2,L-threonine ammonia-lyase activity,MF,
2230,GO:0004795,1,0.994609042399123,0,1,threonine synthase activity,MF,
2231,GO:0004796,1,0.994609871305069,0,1,thromboxane-A synthase activity,MF,
2232,GO:0004797,1,0.987074068854989,0,2,thymidine kinase activity,MF,
2233,GO:0004798,1,0.989018055684255,0,2,thymidylate kinase activity,MF,
2234,GO:0004799,1,0.994744420879121,0,1,thymidylate synthase activity,MF,
2235,GO:0004800,1,0.985558169981082,0,2,thyroxine 5'-deiodinase activity,MF,
2236,GO:0004801,1,0.994795175432631,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2237,GO:0004802,1,0.989027331884342,0,2,transketolase activity,MF,
2238,GO:0004803,1,0.9933109426293,0,1,transposase activity,MF,
2239,GO:0004806,1,0.899104900460205,0,18,triglyceride lipase activity,MF,
2240,GO:0004807,1,0.994765921842978,0,1,triose-phosphate isomerase activity,MF,
2241,GO:0004809,1,0.983643866848245,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2242,GO:0004810,1,0.994551376364011,0,1,tRNA adenylyltransferase activity,MF,
2243,GO:0004812,1,0.772390722207143,0,44,aminoacyl-tRNA ligase activity,MF,
2244,GO:0004813,1,0.981252851309286,0,3,alanine-tRNA ligase activity,MF,
2245,GO:0004814,1,0.983934573681073,0,3,arginine-tRNA ligase activity,MF,
2246,GO:0004815,1,0.988470153363598,0,2,aspartate-tRNA ligase activity,MF,
2247,GO:0004816,1,0.988835883422412,0,2,asparagine-tRNA ligase activity,MF,
2248,GO:0004817,1,0.989091774006185,0,2,cysteine-tRNA ligase activity,MF,
2249,GO:0004818,1,0.985775594135081,0,2,glutamate-tRNA ligase activity,MF,
2250,GO:0004819,1,0.986996339256142,0,2,glutamine-tRNA ligase activity,MF,
2251,GO:0004820,1,0.98909447747533,0,2,glycine-tRNA ligase activity,MF,
2252,GO:0004821,1,0.989140585336022,0,2,histidine-tRNA ligase activity,MF,
2253,GO:0004822,1,0.986659638754506,0,2,isoleucine-tRNA ligase activity,MF,
2254,GO:0004823,1,0.985662435274055,0,2,leucine-tRNA ligase activity,MF,
2255,GO:0004824,1,0.99461053300476,0,1,lysine-tRNA ligase activity,MF,
2256,GO:0004825,1,0.988483199592305,0,2,methionine-tRNA ligase activity,MF,
2257,GO:0004826,1,0.972763910101612,0,5,phenylalanine-tRNA ligase activity,MF,
2258,GO:0004827,1,0.981744406378944,0,3,proline-tRNA ligase activity,MF,
2259,GO:0004828,1,0.989323991196765,0,2,serine-tRNA ligase activity,MF,
2260,GO:0004829,1,0.982817525715211,0,3,threonine-tRNA ligase activity,MF,
2261,GO:0004830,1,0.988678918870866,0,2,tryptophan-tRNA ligase activity,MF,
2262,GO:0004831,1,0.988711991651328,0,2,tyrosine-tRNA ligase activity,MF,
2263,GO:0004832,1,0.979343557181537,0,3,valine-tRNA ligase activity,MF,
2264,GO:0004833,1,0.98949568965263,0,2,tryptophan 2,3-dioxygenase activity,MF,
2265,GO:0004835,1,0.992178219384704,0,1,tubulin-tyrosine ligase activity,MF,
2266,GO:0004838,1,0.994319526247071,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2267,GO:0004839,1,0.965770441044661,0,5,ubiquitin activating enzyme activity,MF,
2268,GO:0004842,1,0.0532134681970157,0,422,ubiquitin-protein transferase activity,MF,
2269,GO:0004843,1,0.59708026181401,0,70,thiol-dependent ubiquitin-specific protease activity,MF,
2270,GO:0004844,1,0.973193032978354,0,5,uracil DNA N-glycosylase activity,MF,
2271,GO:0004849,1,0.973081083733148,0,5,uridine kinase activity,MF,
2272,GO:0004850,1,0.989220513629679,0,2,uridine phosphorylase activity,MF,
2273,GO:0004852,1,0.994780954590212,0,1,uroporphyrinogen-III synthase activity,MF,
2274,GO:0004853,1,0.994776757094452,0,1,uroporphyrinogen decarboxylase activity,MF,
2275,GO:0004854,1,0.98401033320613,0,2,xanthine dehydrogenase activity,MF,
2276,GO:0004855,1,0.991559595039779,0,1,xanthine oxidase activity,MF,
2277,GO:0004856,1,0.993624384679582,0,1,xylulokinase activity,MF,
2281,GO:0004861,1,0.932747692655026,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2282,GO:0004862,1,0.950269406275765,0,9,cAMP-dependent protein kinase inhibitor activity,MF,
2284,GO:0004865,1,0.947035527485319,0,10,protein serine/threonine phosphatase inhibitor activity,MF,
2289,GO:0004873,1,0.989557324497017,0,2,asialoglycoprotein receptor activity,MF,
2290,GO:0004874,1,0.983655890670298,0,2,aryl hydrocarbon receptor activity,MF,
2291,GO:0004875,1,0.956177735077469,0,7,complement receptor activity,MF,
2292,GO:0004876,1,0.994659055545952,0,1,complement component C3a receptor activity,MF,
2293,GO:0004877,1,0.987965628034237,0,1,complement component C3b receptor activity,MF,
2294,GO:0004878,1,0.988870865227076,0,2,complement component C5a receptor activity,MF,
2295,GO:0004879,1,0.727320555138037,0,46,nuclear receptor activity,MF,
2296,GO:0004882,1,0.988152255633948,0,2,androgen receptor activity,MF,
2297,GO:0004883,1,0.990654362670238,0,1,glucocorticoid receptor activity,MF,
2298,GO:0004886,1,0.980958653710827,0,3,9-cis retinoic acid receptor activity,MF,
2299,GO:0004887,1,0.960256686935571,0,6,thyroid hormone receptor activity,MF,
2303,GO:0004897,1,0.969392184191442,0,4,ciliary neurotrophic factor receptor activity,MF,
2304,GO:0004900,1,0.994686122796066,0,1,erythropoietin receptor activity,MF,
2305,GO:0004904,1,0.969805573145501,0,5,interferon receptor activity,MF,
2306,GO:0004905,1,0.986010984788587,0,2,type I interferon receptor activity,MF,
2307,GO:0004906,1,0.989207371007371,0,2,interferon-gamma receptor activity,MF,
2308,GO:0004908,1,0.958629192757308,0,7,interleukin-1 receptor activity,MF,
2309,GO:0004909,1,0.987131943834821,0,2,interleukin-1, Type I, activating receptor activity,MF,
2310,GO:0004910,1,0.988979316879964,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2311,GO:0004911,1,0.982177164296668,0,3,interleukin-2 receptor activity,MF,
2312,GO:0004912,1,0.992499060298947,0,1,interleukin-3 receptor activity,MF,
2313,GO:0004913,1,0.989287270207031,0,2,interleukin-4 receptor activity,MF,
2314,GO:0004914,1,0.987177441379057,0,2,interleukin-5 receptor activity,MF,
2315,GO:0004915,1,0.987293441777,0,2,interleukin-6 receptor activity,MF,
2316,GO:0004917,1,0.989478150752121,0,2,interleukin-7 receptor activity,MF,
2317,GO:0004918,1,0.988815938566241,0,2,interleukin-8 receptor activity,MF,
2318,GO:0004920,1,0.969044667606472,0,5,interleukin-10 receptor activity,MF,
2319,GO:0004921,1,0.994033683966511,0,1,interleukin-11 receptor activity,MF,
2320,GO:0004923,1,0.981263165958633,0,2,leukemia inhibitory factor receptor activity,MF,
2321,GO:0004924,1,0.975049840400321,0,3,oncostatin-M receptor activity,MF,
2322,GO:0004925,1,0.985693207443608,0,1,prolactin receptor activity,MF,
2324,GO:0004931,1,0.962056490893652,0,7,extracellularly ATP-gated cation channel activity,MF,
2325,GO:0004935,1,0.9454444619004,0,10,adrenergic receptor activity,MF,
2326,GO:0004936,1,0.971967828587966,0,5,alpha-adrenergic receptor activity,MF,
2327,GO:0004937,1,0.983611361033537,0,3,alpha1-adrenergic receptor activity,MF,
2328,GO:0004938,1,0.988164412523555,0,2,alpha2-adrenergic receptor activity,MF,
2329,GO:0004939,1,0.983377806762913,0,3,beta-adrenergic receptor activity,MF,
2330,GO:0004940,1,0.994265148661174,0,1,beta1-adrenergic receptor activity,MF,
2331,GO:0004941,1,0.994633983377533,0,1,beta2-adrenergic receptor activity,MF,
2332,GO:0004945,1,0.98422401450165,0,3,angiotensin type II receptor activity,MF,
2333,GO:0004946,1,0.994773414121803,0,1,bombesin receptor activity,MF,
2334,GO:0004947,1,0.987986002886858,0,2,bradykinin receptor activity,MF,
2335,GO:0004948,1,0.986083760759588,0,2,calcitonin receptor activity,MF,
2336,GO:0004949,1,0.979839956664104,0,3,cannabinoid receptor activity,MF,
2338,GO:0004951,1,0.989361100438341,0,2,cholecystokinin receptor activity,MF,
2339,GO:0004952,1,0.962150046116196,0,7,dopamine neurotransmitter receptor activity,MF,
2340,GO:0004953,1,0.907654131164065,0,17,icosanoid receptor activity,MF,
2341,GO:0004954,1,0.938181560299083,0,11,prostanoid receptor activity,MF,
2342,GO:0004955,1,0.943322005677796,0,10,prostaglandin receptor activity,MF,
2343,GO:0004956,1,0.988559448556813,0,2,prostaglandin D receptor activity,MF,
2344,GO:0004957,1,0.966754455482724,0,6,prostaglandin E receptor activity,MF,
2345,GO:0004958,1,0.986292770293658,0,2,prostaglandin F receptor activity,MF,
2346,GO:0004960,1,0.994553872164583,0,1,thromboxane receptor activity,MF,
2347,GO:0004961,1,0.994553872164583,0,1,thromboxane A2 receptor activity,MF,
2348,GO:0004962,1,0.986627249552027,0,2,endothelin receptor activity,MF,
2350,GO:0004966,1,0.947208121374791,0,10,galanin receptor activity,MF,
2351,GO:0004967,1,0.988841239774784,0,2,glucagon receptor activity,MF,
2352,GO:0004968,1,0.993110677120024,0,1,gonadotropin-releasing hormone receptor activity,MF,
2353,GO:0004969,1,0.970849249683272,0,5,histamine receptor activity,MF,
2355,GO:0004971,1,0.968559561619811,0,4,AMPA glutamate receptor activity,MF,
2357,GO:0004974,1,0.967481502696901,0,6,leukotriene receptor activity,MF,
2358,GO:0004977,1,0.978553752243209,0,4,melanocortin receptor activity,MF,
2359,GO:0004979,1,0.994682541933244,0,1,beta-endorphin receptor activity,MF,
2360,GO:0004980,1,0.988908725675706,0,2,melanocyte-stimulating hormone receptor activity,MF,
2361,GO:0004982,1,0.983979634535452,0,3,N-formyl peptide receptor activity,MF,
2362,GO:0004983,1,0.950009479870806,0,9,neuropeptide Y receptor activity,MF,
2363,GO:0004984,1,0.908357215892685,0,18,olfactory receptor activity,MF,
2364,GO:0004985,1,0.955500461979432,0,8,opioid receptor activity,MF,
2365,GO:0004990,1,0.993001581412764,0,1,oxytocin receptor activity,MF,
2366,GO:0004991,1,0.988979786376222,0,2,parathyroid hormone receptor activity,MF,
2367,GO:0004992,1,0.979683678260228,0,3,platelet activating factor receptor activity,MF,
2368,GO:0004993,1,0.928906582872151,0,13,G-protein coupled serotonin receptor activity,MF,
2369,GO:0004994,1,0.976940170958767,0,4,somatostatin receptor activity,MF,
2370,GO:0004995,1,0.983287461680711,0,3,tachykinin receptor activity,MF,
2371,GO:0004996,1,0.988295874506839,0,2,thyroid-stimulating hormone receptor activity,MF,
2372,GO:0004998,1,0.986454347770375,0,2,transferrin receptor activity,MF,
2373,GO:0004999,1,0.982525047967101,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2374,GO:0005000,1,0.964611098273286,0,6,vasopressin receptor activity,MF,
2375,GO:0005001,1,0.873684129692419,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2376,GO:0005003,1,0.877489294010873,0,19,ephrin receptor activity,MF,
2377,GO:0005004,1,0.947741059978699,0,7,GPI-linked ephrin receptor activity,MF,
2378,GO:0005005,1,0.887558093482456,0,17,transmembrane-ephrin receptor activity,MF,
2379,GO:0005006,1,0.988797101954685,0,2,epidermal growth factor-activated receptor activity,MF,
2380,GO:0005007,1,0.966682705006194,0,5,fibroblast growth factor-activated receptor activity,MF,
2381,GO:0005008,1,0.990606011025283,0,1,hepatocyte growth factor-activated receptor activity,MF,
2382,GO:0005009,1,0.988224859665897,0,1,insulin-activated receptor activity,MF,
2383,GO:0005010,1,0.959836940404693,0,4,insulin-like growth factor-activated receptor activity,MF,
2384,GO:0005011,1,0.985961331436615,0,2,macrophage colony-stimulating factor receptor activity,MF,
2385,GO:0005017,1,0.977186939684187,0,3,platelet-derived growth factor-activated receptor activity,MF,
2386,GO:0005018,1,0.990681137109418,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2387,GO:0005019,1,0.986380134230394,0,2,platelet-derived growth factor beta-receptor activity,MF,
2388,GO:0005020,1,0.992154089340602,0,1,stem cell factor receptor activity,MF,
2389,GO:0005021,1,0.947721526532092,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2390,GO:0005024,1,0.939643907594914,0,8,transforming growth factor beta-activated receptor activity,MF,
2391,GO:0005025,1,0.970363893624789,0,4,transforming growth factor beta receptor activity, type I,MF,
2392,GO:0005026,1,0.992691020896154,0,1,transforming growth factor beta receptor activity, type II,MF,
2393,GO:0005030,1,0.969353308684563,0,4,neurotrophin receptor activity,MF,
2394,GO:0005031,1,0.872554726760293,0,24,tumor necrosis factor-activated receptor activity,MF,
2395,GO:0005034,1,0.994062729449467,0,1,osmosensor activity,MF,
2396,GO:0005035,1,0.872554726760293,0,24,death receptor activity,MF,
2397,GO:0005041,1,0.884874099699314,0,13,low-density lipoprotein particle receptor activity,MF,
2398,GO:0005042,1,0.95179761042501,0,6,netrin receptor activity,MF,
2400,GO:0005046,1,0.989116578059413,0,2,KDEL sequence binding,MF,
2403,GO:0005049,1,0.938006648420826,0,8,nuclear export signal receptor activity,MF,
2404,GO:0005052,1,0.987802860104689,0,2,peroxisome matrix targeting signal-1 binding,MF,
2405,GO:0005053,1,0.994761736988657,0,1,peroxisome matrix targeting signal-2 binding,MF,
2406,GO:0005055,1,0.989319583541543,0,2,laminin receptor activity,MF,
2407,GO:0005057,1,0.307566470969933,0,163,signal transducer activity, downstream of receptor,MF,
2408,GO:0005068,1,0.918989035826761,0,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2410,GO:0005072,1,0.922732942221945,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2411,GO:0005078,1,0.939608532958187,0,7,MAP-kinase scaffold activity,MF,
2412,GO:0005080,1,0.750145906246666,0,43,protein kinase C binding,MF,
2414,GO:0005086,1,0.850640580913564,0,20,ARF guanyl-nucleotide exchange factor activity,MF,
2415,GO:0005087,1,0.978268537030329,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2417,GO:0005089,1,0.534802713074991,0,77,Rho guanyl-nucleotide exchange factor activity,MF,
2418,GO:0005090,1,0.994590999317122,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2419,GO:0005092,1,0.91857266911354,0,14,GDP-dissociation inhibitor activity,MF,
2420,GO:0005093,1,0.989015530093701,0,2,Rab GDP-dissociation inhibitor activity,MF,
2421,GO:0005094,1,0.98438502229534,0,3,Rho GDP-dissociation inhibitor activity,MF,
2422,GO:0005095,1,0.9088341183475,0,14,GTPase inhibitor activity,MF,
2423,GO:0005096,1,0.149313430878975,0,263,GTPase activator activity,MF,
2425,GO:0005104,1,0.877737220592814,0,20,fibroblast growth factor receptor binding,MF,
2426,GO:0005105,1,0.984189447820602,0,3,type 1 fibroblast growth factor receptor binding,MF,
2427,GO:0005109,1,0.811817557332171,0,33,frizzled binding,MF,
2428,GO:0005111,1,0.98447232071254,0,3,type 2 fibroblast growth factor receptor binding,MF,
2429,GO:0005112,1,0.845317231583083,0,21,Notch binding,MF,
2430,GO:0005113,1,0.956125277347301,0,7,patched binding,MF,
2431,GO:0005114,1,0.952311294574895,0,7,type II transforming growth factor beta receptor binding,MF,
2432,GO:0005115,1,0.991465911434634,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2433,GO:0005119,1,0.97678400833142,0,3,smoothened binding,MF,
2434,GO:0005123,1,0.907136442571196,0,16,death receptor binding,MF,
2435,GO:0005124,1,0.978723951867784,0,4,scavenger receptor binding,MF,
2438,GO:0005127,1,0.965713796124055,0,5,ciliary neurotrophic factor receptor binding,MF,
2439,GO:0005128,1,0.988794659508452,0,2,erythropoietin receptor binding,MF,
2440,GO:0005130,1,0.994756553045943,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2441,GO:0005131,1,0.972253747084166,0,4,growth hormone receptor binding,MF,
2442,GO:0005134,1,0.983295195666951,0,3,interleukin-2 receptor binding,MF,
2443,GO:0005135,1,0.993978598971753,0,1,interleukin-3 receptor binding,MF,
2444,GO:0005136,1,0.9888260158012,0,2,interleukin-4 receptor binding,MF,
2445,GO:0005137,1,0.994591348141956,0,1,interleukin-5 receptor binding,MF,
2446,GO:0005138,1,0.958042204208611,0,7,interleukin-6 receptor binding,MF,
2447,GO:0005139,1,0.989101726885487,0,2,interleukin-7 receptor binding,MF,
2448,GO:0005141,1,0.99473599633455,0,1,interleukin-10 receptor binding,MF,
2449,GO:0005142,1,0.994520284237139,0,1,interleukin-11 receptor binding,MF,
2450,GO:0005143,1,0.981557428050469,0,3,interleukin-12 receptor binding,MF,
2451,GO:0005144,1,0.994790910327561,0,1,interleukin-13 receptor binding,MF,
2452,GO:0005146,1,0.988188784216752,0,2,leukemia inhibitory factor receptor binding,MF,
2453,GO:0005147,1,0.994683827021034,0,1,oncostatin-M receptor binding,MF,
2454,GO:0005148,1,0.994801074932632,0,1,prolactin receptor binding,MF,
2455,GO:0005149,1,0.934671451462569,0,11,interleukin-1 receptor binding,MF,
2456,GO:0005150,1,0.98844169191003,0,2,interleukin-1, Type I receptor binding,MF,
2457,GO:0005151,1,0.986727149975538,0,2,interleukin-1, Type II receptor binding,MF,
2458,GO:0005152,1,0.985180743125533,0,2,interleukin-1 receptor antagonist activity,MF,
2459,GO:0005153,1,0.988432723912149,0,2,interleukin-8 receptor binding,MF,
2460,GO:0005154,1,0.81454837041464,0,29,epidermal growth factor receptor binding,MF,
2461,GO:0005157,1,0.984033859992209,0,3,macrophage colony-stimulating factor receptor binding,MF,
2462,GO:0005158,1,0.835550298232351,0,21,insulin receptor binding,MF,
2463,GO:0005159,1,0.909757053841071,0,13,insulin-like growth factor receptor binding,MF,
2465,GO:0005161,1,0.905485447472393,0,14,platelet-derived growth factor receptor binding,MF,
2466,GO:0005163,1,0.994814550809883,0,1,nerve growth factor receptor binding,MF,
2467,GO:0005164,1,0.850281189253032,0,29,tumor necrosis factor receptor binding,MF,
2468,GO:0005165,1,0.92847142592745,0,11,neurotrophin receptor binding,MF,
2469,GO:0005166,1,0.984081057029849,0,3,neurotrophin p75 receptor binding,MF,
2470,GO:0005167,1,0.943503511724943,0,8,neurotrophin TRK receptor binding,MF,
2471,GO:0005168,1,0.954790792950017,0,6,neurotrophin TRKA receptor binding,MF,
2472,GO:0005169,1,0.980273672124012,0,3,neurotrophin TRKB receptor binding,MF,
2473,GO:0005170,1,0.991996332460478,0,1,neurotrophin TRKC receptor binding,MF,
2474,GO:0005171,1,0.989302329383219,0,2,hepatocyte growth factor receptor binding,MF,
2475,GO:0005172,1,0.938040300249883,0,10,vascular endothelial growth factor receptor binding,MF,
2476,GO:0005173,1,0.975229352648842,0,3,stem cell factor receptor binding,MF,
2477,GO:0005174,1,0.989268607585419,0,2,CD40 receptor binding,MF,
2478,GO:0005175,1,0.994835559032502,0,1,CD27 receptor binding,MF,
2479,GO:0005176,1,0.982359114551814,0,3,ErbB-2 class receptor binding,MF,
2482,GO:0005183,1,0.989587299940688,0,2,gonadotropin hormone-releasing hormone activity,MF,
2483,GO:0005184,1,0.899323776499122,0,20,neuropeptide hormone activity,MF,
2485,GO:0005199,1,0.993901121617639,0,1,structural constituent of cell wall,MF,
2492,GO:0005219,1,0.942858309372587,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2493,GO:0005220,1,0.960877806928339,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2494,GO:0005221,1,0.941815648990825,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2495,GO:0005222,1,0.947193133748665,0,8,intracellular cAMP activated cation channel activity,MF,
2496,GO:0005223,1,0.964940714594953,0,6,intracellular cGMP activated cation channel activity,MF,
2497,GO:0005225,1,0.931116522553246,0,10,volume-sensitive anion channel activity,MF,
2498,GO:0005227,1,0.841890192335379,0,27,calcium activated cation channel activity,MF,
2499,GO:0005228,1,0.983990666688173,0,2,intracellular sodium activated potassium channel activity,MF,
2500,GO:0005229,1,0.888411335926326,0,18,intracellular calcium activated chloride channel activity,MF,
2504,GO:0005237,1,0.900886898302981,0,15,inhibitory extracellular ligand-gated ion channel activity,MF,
2505,GO:0005242,1,0.88437610293987,0,20,inward rectifier potassium channel activity,MF,
2506,GO:0005243,1,0.939315538484612,0,10,gap junction channel activity,MF,
2508,GO:0005245,1,0.719777937684384,0,41,voltage-gated calcium channel activity,MF,
2509,GO:0005246,1,0.821737209216486,0,30,calcium channel regulator activity,MF,
2510,GO:0005247,1,0.930483908524229,0,10,voltage-gated chloride channel activity,MF,
2511,GO:0005248,1,0.809201508874449,0,23,voltage-gated sodium channel activity,MF,
2515,GO:0005252,1,0.993370408642721,0,1,open rectifier potassium channel activity,MF,
2518,GO:0005260,1,0.991137137372775,0,1,intracellularly ATP-gated chloride channel activity,MF,
2522,GO:0005272,1,0.70102450164807,0,44,sodium channel activity,MF,
2523,GO:0005275,1,0.988842060656631,0,2,amine transmembrane transporter activity,MF,
2524,GO:0005277,1,0.98371753574617,0,3,acetylcholine transmembrane transporter activity,MF,
2525,GO:0005280,1,0.975118881454731,0,4,amino acid:proton symporter activity,MF,
2526,GO:0005283,1,0.890373398741052,0,17,amino acid:sodium symporter activity,MF,
2527,GO:0005287,1,0.984256955581072,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2528,GO:0005289,1,0.984256955581072,0,2,high-affinity arginine transmembrane transporter activity,MF,
2529,GO:0005290,1,0.983181103248665,0,3,L-histidine transmembrane transporter activity,MF,
2530,GO:0005292,1,0.984256955581072,0,2,high-affinity lysine transmembrane transporter activity,MF,
2531,GO:0005294,1,0.987654884655252,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2532,GO:0005295,1,0.988305875706786,0,2,neutral amino acid:sodium symporter activity,MF,
2533,GO:0005298,1,0.986625916108147,0,2,proline:sodium symporter activity,MF,
2534,GO:0005302,1,0.994064549318113,0,1,L-tyrosine transmembrane transporter activity,MF,
2535,GO:0005308,1,0.98653551826146,0,2,creatine transmembrane transporter activity,MF,
2536,GO:0005309,1,0.993757862295183,0,1,creatine:sodium symporter activity,MF,
2537,GO:0005310,1,0.790079022729084,0,35,dicarboxylic acid transmembrane transporter activity,MF,
2538,GO:0005313,1,0.905465463861295,0,14,L-glutamate transmembrane transporter activity,MF,
2539,GO:0005314,1,0.951762377637633,0,7,high-affinity glutamate transmembrane transporter activity,MF,
2540,GO:0005315,1,0.971158666537237,0,4,inorganic phosphate transmembrane transporter activity,MF,
2541,GO:0005316,1,0.993964744380412,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2543,GO:0005324,1,0.97018040942524,0,5,long-chain fatty acid transporter activity,MF,
2544,GO:0005326,1,0.735740729343567,0,47,neurotransmitter transporter activity,MF,
2545,GO:0005328,1,0.854425565634383,0,23,neurotransmitter:sodium symporter activity,MF,
2546,GO:0005329,1,0.961566248896599,0,6,dopamine transmembrane transporter activity,MF,
2547,GO:0005330,1,0.980255274399148,0,3,dopamine:sodium symporter activity,MF,
2548,GO:0005332,1,0.976274749973508,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2549,GO:0005333,1,0.983137650743475,0,3,norepinephrine transmembrane transporter activity,MF,
2550,GO:0005334,1,0.99390829171135,0,1,norepinephrine:sodium symporter activity,MF,
2551,GO:0005335,1,0.992817761201889,0,1,serotonin:sodium symporter activity,MF,
2552,GO:0005337,1,0.967438675433496,0,6,nucleoside transmembrane transporter activity,MF,
2553,GO:0005338,1,0.928656356019928,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2555,GO:0005343,1,0.836762808746609,0,26,organic acid:sodium symporter activity,MF,
2556,GO:0005344,1,0.930429132541783,0,13,oxygen carrier activity,MF,
2557,GO:0005345,1,0.971413151193089,0,5,purine nucleobase transmembrane transporter activity,MF,
2558,GO:0005346,1,0.938250740532886,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2559,GO:0005347,1,0.953727832516343,0,8,ATP transmembrane transporter activity,MF,
2560,GO:0005350,1,0.983452797390589,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2561,GO:0005351,1,0.936986344211093,0,10,carbohydrate:proton symporter activity,MF,
2562,GO:0005353,1,0.99453369805972,0,1,fructose transmembrane transporter activity,MF,
2563,GO:0005355,1,0.888739768352893,0,19,glucose transmembrane transporter activity,MF,
2564,GO:0005362,1,0.988577977880594,0,2,low-affinity glucose:sodium symporter activity,MF,
2565,GO:0005365,1,0.976282592160144,0,2,myo-inositol transmembrane transporter activity,MF,
2566,GO:0005366,1,0.990256044547118,0,1,myo-inositol:proton symporter activity,MF,
2567,GO:0005367,1,0.985890419223253,0,1,myo-inositol:sodium symporter activity,MF,
2568,GO:0005368,1,0.990762607085695,0,1,taurine transmembrane transporter activity,MF,
2569,GO:0005369,1,0.990762607085695,0,1,taurine:sodium symporter activity,MF,
2570,GO:0005372,1,0.93836866653948,0,11,water transmembrane transporter activity,MF,
2571,GO:0005375,1,0.955815092406211,0,6,copper ion transmembrane transporter activity,MF,
2572,GO:0005381,1,0.940769647399767,0,10,iron ion transmembrane transporter activity,MF,
2573,GO:0005384,1,0.962636042986738,0,6,manganese ion transmembrane transporter activity,MF,
2574,GO:0005385,1,0.889812433134926,0,19,zinc ion transmembrane transporter activity,MF,
2575,GO:0005388,1,0.890291246680572,0,14,calcium-transporting ATPase activity,MF,
2576,GO:0005391,1,0.9289937946804,0,12,sodium:potassium-exchanging ATPase activity,MF,
2577,GO:0005395,1,0.989889178210061,0,1,eye pigment precursor transporter activity,MF,
2578,GO:0005402,1,0.895612746750182,0,17,carbohydrate:cation symporter activity,MF,
2579,GO:0005412,1,0.965240286448946,0,6,glucose:sodium symporter activity,MF,
2580,GO:0005415,1,0.98923244394535,0,2,nucleoside:sodium symporter activity,MF,
2581,GO:0005416,1,0.877890644964274,0,19,amino acid:cation symporter activity,MF,
2582,GO:0005427,1,0.993611526651874,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2584,GO:0005436,1,0.964849223978867,0,6,sodium:phosphate symporter activity,MF,
2585,GO:0005451,1,0.917865186408554,0,13,monovalent cation:proton antiporter activity,MF,
2586,GO:0005452,1,0.841876119022852,0,26,inorganic anion exchanger activity,MF,
2587,GO:0005456,1,0.994695328496284,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2588,GO:0005457,1,0.984526782854038,0,2,GDP-fucose transmembrane transporter activity,MF,
2589,GO:0005459,1,0.989544629504097,0,2,UDP-galactose transmembrane transporter activity,MF,
2590,GO:0005461,1,0.990809092715381,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2591,GO:0005462,1,0.985094642420816,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2592,GO:0005464,1,0.99044699374064,0,1,UDP-xylose transmembrane transporter activity,MF,
2593,GO:0005471,1,0.987759810769889,0,2,ATP:ADP antiporter activity,MF,
2594,GO:0005476,1,0.982877384512219,0,3,carnitine:acyl carnitine antiporter activity,MF,
2595,GO:0005477,1,0.99376040335318,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2596,GO:0005483,1,0.981864368275285,0,3,soluble NSF attachment protein activity,MF,
2599,GO:0005496,1,0.594343525569371,0,78,steroid binding,MF,
2600,GO:0005497,1,0.978561970963273,0,4,androgen binding,MF,
2601,GO:0005499,1,0.974292877388944,0,4,vitamin D binding,MF,
2602,GO:0005501,1,0.868402679720353,0,23,retinoid binding,MF,
2603,GO:0005502,1,0.976408196637577,0,4,11-cis retinal binding,MF,
2604,GO:0005503,1,0.987358146072318,0,2,all-trans retinal binding,MF,
2612,GO:0005518,1,0.662905867052475,0,59,collagen binding,MF,
2613,GO:0005519,1,0.993367590940043,0,1,cytoskeletal regulatory protein binding,MF,
2615,GO:0005521,1,0.896145411147537,0,15,lamin binding,MF,
2616,GO:0005522,1,0.918339772678756,0,10,profilin binding,MF,
2617,GO:0005523,1,0.918596581145473,0,13,tropomyosin binding,MF,
2620,GO:0005527,1,0.928185372134552,0,13,macrolide binding,MF,
2621,GO:0005528,1,0.928185372134552,0,13,FK506 binding,MF,
2622,GO:0005534,1,0.972031131725405,0,5,galactose binding,MF,
2623,GO:0005536,1,0.933188217841242,0,11,glucose binding,MF,
2624,GO:0005537,1,0.917353897986942,0,14,mannose binding,MF,
2626,GO:0005540,1,0.874798439069697,0,19,hyaluronic acid binding,MF,
2627,GO:0005542,1,0.94346373359019,0,10,folic acid binding,MF,
2632,GO:0005547,1,0.786636246799223,0,33,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2633,GO:0005548,1,0.678645140348078,0,52,phospholipid transporter activity,MF,
2634,GO:0005549,1,0.979263717434363,0,4,odorant binding,MF,
2637,GO:0005577,1,0.952883211405464,0,7,fibrinogen complex,CC,
2639,GO:0005579,1,0.973438512347543,0,4,membrane attack complex,CC,
2641,GO:0005582,1,0.992021611577984,0,1,collagen type XV trimer,CC,
2644,GO:0005585,1,0.992314215160671,0,1,collagen type II trimer,CC,
2647,GO:0005588,1,0.970394270863,0,3,collagen type V trimer,CC,
2648,GO:0005589,1,0.976513428405316,0,3,collagen type VI trimer,CC,
2649,GO:0005590,1,0.988009572257169,0,1,collagen type VII trimer,CC,
2650,GO:0005591,1,0.994394193991265,0,1,collagen type VIII trimer,CC,
2651,GO:0005592,1,0.981178731306704,0,2,collagen type XI trimer,CC,
2652,GO:0005593,1,0.953341247081045,0,6,FACIT collagen trimer,CC,
2653,GO:0005594,1,0.982654752913692,0,3,collagen type IX trimer,CC,
2654,GO:0005595,1,0.987437568977884,0,1,collagen type XII trimer,CC,
2655,GO:0005596,1,0.990780161608336,0,1,collagen type XIV trimer,CC,
2656,GO:0005597,1,0.991662926838147,0,1,collagen type XVI trimer,CC,
2657,GO:0005598,1,0.994394193991265,0,1,short-chain collagen trimer,CC,
2658,GO:0005600,1,0.994132026395568,0,1,collagen type XIII trimer,CC,
2659,GO:0005602,1,0.989652132105274,0,2,complement component C1 complex,CC,
2661,GO:0005605,1,0.83148695404447,0,20,basal lamina,CC,
2662,GO:0005606,1,0.96882992788208,0,3,laminin-1 complex,CC,
2663,GO:0005607,1,0.983748473340018,0,2,laminin-2 complex,CC,
2664,GO:0005608,1,0.97930804394497,0,2,laminin-3 complex,CC,
2665,GO:0005610,1,0.968775332561426,0,3,laminin-5 complex,CC,
2666,GO:0005614,1,0.917315863183836,0,12,interstitial matrix,CC,
2672,GO:0005637,1,0.716194693827705,0,50,nuclear inner membrane,CC,
2673,GO:0005638,1,0.975975369713108,0,4,lamin filament,CC,
2674,GO:0005639,1,0.919528841968475,0,14,integral component of nuclear inner membrane,CC,
2675,GO:0005640,1,0.855672858199676,0,20,nuclear outer membrane,CC,
2676,GO:0005641,1,0.942141816959903,0,8,nuclear envelope lumen,CC,
2677,GO:0005642,1,0.959417248741002,0,5,annulate lamellae,CC,
2678,GO:0005643,1,0.580022177200173,0,76,nuclear pore,CC,
2679,GO:0005652,1,0.941291557831081,0,9,nuclear lamina,CC,
2681,GO:0005655,1,0.956014836570007,0,8,nucleolar ribonuclease P complex,CC,
2682,GO:0005656,1,0.983817213440429,0,3,nuclear pre-replicative complex,CC,
2683,GO:0005657,1,0.657249817528428,0,67,replication fork,CC,
2684,GO:0005658,1,0.964150089073574,0,6,alpha DNA polymerase:primase complex,CC,
2685,GO:0005662,1,0.91684020147939,0,14,DNA replication factor A complex,CC,
2686,GO:0005663,1,0.966450922474431,0,6,DNA replication factor C complex,CC,
2687,GO:0005664,1,0.949582849192699,0,9,nuclear origin of replication recognition complex,CC,
2688,GO:0005665,1,0.893166064571569,0,18,DNA-directed RNA polymerase II, core complex,CC,
2689,GO:0005666,1,0.90657136057199,0,17,DNA-directed RNA polymerase III complex,CC,
2690,GO:0005667,1,0.119818639168813,0,319,transcription factor complex,CC,
2691,GO:0005668,1,0.989359548228908,0,2,RNA polymerase transcription factor SL1 complex,CC,
2692,GO:0005669,1,0.801046412294678,0,36,transcription factor TFIID complex,CC,
2693,GO:0005671,1,0.917067131924358,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2694,GO:0005672,1,0.973981436393816,0,5,transcription factor TFIIA complex,CC,
2695,GO:0005673,1,0.988934575803948,0,2,transcription factor TFIIE complex,CC,
2696,GO:0005674,1,0.989223797580598,0,2,transcription factor TFIIF complex,CC,
2697,GO:0005675,1,0.934699475333381,0,12,holo TFIIH complex,CC,
2698,GO:0005677,1,0.94020166007028,0,8,chromatin silencing complex,CC,
2699,GO:0005680,1,0.881881195079671,0,21,anaphase-promoting complex,CC,
2701,GO:0005682,1,0.852818571040855,0,22,U5 snRNP,CC,
2702,GO:0005683,1,0.963832950467631,0,7,U7 snRNP,CC,
2703,GO:0005684,1,0.706704605099239,0,57,U2-type spliceosomal complex,CC,
2704,GO:0005685,1,0.884519548244093,0,20,U1 snRNP,CC,
2705,GO:0005686,1,0.887207920675069,0,20,U2 snRNP,CC,
2706,GO:0005687,1,0.934257792008353,0,11,U4 snRNP,CC,
2707,GO:0005688,1,0.958073473540597,0,8,U6 snRNP,CC,
2708,GO:0005689,1,0.861816705168284,0,26,U12-type spliceosomal complex,CC,
2709,GO:0005690,1,0.994582529486301,0,1,U4atac snRNP,CC,
2710,GO:0005691,1,0.992974831045404,0,1,U6atac snRNP,CC,
2711,GO:0005694,1,0.0019490001938663,0,900,chromosome,CC,
2712,GO:0005697,1,0.863272076745267,0,22,telomerase holoenzyme complex,CC,
2713,GO:0005712,1,0.983917516936872,0,2,chiasma,CC,
2714,GO:0005713,1,0.994470477599369,0,1,recombination nodule,CC,
2715,GO:0005715,1,0.994470477599369,0,1,late recombination nodule,CC,
2716,GO:0005719,1,0.869626163881936,0,23,nuclear euchromatin,CC,
2717,GO:0005720,1,0.810897788322487,0,31,nuclear heterochromatin,CC,
2718,GO:0005721,1,0.870304088892,0,19,pericentric heterochromatin,CC,
2719,GO:0005724,1,0.99473421612549,0,1,nuclear telomeric heterochromatin,CC,
2720,GO:0005726,1,0.970880837766971,0,4,perichromatin fibrils,CC,
2721,GO:0005730,1,0.00286963874964273,0,877,nucleolus,CC,
2722,GO:0005731,1,0.994717517892978,0,1,nucleolus organizer region,CC,
2723,GO:0005732,1,0.896712131161249,0,20,small nucleolar ribonucleoprotein complex,CC,
2724,GO:0005736,1,0.929044654352045,0,12,DNA-directed RNA polymerase I complex,CC,
2728,GO:0005741,1,0.348719859190982,0,163,mitochondrial outer membrane,CC,
2729,GO:0005742,1,0.957425852512497,0,8,mitochondrial outer membrane translocase complex,CC,
2731,GO:0005744,1,0.940489344981131,0,11,mitochondrial inner membrane presequence translocase complex,CC,
2732,GO:0005745,1,0.988577507530615,0,2,m-AAA complex,CC,
2733,GO:0005746,1,0.662033616546947,0,76,mitochondrial respiratory chain,CC,
2734,GO:0005747,1,0.795565393732025,0,43,mitochondrial respiratory chain complex I,CC,
2735,GO:0005749,1,0.978605012937881,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2736,GO:0005750,1,0.94054230991101,0,11,mitochondrial respiratory chain complex III,CC,
2737,GO:0005751,1,0.934713552507505,0,13,mitochondrial respiratory chain complex IV,CC,
2738,GO:0005753,1,0.994581099461193,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2739,GO:0005757,1,0.978634317090436,0,4,mitochondrial permeability transition pore complex,CC,
2740,GO:0005758,1,0.679538921599627,0,69,mitochondrial intermembrane space,CC,
2741,GO:0005759,1,0.0835101671958377,0,420,mitochondrial matrix,CC,
2742,GO:0005760,1,0.985877899648595,0,2,gamma DNA polymerase complex,CC,
2743,GO:0005761,1,0.643740448120203,0,82,mitochondrial ribosome,CC,
2744,GO:0005762,1,0.762747327489248,0,50,mitochondrial large ribosomal subunit,CC,
2745,GO:0005763,1,0.867374407960597,0,27,mitochondrial small ribosomal subunit,CC,
2749,GO:0005767,1,0.924091768909678,0,13,secondary lysosome,CC,
2757,GO:0005776,1,0.567109154169606,0,87,autophagosome,CC,
2759,GO:0005778,1,0.69329760450466,0,57,peroxisomal membrane,CC,
2760,GO:0005779,1,0.906037395155408,0,17,integral component of peroxisomal membrane,CC,
2761,GO:0005782,1,0.78544805620796,0,41,peroxisomal matrix,CC,
2763,GO:0005784,1,0.979148468683298,0,4,Sec61 translocon complex,CC,
2765,GO:0005786,1,0.967291467895462,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2766,GO:0005787,1,0.971852904681406,0,5,signal peptidase complex,CC,
2769,GO:0005790,1,0.783209314135445,0,31,smooth endoplasmic reticulum,CC,
2771,GO:0005793,1,0.477245527612047,0,113,endoplasmic reticulum-Golgi intermediate compartment,CC,
2775,GO:0005797,1,0.952896558345078,0,8,Golgi medial cisterna,CC,
2777,GO:0005801,1,0.690826010681826,0,54,cis-Golgi network,CC,
2780,GO:0005813,1,0.0401070588482973,0,466,centrosome,CC,
2781,GO:0005814,1,0.433427898685434,0,118,centriole,CC,
2782,GO:0005815,1,0.010168951797444,0,659,microtubule organizing center,CC,
2783,GO:0005816,1,0.962060121167428,0,6,spindle pole body,CC,
2784,GO:0005818,1,0.943774503419961,0,8,aster,CC,
2785,GO:0005819,1,0.123240883829204,0,305,spindle,CC,
2786,GO:0005826,1,0.962647693333703,0,5,actomyosin contractile ring,CC,
2787,GO:0005827,1,0.966313440922319,0,5,polar microtubule,CC,
2788,GO:0005828,1,0.942144994259115,0,7,kinetochore microtubule,CC,
2790,GO:0005832,1,0.935316699265626,0,11,chaperonin-containing T-complex,CC,
2791,GO:0005833,1,0.944018938231672,0,11,hemoglobin complex,CC,
2793,GO:0005838,1,0.893018494754767,0,21,proteasome regulatory particle,CC,
2794,GO:0005839,1,0.89979174001942,0,19,proteasome core complex,CC,
2795,GO:0005840,1,0.276123150727171,0,228,ribosome,CC,
2797,GO:0005845,1,0.929988321747494,0,11,mRNA cap binding complex,CC,
2798,GO:0005846,1,0.986591384365542,0,2,nuclear cap binding complex,CC,
2799,GO:0005847,1,0.903158567356297,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2800,GO:0005849,1,0.890622610146454,0,18,mRNA cleavage factor complex,CC,
2801,GO:0005850,1,0.975102633320018,0,4,eukaryotic translation initiation factor 2 complex,CC,
2802,GO:0005851,1,0.966726959095106,0,6,eukaryotic translation initiation factor 2B complex,CC,
2803,GO:0005852,1,0.905886930775577,0,17,eukaryotic translation initiation factor 3 complex,CC,
2804,GO:0005853,1,0.978245360982622,0,4,eukaryotic translation elongation factor 1 complex,CC,
2805,GO:0005854,1,0.987440022144839,0,2,nascent polypeptide-associated complex,CC,
2807,GO:0005858,1,0.828633136875371,0,17,axonemal dynein complex,CC,
2808,GO:0005859,1,0.824835706119481,0,23,muscle myosin complex,CC,
2809,GO:0005861,1,0.955764134264754,0,8,troponin complex,CC,
2810,GO:0005862,1,0.976905623544095,0,4,muscle thin filament tropomyosin,CC,
2811,GO:0005863,1,0.978448347082293,0,3,striated muscle myosin thick filament,CC,
2812,GO:0005865,1,0.801234982550841,0,30,striated muscle thin filament,CC,
2813,GO:0005868,1,0.854449121774642,0,22,cytoplasmic dynein complex,CC,
2814,GO:0005869,1,0.955017435050539,0,8,dynactin complex,CC,
2815,GO:0005871,1,0.682669097859175,0,50,kinesin complex,CC,
2816,GO:0005873,1,0.983740465847332,0,2,plus-end kinesin complex,CC,
2817,GO:0005874,1,0.0604945032310639,0,380,microtubule,CC,
2818,GO:0005875,1,0.329651788504355,0,141,microtubule associated complex,CC,
2819,GO:0005876,1,0.671202288419009,0,57,spindle microtubule,CC,
2820,GO:0005879,1,0.968901699111616,0,4,axonemal microtubule,CC,
2821,GO:0005880,1,0.994766158800029,0,1,nuclear microtubule,CC,
2822,GO:0005881,1,0.688561514216777,0,54,cytoplasmic microtubule,CC,
2826,GO:0005885,1,0.942048562788082,0,11,Arp2/3 protein complex,CC,
2829,GO:0005889,1,0.987489923627055,0,2,potassium:proton exchanging ATPase complex,CC,
2830,GO:0005890,1,0.935908864527366,0,11,sodium:potassium-exchanging ATPase complex,CC,
2831,GO:0005891,1,0.725372771241319,0,40,voltage-gated calcium channel complex,CC,
2832,GO:0005892,1,0.906379950090526,0,16,acetylcholine-gated channel complex,CC,
2833,GO:0005895,1,0.994591348141956,0,1,interleukin-5 receptor complex,CC,
2834,GO:0005896,1,0.982160903547725,0,3,interleukin-6 receptor complex,CC,
2835,GO:0005898,1,0.993336502465878,0,1,interleukin-13 receptor complex,CC,
2836,GO:0005899,1,0.968410349082282,0,3,insulin receptor complex,CC,
2837,GO:0005900,1,0.987740305922103,0,2,oncostatin-M receptor complex,CC,
2838,GO:0005901,1,0.585481559600103,0,73,caveola,CC,
2845,GO:0005914,1,0.993921767359053,0,1,spot adherens junction,CC,
2846,GO:0005915,1,0.951934899257941,0,7,zonula adherens,CC,
2847,GO:0005916,1,0.931347581596412,0,10,fascia adherens,CC,
2848,GO:0005921,1,0.863859954356874,0,24,gap junction,CC,
2849,GO:0005922,1,0.919120512983104,0,14,connexin complex,CC,
2850,GO:0005923,1,0.454992202835195,0,109,bicellular tight junction,CC,
2853,GO:0005927,1,0.981518704645198,0,3,muscle tendon junction,CC,
2855,GO:0005930,1,0.465522546247898,0,101,axoneme,CC,
2857,GO:0005940,1,0.927781029838393,0,12,septin ring,CC,
2858,GO:0005942,1,0.87296070128113,0,18,phosphatidylinositol 3-kinase complex,CC,
2859,GO:0005943,1,0.985149493208742,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2860,GO:0005944,1,0.98489076994439,0,2,phosphatidylinositol 3-kinase complex, class IB,CC,
2861,GO:0005945,1,0.988107275433475,0,2,6-phosphofructokinase complex,CC,
2862,GO:0005947,1,0.965508251713626,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2863,GO:0005952,1,0.959130080230232,0,7,cAMP-dependent protein kinase complex,CC,
2864,GO:0005953,1,0.989109220313979,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2865,GO:0005954,1,0.994466831691925,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2866,GO:0005955,1,0.968482003353168,0,4,calcineurin complex,CC,
2867,GO:0005956,1,0.989176715043006,0,2,protein kinase CK2 complex,CC,
2868,GO:0005958,1,0.972424631258829,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2869,GO:0005960,1,0.988299682724856,0,2,glycine cleavage complex,CC,
2870,GO:0005964,1,0.963574686756227,0,5,phosphorylase kinase complex,CC,
2871,GO:0005965,1,0.989054668265066,0,2,protein farnesyltransferase complex,CC,
2872,GO:0005967,1,0.980454438182423,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2873,GO:0005968,1,0.973057816524722,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2874,GO:0005969,1,0.989231657242634,0,1,serine-pyruvate aminotransferase complex,CC,
2875,GO:0005971,1,0.98049805936824,0,3,ribonucleoside-diphosphate reductase complex,CC,
2877,GO:0005976,1,0.506559872063793,0,99,polysaccharide metabolic process,BP,
2878,GO:0005977,1,0.620274030441958,0,68,glycogen metabolic process,BP,
2879,GO:0005978,1,0.726821413580328,0,44,glycogen biosynthetic process,BP,
2880,GO:0005979,1,0.830668650183675,0,23,regulation of glycogen biosynthetic process,BP,
2881,GO:0005980,1,0.852049298871227,0,23,glycogen catabolic process,BP,
2882,GO:0005981,1,0.974024634157672,0,4,regulation of glycogen catabolic process,BP,
2883,GO:0005982,1,0.990748156540811,0,1,starch metabolic process,BP,
2884,GO:0005983,1,0.990748156540811,0,1,starch catabolic process,BP,
2885,GO:0005984,1,0.943809237075704,0,9,disaccharide metabolic process,BP,
2886,GO:0005985,1,0.988490098985306,0,2,sucrose metabolic process,BP,
2887,GO:0005986,1,0.994752567879549,0,1,sucrose biosynthetic process,BP,
2888,GO:0005988,1,0.981743184971862,0,3,lactose metabolic process,BP,
2889,GO:0005989,1,0.981743184971862,0,3,lactose biosynthetic process,BP,
2890,GO:0005991,1,0.994201329838088,0,1,trehalose metabolic process,BP,
2892,GO:0005997,1,0.978039924859979,0,4,xylulose metabolic process,BP,
2893,GO:0005998,1,0.993624384679582,0,1,xylulose catabolic process,BP,
2894,GO:0005999,1,0.989433644614715,0,2,xylulose biosynthetic process,BP,
2895,GO:0006000,1,0.927095696056298,0,13,fructose metabolic process,BP,
2896,GO:0006001,1,0.977782588891809,0,4,fructose catabolic process,BP,
2897,GO:0006002,1,0.950563608840327,0,8,fructose 6-phosphate metabolic process,BP,
2898,GO:0006003,1,0.973758749119359,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2900,GO:0006006,1,0.320326529103059,0,172,glucose metabolic process,BP,
2901,GO:0006007,1,0.843521101257329,0,28,glucose catabolic process,BP,
2902,GO:0006011,1,0.957631345760626,0,6,UDP-glucose metabolic process,BP,
2903,GO:0006012,1,0.915074001991396,0,14,galactose metabolic process,BP,
2904,GO:0006013,1,0.94943470214347,0,8,mannose metabolic process,BP,
2905,GO:0006014,1,0.984370551936835,0,3,D-ribose metabolic process,BP,
2906,GO:0006015,1,0.983418523138875,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2907,GO:0006020,1,0.918879244629323,0,11,inositol metabolic process,BP,
2908,GO:0006021,1,0.973483977692193,0,4,inositol biosynthetic process,BP,
2914,GO:0006029,1,0.552482562111673,0,84,proteoglycan metabolic process,BP,
2918,GO:0006041,1,0.977462275592273,0,4,glucosamine metabolic process,BP,
2919,GO:0006043,1,0.989241015879916,0,2,glucosamine catabolic process,BP,
2920,GO:0006044,1,0.908360050366795,0,15,N-acetylglucosamine metabolic process,BP,
2921,GO:0006045,1,0.985619573384287,0,2,N-acetylglucosamine biosynthetic process,BP,
2922,GO:0006046,1,0.983987602870403,0,3,N-acetylglucosamine catabolic process,BP,
2923,GO:0006047,1,0.911907541267959,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2924,GO:0006048,1,0.934661410804601,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2925,GO:0006049,1,0.994224560045487,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2926,GO:0006050,1,0.98953650718336,0,2,mannosamine metabolic process,BP,
2927,GO:0006051,1,0.98953650718336,0,2,N-acetylmannosamine metabolic process,BP,
2928,GO:0006054,1,0.933947571600887,0,11,N-acetylneuraminate metabolic process,BP,
2929,GO:0006055,1,0.994795748772704,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2930,GO:0006056,1,0.994704866976516,0,1,mannoprotein metabolic process,BP,
2931,GO:0006057,1,0.994704866976516,0,1,mannoprotein biosynthetic process,BP,
2932,GO:0006059,1,0.984081728211287,0,3,hexitol metabolic process,BP,
2933,GO:0006060,1,0.989245884599454,0,2,sorbitol metabolic process,BP,
2934,GO:0006061,1,0.994774589322036,0,1,sorbitol biosynthetic process,BP,
2935,GO:0006062,1,0.99444254450294,0,1,sorbitol catabolic process,BP,
2936,GO:0006063,1,0.954151407946888,0,8,uronic acid metabolic process,BP,
2937,GO:0006064,1,0.972717732358086,0,5,glucuronate catabolic process,BP,
2938,GO:0006065,1,0.979577840853809,0,3,UDP-glucuronate biosynthetic process,BP,
2940,GO:0006067,1,0.914799554493187,0,16,ethanol metabolic process,BP,
2941,GO:0006068,1,0.947440532359826,0,10,ethanol catabolic process,BP,
2942,GO:0006069,1,0.954642450401542,0,8,ethanol oxidation,BP,
2943,GO:0006071,1,0.924984270917547,0,12,glycerol metabolic process,BP,
2944,GO:0006072,1,0.940764348201009,0,8,glycerol-3-phosphate metabolic process,BP,
2945,GO:0006073,1,0.614508039396833,0,69,cellular glucan metabolic process,BP,
2946,GO:0006081,1,0.664436451766635,0,69,cellular aldehyde metabolic process,BP,
2948,GO:0006083,1,0.979381732450793,0,3,acetate metabolic process,BP,
2949,GO:0006084,1,0.799501403897965,0,34,acetyl-CoA metabolic process,BP,
2950,GO:0006085,1,0.881506982215141,0,19,acetyl-CoA biosynthetic process,BP,
2951,GO:0006086,1,0.909162646561583,0,14,acetyl-CoA biosynthetic process from pyruvate,BP,
2952,GO:0006089,1,0.934550903861238,0,11,lactate metabolic process,BP,
2953,GO:0006090,1,0.430554531407596,0,126,pyruvate metabolic process,BP,
2954,GO:0006091,1,0.0660626130257829,0,433,generation of precursor metabolites and energy,BP,
2955,GO:0006094,1,0.66637485159434,0,67,gluconeogenesis,BP,
2956,GO:0006096,1,0.532405566604112,0,92,glycolytic process,BP,
2957,GO:0006097,1,0.989271261171851,0,2,glyoxylate cycle,BP,
2958,GO:0006098,1,0.905894211596072,0,17,pentose-phosphate shunt,BP,
2959,GO:0006099,1,0.84522551093373,0,29,tricarboxylic acid cycle,BP,
2960,GO:0006101,1,0.821162894154017,0,33,citrate metabolic process,BP,
2961,GO:0006102,1,0.97335050493217,0,5,isocitrate metabolic process,BP,
2962,GO:0006103,1,0.895237716649121,0,18,2-oxoglutarate metabolic process,BP,
2963,GO:0006104,1,0.966404824432668,0,6,succinyl-CoA metabolic process,BP,
2964,GO:0006105,1,0.934553309176577,0,11,succinate metabolic process,BP,
2965,GO:0006106,1,0.983869427582865,0,3,fumarate metabolic process,BP,
2966,GO:0006107,1,0.930558435628258,0,12,oxaloacetate metabolic process,BP,
2967,GO:0006108,1,0.960756518863548,0,7,malate metabolic process,BP,
2968,GO:0006109,1,0.336800819126364,0,155,regulation of carbohydrate metabolic process,BP,
2969,GO:0006110,1,0.642672510729095,0,61,regulation of glycolytic process,BP,
2970,GO:0006111,1,0.84095801502664,0,26,regulation of gluconeogenesis,BP,
2971,GO:0006112,1,0.574606341335524,0,80,energy reserve metabolic process,BP,
2972,GO:0006114,1,0.971877337712608,0,5,glycerol biosynthetic process,BP,
2973,GO:0006116,1,0.974998053591845,0,4,NADH oxidation,BP,
2974,GO:0006117,1,0.994418462131223,0,1,acetaldehyde metabolic process,BP,
2975,GO:0006119,1,0.575259166778654,0,98,oxidative phosphorylation,BP,
2976,GO:0006120,1,0.790528904859096,0,44,mitochondrial electron transport, NADH to ubiquinone,BP,
2977,GO:0006121,1,0.978598944897891,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2978,GO:0006122,1,0.924781818869193,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2979,GO:0006123,1,0.912766484000485,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2980,GO:0006127,1,0.985672722189292,0,2,glycerophosphate shuttle,BP,
2983,GO:0006144,1,0.876414243874065,0,22,purine nucleobase metabolic process,BP,
2984,GO:0006145,1,0.970251355638215,0,4,purine nucleobase catabolic process,BP,
2985,GO:0006147,1,0.991886675411333,0,1,guanine catabolic process,BP,
2986,GO:0006148,1,0.99449489995418,0,1,inosine catabolic process,BP,
2987,GO:0006152,1,0.966148068651358,0,6,purine nucleoside catabolic process,BP,
2988,GO:0006154,1,0.989204557599544,0,2,adenosine catabolic process,BP,
2989,GO:0006157,1,0.994752919170352,0,1,deoxyadenosine catabolic process,BP,
2992,GO:0006165,1,0.484344671549863,0,109,nucleoside diphosphate phosphorylation,BP,
2993,GO:0006166,1,0.971648505534852,0,5,purine ribonucleoside salvage,BP,
2994,GO:0006167,1,0.96811110878606,0,6,AMP biosynthetic process,BP,
2995,GO:0006168,1,0.984352295146986,0,3,adenine salvage,BP,
2996,GO:0006169,1,0.994628394990776,0,1,adenosine salvage,BP,
2998,GO:0006172,1,0.988293136148262,0,2,ADP biosynthetic process,BP,
2999,GO:0006173,1,0.993711293856174,0,1,dADP biosynthetic process,BP,
3000,GO:0006174,1,0.994313214468247,0,1,dADP phosphorylation,BP,
3001,GO:0006175,1,0.994628394990776,0,1,dATP biosynthetic process,BP,
3002,GO:0006177,1,0.973368002209553,0,5,GMP biosynthetic process,BP,
3003,GO:0006178,1,0.989465332158368,0,2,guanine salvage,BP,
3004,GO:0006182,1,0.809376427972703,0,31,cGMP biosynthetic process,BP,
3005,GO:0006183,1,0.948346934232111,0,10,GTP biosynthetic process,BP,
3006,GO:0006185,1,0.99481895161955,0,1,dGDP biosynthetic process,BP,
3007,GO:0006186,1,0.994313214468247,0,1,dGDP phosphorylation,BP,
3008,GO:0006188,1,0.94031371302274,0,10,IMP biosynthetic process,BP,
3009,GO:0006189,1,0.963202941688482,0,6,'de novo' IMP biosynthetic process,BP,
3010,GO:0006193,1,0.994809962505009,0,1,ITP catabolic process,BP,
3011,GO:0006195,1,0.744047739125715,0,44,purine nucleotide catabolic process,BP,
3012,GO:0006196,1,0.986351822094033,0,2,AMP catabolic process,BP,
3013,GO:0006198,1,0.87879023567017,0,17,cAMP catabolic process,BP,
3014,GO:0006203,1,0.983594143177075,0,3,dGTP catabolic process,BP,
3016,GO:0006207,1,0.95429983177719,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3017,GO:0006208,1,0.983367606214614,0,3,pyrimidine nucleobase catabolic process,BP,
3018,GO:0006210,1,0.983367606214614,0,3,thymine catabolic process,BP,
3019,GO:0006211,1,0.962463298719057,0,3,5-methylcytosine catabolic process,BP,
3020,GO:0006212,1,0.988722123659977,0,2,uracil catabolic process,BP,
3022,GO:0006214,1,0.994085496691891,0,1,thymidine catabolic process,BP,
3023,GO:0006216,1,0.9572262478568,0,8,cytidine catabolic process,BP,
3024,GO:0006218,1,0.994696058670233,0,1,uridine catabolic process,BP,
3025,GO:0006220,1,0.778732837230976,0,45,pyrimidine nucleotide metabolic process,BP,
3026,GO:0006221,1,0.84054450788316,0,31,pyrimidine nucleotide biosynthetic process,BP,
3027,GO:0006222,1,0.942610820873643,0,10,UMP biosynthetic process,BP,
3028,GO:0006226,1,0.984138737251341,0,3,dUMP biosynthetic process,BP,
3029,GO:0006227,1,0.989018055684255,0,2,dUDP biosynthetic process,BP,
3030,GO:0006228,1,0.949221761711748,0,9,UTP biosynthetic process,BP,
3031,GO:0006231,1,0.983941247431989,0,3,dTMP biosynthetic process,BP,
3032,GO:0006233,1,0.989018055684255,0,2,dTDP biosynthetic process,BP,
3033,GO:0006235,1,0.978689287908048,0,4,dTTP biosynthetic process,BP,
3034,GO:0006238,1,0.994795060212627,0,1,CMP salvage,BP,
3035,GO:0006241,1,0.931953755651782,0,13,CTP biosynthetic process,BP,
3036,GO:0006244,1,0.932078264175114,0,13,pyrimidine nucleotide catabolic process,BP,
3037,GO:0006253,1,0.994808547067552,0,1,dCTP catabolic process,BP,
3038,GO:0006256,1,0.994217517852663,0,1,UDP catabolic process,BP,
3039,GO:0006258,1,0.989396636673913,0,2,UDP-glucose catabolic process,BP,
3042,GO:0006261,1,0.406200023487065,0,141,DNA-dependent DNA replication,BP,
3043,GO:0006264,1,0.938412477720419,0,10,mitochondrial DNA replication,BP,
3044,GO:0006265,1,0.943650000276498,0,9,DNA topological change,BP,
3045,GO:0006266,1,0.874579506274221,0,23,DNA ligation,BP,
3046,GO:0006267,1,0.983817213440429,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3047,GO:0006268,1,0.959800094372345,0,7,DNA unwinding involved in DNA replication,BP,
3048,GO:0006269,1,0.969741668823677,0,5,DNA replication, synthesis of RNA primer,BP,
3049,GO:0006270,1,0.777533611722075,0,42,DNA replication initiation,BP,
3050,GO:0006271,1,0.884589332646231,0,20,DNA strand elongation involved in DNA replication,BP,
3051,GO:0006272,1,0.976192456380394,0,3,leading strand elongation,BP,
3052,GO:0006273,1,0.934701195788158,0,11,lagging strand elongation,BP,
3054,GO:0006278,1,0.632644088091139,0,67,RNA-dependent DNA biosynthetic process,BP,
3055,GO:0006281,1,0.0422647890857313,0,475,DNA repair,BP,
3056,GO:0006282,1,0.555656320712563,0,89,regulation of DNA repair,BP,
3057,GO:0006283,1,0.644050001505693,0,73,transcription-coupled nucleotide-excision repair,BP,
3058,GO:0006284,1,0.766829038200446,0,41,base-excision repair,BP,
3059,GO:0006285,1,0.947376614666356,0,10,base-excision repair, AP site formation,BP,
3060,GO:0006286,1,0.989580404562145,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3061,GO:0006287,1,0.965759528428827,0,5,base-excision repair, gap-filling,BP,
3062,GO:0006288,1,0.983374757942123,0,3,base-excision repair, DNA ligation,BP,
3063,GO:0006289,1,0.50266881233512,0,112,nucleotide-excision repair,BP,
3064,GO:0006290,1,0.951790000208109,0,7,pyrimidine dimer repair,BP,
3065,GO:0006293,1,0.875194955213935,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3066,GO:0006294,1,0.840722962603878,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3067,GO:0006295,1,0.875194955213935,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3068,GO:0006296,1,0.798905403257857,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3069,GO:0006297,1,0.870750936925401,0,23,nucleotide-excision repair, DNA gap filling,BP,
3070,GO:0006298,1,0.826717335262339,0,30,mismatch repair,BP,
3071,GO:0006301,1,0.735108548256788,0,48,postreplication repair,BP,
3072,GO:0006302,1,0.281906717788067,0,189,double-strand break repair,BP,
3073,GO:0006303,1,0.66528262734266,0,58,double-strand break repair via nonhomologous end joining,BP,
3074,GO:0006304,1,0.539991471459471,0,93,DNA modification,BP,
3075,GO:0006305,1,0.692062061022542,0,54,DNA alkylation,BP,
3076,GO:0006306,1,0.692062061022542,0,54,DNA methylation,BP,
3077,GO:0006307,1,0.942708526148997,0,10,DNA dealkylation involved in DNA repair,BP,
3078,GO:0006308,1,0.797947345837541,0,35,DNA catabolic process,BP,
3079,GO:0006309,1,0.878046872539702,0,20,apoptotic DNA fragmentation,BP,
3080,GO:0006310,1,0.213924376150642,0,232,DNA recombination,BP,
3081,GO:0006311,1,0.976410793918331,0,4,meiotic gene conversion,BP,
3082,GO:0006312,1,0.851485730545931,0,23,mitotic recombination,BP,
3083,GO:0006313,1,0.9933109426293,0,1,transposition, DNA-mediated,BP,
3084,GO:0006323,1,0.392863471176892,0,142,DNA packaging,BP,
3085,GO:0006325,1,0.00878910994805318,0,676,chromatin organization,BP,
3086,GO:0006333,1,0.430279426412966,0,133,chromatin assembly or disassembly,BP,
3087,GO:0006334,1,0.580061346251559,0,91,nucleosome assembly,BP,
3088,GO:0006335,1,0.921384878051559,0,14,DNA replication-dependent nucleosome assembly,BP,
3089,GO:0006336,1,0.782266302182761,0,40,DNA replication-independent nucleosome assembly,BP,
3090,GO:0006337,1,0.887019984506992,0,17,nucleosome disassembly,BP,
3091,GO:0006338,1,0.3417113275302,0,159,chromatin remodeling,BP,
3092,GO:0006342,1,0.606193438359565,0,75,chromatin silencing,BP,
3093,GO:0006343,1,0.993492405533006,0,1,establishment of chromatin silencing,BP,
3094,GO:0006344,1,0.967869227322681,0,4,maintenance of chromatin silencing,BP,
3095,GO:0006346,1,0.910327289515438,0,14,methylation-dependent chromatin silencing,BP,
3096,GO:0006348,1,0.948145736290613,0,8,chromatin silencing at telomere,BP,
3097,GO:0006349,1,0.891137010245073,0,16,regulation of gene expression by genetic imprinting,BP,
3099,GO:0006352,1,0.219992637426723,0,225,DNA-templated transcription, initiation,BP,
3100,GO:0006353,1,0.522145552645422,0,107,DNA-templated transcription, termination,BP,
3101,GO:0006354,1,0.460665442852377,0,122,DNA-templated transcription, elongation,BP,
3103,GO:0006356,1,0.810295075401513,0,30,regulation of transcription by RNA polymerase I,BP,
3105,GO:0006359,1,0.829770875906134,0,27,regulation of transcription by RNA polymerase III,BP,
3106,GO:0006360,1,0.674975358821694,0,59,transcription by RNA polymerase I,BP,
3107,GO:0006361,1,0.80589646500529,0,35,transcription initiation from RNA polymerase I promoter,BP,
3108,GO:0006362,1,0.832530399473495,0,30,transcription elongation from RNA polymerase I promoter,BP,
3109,GO:0006363,1,0.835624071897695,0,30,termination of RNA polymerase I transcription,BP,
3110,GO:0006364,1,0.229632710361931,0,249,rRNA processing,BP,
3112,GO:0006367,1,0.304939068831267,0,177,transcription initiation from RNA polymerase II promoter,BP,
3113,GO:0006368,1,0.537137792417359,0,97,transcription elongation from RNA polymerase II promoter,BP,
3114,GO:0006369,1,0.661247301233747,0,68,termination of RNA polymerase II transcription,BP,
3115,GO:0006370,1,0.829818889201523,0,31,7-methylguanosine mRNA capping,BP,
3116,GO:0006376,1,0.839876528613641,0,27,mRNA splice site selection,BP,
3117,GO:0006378,1,0.769505405102323,0,40,mRNA polyadenylation,BP,
3118,GO:0006379,1,0.845818745547668,0,27,mRNA cleavage,BP,
3119,GO:0006382,1,0.960708175114354,0,5,adenosine to inosine editing,BP,
3120,GO:0006383,1,0.712464289797268,0,53,transcription by RNA polymerase III,BP,
3121,GO:0006384,1,0.94695715074772,0,7,transcription initiation from RNA polymerase III promoter,BP,
3122,GO:0006386,1,0.994830618070263,0,1,termination of RNA polymerase III transcription,BP,
3123,GO:0006388,1,0.925925086302329,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3124,GO:0006390,1,0.916362171549286,0,13,mitochondrial transcription,BP,
3125,GO:0006391,1,0.982979359736241,0,3,transcription initiation from mitochondrial promoter,BP,
3126,GO:0006393,1,0.988658446617857,0,2,termination of mitochondrial transcription,BP,
3129,GO:0006398,1,0.969133069038499,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3130,GO:0006399,1,0.346649714889135,0,181,tRNA metabolic process,BP,
3131,GO:0006400,1,0.652578150877941,0,73,tRNA modification,BP,
3134,GO:0006403,1,0.236497178206129,0,216,RNA localization,BP,
3135,GO:0006404,1,0.977254742621662,0,3,RNA import into nucleus,BP,
3136,GO:0006405,1,0.412166464902024,0,135,RNA export from nucleus,BP,
3137,GO:0006406,1,0.502164937036901,0,104,mRNA export from nucleus,BP,
3138,GO:0006407,1,0.978369316964862,0,3,rRNA export from nucleus,BP,
3139,GO:0006408,1,0.989355755049574,0,2,snRNA export from nucleus,BP,
3140,GO:0006409,1,0.801411221728817,0,31,tRNA export from nucleus,BP,
3142,GO:0006413,1,0.323050574456764,0,191,translational initiation,BP,
3143,GO:0006414,1,0.482648487593127,0,126,translational elongation,BP,
3144,GO:0006415,1,0.574291303354355,0,99,translational termination,BP,
3146,GO:0006418,1,0.752139576782988,0,49,tRNA aminoacylation for protein translation,BP,
3147,GO:0006419,1,0.981252851309286,0,3,alanyl-tRNA aminoacylation,BP,
3148,GO:0006420,1,0.983934573681073,0,3,arginyl-tRNA aminoacylation,BP,
3149,GO:0006421,1,0.982811508953875,0,3,asparaginyl-tRNA aminoacylation,BP,
3150,GO:0006422,1,0.994528864719562,0,1,aspartyl-tRNA aminoacylation,BP,
3151,GO:0006423,1,0.989091774006185,0,2,cysteinyl-tRNA aminoacylation,BP,
3152,GO:0006424,1,0.985775594135081,0,2,glutamyl-tRNA aminoacylation,BP,
3153,GO:0006425,1,0.986996339256142,0,2,glutaminyl-tRNA aminoacylation,BP,
3154,GO:0006426,1,0.98909447747533,0,2,glycyl-tRNA aminoacylation,BP,
3155,GO:0006427,1,0.989140585336022,0,2,histidyl-tRNA aminoacylation,BP,
3156,GO:0006428,1,0.986659638754506,0,2,isoleucyl-tRNA aminoacylation,BP,
3157,GO:0006429,1,0.985662435274055,0,2,leucyl-tRNA aminoacylation,BP,
3158,GO:0006430,1,0.99461053300476,0,1,lysyl-tRNA aminoacylation,BP,
3159,GO:0006431,1,0.988483199592305,0,2,methionyl-tRNA aminoacylation,BP,
3160,GO:0006432,1,0.972763910101612,0,5,phenylalanyl-tRNA aminoacylation,BP,
3161,GO:0006433,1,0.981744406378944,0,3,prolyl-tRNA aminoacylation,BP,
3162,GO:0006434,1,0.989323991196765,0,2,seryl-tRNA aminoacylation,BP,
3163,GO:0006435,1,0.982817525715211,0,3,threonyl-tRNA aminoacylation,BP,
3164,GO:0006436,1,0.988678918870866,0,2,tryptophanyl-tRNA aminoacylation,BP,
3165,GO:0006437,1,0.988711991651328,0,2,tyrosyl-tRNA aminoacylation,BP,
3166,GO:0006438,1,0.979343557181537,0,3,valyl-tRNA aminoacylation,BP,
3167,GO:0006446,1,0.622321964055217,0,74,regulation of translational initiation,BP,
3168,GO:0006447,1,0.979546348865549,0,3,regulation of translational initiation by iron,BP,
3169,GO:0006448,1,0.890730259033287,0,18,regulation of translational elongation,BP,
3170,GO:0006449,1,0.94982781767257,0,8,regulation of translational termination,BP,
3171,GO:0006450,1,0.899509984654125,0,18,regulation of translational fidelity,BP,
3172,GO:0006451,1,0.946770271849025,0,8,translational readthrough,BP,
3173,GO:0006452,1,0.980203664364875,0,3,translational frameshifting,BP,
3174,GO:0006457,1,0.257416853000887,0,225,protein folding,BP,
3175,GO:0006458,1,0.74580984210945,0,48,'de novo' protein folding,BP,
3176,GO:0006463,1,0.993582537533008,0,1,steroid hormone receptor complex assembly,BP,
3178,GO:0006465,1,0.891746366624582,0,20,signal peptide processing,BP,
3182,GO:0006471,1,0.845961364231905,0,26,protein ADP-ribosylation,BP,
3183,GO:0006473,1,0.312758567163834,0,174,protein acetylation,BP,
3184,GO:0006474,1,0.89265860913794,0,16,N-terminal protein amino acid acetylation,BP,
3185,GO:0006475,1,0.373007778680526,0,146,internal protein amino acid acetylation,BP,
3186,GO:0006476,1,0.510845794431528,0,95,protein deacetylation,BP,
3187,GO:0006477,1,0.960454648811753,0,6,protein sulfation,BP,
3188,GO:0006478,1,0.989318219384065,0,2,peptidyl-tyrosine sulfation,BP,
3189,GO:0006479,1,0.325402836322557,0,163,protein methylation,BP,
3190,GO:0006480,1,0.989164979561403,0,2,N-terminal protein amino acid methylation,BP,
3191,GO:0006481,1,0.981670756102014,0,3,C-terminal protein methylation,BP,
3192,GO:0006482,1,0.795743794764366,0,29,protein demethylation,BP,
3194,GO:0006487,1,0.577270054761373,0,89,protein N-linked glycosylation,BP,
3195,GO:0006488,1,0.882606178985873,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3196,GO:0006489,1,0.960060700111238,0,7,dolichyl diphosphate biosynthetic process,BP,
3197,GO:0006490,1,0.877692483413554,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3201,GO:0006498,1,0.958401957104189,0,6,N-terminal protein lipidation,BP,
3202,GO:0006499,1,0.968745928877543,0,4,N-terminal protein myristoylation,BP,
3203,GO:0006500,1,0.989325679018123,0,2,N-terminal protein palmitoylation,BP,
3205,GO:0006505,1,0.82286786191259,0,33,GPI anchor metabolic process,BP,
3206,GO:0006506,1,0.831740650912485,0,31,GPI anchor biosynthetic process,BP,
3207,GO:0006507,1,0.994546146440205,0,1,GPI anchor release,BP,
3210,GO:0006511,1,0.0259694137020165,0,539,ubiquitin-dependent protein catabolic process,BP,
3211,GO:0006513,1,0.643669740081505,0,63,protein monoubiquitination,BP,
3212,GO:0006515,1,0.845212773249736,0,25,protein quality control for misfolded or incompletely synthesized proteins,BP,
3213,GO:0006516,1,0.895084627179036,0,17,glycoprotein catabolic process,BP,
3214,GO:0006517,1,0.791939126025575,0,34,protein deglycosylation,BP,
3218,GO:0006522,1,0.977763477991754,0,4,alanine metabolic process,BP,
3219,GO:0006524,1,0.977763477991754,0,4,alanine catabolic process,BP,
3220,GO:0006525,1,0.879340791510867,0,20,arginine metabolic process,BP,
3221,GO:0006526,1,0.960993436765445,0,6,arginine biosynthetic process,BP,
3222,GO:0006527,1,0.929956277671382,0,11,arginine catabolic process,BP,
3223,GO:0006528,1,0.973273853087247,0,5,asparagine metabolic process,BP,
3224,GO:0006529,1,0.989030398542692,0,2,asparagine biosynthetic process,BP,
3225,GO:0006530,1,0.989223230067923,0,2,asparagine catabolic process,BP,
3226,GO:0006531,1,0.943766188933945,0,10,aspartate metabolic process,BP,
3227,GO:0006532,1,0.989111672169772,0,2,aspartate biosynthetic process,BP,
3228,GO:0006533,1,0.983945160096507,0,3,aspartate catabolic process,BP,
3229,GO:0006534,1,0.926130370546163,0,13,cysteine metabolic process,BP,
3230,GO:0006535,1,0.994406694608454,0,1,cysteine biosynthetic process from serine,BP,
3232,GO:0006537,1,0.969764505659876,0,5,glutamate biosynthetic process,BP,
3233,GO:0006538,1,0.947430124060616,0,9,glutamate catabolic process,BP,
3234,GO:0006539,1,0.994672815773164,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3235,GO:0006540,1,0.981205079760042,0,3,glutamate decarboxylation to succinate,BP,
3236,GO:0006541,1,0.855194569432798,0,23,glutamine metabolic process,BP,
3237,GO:0006542,1,0.984953383039074,0,2,glutamine biosynthetic process,BP,
3238,GO:0006543,1,0.981094097650522,0,3,glutamine catabolic process,BP,
3239,GO:0006544,1,0.944676434761751,0,10,glycine metabolic process,BP,
3240,GO:0006545,1,0.983867320915301,0,3,glycine biosynthetic process,BP,
3241,GO:0006546,1,0.98298499626644,0,3,glycine catabolic process,BP,
3242,GO:0006547,1,0.949441438002213,0,9,histidine metabolic process,BP,
3243,GO:0006548,1,0.960619943510435,0,7,histidine catabolic process,BP,
3244,GO:0006549,1,0.968023526195606,0,5,isoleucine metabolic process,BP,
3245,GO:0006550,1,0.989366771917527,0,2,isoleucine catabolic process,BP,
3246,GO:0006551,1,0.949602331264048,0,8,leucine metabolic process,BP,
3247,GO:0006552,1,0.965258627732586,0,6,leucine catabolic process,BP,
3248,GO:0006553,1,0.924625339878254,0,13,lysine metabolic process,BP,
3249,GO:0006554,1,0.92996583832123,0,12,lysine catabolic process,BP,
3250,GO:0006555,1,0.879387072698044,0,20,methionine metabolic process,BP,
3251,GO:0006556,1,0.982873127089023,0,3,S-adenosylmethionine biosynthetic process,BP,
3252,GO:0006557,1,0.99398281120159,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3253,GO:0006558,1,0.947577744697086,0,10,L-phenylalanine metabolic process,BP,
3254,GO:0006559,1,0.947577744697086,0,10,L-phenylalanine catabolic process,BP,
3255,GO:0006560,1,0.961807104470393,0,7,proline metabolic process,BP,
3256,GO:0006561,1,0.97804731357361,0,4,proline biosynthetic process,BP,
3257,GO:0006562,1,0.98339893122961,0,3,proline catabolic process,BP,
3258,GO:0006563,1,0.942101365993968,0,11,L-serine metabolic process,BP,
3259,GO:0006564,1,0.96810060228359,0,6,L-serine biosynthetic process,BP,
3260,GO:0006565,1,0.978569781587805,0,4,L-serine catabolic process,BP,
3261,GO:0006566,1,0.97903432853463,0,4,threonine metabolic process,BP,
3262,GO:0006567,1,0.984341709404327,0,3,threonine catabolic process,BP,
3263,GO:0006568,1,0.945452666616709,0,9,tryptophan metabolic process,BP,
3264,GO:0006569,1,0.96128340726343,0,7,tryptophan catabolic process,BP,
3265,GO:0006570,1,0.957943638064008,0,8,tyrosine metabolic process,BP,
3267,GO:0006573,1,0.942004247516647,0,9,valine metabolic process,BP,
3268,GO:0006574,1,0.978650879804533,0,4,valine catabolic process,BP,
3271,GO:0006577,1,0.906059820664041,0,17,amino-acid betaine metabolic process,BP,
3272,GO:0006578,1,0.96036200818466,0,7,amino-acid betaine biosynthetic process,BP,
3273,GO:0006579,1,0.983118148517712,0,3,amino-acid betaine catabolic process,BP,
3274,GO:0006580,1,0.994358236185322,0,1,ethanolamine metabolic process,BP,
3275,GO:0006581,1,0.988612365486382,0,2,acetylcholine catabolic process,BP,
3276,GO:0006582,1,0.890432794654699,0,16,melanin metabolic process,BP,
3277,GO:0006583,1,0.994522136054588,0,1,melanin biosynthetic process from tyrosine,BP,
3279,GO:0006585,1,0.994671741245347,0,1,dopamine biosynthetic process from tyrosine,BP,
3280,GO:0006586,1,0.925380807830785,0,13,indolalkylamine metabolic process,BP,
3282,GO:0006590,1,0.913764498416275,0,13,thyroid hormone generation,BP,
3283,GO:0006591,1,0.9505004397506,0,9,ornithine metabolic process,BP,
3284,GO:0006592,1,0.993817351434055,0,1,ornithine biosynthetic process,BP,
3285,GO:0006593,1,0.994731610069127,0,1,ornithine catabolic process,BP,
3286,GO:0006595,1,0.916208219896246,0,16,polyamine metabolic process,BP,
3287,GO:0006596,1,0.930831511250898,0,13,polyamine biosynthetic process,BP,
3288,GO:0006597,1,0.988737155477934,0,2,spermine biosynthetic process,BP,
3289,GO:0006598,1,0.968781943129015,0,6,polyamine catabolic process,BP,
3290,GO:0006600,1,0.941765708009284,0,10,creatine metabolic process,BP,
3291,GO:0006601,1,0.989260157800274,0,2,creatine biosynthetic process,BP,
3293,GO:0006606,1,0.413860265444034,0,128,protein import into nucleus,BP,
3294,GO:0006607,1,0.850974276516338,0,20,NLS-bearing protein import into nucleus,BP,
3295,GO:0006610,1,0.94215692473522,0,8,ribosomal protein import into nucleus,BP,
3296,GO:0006611,1,0.316765567602923,0,173,protein export from nucleus,BP,
3298,GO:0006613,1,0.595062029247861,0,95,cotranslational protein targeting to membrane,BP,
3299,GO:0006614,1,0.618542454844668,0,90,SRP-dependent cotranslational protein targeting to membrane,BP,
3300,GO:0006616,1,0.967658092325435,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3301,GO:0006617,1,0.989417390845679,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3302,GO:0006620,1,0.95323791610728,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3303,GO:0006621,1,0.942677376444212,0,10,protein retention in ER lumen,BP,
3304,GO:0006622,1,0.871939836717847,0,19,protein targeting to lysosome,BP,
3305,GO:0006623,1,0.783731055043171,0,31,protein targeting to vacuole,BP,
3306,GO:0006624,1,0.989476810011819,0,2,vacuolar protein processing,BP,
3307,GO:0006625,1,0.900963300947449,0,17,protein targeting to peroxisome,BP,
3308,GO:0006626,1,0.439784585349359,0,135,protein targeting to mitochondrion,BP,
3309,GO:0006627,1,0.950733154388275,0,8,protein processing involved in protein targeting to mitochondrion,BP,
3313,GO:0006635,1,0.644256409296701,0,70,fatty acid beta-oxidation,BP,
3315,GO:0006637,1,0.567713513347993,0,91,acyl-CoA metabolic process,BP,
3319,GO:0006642,1,0.964090576908238,0,4,triglyceride mobilization,BP,
3322,GO:0006646,1,0.916823350109655,0,14,phosphatidylethanolamine biosynthetic process,BP,
3323,GO:0006649,1,0.984021762266398,0,2,phospholipid transfer to membrane,BP,
3325,GO:0006651,1,0.984881004519927,0,2,diacylglycerol biosynthetic process,BP,
3327,GO:0006655,1,0.942663479905258,0,10,phosphatidylglycerol biosynthetic process,BP,
3328,GO:0006656,1,0.820115393608302,0,33,phosphatidylcholine biosynthetic process,BP,
3329,GO:0006657,1,0.958537370397418,0,7,CDP-choline pathway,BP,
3331,GO:0006659,1,0.977443862715442,0,4,phosphatidylserine biosynthetic process,BP,
3332,GO:0006660,1,0.994702993187325,0,1,phosphatidylserine catabolic process,BP,
3334,GO:0006662,1,0.929702617312822,0,12,glycerol ether metabolic process,BP,
3335,GO:0006663,1,0.975788363597843,0,4,platelet activating factor biosynthetic process,BP,
3338,GO:0006666,1,0.992135192419658,0,1,3-keto-sphinganine metabolic process,BP,
3339,GO:0006667,1,0.979604334150154,0,3,sphinganine metabolic process,BP,
3340,GO:0006668,1,0.988183840141381,0,2,sphinganine-1-phosphate metabolic process,BP,
3341,GO:0006669,1,0.994196752020075,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3342,GO:0006670,1,0.935360547264713,0,11,sphingosine metabolic process,BP,
3343,GO:0006671,1,0.992965896436137,0,1,phytosphingosine metabolic process,BP,
3345,GO:0006677,1,0.899692825188139,0,18,glycosylceramide metabolic process,BP,
3346,GO:0006678,1,0.957113967439435,0,7,glucosylceramide metabolic process,BP,
3347,GO:0006679,1,0.987006314070354,0,2,glucosylceramide biosynthetic process,BP,
3348,GO:0006680,1,0.982594343339353,0,3,glucosylceramide catabolic process,BP,
3349,GO:0006681,1,0.953975830573904,0,8,galactosylceramide metabolic process,BP,
3350,GO:0006682,1,0.972255179043827,0,5,galactosylceramide biosynthetic process,BP,
3351,GO:0006683,1,0.994231552574136,0,1,galactosylceramide catabolic process,BP,
3352,GO:0006684,1,0.919696155051158,0,13,sphingomyelin metabolic process,BP,
3353,GO:0006685,1,0.968614127145903,0,5,sphingomyelin catabolic process,BP,
3354,GO:0006686,1,0.959665472722514,0,6,sphingomyelin biosynthetic process,BP,
3357,GO:0006689,1,0.972185354843031,0,5,ganglioside catabolic process,BP,
3359,GO:0006691,1,0.890724731588914,0,20,leukotriene metabolic process,BP,
3363,GO:0006695,1,0.66102890798435,0,62,cholesterol biosynthetic process,BP,
3364,GO:0006696,1,0.989241145687406,0,2,ergosterol biosynthetic process,BP,
3365,GO:0006699,1,0.826091716011724,0,32,bile acid biosynthetic process,BP,
3368,GO:0006702,1,0.956223023699741,0,7,androgen biosynthetic process,BP,
3369,GO:0006703,1,0.946164698833324,0,10,estrogen biosynthetic process,BP,
3370,GO:0006704,1,0.921958697460196,0,13,glucocorticoid biosynthetic process,BP,
3371,GO:0006705,1,0.949117225668937,0,8,mineralocorticoid biosynthetic process,BP,
3373,GO:0006707,1,0.947100106321734,0,9,cholesterol catabolic process,BP,
3375,GO:0006711,1,0.994702993187325,0,1,estrogen catabolic process,BP,
3376,GO:0006713,1,0.99470133978491,0,1,glucocorticoid catabolic process,BP,
3377,GO:0006714,1,0.989566015395049,0,2,sesquiterpenoid metabolic process,BP,
3378,GO:0006720,1,0.517639824467788,0,103,isoprenoid metabolic process,BP,
3379,GO:0006721,1,0.574961512154257,0,85,terpenoid metabolic process,BP,
3380,GO:0006722,1,0.99449814413672,0,1,triterpenoid metabolic process,BP,
3382,GO:0006726,1,0.981425848523462,0,3,eye pigment biosynthetic process,BP,
3383,GO:0006729,1,0.962347261104178,0,7,tetrahydrobiopterin biosynthetic process,BP,
3384,GO:0006730,1,0.818198558151443,0,33,one-carbon metabolic process,BP,
3387,GO:0006734,1,0.809906383665175,0,35,NADH metabolic process,BP,
3388,GO:0006735,1,0.866360278589644,0,24,NADH regeneration,BP,
3389,GO:0006738,1,0.99449489995418,0,1,nicotinamide riboside catabolic process,BP,
3390,GO:0006739,1,0.823640871287561,0,33,NADP metabolic process,BP,
3391,GO:0006740,1,0.981843250658144,0,3,NADPH regeneration,BP,
3392,GO:0006741,1,0.977133071041778,0,4,NADP biosynthetic process,BP,
3393,GO:0006742,1,0.983525933418588,0,3,NADP catabolic process,BP,
3394,GO:0006743,1,0.919920353168197,0,15,ubiquinone metabolic process,BP,
3395,GO:0006744,1,0.926555882419654,0,14,ubiquinone biosynthetic process,BP,
3396,GO:0006747,1,0.994653204781261,0,1,FAD biosynthetic process,BP,
3397,GO:0006749,1,0.773551076933827,0,46,glutathione metabolic process,BP,
3398,GO:0006750,1,0.92255914141518,0,14,glutathione biosynthetic process,BP,
3399,GO:0006751,1,0.973196113747117,0,5,glutathione catabolic process,BP,
3401,GO:0006754,1,0.465500807678649,0,115,ATP biosynthetic process,BP,
3402,GO:0006756,1,0.994313214468247,0,1,AMP phosphorylation,BP,
3403,GO:0006757,1,0.529358794538422,0,93,ATP generation from ADP,BP,
3404,GO:0006760,1,0.841982175139704,0,28,folic acid-containing compound metabolic process,BP,
3405,GO:0006766,1,0.455229032158982,0,123,vitamin metabolic process,BP,
3406,GO:0006767,1,0.578712006764888,0,84,water-soluble vitamin metabolic process,BP,
3407,GO:0006768,1,0.935143044825456,0,10,biotin metabolic process,BP,
3408,GO:0006771,1,0.957272602162606,0,7,riboflavin metabolic process,BP,
3409,GO:0006772,1,0.978225905845748,0,4,thiamine metabolic process,BP,
3410,GO:0006775,1,0.790877170151756,0,37,fat-soluble vitamin metabolic process,BP,
3411,GO:0006776,1,0.959190033499712,0,7,vitamin A metabolic process,BP,
3412,GO:0006777,1,0.964891696195635,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3413,GO:0006778,1,0.824425493503082,0,31,porphyrin-containing compound metabolic process,BP,
3414,GO:0006779,1,0.862242609285405,0,23,porphyrin-containing compound biosynthetic process,BP,
3415,GO:0006780,1,0.989399555185375,0,2,uroporphyrinogen III biosynthetic process,BP,
3416,GO:0006781,1,0.994590650166733,0,1,succinyl-CoA pathway,BP,
3417,GO:0006782,1,0.957394207088741,0,8,protoporphyrinogen IX biosynthetic process,BP,
3418,GO:0006783,1,0.886478604822029,0,19,heme biosynthetic process,BP,
3419,GO:0006784,1,0.984418894362718,0,2,heme a biosynthetic process,BP,
3420,GO:0006787,1,0.979263902101268,0,4,porphyrin-containing compound catabolic process,BP,
3421,GO:0006788,1,0.989490473046599,0,2,heme oxidation,BP,
3427,GO:0006801,1,0.706923140057937,0,56,superoxide metabolic process,BP,
3430,GO:0006808,1,0.983012702086855,0,3,regulation of nitrogen utilization,BP,
3438,GO:0006817,1,0.883047140431368,0,18,phosphate ion transport,BP,
3441,GO:0006824,1,0.977374151343846,0,4,cobalt ion transport,BP,
3444,GO:0006828,1,0.936016350339177,0,10,manganese ion transport,BP,
3445,GO:0006829,1,0.865242987954236,0,23,zinc ion transport,BP,
3446,GO:0006833,1,0.913969663330666,0,15,water transport,BP,
3449,GO:0006837,1,0.91314711199735,0,15,serotonin transport,BP,
3450,GO:0006839,1,0.185364540032295,0,277,mitochondrial transport,BP,
3451,GO:0006842,1,0.975477126885807,0,4,tricarboxylic acid transport,BP,
3452,GO:0006843,1,0.99474103000378,0,1,mitochondrial citrate transmembrane transport,BP,
3453,GO:0006844,1,0.989224769531999,0,2,acyl carnitine transport,BP,
3454,GO:0006848,1,0.977279070398313,0,4,pyruvate transport,BP,
3455,GO:0006850,1,0.988658446617857,0,2,mitochondrial pyruvate transmembrane transport,BP,
3456,GO:0006851,1,0.875365793134907,0,22,mitochondrial calcium ion transmembrane transport,BP,
3457,GO:0006853,1,0.934999232089661,0,9,carnitine shuttle,BP,
3459,GO:0006857,1,0.949271718604424,0,8,oligopeptide transport,BP,
3460,GO:0006858,1,0.983231751781551,0,3,extracellular transport,BP,
3461,GO:0006862,1,0.888864788730805,0,20,nucleotide transport,BP,
3462,GO:0006863,1,0.966331076609585,0,6,purine nucleobase transport,BP,
3463,GO:0006864,1,0.98749906620752,0,2,pyrimidine nucleotide transport,BP,
3465,GO:0006867,1,0.988814657592716,0,2,asparagine transport,BP,
3466,GO:0006868,1,0.963379461483522,0,6,glutamine transport,BP,
3471,GO:0006876,1,0.993476349999722,0,1,cellular cadmium ion homeostasis,BP,
3472,GO:0006878,1,0.91894058273446,0,13,cellular copper ion homeostasis,BP,
3474,GO:0006880,1,0.98434957823225,0,3,intracellular sequestering of iron ion,BP,
3475,GO:0006882,1,0.825448679461243,0,32,cellular zinc ion homeostasis,BP,
3476,GO:0006883,1,0.892736669284407,0,17,cellular sodium ion homeostasis,BP,
3477,GO:0006884,1,0.856304242512503,0,22,cell volume homeostasis,BP,
3478,GO:0006885,1,0.535897459132151,0,96,regulation of pH,BP,
3481,GO:0006888,1,0.28215933573525,0,186,ER to Golgi vesicle-mediated transport,BP,
3482,GO:0006890,1,0.596005321782632,0,79,retrograde vesicle-mediated transport, Golgi to ER,BP,
3483,GO:0006891,1,0.811832445766816,0,33,intra-Golgi vesicle-mediated transport,BP,
3484,GO:0006892,1,0.510081020058908,0,92,post-Golgi vesicle-mediated transport,BP,
3485,GO:0006893,1,0.718655511191859,0,47,Golgi to plasma membrane transport,BP,
3486,GO:0006895,1,0.85225792914307,0,19,Golgi to endosome transport,BP,
3487,GO:0006896,1,0.913072934945628,0,14,Golgi to vacuole transport,BP,
3491,GO:0006901,1,0.642219597279817,0,66,vesicle coating,BP,
3492,GO:0006903,1,0.564758029065017,0,85,vesicle targeting,BP,
3495,GO:0006907,1,0.89427092106203,0,18,pinocytosis,BP,
3497,GO:0006910,1,0.915720547060663,0,14,phagocytosis, recognition,BP,
3498,GO:0006911,1,0.750632862355928,0,44,phagocytosis, engulfment,BP,
3499,GO:0006913,1,0.112068531255227,0,324,nucleocytoplasmic transport,BP,
3500,GO:0006914,1,0.0486817140538102,0,457,autophagy,BP,
3502,GO:0006919,1,0.586645257900937,0,86,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3503,GO:0006921,1,0.822334524049365,0,30,cellular component disassembly involved in execution phase of apoptosis,BP,
3504,GO:0006924,1,0.948117632848102,0,9,activation-induced cell death of T cells,BP,
3508,GO:0006930,1,0.946716133204966,0,8,substrate-dependent cell migration, cell extension,BP,
3510,GO:0006933,1,0.981714406814239,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3513,GO:0006937,1,0.374078316002492,0,143,regulation of muscle contraction,BP,
3514,GO:0006939,1,0.538205588094607,0,94,smooth muscle contraction,BP,
3515,GO:0006940,1,0.705787048899067,0,55,regulation of smooth muscle contraction,BP,
3516,GO:0006941,1,0.318812629624738,0,160,striated muscle contraction,BP,
3517,GO:0006942,1,0.559591499703817,0,80,regulation of striated muscle contraction,BP,
3518,GO:0006948,1,0.994098345805747,0,1,induction by virus of host cell-cell fusion,BP,
3526,GO:0006957,1,0.934474909072816,0,10,complement activation, alternative pathway,BP,
3529,GO:0006968,1,0.750145726558439,0,49,cellular defense response,BP,
3530,GO:0006970,1,0.649657910532516,0,66,response to osmotic stress,BP,
3531,GO:0006971,1,0.931357279097329,0,9,hypotonic response,BP,
3532,GO:0006972,1,0.882451668143742,0,20,hyperosmotic response,BP,
3533,GO:0006974,1,0.00662455511506737,0,745,cellular response to DNA damage stimulus,BP,
3534,GO:0006975,1,0.946341841004894,0,8,DNA damage induced protein phosphorylation,BP,
3535,GO:0006977,1,0.680162620944117,0,60,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3536,GO:0006978,1,0.871245115320595,0,19,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3538,GO:0006982,1,0.989559244342344,0,2,response to lipid hydroperoxide,BP,
3539,GO:0006983,1,0.934483262132701,0,10,ER overload response,BP,
3542,GO:0006987,1,0.952039564363071,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3543,GO:0006990,1,0.978018167065176,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3544,GO:0006991,1,0.938688369840557,0,10,response to sterol depletion,BP,
3545,GO:0006995,1,0.940271910194968,0,11,cellular response to nitrogen starvation,BP,
3548,GO:0006998,1,0.580650602112621,0,81,nuclear envelope organization,BP,
3549,GO:0006999,1,0.894643689828582,0,15,nuclear pore organization,BP,
3550,GO:0007000,1,0.955720579757355,0,7,nucleolus organization,BP,
3551,GO:0007004,1,0.644776304663504,0,65,telomere maintenance via telomerase,BP,
3553,GO:0007006,1,0.542110224763263,0,103,mitochondrial membrane organization,BP,
3554,GO:0007007,1,0.881196437837376,0,22,inner mitochondrial membrane organization,BP,
3555,GO:0007008,1,0.993889919208563,0,1,outer mitochondrial membrane organization,BP,
3556,GO:0007009,1,0.577157689755727,0,73,plasma membrane organization,BP,
3558,GO:0007014,1,0.993608860486893,0,1,actin ubiquitination,BP,
3559,GO:0007015,1,0.0783935003775895,0,360,actin filament organization,BP,
3560,GO:0007016,1,0.908506686952568,0,10,cytoskeletal anchoring at plasma membrane,BP,
3563,GO:0007019,1,0.75205188893827,0,38,microtubule depolymerization,BP,
3564,GO:0007020,1,0.831903983763141,0,25,microtubule nucleation,BP,
3565,GO:0007021,1,0.961975256909731,0,7,tubulin complex assembly,BP,
3566,GO:0007023,1,0.977316098073559,0,4,post-chaperonin tubulin folding pathway,BP,
3567,GO:0007026,1,0.845881279690089,0,22,negative regulation of microtubule depolymerization,BP,
3568,GO:0007028,1,0.928160524703369,0,9,cytoplasm organization,BP,
3569,GO:0007029,1,0.738625761733838,0,46,endoplasmic reticulum organization,BP,
3570,GO:0007030,1,0.400854313865814,0,128,Golgi organization,BP,
3571,GO:0007031,1,0.820094037109851,0,31,peroxisome organization,BP,
3572,GO:0007032,1,0.639342658127696,0,69,endosome organization,BP,
3574,GO:0007034,1,0.418531963695579,0,123,vacuolar transport,BP,
3575,GO:0007035,1,0.866083416769609,0,22,vacuolar acidification,BP,
3576,GO:0007039,1,0.8996380536463,0,14,protein catabolic process in the vacuole,BP,
3577,GO:0007040,1,0.677595419757375,0,58,lysosome organization,BP,
3578,GO:0007041,1,0.514949034200519,0,93,lysosomal transport,BP,
3579,GO:0007042,1,0.957969895701348,0,8,lysosomal lumen acidification,BP,
3580,GO:0007043,1,0.469216867965964,0,109,cell-cell junction assembly,BP,
3581,GO:0007044,1,0.50456772501431,0,87,cell-substrate junction assembly,BP,
3582,GO:0007045,1,0.583483740778872,0,71,cell-substrate adherens junction assembly,BP,
3584,GO:0007050,1,0.213101264821208,0,235,cell cycle arrest,BP,
3585,GO:0007051,1,0.313190248963845,0,163,spindle organization,BP,
3586,GO:0007052,1,0.473925351004079,0,106,mitotic spindle organization,BP,
3587,GO:0007056,1,0.989185560701113,0,2,spindle assembly involved in female meiosis,BP,
3588,GO:0007057,1,0.989185560701113,0,2,spindle assembly involved in female meiosis I,BP,
3589,GO:0007059,1,0.107688188569615,0,328,chromosome segregation,BP,
3590,GO:0007060,1,0.977390720799447,0,4,male meiosis chromosome segregation,BP,
3591,GO:0007062,1,0.431008243372593,0,123,sister chromatid cohesion,BP,
3592,GO:0007063,1,0.867865116696517,0,19,regulation of sister chromatid cohesion,BP,
3593,GO:0007064,1,0.858857257062737,0,19,mitotic sister chromatid cohesion,BP,
3594,GO:0007066,1,0.994822680930925,0,1,female meiosis sister chromatid cohesion,BP,
3595,GO:0007072,1,0.994717517892978,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3596,GO:0007076,1,0.867352098002852,0,16,mitotic chromosome condensation,BP,
3597,GO:0007077,1,0.745489284617833,0,42,mitotic nuclear envelope disassembly,BP,
3598,GO:0007079,1,0.976072328006856,0,3,mitotic chromosome movement towards spindle pole,BP,
3599,GO:0007080,1,0.766923695165501,0,44,mitotic metaphase plate congression,BP,
3600,GO:0007084,1,0.945333717271469,0,10,mitotic nuclear envelope reassembly,BP,
3601,GO:0007088,1,0.35040979262403,0,151,regulation of mitotic nuclear division,BP,
3602,GO:0007089,1,0.973118801588665,0,4,traversing start control point of mitotic cell cycle,BP,
3603,GO:0007091,1,0.703882306020551,0,51,metaphase/anaphase transition of mitotic cell cycle,BP,
3604,GO:0007093,1,0.358154480365574,0,157,mitotic cell cycle checkpoint,BP,
3605,GO:0007094,1,0.808741947625953,0,31,mitotic spindle assembly checkpoint,BP,
3606,GO:0007095,1,0.874751704990651,0,19,mitotic G2 DNA damage checkpoint,BP,
3607,GO:0007096,1,0.906629600244553,0,16,regulation of exit from mitosis,BP,
3608,GO:0007097,1,0.848879352742214,0,19,nuclear migration,BP,
3609,GO:0007098,1,0.450693400095303,0,114,centrosome cycle,BP,
3610,GO:0007099,1,0.820489061291284,0,29,centriole replication,BP,
3611,GO:0007100,1,0.901733134697245,0,15,mitotic centrosome separation,BP,
3612,GO:0007113,1,0.984030460439328,0,3,endomitotic cell cycle,BP,
3613,GO:0007127,1,0.540253443395309,0,96,meiosis I,BP,
3614,GO:0007129,1,0.810709991474028,0,34,synapsis,BP,
3615,GO:0007130,1,0.900420044174505,0,16,synaptonemal complex assembly,BP,
3616,GO:0007131,1,0.75216244880633,0,44,reciprocal meiotic recombination,BP,
3617,GO:0007135,1,0.95482072428167,0,8,meiosis II,BP,
3618,GO:0007140,1,0.767430190062591,0,39,male meiotic nuclear division,BP,
3619,GO:0007141,1,0.890889356189388,0,18,male meiosis I,BP,
3620,GO:0007143,1,0.857147284391863,0,23,female meiotic nuclear division,BP,
3621,GO:0007144,1,0.956816299994345,0,7,female meiosis I,BP,
3622,GO:0007146,1,0.994313214468247,0,1,meiotic recombination nodule assembly,BP,
3623,GO:0007147,1,0.993683167506713,0,1,female meiosis II,BP,
3627,GO:0007157,1,0.744253024657644,0,43,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
3631,GO:0007161,1,0.960825790783721,0,4,calcium-independent cell-matrix adhesion,BP,
3634,GO:0007164,1,0.462449056496965,0,117,establishment of tissue polarity,BP,
3638,GO:0007168,1,0.97154246794769,0,5,receptor guanylyl cyclase signaling pathway,BP,
3640,GO:0007171,1,0.912897462676935,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3641,GO:0007172,1,0.951724361444587,0,8,signal complex assembly,BP,
3643,GO:0007174,1,0.994567620053009,0,1,epidermal growth factor catabolic process,BP,
3644,GO:0007175,1,0.908466047285223,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3645,GO:0007176,1,0.837802810025982,0,27,regulation of epidermal growth factor-activated receptor activity,BP,
3649,GO:0007182,1,0.95170021150589,0,6,common-partner SMAD protein phosphorylation,BP,
3650,GO:0007183,1,0.901160687758813,0,14,SMAD protein complex assembly,BP,
3651,GO:0007185,1,0.943768286548402,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3660,GO:0007195,1,0.960857018051,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3661,GO:0007196,1,0.929006429259757,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3662,GO:0007197,1,0.965483543108663,0,6,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3663,GO:0007198,1,0.978270536463383,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3664,GO:0007199,1,0.994418214015936,0,1,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3666,GO:0007202,1,0.878140054207426,0,22,activation of phospholipase C activity,BP,
3668,GO:0007205,1,0.837009853324354,0,25,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
3669,GO:0007206,1,0.982573798621607,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3670,GO:0007207,1,0.967047454870275,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3671,GO:0007208,1,0.98668375168056,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3672,GO:0007210,1,0.928906582872151,0,13,serotonin receptor signaling pathway,BP,
3674,GO:0007213,1,0.905510112048334,0,16,G-protein coupled acetylcholine receptor signaling pathway,BP,
3677,GO:0007216,1,0.892724052322828,0,15,G-protein coupled glutamate receptor signaling pathway,BP,
3678,GO:0007217,1,0.962695457115285,0,7,tachykinin receptor signaling pathway,BP,
3679,GO:0007218,1,0.59741688347931,0,89,neuropeptide signaling pathway,BP,
3681,GO:0007220,1,0.889984091177347,0,17,Notch receptor processing,BP,
3682,GO:0007221,1,0.855621881262537,0,18,positive regulation of transcription of Notch receptor target,BP,
3683,GO:0007223,1,0.758382370012273,0,38,Wnt signaling pathway, calcium modulating pathway,BP,
3684,GO:0007224,1,0.424052171616924,0,124,smoothened signaling pathway,BP,
3685,GO:0007225,1,0.99260921688863,0,1,patched ligand maturation,BP,
3686,GO:0007227,1,0.974376509623015,0,4,signal transduction downstream of smoothened,BP,
3687,GO:0007228,1,0.980857466601708,0,3,positive regulation of hh target transcription factor activity,BP,
3689,GO:0007231,1,0.983560061390794,0,3,osmosensory signaling pathway,BP,
3692,GO:0007252,1,0.91014821019742,0,14,I-kappaB phosphorylation,BP,
3693,GO:0007253,1,0.961514239259128,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3694,GO:0007254,1,0.280875320851812,0,187,JNK cascade,BP,
3695,GO:0007256,1,0.951342894756594,0,6,activation of JNKK activity,BP,
3696,GO:0007257,1,0.803551111863973,0,32,activation of JUN kinase activity,BP,
3697,GO:0007258,1,0.97553018110182,0,4,JUN phosphorylation,BP,
3700,GO:0007263,1,0.874852298766798,0,21,nitric oxide mediated signal transduction,BP,
3707,GO:0007270,1,0.930433370893584,0,8,neuron-neuron synaptic transmission,BP,
3708,GO:0007271,1,0.822544098430719,0,32,synaptic transmission, cholinergic,BP,
3710,GO:0007274,1,0.844866181131562,0,26,neuromuscular synaptic transmission,BP,
3712,GO:0007276,1,0.0288170907146298,0,528,gamete generation,BP,
3713,GO:0007281,1,0.2810236574428,0,191,germ cell development,BP,
3714,GO:0007283,1,0.0704366008935363,0,399,spermatogenesis,BP,
3715,GO:0007284,1,0.986120281096655,0,2,spermatogonial cell division,BP,
3716,GO:0007286,1,0.51774713573211,0,100,spermatid development,BP,
3717,GO:0007288,1,0.934724648156683,0,10,sperm axoneme assembly,BP,
3718,GO:0007289,1,0.899717138615717,0,14,spermatid nucleus differentiation,BP,
3719,GO:0007290,1,0.992578927649358,0,1,spermatid nucleus elongation,BP,
3720,GO:0007291,1,0.994819745215931,0,1,sperm individualization,BP,
3721,GO:0007292,1,0.493678471172694,0,105,female gamete generation,BP,
3722,GO:0007296,1,0.965105754643929,0,4,vitellogenesis,BP,
3723,GO:0007308,1,0.98822662674325,0,2,oocyte construction,BP,
3724,GO:0007309,1,0.98822662674325,0,2,oocyte axis specification,BP,
3725,GO:0007314,1,0.98822662674325,0,2,oocyte anterior/posterior axis specification,BP,
3726,GO:0007315,1,0.98822662674325,0,2,pole plasm assembly,BP,
3727,GO:0007320,1,0.939932178615504,0,10,insemination,BP,
3728,GO:0007338,1,0.525974025032643,0,105,single fertilization,BP,
3729,GO:0007339,1,0.868718069787842,0,25,binding of sperm to zona pellucida,BP,
3730,GO:0007340,1,0.839674338234506,0,27,acrosome reaction,BP,
3731,GO:0007341,1,0.967363651680548,0,6,penetration of zona pellucida,BP,
3732,GO:0007342,1,0.953024100227197,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3733,GO:0007343,1,0.985064817533878,0,2,egg activation,BP,
3734,GO:0007344,1,0.994711067543834,0,1,pronuclear fusion,BP,
3736,GO:0007349,1,0.994819745215931,0,1,cellularization,BP,
3737,GO:0007350,1,0.904663776115873,0,15,blastoderm segmentation,BP,
3738,GO:0007351,1,0.923130710244484,0,12,tripartite regional subdivision,BP,
3739,GO:0007352,1,0.976169962289899,0,3,zygotic specification of dorsal/ventral axis,BP,
3740,GO:0007354,1,0.977803263770577,0,4,zygotic determination of anterior/posterior axis, embryo,BP,
3741,GO:0007356,1,0.98375287291128,0,3,thorax and anterior abdomen determination,BP,
3742,GO:0007368,1,0.472773707799564,0,109,determination of left/right symmetry,BP,
3744,GO:0007371,1,0.993584328135496,0,1,ventral midline determination,BP,
3745,GO:0007379,1,0.915405351599055,0,15,segment specification,BP,
3746,GO:0007386,1,0.965882829550282,0,5,compartment pattern specification,BP,
3747,GO:0007387,1,0.994348952544923,0,1,anterior compartment pattern formation,BP,
3748,GO:0007388,1,0.994348952544923,0,1,posterior compartment specification,BP,
3749,GO:0007389,1,0.0666658269585703,0,395,pattern specification process,BP,
3750,GO:0007398,1,0.887095144773063,0,18,ectoderm development,BP,
3752,GO:0007400,1,0.994468201715917,0,1,neuroblast fate determination,BP,
3753,GO:0007402,1,0.989397984984049,0,2,ganglion mother cell fate determination,BP,
3754,GO:0007403,1,0.993855145749219,0,1,glial cell fate determination,BP,
3755,GO:0007405,1,0.68351019749066,0,53,neuroblast proliferation,BP,
3756,GO:0007406,1,0.961985321795466,0,5,negative regulation of neuroblast proliferation,BP,
3759,GO:0007412,1,0.98826452654121,0,2,axon target recognition,BP,
3763,GO:0007418,1,0.972901930677497,0,4,ventral midline development,BP,
3765,GO:0007422,1,0.574664999602935,0,74,peripheral nervous system development,BP,
3767,GO:0007431,1,0.764437670047786,0,38,salivary gland development,BP,
3768,GO:0007435,1,0.786633427312626,0,34,salivary gland morphogenesis,BP,
3769,GO:0007439,1,0.988656661634221,0,2,ectodermal digestive tract development,BP,
3770,GO:0007440,1,0.91761524166117,0,10,foregut morphogenesis,BP,
3771,GO:0007442,1,0.94919369412576,0,7,hindgut morphogenesis,BP,
3772,GO:0007468,1,0.989082352976684,0,2,regulation of rhodopsin gene expression,BP,
3774,GO:0007493,1,0.988354597631869,0,2,endodermal cell fate determination,BP,
3775,GO:0007494,1,0.930415005908943,0,11,midgut development,BP,
3776,GO:0007495,1,0.99404256551509,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3777,GO:0007497,1,0.985574209091623,0,2,posterior midgut development,BP,
3778,GO:0007498,1,0.476040012057013,0,112,mesoderm development,BP,
3779,GO:0007499,1,0.992719021149526,0,1,ectoderm and mesoderm interaction,BP,
3780,GO:0007500,1,0.988951240760659,0,2,mesodermal cell fate determination,BP,
3781,GO:0007501,1,0.926077045589671,0,13,mesodermal cell fate specification,BP,
3782,GO:0007506,1,0.987555653784359,0,2,gonadal mesoderm development,BP,
3784,GO:0007509,1,0.990714116409062,0,1,mesoderm migration involved in gastrulation,BP,
3785,GO:0007512,1,0.919136995499195,0,12,adult heart development,BP,
3787,GO:0007518,1,0.989240642503016,0,2,myoblast fate determination,BP,
3788,GO:0007519,1,0.363443980769724,0,150,skeletal muscle tissue development,BP,
3790,GO:0007521,1,0.984928446815045,0,2,muscle cell fate determination,BP,
3791,GO:0007522,1,0.991321073025332,0,1,visceral muscle development,BP,
3792,GO:0007525,1,0.969813809960211,0,2,somatic muscle development,BP,
3794,GO:0007529,1,0.986660073187149,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3795,GO:0007530,1,0.875052954873204,0,21,sex determination,BP,
3796,GO:0007538,1,0.985366539081611,0,2,primary sex determination,BP,
3797,GO:0007542,1,0.985366539081611,0,2,primary sex determination, germ-line,BP,
3798,GO:0007548,1,0.202600671783285,0,232,sex differentiation,BP,
3799,GO:0007549,1,0.906108252978347,0,12,dosage compensation,BP,
3802,GO:0007567,1,0.902653065285663,0,16,parturition,BP,
3805,GO:0007571,1,0.994816463596202,0,1,age-dependent general metabolic decline,BP,
3806,GO:0007576,1,0.994434380686781,0,1,nucleolar fragmentation,BP,
3810,GO:0007588,1,0.727884174910051,0,50,excretion,BP,
3812,GO:0007595,1,0.751317342756869,0,39,lactation,BP,
3815,GO:0007598,1,0.978004340784709,0,4,blood coagulation, extrinsic pathway,BP,
3819,GO:0007602,1,0.78227697131019,0,41,phototransduction,BP,
3832,GO:0007619,1,0.979089086410475,0,3,courtship behavior,BP,
3833,GO:0007620,1,0.903551204470783,0,16,copulation,BP,
3834,GO:0007621,1,0.977875113665263,0,3,negative regulation of female receptivity,BP,
3835,GO:0007622,1,0.775066991097288,0,40,rhythmic behavior,BP,
3837,GO:0007624,1,0.99320767283986,0,1,ultradian rhythm,BP,
3838,GO:0007625,1,0.908943182491832,0,15,grooming behavior,BP,
3840,GO:0007628,1,0.822914561575657,0,26,adult walking behavior,BP,
3843,GO:0007634,1,0.994483050418908,0,1,optokinetic behavior,BP,
3845,GO:0007638,1,0.891975171469173,0,13,mechanosensory behavior,BP,
3850,GO:0008017,1,0.147225078203533,0,246,microtubule binding,MF,
3851,GO:0008020,1,0.957268028982724,0,8,G-protein coupled photoreceptor activity,MF,
3855,GO:0008024,1,0.94414778732161,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3856,GO:0008026,1,0.548598519333501,0,91,ATP-dependent helicase activity,MF,
3858,GO:0008033,1,0.503144834081419,0,118,tRNA processing,BP,
3859,GO:0008035,1,0.961298475176588,0,7,high-density lipoprotein particle binding,MF,
3862,GO:0008043,1,0.989650724859325,0,2,intracellular ferritin complex,CC,
3863,GO:0008045,1,0.852092039123108,0,21,motor neuron axon guidance,BP,
3864,GO:0008046,1,0.946041929247897,0,7,axon guidance receptor activity,MF,
3866,GO:0008048,1,0.98411399535645,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3867,GO:0008049,1,0.994671202280983,0,1,male courtship behavior,BP,
3868,GO:0008050,1,0.984335235894633,0,2,female courtship behavior,BP,
3869,GO:0008052,1,0.994818658650597,0,1,sensory organ boundary specification,BP,
3870,GO:0008053,1,0.883493736114065,0,21,mitochondrial fusion,BP,
3871,GO:0008057,1,0.989806583241298,0,1,eye pigment granule organization,BP,
3873,GO:0008063,1,0.963113918268622,0,6,Toll signaling pathway,BP,
3874,GO:0008064,1,0.327871710783684,0,166,regulation of actin polymerization or depolymerization,BP,
3875,GO:0008065,1,0.981934057080261,0,3,establishment of blood-nerve barrier,BP,
3877,GO:0008068,1,0.994184890625447,0,1,extracellularly glutamate-gated chloride channel activity,MF,
3878,GO:0008073,1,0.984382785402669,0,3,ornithine decarboxylase inhibitor activity,MF,
3879,GO:0008074,1,0.906459432229687,0,12,guanylate cyclase complex, soluble,CC,
3881,GO:0008078,1,0.980455345580522,0,3,mesodermal cell migration,BP,
3882,GO:0008079,1,0.961471168353941,0,6,translation termination factor activity,MF,
3883,GO:0008080,1,0.5957696051796,0,77,N-acetyltransferase activity,MF,
3884,GO:0008081,1,0.567875229567619,0,83,phosphoric diester hydrolase activity,MF,
3886,GO:0008088,1,0.68084215143248,0,54,axo-dendritic transport,BP,
3887,GO:0008089,1,0.781418180655571,0,37,anterograde axonal transport,BP,
3888,GO:0008090,1,0.939568002221389,0,8,retrograde axonal transport,BP,
3889,GO:0008091,1,0.918637764715893,0,8,spectrin,CC,
3891,GO:0008093,1,0.919596774884161,0,12,cytoskeletal adaptor activity,MF,
3893,GO:0008097,1,0.943783332577311,0,10,5S rRNA binding,MF,
3895,GO:0008106,1,0.903414604922857,0,19,alcohol dehydrogenase (NADP+) activity,MF,
3896,GO:0008107,1,0.993113605288307,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3897,GO:0008108,1,0.994783652257647,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3898,GO:0008109,1,0.986733576367215,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3899,GO:0008111,1,0.994652627377944,0,1,alpha-methylacyl-CoA racemase activity,MF,
3901,GO:0008113,1,0.989573325207008,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3902,GO:0008115,1,0.994494465846789,0,1,sarcosine oxidase activity,MF,
3903,GO:0008116,1,0.991709357575751,0,1,prostaglandin-I synthase activity,MF,
3904,GO:0008117,1,0.991529048879274,0,1,sphinganine-1-phosphate aldolase activity,MF,
3905,GO:0008118,1,0.994570757074383,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3906,GO:0008119,1,0.993993868354449,0,1,thiopurine S-methyltransferase activity,MF,
3907,GO:0008120,1,0.994735207544296,0,1,ceramide glucosyltransferase activity,MF,
3908,GO:0008121,1,0.962288914958679,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3909,GO:0008124,1,0.989357128751801,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3910,GO:0008126,1,0.994273052560318,0,1,acetylesterase activity,MF,
3911,GO:0008127,1,0.994788686110399,0,1,quercetin 2,3-dioxygenase activity,MF,
3912,GO:0008131,1,0.969956713845494,0,5,primary amine oxidase activity,MF,
3913,GO:0008134,1,0.0162102410230079,0,597,transcription factor binding,MF,
3914,GO:0008135,1,0.58553397868635,0,84,translation factor activity, RNA binding,MF,
3915,GO:0008137,1,0.817341139314051,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3916,GO:0008138,1,0.776810914840604,0,40,protein tyrosine/serine/threonine phosphatase activity,MF,
3917,GO:0008139,1,0.850206773283594,0,22,nuclear localization sequence binding,MF,
3918,GO:0008140,1,0.949334114347648,0,8,cAMP response element binding protein binding,MF,
3919,GO:0008142,1,0.961774737102876,0,5,oxysterol binding,MF,
3920,GO:0008143,1,0.899001639906986,0,16,poly(A) binding,MF,
3922,GO:0008146,1,0.739087859810256,0,47,sulfotransferase activity,MF,
3923,GO:0008147,1,0.989701629760704,0,2,structural constituent of bone,MF,
3926,GO:0008154,1,0.284969616073051,0,187,actin polymerization or depolymerization,BP,
3928,GO:0008157,1,0.880779891976937,0,19,protein phosphatase 1 binding,MF,
3929,GO:0008158,1,0.977700531228912,0,3,hedgehog receptor activity,MF,
3930,GO:0008160,1,0.994399580589311,0,1,protein tyrosine phosphatase activator activity,MF,
3932,GO:0008169,1,0.982171761935783,0,3,C-methyltransferase activity,MF,
3934,GO:0008171,1,0.898234201274958,0,18,O-methyltransferase activity,MF,
3935,GO:0008172,1,0.959764606162566,0,6,S-methyltransferase activity,MF,
3936,GO:0008173,1,0.73513663379003,0,51,RNA methyltransferase activity,MF,
3937,GO:0008174,1,0.947534278593106,0,9,mRNA methyltransferase activity,MF,
3938,GO:0008175,1,0.845925409140131,0,27,tRNA methyltransferase activity,MF,
3939,GO:0008176,1,0.989518126006726,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3940,GO:0008177,1,0.978605012937881,0,4,succinate dehydrogenase (ubiquinone) activity,MF,
3941,GO:0008179,1,0.909094499654515,0,13,adenylate cyclase binding,MF,
3942,GO:0008180,1,0.810276161374797,0,33,COP9 signalosome,CC,
3943,GO:0008184,1,0.981413766829249,0,3,glycogen phosphorylase activity,MF,
3944,GO:0008186,1,0.657006685236289,0,65,RNA-dependent ATPase activity,MF,
3945,GO:0008187,1,0.862942191988662,0,23,poly-pyrimidine tract binding,MF,
3946,GO:0008188,1,0.766452094549322,0,46,neuropeptide receptor activity,MF,
3947,GO:0008190,1,0.933018775279852,0,10,eukaryotic initiation factor 4E binding,MF,
3949,GO:0008192,1,0.981030458457977,0,3,RNA guanylyltransferase activity,MF,
3950,GO:0008193,1,0.98806125938762,0,2,tRNA guanylyltransferase activity,MF,
3952,GO:0008195,1,0.976171510731403,0,3,phosphatidate phosphatase activity,MF,
3953,GO:0008198,1,0.874319176602467,0,21,ferrous iron binding,MF,
3954,GO:0008199,1,0.963968506148487,0,6,ferric iron binding,MF,
3955,GO:0008200,1,0.810158592380429,0,31,ion channel inhibitor activity,MF,
3958,GO:0008203,1,0.454190876881134,0,119,cholesterol metabolic process,BP,
3959,GO:0008204,1,0.989241145687406,0,2,ergosterol metabolic process,BP,
3960,GO:0008206,1,0.769674412486461,0,43,bile acid metabolic process,BP,
3963,GO:0008210,1,0.899139345788847,0,18,estrogen metabolic process,BP,
3964,GO:0008211,1,0.885276598466276,0,20,glucocorticoid metabolic process,BP,
3965,GO:0008212,1,0.949117225668937,0,8,mineralocorticoid metabolic process,BP,
3966,GO:0008213,1,0.325402836322557,0,163,protein alkylation,BP,
3967,GO:0008214,1,0.795743794764366,0,29,protein dealkylation,BP,
3968,GO:0008215,1,0.962874606329443,0,7,spermine metabolic process,BP,
3969,GO:0008216,1,0.957892724970991,0,8,spermidine metabolic process,BP,
3971,GO:0008218,1,0.993806562085334,0,1,bioluminescence,BP,
3973,GO:0008227,1,0.83337049348189,0,32,G-protein coupled amine receptor activity,MF,
3976,GO:0008234,1,0.337329041492218,0,158,cysteine-type peptidase activity,MF,
3981,GO:0008239,1,0.938846289270044,0,11,dipeptidyl-peptidase activity,MF,
3982,GO:0008240,1,0.980416097850243,0,3,tripeptidyl-peptidase activity,MF,
3983,GO:0008241,1,0.993905506281561,0,1,peptidyl-dipeptidase activity,MF,
3984,GO:0008242,1,0.944872481507607,0,9,omega peptidase activity,MF,
3985,GO:0008250,1,0.935986952748087,0,12,oligosaccharyltransferase complex,CC,
3986,GO:0008251,1,0.985418268643961,0,2,tRNA-specific adenosine deaminase activity,MF,
3987,GO:0008252,1,0.91392200101801,0,14,nucleotidase activity,MF,
3988,GO:0008253,1,0.928262732526125,0,12,5'-nucleotidase activity,MF,
3989,GO:0008254,1,0.990034676019442,0,1,3'-nucleotidase activity,MF,
3990,GO:0008260,1,0.98846251045878,0,2,3-oxoacid CoA-transferase activity,MF,
3991,GO:0008263,1,0.988496928724615,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3992,GO:0008265,1,0.994335363210544,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3993,GO:0008266,1,0.886892449916389,0,19,poly(U) RNA binding,MF,
3994,GO:0008267,1,0.989232647435707,0,1,poly-glutamine tract binding,MF,
3995,GO:0008269,1,0.989280055705322,0,2,JAK pathway signal transduction adaptor activity,MF,
3997,GO:0008271,1,0.93483778850386,0,10,secondary active sulfate transmembrane transporter activity,MF,
3998,GO:0008272,1,0.92421165044639,0,12,sulfate transport,BP,
3999,GO:0008273,1,0.972753635474894,0,4,calcium, potassium:sodium antiporter activity,MF,
4000,GO:0008274,1,0.950643572325559,0,7,gamma-tubulin ring complex,CC,
4001,GO:0008275,1,0.974175494361586,0,4,gamma-tubulin small complex,CC,
4002,GO:0008276,1,0.600062764073933,0,77,protein methyltransferase activity,MF,
4004,GO:0008278,1,0.929787814104251,0,10,cohesin complex,CC,
4005,GO:0008281,1,0.985044073718183,0,2,sulfonylurea receptor activity,MF,
4006,GO:0008282,1,0.973873717923098,0,4,inward rectifying potassium channel,CC,
4011,GO:0008287,1,0.753255183428168,0,44,protein serine/threonine phosphatase complex,CC,
4013,GO:0008290,1,0.959401469365036,0,7,F-actin capping protein complex,CC,
4014,GO:0008291,1,0.983059239152937,0,3,acetylcholine metabolic process,BP,
4015,GO:0008292,1,0.994383550341847,0,1,acetylcholine biosynthetic process,BP,
4016,GO:0008294,1,0.978400602187391,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4017,GO:0008295,1,0.978254369842086,0,4,spermidine biosynthetic process,BP,
4018,GO:0008296,1,0.941433684081704,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4019,GO:0008297,1,0.956266724462388,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4020,GO:0008298,1,0.934067613963715,0,12,intracellular mRNA localization,BP,
4021,GO:0008299,1,0.854149060566533,0,27,isoprenoid biosynthetic process,BP,
4022,GO:0008300,1,0.961083427936432,0,7,isoprenoid catabolic process,BP,
4023,GO:0008301,1,0.893332322439731,0,18,DNA binding, bending,MF,
4024,GO:0008305,1,0.790618978524121,0,32,integrin complex,CC,
4026,GO:0008307,1,0.697324724515621,0,43,structural constituent of muscle,MF,
4027,GO:0008308,1,0.901262937831095,0,16,voltage-gated anion channel activity,MF,
4028,GO:0008309,1,0.978186202774758,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4029,GO:0008310,1,0.967515331036797,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4030,GO:0008311,1,0.989440559247727,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4031,GO:0008312,1,0.962047377150405,0,7,7S RNA binding,MF,
4032,GO:0008318,1,0.95413050668859,0,7,protein prenyltransferase activity,MF,
4033,GO:0008320,1,0.931366222373,0,13,protein transmembrane transporter activity,MF,
4034,GO:0008321,1,0.977732325397821,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4036,GO:0008327,1,0.905043276208587,0,15,methyl-CpG binding,MF,
4038,GO:0008329,1,0.91695395727294,0,14,signaling pattern recognition receptor activity,MF,
4039,GO:0008330,1,0.978314088474915,0,4,protein tyrosine/threonine phosphatase activity,MF,
4040,GO:0008331,1,0.891167614544946,0,12,high voltage-gated calcium channel activity,MF,
4041,GO:0008332,1,0.961395093908833,0,4,low voltage-gated calcium channel activity,MF,
4042,GO:0008333,1,0.699512131478613,0,52,endosome to lysosome transport,BP,
4043,GO:0008334,1,0.844262684117494,0,24,histone mRNA metabolic process,BP,
4044,GO:0008336,1,0.994676012241614,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4045,GO:0008340,1,0.911634563714195,0,11,determination of adult lifespan,BP,
4046,GO:0008343,1,0.952466954220619,0,8,adult feeding behavior,BP,
4049,GO:0008348,1,0.993650835388071,0,1,negative regulation of antimicrobial humoral response,BP,
4050,GO:0008349,1,0.922489457540777,0,11,MAP kinase kinase kinase kinase activity,MF,
4051,GO:0008352,1,0.994376184436191,0,1,katanin complex,CC,
4052,GO:0008353,1,0.906875913682231,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4053,GO:0008354,1,0.954978479972752,0,7,germ cell migration,BP,
4055,GO:0008356,1,0.883098893941705,0,18,asymmetric cell division,BP,
4056,GO:0008358,1,0.98822662674325,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4061,GO:0008374,1,0.784166262099727,0,37,O-acyltransferase activity,MF,
4062,GO:0008375,1,0.715382722364402,0,53,acetylglucosaminyltransferase activity,MF,
4064,GO:0008378,1,0.832335210205406,0,31,galactosyltransferase activity,MF,
4065,GO:0008379,1,0.974296596240625,0,5,thioredoxin peroxidase activity,MF,
4068,GO:0008384,1,0.987211658048128,0,2,IkappaB kinase activity,MF,
4069,GO:0008385,1,0.942379185375576,0,9,IkappaB kinase complex,CC,
4070,GO:0008386,1,0.994653493041565,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4071,GO:0008387,1,0.994550219572822,0,1,steroid 7-alpha-hydroxylase activity,MF,
4072,GO:0008389,1,0.989444602377612,0,2,coumarin 7-hydroxylase activity,MF,
4073,GO:0008391,1,0.95796691067956,0,8,arachidonic acid monooxygenase activity,MF,
4074,GO:0008392,1,0.95796691067956,0,8,arachidonic acid epoxygenase activity,MF,
4075,GO:0008395,1,0.883506090461137,0,22,steroid hydroxylase activity,MF,
4076,GO:0008396,1,0.989082532236008,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4077,GO:0008397,1,0.993398504973974,0,1,sterol 12-alpha-hydroxylase activity,MF,
4078,GO:0008398,1,0.994121593413458,0,1,sterol 14-demethylase activity,MF,
4079,GO:0008401,1,0.981918764386077,0,3,retinoic acid 4-hydroxylase activity,MF,
4080,GO:0008403,1,0.994051029995373,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4081,GO:0008404,1,0.994683827021034,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4082,GO:0008405,1,0.994683827021034,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4083,GO:0008406,1,0.286347757316397,0,184,gonad development,BP,
4084,GO:0008408,1,0.732945623889547,0,48,3'-5' exonuclease activity,MF,
4085,GO:0008409,1,0.892781437321003,0,16,5'-3' exonuclease activity,MF,
4086,GO:0008410,1,0.977623484902911,0,4,CoA-transferase activity,MF,
4087,GO:0008413,1,0.989500643655537,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4089,GO:0008418,1,0.994808731923091,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4090,GO:0008419,1,0.994380928735826,0,1,RNA lariat debranching enzyme activity,MF,
4091,GO:0008420,1,0.952469526113839,0,8,CTD phosphatase activity,MF,
4092,GO:0008422,1,0.975581899230666,0,4,beta-glucosidase activity,MF,
4093,GO:0008424,1,0.993963198486243,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4094,GO:0008425,1,0.99479271690561,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4095,GO:0008426,1,0.9832875434296,0,3,protein kinase C inhibitor activity,MF,
4096,GO:0008427,1,0.984207078322542,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4097,GO:0008428,1,0.982054282134987,0,3,ribonuclease inhibitor activity,MF,
4098,GO:0008429,1,0.940930668484461,0,9,phosphatidylethanolamine binding,MF,
4099,GO:0008430,1,0.973342697681587,0,4,selenium binding,MF,
4100,GO:0008431,1,0.9885618069184,0,2,vitamin E binding,MF,
4101,GO:0008432,1,0.944622577633112,0,8,JUN kinase binding,MF,
4102,GO:0008434,1,0.992638417255533,0,1,calcitriol receptor activity,MF,
4103,GO:0008437,1,0.994643675254627,0,1,thyrotropin-releasing hormone activity,MF,
4104,GO:0008440,1,0.967941322609309,0,5,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4105,GO:0008441,1,0.984562402526782,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4106,GO:0008442,1,0.994651323911288,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4107,GO:0008443,1,0.956776467493378,0,7,phosphofructokinase activity,MF,
4108,GO:0008444,1,0.994581815133195,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4109,GO:0008445,1,0.994737951479012,0,1,D-aspartate oxidase activity,MF,
4110,GO:0008446,1,0.994726273936045,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4111,GO:0008448,1,0.994690024540163,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4112,GO:0008449,1,0.977155457727726,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4113,GO:0008452,1,0.994313214468247,0,1,RNA ligase activity,MF,
4114,GO:0008453,1,0.983458529289781,0,3,alanine-glyoxylate transaminase activity,MF,
4115,GO:0008454,1,0.980387642737497,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4116,GO:0008455,1,0.994351969086881,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4117,GO:0008456,1,0.993595945906608,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4118,GO:0008457,1,0.993233639372639,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4119,GO:0008458,1,0.993992347369817,0,1,carnitine O-octanoyltransferase activity,MF,
4120,GO:0008459,1,0.984884484834879,0,2,chondroitin 6-sulfotransferase activity,MF,
4121,GO:0008460,1,0.994671202280983,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4122,GO:0008465,1,0.994795862889762,0,1,glycerate dehydrogenase activity,MF,
4123,GO:0008466,1,0.988641254660087,0,2,glycogenin glucosyltransferase activity,MF,
4124,GO:0008467,1,0.967215901203234,0,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4125,GO:0008469,1,0.951235112184727,0,9,histone-arginine N-methyltransferase activity,MF,
4126,GO:0008470,1,0.992731219328811,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4127,GO:0008474,1,0.944174318306776,0,10,palmitoyl-(protein) hydrolase activity,MF,
4128,GO:0008475,1,0.981758865255637,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4129,GO:0008476,1,0.989318219384065,0,2,protein-tyrosine sulfotransferase activity,MF,
4130,GO:0008478,1,0.989871031585885,0,1,pyridoxal kinase activity,MF,
4131,GO:0008479,1,0.978850486307431,0,4,queuine tRNA-ribosyltransferase activity,MF,
4132,GO:0008480,1,0.993946498910126,0,1,sarcosine dehydrogenase activity,MF,
4133,GO:0008481,1,0.988909845278224,0,2,sphinganine kinase activity,MF,
4134,GO:0008482,1,0.994528459656984,0,1,sulfite oxidase activity,MF,
4135,GO:0008483,1,0.897465263664047,0,17,transaminase activity,MF,
4136,GO:0008484,1,0.898965086350909,0,16,sulfuric ester hydrolase activity,MF,
4137,GO:0008486,1,0.97668461576008,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4138,GO:0008488,1,0.994052863976412,0,1,gamma-glutamyl carboxylase activity,MF,
4139,GO:0008489,1,0.994236291570829,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4140,GO:0008493,1,0.994682928185635,0,1,tetracycline transmembrane transporter activity,MF,
4141,GO:0008494,1,0.934387394940681,0,11,translation activator activity,MF,
4142,GO:0008495,1,0.994172900929179,0,1,protoheme IX farnesyltransferase activity,MF,
4143,GO:0008496,1,0.993100908611021,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4144,GO:0008499,1,0.932237361123392,0,12,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4145,GO:0008502,1,0.978063551818837,0,4,melatonin receptor activity,MF,
4146,GO:0008503,1,0.93195250331993,0,10,benzodiazepine receptor activity,MF,
4147,GO:0008504,1,0.945477477840849,0,9,monoamine transmembrane transporter activity,MF,
4148,GO:0008506,1,0.982452627648068,0,3,sucrose:proton symporter activity,MF,
4149,GO:0008507,1,0.993722041756994,0,1,sodium:iodide symporter activity,MF,
4150,GO:0008508,1,0.978996604065842,0,4,bile acid:sodium symporter activity,MF,
4152,GO:0008510,1,0.930802145606199,0,9,sodium:bicarbonate symporter activity,MF,
4153,GO:0008511,1,0.983080421170662,0,2,sodium:potassium:chloride symporter activity,MF,
4154,GO:0008513,1,0.983803594021164,0,3,secondary active organic cation transmembrane transporter activity,MF,
4156,GO:0008515,1,0.982452627648068,0,3,sucrose transmembrane transporter activity,MF,
4157,GO:0008517,1,0.963089654929972,0,6,folic acid transmembrane transporter activity,MF,
4158,GO:0008518,1,0.994275469969769,0,1,reduced folate carrier activity,MF,
4159,GO:0008519,1,0.844891844115093,0,28,ammonium transmembrane transporter activity,MF,
4160,GO:0008520,1,0.990297826543863,0,1,L-ascorbate:sodium symporter activity,MF,
4161,GO:0008521,1,0.994376713196624,0,1,acetyl-CoA transmembrane transporter activity,MF,
4162,GO:0008523,1,0.993951952230398,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4163,GO:0008525,1,0.941828924064846,0,8,phosphatidylcholine transporter activity,MF,
4164,GO:0008526,1,0.946060023966183,0,8,phosphatidylinositol transporter activity,MF,
4165,GO:0008527,1,0.927914814051592,0,14,taste receptor activity,MF,
4167,GO:0008531,1,0.994351969086881,0,1,riboflavin kinase activity,MF,
4168,GO:0008532,1,0.954991541894058,0,8,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4169,GO:0008534,1,0.979161771305677,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4170,GO:0008535,1,0.869251959151205,0,24,respiratory chain complex IV assembly,BP,
4171,GO:0008536,1,0.780375678688952,0,33,Ran GTPase binding,MF,
4172,GO:0008537,1,0.983761462793627,0,3,proteasome activator complex,CC,
4173,GO:0008540,1,0.936606283970229,0,12,proteasome regulatory particle, base subcomplex,CC,
4174,GO:0008541,1,0.96357085883647,0,7,proteasome regulatory particle, lid subcomplex,CC,
4176,GO:0008543,1,0.513437271512745,0,99,fibroblast growth factor receptor signaling pathway,BP,
4178,GO:0008545,1,0.98751249381916,0,2,JUN kinase kinase activity,MF,
4179,GO:0008553,1,0.919896271279635,0,13,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4180,GO:0008554,1,0.992555783203265,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4181,GO:0008555,1,0.991951013229759,0,1,chloride-transporting ATPase activity,MF,
4182,GO:0008556,1,0.9289937946804,0,12,potassium-transporting ATPase activity,MF,
4184,GO:0008565,1,0.596643852643796,0,77,protein transporter activity,MF,
4185,GO:0008568,1,0.936409836490372,0,10,microtubule-severing ATPase activity,MF,
4186,GO:0008569,1,0.787787284842347,0,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4187,GO:0008574,1,0.802206017257082,0,30,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4188,GO:0008579,1,0.992047930536817,0,1,JUN kinase phosphatase activity,MF,
4189,GO:0008582,1,0.964462656044288,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4190,GO:0008584,1,0.455245974959769,0,116,male gonad development,BP,
4191,GO:0008585,1,0.552803406786832,0,86,female gonad development,BP,
4192,GO:0008589,1,0.595748291365591,0,73,regulation of smoothened signaling pathway,BP,
4193,GO:0008591,1,0.994697994008713,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4194,GO:0008592,1,0.994002209945759,0,1,regulation of Toll signaling pathway,BP,
4197,GO:0008595,1,0.923130710244484,0,12,anterior/posterior axis specification, embryo,BP,
4198,GO:0008597,1,0.983257123391075,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4200,GO:0008607,1,0.982925768839428,0,3,phosphorylase kinase regulator activity,MF,
4201,GO:0008608,1,0.826122490269501,0,30,attachment of spindle microtubules to kinetochore,BP,
4202,GO:0008609,1,0.98957591087707,0,1,alkylglycerone-phosphate synthase activity,MF,
4204,GO:0008611,1,0.965987316046413,0,5,ether lipid biosynthetic process,BP,
4205,GO:0008612,1,0.976257799359915,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4206,GO:0008614,1,0.988462510489358,0,2,pyridoxine metabolic process,BP,
4207,GO:0008615,1,0.988462510489358,0,2,pyridoxine biosynthetic process,BP,
4208,GO:0008616,1,0.983984117433508,0,3,queuosine biosynthetic process,BP,
4209,GO:0008617,1,0.994817387140874,0,1,guanosine metabolic process,BP,
4210,GO:0008622,1,0.968340033904782,0,5,epsilon DNA polymerase complex,CC,
4211,GO:0008623,1,0.985844632653592,0,2,CHRAC,CC,
4213,GO:0008626,1,0.965700540959062,0,6,granzyme-mediated apoptotic signaling pathway,BP,
4214,GO:0008627,1,0.947196719205958,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4215,GO:0008628,1,0.984026546671675,0,3,hormone-mediated apoptotic signaling pathway,BP,
4216,GO:0008630,1,0.527965745693064,0,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
4217,GO:0008631,1,0.776368489277277,0,42,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4218,GO:0008635,1,0.945282414336491,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4219,GO:0008637,1,0.503412253172843,0,114,apoptotic mitochondrial changes,BP,
4220,GO:0008641,1,0.939353891441999,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4221,GO:0008643,1,0.422911001869294,0,129,carbohydrate transport,BP,
4222,GO:0008645,1,0.512901714088043,0,98,hexose transmembrane transport,BP,
4223,GO:0008649,1,0.916621273404013,0,15,rRNA methyltransferase activity,MF,
4224,GO:0008650,1,0.993732322532715,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4225,GO:0008652,1,0.624100504364563,0,75,cellular amino acid biosynthetic process,BP,
4228,GO:0008656,1,0.911615750261118,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4229,GO:0008670,1,0.989565221790416,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4230,GO:0008689,1,0.99479271690561,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4231,GO:0008700,1,0.994313214468247,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4232,GO:0008705,1,0.98678675433376,0,1,methionine synthase activity,MF,
4233,GO:0008709,1,0.994821720216463,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4234,GO:0008721,1,0.994465458292206,0,1,D-serine ammonia-lyase activity,MF,
4235,GO:0008725,1,0.994811251181433,0,1,DNA-3-methyladenine glycosylase activity,MF,
4236,GO:0008732,1,0.989069378057645,0,2,L-allo-threonine aldolase activity,MF,
4237,GO:0008745,1,0.994821753834788,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4238,GO:0008746,1,0.987528919870452,0,2,NAD(P)+ transhydrogenase activity,MF,
4239,GO:0008747,1,0.994749185036962,0,1,N-acetylneuraminate lyase activity,MF,
4240,GO:0008750,1,0.992679803161637,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4241,GO:0008753,1,0.993833035243822,0,1,NADPH dehydrogenase (quinone) activity,MF,
4243,GO:0008761,1,0.992031088059534,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4244,GO:0008768,1,0.994827028354649,0,1,UDP-sugar diphosphatase activity,MF,
4245,GO:0008775,1,0.99469263046507,0,1,acetate CoA-transferase activity,MF,
4246,GO:0008781,1,0.989534964907246,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4247,GO:0008783,1,0.994580382469011,0,1,agmatinase activity,MF,
4248,GO:0008785,1,0.99474809953618,0,1,alkyl hydroperoxide reductase activity,MF,
4249,GO:0008792,1,0.994313214468247,0,1,arginine decarboxylase activity,MF,
4250,GO:0008794,1,0.994824330879583,0,1,arsenate reductase (glutaredoxin) activity,MF,
4251,GO:0008796,1,0.989170597887527,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4252,GO:0008798,1,0.986130956238434,0,2,beta-aspartyl-peptidase activity,MF,
4253,GO:0008802,1,0.993740008944569,0,1,betaine-aldehyde dehydrogenase activity,MF,
4254,GO:0008803,1,0.99481909722367,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4255,GO:0008808,1,0.993530696504981,0,1,cardiolipin synthase activity,MF,
4256,GO:0008812,1,0.993670099228364,0,1,choline dehydrogenase activity,MF,
4257,GO:0008817,1,0.993213451560273,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4258,GO:0008821,1,0.95359270325526,0,8,crossover junction endodeoxyribonuclease activity,MF,
4260,GO:0008829,1,0.994693615343317,0,1,dCTP deaminase activity,MF,
4261,GO:0008832,1,0.994031455799731,0,1,dGTPase activity,MF,
4262,GO:0008841,1,0.994460393542134,0,1,dihydrofolate synthase activity,MF,
4263,GO:0008843,1,0.994536892262681,0,1,endochitinase activity,MF,
4264,GO:0008852,1,0.99427908318283,0,1,exodeoxyribonuclease I activity,MF,
4265,GO:0008853,1,0.977082786680267,0,4,exodeoxyribonuclease III activity,MF,
4266,GO:0008859,1,0.994821416065273,0,1,exoribonuclease II activity,MF,
4267,GO:0008865,1,0.966283608778596,0,5,fructokinase activity,MF,
4268,GO:0008887,1,0.994002966266373,0,1,glycerate kinase activity,MF,
4269,GO:0008889,1,0.968476671167224,0,5,glycerophosphodiester phosphodiesterase activity,MF,
4270,GO:0008890,1,0.994744607027672,0,1,glycine C-acetyltransferase activity,MF,
4271,GO:0008891,1,0.994710614731861,0,1,glycolate oxidase activity,MF,
4272,GO:0008892,1,0.991886675411333,0,1,guanine deaminase activity,MF,
4273,GO:0008893,1,0.994814956602968,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4274,GO:0008894,1,0.994334803248899,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4275,GO:0008897,1,0.994261476402691,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4276,GO:0008900,1,0.982319928572264,0,3,potassium:proton exchanging ATPase activity,MF,
4277,GO:0008903,1,0.994809191178855,0,1,hydroxypyruvate isomerase activity,MF,
4278,GO:0008905,1,0.99474064851731,0,1,mannose-phosphate guanylyltransferase activity,MF,
4279,GO:0008934,1,0.973008887049923,0,4,inositol monophosphate 1-phosphatase activity,MF,
4280,GO:0008940,1,0.981825219655363,0,3,nitrate reductase activity,MF,
4281,GO:0008941,1,0.989140960332087,0,2,nitric oxide dioxygenase activity,MF,
4282,GO:0008948,1,0.976217887760421,0,4,oxaloacetate decarboxylase activity,MF,
4283,GO:0008955,1,0.993389156013613,0,1,peptidoglycan glycosyltransferase activity,MF,
4284,GO:0008962,1,0.989088663621857,0,2,phosphatidylglycerophosphatase activity,MF,
4285,GO:0008963,1,0.994598940247943,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4286,GO:0008967,1,0.988750755560242,0,2,phosphoglycolate phosphatase activity,MF,
4287,GO:0008970,1,0.949938870857791,0,9,phosphatidylcholine 1-acylhydrolase activity,MF,
4288,GO:0008973,1,0.993996147337102,0,1,phosphopentomutase activity,MF,
4289,GO:0008988,1,0.988658446617857,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4290,GO:0008995,1,0.994412229846995,0,1,ribonuclease E activity,MF,
4291,GO:0009000,1,0.994471838642576,0,1,selenocysteine lyase activity,MF,
4292,GO:0009007,1,0.993642041545025,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4293,GO:0009008,1,0.967243206971196,0,5,DNA-methyltransferase activity,MF,
4294,GO:0009013,1,0.992184511093937,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4295,GO:0009019,1,0.975223227435921,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4296,GO:0009020,1,0.994657071538414,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4298,GO:0009041,1,0.983345558994345,0,3,uridylate kinase activity,MF,
4299,GO:0009048,1,0.915933750642182,0,10,dosage compensation by inactivation of X chromosome,BP,
4300,GO:0009051,1,0.984087165435949,0,3,pentose-phosphate shunt, oxidative branch,BP,
4301,GO:0009052,1,0.972438864427083,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4302,GO:0009055,1,0.565488053570874,0,101,electron transfer activity,MF,
4307,GO:0009060,1,0.649444749971049,0,74,aerobic respiration,BP,
4308,GO:0009061,1,0.99450222406752,0,1,anaerobic respiration,BP,
4309,GO:0009062,1,0.522637319239738,0,104,fatty acid catabolic process,BP,
4310,GO:0009063,1,0.516589355637942,0,110,cellular amino acid catabolic process,BP,
4312,GO:0009065,1,0.840811406799243,0,28,glutamine family amino acid catabolic process,BP,
4313,GO:0009066,1,0.717577576496267,0,55,aspartate family amino acid metabolic process,BP,
4314,GO:0009067,1,0.872014514991999,0,22,aspartate family amino acid biosynthetic process,BP,
4315,GO:0009068,1,0.885500264159902,0,21,aspartate family amino acid catabolic process,BP,
4316,GO:0009069,1,0.812994186535577,0,36,serine family amino acid metabolic process,BP,
4317,GO:0009070,1,0.920820615314757,0,15,serine family amino acid biosynthetic process,BP,
4318,GO:0009071,1,0.941704541224549,0,11,serine family amino acid catabolic process,BP,
4319,GO:0009072,1,0.871995934684747,0,24,aromatic amino acid family metabolic process,BP,
4320,GO:0009074,1,0.906038946898633,0,18,aromatic amino acid family catabolic process,BP,
4321,GO:0009078,1,0.977763477991754,0,4,pyruvate family amino acid metabolic process,BP,
4322,GO:0009080,1,0.977763477991754,0,4,pyruvate family amino acid catabolic process,BP,
4323,GO:0009081,1,0.854635511667493,0,24,branched-chain amino acid metabolic process,BP,
4324,GO:0009082,1,0.983785891489177,0,2,branched-chain amino acid biosynthetic process,BP,
4325,GO:0009083,1,0.873502482845046,0,21,branched-chain amino acid catabolic process,BP,
4326,GO:0009084,1,0.897726468100124,0,17,glutamine family amino acid biosynthetic process,BP,
4327,GO:0009085,1,0.985722588916567,0,2,lysine biosynthetic process,BP,
4328,GO:0009086,1,0.926153495350584,0,12,methionine biosynthetic process,BP,
4329,GO:0009087,1,0.993870578186373,0,1,methionine catabolic process,BP,
4330,GO:0009088,1,0.994609042399123,0,1,threonine biosynthetic process,BP,
4331,GO:0009092,1,0.977882159323841,0,4,homoserine metabolic process,BP,
4332,GO:0009093,1,0.983972524267217,0,3,cysteine catabolic process,BP,
4333,GO:0009098,1,0.983785891489177,0,2,leucine biosynthetic process,BP,
4334,GO:0009099,1,0.983785891489177,0,2,valine biosynthetic process,BP,
4337,GO:0009106,1,0.988479696862537,0,2,lipoate metabolic process,BP,
4338,GO:0009107,1,0.994726586318505,0,1,lipoate biosynthetic process,BP,
4340,GO:0009109,1,0.91900756650063,0,14,coenzyme catabolic process,BP,
4341,GO:0009110,1,0.879331534647409,0,21,vitamin biosynthetic process,BP,
4342,GO:0009111,1,0.943210524801098,0,10,vitamin catabolic process,BP,
4344,GO:0009113,1,0.92829736459853,0,13,purine nucleobase biosynthetic process,BP,
4345,GO:0009115,1,0.98401033320613,0,2,xanthine catabolic process,BP,
4348,GO:0009119,1,0.557977970348078,0,94,ribonucleoside metabolic process,BP,
4349,GO:0009120,1,0.965892913036882,0,6,deoxyribonucleoside metabolic process,BP,
4350,GO:0009123,1,0.145349269906934,0,306,nucleoside monophosphate metabolic process,BP,
4351,GO:0009124,1,0.360410869632427,0,159,nucleoside monophosphate biosynthetic process,BP,
4352,GO:0009125,1,0.937978670303086,0,11,nucleoside monophosphate catabolic process,BP,
4353,GO:0009126,1,0.1690166819865,0,280,purine nucleoside monophosphate metabolic process,BP,
4354,GO:0009127,1,0.409387812337158,0,137,purine nucleoside monophosphate biosynthetic process,BP,
4355,GO:0009128,1,0.948333260072191,0,9,purine nucleoside monophosphate catabolic process,BP,
4356,GO:0009129,1,0.912842442358163,0,16,pyrimidine nucleoside monophosphate metabolic process,BP,
4357,GO:0009130,1,0.917669638329485,0,15,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4358,GO:0009131,1,0.994744234496313,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4359,GO:0009132,1,0.408820183329536,0,134,nucleoside diphosphate metabolic process,BP,
4360,GO:0009133,1,0.967111455363588,0,6,nucleoside diphosphate biosynthetic process,BP,
4361,GO:0009134,1,0.964487315850517,0,6,nucleoside diphosphate catabolic process,BP,
4362,GO:0009135,1,0.458863563696283,0,113,purine nucleoside diphosphate metabolic process,BP,
4363,GO:0009136,1,0.98317213947699,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4364,GO:0009137,1,0.980763008104989,0,3,purine nucleoside diphosphate catabolic process,BP,
4365,GO:0009138,1,0.983298446106027,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4366,GO:0009139,1,0.989018055684255,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4367,GO:0009140,1,0.994217517852663,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4368,GO:0009141,1,0.161018226875469,0,291,nucleoside triphosphate metabolic process,BP,
4369,GO:0009142,1,0.396945207084647,0,143,nucleoside triphosphate biosynthetic process,BP,
4370,GO:0009143,1,0.928930541617861,0,12,nucleoside triphosphate catabolic process,BP,
4371,GO:0009144,1,0.181447434059213,0,271,purine nucleoside triphosphate metabolic process,BP,
4372,GO:0009145,1,0.438886637395864,0,126,purine nucleoside triphosphate biosynthetic process,BP,
4373,GO:0009146,1,0.964849645227279,0,6,purine nucleoside triphosphate catabolic process,BP,
4374,GO:0009147,1,0.888555019815568,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4375,GO:0009148,1,0.903053967347753,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4376,GO:0009149,1,0.989516359411694,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4378,GO:0009151,1,0.943293582230536,0,10,purine deoxyribonucleotide metabolic process,BP,
4380,GO:0009153,1,0.983251726133201,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4381,GO:0009154,1,0.805349772851086,0,31,purine ribonucleotide catabolic process,BP,
4382,GO:0009155,1,0.96988492128746,0,5,purine deoxyribonucleotide catabolic process,BP,
4383,GO:0009156,1,0.381396778555462,0,149,ribonucleoside monophosphate biosynthetic process,BP,
4384,GO:0009157,1,0.95063500816985,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4385,GO:0009158,1,0.953283851478635,0,8,ribonucleoside monophosphate catabolic process,BP,
4386,GO:0009159,1,0.989087039768979,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4387,GO:0009161,1,0.158197784771202,0,291,ribonucleoside monophosphate metabolic process,BP,
4388,GO:0009162,1,0.935381028370087,0,12,deoxyribonucleoside monophosphate metabolic process,BP,
4392,GO:0009166,1,0.352987806809483,0,156,nucleotide catabolic process,BP,
4393,GO:0009167,1,0.169914404198882,0,279,purine ribonucleoside monophosphate metabolic process,BP,
4394,GO:0009168,1,0.409387812337158,0,137,purine ribonucleoside monophosphate biosynthetic process,BP,
4395,GO:0009169,1,0.953283851478635,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4396,GO:0009170,1,0.99481895161955,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4397,GO:0009173,1,0.942610820873643,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4398,GO:0009174,1,0.942610820873643,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4399,GO:0009176,1,0.968437609299401,0,6,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4400,GO:0009177,1,0.973555759887015,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4401,GO:0009178,1,0.994744234496313,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4402,GO:0009179,1,0.458863563696283,0,113,purine ribonucleoside diphosphate metabolic process,BP,
4403,GO:0009180,1,0.98317213947699,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4404,GO:0009181,1,0.980763008104989,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4405,GO:0009182,1,0.982940114940218,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4406,GO:0009183,1,0.988562503317538,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4407,GO:0009185,1,0.453798342932562,0,115,ribonucleoside diphosphate metabolic process,BP,
4408,GO:0009186,1,0.972143672114026,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4410,GO:0009188,1,0.98317213947699,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4411,GO:0009189,1,0.977704921676588,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4413,GO:0009191,1,0.970018243489778,0,5,ribonucleoside diphosphate catabolic process,BP,
4414,GO:0009193,1,0.994217517852663,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4415,GO:0009195,1,0.994217517852663,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4416,GO:0009196,1,0.989018055684255,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4417,GO:0009197,1,0.989018055684255,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4418,GO:0009199,1,0.181990383868591,0,270,ribonucleoside triphosphate metabolic process,BP,
4419,GO:0009200,1,0.912317441746413,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4420,GO:0009201,1,0.42459348512901,0,131,ribonucleoside triphosphate biosynthetic process,BP,
4421,GO:0009202,1,0.967893842913441,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4422,GO:0009203,1,0.994809962505009,0,1,ribonucleoside triphosphate catabolic process,BP,
4423,GO:0009204,1,0.959713900140354,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4424,GO:0009205,1,0.18920310475694,0,264,purine ribonucleoside triphosphate metabolic process,BP,
4425,GO:0009206,1,0.441276430901268,0,125,purine ribonucleoside triphosphate biosynthetic process,BP,
4426,GO:0009207,1,0.994809962505009,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4427,GO:0009208,1,0.917549510768233,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4428,GO:0009209,1,0.922733747896266,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4429,GO:0009211,1,0.968426859274524,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4430,GO:0009212,1,0.978689287908048,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4431,GO:0009213,1,0.989516359411694,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4432,GO:0009214,1,0.858910879126223,0,20,cyclic nucleotide catabolic process,BP,
4433,GO:0009215,1,0.949266339968928,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4434,GO:0009216,1,0.988971852501769,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4435,GO:0009217,1,0.96988492128746,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4436,GO:0009218,1,0.876866305828299,0,23,pyrimidine ribonucleotide metabolic process,BP,
4437,GO:0009219,1,0.902759181856531,0,19,pyrimidine deoxyribonucleotide metabolic process,BP,
4438,GO:0009220,1,0.886957896476601,0,21,pyrimidine ribonucleotide biosynthetic process,BP,
4439,GO:0009221,1,0.957839250452975,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4440,GO:0009222,1,0.994217517852663,0,1,pyrimidine ribonucleotide catabolic process,BP,
4441,GO:0009223,1,0.937502850830604,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4442,GO:0009224,1,0.994795060212627,0,1,CMP biosynthetic process,BP,
4443,GO:0009225,1,0.798881130414544,0,36,nucleotide-sugar metabolic process,BP,
4444,GO:0009226,1,0.871705978276741,0,23,nucleotide-sugar biosynthetic process,BP,
4445,GO:0009227,1,0.983681827748524,0,3,nucleotide-sugar catabolic process,BP,
4446,GO:0009229,1,0.994517803950429,0,1,thiamine diphosphate biosynthetic process,BP,
4447,GO:0009231,1,0.994351969086881,0,1,riboflavin biosynthetic process,BP,
4448,GO:0009233,1,0.987740882960022,0,2,menaquinone metabolic process,BP,
4449,GO:0009234,1,0.993665731148129,0,1,menaquinone biosynthetic process,BP,
4450,GO:0009235,1,0.876270067327138,0,19,cobalamin metabolic process,BP,
4451,GO:0009236,1,0.97898295645857,0,3,cobalamin biosynthetic process,BP,
4452,GO:0009237,1,0.994222644359545,0,1,siderophore metabolic process,BP,
4453,GO:0009240,1,0.978880394715892,0,4,isopentenyl diphosphate biosynthetic process,BP,
4454,GO:0009245,1,0.989698593754242,0,2,lipid A biosynthetic process,BP,
4456,GO:0009249,1,0.959090206908376,0,8,protein lipoylation,BP,
4457,GO:0009250,1,0.726821413580328,0,44,glucan biosynthetic process,BP,
4458,GO:0009251,1,0.844153713648296,0,24,glucan catabolic process,BP,
4459,GO:0009253,1,0.989667194221867,0,2,peptidoglycan catabolic process,BP,
4460,GO:0009256,1,0.966278371221753,0,5,10-formyltetrahydrofolate metabolic process,BP,
4461,GO:0009257,1,0.987548713999019,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4462,GO:0009258,1,0.98385872548037,0,2,10-formyltetrahydrofolate catabolic process,BP,
4465,GO:0009261,1,0.800682787678234,0,32,ribonucleotide catabolic process,BP,
4466,GO:0009262,1,0.830463450220826,0,33,deoxyribonucleotide metabolic process,BP,
4467,GO:0009263,1,0.923412580246046,0,14,deoxyribonucleotide biosynthetic process,BP,
4468,GO:0009264,1,0.904442439334845,0,18,deoxyribonucleotide catabolic process,BP,
4469,GO:0009265,1,0.941790234662686,0,11,2'-deoxyribonucleotide biosynthetic process,BP,
4471,GO:0009267,1,0.428024745851877,0,130,cellular response to starvation,BP,
4472,GO:0009268,1,0.807550587726398,0,36,response to pH,BP,
4473,GO:0009295,1,0.773379354230417,0,41,nucleoid,CC,
4474,GO:0009298,1,0.97893467527032,0,4,GDP-mannose biosynthetic process,BP,
4475,GO:0009299,1,0.846250994333625,0,25,mRNA transcription,BP,
4476,GO:0009301,1,0.664026588759881,0,66,snRNA transcription,BP,
4477,GO:0009303,1,0.842833965599204,0,27,rRNA transcription,BP,
4478,GO:0009304,1,0.95511497292485,0,7,tRNA transcription,BP,
4479,GO:0009305,1,0.991278145749113,0,1,protein biotinylation,BP,
4483,GO:0009310,1,0.8820856184106,0,21,amine catabolic process,BP,
4486,GO:0009313,1,0.937543450314544,0,11,oligosaccharide catabolic process,BP,
4488,GO:0009328,1,0.977959847403731,0,4,phenylalanine-tRNA ligase complex,CC,
4489,GO:0009330,1,0.985217180084228,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4490,GO:0009331,1,0.979194252827152,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4491,GO:0009346,1,0.992999107928046,0,1,citrate lyase complex,CC,
4492,GO:0009353,1,0.994785232787907,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4493,GO:0009360,1,0.994355245655722,0,1,DNA polymerase III complex,CC,
4494,GO:0009368,1,0.98935151739152,0,2,endopeptidase Clp complex,CC,
4495,GO:0009372,1,0.993970144807525,0,1,quorum sensing,BP,
4496,GO:0009374,1,0.962074917979976,0,5,biotin binding,MF,
4497,GO:0009378,1,0.965580416097614,0,5,four-way junction helicase activity,MF,
4498,GO:0009383,1,0.987313638834803,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4499,GO:0009384,1,0.992031088059534,0,1,N-acylmannosamine kinase activity,MF,
4500,GO:0009386,1,0.989311342694571,0,2,translational attenuation,BP,
4501,GO:0009394,1,0.851515997119225,0,29,2'-deoxyribonucleotide metabolic process,BP,
4502,GO:0009395,1,0.824717552658098,0,31,phospholipid catabolic process,BP,
4503,GO:0009396,1,0.949310932089598,0,9,folic acid-containing compound biosynthetic process,BP,
4504,GO:0009397,1,0.971569116571644,0,4,folic acid-containing compound catabolic process,BP,
4505,GO:0009398,1,0.994351969086881,0,1,FMN biosynthetic process,BP,
4506,GO:0009400,1,0.994271234998612,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4507,GO:0009403,1,0.973763513991833,0,4,toxin biosynthetic process,BP,
4508,GO:0009404,1,0.887316806140341,0,20,toxin metabolic process,BP,
4509,GO:0009405,1,0.983318715373614,0,2,pathogenesis,BP,
4510,GO:0009407,1,0.973696934923662,0,5,toxin catabolic process,BP,
4514,GO:0009411,1,0.428136302063778,0,129,response to UV,BP,
4515,GO:0009414,1,0.960163893215208,0,7,response to water deprivation,BP,
4516,GO:0009415,1,0.923423950710925,0,12,response to water,BP,
4519,GO:0009436,1,0.989083853319448,0,2,glyoxylate catabolic process,BP,
4520,GO:0009437,1,0.928178238003574,0,13,carnitine metabolic process,BP,
4521,GO:0009438,1,0.973287095562531,0,5,methylglyoxal metabolic process,BP,
4522,GO:0009439,1,0.989598231165809,0,2,cyanate metabolic process,BP,
4523,GO:0009440,1,0.989598231165809,0,2,cyanate catabolic process,BP,
4524,GO:0009441,1,0.979660726900499,0,3,glycolate metabolic process,BP,
4525,GO:0009443,1,0.989871031585885,0,1,pyridoxal 5'-phosphate salvage,BP,
4526,GO:0009444,1,0.992021085054056,0,1,pyruvate oxidation,BP,
4527,GO:0009445,1,0.961584921251676,0,7,putrescine metabolic process,BP,
4528,GO:0009446,1,0.971638689963252,0,5,putrescine biosynthetic process,BP,
4529,GO:0009447,1,0.984431844357785,0,3,putrescine catabolic process,BP,
4530,GO:0009448,1,0.973063184654291,0,4,gamma-aminobutyric acid metabolic process,BP,
4531,GO:0009449,1,0.980729550559029,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4532,GO:0009450,1,0.984674845686623,0,2,gamma-aminobutyric acid catabolic process,BP,
4533,GO:0009451,1,0.46404919227401,0,130,RNA modification,BP,
4534,GO:0009452,1,0.824517697089179,0,32,7-methylguanosine RNA capping,BP,
4535,GO:0009566,1,0.431744265893599,0,133,fertilization,BP,
4536,GO:0009581,1,0.483646287320131,0,105,detection of external stimulus,BP,
4537,GO:0009582,1,0.474531948247371,0,108,detection of abiotic stimulus,BP,
4538,GO:0009583,1,0.720004740337193,0,53,detection of light stimulus,BP,
4539,GO:0009584,1,0.764062728786881,0,43,detection of visible light,BP,
4540,GO:0009590,1,0.99462933328042,0,1,detection of gravity,BP,
4542,GO:0009595,1,0.880212716486917,0,19,detection of biotic stimulus,BP,
4543,GO:0009597,1,0.970195050100937,0,5,detection of virus,BP,
4546,GO:0009608,1,0.988062129570731,0,2,response to symbiont,BP,
4547,GO:0009609,1,0.988062129570731,0,2,response to symbiotic bacterium,BP,
4553,GO:0009624,1,0.994403147306235,0,1,response to nematode,BP,
4555,GO:0009629,1,0.945385741210287,0,10,response to gravity,BP,
4556,GO:0009631,1,0.992230608764739,0,1,cold acclimation,BP,
4557,GO:0009635,1,0.941092786750541,0,11,response to herbicide,BP,
4559,GO:0009637,1,0.987235834449658,0,2,response to blue light,BP,
4560,GO:0009642,1,0.932331445435999,0,11,response to light intensity,BP,
4561,GO:0009644,1,0.986723489295231,0,2,response to high light intensity,BP,
4562,GO:0009645,1,0.993806562085334,0,1,response to low light intensity stimulus,BP,
4563,GO:0009646,1,0.993960877222941,0,1,response to absence of light,BP,
4564,GO:0009648,1,0.85659903036895,0,24,photoperiodism,BP,
4565,GO:0009649,1,0.846800895057026,0,26,entrainment of circadian clock,BP,
4566,GO:0009650,1,0.925701767481286,0,13,UV protection,BP,
4567,GO:0009651,1,0.883517187272306,0,20,response to salt stress,BP,
4569,GO:0009669,1,0.982452627648068,0,3,sucrose:cation symporter activity,MF,
4570,GO:0009673,1,0.993652591359216,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4571,GO:0009674,1,0.983080421170662,0,2,potassium:sodium symporter activity,MF,
4572,GO:0009692,1,0.994403147306235,0,1,ethylene metabolic process,BP,
4573,GO:0009698,1,0.968363442226816,0,6,phenylpropanoid metabolic process,BP,
4577,GO:0009720,1,0.994182569300835,0,1,detection of hormone stimulus,BP,
4579,GO:0009726,1,0.974892219757582,0,3,detection of endogenous stimulus,BP,
4580,GO:0009730,1,0.978328877364322,0,4,detection of carbohydrate stimulus,BP,
4581,GO:0009732,1,0.978328877364322,0,4,detection of hexose stimulus,BP,
4582,GO:0009737,1,0.993003559696667,0,1,response to abscisic acid,BP,
4583,GO:0009738,1,0.993003559696667,0,1,abscisic acid-activated signaling pathway,BP,
4585,GO:0009744,1,0.973890621712124,0,4,response to sucrose,BP,
4588,GO:0009750,1,0.951892353497382,0,8,response to fructose,BP,
4589,GO:0009753,1,0.979297022624437,0,4,response to jasmonic acid,BP,
4590,GO:0009755,1,0.248482501836207,0,203,hormone-mediated signaling pathway,BP,
4591,GO:0009756,1,0.959545414677352,0,7,carbohydrate mediated signaling,BP,
4592,GO:0009757,1,0.970613973699988,0,5,hexose mediated signaling,BP,
4593,GO:0009758,1,0.988495768566121,0,1,carbohydrate utilization,BP,
4594,GO:0009785,1,0.987235834449658,0,2,blue light signaling pathway,BP,
4595,GO:0009786,1,0.966791172291313,0,4,regulation of asymmetric cell division,BP,
4596,GO:0009787,1,0.993003559696667,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4597,GO:0009789,1,0.993003559696667,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4599,GO:0009791,1,0.516252203912165,0,84,post-embryonic development,BP,
4601,GO:0009794,1,0.976672143105948,0,4,regulation of mitotic cell cycle, embryonic,BP,
4602,GO:0009798,1,0.572702452548458,0,81,axis specification,BP,
4603,GO:0009799,1,0.448222235355886,0,118,specification of symmetry,BP,
4604,GO:0009804,1,0.968363442226816,0,6,coumarin metabolic process,BP,
4605,GO:0009810,1,0.994576777660623,0,1,stilbene metabolic process,BP,
4606,GO:0009812,1,0.964671328180367,0,6,flavonoid metabolic process,BP,
4607,GO:0009814,1,0.994579304502616,0,1,defense response, incompatible interaction,BP,
4608,GO:0009817,1,0.994579304502616,0,1,defense response to fungus, incompatible interaction,BP,
4609,GO:0009820,1,0.973537049782727,0,5,alkaloid metabolic process,BP,
4610,GO:0009822,1,0.989490293030575,0,2,alkaloid catabolic process,BP,
4611,GO:0009826,1,0.985449596009344,0,2,unidimensional cell growth,BP,
4612,GO:0009838,1,0.973222389973621,0,5,abscission,BP,
4613,GO:0009841,1,0.994518218221441,0,1,mitochondrial endopeptidase Clp complex,CC,
4614,GO:0009850,1,0.989520865531874,0,2,auxin metabolic process,BP,
4615,GO:0009852,1,0.989520865531874,0,2,auxin catabolic process,BP,
4616,GO:0009855,1,0.450628386696623,0,117,determination of bilateral symmetry,BP,
4617,GO:0009880,1,0.670648564321688,0,56,embryonic pattern specification,BP,
4618,GO:0009881,1,0.945043994714861,0,10,photoreceptor activity,MF,
4619,GO:0009882,1,0.987235834449658,0,2,blue light photoreceptor activity,MF,
4620,GO:0009886,1,0.915761217794226,0,11,post-embryonic animal morphogenesis,BP,
4630,GO:0009896,1,0.076316612180259,0,367,positive regulation of catabolic process,BP,
4633,GO:0009912,1,0.964832702252353,0,5,auditory receptor cell fate commitment,BP,
4636,GO:0009918,1,0.994379087616678,0,1,sterol delta7 reductase activity,MF,
4637,GO:0009922,1,0.964347280122246,0,6,fatty acid elongase activity,MF,
4638,GO:0009925,1,0.773016490223564,0,33,basal plasma membrane,CC,
4639,GO:0009931,1,0.935208754523376,0,10,calcium-dependent protein serine/threonine kinase activity,MF,
4640,GO:0009946,1,0.983988799793673,0,3,proximal/distal axis specification,BP,
4641,GO:0009948,1,0.753221087642151,0,43,anterior/posterior axis specification,BP,
4642,GO:0009949,1,0.994746455661165,0,1,polarity specification of anterior/posterior axis,BP,
4643,GO:0009950,1,0.878896170090835,0,17,dorsal/ventral axis specification,BP,
4644,GO:0009952,1,0.280927474168755,0,184,anterior/posterior pattern specification,BP,
4645,GO:0009953,1,0.561681797902262,0,89,dorsal/ventral pattern formation,BP,
4646,GO:0009954,1,0.815249552487612,0,32,proximal/distal pattern formation,BP,
4647,GO:0009955,1,0.994578223558621,0,1,adaxial/abaxial pattern specification,BP,
4648,GO:0009956,1,0.993429700242148,0,1,radial pattern formation,BP,
4649,GO:0009957,1,0.977401014973155,0,3,epidermal cell fate specification,BP,
4653,GO:0009972,1,0.9572262478568,0,8,cytidine deamination,BP,
4654,GO:0009975,1,0.884679355082271,0,16,cyclase activity,MF,
4655,GO:0009982,1,0.928972189601617,0,13,pseudouridine synthase activity,MF,
4660,GO:0009992,1,0.994586964392058,0,1,cellular water homeostasis,BP,
4661,GO:0009994,1,0.757259946208699,0,43,oocyte differentiation,BP,
4662,GO:0009996,1,0.972468692067236,0,5,negative regulation of cell fate specification,BP,
4664,GO:0010002,1,0.896491635653483,0,16,cardioblast differentiation,BP,
4666,GO:0010009,1,0.972208043350376,0,5,cytoplasmic side of endosome membrane,CC,
4667,GO:0010015,1,0.994831355742962,0,1,root morphogenesis,BP,
4668,GO:0010021,1,0.994065276644534,0,1,amylopectin biosynthetic process,BP,
4669,GO:0010025,1,0.986709230365435,0,2,wax biosynthetic process,BP,
4670,GO:0010032,1,0.961077284546825,0,5,meiotic chromosome condensation,BP,
4672,GO:0010034,1,0.993761249845209,0,1,response to acetate,BP,
4674,GO:0010037,1,0.99410790486687,0,1,response to carbon dioxide,BP,
4676,GO:0010039,1,0.816259859773809,0,32,response to iron ion,BP,
4677,GO:0010040,1,0.97740728720366,0,4,response to iron(II) ion,BP,
4678,GO:0010041,1,0.967537676195422,0,5,response to iron(III) ion,BP,
4679,GO:0010042,1,0.896952199905779,0,16,response to manganese ion,BP,
4680,GO:0010043,1,0.7439881848124,0,49,response to zinc ion,BP,
4681,GO:0010044,1,0.972173424006462,0,5,response to aluminum ion,BP,
4682,GO:0010045,1,0.989679030537738,0,1,response to nickel cation,BP,
4683,GO:0010046,1,0.965772995811546,0,6,response to mycotoxin,BP,
4684,GO:0010053,1,0.994831355742962,0,1,root epidermal cell differentiation,BP,
4685,GO:0010054,1,0.994831355742962,0,1,trichoblast differentiation,BP,
4686,GO:0010070,1,0.994494465846789,0,1,zygote asymmetric cell division,BP,
4687,GO:0010085,1,0.99461918156608,0,1,polarity specification of proximal/distal axis,BP,
4688,GO:0010092,1,0.823411723895821,0,29,specification of animal organ identity,BP,
4689,GO:0010106,1,0.994660744776641,0,1,cellular response to iron ion starvation,BP,
4690,GO:0010107,1,0.765551050373909,0,40,potassium ion import,BP,
4691,GO:0010121,1,0.994650305971359,0,1,arginine catabolic process to proline via ornithine,BP,
4692,GO:0010124,1,0.989520865531874,0,2,phenylacetate catabolic process,BP,
4693,GO:0010133,1,0.988598158379488,0,2,proline catabolic process to glutamate,BP,
4694,GO:0010138,1,0.973560671501612,0,5,pyrimidine ribonucleotide salvage,BP,
4695,GO:0010139,1,0.994738533349941,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4696,GO:0010142,1,0.988338442614443,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4697,GO:0010155,1,0.916348721001962,0,15,regulation of proton transport,BP,
4698,GO:0010157,1,0.989422279829859,0,1,response to chlorate,BP,
4699,GO:0010159,1,0.981407181356944,0,3,specification of animal organ position,BP,
4700,GO:0010160,1,0.994818658650597,0,1,formation of animal organ boundary,BP,
4701,GO:0010164,1,0.994738533349941,0,1,response to cesium ion,BP,
4703,GO:0010166,1,0.986709230365435,0,2,wax metabolic process,BP,
4705,GO:0010172,1,0.915975818877067,0,11,embryonic body morphogenesis,BP,
4706,GO:0010181,1,0.932576073247042,0,11,FMN binding,MF,
4707,GO:0010182,1,0.970613973699988,0,5,sugar mediated signaling pathway,BP,
4708,GO:0010189,1,0.994726169684683,0,1,vitamin E biosynthetic process,BP,
4709,GO:0010193,1,0.978053391163831,0,4,response to ozone,BP,
4711,GO:0010216,1,0.965593784314447,0,5,maintenance of DNA methylation,BP,
4712,GO:0010224,1,0.902781862546788,0,17,response to UV-B,BP,
4713,GO:0010225,1,0.906752347588091,0,13,response to UV-C,BP,
4715,GO:0010232,1,0.994085496691891,0,1,vascular transport,BP,
4717,GO:0010248,1,0.925977577465638,0,13,establishment or maintenance of transmembrane electrochemical gradient,BP,
4718,GO:0010255,1,0.970613973699988,0,5,glucose mediated signaling pathway,BP,
4719,GO:0010256,1,0.0617954292355878,0,392,endomembrane system organization,BP,
4720,GO:0010257,1,0.744556248467284,0,55,NADH dehydrogenase complex assembly,BP,
4722,GO:0010265,1,0.961119031259159,0,6,SCF complex assembly,BP,
4723,GO:0010266,1,0.978901619953874,0,3,response to vitamin B1,BP,
4724,GO:0010269,1,0.962231547862828,0,5,response to selenium ion,BP,
4725,GO:0010273,1,0.938883410062684,0,11,detoxification of copper ion,BP,
4726,GO:0010286,1,0.973371198385459,0,5,heat acclimation,BP,
4727,GO:0010288,1,0.873950195509484,0,21,response to lead ion,BP,
4728,GO:0010309,1,0.99472689814391,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4729,GO:0010310,1,0.922384549942056,0,14,regulation of hydrogen peroxide metabolic process,BP,
4730,GO:0010314,1,0.928446628241619,0,10,phosphatidylinositol-5-phosphate binding,MF,
4731,GO:0010324,1,0.673109162064304,0,61,membrane invagination,BP,
4733,GO:0010335,1,0.992862031651417,0,1,response to non-ionic osmotic stress,BP,
4734,GO:0010340,1,0.963470345814211,0,6,carboxyl-O-methyltransferase activity,MF,
4735,GO:0010348,1,0.994313214468247,0,1,lithium:proton antiporter activity,MF,
4736,GO:0010359,1,0.937893394844185,0,9,regulation of anion channel activity,BP,
4737,GO:0010360,1,0.98143534557272,0,3,negative regulation of anion channel activity,BP,
4738,GO:0010369,1,0.907555122866787,0,14,chromocenter,CC,
4739,GO:0010370,1,0.988176104204097,0,2,perinucleolar chromocenter,CC,
4740,GO:0010385,1,0.968742812399835,0,5,double-stranded methylated DNA binding,MF,
4741,GO:0010387,1,0.988889097153613,0,2,COP9 signalosome assembly,BP,
4742,GO:0010389,1,0.294979316197871,0,186,regulation of G2/M transition of mitotic cell cycle,BP,
4743,GO:0010390,1,0.831237371589408,0,27,histone monoubiquitination,BP,
4744,GO:0010412,1,0.993938289745582,0,1,mannan metabolic process,BP,
4745,GO:0010420,1,0.99479271690561,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4746,GO:0010421,1,0.927152146554331,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4747,GO:0010428,1,0.991397622892239,0,1,methyl-CpNpG binding,MF,
4748,GO:0010430,1,0.992647113988698,0,1,fatty acid omega-oxidation,BP,
4749,GO:0010446,1,0.98792308666935,0,2,response to alkaline pH,BP,
4750,GO:0010447,1,0.892922563853597,0,19,response to acidic pH,BP,
4751,GO:0010452,1,0.924629270869631,0,9,histone H3-K36 methylation,BP,
4752,GO:0010453,1,0.871056371027424,0,23,regulation of cell fate commitment,BP,
4753,GO:0010454,1,0.946177656043785,0,10,negative regulation of cell fate commitment,BP,
4754,GO:0010455,1,0.964493640105508,0,6,positive regulation of cell fate commitment,BP,
4755,GO:0010457,1,0.915361172637548,0,11,centriole-centriole cohesion,BP,
4756,GO:0010458,1,0.8416225655353,0,27,exit from mitosis,BP,
4757,GO:0010459,1,0.950142313594116,0,9,negative regulation of heart rate,BP,
4759,GO:0010463,1,0.728828578476694,0,46,mesenchymal cell proliferation,BP,
4760,GO:0010464,1,0.794185783461709,0,35,regulation of mesenchymal cell proliferation,BP,
4761,GO:0010465,1,0.984665923700469,0,2,nerve growth factor receptor activity,MF,
4766,GO:0010470,1,0.80836888398885,0,32,regulation of gastrulation,BP,
4767,GO:0010477,1,0.993995388009112,0,1,response to sulfur dioxide,BP,
4768,GO:0010481,1,0.98754376708624,0,2,epidermal cell division,BP,
4769,GO:0010482,1,0.98754376708624,0,2,regulation of epidermal cell division,BP,
4770,GO:0010484,1,0.967151214484704,0,4,H3 histone acetyltransferase activity,MF,
4771,GO:0010485,1,0.882313035754981,0,18,H4 histone acetyltransferase activity,MF,
4772,GO:0010494,1,0.737673985144643,0,42,cytoplasmic stress granule,CC,
4773,GO:0010496,1,0.994644568067902,0,1,intercellular transport,BP,
4774,GO:0010498,1,0.0578023650212525,0,436,proteasomal protein catabolic process,BP,
4775,GO:0010499,1,0.887698694606411,0,21,proteasomal ubiquitin-independent protein catabolic process,BP,
4776,GO:0010501,1,0.762329031125112,0,44,RNA secondary structure unwinding,BP,
4777,GO:0010506,1,0.13902275171643,0,293,regulation of autophagy,BP,
4778,GO:0010507,1,0.631468552288283,0,67,negative regulation of autophagy,BP,
4779,GO:0010508,1,0.497132962001012,0,98,positive regulation of autophagy,BP,
4780,GO:0010509,1,0.99178324519181,0,1,polyamine homeostasis,BP,
4781,GO:0010510,1,0.919601048634867,0,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4782,GO:0010511,1,0.959907128849883,0,7,regulation of phosphatidylinositol biosynthetic process,BP,
4783,GO:0010512,1,0.988598596460856,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4784,GO:0010513,1,0.970980918576296,0,5,positive regulation of phosphatidylinositol biosynthetic process,BP,
4786,GO:0010518,1,0.740207498773473,0,45,positive regulation of phospholipase activity,BP,
4788,GO:0010520,1,0.982187451738112,0,3,regulation of reciprocal meiotic recombination,BP,
4789,GO:0010521,1,0.982546488990249,0,3,telomerase inhibitor activity,MF,
4791,GO:0010523,1,0.900598935994256,0,17,negative regulation of calcium ion transport into cytosol,BP,
4793,GO:0010528,1,0.900373306478247,0,17,regulation of transposition,BP,
4794,GO:0010529,1,0.900373306478247,0,17,negative regulation of transposition,BP,
4795,GO:0010533,1,0.978876047315025,0,4,regulation of activation of Janus kinase activity,BP,
4796,GO:0010536,1,0.989261984525101,0,2,positive regulation of activation of Janus kinase activity,BP,
4798,GO:0010544,1,0.895956894819434,0,17,negative regulation of platelet activation,BP,
4802,GO:0010559,1,0.788340991431928,0,36,regulation of glycoprotein biosynthetic process,BP,
4803,GO:0010560,1,0.87749190174523,0,19,positive regulation of glycoprotein biosynthetic process,BP,
4804,GO:0010561,1,0.940528633357724,0,10,negative regulation of glycoprotein biosynthetic process,BP,
4809,GO:0010566,1,0.923223395657211,0,13,regulation of ketone biosynthetic process,BP,
4810,GO:0010569,1,0.827063488889902,0,27,regulation of double-strand break repair via homologous recombination,BP,
4811,GO:0010571,1,0.951437268844051,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4813,GO:0010573,1,0.810437752199885,0,31,vascular endothelial growth factor production,BP,
4814,GO:0010574,1,0.817428626539835,0,30,regulation of vascular endothelial growth factor production,BP,
4815,GO:0010575,1,0.839580365356252,0,25,positive regulation of vascular endothelial growth factor production,BP,
4816,GO:0010578,1,0.994426105278636,0,1,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4817,GO:0010585,1,0.994666025312145,0,1,glutamine secretion,BP,
4818,GO:0010586,1,0.86472277177568,0,22,miRNA metabolic process,BP,
4819,GO:0010587,1,0.964652532364256,0,5,miRNA catabolic process,BP,
4820,GO:0010591,1,0.828437595506991,0,27,regulation of lamellipodium assembly,BP,
4821,GO:0010592,1,0.897536270696407,0,15,positive regulation of lamellipodium assembly,BP,
4822,GO:0010593,1,0.983389278838494,0,2,negative regulation of lamellipodium assembly,BP,
4825,GO:0010596,1,0.746135896180503,0,42,negative regulation of endothelial cell migration,BP,
4826,GO:0010603,1,0.938251027985379,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4829,GO:0010606,1,0.956489839269467,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4830,GO:0010607,1,0.994656502053318,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4832,GO:0010609,1,0.988882965170337,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4833,GO:0010610,1,0.988699501513044,0,1,regulation of mRNA stability involved in response to stress,BP,
4834,GO:0010611,1,0.727041773810364,0,44,regulation of cardiac muscle hypertrophy,BP,
4835,GO:0010612,1,0.941923961951125,0,8,regulation of cardiac muscle adaptation,BP,
4836,GO:0010613,1,0.829962646800683,0,26,positive regulation of cardiac muscle hypertrophy,BP,
4837,GO:0010614,1,0.894879970436808,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4838,GO:0010615,1,0.986586952457581,0,2,positive regulation of cardiac muscle adaptation,BP,
4839,GO:0010616,1,0.954735767908726,0,6,negative regulation of cardiac muscle adaptation,BP,
4840,GO:0010621,1,0.983975440480062,0,3,negative regulation of transcription by transcription factor localization,BP,
4841,GO:0010623,1,0.920379235520465,0,12,programmed cell death involved in cell development,BP,
4842,GO:0010624,1,0.956010474183816,0,6,regulation of Schwann cell proliferation,BP,
4843,GO:0010625,1,0.994477921821071,0,1,positive regulation of Schwann cell proliferation,BP,
4844,GO:0010626,1,0.96132105281404,0,5,negative regulation of Schwann cell proliferation,BP,
4849,GO:0010633,1,0.674384385717849,0,57,negative regulation of epithelial cell migration,BP,
4851,GO:0010635,1,0.951735940048476,0,8,regulation of mitochondrial fusion,BP,
4852,GO:0010636,1,0.985371069606594,0,2,positive regulation of mitochondrial fusion,BP,
4853,GO:0010637,1,0.971362607912311,0,5,negative regulation of mitochondrial fusion,BP,
4855,GO:0010639,1,0.104153280902184,0,327,negative regulation of organelle organization,BP,
4856,GO:0010640,1,0.853790781925946,0,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4857,GO:0010641,1,0.965257386772028,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4858,GO:0010642,1,0.890514878687093,0,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4859,GO:0010643,1,0.988286177367496,0,2,cell communication by chemical coupling,BP,
4860,GO:0010644,1,0.811116141536211,0,27,cell communication by electrical coupling,BP,
4861,GO:0010645,1,0.994085496691891,0,1,regulation of cell communication by chemical coupling,BP,
4865,GO:0010649,1,0.9173971401885,0,12,regulation of cell communication by electrical coupling,BP,
4866,GO:0010650,1,0.980316229363944,0,2,positive regulation of cell communication by electrical coupling,BP,
4867,GO:0010652,1,0.994085496691891,0,1,positive regulation of cell communication by chemical coupling,BP,
4868,GO:0010656,1,0.812059618823535,0,32,negative regulation of muscle cell apoptotic process,BP,
4869,GO:0010657,1,0.698486941495731,0,55,muscle cell apoptotic process,BP,
4870,GO:0010658,1,0.811673471246383,0,32,striated muscle cell apoptotic process,BP,
4871,GO:0010659,1,0.821737008032439,0,30,cardiac muscle cell apoptotic process,BP,
4872,GO:0010660,1,0.713762844948181,0,52,regulation of muscle cell apoptotic process,BP,
4873,GO:0010661,1,0.883415487064123,0,19,positive regulation of muscle cell apoptotic process,BP,
4874,GO:0010662,1,0.824626630497441,0,30,regulation of striated muscle cell apoptotic process,BP,
4875,GO:0010663,1,0.941635432100374,0,9,positive regulation of striated muscle cell apoptotic process,BP,
4876,GO:0010664,1,0.869533028390779,0,22,negative regulation of striated muscle cell apoptotic process,BP,
4877,GO:0010665,1,0.834849139250618,0,28,regulation of cardiac muscle cell apoptotic process,BP,
4878,GO:0010666,1,0.941635432100374,0,9,positive regulation of cardiac muscle cell apoptotic process,BP,
4879,GO:0010667,1,0.886659061433015,0,19,negative regulation of cardiac muscle cell apoptotic process,BP,
4880,GO:0010668,1,0.960033399643653,0,6,ectodermal cell differentiation,BP,
4882,GO:0010675,1,0.483080276368053,0,104,regulation of cellular carbohydrate metabolic process,BP,
4883,GO:0010676,1,0.72614055219735,0,44,positive regulation of cellular carbohydrate metabolic process,BP,
4884,GO:0010677,1,0.821893436432618,0,29,negative regulation of cellular carbohydrate metabolic process,BP,
4885,GO:0010692,1,0.927940708436543,0,9,regulation of alkaline phosphatase activity,BP,
4886,GO:0010693,1,0.979832774302916,0,3,negative regulation of alkaline phosphatase activity,BP,
4887,GO:0010694,1,0.947050364822345,0,6,positive regulation of alkaline phosphatase activity,BP,
4888,GO:0010698,1,0.988575734001686,0,2,acetyltransferase activator activity,MF,
4889,GO:0010700,1,0.972098703948861,0,5,negative regulation of norepinephrine secretion,BP,
4891,GO:0010705,1,0.987134254584689,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4892,GO:0010710,1,0.98279219814942,0,3,regulation of collagen catabolic process,BP,
4893,GO:0010711,1,0.994831580179448,0,1,negative regulation of collagen catabolic process,BP,
4895,GO:0010713,1,0.955111585883288,0,8,negative regulation of collagen metabolic process,BP,
4898,GO:0010716,1,0.977325167641172,0,4,negative regulation of extracellular matrix disassembly,BP,
4901,GO:0010719,1,0.858245473292024,0,26,negative regulation of epithelial to mesenchymal transition,BP,
4904,GO:0010722,1,0.990091414626842,0,1,regulation of ferrochelatase activity,BP,
4905,GO:0010724,1,0.975908601243561,0,4,regulation of definitive erythrocyte differentiation,BP,
4906,GO:0010725,1,0.988691014725559,0,2,regulation of primitive erythrocyte differentiation,BP,
4907,GO:0010726,1,0.988723610887287,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4908,GO:0010727,1,0.95834153380789,0,7,negative regulation of hydrogen peroxide metabolic process,BP,
4909,GO:0010728,1,0.974919899062221,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4910,GO:0010729,1,0.994637349868991,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4911,GO:0010730,1,0.980177297269888,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4912,GO:0010731,1,0.989393130173854,0,2,protein glutathionylation,BP,
4913,GO:0010732,1,0.989393130173854,0,2,regulation of protein glutathionylation,BP,
4914,GO:0010734,1,0.989393130173854,0,2,negative regulation of protein glutathionylation,BP,
4915,GO:0010735,1,0.974231291967233,0,4,positive regulation of transcription via serum response element binding,BP,
4916,GO:0010736,1,0.987743511399814,0,2,serum response element binding,MF,
4919,GO:0010739,1,0.961600459041219,0,6,positive regulation of protein kinase A signaling,BP,
4923,GO:0010745,1,0.916483021989657,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4924,GO:0010746,1,0.968462126584021,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4925,GO:0010748,1,0.968462126584021,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4926,GO:0010749,1,0.96264993335446,0,5,regulation of nitric oxide mediated signal transduction,BP,
4927,GO:0010750,1,0.987355932377618,0,2,positive regulation of nitric oxide mediated signal transduction,BP,
4928,GO:0010751,1,0.974980758123797,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4929,GO:0010752,1,0.984565873561956,0,2,regulation of cGMP-mediated signaling,BP,
4930,GO:0010754,1,0.991498521274734,0,1,negative regulation of cGMP-mediated signaling,BP,
4932,GO:0010756,1,0.973367961799854,0,5,positive regulation of plasminogen activation,BP,
4934,GO:0010758,1,0.894025708034815,0,18,regulation of macrophage chemotaxis,BP,
4935,GO:0010759,1,0.940036486822395,0,10,positive regulation of macrophage chemotaxis,BP,
4936,GO:0010760,1,0.969521226921214,0,5,negative regulation of macrophage chemotaxis,BP,
4937,GO:0010761,1,0.767761943163964,0,38,fibroblast migration,BP,
4938,GO:0010762,1,0.835946860085489,0,28,regulation of fibroblast migration,BP,
4939,GO:0010763,1,0.928945086064038,0,11,positive regulation of fibroblast migration,BP,
4940,GO:0010764,1,0.952344988414729,0,8,negative regulation of fibroblast migration,BP,
4941,GO:0010765,1,0.804197813532145,0,31,positive regulation of sodium ion transport,BP,
4942,GO:0010766,1,0.901546781830016,0,14,negative regulation of sodium ion transport,BP,
4943,GO:0010767,1,0.975009104127323,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4944,GO:0010768,1,0.980537109294063,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4948,GO:0010789,1,0.994313214468247,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4949,GO:0010792,1,0.971320293574414,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4950,GO:0010793,1,0.963477637689546,0,5,regulation of mRNA export from nucleus,BP,
4951,GO:0010795,1,0.99479271690561,0,1,regulation of ubiquinone biosynthetic process,BP,
4952,GO:0010796,1,0.984087917794487,0,3,regulation of multivesicular body size,BP,
4953,GO:0010797,1,0.994798656624276,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4956,GO:0010801,1,0.913664925214001,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
4957,GO:0010803,1,0.721795361279588,0,54,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4958,GO:0010804,1,0.908991899834948,0,17,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4959,GO:0010807,1,0.960523164792717,0,6,regulation of synaptic vesicle priming,BP,
4960,GO:0010808,1,0.990875304073107,0,1,positive regulation of synaptic vesicle priming,BP,
4964,GO:0010813,1,0.987014700753063,0,2,neuropeptide catabolic process,BP,
4965,GO:0010814,1,0.992210712150724,0,1,substance P catabolic process,BP,
4966,GO:0010815,1,0.973828241128701,0,4,bradykinin catabolic process,BP,
4967,GO:0010816,1,0.992210712150724,0,1,calcitonin catabolic process,BP,
4971,GO:0010820,1,0.947673273801334,0,9,positive regulation of T cell chemotaxis,BP,
4972,GO:0010821,1,0.259231451942521,0,209,regulation of mitochondrion organization,BP,
4973,GO:0010822,1,0.364147391118013,0,156,positive regulation of mitochondrion organization,BP,
4974,GO:0010823,1,0.751026164510935,0,45,negative regulation of mitochondrion organization,BP,
4975,GO:0010824,1,0.767105135554694,0,39,regulation of centrosome duplication,BP,
4976,GO:0010825,1,0.960110585946057,0,6,positive regulation of centrosome duplication,BP,
4977,GO:0010826,1,0.920604083981619,0,12,negative regulation of centrosome duplication,BP,
4978,GO:0010827,1,0.62555583203959,0,67,regulation of glucose transmembrane transport,BP,
4979,GO:0010828,1,0.744079678058758,0,40,positive regulation of glucose transmembrane transport,BP,
4980,GO:0010829,1,0.904913795649913,0,16,negative regulation of glucose transmembrane transport,BP,
4984,GO:0010833,1,0.604616725162974,0,75,telomere maintenance via telomere lengthening,BP,
4985,GO:0010835,1,0.964116604255445,0,6,regulation of protein ADP-ribosylation,BP,
4986,GO:0010836,1,0.984050586788696,0,3,negative regulation of protein ADP-ribosylation,BP,
4987,GO:0010837,1,0.834012932179058,0,25,regulation of keratinocyte proliferation,BP,
4988,GO:0010838,1,0.954453003779686,0,7,positive regulation of keratinocyte proliferation,BP,
4989,GO:0010839,1,0.915978132061951,0,11,negative regulation of keratinocyte proliferation,BP,
4990,GO:0010840,1,0.976918310207008,0,4,regulation of circadian sleep/wake cycle, wakefulness,BP,
4991,GO:0010841,1,0.982129602541151,0,3,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4992,GO:0010842,1,0.856745537922116,0,19,retina layer formation,BP,
4993,GO:0010845,1,0.988053416297233,0,2,positive regulation of reciprocal meiotic recombination,BP,
4994,GO:0010847,1,0.968020163604327,0,4,regulation of chromatin assembly,BP,
4995,GO:0010848,1,0.987000052219596,0,2,regulation of chromatin disassembly,BP,
4996,GO:0010849,1,0.994581099461193,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4997,GO:0010851,1,0.972180684473215,0,5,cyclase regulator activity,MF,
4998,GO:0010853,1,0.978880680244125,0,4,cyclase activator activity,MF,
4999,GO:0010854,1,0.993156908633779,0,1,adenylate cyclase regulator activity,MF,
5000,GO:0010855,1,0.993156908633779,0,1,adenylate cyclase inhibitor activity,MF,
5001,GO:0010856,1,0.993967060794866,0,1,adenylate cyclase activator activity,MF,
5002,GO:0010857,1,0.929945302100819,0,11,calcium-dependent protein kinase activity,MF,
5003,GO:0010858,1,0.984207078322542,0,3,calcium-dependent protein kinase regulator activity,MF,
5004,GO:0010859,1,0.992980782531353,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5006,GO:0010863,1,0.809347749805425,0,31,positive regulation of phospholipase C activity,BP,
5007,GO:0010866,1,0.912013144775312,0,15,regulation of triglyceride biosynthetic process,BP,
5008,GO:0010867,1,0.936838065805097,0,11,positive regulation of triglyceride biosynthetic process,BP,
5009,GO:0010868,1,0.986276874895138,0,2,negative regulation of triglyceride biosynthetic process,BP,
5010,GO:0010869,1,0.875501313196902,0,19,regulation of receptor biosynthetic process,BP,
5011,GO:0010870,1,0.93484915793075,0,11,positive regulation of receptor biosynthetic process,BP,
5012,GO:0010871,1,0.959725569071135,0,5,negative regulation of receptor biosynthetic process,BP,
5013,GO:0010872,1,0.957281478130232,0,8,regulation of cholesterol esterification,BP,
5014,GO:0010873,1,0.968393924878528,0,6,positive regulation of cholesterol esterification,BP,
5015,GO:0010874,1,0.871937129440151,0,18,regulation of cholesterol efflux,BP,
5016,GO:0010875,1,0.89926718817438,0,13,positive regulation of cholesterol efflux,BP,
5018,GO:0010877,1,0.989386090071134,0,2,lipid transport involved in lipid storage,BP,
5019,GO:0010878,1,0.893297009248062,0,15,cholesterol storage,BP,
5020,GO:0010879,1,0.994555591563614,0,1,cholesterol transport involved in cholesterol storage,BP,
5022,GO:0010881,1,0.869170639243041,0,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
5023,GO:0010882,1,0.834538062561455,0,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,
5026,GO:0010885,1,0.903734408166226,0,13,regulation of cholesterol storage,BP,
5027,GO:0010886,1,0.947977509166924,0,7,positive regulation of cholesterol storage,BP,
5028,GO:0010887,1,0.953353270791834,0,6,negative regulation of cholesterol storage,BP,
5029,GO:0010888,1,0.890625199820065,0,16,negative regulation of lipid storage,BP,
5030,GO:0010889,1,0.921587553784282,0,12,regulation of sequestering of triglyceride,BP,
5031,GO:0010890,1,0.960726326539354,0,7,positive regulation of sequestering of triglyceride,BP,
5032,GO:0010891,1,0.959277248269619,0,5,negative regulation of sequestering of triglyceride,BP,
5033,GO:0010893,1,0.920983016972808,0,13,positive regulation of steroid biosynthetic process,BP,
5034,GO:0010894,1,0.880365136817148,0,22,negative regulation of steroid biosynthetic process,BP,
5035,GO:0010896,1,0.953039126403592,0,8,regulation of triglyceride catabolic process,BP,
5036,GO:0010897,1,0.981095709937439,0,3,negative regulation of triglyceride catabolic process,BP,
5037,GO:0010898,1,0.971408188418669,0,5,positive regulation of triglyceride catabolic process,BP,
5038,GO:0010899,1,0.981376487214657,0,3,regulation of phosphatidylcholine catabolic process,BP,
5039,GO:0010900,1,0.994840676974662,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5040,GO:0010901,1,0.989685474308058,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5041,GO:0010902,1,0.994833825288323,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5042,GO:0010903,1,0.99482518139384,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5043,GO:0010904,1,0.994585019354448,0,1,regulation of UDP-glucose catabolic process,BP,
5044,GO:0010905,1,0.994585019354448,0,1,negative regulation of UDP-glucose catabolic process,BP,
5045,GO:0010906,1,0.558407537426009,0,81,regulation of glucose metabolic process,BP,
5046,GO:0010907,1,0.807583199441947,0,28,positive regulation of glucose metabolic process,BP,
5047,GO:0010908,1,0.981642441560433,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5048,GO:0010909,1,0.981642441560433,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5049,GO:0010911,1,0.951663889268784,0,7,regulation of isomerase activity,BP,
5050,GO:0010912,1,0.951663889268784,0,7,positive regulation of isomerase activity,BP,
5051,GO:0010915,1,0.984501097111505,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5052,GO:0010916,1,0.984501097111505,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5053,GO:0010917,1,0.954082870672151,0,8,negative regulation of mitochondrial membrane potential,BP,
5054,GO:0010918,1,0.952849713720312,0,8,positive regulation of mitochondrial membrane potential,BP,
5055,GO:0010919,1,0.930084452277691,0,12,regulation of inositol phosphate biosynthetic process,BP,
5056,GO:0010920,1,0.994265759215158,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5058,GO:0010922,1,0.806720157977066,0,28,positive regulation of phosphatase activity,BP,
5060,GO:0010924,1,0.994265759215158,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5061,GO:0010925,1,0.994265759215158,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5062,GO:0010927,1,0.470353172358198,0,96,cellular component assembly involved in morphogenesis,BP,
5063,GO:0010931,1,0.98901153125758,0,1,macrophage tolerance induction,BP,
5064,GO:0010932,1,0.98901153125758,0,1,regulation of macrophage tolerance induction,BP,
5065,GO:0010933,1,0.98901153125758,0,1,positive regulation of macrophage tolerance induction,BP,
5066,GO:0010934,1,0.911730517265865,0,14,macrophage cytokine production,BP,
5067,GO:0010935,1,0.922830796705951,0,12,regulation of macrophage cytokine production,BP,
5068,GO:0010936,1,0.965055710275226,0,5,negative regulation of macrophage cytokine production,BP,
5069,GO:0010938,1,0.993659605855793,0,1,cytoplasmic microtubule depolymerization,BP,
5070,GO:0010939,1,0.858482544057993,0,27,regulation of necrotic cell death,BP,
5071,GO:0010940,1,0.967788132769555,0,6,positive regulation of necrotic cell death,BP,
5074,GO:0010944,1,0.949331039733893,0,8,negative regulation of transcription by competitive promoter binding,BP,
5075,GO:0010948,1,0.139307856972778,0,304,negative regulation of cell cycle process,BP,
5076,GO:0010949,1,0.994370341336446,0,1,negative regulation of intestinal phytosterol absorption,BP,
5080,GO:0010954,1,0.888277323396303,0,18,positive regulation of protein processing,BP,
5082,GO:0010956,1,0.982170472025391,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5083,GO:0010957,1,0.971725561366812,0,5,negative regulation of vitamin D biosynthetic process,BP,
5084,GO:0010958,1,0.960827407211271,0,6,regulation of amino acid import across plasma membrane,BP,
5086,GO:0010960,1,0.920622685219501,0,10,magnesium ion homeostasis,BP,
5087,GO:0010961,1,0.969505385894175,0,4,cellular magnesium ion homeostasis,BP,
5088,GO:0010962,1,0.830668650183675,0,23,regulation of glucan biosynthetic process,BP,
5089,GO:0010963,1,0.989214622297562,0,2,regulation of L-arginine import,BP,
5090,GO:0010965,1,0.700233349972923,0,52,regulation of mitotic sister chromatid separation,BP,
5091,GO:0010966,1,0.969277486685876,0,4,regulation of phosphate transport,BP,
5092,GO:0010967,1,0.994722055363197,0,1,regulation of polyamine biosynthetic process,BP,
5093,GO:0010968,1,0.963267447532421,0,6,regulation of microtubule nucleation,BP,
5094,GO:0010970,1,0.375367034105175,0,137,transport along microtubule,BP,
5095,GO:0010971,1,0.874160203527957,0,21,positive regulation of G2/M transition of mitotic cell cycle,BP,
5096,GO:0010972,1,0.598300139563789,0,86,negative regulation of G2/M transition of mitotic cell cycle,BP,
5100,GO:0010979,1,0.987139185821871,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5101,GO:0010980,1,0.987139185821871,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5102,GO:0010982,1,0.987792411651675,0,2,regulation of high-density lipoprotein particle clearance,BP,
5103,GO:0010983,1,0.987792411651675,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5105,GO:0010985,1,0.959717394486885,0,7,negative regulation of lipoprotein particle clearance,BP,
5108,GO:0010989,1,0.974830015699869,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5109,GO:0010990,1,0.95934588988669,0,6,regulation of SMAD protein complex assembly,BP,
5110,GO:0010991,1,0.965775357346838,0,5,negative regulation of SMAD protein complex assembly,BP,
5111,GO:0010992,1,0.955557740720918,0,7,ubiquitin recycling,BP,
5112,GO:0010994,1,0.970528195432237,0,5,free ubiquitin chain polymerization,BP,
5114,GO:0010997,1,0.968280697109016,0,5,anaphase-promoting complex binding,MF,
5115,GO:0010998,1,0.935016845668229,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5116,GO:0010999,1,0.992887601411239,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5121,GO:0012510,1,0.912294259071935,0,14,trans-Golgi network transport vesicle membrane,CC,
5123,GO:0014003,1,0.790468026404008,0,38,oligodendrocyte development,BP,
5124,GO:0014004,1,0.981823776793693,0,3,microglia differentiation,BP,
5125,GO:0014005,1,0.981823776793693,0,3,microglia development,BP,
5126,GO:0014009,1,0.782989877044796,0,34,glial cell proliferation,BP,
5127,GO:0014010,1,0.947731665983777,0,7,Schwann cell proliferation,BP,
5128,GO:0014011,1,0.994313214468247,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5129,GO:0014012,1,0.968795441106004,0,5,peripheral nervous system axon regeneration,BP,
5130,GO:0014013,1,0.517037060579836,0,98,regulation of gliogenesis,BP,
5131,GO:0014014,1,0.784587526991978,0,36,negative regulation of gliogenesis,BP,
5132,GO:0014015,1,0.699318373335532,0,54,positive regulation of gliogenesis,BP,
5133,GO:0014016,1,0.983488018525196,0,3,neuroblast differentiation,BP,
5134,GO:0014017,1,0.994468201715917,0,1,neuroblast fate commitment,BP,
5136,GO:0014022,1,0.980479326552003,0,3,neural plate elongation,BP,
5137,GO:0014028,1,0.986461504815136,0,2,notochord formation,BP,
5138,GO:0014029,1,0.927485598593286,0,11,neural crest formation,BP,
5139,GO:0014031,1,0.613805420101015,0,72,mesenchymal cell development,BP,
5140,GO:0014032,1,0.633263369463487,0,68,neural crest cell development,BP,
5141,GO:0014033,1,0.59819275266586,0,75,neural crest cell differentiation,BP,
5142,GO:0014034,1,0.981230360379424,0,3,neural crest cell fate commitment,BP,
5143,GO:0014036,1,0.988253609963198,0,2,neural crest cell fate specification,BP,
5144,GO:0014037,1,0.748326616795881,0,36,Schwann cell differentiation,BP,
5145,GO:0014038,1,0.976374302561215,0,3,regulation of Schwann cell differentiation,BP,
5146,GO:0014040,1,0.981566705744345,0,2,positive regulation of Schwann cell differentiation,BP,
5147,GO:0014041,1,0.931463823174505,0,9,regulation of neuron maturation,BP,
5148,GO:0014042,1,0.965771238738088,0,4,positive regulation of neuron maturation,BP,
5149,GO:0014043,1,0.98127374720423,0,3,negative regulation of neuron maturation,BP,
5150,GO:0014044,1,0.790283225728171,0,28,Schwann cell development,BP,
5151,GO:0014045,1,0.976293008395842,0,4,establishment of endothelial blood-brain barrier,BP,
5152,GO:0014046,1,0.869946181675793,0,22,dopamine secretion,BP,
5154,GO:0014048,1,0.917320928786176,0,14,regulation of glutamate secretion,BP,
5155,GO:0014049,1,0.94993772271599,0,8,positive regulation of glutamate secretion,BP,
5156,GO:0014050,1,0.971458902790053,0,5,negative regulation of glutamate secretion,BP,
5157,GO:0014051,1,0.932177343087752,0,9,gamma-aminobutyric acid secretion,BP,
5158,GO:0014052,1,0.960815002246617,0,6,regulation of gamma-aminobutyric acid secretion,BP,
5159,GO:0014053,1,0.992431771564765,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5160,GO:0014054,1,0.975028935609472,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5161,GO:0014055,1,0.983381657596172,0,3,acetylcholine secretion, neurotransmission,BP,
5162,GO:0014056,1,0.983381657596172,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5163,GO:0014057,1,0.988950520809949,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5164,GO:0014059,1,0.869946181675793,0,22,regulation of dopamine secretion,BP,
5165,GO:0014060,1,0.977928139866369,0,4,regulation of epinephrine secretion,BP,
5167,GO:0014062,1,0.960901903328186,0,7,regulation of serotonin secretion,BP,
5168,GO:0014063,1,0.97801810154204,0,4,negative regulation of serotonin secretion,BP,
5169,GO:0014064,1,0.992817761201889,0,1,positive regulation of serotonin secretion,BP,
5170,GO:0014065,1,0.440753979888104,0,116,phosphatidylinositol 3-kinase signaling,BP,
5171,GO:0014066,1,0.544470771922926,0,88,regulation of phosphatidylinositol 3-kinase signaling,BP,
5172,GO:0014067,1,0.936347898975787,0,10,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5173,GO:0014068,1,0.655906803879561,0,60,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
5180,GO:0014704,1,0.704101397865268,0,47,intercalated disc,CC,
5181,GO:0014705,1,0.993111653298735,0,1,C zone,CC,
5182,GO:0014706,1,0.09140842446068,0,332,striated muscle tissue development,BP,
5183,GO:0014707,1,0.989167037882672,0,2,branchiomeric skeletal muscle development,BP,
5184,GO:0014717,1,0.988805034371209,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5185,GO:0014718,1,0.988805034371209,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5186,GO:0014719,1,0.966170297586501,0,5,skeletal muscle satellite cell activation,BP,
5187,GO:0014721,1,0.965471079791807,0,5,twitch skeletal muscle contraction,BP,
5188,GO:0014722,1,0.963309379840834,0,6,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5189,GO:0014724,1,0.985048831838819,0,2,regulation of twitch skeletal muscle contraction,BP,
5190,GO:0014728,1,0.991227950140997,0,1,regulation of the force of skeletal muscle contraction,BP,
5191,GO:0014731,1,0.930265475688698,0,7,spectrin-associated cytoskeleton,CC,
5192,GO:0014732,1,0.956849659092126,0,7,skeletal muscle atrophy,BP,
5193,GO:0014733,1,0.917322520703051,0,11,regulation of skeletal muscle adaptation,BP,
5194,GO:0014734,1,0.974386242394319,0,3,skeletal muscle hypertrophy,BP,
5195,GO:0014735,1,0.978132900977998,0,3,regulation of muscle atrophy,BP,
5196,GO:0014736,1,0.983333003987324,0,2,negative regulation of muscle atrophy,BP,
5197,GO:0014737,1,0.994712644263035,0,1,positive regulation of muscle atrophy,BP,
5198,GO:0014738,1,0.983616364609762,0,3,regulation of muscle hyperplasia,BP,
5199,GO:0014739,1,0.994836616853792,0,1,positive regulation of muscle hyperplasia,BP,
5200,GO:0014740,1,0.988722093899095,0,2,negative regulation of muscle hyperplasia,BP,
5201,GO:0014741,1,0.881789060443571,0,18,negative regulation of muscle hypertrophy,BP,
5202,GO:0014742,1,0.829962646800683,0,26,positive regulation of muscle hypertrophy,BP,
5203,GO:0014743,1,0.716384179475552,0,46,regulation of muscle hypertrophy,BP,
5204,GO:0014744,1,0.965067397511132,0,5,positive regulation of muscle adaptation,BP,
5205,GO:0014745,1,0.919905378373541,0,11,negative regulation of muscle adaptation,BP,
5206,GO:0014802,1,0.967013994355853,0,4,terminal cisterna,CC,
5207,GO:0014804,1,0.994656216872325,0,1,terminal cisterna lumen,CC,
5208,GO:0014805,1,0.978983456724151,0,4,smooth muscle adaptation,BP,
5209,GO:0014806,1,0.98925181640409,0,2,smooth muscle hyperplasia,BP,
5210,GO:0014807,1,0.955456094522272,0,7,regulation of somitogenesis,BP,
5211,GO:0014808,1,0.794295895855878,0,28,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5212,GO:0014809,1,0.968874317622019,0,5,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5213,GO:0014810,1,0.994831174117676,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5215,GO:0014813,1,0.994556733991284,0,1,skeletal muscle satellite cell commitment,BP,
5216,GO:0014816,1,0.946862165006095,0,7,skeletal muscle satellite cell differentiation,BP,
5217,GO:0014819,1,0.928972589345308,0,11,regulation of skeletal muscle contraction,BP,
5218,GO:0014820,1,0.945898139343895,0,9,tonic smooth muscle contraction,BP,
5219,GO:0014821,1,0.900725157312895,0,18,phasic smooth muscle contraction,BP,
5220,GO:0014822,1,0.994428550852589,0,1,detection of wounding,BP,
5222,GO:0014824,1,0.960737319848793,0,7,artery smooth muscle contraction,BP,
5223,GO:0014825,1,0.994829653520256,0,1,stomach fundus smooth muscle contraction,BP,
5224,GO:0014826,1,0.977089124438145,0,4,vein smooth muscle contraction,BP,
5225,GO:0014827,1,0.965477622246508,0,6,intestine smooth muscle contraction,BP,
5226,GO:0014828,1,0.992154089340602,0,1,distal stomach smooth muscle contraction,BP,
5227,GO:0014829,1,0.879173464467652,0,19,vascular smooth muscle contraction,BP,
5228,GO:0014831,1,0.934140083293359,0,11,gastro-intestinal system smooth muscle contraction,BP,
5229,GO:0014832,1,0.956636698004326,0,7,urinary bladder smooth muscle contraction,BP,
5230,GO:0014834,1,0.972865835515489,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5231,GO:0014835,1,0.987630306452296,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5233,GO:0014841,1,0.913777062498625,0,13,skeletal muscle satellite cell proliferation,BP,
5234,GO:0014842,1,0.923432795916714,0,12,regulation of skeletal muscle satellite cell proliferation,BP,
5235,GO:0014843,1,0.990495140566307,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5236,GO:0014846,1,0.984832931293063,0,2,esophagus smooth muscle contraction,BP,
5237,GO:0014847,1,0.994829653520256,0,1,proximal stomach smooth muscle contraction,BP,
5238,GO:0014848,1,0.956636698004326,0,7,urinary tract smooth muscle contraction,BP,
5240,GO:0014852,1,0.99425809674193,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5241,GO:0014853,1,0.99425809674193,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5242,GO:0014854,1,0.906310902602043,0,13,response to inactivity,BP,
5243,GO:0014855,1,0.666164413228509,0,59,striated muscle cell proliferation,BP,
5244,GO:0014856,1,0.908972172708419,0,14,skeletal muscle cell proliferation,BP,
5245,GO:0014857,1,0.918577642423399,0,13,regulation of skeletal muscle cell proliferation,BP,
5246,GO:0014858,1,0.979296188825238,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5247,GO:0014859,1,0.98101497006438,0,3,negative regulation of skeletal muscle cell proliferation,BP,
5248,GO:0014861,1,0.991946795904036,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5249,GO:0014862,1,0.991227950140997,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5250,GO:0014866,1,0.893936972818485,0,12,skeletal myofibril assembly,BP,
5251,GO:0014870,1,0.921302018709898,0,10,response to muscle inactivity,BP,
5252,GO:0014873,1,0.989160077275588,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5253,GO:0014874,1,0.896243414579095,0,14,response to stimulus involved in regulation of muscle adaptation,BP,
5254,GO:0014876,1,0.994777752886812,0,1,response to injury involved in regulation of muscle adaptation,BP,
5255,GO:0014877,1,0.926575260679998,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5256,GO:0014878,1,0.97265642264765,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5257,GO:0014883,1,0.954602660892011,0,6,transition between fast and slow fiber,BP,
5258,GO:0014886,1,0.993983193638579,0,1,transition between slow and fast fiber,BP,
5259,GO:0014887,1,0.84936010875816,0,22,cardiac muscle adaptation,BP,
5260,GO:0014888,1,0.749488177774745,0,41,striated muscle adaptation,BP,
5261,GO:0014889,1,0.925361434514723,0,12,muscle atrophy,BP,
5262,GO:0014891,1,0.951427335320833,0,8,striated muscle atrophy,BP,
5263,GO:0014894,1,0.926575260679998,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5264,GO:0014895,1,0.994834972089459,0,1,smooth muscle hypertrophy,BP,
5265,GO:0014896,1,0.566977045520568,0,73,muscle hypertrophy,BP,
5266,GO:0014897,1,0.573229135072617,0,71,striated muscle hypertrophy,BP,
5267,GO:0014898,1,0.84936010875816,0,22,cardiac muscle hypertrophy in response to stress,BP,
5268,GO:0014900,1,0.978452311498651,0,4,muscle hyperplasia,BP,
5269,GO:0014901,1,0.988805034371209,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
5271,GO:0014904,1,0.810717121426138,0,31,myotube cell development,BP,
5272,GO:0014908,1,0.985749135813188,0,2,myotube differentiation involved in skeletal muscle regeneration,BP,
5277,GO:0014916,1,0.971737038739802,0,3,regulation of lung blood pressure,BP,
5278,GO:0015002,1,0.887422625962654,0,22,heme-copper terminal oxidase activity,MF,
5279,GO:0015012,1,0.836125830874064,0,25,heparan sulfate proteoglycan biosynthetic process,BP,
5280,GO:0015014,1,0.955476413118406,0,6,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5281,GO:0015015,1,0.958581269978794,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5282,GO:0015016,1,0.968197725914554,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5283,GO:0015018,1,0.983247338101224,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5284,GO:0015019,1,0.992109980429546,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5285,GO:0015020,1,0.91911177275249,0,14,glucuronosyltransferase activity,MF,
5286,GO:0015026,1,0.78758992859932,0,36,coreceptor activity,MF,
5287,GO:0015030,1,0.722641608692821,0,53,Cajal body,CC,
5289,GO:0015035,1,0.890941134626971,0,20,protein disulfide oxidoreductase activity,MF,
5290,GO:0015036,1,0.815220390465025,0,36,disulfide oxidoreductase activity,MF,
5291,GO:0015037,1,0.932217508124268,0,13,peptide disulfide oxidoreductase activity,MF,
5292,GO:0015038,1,0.974021570940487,0,5,glutathione disulfide oxidoreductase activity,MF,
5293,GO:0015039,1,0.994673885774967,0,1,NADPH-adrenodoxin reductase activity,MF,
5294,GO:0015052,1,0.994386682994892,0,1,beta3-adrenergic receptor activity,MF,
5295,GO:0015054,1,0.994607712026897,0,1,gastrin receptor activity,MF,
5296,GO:0015056,1,0.989176648521577,0,2,corticotrophin-releasing factor receptor activity,MF,
5297,GO:0015057,1,0.970791118409151,0,5,thrombin-activated receptor activity,MF,
5298,GO:0015065,1,0.98394626360317,0,3,uridine nucleotide receptor activity,MF,
5299,GO:0015067,1,0.994413731188465,0,1,amidinotransferase activity,MF,
5300,GO:0015068,1,0.994413731188465,0,1,glycine amidinotransferase activity,MF,
5301,GO:0015074,1,0.934022900649816,0,10,DNA integration,BP,
5304,GO:0015078,1,0.549235720852216,0,98,proton transmembrane transporter activity,MF,
5308,GO:0015086,1,0.993181610100549,0,1,cadmium ion transmembrane transporter activity,MF,
5309,GO:0015087,1,0.993181610100549,0,1,cobalt ion transmembrane transporter activity,MF,
5310,GO:0015091,1,0.980828331126721,0,3,ferric iron transmembrane transporter activity,MF,
5311,GO:0015093,1,0.979890098705127,0,3,ferrous iron transmembrane transporter activity,MF,
5312,GO:0015094,1,0.993181610100549,0,1,lead ion transmembrane transporter activity,MF,
5313,GO:0015095,1,0.900175595939972,0,16,magnesium ion transmembrane transporter activity,MF,
5314,GO:0015098,1,0.994673752271903,0,1,molybdate ion transmembrane transporter activity,MF,
5315,GO:0015101,1,0.864612156904309,0,25,organic cation transmembrane transporter activity,MF,
5317,GO:0015105,1,0.994790666239935,0,1,arsenite transmembrane transporter activity,MF,
5318,GO:0015106,1,0.857353440743094,0,21,bicarbonate transmembrane transporter activity,MF,
5320,GO:0015111,1,0.979407025684907,0,3,iodide transmembrane transporter activity,MF,
5321,GO:0015112,1,0.994380403205957,0,1,nitrate transmembrane transporter activity,MF,
5322,GO:0015114,1,0.925639201487196,0,11,phosphate ion transmembrane transporter activity,MF,
5323,GO:0015116,1,0.929857375807714,0,11,sulfate transmembrane transporter activity,MF,
5324,GO:0015117,1,0.994676012241614,0,1,thiosulfate transmembrane transporter activity,MF,
5325,GO:0015119,1,0.98199173187058,0,3,hexose phosphate transmembrane transporter activity,MF,
5327,GO:0015126,1,0.992555783203265,0,1,canalicular bile acid transmembrane transporter activity,MF,
5328,GO:0015127,1,0.992265130732741,0,1,bilirubin transmembrane transporter activity,MF,
5329,GO:0015129,1,0.9677188889361,0,5,lactate transmembrane transporter activity,MF,
5330,GO:0015130,1,0.99321200732669,0,1,mevalonate transmembrane transporter activity,MF,
5331,GO:0015131,1,0.994676012241614,0,1,oxaloacetate transmembrane transporter activity,MF,
5332,GO:0015132,1,0.993126281215282,0,1,prostaglandin transmembrane transporter activity,MF,
5333,GO:0015136,1,0.993940638781848,0,1,sialic acid transmembrane transporter activity,MF,
5334,GO:0015137,1,0.975477126885807,0,4,citrate transmembrane transporter activity,MF,
5335,GO:0015139,1,0.994260248918568,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5336,GO:0015140,1,0.989407393263854,0,2,malate transmembrane transporter activity,MF,
5337,GO:0015141,1,0.98208710772751,0,3,succinate transmembrane transporter activity,MF,
5338,GO:0015142,1,0.975477126885807,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5339,GO:0015143,1,0.973261197513924,0,5,urate transmembrane transporter activity,MF,
5340,GO:0015144,1,0.817235564678902,0,33,carbohydrate transmembrane transporter activity,MF,
5341,GO:0015145,1,0.875239738162414,0,21,monosaccharide transmembrane transporter activity,MF,
5342,GO:0015149,1,0.883825300002864,0,20,hexose transmembrane transporter activity,MF,
5343,GO:0015152,1,0.994611687935326,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5344,GO:0015154,1,0.982452627648068,0,3,disaccharide transmembrane transporter activity,MF,
5345,GO:0015157,1,0.982452627648068,0,3,oligosaccharide transmembrane transporter activity,MF,
5346,GO:0015165,1,0.939590451096281,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5347,GO:0015166,1,0.944673433569205,0,8,polyol transmembrane transporter activity,MF,
5348,GO:0015168,1,0.972966029570242,0,5,glycerol transmembrane transporter activity,MF,
5349,GO:0015171,1,0.625505972910302,0,72,amino acid transmembrane transporter activity,MF,
5350,GO:0015172,1,0.905465463861295,0,14,acidic amino acid transmembrane transporter activity,MF,
5351,GO:0015173,1,0.98287680935184,0,3,aromatic amino acid transmembrane transporter activity,MF,
5352,GO:0015174,1,0.932186793792893,0,11,basic amino acid transmembrane transporter activity,MF,
5353,GO:0015175,1,0.829904793037307,0,29,neutral amino acid transmembrane transporter activity,MF,
5354,GO:0015179,1,0.705534737851023,0,53,L-amino acid transmembrane transporter activity,MF,
5355,GO:0015180,1,0.968239284435693,0,5,L-alanine transmembrane transporter activity,MF,
5356,GO:0015181,1,0.958574832126727,0,6,arginine transmembrane transporter activity,MF,
5357,GO:0015182,1,0.988814657592716,0,2,L-asparagine transmembrane transporter activity,MF,
5358,GO:0015183,1,0.976601615964966,0,4,L-aspartate transmembrane transporter activity,MF,
5359,GO:0015184,1,0.980999802700524,0,3,L-cystine transmembrane transporter activity,MF,
5360,GO:0015185,1,0.970827470620335,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5361,GO:0015186,1,0.969336955833448,0,5,L-glutamine transmembrane transporter activity,MF,
5362,GO:0015187,1,0.964014688884309,0,6,glycine transmembrane transporter activity,MF,
5363,GO:0015189,1,0.958574832126727,0,6,L-lysine transmembrane transporter activity,MF,
5364,GO:0015190,1,0.994310328579444,0,1,L-leucine transmembrane transporter activity,MF,
5365,GO:0015191,1,0.994310328579444,0,1,L-methionine transmembrane transporter activity,MF,
5366,GO:0015193,1,0.965069151551866,0,5,L-proline transmembrane transporter activity,MF,
5367,GO:0015194,1,0.950538163026303,0,9,L-serine transmembrane transporter activity,MF,
5368,GO:0015195,1,0.993053360630119,0,1,L-threonine transmembrane transporter activity,MF,
5369,GO:0015196,1,0.994470477599369,0,1,L-tryptophan transmembrane transporter activity,MF,
5370,GO:0015203,1,0.989169117177058,0,2,polyamine transmembrane transporter activity,MF,
5371,GO:0015204,1,0.96529225613615,0,6,urea transmembrane transporter activity,MF,
5372,GO:0015205,1,0.961985613494451,0,6,nucleobase transmembrane transporter activity,MF,
5373,GO:0015207,1,0.987759810769889,0,2,adenine transmembrane transporter activity,MF,
5374,GO:0015215,1,0.909598254864861,0,16,nucleotide transmembrane transporter activity,MF,
5375,GO:0015216,1,0.931450765919547,0,12,purine nucleotide transmembrane transporter activity,MF,
5376,GO:0015217,1,0.948417236005811,0,9,ADP transmembrane transporter activity,MF,
5377,GO:0015218,1,0.98749906620752,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5378,GO:0015220,1,0.964556157111121,0,6,choline transmembrane transporter activity,MF,
5379,GO:0015222,1,0.98186603402546,0,3,serotonin transmembrane transporter activity,MF,
5380,GO:0015226,1,0.966458007144946,0,6,carnitine transmembrane transporter activity,MF,
5381,GO:0015227,1,0.989224769531999,0,2,acyl carnitine transmembrane transporter activity,MF,
5382,GO:0015228,1,0.98316336736653,0,3,coenzyme A transmembrane transporter activity,MF,
5383,GO:0015229,1,0.990297826543863,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5384,GO:0015230,1,0.988743130114006,0,2,FAD transmembrane transporter activity,MF,
5385,GO:0015232,1,0.949900096626676,0,8,heme transporter activity,MF,
5386,GO:0015234,1,0.982080338413114,0,3,thiamine transmembrane transporter activity,MF,
5388,GO:0015245,1,0.954507846369571,0,8,fatty acid transmembrane transporter activity,MF,
5389,GO:0015247,1,0.977426171028684,0,3,aminophospholipid transmembrane transporter activity,MF,
5391,GO:0015250,1,0.944746208731104,0,10,water channel activity,MF,
5392,GO:0015252,1,0.983311691452966,0,3,proton channel activity,MF,
5393,GO:0015254,1,0.97851956156155,0,4,glycerol channel activity,MF,
5394,GO:0015265,1,0.98221709342649,0,3,urea channel activity,MF,
5396,GO:0015269,1,0.900369951599924,0,17,calcium-activated potassium channel activity,MF,
5398,GO:0015272,1,0.968699641092052,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5401,GO:0015277,1,0.96317180894781,0,5,kainate selective glutamate receptor activity,MF,
5403,GO:0015279,1,0.935054670202538,0,9,store-operated calcium channel activity,MF,
5404,GO:0015280,1,0.950366886398955,0,8,ligand-gated sodium channel activity,MF,
5405,GO:0015288,1,0.96790207797993,0,6,porin activity,MF,
5407,GO:0015292,1,0.994313214468247,0,1,uniporter activity,MF,
5408,GO:0015293,1,0.450335693200451,0,119,symporter activity,MF,
5409,GO:0015294,1,0.552025687637965,0,86,solute:cation symporter activity,MF,
5410,GO:0015295,1,0.875764886251682,0,21,solute:proton symporter activity,MF,
5411,GO:0015296,1,0.926850905550726,0,10,anion:cation symporter activity,MF,
5414,GO:0015299,1,0.889489434499003,0,18,solute:proton antiporter activity,MF,
5415,GO:0015301,1,0.828239573238548,0,28,anion:anion antiporter activity,MF,
5416,GO:0015307,1,0.98334355468105,0,3,drug:proton antiporter activity,MF,
5417,GO:0015315,1,0.98199173187058,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5418,GO:0015317,1,0.994725018825597,0,1,phosphate:proton symporter activity,MF,
5420,GO:0015319,1,0.981915562536157,0,3,sodium:inorganic phosphate symporter activity,MF,
5421,GO:0015321,1,0.969970127576931,0,5,sodium-dependent phosphate transmembrane transporter activity,MF,
5422,GO:0015322,1,0.993611526651874,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5423,GO:0015327,1,0.987654884655252,0,1,cystine:glutamate antiporter activity,MF,
5424,GO:0015328,1,0.987654884655252,0,1,cystine secondary active transmembrane transporter activity,MF,
5425,GO:0015333,1,0.980886406446076,0,3,peptide:proton symporter activity,MF,
5426,GO:0015343,1,0.994313214468247,0,1,siderophore transmembrane transporter activity,MF,
5427,GO:0015347,1,0.859606265218578,0,24,sodium-independent organic anion transmembrane transporter activity,MF,
5428,GO:0015349,1,0.975720774096619,0,4,thyroid hormone transmembrane transporter activity,MF,
5429,GO:0015350,1,0.985115076947691,0,2,methotrexate transmembrane transporter activity,MF,
5430,GO:0015355,1,0.936011610173761,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5431,GO:0015362,1,0.993286228805768,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5432,GO:0015367,1,0.994703463213086,0,1,oxoglutarate:malate antiporter activity,MF,
5434,GO:0015369,1,0.99185396372749,0,1,calcium:proton antiporter activity,MF,
5435,GO:0015370,1,0.65375177564708,0,61,solute:sodium symporter activity,MF,
5436,GO:0015373,1,0.971277864817448,0,4,anion:sodium symporter activity,MF,
5437,GO:0015375,1,0.988305875706786,0,2,glycine:sodium symporter activity,MF,
5438,GO:0015377,1,0.938118908678018,0,8,cation:chloride symporter activity,MF,
5439,GO:0015378,1,0.983080421170662,0,2,sodium:chloride symporter activity,MF,
5440,GO:0015379,1,0.938118908678018,0,8,potassium:chloride symporter activity,MF,
5441,GO:0015382,1,0.994238495123187,0,1,sodium:sulfate symporter activity,MF,
5442,GO:0015385,1,0.923444984210047,0,12,sodium:proton antiporter activity,MF,
5443,GO:0015386,1,0.934045704954876,0,10,potassium:proton antiporter activity,MF,
5444,GO:0015389,1,0.98923244394535,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5445,GO:0015390,1,0.994571308153985,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5446,GO:0015391,1,0.98923244394535,0,2,nucleobase:cation symporter activity,MF,
5449,GO:0015410,1,0.981238854987108,0,3,manganese-transporting ATPase activity,MF,
5450,GO:0015420,1,0.990869091843867,0,1,cobalamin-transporting ATPase activity,MF,
5451,GO:0015421,1,0.993763787736003,0,1,oligopeptide-transporting ATPase activity,MF,
5452,GO:0015431,1,0.990869091843867,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5454,GO:0015433,1,0.98715219424945,0,2,peptide antigen-transporting ATPase activity,MF,
5455,GO:0015439,1,0.994182237287637,0,1,heme-transporting ATPase activity,MF,
5456,GO:0015440,1,0.975305752803669,0,4,peptide-transporting ATPase activity,MF,
5457,GO:0015450,1,0.967863045148287,0,6,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5459,GO:0015464,1,0.892635093923135,0,19,acetylcholine receptor activity,MF,
5460,GO:0015467,1,0.938111370427331,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5461,GO:0015485,1,0.780242010293599,0,37,cholesterol binding,MF,
5462,GO:0015489,1,0.989169117177058,0,2,putrescine transmembrane transporter activity,MF,
5464,GO:0015495,1,0.994421678734291,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5465,GO:0015499,1,0.994379087616678,0,1,formate transmembrane transporter activity,MF,
5466,GO:0015501,1,0.951762377637633,0,7,glutamate:sodium symporter activity,MF,
5467,GO:0015526,1,0.98199173187058,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5468,GO:0015538,1,0.993940638781848,0,1,sialic acid:proton symporter activity,MF,
5469,GO:0015556,1,0.954021702447548,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5470,GO:0015562,1,0.972416254805974,0,4,efflux transmembrane transporter activity,MF,
5471,GO:0015578,1,0.994476800421673,0,1,mannose transmembrane transporter activity,MF,
5472,GO:0015605,1,0.868107138026386,0,23,organophosphate ester transmembrane transporter activity,MF,
5473,GO:0015616,1,0.963738466104494,0,4,DNA translocase activity,MF,
5475,GO:0015630,1,0.000441814204774063,0,1074,microtubule cytoskeleton,CC,
5476,GO:0015631,1,0.0882301575717093,0,322,tubulin binding,MF,
5477,GO:0015633,1,0.994615618372975,0,1,zinc-transporting ATPase activity,MF,
5478,GO:0015636,1,0.994537687322196,0,1,short-chain fatty acid transmembrane transporter activity,MF,
5479,GO:0015643,1,0.947510757104147,0,9,toxic substance binding,MF,
5480,GO:0015645,1,0.903959580042538,0,17,fatty acid ligase activity,MF,
5481,GO:0015651,1,0.942826629892521,0,10,quaternary ammonium group transmembrane transporter activity,MF,
5482,GO:0015658,1,0.994310328579444,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5483,GO:0015660,1,0.994379087616678,0,1,formate efflux transmembrane transporter activity,MF,
5484,GO:0015662,1,0.762261976664595,0,38,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5485,GO:0015665,1,0.989122523361605,0,2,alcohol transmembrane transporter activity,MF,
5486,GO:0015669,1,0.910354268716216,0,17,gas transport,BP,
5487,GO:0015670,1,0.98383475258906,0,3,carbon dioxide transport,BP,
5488,GO:0015671,1,0.925323891698566,0,14,oxygen transport,BP,
5491,GO:0015679,1,0.981420500072227,0,2,plasma membrane copper ion transport,BP,
5492,GO:0015680,1,0.980710823900144,0,3,intracellular copper ion transport,BP,
5494,GO:0015684,1,0.979890098705127,0,3,ferrous iron transport,BP,
5495,GO:0015688,1,0.983817175040538,0,3,iron chelate transport,BP,
5496,GO:0015689,1,0.994673752271903,0,1,molybdate ion transport,BP,
5497,GO:0015691,1,0.975529166684688,0,4,cadmium ion transport,BP,
5498,GO:0015692,1,0.993181610100549,0,1,lead ion transport,BP,
5499,GO:0015693,1,0.892918706152196,0,17,magnesium ion transport,BP,
5500,GO:0015694,1,0.992265130732741,0,1,mercury ion transport,BP,
5501,GO:0015695,1,0.789636053149994,0,39,organic cation transport,BP,
5502,GO:0015696,1,0.59038267828484,0,86,ammonium transport,BP,
5503,GO:0015697,1,0.923163405234974,0,13,quaternary ammonium group transport,BP,
5505,GO:0015700,1,0.994790666239935,0,1,arsenite transport,BP,
5506,GO:0015701,1,0.765798731732203,0,41,bicarbonate transport,BP,
5507,GO:0015705,1,0.957262918101164,0,5,iodide transport,BP,
5508,GO:0015706,1,0.994380403205957,0,1,nitrate transport,BP,
5509,GO:0015707,1,0.993476349999722,0,1,nitrite transport,BP,
5510,GO:0015709,1,0.994676012241614,0,1,thiosulfate transport,BP,
5512,GO:0015712,1,0.96593552332168,0,6,hexose phosphate transport,BP,
5516,GO:0015723,1,0.992265130732741,0,1,bilirubin transport,BP,
5517,GO:0015724,1,0.994379087616678,0,1,formate transport,BP,
5518,GO:0015727,1,0.960988107625911,0,6,lactate transport,BP,
5519,GO:0015728,1,0.99321200732669,0,1,mevalonate transport,BP,
5520,GO:0015729,1,0.994676012241614,0,1,oxaloacetate transport,BP,
5521,GO:0015732,1,0.923144670476026,0,13,prostaglandin transport,BP,
5522,GO:0015734,1,0.990762607085695,0,1,taurine transport,BP,
5523,GO:0015739,1,0.993940638781848,0,1,sialic acid transport,BP,
5524,GO:0015740,1,0.919829530461349,0,12,C4-dicarboxylate transport,BP,
5525,GO:0015742,1,0.983661761489597,0,3,alpha-ketoglutarate transport,BP,
5526,GO:0015743,1,0.994676012241614,0,1,malate transport,BP,
5527,GO:0015744,1,0.98208710772751,0,3,succinate transport,BP,
5528,GO:0015746,1,0.975477126885807,0,4,citrate transport,BP,
5529,GO:0015747,1,0.967833919026116,0,6,urate transport,BP,
5530,GO:0015748,1,0.562833086479273,0,84,organophosphate ester transport,BP,
5531,GO:0015749,1,0.507892319210098,0,99,monosaccharide transmembrane transport,BP,
5532,GO:0015755,1,0.99453369805972,0,1,fructose transmembrane transport,BP,
5533,GO:0015760,1,0.96593552332168,0,6,glucose-6-phosphate transport,BP,
5534,GO:0015761,1,0.994476800421673,0,1,mannose transmembrane transport,BP,
5535,GO:0015766,1,0.982452627648068,0,3,disaccharide transport,BP,
5536,GO:0015770,1,0.982452627648068,0,3,sucrose transport,BP,
5537,GO:0015772,1,0.982452627648068,0,3,oligosaccharide transport,BP,
5538,GO:0015780,1,0.923594859362068,0,13,nucleotide-sugar transmembrane transport,BP,
5539,GO:0015782,1,0.994695328496284,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5540,GO:0015783,1,0.984526782854038,0,2,GDP-fucose transmembrane transport,BP,
5541,GO:0015786,1,0.994553680693229,0,1,UDP-glucose transmembrane transport,BP,
5542,GO:0015787,1,0.990809092715381,0,1,UDP-glucuronic acid transmembrane transport,BP,
5543,GO:0015790,1,0.99044699374064,0,1,UDP-xylose transmembrane transport,BP,
5544,GO:0015791,1,0.926469201909885,0,10,polyol transport,BP,
5545,GO:0015793,1,0.972966029570242,0,5,glycerol transport,BP,
5546,GO:0015797,1,0.994379087616678,0,1,mannitol transport,BP,
5547,GO:0015798,1,0.9576089865143,0,4,myo-inositol transport,BP,
5549,GO:0015801,1,0.97144001428723,0,5,aromatic amino acid transport,BP,
5550,GO:0015802,1,0.927553710234205,0,12,basic amino acid transport,BP,
5551,GO:0015803,1,0.973009565773329,0,4,branched-chain amino acid transport,BP,
5552,GO:0015804,1,0.811450244112813,0,33,neutral amino acid transport,BP,
5553,GO:0015805,1,0.994569468293183,0,1,S-adenosyl-L-methionine transport,BP,
5554,GO:0015807,1,0.670140564444929,0,60,L-amino acid transport,BP,
5555,GO:0015808,1,0.968239284435693,0,5,L-alanine transport,BP,
5556,GO:0015809,1,0.948382488288028,0,8,arginine transport,BP,
5557,GO:0015810,1,0.98219096194573,0,3,aspartate transmembrane transport,BP,
5558,GO:0015811,1,0.980999802700524,0,3,L-cystine transport,BP,
5559,GO:0015812,1,0.911483109518402,0,13,gamma-aminobutyric acid transport,BP,
5560,GO:0015813,1,0.850693833499531,0,23,L-glutamate transmembrane transport,BP,
5561,GO:0015816,1,0.947515127093713,0,8,glycine transport,BP,
5562,GO:0015817,1,0.988807726353778,0,2,histidine transport,BP,
5563,GO:0015819,1,0.994676541045561,0,1,lysine transport,BP,
5564,GO:0015820,1,0.978578558731216,0,3,leucine transport,BP,
5565,GO:0015821,1,0.994310328579444,0,1,methionine transport,BP,
5566,GO:0015822,1,0.957522322553041,0,6,ornithine transport,BP,
5567,GO:0015824,1,0.94956081515288,0,7,proline transport,BP,
5568,GO:0015825,1,0.950538163026303,0,9,L-serine transport,BP,
5569,GO:0015826,1,0.993053360630119,0,1,threonine transport,BP,
5570,GO:0015827,1,0.982900128073508,0,3,tryptophan transport,BP,
5571,GO:0015828,1,0.994064549318113,0,1,tyrosine transport,BP,
5574,GO:0015838,1,0.94630687240912,0,9,amino-acid betaine transport,BP,
5575,GO:0015840,1,0.965324668575283,0,6,urea transport,BP,
5576,GO:0015842,1,0.978425305022611,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5578,GO:0015846,1,0.960264144413045,0,7,polyamine transport,BP,
5579,GO:0015847,1,0.989169117177058,0,2,putrescine transport,BP,
5582,GO:0015851,1,0.956952370903038,0,7,nucleobase transport,BP,
5583,GO:0015853,1,0.982593077635577,0,3,adenine transport,BP,
5584,GO:0015855,1,0.983452797390589,0,3,pyrimidine nucleobase transport,BP,
5585,GO:0015858,1,0.961898129301402,0,7,nucleoside transport,BP,
5586,GO:0015860,1,0.994571308153985,0,1,purine nucleoside transmembrane transport,BP,
5587,GO:0015862,1,0.994529673788846,0,1,uridine transport,BP,
5588,GO:0015864,1,0.989130382948201,0,2,pyrimidine nucleoside transport,BP,
5589,GO:0015865,1,0.915655810014823,0,15,purine nucleotide transport,BP,
5590,GO:0015866,1,0.948417236005811,0,9,ADP transport,BP,
5591,GO:0015867,1,0.942522636437546,0,10,ATP transport,BP,
5592,GO:0015868,1,0.922341622512755,0,14,purine ribonucleotide transport,BP,
5593,GO:0015870,1,0.977857620059797,0,4,acetylcholine transport,BP,
5594,GO:0015871,1,0.953537262966741,0,7,choline transport,BP,
5595,GO:0015872,1,0.804879493447223,0,35,dopamine transport,BP,
5597,GO:0015876,1,0.994376713196624,0,1,acetyl-CoA transport,BP,
5598,GO:0015878,1,0.993951952230398,0,1,biotin transport,BP,
5599,GO:0015879,1,0.961247059423212,0,7,carnitine transport,BP,
5600,GO:0015880,1,0.98316336736653,0,3,coenzyme A transport,BP,
5601,GO:0015881,1,0.98653551826146,0,2,creatine transmembrane transport,BP,
5602,GO:0015882,1,0.990297826543863,0,1,L-ascorbic acid transmembrane transport,BP,
5603,GO:0015884,1,0.941166295283788,0,8,folic acid transport,BP,
5604,GO:0015886,1,0.949900096626676,0,8,heme transport,BP,
5605,GO:0015887,1,0.993951952230398,0,1,pantothenate transmembrane transport,BP,
5606,GO:0015888,1,0.98159514255114,0,3,thiamine transport,BP,
5607,GO:0015889,1,0.956111318606956,0,6,cobalamin transport,BP,
5608,GO:0015891,1,0.983817175040538,0,3,siderophore transport,BP,
5610,GO:0015904,1,0.994682928185635,0,1,tetracycline transport,BP,
5613,GO:0015910,1,0.988224845321651,0,2,peroxisomal long-chain fatty acid import,BP,
5614,GO:0015911,1,0.963147098028993,0,5,plasma membrane long-chain fatty acid transport,BP,
5615,GO:0015912,1,0.994537687322196,0,1,short-chain fatty acid transport,BP,
5616,GO:0015913,1,0.994537687322196,0,1,short-chain fatty acid import,BP,
5617,GO:0015914,1,0.655778969687114,0,58,phospholipid transport,BP,
5618,GO:0015916,1,0.994376713196624,0,1,fatty-acyl-CoA transport,BP,
5619,GO:0015917,1,0.967566002399224,0,4,aminophospholipid transport,BP,
5621,GO:0015919,1,0.906331869210391,0,16,peroxisomal membrane transport,BP,
5622,GO:0015920,1,0.989084184706041,0,2,lipopolysaccharide transport,BP,
5623,GO:0015922,1,0.994737951479012,0,1,aspartate oxidase activity,MF,
5624,GO:0015923,1,0.905307897517589,0,14,mannosidase activity,MF,
5625,GO:0015924,1,0.935055156153494,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5626,GO:0015925,1,0.955415105455619,0,8,galactosidase activity,MF,
5627,GO:0015926,1,0.932497759901912,0,10,glucosidase activity,MF,
5628,GO:0015928,1,0.989252082607952,0,2,fucosidase activity,MF,
5629,GO:0015929,1,0.927364771488174,0,13,hexosaminidase activity,MF,
5630,GO:0015931,1,0.23257204350714,0,221,nucleobase-containing compound transport,BP,
5631,GO:0015932,1,0.805452260205256,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5632,GO:0015934,1,0.543058467560685,0,113,large ribosomal subunit,CC,
5633,GO:0015935,1,0.683748301080764,0,69,small ribosomal subunit,CC,
5634,GO:0015936,1,0.916900697279546,0,15,coenzyme A metabolic process,BP,
5635,GO:0015937,1,0.946559128946268,0,10,coenzyme A biosynthetic process,BP,
5636,GO:0015938,1,0.994817387140874,0,1,coenzyme A catabolic process,BP,
5637,GO:0015939,1,0.950425772705691,0,8,pantothenate metabolic process,BP,
5638,GO:0015942,1,0.966238212204626,0,6,formate metabolic process,BP,
5639,GO:0015949,1,0.835603455101817,0,32,nucleobase-containing small molecule interconversion,BP,
5640,GO:0015950,1,0.989462300783792,0,2,purine nucleotide interconversion,BP,
5641,GO:0015951,1,0.989462300783792,0,2,purine ribonucleotide interconversion,BP,
5642,GO:0015959,1,0.959732842182599,0,7,diadenosine polyphosphate metabolic process,BP,
5643,GO:0015960,1,0.98264761565909,0,3,diadenosine polyphosphate biosynthetic process,BP,
5644,GO:0015961,1,0.97668461576008,0,4,diadenosine polyphosphate catabolic process,BP,
5645,GO:0015965,1,0.98264761565909,0,3,diadenosine tetraphosphate metabolic process,BP,
5646,GO:0015966,1,0.98264761565909,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5647,GO:0015980,1,0.218710201324549,0,244,energy derivation by oxidation of organic compounds,BP,
5648,GO:0015985,1,0.947213912614175,0,9,energy coupled proton transport, down electrochemical gradient,BP,
5649,GO:0015986,1,0.947213912614175,0,9,ATP synthesis coupled proton transport,BP,
5650,GO:0015988,1,0.844837881241063,0,28,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5651,GO:0015990,1,0.994830898197474,0,1,electron transport coupled proton transport,BP,
5652,GO:0015991,1,0.849234830987296,0,27,ATP hydrolysis coupled proton transport,BP,
5653,GO:0016004,1,0.94490618327435,0,9,phospholipase activator activity,MF,
5654,GO:0016005,1,0.986840928436165,0,2,phospholipase A2 activator activity,MF,
5655,GO:0016010,1,0.863180246919007,0,20,dystrophin-associated glycoprotein complex,CC,
5656,GO:0016011,1,0.952071328060938,0,7,dystroglycan complex,CC,
5657,GO:0016012,1,0.96012989814272,0,6,sarcoglycan complex,CC,
5658,GO:0016013,1,0.97398712827386,0,4,syntrophin complex,CC,
5659,GO:0016015,1,0.96718938099895,0,6,morphogen activity,MF,
5660,GO:0016018,1,0.941001743385632,0,10,cyclosporin A binding,MF,
5661,GO:0016019,1,0.989592375138533,0,2,peptidoglycan receptor activity,MF,
5664,GO:0016024,1,0.923131342379133,0,11,CDP-diacylglycerol biosynthetic process,BP,
5665,GO:0016028,1,0.993674461334598,0,1,rhabdomere,CC,
5666,GO:0016031,1,0.993889919208563,0,1,tRNA import into mitochondrion,BP,
5668,GO:0016034,1,0.994783652257647,0,1,maleylacetoacetate isomerase activity,MF,
5669,GO:0016035,1,0.981531259396051,0,2,zeta DNA polymerase complex,CC,
5670,GO:0016036,1,0.994553872164583,0,1,cellular response to phosphate starvation,BP,
5671,GO:0016037,1,0.994317809914055,0,1,light absorption,BP,
5672,GO:0016038,1,0.994317809914055,0,1,absorption of visible light,BP,
5675,GO:0016045,1,0.931712331597319,0,10,detection of bacterium,BP,
5676,GO:0016046,1,0.991666092039416,0,1,detection of fungus,BP,
5677,GO:0016048,1,0.890768128765298,0,18,detection of temperature stimulus,BP,
5683,GO:0016054,1,0.215707381055007,0,251,organic acid catabolic process,BP,
5685,GO:0016056,1,0.870490231284554,0,23,rhodopsin mediated signaling pathway,BP,
5686,GO:0016062,1,0.994424633269304,0,1,adaptation of rhodopsin mediated signaling,BP,
5688,GO:0016068,1,0.98405802831529,0,3,type I hypersensitivity,BP,
5691,GO:0016072,1,0.18763460480658,0,279,rRNA metabolic process,BP,
5692,GO:0016073,1,0.602099584276113,0,84,snRNA metabolic process,BP,
5693,GO:0016074,1,0.935354249159923,0,12,snoRNA metabolic process,BP,
5694,GO:0016075,1,0.904756520194932,0,16,rRNA catabolic process,BP,
5695,GO:0016077,1,0.991266113753993,0,1,snoRNA catabolic process,BP,
5696,GO:0016078,1,0.966824854532997,0,6,tRNA catabolic process,BP,
5698,GO:0016080,1,0.969863858980579,0,4,synaptic vesicle targeting,BP,
5701,GO:0016093,1,0.955466403584393,0,8,polyprenol metabolic process,BP,
5702,GO:0016094,1,0.981000606161351,0,3,polyprenol biosynthetic process,BP,
5703,GO:0016095,1,0.984000819110263,0,3,polyprenol catabolic process,BP,
5704,GO:0016098,1,0.98949937488894,0,2,monoterpenoid metabolic process,BP,
5705,GO:0016101,1,0.601074898386906,0,77,diterpenoid metabolic process,BP,
5706,GO:0016102,1,0.950167665002888,0,9,diterpenoid biosynthetic process,BP,
5707,GO:0016103,1,0.982349534393495,0,3,diterpenoid catabolic process,BP,
5708,GO:0016107,1,0.989566015395049,0,2,sesquiterpenoid catabolic process,BP,
5709,GO:0016108,1,0.983071670003672,0,3,tetraterpenoid metabolic process,BP,
5710,GO:0016109,1,0.994399069470243,0,1,tetraterpenoid biosynthetic process,BP,
5711,GO:0016114,1,0.92361746238686,0,14,terpenoid biosynthetic process,BP,
5712,GO:0016115,1,0.972097896608939,0,5,terpenoid catabolic process,BP,
5713,GO:0016116,1,0.983071670003672,0,3,carotenoid metabolic process,BP,
5714,GO:0016117,1,0.994399069470243,0,1,carotenoid biosynthetic process,BP,
5715,GO:0016119,1,0.988609435945472,0,2,carotene metabolic process,BP,
5716,GO:0016121,1,0.9942639262759,0,1,carotene catabolic process,BP,
5717,GO:0016122,1,0.988694803346268,0,2,xanthophyll metabolic process,BP,
5718,GO:0016123,1,0.994399069470243,0,1,xanthophyll biosynthetic process,BP,
5719,GO:0016125,1,0.414617509112814,0,134,sterol metabolic process,BP,
5720,GO:0016126,1,0.639601288090536,0,68,sterol biosynthetic process,BP,
5721,GO:0016127,1,0.947100106321734,0,9,sterol catabolic process,BP,
5722,GO:0016128,1,0.983680107388829,0,3,phytosteroid metabolic process,BP,
5723,GO:0016129,1,0.983680107388829,0,3,phytosteroid biosynthetic process,BP,
5724,GO:0016131,1,0.994379087616678,0,1,brassinosteroid metabolic process,BP,
5725,GO:0016132,1,0.994379087616678,0,1,brassinosteroid biosynthetic process,BP,
5726,GO:0016137,1,0.910765238223234,0,17,glycoside metabolic process,BP,
5727,GO:0016139,1,0.955762528456749,0,8,glycoside catabolic process,BP,
5728,GO:0016149,1,0.993629691344804,0,1,translation release factor activity, codon specific,MF,
5729,GO:0016150,1,0.994737951479012,0,1,translation release factor activity, codon nonspecific,MF,
5730,GO:0016151,1,0.989308802795328,0,2,nickel cation binding,MF,
5731,GO:0016153,1,0.993899924200937,0,1,urocanate hydratase activity,MF,
5733,GO:0016155,1,0.98385872548037,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5734,GO:0016160,1,0.980195111936821,0,3,amylase activity,MF,
5735,GO:0016165,1,0.988939688638383,0,2,linoleate 13S-lipoxygenase activity,MF,
5736,GO:0016167,1,0.982297702634508,0,2,glial cell-derived neurotrophic factor receptor activity,MF,
5737,GO:0016174,1,0.957786928090355,0,6,NAD(P)H oxidase activity,MF,
5738,GO:0016175,1,0.95338898784778,0,8,superoxide-generating NADPH oxidase activity,MF,
5739,GO:0016176,1,0.944823994690626,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5740,GO:0016180,1,0.868177647964217,0,23,snRNA processing,BP,
5741,GO:0016182,1,0.992525900258898,0,1,synaptic vesicle budding from endosome,BP,
5742,GO:0016185,1,0.977433766803295,0,3,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5743,GO:0016188,1,0.920315303625834,0,11,synaptic vesicle maturation,BP,
5744,GO:0016189,1,0.989231657242634,0,1,synaptic vesicle to endosome fusion,BP,
5747,GO:0016197,1,0.284594156514718,0,183,endosomal transport,BP,
5748,GO:0016198,1,0.957267586868872,0,6,axon choice point recognition,BP,
5749,GO:0016199,1,0.968189891276183,0,4,axon midline choice point recognition,BP,
5750,GO:0016202,1,0.446784111663923,0,115,regulation of striated muscle tissue development,BP,
5751,GO:0016206,1,0.988720978394891,0,2,catechol O-methyltransferase activity,MF,
5752,GO:0016208,1,0.944589917917868,0,10,AMP binding,MF,
5753,GO:0016209,1,0.661245179381734,0,71,antioxidant activity,MF,
5754,GO:0016211,1,0.984953383039074,0,2,ammonia ligase activity,MF,
5755,GO:0016212,1,0.989078583877304,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5756,GO:0016213,1,0.994063821636701,0,1,linoleoyl-CoA desaturase activity,MF,
5757,GO:0016215,1,0.980456825762876,0,3,acyl-CoA desaturase activity,MF,
5758,GO:0016222,1,0.988713796306473,0,2,procollagen-proline 4-dioxygenase complex,CC,
5759,GO:0016226,1,0.892079568737846,0,20,iron-sulfur cluster assembly,BP,
5760,GO:0016229,1,0.874801891352808,0,25,steroid dehydrogenase activity,MF,
5761,GO:0016230,1,0.988549559271588,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5762,GO:0016231,1,0.992207569279162,0,1,beta-N-acetylglucosaminidase activity,MF,
5763,GO:0016232,1,0.994289236358202,0,1,HNK-1 sulfotransferase activity,MF,
5764,GO:0016233,1,0.75045864953025,0,42,telomere capping,BP,
5765,GO:0016234,1,0.575137873876978,0,77,inclusion body,CC,
5766,GO:0016235,1,0.754640746800705,0,41,aggresome,CC,
5767,GO:0016236,1,0.16233949010235,0,279,macroautophagy,BP,
5768,GO:0016237,1,0.992371518296249,0,1,lysosomal microautophagy,BP,
5769,GO:0016239,1,0.655346406093058,0,58,positive regulation of macroautophagy,BP,
5770,GO:0016240,1,0.972869833580528,0,4,autophagosome membrane docking,BP,
5771,GO:0016241,1,0.352754178613249,0,156,regulation of macroautophagy,BP,
5772,GO:0016242,1,0.828083521734414,0,27,negative regulation of macroautophagy,BP,
5773,GO:0016243,1,0.993342167507596,0,1,regulation of autophagosome size,BP,
5774,GO:0016246,1,0.903134674144177,0,15,RNA interference,BP,
5776,GO:0016248,1,0.804873104641111,0,32,channel inhibitor activity,MF,
5777,GO:0016250,1,0.994316663584809,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5778,GO:0016254,1,0.912586435426352,0,16,preassembly of GPI anchor in ER membrane,BP,
5779,GO:0016255,1,0.952854829387437,0,7,attachment of GPI anchor to protein,BP,
5780,GO:0016256,1,0.986521485237546,0,2,N-glycan processing to lysosome,BP,
5781,GO:0016259,1,0.975522473819979,0,4,selenocysteine metabolic process,BP,
5782,GO:0016260,1,0.988994073781482,0,2,selenocysteine biosynthetic process,BP,
5783,GO:0016262,1,0.980950981164432,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5784,GO:0016263,1,0.989388497610348,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5785,GO:0016264,1,0.938079532438734,0,10,gap junction assembly,BP,
5787,GO:0016267,1,0.989388497610348,0,2,O-glycan processing, core 1,BP,
5788,GO:0016272,1,0.964153090747528,0,7,prefoldin complex,CC,
5789,GO:0016273,1,0.935360967720436,0,12,arginine N-methyltransferase activity,MF,
5790,GO:0016274,1,0.935360967720436,0,12,protein-arginine N-methyltransferase activity,MF,
5791,GO:0016277,1,0.994499220980243,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5792,GO:0016278,1,0.6994418916974,0,51,lysine N-methyltransferase activity,MF,
5793,GO:0016279,1,0.703456355842828,0,50,protein-lysine N-methyltransferase activity,MF,
5794,GO:0016281,1,0.942653287173015,0,9,eukaryotic translation initiation factor 4F complex,CC,
5795,GO:0016282,1,0.992865043221225,0,1,eukaryotic 43S preinitiation complex,CC,
5796,GO:0016286,1,0.978219519419194,0,4,small conductance calcium-activated potassium channel activity,MF,
5797,GO:0016287,1,0.994360673758275,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5798,GO:0016289,1,0.910445511468736,0,17,CoA hydrolase activity,MF,
5799,GO:0016290,1,0.952098860884775,0,9,palmitoyl-CoA hydrolase activity,MF,
5800,GO:0016295,1,0.983537681319841,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5801,GO:0016296,1,0.983537681319841,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5802,GO:0016297,1,0.983537681319841,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5804,GO:0016300,1,0.981760566007886,0,3,tRNA (uracil) methyltransferase activity,MF,
5806,GO:0016303,1,0.754175404914304,0,37,1-phosphatidylinositol-3-kinase activity,MF,
5807,GO:0016307,1,0.896496252886741,0,15,phosphatidylinositol phosphate kinase activity,MF,
5808,GO:0016308,1,0.96049405474796,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5809,GO:0016309,1,0.987623702640961,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5812,GO:0016312,1,0.972730936101671,0,4,inositol bisphosphate phosphatase activity,MF,
5813,GO:0016314,1,0.979102972155386,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5814,GO:0016316,1,0.983884906964313,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5815,GO:0016320,1,0.983935831241449,0,2,endoplasmic reticulum membrane fusion,BP,
5816,GO:0016321,1,0.977711015172542,0,4,female meiosis chromosome segregation,BP,
5817,GO:0016322,1,0.938679269648984,0,10,neuron remodeling,BP,
5820,GO:0016327,1,0.906351626614227,0,16,apicolateral plasma membrane,CC,
5823,GO:0016332,1,0.993430164370044,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5824,GO:0016333,1,0.994212042342004,0,1,morphogenesis of follicular epithelium,BP,
5825,GO:0016334,1,0.994212042342004,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5826,GO:0016338,1,0.904138909326763,0,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5827,GO:0016339,1,0.804420125678746,0,33,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5828,GO:0016340,1,0.981671464608988,0,2,calcium-dependent cell-matrix adhesion,BP,
5829,GO:0016342,1,0.827049110496079,0,28,catenin complex,CC,
5830,GO:0016344,1,0.978746952014175,0,3,meiotic chromosome movement towards spindle pole,BP,
5832,GO:0016361,1,0.970935537497821,0,4,activin receptor activity, type I,MF,
5833,GO:0016362,1,0.971707990794304,0,2,activin receptor activity, type II,MF,
5834,GO:0016363,1,0.492040402164825,0,103,nuclear matrix,CC,
5835,GO:0016401,1,0.97367333242191,0,4,palmitoyl-CoA oxidase activity,MF,
5836,GO:0016402,1,0.988833806020496,0,2,pristanoyl-CoA oxidase activity,MF,
5837,GO:0016403,1,0.988163339056869,0,2,dimethylargininase activity,MF,
5838,GO:0016404,1,0.987247968139118,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5839,GO:0016405,1,0.876858725769403,0,22,CoA-ligase activity,MF,
5840,GO:0016406,1,0.964961706818879,0,6,carnitine O-acyltransferase activity,MF,
5841,GO:0016407,1,0.531803313045158,0,94,acetyltransferase activity,MF,
5842,GO:0016408,1,0.906108105583062,0,17,C-acyltransferase activity,MF,
5843,GO:0016409,1,0.786067322365911,0,38,palmitoyltransferase activity,MF,
5844,GO:0016410,1,0.545103181178052,0,92,N-acyltransferase activity,MF,
5845,GO:0016411,1,0.866112712974323,0,21,acylglycerol O-acyltransferase activity,MF,
5846,GO:0016413,1,0.957347392473406,0,7,O-acetyltransferase activity,MF,
5847,GO:0016414,1,0.993992347369817,0,1,O-octanoyltransferase activity,MF,
5848,GO:0016415,1,0.988844497292884,0,2,octanoyltransferase activity,MF,
5849,GO:0016416,1,0.96901807123876,0,5,O-palmitoyltransferase activity,MF,
5850,GO:0016417,1,0.819553652449466,0,31,S-acyltransferase activity,MF,
5851,GO:0016418,1,0.981853590935214,0,2,S-acetyltransferase activity,MF,
5852,GO:0016419,1,0.98348969877463,0,2,S-malonyltransferase activity,MF,
5853,GO:0016420,1,0.98348969877463,0,2,malonyltransferase activity,MF,
5854,GO:0016421,1,0.965691120769808,0,5,CoA carboxylase activity,MF,
5855,GO:0016422,1,0.983669149063477,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5856,GO:0016423,1,0.925541808864554,0,13,tRNA (guanine) methyltransferase activity,MF,
5857,GO:0016426,1,0.983099359241731,0,3,tRNA (adenine) methyltransferase activity,MF,
5858,GO:0016427,1,0.947456962354309,0,8,tRNA (cytosine) methyltransferase activity,MF,
5859,GO:0016428,1,0.973683390026937,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5860,GO:0016429,1,0.983099359241731,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5861,GO:0016433,1,0.967563255168596,0,6,rRNA (adenine) methyltransferase activity,MF,
5862,GO:0016434,1,0.981698282709487,0,3,rRNA (cytosine) methyltransferase activity,MF,
5863,GO:0016435,1,0.980876398314198,0,3,rRNA (guanine) methyltransferase activity,MF,
5864,GO:0016436,1,0.987917175042163,0,2,rRNA (uridine) methyltransferase activity,MF,
5865,GO:0016441,1,0.430205440750239,0,121,posttranscriptional gene silencing,BP,
5866,GO:0016442,1,0.918930095183048,0,11,RISC complex,CC,
5867,GO:0016444,1,0.705467967584233,0,51,somatic cell DNA recombination,BP,
5868,GO:0016445,1,0.726697780622007,0,48,somatic diversification of immunoglobulins,BP,
5869,GO:0016446,1,0.932966209204472,0,11,somatic hypermutation of immunoglobulin genes,BP,
5870,GO:0016447,1,0.751837040392506,0,43,somatic recombination of immunoglobulin gene segments,BP,
5871,GO:0016453,1,0.978409240383459,0,4,C-acetyltransferase activity,MF,
5872,GO:0016454,1,0.967235594272168,0,5,C-palmitoyltransferase activity,MF,
5873,GO:0016458,1,0.231235742129121,0,212,gene silencing,BP,
5874,GO:0016459,1,0.576195837040836,0,64,myosin complex,CC,
5875,GO:0016460,1,0.782485996277194,0,29,myosin II complex,CC,
5876,GO:0016461,1,0.914855954932087,0,10,unconventional myosin complex,CC,
5878,GO:0016469,1,0.850927712321508,0,28,proton-transporting two-sector ATPase complex,CC,
5879,GO:0016471,1,0.914033796864887,0,15,vacuolar proton-transporting V-type ATPase complex,CC,
5880,GO:0016476,1,0.980492493146332,0,3,regulation of embryonic cell shape,BP,
5882,GO:0016479,1,0.9717916856741,0,4,negative regulation of transcription by RNA polymerase I,BP,
5883,GO:0016480,1,0.983970632259191,0,3,negative regulation of transcription by RNA polymerase III,BP,
5884,GO:0016482,1,0.375646034013732,0,136,cytosolic transport,BP,
5886,GO:0016486,1,0.842539205284911,0,27,peptide hormone processing,BP,
5887,GO:0016487,1,0.989566015395049,0,2,farnesol metabolic process,BP,
5888,GO:0016488,1,0.989566015395049,0,2,farnesol catabolic process,BP,
5890,GO:0016492,1,0.987998818596094,0,2,G-protein coupled neurotensin receptor activity,MF,
5891,GO:0016493,1,0.945620900877724,0,10,C-C chemokine receptor activity,MF,
5892,GO:0016494,1,0.956950871909846,0,8,C-X-C chemokine receptor activity,MF,
5893,GO:0016495,1,0.994046251398349,0,1,C-X3-C chemokine receptor activity,MF,
5894,GO:0016496,1,0.993990825057106,0,1,substance P receptor activity,MF,
5895,GO:0016497,1,0.994494031374247,0,1,substance K receptor activity,MF,
5896,GO:0016499,1,0.989366648742806,0,2,orexin receptor activity,MF,
5897,GO:0016500,1,0.934292905706433,0,10,protein-hormone receptor activity,MF,
5898,GO:0016501,1,0.988863982936088,0,2,prostacyclin receptor activity,MF,
5899,GO:0016502,1,0.89516087890028,0,20,nucleotide receptor activity,MF,
5900,GO:0016503,1,0.994787423588828,0,1,pheromone receptor activity,MF,
5901,GO:0016504,1,0.800364776459279,0,35,peptidase activator activity,MF,
5902,GO:0016505,1,0.894181318087704,0,17,peptidase activator activity involved in apoptotic process,MF,
5903,GO:0016507,1,0.994138245464926,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5904,GO:0016508,1,0.982035416055629,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5905,GO:0016509,1,0.9832483615504,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5906,GO:0016514,1,0.899061310325337,0,15,SWI/SNF complex,CC,
5907,GO:0016517,1,0.994649138174134,0,1,interleukin-12 receptor activity,MF,
5908,GO:0016519,1,0.994635211808564,0,1,gastric inhibitory peptide receptor activity,MF,
5909,GO:0016520,1,0.987577728468979,0,2,growth hormone-releasing hormone receptor activity,MF,
5910,GO:0016521,1,0.994053230509328,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5914,GO:0016530,1,0.953397655804692,0,7,metallochaperone activity,MF,
5915,GO:0016531,1,0.968467081999344,0,5,copper chaperone activity,MF,
5916,GO:0016532,1,0.978540570769763,0,3,superoxide dismutase copper chaperone activity,MF,
5917,GO:0016533,1,0.982856991325436,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5918,GO:0016534,1,0.987989870511047,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5919,GO:0016538,1,0.846234267405075,0,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5920,GO:0016539,1,0.994746455661165,0,1,intein-mediated protein splicing,BP,
5921,GO:0016540,1,0.92229275931476,0,13,protein autoprocessing,BP,
5922,GO:0016553,1,0.913203684798657,0,14,base conversion or substitution editing,BP,
5923,GO:0016554,1,0.950571953250379,0,9,cytidine to uridine editing,BP,
5924,GO:0016556,1,0.919875604682507,0,15,mRNA modification,BP,
5925,GO:0016557,1,0.983890630896757,0,3,peroxisome membrane biogenesis,BP,
5926,GO:0016558,1,0.930182180366509,0,12,protein import into peroxisome matrix,BP,
5928,GO:0016560,1,0.97550270734286,0,4,protein import into peroxisome matrix, docking,BP,
5929,GO:0016561,1,0.988485918953233,0,2,protein import into peroxisome matrix, translocation,BP,
5931,GO:0016569,1,0.0485308762837082,0,427,covalent chromatin modification,BP,
5932,GO:0016570,1,0.0511475720349471,0,419,histone modification,BP,
5933,GO:0016571,1,0.417985439280088,0,122,histone methylation,BP,
5934,GO:0016572,1,0.800372208258631,0,34,histone phosphorylation,BP,
5935,GO:0016573,1,0.393661960380522,0,137,histone acetylation,BP,
5936,GO:0016574,1,0.735679200115744,0,43,histone ubiquitination,BP,
5937,GO:0016575,1,0.560000570118977,0,83,histone deacetylation,BP,
5938,GO:0016576,1,0.961486855483949,0,6,histone dephosphorylation,BP,
5939,GO:0016577,1,0.804506453327009,0,27,histone demethylation,BP,
5940,GO:0016578,1,0.859447666624629,0,22,histone deubiquitination,BP,
5941,GO:0016579,1,0.178698922332034,0,249,protein deubiquitination,BP,
5942,GO:0016580,1,0.914517560074978,0,12,Sin3 complex,CC,
5943,GO:0016581,1,0.874164894137081,0,17,NuRD complex,CC,
5944,GO:0016584,1,0.959028512770007,0,7,nucleosome positioning,BP,
5945,GO:0016586,1,0.982644851381959,0,2,RSC-type complex,CC,
5946,GO:0016589,1,0.946448337232123,0,7,NURF complex,CC,
5947,GO:0016590,1,0.991307980375937,0,1,ACF complex,CC,
5948,GO:0016591,1,0.495528380366728,0,107,DNA-directed RNA polymerase II, holoenzyme,CC,
5949,GO:0016592,1,0.77673159215871,0,36,mediator complex,CC,
5950,GO:0016593,1,0.945434673667138,0,8,Cdc73/Paf1 complex,CC,
5953,GO:0016596,1,0.994313214468247,0,1,thienylcyclohexylpiperidine binding,MF,
5955,GO:0016598,1,0.989293154928348,0,2,protein arginylation,BP,
5956,GO:0016600,1,0.933377559873749,0,9,flotillin complex,CC,
5957,GO:0016601,1,0.77443324223312,0,37,Rac protein signal transduction,BP,
5958,GO:0016602,1,0.974579094634141,0,4,CCAAT-binding factor complex,CC,
5959,GO:0016603,1,0.989341385594393,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5961,GO:0016605,1,0.521594027974762,0,94,PML body,CC,
5963,GO:0016608,1,0.989701274408168,0,2,growth hormone-releasing hormone activity,MF,
5964,GO:0016614,1,0.501037375799988,0,118,oxidoreductase activity, acting on CH-OH group of donors,MF,
5965,GO:0016615,1,0.960696846491143,0,7,malate dehydrogenase activity,MF,
5966,GO:0016616,1,0.552084521696673,0,104,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
5967,GO:0016618,1,0.983233262271782,0,3,hydroxypyruvate reductase activity,MF,
5968,GO:0016620,1,0.823342228182356,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5969,GO:0016623,1,0.987137601027654,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5970,GO:0016624,1,0.952411787150077,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5971,GO:0016627,1,0.724400445184757,0,54,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5972,GO:0016628,1,0.868661203116035,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5973,GO:0016634,1,0.952214679295823,0,8,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5974,GO:0016635,1,0.973342876147379,0,5,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5976,GO:0016639,1,0.98321032981241,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5978,GO:0016642,1,0.993507489775592,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5979,GO:0016645,1,0.862671297577452,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5980,GO:0016646,1,0.902555732187958,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5981,GO:0016647,1,0.983925095804988,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5982,GO:0016649,1,0.988551267231191,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5983,GO:0016651,1,0.57246267880014,0,98,oxidoreductase activity, acting on NAD(P)H,MF,
5984,GO:0016652,1,0.987528919870452,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5985,GO:0016653,1,0.918488495134074,0,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5986,GO:0016655,1,0.758273381437492,0,52,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5987,GO:0016657,1,0.989462300783792,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5988,GO:0016661,1,0.971260457896873,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5989,GO:0016662,1,0.994406694608454,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5991,GO:0016668,1,0.930164294060157,0,13,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5992,GO:0016670,1,0.950833396881241,0,8,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5993,GO:0016671,1,0.940139631748132,0,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5994,GO:0016672,1,0.989618241520137,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5995,GO:0016675,1,0.882493337437107,0,23,oxidoreductase activity, acting on a heme group of donors,MF,
5996,GO:0016676,1,0.887422625962654,0,22,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5997,GO:0016679,1,0.956901058502937,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5998,GO:0016681,1,0.962288914958679,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5999,GO:0016684,1,0.780270558593812,0,42,oxidoreductase activity, acting on peroxide as acceptor,MF,
6000,GO:0016701,1,0.869459070886477,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
6001,GO:0016702,1,0.869459070886477,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
6003,GO:0016706,1,0.755535195144034,0,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
6004,GO:0016708,1,0.989140960332087,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6005,GO:0016709,1,0.801703623643639,0,36,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6006,GO:0016711,1,0.994403147306235,0,1,flavonoid 3'-monooxygenase activity,MF,
6007,GO:0016712,1,0.89683261183947,0,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6008,GO:0016713,1,0.989395680448928,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
6009,GO:0016714,1,0.962495189649646,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
6011,GO:0016717,1,0.967993774746185,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
6012,GO:0016721,1,0.97394297689629,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6016,GO:0016725,1,0.954422168067843,0,7,oxidoreductase activity, acting on CH or CH2 groups,MF,
6017,GO:0016726,1,0.98401033320613,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
6018,GO:0016727,1,0.991559595039779,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6019,GO:0016728,1,0.98049805936824,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6020,GO:0016730,1,0.994673885774967,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6021,GO:0016731,1,0.994673885774967,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6024,GO:0016742,1,0.951340774834095,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6025,GO:0016743,1,0.976576492985218,0,3,carboxyl- or carbamoyltransferase activity,MF,
6026,GO:0016744,1,0.983879050857146,0,3,transferase activity, transferring aldehyde or ketonic groups,MF,
6027,GO:0016746,1,0.243469954730893,0,220,transferase activity, transferring acyl groups,MF,
6028,GO:0016747,1,0.286448473907231,0,193,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6029,GO:0016748,1,0.983521161212022,0,3,succinyltransferase activity,MF,
6030,GO:0016749,1,0.989192233409595,0,2,N-succinyltransferase activity,MF,
6031,GO:0016751,1,0.994267588319634,0,1,S-succinyltransferase activity,MF,
6032,GO:0016755,1,0.934483503802215,0,12,transferase activity, transferring amino-acyl groups,MF,
6036,GO:0016765,1,0.732278968137184,0,54,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6037,GO:0016768,1,0.994722907064065,0,1,spermine synthase activity,MF,
6038,GO:0016769,1,0.887788564520279,0,19,transferase activity, transferring nitrogenous groups,MF,
6041,GO:0016774,1,0.983025093941202,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6042,GO:0016775,1,0.923144610941605,0,12,phosphotransferase activity, nitrogenous group as acceptor,MF,
6043,GO:0016776,1,0.76883747834719,0,41,phosphotransferase activity, phosphate group as acceptor,MF,
6044,GO:0016778,1,0.973034064247021,0,5,diphosphotransferase activity,MF,
6045,GO:0016779,1,0.429121066661769,0,132,nucleotidyltransferase activity,MF,
6046,GO:0016780,1,0.895016966934171,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6047,GO:0016781,1,0.988994073781482,0,2,phosphotransferase activity, paired acceptors,MF,
6048,GO:0016782,1,0.666281070645277,0,66,transferase activity, transferring sulfur-containing groups,MF,
6049,GO:0016783,1,0.937909876990749,0,12,sulfurtransferase activity,MF,
6050,GO:0016784,1,0.994763606144711,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6051,GO:0016785,1,0.991662926838147,0,1,transferase activity, transferring selenium-containing groups,MF,
6054,GO:0016790,1,0.831688316636651,0,32,thiolester hydrolase activity,MF,
6056,GO:0016793,1,0.994031455799731,0,1,triphosphoric monoester hydrolase activity,MF,
6057,GO:0016794,1,0.994814956602968,0,1,diphosphoric monoester hydrolase activity,MF,
6058,GO:0016796,1,0.718618230422372,0,50,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6060,GO:0016799,1,0.88238993171344,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6061,GO:0016801,1,0.922523559954689,0,14,hydrolase activity, acting on ether bonds,MF,
6062,GO:0016802,1,0.980270778395442,0,3,trialkylsulfonium hydrolase activity,MF,
6063,GO:0016803,1,0.941101937335932,0,11,ether hydrolase activity,MF,
6064,GO:0016805,1,0.909378331090889,0,16,dipeptidase activity,MF,
6065,GO:0016807,1,0.994313214468247,0,1,cysteine-type carboxypeptidase activity,MF,
6066,GO:0016810,1,0.421391421290677,0,137,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
6067,GO:0016811,1,0.585480659237596,0,84,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6068,GO:0016812,1,0.951759179898075,0,7,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6069,GO:0016813,1,0.943422167129985,0,10,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6070,GO:0016814,1,0.834189846395771,0,30,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6071,GO:0016815,1,0.994780129678445,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6074,GO:0016822,1,0.984335538067658,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6075,GO:0016823,1,0.984335538067658,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6076,GO:0016826,1,0.994316663584809,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6077,GO:0016829,1,0.384823097387159,0,160,lyase activity,MF,
6078,GO:0016830,1,0.761149622771336,0,47,carbon-carbon lyase activity,MF,
6079,GO:0016831,1,0.829979282104064,0,32,carboxy-lyase activity,MF,
6080,GO:0016832,1,0.954488713142163,0,8,aldehyde-lyase activity,MF,
6081,GO:0016833,1,0.964261819868331,0,6,oxo-acid-lyase activity,MF,
6082,GO:0016835,1,0.682693577844558,0,66,carbon-oxygen lyase activity,MF,
6083,GO:0016836,1,0.758978667415558,0,48,hydro-lyase activity,MF,
6084,GO:0016838,1,0.983832110553418,0,3,carbon-oxygen lyase activity, acting on phosphates,MF,
6085,GO:0016840,1,0.93098443110721,0,13,carbon-nitrogen lyase activity,MF,
6086,GO:0016841,1,0.973012104853141,0,5,ammonia-lyase activity,MF,
6087,GO:0016842,1,0.962292652252754,0,7,amidine-lyase activity,MF,
6088,GO:0016843,1,0.994313214468247,0,1,amine-lyase activity,MF,
6089,GO:0016844,1,0.994313214468247,0,1,strictosidine synthase activity,MF,
6090,GO:0016846,1,0.953475379966302,0,9,carbon-sulfur lyase activity,MF,
6091,GO:0016849,1,0.883831359477681,0,16,phosphorus-oxygen lyase activity,MF,
6092,GO:0016853,1,0.455874591755902,0,132,isomerase activity,MF,
6093,GO:0016854,1,0.905892301006151,0,16,racemase and epimerase activity,MF,
6094,GO:0016855,1,0.994465458292206,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6095,GO:0016857,1,0.930347536680437,0,11,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6096,GO:0016859,1,0.822333526251215,0,33,cis-trans isomerase activity,MF,
6097,GO:0016860,1,0.779530976272196,0,43,intramolecular oxidoreductase activity,MF,
6098,GO:0016861,1,0.957695180073232,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6099,GO:0016862,1,0.989701588135291,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6100,GO:0016863,1,0.946588222100541,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6101,GO:0016864,1,0.899953906879261,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6102,GO:0016866,1,0.85377716691054,0,27,intramolecular transferase activity,MF,
6103,GO:0016868,1,0.935951495191849,0,11,intramolecular transferase activity, phosphotransferases,MF,
6104,GO:0016872,1,0.994556353522904,0,1,intramolecular lyase activity,MF,
6105,GO:0016874,1,0.39156822176194,0,150,ligase activity,MF,
6106,GO:0016875,1,0.772390722207143,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6107,GO:0016877,1,0.805290793367527,0,36,ligase activity, forming carbon-sulfur bonds,MF,
6108,GO:0016878,1,0.857364251300127,0,26,acid-thiol ligase activity,MF,
6109,GO:0016879,1,0.729721178983773,0,48,ligase activity, forming carbon-nitrogen bonds,MF,
6110,GO:0016880,1,0.97935131755943,0,3,acid-ammonia (or amide) ligase activity,MF,
6111,GO:0016881,1,0.890712853815554,0,19,acid-amino acid ligase activity,MF,
6112,GO:0016882,1,0.988695946044195,0,2,cyclo-ligase activity,MF,
6113,GO:0016884,1,0.935826748879988,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6114,GO:0016885,1,0.954063739837026,0,7,ligase activity, forming carbon-carbon bonds,MF,
6115,GO:0016886,1,0.943135444721847,0,10,ligase activity, forming phosphoric ester bonds,MF,
6117,GO:0016888,1,0.935113077508534,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6118,GO:0016889,1,0.893239728119851,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6119,GO:0016890,1,0.987725673643294,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6120,GO:0016891,1,0.850925143814866,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6121,GO:0016892,1,0.958447056718638,0,8,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6122,GO:0016893,1,0.815124160885663,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6123,GO:0016894,1,0.856081887535676,0,28,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6124,GO:0016895,1,0.89089407207213,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6125,GO:0016896,1,0.802639102422936,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6126,GO:0016898,1,0.989075745694475,0,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6127,GO:0016899,1,0.97960017914138,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6128,GO:0016900,1,0.989655062385533,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6129,GO:0016901,1,0.985672722189292,0,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6130,GO:0016903,1,0.777592766350349,0,41,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6131,GO:0016907,1,0.965483543108663,0,6,G-protein coupled acetylcholine receptor activity,MF,
6132,GO:0016909,1,0.981286714231871,0,3,SAP kinase activity,MF,
6134,GO:0016918,1,0.930371847856763,0,13,retinal binding,MF,
6135,GO:0016920,1,0.990176686714676,0,1,pyroglutamyl-peptidase activity,MF,
6136,GO:0016922,1,0.847980726935477,0,21,ligand-dependent nuclear receptor binding,MF,
6137,GO:0016925,1,0.553468062351473,0,88,protein sumoylation,BP,
6138,GO:0016926,1,0.951864976622762,0,7,protein desumoylation,BP,
6139,GO:0016929,1,0.956913494834667,0,6,SUMO-specific protease activity,MF,
6140,GO:0016933,1,0.971507146577796,0,5,extracellularly glycine-gated ion channel activity,MF,
6141,GO:0016934,1,0.971507146577796,0,5,extracellularly glycine-gated chloride channel activity,MF,
6142,GO:0016935,1,0.98787098612731,0,2,glycine-gated chloride channel complex,CC,
6143,GO:0016936,1,0.979018683756341,0,4,galactoside binding,MF,
6144,GO:0016938,1,0.99420426232661,0,1,kinesin I complex,CC,
6145,GO:0016939,1,0.976551545685357,0,3,kinesin II complex,CC,
6146,GO:0016941,1,0.981491705872134,0,3,natriuretic peptide receptor activity,MF,
6147,GO:0016942,1,0.965359697925251,0,5,insulin-like growth factor binding protein complex,CC,
6148,GO:0016964,1,0.982995869685613,0,1,alpha-2 macroglobulin receptor activity,MF,
6149,GO:0016971,1,0.981637858119575,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6150,GO:0016972,1,0.974373387771054,0,4,thiol oxidase activity,MF,
6151,GO:0016973,1,0.930061781032846,0,12,poly(A)+ mRNA export from nucleus,BP,
6152,GO:0016979,1,0.994773118238287,0,1,lipoate-protein ligase activity,MF,
6153,GO:0016990,1,0.994551376364011,0,1,arginine deiminase activity,MF,
6154,GO:0016992,1,0.994726586318505,0,1,lipoate synthase activity,MF,
6155,GO:0016997,1,0.972787726947417,0,5,alpha-sialidase activity,MF,
6156,GO:0016998,1,0.978520782220887,0,4,cell wall macromolecule catabolic process,BP,
6157,GO:0016999,1,0.48175885690491,0,124,antibiotic metabolic process,BP,
6158,GO:0017000,1,0.906274465660307,0,15,antibiotic biosynthetic process,BP,
6159,GO:0017001,1,0.782921853148225,0,43,antibiotic catabolic process,BP,
6160,GO:0017002,1,0.935986814308221,0,7,activin-activated receptor activity,MF,
6161,GO:0017003,1,0.994546730640956,0,1,protein-heme linkage,BP,
6162,GO:0017004,1,0.818588117749332,0,34,cytochrome complex assembly,BP,
6163,GO:0017005,1,0.993670099228364,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6164,GO:0017006,1,0.994546730640956,0,1,protein-tetrapyrrole linkage,BP,
6165,GO:0017014,1,0.910319203289731,0,13,protein nitrosylation,BP,
6168,GO:0017017,1,0.938387658982629,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6169,GO:0017018,1,0.96666522530753,0,4,myosin phosphatase activity,MF,
6170,GO:0017020,1,0.99425809674193,0,1,myosin phosphatase regulator activity,MF,
6171,GO:0017022,1,0.668244064263893,0,58,myosin binding,MF,
6172,GO:0017024,1,0.994825300762046,0,1,myosin I binding,MF,
6173,GO:0017025,1,0.852018826105898,0,25,TBP-class protein binding,MF,
6174,GO:0017034,1,0.958854546589344,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6175,GO:0017038,1,0.307191321102351,0,179,protein import,BP,
6176,GO:0017040,1,0.971337542674104,0,5,N-acylsphingosine amidohydrolase activity,MF,
6177,GO:0017042,1,0.99472470365035,0,1,glycosylceramidase activity,MF,
6178,GO:0017045,1,0.994791517233043,0,1,corticotropin-releasing hormone activity,MF,
6179,GO:0017046,1,0.786781496403507,0,36,peptide hormone binding,MF,
6180,GO:0017048,1,0.283637260201741,0,164,Rho GTPase binding,MF,
6181,GO:0017049,1,0.877592589434123,0,20,GTP-Rho binding,MF,
6182,GO:0017050,1,0.988909845278224,0,2,D-erythro-sphingosine kinase activity,MF,
6183,GO:0017053,1,0.541880217808196,0,82,transcriptional repressor complex,CC,
6184,GO:0017055,1,0.988382346706516,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6185,GO:0017056,1,0.848561898943224,0,23,structural constituent of nuclear pore,MF,
6186,GO:0017057,1,0.983047981066264,0,2,6-phosphogluconolactonase activity,MF,
6187,GO:0017059,1,0.951837456710385,0,8,serine C-palmitoyltransferase complex,CC,
6188,GO:0017060,1,0.983440810603246,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6189,GO:0017061,1,0.99242762232126,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6190,GO:0017062,1,0.946879650384161,0,9,respiratory chain complex III assembly,BP,
6191,GO:0017064,1,0.98928131287472,0,2,fatty acid amide hydrolase activity,MF,
6192,GO:0017065,1,0.994747371244621,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6193,GO:0017069,1,0.79609256425492,0,38,snRNA binding,MF,
6194,GO:0017070,1,0.935872383718684,0,11,U6 snRNA binding,MF,
6195,GO:0017071,1,0.993660043761333,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6198,GO:0017077,1,0.989290016975703,0,2,oxidative phosphorylation uncoupler activity,MF,
6199,GO:0017080,1,0.805628891377314,0,33,sodium channel regulator activity,MF,
6200,GO:0017081,1,0.897706436932295,0,16,chloride channel regulator activity,MF,
6201,GO:0017082,1,0.994313214468247,0,1,mineralocorticoid receptor activity,MF,
6202,GO:0017084,1,0.993817351434055,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6203,GO:0017085,1,0.903949293746158,0,16,response to insecticide,BP,
6204,GO:0017087,1,0.993416221522857,0,1,mitochondrial processing peptidase complex,CC,
6205,GO:0017089,1,0.989199347624171,0,2,glycolipid transporter activity,MF,
6206,GO:0017090,1,0.994213655836536,0,1,meprin A complex,CC,
6207,GO:0017091,1,0.860119418217191,0,24,AU-rich element binding,MF,
6208,GO:0017095,1,0.975897585349217,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6209,GO:0017098,1,0.988975396820678,0,2,sulfonylurea receptor binding,MF,
6210,GO:0017099,1,0.977694362111163,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6211,GO:0017101,1,0.930573313296213,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
6212,GO:0017102,1,0.988534636674923,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6213,GO:0017108,1,0.970775015044409,0,5,5'-flap endonuclease activity,MF,
6214,GO:0017109,1,0.987755890252162,0,2,glutamate-cysteine ligase complex,CC,
6215,GO:0017110,1,0.918215396066877,0,13,nucleoside-diphosphatase activity,MF,
6217,GO:0017112,1,0.697757983826866,0,51,Rab guanyl-nucleotide exchange factor activity,MF,
6218,GO:0017113,1,0.994085496691891,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6219,GO:0017116,1,0.981121595522892,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6220,GO:0017119,1,0.922379851108668,0,13,Golgi transport complex,CC,
6221,GO:0017121,1,0.939375842405864,0,10,phospholipid scrambling,BP,
6223,GO:0017125,1,0.992605626623903,0,1,deoxycytidyl transferase activity,MF,
6224,GO:0017126,1,0.991995805687174,0,1,nucleologenesis,BP,
6225,GO:0017127,1,0.902266197557764,0,15,cholesterol transporter activity,MF,
6226,GO:0017128,1,0.950117511888692,0,8,phospholipid scramblase activity,MF,
6227,GO:0017129,1,0.988325191236664,0,2,triglyceride binding,MF,
6228,GO:0017130,1,0.990439316474678,0,1,poly(C) RNA binding,MF,
6229,GO:0017133,1,0.994520284237139,0,1,mitochondrial electron transfer flavoprotein complex,CC,
6230,GO:0017134,1,0.861082353871262,0,21,fibroblast growth factor binding,MF,
6231,GO:0017136,1,0.899747377893229,0,16,NAD-dependent histone deacetylase activity,MF,
6233,GO:0017143,1,0.988805478628717,0,2,insecticide metabolic process,BP,
6235,GO:0017145,1,0.771872654142238,0,37,stem cell division,BP,
6237,GO:0017147,1,0.812916815706653,0,31,Wnt-protein binding,MF,
6238,GO:0017148,1,0.234272721322897,0,206,negative regulation of translation,BP,
6239,GO:0017150,1,0.978439163542573,0,4,tRNA dihydrouridine synthase activity,MF,
6240,GO:0017151,1,0.948115590080756,0,8,DEAD/H-box RNA helicase binding,MF,
6241,GO:0017153,1,0.939711322029792,0,9,sodium:dicarboxylate symporter activity,MF,
6242,GO:0017154,1,0.903686868885401,0,11,semaphorin receptor activity,MF,
6246,GO:0017159,1,0.982952298788857,0,3,pantetheine hydrolase activity,MF,
6247,GO:0017160,1,0.891092485788641,0,16,Ral GTPase binding,MF,
6248,GO:0017161,1,0.983884906964313,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6249,GO:0017162,1,0.937442117271579,0,9,aryl hydrocarbon receptor binding,MF,
6250,GO:0017166,1,0.918229370427746,0,10,vinculin binding,MF,
6251,GO:0017168,1,0.993315684100996,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6252,GO:0017169,1,0.961328334695831,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6254,GO:0017172,1,0.994739305834967,0,1,cysteine dioxygenase activity,MF,
6255,GO:0017174,1,0.994812803943105,0,1,glycine N-methyltransferase activity,MF,
6256,GO:0017176,1,0.962757801290671,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6257,GO:0017177,1,0.993434803223848,0,1,glucosidase II complex,CC,
6258,GO:0017178,1,0.994313214468247,0,1,diphthine-ammonia ligase activity,MF,
6259,GO:0017182,1,0.954958067410489,0,8,peptidyl-diphthamide metabolic process,BP,
6260,GO:0017183,1,0.954958067410489,0,8,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6261,GO:0017185,1,0.953614610948278,0,8,peptidyl-lysine hydroxylation,BP,
6262,GO:0017186,1,0.989341385594393,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6263,GO:0017187,1,0.956639319960992,0,8,peptidyl-glutamic acid carboxylation,BP,
6264,GO:0017188,1,0.991433328042963,0,1,aspartate N-acetyltransferase activity,MF,
6265,GO:0017196,1,0.960566535688378,0,6,N-terminal peptidyl-methionine acetylation,BP,
6266,GO:0017198,1,0.989610090810955,0,2,N-terminal peptidyl-serine acetylation,BP,
6267,GO:0018002,1,0.989610090810955,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6268,GO:0018008,1,0.984854102081143,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6269,GO:0018009,1,0.994602001112438,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6270,GO:0018011,1,0.994313214468247,0,1,N-terminal peptidyl-alanine methylation,BP,
6271,GO:0018012,1,0.994313214468247,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6272,GO:0018013,1,0.994313214468247,0,1,N-terminal peptidyl-glycine methylation,BP,
6273,GO:0018016,1,0.994313214468247,0,1,N-terminal peptidyl-proline dimethylation,BP,
6274,GO:0018022,1,0.470397570262291,0,104,peptidyl-lysine methylation,BP,
6275,GO:0018023,1,0.778649876479293,0,35,peptidyl-lysine trimethylation,BP,
6276,GO:0018024,1,0.74219154620333,0,41,histone-lysine N-methyltransferase activity,MF,
6277,GO:0018025,1,0.994313214468247,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6278,GO:0018026,1,0.946229291483781,0,8,peptidyl-lysine monomethylation,BP,
6279,GO:0018027,1,0.899782680758896,0,15,peptidyl-lysine dimethylation,BP,
6280,GO:0018032,1,0.99359549975056,0,1,protein amidation,BP,
6281,GO:0018057,1,0.975782111930968,0,4,peptidyl-lysine oxidation,BP,
6282,GO:0018063,1,0.994546730640956,0,1,cytochrome c-heme linkage,BP,
6283,GO:0018065,1,0.938898486369844,0,12,protein-cofactor linkage,BP,
6284,GO:0018076,1,0.961222288113632,0,4,N-terminal peptidyl-lysine acetylation,BP,
6285,GO:0018094,1,0.988484195049334,0,2,protein polyglycylation,BP,
6286,GO:0018095,1,0.946076042161401,0,9,protein polyglutamylation,BP,
6287,GO:0018101,1,0.975279410549987,0,4,protein citrullination,BP,
6288,GO:0018103,1,0.963427208163996,0,5,protein C-linked glycosylation,BP,
6289,GO:0018105,1,0.166235310200744,0,255,peptidyl-serine phosphorylation,BP,
6290,GO:0018106,1,0.994833393939528,0,1,peptidyl-histidine phosphorylation,BP,
6293,GO:0018114,1,0.994465458292206,0,1,threonine racemase activity,MF,
6294,GO:0018117,1,0.994732013676537,0,1,protein adenylylation,BP,
6295,GO:0018119,1,0.910319203289731,0,13,peptidyl-cysteine S-nitrosylation,BP,
6296,GO:0018125,1,0.983395102450995,0,3,peptidyl-cysteine methylation,BP,
6297,GO:0018126,1,0.870370981850614,0,22,protein hydroxylation,BP,
6301,GO:0018153,1,0.988869520363358,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6302,GO:0018158,1,0.932889724126527,0,12,protein oxidation,BP,
6303,GO:0018160,1,0.994764489884017,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6304,GO:0018166,1,0.992178219384704,0,1,C-terminal protein-tyrosinylation,BP,
6305,GO:0018171,1,0.977123762282941,0,4,peptidyl-cysteine oxidation,BP,
6306,GO:0018175,1,0.994732013676537,0,1,protein nucleotidylation,BP,
6307,GO:0018192,1,0.994477249259959,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6309,GO:0018194,1,0.994313214468247,0,1,peptidyl-alanine modification,BP,
6310,GO:0018195,1,0.881653474237305,0,22,peptidyl-arginine modification,BP,
6311,GO:0018196,1,0.765047052649135,0,43,peptidyl-asparagine modification,BP,
6312,GO:0018197,1,0.977538271958167,0,3,peptidyl-aspartic acid modification,BP,
6313,GO:0018198,1,0.749363526233259,0,45,peptidyl-cysteine modification,BP,
6314,GO:0018199,1,0.97832836654458,0,4,peptidyl-glutamine modification,BP,
6315,GO:0018200,1,0.84877397969467,0,28,peptidyl-glutamic acid modification,BP,
6316,GO:0018201,1,0.979252595661419,0,3,peptidyl-glycine modification,BP,
6317,GO:0018202,1,0.940849388243272,0,10,peptidyl-histidine modification,BP,
6318,GO:0018205,1,0.0875015271529089,0,357,peptidyl-lysine modification,BP,
6319,GO:0018206,1,0.933997515915989,0,11,peptidyl-methionine modification,BP,
6320,GO:0018208,1,0.762185395840181,0,45,peptidyl-proline modification,BP,
6323,GO:0018211,1,0.963427208163996,0,5,peptidyl-tryptophan modification,BP,
6325,GO:0018214,1,0.956639319960992,0,8,protein carboxylation,BP,
6326,GO:0018216,1,0.918680205525383,0,15,peptidyl-arginine methylation,BP,
6327,GO:0018217,1,0.993342167507596,0,1,peptidyl-aspartic acid phosphorylation,BP,
6328,GO:0018230,1,0.870913060578012,0,22,peptidyl-L-cysteine S-palmitoylation,BP,
6329,GO:0018231,1,0.870913060578012,0,22,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6332,GO:0018262,1,0.988869520363358,0,2,isopeptide cross-linking,BP,
6333,GO:0018271,1,0.991278145749113,0,1,biotin-protein ligase activity,MF,
6334,GO:0018272,1,0.994711632107073,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6335,GO:0018277,1,0.994516558998709,0,1,protein deamination,BP,
6336,GO:0018279,1,0.772521141964157,0,42,protein N-linked glycosylation via asparagine,BP,
6337,GO:0018282,1,0.984655139474164,0,2,metal incorporation into metallo-sulfur cluster,BP,
6338,GO:0018283,1,0.984655139474164,0,2,iron incorporation into metallo-sulfur cluster,BP,
6339,GO:0018293,1,0.994799526798642,0,1,protein-FAD linkage,BP,
6340,GO:0018298,1,0.955611916501059,0,8,protein-chromophore linkage,BP,
6341,GO:0018307,1,0.989328432489846,0,2,enzyme active site formation,BP,
6342,GO:0018312,1,0.988059353916983,0,2,peptidyl-serine ADP-ribosylation,BP,
6343,GO:0018315,1,0.993089170363745,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6344,GO:0018317,1,0.963427208163996,0,5,protein C-linked glycosylation via tryptophan,BP,
6345,GO:0018322,1,0.992178219384704,0,1,protein tyrosinylation,BP,
6346,GO:0018323,1,0.994822876044542,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6347,GO:0018335,1,0.975353402862116,0,4,protein succinylation,BP,
6348,GO:0018342,1,0.939534328425072,0,9,protein prenylation,BP,
6349,GO:0018343,1,0.989054668265066,0,2,protein farnesylation,BP,
6350,GO:0018344,1,0.957118085896751,0,7,protein geranylgeranylation,BP,
6351,GO:0018345,1,0.819882859545848,0,32,protein palmitoylation,BP,
6352,GO:0018350,1,0.994505209403857,0,1,protein esterification,BP,
6353,GO:0018352,1,0.989253998649651,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6354,GO:0018364,1,0.989668365398275,0,2,peptidyl-glutamine methylation,BP,
6355,GO:0018377,1,0.968745928877543,0,4,protein myristoylation,BP,
6356,GO:0018393,1,0.386976174180734,0,140,internal peptidyl-lysine acetylation,BP,
6357,GO:0018394,1,0.369610265898175,0,147,peptidyl-lysine acetylation,BP,
6358,GO:0018395,1,0.993689247411896,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6359,GO:0018400,1,0.990618350215104,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6360,GO:0018401,1,0.968199249106399,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6361,GO:0018406,1,0.963427208163996,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6363,GO:0018423,1,0.989049545135558,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6364,GO:0018444,1,0.978157404252469,0,3,translation release factor complex,CC,
6365,GO:0018455,1,0.994791153657207,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6366,GO:0018467,1,0.994384596167024,0,1,formaldehyde dehydrogenase activity,MF,
6367,GO:0018478,1,0.994585019354448,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6368,GO:0018479,1,0.989344247050923,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6369,GO:0018549,1,0.994719042753907,0,1,methanethiol oxidase activity,MF,
6370,GO:0018585,1,0.994592913829286,0,1,fluorene oxygenase activity,MF,
6371,GO:0018636,1,0.984416200855396,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6372,GO:0018685,1,0.994714208385392,0,1,alkane 1-monooxygenase activity,MF,
6373,GO:0018733,1,0.994800916507524,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6374,GO:0018738,1,0.994800598465232,0,1,S-formylglutathione hydrolase activity,MF,
6375,GO:0018773,1,0.99472564749793,0,1,acetylpyruvate hydrolase activity,MF,
6376,GO:0018812,1,0.977444251132158,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6377,GO:0018872,1,0.994470023170916,0,1,arsonoacetate metabolic process,BP,
6378,GO:0018874,1,0.994627139633185,0,1,benzoate metabolic process,BP,
6379,GO:0018879,1,0.988994187547319,0,2,biphenyl metabolic process,BP,
6380,GO:0018885,1,0.994727520125496,0,1,carbon tetrachloride metabolic process,BP,
6381,GO:0018894,1,0.988805478628717,0,2,dibenzo-p-dioxin metabolic process,BP,
6382,GO:0018904,1,0.909861718742358,0,16,ether metabolic process,BP,
6383,GO:0018910,1,0.994727520125496,0,1,benzene metabolic process,BP,
6384,GO:0018916,1,0.977812171146801,0,4,nitrobenzene metabolic process,BP,
6385,GO:0018917,1,0.994592913829286,0,1,fluorene metabolic process,BP,
6386,GO:0018931,1,0.994774589322036,0,1,naphthalene metabolic process,BP,
6388,GO:0018963,1,0.989072575643987,0,2,phthalate metabolic process,BP,
6390,GO:0018969,1,0.994239752010479,0,1,thiocyanate metabolic process,BP,
6391,GO:0018992,1,0.985366539081611,0,2,germ-line sex determination,BP,
6392,GO:0018993,1,0.988407826480598,0,2,somatic sex determination,BP,
6393,GO:0018995,1,0.647862052474353,0,65,host,CC,
6395,GO:0019002,1,0.986747699978839,0,2,GMP binding,MF,
6397,GO:0019005,1,0.709947605985381,0,55,SCF ubiquitin ligase complex,CC,
6398,GO:0019008,1,0.987997034674246,0,2,molybdopterin synthase complex,CC,
6399,GO:0019034,1,0.98547428097576,0,2,viral replication complex,CC,
6400,GO:0019035,1,0.991583832979523,0,1,viral integration complex,CC,
6401,GO:0019042,1,0.930889801979332,0,11,viral latency,BP,
6402,GO:0019043,1,0.950147347898076,0,9,establishment of viral latency,BP,
6403,GO:0019045,1,0.97974229251673,0,2,latent virus replication,BP,
6404,GO:0019046,1,0.97974229251673,0,2,release from viral latency,BP,
6405,GO:0019048,1,0.796310582325231,0,32,modulation by virus of host morphology or physiology,BP,
6406,GO:0019049,1,0.972722566613264,0,4,evasion or tolerance of host defenses by virus,BP,
6407,GO:0019050,1,0.983694538813033,0,3,suppression by virus of host apoptotic process,BP,
6408,GO:0019054,1,0.870929880424122,0,21,modulation by virus of host process,BP,
6409,GO:0019056,1,0.994254086098554,0,1,modulation by virus of host transcription,BP,
6411,GO:0019060,1,0.989547006477997,0,2,intracellular transport of viral protein in host cell,BP,
6412,GO:0019061,1,0.994551761275117,0,1,uncoating of virus,BP,
6413,GO:0019062,1,0.95675341097091,0,7,virion attachment to host cell,BP,
6414,GO:0019064,1,0.966617115612413,0,6,fusion of virus membrane with host plasma membrane,BP,
6415,GO:0019065,1,0.981072252761759,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6416,GO:0019068,1,0.803920117120916,0,37,virion assembly,BP,
6417,GO:0019072,1,0.984435841523714,0,2,viral genome packaging,BP,
6418,GO:0019074,1,0.984435841523714,0,2,viral RNA genome packaging,BP,
6419,GO:0019075,1,0.988658446617857,0,2,virus maturation,BP,
6420,GO:0019076,1,0.811737459688886,0,33,viral release from host cell,BP,
6422,GO:0019080,1,0.328791481420751,0,184,viral gene expression,BP,
6423,GO:0019081,1,0.912154007494056,0,14,viral translation,BP,
6424,GO:0019082,1,0.993164182413726,0,1,viral protein processing,BP,
6425,GO:0019083,1,0.360637402452909,0,170,viral transcription,BP,
6426,GO:0019085,1,0.986803683584589,0,2,early viral transcription,BP,
6427,GO:0019086,1,0.976409924204289,0,4,late viral transcription,BP,
6428,GO:0019087,1,0.977698271324945,0,3,transformation of host cell by virus,BP,
6429,GO:0019088,1,0.994744420879121,0,1,immortalization of host cell by virus,BP,
6430,GO:0019089,1,0.990879446124348,0,1,transmission of virus,BP,
6432,GO:0019100,1,0.985366539081611,0,2,male germ-line sex determination,BP,
6433,GO:0019101,1,0.994230284913538,0,1,female somatic sex determination,BP,
6434,GO:0019102,1,0.994144090797444,0,1,male somatic sex determination,BP,
6435,GO:0019103,1,0.965533817757328,0,6,pyrimidine nucleotide binding,MF,
6436,GO:0019104,1,0.92265151100914,0,15,DNA N-glycosylase activity,MF,
6437,GO:0019107,1,0.984854102081143,0,2,myristoyltransferase activity,MF,
6438,GO:0019115,1,0.994650742674621,0,1,benzaldehyde dehydrogenase activity,MF,
6439,GO:0019118,1,0.994780129678445,0,1,phenanthrene-epoxide hydrolase activity,MF,
6440,GO:0019119,1,0.994780129678445,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6441,GO:0019135,1,0.994676936911799,0,1,deoxyhypusine monooxygenase activity,MF,
6442,GO:0019136,1,0.976462903157479,0,4,deoxynucleoside kinase activity,MF,
6443,GO:0019144,1,0.989579855476214,0,2,ADP-sugar diphosphatase activity,MF,
6444,GO:0019145,1,0.99445341344511,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6445,GO:0019150,1,0.994626982367122,0,1,D-ribulokinase activity,MF,
6446,GO:0019153,1,0.994741979576544,0,1,protein-disulfide reductase (glutathione) activity,MF,
6447,GO:0019158,1,0.966283608778596,0,5,mannokinase activity,MF,
6448,GO:0019166,1,0.984020009014613,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6449,GO:0019171,1,0.988770284686703,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6450,GO:0019184,1,0.911474212684495,0,16,nonribosomal peptide biosynthetic process,BP,
6451,GO:0019185,1,0.987107412463564,0,2,snRNA-activating protein complex,CC,
6452,GO:0019187,1,0.993403173169431,0,1,beta-1,4-mannosyltransferase activity,MF,
6453,GO:0019198,1,0.873684129692419,0,16,transmembrane receptor protein phosphatase activity,MF,
6454,GO:0019199,1,0.540356268746033,0,80,transmembrane receptor protein kinase activity,MF,
6455,GO:0019200,1,0.872290039097938,0,22,carbohydrate kinase activity,MF,
6456,GO:0019201,1,0.844257101550332,0,25,nucleotide kinase activity,MF,
6457,GO:0019202,1,0.988165375574901,0,2,amino acid kinase activity,MF,
6458,GO:0019203,1,0.952267259967426,0,8,carbohydrate phosphatase activity,MF,
6459,GO:0019205,1,0.731980632441497,0,49,nucleobase-containing compound kinase activity,MF,
6460,GO:0019206,1,0.923235180272704,0,14,nucleoside kinase activity,MF,
6465,GO:0019211,1,0.937889087944486,0,10,phosphatase activator activity,MF,
6467,GO:0019213,1,0.687797452964348,0,55,deacetylase activity,MF,
6471,GO:0019218,1,0.537081128443231,0,97,regulation of steroid metabolic process,BP,
6477,GO:0019227,1,0.956367861135742,0,6,neuronal action potential propagation,BP,
6478,GO:0019228,1,0.756785252450741,0,34,neuronal action potential,BP,
6480,GO:0019230,1,0.969956703619082,0,4,proprioception,BP,
6482,GO:0019236,1,0.977932205645405,0,4,response to pheromone,BP,
6483,GO:0019237,1,0.96115613430187,0,6,centromeric DNA binding,MF,
6484,GO:0019238,1,0.966343722231143,0,6,cyclohydrolase activity,MF,
6485,GO:0019239,1,0.836179793864073,0,30,deaminase activity,MF,
6486,GO:0019240,1,0.959316435148033,0,5,citrulline biosynthetic process,BP,
6487,GO:0019242,1,0.994617890239844,0,1,methylglyoxal biosynthetic process,BP,
6488,GO:0019243,1,0.988958031364877,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6489,GO:0019244,1,0.9947935455242,0,1,lactate biosynthetic process from pyruvate,BP,
6490,GO:0019249,1,0.980657099200901,0,3,lactate biosynthetic process,BP,
6491,GO:0019254,1,0.983238254885086,0,3,carnitine metabolic process, CoA-linked,BP,
6492,GO:0019255,1,0.989273075359253,0,2,glucose 1-phosphate metabolic process,BP,
6493,GO:0019262,1,0.968575972194053,0,6,N-acetylneuraminate catabolic process,BP,
6494,GO:0019264,1,0.989069378057645,0,2,glycine biosynthetic process from serine,BP,
6495,GO:0019265,1,0.99474103000378,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6496,GO:0019276,1,0.987683916297745,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6497,GO:0019285,1,0.987449339454706,0,2,glycine betaine biosynthetic process from choline,BP,
6498,GO:0019287,1,0.98419324808257,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6499,GO:0019290,1,0.994222644359545,0,1,siderophore biosynthetic process,BP,
6500,GO:0019303,1,0.9896263618539,0,2,D-ribose catabolic process,BP,
6503,GO:0019319,1,0.654332138231585,0,70,hexose biosynthetic process,BP,
6505,GO:0019321,1,0.926545339872982,0,14,pentose metabolic process,BP,
6506,GO:0019322,1,0.978762520322881,0,4,pentose biosynthetic process,BP,
6507,GO:0019323,1,0.972873604080805,0,5,pentose catabolic process,BP,
6509,GO:0019341,1,0.994403147306235,0,1,dibenzo-p-dioxin catabolic process,BP,
6510,GO:0019343,1,0.989147611622062,0,2,cysteine biosynthetic process via cystathionine,BP,
6511,GO:0019344,1,0.983722059366893,0,3,cysteine biosynthetic process,BP,
6512,GO:0019346,1,0.977882159323841,0,4,transsulfuration,BP,
6513,GO:0019348,1,0.971417501145759,0,5,dolichol metabolic process,BP,
6514,GO:0019353,1,0.994350325246087,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6515,GO:0019355,1,0.980128584109915,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6516,GO:0019357,1,0.994313214468247,0,1,nicotinate nucleotide biosynthetic process,BP,
6517,GO:0019358,1,0.994313214468247,0,1,nicotinate nucleotide salvage,BP,
6521,GO:0019364,1,0.983525933418588,0,3,pyridine nucleotide catabolic process,BP,
6522,GO:0019365,1,0.994313214468247,0,1,pyridine nucleotide salvage,BP,
6523,GO:0019367,1,0.964347280122246,0,6,fatty acid elongation, saturated fatty acid,BP,
6524,GO:0019368,1,0.964347280122246,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6525,GO:0019369,1,0.786425697270612,0,41,arachidonic acid metabolic process,BP,
6526,GO:0019370,1,0.940379195986896,0,11,leukotriene biosynthetic process,BP,
6527,GO:0019371,1,0.936634571068898,0,11,cyclooxygenase pathway,BP,
6528,GO:0019372,1,0.914798896981835,0,16,lipoxygenase pathway,BP,
6529,GO:0019373,1,0.940029657218032,0,11,epoxygenase P450 pathway,BP,
6530,GO:0019374,1,0.953975830573904,0,8,galactolipid metabolic process,BP,
6531,GO:0019375,1,0.972255179043827,0,5,galactolipid biosynthetic process,BP,
6532,GO:0019376,1,0.994231552574136,0,1,galactolipid catabolic process,BP,
6533,GO:0019377,1,0.928731148963561,0,13,glycolipid catabolic process,BP,
6534,GO:0019388,1,0.94568768779094,0,9,galactose catabolic process,BP,
6535,GO:0019389,1,0.994386161890337,0,1,glucuronoside metabolic process,BP,
6536,GO:0019391,1,0.994386161890337,0,1,glucuronoside catabolic process,BP,
6537,GO:0019395,1,0.548287887029052,0,95,fatty acid oxidation,BP,
6538,GO:0019400,1,0.910248717362467,0,15,alditol metabolic process,BP,
6539,GO:0019401,1,0.966797432681426,0,6,alditol biosynthetic process,BP,
6540,GO:0019402,1,0.994780267667171,0,1,galactitol metabolic process,BP,
6541,GO:0019405,1,0.961781809849199,0,5,alditol catabolic process,BP,
6542,GO:0019406,1,0.994774589322036,0,1,hexitol biosynthetic process,BP,
6543,GO:0019407,1,0.99444254450294,0,1,hexitol catabolic process,BP,
6544,GO:0019408,1,0.986966773780967,0,2,dolichol biosynthetic process,BP,
6545,GO:0019413,1,0.987097378534875,0,2,acetate biosynthetic process,BP,
6546,GO:0019417,1,0.987223597690358,0,2,sulfur oxidation,BP,
6547,GO:0019418,1,0.979028685769929,0,4,sulfide oxidation,BP,
6548,GO:0019427,1,0.987097378534875,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6549,GO:0019430,1,0.878920164524851,0,22,removal of superoxide radicals,BP,
6550,GO:0019432,1,0.836499098322243,0,28,triglyceride biosynthetic process,BP,
6554,GO:0019441,1,0.96631960419546,0,6,tryptophan catabolic process to kynurenine,BP,
6555,GO:0019442,1,0.989510444605163,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6556,GO:0019448,1,0.983972524267217,0,3,L-cysteine catabolic process,BP,
6557,GO:0019464,1,0.98298499626644,0,3,glycine decarboxylation via glycine cleavage system,BP,
6558,GO:0019470,1,0.977546791052856,0,4,4-hydroxyproline catabolic process,BP,
6559,GO:0019471,1,0.941551187309236,0,10,4-hydroxyproline metabolic process,BP,
6560,GO:0019474,1,0.974977559460426,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6561,GO:0019477,1,0.974977559460426,0,4,L-lysine catabolic process,BP,
6562,GO:0019478,1,0.989506757309471,0,2,D-amino acid catabolic process,BP,
6563,GO:0019482,1,0.977244168008641,0,4,beta-alanine metabolic process,BP,
6564,GO:0019483,1,0.988740324370294,0,2,beta-alanine biosynthetic process,BP,
6565,GO:0019493,1,0.994650305971359,0,1,arginine catabolic process to proline,BP,
6566,GO:0019509,1,0.971024714966591,0,5,L-methionine salvage from methylthioadenosine,BP,
6567,GO:0019510,1,0.99454517104687,0,1,S-adenosylhomocysteine catabolic process,BP,
6568,GO:0019511,1,0.922234956698876,0,13,peptidyl-proline hydroxylation,BP,
6569,GO:0019516,1,0.989234578109904,0,2,lactate oxidation,BP,
6570,GO:0019518,1,0.994744607027672,0,1,L-threonine catabolic process to glycine,BP,
6571,GO:0019519,1,0.99444254450294,0,1,pentitol metabolic process,BP,
6572,GO:0019520,1,0.989004577739304,0,2,aldonic acid metabolic process,BP,
6573,GO:0019521,1,0.989004577739304,0,2,D-gluconate metabolic process,BP,
6574,GO:0019527,1,0.99444254450294,0,1,pentitol catabolic process,BP,
6575,GO:0019530,1,0.96183427091914,0,6,taurine metabolic process,BP,
6576,GO:0019531,1,0.940258421233162,0,9,oxalate transmembrane transporter activity,MF,
6577,GO:0019532,1,0.93531058974117,0,10,oxalate transport,BP,
6578,GO:0019534,1,0.962037879619726,0,5,toxin transmembrane transporter activity,MF,
6580,GO:0019541,1,0.976285667082723,0,4,propionate metabolic process,BP,
6581,GO:0019542,1,0.987097378534875,0,2,propionate biosynthetic process,BP,
6582,GO:0019543,1,0.989048381054196,0,2,propionate catabolic process,BP,
6583,GO:0019544,1,0.994650305971359,0,1,arginine catabolic process to glutamate,BP,
6584,GO:0019546,1,0.994551376364011,0,1,arginine deiminase pathway,BP,
6585,GO:0019547,1,0.989445946288088,0,2,arginine catabolic process to ornithine,BP,
6586,GO:0019550,1,0.989111672169772,0,2,glutamate catabolic process to aspartate,BP,
6587,GO:0019551,1,0.989111672169772,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6588,GO:0019556,1,0.977430482789327,0,4,histidine catabolic process to glutamate and formamide,BP,
6589,GO:0019557,1,0.977430482789327,0,4,histidine catabolic process to glutamate and formate,BP,
6590,GO:0019563,1,0.967158540217567,0,4,glycerol catabolic process,BP,
6591,GO:0019566,1,0.988658446617857,0,2,arabinose metabolic process,BP,
6592,GO:0019585,1,0.954151407946888,0,8,glucuronate metabolic process,BP,
6593,GO:0019605,1,0.989323175419395,0,2,butyrate metabolic process,BP,
6595,GO:0019626,1,0.954159077275032,0,8,short-chain fatty acid catabolic process,BP,
6596,GO:0019627,1,0.924403203351431,0,13,urea metabolic process,BP,
6598,GO:0019640,1,0.972717732358086,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6599,GO:0019646,1,0.912766484000485,0,16,aerobic electron transport chain,BP,
6600,GO:0019673,1,0.963666228822538,0,7,GDP-mannose metabolic process,BP,
6602,GO:0019676,1,0.987628710215918,0,2,ammonia assimilation cycle,BP,
6603,GO:0019677,1,0.988645703407414,0,2,NAD catabolic process,BP,
6604,GO:0019682,1,0.885747890076056,0,21,glyceraldehyde-3-phosphate metabolic process,BP,
6605,GO:0019692,1,0.841915216219134,0,31,deoxyribose phosphate metabolic process,BP,
6607,GO:0019694,1,0.96183427091914,0,6,alkanesulfonate metabolic process,BP,
6608,GO:0019695,1,0.946288191027644,0,9,choline metabolic process,BP,
6609,GO:0019706,1,0.844064033062539,0,27,protein-cysteine S-palmitoyltransferase activity,MF,
6610,GO:0019707,1,0.844064033062539,0,27,protein-cysteine S-acyltransferase activity,MF,
6611,GO:0019720,1,0.964891696195635,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6618,GO:0019740,1,0.968219171189424,0,5,nitrogen utilization,BP,
6619,GO:0019742,1,0.99449814413672,0,1,pentacyclic triterpenoid metabolic process,BP,
6620,GO:0019747,1,0.989649165792025,0,2,regulation of isoprenoid metabolic process,BP,
6621,GO:0019748,1,0.706112090699782,0,56,secondary metabolic process,BP,
6622,GO:0019751,1,0.512358503213742,0,101,polyol metabolic process,BP,
6624,GO:0019755,1,0.949714487750849,0,9,one-carbon compound transport,BP,
6625,GO:0019763,1,0.972487572512855,0,5,immunoglobulin receptor activity,MF,
6626,GO:0019767,1,0.994837946595896,0,1,IgE receptor activity,MF,
6627,GO:0019770,1,0.989475642319655,0,2,IgG receptor activity,MF,
6628,GO:0019772,1,0.994740552997493,0,1,low-affinity IgG receptor activity,MF,
6629,GO:0019773,1,0.964200818755239,0,7,proteasome core complex, alpha-subunit complex,CC,
6630,GO:0019774,1,0.95427850782388,0,9,proteasome core complex, beta-subunit complex,CC,
6631,GO:0019776,1,0.981816929306852,0,3,Atg8 ligase activity,MF,
6632,GO:0019777,1,0.989342120058149,0,2,Atg12 transferase activity,MF,
6633,GO:0019778,1,0.992371518296249,0,1,Atg12 activating enzyme activity,MF,
6634,GO:0019779,1,0.992371518296249,0,1,Atg8 activating enzyme activity,MF,
6635,GO:0019780,1,0.990801857864387,0,1,FAT10 activating enzyme activity,MF,
6636,GO:0019781,1,0.989331319679102,0,2,NEDD8 activating enzyme activity,MF,
6637,GO:0019782,1,0.993931225628618,0,1,ISG15 activating enzyme activity,MF,
6638,GO:0019783,1,0.485358655950353,0,98,ubiquitin-like protein-specific protease activity,MF,
6639,GO:0019784,1,0.962160078826427,0,7,NEDD8-specific protease activity,MF,
6640,GO:0019785,1,0.987943890381521,0,2,ISG15-specific protease activity,MF,
6641,GO:0019787,1,0.0456379682186002,0,446,ubiquitin-like protein transferase activity,MF,
6642,GO:0019788,1,0.964151086376709,0,6,NEDD8 transferase activity,MF,
6643,GO:0019789,1,0.899090545496332,0,16,SUMO transferase activity,MF,
6644,GO:0019797,1,0.98303551799545,0,3,procollagen-proline 3-dioxygenase activity,MF,
6645,GO:0019798,1,0.961384751124216,0,7,procollagen-proline dioxygenase activity,MF,
6646,GO:0019799,1,0.994313214468247,0,1,tubulin N-acetyltransferase activity,MF,
6647,GO:0019800,1,0.965854123985572,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6648,GO:0019805,1,0.981979470438437,0,3,quinolinate biosynthetic process,BP,
6649,GO:0019807,1,0.994777185091177,0,1,aspartoacylase activity,MF,
6650,GO:0019808,1,0.970980036394644,0,5,polyamine binding,MF,
6651,GO:0019809,1,0.984307956201011,0,3,spermidine binding,MF,
6652,GO:0019810,1,0.99398281120159,0,1,putrescine binding,MF,
6653,GO:0019811,1,0.992817761201889,0,1,cocaine binding,MF,
6654,GO:0019814,1,0.971373443210329,0,5,immunoglobulin complex,CC,
6655,GO:0019815,1,0.982009755549088,0,3,B cell receptor complex,CC,
6656,GO:0019825,1,0.827172950758998,0,33,oxygen binding,MF,
6657,GO:0019826,1,0.978085922683359,0,3,oxygen sensor activity,MF,
6658,GO:0019827,1,0.347898889077344,0,148,stem cell population maintenance,BP,
6659,GO:0019828,1,0.981401434070143,0,3,aspartic-type endopeptidase inhibitor activity,MF,
6660,GO:0019829,1,0.698497573330281,0,52,cation-transporting ATPase activity,MF,
6662,GO:0019835,1,0.845243901551627,0,30,cytolysis,BP,
6663,GO:0019836,1,0.988946662515827,0,2,hemolysis by symbiont of host erythrocytes,BP,
6665,GO:0019840,1,0.86347947747745,0,24,isoprenoid binding,MF,
6666,GO:0019841,1,0.939436025962542,0,11,retinol binding,MF,
6667,GO:0019842,1,0.479371626320179,0,119,vitamin binding,MF,
6668,GO:0019843,1,0.72875839061057,0,55,rRNA binding,MF,
6669,GO:0019852,1,0.940597483722929,0,10,L-ascorbic acid metabolic process,BP,
6670,GO:0019853,1,0.989457147096285,0,2,L-ascorbic acid biosynthetic process,BP,
6671,GO:0019855,1,0.944841315299177,0,9,calcium channel inhibitor activity,MF,
6672,GO:0019856,1,0.95429983177719,0,6,pyrimidine nucleobase biosynthetic process,BP,
6673,GO:0019857,1,0.962463298719057,0,3,5-methylcytosine metabolic process,BP,
6674,GO:0019858,1,0.988468721260933,0,2,cytosine metabolic process,BP,
6675,GO:0019859,1,0.983367606214614,0,3,thymine metabolic process,BP,
6676,GO:0019860,1,0.983525227761082,0,3,uracil metabolic process,BP,
6677,GO:0019862,1,0.994747553664999,0,1,IgA binding,MF,
6679,GO:0019864,1,0.953074093984921,0,9,IgG binding,MF,
6682,GO:0019867,1,0.295450917245313,0,183,outer membrane,CC,
6683,GO:0019869,1,0.934942618199185,0,9,chloride channel inhibitor activity,MF,
6684,GO:0019870,1,0.953492521489996,0,6,potassium channel inhibitor activity,MF,
6685,GO:0019871,1,0.956866040837254,0,6,sodium channel inhibitor activity,MF,
6686,GO:0019878,1,0.985722588916567,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6688,GO:0019883,1,0.933735046419346,0,11,antigen processing and presentation of endogenous antigen,BP,
6690,GO:0019885,1,0.955480057258602,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6695,GO:0019896,1,0.925383826647374,0,11,axonal transport of mitochondrion,BP,
6701,GO:0019902,1,0.315494104237566,0,166,phosphatase binding,MF,
6702,GO:0019903,1,0.451425670416468,0,117,protein phosphatase binding,MF,
6705,GO:0019907,1,0.955341447435993,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6706,GO:0019908,1,0.897236014291742,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6707,GO:0019911,1,0.945466930515624,0,10,structural constituent of myelin sheath,MF,
6708,GO:0019912,1,0.989138200651188,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6710,GO:0019918,1,0.977794801489051,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6711,GO:0019919,1,0.95651385697396,0,8,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6714,GO:0019934,1,0.937320710947873,0,10,cGMP-mediated signaling,BP,
6716,GO:0019941,1,0.0244507100720951,0,549,modification-dependent protein catabolic process,BP,
6717,GO:0019948,1,0.988871767036924,0,2,SUMO activating enzyme activity,MF,
6721,GO:0019957,1,0.945232824288702,0,10,C-C chemokine binding,MF,
6722,GO:0019958,1,0.964807874389741,0,6,C-X-C chemokine binding,MF,
6723,GO:0019959,1,0.981569735388707,0,3,interleukin-8 binding,MF,
6724,GO:0019960,1,0.962143750250432,0,5,C-X3-C chemokine binding,MF,
6725,GO:0019961,1,0.985066161423573,0,2,interferon binding,MF,
6726,GO:0019962,1,0.991192434517322,0,1,type I interferon binding,MF,
6727,GO:0019964,1,0.993819834584721,0,1,interferon-gamma binding,MF,
6728,GO:0019966,1,0.954934709960324,0,7,interleukin-1 binding,MF,
6729,GO:0019969,1,0.993602631658359,0,1,interleukin-10 binding,MF,
6730,GO:0019970,1,0.994033683966511,0,1,interleukin-11 binding,MF,
6731,GO:0019972,1,0.994769348797587,0,1,interleukin-12 binding,MF,
6732,GO:0019975,1,0.994769348797587,0,1,interleukin-17 binding,MF,
6733,GO:0019976,1,0.982177164296668,0,3,interleukin-2 binding,MF,
6734,GO:0019981,1,0.987293441777,0,2,interleukin-6 binding,MF,
6735,GO:0019985,1,0.783120060466091,0,38,translesion synthesis,BP,
6736,GO:0019988,1,0.994328051160662,0,1,charged-tRNA amino acid modification,BP,
6737,GO:0019992,1,0.910531346117614,0,12,diacylglycerol binding,MF,
6738,GO:0020003,1,0.983569267953715,0,3,symbiont-containing vacuole,CC,
6739,GO:0020005,1,0.989195219067059,0,2,symbiont-containing vacuole membrane,CC,
6740,GO:0020012,1,0.98651960997864,0,2,evasion or tolerance of host immune response,BP,
6741,GO:0020016,1,0.980489383196448,0,3,ciliary pocket,CC,
6742,GO:0020018,1,0.980489383196448,0,3,ciliary pocket membrane,CC,
6743,GO:0020021,1,0.994744420879121,0,1,immortalization of host cell,BP,
6744,GO:0020027,1,0.923326663614017,0,14,hemoglobin metabolic process,BP,
6745,GO:0020037,1,0.543672201720366,0,99,heme binding,MF,
6746,GO:0021501,1,0.994618536527764,0,1,prechordal plate formation,BP,
6747,GO:0021502,1,0.981363438943317,0,3,neural fold elevation formation,BP,
6748,GO:0021503,1,0.988810866607569,0,1,neural fold bending,BP,
6749,GO:0021508,1,0.990491040548906,0,1,floor plate formation,BP,
6750,GO:0021509,1,0.994647818732383,0,1,roof plate formation,BP,
6752,GO:0021511,1,0.844837254576767,0,25,spinal cord patterning,BP,
6753,GO:0021512,1,0.993099931090031,0,1,spinal cord anterior/posterior patterning,BP,
6754,GO:0021513,1,0.862951770648086,0,23,spinal cord dorsal/ventral patterning,BP,
6755,GO:0021514,1,0.892294672628624,0,17,ventral spinal cord interneuron differentiation,BP,
6757,GO:0021516,1,0.888152063747933,0,19,dorsal spinal cord development,BP,
6759,GO:0021519,1,0.994790910327561,0,1,spinal cord association neuron specification,BP,
6760,GO:0021520,1,0.92240544509873,0,12,spinal cord motor neuron cell fate specification,BP,
6761,GO:0021521,1,0.926339833846224,0,11,ventral spinal cord interneuron specification,BP,
6763,GO:0021523,1,0.969298205989944,0,5,somatic motor neuron differentiation,BP,
6764,GO:0021524,1,0.983875852350027,0,3,visceral motor neuron differentiation,BP,
6765,GO:0021526,1,0.989217877608338,0,2,medial motor column neuron differentiation,BP,
6766,GO:0021527,1,0.932001272787275,0,11,spinal cord association neuron differentiation,BP,
6767,GO:0021528,1,0.994313214468247,0,1,commissural neuron differentiation in spinal cord,BP,
6768,GO:0021529,1,0.983643161060323,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6769,GO:0021530,1,0.983643161060323,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6770,GO:0021532,1,0.783092937929298,0,36,neural tube patterning,BP,
6771,GO:0021533,1,0.874987382871328,0,17,cell differentiation in hindbrain,BP,
6772,GO:0021534,1,0.926172001927433,0,11,cell proliferation in hindbrain,BP,
6773,GO:0021535,1,0.905342046608723,0,13,cell migration in hindbrain,BP,
6774,GO:0021536,1,0.626738418287411,0,70,diencephalon development,BP,
6776,GO:0021538,1,0.977820083588279,0,3,epithalamus development,BP,
6777,GO:0021539,1,0.989339939141421,0,2,subthalamus development,BP,
6778,GO:0021540,1,0.96382574222066,0,5,corpus callosum morphogenesis,BP,
6779,GO:0021541,1,0.993130664163681,0,1,ammon gyrus development,BP,
6780,GO:0021542,1,0.905743798847637,0,15,dentate gyrus development,BP,
6782,GO:0021544,1,0.85113230592227,0,23,subpallium development,BP,
6783,GO:0021545,1,0.751225957872814,0,42,cranial nerve development,BP,
6784,GO:0021546,1,0.971719698811516,0,5,rhombomere development,BP,
6785,GO:0021547,1,0.994618536527764,0,1,midbrain-hindbrain boundary initiation,BP,
6787,GO:0021549,1,0.546035694870479,0,85,cerebellum development,BP,
6788,GO:0021550,1,0.994468201715917,0,1,medulla oblongata development,BP,
6789,GO:0021551,1,0.985579121476668,0,1,central nervous system morphogenesis,BP,
6790,GO:0021553,1,0.973630838803043,0,3,olfactory nerve development,BP,
6791,GO:0021554,1,0.921352428482968,0,11,optic nerve development,BP,
6792,GO:0021555,1,0.981712793027794,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6793,GO:0021557,1,0.983534209268086,0,3,oculomotor nerve development,BP,
6794,GO:0021558,1,0.989516790960814,0,2,trochlear nerve development,BP,
6795,GO:0021559,1,0.937497653208177,0,10,trigeminal nerve development,BP,
6796,GO:0021560,1,0.988429355639407,0,2,abducens nerve development,BP,
6797,GO:0021561,1,0.94156904138558,0,9,facial nerve development,BP,
6798,GO:0021562,1,0.959422588930413,0,6,vestibulocochlear nerve development,BP,
6799,GO:0021563,1,0.963157717963783,0,5,glossopharyngeal nerve development,BP,
6800,GO:0021564,1,0.975337596694646,0,3,vagus nerve development,BP,
6801,GO:0021566,1,0.992403746174346,0,1,hypoglossal nerve development,BP,
6802,GO:0021568,1,0.994784446068881,0,1,rhombomere 2 development,BP,
6803,GO:0021569,1,0.989035040951465,0,2,rhombomere 3 development,BP,
6804,GO:0021570,1,0.994742168781991,0,1,rhombomere 4 development,BP,
6805,GO:0021571,1,0.988210639735293,0,2,rhombomere 5 development,BP,
6806,GO:0021572,1,0.993913057994726,0,1,rhombomere 6 development,BP,
6807,GO:0021575,1,0.757477932426436,0,37,hindbrain morphogenesis,BP,
6808,GO:0021577,1,0.987825349476847,0,2,hindbrain structural organization,BP,
6811,GO:0021587,1,0.772142326000149,0,34,cerebellum morphogenesis,BP,
6812,GO:0021589,1,0.987825349476847,0,2,cerebellum structural organization,BP,
6813,GO:0021590,1,0.977579350922512,0,3,cerebellum maturation,BP,
6814,GO:0021591,1,0.838539434583382,0,24,ventricular system development,BP,
6815,GO:0021592,1,0.992052140199464,0,1,fourth ventricle development,BP,
6816,GO:0021593,1,0.994263008370215,0,1,rhombomere morphogenesis,BP,
6817,GO:0021594,1,0.994263008370215,0,1,rhombomere formation,BP,
6818,GO:0021598,1,0.988429355639407,0,2,abducens nerve morphogenesis,BP,
6819,GO:0021599,1,0.988429355639407,0,2,abducens nerve formation,BP,
6820,GO:0021602,1,0.846403598441771,0,25,cranial nerve morphogenesis,BP,
6821,GO:0021603,1,0.957360096625962,0,7,cranial nerve formation,BP,
6822,GO:0021604,1,0.942593244905985,0,9,cranial nerve structural organization,BP,
6823,GO:0021610,1,0.94156904138558,0,9,facial nerve morphogenesis,BP,
6824,GO:0021612,1,0.954159722422998,0,7,facial nerve structural organization,BP,
6825,GO:0021615,1,0.976310983376197,0,4,glossopharyngeal nerve morphogenesis,BP,
6826,GO:0021618,1,0.992403746174346,0,1,hypoglossal nerve morphogenesis,BP,
6827,GO:0021622,1,0.988708529740207,0,2,oculomotor nerve morphogenesis,BP,
6828,GO:0021623,1,0.988708529740207,0,2,oculomotor nerve formation,BP,
6830,GO:0021631,1,0.954494088321331,0,6,optic nerve morphogenesis,BP,
6831,GO:0021633,1,0.987883492374577,0,2,optic nerve structural organization,BP,
6832,GO:0021634,1,0.993240355502953,0,1,optic nerve formation,BP,
6833,GO:0021636,1,0.964741855302769,0,5,trigeminal nerve morphogenesis,BP,
6834,GO:0021637,1,0.964741855302769,0,5,trigeminal nerve structural organization,BP,
6835,GO:0021639,1,0.994722268664171,0,1,trochlear nerve morphogenesis,BP,
6836,GO:0021642,1,0.994722268664171,0,1,trochlear nerve formation,BP,
6837,GO:0021644,1,0.988655513078646,0,2,vagus nerve morphogenesis,BP,
6838,GO:0021648,1,0.974209229479185,0,4,vestibulocochlear nerve morphogenesis,BP,
6839,GO:0021649,1,0.994463161779309,0,1,vestibulocochlear nerve structural organization,BP,
6840,GO:0021650,1,0.979634420258547,0,3,vestibulocochlear nerve formation,BP,
6841,GO:0021658,1,0.994263008370215,0,1,rhombomere 3 morphogenesis,BP,
6842,GO:0021660,1,0.994263008370215,0,1,rhombomere 3 formation,BP,
6843,GO:0021664,1,0.994263008370215,0,1,rhombomere 5 morphogenesis,BP,
6844,GO:0021666,1,0.994263008370215,0,1,rhombomere 5 formation,BP,
6845,GO:0021670,1,0.930652105068265,0,10,lateral ventricle development,BP,
6847,GO:0021678,1,0.981829189093532,0,3,third ventricle development,BP,
6848,GO:0021679,1,0.988113817708827,0,2,cerebellar molecular layer development,BP,
6849,GO:0021680,1,0.846806192334808,0,21,cerebellar Purkinje cell layer development,BP,
6850,GO:0021681,1,0.913105668506558,0,13,cerebellar granular layer development,BP,
6851,GO:0021682,1,0.991610188829973,0,1,nerve maturation,BP,
6852,GO:0021683,1,0.937369174052456,0,9,cerebellar granular layer morphogenesis,BP,
6853,GO:0021684,1,0.95206977082545,0,7,cerebellar granular layer formation,BP,
6854,GO:0021685,1,0.989955792994312,0,1,cerebellar granular layer structural organization,BP,
6855,GO:0021686,1,0.994733218655072,0,1,cerebellar granular layer maturation,BP,
6856,GO:0021687,1,0.988113817708827,0,2,cerebellar molecular layer morphogenesis,BP,
6857,GO:0021688,1,0.993944547516147,0,1,cerebellar molecular layer formation,BP,
6858,GO:0021691,1,0.982756210951815,0,2,cerebellar Purkinje cell layer maturation,BP,
6859,GO:0021692,1,0.905011310234384,0,11,cerebellar Purkinje cell layer morphogenesis,BP,
6860,GO:0021693,1,0.983960559927363,0,2,cerebellar Purkinje cell layer structural organization,BP,
6861,GO:0021694,1,0.929676426864542,0,8,cerebellar Purkinje cell layer formation,BP,
6862,GO:0021695,1,0.727645456717068,0,44,cerebellar cortex development,BP,
6863,GO:0021696,1,0.807372413694994,0,28,cerebellar cortex morphogenesis,BP,
6864,GO:0021697,1,0.862394433204172,0,19,cerebellar cortex formation,BP,
6865,GO:0021698,1,0.983960559927363,0,2,cerebellar cortex structural organization,BP,
6866,GO:0021699,1,0.977579350922512,0,3,cerebellar cortex maturation,BP,
6868,GO:0021702,1,0.929676426864542,0,8,cerebellar Purkinje cell differentiation,BP,
6869,GO:0021703,1,0.994722268664171,0,1,locus ceruleus development,BP,
6870,GO:0021707,1,0.95206977082545,0,7,cerebellar granule cell differentiation,BP,
6871,GO:0021718,1,0.987989870511047,0,2,superior olivary nucleus development,BP,
6872,GO:0021722,1,0.987989870511047,0,2,superior olivary nucleus maturation,BP,
6873,GO:0021730,1,0.983218292743549,0,2,trigeminal sensory nucleus development,BP,
6874,GO:0021740,1,0.983218292743549,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6875,GO:0021747,1,0.978515009680224,0,3,cochlear nucleus development,BP,
6876,GO:0021750,1,0.994468201715917,0,1,vestibular nucleus development,BP,
6877,GO:0021756,1,0.884073576802678,0,17,striatum development,BP,
6878,GO:0021757,1,0.993670099228364,0,1,caudate nucleus development,BP,
6879,GO:0021758,1,0.993670099228364,0,1,putamen development,BP,
6880,GO:0021759,1,0.9753516705111,0,4,globus pallidus development,BP,
6881,GO:0021761,1,0.508220766077496,0,96,limbic system development,BP,
6883,GO:0021763,1,0.994566878406223,0,1,subthalamic nucleus development,BP,
6884,GO:0021764,1,0.964428590001369,0,4,amygdala development,BP,
6885,GO:0021766,1,0.599760993034311,0,72,hippocampus development,BP,
6886,GO:0021767,1,0.988112011393428,0,1,mammillary body development,BP,
6887,GO:0021768,1,0.993793218715518,0,1,nucleus accumbens development,BP,
6888,GO:0021769,1,0.974202568192363,0,4,orbitofrontal cortex development,BP,
6889,GO:0021771,1,0.991592265754597,0,1,lateral geniculate nucleus development,BP,
6891,GO:0021773,1,0.974448295677093,0,3,striatal medium spiny neuron differentiation,BP,
6892,GO:0021775,1,0.972229965547799,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6893,GO:0021776,1,0.972229965547799,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6894,GO:0021778,1,0.96279673511929,0,5,oligodendrocyte cell fate specification,BP,
6895,GO:0021779,1,0.96279673511929,0,5,oligodendrocyte cell fate commitment,BP,
6896,GO:0021780,1,0.96279673511929,0,5,glial cell fate specification,BP,
6897,GO:0021781,1,0.922606220076726,0,12,glial cell fate commitment,BP,
6899,GO:0021783,1,0.908775589006517,0,14,preganglionic parasympathetic fiber development,BP,
6900,GO:0021784,1,0.988737240465192,0,2,postganglionic parasympathetic fiber development,BP,
6901,GO:0021785,1,0.93997708098174,0,7,branchiomotor neuron axon guidance,BP,
6902,GO:0021793,1,0.993870578186373,0,1,chemorepulsion of branchiomotor axon,BP,
6903,GO:0021794,1,0.911555221926887,0,13,thalamus development,BP,
6904,GO:0021795,1,0.762621528706297,0,38,cerebral cortex cell migration,BP,
6905,GO:0021796,1,0.961384802665617,0,6,cerebral cortex regionalization,BP,
6906,GO:0021797,1,0.983056009756252,0,3,forebrain anterior/posterior pattern specification,BP,
6907,GO:0021798,1,0.951471347954154,0,7,forebrain dorsal/ventral pattern formation,BP,
6908,GO:0021799,1,0.838873302164389,0,24,cerebral cortex radially oriented cell migration,BP,
6909,GO:0021800,1,0.93575538840897,0,8,cerebral cortex tangential migration,BP,
6910,GO:0021801,1,0.879041970422837,0,17,cerebral cortex radial glia guided migration,BP,
6911,GO:0021812,1,0.985885141253514,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6912,GO:0021813,1,0.994411728613377,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6913,GO:0021814,1,0.960340308657429,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6914,GO:0021815,1,0.972487964797782,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6915,GO:0021817,1,0.972487964797782,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6916,GO:0021819,1,0.921980200875964,0,11,layer formation in cerebral cortex,BP,
6917,GO:0021822,1,0.994600473931754,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6918,GO:0021823,1,0.982263393020706,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6919,GO:0021824,1,0.986156053460746,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6920,GO:0021825,1,0.968662576821734,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6921,GO:0021826,1,0.949277542321318,0,8,substrate-independent telencephalic tangential migration,BP,
6922,GO:0021827,1,0.982263393020706,0,2,postnatal olfactory bulb interneuron migration,BP,
6923,GO:0021828,1,0.986156053460746,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6924,GO:0021830,1,0.949277542321318,0,8,interneuron migration from the subpallium to the cortex,BP,
6925,GO:0021831,1,0.994255322042818,0,1,embryonic olfactory bulb interneuron precursor migration,BP,
6926,GO:0021836,1,0.982263393020706,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6927,GO:0021840,1,0.98817158595975,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6928,GO:0021842,1,0.98817158595975,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6929,GO:0021843,1,0.949277542321318,0,8,substrate-independent telencephalic tangential interneuron migration,BP,
6930,GO:0021846,1,0.814750188614704,0,26,cell proliferation in forebrain,BP,
6931,GO:0021847,1,0.979584360057766,0,3,ventricular zone neuroblast division,BP,
6932,GO:0021849,1,0.987521781662267,0,2,neuroblast division in subventricular zone,BP,
6933,GO:0021853,1,0.966529424803856,0,5,cerebral cortex GABAergic interneuron migration,BP,
6934,GO:0021854,1,0.897396079551966,0,18,hypothalamus development,BP,
6935,GO:0021855,1,0.980797402472612,0,3,hypothalamus cell migration,BP,
6936,GO:0021856,1,0.986156053460746,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6937,GO:0021859,1,0.937425964491604,0,8,pyramidal neuron differentiation,BP,
6938,GO:0021860,1,0.946941435286706,0,7,pyramidal neuron development,BP,
6939,GO:0021861,1,0.957108879806297,0,7,forebrain radial glial cell differentiation,BP,
6940,GO:0021869,1,0.959793910923319,0,6,forebrain ventricular zone progenitor cell division,BP,
6941,GO:0021870,1,0.991200788181521,0,1,Cajal-Retzius cell differentiation,BP,
6942,GO:0021871,1,0.870278112308567,0,21,forebrain regionalization,BP,
6943,GO:0021872,1,0.643877714216035,0,63,forebrain generation of neurons,BP,
6944,GO:0021873,1,0.948356506681474,0,7,forebrain neuroblast division,BP,
6945,GO:0021877,1,0.933869964704468,0,10,forebrain neuron fate commitment,BP,
6946,GO:0021879,1,0.692965659459644,0,53,forebrain neuron differentiation,BP,
6947,GO:0021881,1,0.993876640681852,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6948,GO:0021882,1,0.989121887611133,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6949,GO:0021884,1,0.819696656296502,0,28,forebrain neuron development,BP,
6951,GO:0021886,1,0.98104763721572,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6952,GO:0021888,1,0.98104763721572,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6953,GO:0021889,1,0.912151194007888,0,12,olfactory bulb interneuron differentiation,BP,
6954,GO:0021891,1,0.947639472629761,0,7,olfactory bulb interneuron development,BP,
6955,GO:0021892,1,0.940639414708629,0,10,cerebral cortex GABAergic interneuron differentiation,BP,
6956,GO:0021893,1,0.989121887611133,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6957,GO:0021894,1,0.961514794730239,0,6,cerebral cortex GABAergic interneuron development,BP,
6958,GO:0021895,1,0.860377367226896,0,22,cerebral cortex neuron differentiation,BP,
6959,GO:0021896,1,0.977234252298137,0,2,forebrain astrocyte differentiation,BP,
6960,GO:0021897,1,0.977234252298137,0,2,forebrain astrocyte development,BP,
6961,GO:0021898,1,0.983064477894671,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6962,GO:0021902,1,0.955165030990484,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
6963,GO:0021903,1,0.93399680421603,0,10,rostrocaudal neural tube patterning,BP,
6964,GO:0021904,1,0.862580236863482,0,22,dorsal/ventral neural tube patterning,BP,
6965,GO:0021905,1,0.99036824888697,0,1,forebrain-midbrain boundary formation,BP,
6966,GO:0021910,1,0.94341455196475,0,8,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6967,GO:0021912,1,0.980119227470032,0,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
6968,GO:0021913,1,0.974908702812792,0,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
6969,GO:0021914,1,0.970540915659095,0,5,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6971,GO:0021917,1,0.99036824888697,0,1,somatic motor neuron fate commitment,BP,
6972,GO:0021918,1,0.99036824888697,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6973,GO:0021919,1,0.993759556597348,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6974,GO:0021920,1,0.994790910327561,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6975,GO:0021924,1,0.93127263154081,0,10,cell proliferation in external granule layer,BP,
6976,GO:0021930,1,0.93127263154081,0,10,cerebellar granule cell precursor proliferation,BP,
6977,GO:0021932,1,0.937845951838383,0,9,hindbrain radial glia guided cell migration,BP,
6978,GO:0021933,1,0.994733218655072,0,1,radial glia guided migration of cerebellar granule cell,BP,
6979,GO:0021934,1,0.977777900677814,0,2,hindbrain tangential cell migration,BP,
6980,GO:0021935,1,0.977777900677814,0,2,cerebellar granule cell precursor tangential migration,BP,
6981,GO:0021936,1,0.943197071979711,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6982,GO:0021937,1,0.967665486873942,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6983,GO:0021938,1,0.972901930677497,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6984,GO:0021940,1,0.95505623721186,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6985,GO:0021941,1,0.987588431052331,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6986,GO:0021942,1,0.971663292788473,0,4,radial glia guided migration of Purkinje cell,BP,
6987,GO:0021943,1,0.970318254271509,0,4,formation of radial glial scaffolds,BP,
6988,GO:0021952,1,0.832937503669356,0,23,central nervous system projection neuron axonogenesis,BP,
6990,GO:0021954,1,0.611553058208838,0,68,central nervous system neuron development,BP,
6991,GO:0021955,1,0.806666486680432,0,28,central nervous system neuron axonogenesis,BP,
6992,GO:0021956,1,0.994645754301418,0,1,central nervous system interneuron axonogenesis,BP,
6993,GO:0021957,1,0.952381100938709,0,6,corticospinal tract morphogenesis,BP,
6994,GO:0021960,1,0.963416838390367,0,5,anterior commissure morphogenesis,BP,
6995,GO:0021965,1,0.970295380421472,0,3,spinal cord ventral commissure morphogenesis,BP,
6996,GO:0021966,1,0.987195801135743,0,2,corticospinal neuron axon guidance,BP,
6997,GO:0021972,1,0.992365274621187,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6998,GO:0021978,1,0.930318353937302,0,12,telencephalon regionalization,BP,
6999,GO:0021979,1,0.962607023720796,0,6,hypothalamus cell differentiation,BP,
7000,GO:0021983,1,0.771544521604533,0,41,pituitary gland development,BP,
7001,GO:0021984,1,0.931467215852436,0,12,adenohypophysis development,BP,
7002,GO:0021985,1,0.98767532954442,0,2,neurohypophysis development,BP,
7003,GO:0021986,1,0.977820083588279,0,3,habenula development,BP,
7006,GO:0021993,1,0.992052140199464,0,1,initiation of neural tube closure,BP,
7007,GO:0021997,1,0.980490612988497,0,2,neural plate axis specification,BP,
7008,GO:0021998,1,0.993689247411896,0,1,neural plate mediolateral regionalization,BP,
7009,GO:0021999,1,0.958679661102995,0,6,neural plate anterior/posterior regionalization,BP,
7010,GO:0022007,1,0.980479326552003,0,3,convergent extension involved in neural plate elongation,BP,
7012,GO:0022009,1,0.976293008395842,0,4,central nervous system vasculogenesis,BP,
7013,GO:0022010,1,0.898905077091887,0,17,central nervous system myelination,BP,
7014,GO:0022011,1,0.809172892346179,0,25,myelination in peripheral nervous system,BP,
7015,GO:0022012,1,0.989038110568869,0,1,subpallium cell proliferation in forebrain,BP,
7016,GO:0022013,1,0.988699501513044,0,1,pallium cell proliferation in forebrain,BP,
7017,GO:0022018,1,0.989038110568869,0,1,lateral ganglionic eminence cell proliferation,BP,
7018,GO:0022027,1,0.939374671310906,0,6,interkinetic nuclear migration,BP,
7019,GO:0022028,1,0.95153927152305,0,6,tangential migration from the subventricular zone to the olfactory bulb,BP,
7021,GO:0022030,1,0.879041970422837,0,17,telencephalon glial cell migration,BP,
7023,GO:0022038,1,0.902072025781806,0,15,corpus callosum development,BP,
7024,GO:0022400,1,0.885469375583441,0,20,regulation of rhodopsin mediated signaling pathway,BP,
7033,GO:0022410,1,0.87466664644154,0,22,circadian sleep/wake cycle process,BP,
7035,GO:0022412,1,0.172605982813055,0,264,cellular process involved in reproduction in multicellular organism,BP,
7037,GO:0022417,1,0.962930149330239,0,7,protein maturation by protein folding,BP,
7039,GO:0022602,1,0.759994723182568,0,39,ovulation cycle process,BP,
7042,GO:0022605,1,0.963772027268517,0,6,mammalian oogenesis stage,BP,
7045,GO:0022612,1,0.453132620749122,0,111,gland morphogenesis,BP,
7046,GO:0022613,1,0.0640270363255981,0,442,ribonucleoprotein complex biogenesis,BP,
7047,GO:0022614,1,0.966675359765722,0,5,membrane to membrane docking,BP,
7048,GO:0022615,1,0.978651949301141,0,4,protein to membrane docking,BP,
7049,GO:0022616,1,0.84569033629005,0,26,DNA strand elongation,BP,
7051,GO:0022618,1,0.286337967156164,0,195,ribonucleoprotein complex assembly,BP,
7052,GO:0022622,1,0.994831355742962,0,1,root system development,BP,
7053,GO:0022624,1,0.878500876217376,0,24,proteasome accessory complex,CC,
7054,GO:0022625,1,0.716411688158699,0,62,cytosolic large ribosomal subunit,CC,
7055,GO:0022626,1,0.531323395250085,0,114,cytosolic ribosome,CC,
7056,GO:0022627,1,0.776233289056063,0,45,cytosolic small ribosomal subunit,CC,
7059,GO:0022821,1,0.908579228152316,0,14,potassium ion antiporter activity,MF,
7061,GO:0022829,1,0.904094275583369,0,17,wide pore channel activity,MF,
7068,GO:0022840,1,0.906190464746472,0,16,leak channel activity,MF,
7069,GO:0022841,1,0.920306872472737,0,14,potassium ion leak channel activity,MF,
7070,GO:0022842,1,0.906190464746472,0,16,narrow pore channel activity,MF,
7072,GO:0022848,1,0.919998342968521,0,14,acetylcholine-gated cation-selective channel activity,MF,
7074,GO:0022850,1,0.978564686003925,0,4,serotonin-gated cation-selective channel activity,MF,
7076,GO:0022852,1,0.987672359348371,0,2,glycine-gated chloride ion channel activity,MF,
7077,GO:0022853,1,0.693510389808081,0,53,active ion transmembrane transporter activity,MF,
7079,GO:0022858,1,0.968239284435693,0,5,alanine transmembrane transporter activity,MF,
7080,GO:0022884,1,0.918110926966356,0,15,macromolecule transmembrane transporter activity,MF,
7081,GO:0022889,1,0.950538163026303,0,9,serine transmembrane transporter activity,MF,
7083,GO:0022894,1,0.994564272040715,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7085,GO:0022900,1,0.409009909785802,0,158,electron transport chain,BP,
7086,GO:0022904,1,0.579157100325445,0,97,respiratory electron transport chain,BP,
7088,GO:0023016,1,0.975834537825396,0,3,signal transduction by trans-phosphorylation,BP,
7089,GO:0023019,1,0.890399312199664,0,18,signal transduction involved in regulation of gene expression,BP,
7090,GO:0023021,1,0.983426614668474,0,3,termination of signal transduction,BP,
7091,GO:0023023,1,0.895679842863202,0,20,MHC protein complex binding,MF,
7092,GO:0023024,1,0.983682807783764,0,3,MHC class I protein complex binding,MF,
7093,GO:0023025,1,0.988644671673,0,2,MHC class Ib protein complex binding,MF,
7094,GO:0023026,1,0.915519432998551,0,16,MHC class II protein complex binding,MF,
7095,GO:0023029,1,0.970697903083541,0,5,MHC class Ib protein binding,MF,
7096,GO:0023030,1,0.988644671673,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7097,GO:0023035,1,0.952386081456724,0,8,CD40 signaling pathway,BP,
7098,GO:0023041,1,0.96058568935791,0,6,neuronal signal transduction,BP,
7106,GO:0030002,1,0.92826927077186,0,10,cellular anion homeostasis,BP,
7108,GO:0030004,1,0.49271552686812,0,107,cellular monovalent inorganic cation homeostasis,BP,
7109,GO:0030007,1,0.911588745064554,0,14,cellular potassium ion homeostasis,BP,
7110,GO:0030008,1,0.920663647705855,0,14,TRAPP complex,CC,
7112,GO:0030011,1,0.879920989627178,0,17,maintenance of cell polarity,BP,
7113,GO:0030014,1,0.9005090560404,0,15,CCR4-NOT complex,CC,
7114,GO:0030015,1,0.968151323042443,0,5,CCR4-NOT core complex,CC,
7115,GO:0030016,1,0.204051589458668,0,205,myofibril,CC,
7116,GO:0030017,1,0.238783305977497,0,185,sarcomere,CC,
7117,GO:0030018,1,0.370058940727102,0,120,Z disc,CC,
7118,GO:0030020,1,0.954300410169574,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7119,GO:0030021,1,0.994118097015475,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
7125,GO:0030032,1,0.689793892782188,0,53,lamellipodium assembly,BP,
7126,GO:0030033,1,0.891257785918112,0,16,microvillus assembly,BP,
7127,GO:0030035,1,0.971439433160566,0,4,microspike assembly,BP,
7129,GO:0030037,1,0.992372558722202,0,1,actin filament reorganization involved in cell cycle,BP,
7130,GO:0030038,1,0.547046035876329,0,86,contractile actin filament bundle assembly,BP,
7131,GO:0030041,1,0.342799204658394,0,161,actin filament polymerization,BP,
7132,GO:0030042,1,0.709432703039724,0,47,actin filament depolymerization,BP,
7133,GO:0030043,1,0.97800158257578,0,4,actin filament fragmentation,BP,
7134,GO:0030046,1,0.965312320438325,0,5,parallel actin filament bundle assembly,BP,
7135,GO:0030047,1,0.980484507564853,0,3,actin modification,BP,
7138,GO:0030050,1,0.939364277708451,0,8,vesicle transport along actin filament,BP,
7141,GO:0030056,1,0.940194356227618,0,5,hemidesmosome,CC,
7142,GO:0030057,1,0.846416391587119,0,22,desmosome,CC,
7143,GO:0030060,1,0.978913297269029,0,4,L-malate dehydrogenase activity,MF,
7144,GO:0030061,1,0.968829909039157,0,5,mitochondrial crista,CC,
7145,GO:0030062,1,0.960214890850337,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7146,GO:0030070,1,0.971182225570596,0,4,insulin processing,BP,
7147,GO:0030071,1,0.720428382112345,0,48,regulation of mitotic metaphase/anaphase transition,BP,
7150,GO:0030091,1,0.961853575709206,0,7,protein repair,BP,
7155,GO:0030101,1,0.741328154858976,0,49,natural killer cell activation,BP,
7156,GO:0030103,1,0.988931045403135,0,2,vasopressin secretion,BP,
7157,GO:0030104,1,0.679762758203101,0,56,water homeostasis,BP,
7158,GO:0030107,1,0.994260248918568,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7159,GO:0030108,1,0.994763606144711,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7160,GO:0030109,1,0.988962803340386,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7162,GO:0030117,1,0.53140830857141,0,96,membrane coat,CC,
7163,GO:0030118,1,0.717535874946447,0,48,clathrin coat,CC,
7164,GO:0030119,1,0.741050684438392,0,45,AP-type membrane coat adaptor complex,CC,
7165,GO:0030120,1,0.70163328190655,0,54,vesicle coat,CC,
7166,GO:0030121,1,0.962083072172091,0,6,AP-1 adaptor complex,CC,
7167,GO:0030122,1,0.907134166310436,0,14,AP-2 adaptor complex,CC,
7168,GO:0030123,1,0.934732082618406,0,10,AP-3 adaptor complex,CC,
7169,GO:0030124,1,0.974706236131219,0,4,AP-4 adaptor complex,CC,
7170,GO:0030125,1,0.835637333520873,0,26,clathrin vesicle coat,CC,
7171,GO:0030126,1,0.914436482922334,0,15,COPI vesicle coat,CC,
7172,GO:0030127,1,0.912391650549747,0,14,COPII vesicle coat,CC,
7173,GO:0030128,1,0.900495652434253,0,15,clathrin coat of endocytic vesicle,CC,
7174,GO:0030130,1,0.921958506486111,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7175,GO:0030131,1,0.822313019861818,0,29,clathrin adaptor complex,CC,
7176,GO:0030132,1,0.873786905605497,0,19,clathrin coat of coated pit,CC,
7181,GO:0030137,1,0.861435712611751,0,25,COPI-coated vesicle,CC,
7183,GO:0030140,1,0.809431248849355,0,30,trans-Golgi network transport vesicle,CC,
7185,GO:0030144,1,0.982255642937267,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7186,GO:0030145,1,0.727997501070473,0,48,manganese ion binding,MF,
7188,GO:0030149,1,0.878041943639732,0,22,sphingolipid catabolic process,BP,
7189,GO:0030150,1,0.910064038842714,0,17,protein import into mitochondrial matrix,BP,
7190,GO:0030151,1,0.977677662066448,0,4,molybdenum ion binding,MF,
7193,GO:0030156,1,0.994833112633375,0,1,benzodiazepine receptor binding,MF,
7194,GO:0030157,1,0.915715695377909,0,13,pancreatic juice secretion,BP,
7195,GO:0030158,1,0.976177055530578,0,3,protein xylosyltransferase activity,MF,
7200,GO:0030165,1,0.55369321708248,0,82,PDZ domain binding,MF,
7201,GO:0030166,1,0.647635757712843,0,60,proteoglycan biosynthetic process,BP,
7202,GO:0030167,1,0.97525873045331,0,4,proteoglycan catabolic process,BP,
7204,GO:0030169,1,0.910460402494441,0,13,low-density lipoprotein particle binding,MF,
7205,GO:0030170,1,0.764408908289859,0,45,pyridoxal phosphate binding,MF,
7206,GO:0030171,1,0.99471564954953,0,1,voltage-gated proton channel activity,MF,
7207,GO:0030172,1,0.984515040292937,0,3,troponin C binding,MF,
7208,GO:0030173,1,0.77247107245561,0,42,integral component of Golgi membrane,CC,
7209,GO:0030174,1,0.965615895051853,0,6,regulation of DNA-dependent DNA replication initiation,BP,
7215,GO:0030183,1,0.517428155404945,0,96,B cell differentiation,BP,
7216,GO:0030184,1,0.994325787082341,0,1,nitric oxide transmembrane transporter activity,MF,
7217,GO:0030185,1,0.983864254580908,0,3,nitric oxide transport,BP,
7218,GO:0030186,1,0.994764489884017,0,1,melatonin metabolic process,BP,
7219,GO:0030187,1,0.994764489884017,0,1,melatonin biosynthetic process,BP,
7223,GO:0030197,1,0.987294980744798,0,2,extracellular matrix constituent, lubricant activity,MF,
7226,GO:0030200,1,0.982753881854799,0,3,heparan sulfate proteoglycan catabolic process,BP,
7227,GO:0030201,1,0.804354205842338,0,31,heparan sulfate proteoglycan metabolic process,BP,
7228,GO:0030202,1,0.941778407007383,0,8,heparin metabolic process,BP,
7230,GO:0030204,1,0.751556964402424,0,41,chondroitin sulfate metabolic process,BP,
7231,GO:0030205,1,0.908768306597493,0,13,dermatan sulfate metabolic process,BP,
7232,GO:0030206,1,0.835336394645847,0,25,chondroitin sulfate biosynthetic process,BP,
7233,GO:0030207,1,0.908348549474999,0,14,chondroitin sulfate catabolic process,BP,
7234,GO:0030208,1,0.913723486982236,0,12,dermatan sulfate biosynthetic process,BP,
7235,GO:0030209,1,0.994581815133195,0,1,dermatan sulfate catabolic process,BP,
7236,GO:0030210,1,0.941778407007383,0,8,heparin biosynthetic process,BP,
7237,GO:0030212,1,0.809053845673168,0,34,hyaluronan metabolic process,BP,
7238,GO:0030213,1,0.920164927650829,0,13,hyaluronan biosynthetic process,BP,
7239,GO:0030214,1,0.918199015793625,0,14,hyaluronan catabolic process,BP,
7240,GO:0030215,1,0.860221989028878,0,20,semaphorin receptor binding,MF,
7243,GO:0030218,1,0.511217586922004,0,101,erythrocyte differentiation,BP,
7244,GO:0030219,1,0.624886653945439,0,70,megakaryocyte differentiation,BP,
7245,GO:0030220,1,0.8800272983644,0,18,platelet formation,BP,
7246,GO:0030221,1,0.987148218813397,0,2,basophil differentiation,BP,
7247,GO:0030222,1,0.982446629579704,0,3,eosinophil differentiation,BP,
7248,GO:0030223,1,0.964637614284371,0,6,neutrophil differentiation,BP,
7249,GO:0030224,1,0.8180431951873,0,30,monocyte differentiation,BP,
7250,GO:0030225,1,0.797363019121007,0,37,macrophage differentiation,BP,
7251,GO:0030226,1,0.960813941958626,0,3,apolipoprotein receptor activity,MF,
7252,GO:0030228,1,0.869944499204862,0,16,lipoprotein particle receptor activity,MF,
7253,GO:0030229,1,0.973469052666898,0,4,very-low-density lipoprotein particle receptor activity,MF,
7254,GO:0030233,1,0.994733018433186,0,1,deoxynucleotide transmembrane transporter activity,MF,
7256,GO:0030235,1,0.952006828048474,0,7,nitric-oxide synthase regulator activity,MF,
7257,GO:0030237,1,0.987705356153832,0,2,female sex determination,BP,
7258,GO:0030238,1,0.910580035507372,0,14,male sex determination,BP,
7259,GO:0030239,1,0.616158597011175,0,63,myofibril assembly,BP,
7260,GO:0030240,1,0.907541201143333,0,10,skeletal muscle thin filament assembly,BP,
7261,GO:0030241,1,0.920878131308597,0,7,skeletal muscle myosin thick filament assembly,BP,
7262,GO:0030242,1,0.965262239694341,0,5,autophagy of peroxisome,BP,
7265,GO:0030249,1,0.978880680244125,0,4,guanylate cyclase regulator activity,MF,
7266,GO:0030250,1,0.978880680244125,0,4,guanylate cyclase activator activity,MF,
7267,GO:0030252,1,0.907645030036561,0,14,growth hormone secretion,BP,
7268,GO:0030258,1,0.195542363219226,0,243,lipid modification,BP,
7269,GO:0030259,1,0.960478707459015,0,7,lipid glycosylation,BP,
7271,GO:0030261,1,0.810506649688528,0,27,chromosome condensation,BP,
7272,GO:0030262,1,0.831370362919741,0,28,apoptotic nuclear changes,BP,
7273,GO:0030263,1,0.972850687543537,0,4,apoptotic chromosome condensation,BP,
7274,GO:0030264,1,0.994313214468247,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7275,GO:0030267,1,0.983233262271782,0,3,glyoxylate reductase (NADP) activity,MF,
7276,GO:0030272,1,0.994826005884176,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7277,GO:0030273,1,0.99449272576412,0,1,melanin-concentrating hormone receptor activity,MF,
7278,GO:0030274,1,0.960061415181608,0,6,LIM domain binding,MF,
7279,GO:0030275,1,0.902034245537091,0,15,LRR domain binding,MF,
7283,GO:0030279,1,0.662416481357363,0,60,negative regulation of ossification,BP,
7284,GO:0030280,1,0.965608750275222,0,6,structural constituent of epidermis,MF,
7286,GO:0030283,1,0.994821720216463,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
7287,GO:0030284,1,0.967901655677508,0,5,estrogen receptor activity,MF,
7288,GO:0030285,1,0.898272407628623,0,17,integral component of synaptic vesicle membrane,CC,
7289,GO:0030286,1,0.650992439558476,0,48,dynein complex,CC,
7290,GO:0030289,1,0.983033883618321,0,3,protein phosphatase 4 complex,CC,
7291,GO:0030290,1,0.993726329867365,0,1,sphingolipid activator protein activity,MF,
7292,GO:0030291,1,0.815078972174496,0,33,protein serine/threonine kinase inhibitor activity,MF,
7293,GO:0030292,1,0.980884556510669,0,3,protein tyrosine kinase inhibitor activity,MF,
7294,GO:0030294,1,0.994576596550126,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7296,GO:0030296,1,0.899260707892659,0,15,protein tyrosine kinase activator activity,MF,
7297,GO:0030297,1,0.954099370383435,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7298,GO:0030299,1,0.952350770607744,0,8,intestinal cholesterol absorption,BP,
7299,GO:0030300,1,0.983145874587478,0,3,regulation of intestinal cholesterol absorption,BP,
7301,GO:0030302,1,0.994733018433186,0,1,deoxynucleotide transport,BP,
7302,GO:0030305,1,0.987832827740644,0,2,heparanase activity,MF,
7303,GO:0030306,1,0.9385478842765,0,8,ADP-ribosylation factor binding,MF,
7306,GO:0030309,1,0.95463505949085,0,8,poly-N-acetyllactosamine metabolic process,BP,
7307,GO:0030311,1,0.96045564693308,0,7,poly-N-acetyllactosamine biosynthetic process,BP,
7308,GO:0030312,1,0.99456240023169,0,1,external encapsulating structure,CC,
7310,GO:0030315,1,0.691142561649627,0,44,T-tubule,CC,
7312,GO:0030317,1,0.664273099809378,0,61,flagellated sperm motility,BP,
7313,GO:0030318,1,0.843030109020661,0,22,melanocyte differentiation,BP,
7314,GO:0030320,1,0.92826927077186,0,10,cellular monovalent inorganic anion homeostasis,BP,
7315,GO:0030321,1,0.968909413647162,0,5,transepithelial chloride transport,BP,
7316,GO:0030322,1,0.920177124568146,0,14,stabilization of membrane potential,BP,
7319,GO:0030325,1,0.876369571733272,0,19,adrenal gland development,BP,
7320,GO:0030326,1,0.413348962542826,0,122,embryonic limb morphogenesis,BP,
7321,GO:0030327,1,0.980569021182621,0,3,prenylated protein catabolic process,BP,
7322,GO:0030328,1,0.986426861842812,0,2,prenylcysteine catabolic process,BP,
7323,GO:0030329,1,0.986426861842812,0,2,prenylcysteine metabolic process,BP,
7324,GO:0030330,1,0.485617899661428,0,107,DNA damage response, signal transduction by p53 class mediator,BP,
7325,GO:0030331,1,0.768004519737553,0,37,estrogen receptor binding,MF,
7326,GO:0030332,1,0.819052323413937,0,30,cyclin binding,MF,
7330,GO:0030337,1,0.989126301636035,0,2,DNA polymerase processivity factor activity,MF,
7331,GO:0030342,1,0.994051029995373,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7332,GO:0030343,1,0.994738533349941,0,1,vitamin D3 25-hydroxylase activity,MF,
7333,GO:0030345,1,0.994118097015475,0,1,structural constituent of tooth enamel,MF,
7334,GO:0030346,1,0.951150533589915,0,7,protein phosphatase 2B binding,MF,
7335,GO:0030348,1,0.980595017596535,0,3,syntaxin-3 binding,MF,
7336,GO:0030350,1,0.984693113840164,0,2,iron-responsive element binding,MF,
7337,GO:0030351,1,0.994270628287957,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7338,GO:0030366,1,0.989530457924376,0,2,molybdopterin synthase activity,MF,
7339,GO:0030368,1,0.948714663555817,0,8,interleukin-17 receptor activity,MF,
7340,GO:0030369,1,0.986487483466301,0,2,ICAM-3 receptor activity,MF,
7341,GO:0030371,1,0.844328714526058,0,24,translation repressor activity,MF,
7342,GO:0030372,1,0.992552694565599,0,1,high molecular weight B cell growth factor receptor binding,MF,
7343,GO:0030374,1,0.613086309952117,0,68,ligand-dependent nuclear receptor transcription coactivator activity,MF,
7344,GO:0030375,1,0.967632772100468,0,4,thyroid hormone receptor coactivator activity,MF,
7345,GO:0030377,1,0.994769195271256,0,1,urokinase plasminogen activator receptor activity,MF,
7346,GO:0030378,1,0.994465458292206,0,1,serine racemase activity,MF,
7347,GO:0030379,1,0.990228555268828,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7348,GO:0030382,1,0.994711970071648,0,1,sperm mitochondrion organization,BP,
7349,GO:0030387,1,0.994769960778226,0,1,fructosamine-3-kinase activity,MF,
7350,GO:0030388,1,0.973066660206128,0,5,fructose 1,6-bisphosphate metabolic process,BP,
7351,GO:0030389,1,0.989631886409811,0,2,fructosamine metabolic process,BP,
7352,GO:0030393,1,0.994769960778226,0,1,fructoselysine metabolic process,BP,
7353,GO:0030395,1,0.989578494398325,0,2,lactose binding,MF,
7354,GO:0030397,1,0.726128370642189,0,46,membrane disassembly,BP,
7355,GO:0030407,1,0.994673618698266,0,1,formimidoyltransferase activity,MF,
7356,GO:0030409,1,0.994673618698266,0,1,glutamate formimidoyltransferase activity,MF,
7357,GO:0030412,1,0.994673618698266,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7359,GO:0030421,1,0.99482518139384,0,1,defecation,BP,
7360,GO:0030422,1,0.942932375059236,0,9,production of siRNA involved in RNA interference,BP,
7361,GO:0030423,1,0.969616503043132,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7366,GO:0030429,1,0.994761655063573,0,1,kynureninase activity,MF,
7367,GO:0030430,1,0.965057773516906,0,6,host cell cytoplasm,CC,
7368,GO:0030431,1,0.820528442072931,0,30,sleep,BP,
7369,GO:0030432,1,0.95484122112958,0,8,peristalsis,BP,
7370,GO:0030433,1,0.643897627128381,0,70,ubiquitin-dependent ERAD pathway,BP,
7372,GO:0030450,1,0.982595036636778,0,2,regulation of complement activation, classical pathway,BP,
7373,GO:0030451,1,0.987965628034237,0,1,regulation of complement activation, alternative pathway,BP,
7374,GO:0030473,1,0.958569455724915,0,5,nuclear migration along microtubule,BP,
7375,GO:0030474,1,0.994313214468247,0,1,spindle pole body duplication,BP,
7376,GO:0030478,1,0.973825827680094,0,4,actin cap,CC,
7377,GO:0030479,1,0.950090800788503,0,7,actin cortical patch,CC,
7378,GO:0030485,1,0.987552679480884,0,2,smooth muscle contractile fiber,CC,
7379,GO:0030488,1,0.829643056257449,0,31,tRNA methylation,BP,
7380,GO:0030490,1,0.734768144618054,0,51,maturation of SSU-rRNA,BP,
7381,GO:0030492,1,0.97941447452632,0,4,hemoglobin binding,MF,
7383,GO:0030497,1,0.937686653843804,0,11,fatty acid elongation,BP,
7386,GO:0030502,1,0.932633353907888,0,11,negative regulation of bone mineralization,BP,
7387,GO:0030504,1,0.989046974786774,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7388,GO:0030505,1,0.978954154086733,0,2,inorganic diphosphate transport,BP,
7389,GO:0030506,1,0.845908095177062,0,17,ankyrin binding,MF,
7392,GO:0030510,1,0.553916468306488,0,81,regulation of BMP signaling pathway,BP,
7394,GO:0030512,1,0.619593164943741,0,66,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7395,GO:0030513,1,0.793793546220259,0,31,positive regulation of BMP signaling pathway,BP,
7396,GO:0030514,1,0.722620715642734,0,45,negative regulation of BMP signaling pathway,BP,
7397,GO:0030515,1,0.837936213490551,0,29,snoRNA binding,MF,
7400,GO:0030518,1,0.414796849292702,0,128,intracellular steroid hormone receptor signaling pathway,BP,
7401,GO:0030520,1,0.695231365920055,0,54,intracellular estrogen receptor signaling pathway,BP,
7402,GO:0030521,1,0.652414324394797,0,61,androgen receptor signaling pathway,BP,
7403,GO:0030522,1,0.169562027942861,0,261,intracellular receptor signaling pathway,BP,
7404,GO:0030523,1,0.993005537531851,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7405,GO:0030526,1,0.992499060298947,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7406,GO:0030532,1,0.646450512299254,0,68,small nuclear ribonucleoprotein complex,CC,
7408,GO:0030538,1,0.98246967618062,0,3,embryonic genitalia morphogenesis,BP,
7409,GO:0030539,1,0.881488623930737,0,19,male genitalia development,BP,
7410,GO:0030540,1,0.884065406601861,0,16,female genitalia development,BP,
7411,GO:0030544,1,0.795605056783194,0,36,Hsp70 protein binding,MF,
7413,GO:0030546,1,0.924650829283755,0,11,receptor activator activity,MF,
7414,GO:0030547,1,0.893963253783944,0,19,receptor inhibitor activity,MF,
7415,GO:0030548,1,0.960867326942178,0,7,acetylcholine receptor regulator activity,MF,
7416,GO:0030549,1,0.994805351592464,0,1,acetylcholine receptor activator activity,MF,
7417,GO:0030550,1,0.976123965928184,0,4,acetylcholine receptor inhibitor activity,MF,
7418,GO:0030551,1,0.781603784987266,0,35,cyclic nucleotide binding,MF,
7419,GO:0030552,1,0.842054305563592,0,24,cAMP binding,MF,
7420,GO:0030553,1,0.912396943507319,0,13,cGMP binding,MF,
7422,GO:0030572,1,0.993530696504981,0,1,phosphatidyltransferase activity,MF,
7423,GO:0030573,1,0.989227791582277,0,2,bile acid catabolic process,BP,
7426,GO:0030576,1,0.982464204371908,0,3,Cajal body organization,BP,
7427,GO:0030578,1,0.964426787298612,0,4,PML body organization,BP,
7428,GO:0030579,1,0.966712411376617,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7429,GO:0030580,1,0.99479271690561,0,1,quinone cofactor methyltransferase activity,MF,
7430,GO:0030581,1,0.989547006477997,0,2,symbiont intracellular protein transport in host,BP,
7431,GO:0030586,1,0.993960877222941,0,1,[methionine synthase] reductase activity,MF,
7435,GO:0030611,1,0.994824330879583,0,1,arsenate reductase activity,MF,
7436,GO:0030613,1,0.984495770937825,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7437,GO:0030614,1,0.984495770937825,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7438,GO:0030616,1,0.988496738198091,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7439,GO:0030617,1,0.988401542992703,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7440,GO:0030618,1,0.955328137064694,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7441,GO:0030619,1,0.955863070164191,0,7,U1 snRNA binding,MF,
7442,GO:0030620,1,0.964193249909627,0,6,U2 snRNA binding,MF,
7443,GO:0030621,1,0.968498745289331,0,5,U4 snRNA binding,MF,
7444,GO:0030622,1,0.986524265012852,0,2,U4atac snRNA binding,MF,
7445,GO:0030623,1,0.989925498511032,0,1,U5 snRNA binding,MF,
7446,GO:0030624,1,0.992974831045404,0,1,U6atac snRNA binding,MF,
7447,GO:0030626,1,0.988214209784907,0,2,U12 snRNA binding,MF,
7448,GO:0030627,1,0.98908375256642,0,2,pre-mRNA 5'-splice site binding,MF,
7449,GO:0030628,1,0.966923573227966,0,6,pre-mRNA 3'-splice site binding,MF,
7450,GO:0030629,1,0.994313214468247,0,1,U6 snRNA 3'-end binding,MF,
7451,GO:0030638,1,0.958047737736096,0,8,polyketide metabolic process,BP,
7452,GO:0030641,1,0.558615864372903,0,89,regulation of cellular pH,BP,
7453,GO:0030643,1,0.95383772737283,0,6,cellular phosphate ion homeostasis,BP,
7454,GO:0030644,1,0.973206610559684,0,4,cellular chloride ion homeostasis,BP,
7455,GO:0030647,1,0.958047737736096,0,8,aminoglycoside antibiotic metabolic process,BP,
7456,GO:0030653,1,0.992265130732741,0,1,beta-lactam antibiotic metabolic process,BP,
7457,GO:0030656,1,0.93654499087054,0,11,regulation of vitamin metabolic process,BP,
7462,GO:0030663,1,0.899983100091203,0,18,COPI-coated vesicle membrane,CC,
7467,GO:0030670,1,0.652598530188882,0,68,phagocytic vesicle membrane,CC,
7469,GO:0030673,1,0.873186754474396,0,16,axolemma,CC,
7471,GO:0030676,1,0.887926762151958,0,16,Rac guanyl-nucleotide exchange factor activity,MF,
7472,GO:0030677,1,0.929490610786744,0,13,ribonuclease P complex,CC,
7473,GO:0030678,1,0.98362627515828,0,3,mitochondrial ribonuclease P complex,CC,
7474,GO:0030681,1,0.944972020041823,0,10,multimeric ribonuclease P complex,CC,
7475,GO:0030682,1,0.98651960997864,0,2,evasion or tolerance of host defense response,BP,
7476,GO:0030683,1,0.98651960997864,0,2,evasion or tolerance by virus of host immune response,BP,
7477,GO:0030684,1,0.634011237400557,0,72,preribosome,CC,
7478,GO:0030686,1,0.824075369855581,0,30,90S preribosome,CC,
7479,GO:0030687,1,0.856892960669025,0,24,preribosome, large subunit precursor,CC,
7480,GO:0030688,1,0.925295152333648,0,12,preribosome, small subunit precursor,CC,
7481,GO:0030689,1,0.98333502003663,0,3,Noc complex,CC,
7482,GO:0030690,1,0.9942910151926,0,1,Noc1p-Noc2p complex,CC,
7483,GO:0030691,1,0.9942910151926,0,1,Noc2p-Noc3p complex,CC,
7484,GO:0030692,1,0.98898172609298,0,2,Noc4p-Nop14p complex,CC,
7485,GO:0030695,1,0.122565546801714,0,293,GTPase regulator activity,MF,
7486,GO:0030696,1,0.994059083070697,0,1,tRNA (m5U54) methyltransferase activity,MF,
7487,GO:0030697,1,0.994059083070697,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7488,GO:0030702,1,0.993315684100996,0,1,chromatin silencing at centromere,BP,
7489,GO:0030705,1,0.309180057127796,0,159,cytoskeleton-dependent intracellular transport,BP,
7490,GO:0030718,1,0.98828379125283,0,2,germ-line stem cell population maintenance,BP,
7491,GO:0030719,1,0.98822662674325,0,2,P granule organization,BP,
7492,GO:0030728,1,0.876518744184037,0,19,ovulation,BP,
7493,GO:0030729,1,0.993928077864815,0,1,acetoacetate-CoA ligase activity,MF,
7494,GO:0030730,1,0.902603895832291,0,15,sequestering of triglyceride,BP,
7495,GO:0030731,1,0.994817765573483,0,1,guanidinoacetate N-methyltransferase activity,MF,
7496,GO:0030742,1,0.859070373121378,0,23,GTP-dependent protein binding,MF,
7497,GO:0030748,1,0.994429038802581,0,1,amine N-methyltransferase activity,MF,
7499,GO:0030791,1,0.994470023170916,0,1,arsenite methyltransferase activity,MF,
7500,GO:0030792,1,0.994470023170916,0,1,methylarsonite methyltransferase activity,MF,
7506,GO:0030804,1,0.824124575009491,0,32,positive regulation of cyclic nucleotide biosynthetic process,BP,
7507,GO:0030805,1,0.975885692797553,0,3,regulation of cyclic nucleotide catabolic process,BP,
7508,GO:0030806,1,0.984459949655233,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7509,GO:0030807,1,0.991291751661753,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7512,GO:0030810,1,0.696385794984039,0,56,positive regulation of nucleotide biosynthetic process,BP,
7513,GO:0030811,1,0.627107136544949,0,64,regulation of nucleotide catabolic process,BP,
7514,GO:0030812,1,0.913701349624126,0,12,negative regulation of nucleotide catabolic process,BP,
7515,GO:0030813,1,0.88130248025583,0,17,positive regulation of nucleotide catabolic process,BP,
7521,GO:0030819,1,0.901667598004837,0,17,positive regulation of cAMP biosynthetic process,BP,
7522,GO:0030820,1,0.975885692797553,0,3,regulation of cAMP catabolic process,BP,
7523,GO:0030821,1,0.984459949655233,0,2,negative regulation of cAMP catabolic process,BP,
7524,GO:0030822,1,0.991291751661753,0,1,positive regulation of cAMP catabolic process,BP,
7525,GO:0030823,1,0.868948552790924,0,22,regulation of cGMP metabolic process,BP,
7526,GO:0030824,1,0.994774443149678,0,1,negative regulation of cGMP metabolic process,BP,
7527,GO:0030825,1,0.901425531102947,0,17,positive regulation of cGMP metabolic process,BP,
7528,GO:0030826,1,0.902941226408946,0,17,regulation of cGMP biosynthetic process,BP,
7529,GO:0030827,1,0.994774443149678,0,1,negative regulation of cGMP biosynthetic process,BP,
7530,GO:0030828,1,0.914085545094846,0,15,positive regulation of cGMP biosynthetic process,BP,
7531,GO:0030832,1,0.319672129935996,0,167,regulation of actin filament length,BP,
7532,GO:0030833,1,0.376111170902373,0,147,regulation of actin filament polymerization,BP,
7533,GO:0030834,1,0.726539931927292,0,44,regulation of actin filament depolymerization,BP,
7534,GO:0030835,1,0.776551032194826,0,34,negative regulation of actin filament depolymerization,BP,
7535,GO:0030836,1,0.935673991218702,0,10,positive regulation of actin filament depolymerization,BP,
7536,GO:0030837,1,0.700458373604026,0,51,negative regulation of actin filament polymerization,BP,
7537,GO:0030838,1,0.573860077649889,0,88,positive regulation of actin filament polymerization,BP,
7538,GO:0030842,1,0.991763188933687,0,1,regulation of intermediate filament depolymerization,BP,
7539,GO:0030844,1,0.991763188933687,0,1,positive regulation of intermediate filament depolymerization,BP,
7540,GO:0030845,1,0.994265759215158,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7541,GO:0030846,1,0.986374012045264,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7542,GO:0030849,1,0.986949983730337,0,2,autosome,CC,
7544,GO:0030851,1,0.851466992126943,0,26,granulocyte differentiation,BP,
7545,GO:0030852,1,0.922215070709692,0,13,regulation of granulocyte differentiation,BP,
7546,GO:0030853,1,0.956124849392053,0,7,negative regulation of granulocyte differentiation,BP,
7547,GO:0030854,1,0.958456366905959,0,7,positive regulation of granulocyte differentiation,BP,
7550,GO:0030857,1,0.801162997453244,0,33,negative regulation of epithelial cell differentiation,BP,
7552,GO:0030859,1,0.881792234330447,0,18,polarized epithelial cell differentiation,BP,
7553,GO:0030860,1,0.986268623429344,0,2,regulation of polarized epithelial cell differentiation,BP,
7554,GO:0030862,1,0.99176582790506,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7556,GO:0030864,1,0.576751036832963,0,72,cortical actin cytoskeleton,CC,
7557,GO:0030865,1,0.715408448681271,0,49,cortical cytoskeleton organization,BP,
7558,GO:0030866,1,0.763108936752078,0,39,cortical actin cytoskeleton organization,BP,
7560,GO:0030868,1,0.969484020444027,0,5,smooth endoplasmic reticulum membrane,CC,
7561,GO:0030870,1,0.966257981329963,0,5,Mre11 complex,CC,
7562,GO:0030874,1,0.994717517892978,0,1,nucleolar chromatin,CC,
7563,GO:0030877,1,0.91346022381272,0,12,beta-catenin destruction complex,CC,
7564,GO:0030878,1,0.852459012743121,0,25,thyroid gland development,BP,
7565,GO:0030879,1,0.406064600047026,0,125,mammary gland development,BP,
7566,GO:0030880,1,0.41804890805703,0,134,RNA polymerase complex,CC,
7567,GO:0030881,1,0.962045230561678,0,7,beta-2-microglobulin binding,MF,
7568,GO:0030882,1,0.98267481816854,0,3,lipid antigen binding,MF,
7569,GO:0030883,1,0.98267481816854,0,3,endogenous lipid antigen binding,MF,
7570,GO:0030884,1,0.98267481816854,0,3,exogenous lipid antigen binding,MF,
7571,GO:0030885,1,0.973890774901622,0,5,regulation of myeloid dendritic cell activation,BP,
7572,GO:0030886,1,0.984130870927491,0,3,negative regulation of myeloid dendritic cell activation,BP,
7573,GO:0030887,1,0.994754315251679,0,1,positive regulation of myeloid dendritic cell activation,BP,
7574,GO:0030888,1,0.699869251112683,0,55,regulation of B cell proliferation,BP,
7575,GO:0030889,1,0.896653948082175,0,16,negative regulation of B cell proliferation,BP,
7576,GO:0030890,1,0.796700958022685,0,36,positive regulation of B cell proliferation,BP,
7577,GO:0030891,1,0.976549769402219,0,4,VCB complex,CC,
7578,GO:0030893,1,0.957005534238408,0,6,meiotic cohesin complex,CC,
7579,GO:0030894,1,0.855132396628676,0,26,replisome,CC,
7580,GO:0030895,1,0.989053149135168,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7581,GO:0030896,1,0.971407715065161,0,5,checkpoint clamp complex,CC,
7582,GO:0030897,1,0.901048518374153,0,14,HOPS complex,CC,
7583,GO:0030898,1,0.896744479814517,0,12,actin-dependent ATPase activity,MF,
7584,GO:0030899,1,0.984504542031238,0,3,calcium-dependent ATPase activity,MF,
7588,GO:0030903,1,0.894812413595355,0,16,notochord development,BP,
7589,GO:0030904,1,0.867600101658275,0,21,retromer complex,CC,
7590,GO:0030905,1,0.972822853173489,0,4,retromer, tubulation complex,CC,
7591,GO:0030906,1,0.977010243532978,0,4,retromer, cargo-selective complex,CC,
7592,GO:0030908,1,0.994746455661165,0,1,protein splicing,BP,
7593,GO:0030910,1,0.973696735107235,0,4,olfactory placode formation,BP,
7594,GO:0030911,1,0.946431401663832,0,8,TPR domain binding,MF,
7595,GO:0030913,1,0.945820526997742,0,7,paranodal junction assembly,BP,
7596,GO:0030914,1,0.929213271089016,0,11,STAGA complex,CC,
7597,GO:0030915,1,0.963133109237668,0,6,Smc5-Smc6 complex,CC,
7598,GO:0030916,1,0.950414786279434,0,8,otic vesicle formation,BP,
7599,GO:0030917,1,0.953400304811051,0,7,midbrain-hindbrain boundary development,BP,
7600,GO:0030920,1,0.989610090810955,0,2,peptidyl-serine acetylation,BP,
7601,GO:0030934,1,0.966599239726273,0,3,anchoring collagen complex,CC,
7602,GO:0030935,1,0.994394193991265,0,1,sheet-forming collagen trimer,CC,
7603,GO:0030936,1,0.994132026395568,0,1,transmembrane collagen trimer,CC,
7604,GO:0030942,1,0.983901557007361,0,3,endoplasmic reticulum signal peptide binding,MF,
7605,GO:0030943,1,0.983078382813944,0,3,mitochondrion targeting sequence binding,MF,
7606,GO:0030947,1,0.829256090263367,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7607,GO:0030948,1,0.942286135756473,0,9,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7608,GO:0030949,1,0.907320579094473,0,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7609,GO:0030950,1,0.914515972395941,0,14,establishment or maintenance of actin cytoskeleton polarity,BP,
7610,GO:0030951,1,0.973513265479965,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7611,GO:0030952,1,0.89027206391446,0,18,establishment or maintenance of cytoskeleton polarity,BP,
7612,GO:0030953,1,0.947286684945582,0,7,astral microtubule organization,BP,
7613,GO:0030955,1,0.905230096742689,0,14,potassium ion binding,MF,
7614,GO:0030956,1,0.982486913114351,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7615,GO:0030957,1,0.940466329087903,0,10,Tat protein binding,MF,
7616,GO:0030961,1,0.994313214468247,0,1,peptidyl-arginine hydroxylation,BP,
7617,GO:0030964,1,0.795565393732025,0,43,NADH dehydrogenase complex,CC,
7619,GO:0030969,1,0.982046460552819,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7620,GO:0030970,1,0.849095263628216,0,26,retrograde protein transport, ER to cytosol,BP,
7621,GO:0030971,1,0.680165163574368,0,55,receptor tyrosine kinase binding,MF,
7622,GO:0030974,1,0.989145855939088,0,2,thiamine pyrophosphate transmembrane transport,BP,
7623,GO:0030975,1,0.994517803950429,0,1,thiamine binding,MF,
7624,GO:0030976,1,0.968456009047602,0,5,thiamine pyrophosphate binding,MF,
7625,GO:0030977,1,0.994695815547396,0,1,taurine binding,MF,
7626,GO:0030981,1,0.973979566085101,0,3,cortical microtubule cytoskeleton,CC,
7627,GO:0030983,1,0.921005317837739,0,13,mismatched DNA binding,MF,
7628,GO:0030984,1,0.989146378868334,0,2,kininogen binding,MF,
7629,GO:0030990,1,0.820688599884445,0,31,intraciliary transport particle,CC,
7630,GO:0030991,1,0.944264826114985,0,8,intraciliary transport particle A,CC,
7631,GO:0030992,1,0.886728293984049,0,20,intraciliary transport particle B,CC,
7632,GO:0030997,1,0.977526715193254,0,3,regulation of centriole-centriole cohesion,BP,
7633,GO:0031000,1,0.853751664799339,0,18,response to caffeine,BP,
7634,GO:0031001,1,0.994313214468247,0,1,response to brefeldin A,BP,
7635,GO:0031005,1,0.927331443692272,0,11,filamin binding,MF,
7636,GO:0031010,1,0.918034186801975,0,11,ISWI-type complex,CC,
7637,GO:0031011,1,0.916479641660678,0,15,Ino80 complex,CC,
7639,GO:0031013,1,0.973509721944277,0,5,troponin I binding,MF,
7640,GO:0031014,1,0.979472130577739,0,4,troponin T binding,MF,
7642,GO:0031017,1,0.967088585204224,0,5,exocrine pancreas development,BP,
7644,GO:0031021,1,0.982787212899073,0,3,interphase microtubule organizing center,CC,
7645,GO:0031022,1,0.97875731964727,0,2,nuclear migration along microfilament,BP,
7646,GO:0031023,1,0.421123198969575,0,123,microtubule organizing center organization,BP,
7647,GO:0031032,1,0.265591472621072,0,179,actomyosin structure organization,BP,
7648,GO:0031033,1,0.875309432272198,0,15,myosin filament organization,BP,
7649,GO:0031034,1,0.880057793314531,0,14,myosin filament assembly,BP,
7650,GO:0031038,1,0.994611358350175,0,1,myosin II filament organization,BP,
7651,GO:0031045,1,0.914156158206337,0,13,dense core granule,CC,
7652,GO:0031047,1,0.381857197447784,0,140,gene silencing by RNA,BP,
7653,GO:0031048,1,0.987197448681487,0,2,chromatin silencing by small RNA,BP,
7654,GO:0031049,1,0.994281782907077,0,1,programmed DNA elimination,BP,
7655,GO:0031050,1,0.739673549138274,0,43,dsRNA fragmentation,BP,
7656,GO:0031052,1,0.994281782907077,0,1,chromosome breakage,BP,
7657,GO:0031053,1,0.931006014702314,0,10,primary miRNA processing,BP,
7658,GO:0031054,1,0.914326677579413,0,13,pre-miRNA processing,BP,
7659,GO:0031055,1,0.832216539916364,0,32,chromatin remodeling at centromere,BP,
7660,GO:0031056,1,0.398360428647632,0,132,regulation of histone modification,BP,
7661,GO:0031057,1,0.769850455666674,0,37,negative regulation of histone modification,BP,
7662,GO:0031058,1,0.578445516727524,0,81,positive regulation of histone modification,BP,
7663,GO:0031060,1,0.662090481183875,0,57,regulation of histone methylation,BP,
7664,GO:0031061,1,0.884723474167869,0,17,negative regulation of histone methylation,BP,
7665,GO:0031062,1,0.792897766074208,0,33,positive regulation of histone methylation,BP,
7666,GO:0031063,1,0.840180488610346,0,25,regulation of histone deacetylation,BP,
7667,GO:0031064,1,0.967827895537257,0,4,negative regulation of histone deacetylation,BP,
7668,GO:0031065,1,0.888175747328844,0,17,positive regulation of histone deacetylation,BP,
7669,GO:0031069,1,0.85422026265664,0,24,hair follicle morphogenesis,BP,
7670,GO:0031071,1,0.994509864914769,0,1,cysteine desulfurase activity,MF,
7672,GO:0031074,1,0.979884370888731,0,3,nucleocytoplasmic transport complex,CC,
7673,GO:0031076,1,0.754007315414159,0,37,embryonic camera-type eye development,BP,
7674,GO:0031077,1,0.953395752419253,0,7,post-embryonic camera-type eye development,BP,
7675,GO:0031078,1,0.925499391471389,0,11,histone deacetylase activity (H3-K14 specific),MF,
7676,GO:0031080,1,0.93381384155981,0,10,nuclear pore outer ring,CC,
7677,GO:0031081,1,0.987516848126927,0,2,nuclear pore distribution,BP,
7680,GO:0031084,1,0.980029822784383,0,3,BLOC-2 complex,CC,
7681,GO:0031085,1,0.987454205935827,0,2,BLOC-3 complex,CC,
7682,GO:0031086,1,0.959390560585055,0,7,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7683,GO:0031087,1,0.965028223656792,0,6,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7684,GO:0031088,1,0.95773223847151,0,6,platelet dense granule membrane,CC,
7685,GO:0031089,1,0.939312930906017,0,11,platelet dense granule lumen,CC,
7690,GO:0031094,1,0.907128582841245,0,11,platelet dense tubular network,CC,
7691,GO:0031095,1,0.918064191426564,0,9,platelet dense tubular network membrane,CC,
7692,GO:0031098,1,0.165298707552814,0,269,stress-activated protein kinase signaling cascade,BP,
7697,GO:0031104,1,0.993259985943002,0,1,dendrite regeneration,BP,
7698,GO:0031105,1,0.927781029838393,0,12,septin complex,CC,
7699,GO:0031106,1,0.907290776948001,0,15,septin ring organization,BP,
7700,GO:0031109,1,0.501953207215741,0,98,microtubule polymerization or depolymerization,BP,
7701,GO:0031110,1,0.617557135427925,0,67,regulation of microtubule polymerization or depolymerization,BP,
7702,GO:0031111,1,0.795683119381405,0,32,negative regulation of microtubule polymerization or depolymerization,BP,
7703,GO:0031112,1,0.820808482096082,0,27,positive regulation of microtubule polymerization or depolymerization,BP,
7704,GO:0031113,1,0.747510213016065,0,41,regulation of microtubule polymerization,BP,
7705,GO:0031114,1,0.812988811643563,0,26,regulation of microtubule depolymerization,BP,
7706,GO:0031115,1,0.935889442157301,0,11,negative regulation of microtubule polymerization,BP,
7707,GO:0031116,1,0.834718721084343,0,24,positive regulation of microtubule polymerization,BP,
7708,GO:0031117,1,0.983365249063788,0,3,positive regulation of microtubule depolymerization,BP,
7709,GO:0031118,1,0.958466861468873,0,8,rRNA pseudouridine synthesis,BP,
7710,GO:0031119,1,0.962244606890462,0,7,tRNA pseudouridine synthesis,BP,
7711,GO:0031120,1,0.979033585216023,0,4,snRNA pseudouridine synthesis,BP,
7712,GO:0031122,1,0.678942992921053,0,52,cytoplasmic microtubule organization,BP,
7713,GO:0031123,1,0.474421665075775,0,120,RNA 3'-end processing,BP,
7714,GO:0031124,1,0.579022952737103,0,88,mRNA 3'-end processing,BP,
7715,GO:0031125,1,0.936803877054145,0,12,rRNA 3'-end processing,BP,
7716,GO:0031126,1,0.963551373595926,0,7,snoRNA 3'-end processing,BP,
7717,GO:0031127,1,0.993113605288307,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7718,GO:0031128,1,0.829415960698703,0,28,developmental induction,BP,
7719,GO:0031129,1,0.992141492576957,0,1,inductive cell-cell signaling,BP,
7720,GO:0031133,1,0.971312856410626,0,4,regulation of axon diameter,BP,
7721,GO:0031134,1,0.981676226499594,0,3,sister chromatid biorientation,BP,
7722,GO:0031143,1,0.916579269005685,0,14,pseudopodium,CC,
7723,GO:0031145,1,0.648515604257116,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7724,GO:0031146,1,0.664689623044595,0,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7725,GO:0031151,1,0.989798535205077,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7726,GO:0031161,1,0.994071082447412,0,1,phosphatidylinositol catabolic process,BP,
7727,GO:0031163,1,0.892079568737846,0,20,metallo-sulfur cluster assembly,BP,
7728,GO:0031166,1,0.980954230531929,0,3,integral component of vacuolar membrane,CC,
7729,GO:0031167,1,0.901650520719277,0,18,rRNA methylation,BP,
7731,GO:0031177,1,0.978583416476955,0,3,phosphopantetheine binding,MF,
7732,GO:0031179,1,0.99359549975056,0,1,peptide modification,BP,
7734,GO:0031204,1,0.978546408338919,0,3,posttranslational protein targeting to membrane, translocation,BP,
7735,GO:0031205,1,0.977865025765721,0,3,endoplasmic reticulum Sec complex,CC,
7736,GO:0031208,1,0.984948315558058,0,2,POZ domain binding,MF,
7737,GO:0031209,1,0.944169523953225,0,8,SCAR complex,CC,
7738,GO:0031210,1,0.894397712027237,0,17,phosphatidylcholine binding,MF,
7739,GO:0031211,1,0.951837456710385,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7740,GO:0031213,1,0.98571549551325,0,2,RSF complex,CC,
7742,GO:0031223,1,0.908395517811025,0,11,auditory behavior,BP,
7747,GO:0031228,1,0.754841790316323,0,46,intrinsic component of Golgi membrane,CC,
7748,GO:0031229,1,0.919528841968475,0,14,intrinsic component of nuclear inner membrane,CC,
7749,GO:0031231,1,0.906037395155408,0,17,intrinsic component of peroxisomal membrane,CC,
7751,GO:0031233,1,0.890193834790995,0,18,intrinsic component of external side of plasma membrane,CC,
7753,GO:0031235,1,0.88957208958659,0,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7754,GO:0031247,1,0.988977551058649,0,2,actin rod assembly,BP,
7755,GO:0031248,1,0.568934374520389,0,85,protein acetyltransferase complex,CC,
7756,GO:0031249,1,0.994490979828834,0,1,denatured protein binding,MF,
7757,GO:0031251,1,0.983745182816153,0,2,PAN complex,CC,
7760,GO:0031254,1,0.919391279463634,0,13,cell trailing edge,CC,
7762,GO:0031257,1,0.994313214468247,0,1,cell trailing edge membrane,CC,
7764,GO:0031259,1,0.994313214468247,0,1,uropod membrane,CC,
7765,GO:0031261,1,0.971564114007016,0,5,DNA replication preinitiation complex,CC,
7766,GO:0031262,1,0.979036025541806,0,4,Ndc80 complex,CC,
7767,GO:0031264,1,0.947893177404726,0,9,death-inducing signaling complex,CC,
7768,GO:0031265,1,0.964542596727776,0,6,CD95 death-inducing signaling complex,CC,
7770,GO:0031268,1,0.920309538504722,0,13,pseudopodium organization,BP,
7771,GO:0031269,1,0.920309538504722,0,13,pseudopodium assembly,BP,
7772,GO:0031271,1,0.994313214468247,0,1,lateral pseudopodium assembly,BP,
7773,GO:0031272,1,0.920309538504722,0,13,regulation of pseudopodium assembly,BP,
7774,GO:0031274,1,0.925577159887906,0,12,positive regulation of pseudopodium assembly,BP,
7775,GO:0031275,1,0.994313214468247,0,1,regulation of lateral pseudopodium assembly,BP,
7778,GO:0031281,1,0.901271287452756,0,16,positive regulation of cyclase activity,BP,
7779,GO:0031282,1,0.947139117145799,0,9,regulation of guanylate cyclase activity,BP,
7780,GO:0031283,1,0.994774443149678,0,1,negative regulation of guanylate cyclase activity,BP,
7781,GO:0031284,1,0.952116895900695,0,8,positive regulation of guanylate cyclase activity,BP,
7782,GO:0031289,1,0.994140999635304,0,1,actin phosphorylation,BP,
7783,GO:0031290,1,0.867704102484048,0,19,retinal ganglion cell axon guidance,BP,
7784,GO:0031291,1,0.982216036050729,0,3,Ran protein signal transduction,BP,
7785,GO:0031293,1,0.853310669827332,0,24,membrane protein intracellular domain proteolysis,BP,
7788,GO:0031296,1,0.98450712355974,0,3,B cell costimulation,BP,
7789,GO:0031297,1,0.83048131237638,0,27,replication fork processing,BP,
7790,GO:0031298,1,0.945027877583088,0,9,replication fork protection complex,CC,
7791,GO:0031300,1,0.334135039558421,0,182,intrinsic component of organelle membrane,CC,
7792,GO:0031301,1,0.365146041315588,0,167,integral component of organelle membrane,CC,
7793,GO:0031302,1,0.992210712150724,0,1,intrinsic component of endosome membrane,CC,
7794,GO:0031304,1,0.820142141896998,0,35,intrinsic component of mitochondrial inner membrane,CC,
7795,GO:0031305,1,0.820142141896998,0,35,integral component of mitochondrial inner membrane,CC,
7796,GO:0031306,1,0.871247801807557,0,23,intrinsic component of mitochondrial outer membrane,CC,
7797,GO:0031307,1,0.877626902757228,0,22,integral component of mitochondrial outer membrane,CC,
7798,GO:0031308,1,0.994313214468247,0,1,intrinsic component of nuclear outer membrane,CC,
7799,GO:0031309,1,0.994313214468247,0,1,integral component of nuclear outer membrane,CC,
7800,GO:0031310,1,0.980954230531929,0,3,intrinsic component of vacuolar membrane,CC,
7803,GO:0031314,1,0.968546635705351,0,5,extrinsic component of mitochondrial inner membrane,CC,
7804,GO:0031315,1,0.984575515053279,0,2,extrinsic component of mitochondrial outer membrane,CC,
7805,GO:0031320,1,0.99444254450294,0,1,hexitol dehydrogenase activity,MF,
7814,GO:0031331,1,0.110588952849475,0,314,positive regulation of cellular catabolic process,BP,
7815,GO:0031332,1,0.918930095183048,0,11,RNAi effector complex,CC,
7816,GO:0031333,1,0.449379177588462,0,119,negative regulation of protein complex assembly,BP,
7817,GO:0031334,1,0.211473686194273,0,232,positive regulation of protein complex assembly,BP,
7818,GO:0031335,1,0.989039051876076,0,2,regulation of sulfur amino acid metabolic process,BP,
7819,GO:0031337,1,0.994553872164583,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7821,GO:0031339,1,0.959604623322404,0,6,negative regulation of vesicle fusion,BP,
7823,GO:0031341,1,0.70420331002582,0,60,regulation of cell killing,BP,
7824,GO:0031342,1,0.912639254148359,0,16,negative regulation of cell killing,BP,
7825,GO:0031343,1,0.798426525556795,0,38,positive regulation of cell killing,BP,
7832,GO:0031362,1,0.910577745783861,0,14,anchored component of external side of plasma membrane,CC,
7833,GO:0031365,1,0.827053868831737,0,28,N-terminal protein amino acid modification,BP,
7834,GO:0031369,1,0.8341584407888,0,29,translation initiation factor binding,MF,
7835,GO:0031370,1,0.992604087658063,0,1,eukaryotic initiation factor 4G binding,MF,
7836,GO:0031371,1,0.954960879719065,0,8,ubiquitin conjugating enzyme complex,CC,
7837,GO:0031372,1,0.989217700711097,0,2,UBC13-MMS2 complex,CC,
7838,GO:0031379,1,0.987341914460153,0,2,RNA-directed RNA polymerase complex,CC,
7839,GO:0031380,1,0.993960877222941,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7840,GO:0031386,1,0.916803583631914,0,16,protein tag,MF,
7841,GO:0031389,1,0.994239123774774,0,1,Rad17 RFC-like complex,CC,
7842,GO:0031390,1,0.955911864704501,0,8,Ctf18 RFC-like complex,CC,
7844,GO:0031393,1,0.987617433050128,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7846,GO:0031396,1,0.332795380518388,0,170,regulation of protein ubiquitination,BP,
7847,GO:0031397,1,0.669867507782526,0,61,negative regulation of protein ubiquitination,BP,
7848,GO:0031398,1,0.542822692843785,0,97,positive regulation of protein ubiquitination,BP,
7852,GO:0031402,1,0.914650400530261,0,12,sodium ion binding,MF,
7853,GO:0031403,1,0.983808681357083,0,2,lithium ion binding,MF,
7854,GO:0031404,1,0.945456315087044,0,9,chloride ion binding,MF,
7855,GO:0031405,1,0.986571020561457,0,1,lipoic acid binding,MF,
7857,GO:0031407,1,0.994515310835667,0,1,oxylipin metabolic process,BP,
7859,GO:0031414,1,0.930547065092936,0,10,N-terminal protein acetyltransferase complex,CC,
7860,GO:0031415,1,0.970109388603127,0,5,NatA complex,CC,
7861,GO:0031416,1,0.986322795346383,0,2,NatB complex,CC,
7862,GO:0031417,1,0.972536062955579,0,3,NatC complex,CC,
7863,GO:0031418,1,0.888445858128015,0,20,L-ascorbic acid binding,MF,
7864,GO:0031419,1,0.934624098641043,0,9,cobalamin binding,MF,
7865,GO:0031420,1,0.871832838946994,0,19,alkali metal ion binding,MF,
7866,GO:0031424,1,0.648777687793822,0,70,keratinization,BP,
7867,GO:0031427,1,0.975061367437033,0,4,response to methotrexate,BP,
7868,GO:0031428,1,0.979007656938304,0,4,box C/D snoRNP complex,CC,
7869,GO:0031429,1,0.973947915496292,0,5,box H/ACA snoRNP complex,CC,
7870,GO:0031430,1,0.777414083730219,0,29,M band,CC,
7871,GO:0031431,1,0.987756426242644,0,2,Dbf4-dependent protein kinase complex,CC,
7872,GO:0031432,1,0.904453810806953,0,14,titin binding,MF,
7873,GO:0031433,1,0.93782090207108,0,6,telethonin binding,MF,
7874,GO:0031434,1,0.601365626049612,0,69,mitogen-activated protein kinase kinase binding,MF,
7875,GO:0031435,1,0.905777216987728,0,15,mitogen-activated protein kinase kinase kinase binding,MF,
7876,GO:0031436,1,0.98459282371152,0,2,BRCA1-BARD1 complex,CC,
7877,GO:0031437,1,0.981675561494571,0,3,regulation of mRNA cleavage,BP,
7878,GO:0031438,1,0.994122291572137,0,1,negative regulation of mRNA cleavage,BP,
7879,GO:0031439,1,0.987480412879725,0,2,positive regulation of mRNA cleavage,BP,
7880,GO:0031440,1,0.868778963333906,0,22,regulation of mRNA 3'-end processing,BP,
7881,GO:0031441,1,0.945475770632818,0,9,negative regulation of mRNA 3'-end processing,BP,
7882,GO:0031442,1,0.942228995445141,0,9,positive regulation of mRNA 3'-end processing,BP,
7883,GO:0031443,1,0.984206114063909,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7884,GO:0031444,1,0.980967318128577,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7885,GO:0031445,1,0.982364192988208,0,2,regulation of heterochromatin assembly,BP,
7886,GO:0031446,1,0.99376674559648,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7887,GO:0031448,1,0.99376674559648,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7888,GO:0031449,1,0.991227950140997,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7889,GO:0031453,1,0.982364192988208,0,2,positive regulation of heterochromatin assembly,BP,
7890,GO:0031455,1,0.987449339454706,0,2,glycine betaine metabolic process,BP,
7891,GO:0031456,1,0.987449339454706,0,2,glycine betaine biosynthetic process,BP,
7892,GO:0031460,1,0.99245664701154,0,1,glycine betaine transport,BP,
7893,GO:0031461,1,0.306303035758487,0,180,cullin-RING ubiquitin ligase complex,CC,
7894,GO:0031462,1,0.909926977648441,0,14,Cul2-RING ubiquitin ligase complex,CC,
7895,GO:0031463,1,0.638824531037027,0,66,Cul3-RING ubiquitin ligase complex,CC,
7896,GO:0031464,1,0.930109369309054,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7897,GO:0031465,1,0.967928971142746,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7898,GO:0031466,1,0.963411344055498,0,6,Cul5-RING ubiquitin ligase complex,CC,
7899,GO:0031467,1,0.968878836086912,0,5,Cul7-RING ubiquitin ligase complex,CC,
7900,GO:0031468,1,0.899836205840959,0,18,nuclear envelope reassembly,BP,
7901,GO:0031475,1,0.994756040007414,0,1,myosin V complex,CC,
7902,GO:0031477,1,0.989874055397202,0,1,myosin VII complex,CC,
7903,GO:0031489,1,0.906734026340104,0,16,myosin V binding,MF,
7904,GO:0031490,1,0.534859543334383,0,91,chromatin DNA binding,MF,
7905,GO:0031491,1,0.699173112130675,0,55,nucleosome binding,MF,
7906,GO:0031492,1,0.818678329137756,0,32,nucleosomal DNA binding,MF,
7907,GO:0031493,1,0.989062205473514,0,2,nucleosomal histone binding,MF,
7908,GO:0031497,1,0.516711885985962,0,108,chromatin assembly,BP,
7909,GO:0031498,1,0.875475031889245,0,19,chromatin disassembly,BP,
7910,GO:0031501,1,0.979087694419296,0,4,mannosyltransferase complex,CC,
7912,GO:0031506,1,0.994704866976516,0,1,cell wall glycoprotein biosynthetic process,BP,
7913,GO:0031507,1,0.93636587776447,0,9,heterochromatin assembly,BP,
7914,GO:0031508,1,0.988927758433022,0,2,pericentric heterochromatin assembly,BP,
7915,GO:0031509,1,0.99473421612549,0,1,telomeric heterochromatin assembly,BP,
7916,GO:0031510,1,0.983696755358594,0,3,SUMO activating enzyme complex,CC,
7918,GO:0031515,1,0.983318962915238,0,3,tRNA (m1A) methyltransferase complex,CC,
7919,GO:0031519,1,0.727239829140974,0,46,PcG protein complex,CC,
7920,GO:0031523,1,0.983132148648317,0,2,Myb complex,CC,
7924,GO:0031529,1,0.762179621119169,0,44,ruffle organization,BP,
7925,GO:0031530,1,0.989587299940688,0,2,gonadotropin-releasing hormone receptor binding,MF,
7926,GO:0031531,1,0.994785232787907,0,1,thyrotropin-releasing hormone receptor binding,MF,
7928,GO:0031533,1,0.991075673892161,0,1,mRNA cap methyltransferase complex,CC,
7929,GO:0031536,1,0.978769255146032,0,4,positive regulation of exit from mitosis,BP,
7930,GO:0031543,1,0.930975255900917,0,12,peptidyl-proline dioxygenase activity,MF,
7931,GO:0031544,1,0.97728837853995,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7932,GO:0031545,1,0.952621219749634,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7933,GO:0031547,1,0.959175980010019,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
7934,GO:0031548,1,0.985318233387901,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7935,GO:0031549,1,0.991934142487842,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7936,GO:0031550,1,0.993330831938416,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7937,GO:0031554,1,0.986374012045264,0,1,regulation of DNA-templated transcription, termination,BP,
7938,GO:0031559,1,0.99309846458083,0,1,oxidosqualene cyclase activity,MF,
7939,GO:0031570,1,0.354887623396594,0,157,DNA integrity checkpoint,BP,
7940,GO:0031571,1,0.633370451170782,0,69,mitotic G1 DNA damage checkpoint,BP,
7941,GO:0031572,1,0.801305447211739,0,32,G2 DNA damage checkpoint,BP,
7942,GO:0031573,1,0.921152545870406,0,14,intra-S DNA damage checkpoint,BP,
7943,GO:0031577,1,0.795098980866429,0,34,spindle checkpoint,BP,
7945,GO:0031580,1,0.948267452687395,0,9,membrane raft distribution,BP,
7946,GO:0031581,1,0.909884592924755,0,11,hemidesmosome assembly,BP,
7947,GO:0031583,1,0.994614803267906,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7948,GO:0031584,1,0.969476554469524,0,5,activation of phospholipase D activity,BP,
7949,GO:0031585,1,0.955934089394869,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7950,GO:0031587,1,0.970184792440733,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7951,GO:0031588,1,0.93901756249331,0,9,nucleotide-activated protein kinase complex,CC,
7953,GO:0031590,1,0.988575984002802,0,2,wybutosine metabolic process,BP,
7954,GO:0031591,1,0.988575984002802,0,2,wybutosine biosynthetic process,BP,
7955,GO:0031592,1,0.989309967387124,0,1,centrosomal corona,CC,
7956,GO:0031593,1,0.794065676919018,0,35,polyubiquitin modification-dependent protein binding,MF,
7958,GO:0031595,1,0.957824411389616,0,8,nuclear proteasome complex,CC,
7959,GO:0031597,1,0.934158626530217,0,12,cytosolic proteasome complex,CC,
7960,GO:0031616,1,0.942211187421364,0,10,spindle pole centrosome,CC,
7961,GO:0031618,1,0.929181447298061,0,9,nuclear pericentric heterochromatin,CC,
7962,GO:0031620,1,0.956464633461483,0,7,regulation of fever generation,BP,
7963,GO:0031622,1,0.963139267052993,0,6,positive regulation of fever generation,BP,
7965,GO:0031624,1,0.786936869802141,0,33,ubiquitin conjugating enzyme binding,MF,
7966,GO:0031625,1,0.149569954842627,0,292,ubiquitin protein ligase binding,MF,
7967,GO:0031626,1,0.992134142280457,0,1,beta-endorphin binding,MF,
7968,GO:0031627,1,0.98222705903274,0,3,telomeric loop formation,BP,
7969,GO:0031628,1,0.950217902256605,0,8,opioid receptor binding,MF,
7971,GO:0031630,1,0.982048101749462,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7972,GO:0031635,1,0.987112842087453,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7977,GO:0031642,1,0.959693258100586,0,6,negative regulation of myelination,BP,
7978,GO:0031643,1,0.916906762605368,0,13,positive regulation of myelination,BP,
7980,GO:0031645,1,0.926956976263232,0,12,negative regulation of neurological system process,BP,
7982,GO:0031647,1,0.208635730991024,0,236,regulation of protein stability,BP,
7983,GO:0031648,1,0.743999001102376,0,42,protein destabilization,BP,
7984,GO:0031649,1,0.894827616124556,0,18,heat generation,BP,
7985,GO:0031650,1,0.926430710636646,0,12,regulation of heat generation,BP,
7986,GO:0031651,1,0.993190308254836,0,1,negative regulation of heat generation,BP,
7987,GO:0031652,1,0.939298147749338,0,10,positive regulation of heat generation,BP,
7988,GO:0031657,1,0.902203933306976,0,14,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7989,GO:0031658,1,0.951106244312953,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7990,GO:0031659,1,0.948608837632378,0,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7994,GO:0031666,1,0.946666638449029,0,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7999,GO:0031672,1,0.713244476706477,0,39,A band,CC,
8000,GO:0031673,1,0.980856806784158,0,1,H zone,CC,
8001,GO:0031674,1,0.34562901114996,0,131,I band,CC,
8002,GO:0031681,1,0.948992655694534,0,9,G-protein beta-subunit binding,MF,
8003,GO:0031682,1,0.99414683200963,0,1,G-protein gamma-subunit binding,MF,
8005,GO:0031685,1,0.982230934630721,0,3,adenosine receptor binding,MF,
8006,GO:0031686,1,0.994102602550091,0,1,A1 adenosine receptor binding,MF,
8007,GO:0031687,1,0.994739305834967,0,1,A2A adenosine receptor binding,MF,
8008,GO:0031690,1,0.887690091601289,0,18,adrenergic receptor binding,MF,
8009,GO:0031691,1,0.989279371320692,0,2,alpha-1A adrenergic receptor binding,MF,
8010,GO:0031692,1,0.982819505646477,0,3,alpha-1B adrenergic receptor binding,MF,
8011,GO:0031694,1,0.978382126270492,0,4,alpha-2A adrenergic receptor binding,MF,
8012,GO:0031695,1,0.994474776049065,0,1,alpha-2B adrenergic receptor binding,MF,
8013,GO:0031696,1,0.987981324329063,0,2,alpha-2C adrenergic receptor binding,MF,
8014,GO:0031697,1,0.969074856669979,0,4,beta-1 adrenergic receptor binding,MF,
8015,GO:0031698,1,0.969663831841126,0,4,beta-2 adrenergic receptor binding,MF,
8016,GO:0031699,1,0.987614836195606,0,2,beta-3 adrenergic receptor binding,MF,
8018,GO:0031701,1,0.929598392908236,0,11,angiotensin receptor binding,MF,
8019,GO:0031702,1,0.934668870058148,0,10,type 1 angiotensin receptor binding,MF,
8020,GO:0031703,1,0.994418214015936,0,1,type 2 angiotensin receptor binding,MF,
8021,GO:0031704,1,0.994016522465217,0,1,apelin receptor binding,MF,
8022,GO:0031705,1,0.983906226072933,0,3,bombesin receptor binding,MF,
8023,GO:0031707,1,0.994614803267906,0,1,endothelin A receptor binding,MF,
8024,GO:0031708,1,0.983906226072933,0,3,endothelin B receptor binding,MF,
8025,GO:0031711,1,0.98847019156308,0,2,bradykinin receptor binding,MF,
8026,GO:0031714,1,0.992204426059883,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8027,GO:0031715,1,0.992204426059883,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8028,GO:0031717,1,0.994733218655072,0,1,cannabinoid receptor binding,MF,
8029,GO:0031718,1,0.994733218655072,0,1,type 1 cannabinoid receptor binding,MF,
8030,GO:0031720,1,0.984592084682945,0,3,haptoglobin binding,MF,
8031,GO:0031724,1,0.994800064853307,0,1,CXCR5 chemokine receptor binding,MF,
8032,GO:0031726,1,0.994830237968053,0,1,CCR1 chemokine receptor binding,MF,
8034,GO:0031728,1,0.989705978424096,0,2,CCR3 chemokine receptor binding,MF,
8035,GO:0031730,1,0.973484490642457,0,4,CCR5 chemokine receptor binding,MF,
8036,GO:0031731,1,0.989695446836676,0,2,CCR6 chemokine receptor binding,MF,
8037,GO:0031732,1,0.989688080020552,0,2,CCR7 chemokine receptor binding,MF,
8038,GO:0031735,1,0.98454037159364,0,3,CCR10 chemokine receptor binding,MF,
8039,GO:0031737,1,0.993979365570334,0,1,CX3C chemokine receptor binding,MF,
8040,GO:0031739,1,0.994607712026897,0,1,cholecystokinin receptor binding,MF,
8041,GO:0031741,1,0.994607712026897,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8042,GO:0031748,1,0.957004414439529,0,7,D1 dopamine receptor binding,MF,
8043,GO:0031749,1,0.982495587341811,0,3,D2 dopamine receptor binding,MF,
8044,GO:0031750,1,0.989049322317504,0,2,D3 dopamine receptor binding,MF,
8045,GO:0031751,1,0.994727623572928,0,1,D4 dopamine receptor binding,MF,
8046,GO:0031752,1,0.978825434794688,0,3,D5 dopamine receptor binding,MF,
8047,GO:0031753,1,0.994303359203057,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8048,GO:0031755,1,0.994303359203057,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8049,GO:0031762,1,0.989279371320692,0,2,follicle-stimulating hormone receptor binding,MF,
8050,GO:0031763,1,0.994831355742962,0,1,galanin receptor binding,MF,
8051,GO:0031764,1,0.994831355742962,0,1,type 1 galanin receptor binding,MF,
8052,GO:0031765,1,0.994831355742962,0,1,type 2 galanin receptor binding,MF,
8053,GO:0031766,1,0.994831355742962,0,1,type 3 galanin receptor binding,MF,
8054,GO:0031768,1,0.994834055115578,0,1,ghrelin receptor binding,MF,
8055,GO:0031770,1,0.994840832898659,0,1,growth hormone-releasing hormone receptor binding,MF,
8056,GO:0031773,1,0.994834130876615,0,1,kisspeptin receptor binding,MF,
8057,GO:0031775,1,0.989015467670684,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8058,GO:0031779,1,0.979199078630385,0,4,melanocortin receptor binding,MF,
8059,GO:0031780,1,0.989433666251327,0,2,corticotropin hormone receptor binding,MF,
8060,GO:0031781,1,0.979199078630385,0,4,type 3 melanocortin receptor binding,MF,
8061,GO:0031782,1,0.979199078630385,0,4,type 4 melanocortin receptor binding,MF,
8062,GO:0031783,1,0.989433666251327,0,2,type 5 melanocortin receptor binding,MF,
8063,GO:0031798,1,0.989603414057109,0,1,type 1 metabotropic glutamate receptor binding,MF,
8064,GO:0031802,1,0.96812875209067,0,5,type 5 metabotropic glutamate receptor binding,MF,
8065,GO:0031811,1,0.993442679092061,0,1,G-protein coupled nucleotide receptor binding,MF,
8066,GO:0031812,1,0.993442679092061,0,1,P2Y1 nucleotide receptor binding,MF,
8067,GO:0031821,1,0.957942901148265,0,7,G-protein coupled serotonin receptor binding,MF,
8068,GO:0031826,1,0.984091146010316,0,3,type 2A serotonin receptor binding,MF,
8069,GO:0031834,1,0.99480651789796,0,1,neurokinin receptor binding,MF,
8070,GO:0031835,1,0.99480651789796,0,1,substance P receptor binding,MF,
8071,GO:0031838,1,0.979454326251141,0,4,haptoglobin-hemoglobin complex,CC,
8072,GO:0031839,1,0.994829653520256,0,1,type 1 neuromedin U receptor binding,MF,
8073,GO:0031840,1,0.994829653520256,0,1,type 2 neuromedin U receptor binding,MF,
8074,GO:0031841,1,0.994838740001473,0,1,neuropeptide Y receptor binding,MF,
8075,GO:0031848,1,0.938637206371875,0,10,protection from non-homologous end joining at telomere,BP,
8077,GO:0031852,1,0.970783823490181,0,4,mu-type opioid receptor binding,MF,
8078,GO:0031858,1,0.994053230509328,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8079,GO:0031859,1,0.994672010302178,0,1,platelet activating factor receptor binding,MF,
8080,GO:0031860,1,0.978005215566424,0,3,telomeric 3' overhang formation,BP,
8081,GO:0031862,1,0.984767330933203,0,2,prostanoid receptor binding,MF,
8082,GO:0031867,1,0.993497439474095,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8083,GO:0031870,1,0.991213322085029,0,1,thromboxane A2 receptor binding,MF,
8084,GO:0031871,1,0.980355614106343,0,3,proteinase activated receptor binding,MF,
8085,GO:0031877,1,0.990609095442831,0,1,somatostatin receptor binding,MF,
8086,GO:0031883,1,0.994613658820673,0,1,taste receptor binding,MF,
8087,GO:0031893,1,0.987818100524521,0,2,vasopressin receptor binding,MF,
8088,GO:0031894,1,0.993202853609457,0,1,V1A vasopressin receptor binding,MF,
8089,GO:0031896,1,0.994578764403092,0,1,V2 vasopressin receptor binding,MF,
8092,GO:0031903,1,0.69329760450466,0,57,microbody membrane,CC,
8093,GO:0031904,1,0.827994159242191,0,27,endosome lumen,CC,
8094,GO:0031905,1,0.9824672458882,0,3,early endosome lumen,CC,
8095,GO:0031906,1,0.969085895038513,0,6,late endosome lumen,CC,
8096,GO:0031907,1,0.78544805620796,0,41,microbody lumen,CC,
8097,GO:0031914,1,0.96960686905023,0,4,negative regulation of synaptic plasticity,BP,
8099,GO:0031929,1,0.502311868096238,0,99,TOR signaling,BP,
8100,GO:0031930,1,0.994765605144654,0,1,mitochondria-nucleus signaling pathway,BP,
8101,GO:0031931,1,0.948539405658513,0,7,TORC1 complex,CC,
8102,GO:0031932,1,0.916781854638883,0,13,TORC2 complex,CC,
8103,GO:0031933,1,0.975752289711658,0,3,telomeric heterochromatin,CC,
8104,GO:0031935,1,0.869107933098987,0,19,regulation of chromatin silencing,BP,
8105,GO:0031936,1,0.936994828408375,0,8,negative regulation of chromatin silencing,BP,
8106,GO:0031937,1,0.944821556238174,0,8,positive regulation of chromatin silencing,BP,
8107,GO:0031938,1,0.989429141938425,0,2,regulation of chromatin silencing at telomere,BP,
8108,GO:0031940,1,0.99473421612549,0,1,positive regulation of chromatin silencing at telomere,BP,
8110,GO:0031943,1,0.947197332409127,0,9,regulation of glucocorticoid metabolic process,BP,
8111,GO:0031944,1,0.970564983755838,0,5,negative regulation of glucocorticoid metabolic process,BP,
8112,GO:0031945,1,0.993437584411502,0,1,positive regulation of glucocorticoid metabolic process,BP,
8113,GO:0031946,1,0.957156777411182,0,7,regulation of glucocorticoid biosynthetic process,BP,
8114,GO:0031947,1,0.970564983755838,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8115,GO:0031948,1,0.993437584411502,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8116,GO:0031952,1,0.767447642212698,0,39,regulation of protein autophosphorylation,BP,
8117,GO:0031953,1,0.938621991896936,0,10,negative regulation of protein autophosphorylation,BP,
8118,GO:0031954,1,0.843546463444925,0,25,positive regulation of protein autophosphorylation,BP,
8119,GO:0031956,1,0.956372099357041,0,7,medium-chain fatty acid-CoA ligase activity,MF,
8120,GO:0031957,1,0.948028955172382,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8122,GO:0031959,1,0.986386029154905,0,2,mineralocorticoid receptor signaling pathway,BP,
8124,GO:0031962,1,0.991390800656278,0,1,mineralocorticoid receptor binding,MF,
8128,GO:0031968,1,0.301344488105378,0,181,organelle outer membrane,CC,
8129,GO:0031970,1,0.640074294305463,0,77,organelle envelope lumen,CC,
8137,GO:0031987,1,0.941078343066359,0,8,locomotion involved in locomotory behavior,BP,
8138,GO:0031989,1,0.994773414121803,0,1,bombesin receptor signaling pathway,BP,
8139,GO:0031990,1,0.982165351631437,0,2,mRNA export from nucleus in response to heat stress,BP,
8142,GO:0031996,1,0.936507113373387,0,11,thioesterase binding,MF,
8143,GO:0031997,1,0.982560191060591,0,3,N-terminal myristoylation domain binding,MF,
8144,GO:0031998,1,0.878508902198711,0,16,regulation of fatty acid beta-oxidation,BP,
8145,GO:0031999,1,0.968590842913092,0,4,negative regulation of fatty acid beta-oxidation,BP,
8146,GO:0032000,1,0.92985087390804,0,9,positive regulation of fatty acid beta-oxidation,BP,
8147,GO:0032002,1,0.989006520270277,0,2,interleukin-28 receptor complex,CC,
8148,GO:0032006,1,0.567420045277027,0,82,regulation of TOR signaling,BP,
8149,GO:0032007,1,0.768710428541908,0,38,negative regulation of TOR signaling,BP,
8150,GO:0032008,1,0.803008080375861,0,33,positive regulation of TOR signaling,BP,
8151,GO:0032009,1,0.944606752883157,0,8,early phagosome,CC,
8152,GO:0032010,1,0.972857914504238,0,5,phagolysosome,CC,
8153,GO:0032011,1,0.721713832439902,0,44,ARF protein signal transduction,BP,
8154,GO:0032012,1,0.721713832439902,0,44,regulation of ARF protein signal transduction,BP,
8155,GO:0032020,1,0.967263824608452,0,6,ISG15-protein conjugation,BP,
8156,GO:0032021,1,0.977444251132158,0,4,NELF complex,CC,
8157,GO:0032023,1,0.994550219572822,0,1,trypsinogen activation,BP,
8158,GO:0032024,1,0.687125993605079,0,61,positive regulation of insulin secretion,BP,
8159,GO:0032025,1,0.94595789568197,0,9,response to cobalt ion,BP,
8160,GO:0032026,1,0.881253952237542,0,16,response to magnesium ion,BP,
8161,GO:0032027,1,0.966908111544668,0,5,myosin light chain binding,MF,
8162,GO:0032028,1,0.994611687935326,0,1,myosin head/neck binding,MF,
8163,GO:0032029,1,0.985700324216999,0,1,myosin tail binding,MF,
8164,GO:0032036,1,0.941475087634008,0,9,myosin heavy chain binding,MF,
8165,GO:0032038,1,0.989675472409153,0,2,myosin II heavy chain binding,MF,
8166,GO:0032039,1,0.893597394664514,0,15,integrator complex,CC,
8167,GO:0032040,1,0.818564347056913,0,32,small-subunit processome,CC,
8168,GO:0032041,1,0.925499391471389,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8169,GO:0032042,1,0.902400399884312,0,16,mitochondrial DNA metabolic process,BP,
8170,GO:0032044,1,0.988390849769582,0,2,DSIF complex,CC,
8171,GO:0032045,1,0.909561403335491,0,13,guanyl-nucleotide exchange factor complex,CC,
8172,GO:0032048,1,0.918635487693999,0,14,cardiolipin metabolic process,BP,
8173,GO:0032049,1,0.954888118578522,0,8,cardiolipin biosynthetic process,BP,
8174,GO:0032050,1,0.944086087019027,0,7,clathrin heavy chain binding,MF,
8175,GO:0032051,1,0.958882144722482,0,5,clathrin light chain binding,MF,
8176,GO:0032052,1,0.946449274241181,0,10,bile acid binding,MF,
8177,GO:0032053,1,0.984947589842288,0,2,ciliary basal body organization,BP,
8178,GO:0032055,1,0.961534966877151,0,6,negative regulation of translation in response to stress,BP,
8179,GO:0032056,1,0.961413911551139,0,6,positive regulation of translation in response to stress,BP,
8180,GO:0032057,1,0.97265670146493,0,4,negative regulation of translational initiation in response to stress,BP,
8181,GO:0032058,1,0.971873691743409,0,4,positive regulation of translational initiation in response to stress,BP,
8182,GO:0032059,1,0.948872597768987,0,8,bleb,CC,
8184,GO:0032069,1,0.836140830794368,0,30,regulation of nuclease activity,BP,
8185,GO:0032070,1,0.944308185663901,0,10,regulation of deoxyribonuclease activity,BP,
8186,GO:0032071,1,0.954661027555205,0,8,regulation of endodeoxyribonuclease activity,BP,
8187,GO:0032072,1,0.993856775188206,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8188,GO:0032074,1,0.960261327354566,0,7,negative regulation of nuclease activity,BP,
8189,GO:0032075,1,0.910148619368626,0,16,positive regulation of nuclease activity,BP,
8190,GO:0032076,1,0.989201777043458,0,2,negative regulation of deoxyribonuclease activity,BP,
8191,GO:0032077,1,0.971892898159994,0,5,positive regulation of deoxyribonuclease activity,BP,
8192,GO:0032078,1,0.994825241144255,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8193,GO:0032079,1,0.976990339331217,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8194,GO:0032088,1,0.602950936655942,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8195,GO:0032089,1,0.986378862306243,0,2,NACHT domain binding,MF,
8196,GO:0032090,1,0.988624400681062,0,2,Pyrin domain binding,MF,
8199,GO:0032093,1,0.994313214468247,0,1,SAM domain binding,MF,
8200,GO:0032094,1,0.816327010297409,0,32,response to food,BP,
8201,GO:0032095,1,0.899523937693848,0,17,regulation of response to food,BP,
8202,GO:0032096,1,0.934743464121442,0,11,negative regulation of response to food,BP,
8203,GO:0032097,1,0.984435963959602,0,3,positive regulation of response to food,BP,
8204,GO:0032098,1,0.891669464730176,0,19,regulation of appetite,BP,
8205,GO:0032099,1,0.934743464121442,0,11,negative regulation of appetite,BP,
8206,GO:0032100,1,0.984435963959602,0,3,positive regulation of appetite,BP,
8210,GO:0032104,1,0.862707412413077,0,23,regulation of response to extracellular stimulus,BP,
8211,GO:0032105,1,0.922503561602514,0,13,negative regulation of response to extracellular stimulus,BP,
8212,GO:0032106,1,0.97369738240207,0,5,positive regulation of response to extracellular stimulus,BP,
8213,GO:0032107,1,0.862707412413077,0,23,regulation of response to nutrient levels,BP,
8214,GO:0032108,1,0.922503561602514,0,13,negative regulation of response to nutrient levels,BP,
8215,GO:0032109,1,0.97369738240207,0,5,positive regulation of response to nutrient levels,BP,
8216,GO:0032116,1,0.981570189219491,0,2,SMC loading complex,CC,
8217,GO:0032119,1,0.933632289037735,0,11,sequestering of zinc ion,BP,
8218,GO:0032127,1,0.987366325517546,0,2,dense core granule membrane,CC,
8219,GO:0032129,1,0.98826054833302,0,2,histone deacetylase activity (H3-K9 specific),MF,
8220,GO:0032133,1,0.973388112597863,0,5,chromosome passenger complex,CC,
8221,GO:0032135,1,0.963139074340697,0,6,DNA insertion or deletion binding,MF,
8222,GO:0032137,1,0.981678840192067,0,3,guanine/thymine mispair binding,MF,
8223,GO:0032138,1,0.974337230867867,0,4,single base insertion or deletion binding,MF,
8224,GO:0032139,1,0.981677896009618,0,3,dinucleotide insertion or deletion binding,MF,
8225,GO:0032142,1,0.979950191403607,0,3,single guanine insertion binding,MF,
8226,GO:0032143,1,0.987137946676319,0,2,single thymine insertion binding,MF,
8227,GO:0032144,1,0.992431771564765,0,1,4-aminobutyrate transaminase complex,CC,
8228,GO:0032145,1,0.992431771564765,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8230,GO:0032148,1,0.814966639529125,0,29,activation of protein kinase B activity,BP,
8231,GO:0032153,1,0.593852846840412,0,77,cell division site,CC,
8232,GO:0032154,1,0.698494015161084,0,52,cleavage furrow,CC,
8233,GO:0032155,1,0.657206307812101,0,61,cell division site part,CC,
8234,GO:0032156,1,0.921403479940761,0,13,septin cytoskeleton,CC,
8235,GO:0032160,1,0.927781029838393,0,12,septin filament array,CC,
8236,GO:0032173,1,0.994172566063925,0,1,septin collar,CC,
8237,GO:0032181,1,0.986826140148448,0,2,dinucleotide repeat insertion binding,MF,
8238,GO:0032182,1,0.576265558362445,0,83,ubiquitin-like protein binding,MF,
8239,GO:0032183,1,0.898685908307497,0,14,SUMO binding,MF,
8240,GO:0032184,1,0.96245678191462,0,5,SUMO polymer binding,MF,
8241,GO:0032185,1,0.902126198661196,0,16,septin cytoskeleton organization,BP,
8242,GO:0032190,1,0.984166170394606,0,3,acrosin binding,MF,
8243,GO:0032194,1,0.993665731148129,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8244,GO:0032196,1,0.88882723494804,0,19,transposition,BP,
8245,GO:0032200,1,0.365368967396047,0,149,telomere organization,BP,
8246,GO:0032201,1,0.847698055598018,0,27,telomere maintenance via semi-conservative replication,BP,
8247,GO:0032202,1,0.9773993990703,0,4,telomere assembly,BP,
8248,GO:0032203,1,0.994684466974914,0,1,telomere formation via telomerase,BP,
8249,GO:0032204,1,0.588719266067488,0,76,regulation of telomere maintenance,BP,
8250,GO:0032205,1,0.775148338762699,0,34,negative regulation of telomere maintenance,BP,
8251,GO:0032206,1,0.724938323641508,0,49,positive regulation of telomere maintenance,BP,
8252,GO:0032207,1,0.994238495123187,0,1,regulation of telomere maintenance via recombination,BP,
8253,GO:0032208,1,0.994238495123187,0,1,negative regulation of telomere maintenance via recombination,BP,
8254,GO:0032210,1,0.701211437066817,0,52,regulation of telomere maintenance via telomerase,BP,
8255,GO:0032211,1,0.872398420620995,0,19,negative regulation of telomere maintenance via telomerase,BP,
8256,GO:0032212,1,0.80294981849022,0,34,positive regulation of telomere maintenance via telomerase,BP,
8257,GO:0032213,1,0.988487399051714,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8258,GO:0032214,1,0.988487399051714,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8259,GO:0032217,1,0.977924433088393,0,4,riboflavin transmembrane transporter activity,MF,
8260,GO:0032218,1,0.98303551799545,0,3,riboflavin transport,BP,
8261,GO:0032222,1,0.954942131178108,0,7,regulation of synaptic transmission, cholinergic,BP,
8262,GO:0032223,1,0.994417965802798,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8263,GO:0032224,1,0.965744225904246,0,5,positive regulation of synaptic transmission, cholinergic,BP,
8264,GO:0032225,1,0.912951455729667,0,15,regulation of synaptic transmission, dopaminergic,BP,
8265,GO:0032226,1,0.959934699767561,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8266,GO:0032227,1,0.979869242908759,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8267,GO:0032228,1,0.807876924829929,0,30,regulation of synaptic transmission, GABAergic,BP,
8268,GO:0032229,1,0.96525800264737,0,6,negative regulation of synaptic transmission, GABAergic,BP,
8269,GO:0032230,1,0.924744003905853,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8270,GO:0032231,1,0.542823063255826,0,86,regulation of actin filament bundle assembly,BP,
8271,GO:0032232,1,0.848131596166848,0,22,negative regulation of actin filament bundle assembly,BP,
8272,GO:0032233,1,0.687531180862251,0,56,positive regulation of actin filament bundle assembly,BP,
8273,GO:0032237,1,0.973129811614768,0,4,activation of store-operated calcium channel activity,BP,
8274,GO:0032239,1,0.880463811968296,0,17,regulation of nucleobase-containing compound transport,BP,
8275,GO:0032240,1,0.979274465226561,0,2,negative regulation of nucleobase-containing compound transport,BP,
8276,GO:0032241,1,0.946422326687588,0,8,positive regulation of nucleobase-containing compound transport,BP,
8277,GO:0032242,1,0.994274866261634,0,1,regulation of nucleoside transport,BP,
8278,GO:0032244,1,0.994274866261634,0,1,positive regulation of nucleoside transport,BP,
8279,GO:0032252,1,0.964400595030496,0,4,secretory granule localization,BP,
8280,GO:0032253,1,0.994313214468247,0,1,dense core granule localization,BP,
8281,GO:0032258,1,0.988940861504958,0,2,protein localization by the Cvt pathway,BP,
8283,GO:0032261,1,0.960910986630487,0,7,purine nucleotide salvage,BP,
8284,GO:0032262,1,0.968436943461911,0,6,pyrimidine nucleotide salvage,BP,
8285,GO:0032263,1,0.989465332158368,0,2,GMP salvage,BP,
8286,GO:0032264,1,0.976245143621311,0,4,IMP salvage,BP,
8291,GO:0032271,1,0.270723562335478,0,193,regulation of protein polymerization,BP,
8292,GO:0032272,1,0.651946816074243,0,63,negative regulation of protein polymerization,BP,
8293,GO:0032273,1,0.464649810600294,0,116,positive regulation of protein polymerization,BP,
8294,GO:0032274,1,0.911305435725385,0,14,gonadotropin secretion,BP,
8295,GO:0032275,1,0.932711106578614,0,10,luteinizing hormone secretion,BP,
8296,GO:0032276,1,0.938237966040449,0,10,regulation of gonadotropin secretion,BP,
8297,GO:0032277,1,0.965566754684321,0,6,negative regulation of gonadotropin secretion,BP,
8298,GO:0032278,1,0.955653314102307,0,7,positive regulation of gonadotropin secretion,BP,
8300,GO:0032280,1,0.942068770755258,0,8,symmetric synapse,CC,
8302,GO:0032286,1,0.97507369139391,0,4,central nervous system myelin maintenance,BP,
8303,GO:0032287,1,0.912634497126294,0,9,peripheral nervous system myelin maintenance,BP,
8304,GO:0032288,1,0.85105328861089,0,20,myelin assembly,BP,
8305,GO:0032289,1,0.982881310626893,0,3,central nervous system myelin formation,BP,
8306,GO:0032290,1,0.954692700713645,0,4,peripheral nervous system myelin formation,BP,
8307,GO:0032291,1,0.898905077091887,0,17,axon ensheathment in central nervous system,BP,
8308,GO:0032292,1,0.809172892346179,0,25,peripheral nervous system axon ensheathment,BP,
8309,GO:0032296,1,0.969349051541781,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8310,GO:0032298,1,0.994564085239738,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8311,GO:0032299,1,0.983946966669842,0,3,ribonuclease H2 complex,CC,
8312,GO:0032300,1,0.93941328730354,0,9,mismatch repair complex,CC,
8313,GO:0032301,1,0.987137946676319,0,2,MutSalpha complex,CC,
8314,GO:0032302,1,0.986826140148448,0,2,MutSbeta complex,CC,
8315,GO:0032303,1,0.935535380486332,0,11,regulation of icosanoid secretion,BP,
8316,GO:0032304,1,0.99230378026243,0,1,negative regulation of icosanoid secretion,BP,
8317,GO:0032305,1,0.942789152765645,0,10,positive regulation of icosanoid secretion,BP,
8318,GO:0032306,1,0.962303560354337,0,7,regulation of prostaglandin secretion,BP,
8319,GO:0032308,1,0.962303560354337,0,7,positive regulation of prostaglandin secretion,BP,
8321,GO:0032310,1,0.943053955177393,0,10,prostaglandin secretion,BP,
8322,GO:0032311,1,0.989521353824126,0,2,angiogenin-PRI complex,CC,
8323,GO:0032324,1,0.959806553825593,0,7,molybdopterin cofactor biosynthetic process,BP,
8324,GO:0032328,1,0.947069577723074,0,8,alanine transport,BP,
8325,GO:0032329,1,0.945228357461791,0,10,serine transport,BP,
8326,GO:0032330,1,0.748373414330731,0,42,regulation of chondrocyte differentiation,BP,
8327,GO:0032331,1,0.896635015104254,0,17,negative regulation of chondrocyte differentiation,BP,
8328,GO:0032332,1,0.87658278803458,0,19,positive regulation of chondrocyte differentiation,BP,
8329,GO:0032341,1,0.954237441480778,0,7,aldosterone metabolic process,BP,
8330,GO:0032342,1,0.954237441480778,0,7,aldosterone biosynthetic process,BP,
8331,GO:0032344,1,0.964707240001153,0,6,regulation of aldosterone metabolic process,BP,
8332,GO:0032345,1,0.976846717950336,0,4,negative regulation of aldosterone metabolic process,BP,
8333,GO:0032346,1,0.987575685485959,0,2,positive regulation of aldosterone metabolic process,BP,
8334,GO:0032347,1,0.964707240001153,0,6,regulation of aldosterone biosynthetic process,BP,
8335,GO:0032348,1,0.976846717950336,0,4,negative regulation of aldosterone biosynthetic process,BP,
8336,GO:0032349,1,0.987575685485959,0,2,positive regulation of aldosterone biosynthetic process,BP,
8337,GO:0032350,1,0.822868457074757,0,31,regulation of hormone metabolic process,BP,
8338,GO:0032351,1,0.937180316057649,0,11,negative regulation of hormone metabolic process,BP,
8339,GO:0032352,1,0.927148464580865,0,12,positive regulation of hormone metabolic process,BP,
8340,GO:0032353,1,0.942084592003121,0,10,negative regulation of hormone biosynthetic process,BP,
8341,GO:0032354,1,0.900855187232566,0,14,response to follicle-stimulating hormone,BP,
8343,GO:0032356,1,0.938732469829843,0,10,oxidized DNA binding,MF,
8344,GO:0032357,1,0.943823204010108,0,9,oxidized purine DNA binding,MF,
8345,GO:0032358,1,0.994828327254872,0,1,oxidized pyrimidine DNA binding,MF,
8346,GO:0032361,1,0.994644568067902,0,1,pyridoxal phosphate catabolic process,BP,
8347,GO:0032364,1,0.96161917772153,0,6,oxygen homeostasis,BP,
8352,GO:0032369,1,0.876474338547391,0,19,negative regulation of lipid transport,BP,
8355,GO:0032372,1,0.952225279524937,0,8,negative regulation of sterol transport,BP,
8358,GO:0032375,1,0.952225279524937,0,8,negative regulation of cholesterol transport,BP,
8361,GO:0032378,1,0.993671844789405,0,1,negative regulation of intracellular lipid transport,BP,
8364,GO:0032381,1,0.993671844789405,0,1,negative regulation of intracellular sterol transport,BP,
8367,GO:0032384,1,0.993671844789405,0,1,negative regulation of intracellular cholesterol transport,BP,
8370,GO:0032387,1,0.703139700160438,0,56,negative regulation of intracellular transport,BP,
8372,GO:0032389,1,0.974387601697377,0,4,MutLalpha complex,CC,
8373,GO:0032391,1,0.796239488627849,0,32,photoreceptor connecting cilium,CC,
8375,GO:0032393,1,0.962850799659993,0,7,MHC class I receptor activity,MF,
8376,GO:0032394,1,0.994745719007715,0,1,MHC class Ib receptor activity,MF,
8378,GO:0032396,1,0.983243827778762,0,3,inhibitory MHC class I receptor activity,MF,
8379,GO:0032397,1,0.994763606144711,0,1,activating MHC class I receptor activity,MF,
8380,GO:0032398,1,0.994725856558683,0,1,MHC class Ib protein complex,CC,
8381,GO:0032400,1,0.8502273018106,0,26,melanosome localization,BP,
8382,GO:0032401,1,0.85986138169313,0,24,establishment of melanosome localization,BP,
8383,GO:0032402,1,0.868729094136356,0,23,melanosome transport,BP,
8384,GO:0032404,1,0.950112480639265,0,8,mismatch repair complex binding,MF,
8385,GO:0032405,1,0.966036052666438,0,5,MutLalpha complex binding,MF,
8386,GO:0032407,1,0.967545521493299,0,5,MutSalpha complex binding,MF,
8388,GO:0032410,1,0.647747318657869,0,67,negative regulation of transporter activity,BP,
8389,GO:0032411,1,0.514046490250011,0,93,positive regulation of transporter activity,BP,
8391,GO:0032413,1,0.677886344137651,0,60,negative regulation of ion transmembrane transporter activity,BP,
8392,GO:0032414,1,0.541674310034166,0,84,positive regulation of ion transmembrane transporter activity,BP,
8393,GO:0032415,1,0.972295149064659,0,5,regulation of sodium:proton antiporter activity,BP,
8394,GO:0032416,1,0.994643973158254,0,1,negative regulation of sodium:proton antiporter activity,BP,
8395,GO:0032417,1,0.977532024869271,0,4,positive regulation of sodium:proton antiporter activity,BP,
8397,GO:0032419,1,0.994567620053009,0,1,extrinsic component of lysosome membrane,CC,
8398,GO:0032420,1,0.756226187773846,0,39,stereocilium,CC,
8399,GO:0032421,1,0.734290496730203,0,44,stereocilium bundle,CC,
8400,GO:0032422,1,0.972033440134232,0,4,purine-rich negative regulatory element binding,MF,
8401,GO:0032423,1,0.981169904767113,0,3,regulation of mismatch repair,BP,
8402,GO:0032425,1,0.987967513129176,0,2,positive regulation of mismatch repair,BP,
8403,GO:0032426,1,0.907770223745899,0,15,stereocilium tip,CC,
8404,GO:0032427,1,0.987448225890225,0,2,GBD domain binding,MF,
8405,GO:0032428,1,0.993726329867365,0,1,beta-N-acetylgalactosaminidase activity,MF,
8407,GO:0032430,1,0.971124141933752,0,5,positive regulation of phospholipase A2 activity,BP,
8408,GO:0032431,1,0.983958010044002,0,3,activation of phospholipase A2 activity,BP,
8409,GO:0032432,1,0.665832277049233,0,56,actin filament bundle,CC,
8410,GO:0032433,1,0.880883754906783,0,16,filopodium tip,CC,
8411,GO:0032434,1,0.482418679190709,0,113,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8412,GO:0032435,1,0.839689066670847,0,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8413,GO:0032436,1,0.605166411927767,0,78,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8414,GO:0032437,1,0.959344648890357,0,5,cuticular plate,CC,
8415,GO:0032438,1,0.838758997213923,0,26,melanosome organization,BP,
8416,GO:0032440,1,0.994794365016368,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8417,GO:0032444,1,0.970277126771791,0,3,activin responsive factor complex,CC,
8418,GO:0032445,1,0.99453369805972,0,1,fructose import,BP,
8420,GO:0032447,1,0.994477249259959,0,1,protein urmylation,BP,
8421,GO:0032448,1,0.994745164069223,0,1,DNA hairpin binding,MF,
8422,GO:0032449,1,0.968032616413401,0,5,CBM complex,CC,
8423,GO:0032450,1,0.977375830895706,0,3,maltose alpha-glucosidase activity,MF,
8424,GO:0032451,1,0.772414361820959,0,34,demethylase activity,MF,
8425,GO:0032452,1,0.81359998414486,0,25,histone demethylase activity,MF,
8426,GO:0032453,1,0.948626852158017,0,6,histone demethylase activity (H3-K4 specific),MF,
8427,GO:0032454,1,0.91084227004285,0,12,histone demethylase activity (H3-K9 specific),MF,
8428,GO:0032455,1,0.976050639331437,0,4,nerve growth factor processing,BP,
8429,GO:0032456,1,0.791425850952718,0,34,endocytic recycling,BP,
8430,GO:0032458,1,0.993463464090737,0,1,slow endocytic recycling,BP,
8431,GO:0032459,1,0.795050183451536,0,36,regulation of protein oligomerization,BP,
8432,GO:0032460,1,0.908637545797944,0,14,negative regulation of protein oligomerization,BP,
8433,GO:0032461,1,0.88097722947137,0,21,positive regulation of protein oligomerization,BP,
8434,GO:0032462,1,0.90515203910562,0,17,regulation of protein homooligomerization,BP,
8435,GO:0032463,1,0.943516421535182,0,10,negative regulation of protein homooligomerization,BP,
8436,GO:0032464,1,0.958849594956552,0,7,positive regulation of protein homooligomerization,BP,
8437,GO:0032465,1,0.592447727478558,0,73,regulation of cytokinesis,BP,
8438,GO:0032466,1,0.957039055521484,0,7,negative regulation of cytokinesis,BP,
8439,GO:0032467,1,0.818087610630166,0,29,positive regulation of cytokinesis,BP,
8440,GO:0032468,1,0.993794054734065,0,1,Golgi calcium ion homeostasis,BP,
8441,GO:0032469,1,0.867513826398567,0,21,endoplasmic reticulum calcium ion homeostasis,BP,
8442,GO:0032470,1,0.982850004625619,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8443,GO:0032471,1,0.952655336221041,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8444,GO:0032472,1,0.988481968215104,0,2,Golgi calcium ion transport,BP,
8445,GO:0032473,1,0.988022957922514,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8446,GO:0032474,1,0.980569985533566,0,3,otolith morphogenesis,BP,
8447,GO:0032475,1,0.994383550341847,0,1,otolith formation,BP,
8448,GO:0032479,1,0.471539022061732,0,115,regulation of type I interferon production,BP,
8449,GO:0032480,1,0.743810722148763,0,45,negative regulation of type I interferon production,BP,
8450,GO:0032481,1,0.634230068163192,0,69,positive regulation of type I interferon production,BP,
8451,GO:0032482,1,0.668004346128283,0,68,Rab protein signal transduction,BP,
8452,GO:0032483,1,0.971242410057258,0,4,regulation of Rab protein signal transduction,BP,
8453,GO:0032484,1,0.976549179245871,0,3,Ral protein signal transduction,BP,
8454,GO:0032485,1,0.976549179245871,0,3,regulation of Ral protein signal transduction,BP,
8455,GO:0032486,1,0.908619857295159,0,13,Rap protein signal transduction,BP,
8456,GO:0032487,1,0.976660998116026,0,3,regulation of Rap protein signal transduction,BP,
8457,GO:0032488,1,0.909107142560274,0,14,Cdc42 protein signal transduction,BP,
8458,GO:0032489,1,0.958198669484062,0,6,regulation of Cdc42 protein signal transduction,BP,
8459,GO:0032490,1,0.919725598428535,0,12,detection of molecule of bacterial origin,BP,
8460,GO:0032493,1,0.946878350077162,0,8,response to bacterial lipoprotein,BP,
8461,GO:0032494,1,0.938586906538098,0,10,response to peptidoglycan,BP,
8462,GO:0032495,1,0.906835076614592,0,14,response to muramyl dipeptide,BP,
8464,GO:0032497,1,0.975897493802015,0,4,detection of lipopolysaccharide,BP,
8465,GO:0032498,1,0.992867050439484,0,1,detection of muramyl dipeptide,BP,
8466,GO:0032499,1,0.987717895894285,0,2,detection of peptidoglycan,BP,
8467,GO:0032500,1,0.992867050439484,0,1,muramyl dipeptide binding,MF,
8471,GO:0032506,1,0.856005264007872,0,23,cytokinetic process,BP,
8472,GO:0032507,1,0.589779757833592,0,72,maintenance of protein location in cell,BP,
8474,GO:0032509,1,0.872791741480026,0,21,endosome transport via multivesicular body sorting pathway,BP,
8475,GO:0032510,1,0.955727185324591,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8476,GO:0032511,1,0.954766717727928,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8478,GO:0032516,1,0.885026892574647,0,16,positive regulation of phosphoprotein phosphatase activity,BP,
8479,GO:0032525,1,0.940469676100187,0,9,somite rostral/caudal axis specification,BP,
8481,GO:0032527,1,0.77134975725125,0,39,protein exit from endoplasmic reticulum,BP,
8482,GO:0032528,1,0.850440720254944,0,23,microvillus organization,BP,
8483,GO:0032530,1,0.923681628455641,0,12,regulation of microvillus organization,BP,
8484,GO:0032532,1,0.964699999012104,0,6,regulation of microvillus length,BP,
8485,GO:0032534,1,0.957495648492517,0,6,regulation of microvillus assembly,BP,
8487,GO:0032536,1,0.930855675903405,0,11,regulation of cell projection size,BP,
8488,GO:0032541,1,0.970795823064596,0,5,cortical endoplasmic reticulum,CC,
8489,GO:0032542,1,0.988264994151414,0,2,sulfiredoxin activity,MF,
8490,GO:0032543,1,0.493040083211109,0,127,mitochondrial translation,BP,
8491,GO:0032545,1,0.987993061926553,0,2,CURI complex,CC,
8494,GO:0032551,1,0.986172059899896,0,2,pyrimidine ribonucleoside binding,MF,
8495,GO:0032552,1,0.967269385885236,0,6,deoxyribonucleotide binding,MF,
8497,GO:0032554,1,0.977519671683656,0,4,purine deoxyribonucleotide binding,MF,
8499,GO:0032556,1,0.989516359411694,0,2,pyrimidine deoxyribonucleotide binding,MF,
8500,GO:0032557,1,0.980845282363891,0,3,pyrimidine ribonucleotide binding,MF,
8501,GO:0032558,1,0.983390059730726,0,3,adenyl deoxyribonucleotide binding,MF,
8503,GO:0032560,1,0.994031455799731,0,1,guanyl deoxyribonucleotide binding,MF,
8505,GO:0032564,1,0.983390059730726,0,3,dATP binding,MF,
8506,GO:0032567,1,0.994031455799731,0,1,dGTP binding,MF,
8507,GO:0032570,1,0.775903803966293,0,41,response to progesterone,BP,
8509,GO:0032574,1,0.993380727781866,0,1,5'-3' RNA helicase activity,MF,
8510,GO:0032575,1,0.993380727781866,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8512,GO:0032581,1,0.994687514808973,0,1,ER-dependent peroxisome organization,BP,
8513,GO:0032584,1,0.964839706025975,0,6,growth cone membrane,CC,
8514,GO:0032585,1,0.949039041804568,0,9,multivesicular body membrane,CC,
8520,GO:0032592,1,0.686756690381233,0,65,integral component of mitochondrial membrane,CC,
8521,GO:0032593,1,0.948562976270221,0,7,insulin-responsive compartment,CC,
8523,GO:0032596,1,0.969383923219556,0,5,protein transport into membrane raft,BP,
8524,GO:0032601,1,0.994790910327561,0,1,connective tissue growth factor production,BP,
8526,GO:0032603,1,0.994824207229569,0,1,fractalkine production,BP,
8527,GO:0032604,1,0.929522341883126,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8528,GO:0032605,1,0.994031455799731,0,1,hepatocyte growth factor production,BP,
8529,GO:0032606,1,0.4690533294742,0,116,type I interferon production,BP,
8530,GO:0032607,1,0.835820988764462,0,26,interferon-alpha production,BP,
8531,GO:0032608,1,0.738378483971064,0,47,interferon-beta production,BP,
8532,GO:0032609,1,0.581211503546858,0,91,interferon-gamma production,BP,
8533,GO:0032610,1,0.962596377541299,0,7,interleukin-1 alpha production,BP,
8534,GO:0032611,1,0.691199699071024,0,59,interleukin-1 beta production,BP,
8536,GO:0032613,1,0.781952727033793,0,42,interleukin-10 production,BP,
8537,GO:0032615,1,0.739062756979403,0,49,interleukin-12 production,BP,
8538,GO:0032616,1,0.903424690920888,0,17,interleukin-13 production,BP,
8539,GO:0032618,1,0.989455832035517,0,2,interleukin-15 production,BP,
8540,GO:0032620,1,0.890628072890284,0,20,interleukin-17 production,BP,
8541,GO:0032621,1,0.950320038451204,0,8,interleukin-18 production,BP,
8543,GO:0032625,1,0.993739582468635,0,1,interleukin-21 production,BP,
8544,GO:0032627,1,0.969345227315798,0,5,interleukin-23 production,BP,
8545,GO:0032632,1,0.980446536340775,0,3,interleukin-3 production,BP,
8546,GO:0032633,1,0.829018103082773,0,31,interleukin-4 production,BP,
8547,GO:0032634,1,0.910797527357925,0,15,interleukin-5 production,BP,
8548,GO:0032635,1,0.520519804679051,0,105,interleukin-6 production,BP,
8550,GO:0032639,1,0.988911395789226,0,2,TRAIL production,BP,
8552,GO:0032641,1,0.988483065338893,0,2,lymphotoxin A production,BP,
8554,GO:0032643,1,0.994790910327561,0,1,regulation of connective tissue growth factor production,BP,
8555,GO:0032644,1,0.994824207229569,0,1,regulation of fractalkine production,BP,
8556,GO:0032645,1,0.934464446210187,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8557,GO:0032646,1,0.994031455799731,0,1,regulation of hepatocyte growth factor production,BP,
8558,GO:0032647,1,0.84022472231588,0,25,regulation of interferon-alpha production,BP,
8559,GO:0032648,1,0.746970518246006,0,45,regulation of interferon-beta production,BP,
8560,GO:0032649,1,0.622672285082216,0,80,regulation of interferon-gamma production,BP,
8561,GO:0032650,1,0.967593178610067,0,6,regulation of interleukin-1 alpha production,BP,
8562,GO:0032651,1,0.731308375598043,0,51,regulation of interleukin-1 beta production,BP,
8564,GO:0032653,1,0.791000998577681,0,40,regulation of interleukin-10 production,BP,
8565,GO:0032655,1,0.747917585931253,0,47,regulation of interleukin-12 production,BP,
8566,GO:0032656,1,0.908146421109005,0,16,regulation of interleukin-13 production,BP,
8567,GO:0032658,1,0.994702522107098,0,1,regulation of interleukin-15 production,BP,
8568,GO:0032660,1,0.905448258797986,0,17,regulation of interleukin-17 production,BP,
8569,GO:0032661,1,0.963367254469063,0,6,regulation of interleukin-18 production,BP,
8571,GO:0032667,1,0.969345227315798,0,5,regulation of interleukin-23 production,BP,
8572,GO:0032672,1,0.986885478923199,0,2,regulation of interleukin-3 production,BP,
8573,GO:0032673,1,0.864575046104905,0,25,regulation of interleukin-4 production,BP,
8574,GO:0032674,1,0.910797527357925,0,15,regulation of interleukin-5 production,BP,
8575,GO:0032675,1,0.550018638133734,0,97,regulation of interleukin-6 production,BP,
8577,GO:0032679,1,0.988911395789226,0,2,regulation of TRAIL production,BP,
8579,GO:0032681,1,0.994346750857925,0,1,regulation of lymphotoxin A production,BP,
8580,GO:0032682,1,0.914119056709763,0,16,negative regulation of chemokine production,BP,
8581,GO:0032685,1,0.993981663397153,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8582,GO:0032686,1,0.994031455799731,0,1,negative regulation of hepatocyte growth factor production,BP,
8583,GO:0032687,1,0.960872910143503,0,6,negative regulation of interferon-alpha production,BP,
8584,GO:0032688,1,0.917247693853589,0,14,negative regulation of interferon-beta production,BP,
8585,GO:0032689,1,0.860251579857998,0,26,negative regulation of interferon-gamma production,BP,
8586,GO:0032690,1,0.994770265495778,0,1,negative regulation of interleukin-1 alpha production,BP,
8587,GO:0032691,1,0.915874806131323,0,15,negative regulation of interleukin-1 beta production,BP,
8588,GO:0032692,1,0.88547640005647,0,21,negative regulation of interleukin-1 production,BP,
8589,GO:0032693,1,0.922700477436411,0,14,negative regulation of interleukin-10 production,BP,
8590,GO:0032695,1,0.90028483250017,0,16,negative regulation of interleukin-12 production,BP,
8591,GO:0032696,1,0.982226974881075,0,3,negative regulation of interleukin-13 production,BP,
8592,GO:0032700,1,0.947722824185558,0,9,negative regulation of interleukin-17 production,BP,
8593,GO:0032701,1,0.988749024944468,0,2,negative regulation of interleukin-18 production,BP,
8595,GO:0032707,1,0.986225002438733,0,2,negative regulation of interleukin-23 production,BP,
8596,GO:0032712,1,0.994533297210656,0,1,negative regulation of interleukin-3 production,BP,
8597,GO:0032713,1,0.970839007593585,0,5,negative regulation of interleukin-4 production,BP,
8598,GO:0032714,1,0.982105803717575,0,3,negative regulation of interleukin-5 production,BP,
8599,GO:0032715,1,0.814572772885316,0,33,negative regulation of interleukin-6 production,BP,
8601,GO:0032720,1,0.775427809495167,0,43,negative regulation of tumor necrosis factor production,BP,
8603,GO:0032723,1,0.994790910327561,0,1,positive regulation of connective tissue growth factor production,BP,
8604,GO:0032724,1,0.994824207229569,0,1,positive regulation of fractalkine production,BP,
8605,GO:0032725,1,0.940125925769689,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8606,GO:0032727,1,0.874485809706491,0,19,positive regulation of interferon-alpha production,BP,
8607,GO:0032728,1,0.826028691888756,0,29,positive regulation of interferon-beta production,BP,
8608,GO:0032729,1,0.717377856811757,0,55,positive regulation of interferon-gamma production,BP,
8609,GO:0032730,1,0.972681451689786,0,5,positive regulation of interleukin-1 alpha production,BP,
8610,GO:0032731,1,0.815523673264055,0,32,positive regulation of interleukin-1 beta production,BP,
8611,GO:0032732,1,0.785968160368748,0,38,positive regulation of interleukin-1 production,BP,
8612,GO:0032733,1,0.848438710507925,0,28,positive regulation of interleukin-10 production,BP,
8613,GO:0032735,1,0.843305897882665,0,29,positive regulation of interleukin-12 production,BP,
8614,GO:0032736,1,0.92459199887484,0,13,positive regulation of interleukin-13 production,BP,
8615,GO:0032738,1,0.994702522107098,0,1,positive regulation of interleukin-15 production,BP,
8616,GO:0032740,1,0.950235575547106,0,9,positive regulation of interleukin-17 production,BP,
8617,GO:0032741,1,0.9802125597151,0,3,positive regulation of interleukin-18 production,BP,
8619,GO:0032747,1,0.988244416858121,0,2,positive regulation of interleukin-23 production,BP,
8620,GO:0032752,1,0.992310563490457,0,1,positive regulation of interleukin-3 production,BP,
8621,GO:0032753,1,0.885695967041345,0,21,positive regulation of interleukin-4 production,BP,
8622,GO:0032754,1,0.932407636366742,0,11,positive regulation of interleukin-5 production,BP,
8623,GO:0032755,1,0.674319861613795,0,64,positive regulation of interleukin-6 production,BP,
8625,GO:0032759,1,0.988911395789226,0,2,positive regulation of TRAIL production,BP,
8626,GO:0032760,1,0.657138986840196,0,64,positive regulation of tumor necrosis factor production,BP,
8627,GO:0032761,1,0.994346750857925,0,1,positive regulation of lymphotoxin A production,BP,
8628,GO:0032762,1,0.957063774390693,0,7,mast cell cytokine production,BP,
8629,GO:0032763,1,0.969842808373774,0,5,regulation of mast cell cytokine production,BP,
8630,GO:0032764,1,0.988548676674784,0,2,negative regulation of mast cell cytokine production,BP,
8631,GO:0032765,1,0.981079603057444,0,3,positive regulation of mast cell cytokine production,BP,
8632,GO:0032767,1,0.977344527193507,0,3,copper-dependent protein binding,MF,
8633,GO:0032768,1,0.737670977947967,0,49,regulation of monooxygenase activity,BP,
8634,GO:0032769,1,0.936560554363769,0,10,negative regulation of monooxygenase activity,BP,
8635,GO:0032770,1,0.869684669341221,0,23,positive regulation of monooxygenase activity,BP,
8636,GO:0032771,1,0.993070549408301,0,1,regulation of monophenol monooxygenase activity,BP,
8637,GO:0032773,1,0.993070549408301,0,1,positive regulation of monophenol monooxygenase activity,BP,
8639,GO:0032775,1,0.993642041545025,0,1,DNA methylation on adenine,BP,
8640,GO:0032776,1,0.978530392639415,0,3,DNA methylation on cytosine,BP,
8641,GO:0032777,1,0.97737231992827,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8643,GO:0032781,1,0.737852059175443,0,51,positive regulation of ATPase activity,BP,
8644,GO:0032782,1,0.977157664556477,0,4,bile acid secretion,BP,
8646,GO:0032784,1,0.77358750316999,0,41,regulation of DNA-templated transcription, elongation,BP,
8647,GO:0032785,1,0.921636819018145,0,13,negative regulation of DNA-templated transcription, elongation,BP,
8648,GO:0032786,1,0.864139528446032,0,23,positive regulation of DNA-templated transcription, elongation,BP,
8650,GO:0032788,1,0.994736192929894,0,1,saturated monocarboxylic acid metabolic process,BP,
8651,GO:0032789,1,0.994736192929894,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8652,GO:0032790,1,0.949438905633516,0,8,ribosome disassembly,BP,
8653,GO:0032792,1,0.968738114595013,0,5,negative regulation of CREB transcription factor activity,BP,
8654,GO:0032793,1,0.903495633299405,0,14,positive regulation of CREB transcription factor activity,BP,
8655,GO:0032794,1,0.8976484813057,0,14,GTPase activating protein binding,MF,
8656,GO:0032795,1,0.982657409562415,0,3,heterotrimeric G-protein binding,MF,
8657,GO:0032796,1,0.984506515952742,0,2,uropod organization,BP,
8658,GO:0032797,1,0.930943491563458,0,12,SMN complex,CC,
8659,GO:0032798,1,0.988658446617857,0,2,Swi5-Sfr1 complex,CC,
8661,GO:0032800,1,0.856077554264778,0,23,receptor biosynthetic process,BP,
8666,GO:0032805,1,0.988506891150512,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8667,GO:0032806,1,0.856549124228325,0,24,carboxy-terminal domain protein kinase complex,CC,
8668,GO:0032807,1,0.976722962137177,0,4,DNA ligase IV complex,CC,
8669,GO:0032808,1,0.951047363149987,0,7,lacrimal gland development,BP,
8671,GO:0032810,1,0.987167943329317,0,2,sterol response element binding,MF,
8672,GO:0032811,1,0.983016963331393,0,3,negative regulation of epinephrine secretion,BP,
8673,GO:0032812,1,0.994824145201937,0,1,positive regulation of epinephrine secretion,BP,
8674,GO:0032813,1,0.779884526863542,0,43,tumor necrosis factor receptor superfamily binding,MF,
8675,GO:0032814,1,0.874391798587646,0,22,regulation of natural killer cell activation,BP,
8676,GO:0032815,1,0.973222322948533,0,5,negative regulation of natural killer cell activation,BP,
8677,GO:0032816,1,0.921143205556191,0,13,positive regulation of natural killer cell activation,BP,
8678,GO:0032817,1,0.965109541918008,0,6,regulation of natural killer cell proliferation,BP,
8679,GO:0032819,1,0.976775648533883,0,4,positive regulation of natural killer cell proliferation,BP,
8680,GO:0032823,1,0.938317863027908,0,10,regulation of natural killer cell differentiation,BP,
8681,GO:0032824,1,0.994821753834788,0,1,negative regulation of natural killer cell differentiation,BP,
8682,GO:0032825,1,0.955438058601979,0,7,positive regulation of natural killer cell differentiation,BP,
8683,GO:0032826,1,0.989580071327517,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8684,GO:0032827,1,0.994821753834788,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8685,GO:0032829,1,0.989283931793477,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8686,GO:0032831,1,0.989283931793477,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8687,GO:0032832,1,0.994727313045411,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8688,GO:0032834,1,0.994727313045411,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8689,GO:0032835,1,0.672843737815504,0,54,glomerulus development,BP,
8690,GO:0032836,1,0.920888791375498,0,10,glomerular basement membrane development,BP,
8691,GO:0032838,1,0.290446547656879,0,169,plasma membrane bounded cell projection cytoplasm,CC,
8692,GO:0032839,1,0.831747996282843,0,27,dendrite cytoplasm,CC,
8693,GO:0032841,1,0.993693582881017,0,1,calcitonin binding,MF,
8694,GO:0032847,1,0.976366513943174,0,4,regulation of cellular pH reduction,BP,
8695,GO:0032848,1,0.993489657296534,0,1,negative regulation of cellular pH reduction,BP,
8696,GO:0032849,1,0.982765765031872,0,3,positive regulation of cellular pH reduction,BP,
8700,GO:0032872,1,0.270789213289477,0,193,regulation of stress-activated MAPK cascade,BP,
8701,GO:0032873,1,0.774844075213539,0,39,negative regulation of stress-activated MAPK cascade,BP,
8702,GO:0032874,1,0.399501861612282,0,136,positive regulation of stress-activated MAPK cascade,BP,
8703,GO:0032875,1,0.945972274544969,0,7,regulation of DNA endoreduplication,BP,
8704,GO:0032876,1,0.965943212134909,0,4,negative regulation of DNA endoreduplication,BP,
8705,GO:0032877,1,0.985216129031107,0,2,positive regulation of DNA endoreduplication,BP,
8706,GO:0032878,1,0.853982895401289,0,21,regulation of establishment or maintenance of cell polarity,BP,
8709,GO:0032881,1,0.777331042914134,0,33,regulation of polysaccharide metabolic process,BP,
8710,GO:0032885,1,0.790709845220438,0,30,regulation of polysaccharide biosynthetic process,BP,
8711,GO:0032886,1,0.254007109927362,0,190,regulation of microtubule-based process,BP,
8712,GO:0032887,1,0.990054929762495,0,1,regulation of spindle elongation,BP,
8713,GO:0032888,1,0.990054929762495,0,1,regulation of mitotic spindle elongation,BP,
8714,GO:0032889,1,0.994443973651689,0,1,regulation of vacuole fusion, non-autophagic,BP,
8715,GO:0032890,1,0.760754561461336,0,42,regulation of organic acid transport,BP,
8716,GO:0032891,1,0.90544751634026,0,15,negative regulation of organic acid transport,BP,
8717,GO:0032892,1,0.874307418552405,0,22,positive regulation of organic acid transport,BP,
8718,GO:0032897,1,0.882481336434749,0,20,negative regulation of viral transcription,BP,
8719,GO:0032898,1,0.975077263647591,0,4,neurotrophin production,BP,
8720,GO:0032899,1,0.987763450932063,0,2,regulation of neurotrophin production,BP,
8721,GO:0032900,1,0.994274866261634,0,1,negative regulation of neurotrophin production,BP,
8722,GO:0032901,1,0.993451466202994,0,1,positive regulation of neurotrophin production,BP,
8723,GO:0032902,1,0.98715822582776,0,2,nerve growth factor production,BP,
8724,GO:0032905,1,0.939011400455713,0,10,transforming growth factor beta1 production,BP,
8725,GO:0032906,1,0.942958901518359,0,8,transforming growth factor beta2 production,BP,
8726,GO:0032907,1,0.979053059863978,0,2,transforming growth factor beta3 production,BP,
8727,GO:0032908,1,0.939011400455713,0,10,regulation of transforming growth factor beta1 production,BP,
8728,GO:0032909,1,0.942958901518359,0,8,regulation of transforming growth factor beta2 production,BP,
8729,GO:0032910,1,0.979053059863978,0,2,regulation of transforming growth factor beta3 production,BP,
8730,GO:0032911,1,0.973691698762998,0,4,negative regulation of transforming growth factor beta1 production,BP,
8731,GO:0032912,1,0.986910499150359,0,2,negative regulation of transforming growth factor beta2 production,BP,
8732,GO:0032914,1,0.964391996571963,0,6,positive regulation of transforming growth factor beta1 production,BP,
8733,GO:0032915,1,0.989302818087634,0,2,positive regulation of transforming growth factor beta2 production,BP,
8734,GO:0032916,1,0.979053059863978,0,2,positive regulation of transforming growth factor beta3 production,BP,
8735,GO:0032917,1,0.984307956201011,0,3,polyamine acetylation,BP,
8736,GO:0032918,1,0.984307956201011,0,3,spermidine acetylation,BP,
8737,GO:0032919,1,0.99482079915527,0,1,spermine acetylation,BP,
8738,GO:0032920,1,0.99482079915527,0,1,putrescine acetylation,BP,
8739,GO:0032922,1,0.68684814601489,0,50,circadian regulation of gene expression,BP,
8740,GO:0032924,1,0.773171580386064,0,37,activin receptor signaling pathway,BP,
8741,GO:0032925,1,0.855866381321301,0,23,regulation of activin receptor signaling pathway,BP,
8742,GO:0032926,1,0.943159860777286,0,9,negative regulation of activin receptor signaling pathway,BP,
8743,GO:0032927,1,0.937697522787624,0,8,positive regulation of activin receptor signaling pathway,BP,
8744,GO:0032928,1,0.909821149370676,0,16,regulation of superoxide anion generation,BP,
8745,GO:0032929,1,0.989572944220704,0,2,negative regulation of superoxide anion generation,BP,
8746,GO:0032930,1,0.92654600757845,0,13,positive regulation of superoxide anion generation,BP,
8747,GO:0032933,1,0.951541275647701,0,8,SREBP signaling pathway,BP,
8748,GO:0032934,1,0.755173957006737,0,41,sterol binding,MF,
8749,GO:0032937,1,0.981912339322352,0,3,SREBP-SCAP-Insig complex,CC,
8751,GO:0032941,1,0.812964901659737,0,33,secretion by tissue,BP,
8754,GO:0032945,1,0.666622503480902,0,64,negative regulation of mononuclear cell proliferation,BP,
8757,GO:0032954,1,0.984938032273025,0,2,regulation of cytokinetic process,BP,
8758,GO:0032956,1,0.115853812628819,0,306,regulation of actin cytoskeleton organization,BP,
8759,GO:0032957,1,0.947083848286094,0,8,inositol trisphosphate metabolic process,BP,
8760,GO:0032958,1,0.855514184483075,0,24,inositol phosphate biosynthetic process,BP,
8761,GO:0032959,1,0.961350374964655,0,6,inositol trisphosphate biosynthetic process,BP,
8762,GO:0032960,1,0.97466019575299,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8763,GO:0032962,1,0.981523791239906,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8767,GO:0032966,1,0.960075679299469,0,7,negative regulation of collagen biosynthetic process,BP,
8769,GO:0032968,1,0.912623059206492,0,14,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8771,GO:0032971,1,0.977244841588531,0,4,regulation of muscle filament sliding,BP,
8772,GO:0032972,1,0.989667810098874,0,2,regulation of muscle filament sliding speed,BP,
8773,GO:0032976,1,0.994829850254701,0,1,release of matrix enzymes from mitochondria,BP,
8774,GO:0032977,1,0.992834887840419,0,1,membrane insertase activity,MF,
8775,GO:0032978,1,0.992834887840419,0,1,protein insertion into membrane from inner side,BP,
8776,GO:0032979,1,0.992834887840419,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8777,GO:0032980,1,0.994493596536389,0,1,keratinocyte activation,BP,
8778,GO:0032981,1,0.744556248467284,0,55,mitochondrial respiratory chain complex I assembly,BP,
8779,GO:0032982,1,0.855221385903239,0,19,myosin filament,CC,
8780,GO:0032983,1,0.96317180894781,0,5,kainate selective glutamate receptor complex,CC,
8782,GO:0032986,1,0.87759151637797,0,19,protein-DNA complex disassembly,BP,
8783,GO:0032988,1,0.920765553626544,0,13,ribonucleoprotein complex disassembly,BP,
8788,GO:0032994,1,0.798508214959383,0,34,protein-lipid complex,CC,
8789,GO:0032996,1,0.994682025960697,0,1,Bcl3-Bcl10 complex,CC,
8790,GO:0032997,1,0.989584194046402,0,2,Fc receptor complex,CC,
8791,GO:0032998,1,0.989584194046402,0,2,Fc-epsilon receptor I complex,CC,
8792,GO:0033002,1,0.327920050007167,0,167,muscle cell proliferation,BP,
8793,GO:0033003,1,0.809289227105471,0,35,regulation of mast cell activation,BP,
8794,GO:0033004,1,0.938522631130607,0,11,negative regulation of mast cell activation,BP,
8795,GO:0033005,1,0.912798762721944,0,15,positive regulation of mast cell activation,BP,
8796,GO:0033006,1,0.85043860966415,0,27,regulation of mast cell activation involved in immune response,BP,
8797,GO:0033007,1,0.962160779657384,0,7,negative regulation of mast cell activation involved in immune response,BP,
8798,GO:0033008,1,0.930510010663208,0,12,positive regulation of mast cell activation involved in immune response,BP,
8799,GO:0033010,1,0.945508153646606,0,7,paranodal junction,CC,
8800,GO:0033011,1,0.989228223917385,0,2,perinuclear theca,CC,
8801,GO:0033013,1,0.722234902338241,0,50,tetrapyrrole metabolic process,BP,
8802,GO:0033014,1,0.844094228141587,0,26,tetrapyrrole biosynthetic process,BP,
8803,GO:0033015,1,0.979263902101268,0,4,tetrapyrrole catabolic process,BP,
8805,GO:0033018,1,0.958782899704835,0,7,sarcoplasmic reticulum lumen,CC,
8806,GO:0033023,1,0.980632645870748,0,3,mast cell homeostasis,BP,
8807,GO:0033024,1,0.980632645870748,0,3,mast cell apoptotic process,BP,
8808,GO:0033025,1,0.980632645870748,0,3,regulation of mast cell apoptotic process,BP,
8809,GO:0033026,1,0.986811738034258,0,2,negative regulation of mast cell apoptotic process,BP,
8812,GO:0033030,1,0.985493317390923,0,2,negative regulation of neutrophil apoptotic process,BP,
8815,GO:0033033,1,0.922665320349172,0,13,negative regulation of myeloid cell apoptotic process,BP,
8818,GO:0033037,1,0.991558014647456,0,1,polysaccharide localization,BP,
8819,GO:0033038,1,0.949132205709697,0,10,bitter taste receptor activity,MF,
8820,GO:0033040,1,0.994130640221456,0,1,sour taste receptor activity,MF,
8821,GO:0033041,1,0.994428062514543,0,1,sweet taste receptor activity,MF,
8823,GO:0033044,1,0.12759526427883,0,295,regulation of chromosome organization,BP,
8824,GO:0033045,1,0.6098930959627,0,70,regulation of sister chromatid segregation,BP,
8825,GO:0033046,1,0.76731749253427,0,37,negative regulation of sister chromatid segregation,BP,
8826,GO:0033047,1,0.643994772082112,0,61,regulation of mitotic sister chromatid segregation,BP,
8827,GO:0033048,1,0.774600601787818,0,36,negative regulation of mitotic sister chromatid segregation,BP,
8828,GO:0033058,1,0.971061218540285,0,3,directional locomotion,BP,
8829,GO:0033059,1,0.705635780982011,0,52,cellular pigmentation,BP,
8830,GO:0033061,1,0.950822172875813,0,9,DNA recombinase mediator complex,CC,
8831,GO:0033063,1,0.961733966651991,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8832,GO:0033065,1,0.989256031183841,0,2,Rad51C-XRCC3 complex,CC,
8833,GO:0033076,1,0.984138934539647,0,3,isoquinoline alkaloid metabolic process,BP,
8834,GO:0033077,1,0.66912423037785,0,60,T cell differentiation in thymus,BP,
8835,GO:0033078,1,0.981988426614874,0,3,extrathymic T cell differentiation,BP,
8836,GO:0033079,1,0.959858283593761,0,7,immature T cell proliferation,BP,
8837,GO:0033080,1,0.970379600058259,0,5,immature T cell proliferation in thymus,BP,
8838,GO:0033081,1,0.880673604527315,0,20,regulation of T cell differentiation in thymus,BP,
8839,GO:0033082,1,0.987202040757554,0,2,regulation of extrathymic T cell differentiation,BP,
8840,GO:0033083,1,0.966201070715759,0,6,regulation of immature T cell proliferation,BP,
8841,GO:0033084,1,0.976791210846441,0,4,regulation of immature T cell proliferation in thymus,BP,
8842,GO:0033085,1,0.966329821699327,0,6,negative regulation of T cell differentiation in thymus,BP,
8843,GO:0033087,1,0.982139254176828,0,3,negative regulation of immature T cell proliferation,BP,
8844,GO:0033088,1,0.987354306796328,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8845,GO:0033089,1,0.944831803166136,0,9,positive regulation of T cell differentiation in thymus,BP,
8846,GO:0033091,1,0.983774875046011,0,3,positive regulation of immature T cell proliferation,BP,
8847,GO:0033092,1,0.989302970698303,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8848,GO:0033093,1,0.963003722795842,0,5,Weibel-Palade body,CC,
8849,GO:0033106,1,0.983604311225748,0,3,cis-Golgi network membrane,CC,
8850,GO:0033108,1,0.618335235823586,0,87,mitochondrial respiratory chain complex assembly,BP,
8851,GO:0033116,1,0.672943862529506,0,62,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8852,GO:0033119,1,0.868788971778126,0,24,negative regulation of RNA splicing,BP,
8853,GO:0033120,1,0.818525173683771,0,30,positive regulation of RNA splicing,BP,
8854,GO:0033121,1,0.975885692797553,0,3,regulation of purine nucleotide catabolic process,BP,
8855,GO:0033122,1,0.984459949655233,0,2,negative regulation of purine nucleotide catabolic process,BP,
8856,GO:0033123,1,0.991291751661753,0,1,positive regulation of purine nucleotide catabolic process,BP,
8857,GO:0033127,1,0.921124516279389,0,13,regulation of histone phosphorylation,BP,
8858,GO:0033128,1,0.983875390210774,0,3,negative regulation of histone phosphorylation,BP,
8859,GO:0033129,1,0.947219543357801,0,8,positive regulation of histone phosphorylation,BP,
8860,GO:0033130,1,0.932891877707197,0,10,acetylcholine receptor binding,MF,
8861,GO:0033131,1,0.941059141082841,0,9,regulation of glucokinase activity,BP,
8862,GO:0033132,1,0.977610231508059,0,4,negative regulation of glucokinase activity,BP,
8863,GO:0033133,1,0.962620102775837,0,5,positive regulation of glucokinase activity,BP,
8864,GO:0033135,1,0.495238120186833,0,106,regulation of peptidyl-serine phosphorylation,BP,
8865,GO:0033137,1,0.863755501302515,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8866,GO:0033138,1,0.609206478086251,0,77,positive regulation of peptidyl-serine phosphorylation,BP,
8867,GO:0033139,1,0.974953294701685,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8868,GO:0033140,1,0.994683056798052,0,1,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8869,GO:0033141,1,0.980165822706717,0,3,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8870,GO:0033142,1,0.994582886168677,0,1,progesterone receptor binding,MF,
8871,GO:0033143,1,0.632005112618296,0,70,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8872,GO:0033144,1,0.822872062773138,0,30,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8873,GO:0033145,1,0.906868506545517,0,15,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8874,GO:0033146,1,0.792103645872757,0,35,regulation of intracellular estrogen receptor signaling pathway,BP,
8875,GO:0033147,1,0.922432599423646,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8876,GO:0033148,1,0.941814157595279,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8877,GO:0033149,1,0.98404208087434,0,2,FFAT motif binding,MF,
8878,GO:0033150,1,0.994663259062718,0,1,cytoskeletal calyx,CC,
8879,GO:0033151,1,0.906339491530861,0,12,V(D)J recombination,BP,
8880,GO:0033152,1,0.965757749342944,0,4,immunoglobulin V(D)J recombination,BP,
8881,GO:0033153,1,0.95584595352159,0,5,T cell receptor V(D)J recombination,BP,
8883,GO:0033158,1,0.869059597096897,0,18,regulation of protein import into nucleus, translocation,BP,
8884,GO:0033159,1,0.981492092212395,0,3,negative regulation of protein import into nucleus, translocation,BP,
8885,GO:0033160,1,0.905623022683034,0,11,positive regulation of protein import into nucleus, translocation,BP,
8886,GO:0033162,1,0.941599540174137,0,11,melanosome membrane,CC,
8887,GO:0033165,1,0.987729293447878,0,2,interphotoreceptor matrix,CC,
8888,GO:0033167,1,0.987076826329213,0,1,ARC complex,CC,
8889,GO:0033168,1,0.987076826329213,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8890,GO:0033169,1,0.905757913876883,0,13,histone H3-K9 demethylation,BP,
8891,GO:0033170,1,0.954988708398327,0,8,protein-DNA loading ATPase activity,MF,
8892,GO:0033173,1,0.841332729845362,0,24,calcineurin-NFAT signaling cascade,BP,
8893,GO:0033176,1,0.869242618529461,0,24,proton-transporting V-type ATPase complex,CC,
8894,GO:0033177,1,0.937134484816046,0,11,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8895,GO:0033178,1,0.93741011271394,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8896,GO:0033179,1,0.942058832259306,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8897,GO:0033180,1,0.947397732847964,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8898,GO:0033181,1,0.989268139089536,0,2,plasma membrane proton-transporting V-type ATPase complex,CC,
8899,GO:0033182,1,0.932417760091592,0,10,regulation of histone ubiquitination,BP,
8900,GO:0033183,1,0.973390693281286,0,3,negative regulation of histone ubiquitination,BP,
8901,GO:0033184,1,0.968511481050855,0,5,positive regulation of histone ubiquitination,BP,
8902,GO:0033185,1,0.984486913233565,0,3,dolichol-phosphate-mannose synthase complex,CC,
8903,GO:0033186,1,0.977928323661364,0,3,CAF-1 complex,CC,
8904,GO:0033188,1,0.979606678677528,0,3,sphingomyelin synthase activity,MF,
8905,GO:0033189,1,0.916145679973928,0,15,response to vitamin A,BP,
8906,GO:0033192,1,0.963262503454931,0,5,calmodulin-dependent protein phosphatase activity,MF,
8907,GO:0033193,1,0.99234549051893,0,1,Lsd1/2 complex,CC,
8908,GO:0033194,1,0.905805021421582,0,16,response to hydroperoxide,BP,
8910,GO:0033198,1,0.823000082091254,0,30,response to ATP,BP,
8911,GO:0033202,1,0.916479641660678,0,15,DNA helicase complex,CC,
8912,GO:0033204,1,0.994463851720218,0,1,ribonuclease P RNA binding,MF,
8913,GO:0033206,1,0.964995597534352,0,5,meiotic cytokinesis,BP,
8915,GO:0033210,1,0.946702251976525,0,9,leptin-mediated signaling pathway,BP,
8916,GO:0033211,1,0.970402150535712,0,5,adiponectin-activated signaling pathway,BP,
8921,GO:0033220,1,0.975305752803669,0,4,amide-transporting ATPase activity,MF,
8922,GO:0033227,1,0.969063744136654,0,5,dsRNA transport,BP,
8923,GO:0033229,1,0.993595945906608,0,1,cysteine transmembrane transporter activity,MF,
8924,GO:0033231,1,0.993356305776653,0,1,carbohydrate export,BP,
8925,GO:0033233,1,0.877369837493783,0,21,regulation of protein sumoylation,BP,
8926,GO:0033234,1,0.940525663267975,0,10,negative regulation of protein sumoylation,BP,
8927,GO:0033235,1,0.933031553481046,0,11,positive regulation of protein sumoylation,BP,
8930,GO:0033240,1,0.949620752812602,0,9,positive regulation of cellular amine metabolic process,BP,
8931,GO:0033241,1,0.988441996649535,0,1,regulation of cellular amine catabolic process,BP,
8932,GO:0033242,1,0.988441996649535,0,1,negative regulation of cellular amine catabolic process,BP,
8933,GO:0033256,1,0.960853682642614,0,7,I-kappaB/NF-kappaB complex,CC,
8934,GO:0033257,1,0.988840806325752,0,2,Bcl3/NF-kappaB2 complex,CC,
8935,GO:0033260,1,0.731954478828883,0,49,nuclear DNA replication,BP,
8936,GO:0033262,1,0.919577372386875,0,12,regulation of nuclear cell cycle DNA replication,BP,
8937,GO:0033263,1,0.972648379994949,0,4,CORVET complex,CC,
8938,GO:0033265,1,0.988870776360246,0,2,choline binding,MF,
8940,GO:0033268,1,0.87943681813218,0,15,node of Ranvier,CC,
8941,GO:0033269,1,0.975935940045276,0,4,internode region of axon,CC,
8942,GO:0033270,1,0.905849906156146,0,12,paranode region of axon,CC,
8944,GO:0033274,1,0.99010256999547,0,1,response to vitamin B2,BP,
8946,GO:0033276,1,0.917144428448268,0,13,transcription factor TFTC complex,CC,
8947,GO:0033277,1,0.985596550027988,0,2,abortive mitotic cell cycle,BP,
8948,GO:0033278,1,0.96734741279006,0,5,cell proliferation in midbrain,BP,
8953,GO:0033290,1,0.993187410039051,0,1,eukaryotic 48S preinitiation complex,CC,
8954,GO:0033291,1,0.99484182519957,0,1,eukaryotic 80S initiation complex,CC,
8955,GO:0033292,1,0.97827034526185,0,2,T-tubule organization,BP,
8957,GO:0033299,1,0.970458709052599,0,5,secretion of lysosomal enzymes,BP,
8958,GO:0033300,1,0.981005006074081,0,3,dehydroascorbic acid transmembrane transporter activity,MF,
8959,GO:0033301,1,0.993603076934533,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8960,GO:0033306,1,0.988274779360279,0,2,phytol metabolic process,BP,
8961,GO:0033313,1,0.970428874982058,0,5,meiotic cell cycle checkpoint,BP,
8962,GO:0033314,1,0.952926940340583,0,8,mitotic DNA replication checkpoint,BP,
8963,GO:0033316,1,0.994151614391548,0,1,meiotic spindle assembly checkpoint,BP,
8964,GO:0033319,1,0.994616269044617,0,1,UDP-D-xylose metabolic process,BP,
8965,GO:0033320,1,0.994616269044617,0,1,UDP-D-xylose biosynthetic process,BP,
8966,GO:0033326,1,0.986796465643942,0,2,cerebrospinal fluid secretion,BP,
8967,GO:0033327,1,0.937495051172488,0,10,Leydig cell differentiation,BP,
8968,GO:0033328,1,0.993694882327013,0,1,peroxisome membrane targeting sequence binding,MF,
8969,GO:0033341,1,0.983866549480355,0,2,regulation of collagen binding,BP,
8970,GO:0033342,1,0.994444449268529,0,1,negative regulation of collagen binding,BP,
8971,GO:0033343,1,0.989363594852658,0,1,positive regulation of collagen binding,BP,
8972,GO:0033344,1,0.79016357841533,0,32,cholesterol efflux,BP,
8973,GO:0033345,1,0.994509232637709,0,1,asparagine catabolic process via L-aspartate,BP,
8974,GO:0033353,1,0.974349626433062,0,4,S-adenosylmethionine cycle,BP,
8975,GO:0033363,1,0.830786359512382,0,25,secretory granule organization,BP,
8976,GO:0033364,1,0.979068040397827,0,2,mast cell secretory granule organization,BP,
8978,GO:0033366,1,0.994794597487769,0,1,protein localization to secretory granule,BP,
8979,GO:0033367,1,0.994794597487769,0,1,protein localization to mast cell secretory granule,BP,
8980,GO:0033368,1,0.994794597487769,0,1,protease localization to mast cell secretory granule,BP,
8981,GO:0033370,1,0.994794597487769,0,1,maintenance of protein location in mast cell secretory granule,BP,
8982,GO:0033371,1,0.994794597487769,0,1,T cell secretory granule organization,BP,
8983,GO:0033373,1,0.994794597487769,0,1,maintenance of protease location in mast cell secretory granule,BP,
8984,GO:0033374,1,0.994794597487769,0,1,protein localization to T cell secretory granule,BP,
8985,GO:0033375,1,0.994794597487769,0,1,protease localization to T cell secretory granule,BP,
8986,GO:0033377,1,0.994794597487769,0,1,maintenance of protein location in T cell secretory granule,BP,
8987,GO:0033379,1,0.994794597487769,0,1,maintenance of protease location in T cell secretory granule,BP,
8988,GO:0033380,1,0.994794597487769,0,1,granzyme B localization to T cell secretory granule,BP,
8989,GO:0033382,1,0.994794597487769,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8990,GO:0033383,1,0.989083374199378,0,2,geranyl diphosphate metabolic process,BP,
8991,GO:0033384,1,0.989083374199378,0,2,geranyl diphosphate biosynthetic process,BP,
8992,GO:0033385,1,0.994292198937649,0,1,geranylgeranyl diphosphate metabolic process,BP,
8993,GO:0033386,1,0.994292198937649,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8994,GO:0033387,1,0.982119038716112,0,3,putrescine biosynthetic process from ornithine,BP,
8995,GO:0033388,1,0.994580382469011,0,1,putrescine biosynthetic process from arginine,BP,
8996,GO:0033391,1,0.926457599589094,0,11,chromatoid body,CC,
8997,GO:0033396,1,0.994623343944697,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8998,GO:0033477,1,0.994646935762422,0,1,S-methylmethionine metabolic process,BP,
8999,GO:0033483,1,0.944333059186449,0,9,gas homeostasis,BP,
9000,GO:0033484,1,0.982030918007393,0,3,nitric oxide homeostasis,BP,
9001,GO:0033488,1,0.994121593413458,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
9002,GO:0033489,1,0.976767020617,0,4,cholesterol biosynthetic process via desmosterol,BP,
9003,GO:0033490,1,0.976767020617,0,4,cholesterol biosynthetic process via lathosterol,BP,
9004,GO:0033499,1,0.989275866138772,0,2,galactose catabolic process via UDP-galactose,BP,
9006,GO:0033503,1,0.97581294373002,0,4,HULC complex,CC,
9007,GO:0033504,1,0.963727290128051,0,5,floor plate development,BP,
9008,GO:0033505,1,0.985160880417203,0,2,floor plate morphogenesis,BP,
9009,GO:0033512,1,0.980376121102006,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
9010,GO:0033514,1,0.994494465846789,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9011,GO:0033522,1,0.842111849620594,0,24,histone H2A ubiquitination,BP,
9012,GO:0033523,1,0.92386112366711,0,12,histone H2B ubiquitination,BP,
9013,GO:0033526,1,0.994350325246087,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
9014,GO:0033539,1,0.91841616677127,0,14,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
9015,GO:0033540,1,0.919373331403792,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9016,GO:0033549,1,0.932034163279556,0,12,MAP kinase phosphatase activity,MF,
9017,GO:0033552,1,0.994413231134376,0,1,response to vitamin B3,BP,
9018,GO:0033553,1,0.971180184554288,0,4,rDNA heterochromatin,CC,
9020,GO:0033555,1,0.641383058534193,0,66,multicellular organismal response to stress,BP,
9021,GO:0033557,1,0.988658446617857,0,2,Slx1-Slx4 complex,CC,
9022,GO:0033558,1,0.737534696576905,0,44,protein deacetylase activity,MF,
9024,GO:0033560,1,0.993423662588231,0,1,folate reductase activity,MF,
9025,GO:0033561,1,0.891072912885482,0,18,regulation of water loss via skin,BP,
9026,GO:0033563,1,0.971477602314469,0,3,dorsal/ventral axon guidance,BP,
9027,GO:0033564,1,0.953478732417242,0,6,anterior/posterior axon guidance,BP,
9028,GO:0033565,1,0.980141557478634,0,3,ESCRT-0 complex,CC,
9029,GO:0033566,1,0.988836947166334,0,2,gamma-tubulin complex localization,BP,
9030,GO:0033567,1,0.971459135132852,0,5,DNA replication, Okazaki fragment processing,BP,
9031,GO:0033570,1,0.986454347770375,0,2,transferrin transmembrane transporter activity,MF,
9034,GO:0033577,1,0.98870550006574,0,2,protein glycosylation in endoplasmic reticulum,BP,
9035,GO:0033578,1,0.967778396509172,0,5,protein glycosylation in Golgi,BP,
9036,GO:0033588,1,0.972148208677058,0,5,Elongator holoenzyme complex,CC,
9037,GO:0033590,1,0.983677513729405,0,3,response to cobalamin,BP,
9038,GO:0033591,1,0.967086515833845,0,5,response to L-ascorbic acid,BP,
9039,GO:0033592,1,0.967408204936856,0,5,RNA strand annealing activity,MF,
9040,GO:0033593,1,0.986037587539308,0,1,BRCA2-MAGE-D1 complex,CC,
9041,GO:0033594,1,0.978103050012657,0,4,response to hydroxyisoflavone,BP,
9042,GO:0033595,1,0.988688762364342,0,2,response to genistein,BP,
9043,GO:0033596,1,0.980448599659256,0,2,TSC1-TSC2 complex,CC,
9044,GO:0033597,1,0.994596025494779,0,1,mitotic checkpoint complex,CC,
9045,GO:0033598,1,0.828164167179786,0,26,mammary gland epithelial cell proliferation,BP,
9046,GO:0033599,1,0.881202371320021,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9047,GO:0033600,1,0.965190041906479,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9048,GO:0033601,1,0.938256630624779,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
9049,GO:0033602,1,0.978454114722005,0,3,negative regulation of dopamine secretion,BP,
9050,GO:0033603,1,0.962150235253866,0,6,positive regulation of dopamine secretion,BP,
9053,GO:0033608,1,0.994313214468247,0,1,formyl-CoA transferase activity,MF,
9054,GO:0033609,1,0.994313214468247,0,1,oxalate metabolic process,BP,
9055,GO:0033612,1,0.887560080775461,0,19,receptor serine/threonine kinase binding,MF,
9056,GO:0033613,1,0.606220826721157,0,70,activating transcription factor binding,MF,
9057,GO:0033615,1,0.982752378802413,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9058,GO:0033617,1,0.892723445236783,0,20,mitochondrial respiratory chain complex IV assembly,BP,
9060,GO:0033622,1,0.87857329617356,0,19,integrin activation,BP,
9061,GO:0033623,1,0.937590982086715,0,10,regulation of integrin activation,BP,
9062,GO:0033624,1,0.983883315634299,0,2,negative regulation of integrin activation,BP,
9063,GO:0033625,1,0.970631834204448,0,5,positive regulation of integrin activation,BP,
9064,GO:0033626,1,0.993611526651874,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9069,GO:0033631,1,0.930614559928052,0,11,cell-cell adhesion mediated by integrin,BP,
9070,GO:0033632,1,0.956402671732094,0,7,regulation of cell-cell adhesion mediated by integrin,BP,
9071,GO:0033633,1,0.992500093429197,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9072,GO:0033634,1,0.980595808861182,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
9073,GO:0033643,1,0.927273930570883,0,12,host cell part,CC,
9074,GO:0033644,1,0.993166120876802,0,1,host cell membrane,CC,
9075,GO:0033646,1,0.945843031066811,0,9,host intracellular part,CC,
9076,GO:0033647,1,0.968906759046448,0,5,host intracellular organelle,CC,
9077,GO:0033648,1,0.968906759046448,0,5,host intracellular membrane-bounded organelle,CC,
9078,GO:0033650,1,0.994709706005916,0,1,host cell mitochondrion,CC,
9079,GO:0033655,1,0.965057773516906,0,6,host cell cytoplasm part,CC,
9080,GO:0033668,1,0.977012816296207,0,4,negative regulation by symbiont of host apoptotic process,BP,
9084,GO:0033677,1,0.981559759655786,0,3,DNA/RNA helicase activity,MF,
9085,GO:0033678,1,0.994374595726998,0,1,5'-3' DNA/RNA helicase activity,MF,
9086,GO:0033679,1,0.99273172731714,0,1,3'-5' DNA/RNA helicase activity,MF,
9087,GO:0033680,1,0.98714680371583,0,2,ATP-dependent DNA/RNA helicase activity,MF,
9088,GO:0033681,1,0.99273172731714,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
9089,GO:0033682,1,0.994374595726998,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9090,GO:0033683,1,0.790107928834866,0,39,nucleotide-excision repair, DNA incision,BP,
9091,GO:0033684,1,0.954001443703945,0,7,regulation of luteinizing hormone secretion,BP,
9092,GO:0033685,1,0.981784690844872,0,3,negative regulation of luteinizing hormone secretion,BP,
9093,GO:0033686,1,0.971706410454458,0,4,positive regulation of luteinizing hormone secretion,BP,
9096,GO:0033689,1,0.937786890752472,0,9,negative regulation of osteoblast proliferation,BP,
9099,GO:0033692,1,0.651244432072312,0,61,cellular polysaccharide biosynthetic process,BP,
9100,GO:0033693,1,0.987888403489169,0,2,neurofilament bundle assembly,BP,
9101,GO:0033695,1,0.994666025312145,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9102,GO:0033699,1,0.994638867968558,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9103,GO:0033700,1,0.940961915885086,0,8,phospholipid efflux,BP,
9104,GO:0033735,1,0.994822021516343,0,1,aspartate dehydrogenase activity,MF,
9105,GO:0033737,1,0.99445341344511,0,1,1-pyrroline dehydrogenase activity,MF,
9106,GO:0033743,1,0.977065037355515,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9107,GO:0033745,1,0.982189005363922,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9108,GO:0033746,1,0.993689247411896,0,1,histone demethylase activity (H3-R2 specific),MF,
9109,GO:0033749,1,0.993689247411896,0,1,histone demethylase activity (H4-R3 specific),MF,
9110,GO:0033750,1,0.928683779732961,0,13,ribosome localization,BP,
9111,GO:0033754,1,0.994746822591445,0,1,indoleamine 2,3-dioxygenase activity,MF,
9112,GO:0033762,1,0.727489626249356,0,47,response to glucagon,BP,
9113,GO:0033764,1,0.889451669291696,0,22,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9114,GO:0033765,1,0.988963751499022,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9115,GO:0033768,1,0.994207835395026,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9116,GO:0033778,1,0.993398504973974,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9117,GO:0033781,1,0.994618536527764,0,1,cholesterol 24-hydroxylase activity,MF,
9118,GO:0033787,1,0.994270628287957,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9119,GO:0033791,1,0.994534898507046,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9120,GO:0033798,1,0.994614640011293,0,1,thyroxine 5-deiodinase activity,MF,
9121,GO:0033814,1,0.994771926335018,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9122,GO:0033819,1,0.994821348087557,0,1,lipoyl(octanoyl) transferase activity,MF,
9123,GO:0033823,1,0.99417957762911,0,1,procollagen glucosyltransferase activity,MF,
9124,GO:0033829,1,0.983988274586326,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9125,GO:0033842,1,0.987691425891636,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9126,GO:0033857,1,0.98376503054785,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9127,GO:0033858,1,0.994053963311634,0,1,N-acetylgalactosamine kinase activity,MF,
9128,GO:0033860,1,0.962862658010771,0,7,regulation of NAD(P)H oxidase activity,BP,
9129,GO:0033861,1,0.989332430182367,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9130,GO:0033862,1,0.994181572964984,0,1,UMP kinase activity,MF,
9131,GO:0033864,1,0.973247649588585,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9132,GO:0033865,1,0.796387476759204,0,38,nucleoside bisphosphate metabolic process,BP,
9133,GO:0033866,1,0.909503449998484,0,16,nucleoside bisphosphate biosynthetic process,BP,
9134,GO:0033867,1,0.994732817968339,0,1,Fas-activated serine/threonine kinase activity,MF,
9135,GO:0033869,1,0.994817387140874,0,1,nucleoside bisphosphate catabolic process,BP,
9136,GO:0033871,1,0.994660463963978,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9137,GO:0033872,1,0.989110858203868,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9138,GO:0033875,1,0.796387476759204,0,38,ribonucleoside bisphosphate metabolic process,BP,
9139,GO:0033878,1,0.993522975324071,0,1,hormone-sensitive lipase activity,MF,
9140,GO:0033882,1,0.994804510652366,0,1,choloyl-CoA hydrolase activity,MF,
9141,GO:0033883,1,0.989480085067287,0,2,pyridoxal phosphatase activity,MF,
9142,GO:0033885,1,0.994576777660623,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9143,GO:0033897,1,0.994794597487769,0,1,ribonuclease T2 activity,MF,
9144,GO:0033906,1,0.989267402072535,0,2,hyaluronoglucuronidase activity,MF,
9145,GO:0033919,1,0.993434803223848,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9146,GO:0033925,1,0.992862031651417,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9147,GO:0033961,1,0.994710728031711,0,1,cis-stilbene-oxide hydrolase activity,MF,
9148,GO:0033962,1,0.862528043505141,0,18,cytoplasmic mRNA processing body assembly,BP,
9149,GO:0033967,1,0.994803505452008,0,1,box C/D snoRNA metabolic process,BP,
9150,GO:0033979,1,0.994418462131223,0,1,box H/ACA snoRNA metabolic process,BP,
9151,GO:0033981,1,0.994836463341554,0,1,D-dopachrome decarboxylase activity,MF,
9152,GO:0033989,1,0.994360132791974,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9154,GO:0034014,1,0.994546146440205,0,1,response to triglyceride,BP,
9155,GO:0034030,1,0.909503449998484,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
9156,GO:0034031,1,0.994817387140874,0,1,ribonucleoside bisphosphate catabolic process,BP,
9157,GO:0034032,1,0.796387476759204,0,38,purine nucleoside bisphosphate metabolic process,BP,
9158,GO:0034033,1,0.909503449998484,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
9159,GO:0034034,1,0.994817387140874,0,1,purine nucleoside bisphosphate catabolic process,BP,
9160,GO:0034035,1,0.868670866061183,0,23,purine ribonucleoside bisphosphate metabolic process,BP,
9161,GO:0034036,1,0.96087331308307,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9162,GO:0034038,1,0.994801547829737,0,1,deoxyhypusine synthase activity,MF,
9163,GO:0034039,1,0.989385495511616,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9165,GO:0034041,1,0.982251891285984,0,3,sterol-transporting ATPase activity,MF,
9166,GO:0034045,1,0.891793056868879,0,16,phagophore assembly site membrane,CC,
9167,GO:0034046,1,0.946632898339197,0,7,poly(G) binding,MF,
9168,GO:0034056,1,0.973146458863822,0,4,estrogen response element binding,MF,
9169,GO:0034057,1,0.987796658554117,0,2,RNA strand-exchange activity,MF,
9170,GO:0034058,1,0.929594371823394,0,10,endosomal vesicle fusion,BP,
9171,GO:0034059,1,0.977523058228436,0,3,response to anoxia,BP,
9172,GO:0034061,1,0.783278545144979,0,35,DNA polymerase activity,MF,
9173,GO:0034062,1,0.774165988102923,0,43,5'-3' RNA polymerase activity,MF,
9174,GO:0034063,1,0.906548867388189,0,13,stress granule assembly,BP,
9175,GO:0034066,1,0.989131116417836,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9176,GO:0034067,1,0.840016681015755,0,21,protein localization to Golgi apparatus,BP,
9177,GO:0034080,1,0.841550403347816,0,30,CENP-A containing nucleosome assembly,BP,
9178,GO:0034085,1,0.957627096203544,0,6,establishment of sister chromatid cohesion,BP,
9179,GO:0034086,1,0.921040036747243,0,10,maintenance of sister chromatid cohesion,BP,
9180,GO:0034087,1,0.980994134160186,0,2,establishment of mitotic sister chromatid cohesion,BP,
9181,GO:0034088,1,0.921040036747243,0,10,maintenance of mitotic sister chromatid cohesion,BP,
9182,GO:0034091,1,0.950560549954401,0,6,regulation of maintenance of sister chromatid cohesion,BP,
9183,GO:0034092,1,0.969081184802869,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9184,GO:0034093,1,0.980894396062914,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9186,GO:0034098,1,0.942460824003882,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9187,GO:0034101,1,0.488112402346097,0,109,erythrocyte homeostasis,BP,
9189,GO:0034104,1,0.900701488440093,0,16,negative regulation of tissue remodeling,BP,
9193,GO:0034111,1,0.914067585099648,0,14,negative regulation of homotypic cell-cell adhesion,BP,
9195,GO:0034113,1,0.737819608430771,0,46,heterotypic cell-cell adhesion,BP,
9196,GO:0034114,1,0.906499433645895,0,17,regulation of heterotypic cell-cell adhesion,BP,
9197,GO:0034115,1,0.95672600707755,0,8,negative regulation of heterotypic cell-cell adhesion,BP,
9198,GO:0034116,1,0.942533778936328,0,10,positive regulation of heterotypic cell-cell adhesion,BP,
9199,GO:0034117,1,0.994838833093777,0,1,erythrocyte aggregation,BP,
9200,GO:0034118,1,0.994838833093777,0,1,regulation of erythrocyte aggregation,BP,
9201,GO:0034120,1,0.994838833093777,0,1,positive regulation of erythrocyte aggregation,BP,
9203,GO:0034122,1,0.798694752973405,0,33,negative regulation of toll-like receptor signaling pathway,BP,
9205,GO:0034124,1,0.977962866501028,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9206,GO:0034125,1,0.989412274493262,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9207,GO:0034127,1,0.949952177509751,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9208,GO:0034128,1,0.955062286552053,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9209,GO:0034130,1,0.994270021149309,0,1,toll-like receptor 1 signaling pathway,BP,
9210,GO:0034134,1,0.928294894058462,0,12,toll-like receptor 2 signaling pathway,BP,
9211,GO:0034135,1,0.957328543357973,0,7,regulation of toll-like receptor 2 signaling pathway,BP,
9212,GO:0034136,1,0.978631571083843,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
9213,GO:0034137,1,0.978236471973519,0,4,positive regulation of toll-like receptor 2 signaling pathway,BP,
9214,GO:0034138,1,0.893352071721616,0,19,toll-like receptor 3 signaling pathway,BP,
9215,GO:0034139,1,0.945966062666579,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9216,GO:0034140,1,0.980526686447525,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9217,GO:0034141,1,0.959211409550101,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9220,GO:0034144,1,0.963824802087778,0,6,negative regulation of toll-like receptor 4 signaling pathway,BP,
9222,GO:0034146,1,0.986064643996801,0,2,toll-like receptor 5 signaling pathway,BP,
9223,GO:0034147,1,0.99292707905012,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9224,GO:0034148,1,0.99292707905012,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9225,GO:0034150,1,0.991424923868559,0,1,toll-like receptor 6 signaling pathway,BP,
9226,GO:0034154,1,0.957853891026826,0,7,toll-like receptor 7 signaling pathway,BP,
9227,GO:0034155,1,0.983219617814352,0,3,regulation of toll-like receptor 7 signaling pathway,BP,
9228,GO:0034156,1,0.994719259578768,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9229,GO:0034157,1,0.988439918451664,0,2,positive regulation of toll-like receptor 7 signaling pathway,BP,
9230,GO:0034158,1,0.993144769812266,0,1,toll-like receptor 8 signaling pathway,BP,
9231,GO:0034162,1,0.880266063088232,0,20,toll-like receptor 9 signaling pathway,BP,
9232,GO:0034163,1,0.961234982992012,0,6,regulation of toll-like receptor 9 signaling pathway,BP,
9233,GO:0034164,1,0.985387683247254,0,2,negative regulation of toll-like receptor 9 signaling pathway,BP,
9234,GO:0034165,1,0.987677752184067,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9235,GO:0034166,1,0.993947668792974,0,1,toll-like receptor 10 signaling pathway,BP,
9236,GO:0034182,1,0.950560549954401,0,6,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9237,GO:0034183,1,0.969081184802869,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9238,GO:0034184,1,0.980894396062914,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9239,GO:0034185,1,0.875805180664953,0,16,apolipoprotein binding,MF,
9240,GO:0034186,1,0.970885811655727,0,4,apolipoprotein A-I binding,MF,
9241,GO:0034188,1,0.977438176542627,0,2,apolipoprotein A-I receptor activity,MF,
9242,GO:0034189,1,0.987413966587081,0,2,very-low-density lipoprotein particle binding,MF,
9243,GO:0034190,1,0.966776787517682,0,5,apolipoprotein receptor binding,MF,
9244,GO:0034191,1,0.972935357491295,0,4,apolipoprotein A-I receptor binding,MF,
9245,GO:0034196,1,0.977575523509148,0,4,acylglycerol transport,BP,
9246,GO:0034197,1,0.977575523509148,0,4,triglyceride transport,BP,
9247,GO:0034198,1,0.769753430197001,0,42,cellular response to amino acid starvation,BP,
9248,GO:0034199,1,0.885955820378727,0,16,activation of protein kinase A activity,BP,
9249,GO:0034201,1,0.968674396217798,0,5,response to oleic acid,BP,
9250,GO:0034203,1,0.99223793542576,0,1,glycolipid translocation,BP,
9251,GO:0034204,1,0.811698074800076,0,24,lipid translocation,BP,
9252,GO:0034205,1,0.849906878018662,0,23,amyloid-beta formation,BP,
9253,GO:0034211,1,0.988022957922514,0,1,GTP-dependent protein kinase activity,MF,
9254,GO:0034212,1,0.658692543843099,0,60,peptide N-acetyltransferase activity,MF,
9255,GO:0034213,1,0.994751153599084,0,1,quinolinate catabolic process,BP,
9256,GO:0034214,1,0.949430659187354,0,8,protein hexamerization,BP,
9257,GO:0034219,1,0.498943907624649,0,102,carbohydrate transmembrane transport,BP,
9259,GO:0034224,1,0.994561837041065,0,1,cellular response to zinc ion starvation,BP,
9260,GO:0034227,1,0.973499151161542,0,5,tRNA thio-modification,BP,
9261,GO:0034230,1,0.992606139575109,0,1,enkephalin processing,BP,
9262,GO:0034231,1,0.992606139575109,0,1,islet amyloid polypeptide processing,BP,
9263,GO:0034235,1,0.966044114343779,0,6,GPI anchor binding,MF,
9264,GO:0034236,1,0.9050889121562,0,14,protein kinase A catalytic subunit binding,MF,
9265,GO:0034237,1,0.860374279617131,0,18,protein kinase A regulatory subunit binding,MF,
9266,GO:0034238,1,0.993358188221718,0,1,macrophage fusion,BP,
9267,GO:0034239,1,0.993358188221718,0,1,regulation of macrophage fusion,BP,
9268,GO:0034241,1,0.993358188221718,0,1,positive regulation of macrophage fusion,BP,
9270,GO:0034243,1,0.850515093028066,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9271,GO:0034244,1,0.933631585047143,0,11,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9272,GO:0034245,1,0.993517516373773,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9273,GO:0034247,1,0.994789682286116,0,1,snoRNA splicing,BP,
9275,GO:0034249,1,0.210062335240767,0,222,negative regulation of cellular amide metabolic process,BP,
9277,GO:0034255,1,0.99459757150219,0,1,regulation of urea metabolic process,BP,
9278,GO:0034260,1,0.736657086240895,0,44,negative regulation of GTPase activity,BP,
9279,GO:0034271,1,0.98112046850493,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9280,GO:0034272,1,0.98112046850493,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9281,GO:0034274,1,0.97974934759566,0,3,Atg12-Atg5-Atg16 complex,CC,
9282,GO:0034275,1,0.994746822591445,0,1,kynurenic acid metabolic process,BP,
9283,GO:0034276,1,0.994746822591445,0,1,kynurenic acid biosynthetic process,BP,
9285,GO:0034285,1,0.973890621712124,0,4,response to disaccharide,BP,
9286,GO:0034287,1,0.978328877364322,0,4,detection of monosaccharide stimulus,BP,
9287,GO:0034308,1,0.740746231399287,0,51,primary alcohol metabolic process,BP,
9288,GO:0034309,1,0.994822876044542,0,1,primary alcohol biosynthetic process,BP,
9289,GO:0034310,1,0.932587377979554,0,13,primary alcohol catabolic process,BP,
9290,GO:0034311,1,0.8954101116367,0,19,diol metabolic process,BP,
9291,GO:0034312,1,0.910338678865909,0,16,diol biosynthetic process,BP,
9292,GO:0034314,1,0.824421073787212,0,31,Arp2/3 complex-mediated actin nucleation,BP,
9293,GO:0034315,1,0.911111448069907,0,15,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9294,GO:0034316,1,0.970547509830321,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9295,GO:0034329,1,0.205500392624674,0,216,cell junction assembly,BP,
9296,GO:0034330,1,0.151080831048564,0,257,cell junction organization,BP,
9297,GO:0034331,1,0.932574321932781,0,11,cell junction maintenance,BP,
9298,GO:0034332,1,0.412198925455329,0,121,adherens junction organization,BP,
9299,GO:0034333,1,0.542856414390518,0,81,adherens junction assembly,BP,
9300,GO:0034334,1,0.972759638665003,0,4,adherens junction maintenance,BP,
9301,GO:0034338,1,0.972276776946052,0,4,short-chain carboxylesterase activity,MF,
9302,GO:0034340,1,0.624561617409177,0,75,response to type I interferon,BP,
9304,GO:0034342,1,0.988948958782957,0,2,response to type III interferon,BP,
9305,GO:0034343,1,0.980707661877833,0,3,type III interferon production,BP,
9306,GO:0034344,1,0.980707661877833,0,3,regulation of type III interferon production,BP,
9307,GO:0034346,1,0.994146489692574,0,1,positive regulation of type III interferon production,BP,
9311,GO:0034353,1,0.994313214468247,0,1,RNA pyrophosphohydrolase activity,MF,
9312,GO:0034354,1,0.994790052697,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9313,GO:0034355,1,0.994313214468247,0,1,NAD salvage,BP,
9315,GO:0034358,1,0.807509640473389,0,32,plasma lipoprotein particle,CC,
9316,GO:0034359,1,0.983672740350554,0,1,mature chylomicron,CC,
9317,GO:0034360,1,0.983672740350554,0,1,chylomicron remnant,CC,
9318,GO:0034361,1,0.908660480936541,0,15,very-low-density lipoprotein particle,CC,
9319,GO:0034362,1,0.916827879650877,0,12,low-density lipoprotein particle,CC,
9320,GO:0034363,1,0.968463695909438,0,4,intermediate-density lipoprotein particle,CC,
9321,GO:0034364,1,0.884551610383919,0,21,high-density lipoprotein particle,CC,
9322,GO:0034365,1,0.984539333869802,0,3,discoidal high-density lipoprotein particle,CC,
9323,GO:0034366,1,0.96867986838839,0,6,spherical high-density lipoprotein particle,CC,
9327,GO:0034370,1,0.947145708417023,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9328,GO:0034371,1,0.962240554175426,0,5,chylomicron remodeling,BP,
9329,GO:0034372,1,0.962872673505729,0,7,very-low-density lipoprotein particle remodeling,BP,
9330,GO:0034373,1,0.994740266082025,0,1,intermediate-density lipoprotein particle remodeling,BP,
9332,GO:0034375,1,0.920946771822105,0,14,high-density lipoprotein particle remodeling,BP,
9333,GO:0034377,1,0.859319403988404,0,22,plasma lipoprotein particle assembly,BP,
9334,GO:0034378,1,0.948567380639193,0,7,chylomicron assembly,BP,
9335,GO:0034379,1,0.937903553985592,0,9,very-low-density lipoprotein particle assembly,BP,
9336,GO:0034380,1,0.928779368368919,0,11,high-density lipoprotein particle assembly,BP,
9338,GO:0034382,1,0.950377157565617,0,7,chylomicron remnant clearance,BP,
9340,GO:0034384,1,0.93444305090926,0,10,high-density lipoprotein particle clearance,BP,
9341,GO:0034385,1,0.908660480936541,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9342,GO:0034386,1,0.992431771564765,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9343,GO:0034388,1,0.962367699106681,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9344,GO:0034389,1,0.901742998061484,0,17,lipid particle organization,BP,
9345,GO:0034390,1,0.891676374519084,0,17,smooth muscle cell apoptotic process,BP,
9346,GO:0034391,1,0.891676374519084,0,17,regulation of smooth muscle cell apoptotic process,BP,
9347,GO:0034392,1,0.961885632277348,0,5,negative regulation of smooth muscle cell apoptotic process,BP,
9348,GO:0034393,1,0.938207466121869,0,10,positive regulation of smooth muscle cell apoptotic process,BP,
9349,GO:0034394,1,0.700487880241461,0,51,protein localization to cell surface,BP,
9350,GO:0034395,1,0.98869391003316,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9351,GO:0034397,1,0.926555471364729,0,11,telomere localization,BP,
9352,GO:0034398,1,0.961942166932611,0,6,telomere tethering at nuclear periphery,BP,
9353,GO:0034399,1,0.409109188286044,0,128,nuclear periphery,CC,
9354,GO:0034402,1,0.985928046046034,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9356,GO:0034405,1,0.798832226991349,0,33,response to fluid shear stress,BP,
9357,GO:0034414,1,0.988118019550024,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9358,GO:0034416,1,0.994270628287957,0,1,bisphosphoglycerate phosphatase activity,MF,
9359,GO:0034417,1,0.994270628287957,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9360,GO:0034418,1,0.989119178242053,0,2,urate biosynthetic process,BP,
9361,GO:0034421,1,0.981426896020354,0,3,post-translational protein acetylation,BP,
9362,GO:0034423,1,0.994390319498222,0,1,autophagosome lumen,CC,
9363,GO:0034427,1,0.946337038276197,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9364,GO:0034431,1,0.97668461576008,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9365,GO:0034432,1,0.97668461576008,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9366,GO:0034433,1,0.946446882725508,0,10,steroid esterification,BP,
9367,GO:0034434,1,0.946446882725508,0,10,sterol esterification,BP,
9368,GO:0034435,1,0.946446882725508,0,10,cholesterol esterification,BP,
9369,GO:0034436,1,0.982802416492823,0,3,glycoprotein transport,BP,
9370,GO:0034437,1,0.987921506664515,0,2,glycoprotein transporter activity,MF,
9371,GO:0034439,1,0.988694782132626,0,2,lipoprotein lipid oxidation,BP,
9372,GO:0034440,1,0.542514696649066,0,97,lipid oxidation,BP,
9373,GO:0034441,1,0.98955806541764,0,2,plasma lipoprotein particle oxidation,BP,
9374,GO:0034442,1,0.988694782132626,0,2,regulation of lipoprotein oxidation,BP,
9375,GO:0034443,1,0.994807234511731,0,1,negative regulation of lipoprotein oxidation,BP,
9376,GO:0034444,1,0.99483210716768,0,1,regulation of plasma lipoprotein oxidation,BP,
9377,GO:0034445,1,0.99483210716768,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9379,GO:0034447,1,0.946957349275924,0,8,very-low-density lipoprotein particle clearance,BP,
9380,GO:0034448,1,0.971535625591145,0,5,EGO complex,CC,
9381,GO:0034450,1,0.911741885784469,0,13,ubiquitin-ubiquitin ligase activity,MF,
9382,GO:0034451,1,0.820105394153208,0,27,centriolar satellite,CC,
9383,GO:0034452,1,0.915435757513633,0,10,dynactin binding,MF,
9384,GO:0034453,1,0.834408702756912,0,22,microtubule anchoring,BP,
9385,GO:0034454,1,0.924681111606873,0,9,microtubule anchoring at centrosome,BP,
9386,GO:0034455,1,0.984958454402957,0,2,t-UTP complex,CC,
9387,GO:0034456,1,0.987993061926553,0,2,UTP-C complex,CC,
9388,GO:0034457,1,0.984155237832503,0,3,Mpp10 complex,CC,
9389,GO:0034458,1,0.987235189145446,0,2,3'-5' RNA helicase activity,MF,
9390,GO:0034459,1,0.99273172731714,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9391,GO:0034462,1,0.994561273088904,0,1,small-subunit processome assembly,BP,
9392,GO:0034463,1,0.99484182519957,0,1,90S preribosome assembly,BP,
9393,GO:0034464,1,0.948975633776019,0,9,BBSome,CC,
9394,GO:0034465,1,0.974479493022586,0,4,response to carbon monoxide,BP,
9395,GO:0034466,1,0.994317236960261,0,1,chromaffin granule lumen,CC,
9396,GO:0034470,1,0.0963361350753585,0,389,ncRNA processing,BP,
9397,GO:0034471,1,0.892657457641122,0,19,ncRNA 5'-end processing,BP,
9398,GO:0034472,1,0.910511382602882,0,15,snRNA 3'-end processing,BP,
9399,GO:0034473,1,0.984396584521881,0,3,U1 snRNA 3'-end processing,BP,
9400,GO:0034474,1,0.990244842749028,0,1,U2 snRNA 3'-end processing,BP,
9401,GO:0034475,1,0.95882213367247,0,8,U4 snRNA 3'-end processing,BP,
9402,GO:0034476,1,0.984396584521881,0,3,U5 snRNA 3'-end processing,BP,
9403,GO:0034477,1,0.994313214468247,0,1,U6 snRNA 3'-end processing,BP,
9404,GO:0034481,1,0.960927971171365,0,6,chondroitin sulfotransferase activity,MF,
9405,GO:0034483,1,0.907628662599088,0,14,heparan sulfate sulfotransferase activity,MF,
9406,GO:0034485,1,0.973955023114322,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9407,GO:0034497,1,0.916929441458623,0,13,protein localization to phagophore assembly site,BP,
9408,GO:0034498,1,0.946423208425694,0,8,early endosome to Golgi transport,BP,
9409,GO:0034499,1,0.982920928989986,0,2,late endosome to Golgi transport,BP,
9410,GO:0034501,1,0.912888145269831,0,16,protein localization to kinetochore,BP,
9411,GO:0034502,1,0.631642002703426,0,70,protein localization to chromosome,BP,
9414,GO:0034506,1,0.993320421893173,0,1,chromosome, centromeric core domain,CC,
9415,GO:0034508,1,0.777635307047972,0,40,centromere complex assembly,BP,
9416,GO:0034511,1,0.966005848212387,0,5,U3 snoRNA binding,MF,
9417,GO:0034513,1,0.973947915496292,0,5,box H/ACA snoRNA binding,MF,
9418,GO:0034515,1,0.988244197949299,0,2,proteasome storage granule,CC,
9419,GO:0034516,1,0.994761655063573,0,1,response to vitamin B6,BP,
9420,GO:0034518,1,0.929988321747494,0,11,RNA cap binding complex,CC,
9421,GO:0034545,1,0.99472564749793,0,1,fumarylpyruvate hydrolase activity,MF,
9422,GO:0034551,1,0.946879650384161,0,9,mitochondrial respiratory chain complex III assembly,BP,
9423,GO:0034552,1,0.989633685605987,0,2,respiratory chain complex II assembly,BP,
9424,GO:0034553,1,0.989633685605987,0,2,mitochondrial respiratory chain complex II assembly,BP,
9425,GO:0034584,1,0.987560873002921,0,2,piRNA binding,MF,
9426,GO:0034587,1,0.917288045263871,0,14,piRNA metabolic process,BP,
9427,GO:0034589,1,0.993053360630119,0,1,hydroxyproline transport,BP,
9428,GO:0034590,1,0.993053360630119,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9429,GO:0034593,1,0.830708150078574,0,25,phosphatidylinositol bisphosphate phosphatase activity,MF,
9430,GO:0034594,1,0.960805266452598,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9431,GO:0034595,1,0.911039150548044,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9432,GO:0034596,1,0.94004542702821,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9433,GO:0034597,1,0.983884906964313,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9435,GO:0034602,1,0.993050902154568,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9436,GO:0034603,1,0.970101285046887,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9437,GO:0034604,1,0.970101285046887,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9442,GO:0034616,1,0.912888889282244,0,14,response to laminar fluid shear stress,BP,
9443,GO:0034617,1,0.972658306637455,0,4,tetrahydrobiopterin binding,MF,
9444,GO:0034618,1,0.962082930658324,0,6,arginine binding,MF,
9447,GO:0034625,1,0.964347280122246,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9448,GO:0034626,1,0.964347280122246,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9449,GO:0034627,1,0.975021142780246,0,4,'de novo' NAD biosynthetic process,BP,
9450,GO:0034628,1,0.980128584109915,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9451,GO:0034629,1,0.868811224446175,0,23,cellular protein-containing complex localization,BP,
9452,GO:0034632,1,0.989122523361605,0,2,retinol transmembrane transporter activity,MF,
9453,GO:0034633,1,0.989122523361605,0,2,retinol transport,BP,
9454,GO:0034634,1,0.990869091843867,0,1,glutathione transmembrane transporter activity,MF,
9455,GO:0034635,1,0.985561484989307,0,2,glutathione transport,BP,
9456,GO:0034637,1,0.598347061845434,0,75,cellular carbohydrate biosynthetic process,BP,
9457,GO:0034638,1,0.95388499854777,0,8,phosphatidylcholine catabolic process,BP,
9458,GO:0034640,1,0.994011263608766,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9460,GO:0034643,1,0.868024830138799,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
9461,GO:0034644,1,0.604655848519124,0,74,cellular response to UV,BP,
9463,GO:0034647,1,0.977487850002467,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9464,GO:0034648,1,0.965367700031885,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9465,GO:0034649,1,0.993451466202994,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9466,GO:0034650,1,0.947800226959962,0,8,cortisol metabolic process,BP,
9467,GO:0034651,1,0.952897352570056,0,7,cortisol biosynthetic process,BP,
9468,GO:0034653,1,0.982349534393495,0,3,retinoic acid catabolic process,BP,
9472,GO:0034657,1,0.974650579261058,0,4,GID complex,CC,
9473,GO:0034660,1,0.0359363268838462,0,546,ncRNA metabolic process,BP,
9474,GO:0034661,1,0.849473933372052,0,24,ncRNA catabolic process,BP,
9475,GO:0034663,1,0.947760665462304,0,9,endoplasmic reticulum chaperone complex,CC,
9476,GO:0034665,1,0.986145409677344,0,2,integrin alpha1-beta1 complex,CC,
9477,GO:0034666,1,0.977222817100251,0,3,integrin alpha2-beta1 complex,CC,
9478,GO:0034667,1,0.985984331701276,0,2,integrin alpha3-beta1 complex,CC,
9479,GO:0034668,1,0.993409701531341,0,1,integrin alpha4-beta1 complex,CC,
9480,GO:0034669,1,0.985552842766871,0,2,integrin alpha4-beta7 complex,CC,
9481,GO:0034670,1,0.987556185571821,0,1,chemotaxis to arachidonic acid,BP,
9482,GO:0034673,1,0.977866967729636,0,3,inhibin-betaglycan-ActRII complex,CC,
9483,GO:0034676,1,0.991541159919551,0,1,integrin alpha6-beta4 complex,CC,
9484,GO:0034677,1,0.993563684517787,0,1,integrin alpha7-beta1 complex,CC,
9485,GO:0034678,1,0.980425679298004,0,3,integrin alpha8-beta1 complex,CC,
9486,GO:0034679,1,0.993362891568395,0,1,integrin alpha9-beta1 complex,CC,
9487,GO:0034680,1,0.985757341408623,0,2,integrin alpha10-beta1 complex,CC,
9488,GO:0034681,1,0.985932059252192,0,2,integrin alpha11-beta1 complex,CC,
9489,GO:0034683,1,0.982836934752888,0,2,integrin alphav-beta3 complex,CC,
9490,GO:0034684,1,0.984267288885594,0,2,integrin alphav-beta5 complex,CC,
9491,GO:0034685,1,0.984867880351415,0,2,integrin alphav-beta6 complex,CC,
9492,GO:0034686,1,0.978918465802783,0,2,integrin alphav-beta8 complex,CC,
9493,GO:0034687,1,0.986487483466301,0,2,integrin alphaL-beta2 complex,CC,
9494,GO:0034688,1,0.986838836495641,0,2,integrin alphaM-beta2 complex,CC,
9495,GO:0034693,1,0.994473196325914,0,1,U11/U12 snRNP,CC,
9496,GO:0034694,1,0.818243231200345,0,29,response to prostaglandin,BP,
9497,GO:0034695,1,0.865846081172757,0,22,response to prostaglandin E,BP,
9498,GO:0034696,1,0.989056326182502,0,2,response to prostaglandin F,BP,
9499,GO:0034698,1,0.842893995102257,0,25,response to gonadotropin,BP,
9500,GO:0034699,1,0.979653383002179,0,3,response to luteinizing hormone,BP,
9503,GO:0034704,1,0.615080354613881,0,60,calcium channel complex,CC,
9505,GO:0034706,1,0.821935746366465,0,23,sodium channel complex,CC,
9507,GO:0034708,1,0.552102184933671,0,88,methyltransferase complex,CC,
9508,GO:0034709,1,0.938714996200097,0,12,methylosome,CC,
9509,GO:0034711,1,0.969317256818975,0,5,inhibin binding,MF,
9510,GO:0034713,1,0.941047282481158,0,9,type I transforming growth factor beta receptor binding,MF,
9511,GO:0034714,1,0.980882058250029,0,3,type III transforming growth factor beta receptor binding,MF,
9512,GO:0034715,1,0.969111420944955,0,6,pICln-Sm protein complex,CC,
9513,GO:0034718,1,0.99189828064876,0,1,SMN-Gemin2 complex,CC,
9514,GO:0034719,1,0.909058731056271,0,17,SMN-Sm protein complex,CC,
9515,GO:0034720,1,0.948626852158017,0,6,histone H3-K4 demethylation,BP,
9516,GO:0034721,1,0.977487850002467,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9517,GO:0034722,1,0.994760750257505,0,1,gamma-glutamyl-peptidase activity,MF,
9518,GO:0034723,1,0.921384878051559,0,14,DNA replication-dependent nucleosome organization,BP,
9519,GO:0034724,1,0.776503508062655,0,41,DNA replication-independent nucleosome organization,BP,
9520,GO:0034727,1,0.992371518296249,0,1,piecemeal microautophagy of the nucleus,BP,
9521,GO:0034728,1,0.478245963177021,0,117,nucleosome organization,BP,
9522,GO:0034729,1,0.977786055255475,0,3,histone H3-K79 methylation,BP,
9523,GO:0034736,1,0.9938738135908,0,1,cholesterol O-acyltransferase activity,MF,
9524,GO:0034739,1,0.989405906900349,0,2,histone deacetylase activity (H4-K16 specific),MF,
9525,GO:0034750,1,0.986027747620557,0,2,Scrib-APC-beta-catenin complex,CC,
9526,GO:0034751,1,0.98038639130905,0,3,aryl hydrocarbon receptor complex,CC,
9527,GO:0034752,1,0.991030940628369,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9528,GO:0034753,1,0.991030940628369,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9531,GO:0034756,1,0.967784421926599,0,5,regulation of iron ion transport,BP,
9532,GO:0034757,1,0.983659154336735,0,2,negative regulation of iron ion transport,BP,
9533,GO:0034759,1,0.983659154336735,0,2,regulation of iron ion transmembrane transport,BP,
9534,GO:0034760,1,0.983659154336735,0,2,negative regulation of iron ion transmembrane transport,BP,
9536,GO:0034763,1,0.519502560923086,0,100,negative regulation of transmembrane transport,BP,
9539,GO:0034766,1,0.58866188548734,0,80,negative regulation of ion transmembrane transport,BP,
9541,GO:0034769,1,0.987907783623117,0,2,basement membrane disassembly,BP,
9542,GO:0034770,1,0.944710313264015,0,6,histone H4-K20 methylation,BP,
9543,GO:0034773,1,0.968688882037608,0,4,histone H4-K20 trimethylation,BP,
9545,GO:0034775,1,0.990869091843867,0,1,glutathione transmembrane transport,BP,
9547,GO:0034777,1,0.994566692784395,0,1,recycling endosome lumen,CC,
9548,GO:0034875,1,0.994666025312145,0,1,caffeine oxidase activity,MF,
9549,GO:0034899,1,0.994620307380141,0,1,trimethylamine monooxygenase activity,MF,
9550,GO:0034959,1,0.992210712150724,0,1,endothelin maturation,BP,
9551,GO:0034963,1,0.994803505452008,0,1,box C/D snoRNA processing,BP,
9552,GO:0034964,1,0.994418462131223,0,1,box H/ACA snoRNA processing,BP,
9553,GO:0034968,1,0.493511895819099,0,96,histone lysine methylation,BP,
9554,GO:0034969,1,0.934274089709216,0,12,histone arginine methylation,BP,
9555,GO:0034970,1,0.988608591557149,0,2,histone H3-R2 methylation,BP,
9556,GO:0034971,1,0.98881619797004,0,2,histone H3-R17 methylation,BP,
9557,GO:0034975,1,0.925310523227878,0,13,protein folding in endoplasmic reticulum,BP,
9559,GO:0034979,1,0.894403960965035,0,17,NAD-dependent protein deacetylase activity,MF,
9560,GO:0034982,1,0.929079258547266,0,12,mitochondrial protein processing,BP,
9561,GO:0034983,1,0.952819579249076,0,7,peptidyl-lysine deacetylation,BP,
9562,GO:0034986,1,0.984444862614191,0,2,iron chaperone activity,MF,
9563,GO:0034987,1,0.962059398338992,0,6,immunoglobulin receptor binding,MF,
9564,GO:0034988,1,0.983267397285717,0,2,Fc-gamma receptor I complex binding,MF,
9565,GO:0034991,1,0.975765506054344,0,4,nuclear meiotic cohesin complex,CC,
9566,GO:0034992,1,0.937058794208955,0,7,microtubule organizing center attachment site,CC,
9567,GO:0034993,1,0.937058794208955,0,7,meiotic nuclear membrane microtubule tethering complex,CC,
9568,GO:0034998,1,0.994313214468247,0,1,oligosaccharyltransferase I complex,CC,
9569,GO:0035004,1,0.606402052010299,0,69,phosphatidylinositol 3-kinase activity,MF,
9570,GO:0035005,1,0.943883512449811,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9571,GO:0035014,1,0.946243692994012,0,8,phosphatidylinositol 3-kinase regulator activity,MF,
9572,GO:0035019,1,0.639365896961425,0,67,somatic stem cell population maintenance,BP,
9573,GO:0035020,1,0.88711692711692,0,16,regulation of Rac protein signal transduction,BP,
9574,GO:0035021,1,0.966459993928599,0,4,negative regulation of Rac protein signal transduction,BP,
9575,GO:0035022,1,0.970903156061547,0,4,positive regulation of Rac protein signal transduction,BP,
9577,GO:0035024,1,0.878085189540181,0,18,negative regulation of Rho protein signal transduction,BP,
9579,GO:0035026,1,0.986735918220827,0,2,leading edge cell differentiation,BP,
9580,GO:0035032,1,0.9646155492603,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9581,GO:0035033,1,0.981324177588042,0,3,histone deacetylase regulator activity,MF,
9582,GO:0035034,1,0.988698383417962,0,2,histone acetyltransferase regulator activity,MF,
9583,GO:0035035,1,0.814355723429043,0,29,histone acetyltransferase binding,MF,
9584,GO:0035036,1,0.812051018396231,0,37,sperm-egg recognition,BP,
9585,GO:0035037,1,0.992837907316111,0,1,sperm entry,BP,
9586,GO:0035038,1,0.988694341451564,0,2,female pronucleus assembly,BP,
9587,GO:0035039,1,0.994536095807949,0,1,male pronucleus assembly,BP,
9588,GO:0035050,1,0.619096579753166,0,69,embryonic heart tube development,BP,
9589,GO:0035051,1,0.418799292639412,0,119,cardiocyte differentiation,BP,
9590,GO:0035054,1,0.982625375232569,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9591,GO:0035061,1,0.968739251465455,0,4,interchromatin granule,CC,
9593,GO:0035064,1,0.670257745140231,0,56,methylated histone binding,MF,
9594,GO:0035065,1,0.714758317333168,0,52,regulation of histone acetylation,BP,
9595,GO:0035066,1,0.834780399605088,0,28,positive regulation of histone acetylation,BP,
9596,GO:0035067,1,0.896331171329724,0,17,negative regulation of histone acetylation,BP,
9597,GO:0035068,1,0.934527115827676,0,9,micro-ribonucleoprotein complex,CC,
9598,GO:0035082,1,0.687416912258903,0,52,axoneme assembly,BP,
9599,GO:0035087,1,0.971161528997381,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9600,GO:0035088,1,0.736379872132446,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9601,GO:0035089,1,0.891644107796304,0,17,establishment of apical/basal cell polarity,BP,
9602,GO:0035090,1,0.924003762528269,0,12,maintenance of apical/basal cell polarity,BP,
9604,GO:0035092,1,0.953019541357032,0,6,sperm chromatin condensation,BP,
9605,GO:0035093,1,0.964800536562126,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9606,GO:0035094,1,0.75951549856311,0,42,response to nicotine,BP,
9607,GO:0035095,1,0.949655759352183,0,7,behavioral response to nicotine,BP,
9608,GO:0035097,1,0.616710897931109,0,68,histone methyltransferase complex,CC,
9609,GO:0035098,1,0.896207380127281,0,16,ESC/E(Z) complex,CC,
9610,GO:0035101,1,0.981392172203502,0,3,FACT complex,CC,
9611,GO:0035102,1,0.927242933481448,0,11,PRC1 complex,CC,
9612,GO:0035106,1,0.982488070237876,0,3,operant conditioning,BP,
9613,GO:0035107,1,0.350797535689257,0,142,appendage morphogenesis,BP,
9614,GO:0035108,1,0.350797535689257,0,142,limb morphogenesis,BP,
9615,GO:0035112,1,0.921783775974401,0,11,genitalia morphogenesis,BP,
9616,GO:0035113,1,0.413348962542826,0,122,embryonic appendage morphogenesis,BP,
9617,GO:0035115,1,0.809509399201086,0,32,embryonic forelimb morphogenesis,BP,
9618,GO:0035116,1,0.828361687146561,0,28,embryonic hindlimb morphogenesis,BP,
9619,GO:0035120,1,0.986267357554897,0,1,post-embryonic appendage morphogenesis,BP,
9620,GO:0035127,1,0.986267357554897,0,1,post-embryonic limb morphogenesis,BP,
9621,GO:0035128,1,0.986267357554897,0,1,post-embryonic forelimb morphogenesis,BP,
9622,GO:0035136,1,0.755427849050467,0,40,forelimb morphogenesis,BP,
9623,GO:0035137,1,0.776908391553725,0,36,hindlimb morphogenesis,BP,
9624,GO:0035145,1,0.889140249765245,0,19,exon-exon junction complex,CC,
9627,GO:0035162,1,0.867793690444825,0,20,embryonic hemopoiesis,BP,
9628,GO:0035166,1,0.980902074692825,0,3,post-embryonic hemopoiesis,BP,
9629,GO:0035173,1,0.895030279339571,0,16,histone kinase activity,MF,
9630,GO:0035174,1,0.954426483272672,0,7,histone serine kinase activity,MF,
9631,GO:0035175,1,0.994719259578768,0,1,histone kinase activity (H3-S10 specific),MF,
9633,GO:0035184,1,0.964187731540582,0,5,histone threonine kinase activity,MF,
9634,GO:0035188,1,0.993993108028265,0,1,hatching,BP,
9635,GO:0035189,1,0.981611066447064,0,3,Rb-E2F complex,CC,
9636,GO:0035194,1,0.434873925049183,0,120,posttranscriptional gene silencing by RNA,BP,
9637,GO:0035195,1,0.451332156913668,0,114,gene silencing by miRNA,BP,
9638,GO:0035196,1,0.753496009878783,0,40,production of miRNAs involved in gene silencing by miRNA,BP,
9639,GO:0035197,1,0.928870688579957,0,10,siRNA binding,MF,
9640,GO:0035198,1,0.869706335475321,0,22,miRNA binding,MF,
9641,GO:0035226,1,0.994120894880831,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9642,GO:0035227,1,0.994120894880831,0,1,regulation of glutamate-cysteine ligase activity,BP,
9643,GO:0035229,1,0.994120894880831,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9644,GO:0035234,1,0.946607846714704,0,7,ectopic germ cell programmed cell death,BP,
9646,GO:0035238,1,0.994313214468247,0,1,vitamin A biosynthetic process,BP,
9648,GO:0035240,1,0.955618105204307,0,8,dopamine binding,MF,
9649,GO:0035241,1,0.977908706636464,0,4,protein-arginine omega-N monomethyltransferase activity,MF,
9650,GO:0035242,1,0.95651385697396,0,8,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9651,GO:0035243,1,0.977794801489051,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9652,GO:0035246,1,0.935360967720436,0,12,peptidyl-arginine N-methylation,BP,
9653,GO:0035247,1,0.945822942088006,0,10,peptidyl-arginine omega-N-methylation,BP,
9654,GO:0035248,1,0.994257172793194,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9656,GO:0035250,1,0.852355035070904,0,27,UDP-galactosyltransferase activity,MF,
9657,GO:0035251,1,0.940841672132217,0,9,UDP-glucosyltransferase activity,MF,
9658,GO:0035252,1,0.955691231084027,0,6,UDP-xylosyltransferase activity,MF,
9659,GO:0035253,1,0.922321502064935,0,11,ciliary rootlet,CC,
9662,GO:0035256,1,0.951336592508511,0,8,G-protein coupled glutamate receptor binding,MF,
9663,GO:0035257,1,0.370124644700398,0,144,nuclear hormone receptor binding,MF,
9664,GO:0035258,1,0.557583036251669,0,84,steroid hormone receptor binding,MF,
9665,GO:0035259,1,0.907240088428183,0,14,glucocorticoid receptor binding,MF,
9666,GO:0035261,1,0.974584310554115,0,2,external genitalia morphogenesis,BP,
9667,GO:0035262,1,0.983102100904275,0,2,gonad morphogenesis,BP,
9669,GO:0035265,1,0.364801813248188,0,142,organ growth,BP,
9670,GO:0035267,1,0.888665140100725,0,18,NuA4 histone acetyltransferase complex,CC,
9671,GO:0035268,1,0.891294757312619,0,17,protein mannosylation,BP,
9672,GO:0035269,1,0.927294317985736,0,12,protein O-linked mannosylation,BP,
9674,GO:0035272,1,0.71836562220424,0,47,exocrine system development,BP,
9675,GO:0035276,1,0.986484854824313,0,2,ethanol binding,MF,
9676,GO:0035278,1,0.901760085259167,0,13,miRNA mediated inhibition of translation,BP,
9677,GO:0035279,1,0.9880633393777,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9678,GO:0035280,1,0.950858676212765,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9679,GO:0035281,1,0.986791264042693,0,2,pre-miRNA export from nucleus,BP,
9680,GO:0035282,1,0.559533314985493,0,83,segmentation,BP,
9681,GO:0035283,1,0.988210639735293,0,2,central nervous system segmentation,BP,
9682,GO:0035284,1,0.988210639735293,0,2,brain segmentation,BP,
9683,GO:0035290,1,0.980011151771409,0,3,trunk segmentation,BP,
9686,GO:0035299,1,0.992949991014312,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9690,GO:0035306,1,0.713600003813255,0,48,positive regulation of dephosphorylation,BP,
9691,GO:0035307,1,0.782956693315128,0,36,positive regulation of protein dephosphorylation,BP,
9693,GO:0035312,1,0.963670380612607,0,6,5'-3' exodeoxyribonuclease activity,MF,
9694,GO:0035313,1,0.892155472786902,0,14,wound healing, spreading of epidermal cells,BP,
9695,GO:0035315,1,0.77734323925189,0,36,hair cell differentiation,BP,
9696,GO:0035325,1,0.940747234599174,0,10,Toll-like receptor binding,MF,
9697,GO:0035326,1,0.509858648690623,0,100,enhancer binding,MF,
9698,GO:0035327,1,0.871944128787236,0,21,transcriptionally active chromatin,CC,
9699,GO:0035329,1,0.734637315243311,0,38,hippo signaling,BP,
9700,GO:0035330,1,0.911133353452065,0,11,regulation of hippo signaling,BP,
9701,GO:0035331,1,0.935114489569649,0,8,negative regulation of hippo signaling,BP,
9702,GO:0035332,1,0.978425310448971,0,2,positive regulation of hippo signaling,BP,
9703,GO:0035333,1,0.914870034044903,0,13,Notch receptor processing, ligand-dependent,BP,
9705,GO:0035336,1,0.875188532107902,0,22,long-chain fatty-acyl-CoA metabolic process,BP,
9706,GO:0035337,1,0.806380753875595,0,35,fatty-acyl-CoA metabolic process,BP,
9707,GO:0035338,1,0.907332376064235,0,16,long-chain fatty-acyl-CoA biosynthetic process,BP,
9708,GO:0035339,1,0.978848146576748,0,4,SPOTS complex,CC,
9709,GO:0035349,1,0.98316336736653,0,3,coenzyme A transmembrane transport,BP,
9710,GO:0035350,1,0.988743130114006,0,2,FAD transmembrane transport,BP,
9711,GO:0035352,1,0.994555591563614,0,1,NAD transmembrane transport,BP,
9712,GO:0035354,1,0.988182603174515,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9713,GO:0035355,1,0.991424923868559,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9714,GO:0035356,1,0.960612699637851,0,7,cellular triglyceride homeostasis,BP,
9715,GO:0035357,1,0.873371611205672,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9716,GO:0035358,1,0.926061488037843,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9717,GO:0035359,1,0.982606252574844,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9718,GO:0035360,1,0.954021222346347,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9719,GO:0035363,1,0.976883682235922,0,4,histone locus body,CC,
9720,GO:0035368,1,0.973825752431885,0,4,selenocysteine insertion sequence binding,MF,
9721,GO:0035370,1,0.988997948659449,0,2,UBC13-UEV1A complex,CC,
9722,GO:0035371,1,0.857288945497536,0,18,microtubule plus-end,CC,
9723,GO:0035372,1,0.910093865393155,0,13,protein localization to microtubule,BP,
9724,GO:0035373,1,0.97020170837604,0,3,chondroitin sulfate proteoglycan binding,MF,
9725,GO:0035374,1,0.957064441206422,0,6,chondroitin sulfate binding,MF,
9726,GO:0035375,1,0.989552924300286,0,1,zymogen binding,MF,
9727,GO:0035376,1,0.960212471559498,0,7,sterol import,BP,
9728,GO:0035377,1,0.985512715168311,0,2,transepithelial water transport,BP,
9729,GO:0035378,1,0.994325787082341,0,1,carbon dioxide transmembrane transport,BP,
9730,GO:0035379,1,0.994325787082341,0,1,carbon dioxide transmembrane transporter activity,MF,
9731,GO:0035381,1,0.953526633086097,0,8,ATP-gated ion channel activity,MF,
9732,GO:0035383,1,0.567713513347993,0,91,thioester metabolic process,BP,
9733,GO:0035384,1,0.741153266148195,0,46,thioester biosynthetic process,BP,
9734,GO:0035385,1,0.943925201734094,0,7,Roundabout signaling pathway,BP,
9735,GO:0035397,1,0.994098345805747,0,1,helper T cell enhancement of adaptive immune response,BP,
9736,GO:0035400,1,0.992027929434021,0,1,histone tyrosine kinase activity,MF,
9737,GO:0035401,1,0.992027929434021,0,1,histone kinase activity (H3-Y41 specific),MF,
9738,GO:0035402,1,0.988548979317479,0,2,histone kinase activity (H3-T11 specific),MF,
9739,GO:0035403,1,0.980538345091104,0,2,histone kinase activity (H3-T6 specific),MF,
9740,GO:0035404,1,0.927268390646064,0,12,histone-serine phosphorylation,BP,
9741,GO:0035405,1,0.964187731540582,0,5,histone-threonine phosphorylation,BP,
9742,GO:0035406,1,0.992027929434021,0,1,histone-tyrosine phosphorylation,BP,
9743,GO:0035407,1,0.988548979317479,0,2,histone H3-T11 phosphorylation,BP,
9744,GO:0035408,1,0.980538345091104,0,2,histone H3-T6 phosphorylation,BP,
9745,GO:0035409,1,0.992027929434021,0,1,histone H3-Y41 phosphorylation,BP,
9746,GO:0035410,1,0.994797329784172,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9748,GO:0035425,1,0.987365994995134,0,2,autocrine signaling,BP,
9749,GO:0035426,1,0.965095508724386,0,5,extracellular matrix-cell signaling,BP,
9750,GO:0035434,1,0.955815092406211,0,6,copper ion transmembrane transport,BP,
9751,GO:0035435,1,0.937507221531392,0,9,phosphate ion transmembrane transport,BP,
9752,GO:0035437,1,0.924388629282452,0,13,maintenance of protein localization in endoplasmic reticulum,BP,
9753,GO:0035438,1,0.99472354321251,0,1,cyclic-di-GMP binding,MF,
9754,GO:0035441,1,0.974276098891189,0,3,cell migration involved in vasculogenesis,BP,
9755,GO:0035442,1,0.989136565088683,0,2,dipeptide transmembrane transport,BP,
9756,GO:0035443,1,0.990869091843867,0,1,tripeptide transmembrane transport,BP,
9757,GO:0035445,1,0.994092649651812,0,1,borate transmembrane transport,BP,
9758,GO:0035455,1,0.87913052810557,0,20,response to interferon-alpha,BP,
9759,GO:0035456,1,0.891308994195306,0,20,response to interferon-beta,BP,
9760,GO:0035457,1,0.932674357065399,0,10,cellular response to interferon-alpha,BP,
9761,GO:0035458,1,0.925599010111795,0,13,cellular response to interferon-beta,BP,
9762,GO:0035459,1,0.873872636762516,0,20,cargo loading into vesicle,BP,
9763,GO:0035461,1,0.919416533472928,0,11,vitamin transmembrane transport,BP,
9764,GO:0035469,1,0.966625679134257,0,5,determination of pancreatic left/right asymmetry,BP,
9765,GO:0035470,1,0.989451524739995,0,2,positive regulation of vascular wound healing,BP,
9766,GO:0035473,1,0.966133967179166,0,4,lipase binding,MF,
9767,GO:0035480,1,0.994804610227398,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9768,GO:0035481,1,0.994804610227398,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9770,GO:0035483,1,0.98458022639415,0,3,gastric emptying,BP,
9771,GO:0035485,1,0.994688018940532,0,1,adenine/guanine mispair binding,MF,
9774,GO:0035493,1,0.911388788869333,0,15,SNARE complex assembly,BP,
9775,GO:0035494,1,0.982554394449031,0,3,SNARE complex disassembly,BP,
9776,GO:0035497,1,0.917514194274695,0,13,cAMP response element binding,MF,
9777,GO:0035498,1,0.993386348085117,0,1,carnosine metabolic process,BP,
9778,GO:0035499,1,0.993386348085117,0,1,carnosine biosynthetic process,BP,
9779,GO:0035500,1,0.987880115487434,0,2,MH2 domain binding,MF,
9780,GO:0035501,1,0.994281782907077,0,1,MH1 domain binding,MF,
9781,GO:0035502,1,0.970332274955783,0,5,metanephric part of ureteric bud development,BP,
9782,GO:0035504,1,0.994759422258622,0,1,regulation of myosin light chain kinase activity,BP,
9783,GO:0035505,1,0.994759422258622,0,1,positive regulation of myosin light chain kinase activity,BP,
9784,GO:0035507,1,0.946414190728706,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9785,GO:0035508,1,0.991713579244886,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9786,GO:0035509,1,0.963537842269821,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9787,GO:0035510,1,0.821531588021267,0,28,DNA dealkylation,BP,
9788,GO:0035511,1,0.971370705367289,0,5,oxidative DNA demethylation,BP,
9789,GO:0035513,1,0.97628664299971,0,4,oxidative RNA demethylation,BP,
9790,GO:0035514,1,0.982729765771587,0,3,DNA demethylase activity,MF,
9791,GO:0035515,1,0.97628664299971,0,4,oxidative RNA demethylase activity,MF,
9792,GO:0035516,1,0.99306269615796,0,1,oxidative DNA demethylase activity,MF,
9793,GO:0035517,1,0.967096321247326,0,4,PR-DUB complex,CC,
9794,GO:0035518,1,0.896636546007525,0,16,histone H2A monoubiquitination,BP,
9795,GO:0035519,1,0.975500411807221,0,4,protein K29-linked ubiquitination,BP,
9796,GO:0035520,1,0.935884658337956,0,9,monoubiquitinated protein deubiquitination,BP,
9797,GO:0035521,1,0.975817244606366,0,4,monoubiquitinated histone deubiquitination,BP,
9798,GO:0035522,1,0.975817244606366,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9799,GO:0035523,1,0.972977549406787,0,3,protein K29-linked deubiquitination,BP,
9800,GO:0035524,1,0.965069151551866,0,5,proline transmembrane transport,BP,
9801,GO:0035525,1,0.994418462131223,0,1,NF-kappaB p50/p65 complex,CC,
9802,GO:0035526,1,0.985687739793073,0,2,retrograde transport, plasma membrane to Golgi,BP,
9803,GO:0035529,1,0.957489490920862,0,7,NADH pyrophosphatase activity,MF,
9804,GO:0035538,1,0.993987395007494,0,1,carbohydrate response element binding,MF,
9805,GO:0035539,1,0.989500643655537,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9806,GO:0035542,1,0.943907637999533,0,9,regulation of SNARE complex assembly,BP,
9807,GO:0035544,1,0.980154231365031,0,3,negative regulation of SNARE complex assembly,BP,
9808,GO:0035545,1,0.993407837135653,0,1,determination of left/right asymmetry in nervous system,BP,
9809,GO:0035546,1,0.959783334521091,0,5,interferon-beta secretion,BP,
9810,GO:0035547,1,0.959783334521091,0,5,regulation of interferon-beta secretion,BP,
9811,GO:0035548,1,0.994260248918568,0,1,negative regulation of interferon-beta secretion,BP,
9812,GO:0035549,1,0.965326014728013,0,4,positive regulation of interferon-beta secretion,BP,
9813,GO:0035552,1,0.982327179219101,0,3,oxidative single-stranded DNA demethylation,BP,
9814,GO:0035553,1,0.981771106355893,0,3,oxidative single-stranded RNA demethylation,BP,
9816,GO:0035561,1,0.874236813826101,0,21,regulation of chromatin binding,BP,
9817,GO:0035562,1,0.951257919216981,0,7,negative regulation of chromatin binding,BP,
9818,GO:0035563,1,0.924758082528454,0,13,positive regulation of chromatin binding,BP,
9819,GO:0035564,1,0.981343473192247,0,2,regulation of kidney size,BP,
9820,GO:0035566,1,0.993240355502953,0,1,regulation of metanephros size,BP,
9821,GO:0035567,1,0.363966369664842,0,150,non-canonical Wnt signaling pathway,BP,
9822,GO:0035568,1,0.994313214468247,0,1,N-terminal peptidyl-proline methylation,BP,
9823,GO:0035570,1,0.994313214468247,0,1,N-terminal peptidyl-serine methylation,BP,
9824,GO:0035572,1,0.994313214468247,0,1,N-terminal peptidyl-serine dimethylation,BP,
9825,GO:0035573,1,0.994313214468247,0,1,N-terminal peptidyl-serine trimethylation,BP,
9826,GO:0035574,1,0.985580163967885,0,2,histone H4-K20 demethylation,BP,
9827,GO:0035575,1,0.985580163967885,0,2,histone demethylase activity (H4-K20 specific),MF,
9828,GO:0035577,1,0.694334736493757,0,56,azurophil granule membrane,CC,
9832,GO:0035581,1,0.937518903453043,0,8,sequestering of extracellular ligand from receptor,BP,
9833,GO:0035582,1,0.970182034651384,0,4,sequestering of BMP in extracellular matrix,BP,
9834,GO:0035583,1,0.964884714224732,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9835,GO:0035584,1,0.882261106914023,0,18,calcium-mediated signaling using intracellular calcium source,BP,
9836,GO:0035585,1,0.978553038440066,0,2,calcium-mediated signaling using extracellular calcium source,BP,
9837,GO:0035586,1,0.88034763916125,0,23,purinergic receptor activity,MF,
9838,GO:0035587,1,0.840722634137774,0,30,purinergic receptor signaling pathway,BP,
9839,GO:0035588,1,0.880478272267683,0,22,G-protein coupled purinergic receptor signaling pathway,BP,
9840,GO:0035589,1,0.930491997285683,0,13,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9841,GO:0035590,1,0.888500815181839,0,21,purinergic nucleotide receptor signaling pathway,BP,
9843,GO:0035594,1,0.977543347401813,0,4,ganglioside binding,MF,
9844,GO:0035596,1,0.988640577376153,0,2,methylthiotransferase activity,MF,
9845,GO:0035597,1,0.994637654093806,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9846,GO:0035598,1,0.993970914998405,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9847,GO:0035600,1,0.988640577376153,0,2,tRNA methylthiolation,BP,
9848,GO:0035601,1,0.482073873505935,0,105,protein deacylation,BP,
9849,GO:0035602,1,0.99325376785794,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9850,GO:0035603,1,0.99325376785794,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9851,GO:0035604,1,0.99325376785794,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9852,GO:0035605,1,0.994786785076571,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9853,GO:0035606,1,0.989651804580845,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9854,GO:0035607,1,0.984980765126947,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9855,GO:0035608,1,0.958797749844308,0,7,protein deglutamylation,BP,
9856,GO:0035609,1,0.976362101648393,0,4,C-terminal protein deglutamylation,BP,
9857,GO:0035610,1,0.97496488034351,0,4,protein side chain deglutamylation,BP,
9858,GO:0035611,1,0.994272749901274,0,1,protein branching point deglutamylation,BP,
9859,GO:0035612,1,0.93125923036363,0,8,AP-2 adaptor complex binding,MF,
9860,GO:0035613,1,0.898858182947073,0,15,RNA stem-loop binding,MF,
9861,GO:0035614,1,0.983800371711736,0,3,snRNA stem-loop binding,MF,
9862,GO:0035615,1,0.927943003783169,0,11,clathrin adaptor activity,MF,
9863,GO:0035616,1,0.978813815164244,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9864,GO:0035617,1,0.980535389189218,0,3,stress granule disassembly,BP,
9865,GO:0035620,1,0.973671865197717,0,4,ceramide transporter activity,MF,
9866,GO:0035621,1,0.986612627502007,0,2,ER to Golgi ceramide transport,BP,
9867,GO:0035622,1,0.993418082828812,0,1,intrahepatic bile duct development,BP,
9868,GO:0035623,1,0.994000696299458,0,1,renal glucose absorption,BP,
9869,GO:0035624,1,0.971420701449479,0,4,receptor transactivation,BP,
9870,GO:0035625,1,0.981976934587355,0,3,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9871,GO:0035627,1,0.951968403401954,0,7,ceramide transport,BP,
9873,GO:0035631,1,0.936998028790968,0,11,CD40 receptor complex,CC,
9874,GO:0035633,1,0.973375728276287,0,4,maintenance of permeability of blood-brain barrier,BP,
9875,GO:0035634,1,0.980505524908929,0,3,response to stilbenoid,BP,
9876,GO:0035635,1,0.879674018970998,0,18,entry of bacterium into host cell,BP,
9878,GO:0035638,1,0.99260921688863,0,1,signal maturation,BP,
9882,GO:0035642,1,0.994187537627371,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9883,GO:0035643,1,0.994721628008858,0,1,L-DOPA receptor activity,MF,
9884,GO:0035644,1,0.994167867684156,0,1,phosphoanandamide dephosphorylation,BP,
9885,GO:0035645,1,0.993072511536609,0,1,enteric smooth muscle cell differentiation,BP,
9886,GO:0035646,1,0.939439639580976,0,10,endosome to melanosome transport,BP,
9887,GO:0035650,1,0.977430468952968,0,4,AP-1 adaptor complex binding,MF,
9888,GO:0035651,1,0.982837598961356,0,3,AP-3 adaptor complex binding,MF,
9889,GO:0035655,1,0.955716570106431,0,8,interleukin-18-mediated signaling pathway,BP,
9890,GO:0035658,1,0.983005336432223,0,3,Mon1-Ccz1 complex,CC,
9891,GO:0035659,1,0.994718608345621,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9892,GO:0035662,1,0.984462705236617,0,3,Toll-like receptor 4 binding,MF,
9893,GO:0035663,1,0.98052088927369,0,3,Toll-like receptor 2 binding,MF,
9894,GO:0035664,1,0.994702522107098,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9895,GO:0035665,1,0.994702522107098,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9896,GO:0035666,1,0.852591437230304,0,27,TRIF-dependent toll-like receptor signaling pathway,BP,
9897,GO:0035668,1,0.986020157625828,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9898,GO:0035669,1,0.986020157625828,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9899,GO:0035671,1,0.983817928950286,0,3,enone reductase activity,MF,
9900,GO:0035672,1,0.959856006615236,0,6,oligopeptide transmembrane transport,BP,
9901,GO:0035673,1,0.970401046443782,0,4,oligopeptide transmembrane transporter activity,MF,
9902,GO:0035674,1,0.988790570553163,0,2,tricarboxylic acid transmembrane transport,BP,
9903,GO:0035675,1,0.994383550341847,0,1,neuromast hair cell development,BP,
9905,GO:0035686,1,0.977221019934874,0,4,sperm fibrous sheath,CC,
9907,GO:0035691,1,0.987840347175557,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9908,GO:0035692,1,0.987184343619382,0,2,macrophage migration inhibitory factor receptor complex,CC,
9909,GO:0035693,1,0.994786913167145,0,1,NOS2-CD74 complex,CC,
9910,GO:0035694,1,0.975218188515266,0,4,mitochondrial protein catabolic process,BP,
9911,GO:0035695,1,0.993050902154568,0,1,mitophagy by induced vacuole formation,BP,
9912,GO:0035696,1,0.978445395617349,0,3,monocyte extravasation,BP,
9913,GO:0035697,1,0.983895509572644,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9914,GO:0035698,1,0.989381009148301,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9915,GO:0035700,1,0.989188515777733,0,2,astrocyte chemotaxis,BP,
9916,GO:0035701,1,0.958192629285431,0,6,hematopoietic stem cell migration,BP,
9917,GO:0035704,1,0.99445621570624,0,1,helper T cell chemotaxis,BP,
9918,GO:0035705,1,0.99445621570624,0,1,T-helper 17 cell chemotaxis,BP,
9919,GO:0035708,1,0.993802399849716,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9920,GO:0035709,1,0.988413891079859,0,2,memory T cell activation,BP,
9922,GO:0035711,1,0.988686410650513,0,2,T-helper 1 cell activation,BP,
9923,GO:0035712,1,0.987815658365665,0,2,T-helper 2 cell activation,BP,
9924,GO:0035713,1,0.993802399849716,0,1,response to nitrogen dioxide,BP,
9925,GO:0035715,1,0.99445621570624,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9926,GO:0035716,1,0.99445621570624,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9927,GO:0035717,1,0.988856925284829,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9928,GO:0035718,1,0.989575195774172,0,2,macrophage migration inhibitory factor binding,MF,
9929,GO:0035720,1,0.979352224977855,0,3,intraciliary anterograde transport,BP,
9930,GO:0035721,1,0.911672348048759,0,12,intraciliary retrograde transport,BP,
9932,GO:0035723,1,0.915261211787561,0,13,interleukin-15-mediated signaling pathway,BP,
9933,GO:0035724,1,0.990477206308103,0,1,CD24 biosynthetic process,BP,
9935,GO:0035726,1,0.955595253845432,0,7,common myeloid progenitor cell proliferation,BP,
9936,GO:0035727,1,0.972092771798932,0,5,lysophosphatidic acid binding,MF,
9937,GO:0035728,1,0.894499110865939,0,16,response to hepatocyte growth factor,BP,
9938,GO:0035729,1,0.909073303470742,0,14,cellular response to hepatocyte growth factor stimulus,BP,
9939,GO:0035730,1,0.994821143304119,0,1,S-nitrosoglutathione binding,MF,
9940,GO:0035731,1,0.994821143304119,0,1,dinitrosyl-iron complex binding,MF,
9941,GO:0035732,1,0.994821143304119,0,1,nitric oxide storage,BP,
9942,GO:0035733,1,0.956620848179927,0,7,hepatic stellate cell activation,BP,
9943,GO:0035735,1,0.756004643504272,0,40,intraciliary transport involved in cilium assembly,BP,
9944,GO:0035739,1,0.965211694312323,0,6,CD4-positive, alpha-beta T cell proliferation,BP,
9945,GO:0035740,1,0.9833600031658,0,3,CD8-positive, alpha-beta T cell proliferation,BP,
9946,GO:0035743,1,0.924295054165622,0,14,CD4-positive, alpha-beta T cell cytokine production,BP,
9947,GO:0035744,1,0.978910487417772,0,4,T-helper 1 cell cytokine production,BP,
9948,GO:0035745,1,0.944727248998776,0,10,T-helper 2 cell cytokine production,BP,
9949,GO:0035746,1,0.994797996453385,0,1,granzyme A production,BP,
9951,GO:0035748,1,0.959654665784394,0,6,myelin sheath abaxonal region,CC,
9953,GO:0035750,1,0.99196260956886,0,1,protein localization to myelin sheath abaxonal region,BP,
9954,GO:0035751,1,0.931196651861055,0,12,regulation of lysosomal lumen pH,BP,
9955,GO:0035752,1,0.994672144724322,0,1,lysosomal lumen pH elevation,BP,
9956,GO:0035754,1,0.953770862701328,0,8,B cell chemotaxis,BP,
9957,GO:0035755,1,0.994421678734291,0,1,cardiolipin hydrolase activity,MF,
9958,GO:0035757,1,0.994590650166733,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9959,GO:0035758,1,0.994590650166733,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9960,GO:0035759,1,0.989201567059358,0,2,mesangial cell-matrix adhesion,BP,
9961,GO:0035766,1,0.965707956149808,0,5,cell chemotaxis to fibroblast growth factor,BP,
9962,GO:0035767,1,0.848322793135049,0,23,endothelial cell chemotaxis,BP,
9963,GO:0035768,1,0.965707956149808,0,5,endothelial cell chemotaxis to fibroblast growth factor,BP,
9965,GO:0035771,1,0.954349781180528,0,7,interleukin-4-mediated signaling pathway,BP,
9966,GO:0035772,1,0.994708105758453,0,1,interleukin-13-mediated signaling pathway,BP,
9967,GO:0035773,1,0.698759494198457,0,55,insulin secretion involved in cellular response to glucose stimulus,BP,
9968,GO:0035774,1,0.862011223331517,0,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9969,GO:0035782,1,0.994797996453385,0,1,mature natural killer cell chemotaxis,BP,
9970,GO:0035783,1,0.993802399849716,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
9971,GO:0035787,1,0.972409399146475,0,4,cell migration involved in kidney development,BP,
9972,GO:0035788,1,0.98027118327346,0,3,cell migration involved in metanephros development,BP,
9973,GO:0035789,1,0.98027118327346,0,3,metanephric mesenchymal cell migration,BP,
9974,GO:0035790,1,0.984232223732074,0,2,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9975,GO:0035791,1,0.901029580149376,0,13,platelet-derived growth factor receptor-beta signaling pathway,BP,
9976,GO:0035793,1,0.98027118327346,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9977,GO:0035794,1,0.708013204029539,0,59,positive regulation of mitochondrial membrane permeability,BP,
9978,GO:0035795,1,0.969555765209962,0,5,negative regulation of mitochondrial membrane permeability,BP,
9979,GO:0035799,1,0.974044907924232,0,4,ureter maturation,BP,
9980,GO:0035800,1,0.988278679129672,0,2,deubiquitinase activator activity,MF,
9981,GO:0035801,1,0.98890247535475,0,2,adrenal cortex development,BP,
9982,GO:0035802,1,0.98890247535475,0,2,adrenal cortex formation,BP,
9983,GO:0035803,1,0.989572879555717,0,2,egg coat formation,BP,
9984,GO:0035805,1,0.99456240023169,0,1,egg coat,CC,
9986,GO:0035810,1,0.929266044891476,0,12,positive regulation of urine volume,BP,
9987,GO:0035811,1,0.980708293553549,0,3,negative regulation of urine volume,BP,
9988,GO:0035812,1,0.909687152391926,0,16,renal sodium excretion,BP,
9989,GO:0035813,1,0.909687152391926,0,16,regulation of renal sodium excretion,BP,
9990,GO:0035814,1,0.972976951251872,0,5,negative regulation of renal sodium excretion,BP,
9991,GO:0035815,1,0.947325485837548,0,9,positive regulation of renal sodium excretion,BP,
9993,GO:0035822,1,0.967446677583914,0,5,gene conversion,BP,
9994,GO:0035825,1,0.75216244880633,0,44,homologous recombination,BP,
9995,GO:0035838,1,0.976386861225867,0,3,growing cell tip,CC,
9996,GO:0035841,1,0.98310643155212,0,2,new growing cell tip,CC,
9997,GO:0035844,1,0.974103497667969,0,4,cloaca development,BP,
9999,GO:0035850,1,0.745970992338473,0,41,epithelial cell differentiation involved in kidney development,BP,
10000,GO:0035851,1,0.9941921545894,0,1,Krueppel-associated box domain binding,MF,
10001,GO:0035853,1,0.992874072573217,0,1,chromosome passenger complex localization to spindle midzone,BP,
10002,GO:0035854,1,0.988691014725559,0,2,eosinophil fate commitment,BP,
10003,GO:0035855,1,0.896582586911244,0,15,megakaryocyte development,BP,
10004,GO:0035859,1,0.926160597563489,0,13,Seh1-associated complex,CC,
10005,GO:0035860,1,0.961712917706201,0,5,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
10006,GO:0035861,1,0.815417677118288,0,30,site of double-strand break,CC,
10007,GO:0035862,1,0.991266113753993,0,1,dITP metabolic process,BP,
10008,GO:0035863,1,0.991266113753993,0,1,dITP catabolic process,BP,
10009,GO:0035864,1,0.934532780806261,0,10,response to potassium ion,BP,
10010,GO:0035865,1,0.959213655671011,0,6,cellular response to potassium ion,BP,
10011,GO:0035866,1,0.971523443735563,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
10012,GO:0035867,1,0.959546983773509,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10013,GO:0035868,1,0.976798105017961,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
10014,GO:0035869,1,0.677251272799773,0,58,ciliary transition zone,CC,
10015,GO:0035870,1,0.986120955320621,0,2,dITP diphosphatase activity,MF,
10016,GO:0035871,1,0.936022827044639,0,8,protein K11-linked deubiquitination,BP,
10017,GO:0035872,1,0.796861227982158,0,35,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10018,GO:0035873,1,0.960988107625911,0,6,lactate transmembrane transport,BP,
10019,GO:0035877,1,0.975533134064643,0,4,death effector domain binding,MF,
10020,GO:0035878,1,0.95040915160318,0,8,nail development,BP,
10021,GO:0035879,1,0.98101335123471,0,3,plasma membrane lactate transport,BP,
10022,GO:0035880,1,0.982900887507302,0,3,embryonic nail plate morphogenesis,BP,
10023,GO:0035881,1,0.959291710372547,0,7,amacrine cell differentiation,BP,
10024,GO:0035883,1,0.844392247560601,0,25,enteroendocrine cell differentiation,BP,
10026,GO:0035887,1,0.994711632107073,0,1,aortic smooth muscle cell differentiation,BP,
10027,GO:0035890,1,0.811737459688886,0,33,exit from host,BP,
10028,GO:0035891,1,0.811737459688886,0,33,exit from host cell,BP,
10029,GO:0035897,1,0.966340965692296,0,6,proteolysis in other organism,BP,
10030,GO:0035898,1,0.980596582929538,0,3,parathyroid hormone secretion,BP,
10031,GO:0035900,1,0.963298424251319,0,6,response to isolation stress,BP,
10032,GO:0035902,1,0.885140502131081,0,19,response to immobilization stress,BP,
10034,GO:0035905,1,0.974009422989669,0,4,ascending aorta development,BP,
10035,GO:0035907,1,0.946553609970484,0,9,dorsal aorta development,BP,
10037,GO:0035910,1,0.974009422989669,0,4,ascending aorta morphogenesis,BP,
10038,GO:0035912,1,0.952295681872602,0,8,dorsal aorta morphogenesis,BP,
10039,GO:0035914,1,0.661457900353396,0,61,skeletal muscle cell differentiation,BP,
10040,GO:0035915,1,0.98439339167185,0,3,pore formation in membrane of other organism,BP,
10041,GO:0035921,1,0.994615292566471,0,1,desmosome disassembly,BP,
10042,GO:0035922,1,0.994741695325515,0,1,foramen ovale closure,BP,
10044,GO:0035925,1,0.923835757016976,0,12,mRNA 3'-UTR AU-rich region binding,MF,
10046,GO:0035927,1,0.976480530428392,0,4,RNA import into mitochondrion,BP,
10047,GO:0035928,1,0.982484649179539,0,3,rRNA import into mitochondrion,BP,
10048,GO:0035929,1,0.898250271999086,0,18,steroid hormone secretion,BP,
10049,GO:0035930,1,0.927662068943004,0,13,corticosteroid hormone secretion,BP,
10050,GO:0035931,1,0.977586174181281,0,4,mineralocorticoid secretion,BP,
10051,GO:0035932,1,0.977586174181281,0,4,aldosterone secretion,BP,
10052,GO:0035933,1,0.948942535400448,0,9,glucocorticoid secretion,BP,
10053,GO:0035934,1,0.978982533398333,0,4,corticosterone secretion,BP,
10054,GO:0035935,1,0.993973223617764,0,1,androgen secretion,BP,
10055,GO:0035936,1,0.984372617208178,0,2,testosterone secretion,BP,
10057,GO:0035939,1,0.982257508999363,0,3,microsatellite binding,MF,
10058,GO:0035945,1,0.994463621833979,0,1,mitochondrial ncRNA surveillance,BP,
10059,GO:0035946,1,0.994463621833979,0,1,mitochondrial mRNA surveillance,BP,
10060,GO:0035947,1,0.967021127931247,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10061,GO:0035948,1,0.980815595888635,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10062,GO:0035962,1,0.982666274721851,0,3,response to interleukin-13,BP,
10063,GO:0035963,1,0.982666274721851,0,3,cellular response to interleukin-13,BP,
10064,GO:0035964,1,0.962671013285299,0,6,COPI-coated vesicle budding,BP,
10065,GO:0035965,1,0.970361493303369,0,5,cardiolipin acyl-chain remodeling,BP,
10068,GO:0035970,1,0.903633186720676,0,16,peptidyl-threonine dephosphorylation,BP,
10069,GO:0035971,1,0.994797996453385,0,1,peptidyl-histidine dephosphorylation,BP,
10070,GO:0035973,1,0.948013058249971,0,7,aggrephagy,BP,
10071,GO:0035976,1,0.97303221028969,0,5,transcription factor AP-1 complex,CC,
10072,GO:0035977,1,0.971065754094431,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10073,GO:0035978,1,0.994281782907077,0,1,histone H2A-S139 phosphorylation,BP,
10074,GO:0035981,1,0.987620194965483,0,2,tongue muscle cell differentiation,BP,
10075,GO:0035983,1,0.973720017607324,0,4,response to trichostatin A,BP,
10076,GO:0035984,1,0.973720017607324,0,4,cellular response to trichostatin A,BP,
10077,GO:0035985,1,0.978601891336601,0,4,senescence-associated heterochromatin focus,CC,
10078,GO:0035986,1,0.983825484499136,0,3,senescence-associated heterochromatin focus assembly,BP,
10081,GO:0035989,1,0.963391283514448,0,5,tendon development,BP,
10082,GO:0035990,1,0.984215827574766,0,3,tendon cell differentiation,BP,
10083,GO:0035992,1,0.984215827574766,0,3,tendon formation,BP,
10084,GO:0035993,1,0.989298130100755,0,2,deltoid tuberosity development,BP,
10085,GO:0035994,1,0.857004378367115,0,18,response to muscle stretch,BP,
10086,GO:0035995,1,0.954917576490426,0,3,detection of muscle stretch,BP,
10087,GO:0035998,1,0.994658631603326,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10088,GO:0035999,1,0.946698793168452,0,9,tetrahydrofolate interconversion,BP,
10089,GO:0036002,1,0.797122817675709,0,35,pre-mRNA binding,MF,
10090,GO:0036003,1,0.854842578003776,0,25,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10091,GO:0036004,1,0.994796543747813,0,1,GAF domain binding,MF,
10092,GO:0036005,1,0.952183145462666,0,8,response to macrophage colony-stimulating factor,BP,
10093,GO:0036006,1,0.952183145462666,0,8,cellular response to macrophage colony-stimulating factor stimulus,BP,
10094,GO:0036009,1,0.994803505452008,0,1,protein-glutamine N-methyltransferase activity,MF,
10095,GO:0036010,1,0.878503888534683,0,18,protein localization to endosome,BP,
10096,GO:0036015,1,0.972363867601054,0,4,response to interleukin-3,BP,
10097,GO:0036016,1,0.972363867601054,0,4,cellular response to interleukin-3,BP,
10098,GO:0036017,1,0.961533145352217,0,7,response to erythropoietin,BP,
10099,GO:0036018,1,0.966520896136276,0,6,cellular response to erythropoietin,BP,
10100,GO:0036019,1,0.878163859751383,0,19,endolysosome,CC,
10101,GO:0036020,1,0.904685260034869,0,14,endolysosome membrane,CC,
10102,GO:0036021,1,0.970713309667047,0,5,endolysosome lumen,CC,
10103,GO:0036022,1,0.983315522615845,0,3,limb joint morphogenesis,BP,
10104,GO:0036023,1,0.983315522615845,0,3,embryonic skeletal limb joint morphogenesis,BP,
10105,GO:0036024,1,0.994536892262681,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10106,GO:0036025,1,0.994536892262681,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10107,GO:0036026,1,0.994536892262681,0,1,protein C inhibitor-PLAT complex,CC,
10108,GO:0036027,1,0.994536892262681,0,1,protein C inhibitor-PLAU complex,CC,
10109,GO:0036028,1,0.994536892262681,0,1,protein C inhibitor-thrombin complex,CC,
10110,GO:0036029,1,0.994536892262681,0,1,protein C inhibitor-KLK3 complex,CC,
10111,GO:0036030,1,0.994536892262681,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10112,GO:0036033,1,0.957745218177476,0,4,mediator complex binding,MF,
10113,GO:0036034,1,0.988920712607725,0,2,mediator complex assembly,BP,
10115,GO:0036037,1,0.926113452957601,0,13,CD8-positive, alpha-beta T cell activation,BP,
10116,GO:0036038,1,0.92266060014212,0,13,MKS complex,CC,
10117,GO:0036041,1,0.95249473229914,0,9,long-chain fatty acid binding,MF,
10118,GO:0036042,1,0.978821157053851,0,4,long-chain fatty acyl-CoA binding,MF,
10119,GO:0036046,1,0.994067456491409,0,1,protein demalonylation,BP,
10120,GO:0036047,1,0.994067456491409,0,1,peptidyl-lysine demalonylation,BP,
10121,GO:0036048,1,0.994067456491409,0,1,protein desuccinylation,BP,
10122,GO:0036049,1,0.994067456491409,0,1,peptidyl-lysine desuccinylation,BP,
10123,GO:0036053,1,0.99434619940342,0,1,glomerular endothelium fenestra,CC,
10124,GO:0036054,1,0.994067456491409,0,1,protein-malonyllysine demalonylase activity,MF,
10125,GO:0036055,1,0.994067456491409,0,1,protein-succinyllysine desuccinylase activity,MF,
10126,GO:0036056,1,0.944958705284847,0,7,filtration diaphragm,CC,
10127,GO:0036057,1,0.944958705284847,0,7,slit diaphragm,CC,
10128,GO:0036058,1,0.993318053458875,0,1,filtration diaphragm assembly,BP,
10129,GO:0036060,1,0.993318053458875,0,1,slit diaphragm assembly,BP,
10130,GO:0036064,1,0.500714201309177,0,101,ciliary basal body,CC,
10132,GO:0036066,1,0.909065430280818,0,14,protein O-linked fucosylation,BP,
10133,GO:0036071,1,0.993963198486243,0,1,N-glycan fucosylation,BP,
10136,GO:0036080,1,0.984526782854038,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
10137,GO:0036085,1,0.994023259389389,0,1,GDP-fucose import into Golgi lumen,BP,
10138,GO:0036088,1,0.994741410542591,0,1,D-serine catabolic process,BP,
10139,GO:0036089,1,0.955503713939867,0,7,cleavage furrow formation,BP,
10140,GO:0036090,1,0.989308140636091,0,2,cleavage furrow ingression,BP,
10141,GO:0036091,1,0.965100862154175,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10142,GO:0036092,1,0.711424771255024,0,44,phosphatidylinositol-3-phosphate biosynthetic process,BP,
10143,GO:0036093,1,0.968106096225629,0,6,germ cell proliferation,BP,
10145,GO:0036100,1,0.988920929278005,0,2,leukotriene catabolic process,BP,
10146,GO:0036101,1,0.988920929278005,0,2,leukotriene B4 catabolic process,BP,
10147,GO:0036102,1,0.988920929278005,0,2,leukotriene B4 metabolic process,BP,
10148,GO:0036105,1,0.993694882327013,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10149,GO:0036109,1,0.927266833979926,0,12,alpha-linolenic acid metabolic process,BP,
10150,GO:0036111,1,0.994360132791974,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10151,GO:0036112,1,0.98339758144267,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10152,GO:0036114,1,0.994754228421442,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10153,GO:0036115,1,0.994754228421442,0,1,fatty-acyl-CoA catabolic process,BP,
10154,GO:0036116,1,0.994754228421442,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10155,GO:0036117,1,0.989041566890673,0,2,hyaluranon cable,CC,
10156,GO:0036118,1,0.982429774209115,0,3,hyaluranon cable assembly,BP,
10157,GO:0036119,1,0.857145234177156,0,21,response to platelet-derived growth factor,BP,
10158,GO:0036120,1,0.862156512789246,0,20,cellular response to platelet-derived growth factor stimulus,BP,
10159,GO:0036122,1,0.94092503540252,0,9,BMP binding,MF,
10160,GO:0036123,1,0.965517264508797,0,6,histone H3-K9 dimethylation,BP,
10161,GO:0036124,1,0.900749391261909,0,14,histone H3-K9 trimethylation,BP,
10162,GO:0036125,1,0.994138245464926,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10163,GO:0036126,1,0.674681426969952,0,64,sperm flagellum,CC,
10164,GO:0036128,1,0.960420943179076,0,7,CatSper complex,CC,
10165,GO:0036130,1,0.994797329784172,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10166,GO:0036131,1,0.994797329784172,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10167,GO:0036132,1,0.981170754489103,0,3,13-prostaglandin reductase activity,MF,
10168,GO:0036134,1,0.994609871305069,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10169,GO:0036135,1,0.984406012703786,0,2,Schwann cell migration,BP,
10170,GO:0036137,1,0.989078583877304,0,2,kynurenine aminotransferase activity,MF,
10171,GO:0036138,1,0.990349864977928,0,1,peptidyl-histidine hydroxylation,BP,
10172,GO:0036139,1,0.990349864977928,0,1,peptidyl-histidine dioxygenase activity,MF,
10173,GO:0036140,1,0.990349864977928,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10174,GO:0036143,1,0.994827848682047,0,1,kringle domain binding,MF,
10175,GO:0036145,1,0.994703228331935,0,1,dendritic cell homeostasis,BP,
10176,GO:0036146,1,0.971035442160038,0,5,cellular response to mycotoxin,BP,
10182,GO:0036153,1,0.994293380968546,0,1,triglyceride acyl-chain remodeling,BP,
10183,GO:0036155,1,0.970309468451567,0,5,acylglycerol acyl-chain remodeling,BP,
10184,GO:0036156,1,0.944161570642933,0,4,inner dynein arm,CC,
10185,GO:0036157,1,0.925745632437974,0,9,outer dynein arm,CC,
10186,GO:0036158,1,0.889889284423132,0,16,outer dynein arm assembly,BP,
10187,GO:0036159,1,0.891518184016421,0,14,inner dynein arm assembly,BP,
10188,GO:0036164,1,0.994810097397024,0,1,cell-abiotic substrate adhesion,BP,
10189,GO:0036166,1,0.969363241030828,0,4,phenotypic switching,BP,
10190,GO:0036179,1,0.994324084621906,0,1,osteoclast maturation,BP,
10191,GO:0036194,1,0.984333982070312,0,3,muscle cell projection,CC,
10192,GO:0036195,1,0.984333982070312,0,3,muscle cell projection membrane,CC,
10194,GO:0036213,1,0.994586434910566,0,1,contractile ring contraction,BP,
10195,GO:0036215,1,0.986395270501289,0,2,response to stem cell factor,BP,
10196,GO:0036216,1,0.986395270501289,0,2,cellular response to stem cell factor stimulus,BP,
10197,GO:0036219,1,0.994834055115578,0,1,GTP diphosphatase activity,MF,
10198,GO:0036220,1,0.994809962505009,0,1,ITP diphosphatase activity,MF,
10199,GO:0036222,1,0.994809962505009,0,1,XTP diphosphatase activity,MF,
10200,GO:0036228,1,0.987605934566092,0,2,protein localization to nuclear inner membrane,BP,
10202,GO:0036245,1,0.98730648329668,0,2,cellular response to menadione,BP,
10203,GO:0036250,1,0.994665749980841,0,1,peroxisome transport along microtubule,BP,
10204,GO:0036255,1,0.993507489775592,0,1,response to methylamine,BP,
10205,GO:0036257,1,0.834416741780968,0,31,multivesicular body organization,BP,
10206,GO:0036258,1,0.839210964254994,0,30,multivesicular body assembly,BP,
10207,GO:0036260,1,0.824517697089179,0,32,RNA capping,BP,
10208,GO:0036261,1,0.993623499440701,0,1,7-methylguanosine cap hypermethylation,BP,
10209,GO:0036265,1,0.97562342704186,0,4,RNA (guanine-N7)-methylation,BP,
10210,GO:0036266,1,0.994432201029796,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10211,GO:0036269,1,0.985834755845653,0,2,swimming behavior,BP,
10212,GO:0036270,1,0.853751664799339,0,18,response to diuretic,BP,
10213,GO:0036284,1,0.98441628358418,0,2,tubulobulbar complex,CC,
10214,GO:0036289,1,0.949338787895938,0,7,peptidyl-serine autophosphorylation,BP,
10215,GO:0036290,1,0.993326102345204,0,1,protein trans-autophosphorylation,BP,
10218,GO:0036294,1,0.2874366378469,0,190,cellular response to decreased oxygen levels,BP,
10219,GO:0036295,1,0.920617530340542,0,13,cellular response to increased oxygen levels,BP,
10221,GO:0036297,1,0.755636086421971,0,44,interstrand cross-link repair,BP,
10222,GO:0036301,1,0.971740326877283,0,5,macrophage colony-stimulating factor production,BP,
10223,GO:0036302,1,0.944021171886218,0,7,atrioventricular canal development,BP,
10225,GO:0036304,1,0.988944109164873,0,2,umbilical cord morphogenesis,BP,
10226,GO:0036306,1,0.994741695325515,0,1,embryonic heart tube elongation,BP,
10227,GO:0036309,1,0.96707245531051,0,2,protein localization to M-band,BP,
10229,GO:0036312,1,0.932587388256249,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10230,GO:0036313,1,0.994486589318106,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10231,GO:0036314,1,0.832581734471961,0,23,response to sterol,BP,
10232,GO:0036315,1,0.887206731977822,0,15,cellular response to sterol,BP,
10233,GO:0036316,1,0.994347577264868,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10234,GO:0036317,1,0.994313214468247,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10235,GO:0036323,1,0.992612806232275,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10236,GO:0036324,1,0.987716875072049,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10237,GO:0036326,1,0.992612806232275,0,1,VEGF-A-activated receptor activity,MF,
10238,GO:0036327,1,0.992612806232275,0,1,VEGF-B-activated receptor activity,MF,
10239,GO:0036328,1,0.992132567011629,0,1,VEGF-C-activated receptor activity,MF,
10240,GO:0036332,1,0.992612806232275,0,1,placental growth factor-activated receptor activity,MF,
10241,GO:0036333,1,0.994390578497391,0,1,hepatocyte homeostasis,BP,
10242,GO:0036335,1,0.992076337913693,0,1,intestinal stem cell homeostasis,BP,
10243,GO:0036336,1,0.850622804737755,0,26,dendritic cell migration,BP,
10244,GO:0036337,1,0.972531775021937,0,4,Fas signaling pathway,BP,
10245,GO:0036342,1,0.897970030337945,0,15,post-anal tail morphogenesis,BP,
10246,GO:0036343,1,0.977645499501355,0,4,psychomotor behavior,BP,
10247,GO:0036344,1,0.87535426390892,0,19,platelet morphogenesis,BP,
10248,GO:0036345,1,0.988998097733721,0,2,platelet maturation,BP,
10249,GO:0036351,1,0.994535697056988,0,1,histone H2A-K13 ubiquitination,BP,
10250,GO:0036352,1,0.994535697056988,0,1,histone H2A-K15 ubiquitination,BP,
10251,GO:0036353,1,0.952914082725053,0,7,histone H2A-K119 monoubiquitination,BP,
10252,GO:0036361,1,0.994465458292206,0,1,racemase activity, acting on amino acids and derivatives,MF,
10253,GO:0036363,1,0.987251009323982,0,2,transforming growth factor beta activation,BP,
10254,GO:0036367,1,0.994424633269304,0,1,light adaption,BP,
10255,GO:0036369,1,0.979556077053727,0,2,transcription factor catabolic process,BP,
10256,GO:0036371,1,0.989136726876157,0,1,protein localization to T-tubule,BP,
10257,GO:0036372,1,0.994820029435987,0,1,opsin transport,BP,
10258,GO:0036374,1,0.983445508560032,0,3,glutathione hydrolase activity,MF,
10259,GO:0036376,1,0.909488500190691,0,15,sodium ion export across plasma membrane,BP,
10260,GO:0036378,1,0.989227783080573,0,2,calcitriol biosynthetic process from calciol,BP,
10261,GO:0036379,1,0.796102857944058,0,31,myofilament,CC,
10262,GO:0036387,1,0.983817213440429,0,3,pre-replicative complex,CC,
10263,GO:0036388,1,0.983817213440429,0,3,pre-replicative complex assembly,BP,
10264,GO:0036392,1,0.993608860486893,0,1,chemokine (C-C motif) ligand 20 production,BP,
10265,GO:0036393,1,0.994239752010479,0,1,thiocyanate peroxidase activity,MF,
10266,GO:0036396,1,0.984067428092758,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
10267,GO:0036398,1,0.988487452533817,0,2,TCR signalosome,CC,
10268,GO:0036399,1,0.993970144807525,0,1,TCR signalosome assembly,BP,
10269,GO:0036402,1,0.968949470014758,0,6,proteasome-activating ATPase activity,MF,
10270,GO:0036403,1,0.994393936390763,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10271,GO:0036404,1,0.987076826329213,0,1,conversion of ds siRNA to ss siRNA,BP,
10272,GO:0036413,1,0.987574953565563,0,2,histone H3-R26 citrullination,BP,
10273,GO:0036414,1,0.975279410549987,0,4,histone citrullination,BP,
10274,GO:0036435,1,0.988290531366255,0,2,K48-linked polyubiquitin modification-dependent protein binding,MF,
10275,GO:0036438,1,0.975602141345758,0,4,maintenance of lens transparency,BP,
10276,GO:0036440,1,0.994184890625447,0,1,citrate synthase activity,MF,
10277,GO:0036442,1,0.846415160520126,0,27,proton-exporting ATPase activity,MF,
10278,GO:0036444,1,0.951522619608285,0,8,calcium import into the mitochondrion,BP,
10279,GO:0036445,1,0.909777702720219,0,13,neuronal stem cell division,BP,
10280,GO:0036446,1,0.978867698366143,0,3,myofibroblast differentiation,BP,
10281,GO:0036449,1,0.936837572823886,0,7,microtubule minus-end,CC,
10282,GO:0036451,1,0.988658446617857,0,2,cap mRNA methylation,BP,
10283,GO:0036452,1,0.849331590547517,0,28,ESCRT complex,CC,
10284,GO:0036454,1,0.965359697925251,0,5,growth factor complex,CC,
10285,GO:0036455,1,0.994807847964855,0,1,iron-sulfur transferase activity,MF,
10287,GO:0036459,1,0.518355466641666,0,88,thiol-dependent ubiquitinyl hydrolase activity,MF,
10288,GO:0036461,1,0.989601118368263,0,2,BLOC-2 complex binding,MF,
10289,GO:0036462,1,0.957556213328919,0,7,TRAIL-activated apoptotic signaling pathway,BP,
10292,GO:0036466,1,0.98538980186176,0,2,synaptic vesicle recycling via endosome,BP,
10293,GO:0036468,1,0.994639019362965,0,1,L-dopa decarboxylase activity,MF,
10294,GO:0036470,1,0.994822876044542,0,1,tyrosine 3-monooxygenase activator activity,MF,
10295,GO:0036471,1,0.994822876044542,0,1,cellular response to glyoxal,BP,
10296,GO:0036473,1,0.627849236425977,0,73,cell death in response to oxidative stress,BP,
10297,GO:0036474,1,0.84835432413456,0,26,cell death in response to hydrogen peroxide,BP,
10298,GO:0036475,1,0.867100982583947,0,21,neuron death in response to oxidative stress,BP,
10299,GO:0036476,1,0.976166831642324,0,4,neuron death in response to hydrogen peroxide,BP,
10301,GO:0036478,1,0.994822876044542,0,1,L-dopa decarboxylase activator activity,MF,
10302,GO:0036479,1,0.988022957922514,0,1,peroxidase inhibitor activity,MF,
10303,GO:0036480,1,0.957831208739901,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10304,GO:0036481,1,0.967218619386202,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10305,GO:0036482,1,0.989227359261336,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10306,GO:0036483,1,0.992797577257253,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10307,GO:0036484,1,0.980011151771409,0,3,trunk neural crest cell migration,BP,
10308,GO:0036486,1,0.980011151771409,0,3,ventral trunk neural crest cell migration,BP,
10309,GO:0036487,1,0.988441996649535,0,1,nitric-oxide synthase inhibitor activity,MF,
10310,GO:0036488,1,0.989542306737567,0,2,CHOP-C/EBP complex,CC,
10311,GO:0036490,1,0.947040008593111,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
10312,GO:0036491,1,0.952948043473672,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10313,GO:0036492,1,0.958211398067196,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10314,GO:0036493,1,0.98105808204556,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10315,GO:0036494,1,0.991729411250897,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10316,GO:0036496,1,0.989301914324715,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10317,GO:0036497,1,0.9945094434866,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10318,GO:0036498,1,0.64678657917676,0,67,IRE1-mediated unfolded protein response,BP,
10320,GO:0036500,1,0.941788984781261,0,10,ATF6-mediated unfolded protein response,BP,
10321,GO:0036501,1,0.992967882667362,0,1,UFD1-NPL4 complex,CC,
10322,GO:0036502,1,0.994079748257803,0,1,Derlin-1-VIMP complex,CC,
10323,GO:0036503,1,0.564225247941281,0,89,ERAD pathway,BP,
10324,GO:0036505,1,0.988712431514255,0,2,prosaposin receptor activity,MF,
10325,GO:0036506,1,0.978386935365964,0,3,maintenance of unfolded protein,BP,
10326,GO:0036507,1,0.846939144985688,0,24,protein demannosylation,BP,
10327,GO:0036508,1,0.846939144985688,0,24,protein alpha-1,2-demannosylation,BP,
10328,GO:0036509,1,0.989031810493888,0,2,trimming of terminal mannose on B branch,BP,
10329,GO:0036510,1,0.980256945948595,0,3,trimming of terminal mannose on C branch,BP,
10330,GO:0036511,1,0.989031810493888,0,2,trimming of first mannose on A branch,BP,
10331,GO:0036512,1,0.989031810493888,0,2,trimming of second mannose on A branch,BP,
10332,GO:0036513,1,0.932302682838119,0,11,Derlin-1 retrotranslocation complex,CC,
10333,GO:0036514,1,0.957323386255727,0,5,dopaminergic neuron axon guidance,BP,
10334,GO:0036515,1,0.962901836965263,0,4,serotonergic neuron axon guidance,BP,
10335,GO:0036517,1,0.991465911434634,0,1,chemoattraction of serotonergic neuron axon,BP,
10336,GO:0036518,1,0.985723651219135,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10337,GO:0036524,1,0.994822876044542,0,1,protein deglycase activity,MF,
10338,GO:0036525,1,0.994822876044542,0,1,protein deglycation,BP,
10339,GO:0036526,1,0.994822876044542,0,1,peptidyl-cysteine deglycation,BP,
10340,GO:0036527,1,0.994822876044542,0,1,peptidyl-arginine deglycation,BP,
10341,GO:0036528,1,0.994822876044542,0,1,peptidyl-lysine deglycation,BP,
10342,GO:0036529,1,0.994822876044542,0,1,protein deglycation, glyoxal removal,BP,
10343,GO:0036530,1,0.994822876044542,0,1,protein deglycation, methylglyoxal removal,BP,
10344,GO:0036531,1,0.994822876044542,0,1,glutathione deglycation,BP,
10345,GO:0038001,1,0.9734070384913,0,3,paracrine signaling,BP,
10346,GO:0038002,1,0.991969461011829,0,1,endocrine signaling,BP,
10347,GO:0038003,1,0.943857144030141,0,10,opioid receptor signaling pathway,BP,
10348,GO:0038007,1,0.945022808868505,0,7,netrin-activated signaling pathway,BP,
10349,GO:0038016,1,0.988384878770457,0,2,insulin receptor internalization,BP,
10350,GO:0038018,1,0.983593247421674,0,2,Wnt receptor catabolic process,BP,
10351,GO:0038021,1,0.993094063416766,0,1,leptin receptor activity,MF,
10354,GO:0038025,1,0.986876160310957,0,2,reelin receptor activity,MF,
10355,GO:0038026,1,0.965967474584645,0,4,reelin-mediated signaling pathway,BP,
10356,GO:0038027,1,0.955534481544678,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10357,GO:0038028,1,0.974555509384554,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10358,GO:0038030,1,0.95460060573233,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10359,GO:0038031,1,0.960908996366606,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10360,GO:0038033,1,0.967841617137345,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10361,GO:0038034,1,0.652422258823155,0,67,signal transduction in absence of ligand,BP,
10362,GO:0038036,1,0.95479868165353,0,8,sphingosine-1-phosphate receptor activity,MF,
10364,GO:0038038,1,0.990363141334489,0,1,G-protein coupled receptor homodimeric complex,CC,
10367,GO:0038043,1,0.987177441379057,0,2,interleukin-5-mediated signaling pathway,BP,
10369,GO:0038046,1,0.994705332797312,0,1,enkephalin receptor activity,MF,
10370,GO:0038047,1,0.994682541933244,0,1,morphine receptor activity,MF,
10371,GO:0038048,1,0.992390237692834,0,1,dynorphin receptor activity,MF,
10372,GO:0038049,1,0.976781964621116,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10373,GO:0038051,1,0.990654362670238,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10374,GO:0038052,1,0.985461472003727,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10375,GO:0038060,1,0.993920977146251,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
10377,GO:0038062,1,0.987563590542538,0,2,protein tyrosine kinase collagen receptor activity,MF,
10379,GO:0038064,1,0.969552061695076,0,4,collagen receptor activity,MF,
10381,GO:0038066,1,0.78784086324701,0,37,p38MAPK cascade,BP,
10382,GO:0038083,1,0.694261545916129,0,52,peptidyl-tyrosine autophosphorylation,BP,
10383,GO:0038084,1,0.832669359935364,0,25,vascular endothelial growth factor signaling pathway,BP,
10384,GO:0038085,1,0.963226038051305,0,5,vascular endothelial growth factor binding,MF,
10385,GO:0038086,1,0.976222057617392,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10386,GO:0038089,1,0.95047156845264,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10387,GO:0038091,1,0.976222057617392,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10388,GO:0038092,1,0.906165695405694,0,15,nodal signaling pathway,BP,
10389,GO:0038093,1,0.328914320569345,0,178,Fc receptor signaling pathway,BP,
10390,GO:0038094,1,0.623728372498935,0,74,Fc-gamma receptor signaling pathway,BP,
10391,GO:0038095,1,0.482827915693719,0,118,Fc-epsilon receptor signaling pathway,BP,
10392,GO:0038096,1,0.637188260892889,0,70,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10393,GO:0038097,1,0.992021085054056,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10394,GO:0038098,1,0.987847158870652,0,2,sequestering of BMP from receptor via BMP binding,BP,
10395,GO:0038100,1,0.97818805086013,0,3,nodal binding,MF,
10396,GO:0038101,1,0.994715096533295,0,1,sequestering of nodal from receptor via nodal binding,BP,
10397,GO:0038107,1,0.955904749570257,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10398,GO:0038108,1,0.977198240026437,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10399,GO:0038109,1,0.986395270501289,0,2,Kit signaling pathway,BP,
10400,GO:0038110,1,0.927912614454813,0,11,interleukin-2-mediated signaling pathway,BP,
10401,GO:0038111,1,0.880525991832266,0,18,interleukin-7-mediated signaling pathway,BP,
10402,GO:0038112,1,0.988815938566241,0,2,interleukin-8-mediated signaling pathway,BP,
10403,GO:0038113,1,0.979040658952527,0,3,interleukin-9-mediated signaling pathway,BP,
10404,GO:0038114,1,0.954213295548927,0,7,interleukin-21-mediated signaling pathway,BP,
10405,GO:0038115,1,0.994590650166733,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10406,GO:0038116,1,0.994590650166733,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10407,GO:0038117,1,0.994590650166733,0,1,C-C motif chemokine 19 receptor activity,MF,
10408,GO:0038118,1,0.99481422338587,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10409,GO:0038121,1,0.994590650166733,0,1,C-C motif chemokine 21 receptor activity,MF,
10410,GO:0038123,1,0.982987776684152,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10411,GO:0038124,1,0.974903216632078,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10413,GO:0038128,1,0.771802570327064,0,38,ERBB2 signaling pathway,BP,
10414,GO:0038129,1,0.983712271330733,0,3,ERBB3 signaling pathway,BP,
10415,GO:0038131,1,0.988664635494009,0,2,neuregulin receptor activity,MF,
10416,GO:0038132,1,0.960465178321824,0,5,neuregulin binding,MF,
10417,GO:0038133,1,0.994632750073862,0,1,ERBB2-ERBB3 signaling pathway,BP,
10418,GO:0038145,1,0.970233343694911,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10419,GO:0038154,1,0.994033683966511,0,1,interleukin-11-mediated signaling pathway,BP,
10420,GO:0038155,1,0.956510014735972,0,7,interleukin-23-mediated signaling pathway,BP,
10421,GO:0038156,1,0.992499060298947,0,1,interleukin-3-mediated signaling pathway,BP,
10422,GO:0038158,1,0.988579983889377,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10423,GO:0038161,1,0.98008697711916,0,2,prolactin signaling pathway,BP,
10424,GO:0038162,1,0.981734196451173,0,3,erythropoietin-mediated signaling pathway,BP,
10425,GO:0038163,1,0.983274720091567,0,3,thrombopoietin-mediated signaling pathway,BP,
10426,GO:0038164,1,0.993664856817801,0,1,thrombopoietin receptor activity,MF,
10427,GO:0038165,1,0.969865000447462,0,4,oncostatin-M-mediated signaling pathway,BP,
10428,GO:0038166,1,0.94641801163047,0,9,angiotensin-activated signaling pathway,BP,
10429,GO:0038167,1,0.99196840699052,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10430,GO:0038168,1,0.99196840699052,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10431,GO:0038169,1,0.976940170958767,0,4,somatostatin receptor signaling pathway,BP,
10432,GO:0038170,1,0.976940170958767,0,4,somatostatin signaling pathway,BP,
10433,GO:0038171,1,0.953968782889737,0,7,cannabinoid signaling pathway,BP,
10434,GO:0038172,1,0.982556107673062,0,3,interleukin-33-mediated signaling pathway,BP,
10435,GO:0038178,1,0.988870865227076,0,2,complement component C5a signaling pathway,BP,
10436,GO:0038179,1,0.787843757445893,0,35,neurotrophin signaling pathway,BP,
10437,GO:0038180,1,0.916884796526787,0,12,nerve growth factor signaling pathway,BP,
10438,GO:0038181,1,0.982102120464961,0,3,bile acid receptor activity,MF,
10439,GO:0038182,1,0.994760750257505,0,1,G-protein coupled bile acid receptor activity,MF,
10440,GO:0038183,1,0.982102120464961,0,3,bile acid signaling pathway,BP,
10441,GO:0038184,1,0.994760750257505,0,1,cell surface bile acid receptor signaling pathway,BP,
10442,GO:0038185,1,0.99459757150219,0,1,intracellular bile acid receptor signaling pathway,BP,
10443,GO:0038186,1,0.992638417255533,0,1,lithocholic acid receptor activity,MF,
10444,GO:0038187,1,0.91695395727294,0,14,pattern recognition receptor activity,MF,
10445,GO:0038188,1,0.989361100438341,0,2,cholecystokinin signaling pathway,BP,
10446,GO:0038189,1,0.974744751602062,0,4,neuropilin signaling pathway,BP,
10447,GO:0038190,1,0.988274137580037,0,2,VEGF-activated neuropilin signaling pathway,BP,
10448,GO:0038191,1,0.865630646331773,0,19,neuropilin binding,MF,
10449,GO:0038192,1,0.994635211808564,0,1,gastric inhibitory peptide signaling pathway,BP,
10450,GO:0038193,1,0.994553872164583,0,1,thromboxane A2 signaling pathway,BP,
10451,GO:0038194,1,0.988295874506839,0,2,thyroid-stimulating hormone signaling pathway,BP,
10452,GO:0038195,1,0.994769195271256,0,1,urokinase plasminogen activator signaling pathway,BP,
10453,GO:0038201,1,0.894869496031406,0,16,TOR complex,CC,
10454,GO:0038202,1,0.803575024226753,0,32,TORC1 signaling,BP,
10455,GO:0038203,1,0.959737454859326,0,7,TORC2 signaling,BP,
10456,GO:0039003,1,0.986751226142549,0,2,pronephric field specification,BP,
10457,GO:0039007,1,0.99176582790506,0,1,pronephric nephron morphogenesis,BP,
10458,GO:0039008,1,0.99176582790506,0,1,pronephric nephron tubule morphogenesis,BP,
10459,GO:0039017,1,0.986751226142549,0,2,pattern specification involved in pronephros development,BP,
10460,GO:0039019,1,0.985490128139578,0,2,pronephric nephron development,BP,
10461,GO:0039020,1,0.99176582790506,0,1,pronephric nephron tubule development,BP,
10462,GO:0039022,1,0.99176582790506,0,1,pronephric duct development,BP,
10463,GO:0039023,1,0.99176582790506,0,1,pronephric duct morphogenesis,BP,
10464,GO:0039502,1,0.992124689597619,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
10465,GO:0039503,1,0.992124689597619,0,1,suppression by virus of host innate immune response,BP,
10466,GO:0039506,1,0.986490206245001,0,2,modulation by virus of host molecular function,BP,
10467,GO:0039507,1,0.986490206245001,0,2,suppression by virus of host molecular function,BP,
10468,GO:0039513,1,0.994321238790888,0,1,suppression by virus of host catalytic activity,BP,
10469,GO:0039514,1,0.992124689597619,0,1,suppression by virus of host JAK-STAT cascade,BP,
10470,GO:0039516,1,0.994321238790888,0,1,modulation by virus of host catalytic activity,BP,
10471,GO:0039519,1,0.98420634749241,0,2,modulation by virus of host autophagy,BP,
10472,GO:0039520,1,0.991772689253938,0,1,induction by virus of host autophagy,BP,
10473,GO:0039521,1,0.992371518296249,0,1,suppression by virus of host autophagy,BP,
10474,GO:0039526,1,0.983694538813033,0,3,modulation by virus of host apoptotic process,BP,
10475,GO:0039528,1,0.869466051926741,0,20,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10476,GO:0039529,1,0.895000619760904,0,15,RIG-I signaling pathway,BP,
10477,GO:0039530,1,0.94645627360212,0,8,MDA-5 signaling pathway,BP,
10478,GO:0039531,1,0.896595679482719,0,15,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10479,GO:0039532,1,0.943276557198838,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10480,GO:0039533,1,0.962503648845569,0,5,regulation of MDA-5 signaling pathway,BP,
10481,GO:0039534,1,0.982608547138039,0,3,negative regulation of MDA-5 signaling pathway,BP,
10482,GO:0039535,1,0.907524979316697,0,13,regulation of RIG-I signaling pathway,BP,
10483,GO:0039536,1,0.954769020088108,0,7,negative regulation of RIG-I signaling pathway,BP,
10484,GO:0039552,1,0.991820189858442,0,1,RIG-I binding,MF,
10485,GO:0039562,1,0.992124689597619,0,1,suppression by virus of host STAT activity,BP,
10486,GO:0039563,1,0.992124689597619,0,1,suppression by virus of host STAT1 activity,BP,
10487,GO:0039564,1,0.992124689597619,0,1,suppression by virus of host STAT2 activity,BP,
10488,GO:0039650,1,0.994321238790888,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10489,GO:0039656,1,0.983169767103034,0,3,modulation by virus of host gene expression,BP,
10490,GO:0039663,1,0.966617115612413,0,6,membrane fusion involved in viral entry into host cell,BP,
10491,GO:0039689,1,0.98257970986702,0,3,negative stranded viral RNA replication,BP,
10492,GO:0039692,1,0.932660687091874,0,12,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10493,GO:0039694,1,0.849306721124815,0,26,viral RNA genome replication,BP,
10494,GO:0039695,1,0.99273172731714,0,1,DNA-templated viral transcription,BP,
10495,GO:0039702,1,0.886596683543616,0,21,viral budding via host ESCRT complex,BP,
10496,GO:0039706,1,0.930418407564622,0,11,co-receptor binding,MF,
10497,GO:0039713,1,0.993843297646569,0,1,viral factory,CC,
10498,GO:0039714,1,0.993843297646569,0,1,cytoplasmic viral factory,CC,
10499,GO:0040001,1,0.841516690533786,0,24,establishment of mitotic spindle localization,BP,
10502,GO:0040009,1,0.955648632393019,0,5,regulation of growth rate,BP,
10503,GO:0040010,1,0.994834055115578,0,1,positive regulation of growth rate,BP,
10507,GO:0040014,1,0.651383511782685,0,61,regulation of multicellular organism growth,BP,
10508,GO:0040015,1,0.925254516389019,0,11,negative regulation of multicellular organism growth,BP,
10509,GO:0040016,1,0.959610622520643,0,6,embryonic cleavage,BP,
10511,GO:0040018,1,0.815558995106092,0,29,positive regulation of multicellular organism growth,BP,
10512,GO:0040019,1,0.816886191739417,0,29,positive regulation of embryonic development,BP,
10513,GO:0040020,1,0.852504721509053,0,26,regulation of meiotic nuclear division,BP,
10514,GO:0040029,1,0.156473351936715,0,266,regulation of gene expression, epigenetic,BP,
10515,GO:0040030,1,0.988409603451761,0,2,regulation of molecular function, epigenetic,BP,
10516,GO:0040031,1,0.96794412601695,0,6,snRNA modification,BP,
10517,GO:0040032,1,0.994675349656175,0,1,post-embryonic body morphogenesis,BP,
10518,GO:0040033,1,0.901760085259167,0,13,negative regulation of translation, ncRNA-mediated,BP,
10519,GO:0040034,1,0.923619583888202,0,12,regulation of development, heterochronic,BP,
10520,GO:0040036,1,0.843165191136668,0,26,regulation of fibroblast growth factor receptor signaling pathway,BP,
10521,GO:0040037,1,0.916757169101698,0,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10522,GO:0040038,1,0.976921569397835,0,3,polar body extrusion after meiotic divisions,BP,
10523,GO:0040040,1,0.991220635417185,0,1,thermosensory behavior,BP,
10524,GO:0042000,1,0.994494248656162,0,1,translocation of peptides or proteins into host,BP,
10525,GO:0042007,1,0.994772225568575,0,1,interleukin-18 binding,MF,
10526,GO:0042008,1,0.993773915406647,0,1,interleukin-18 receptor activity,MF,
10527,GO:0042011,1,0.994098345805747,0,1,interleukin-16 binding,MF,
10528,GO:0042012,1,0.994098345805747,0,1,interleukin-16 receptor activity,MF,
10529,GO:0042015,1,0.982667716007412,0,3,interleukin-20 binding,MF,
10530,GO:0042019,1,0.994649138174134,0,1,interleukin-23 binding,MF,
10531,GO:0042020,1,0.994649138174134,0,1,interleukin-23 receptor activity,MF,
10532,GO:0042022,1,0.994649138174134,0,1,interleukin-12 receptor complex,CC,
10533,GO:0042023,1,0.940589753287729,0,8,DNA endoreduplication,BP,
10534,GO:0042025,1,0.980096553185066,0,3,host cell nucleus,CC,
10535,GO:0042026,1,0.85816205632349,0,26,protein refolding,BP,
10536,GO:0042030,1,0.977088138433078,0,3,ATPase inhibitor activity,MF,
10537,GO:0042033,1,0.934308743645775,0,12,chemokine biosynthetic process,BP,
10538,GO:0042035,1,0.578448454752008,0,88,regulation of cytokine biosynthetic process,BP,
10539,GO:0042036,1,0.848690313499668,0,28,negative regulation of cytokine biosynthetic process,BP,
10540,GO:0042040,1,0.993089170363745,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10541,GO:0042043,1,0.911715532673827,0,13,neurexin family protein binding,MF,
10542,GO:0042044,1,0.875012328178374,0,21,fluid transport,BP,
10543,GO:0042045,1,0.949146736659654,0,7,epithelial fluid transport,BP,
10545,GO:0042053,1,0.896246090161199,0,18,regulation of dopamine metabolic process,BP,
10546,GO:0042054,1,0.694021069290625,0,53,histone methyltransferase activity,MF,
10552,GO:0042069,1,0.896246090161199,0,18,regulation of catecholamine metabolic process,BP,
10553,GO:0042073,1,0.708544586686538,0,50,intraciliary transport,BP,
10554,GO:0042074,1,0.909526355949562,0,13,cell migration involved in gastrulation,BP,
10555,GO:0042078,1,0.982683323199068,0,3,germ-line stem cell division,BP,
10556,GO:0042083,1,0.994744420879121,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10557,GO:0042084,1,0.98678675433376,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10559,GO:0042089,1,0.555126262815639,0,95,cytokine biosynthetic process,BP,
10560,GO:0042090,1,0.954779182786557,0,7,interleukin-12 biosynthetic process,BP,
10561,GO:0042091,1,0.980514272706092,0,3,interleukin-10 biosynthetic process,BP,
10564,GO:0042094,1,0.888476262515003,0,20,interleukin-2 biosynthetic process,BP,
10565,GO:0042095,1,0.915701981655716,0,15,interferon-gamma biosynthetic process,BP,
10566,GO:0042097,1,0.980484142285252,0,3,interleukin-4 biosynthetic process,BP,
10568,GO:0042100,1,0.648100796408343,0,68,B cell proliferation,BP,
10569,GO:0042101,1,0.895402964149975,0,19,T cell receptor complex,CC,
10572,GO:0042105,1,0.973936296032873,0,5,alpha-beta T cell receptor complex,CC,
10573,GO:0042107,1,0.552137784640012,0,96,cytokine metabolic process,BP,
10574,GO:0042108,1,0.722609693265123,0,52,positive regulation of cytokine biosynthetic process,BP,
10575,GO:0042109,1,0.988483065338893,0,2,lymphotoxin A biosynthetic process,BP,
10577,GO:0042113,1,0.271887536119244,0,197,B cell activation,BP,
10578,GO:0042116,1,0.664342347556323,0,60,macrophage activation,BP,
10579,GO:0042117,1,0.959930799118078,0,7,monocyte activation,BP,
10582,GO:0042126,1,0.977792371282875,0,4,nitrate metabolic process,BP,
10584,GO:0042128,1,0.994528459656984,0,1,nitrate assimilation,BP,
10586,GO:0042130,1,0.729110099508845,0,51,negative regulation of T cell proliferation,BP,
10587,GO:0042131,1,0.994443259508373,0,1,thiamine phosphate phosphatase activity,MF,
10588,GO:0042132,1,0.994752567879549,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10590,GO:0042134,1,0.989493132929671,0,2,rRNA primary transcript binding,MF,
10591,GO:0042135,1,0.879570646976469,0,21,neurotransmitter catabolic process,BP,
10593,GO:0042137,1,0.988887575338058,0,2,sequestering of neurotransmitter,BP,
10594,GO:0042138,1,0.983204626901101,0,3,meiotic DNA double-strand break formation,BP,
10595,GO:0042140,1,0.994313214468247,0,1,late meiotic recombination nodule assembly,BP,
10596,GO:0042144,1,0.986957559226236,0,2,vacuole fusion, non-autophagic,BP,
10597,GO:0042147,1,0.60466680658667,0,72,retrograde transport, endosome to Golgi,BP,
10598,GO:0042148,1,0.953586026373254,0,8,strand invasion,BP,
10599,GO:0042149,1,0.787614251629683,0,37,cellular response to glucose starvation,BP,
10602,GO:0042159,1,0.903892154074904,0,14,lipoprotein catabolic process,BP,
10603,GO:0042160,1,0.988694782132626,0,2,lipoprotein modification,BP,
10604,GO:0042161,1,0.988694782132626,0,2,lipoprotein oxidation,BP,
10605,GO:0042162,1,0.784349209251071,0,36,telomeric DNA binding,MF,
10606,GO:0042163,1,0.994769348797587,0,1,interleukin-12 beta subunit binding,MF,
10608,GO:0042166,1,0.90915393234284,0,16,acetylcholine binding,MF,
10609,GO:0042167,1,0.979263902101268,0,4,heme catabolic process,BP,
10610,GO:0042168,1,0.85850266159087,0,25,heme metabolic process,BP,
10611,GO:0042169,1,0.797619370547592,0,32,SH2 domain binding,MF,
10612,GO:0042171,1,0.881286838622914,0,18,lysophosphatidic acid acyltransferase activity,MF,
10616,GO:0042178,1,0.945797411437558,0,10,xenobiotic catabolic process,BP,
10619,GO:0042182,1,0.966737539204258,0,6,ketone catabolic process,BP,
10620,GO:0042197,1,0.994727520125496,0,1,halogenated hydrocarbon metabolic process,BP,
10621,GO:0042214,1,0.983341266522843,0,3,terpene metabolic process,BP,
10622,GO:0042219,1,0.886562405155156,0,20,cellular modified amino acid catabolic process,BP,
10623,GO:0042220,1,0.757109296560541,0,41,response to cocaine,BP,
10625,GO:0042222,1,0.98382001794021,0,3,interleukin-1 biosynthetic process,BP,
10626,GO:0042223,1,0.992310563490457,0,1,interleukin-3 biosynthetic process,BP,
10627,GO:0042226,1,0.917971346271785,0,14,interleukin-6 biosynthetic process,BP,
10628,GO:0042228,1,0.93882434107309,0,10,interleukin-8 biosynthetic process,BP,
10629,GO:0042231,1,0.986861002354086,0,2,interleukin-13 biosynthetic process,BP,
10630,GO:0042241,1,0.994002209945759,0,1,interleukin-18 biosynthetic process,BP,
10631,GO:0042245,1,0.987515787824307,0,2,RNA repair,BP,
10633,GO:0042247,1,0.994212042342004,0,1,establishment of planar polarity of follicular epithelium,BP,
10634,GO:0042249,1,0.885265308659264,0,17,establishment of planar polarity of embryonic epithelium,BP,
10635,GO:0042253,1,0.981551505553187,0,3,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10636,GO:0042254,1,0.157764275111348,0,309,ribosome biogenesis,BP,
10637,GO:0042255,1,0.73525903392544,0,53,ribosome assembly,BP,
10638,GO:0042256,1,0.969568288172157,0,5,mature ribosome assembly,BP,
10639,GO:0042262,1,0.973789127128938,0,5,DNA protection,BP,
10640,GO:0042264,1,0.984091233112017,0,2,peptidyl-aspartic acid hydroxylation,BP,
10641,GO:0042265,1,0.990349864977928,0,1,peptidyl-asparagine hydroxylation,BP,
10642,GO:0042267,1,0.747176044276581,0,48,natural killer cell mediated cytotoxicity,BP,
10643,GO:0042268,1,0.946142306764705,0,10,regulation of cytolysis,BP,
10644,GO:0042269,1,0.830637705959872,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10645,GO:0042270,1,0.98796995523479,0,2,protection from natural killer cell mediated cytotoxicity,BP,
10646,GO:0042271,1,0.979589770978418,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10647,GO:0042272,1,0.973586097410122,0,3,nuclear RNA export factor complex,CC,
10648,GO:0042273,1,0.677845787403857,0,66,ribosomal large subunit biogenesis,BP,
10649,GO:0042274,1,0.673169331802624,0,67,ribosomal small subunit biogenesis,BP,
10650,GO:0042275,1,0.994755868545381,0,1,error-free postreplication DNA repair,BP,
10651,GO:0042276,1,0.886199489084898,0,19,error-prone translesion synthesis,BP,
10653,GO:0042278,1,0.628767988754511,0,73,purine nucleoside metabolic process,BP,
10654,GO:0042281,1,0.988642652782418,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10655,GO:0042282,1,0.992843943660307,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10656,GO:0042284,1,0.989487697075519,0,2,sphingolipid delta-4 desaturase activity,MF,
10657,GO:0042285,1,0.955691231084027,0,6,xylosyltransferase activity,MF,
10658,GO:0042287,1,0.854295333747008,0,27,MHC protein binding,MF,
10659,GO:0042288,1,0.913250377025348,0,16,MHC class I protein binding,MF,
10660,GO:0042289,1,0.965745137856022,0,6,MHC class II protein binding,MF,
10661,GO:0042292,1,0.994477249259959,0,1,URM1 activating enzyme activity,MF,
10662,GO:0042296,1,0.978224088187418,0,4,ISG15 transferase activity,MF,
10663,GO:0042297,1,0.930538526782743,0,7,vocal learning,BP,
10664,GO:0042301,1,0.936714926471575,0,11,phosphate ion binding,MF,
10667,GO:0042306,1,0.720447751705972,0,47,regulation of protein import into nucleus,BP,
10668,GO:0042307,1,0.796296593475534,0,30,positive regulation of protein import into nucleus,BP,
10669,GO:0042308,1,0.941320762813455,0,10,negative regulation of protein import into nucleus,BP,
10670,GO:0042309,1,0.994317236960261,0,1,homoiothermy,BP,
10672,GO:0042311,1,0.843525163597569,0,28,vasodilation,BP,
10673,GO:0042313,1,0.994614803267906,0,1,protein kinase C deactivation,BP,
10674,GO:0042316,1,0.992265130732741,0,1,penicillin metabolic process,BP,
10675,GO:0042320,1,0.971192729253861,0,5,regulation of circadian sleep/wake cycle, REM sleep,BP,
10676,GO:0042321,1,0.973318024387263,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10677,GO:0042322,1,0.989652210982671,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10678,GO:0042323,1,0.98905752656264,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10682,GO:0042328,1,0.968438050152942,0,4,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10684,GO:0042335,1,0.977352441395588,0,3,cuticle development,BP,
10687,GO:0042350,1,0.9830190245133,0,3,GDP-L-fucose biosynthetic process,BP,
10688,GO:0042351,1,0.98953365752882,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10689,GO:0042352,1,0.993417152262193,0,1,GDP-L-fucose salvage,BP,
10692,GO:0042356,1,0.994780129678445,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10693,GO:0042357,1,0.989246482958458,0,2,thiamine diphosphate metabolic process,BP,
10694,GO:0042359,1,0.877395765791442,0,19,vitamin D metabolic process,BP,
10695,GO:0042360,1,0.983917815342708,0,3,vitamin E metabolic process,BP,
10696,GO:0042361,1,0.994037760868754,0,1,menaquinone catabolic process,BP,
10697,GO:0042362,1,0.933093680513995,0,12,fat-soluble vitamin biosynthetic process,BP,
10698,GO:0042363,1,0.965302205662182,0,6,fat-soluble vitamin catabolic process,BP,
10699,GO:0042364,1,0.942421645464011,0,9,water-soluble vitamin biosynthetic process,BP,
10700,GO:0042365,1,0.982221575216245,0,3,water-soluble vitamin catabolic process,BP,
10701,GO:0042368,1,0.949429079120188,0,9,vitamin D biosynthetic process,BP,
10702,GO:0042369,1,0.988544050556692,0,2,vitamin D catabolic process,BP,
10703,GO:0042371,1,0.993665731148129,0,1,vitamin K biosynthetic process,BP,
10704,GO:0042373,1,0.972432751534721,0,5,vitamin K metabolic process,BP,
10705,GO:0042374,1,0.988877683612912,0,2,phylloquinone metabolic process,BP,
10706,GO:0042376,1,0.988877683612912,0,2,phylloquinone catabolic process,BP,
10707,GO:0042377,1,0.994037760868754,0,1,vitamin K catabolic process,BP,
10709,GO:0042382,1,0.961603793761189,0,6,paraspeckles,CC,
10712,GO:0042392,1,0.98878375310951,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10713,GO:0042393,1,0.302373767186232,0,170,histone binding,MF,
10714,GO:0042398,1,0.811178002893325,0,36,cellular modified amino acid biosynthetic process,BP,
10716,GO:0042402,1,0.892411785224138,0,20,cellular biogenic amine catabolic process,BP,
10717,GO:0042403,1,0.888578963878562,0,17,thyroid hormone metabolic process,BP,
10718,GO:0042404,1,0.994614640011293,0,1,thyroid hormone catabolic process,BP,
10719,GO:0042405,1,0.905672093235334,0,11,nuclear inclusion body,CC,
10720,GO:0042406,1,0.978091604893738,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
10721,GO:0042407,1,0.918243865202356,0,15,cristae formation,BP,
10722,GO:0042412,1,0.989120691618019,0,2,taurine biosynthetic process,BP,
10723,GO:0042413,1,0.994459004331847,0,1,carnitine catabolic process,BP,
10724,GO:0042414,1,0.97838127252854,0,3,epinephrine metabolic process,BP,
10726,GO:0042416,1,0.936920562600759,0,11,dopamine biosynthetic process,BP,
10728,GO:0042418,1,0.989503955664251,0,2,epinephrine biosynthetic process,BP,
10733,GO:0042426,1,0.963298169398889,0,6,choline catabolic process,BP,
10734,GO:0042427,1,0.983934125669347,0,3,serotonin biosynthetic process,BP,
10735,GO:0042428,1,0.924525002742367,0,10,serotonin metabolic process,BP,
10736,GO:0042430,1,0.879370157546622,0,19,indole-containing compound metabolic process,BP,
10737,GO:0042435,1,0.978781895221106,0,4,indole-containing compound biosynthetic process,BP,
10738,GO:0042436,1,0.96128340726343,0,7,indole-containing compound catabolic process,BP,
10739,GO:0042438,1,0.896274217163614,0,15,melanin biosynthetic process,BP,
10741,GO:0042440,1,0.690052538338024,0,58,pigment metabolic process,BP,
10742,GO:0042441,1,0.981425848523462,0,3,eye pigment metabolic process,BP,
10747,GO:0042450,1,0.989406760024357,0,2,arginine biosynthetic process via ornithine,BP,
10748,GO:0042451,1,0.890294677990688,0,21,purine nucleoside biosynthetic process,BP,
10749,GO:0042454,1,0.914575653008504,0,16,ribonucleoside catabolic process,BP,
10750,GO:0042455,1,0.815543511106522,0,36,ribonucleoside biosynthetic process,BP,
10752,GO:0042462,1,0.826108864487545,0,28,eye photoreceptor cell development,BP,
10754,GO:0042471,1,0.481654584350883,0,108,ear morphogenesis,BP,
10755,GO:0042472,1,0.541908940583904,0,89,inner ear morphogenesis,BP,
10756,GO:0042473,1,0.945523121422086,0,9,outer ear morphogenesis,BP,
10757,GO:0042474,1,0.895307260166781,0,19,middle ear morphogenesis,BP,
10760,GO:0042481,1,0.888473794646939,0,20,regulation of odontogenesis,BP,
10761,GO:0042482,1,0.961421257322271,0,7,positive regulation of odontogenesis,BP,
10762,GO:0042483,1,0.974215440110329,0,4,negative regulation of odontogenesis,BP,
10763,GO:0042487,1,0.948721030644177,0,9,regulation of odontogenesis of dentin-containing tooth,BP,
10764,GO:0042488,1,0.994488349929807,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10765,GO:0042489,1,0.988625044182764,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10767,GO:0042491,1,0.817203542425063,0,29,inner ear auditory receptor cell differentiation,BP,
10768,GO:0042492,1,0.959002808571803,0,6,gamma-delta T cell differentiation,BP,
10770,GO:0042494,1,0.962131252592946,0,5,detection of bacterial lipoprotein,BP,
10771,GO:0042495,1,0.988182603174515,0,2,detection of triacyl bacterial lipopeptide,BP,
10772,GO:0042496,1,0.985354752110005,0,2,detection of diacyl bacterial lipopeptide,BP,
10773,GO:0042497,1,0.993877851178825,0,1,triacyl lipopeptide binding,MF,
10774,GO:0042500,1,0.963067830868777,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10775,GO:0042501,1,0.957552000460445,0,7,serine phosphorylation of STAT protein,BP,
10779,GO:0042533,1,0.893663618712634,0,18,tumor necrosis factor biosynthetic process,BP,
10780,GO:0042534,1,0.893663618712634,0,18,regulation of tumor necrosis factor biosynthetic process,BP,
10781,GO:0042535,1,0.930029254243332,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10782,GO:0042536,1,0.972892680664243,0,5,negative regulation of tumor necrosis factor biosynthetic process,BP,
10783,GO:0042537,1,0.904934421377311,0,18,benzene-containing compound metabolic process,BP,
10784,GO:0042538,1,0.959904329862755,0,7,hyperosmotic salinity response,BP,
10785,GO:0042539,1,0.983881256112613,0,2,hypotonic salinity response,BP,
10786,GO:0042541,1,0.949727423669773,0,9,hemoglobin biosynthetic process,BP,
10788,GO:0042543,1,0.994839037738023,0,1,protein N-linked glycosylation via arginine,BP,
10789,GO:0042546,1,0.994704866976516,0,1,cell wall biogenesis,BP,
10792,GO:0042554,1,0.861083719792886,0,25,superoxide anion generation,BP,
10793,GO:0042555,1,0.936886431089352,0,11,MCM complex,CC,
10794,GO:0042558,1,0.809132712096532,0,34,pteridine-containing compound metabolic process,BP,
10795,GO:0042559,1,0.924543371829651,0,14,pteridine-containing compound biosynthetic process,BP,
10796,GO:0042560,1,0.971569116571644,0,4,pteridine-containing compound catabolic process,BP,
10797,GO:0042562,1,0.589442379115396,0,83,hormone binding,MF,
10798,GO:0042564,1,0.993001581412764,0,1,NLS-dependent protein nuclear import complex,CC,
10799,GO:0042565,1,0.986791264042693,0,2,RNA nuclear export complex,CC,
10800,GO:0042567,1,0.970387102481428,0,4,insulin-like growth factor ternary complex,CC,
10801,GO:0042568,1,0.994820729897708,0,1,insulin-like growth factor binary complex,CC,
10802,GO:0042571,1,0.989170789444728,0,2,immunoglobulin complex, circulating,CC,
10803,GO:0042572,1,0.852793885107137,0,27,retinol metabolic process,BP,
10804,GO:0042573,1,0.904633873165986,0,17,retinoic acid metabolic process,BP,
10805,GO:0042574,1,0.924708614220707,0,13,retinal metabolic process,BP,
10806,GO:0042575,1,0.896552950110836,0,16,DNA polymerase complex,CC,
10807,GO:0042577,1,0.988625426916342,0,2,lipid phosphatase activity,MF,
10812,GO:0042583,1,0.944959052702248,0,8,chromaffin granule,CC,
10813,GO:0042584,1,0.955538297854234,0,6,chromaffin granule membrane,CC,
10814,GO:0042585,1,0.994566507078466,0,1,germinal vesicle,CC,
10815,GO:0042586,1,0.994804808863941,0,1,peptide deformylase activity,MF,
10816,GO:0042587,1,0.964379395981699,0,5,glycogen granule,CC,
10817,GO:0042588,1,0.92525330315113,0,12,zymogen granule,CC,
10818,GO:0042589,1,0.937125384412885,0,10,zymogen granule membrane,CC,
10823,GO:0042595,1,0.98834983620937,0,2,behavioral response to starvation,BP,
10824,GO:0042596,1,0.786562886994582,0,37,fear response,BP,
10825,GO:0042599,1,0.906716137843196,0,16,lamellar body,CC,
10826,GO:0042602,1,0.994827469416644,0,1,riboflavin reductase (NADPH) activity,MF,
10828,GO:0042608,1,0.959841474218074,0,7,T cell receptor binding,MF,
10829,GO:0042609,1,0.957192259313048,0,7,CD4 receptor binding,MF,
10830,GO:0042610,1,0.989259013514813,0,2,CD8 receptor binding,MF,
10832,GO:0042612,1,0.958879370332994,0,8,MHC class I protein complex,CC,
10836,GO:0042624,1,0.994834972089459,0,1,ATPase activity, uncoupled,MF,
10837,GO:0042625,1,0.693510389808081,0,53,ATPase coupled ion transmembrane transporter activity,MF,
10839,GO:0042627,1,0.941732768817124,0,9,chylomicron,CC,
10840,GO:0042628,1,0.994556924097726,0,1,mating plug formation,BP,
10842,GO:0042631,1,0.986974380614311,0,2,cellular response to water deprivation,BP,
10843,GO:0042632,1,0.710082400465144,0,53,cholesterol homeostasis,BP,
10846,GO:0042635,1,0.927212481755443,0,12,positive regulation of hair cycle,BP,
10848,GO:0042637,1,0.97485582631457,0,4,catagen,BP,
10850,GO:0042641,1,0.613652844664987,0,64,actomyosin,CC,
10851,GO:0042643,1,0.987874721527445,0,2,actomyosin, actin portion,CC,
10852,GO:0042645,1,0.773379354230417,0,41,mitochondrial nucleoid,CC,
10853,GO:0042658,1,0.994786913167145,0,1,MHC class II protein binding, via antigen binding groove,MF,
10854,GO:0042659,1,0.930745287669721,0,11,regulation of cell fate specification,BP,
10855,GO:0042660,1,0.990495140566307,0,1,positive regulation of cell fate specification,BP,
10856,GO:0042661,1,0.964561348124469,0,6,regulation of mesodermal cell fate specification,BP,
10857,GO:0042662,1,0.978843104056013,0,4,negative regulation of mesodermal cell fate specification,BP,
10858,GO:0042663,1,0.983997296163206,0,3,regulation of endodermal cell fate specification,BP,
10859,GO:0042664,1,0.994804610227398,0,1,negative regulation of endodermal cell fate specification,BP,
10860,GO:0042665,1,0.993489199089586,0,1,regulation of ectodermal cell fate specification,BP,
10861,GO:0042666,1,0.993489199089586,0,1,negative regulation of ectodermal cell fate specification,BP,
10862,GO:0042668,1,0.989582364206258,0,2,auditory receptor cell fate determination,BP,
10863,GO:0042670,1,0.951466528848692,0,8,retinal cone cell differentiation,BP,
10865,GO:0042693,1,0.9309818943278,0,12,muscle cell fate commitment,BP,
10866,GO:0042695,1,0.965189727110533,0,5,thelarche,BP,
10868,GO:0042699,1,0.989279371320692,0,2,follicle-stimulating hormone signaling pathway,BP,
10869,GO:0042700,1,0.992729695234148,0,1,luteinizing hormone signaling pathway,BP,
10870,GO:0042701,1,0.974190899517372,0,4,progesterone secretion,BP,
10871,GO:0042704,1,0.986228844180182,0,2,uterine wall breakdown,BP,
10872,GO:0042709,1,0.994519458898102,0,1,succinate-CoA ligase complex,CC,
10874,GO:0042711,1,0.924898892290368,0,12,maternal behavior,BP,
10875,GO:0042713,1,0.965577019017478,0,5,sperm ejaculation,BP,
10876,GO:0042719,1,0.973717453304202,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10877,GO:0042720,1,0.989613355100573,0,2,mitochondrial inner membrane peptidase complex,CC,
10878,GO:0042721,1,0.973192417143164,0,5,mitochondrial inner membrane protein insertion complex,CC,
10879,GO:0042723,1,0.960692600603339,0,7,thiamine-containing compound metabolic process,BP,
10880,GO:0042726,1,0.951016160605549,0,8,flavin-containing compound metabolic process,BP,
10881,GO:0042727,1,0.989035072055201,0,2,flavin-containing compound biosynthetic process,BP,
10882,GO:0042728,1,0.993467149498226,0,1,flavin-containing compound catabolic process,BP,
10884,GO:0042731,1,0.974002992020901,0,4,PH domain binding,MF,
10885,GO:0042732,1,0.983356483529681,0,3,D-xylose metabolic process,BP,
10886,GO:0042733,1,0.65548275262671,0,60,embryonic digit morphogenesis,BP,
10889,GO:0042738,1,0.914796957117859,0,15,exogenous drug catabolic process,BP,
10891,GO:0042743,1,0.790136864848349,0,40,hydrogen peroxide metabolic process,BP,
10892,GO:0042744,1,0.881386273306886,0,21,hydrogen peroxide catabolic process,BP,
10893,GO:0042745,1,0.865247660278236,0,24,circadian sleep/wake cycle,BP,
10894,GO:0042746,1,0.976918310207008,0,4,circadian sleep/wake cycle, wakefulness,BP,
10895,GO:0042747,1,0.95549981093393,0,8,circadian sleep/wake cycle, REM sleep,BP,
10896,GO:0042748,1,0.948291061347075,0,8,circadian sleep/wake cycle, non-REM sleep,BP,
10897,GO:0042749,1,0.899325717663893,0,18,regulation of circadian sleep/wake cycle,BP,
10898,GO:0042752,1,0.531060600546261,0,92,regulation of circadian rhythm,BP,
10899,GO:0042753,1,0.90056525294062,0,16,positive regulation of circadian rhythm,BP,
10900,GO:0042754,1,0.921566200192442,0,13,negative regulation of circadian rhythm,BP,
10901,GO:0042755,1,0.855812184152423,0,25,eating behavior,BP,
10902,GO:0042756,1,0.955423580163761,0,8,drinking behavior,BP,
10903,GO:0042758,1,0.955280604799964,0,8,long-chain fatty acid catabolic process,BP,
10904,GO:0042759,1,0.915672155142099,0,12,long-chain fatty acid biosynthetic process,BP,
10905,GO:0042760,1,0.958624243386602,0,7,very long-chain fatty acid catabolic process,BP,
10906,GO:0042761,1,0.932329976810496,0,12,very long-chain fatty acid biosynthetic process,BP,
10907,GO:0042762,1,0.88964149895594,0,17,regulation of sulfur metabolic process,BP,
10908,GO:0042765,1,0.971191116161672,0,5,GPI-anchor transamidase complex,CC,
10909,GO:0042766,1,0.988986446945411,0,1,nucleosome mobilization,BP,
10910,GO:0042769,1,0.800864459472664,0,37,DNA damage response, detection of DNA damage,BP,
10911,GO:0042770,1,0.424522928696227,0,127,signal transduction in response to DNA damage,BP,
10912,GO:0042771,1,0.761661141041281,0,42,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10913,GO:0042772,1,0.866714007950624,0,20,DNA damage response, signal transduction resulting in transcription,BP,
10914,GO:0042773,1,0.640073690738339,0,81,ATP synthesis coupled electron transport,BP,
10915,GO:0042774,1,0.994313214468247,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10916,GO:0042775,1,0.643750692846704,0,80,mitochondrial ATP synthesis coupled electron transport,BP,
10917,GO:0042776,1,0.979366065341826,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10918,GO:0042779,1,0.988118019550024,0,2,tRNA 3'-trailer cleavage,BP,
10919,GO:0042780,1,0.961274670468149,0,7,tRNA 3'-end processing,BP,
10920,GO:0042781,1,0.988118019550024,0,2,3'-tRNA processing endoribonuclease activity,MF,
10921,GO:0042788,1,0.839228892904471,0,30,polysomal ribosome,CC,
10922,GO:0042789,1,0.879438422242525,0,19,mRNA transcription by RNA polymerase II,BP,
10923,GO:0042790,1,0.925843197801901,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10924,GO:0042791,1,0.961185256183377,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10925,GO:0042795,1,0.664026588759881,0,66,snRNA transcription by RNA polymerase II,BP,
10926,GO:0042796,1,0.964286195857676,0,6,snRNA transcription by RNA polymerase III,BP,
10927,GO:0042797,1,0.961185256183377,0,6,tRNA transcription by RNA polymerase III,BP,
10928,GO:0042799,1,0.984976842167144,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10929,GO:0042800,1,0.896201328824342,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10932,GO:0042805,1,0.713606339037483,0,41,actinin binding,MF,
10933,GO:0042806,1,0.977964876551983,0,4,fucose binding,MF,
10934,GO:0042809,1,0.894647248875555,0,15,vitamin D receptor binding,MF,
10935,GO:0042813,1,0.856291294462344,0,22,Wnt-activated receptor activity,MF,
10936,GO:0042816,1,0.96579717156492,0,5,vitamin B6 metabolic process,BP,
10937,GO:0042819,1,0.978449249785332,0,3,vitamin B6 biosynthetic process,BP,
10938,GO:0042820,1,0.994644568067902,0,1,vitamin B6 catabolic process,BP,
10939,GO:0042822,1,0.978486005148907,0,3,pyridoxal phosphate metabolic process,BP,
10940,GO:0042823,1,0.983755300327633,0,2,pyridoxal phosphate biosynthetic process,BP,
10941,GO:0042824,1,0.976194619226697,0,4,MHC class I peptide loading complex,CC,
10942,GO:0042825,1,0.981427285897645,0,3,TAP complex,CC,
10943,GO:0042826,1,0.492497498192415,0,104,histone deacetylase binding,MF,
10944,GO:0042827,1,0.893324487609012,0,18,platelet dense granule,CC,
10945,GO:0042832,1,0.888876995639225,0,19,defense response to protozoan,BP,
10946,GO:0042834,1,0.946692255181908,0,9,peptidoglycan binding,MF,
10947,GO:0042835,1,0.985988360863592,0,2,BRE binding,MF,
10948,GO:0042839,1,0.994763606144711,0,1,D-glucuronate metabolic process,BP,
10949,GO:0042840,1,0.994763606144711,0,1,D-glucuronate catabolic process,BP,
10950,GO:0042843,1,0.994811513569139,0,1,D-xylose catabolic process,BP,
10951,GO:0042851,1,0.982933208727685,0,3,L-alanine metabolic process,BP,
10952,GO:0042853,1,0.982933208727685,0,3,L-alanine catabolic process,BP,
10953,GO:0042866,1,0.520852362088786,0,96,pyruvate biosynthetic process,BP,
10954,GO:0042883,1,0.993595945906608,0,1,cysteine transport,BP,
10956,GO:0042887,1,0.806254437783992,0,36,amide transmembrane transporter activity,MF,
10957,GO:0042891,1,0.951710038941886,0,8,antibiotic transport,BP,
10958,GO:0042895,1,0.964833607240628,0,6,antibiotic transmembrane transporter activity,MF,
10959,GO:0042903,1,0.98792605280832,0,2,tubulin deacetylase activity,MF,
10960,GO:0042904,1,0.977728980066791,0,4,9-cis-retinoic acid biosynthetic process,BP,
10961,GO:0042905,1,0.977728980066791,0,4,9-cis-retinoic acid metabolic process,BP,
10964,GO:0042921,1,0.895984136468785,0,15,glucocorticoid receptor signaling pathway,BP,
10965,GO:0042922,1,0.994829653520256,0,1,neuromedin U receptor binding,MF,
10966,GO:0042923,1,0.897946733062006,0,19,neuropeptide binding,MF,
10967,GO:0042924,1,0.98863575315942,0,2,neuromedin U binding,MF,
10968,GO:0042930,1,0.994313214468247,0,1,enterobactin transport,BP,
10969,GO:0042931,1,0.994313214468247,0,1,enterobactin transmembrane transporter activity,MF,
10970,GO:0042937,1,0.990869091843867,0,1,tripeptide transmembrane transporter activity,MF,
10971,GO:0042938,1,0.989136565088683,0,2,dipeptide transport,BP,
10972,GO:0042939,1,0.985561484989307,0,2,tripeptide transport,BP,
10973,GO:0042940,1,0.95585212304568,0,6,D-amino acid transport,BP,
10974,GO:0042941,1,0.994659055545952,0,1,D-alanine transport,BP,
10975,GO:0042942,1,0.989105301856042,0,2,D-serine transport,BP,
10976,GO:0042946,1,0.994313214468247,0,1,glucoside transport,BP,
10977,GO:0042947,1,0.994313214468247,0,1,glucoside transmembrane transporter activity,MF,
10978,GO:0042953,1,0.880276613982963,0,13,lipoprotein transport,BP,
10979,GO:0042954,1,0.940038918048228,0,6,lipoprotein transporter activity,MF,
10980,GO:0042974,1,0.845297988083701,0,24,retinoic acid receptor binding,MF,
10981,GO:0042975,1,0.916914822933191,0,11,peroxisome proliferator activated receptor binding,MF,
10982,GO:0042976,1,0.938232896641305,0,9,activation of Janus kinase activity,BP,
10983,GO:0042978,1,0.973299441557804,0,3,ornithine decarboxylase activator activity,MF,
10984,GO:0042979,1,0.958095133689568,0,6,ornithine decarboxylase regulator activity,MF,
10986,GO:0042982,1,0.737855738558671,0,46,amyloid precursor protein metabolic process,BP,
10987,GO:0042983,1,0.940460170652937,0,10,amyloid precursor protein biosynthetic process,BP,
10988,GO:0042984,1,0.940460170652937,0,10,regulation of amyloid precursor protein biosynthetic process,BP,
10989,GO:0042985,1,0.969094570815389,0,5,negative regulation of amyloid precursor protein biosynthetic process,BP,
10990,GO:0042986,1,0.988565543703135,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10991,GO:0042987,1,0.801698852511257,0,32,amyloid precursor protein catabolic process,BP,
10992,GO:0042988,1,0.992148316418677,0,1,X11-like protein binding,MF,
10993,GO:0042989,1,0.947615467369526,0,10,sequestering of actin monomers,BP,
10994,GO:0042994,1,0.890939736473759,0,18,cytoplasmic sequestering of transcription factor,BP,
10996,GO:0042996,1,0.96316013162116,0,6,regulation of Golgi to plasma membrane protein transport,BP,
10997,GO:0042997,1,0.976312161160687,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
10998,GO:0042998,1,0.986532076211577,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10999,GO:0042999,1,0.992765712660246,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
11000,GO:0043000,1,0.987571376924087,0,2,Golgi to plasma membrane CFTR protein transport,BP,
11001,GO:0043001,1,0.805921426397316,0,31,Golgi to plasma membrane protein transport,BP,
11002,GO:0043002,1,0.992765712660246,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
11003,GO:0043004,1,0.992765712660246,0,1,cytoplasmic sequestering of CFTR protein,BP,
11005,GO:0043006,1,0.989082128430026,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
11006,GO:0043008,1,0.955426180487812,0,8,ATP-dependent protein binding,MF,
11009,GO:0043011,1,0.915281300029999,0,15,myeloid dendritic cell differentiation,BP,
11010,GO:0043012,1,0.994410724965491,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11011,GO:0043014,1,0.835305357018252,0,27,alpha-tubulin binding,MF,
11012,GO:0043015,1,0.842464348650837,0,26,gamma-tubulin binding,MF,
11013,GO:0043016,1,0.994346750857925,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11014,GO:0043017,1,0.994346750857925,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11015,GO:0043020,1,0.950189955325253,0,9,NADPH oxidase complex,CC,
11017,GO:0043022,1,0.734128975281638,0,47,ribosome binding,MF,
11018,GO:0043023,1,0.934086759614344,0,11,ribosomal large subunit binding,MF,
11019,GO:0043024,1,0.913948970749359,0,14,ribosomal small subunit binding,MF,
11021,GO:0043027,1,0.862541931180602,0,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
11022,GO:0043028,1,0.781652056144731,0,38,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
11023,GO:0043029,1,0.791845815487362,0,37,T cell homeostasis,BP,
11024,GO:0043030,1,0.777755471493716,0,36,regulation of macrophage activation,BP,
11025,GO:0043031,1,0.955336866885208,0,8,negative regulation of macrophage activation,BP,
11026,GO:0043032,1,0.869693181211573,0,21,positive regulation of macrophage activation,BP,
11027,GO:0043033,1,0.990048852467886,0,1,isoamylase complex,CC,
11028,GO:0043034,1,0.837594828179992,0,19,costamere,CC,
11029,GO:0043035,1,0.993538403096635,0,1,chromatin insulator sequence binding,MF,
11030,GO:0043038,1,0.734287184381168,0,53,amino acid activation,BP,
11031,GO:0043039,1,0.738930021747022,0,52,tRNA aminoacylation,BP,
11032,GO:0043041,1,0.99373574128605,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11034,GO:0043044,1,0.664561659921176,0,62,ATP-dependent chromatin remodeling,BP,
11035,GO:0043045,1,0.956000897929254,0,6,DNA methylation involved in embryo development,BP,
11036,GO:0043046,1,0.900904349108839,0,17,DNA methylation involved in gamete generation,BP,
11037,GO:0043047,1,0.934446907149812,0,11,single-stranded telomeric DNA binding,MF,
11038,GO:0043048,1,0.994580023477462,0,1,dolichyl monophosphate biosynthetic process,BP,
11039,GO:0043049,1,0.994125776747889,0,1,otic placode formation,BP,
11040,GO:0043060,1,0.994470477599369,0,1,meiotic metaphase I plate congression,BP,
11042,GO:0043063,1,0.992456129128113,0,1,intercellular bridge organization,BP,
11048,GO:0043073,1,0.922964869754771,0,13,germ cell nucleus,CC,
11050,GO:0043084,1,0.95268431979732,0,7,penile erection,BP,
11054,GO:0043090,1,0.858007542698882,0,22,amino acid import,BP,
11056,GO:0043095,1,0.994834130876615,0,1,regulation of GTP cyclohydrolase I activity,BP,
11057,GO:0043096,1,0.973724107304238,0,5,purine nucleobase salvage,BP,
11059,GO:0043101,1,0.923106372681912,0,14,purine-containing compound salvage,BP,
11060,GO:0043102,1,0.96046814482731,0,7,amino acid salvage,BP,
11061,GO:0043103,1,0.984032953871424,0,3,hypoxanthine salvage,BP,
11062,GO:0043105,1,0.994834130876615,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11063,GO:0043111,1,0.987008183643465,0,2,replication fork arrest,BP,
11068,GO:0043117,1,0.943351149675371,0,10,positive regulation of vascular permeability,BP,
11069,GO:0043120,1,0.971563153925846,0,5,tumor necrosis factor binding,MF,
11070,GO:0043121,1,0.931698424190698,0,10,neurotrophin binding,MF,
11073,GO:0043124,1,0.761672856512744,0,39,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11074,GO:0043125,1,0.973678990312226,0,4,ErbB-3 class receptor binding,MF,
11075,GO:0043126,1,0.994759422258622,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11076,GO:0043128,1,0.994759422258622,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11077,GO:0043129,1,0.948063608045302,0,8,surfactant homeostasis,BP,
11078,GO:0043130,1,0.663411800335908,0,65,ubiquitin binding,MF,
11079,GO:0043131,1,0.992184511093937,0,1,erythrocyte enucleation,BP,
11080,GO:0043132,1,0.988660791790463,0,2,NAD transport,BP,
11081,GO:0043136,1,0.99408046807447,0,1,glycerol-3-phosphatase activity,MF,
11082,GO:0043137,1,0.977226324392297,0,4,DNA replication, removal of RNA primer,BP,
11083,GO:0043138,1,0.923629562372288,0,12,3'-5' DNA helicase activity,MF,
11084,GO:0043139,1,0.959355598300516,0,7,5'-3' DNA helicase activity,MF,
11085,GO:0043140,1,0.950668150040069,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
11086,GO:0043141,1,0.971445143835299,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11087,GO:0043142,1,0.919067756290808,0,13,single-stranded DNA-dependent ATPase activity,MF,
11088,GO:0043144,1,0.958529102512152,0,8,snoRNA processing,BP,
11089,GO:0043149,1,0.547046035876329,0,86,stress fiber assembly,BP,
11090,GO:0043152,1,0.974114283445168,0,4,induction of bacterial agglutination,BP,
11091,GO:0043153,1,0.873040143309497,0,21,entrainment of circadian clock by photoperiod,BP,
11092,GO:0043154,1,0.578281104384377,0,86,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11093,GO:0043159,1,0.988532218647765,0,2,acrosomal matrix,CC,
11094,GO:0043161,1,0.0813604325611325,0,387,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
11095,GO:0043162,1,0.894053321286256,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11096,GO:0043163,1,0.988703107569594,0,2,cell envelope organization,BP,
11101,GO:0043171,1,0.852071120422179,0,25,peptide catabolic process,BP,
11102,GO:0043173,1,0.919178370839484,0,15,nucleotide salvage,BP,
11104,GO:0043175,1,0.795940219591796,0,35,RNA polymerase core enzyme binding,MF,
11105,GO:0043176,1,0.938596124958901,0,11,amine binding,MF,
11107,GO:0043178,1,0.61764330044283,0,69,alcohol binding,MF,
11108,GO:0043179,1,0.994614803267906,0,1,rhythmic excitation,BP,
11109,GO:0043181,1,0.993704826320826,0,1,vacuolar sequestering,BP,
11110,GO:0043183,1,0.988617117928824,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11111,GO:0043184,1,0.95587137144711,0,7,vascular endothelial growth factor receptor 2 binding,MF,
11112,GO:0043185,1,0.994620146783351,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11113,GO:0043186,1,0.915673286007016,0,14,P granule,CC,
11114,GO:0043189,1,0.888665140100725,0,18,H4/H2A histone acetyltransferase complex,CC,
11115,GO:0043190,1,0.950094397177386,0,7,ATP-binding cassette (ABC) transporter complex,CC,
11116,GO:0043194,1,0.898247031452328,0,12,axon initial segment,CC,
11118,GO:0043196,1,0.958965391852138,0,7,varicosity,CC,
11120,GO:0043198,1,0.785201702179114,0,35,dendritic shaft,CC,
11121,GO:0043199,1,0.972334515448933,0,4,sulfate binding,MF,
11123,GO:0043201,1,0.909305757927697,0,12,response to leucine,BP,
11125,GO:0043203,1,0.959346840920328,0,7,axon hillock,CC,
11128,GO:0043208,1,0.960729880787977,0,7,glycosphingolipid binding,MF,
11130,GO:0043210,1,0.994695815547396,0,1,alkanesulfonate binding,MF,
11131,GO:0043215,1,0.993356305776653,0,1,daunorubicin transport,BP,
11132,GO:0043217,1,0.88372617807633,0,14,myelin maintenance,BP,
11134,GO:0043219,1,0.973976010398803,0,4,lateral loop,CC,
11136,GO:0043221,1,0.993471752082344,0,1,SMC family protein binding,MF,
11137,GO:0043224,1,0.989609487700207,0,2,nuclear SCF ubiquitin ligase complex,CC,
11149,GO:0043237,1,0.964338591374091,0,5,laminin-1 binding,MF,
11150,GO:0043240,1,0.944503341919644,0,9,Fanconi anaemia nuclear complex,CC,
11151,GO:0043242,1,0.62895191161357,0,62,negative regulation of protein complex disassembly,BP,
11152,GO:0043243,1,0.795182310209102,0,31,positive regulation of protein complex disassembly,BP,
11153,GO:0043244,1,0.476556994764886,0,98,regulation of protein complex disassembly,BP,
11154,GO:0043247,1,0.916627321684264,0,13,telomere maintenance in response to DNA damage,BP,
11155,GO:0043248,1,0.937981617128475,0,12,proteasome assembly,BP,
11156,GO:0043249,1,0.925380740250338,0,13,erythrocyte maturation,BP,
11157,GO:0043250,1,0.994758920604275,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11158,GO:0043251,1,0.994758920604275,0,1,sodium-dependent organic anion transport,BP,
11159,GO:0043252,1,0.84439525846258,0,27,sodium-independent organic anion transport,BP,
11160,GO:0043254,1,0.0647773456127904,0,404,regulation of protein complex assembly,BP,
11161,GO:0043255,1,0.621508915493428,0,67,regulation of carbohydrate biosynthetic process,BP,
11162,GO:0043256,1,0.923346529241059,0,8,laminin complex,CC,
11163,GO:0043257,1,0.991425974290652,0,1,laminin-8 complex,CC,
11164,GO:0043259,1,0.967084111274801,0,3,laminin-10 complex,CC,
11165,GO:0043260,1,0.967126155485479,0,3,laminin-11 complex,CC,
11166,GO:0043262,1,0.982743097553569,0,3,adenosine-diphosphatase activity,MF,
11167,GO:0043265,1,0.994074699475074,0,1,ectoplasm,CC,
11169,GO:0043267,1,0.845767788831745,0,25,negative regulation of potassium ion transport,BP,
11170,GO:0043268,1,0.752957574735512,0,39,positive regulation of potassium ion transport,BP,
11173,GO:0043271,1,0.461583608672094,0,119,negative regulation of ion transport,BP,
11174,GO:0043273,1,0.991920432332567,0,1,CTPase activity,MF,
11175,GO:0043274,1,0.915003909154742,0,13,phospholipase binding,MF,
11176,GO:0043276,1,0.819341327403502,0,29,anoikis,BP,
11180,GO:0043280,1,0.466150128295175,0,122,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11181,GO:0043281,1,0.274346847524006,0,204,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11182,GO:0043291,1,0.97313791334639,0,2,RAVE complex,CC,
11183,GO:0043292,1,0.190738962461738,0,216,contractile fiber,CC,
11184,GO:0043293,1,0.984943438295487,0,2,apoptosome,CC,
11185,GO:0043295,1,0.940175409135189,0,11,glutathione binding,MF,
11186,GO:0043296,1,0.404827048320403,0,124,apical junction complex,CC,
11187,GO:0043297,1,0.676501545553855,0,57,apical junction assembly,BP,
11189,GO:0043300,1,0.775646181940857,0,41,regulation of leukocyte degranulation,BP,
11190,GO:0043301,1,0.934795518459085,0,11,negative regulation of leukocyte degranulation,BP,
11191,GO:0043302,1,0.883507648846941,0,20,positive regulation of leukocyte degranulation,BP,
11193,GO:0043304,1,0.85043860966415,0,27,regulation of mast cell degranulation,BP,
11194,GO:0043305,1,0.967779514951947,0,6,negative regulation of mast cell degranulation,BP,
11195,GO:0043306,1,0.930510010663208,0,12,positive regulation of mast cell degranulation,BP,
11196,GO:0043307,1,0.973047622633446,0,5,eosinophil activation,BP,
11197,GO:0043308,1,0.978256734112049,0,4,eosinophil degranulation,BP,
11198,GO:0043309,1,0.9835733267752,0,3,regulation of eosinophil degranulation,BP,
11199,GO:0043310,1,0.99445621570624,0,1,negative regulation of eosinophil degranulation,BP,
11200,GO:0043311,1,0.98905704805041,0,2,positive regulation of eosinophil degranulation,BP,
11202,GO:0043313,1,0.945216848211246,0,8,regulation of neutrophil degranulation,BP,
11203,GO:0043314,1,0.98252848702483,0,2,negative regulation of neutrophil degranulation,BP,
11204,GO:0043315,1,0.974762053342644,0,4,positive regulation of neutrophil degranulation,BP,
11205,GO:0043316,1,0.982950912143034,0,3,cytotoxic T cell degranulation,BP,
11206,GO:0043317,1,0.9885892741724,0,2,regulation of cytotoxic T cell degranulation,BP,
11207,GO:0043318,1,0.9885892741724,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11208,GO:0043320,1,0.96724440154693,0,5,natural killer cell degranulation,BP,
11209,GO:0043321,1,0.984893253847284,0,2,regulation of natural killer cell degranulation,BP,
11210,GO:0043323,1,0.984893253847284,0,2,positive regulation of natural killer cell degranulation,BP,
11211,GO:0043324,1,0.981425848523462,0,3,pigment metabolic process involved in developmental pigmentation,BP,
11212,GO:0043325,1,0.871177304089084,0,20,phosphatidylinositol-3,4-bisphosphate binding,MF,
11213,GO:0043328,1,0.9775436783752,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11214,GO:0043330,1,0.838162131278083,0,28,response to exogenous dsRNA,BP,
11215,GO:0043331,1,0.593346645355238,0,78,response to dsRNA,BP,
11216,GO:0043335,1,0.988491735740781,0,2,protein unfolding,BP,
11217,GO:0043337,1,0.993530696504981,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11218,GO:0043353,1,0.943955255039124,0,8,enucleate erythrocyte differentiation,BP,
11219,GO:0043354,1,0.992184511093937,0,1,enucleate erythrocyte maturation,BP,
11220,GO:0043363,1,0.994313214468247,0,1,nucleate erythrocyte differentiation,BP,
11221,GO:0043366,1,0.981749566489403,0,3,beta selection,BP,
11223,GO:0043368,1,0.830972528247457,0,28,positive T cell selection,BP,
11224,GO:0043369,1,0.890376953157384,0,18,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11228,GO:0043373,1,0.916615991752419,0,14,CD4-positive, alpha-beta T cell lineage commitment,BP,
11229,GO:0043374,1,0.946360864182876,0,9,CD8-positive, alpha-beta T cell differentiation,BP,
11230,GO:0043375,1,0.993489657296534,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11231,GO:0043376,1,0.987161747913733,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11232,GO:0043378,1,0.993423662588231,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11233,GO:0043379,1,0.960321137928364,0,6,memory T cell differentiation,BP,
11234,GO:0043380,1,0.971361297130227,0,5,regulation of memory T cell differentiation,BP,
11235,GO:0043382,1,0.977456657947455,0,4,positive regulation of memory T cell differentiation,BP,
11236,GO:0043383,1,0.931522522981865,0,11,negative T cell selection,BP,
11237,GO:0043385,1,0.994333682075354,0,1,mycotoxin metabolic process,BP,
11238,GO:0043387,1,0.994333682075354,0,1,mycotoxin catabolic process,BP,
11239,GO:0043388,1,0.717962406839425,0,51,positive regulation of DNA binding,BP,
11240,GO:0043392,1,0.71247792237298,0,51,negative regulation of DNA binding,BP,
11242,GO:0043394,1,0.766546763494452,0,35,proteoglycan binding,MF,
11243,GO:0043395,1,0.863057402155246,0,19,heparan sulfate proteoglycan binding,MF,
11244,GO:0043396,1,0.986663403879483,0,2,corticotropin-releasing hormone secretion,BP,
11245,GO:0043397,1,0.986663403879483,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11246,GO:0043398,1,0.980693936086082,0,3,HLH domain binding,MF,
11247,GO:0043400,1,0.970110717844311,0,5,cortisol secretion,BP,
11248,GO:0043401,1,0.289630504236168,0,179,steroid hormone mediated signaling pathway,BP,
11249,GO:0043402,1,0.96961535520809,0,3,glucocorticoid mediated signaling pathway,BP,
11251,GO:0043405,1,0.119459434202161,0,315,regulation of MAP kinase activity,BP,
11252,GO:0043406,1,0.184876651764108,0,249,positive regulation of MAP kinase activity,BP,
11253,GO:0043407,1,0.65542256935833,0,67,negative regulation of MAP kinase activity,BP,
11259,GO:0043414,1,0.186765198356913,0,253,macromolecule methylation,BP,
11260,GO:0043415,1,0.970297924496232,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11261,GO:0043416,1,0.970297924496232,0,5,regulation of skeletal muscle tissue regeneration,BP,
11262,GO:0043418,1,0.982954826775376,0,3,homocysteine catabolic process,BP,
11263,GO:0043420,1,0.994761655063573,0,1,anthranilate metabolic process,BP,
11264,GO:0043422,1,0.922510583528479,0,12,protein kinase B binding,MF,
11265,GO:0043423,1,0.993008503441638,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11266,GO:0043425,1,0.84710103237196,0,24,bHLH transcription factor binding,MF,
11267,GO:0043426,1,0.964157624241513,0,5,MRF binding,MF,
11268,GO:0043433,1,0.37239312647995,0,150,negative regulation of DNA binding transcription factor activity,BP,
11270,GO:0043435,1,0.969713337072914,0,5,response to corticotropin-releasing hormone,BP,
11272,GO:0043438,1,0.994251609152875,0,1,acetoacetic acid metabolic process,BP,
11274,GO:0043455,1,0.92347283303233,0,11,regulation of secondary metabolic process,BP,
11275,GO:0043456,1,0.979098321865469,0,4,regulation of pentose-phosphate shunt,BP,
11276,GO:0043457,1,0.873154057370057,0,21,regulation of cellular respiration,BP,
11277,GO:0043461,1,0.977591938176683,0,4,proton-transporting ATP synthase complex assembly,BP,
11279,GO:0043467,1,0.462563227870906,0,108,regulation of generation of precursor metabolites and energy,BP,
11280,GO:0043470,1,0.612680557645401,0,69,regulation of carbohydrate catabolic process,BP,
11281,GO:0043471,1,0.94849407826193,0,9,regulation of cellular carbohydrate catabolic process,BP,
11282,GO:0043473,1,0.526306164466261,0,93,pigmentation,BP,
11283,GO:0043474,1,0.981425848523462,0,3,pigment metabolic process involved in pigmentation,BP,
11284,GO:0043476,1,0.917189225831951,0,12,pigment accumulation,BP,
11285,GO:0043482,1,0.917189225831951,0,12,cellular pigment accumulation,BP,
11287,GO:0043485,1,0.939439639580976,0,10,endosome to pigment granule transport,BP,
11288,GO:0043486,1,0.783517689078357,0,40,histone exchange,BP,
11291,GO:0043489,1,0.784735262486746,0,36,RNA stabilization,BP,
11292,GO:0043490,1,0.987408673467991,0,2,malate-aspartate shuttle,BP,
11295,GO:0043495,1,0.929132378457993,0,10,protein membrane anchor,MF,
11296,GO:0043496,1,0.873847155601401,0,21,regulation of protein homodimerization activity,BP,
11297,GO:0043497,1,0.939644853375038,0,10,regulation of protein heterodimerization activity,BP,
11298,GO:0043500,1,0.560120625531129,0,84,muscle adaptation,BP,
11299,GO:0043501,1,0.863798511302814,0,21,skeletal muscle adaptation,BP,
11300,GO:0043502,1,0.605329191933576,0,68,regulation of muscle adaptation,BP,
11301,GO:0043503,1,0.98948624607,0,2,skeletal muscle fiber adaptation,BP,
11302,GO:0043504,1,0.980709911639034,0,3,mitochondrial DNA repair,BP,
11303,GO:0043506,1,0.587666383807552,0,77,regulation of JUN kinase activity,BP,
11304,GO:0043507,1,0.634367484445507,0,64,positive regulation of JUN kinase activity,BP,
11305,GO:0043508,1,0.924167074058106,0,13,negative regulation of JUN kinase activity,BP,
11306,GO:0043509,1,0.994589950888657,0,1,activin A complex,CC,
11307,GO:0043511,1,0.989390028545291,0,2,inhibin complex,CC,
11308,GO:0043512,1,0.989390028545291,0,2,inhibin A complex,CC,
11309,GO:0043513,1,0.994772076056773,0,1,inhibin B complex,CC,
11310,GO:0043514,1,0.994769348797587,0,1,interleukin-12 complex,CC,
11311,GO:0043515,1,0.96192866388788,0,5,kinetochore binding,MF,
11312,GO:0043516,1,0.825615271275864,0,29,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11313,GO:0043517,1,0.905484534865204,0,14,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11314,GO:0043518,1,0.916719098889459,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11315,GO:0043519,1,0.994611358350175,0,1,regulation of myosin II filament organization,BP,
11316,GO:0043522,1,0.944663320573973,0,9,leucine zipper domain binding,MF,
11319,GO:0043525,1,0.736815889761796,0,46,positive regulation of neuron apoptotic process,BP,
11320,GO:0043527,1,0.97301021041857,0,5,tRNA methyltransferase complex,CC,
11321,GO:0043531,1,0.795409310021416,0,33,ADP binding,MF,
11322,GO:0043532,1,0.990533087038249,0,1,angiostatin binding,MF,
11323,GO:0043533,1,0.960019419047503,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11327,GO:0043537,1,0.818153705415286,0,29,negative regulation of blood vessel endothelial cell migration,BP,
11328,GO:0043538,1,0.994140999635304,0,1,regulation of actin phosphorylation,BP,
11330,GO:0043540,1,0.994712195059427,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11331,GO:0043541,1,0.987781827629299,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11333,GO:0043543,1,0.24019357095711,0,215,protein acylation,BP,
11334,GO:0043544,1,0.993720324739055,0,1,lipoamide binding,MF,
11335,GO:0043545,1,0.959806553825593,0,7,molybdopterin cofactor metabolic process,BP,
11336,GO:0043546,1,0.960835305453415,0,6,molybdopterin cofactor binding,MF,
11338,GO:0043548,1,0.809747482083647,0,27,phosphatidylinositol 3-kinase binding,MF,
11340,GO:0043550,1,0.727996251063725,0,47,regulation of lipid kinase activity,BP,
11341,GO:0043551,1,0.76035999028961,0,40,regulation of phosphatidylinositol 3-kinase activity,BP,
11342,GO:0043552,1,0.813930653987577,0,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,
11343,GO:0043553,1,0.987399060860173,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11344,GO:0043555,1,0.888596979175843,0,18,regulation of translation in response to stress,BP,
11345,GO:0043558,1,0.913843644132326,0,14,regulation of translational initiation in response to stress,BP,
11346,GO:0043559,1,0.952828956127779,0,5,insulin binding,MF,
11347,GO:0043560,1,0.915947340563125,0,11,insulin receptor substrate binding,MF,
11348,GO:0043562,1,0.940271910194968,0,11,cellular response to nitrogen levels,BP,
11349,GO:0043564,1,0.988473661389352,0,2,Ku70:Ku80 complex,CC,
11352,GO:0043568,1,0.934297558170872,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11353,GO:0043569,1,0.952148107949658,0,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11354,GO:0043570,1,0.966745252975045,0,5,maintenance of DNA repeat elements,BP,
11355,GO:0043574,1,0.895235400668234,0,18,peroxisomal transport,BP,
11357,GO:0043578,1,0.967082076900176,0,3,nuclear matrix organization,BP,
11359,GO:0043584,1,0.887718623734306,0,16,nose development,BP,
11360,GO:0043585,1,0.975110357559409,0,3,nose morphogenesis,BP,
11361,GO:0043586,1,0.870974995446621,0,19,tongue development,BP,
11362,GO:0043587,1,0.947820311546001,0,8,tongue morphogenesis,BP,
11365,GO:0043596,1,0.773393523082246,0,41,nuclear replication fork,CC,
11366,GO:0043601,1,0.864306873579935,0,24,nuclear replisome,CC,
11367,GO:0043602,1,0.994452007190411,0,1,nitrate catabolic process,BP,
11370,GO:0043605,1,0.984156153967246,0,3,cellular amide catabolic process,BP,
11371,GO:0043606,1,0.977430482789327,0,4,formamide metabolic process,BP,
11372,GO:0043610,1,0.988495768566121,0,1,regulation of carbohydrate utilization,BP,
11373,GO:0043614,1,0.98525132935135,0,2,multi-eIF complex,CC,
11376,GO:0043618,1,0.51469611873057,0,108,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11377,GO:0043619,1,0.925393669964049,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11378,GO:0043620,1,0.495618573660905,0,113,regulation of DNA-templated transcription in response to stress,BP,
11379,GO:0043621,1,0.681436488344053,0,52,protein self-association,MF,
11380,GO:0043622,1,0.972443111049292,0,4,cortical microtubule organization,BP,
11382,GO:0043625,1,0.977403036097497,0,4,delta DNA polymerase complex,CC,
11383,GO:0043626,1,0.994783718680251,0,1,PCNA complex,CC,
11385,GO:0043628,1,0.845896431050966,0,28,ncRNA 3'-end processing,BP,
11386,GO:0043629,1,0.989210374752329,0,1,ncRNA polyadenylation,BP,
11387,GO:0043630,1,0.989210374752329,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
11388,GO:0043631,1,0.756571702721431,0,42,RNA polyadenylation,BP,
11389,GO:0043632,1,0.0230594253774796,0,558,modification-dependent macromolecule catabolic process,BP,
11390,GO:0043633,1,0.951032551324279,0,8,polyadenylation-dependent RNA catabolic process,BP,
11391,GO:0043634,1,0.957975009533048,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
11392,GO:0043647,1,0.65756525678132,0,62,inositol phosphate metabolic process,BP,
11394,GO:0043649,1,0.896425764776895,0,18,dicarboxylic acid catabolic process,BP,
11395,GO:0043650,1,0.930174726509477,0,12,dicarboxylic acid biosynthetic process,BP,
11396,GO:0043651,1,0.915251610305386,0,15,linoleic acid metabolic process,BP,
11397,GO:0043652,1,0.930773492316717,0,11,engulfment of apoptotic cell,BP,
11398,GO:0043653,1,0.942013813205196,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11399,GO:0043654,1,0.960334752528081,0,6,recognition of apoptotic cell,BP,
11400,GO:0043656,1,0.945843031066811,0,9,intracellular region of host,CC,
11401,GO:0043657,1,0.647862052474353,0,65,host cell,CC,
11404,GO:0043682,1,0.979797308921074,0,2,copper-transporting ATPase activity,MF,
11405,GO:0043686,1,0.983643922881308,0,3,co-translational protein modification,BP,
11407,GO:0043691,1,0.918178020316648,0,13,reverse cholesterol transport,BP,
11408,GO:0043696,1,0.948510020156199,0,7,dedifferentiation,BP,
11409,GO:0043697,1,0.948510020156199,0,7,cell dedifferentiation,BP,
11410,GO:0043733,1,0.994811251181433,0,1,DNA-3-methylbase glycosylase activity,MF,
11411,GO:0043734,1,0.977240000347428,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11412,GO:0043739,1,0.993995388009112,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11413,GO:0043754,1,0.986571020561457,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11414,GO:0043783,1,0.994520284237139,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11415,GO:0043795,1,0.994774589322036,0,1,glyceraldehyde oxidoreductase activity,MF,
11416,GO:0043812,1,0.978013298702465,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11417,GO:0043813,1,0.958929350024019,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11418,GO:0043843,1,0.994428062514543,0,1,ADP-specific glucokinase activity,MF,
11419,GO:0043849,1,0.99422615362888,0,1,Ras palmitoyltransferase activity,MF,
11420,GO:0043855,1,0.941815648990825,0,9,cyclic nucleotide-gated ion channel activity,MF,
11421,GO:0043865,1,0.994310328579444,0,1,methionine transmembrane transporter activity,MF,
11422,GO:0043874,1,0.994640980629597,0,1,acireductone synthase activity,MF,
11423,GO:0043890,1,0.994513223415857,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11424,GO:0043891,1,0.994786785076571,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11427,GO:0043902,1,0.360136544350405,0,158,positive regulation of multi-organism process,BP,
11429,GO:0043914,1,0.993416221522857,0,1,NADPH:sulfur oxidoreductase activity,MF,
11430,GO:0043916,1,0.994811251181433,0,1,DNA-7-methylguanine glycosylase activity,MF,
11431,GO:0043921,1,0.852059584917843,0,24,modulation by host of viral transcription,BP,
11432,GO:0043922,1,0.947839643986533,0,9,negative regulation by host of viral transcription,BP,
11433,GO:0043923,1,0.888197780263128,0,17,positive regulation by host of viral transcription,BP,
11434,GO:0043924,1,0.98181329647042,0,1,suramin binding,MF,
11435,GO:0043928,1,0.817035020990631,0,32,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11437,GO:0043932,1,0.978109685362771,0,4,ossification involved in bone remodeling,BP,
11439,GO:0043946,1,0.994711180585463,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11440,GO:0043947,1,0.994711180585463,0,1,positive regulation by host of symbiont catalytic activity,BP,
11443,GO:0043951,1,0.894596484163087,0,17,negative regulation of cAMP-mediated signaling,BP,
11444,GO:0043954,1,0.781781331354824,0,35,cellular component maintenance,BP,
11445,GO:0043966,1,0.696945171882964,0,56,histone H3 acetylation,BP,
11446,GO:0043967,1,0.654497198057841,0,62,histone H4 acetylation,BP,
11447,GO:0043968,1,0.903669747790079,0,15,histone H2A acetylation,BP,
11448,GO:0043969,1,0.988487043103078,0,1,histone H2B acetylation,BP,
11449,GO:0043970,1,0.916041796380612,0,13,histone H3-K9 acetylation,BP,
11450,GO:0043972,1,0.99262971489523,0,1,histone H3-K23 acetylation,BP,
11451,GO:0043973,1,0.994578043111489,0,1,histone H3-K4 acetylation,BP,
11452,GO:0043974,1,0.978463074692003,0,3,histone H3-K27 acetylation,BP,
11453,GO:0043981,1,0.908769461228862,0,15,histone H4-K5 acetylation,BP,
11454,GO:0043982,1,0.908769461228862,0,15,histone H4-K8 acetylation,BP,
11455,GO:0043983,1,0.961354452838653,0,7,histone H4-K12 acetylation,BP,
11456,GO:0043984,1,0.884048044905068,0,18,histone H4-K16 acetylation,BP,
11457,GO:0043985,1,0.966101638356365,0,6,histone H4-R3 methylation,BP,
11458,GO:0043987,1,0.966617529164109,0,6,histone H3-S10 phosphorylation,BP,
11459,GO:0043988,1,0.983074822691009,0,3,histone H3-S28 phosphorylation,BP,
11460,GO:0043990,1,0.994107552024316,0,1,histone H2A-S1 phosphorylation,BP,
11461,GO:0043994,1,0.99262971489523,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
11462,GO:0043995,1,0.93438118762495,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
11463,GO:0043996,1,0.93438118762495,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
11464,GO:0043997,1,0.994086213620219,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11465,GO:0043998,1,0.993926502107794,0,1,H2A histone acetyltransferase activity,MF,
11466,GO:0044003,1,0.757927308564169,0,40,modification by symbiont of host morphology or physiology,BP,
11467,GO:0044004,1,0.971274772481658,0,5,disruption by symbiont of host cell,BP,
11468,GO:0044007,1,0.990879446124348,0,1,dissemination or transmission of symbiont from host,BP,
11470,GO:0044020,1,0.978319643147497,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11471,GO:0044026,1,0.988350414739167,0,2,DNA hypermethylation,BP,
11472,GO:0044027,1,0.994774076810153,0,1,hypermethylation of CpG island,BP,
11473,GO:0044028,1,0.987117603508708,0,2,DNA hypomethylation,BP,
11474,GO:0044029,1,0.987117603508708,0,2,hypomethylation of CpG island,BP,
11475,GO:0044030,1,0.904439195456835,0,15,regulation of DNA methylation,BP,
11478,GO:0044036,1,0.973338260829255,0,5,cell wall macromolecule metabolic process,BP,
11479,GO:0044038,1,0.994704866976516,0,1,cell wall macromolecule biosynthetic process,BP,
11480,GO:0044042,1,0.614508039396833,0,69,glucan metabolic process,BP,
11481,GO:0044053,1,0.994494248656162,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11484,GO:0044060,1,0.781426049768939,0,40,regulation of endocrine process,BP,
11485,GO:0044062,1,0.89195720412364,0,19,regulation of excretion,BP,
11486,GO:0044065,1,0.906476351101858,0,15,regulation of respiratory system process,BP,
11487,GO:0044068,1,0.847001308336673,0,25,modulation by symbiont of host cellular process,BP,
11488,GO:0044070,1,0.612199438282774,0,73,regulation of anion transport,BP,
11497,GO:0044094,1,0.980096553185066,0,3,host cell nuclear part,CC,
11498,GO:0044105,1,0.994828795741294,0,1,L-xylulose reductase (NAD+) activity,MF,
11500,GO:0044107,1,0.978583677451418,0,4,cellular alcohol metabolic process,BP,
11501,GO:0044108,1,0.978583677451418,0,4,cellular alcohol biosynthetic process,BP,
11502,GO:0044110,1,0.925135804305232,0,14,growth involved in symbiotic interaction,BP,
11505,GO:0044116,1,0.925135804305232,0,14,growth of symbiont involved in interaction with host,BP,
11506,GO:0044117,1,0.929943326363956,0,13,growth of symbiont in host,BP,
11507,GO:0044126,1,0.934787145451561,0,12,regulation of growth of symbiont in host,BP,
11508,GO:0044128,1,0.992250490681664,0,1,positive regulation of growth of symbiont in host,BP,
11509,GO:0044130,1,0.942092237943838,0,11,negative regulation of growth of symbiont in host,BP,
11510,GO:0044133,1,0.994834055115578,0,1,growth of symbiont on or near host,BP,
11511,GO:0044139,1,0.994834055115578,0,1,modulation of growth of symbiont on or near host,BP,
11512,GO:0044140,1,0.994834055115578,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11515,GO:0044146,1,0.937222540714532,0,12,negative regulation of growth of symbiont involved in interaction with host,BP,
11517,GO:0044148,1,0.992250490681664,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11518,GO:0044154,1,0.954157604459245,0,8,histone H3-K14 acetylation,BP,
11519,GO:0044179,1,0.988946662515827,0,2,hemolysis in other organism,BP,
11520,GO:0044183,1,0.797171216798539,0,38,protein binding involved in protein folding,MF,
11521,GO:0044190,1,0.994709706005916,0,1,host cell mitochondrial envelope,CC,
11522,GO:0044194,1,0.973092133452934,0,5,cytolytic granule,CC,
11523,GO:0044205,1,0.979253285093136,0,3,'de novo' UMP biosynthetic process,BP,
11524,GO:0044206,1,0.973560671501612,0,5,UMP salvage,BP,
11525,GO:0044207,1,0.993187410039051,0,1,translation initiation ternary complex,CC,
11526,GO:0044208,1,0.983870038930573,0,3,'de novo' AMP biosynthetic process,BP,
11527,GO:0044209,1,0.989488945203674,0,2,AMP salvage,BP,
11528,GO:0044210,1,0.987746100316896,0,2,'de novo' CTP biosynthetic process,BP,
11529,GO:0044211,1,0.984171217682102,0,3,CTP salvage,BP,
11531,GO:0044213,1,0.92123614973313,0,12,intronic transcription regulatory region DNA binding,MF,
11532,GO:0044214,1,0.95926961301635,0,5,spanning component of plasma membrane,CC,
11537,GO:0044220,1,0.99251248588177,0,1,host cell perinuclear region of cytoplasm,CC,
11538,GO:0044221,1,0.993166120876802,0,1,host cell synapse,CC,
11539,GO:0044224,1,0.922107944135208,0,10,juxtaparanode region of axon,CC,
11540,GO:0044228,1,0.99261844475874,0,1,host cell surface,CC,
11541,GO:0044231,1,0.993166120876802,0,1,host cell presynaptic membrane,CC,
11542,GO:0044232,1,0.882482126201412,0,19,organelle membrane contact site,CC,
11543,GO:0044233,1,0.919886441126691,0,13,ER-mitochondrion membrane contact site,CC,
11546,GO:0044241,1,0.946877156524194,0,9,lipid digestion,BP,
11548,GO:0044245,1,0.980147324984037,0,3,polysaccharide digestion,BP,
11549,GO:0044247,1,0.839028048484634,0,25,cellular polysaccharide catabolic process,BP,
11554,GO:0044258,1,0.994505209403857,0,1,intestinal lipid catabolic process,BP,
11556,GO:0044262,1,0.213597357870397,0,227,cellular carbohydrate metabolic process,BP,
11557,GO:0044264,1,0.543816668167106,0,88,cellular polysaccharide metabolic process,BP,
11564,GO:0044275,1,0.768614313418262,0,39,cellular carbohydrate catabolic process,BP,
11565,GO:0044278,1,0.99482980125161,0,1,cell wall disruption in other organism,BP,
11570,GO:0044284,1,0.994825001345346,0,1,mitochondrial crista junction,CC,
11571,GO:0044291,1,0.631406778335926,0,62,cell-cell contact zone,CC,
11572,GO:0044292,1,0.936330617565108,0,10,dendrite terminus,CC,
11573,GO:0044294,1,0.957234932778869,0,6,dendritic growth cone,CC,
11574,GO:0044295,1,0.859628800479789,0,21,axonal growth cone,CC,
11577,GO:0044299,1,0.990753316815141,0,1,C-fiber,CC,
11578,GO:0044300,1,0.964308825112648,0,5,cerebellar mossy fiber,CC,
11579,GO:0044301,1,0.987670629750374,0,2,climbing fiber,CC,
11580,GO:0044302,1,0.966161895452421,0,4,dentate gyrus mossy fiber,CC,
11581,GO:0044304,1,0.618070370394594,0,62,main axon,CC,
11582,GO:0044305,1,0.961836709302634,0,4,calyx of Held,CC,
11584,GO:0044307,1,0.98507514668399,0,1,dendritic branch,CC,
11585,GO:0044308,1,0.973696884098062,0,3,axonal spine,CC,
11587,GO:0044313,1,0.97387578027469,0,3,protein K6-linked deubiquitination,BP,
11588,GO:0044314,1,0.978447969659322,0,4,protein K27-linked ubiquitination,BP,
11589,GO:0044316,1,0.988060970320133,0,2,cone cell pedicle,CC,
11590,GO:0044317,1,0.994779018494324,0,1,rod spherule,CC,
11592,GO:0044320,1,0.910248581437015,0,15,cellular response to leptin stimulus,BP,
11593,GO:0044321,1,0.888908852452717,0,19,response to leptin,BP,
11594,GO:0044322,1,0.826469434341588,0,28,endoplasmic reticulum quality control compartment,CC,
11595,GO:0044323,1,0.972472255552124,0,4,retinoic acid-responsive element binding,MF,
11596,GO:0044324,1,0.994824453990244,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11598,GO:0044326,1,0.968949550839157,0,4,dendritic spine neck,CC,
11599,GO:0044327,1,0.948300739878161,0,8,dendritic spine head,CC,
11600,GO:0044331,1,0.81526111755428,0,33,cell-cell adhesion mediated by cadherin,BP,
11601,GO:0044332,1,0.940813119232519,0,7,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11602,GO:0044333,1,0.99467890679076,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11603,GO:0044334,1,0.987257481466207,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11604,GO:0044335,1,0.98723754827948,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11605,GO:0044336,1,0.981014229015401,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11606,GO:0044338,1,0.987809777284152,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11607,GO:0044339,1,0.972987491214237,0,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11608,GO:0044340,1,0.963425134008244,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11609,GO:0044341,1,0.957786368048447,0,7,sodium-dependent phosphate transport,BP,
11610,GO:0044342,1,0.906517086113736,0,16,type B pancreatic cell proliferation,BP,
11611,GO:0044343,1,0.992894108735709,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11613,GO:0044345,1,0.992894108735709,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11614,GO:0044346,1,0.883738441464513,0,18,fibroblast apoptotic process,BP,
11615,GO:0044349,1,0.994715539073901,0,1,DNA excision,BP,
11616,GO:0044351,1,0.955704670365105,0,7,macropinocytosis,BP,
11619,GO:0044355,1,0.99476842444519,0,1,clearance of foreign intracellular DNA,BP,
11620,GO:0044356,1,0.99476842444519,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11624,GO:0044375,1,0.984438509109736,0,3,regulation of peroxisome size,BP,
11625,GO:0044378,1,0.985937514624352,0,2,non-sequence-specific DNA binding, bending,MF,
11626,GO:0044380,1,0.688593867130781,0,49,protein localization to cytoskeleton,BP,
11627,GO:0044381,1,0.859568827017151,0,21,glucose import in response to insulin stimulus,BP,
11628,GO:0044387,1,0.948755284642568,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11629,GO:0044388,1,0.973513426535239,0,5,small protein activating enzyme binding,MF,
11630,GO:0044389,1,0.13759843488842,0,305,ubiquitin-like protein ligase binding,MF,
11631,GO:0044390,1,0.761445655174602,0,39,ubiquitin-like protein conjugating enzyme binding,MF,
11632,GO:0044391,1,0.372465866098899,0,181,ribosomal subunit,CC,
11633,GO:0044393,1,0.981991951219837,0,3,microspike,CC,
11634,GO:0044396,1,0.966603074182044,0,5,actin cortical patch organization,BP,
11639,GO:0044413,1,0.972722566613264,0,4,avoidance of host defenses,BP,
11640,GO:0044414,1,0.992124689597619,0,1,suppression of host defenses,BP,
11641,GO:0044415,1,0.972722566613264,0,4,evasion or tolerance of host defenses,BP,
11642,GO:0044416,1,0.994579304502616,0,1,induction by symbiont of host defense response,BP,
11643,GO:0044417,1,0.949273350084708,0,9,translocation of molecules into host,BP,
11650,GO:0044427,1,0.00468963800849278,0,786,chromosomal part,CC,
11658,GO:0044438,1,0.578903524000367,0,89,microbody part,CC,
11659,GO:0044439,1,0.578903524000367,0,89,peroxisomal part,CC,
11665,GO:0044447,1,0.758223140550415,0,29,axoneme part,CC,
11667,GO:0044449,1,0.211287688707699,0,200,contractile fiber part,CC,
11668,GO:0044450,1,0.321793618640619,0,160,microtubule organizing center part,CC,
11670,GO:0044452,1,0.336065019155339,0,170,nucleolar part,CC,
11671,GO:0044453,1,0.914295299271951,0,15,nuclear membrane part,CC,
11672,GO:0044454,1,0.038913789243637,0,481,nuclear chromosome part,CC,
11673,GO:0044455,1,0.377454136600308,0,171,mitochondrial membrane part,CC,
11675,GO:0044458,1,0.890739142390454,0,20,motile cilium assembly,BP,
11679,GO:0044467,1,0.988755964088269,0,2,glial cell-derived neurotrophic factor secretion,BP,
11680,GO:0044495,1,0.994829653520256,0,1,modulation of blood pressure in other organism,BP,
11681,GO:0044497,1,0.994829653520256,0,1,positive regulation of blood pressure in other organism,BP,
11682,GO:0044501,1,0.986143378005718,0,2,modulation of signal transduction in other organism,BP,
11683,GO:0044508,1,0.994082625362248,0,1,glucagon-like peptide 1 receptor activity,MF,
11684,GO:0044524,1,0.994711632107073,0,1,protein sulfhydration,BP,
11685,GO:0044528,1,0.976889226018014,0,4,regulation of mitochondrial mRNA stability,BP,
11686,GO:0044530,1,0.977484798189262,0,3,supraspliceosomal complex,CC,
11687,GO:0044531,1,0.964559460359232,0,6,modulation of programmed cell death in other organism,BP,
11688,GO:0044532,1,0.964559460359232,0,6,modulation of apoptotic process in other organism,BP,
11689,GO:0044533,1,0.982132563269689,0,3,positive regulation of apoptotic process in other organism,BP,
11690,GO:0044537,1,0.994702757779098,0,1,regulation of circulating fibrinogen levels,BP,
11691,GO:0044539,1,0.95974234336181,0,7,long-chain fatty acid import,BP,
11692,GO:0044540,1,0.994711632107073,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11693,GO:0044545,1,0.972248427835279,0,5,NSL complex,CC,
11694,GO:0044546,1,0.92256408882574,0,12,NLRP3 inflammasome complex assembly,BP,
11695,GO:0044547,1,0.969679598939146,0,5,DNA topoisomerase binding,MF,
11697,GO:0044549,1,0.994834130876615,0,1,GTP cyclohydrolase binding,MF,
11698,GO:0044550,1,0.856402562131507,0,22,secondary metabolite biosynthetic process,BP,
11699,GO:0044557,1,0.956479805397221,0,7,relaxation of smooth muscle,BP,
11700,GO:0044558,1,0.992335070383341,0,1,uterine smooth muscle relaxation,BP,
11701,GO:0044565,1,0.988972375950041,0,2,dendritic cell proliferation,BP,
11702,GO:0044571,1,0.979103612929625,0,4,[2Fe-2S] cluster assembly,BP,
11703,GO:0044594,1,0.994360132791974,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11704,GO:0044595,1,0.99479271690561,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11705,GO:0044596,1,0.99479271690561,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11706,GO:0044597,1,0.958047737736096,0,8,daunorubicin metabolic process,BP,
11707,GO:0044598,1,0.958047737736096,0,8,doxorubicin metabolic process,BP,
11708,GO:0044599,1,0.994313214468247,0,1,AP-5 adaptor complex,CC,
11709,GO:0044601,1,0.994732013676537,0,1,protein denucleotidylation,BP,
11710,GO:0044602,1,0.994732013676537,0,1,protein deadenylylation,BP,
11711,GO:0044603,1,0.994732013676537,0,1,protein adenylylhydrolase activity,MF,
11712,GO:0044609,1,0.988945607235181,0,2,DBIRD complex,CC,
11713,GO:0044610,1,0.994555591563614,0,1,FMN transmembrane transporter activity,MF,
11714,GO:0044611,1,0.975814987978476,0,3,nuclear pore inner ring,CC,
11715,GO:0044613,1,0.9319105247591,0,11,nuclear pore central transport channel,CC,
11716,GO:0044614,1,0.966682527867174,0,4,nuclear pore cytoplasmic filaments,CC,
11717,GO:0044615,1,0.930164038794474,0,8,nuclear pore nuclear basket,CC,
11718,GO:0044620,1,0.989698593754242,0,2,ACP phosphopantetheine attachment site binding,MF,
11719,GO:0044648,1,0.994313214468247,0,1,histone H3-K4 dimethylation,BP,
11720,GO:0044650,1,0.946083580555087,0,9,adhesion of symbiont to host cell,BP,
11721,GO:0044651,1,0.994790543911509,0,1,adhesion of symbiont to host epithelial cell,BP,
11722,GO:0044657,1,0.989706709315901,0,2,pore formation in membrane of other organism during symbiotic interaction,BP,
11723,GO:0044665,1,0.826837742778007,0,28,MLL1/2 complex,CC,
11724,GO:0044666,1,0.935556500294127,0,10,MLL3/4 complex,CC,
11728,GO:0044713,1,0.994834055115578,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11729,GO:0044714,1,0.994834055115578,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11730,GO:0044715,1,0.994799310328675,0,1,8-oxo-dGDP phosphatase activity,MF,
11731,GO:0044721,1,0.994665749980841,0,1,protein import into peroxisome matrix, substrate release,BP,
11732,GO:0044722,1,0.993462542276915,0,1,renal phosphate excretion,BP,
11733,GO:0044725,1,0.986421327950836,0,1,chromatin reprogramming in the zygote,BP,
11734,GO:0044727,1,0.986421327950836,0,1,DNA demethylation of male pronucleus,BP,
11735,GO:0044728,1,0.600714583097184,0,74,DNA methylation or demethylation,BP,
11736,GO:0044729,1,0.988285187197403,0,2,hemi-methylated DNA-binding,MF,
11738,GO:0044732,1,0.994313214468247,0,1,mitotic spindle pole body,CC,
11739,GO:0044736,1,0.98303551799545,0,3,acid-sensing ion channel activity,MF,
11740,GO:0044743,1,0.810992206482441,0,37,protein transmembrane import into intracellular organelle,BP,
11741,GO:0044752,1,0.982353473274303,0,3,response to human chorionic gonadotropin,BP,
11742,GO:0044753,1,0.982327286704723,0,2,amphisome,CC,
11743,GO:0044754,1,0.94964428085836,0,8,autolysosome,CC,
11745,GO:0044766,1,0.637591066942883,0,69,multi-organism transport,BP,
11746,GO:0044769,1,0.887807481768537,0,20,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11748,GO:0044771,1,0.988364893434694,0,2,meiotic cell cycle phase transition,BP,
11750,GO:0044773,1,0.518833115516206,0,100,mitotic DNA damage checkpoint,BP,
11751,GO:0044774,1,0.499063695716558,0,106,mitotic DNA integrity checkpoint,BP,
11752,GO:0044778,1,0.989072756786006,0,2,meiotic DNA integrity checkpoint,BP,
11753,GO:0044779,1,0.994151614391548,0,1,meiotic spindle checkpoint,BP,
11754,GO:0044782,1,0.0856147224398339,0,352,cilium organization,BP,
11755,GO:0044783,1,0.629461756473916,0,70,G1 DNA damage checkpoint,BP,
11756,GO:0044784,1,0.703882306020551,0,51,metaphase/anaphase transition of cell cycle,BP,
11757,GO:0044785,1,0.994151614391548,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11758,GO:0044786,1,0.688337129652305,0,57,cell cycle DNA replication,BP,
11760,GO:0044789,1,0.965408591844466,0,5,modulation by host of viral release from host cell,BP,
11761,GO:0044791,1,0.965408591844466,0,5,positive regulation by host of viral release from host cell,BP,
11763,GO:0044794,1,0.916300588876341,0,13,positive regulation by host of viral process,BP,
11764,GO:0044795,1,0.994804709631217,0,1,trans-Golgi network to recycling endosome transport,BP,
11765,GO:0044796,1,0.994783718680251,0,1,DNA polymerase processivity factor complex,CC,
11766,GO:0044798,1,0.306560340026904,0,176,nuclear transcription factor complex,CC,
11767,GO:0044800,1,0.966617115612413,0,6,multi-organism membrane fusion,BP,
11768,GO:0044803,1,0.9593050779932,0,7,multi-organism membrane organization,BP,
11769,GO:0044804,1,0.882579973958666,0,19,autophagy of nucleus,BP,
11770,GO:0044805,1,0.978870044745165,0,3,late nucleophagy,BP,
11771,GO:0044806,1,0.952399963203446,0,7,G-quadruplex DNA unwinding,BP,
11772,GO:0044815,1,0.729441880618044,0,54,DNA packaging complex,CC,
11773,GO:0044818,1,0.837887757927216,0,26,mitotic G2/M transition checkpoint,BP,
11774,GO:0044819,1,0.633370451170782,0,69,mitotic G1/S transition checkpoint,BP,
11775,GO:0044821,1,0.96960953826279,0,5,meiotic telomere tethering at nuclear periphery,BP,
11776,GO:0044827,1,0.919703058312333,0,12,modulation by host of viral genome replication,BP,
11777,GO:0044828,1,0.971313091816966,0,4,negative regulation by host of viral genome replication,BP,
11778,GO:0044829,1,0.949834171832589,0,7,positive regulation by host of viral genome replication,BP,
11779,GO:0044830,1,0.987258519936467,0,2,modulation by host of viral RNA genome replication,BP,
11780,GO:0044837,1,0.952768928996649,0,7,actomyosin contractile ring organization,BP,
11781,GO:0044839,1,0.192053764617151,0,252,cell cycle G2/M phase transition,BP,
11786,GO:0044853,1,0.51478909585333,0,93,plasma membrane raft,CC,
11787,GO:0044854,1,0.977882907495956,0,4,plasma membrane raft assembly,BP,
11788,GO:0044855,1,0.994335643035159,0,1,plasma membrane raft distribution,BP,
11789,GO:0044856,1,0.994335643035159,0,1,plasma membrane raft localization,BP,
11790,GO:0044857,1,0.977882907495956,0,4,plasma membrane raft organization,BP,
11791,GO:0044858,1,0.994335643035159,0,1,plasma membrane raft polarization,BP,
11792,GO:0044860,1,0.975123226696143,0,4,protein localization to plasma membrane raft,BP,
11793,GO:0044861,1,0.986179189871316,0,2,protein transport into plasma membrane raft,BP,
11800,GO:0044872,1,0.880276613982963,0,13,lipoprotein localization,BP,
11802,GO:0044878,1,0.978789748708317,0,4,mitotic cytokinesis checkpoint,BP,
11803,GO:0045002,1,0.96614111076089,0,6,double-strand break repair via single-strand annealing,BP,
11804,GO:0045003,1,0.945462601623747,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11805,GO:0045004,1,0.983258222488125,0,2,DNA replication proofreading,BP,
11806,GO:0045005,1,0.797319556563685,0,33,DNA-dependent DNA replication maintenance of fidelity,BP,
11807,GO:0045006,1,0.937088580386231,0,12,DNA deamination,BP,
11808,GO:0045007,1,0.984251275451001,0,3,depurination,BP,
11809,GO:0045008,1,0.957408323605232,0,8,depyrimidination,BP,
11810,GO:0045009,1,0.941599540174137,0,11,chitosome,CC,
11811,GO:0045010,1,0.747664762183158,0,45,actin nucleation,BP,
11812,GO:0045016,1,0.993918604647418,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11814,GO:0045019,1,0.923996241601758,0,12,negative regulation of nitric oxide biosynthetic process,BP,
11815,GO:0045022,1,0.774087932206857,0,37,early endosome to late endosome transport,BP,
11816,GO:0045023,1,0.740741734140774,0,42,G0 to G1 transition,BP,
11817,GO:0045025,1,0.987259413403358,0,2,mitochondrial degradosome,CC,
11819,GO:0045027,1,0.994613658820673,0,1,DNA end binding,MF,
11820,GO:0045028,1,0.930491997285683,0,13,G-protein coupled purinergic nucleotide receptor activity,MF,
11821,GO:0045029,1,0.989154917698419,0,2,UDP-activated nucleotide receptor activity,MF,
11822,GO:0045030,1,0.994734811701793,0,1,UTP-activated nucleotide receptor activity,MF,
11823,GO:0045031,1,0.988787455398541,0,2,ATP-activated adenosine receptor activity,MF,
11824,GO:0045032,1,0.994102602550091,0,1,ADP-activated adenosine receptor activity,MF,
11825,GO:0045039,1,0.968504817171026,0,6,protein import into mitochondrial inner membrane,BP,
11826,GO:0045040,1,0.967172735901677,0,6,protein import into mitochondrial outer membrane,BP,
11827,GO:0045041,1,0.989320701362592,0,2,protein import into mitochondrial intermembrane space,BP,
11828,GO:0045046,1,0.964154898333725,0,6,protein import into peroxisome membrane,BP,
11829,GO:0045047,1,0.581708769710715,0,100,protein targeting to ER,BP,
11830,GO:0045048,1,0.968812564225475,0,5,protein insertion into ER membrane,BP,
11831,GO:0045053,1,0.936258595795862,0,5,protein retention in Golgi apparatus,BP,
11832,GO:0045054,1,0.977461797208985,0,4,constitutive secretory pathway,BP,
11834,GO:0045056,1,0.899340165284922,0,15,transcytosis,BP,
11835,GO:0045058,1,0.758499017841843,0,42,T cell selection,BP,
11836,GO:0045059,1,0.944428838765059,0,9,positive thymic T cell selection,BP,
11837,GO:0045060,1,0.937647648570722,0,10,negative thymic T cell selection,BP,
11838,GO:0045061,1,0.889121693310246,0,18,thymic T cell selection,BP,
11839,GO:0045062,1,0.994719476150972,0,1,extrathymic T cell selection,BP,
11842,GO:0045065,1,0.982788927039322,0,3,cytotoxic T cell differentiation,BP,
11843,GO:0045066,1,0.851345212341793,0,26,regulatory T cell differentiation,BP,
11845,GO:0045070,1,0.799746439097439,0,32,positive regulation of viral genome replication,BP,
11847,GO:0045072,1,0.920487230796197,0,14,regulation of interferon-gamma biosynthetic process,BP,
11848,GO:0045073,1,0.939190242222849,0,11,regulation of chemokine biosynthetic process,BP,
11849,GO:0045074,1,0.980514272706092,0,3,regulation of interleukin-10 biosynthetic process,BP,
11850,GO:0045075,1,0.954779182786557,0,7,regulation of interleukin-12 biosynthetic process,BP,
11851,GO:0045076,1,0.903780600199502,0,17,regulation of interleukin-2 biosynthetic process,BP,
11852,GO:0045077,1,0.978326877737501,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
11853,GO:0045078,1,0.940891592556545,0,10,positive regulation of interferon-gamma biosynthetic process,BP,
11854,GO:0045079,1,0.984433003277486,0,3,negative regulation of chemokine biosynthetic process,BP,
11855,GO:0045080,1,0.954048858907396,0,8,positive regulation of chemokine biosynthetic process,BP,
11856,GO:0045081,1,0.993693149609638,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11857,GO:0045082,1,0.986738311868318,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
11858,GO:0045083,1,0.993250417267554,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11859,GO:0045084,1,0.969470480693875,0,5,positive regulation of interleukin-12 biosynthetic process,BP,
11860,GO:0045085,1,0.97884620526407,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
11861,GO:0045086,1,0.928296095578249,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
11865,GO:0045091,1,0.937611634587623,0,11,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11866,GO:0045092,1,0.99370568946845,0,1,interleukin-18 receptor complex,CC,
11867,GO:0045095,1,0.882198506679523,0,22,keratin filament,CC,
11868,GO:0045098,1,0.983999434468667,0,3,type III intermediate filament,CC,
11871,GO:0045105,1,0.991763188933687,0,1,intermediate filament polymerization or depolymerization,BP,
11872,GO:0045106,1,0.991763188933687,0,1,intermediate filament depolymerization,BP,
11873,GO:0045108,1,0.991763188933687,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11875,GO:0045110,1,0.967886377465719,0,5,intermediate filament bundle assembly,BP,
11877,GO:0045112,1,0.965067056964408,0,5,integrin biosynthetic process,BP,
11878,GO:0045113,1,0.976032169976125,0,4,regulation of integrin biosynthetic process,BP,
11879,GO:0045116,1,0.916724152323544,0,14,protein neddylation,BP,
11880,GO:0045117,1,0.895944132083361,0,19,azole transport,BP,
11881,GO:0045120,1,0.914808270695467,0,12,pronucleus,CC,
11885,GO:0045125,1,0.919052334960694,0,15,bioactive lipid receptor activity,MF,
11886,GO:0045127,1,0.994745903520556,0,1,N-acetylglucosamine kinase activity,MF,
11887,GO:0045128,1,0.994063821636701,0,1,negative regulation of reciprocal meiotic recombination,BP,
11888,GO:0045130,1,0.994345923521139,0,1,keratan sulfotransferase activity,MF,
11889,GO:0045131,1,0.994184227884395,0,1,pre-mRNA branch point binding,MF,
11890,GO:0045132,1,0.63475439384009,0,70,meiotic chromosome segregation,BP,
11891,GO:0045134,1,0.977187274912907,0,4,uridine-diphosphatase activity,MF,
11892,GO:0045136,1,0.940830542877345,0,9,development of secondary sexual characteristics,BP,
11893,GO:0045137,1,0.277921857396265,0,189,development of primary sexual characteristics,BP,
11894,GO:0045141,1,0.933943561865393,0,10,meiotic telomere clustering,BP,
11895,GO:0045142,1,0.986178664702643,0,2,triplex DNA binding,MF,
11896,GO:0045143,1,0.743713119005712,0,46,homologous chromosome segregation,BP,
11897,GO:0045144,1,0.960892939493519,0,7,meiotic sister chromatid segregation,BP,
11898,GO:0045145,1,0.988377535183964,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11899,GO:0045153,1,0.994798984282798,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11900,GO:0045155,1,0.986658144565159,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11901,GO:0045159,1,0.966034192561987,0,6,myosin II binding,MF,
11903,GO:0045162,1,0.942358041602764,0,7,clustering of voltage-gated sodium channels,BP,
11906,GO:0045167,1,0.994718608345621,0,1,asymmetric protein localization involved in cell fate determination,BP,
11907,GO:0045168,1,0.988743099224592,0,2,cell-cell signaling involved in cell fate commitment,BP,
11908,GO:0045171,1,0.711180532451744,0,54,intercellular bridge,CC,
11909,GO:0045174,1,0.989618241520137,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11910,GO:0045176,1,0.909616244576663,0,11,apical protein localization,BP,
11912,GO:0045178,1,0.686226707841304,0,49,basal part of cell,CC,
11913,GO:0045179,1,0.955020936393481,0,7,apical cortex,CC,
11914,GO:0045180,1,0.955507072454779,0,5,basal cortex,CC,
11915,GO:0045182,1,0.715660398545246,0,50,translation regulator activity,MF,
11916,GO:0045183,1,0.994313214468247,0,1,translation factor activity, non-nucleic acid binding,MF,
11918,GO:0045185,1,0.475188796395298,0,102,maintenance of protein location,BP,
11919,GO:0045186,1,0.989752293504872,0,1,zonula adherens assembly,BP,
11920,GO:0045187,1,0.906192604888609,0,17,regulation of circadian sleep/wake cycle, sleep,BP,
11921,GO:0045188,1,0.959250004743742,0,7,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11922,GO:0045190,1,0.779014640920098,0,39,isotype switching,BP,
11923,GO:0045191,1,0.839941955555596,0,27,regulation of isotype switching,BP,
11924,GO:0045196,1,0.978430892086748,0,3,establishment or maintenance of neuroblast polarity,BP,
11925,GO:0045197,1,0.750118729551528,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11926,GO:0045198,1,0.915897982250497,0,13,establishment of epithelial cell apical/basal polarity,BP,
11927,GO:0045199,1,0.924003762528269,0,12,maintenance of epithelial cell apical/basal polarity,BP,
11928,GO:0045200,1,0.978430892086748,0,3,establishment of neuroblast polarity,BP,
11930,GO:0045204,1,0.978992260839196,0,3,MAPK export from nucleus,BP,
11931,GO:0045208,1,0.993736595332606,0,1,MAPK phosphatase export from nucleus,BP,
11932,GO:0045209,1,0.993736595332606,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11933,GO:0045210,1,0.983332513209099,0,2,FasL biosynthetic process,BP,
11935,GO:0045212,1,0.994417965802798,0,1,neurotransmitter receptor biosynthetic process,BP,
11936,GO:0045213,1,0.983755859482486,0,3,neurotransmitter receptor metabolic process,BP,
11937,GO:0045214,1,0.712173548769137,0,43,sarcomere organization,BP,
11938,GO:0045216,1,0.196239994169571,0,225,cell-cell junction organization,BP,
11939,GO:0045217,1,0.94034386778808,0,10,cell-cell junction maintenance,BP,
11940,GO:0045218,1,0.980860549200151,0,3,zonula adherens maintenance,BP,
11941,GO:0045219,1,0.991872958601188,0,1,regulation of FasL biosynthetic process,BP,
11942,GO:0045221,1,0.991872958601188,0,1,negative regulation of FasL biosynthetic process,BP,
11943,GO:0045222,1,0.994804510652366,0,1,CD4 biosynthetic process,BP,
11944,GO:0045223,1,0.994804510652366,0,1,regulation of CD4 biosynthetic process,BP,
11945,GO:0045225,1,0.994804510652366,0,1,negative regulation of CD4 biosynthetic process,BP,
11946,GO:0045226,1,0.983051891232183,0,3,extracellular polysaccharide biosynthetic process,BP,
11947,GO:0045229,1,0.988703107569594,0,2,external encapsulating structure organization,BP,
11948,GO:0045234,1,0.994702049971153,0,1,protein palmitoleylation,BP,
11950,GO:0045239,1,0.918411942948461,0,13,tricarboxylic acid cycle enzyme complex,CC,
11951,GO:0045240,1,0.928400709331163,0,11,dihydrolipoyl dehydrogenase complex,CC,
11952,GO:0045244,1,0.994519458898102,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11953,GO:0045251,1,0.994520284237139,0,1,electron transfer flavoprotein complex,CC,
11954,GO:0045252,1,0.95656367730168,0,7,oxoglutarate dehydrogenase complex,CC,
11955,GO:0045254,1,0.957836839308513,0,7,pyruvate dehydrogenase complex,CC,
11956,GO:0045257,1,0.978605012937881,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11957,GO:0045259,1,0.989385021940204,0,2,proton-transporting ATP synthase complex,CC,
11958,GO:0045263,1,0.994775895555159,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11959,GO:0045271,1,0.795565393732025,0,43,respiratory chain complex I,CC,
11960,GO:0045272,1,0.983595033111814,0,3,plasma membrane respiratory chain complex I,CC,
11961,GO:0045273,1,0.978605012937881,0,4,respiratory chain complex II,CC,
11962,GO:0045274,1,0.99450222406752,0,1,plasma membrane respiratory chain complex II,CC,
11963,GO:0045275,1,0.94054230991101,0,11,respiratory chain complex III,CC,
11964,GO:0045277,1,0.929887897801714,0,14,respiratory chain complex IV,CC,
11965,GO:0045281,1,0.978605012937881,0,4,succinate dehydrogenase complex,CC,
11966,GO:0045282,1,0.99450222406752,0,1,plasma membrane succinate dehydrogenase complex,CC,
11967,GO:0045283,1,0.978605012937881,0,4,fumarate reductase complex,CC,
11968,GO:0045292,1,0.90253830269304,0,17,mRNA cis splicing, via spliceosome,BP,
11969,GO:0045293,1,0.984067428092758,0,3,mRNA editing complex,CC,
11973,GO:0045297,1,0.994556924097726,0,1,post-mating behavior,BP,
11974,GO:0045298,1,0.964327250699448,0,5,tubulin complex,CC,
11977,GO:0045322,1,0.982086763392775,0,3,unmethylated CpG binding,MF,
11978,GO:0045323,1,0.982322318722327,0,3,interleukin-1 receptor complex,CC,
11979,GO:0045324,1,0.936495954259902,0,11,late endosome to vacuole transport,BP,
11980,GO:0045329,1,0.972571802803381,0,5,carnitine biosynthetic process,BP,
11981,GO:0045332,1,0.81806061184352,0,23,phospholipid translocation,BP,
11982,GO:0045333,1,0.386887221148,0,162,cellular respiration,BP,
11985,GO:0045337,1,0.977547861738428,0,4,farnesyl diphosphate biosynthetic process,BP,
11986,GO:0045338,1,0.972279012217866,0,5,farnesyl diphosphate metabolic process,BP,
11987,GO:0045340,1,0.994822876044542,0,1,mercury ion binding,MF,
11988,GO:0045341,1,0.965428516206053,0,5,MHC class I biosynthetic process,BP,
11989,GO:0045342,1,0.931742525256969,0,11,MHC class II biosynthetic process,BP,
11990,GO:0045343,1,0.965428516206053,0,5,regulation of MHC class I biosynthetic process,BP,
11991,GO:0045345,1,0.965428516206053,0,5,positive regulation of MHC class I biosynthetic process,BP,
11992,GO:0045346,1,0.937864739925459,0,10,regulation of MHC class II biosynthetic process,BP,
11993,GO:0045347,1,0.969094405870486,0,5,negative regulation of MHC class II biosynthetic process,BP,
11994,GO:0045348,1,0.962688249187088,0,6,positive regulation of MHC class II biosynthetic process,BP,
11995,GO:0045349,1,0.963189841974501,0,6,interferon-alpha biosynthetic process,BP,
11996,GO:0045350,1,0.944232574250291,0,9,interferon-beta biosynthetic process,BP,
11997,GO:0045351,1,0.934232891180512,0,11,type I interferon biosynthetic process,BP,
11998,GO:0045352,1,0.994702993187325,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11999,GO:0045353,1,0.994702993187325,0,1,interleukin-1 Type II receptor antagonist activity,MF,
12000,GO:0045354,1,0.963189841974501,0,6,regulation of interferon-alpha biosynthetic process,BP,
12001,GO:0045355,1,0.98952568287063,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
12002,GO:0045356,1,0.973388155887299,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
12003,GO:0045357,1,0.944232574250291,0,9,regulation of interferon-beta biosynthetic process,BP,
12004,GO:0045358,1,0.989528206729638,0,2,negative regulation of interferon-beta biosynthetic process,BP,
12005,GO:0045359,1,0.954229731926517,0,7,positive regulation of interferon-beta biosynthetic process,BP,
12006,GO:0045360,1,0.98382001794021,0,3,regulation of interleukin-1 biosynthetic process,BP,
12007,GO:0045362,1,0.98382001794021,0,3,positive regulation of interleukin-1 biosynthetic process,BP,
12008,GO:0045366,1,0.992014239749268,0,1,regulation of interleukin-13 biosynthetic process,BP,
12009,GO:0045368,1,0.992014239749268,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
12010,GO:0045381,1,0.994002209945759,0,1,regulation of interleukin-18 biosynthetic process,BP,
12011,GO:0045399,1,0.992310563490457,0,1,regulation of interleukin-3 biosynthetic process,BP,
12012,GO:0045401,1,0.992310563490457,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
12013,GO:0045402,1,0.980484142285252,0,3,regulation of interleukin-4 biosynthetic process,BP,
12014,GO:0045403,1,0.993997664993241,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12015,GO:0045404,1,0.986405687770911,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12016,GO:0045408,1,0.923420801034967,0,13,regulation of interleukin-6 biosynthetic process,BP,
12017,GO:0045409,1,0.975942545957604,0,4,negative regulation of interleukin-6 biosynthetic process,BP,
12018,GO:0045410,1,0.956366237512243,0,7,positive regulation of interleukin-6 biosynthetic process,BP,
12019,GO:0045414,1,0.945584306997425,0,9,regulation of interleukin-8 biosynthetic process,BP,
12020,GO:0045415,1,0.978414776945919,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12021,GO:0045416,1,0.961447977596314,0,6,positive regulation of interleukin-8 biosynthetic process,BP,
12022,GO:0045423,1,0.986677295184546,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12023,GO:0045425,1,0.986677295184546,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12029,GO:0045448,1,0.976672143105948,0,4,mitotic cell cycle, embryonic,BP,
12031,GO:0045454,1,0.690823504852322,0,63,cell redox homeostasis,BP,
12033,GO:0045472,1,0.932194516280022,0,10,response to ether,BP,
12034,GO:0045475,1,0.926349121098618,0,10,locomotor rhythm,BP,
12035,GO:0045485,1,0.992938043939549,0,1,omega-6 fatty acid desaturase activity,MF,
12037,GO:0045495,1,0.915673286007016,0,14,pole plasm,CC,
12038,GO:0045499,1,0.85962653696434,0,21,chemorepellent activity,MF,
12039,GO:0045503,1,0.75962969802071,0,24,dynein light chain binding,MF,
12040,GO:0045504,1,0.916934138325989,0,14,dynein heavy chain binding,MF,
12041,GO:0045505,1,0.728356641429665,0,28,dynein intermediate chain binding,MF,
12042,GO:0045509,1,0.988050897547473,0,2,interleukin-27 receptor activity,MF,
12043,GO:0045513,1,0.994769348797587,0,1,interleukin-27 binding,MF,
12044,GO:0045519,1,0.994815117839179,0,1,interleukin-23 receptor binding,MF,
12045,GO:0045523,1,0.989648767116504,0,2,interleukin-27 receptor binding,MF,
12046,GO:0045540,1,0.754115200590342,0,41,regulation of cholesterol biosynthetic process,BP,
12047,GO:0045541,1,0.971677457338694,0,5,negative regulation of cholesterol biosynthetic process,BP,
12048,GO:0045542,1,0.967193361430839,0,5,positive regulation of cholesterol biosynthetic process,BP,
12049,GO:0045545,1,0.953563841959722,0,6,syndecan binding,MF,
12050,GO:0045550,1,0.989566015395049,0,2,geranylgeranyl reductase activity,MF,
12051,GO:0045553,1,0.994155018855482,0,1,TRAIL biosynthetic process,BP,
12052,GO:0045554,1,0.994155018855482,0,1,regulation of TRAIL biosynthetic process,BP,
12053,GO:0045556,1,0.994155018855482,0,1,positive regulation of TRAIL biosynthetic process,BP,
12054,GO:0045569,1,0.976733885748327,0,4,TRAIL binding,MF,
12055,GO:0045575,1,0.987813118604871,0,2,basophil activation,BP,
12057,GO:0045577,1,0.838498803017352,0,27,regulation of B cell differentiation,BP,
12058,GO:0045578,1,0.971120090772571,0,5,negative regulation of B cell differentiation,BP,
12059,GO:0045579,1,0.919102257069508,0,13,positive regulation of B cell differentiation,BP,
12063,GO:0045583,1,0.98845824486153,0,2,regulation of cytotoxic T cell differentiation,BP,
12064,GO:0045585,1,0.98845824486153,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12065,GO:0045586,1,0.971545082801657,0,4,regulation of gamma-delta T cell differentiation,BP,
12066,GO:0045588,1,0.978128385221511,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12067,GO:0045589,1,0.860894477107351,0,24,regulation of regulatory T cell differentiation,BP,
12068,GO:0045590,1,0.982318405285405,0,3,negative regulation of regulatory T cell differentiation,BP,
12069,GO:0045591,1,0.94589310048983,0,10,positive regulation of regulatory T cell differentiation,BP,
12074,GO:0045599,1,0.746767024761656,0,43,negative regulation of fat cell differentiation,BP,
12076,GO:0045601,1,0.809382267951405,0,30,regulation of endothelial cell differentiation,BP,
12077,GO:0045602,1,0.93925898091989,0,8,negative regulation of endothelial cell differentiation,BP,
12078,GO:0045603,1,0.904165048744221,0,15,positive regulation of endothelial cell differentiation,BP,
12079,GO:0045604,1,0.72673686923446,0,48,regulation of epidermal cell differentiation,BP,
12080,GO:0045605,1,0.943557529845562,0,9,negative regulation of epidermal cell differentiation,BP,
12081,GO:0045606,1,0.868597447770901,0,20,positive regulation of epidermal cell differentiation,BP,
12082,GO:0045607,1,0.955410498633955,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
12083,GO:0045608,1,0.976847579881783,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
12084,GO:0045616,1,0.805085182141231,0,31,regulation of keratinocyte differentiation,BP,
12085,GO:0045617,1,0.976459993280994,0,4,negative regulation of keratinocyte differentiation,BP,
12086,GO:0045618,1,0.903129426270256,0,14,positive regulation of keratinocyte differentiation,BP,
12094,GO:0045626,1,0.980308515223266,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12098,GO:0045630,1,0.959780764312425,0,7,positive regulation of T-helper 2 cell differentiation,BP,
12099,GO:0045631,1,0.955410498633955,0,7,regulation of mechanoreceptor differentiation,BP,
12100,GO:0045632,1,0.971755239575628,0,4,negative regulation of mechanoreceptor differentiation,BP,
12101,GO:0045634,1,0.945603369208129,0,7,regulation of melanocyte differentiation,BP,
12102,GO:0045636,1,0.955774492848877,0,5,positive regulation of melanocyte differentiation,BP,
12105,GO:0045639,1,0.616675323372181,0,74,positive regulation of myeloid cell differentiation,BP,
12106,GO:0045643,1,0.993684905838577,0,1,regulation of eosinophil differentiation,BP,
12107,GO:0045645,1,0.993684905838577,0,1,positive regulation of eosinophil differentiation,BP,
12108,GO:0045646,1,0.755881358543987,0,42,regulation of erythrocyte differentiation,BP,
12109,GO:0045647,1,0.950215644125991,0,8,negative regulation of erythrocyte differentiation,BP,
12110,GO:0045648,1,0.83426430104653,0,27,positive regulation of erythrocyte differentiation,BP,
12111,GO:0045649,1,0.889284440032178,0,19,regulation of macrophage differentiation,BP,
12112,GO:0045650,1,0.966242954581767,0,6,negative regulation of macrophage differentiation,BP,
12113,GO:0045651,1,0.920379082651472,0,13,positive regulation of macrophage differentiation,BP,
12114,GO:0045652,1,0.699765435117449,0,54,regulation of megakaryocyte differentiation,BP,
12115,GO:0045653,1,0.956780971713352,0,8,negative regulation of megakaryocyte differentiation,BP,
12116,GO:0045654,1,0.967276477456379,0,6,positive regulation of megakaryocyte differentiation,BP,
12117,GO:0045655,1,0.900863519192613,0,16,regulation of monocyte differentiation,BP,
12118,GO:0045656,1,0.955551430541093,0,6,negative regulation of monocyte differentiation,BP,
12119,GO:0045657,1,0.953839713820789,0,8,positive regulation of monocyte differentiation,BP,
12120,GO:0045658,1,0.980952890169948,0,3,regulation of neutrophil differentiation,BP,
12121,GO:0045659,1,0.986232404990868,0,2,negative regulation of neutrophil differentiation,BP,
12122,GO:0045660,1,0.994647524706435,0,1,positive regulation of neutrophil differentiation,BP,
12125,GO:0045663,1,0.887679545067605,0,17,positive regulation of myoblast differentiation,BP,
12130,GO:0045668,1,0.765020592187591,0,38,negative regulation of osteoblast differentiation,BP,
12134,GO:0045672,1,0.894310221422176,0,17,positive regulation of osteoclast differentiation,BP,
12137,GO:0045684,1,0.809331115509232,0,32,positive regulation of epidermis development,BP,
12138,GO:0045685,1,0.671632647436053,0,61,regulation of glial cell differentiation,BP,
12139,GO:0045686,1,0.869927309536865,0,21,negative regulation of glial cell differentiation,BP,
12140,GO:0045687,1,0.788956859487307,0,37,positive regulation of glial cell differentiation,BP,
12141,GO:0045703,1,0.994797329784172,0,1,ketoreductase activity,MF,
12142,GO:0045713,1,0.940033174003061,0,9,low-density lipoprotein particle receptor biosynthetic process,BP,
12143,GO:0045714,1,0.945059502120747,0,8,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12144,GO:0045715,1,0.982836934752888,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12145,GO:0045716,1,0.977108776846628,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12146,GO:0045717,1,0.922678789878095,0,13,negative regulation of fatty acid biosynthetic process,BP,
12147,GO:0045719,1,0.961948356440909,0,5,negative regulation of glycogen biosynthetic process,BP,
12148,GO:0045720,1,0.988870657963584,0,2,negative regulation of integrin biosynthetic process,BP,
12149,GO:0045721,1,0.947206806884002,0,9,negative regulation of gluconeogenesis,BP,
12150,GO:0045722,1,0.933904946116716,0,9,positive regulation of gluconeogenesis,BP,
12152,GO:0045724,1,0.877050278133716,0,18,positive regulation of cilium assembly,BP,
12153,GO:0045725,1,0.896238692790667,0,13,positive regulation of glycogen biosynthetic process,BP,
12154,GO:0045726,1,0.98632957933772,0,2,positive regulation of integrin biosynthetic process,BP,
12156,GO:0045728,1,0.994594127039949,0,1,respiratory burst after phagocytosis,BP,
12157,GO:0045730,1,0.866987543786607,0,23,respiratory burst,BP,
12158,GO:0045732,1,0.263534791577189,0,198,positive regulation of protein catabolic process,BP,
12159,GO:0045736,1,0.813320379629247,0,30,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12160,GO:0045737,1,0.819111546703809,0,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12161,GO:0045738,1,0.85376762106085,0,22,negative regulation of DNA repair,BP,
12162,GO:0045739,1,0.765944794669946,0,42,positive regulation of DNA repair,BP,
12163,GO:0045740,1,0.711573395611189,0,51,positive regulation of DNA replication,BP,
12164,GO:0045741,1,0.938830998510128,0,10,positive regulation of epidermal growth factor-activated receptor activity,BP,
12165,GO:0045742,1,0.811446065105672,0,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,
12166,GO:0045743,1,0.966662875274021,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12168,GO:0045745,1,0.834923789541483,0,27,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
12169,GO:0045746,1,0.78671249008948,0,39,negative regulation of Notch signaling pathway,BP,
12170,GO:0045747,1,0.726687250433733,0,44,positive regulation of Notch signaling pathway,BP,
12171,GO:0045751,1,0.994002209945759,0,1,negative regulation of Toll signaling pathway,BP,
12172,GO:0045759,1,0.961969741003103,0,6,negative regulation of action potential,BP,
12173,GO:0045760,1,0.928691385430429,0,10,positive regulation of action potential,BP,
12175,GO:0045762,1,0.963401624329176,0,5,positive regulation of adenylate cyclase activity,BP,
12177,GO:0045764,1,0.984058906082088,0,3,positive regulation of cellular amino acid metabolic process,BP,
12180,GO:0045769,1,0.986488784595753,0,1,negative regulation of asymmetric cell division,BP,
12182,GO:0045776,1,0.795036888288208,0,36,negative regulation of blood pressure,BP,
12183,GO:0045777,1,0.825311847271834,0,31,positive regulation of blood pressure,BP,
12185,GO:0045779,1,0.944615219291525,0,9,negative regulation of bone resorption,BP,
12188,GO:0045786,1,0.0230517250996959,0,571,negative regulation of cell cycle,BP,
12190,GO:0045792,1,0.936315800602601,0,9,negative regulation of cell size,BP,
12191,GO:0045793,1,0.934513615385199,0,10,positive regulation of cell size,BP,
12192,GO:0045794,1,0.961665312927148,0,5,negative regulation of cell volume,BP,
12193,GO:0045795,1,0.990383575750161,0,1,positive regulation of cell volume,BP,
12194,GO:0045796,1,0.994370341336446,0,1,negative regulation of intestinal cholesterol absorption,BP,
12195,GO:0045799,1,0.974843345802362,0,3,positive regulation of chromatin assembly or disassembly,BP,
12198,GO:0045813,1,0.994697994008713,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12199,GO:0045814,1,0.546874629179206,0,90,negative regulation of gene expression, epigenetic,BP,
12200,GO:0045815,1,0.68669457937223,0,57,positive regulation of gene expression, epigenetic,BP,
12201,GO:0045819,1,0.993408769418796,0,1,positive regulation of glycogen catabolic process,BP,
12202,GO:0045820,1,0.928135285498097,0,10,negative regulation of glycolytic process,BP,
12203,GO:0045821,1,0.889053639551506,0,16,positive regulation of glycolytic process,BP,
12204,GO:0045822,1,0.877372874905348,0,19,negative regulation of heart contraction,BP,
12207,GO:0045827,1,0.994797329784172,0,1,negative regulation of isoprenoid metabolic process,BP,
12208,GO:0045829,1,0.97680913062218,0,4,negative regulation of isotype switching,BP,
12209,GO:0045830,1,0.883035881355773,0,19,positive regulation of isotype switching,BP,
12210,GO:0045833,1,0.666316350178387,0,66,negative regulation of lipid metabolic process,BP,
12212,GO:0045835,1,0.94724557504147,0,9,negative regulation of meiotic nuclear division,BP,
12213,GO:0045836,1,0.932328288555173,0,11,positive regulation of meiotic nuclear division,BP,
12214,GO:0045837,1,0.949073193290279,0,9,negative regulation of membrane potential,BP,
12215,GO:0045838,1,0.930501628538799,0,11,positive regulation of membrane potential,BP,
12216,GO:0045839,1,0.730190392525151,0,46,negative regulation of mitotic nuclear division,BP,
12217,GO:0045840,1,0.725825183199741,0,45,positive regulation of mitotic nuclear division,BP,
12218,GO:0045841,1,0.803530706798409,0,32,negative regulation of mitotic metaphase/anaphase transition,BP,
12219,GO:0045842,1,0.94746360602429,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
12220,GO:0045843,1,0.758826525253723,0,42,negative regulation of striated muscle tissue development,BP,
12221,GO:0045844,1,0.651768811580525,0,60,positive regulation of striated muscle tissue development,BP,
12222,GO:0045848,1,0.99459757150219,0,1,positive regulation of nitrogen utilization,BP,
12223,GO:0045851,1,0.74589534889037,0,48,pH reduction,BP,
12224,GO:0045852,1,0.973930391758897,0,4,pH elevation,BP,
12229,GO:0045869,1,0.950984940775842,0,9,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12230,GO:0045870,1,0.991583832979523,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12231,GO:0045872,1,0.994653637061439,0,1,positive regulation of rhodopsin gene expression,BP,
12232,GO:0045875,1,0.959989759274859,0,4,negative regulation of sister chromatid cohesion,BP,
12233,GO:0045876,1,0.9449515085031,0,8,positive regulation of sister chromatid cohesion,BP,
12234,GO:0045879,1,0.815681969518051,0,29,negative regulation of smoothened signaling pathway,BP,
12235,GO:0045880,1,0.815368838190671,0,30,positive regulation of smoothened signaling pathway,BP,
12236,GO:0045887,1,0.989907333850919,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12239,GO:0045898,1,0.912150949473972,0,14,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12240,GO:0045899,1,0.92968500204524,0,11,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12241,GO:0045900,1,0.972920873320441,0,4,negative regulation of translational elongation,BP,
12242,GO:0045901,1,0.974501236139452,0,4,positive regulation of translational elongation,BP,
12243,GO:0045903,1,0.984349627506918,0,3,positive regulation of translational fidelity,BP,
12244,GO:0045905,1,0.980203664364875,0,3,positive regulation of translational termination,BP,
12246,GO:0045907,1,0.850515454255251,0,27,positive regulation of vasoconstriction,BP,
12248,GO:0045911,1,0.859541341677777,0,23,positive regulation of DNA recombination,BP,
12249,GO:0045912,1,0.803131900528058,0,32,negative regulation of carbohydrate metabolic process,BP,
12250,GO:0045913,1,0.655072561824121,0,59,positive regulation of carbohydrate metabolic process,BP,
12251,GO:0045914,1,0.981312159393426,0,3,negative regulation of catecholamine metabolic process,BP,
12252,GO:0045915,1,0.965107340394224,0,6,positive regulation of catecholamine metabolic process,BP,
12254,GO:0045917,1,0.980687956791374,0,3,positive regulation of complement activation,BP,
12255,GO:0045918,1,0.9829868956433,0,3,negative regulation of cytolysis,BP,
12256,GO:0045919,1,0.962524037943556,0,7,positive regulation of cytolysis,BP,
12259,GO:0045922,1,0.884109955826293,0,19,negative regulation of fatty acid metabolic process,BP,
12261,GO:0045924,1,0.967150536896389,0,5,regulation of female receptivity,BP,
12262,GO:0045925,1,0.994492071724798,0,1,positive regulation of female receptivity,BP,
12265,GO:0045930,1,0.163629212104708,0,282,negative regulation of mitotic cell cycle,BP,
12267,GO:0045932,1,0.879006080699007,0,19,negative regulation of muscle contraction,BP,
12268,GO:0045933,1,0.762853931955141,0,44,positive regulation of muscle contraction,BP,
12273,GO:0045938,1,0.967810414846724,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12274,GO:0045939,1,0.880365136817148,0,22,negative regulation of steroid metabolic process,BP,
12275,GO:0045940,1,0.891544370706964,0,19,positive regulation of steroid metabolic process,BP,
12276,GO:0045943,1,0.862993601568101,0,21,positive regulation of transcription by RNA polymerase I,BP,
12278,GO:0045945,1,0.922829545048674,0,11,positive regulation of transcription by RNA polymerase III,BP,
12279,GO:0045947,1,0.87921817440478,0,19,negative regulation of translational initiation,BP,
12280,GO:0045948,1,0.843592368138907,0,26,positive regulation of translational initiation,BP,
12281,GO:0045950,1,0.983364272376726,0,3,negative regulation of mitotic recombination,BP,
12282,GO:0045953,1,0.945240674087338,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12283,GO:0045954,1,0.888880481936064,0,19,positive regulation of natural killer cell mediated cytotoxicity,BP,
12284,GO:0045955,1,0.939075601984557,0,9,negative regulation of calcium ion-dependent exocytosis,BP,
12286,GO:0045957,1,0.987965628034237,0,1,negative regulation of complement activation, alternative pathway,BP,
12287,GO:0045959,1,0.982595036636778,0,2,negative regulation of complement activation, classical pathway,BP,
12288,GO:0045963,1,0.981312159393426,0,3,negative regulation of dopamine metabolic process,BP,
12289,GO:0045964,1,0.965107340394224,0,6,positive regulation of dopamine metabolic process,BP,
12290,GO:0045967,1,0.974135217098457,0,2,negative regulation of growth rate,BP,
12291,GO:0045974,1,0.901760085259167,0,13,regulation of translation, ncRNA-mediated,BP,
12292,GO:0045976,1,0.987323434120547,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12293,GO:0045977,1,0.994767180013798,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12296,GO:0045986,1,0.922277267829807,0,12,negative regulation of smooth muscle contraction,BP,
12297,GO:0045987,1,0.828520232818513,0,30,positive regulation of smooth muscle contraction,BP,
12298,GO:0045988,1,0.952599054533734,0,7,negative regulation of striated muscle contraction,BP,
12299,GO:0045989,1,0.920785439579595,0,14,positive regulation of striated muscle contraction,BP,
12300,GO:0045990,1,0.967744580577697,0,5,carbon catabolite regulation of transcription,BP,
12301,GO:0045991,1,0.967744580577697,0,5,carbon catabolite activation of transcription,BP,
12302,GO:0045992,1,0.84517746473693,0,25,negative regulation of embryonic development,BP,
12303,GO:0045993,1,0.992887601411239,0,1,negative regulation of translational initiation by iron,BP,
12304,GO:0045994,1,0.98656413166341,0,2,positive regulation of translational initiation by iron,BP,
12305,GO:0045995,1,0.463450826341257,0,108,regulation of embryonic development,BP,
12306,GO:0046005,1,0.989671182613888,0,2,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12308,GO:0046007,1,0.931263463741185,0,11,negative regulation of activated T cell proliferation,BP,
12309,GO:0046010,1,0.983395610591846,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12310,GO:0046013,1,0.988840000079549,0,2,regulation of T cell homeostatic proliferation,BP,
12311,GO:0046015,1,0.972016677957791,0,5,regulation of transcription by glucose,BP,
12312,GO:0046016,1,0.977170586286381,0,4,positive regulation of transcription by glucose,BP,
12313,GO:0046030,1,0.925468403481764,0,11,inositol trisphosphate phosphatase activity,MF,
12314,GO:0046031,1,0.514002104613758,0,98,ADP metabolic process,BP,
12315,GO:0046032,1,0.994753531741811,0,1,ADP catabolic process,BP,
12316,GO:0046033,1,0.938756104776961,0,11,AMP metabolic process,BP,
12317,GO:0046034,1,0.22505070084384,0,236,ATP metabolic process,BP,
12318,GO:0046035,1,0.994795060212627,0,1,CMP metabolic process,BP,
12319,GO:0046036,1,0.931953755651782,0,13,CTP metabolic process,BP,
12320,GO:0046037,1,0.864622240562157,0,21,GMP metabolic process,BP,
12321,GO:0046038,1,0.994772523962849,0,1,GMP catabolic process,BP,
12322,GO:0046039,1,0.832092884275609,0,30,GTP metabolic process,BP,
12323,GO:0046040,1,0.922570935963836,0,13,IMP metabolic process,BP,
12324,GO:0046041,1,0.989224970262342,0,2,ITP metabolic process,BP,
12325,GO:0046048,1,0.994217517852663,0,1,UDP metabolic process,BP,
12326,GO:0046049,1,0.942610820873643,0,10,UMP metabolic process,BP,
12327,GO:0046051,1,0.943890212098919,0,10,UTP metabolic process,BP,
12328,GO:0046054,1,0.99481895161955,0,1,dGMP metabolic process,BP,
12329,GO:0046056,1,0.988059915163371,0,2,dADP metabolic process,BP,
12331,GO:0046060,1,0.973351335943741,0,5,dATP metabolic process,BP,
12332,GO:0046061,1,0.983706641067431,0,3,dATP catabolic process,BP,
12333,GO:0046065,1,0.994808547067552,0,1,dCTP metabolic process,BP,
12334,GO:0046066,1,0.989161336195277,0,2,dGDP metabolic process,BP,
12335,GO:0046068,1,0.741990909980946,0,42,cGMP metabolic process,BP,
12336,GO:0046069,1,0.956566516598028,0,6,cGMP catabolic process,BP,
12337,GO:0046070,1,0.978495713260796,0,4,dGTP metabolic process,BP,
12338,GO:0046072,1,0.989018055684255,0,2,dTDP metabolic process,BP,
12339,GO:0046073,1,0.983941247431989,0,3,dTMP metabolic process,BP,
12340,GO:0046075,1,0.978689287908048,0,4,dTTP metabolic process,BP,
12341,GO:0046077,1,0.989018055684255,0,2,dUDP metabolic process,BP,
12342,GO:0046078,1,0.973819385496017,0,5,dUMP metabolic process,BP,
12343,GO:0046079,1,0.994744234496313,0,1,dUMP catabolic process,BP,
12344,GO:0046080,1,0.994680471383707,0,1,dUTP metabolic process,BP,
12345,GO:0046081,1,0.994680471383707,0,1,dUTP catabolic process,BP,
12346,GO:0046083,1,0.984352295146986,0,3,adenine metabolic process,BP,
12347,GO:0046084,1,0.984352295146986,0,3,adenine biosynthetic process,BP,
12348,GO:0046085,1,0.948101589465942,0,9,adenosine metabolic process,BP,
12349,GO:0046086,1,0.987955063673564,0,2,adenosine biosynthetic process,BP,
12350,GO:0046087,1,0.9572262478568,0,8,cytidine metabolic process,BP,
12351,GO:0046090,1,0.994752919170352,0,1,deoxyadenosine metabolic process,BP,
12352,GO:0046092,1,0.992291774285326,0,1,deoxycytidine metabolic process,BP,
12353,GO:0046098,1,0.975658707133003,0,4,guanine metabolic process,BP,
12354,GO:0046099,1,0.989465332158368,0,2,guanine biosynthetic process,BP,
12355,GO:0046100,1,0.973490859332798,0,5,hypoxanthine metabolic process,BP,
12356,GO:0046101,1,0.978713222193376,0,4,hypoxanthine biosynthetic process,BP,
12357,GO:0046102,1,0.983758297362771,0,3,inosine metabolic process,BP,
12358,GO:0046103,1,0.989204557599544,0,2,inosine biosynthetic process,BP,
12359,GO:0046104,1,0.981235258443369,0,3,thymidine metabolic process,BP,
12360,GO:0046108,1,0.989220513629679,0,2,uridine metabolic process,BP,
12361,GO:0046110,1,0.978846321219554,0,3,xanthine metabolic process,BP,
12362,GO:0046111,1,0.994752919170352,0,1,xanthine biosynthetic process,BP,
12363,GO:0046112,1,0.885843172891364,0,19,nucleobase biosynthetic process,BP,
12364,GO:0046113,1,0.9597879114295,0,6,nucleobase catabolic process,BP,
12365,GO:0046116,1,0.983984117433508,0,3,queuosine metabolic process,BP,
12366,GO:0046121,1,0.983642916346248,0,3,deoxyribonucleoside catabolic process,BP,
12367,GO:0046122,1,0.989597228959541,0,2,purine deoxyribonucleoside metabolic process,BP,
12368,GO:0046124,1,0.994752919170352,0,1,purine deoxyribonucleoside catabolic process,BP,
12369,GO:0046125,1,0.981235258443369,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12370,GO:0046127,1,0.994085496691891,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12371,GO:0046128,1,0.640397656432882,0,70,purine ribonucleoside metabolic process,BP,
12372,GO:0046129,1,0.890294677990688,0,21,purine ribonucleoside biosynthetic process,BP,
12373,GO:0046130,1,0.966148068651358,0,6,purine ribonucleoside catabolic process,BP,
12374,GO:0046131,1,0.844631733468641,0,30,pyrimidine ribonucleoside metabolic process,BP,
12375,GO:0046132,1,0.892577419504462,0,20,pyrimidine ribonucleoside biosynthetic process,BP,
12376,GO:0046133,1,0.946638490953672,0,10,pyrimidine ribonucleoside catabolic process,BP,
12379,GO:0046136,1,0.98951532430307,0,2,positive regulation of vitamin metabolic process,BP,
12380,GO:0046137,1,0.96666854553933,0,6,negative regulation of vitamin metabolic process,BP,
12381,GO:0046144,1,0.994741410542591,0,1,D-alanine family amino acid metabolic process,BP,
12382,GO:0046146,1,0.962347261104178,0,7,tetrahydrobiopterin metabolic process,BP,
12383,GO:0046148,1,0.723841782447559,0,50,pigment biosynthetic process,BP,
12384,GO:0046149,1,0.979263902101268,0,4,pigment catabolic process,BP,
12385,GO:0046160,1,0.984418894362718,0,2,heme a metabolic process,BP,
12386,GO:0046164,1,0.775149343418485,0,41,alcohol catabolic process,BP,
12388,GO:0046166,1,0.989404547121319,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12389,GO:0046167,1,0.980712619391335,0,2,glycerol-3-phosphate biosynthetic process,BP,
12390,GO:0046168,1,0.987717933654758,0,2,glycerol-3-phosphate catabolic process,BP,
12391,GO:0046173,1,0.724840471862697,0,52,polyol biosynthetic process,BP,
12392,GO:0046174,1,0.887505716845593,0,17,polyol catabolic process,BP,
12393,GO:0046176,1,0.994313214468247,0,1,aldonic acid catabolic process,BP,
12394,GO:0046177,1,0.994313214468247,0,1,D-gluconate catabolic process,BP,
12395,GO:0046184,1,0.916913151716328,0,13,aldehyde biosynthetic process,BP,
12396,GO:0046185,1,0.946786604457466,0,10,aldehyde catabolic process,BP,
12398,GO:0046203,1,0.989550766984749,0,2,spermidine catabolic process,BP,
12399,GO:0046204,1,0.99482079915527,0,1,nor-spermidine metabolic process,BP,
12400,GO:0046208,1,0.978916860468664,0,4,spermine catabolic process,BP,
12402,GO:0046210,1,0.994452007190411,0,1,nitric oxide catabolic process,BP,
12403,GO:0046218,1,0.96128340726343,0,7,indolalkylamine catabolic process,BP,
12404,GO:0046219,1,0.978781895221106,0,4,indolalkylamine biosynthetic process,BP,
12405,GO:0046222,1,0.994333682075354,0,1,aflatoxin metabolic process,BP,
12406,GO:0046223,1,0.994333682075354,0,1,aflatoxin catabolic process,BP,
12407,GO:0046226,1,0.98953465647586,0,2,coumarin catabolic process,BP,
12408,GO:0046247,1,0.9942639262759,0,1,terpene catabolic process,BP,
12409,GO:0046271,1,0.98953465647586,0,2,phenylpropanoid catabolic process,BP,
12410,GO:0046272,1,0.994576777660623,0,1,stilbene catabolic process,BP,
12411,GO:0046292,1,0.9818722778355,0,3,formaldehyde metabolic process,BP,
12412,GO:0046293,1,0.992578927649358,0,1,formaldehyde biosynthetic process,BP,
12413,GO:0046294,1,0.989214100607644,0,2,formaldehyde catabolic process,BP,
12414,GO:0046295,1,0.994822876044542,0,1,glycolate biosynthetic process,BP,
12415,GO:0046296,1,0.994710614731861,0,1,glycolate catabolic process,BP,
12416,GO:0046305,1,0.989120691618019,0,2,alkanesulfonate biosynthetic process,BP,
12417,GO:0046316,1,0.994313214468247,0,1,gluconokinase activity,MF,
12418,GO:0046317,1,0.992230608764739,0,1,regulation of glucosylceramide biosynthetic process,BP,
12419,GO:0046318,1,0.992230608764739,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12420,GO:0046320,1,0.810442171565813,0,28,regulation of fatty acid oxidation,BP,
12421,GO:0046321,1,0.887449382211226,0,15,positive regulation of fatty acid oxidation,BP,
12422,GO:0046322,1,0.947728305538348,0,8,negative regulation of fatty acid oxidation,BP,
12423,GO:0046323,1,0.615162001868067,0,68,glucose import,BP,
12424,GO:0046324,1,0.67114120097721,0,56,regulation of glucose import,BP,
12425,GO:0046325,1,0.927525814370306,0,12,negative regulation of glucose import,BP,
12426,GO:0046326,1,0.765084833585829,0,36,positive regulation of glucose import,BP,
12427,GO:0046327,1,0.989048381054196,0,2,glycerol biosynthetic process from pyruvate,BP,
12428,GO:0046328,1,0.339909062478179,0,157,regulation of JNK cascade,BP,
12429,GO:0046329,1,0.819881597228749,0,30,negative regulation of JNK cascade,BP,
12430,GO:0046330,1,0.454618760636274,0,116,positive regulation of JNK cascade,BP,
12431,GO:0046331,1,0.988743099224592,0,2,lateral inhibition,BP,
12434,GO:0046337,1,0.89350403516419,0,18,phosphatidylethanolamine metabolic process,BP,
12435,GO:0046338,1,0.988141032155411,0,2,phosphatidylethanolamine catabolic process,BP,
12436,GO:0046339,1,0.921549107963144,0,12,diacylglycerol metabolic process,BP,
12437,GO:0046340,1,0.979543002634995,0,3,diacylglycerol catabolic process,BP,
12438,GO:0046341,1,0.918216558346578,0,12,CDP-diacylglycerol metabolic process,BP,
12440,GO:0046349,1,0.921211562408394,0,13,amino sugar biosynthetic process,BP,
12441,GO:0046351,1,0.976590606565023,0,4,disaccharide biosynthetic process,BP,
12442,GO:0046355,1,0.993938289745582,0,1,mannan catabolic process,BP,
12443,GO:0046356,1,0.989446073132205,0,2,acetyl-CoA catabolic process,BP,
12444,GO:0046359,1,0.99466767128089,0,1,butyrate catabolic process,BP,
12445,GO:0046360,1,0.994609042399123,0,1,2-oxobutyrate biosynthetic process,BP,
12446,GO:0046361,1,0.994609042399123,0,1,2-oxobutyrate metabolic process,BP,
12447,GO:0046364,1,0.633595852661905,0,76,monosaccharide biosynthetic process,BP,
12449,GO:0046368,1,0.977083719731865,0,4,GDP-L-fucose metabolic process,BP,
12450,GO:0046370,1,0.989245884599454,0,2,fructose biosynthetic process,BP,
12451,GO:0046373,1,0.988658446617857,0,2,L-arabinose metabolic process,BP,
12452,GO:0046379,1,0.983051891232183,0,3,extracellular polysaccharide metabolic process,BP,
12453,GO:0046380,1,0.993537497200752,0,1,N-acetylneuraminate biosynthetic process,BP,
12454,GO:0046381,1,0.994795748772704,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12455,GO:0046385,1,0.941790234662686,0,11,deoxyribose phosphate biosynthetic process,BP,
12456,GO:0046386,1,0.899006855809522,0,19,deoxyribose phosphate catabolic process,BP,
12458,GO:0046391,1,0.983418523138875,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
12460,GO:0046395,1,0.215707381055007,0,251,carboxylic acid catabolic process,BP,
12461,GO:0046398,1,0.973100672986748,0,4,UDP-glucuronate metabolic process,BP,
12462,GO:0046403,1,0.994715539073901,0,1,polynucleotide 3'-phosphatase activity,MF,
12463,GO:0046404,1,0.979995952483681,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12464,GO:0046415,1,0.954382592204993,0,8,urate metabolic process,BP,
12465,GO:0046416,1,0.984029714031818,0,3,D-amino acid metabolic process,BP,
12469,GO:0046434,1,0.253042697741463,0,208,organophosphate catabolic process,BP,
12470,GO:0046436,1,0.994741410542591,0,1,D-alanine metabolic process,BP,
12471,GO:0046437,1,0.994465458292206,0,1,D-amino acid biosynthetic process,BP,
12472,GO:0046439,1,0.958729232848888,0,7,L-cysteine metabolic process,BP,
12473,GO:0046440,1,0.974977559460426,0,4,L-lysine metabolic process,BP,
12474,GO:0046443,1,0.994653204781261,0,1,FAD metabolic process,BP,
12475,GO:0046444,1,0.994351969086881,0,1,FMN metabolic process,BP,
12476,GO:0046448,1,0.994481717242437,0,1,tropane alkaloid metabolic process,BP,
12477,GO:0046449,1,0.970247927406187,0,4,creatinine metabolic process,BP,
12478,GO:0046452,1,0.982947085397683,0,3,dihydrofolate metabolic process,BP,
12481,GO:0046459,1,0.909511708993127,0,16,short-chain fatty acid metabolic process,BP,
12482,GO:0046460,1,0.823829653428865,0,30,neutral lipid biosynthetic process,BP,
12484,GO:0046462,1,0.989046030670519,0,2,monoacylglycerol metabolic process,BP,
12485,GO:0046463,1,0.823829653428865,0,30,acylglycerol biosynthetic process,BP,
12487,GO:0046465,1,0.960060700111238,0,7,dolichyl diphosphate metabolic process,BP,
12488,GO:0046466,1,0.861984909160327,0,25,membrane lipid catabolic process,BP,
12490,GO:0046469,1,0.962551557081339,0,6,platelet activating factor metabolic process,BP,
12495,GO:0046475,1,0.889963560417921,0,19,glycerophospholipid catabolic process,BP,
12496,GO:0046476,1,0.959618466926314,0,7,glycosylceramide biosynthetic process,BP,
12497,GO:0046477,1,0.960495920106806,0,7,glycosylceramide catabolic process,BP,
12498,GO:0046478,1,0.99253621125495,0,1,lactosylceramide metabolic process,BP,
12499,GO:0046479,1,0.933769437385708,0,12,glycosphingolipid catabolic process,BP,
12501,GO:0046485,1,0.944469348307728,0,9,ether lipid metabolic process,BP,
12503,GO:0046487,1,0.962184999362364,0,7,glyoxylate metabolic process,BP,
12505,GO:0046490,1,0.978880394715892,0,4,isopentenyl diphosphate metabolic process,BP,
12506,GO:0046491,1,0.994826804754926,0,1,L-methylmalonyl-CoA metabolic process,BP,
12507,GO:0046493,1,0.989698593754242,0,2,lipid A metabolic process,BP,
12508,GO:0046495,1,0.99449489995418,0,1,nicotinamide riboside metabolic process,BP,
12510,GO:0046497,1,0.994313214468247,0,1,nicotinate nucleotide metabolic process,BP,
12511,GO:0046498,1,0.964275246910959,0,6,S-adenosylhomocysteine metabolic process,BP,
12512,GO:0046499,1,0.99398281120159,0,1,S-adenosylmethioninamine metabolic process,BP,
12513,GO:0046500,1,0.928497823107371,0,12,S-adenosylmethionine metabolic process,BP,
12514,GO:0046501,1,0.941056140584508,0,10,protoporphyrinogen IX metabolic process,BP,
12515,GO:0046502,1,0.989399555185375,0,2,uroporphyrinogen III metabolic process,BP,
12517,GO:0046504,1,0.965987316046413,0,5,glycerol ether biosynthetic process,BP,
12518,GO:0046511,1,0.984750850686456,0,2,sphinganine biosynthetic process,BP,
12519,GO:0046512,1,0.94597672081121,0,9,sphingosine biosynthetic process,BP,
12521,GO:0046514,1,0.923841528895153,0,14,ceramide catabolic process,BP,
12522,GO:0046519,1,0.917126972798491,0,14,sphingoid metabolic process,BP,
12523,GO:0046520,1,0.939809904431257,0,10,sphingoid biosynthetic process,BP,
12524,GO:0046521,1,0.994682541933244,0,1,sphingoid catabolic process,BP,
12525,GO:0046523,1,0.994099411229548,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12526,GO:0046525,1,0.994715759961389,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12527,GO:0046526,1,0.99444254450294,0,1,D-xylulose reductase activity,MF,
12528,GO:0046527,1,0.89636132612032,0,16,glucosyltransferase activity,MF,
12530,GO:0046532,1,0.959960034059569,0,6,regulation of photoreceptor cell differentiation,BP,
12531,GO:0046533,1,0.959960034059569,0,6,negative regulation of photoreceptor cell differentiation,BP,
12532,GO:0046538,1,0.979098321865469,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12533,GO:0046539,1,0.994824698598226,0,1,histamine N-methyltransferase activity,MF,
12534,GO:0046540,1,0.864827486396272,0,23,U4/U6 x U5 tri-snRNP complex,CC,
12535,GO:0046541,1,0.944442775833645,0,10,saliva secretion,BP,
12536,GO:0046543,1,0.952243649627271,0,7,development of secondary female sexual characteristics,BP,
12537,GO:0046544,1,0.992234795674533,0,1,development of secondary male sexual characteristics,BP,
12538,GO:0046545,1,0.539698687599005,0,90,development of primary female sexual characteristics,BP,
12539,GO:0046546,1,0.451713789237947,0,117,development of primary male sexual characteristics,BP,
12540,GO:0046548,1,0.953306934268989,0,7,retinal rod cell development,BP,
12541,GO:0046549,1,0.951466528848692,0,8,retinal cone cell development,BP,
12542,GO:0046554,1,0.994787677637382,0,1,malate dehydrogenase (NADP+) activity,MF,
12543,GO:0046556,1,0.988658446617857,0,2,alpha-L-arabinofuranosidase activity,MF,
12544,GO:0046570,1,0.994793427710054,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12545,GO:0046573,1,0.984326190869203,0,3,lactonohydrolase activity,MF,
12546,GO:0046577,1,0.993561433883071,0,1,long-chain-alcohol oxidase activity,MF,
12549,GO:0046580,1,0.717167421587559,0,46,negative regulation of Ras protein signal transduction,BP,
12550,GO:0046581,1,0.956621318285016,0,6,intercellular canaliculus,CC,
12551,GO:0046586,1,0.989020653466667,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12552,GO:0046587,1,0.994166185056504,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12553,GO:0046588,1,0.994824576562725,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12554,GO:0046592,1,0.989372702125472,0,2,polyamine oxidase activity,MF,
12557,GO:0046598,1,0.95096979100284,0,9,positive regulation of viral entry into host cell,BP,
12558,GO:0046599,1,0.891627672785795,0,17,regulation of centriole replication,BP,
12559,GO:0046600,1,0.94370514958661,0,8,negative regulation of centriole replication,BP,
12560,GO:0046601,1,0.98145747800252,0,3,positive regulation of centriole replication,BP,
12561,GO:0046602,1,0.931246317358696,0,10,regulation of mitotic centrosome separation,BP,
12562,GO:0046603,1,0.994769731683542,0,1,negative regulation of mitotic centrosome separation,BP,
12563,GO:0046604,1,0.969195645076641,0,4,positive regulation of mitotic centrosome separation,BP,
12564,GO:0046605,1,0.689884326559396,0,54,regulation of centrosome cycle,BP,
12565,GO:0046606,1,0.910838282606587,0,14,negative regulation of centrosome cycle,BP,
12566,GO:0046607,1,0.930523150930305,0,10,positive regulation of centrosome cycle,BP,
12567,GO:0046618,1,0.970017972583785,0,5,drug export,BP,
12568,GO:0046619,1,0.984582050117981,0,2,optic placode formation involved in camera-type eye formation,BP,
12569,GO:0046620,1,0.562917350261034,0,82,regulation of organ growth,BP,
12570,GO:0046621,1,0.844284925945255,0,24,negative regulation of organ growth,BP,
12571,GO:0046622,1,0.730588595054112,0,44,positive regulation of organ growth,BP,
12572,GO:0046623,1,0.990869091843867,0,1,sphingolipid-translocating ATPase activity,MF,
12573,GO:0046624,1,0.942824505724197,0,9,sphingolipid transporter activity,MF,
12574,GO:0046625,1,0.911547240758841,0,16,sphingolipid binding,MF,
12577,GO:0046628,1,0.919113041656982,0,11,positive regulation of insulin receptor signaling pathway,BP,
12578,GO:0046629,1,0.931348013042515,0,11,gamma-delta T cell activation,BP,
12581,GO:0046633,1,0.868402558520488,0,23,alpha-beta T cell proliferation,BP,
12588,GO:0046640,1,0.886852921547856,0,20,regulation of alpha-beta T cell proliferation,BP,
12589,GO:0046641,1,0.911377027641105,0,16,positive regulation of alpha-beta T cell proliferation,BP,
12590,GO:0046642,1,0.969010130098004,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12591,GO:0046643,1,0.959074479593531,0,6,regulation of gamma-delta T cell activation,BP,
12592,GO:0046645,1,0.965574122085964,0,5,positive regulation of gamma-delta T cell activation,BP,
12595,GO:0046653,1,0.895121182397843,0,18,tetrahydrofolate metabolic process,BP,
12596,GO:0046654,1,0.959568349106155,0,7,tetrahydrofolate biosynthetic process,BP,
12597,GO:0046655,1,0.879850689750913,0,20,folic acid metabolic process,BP,
12598,GO:0046657,1,0.987510785436724,0,2,folic acid catabolic process,BP,
12599,GO:0046658,1,0.786957895606956,0,38,anchored component of plasma membrane,CC,
12600,GO:0046660,1,0.487163213923174,0,103,female sex differentiation,BP,
12601,GO:0046661,1,0.388263897601664,0,139,male sex differentiation,BP,
12602,GO:0046666,1,0.97786459635618,0,4,retinal cell programmed cell death,BP,
12603,GO:0046668,1,0.988200511118765,0,2,regulation of retinal cell programmed cell death,BP,
12604,GO:0046671,1,0.993489657296534,0,1,negative regulation of retinal cell programmed cell death,BP,
12607,GO:0046680,1,0.994616918462153,0,1,response to DDT,BP,
12609,GO:0046684,1,0.976732389406697,0,4,response to pyrethroid,BP,
12610,GO:0046685,1,0.839647813090251,0,29,response to arsenic-containing substance,BP,
12611,GO:0046686,1,0.720911088983294,0,56,response to cadmium ion,BP,
12612,GO:0046687,1,0.994810499878824,0,1,response to chromate,BP,
12613,GO:0046688,1,0.840824563611168,0,30,response to copper ion,BP,
12614,GO:0046689,1,0.954412671339967,0,8,response to mercury ion,BP,
12615,GO:0046690,1,0.993806562085334,0,1,response to tellurium ion,BP,
12616,GO:0046691,1,0.994262702189102,0,1,intracellular canaliculus,CC,
12617,GO:0046695,1,0.98393701248366,0,3,SLIK (SAGA-like) complex,CC,
12618,GO:0046696,1,0.970240342705934,0,5,lipopolysaccharide receptor complex,CC,
12621,GO:0046703,1,0.963079680506267,0,7,natural killer cell lectin-like receptor binding,MF,
12622,GO:0046707,1,0.986065012555276,0,2,IDP metabolic process,BP,
12623,GO:0046709,1,0.986065012555276,0,2,IDP catabolic process,BP,
12624,GO:0046710,1,0.906155455483352,0,13,GDP metabolic process,BP,
12625,GO:0046711,1,0.99481895161955,0,1,GDP biosynthetic process,BP,
12626,GO:0046713,1,0.994092649651812,0,1,borate transport,BP,
12627,GO:0046715,1,0.994092649651812,0,1,active borate transmembrane transporter activity,MF,
12628,GO:0046716,1,0.909850671167879,0,15,muscle cell cellular homeostasis,BP,
12631,GO:0046719,1,0.958007404773522,0,7,regulation by virus of viral protein levels in host cell,BP,
12632,GO:0046724,1,0.989149383470223,0,2,oxalic acid secretion,BP,
12633,GO:0046725,1,0.993733177605647,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12634,GO:0046726,1,0.974237492683113,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12635,GO:0046730,1,0.994579304502616,0,1,induction of host immune response by virus,BP,
12636,GO:0046732,1,0.994579304502616,0,1,active induction of host immune response by virus,BP,
12637,GO:0046745,1,0.994313214468247,0,1,viral capsid secondary envelopment,BP,
12638,GO:0046755,1,0.871442174486613,0,24,viral budding,BP,
12639,GO:0046777,1,0.19691978720824,0,226,protein autophosphorylation,BP,
12640,GO:0046778,1,0.988852262801444,0,2,modification by virus of host mRNA processing,BP,
12641,GO:0046782,1,0.683687575893238,0,60,regulation of viral transcription,BP,
12642,GO:0046784,1,0.95453120323481,0,8,viral mRNA export from host cell nucleus,BP,
12643,GO:0046785,1,0.630234425929334,0,66,microtubule polymerization,BP,
12644,GO:0046786,1,0.99243799366005,0,1,viral replication complex formation and maintenance,BP,
12645,GO:0046789,1,0.994031455799731,0,1,host cell surface receptor binding,MF,
12647,GO:0046794,1,0.686655073403375,0,56,transport of virus,BP,
12648,GO:0046811,1,0.986482057522877,0,2,histone deacetylase inhibitor activity,MF,
12649,GO:0046812,1,0.994031455799731,0,1,host cell surface binding,MF,
12650,GO:0046813,1,0.968765684381339,0,5,receptor-mediated virion attachment to host cell,BP,
12651,GO:0046822,1,0.5052119600531,0,97,regulation of nucleocytoplasmic transport,BP,
12652,GO:0046823,1,0.883986256038142,0,19,negative regulation of nucleocytoplasmic transport,BP,
12653,GO:0046824,1,0.665236707588346,0,55,positive regulation of nucleocytoplasmic transport,BP,
12654,GO:0046825,1,0.76028965220744,0,39,regulation of protein export from nucleus,BP,
12655,GO:0046826,1,0.959011361910927,0,7,negative regulation of protein export from nucleus,BP,
12656,GO:0046827,1,0.86518688210515,0,20,positive regulation of protein export from nucleus,BP,
12657,GO:0046831,1,0.891366346325847,0,15,regulation of RNA export from nucleus,BP,
12658,GO:0046832,1,0.979274465226561,0,2,negative regulation of RNA export from nucleus,BP,
12659,GO:0046833,1,0.951874617429798,0,7,positive regulation of RNA export from nucleus,BP,
12660,GO:0046834,1,0.47711632034599,0,103,lipid phosphorylation,BP,
12661,GO:0046835,1,0.848688710937869,0,26,carbohydrate phosphorylation,BP,
12662,GO:0046836,1,0.970850927776544,0,5,glycolipid transport,BP,
12663,GO:0046838,1,0.92847119785531,0,11,phosphorylated carbohydrate dephosphorylation,BP,
12664,GO:0046839,1,0.838506067011823,0,24,phospholipid dephosphorylation,BP,
12665,GO:0046847,1,0.67879039484246,0,54,filopodium assembly,BP,
12666,GO:0046848,1,0.99483932175169,0,1,hydroxyapatite binding,MF,
12669,GO:0046851,1,0.931538036189302,0,11,negative regulation of bone remodeling,BP,
12671,GO:0046854,1,0.52064070584368,0,91,phosphatidylinositol phosphorylation,BP,
12672,GO:0046855,1,0.933979030187319,0,10,inositol phosphate dephosphorylation,BP,
12673,GO:0046856,1,0.843086101713837,0,23,phosphatidylinositol dephosphorylation,BP,
12674,GO:0046864,1,0.989122523361605,0,2,isoprenoid transport,BP,
12675,GO:0046865,1,0.989122523361605,0,2,terpenoid transport,BP,
12676,GO:0046870,1,0.967588568748522,0,5,cadmium ion binding,MF,
12679,GO:0046874,1,0.976824275206609,0,4,quinolinate metabolic process,BP,
12680,GO:0046875,1,0.830761925889393,0,27,ephrin receptor binding,MF,
12681,GO:0046877,1,0.965638124938118,0,6,regulation of saliva secretion,BP,
12682,GO:0046878,1,0.983216789661257,0,3,positive regulation of saliva secretion,BP,
12684,GO:0046880,1,0.960617730063515,0,6,regulation of follicle-stimulating hormone secretion,BP,
12685,GO:0046881,1,0.960617730063515,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12686,GO:0046882,1,0.983484181784011,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12688,GO:0046884,1,0.953505804570756,0,7,follicle-stimulating hormone secretion,BP,
12689,GO:0046885,1,0.85675880462177,0,24,regulation of hormone biosynthetic process,BP,
12690,GO:0046886,1,0.943847304819151,0,9,positive regulation of hormone biosynthetic process,BP,
12695,GO:0046898,1,0.970954243670888,0,4,response to cycloheximide,BP,
12696,GO:0046899,1,0.988730983305591,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12697,GO:0046900,1,0.989249878132874,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12698,GO:0046901,1,0.994460393542134,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12699,GO:0046902,1,0.658086517844625,0,70,regulation of mitochondrial membrane permeability,BP,
12701,GO:0046906,1,0.507919169188829,0,108,tetrapyrrole binding,MF,
12703,GO:0046911,1,0.99480248296677,0,1,metal chelating activity,MF,
12704,GO:0046912,1,0.967447153866058,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12706,GO:0046915,1,0.791008505184855,0,37,transition metal ion transmembrane transporter activity,MF,
12709,GO:0046921,1,0.993963198486243,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12710,GO:0046922,1,0.988060185628543,0,2,peptide-O-fucosyltransferase activity,MF,
12713,GO:0046929,1,0.925290825107372,0,10,negative regulation of neurotransmitter secretion,BP,
12714,GO:0046930,1,0.916103179400652,0,15,pore complex,CC,
12715,GO:0046931,1,0.895605797204808,0,16,pore complex assembly,BP,
12716,GO:0046933,1,0.984337543558133,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
12717,GO:0046934,1,0.651368874925198,0,61,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,
12718,GO:0046935,1,0.964774918369095,0,5,1-phosphatidylinositol-3-kinase regulator activity,MF,
12719,GO:0046939,1,0.467350006341671,0,115,nucleotide phosphorylation,BP,
12720,GO:0046940,1,0.97231978688565,0,5,nucleoside monophosphate phosphorylation,BP,
12723,GO:0046946,1,0.981758865255637,0,3,hydroxylysine metabolic process,BP,
12724,GO:0046947,1,0.981758865255637,0,3,hydroxylysine biosynthetic process,BP,
12725,GO:0046949,1,0.845692622800856,0,27,fatty-acyl-CoA biosynthetic process,BP,
12726,GO:0046950,1,0.939155306574538,0,11,cellular ketone body metabolic process,BP,
12727,GO:0046951,1,0.950122922204067,0,9,ketone body biosynthetic process,BP,
12728,GO:0046952,1,0.977107685020391,0,4,ketone body catabolic process,BP,
12729,GO:0046958,1,0.957441773345766,0,6,nonassociative learning,BP,
12730,GO:0046959,1,0.968559235615116,0,4,habituation,BP,
12731,GO:0046960,1,0.98844747525831,0,2,sensitization,BP,
12732,GO:0046961,1,0.887807481768537,0,20,proton-transporting ATPase activity, rotational mechanism,MF,
12733,GO:0046963,1,0.989286217302936,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12734,GO:0046964,1,0.989286217302936,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12735,GO:0046965,1,0.8994018022354,0,15,retinoid X receptor binding,MF,
12736,GO:0046966,1,0.814808397035997,0,27,thyroid hormone receptor binding,MF,
12737,GO:0046967,1,0.987560099374615,0,2,cytosol to ER transport,BP,
12738,GO:0046968,1,0.986497481907611,0,2,peptide antigen transport,BP,
12739,GO:0046969,1,0.98826054833302,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12740,GO:0046970,1,0.994660463963978,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12741,GO:0046972,1,0.93438118762495,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12742,GO:0046974,1,0.967138056445454,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12743,GO:0046975,1,0.944649834950636,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12744,GO:0046976,1,0.969096954162099,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12745,GO:0046977,1,0.976313506340416,0,4,TAP binding,MF,
12746,GO:0046978,1,0.976313506340416,0,4,TAP1 binding,MF,
12747,GO:0046979,1,0.982879859497327,0,3,TAP2 binding,MF,
12748,GO:0046980,1,0.993320421893173,0,1,tapasin binding,MF,
12751,GO:0046984,1,0.97665902434318,0,4,regulation of hemoglobin biosynthetic process,BP,
12752,GO:0046985,1,0.983656329438078,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12753,GO:0046986,1,0.992887601411239,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12754,GO:0046996,1,0.994313214468247,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
12755,GO:0046997,1,0.9880907684659,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12756,GO:0047006,1,0.989574764872097,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12757,GO:0047012,1,0.994741600457001,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12758,GO:0047015,1,0.994821720216463,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12759,GO:0047016,1,0.994584309607357,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12760,GO:0047017,1,0.989139836102241,0,2,prostaglandin-F synthase activity,MF,
12761,GO:0047020,1,0.994797329784172,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12762,GO:0047021,1,0.994795405320195,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12763,GO:0047023,1,0.979297022624437,0,4,androsterone dehydrogenase activity,MF,
12764,GO:0047025,1,0.988683402028377,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12765,GO:0047035,1,0.969043534262458,0,6,testosterone dehydrogenase (NAD+) activity,MF,
12766,GO:0047042,1,0.994777611244605,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12767,GO:0047045,1,0.984479424250516,0,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12768,GO:0047057,1,0.989655062385533,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12769,GO:0047066,1,0.994822418837371,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12770,GO:0047086,1,0.979297022624437,0,4,ketosteroid monooxygenase activity,MF,
12771,GO:0047105,1,0.99445341344511,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12772,GO:0047115,1,0.979307769304512,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12773,GO:0047117,1,0.988770284686703,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12774,GO:0047127,1,0.994778808703938,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12775,GO:0047130,1,0.99141232102543,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12776,GO:0047131,1,0.99141232102543,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12777,GO:0047134,1,0.967998297515256,0,6,protein-disulfide reductase activity,MF,
12778,GO:0047144,1,0.941085819335837,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12779,GO:0047150,1,0.989131604567153,0,2,betaine-homocysteine S-methyltransferase activity,MF,
12780,GO:0047159,1,0.993391027138226,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12781,GO:0047166,1,0.994669035057097,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12782,GO:0047173,1,0.992464931057538,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12783,GO:0047179,1,0.989639845299329,0,2,platelet-activating factor acetyltransferase activity,MF,
12784,GO:0047184,1,0.969584587026701,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12785,GO:0047186,1,0.993449617639106,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12786,GO:0047191,1,0.993391027138226,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12787,GO:0047192,1,0.980121034171004,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12788,GO:0047220,1,0.994306851532963,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12789,GO:0047223,1,0.994267283735466,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12790,GO:0047237,1,0.981362357708715,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12791,GO:0047238,1,0.968192660745547,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12792,GO:0047256,1,0.993233639372639,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12793,GO:0047263,1,0.994236291570829,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12794,GO:0047273,1,0.99394298497277,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12795,GO:0047275,1,0.988382485438779,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12796,GO:0047277,1,0.994659901468183,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12797,GO:0047280,1,0.992773307653119,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12798,GO:0047288,1,0.987655318827931,0,2,monosialoganglioside sialyltransferase activity,MF,
12799,GO:0047290,1,0.994732416309216,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12800,GO:0047291,1,0.994538084329157,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12801,GO:0047293,1,0.994733618370611,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12802,GO:0047298,1,0.992431771564765,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12803,GO:0047322,1,0.980263244075344,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12804,GO:0047323,1,0.994603353158766,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12805,GO:0047325,1,0.99398930141819,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12806,GO:0047326,1,0.994700150844296,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12807,GO:0047341,1,0.993855960614235,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12808,GO:0047349,1,0.991870320579254,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
12809,GO:0047369,1,0.994313214468247,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12810,GO:0047372,1,0.931398782751102,0,11,acylglycerol lipase activity,MF,
12811,GO:0047374,1,0.982959880069298,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12812,GO:0047389,1,0.985940380504735,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12813,GO:0047390,1,0.993405039265077,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12814,GO:0047391,1,0.982899818803087,0,3,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12815,GO:0047394,1,0.994565577286726,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12816,GO:0047395,1,0.994214944803451,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12817,GO:0047408,1,0.988470023387642,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12818,GO:0047409,1,0.988470023387642,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12819,GO:0047429,1,0.943075035670171,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12820,GO:0047444,1,0.994795748772704,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12821,GO:0047451,1,0.988770284686703,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12822,GO:0047464,1,0.992301692711915,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12823,GO:0047484,1,0.944550892122098,0,9,regulation of response to osmotic stress,BP,
12825,GO:0047493,1,0.979606678677528,0,3,ceramide cholinephosphotransferase activity,MF,
12826,GO:0047496,1,0.760112778083014,0,38,vesicle transport along microtubule,BP,
12827,GO:0047497,1,0.868024830138799,0,19,mitochondrion transport along microtubule,BP,
12829,GO:0047499,1,0.966509944744987,0,6,calcium-independent phospholipase A2 activity,MF,
12830,GO:0047522,1,0.981170754489103,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12831,GO:0047536,1,0.994570757074383,0,1,2-aminoadipate transaminase activity,MF,
12832,GO:0047545,1,0.991192434517322,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12833,GO:0047555,1,0.913319667763733,0,12,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12834,GO:0047560,1,0.992135192419658,0,1,3-dehydrosphinganine reductase activity,MF,
12835,GO:0047578,1,0.9944781458225,0,1,4-hydroxyglutamate transaminase activity,MF,
12836,GO:0047598,1,0.994379087616678,0,1,7-dehydrocholesterol reductase activity,MF,
12837,GO:0047617,1,0.920105336662933,0,15,acyl-CoA hydrolase activity,MF,
12838,GO:0047620,1,0.994214944803451,0,1,acylglycerol kinase activity,MF,
12839,GO:0047621,1,0.99472564749793,0,1,acylpyruvate hydrolase activity,MF,
12840,GO:0047623,1,0.986640464723518,0,2,adenosine-phosphate deaminase activity,MF,
12841,GO:0047631,1,0.973778707282338,0,5,ADP-ribose diphosphatase activity,MF,
12842,GO:0047635,1,0.988130376259267,0,2,alanine-oxo-acid transaminase activity,MF,
12843,GO:0047658,1,0.994722055363197,0,1,alpha-amino-acid esterase activity,MF,
12844,GO:0047661,1,0.994465458292206,0,1,amino-acid racemase activity,MF,
12845,GO:0047676,1,0.992147266687804,0,1,arachidonate-CoA ligase activity,MF,
12846,GO:0047685,1,0.994758332813189,0,1,amine sulfotransferase activity,MF,
12847,GO:0047693,1,0.994834055115578,0,1,ATP diphosphatase activity,MF,
12848,GO:0047696,1,0.988655694696569,0,2,beta-adrenergic receptor kinase activity,MF,
12849,GO:0047704,1,0.994648699027918,0,1,bile-salt sulfotransferase activity,MF,
12850,GO:0047708,1,0.989456932263713,0,2,biotinidase activity,MF,
12851,GO:0047710,1,0.987527513558752,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12852,GO:0047718,1,0.984397575480702,0,3,indanol dehydrogenase activity,MF,
12853,GO:0047726,1,0.994452007190411,0,1,iron-cytochrome-c reductase activity,MF,
12854,GO:0047730,1,0.993386348085117,0,1,carnosine synthase activity,MF,
12855,GO:0047734,1,0.994313214468247,0,1,CDP-glycerol diphosphatase activity,MF,
12856,GO:0047743,1,0.994800598465232,0,1,chlordecone reductase activity,MF,
12857,GO:0047747,1,0.994513641615377,0,1,cholate-CoA ligase activity,MF,
12858,GO:0047750,1,0.989651410620991,0,2,cholestenol delta-isomerase activity,MF,
12859,GO:0047751,1,0.988963751499022,0,2,cholestenone 5-alpha-reductase activity,MF,
12860,GO:0047756,1,0.975679472103487,0,4,chondroitin 4-sulfotransferase activity,MF,
12861,GO:0047757,1,0.981419639580832,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12862,GO:0047760,1,0.972231475688533,0,5,butyrate-CoA ligase activity,MF,
12863,GO:0047777,1,0.991533261091361,0,1,(3S)-citramalyl-CoA lyase activity,MF,
12864,GO:0047787,1,0.994797329784172,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12865,GO:0047800,1,0.993604857486503,0,1,cysteamine dioxygenase activity,MF,
12866,GO:0047801,1,0.994604027262615,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12867,GO:0047837,1,0.994811513569139,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12868,GO:0047840,1,0.994808547067552,0,1,dCTP diphosphatase activity,MF,
12869,GO:0047844,1,0.962714173326919,0,7,deoxycytidine deaminase activity,MF,
12870,GO:0047856,1,0.994800916507524,0,1,dihydrocoumarin hydrolase activity,MF,
12871,GO:0047860,1,0.994791999358909,0,1,diiodophenylpyruvate reductase activity,MF,
12872,GO:0047865,1,0.994108962840413,0,1,dimethylglycine dehydrogenase activity,MF,
12873,GO:0047874,1,0.994609705682281,0,1,dolichyldiphosphatase activity,MF,
12874,GO:0047888,1,0.994659619784739,0,1,fatty acid peroxidase activity,MF,
12875,GO:0047894,1,0.984379502110427,0,3,flavonol 3-sulfotransferase activity,MF,
12876,GO:0047915,1,0.994725228631534,0,1,ganglioside galactosyltransferase activity,MF,
12877,GO:0047933,1,0.988755628108372,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12878,GO:0047936,1,0.988171510293242,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12879,GO:0047939,1,0.994763606144711,0,1,L-glucuronate reductase activity,MF,
12880,GO:0047946,1,0.994623661953221,0,1,glutamine N-acyltransferase activity,MF,
12881,GO:0047961,1,0.989429773249592,0,2,glycine N-acyltransferase activity,MF,
12882,GO:0047963,1,0.993855553218095,0,1,glycine N-choloyltransferase activity,MF,
12883,GO:0047969,1,0.994710614731861,0,1,glyoxylate oxidase activity,MF,
12884,GO:0047977,1,0.988908754683083,0,2,hepoxilin-epoxide hydrolase activity,MF,
12885,GO:0047982,1,0.994711632107073,0,1,homocysteine desulfhydrase activity,MF,
12886,GO:0047988,1,0.994672815773164,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12887,GO:0047992,1,0.994313214468247,0,1,hydroxylysine kinase activity,MF,
12889,GO:0048003,1,0.968831894466839,0,5,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12890,GO:0048006,1,0.993547450799792,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12891,GO:0048007,1,0.968831894466839,0,5,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12892,GO:0048008,1,0.698370335093618,0,48,platelet-derived growth factor receptor signaling pathway,BP,
12894,GO:0048010,1,0.544145821609151,0,91,vascular endothelial growth factor receptor signaling pathway,BP,
12895,GO:0048011,1,0.855098193532589,0,24,neurotrophin TRK receptor signaling pathway,BP,
12896,GO:0048012,1,0.904303044281575,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12898,GO:0048014,1,0.977827762826765,0,3,Tie signaling pathway,BP,
12899,GO:0048015,1,0.370147249042044,0,141,phosphatidylinositol-mediated signaling,BP,
12900,GO:0048016,1,0.764264868544854,0,36,inositol phosphate-mediated signaling,BP,
12901,GO:0048017,1,0.362766112763969,0,144,inositol lipid-mediated signaling,BP,
12903,GO:0048019,1,0.931657734330374,0,12,receptor antagonist activity,MF,
12905,GO:0048021,1,0.953085522010023,0,6,regulation of melanin biosynthetic process,BP,
12906,GO:0048022,1,0.981975357787741,0,2,negative regulation of melanin biosynthetic process,BP,
12907,GO:0048023,1,0.970585141978774,0,4,positive regulation of melanin biosynthetic process,BP,
12908,GO:0048024,1,0.618356548081107,0,75,regulation of mRNA splicing, via spliceosome,BP,
12909,GO:0048025,1,0.893638488816838,0,19,negative regulation of mRNA splicing, via spliceosome,BP,
12910,GO:0048026,1,0.906283697541685,0,16,positive regulation of mRNA splicing, via spliceosome,BP,
12911,GO:0048027,1,0.861263776967563,0,23,mRNA 5'-UTR binding,MF,
12912,GO:0048029,1,0.683162555297016,0,64,monosaccharide binding,MF,
12913,GO:0048030,1,0.984360210764473,0,3,disaccharide binding,MF,
12914,GO:0048033,1,0.994172900929179,0,1,heme o metabolic process,BP,
12915,GO:0048034,1,0.994172900929179,0,1,heme O biosynthetic process,BP,
12916,GO:0048037,1,0.0690935435339945,0,433,cofactor binding,MF,
12917,GO:0048038,1,0.926177230935547,0,14,quinone binding,MF,
12918,GO:0048039,1,0.968553187883923,0,6,ubiquinone binding,MF,
12919,GO:0048040,1,0.994616269044617,0,1,UDP-glucuronate decarboxylase activity,MF,
12920,GO:0048041,1,0.583483740778872,0,71,focal adhesion assembly,BP,
12921,GO:0048048,1,0.760914242569361,0,34,embryonic eye morphogenesis,BP,
12922,GO:0048050,1,0.959730025454068,0,6,post-embryonic eye morphogenesis,BP,
12923,GO:0048066,1,0.746434738574176,0,42,developmental pigmentation,BP,
12924,GO:0048069,1,0.956604739034446,0,7,eye pigmentation,BP,
12925,GO:0048070,1,0.897941778347941,0,15,regulation of developmental pigmentation,BP,
12926,GO:0048073,1,0.986096725720556,0,2,regulation of eye pigmentation,BP,
12927,GO:0048075,1,0.993046967076897,0,1,positive regulation of eye pigmentation,BP,
12928,GO:0048087,1,0.933501296960218,0,9,positive regulation of developmental pigmentation,BP,
12929,GO:0048096,1,0.938659794399586,0,9,chromatin-mediated maintenance of transcription,BP,
12930,GO:0048101,1,0.988545374350358,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12931,GO:0048102,1,0.956204979040407,0,7,autophagic cell death,BP,
12932,GO:0048103,1,0.852183790553596,0,22,somatic stem cell division,BP,
12933,GO:0048104,1,0.964702760680481,0,4,establishment of body hair or bristle planar orientation,BP,
12934,GO:0048105,1,0.964702760680481,0,4,establishment of body hair planar orientation,BP,
12935,GO:0048133,1,0.982683323199068,0,3,male germ-line stem cell asymmetric division,BP,
12936,GO:0048143,1,0.911951024010591,0,12,astrocyte activation,BP,
12940,GO:0048147,1,0.838816014759187,0,27,negative regulation of fibroblast proliferation,BP,
12941,GO:0048148,1,0.908136833511329,0,15,behavioral response to cocaine,BP,
12942,GO:0048149,1,0.936514939992666,0,10,behavioral response to ethanol,BP,
12943,GO:0048156,1,0.936794471700078,0,11,tau protein binding,MF,
12944,GO:0048160,1,0.992729695234148,0,1,primary follicle stage,BP,
12945,GO:0048162,1,0.983990412609033,0,3,multi-layer follicle stage,BP,
12946,GO:0048165,1,0.98454798274091,0,2,fused antrum stage,BP,
12950,GO:0048170,1,0.964103643098909,0,5,positive regulation of long-term neuronal synaptic plasticity,BP,
12952,GO:0048174,1,0.9932585515136,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
12953,GO:0048175,1,0.994031455799731,0,1,hepatocyte growth factor biosynthetic process,BP,
12954,GO:0048176,1,0.994031455799731,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12955,GO:0048178,1,0.994031455799731,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12956,GO:0048179,1,0.977626558807608,0,3,activin receptor complex,CC,
12957,GO:0048180,1,0.994589950888657,0,1,activin complex,CC,
12958,GO:0048185,1,0.918069926666037,0,12,activin binding,MF,
12959,GO:0048188,1,0.912409150490092,0,12,Set1C/COMPASS complex,CC,
12961,GO:0048194,1,0.585126260698243,0,78,Golgi vesicle budding,BP,
12962,GO:0048199,1,0.626468591232638,0,70,vesicle targeting, to, from or within Golgi,BP,
12963,GO:0048200,1,0.962671013285299,0,6,Golgi transport vesicle coating,BP,
12964,GO:0048203,1,0.98895731920447,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12965,GO:0048205,1,0.962671013285299,0,6,COPI coating of Golgi vesicle,BP,
12966,GO:0048207,1,0.659088677728376,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
12967,GO:0048208,1,0.659088677728376,0,62,COPII vesicle coating,BP,
12968,GO:0048209,1,0.986751593849972,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12969,GO:0048210,1,0.976766766491102,0,4,Golgi vesicle fusion to target membrane,BP,
12970,GO:0048211,1,0.987830769745904,0,2,Golgi vesicle docking,BP,
12971,GO:0048213,1,0.989016762793149,0,2,Golgi vesicle prefusion complex stabilization,BP,
12972,GO:0048227,1,0.950480287358717,0,8,plasma membrane to endosome transport,BP,
12973,GO:0048232,1,0.0615212104979713,0,418,male gamete generation,BP,
12974,GO:0048237,1,0.984170919849804,0,3,rough endoplasmic reticulum lumen,CC,
12975,GO:0048239,1,0.988878618262509,0,2,negative regulation of DNA recombination at telomere,BP,
12976,GO:0048240,1,0.886507862673776,0,20,sperm capacitation,BP,
12977,GO:0048241,1,0.972729894399423,0,5,epinephrine transport,BP,
12978,GO:0048242,1,0.977928139866369,0,4,epinephrine secretion,BP,
12980,GO:0048244,1,0.994728757425739,0,1,phytanoyl-CoA dioxygenase activity,MF,
12985,GO:0048250,1,0.989461031205571,0,2,iron import into the mitochondrion,BP,
12987,GO:0048254,1,0.975615701486579,0,4,snoRNA localization,BP,
12988,GO:0048255,1,0.803119602580165,0,32,mRNA stabilization,BP,
12989,GO:0048256,1,0.95966636134752,0,7,flap endonuclease activity,MF,
12990,GO:0048257,1,0.988841261989384,0,2,3'-flap endonuclease activity,MF,
12993,GO:0048261,1,0.899567010305524,0,17,negative regulation of receptor-mediated endocytosis,BP,
12994,GO:0048262,1,0.948753916678928,0,9,determination of dorsal/ventral asymmetry,BP,
12995,GO:0048263,1,0.95432321655675,0,8,determination of dorsal identity,BP,
12996,GO:0048264,1,0.994166858399795,0,1,determination of ventral identity,BP,
12997,GO:0048265,1,0.835390259718909,0,26,response to pain,BP,
12998,GO:0048266,1,0.919875344263145,0,12,behavioral response to pain,BP,
13000,GO:0048269,1,0.988935402191507,0,2,methionine adenosyltransferase complex,CC,
13001,GO:0048270,1,0.994618697904438,0,1,methionine adenosyltransferase regulator activity,MF,
13002,GO:0048273,1,0.959498568231437,0,6,mitogen-activated protein kinase p38 binding,MF,
13004,GO:0048280,1,0.954211248580619,0,8,vesicle fusion with Golgi apparatus,BP,
13006,GO:0048285,1,0.061477786668061,0,407,organelle fission,BP,
13007,GO:0048286,1,0.763498055064113,0,36,lung alveolus development,BP,
13008,GO:0048289,1,0.964394433983037,0,6,isotype switching to IgE isotypes,BP,
13009,GO:0048290,1,0.966674534805922,0,6,isotype switching to IgA isotypes,BP,
13010,GO:0048291,1,0.934607134063662,0,11,isotype switching to IgG isotypes,BP,
13011,GO:0048293,1,0.964394433983037,0,6,regulation of isotype switching to IgE isotypes,BP,
13012,GO:0048294,1,0.982110854556354,0,3,negative regulation of isotype switching to IgE isotypes,BP,
13013,GO:0048295,1,0.981964103059598,0,3,positive regulation of isotype switching to IgE isotypes,BP,
13014,GO:0048296,1,0.972588175897321,0,5,regulation of isotype switching to IgA isotypes,BP,
13015,GO:0048297,1,0.994602677775799,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13016,GO:0048298,1,0.977867219923094,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13017,GO:0048302,1,0.939745373301015,0,10,regulation of isotype switching to IgG isotypes,BP,
13018,GO:0048304,1,0.9566622589301,0,7,positive regulation of isotype switching to IgG isotypes,BP,
13019,GO:0048305,1,0.905227580650945,0,18,immunoglobulin secretion,BP,
13021,GO:0048308,1,0.910840796424838,0,15,organelle inheritance,BP,
13023,GO:0048312,1,0.938399986298332,0,8,intracellular distribution of mitochondria,BP,
13024,GO:0048313,1,0.91605476248707,0,14,Golgi inheritance,BP,
13025,GO:0048318,1,0.958376795651138,0,7,axial mesoderm development,BP,
13026,GO:0048319,1,0.979348029360089,0,3,axial mesoderm morphogenesis,BP,
13027,GO:0048320,1,0.988528443060444,0,2,axial mesoderm formation,BP,
13028,GO:0048321,1,0.99461918156608,0,1,axial mesodermal cell differentiation,BP,
13029,GO:0048322,1,0.99461918156608,0,1,axial mesodermal cell fate commitment,BP,
13030,GO:0048327,1,0.99461918156608,0,1,axial mesodermal cell fate specification,BP,
13031,GO:0048332,1,0.647338770035262,0,64,mesoderm morphogenesis,BP,
13032,GO:0048333,1,0.822585042859685,0,30,mesodermal cell differentiation,BP,
13033,GO:0048338,1,0.993689247411896,0,1,mesoderm structural organization,BP,
13034,GO:0048339,1,0.886972236752269,0,17,paraxial mesoderm development,BP,
13035,GO:0048340,1,0.936539965552592,0,9,paraxial mesoderm morphogenesis,BP,
13036,GO:0048341,1,0.963291098472479,0,6,paraxial mesoderm formation,BP,
13037,GO:0048342,1,0.994726690322179,0,1,paraxial mesodermal cell differentiation,BP,
13038,GO:0048343,1,0.994726690322179,0,1,paraxial mesodermal cell fate commitment,BP,
13039,GO:0048352,1,0.993689247411896,0,1,paraxial mesoderm structural organization,BP,
13040,GO:0048364,1,0.994831355742962,0,1,root development,BP,
13041,GO:0048365,1,0.649767438969944,0,60,Rac GTPase binding,MF,
13042,GO:0048368,1,0.908692743657802,0,15,lateral mesoderm development,BP,
13043,GO:0048369,1,0.974767902484977,0,4,lateral mesoderm morphogenesis,BP,
13044,GO:0048370,1,0.974767902484977,0,4,lateral mesoderm formation,BP,
13045,GO:0048371,1,0.979921672292483,0,3,lateral mesodermal cell differentiation,BP,
13046,GO:0048372,1,0.985412653475705,0,2,lateral mesodermal cell fate commitment,BP,
13047,GO:0048377,1,0.985412653475705,0,2,lateral mesodermal cell fate specification,BP,
13048,GO:0048378,1,0.985412653475705,0,2,regulation of lateral mesodermal cell fate specification,BP,
13049,GO:0048382,1,0.977473802104125,0,4,mesendoderm development,BP,
13050,GO:0048384,1,0.842964691772832,0,28,retinoic acid receptor signaling pathway,BP,
13051,GO:0048385,1,0.912617739669562,0,15,regulation of retinoic acid receptor signaling pathway,BP,
13052,GO:0048386,1,0.976188342629891,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13053,GO:0048387,1,0.949810069222866,0,8,negative regulation of retinoic acid receptor signaling pathway,BP,
13054,GO:0048388,1,0.982878276213068,0,3,endosomal lumen acidification,BP,
13055,GO:0048389,1,0.989406428114059,0,2,intermediate mesoderm development,BP,
13056,GO:0048390,1,0.994702757779098,0,1,intermediate mesoderm morphogenesis,BP,
13057,GO:0048391,1,0.994702757779098,0,1,intermediate mesoderm formation,BP,
13058,GO:0048392,1,0.994702757779098,0,1,intermediate mesodermal cell differentiation,BP,
13059,GO:0048403,1,0.975721186548451,0,3,brain-derived neurotrophic factor binding,MF,
13060,GO:0048406,1,0.960413326341189,0,6,nerve growth factor binding,MF,
13062,GO:0048408,1,0.983290123255085,0,3,epidermal growth factor binding,MF,
13066,GO:0048475,1,0.53140830857141,0,96,coated membrane,CC,
13067,GO:0048476,1,0.973231664535983,0,5,Holliday junction resolvase complex,CC,
13068,GO:0048477,1,0.646261075283819,0,67,oogenesis,BP,
13069,GO:0048478,1,0.94982889196202,0,7,replication fork protection,BP,
13070,GO:0048483,1,0.761358003376575,0,39,autonomic nervous system development,BP,
13071,GO:0048484,1,0.935059847827566,0,10,enteric nervous system development,BP,
13072,GO:0048485,1,0.868294560912003,0,20,sympathetic nervous system development,BP,
13073,GO:0048486,1,0.904077571566486,0,15,parasympathetic nervous system development,BP,
13074,GO:0048487,1,0.795673762811605,0,36,beta-tubulin binding,MF,
13077,GO:0048490,1,0.901469087337393,0,17,anterograde synaptic vesicle transport,BP,
13078,GO:0048495,1,0.958564527191265,0,5,Roundabout binding,MF,
13079,GO:0048496,1,0.964805857745962,0,4,maintenance of animal organ identity,BP,
13080,GO:0048499,1,0.976720786328417,0,4,synaptic vesicle membrane organization,BP,
13081,GO:0048500,1,0.950925788358826,0,9,signal recognition particle,CC,
13082,GO:0048505,1,0.92846167483347,0,11,regulation of timing of cell differentiation,BP,
13084,GO:0048512,1,0.779550389787136,0,39,circadian behavior,BP,
13087,GO:0048515,1,0.500993596894123,0,105,spermatid differentiation,BP,
13090,GO:0048520,1,0.89095495502952,0,18,positive regulation of behavior,BP,
13091,GO:0048521,1,0.928408317558386,0,13,negative regulation of behavior,BP,
13094,GO:0048524,1,0.528806480104441,0,100,positive regulation of viral process,BP,
13096,GO:0048531,1,0.92233800799505,0,14,beta-1,3-galactosyltransferase activity,MF,
13097,GO:0048532,1,0.904870251868631,0,15,anatomical structure arrangement,BP,
13100,GO:0048536,1,0.804278556265374,0,33,spleen development,BP,
13101,GO:0048537,1,0.963519260685137,0,6,mucosal-associated lymphoid tissue development,BP,
13102,GO:0048538,1,0.739574444045426,0,43,thymus development,BP,
13103,GO:0048539,1,0.956856839831151,0,7,bone marrow development,BP,
13104,GO:0048541,1,0.963519260685137,0,6,Peyer's patch development,BP,
13106,GO:0048546,1,0.723206251159148,0,45,digestive tract morphogenesis,BP,
13107,GO:0048548,1,0.94442831895259,0,9,regulation of pinocytosis,BP,
13108,GO:0048549,1,0.973243930267055,0,4,positive regulation of pinocytosis,BP,
13109,GO:0048550,1,0.970400110961792,0,5,negative regulation of pinocytosis,BP,
13110,GO:0048557,1,0.894460971325341,0,16,embryonic digestive tract morphogenesis,BP,
13111,GO:0048560,1,0.989187568650256,0,2,establishment of anatomical structure orientation,BP,
13112,GO:0048561,1,0.99457204175657,0,1,establishment of animal organ orientation,BP,
13113,GO:0048562,1,0.156661058622821,0,268,embryonic organ morphogenesis,BP,
13114,GO:0048563,1,0.94281334869566,0,8,post-embryonic animal organ morphogenesis,BP,
13116,GO:0048566,1,0.809509191674057,0,32,embryonic digestive tract development,BP,
13117,GO:0048567,1,0.994428550852589,0,1,ectodermal digestive tract morphogenesis,BP,
13119,GO:0048569,1,0.89611901780043,0,15,post-embryonic animal organ development,BP,
13120,GO:0048570,1,0.944415054427187,0,8,notochord morphogenesis,BP,
13126,GO:0048592,1,0.383351920688808,0,132,eye morphogenesis,BP,
13127,GO:0048593,1,0.494933546117176,0,98,camera-type eye morphogenesis,BP,
13128,GO:0048596,1,0.814098638334962,0,25,embryonic camera-type eye morphogenesis,BP,
13129,GO:0048597,1,0.984282926721779,0,3,post-embryonic camera-type eye morphogenesis,BP,
13131,GO:0048599,1,0.778356109454388,0,38,oocyte development,BP,
13134,GO:0048611,1,0.988656661634221,0,2,embryonic ectodermal digestive tract development,BP,
13135,GO:0048613,1,0.994428550852589,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13136,GO:0048617,1,0.928796479017103,0,9,embryonic foregut morphogenesis,BP,
13137,GO:0048619,1,0.982439045213437,0,3,embryonic hindgut morphogenesis,BP,
13138,GO:0048625,1,0.969614739252483,0,5,myoblast fate commitment,BP,
13139,GO:0048627,1,0.988803146905461,0,2,myoblast development,BP,
13140,GO:0048630,1,0.954810469010203,0,7,skeletal muscle tissue growth,BP,
13141,GO:0048631,1,0.965065598554158,0,5,regulation of skeletal muscle tissue growth,BP,
13142,GO:0048632,1,0.984841176474981,0,2,negative regulation of skeletal muscle tissue growth,BP,
13143,GO:0048633,1,0.979923067770256,0,3,positive regulation of skeletal muscle tissue growth,BP,
13144,GO:0048634,1,0.441608463781916,0,117,regulation of muscle organ development,BP,
13145,GO:0048635,1,0.754019939450175,0,43,negative regulation of muscle organ development,BP,
13146,GO:0048636,1,0.651768811580525,0,60,positive regulation of muscle organ development,BP,
13150,GO:0048641,1,0.733706068657588,0,46,regulation of skeletal muscle tissue development,BP,
13151,GO:0048642,1,0.917015600606423,0,13,negative regulation of skeletal muscle tissue development,BP,
13152,GO:0048643,1,0.870662735486639,0,21,positive regulation of skeletal muscle tissue development,BP,
13154,GO:0048645,1,0.688376337964921,0,58,animal organ formation,BP,
13156,GO:0048659,1,0.461624425186234,0,117,smooth muscle cell proliferation,BP,
13157,GO:0048660,1,0.47109839978598,0,114,regulation of smooth muscle cell proliferation,BP,
13158,GO:0048661,1,0.614256068700407,0,72,positive regulation of smooth muscle cell proliferation,BP,
13159,GO:0048662,1,0.787356883110057,0,39,negative regulation of smooth muscle cell proliferation,BP,
13160,GO:0048663,1,0.676464695271893,0,60,neuron fate commitment,BP,
13161,GO:0048664,1,0.967323768566557,0,6,neuron fate determination,BP,
13162,GO:0048665,1,0.823042204918207,0,31,neuron fate specification,BP,
13166,GO:0048669,1,0.980710542815836,0,3,collateral sprouting in absence of injury,BP,
13169,GO:0048672,1,0.936003781126275,0,11,positive regulation of collateral sprouting,BP,
13171,GO:0048674,1,0.994482162004173,0,1,collateral sprouting of injured axon,BP,
13176,GO:0048680,1,0.961453006576289,0,7,positive regulation of axon regeneration,BP,
13182,GO:0048687,1,0.988767637550636,0,2,positive regulation of sprouting of injured axon,BP,
13184,GO:0048689,1,0.994482162004173,0,1,formation of growth cone in injured axon,BP,
13186,GO:0048691,1,0.994254086098554,0,1,positive regulation of axon extension involved in regeneration,BP,
13188,GO:0048693,1,0.994482162004173,0,1,regulation of collateral sprouting of injured axon,BP,
13189,GO:0048694,1,0.994482162004173,0,1,positive regulation of collateral sprouting of injured axon,BP,
13190,GO:0048696,1,0.994760088027326,0,1,regulation of collateral sprouting in absence of injury,BP,
13191,GO:0048697,1,0.994760088027326,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13193,GO:0048701,1,0.737549627989338,0,43,embryonic cranial skeleton morphogenesis,BP,
13194,GO:0048702,1,0.950973795612298,0,7,embryonic neurocranium morphogenesis,BP,
13195,GO:0048703,1,0.931811781073864,0,9,embryonic viscerocranium morphogenesis,BP,
13196,GO:0048704,1,0.550414582325928,0,88,embryonic skeletal system morphogenesis,BP,
13200,GO:0048709,1,0.562372816532369,0,87,oligodendrocyte differentiation,BP,
13201,GO:0048710,1,0.831766816836569,0,27,regulation of astrocyte differentiation,BP,
13202,GO:0048711,1,0.914135299272082,0,14,positive regulation of astrocyte differentiation,BP,
13203,GO:0048712,1,0.927971693532514,0,11,negative regulation of astrocyte differentiation,BP,
13204,GO:0048713,1,0.805845425520696,0,33,regulation of oligodendrocyte differentiation,BP,
13205,GO:0048714,1,0.898940585356001,0,17,positive regulation of oligodendrocyte differentiation,BP,
13206,GO:0048715,1,0.923271965711705,0,11,negative regulation of oligodendrocyte differentiation,BP,
13208,GO:0048730,1,0.839930154220057,0,27,epidermis morphogenesis,BP,
13211,GO:0048733,1,0.952652420644979,0,6,sebaceous gland development,BP,
13213,GO:0048738,1,0.248968139989826,0,186,cardiac muscle tissue development,BP,
13214,GO:0048739,1,0.884400931721978,0,13,cardiac muscle fiber development,BP,
13215,GO:0048741,1,0.828190068587802,0,28,skeletal muscle fiber development,BP,
13216,GO:0048742,1,0.941191502055126,0,9,regulation of skeletal muscle fiber development,BP,
13217,GO:0048743,1,0.964236523701761,0,6,positive regulation of skeletal muscle fiber development,BP,
13219,GO:0048747,1,0.677753679519015,0,52,muscle fiber development,BP,
13220,GO:0048749,1,0.993321842508897,0,1,compound eye development,BP,
13221,GO:0048752,1,0.948822734546635,0,7,semicircular canal morphogenesis,BP,
13222,GO:0048753,1,0.833288811486325,0,27,pigment granule organization,BP,
13224,GO:0048755,1,0.933962745376532,0,9,branching morphogenesis of a nerve,BP,
13225,GO:0048757,1,0.939439639580976,0,10,pigment granule maturation,BP,
13227,GO:0048763,1,0.940448151960756,0,4,calcium-induced calcium release activity,MF,
13228,GO:0048764,1,0.994831355742962,0,1,trichoblast maturation,BP,
13229,GO:0048765,1,0.994831355742962,0,1,root hair cell differentiation,BP,
13230,GO:0048767,1,0.994831355742962,0,1,root hair elongation,BP,
13231,GO:0048769,1,0.944186325276534,0,4,sarcomerogenesis,BP,
13235,GO:0048787,1,0.966367637890732,0,5,presynaptic active zone membrane,CC,
13237,GO:0048789,1,0.992429697060513,0,1,cytoskeletal matrix organization at active zone,BP,
13238,GO:0048790,1,0.994759255262444,0,1,maintenance of presynaptic active zone structure,BP,
13240,GO:0048792,1,0.993848616379841,0,1,spontaneous exocytosis of neurotransmitter,BP,
13241,GO:0048793,1,0.956855668807293,0,6,pronephros development,BP,
13243,GO:0048806,1,0.737472358149151,0,40,genitalia development,BP,
13244,GO:0048807,1,0.982479969110996,0,3,female genitalia morphogenesis,BP,
13245,GO:0048808,1,0.9809024671322,0,3,male genitalia morphogenesis,BP,
13250,GO:0048818,1,0.967978101790077,0,5,positive regulation of hair follicle maturation,BP,
13253,GO:0048821,1,0.835613678860029,0,28,erythrocyte development,BP,
13254,GO:0048822,1,0.976073602738086,0,3,enucleate erythrocyte development,BP,
13255,GO:0048823,1,0.994313214468247,0,1,nucleate erythrocyte development,BP,
13257,GO:0048840,1,0.969447086193487,0,5,otolith development,BP,
13258,GO:0048841,1,0.797954535268136,0,27,regulation of axon extension involved in axon guidance,BP,
13259,GO:0048842,1,0.932502805563091,0,7,positive regulation of axon extension involved in axon guidance,BP,
13260,GO:0048843,1,0.866282626650829,0,19,negative regulation of axon extension involved in axon guidance,BP,
13262,GO:0048845,1,0.928484635973693,0,10,venous blood vessel morphogenesis,BP,
13263,GO:0048846,1,0.765017199305511,0,32,axon extension involved in axon guidance,BP,
13264,GO:0048850,1,0.982448102175842,0,2,hypophysis morphogenesis,BP,
13265,GO:0048852,1,0.977134128721367,0,3,diencephalon morphogenesis,BP,
13266,GO:0048853,1,0.909199911242521,0,13,forebrain morphogenesis,BP,
13268,GO:0048855,1,0.990905344188586,0,1,adenohypophysis morphogenesis,BP,
13272,GO:0048859,1,0.967879993532831,0,5,formation of anatomical boundary,BP,
13273,GO:0048861,1,0.969671077032512,0,4,leukemia inhibitory factor signaling pathway,BP,
13274,GO:0048863,1,0.220580296584269,0,234,stem cell differentiation,BP,
13275,GO:0048864,1,0.614707437599829,0,72,stem cell development,BP,
13276,GO:0048865,1,0.955093921791607,0,8,stem cell fate commitment,BP,
13277,GO:0048866,1,0.977651964519432,0,4,stem cell fate specification,BP,
13278,GO:0048867,1,0.983924252411867,0,3,stem cell fate determination,BP,
13283,GO:0048873,1,0.840452461316725,0,27,homeostasis of number of cells within a tissue,BP,
13284,GO:0048874,1,0.993970144807525,0,1,homeostasis of number of cells in a free-living population,BP,
13285,GO:0048875,1,0.936540826291074,0,10,chemical homeostasis within a tissue,BP,
13287,GO:0048880,1,0.974152580210556,0,4,sensory system development,BP,
13288,GO:0048882,1,0.994383550341847,0,1,lateral line development,BP,
13289,GO:0048884,1,0.994383550341847,0,1,neuromast development,BP,
13290,GO:0048886,1,0.994383550341847,0,1,neuromast hair cell differentiation,BP,
13291,GO:0048925,1,0.994383550341847,0,1,lateral line system development,BP,
13292,GO:0048934,1,0.906505220593213,0,13,peripheral nervous system neuron differentiation,BP,
13293,GO:0048935,1,0.906505220593213,0,13,peripheral nervous system neuron development,BP,
13294,GO:0048936,1,0.982716193518422,0,3,peripheral nervous system neuron axonogenesis,BP,
13295,GO:0050000,1,0.629251048778017,0,71,chromosome localization,BP,
13296,GO:0050011,1,0.994743299063165,0,1,itaconyl-CoA hydratase activity,MF,
13297,GO:0050023,1,0.994683313815445,0,1,L-fuconate dehydratase activity,MF,
13298,GO:0050031,1,0.994494465846789,0,1,L-pipecolate oxidase activity,MF,
13299,GO:0050038,1,0.994828795741294,0,1,L-xylulose reductase (NADP+) activity,MF,
13300,GO:0050046,1,0.994313214468247,0,1,lathosterol oxidase activity,MF,
13301,GO:0050051,1,0.988920929278005,0,2,leukotriene-B4 20-monooxygenase activity,MF,
13302,GO:0050072,1,0.951833673272863,0,7,m7G(5')pppN diphosphatase activity,MF,
13303,GO:0050080,1,0.994582172474536,0,1,malonyl-CoA decarboxylase activity,MF,
13304,GO:0050104,1,0.994759255262444,0,1,L-gulonate 3-dehydrogenase activity,MF,
13305,GO:0050115,1,0.992464931057538,0,1,myosin-light-chain-phosphatase activity,MF,
13306,GO:0050119,1,0.982631089937805,0,2,N-acetylglucosamine deacetylase activity,MF,
13307,GO:0050121,1,0.994763363981462,0,1,N-acylglucosamine 2-epimerase activity,MF,
13308,GO:0050124,1,0.993537497200752,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13309,GO:0050129,1,0.994030712388483,0,1,N-formylglutamate deformylase activity,MF,
13310,GO:0050135,1,0.98954981728533,0,2,NAD(P)+ nucleosidase activity,MF,
13311,GO:0050136,1,0.817341139314051,0,38,NADH dehydrogenase (quinone) activity,MF,
13312,GO:0050144,1,0.994313214468247,0,1,nucleoside deoxyribosyltransferase activity,MF,
13313,GO:0050145,1,0.97231978688565,0,5,nucleoside phosphate kinase activity,MF,
13314,GO:0050146,1,0.992005286844517,0,1,nucleoside phosphotransferase activity,MF,
13315,GO:0050152,1,0.994791638047281,0,1,omega-amidase activity,MF,
13316,GO:0050178,1,0.989701588135291,0,2,phenylpyruvate tautomerase activity,MF,
13317,GO:0050185,1,0.981133419981676,0,2,phosphatidylinositol deacylase activity,MF,
13318,GO:0050197,1,0.994536095807949,0,1,phytanate-CoA ligase activity,MF,
13319,GO:0050201,1,0.993417152262193,0,1,fucokinase activity,MF,
13320,GO:0050211,1,0.982903381862464,0,3,procollagen galactosyltransferase activity,MF,
13321,GO:0050220,1,0.979103271826391,0,4,prostaglandin-E synthase activity,MF,
13322,GO:0050221,1,0.994795405320195,0,1,prostaglandin-E2 9-reductase activity,MF,
13323,GO:0050252,1,0.988118398162579,0,2,retinol O-fatty-acyltransferase activity,MF,
13324,GO:0050253,1,0.986526521722972,0,2,retinyl-palmitate esterase activity,MF,
13325,GO:0050254,1,0.989212737435932,0,2,rhodopsin kinase activity,MF,
13326,GO:0050262,1,0.988658446617857,0,2,ribosylnicotinamide kinase activity,MF,
13327,GO:0050265,1,0.977541033435599,0,3,RNA uridylyltransferase activity,MF,
13328,GO:0050277,1,0.993495609624513,0,1,sedoheptulokinase activity,MF,
13329,GO:0050290,1,0.992607165421308,0,1,sphingomyelin phosphodiesterase D activity,MF,
13330,GO:0050291,1,0.961202100640773,0,7,sphingosine N-acyltransferase activity,MF,
13331,GO:0050294,1,0.979106855373193,0,4,steroid sulfotransferase activity,MF,
13332,GO:0050308,1,0.952267259967426,0,8,sugar-phosphatase activity,MF,
13333,GO:0050309,1,0.983094756786994,0,3,sugar-terminal-phosphatase activity,MF,
13334,GO:0050313,1,0.99482079915527,0,1,sulfur dioxygenase activity,MF,
13335,GO:0050321,1,0.914941272800176,0,13,tau-protein kinase activity,MF,
13336,GO:0050333,1,0.994699912260192,0,1,thiamin-triphosphatase activity,MF,
13337,GO:0050337,1,0.994838153190516,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13338,GO:0050346,1,0.994313214468247,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13339,GO:0050347,1,0.988517424220207,0,2,trans-octaprenyltranstransferase activity,MF,
13340,GO:0050353,1,0.9942639262759,0,1,trimethyllysine dioxygenase activity,MF,
13341,GO:0050355,1,0.99288509745476,0,1,triphosphatase activity,MF,
13342,GO:0050379,1,0.992301692711915,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13343,GO:0050405,1,0.980263244075344,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13344,GO:0050421,1,0.994406694608454,0,1,nitrite reductase (NO-forming) activity,MF,
13345,GO:0050427,1,0.868670866061183,0,23,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13346,GO:0050428,1,0.96087331308307,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13347,GO:0050429,1,0.990813227536919,0,1,calcium-dependent phospholipase C activity,MF,
13348,GO:0050431,1,0.870677930135544,0,19,transforming growth factor beta binding,MF,
13351,GO:0050434,1,0.769692343806034,0,41,positive regulation of viral transcription,BP,
13352,GO:0050435,1,0.795654528506847,0,32,amyloid-beta metabolic process,BP,
13353,GO:0050436,1,0.985632038428041,0,2,microfibril binding,MF,
13354,GO:0050444,1,0.993960877222941,0,1,aquacobalamin reductase (NADPH) activity,MF,
13355,GO:0050459,1,0.994313214468247,0,1,ethanolamine-phosphate phospho-lyase activity,MF,
13356,GO:0050462,1,0.994795748772704,0,1,N-acetylneuraminate synthase activity,MF,
13357,GO:0050473,1,0.981729326667614,0,3,arachidonate 15-lipoxygenase activity,MF,
13358,GO:0050479,1,0.994313214468247,0,1,glyceryl-ether monooxygenase activity,MF,
13359,GO:0050480,1,0.994600983713833,0,1,imidazolonepropionase activity,MF,
13361,GO:0050497,1,0.988640577376153,0,2,transferase activity, transferring alkylthio groups,MF,
13362,GO:0050501,1,0.977790818589041,0,4,hyaluronan synthase activity,MF,
13363,GO:0050508,1,0.980956297539279,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13364,GO:0050509,1,0.987544152234644,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13365,GO:0050510,1,0.974417362019735,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13366,GO:0050512,1,0.994617566626888,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13367,GO:0050528,1,0.994504358258735,0,1,acyloxyacyl hydrolase activity,MF,
13368,GO:0050542,1,0.968525251459079,0,6,icosanoid binding,MF,
13369,GO:0050543,1,0.968624177040168,0,6,icosatetraenoic acid binding,MF,
13370,GO:0050544,1,0.973678558825617,0,5,arachidonic acid binding,MF,
13371,GO:0050560,1,0.99390829171135,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13372,GO:0050561,1,0.993422733062869,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13373,GO:0050567,1,0.982486913114351,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13374,GO:0050571,1,0.994739690647471,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13375,GO:0050577,1,0.994780129678445,0,1,GDP-L-fucose synthase activity,MF,
13376,GO:0050610,1,0.989618241520137,0,2,methylarsonate reductase activity,MF,
13377,GO:0050613,1,0.988316868652729,0,2,delta14-sterol reductase activity,MF,
13378,GO:0050614,1,0.993067605326437,0,1,delta24-sterol reductase activity,MF,
13379,GO:0050632,1,0.994771926335018,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13380,GO:0050646,1,0.994708793136084,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13381,GO:0050647,1,0.994708793136084,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13382,GO:0050648,1,0.994708793136084,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13383,GO:0050650,1,0.812397437690351,0,30,chondroitin sulfate proteoglycan biosynthetic process,BP,
13384,GO:0050651,1,0.897140580650587,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13385,GO:0050652,1,0.993600404449861,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13386,GO:0050653,1,0.987031446874608,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13387,GO:0050654,1,0.743387524423007,0,43,chondroitin sulfate proteoglycan metabolic process,BP,
13388,GO:0050655,1,0.892274440932335,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13389,GO:0050656,1,0.960464536490057,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13390,GO:0050657,1,0.297389546988257,0,180,nucleic acid transport,BP,
13391,GO:0050658,1,0.297389546988257,0,180,RNA transport,BP,
13392,GO:0050659,1,0.984295966842652,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13393,GO:0050660,1,0.615451049034208,0,77,flavin adenine dinucleotide binding,MF,
13394,GO:0050661,1,0.758410933868445,0,44,NADP binding,MF,
13395,GO:0050662,1,0.206842155594412,0,258,coenzyme binding,MF,
13397,GO:0050664,1,0.919593138329916,0,13,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13398,GO:0050665,1,0.931021663734817,0,11,hydrogen peroxide biosynthetic process,BP,
13399,GO:0050666,1,0.989039051876076,0,2,regulation of homocysteine metabolic process,BP,
13400,GO:0050667,1,0.916616543581001,0,14,homocysteine metabolic process,BP,
13401,GO:0050668,1,0.994553872164583,0,1,positive regulation of homocysteine metabolic process,BP,
13404,GO:0050672,1,0.666622503480902,0,64,negative regulation of lymphocyte proliferation,BP,
13406,GO:0050674,1,0.994837004944945,0,1,urothelial cell proliferation,BP,
13407,GO:0050675,1,0.994837004944945,0,1,regulation of urothelial cell proliferation,BP,
13408,GO:0050677,1,0.994837004944945,0,1,positive regulation of urothelial cell proliferation,BP,
13409,GO:0050678,1,0.146852564370869,0,278,regulation of epithelial cell proliferation,BP,
13410,GO:0050679,1,0.339894896697691,0,158,positive regulation of epithelial cell proliferation,BP,
13411,GO:0050680,1,0.463450482186821,0,110,negative regulation of epithelial cell proliferation,BP,
13412,GO:0050681,1,0.753082511091774,0,41,androgen receptor binding,MF,
13413,GO:0050682,1,0.973620444888114,0,3,AF-2 domain binding,MF,
13414,GO:0050683,1,0.993239396460582,0,1,AF-1 domain binding,MF,
13415,GO:0050684,1,0.489040230975149,0,112,regulation of mRNA processing,BP,
13416,GO:0050685,1,0.856083738265623,0,25,positive regulation of mRNA processing,BP,
13417,GO:0050686,1,0.839886001074804,0,29,negative regulation of mRNA processing,BP,
13418,GO:0050687,1,0.878081925725876,0,21,negative regulation of defense response to virus,BP,
13419,GO:0050688,1,0.683256239798403,0,58,regulation of defense response to virus,BP,
13420,GO:0050689,1,0.973417850098475,0,5,negative regulation of defense response to virus by host,BP,
13421,GO:0050690,1,0.833703161495263,0,29,regulation of defense response to virus by virus,BP,
13422,GO:0050691,1,0.815133385070505,0,32,regulation of defense response to virus by host,BP,
13423,GO:0050692,1,0.980724579608188,0,3,DBD domain binding,MF,
13424,GO:0050693,1,0.959896271395658,0,6,LBD domain binding,MF,
13425,GO:0050694,1,0.978030643945505,0,4,galactose 3-O-sulfotransferase activity,MF,
13426,GO:0050698,1,0.988413796374603,0,2,proteoglycan sulfotransferase activity,MF,
13428,GO:0050700,1,0.921918963235231,0,12,CARD domain binding,MF,
13429,GO:0050701,1,0.759230478541646,0,44,interleukin-1 secretion,BP,
13430,GO:0050702,1,0.780314556166253,0,39,interleukin-1 beta secretion,BP,
13431,GO:0050703,1,0.973102935250442,0,5,interleukin-1 alpha secretion,BP,
13432,GO:0050704,1,0.798989749356653,0,37,regulation of interleukin-1 secretion,BP,
13433,GO:0050705,1,0.978153724951551,0,4,regulation of interleukin-1 alpha secretion,BP,
13434,GO:0050706,1,0.816918892391691,0,33,regulation of interleukin-1 beta secretion,BP,
13439,GO:0050711,1,0.937594242383633,0,11,negative regulation of interleukin-1 secretion,BP,
13440,GO:0050712,1,0.994770265495778,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13441,GO:0050713,1,0.953508216083859,0,8,negative regulation of interleukin-1 beta secretion,BP,
13444,GO:0050716,1,0.848991113963169,0,26,positive regulation of interleukin-1 secretion,BP,
13445,GO:0050717,1,0.983296972130345,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13446,GO:0050718,1,0.858687771522146,0,24,positive regulation of interleukin-1 beta secretion,BP,
13447,GO:0050719,1,0.994828353545521,0,1,interleukin-1 alpha biosynthetic process,BP,
13448,GO:0050720,1,0.988935008549491,0,2,interleukin-1 beta biosynthetic process,BP,
13449,GO:0050721,1,0.994828353545521,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
13450,GO:0050722,1,0.988935008549491,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13451,GO:0050725,1,0.988935008549491,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13452,GO:0050726,1,0.994828353545521,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
13459,GO:0050733,1,0.967364085546002,0,5,RS domain binding,MF,
13460,GO:0050746,1,0.923018124166866,0,12,regulation of lipoprotein metabolic process,BP,
13461,GO:0050747,1,0.966832350531993,0,5,positive regulation of lipoprotein metabolic process,BP,
13462,GO:0050748,1,0.97254469714322,0,4,negative regulation of lipoprotein metabolic process,BP,
13463,GO:0050750,1,0.875671833400645,0,18,low-density lipoprotein particle receptor binding,MF,
13464,GO:0050751,1,0.994824207229569,0,1,fractalkine biosynthetic process,BP,
13465,GO:0050752,1,0.994824207229569,0,1,regulation of fractalkine biosynthetic process,BP,
13466,GO:0050754,1,0.994824207229569,0,1,positive regulation of fractalkine biosynthetic process,BP,
13467,GO:0050755,1,0.934308743645775,0,12,chemokine metabolic process,BP,
13468,GO:0050756,1,0.994824207229569,0,1,fractalkine metabolic process,BP,
13469,GO:0050757,1,0.989224395560781,0,2,thymidylate synthase biosynthetic process,BP,
13470,GO:0050758,1,0.989224395560781,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13471,GO:0050760,1,0.994387463899266,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13473,GO:0050765,1,0.925776277079404,0,13,negative regulation of phagocytosis,BP,
13482,GO:0050774,1,0.898885372202932,0,15,negative regulation of dendrite morphogenesis,BP,
13487,GO:0050779,1,0.835657534214475,0,24,RNA destabilization,BP,
13488,GO:0050780,1,0.919843025059046,0,13,dopamine receptor binding,MF,
13489,GO:0050783,1,0.994481717242437,0,1,cocaine metabolic process,BP,
13490,GO:0050785,1,0.994783252682507,0,1,advanced glycation end-product receptor activity,MF,
13491,GO:0050786,1,0.94847478449694,0,10,RAGE receptor binding,MF,
13492,GO:0050787,1,0.987127653172337,0,2,detoxification of mercury ion,BP,
13498,GO:0050795,1,0.686093211700415,0,55,regulation of behavior,BP,
13502,GO:0050802,1,0.881347109755555,0,21,circadian sleep/wake cycle, sleep,BP,
13509,GO:0050810,1,0.60882490530849,0,77,regulation of steroid biosynthetic process,BP,
13510,GO:0050811,1,0.906705824672686,0,14,GABA receptor binding,MF,
13511,GO:0050812,1,0.914129169639461,0,13,regulation of acyl-CoA biosynthetic process,BP,
13512,GO:0050815,1,0.962030522243696,0,6,phosphoserine residue binding,MF,
13513,GO:0050816,1,0.979421391018631,0,3,phosphothreonine residue binding,MF,
13518,GO:0050821,1,0.377473581150197,0,147,protein stabilization,BP,
13519,GO:0050822,1,0.993790709022544,0,1,peptide stabilization,BP,
13520,GO:0050823,1,0.993790709022544,0,1,peptide antigen stabilization,BP,
13524,GO:0050833,1,0.977279070398313,0,4,pyruvate transmembrane transporter activity,MF,
13527,GO:0050847,1,0.932851377726857,0,8,progesterone receptor signaling pathway,BP,
13529,GO:0050849,1,0.893983722830341,0,17,negative regulation of calcium-mediated signaling,BP,
13530,GO:0050850,1,0.806554628855697,0,33,positive regulation of calcium-mediated signaling,BP,
13533,GO:0050853,1,0.719958959425268,0,52,B cell receptor signaling pathway,BP,
13535,GO:0050855,1,0.88118335782466,0,20,regulation of B cell receptor signaling pathway,BP,
13537,GO:0050857,1,0.880640410649509,0,20,positive regulation of antigen receptor-mediated signaling pathway,BP,
13539,GO:0050859,1,0.971685423679896,0,5,negative regulation of B cell receptor signaling pathway,BP,
13541,GO:0050861,1,0.953872754628222,0,7,positive regulation of B cell receptor signaling pathway,BP,
13542,GO:0050862,1,0.930428516169959,0,12,positive regulation of T cell receptor signaling pathway,BP,
13544,GO:0050864,1,0.506105035521547,0,106,regulation of B cell activation,BP,
13549,GO:0050869,1,0.821282259206238,0,31,negative regulation of B cell activation,BP,
13551,GO:0050871,1,0.649791519681999,0,68,positive regulation of B cell activation,BP,
13552,GO:0050872,1,0.922211561933047,0,12,white fat cell differentiation,BP,
13556,GO:0050879,1,0.719674881190833,0,47,multicellular organismal movement,BP,
13558,GO:0050881,1,0.719674881190833,0,47,musculoskeletal movement,BP,
13559,GO:0050882,1,0.941449832251425,0,6,voluntary musculoskeletal movement,BP,
13560,GO:0050883,1,0.994468201715917,0,1,musculoskeletal movement, spinal reflex action,BP,
13561,GO:0050884,1,0.906079322102627,0,14,neuromuscular process controlling posture,BP,
13563,GO:0050886,1,0.636880638787146,0,72,endocrine process,BP,
13565,GO:0050891,1,0.698950917709936,0,52,multicellular organismal water homeostasis,BP,
13566,GO:0050892,1,0.84819211739999,0,26,intestinal absorption,BP,
13567,GO:0050893,1,0.97448414826485,0,4,sensory processing,BP,
13568,GO:0050894,1,0.990609095442831,0,1,determination of affect,BP,
13570,GO:0050897,1,0.991266113753993,0,1,cobalt ion binding,MF,
13572,GO:0050901,1,0.860148664118727,0,24,leukocyte tethering or rolling,BP,
13573,GO:0050902,1,0.988454562255302,0,2,leukocyte adhesive activation,BP,
13574,GO:0050904,1,0.985440180104127,0,2,diapedesis,BP,
13578,GO:0050908,1,0.909974122715045,0,14,detection of light stimulus involved in visual perception,BP,
13580,GO:0050910,1,0.931740517312369,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13581,GO:0050911,1,0.908357215892685,0,18,detection of chemical stimulus involved in sensory perception of smell,BP,
13584,GO:0050915,1,0.977264743713076,0,4,sensory perception of sour taste,BP,
13585,GO:0050916,1,0.971673194605166,0,4,sensory perception of sweet taste,BP,
13586,GO:0050917,1,0.965970065145258,0,5,sensory perception of umami taste,BP,
13588,GO:0050919,1,0.757893972023188,0,36,negative chemotaxis,BP,
13592,GO:0050923,1,0.96783904393843,0,4,regulation of negative chemotaxis,BP,
13593,GO:0050924,1,0.992365274621187,0,1,positive regulation of negative chemotaxis,BP,
13594,GO:0050925,1,0.981302896438101,0,2,negative regulation of negative chemotaxis,BP,
13595,GO:0050926,1,0.851970840264456,0,25,regulation of positive chemotaxis,BP,
13597,GO:0050928,1,0.992067922869408,0,1,negative regulation of positive chemotaxis,BP,
13598,GO:0050929,1,0.992365274621187,0,1,induction of negative chemotaxis,BP,
13599,GO:0050930,1,0.9270279149195,0,13,induction of positive chemotaxis,BP,
13600,GO:0050931,1,0.791891361487858,0,32,pigment cell differentiation,BP,
13601,GO:0050932,1,0.934872792863894,0,9,regulation of pigment cell differentiation,BP,
13602,GO:0050942,1,0.944929651048816,0,7,positive regulation of pigment cell differentiation,BP,
13603,GO:0050951,1,0.881399307427587,0,19,sensory perception of temperature stimulus,BP,
13606,GO:0050955,1,0.984944215896084,0,2,thermoception,BP,
13607,GO:0050957,1,0.955900575801127,0,6,equilibrioception,BP,
13608,GO:0050960,1,0.993215857953393,0,1,detection of temperature stimulus involved in thermoception,BP,
13609,GO:0050961,1,0.918778213956602,0,14,detection of temperature stimulus involved in sensory perception,BP,
13610,GO:0050962,1,0.909974122715045,0,14,detection of light stimulus involved in sensory perception,BP,
13611,GO:0050965,1,0.918778213956602,0,14,detection of temperature stimulus involved in sensory perception of pain,BP,
13612,GO:0050966,1,0.941324546891589,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13613,GO:0050968,1,0.987567268863629,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13614,GO:0050974,1,0.857765950316931,0,23,detection of mechanical stimulus involved in sensory perception,BP,
13615,GO:0050975,1,0.978873688438172,0,3,sensory perception of touch,BP,
13616,GO:0050976,1,0.984031574880985,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13617,GO:0050982,1,0.735819146215233,0,38,detection of mechanical stimulus,BP,
13618,GO:0050992,1,0.994602677775799,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13619,GO:0050993,1,0.994602677775799,0,1,dimethylallyl diphosphate metabolic process,BP,
13620,GO:0050994,1,0.744114364752861,0,43,regulation of lipid catabolic process,BP,
13621,GO:0050995,1,0.89196136698875,0,17,negative regulation of lipid catabolic process,BP,
13622,GO:0050996,1,0.886041851444745,0,17,positive regulation of lipid catabolic process,BP,
13623,GO:0050997,1,0.894397712027237,0,17,quaternary ammonium group binding,MF,
13624,GO:0050998,1,0.912116151019236,0,12,nitric-oxide synthase binding,MF,
13625,GO:0050999,1,0.783030700233684,0,39,regulation of nitric-oxide synthase activity,BP,
13626,GO:0051000,1,0.89928164806509,0,17,positive regulation of nitric-oxide synthase activity,BP,
13627,GO:0051001,1,0.959275827599437,0,6,negative regulation of nitric-oxide synthase activity,BP,
13628,GO:0051004,1,0.912995921475546,0,15,regulation of lipoprotein lipase activity,BP,
13629,GO:0051005,1,0.979884434548399,0,3,negative regulation of lipoprotein lipase activity,BP,
13630,GO:0051006,1,0.960871070586774,0,7,positive regulation of lipoprotein lipase activity,BP,
13631,GO:0051010,1,0.884547131077064,0,13,microtubule plus-end binding,MF,
13632,GO:0051011,1,0.923919199140296,0,9,microtubule minus-end binding,MF,
13633,GO:0051012,1,0.986938121915764,0,2,microtubule sliding,BP,
13634,GO:0051013,1,0.954764148719285,0,7,microtubule severing,BP,
13635,GO:0051014,1,0.949819693344177,0,8,actin filament severing,BP,
13636,GO:0051015,1,0.278446568521638,0,167,actin filament binding,MF,
13637,GO:0051016,1,0.918193905152698,0,14,barbed-end actin filament capping,BP,
13638,GO:0051017,1,0.386207105789766,0,139,actin filament bundle assembly,BP,
13640,GO:0051019,1,0.836238522632084,0,26,mitogen-activated protein kinase binding,MF,
13642,GO:0051021,1,0.969848964902891,0,5,GDP-dissociation inhibitor binding,MF,
13643,GO:0051022,1,0.974959773761756,0,4,Rho GDP-dissociation inhibitor binding,MF,
13644,GO:0051023,1,0.921700994242325,0,15,regulation of immunoglobulin secretion,BP,
13645,GO:0051024,1,0.952466026418054,0,9,positive regulation of immunoglobulin secretion,BP,
13646,GO:0051025,1,0.988539045340956,0,2,negative regulation of immunoglobulin secretion,BP,
13647,GO:0051026,1,0.965335014466397,0,6,chiasma assembly,BP,
13648,GO:0051028,1,0.38919989687287,0,138,mRNA transport,BP,
13649,GO:0051029,1,0.961229120196037,0,6,rRNA transport,BP,
13650,GO:0051030,1,0.979026840751919,0,4,snRNA transport,BP,
13651,GO:0051031,1,0.796503716380601,0,32,tRNA transport,BP,
13652,GO:0051032,1,0.985777948933307,0,2,nucleic acid transmembrane transporter activity,MF,
13653,GO:0051033,1,0.985777948933307,0,2,RNA transmembrane transporter activity,MF,
13654,GO:0051036,1,0.971211455860075,0,5,regulation of endosome size,BP,
13655,GO:0051040,1,0.988084348164918,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13656,GO:0051041,1,0.993979365570334,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13657,GO:0051042,1,0.994069633134755,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13659,GO:0051044,1,0.923331449702658,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13669,GO:0051054,1,0.269551996105238,0,201,positive regulation of DNA metabolic process,BP,
13670,GO:0051055,1,0.767613230013795,0,44,negative regulation of lipid biosynthetic process,BP,
13673,GO:0051058,1,0.686144642283587,0,52,negative regulation of small GTPase mediated signal transduction,BP,
13674,GO:0051059,1,0.839532023014849,0,28,NF-kappaB binding,MF,
13675,GO:0051066,1,0.989418101772851,0,2,dihydrobiopterin metabolic process,BP,
13676,GO:0051068,1,0.993720324739055,0,1,dihydrolipoamide metabolic process,BP,
13677,GO:0051081,1,0.726128370642189,0,46,nuclear envelope disassembly,BP,
13678,GO:0051082,1,0.52245397897297,0,108,unfolded protein binding,MF,
13679,GO:0051083,1,0.989323724957858,0,2,'de novo' cotranslational protein folding,BP,
13680,GO:0051084,1,0.822084143640735,0,32,'de novo' posttranslational protein folding,BP,
13681,GO:0051085,1,0.853321481129463,0,27,chaperone cofactor-dependent protein refolding,BP,
13682,GO:0051086,1,0.994655359573688,0,1,chaperone mediated protein folding independent of cofactor,BP,
13684,GO:0051088,1,0.980627534615855,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13685,GO:0051089,1,0.993405039265077,0,1,constitutive protein ectodomain proteolysis,BP,
13691,GO:0051095,1,0.946133238075093,0,9,regulation of helicase activity,BP,
13692,GO:0051096,1,0.962805484772608,0,6,positive regulation of helicase activity,BP,
13693,GO:0051097,1,0.98269018976965,0,3,negative regulation of helicase activity,BP,
13697,GO:0051101,1,0.482492837274591,0,110,regulation of DNA binding,BP,
13698,GO:0051102,1,0.993294794500559,0,1,DNA ligation involved in DNA recombination,BP,
13699,GO:0051103,1,0.938349435796344,0,11,DNA ligation involved in DNA repair,BP,
13700,GO:0051105,1,0.965764279775149,0,6,regulation of DNA ligation,BP,
13701,GO:0051106,1,0.971361797609556,0,5,positive regulation of DNA ligation,BP,
13702,GO:0051107,1,0.994239123774774,0,1,negative regulation of DNA ligation,BP,
13703,GO:0051117,1,0.619655258334718,0,73,ATPase binding,MF,
13704,GO:0051119,1,0.86019032896118,0,24,sugar transmembrane transporter activity,MF,
13705,GO:0051120,1,0.982911283218865,0,3,hepoxilin A3 synthase activity,MF,
13706,GO:0051121,1,0.971974847839193,0,5,hepoxilin metabolic process,BP,
13707,GO:0051122,1,0.971974847839193,0,5,hepoxilin biosynthetic process,BP,
13708,GO:0051123,1,0.819808092162779,0,31,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13710,GO:0051125,1,0.83733909713668,0,27,regulation of actin nucleation,BP,
13711,GO:0051126,1,0.959945616104759,0,7,negative regulation of actin nucleation,BP,
13712,GO:0051127,1,0.897347410868422,0,15,positive regulation of actin nucleation,BP,
13716,GO:0051131,1,0.902203681935935,0,18,chaperone-mediated protein complex assembly,BP,
13717,GO:0051132,1,0.955475475071242,0,8,NK T cell activation,BP,
13718,GO:0051133,1,0.967115282713705,0,6,regulation of NK T cell activation,BP,
13719,GO:0051134,1,0.994676276783979,0,1,negative regulation of NK T cell activation,BP,
13720,GO:0051135,1,0.972292953745639,0,5,positive regulation of NK T cell activation,BP,
13721,GO:0051136,1,0.960894489295396,0,6,regulation of NK T cell differentiation,BP,
13722,GO:0051138,1,0.973354787023731,0,4,positive regulation of NK T cell differentiation,BP,
13723,GO:0051139,1,0.985382928433145,0,2,metal ion:proton antiporter activity,MF,
13724,GO:0051140,1,0.983662573356836,0,3,regulation of NK T cell proliferation,BP,
13725,GO:0051142,1,0.983662573356836,0,3,positive regulation of NK T cell proliferation,BP,
13731,GO:0051150,1,0.844251492018258,0,26,regulation of smooth muscle cell differentiation,BP,
13732,GO:0051151,1,0.929288109922221,0,11,negative regulation of smooth muscle cell differentiation,BP,
13733,GO:0051152,1,0.934487527960827,0,11,positive regulation of smooth muscle cell differentiation,BP,
13737,GO:0051156,1,0.855865673923265,0,26,glucose 6-phosphate metabolic process,BP,
13738,GO:0051160,1,0.99444254450294,0,1,L-xylitol catabolic process,BP,
13739,GO:0051164,1,0.99444254450294,0,1,L-xylitol metabolic process,BP,
13740,GO:0051167,1,0.972717732358086,0,5,xylulose 5-phosphate metabolic process,BP,
13741,GO:0051168,1,0.276798980349396,0,191,nuclear export,BP,
13742,GO:0051169,1,0.110172074523835,0,327,nuclear transport,BP,
13743,GO:0051170,1,0.365356534662687,0,149,import into nucleus,BP,
13748,GO:0051176,1,0.978663312607933,0,3,positive regulation of sulfur metabolic process,BP,
13749,GO:0051177,1,0.966150833778046,0,6,meiotic sister chromatid cohesion,BP,
13751,GO:0051180,1,0.816189314271888,0,30,vitamin transport,BP,
13752,GO:0051181,1,0.76860173610339,0,41,cofactor transport,BP,
13753,GO:0051182,1,0.951386735468596,0,8,coenzyme transport,BP,
13754,GO:0051184,1,0.878685704400192,0,20,cofactor transmembrane transporter activity,MF,
13755,GO:0051185,1,0.962887264648633,0,6,coenzyme transmembrane transporter activity,MF,
13757,GO:0051187,1,0.767557290822106,0,45,cofactor catabolic process,BP,
13759,GO:0051189,1,0.959806553825593,0,7,prosthetic group metabolic process,BP,
13760,GO:0051192,1,0.989698593754242,0,2,prosthetic group binding,MF,
13761,GO:0051193,1,0.522728926530499,0,94,regulation of cofactor metabolic process,BP,
13762,GO:0051194,1,0.874029396531831,0,19,positive regulation of cofactor metabolic process,BP,
13763,GO:0051195,1,0.89627866022692,0,16,negative regulation of cofactor metabolic process,BP,
13764,GO:0051196,1,0.567302773530486,0,80,regulation of coenzyme metabolic process,BP,
13765,GO:0051197,1,0.889053639551506,0,16,positive regulation of coenzyme metabolic process,BP,
13766,GO:0051198,1,0.928135285498097,0,10,negative regulation of coenzyme metabolic process,BP,
13767,GO:0051204,1,0.81801618608136,0,34,protein insertion into mitochondrial membrane,BP,
13771,GO:0051213,1,0.563602861538443,0,85,dioxygenase activity,MF,
13774,GO:0051220,1,0.84948405118398,0,24,cytoplasmic sequestering of protein,BP,
13778,GO:0051225,1,0.473943686259775,0,106,spindle assembly,BP,
13779,GO:0051228,1,0.992163009110972,0,1,mitotic spindle disassembly,BP,
13780,GO:0051230,1,0.992163009110972,0,1,spindle disassembly,BP,
13781,GO:0051231,1,0.931652017748108,0,11,spindle elongation,BP,
13782,GO:0051232,1,0.994511547035216,0,1,meiotic spindle elongation,BP,
13783,GO:0051233,1,0.808158473938606,0,31,spindle midzone,CC,
13786,GO:0051236,1,0.288296085024602,0,183,establishment of RNA localization,BP,
13787,GO:0051238,1,0.91901058199676,0,14,sequestering of metal ion,BP,
13800,GO:0051255,1,0.940742707504793,0,10,spindle midzone assembly,BP,
13801,GO:0051256,1,0.951809470608641,0,8,mitotic spindle midzone assembly,BP,
13802,GO:0051257,1,0.994470477599369,0,1,meiotic spindle midzone assembly,BP,
13803,GO:0051258,1,0.185683246181377,0,250,protein polymerization,BP,
13808,GO:0051264,1,0.994293380968546,0,1,mono-olein transacylation activity,MF,
13809,GO:0051265,1,0.994293380968546,0,1,diolein transacylation activity,MF,
13810,GO:0051267,1,0.993997664993241,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13816,GO:0051280,1,0.925819244869685,0,13,negative regulation of release of sequestered calcium ion into cytosol,BP,
13820,GO:0051284,1,0.908968802536678,0,14,positive regulation of sequestering of calcium ion,BP,
13821,GO:0051286,1,0.951079378490794,0,7,cell tip,CC,
13822,GO:0051287,1,0.724416308607831,0,56,NAD binding,MF,
13823,GO:0051289,1,0.61526379360237,0,75,protein homotetramerization,BP,
13826,GO:0051292,1,0.927287591906732,0,10,nuclear pore complex assembly,BP,
13827,GO:0051293,1,0.774253525186768,0,34,establishment of spindle localization,BP,
13828,GO:0051294,1,0.832354826534407,0,26,establishment of spindle orientation,BP,
13829,GO:0051295,1,0.966872719977144,0,4,establishment of meiotic spindle localization,BP,
13830,GO:0051298,1,0.647407108214581,0,62,centrosome duplication,BP,
13831,GO:0051299,1,0.895934664359671,0,16,centrosome separation,BP,
13832,GO:0051300,1,0.994313214468247,0,1,spindle pole body organization,BP,
13833,GO:0051301,1,0.0219446721650074,0,561,cell division,BP,
13834,GO:0051302,1,0.389423063552816,0,138,regulation of cell division,BP,
13835,GO:0051303,1,0.634288036117043,0,70,establishment of chromosome localization,BP,
13836,GO:0051304,1,0.598538789812731,0,75,chromosome separation,BP,
13837,GO:0051305,1,0.955322849304026,0,6,chromosome movement towards spindle pole,BP,
13838,GO:0051306,1,0.692029214425194,0,54,mitotic sister chromatid separation,BP,
13839,GO:0051307,1,0.896881320865719,0,16,meiotic chromosome separation,BP,
13840,GO:0051308,1,0.994313214468247,0,1,male meiosis chromosome separation,BP,
13841,GO:0051310,1,0.702641649902563,0,55,metaphase plate congression,BP,
13842,GO:0051311,1,0.994470477599369,0,1,meiotic metaphase plate congression,BP,
13843,GO:0051315,1,0.920974097731014,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
13844,GO:0051316,1,0.988903609421398,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13845,GO:0051321,1,0.266292216741031,0,202,meiotic cell cycle,BP,
13849,GO:0051340,1,0.952127519281145,0,9,regulation of ligase activity,BP,
13850,GO:0051341,1,0.613609678573328,0,77,regulation of oxidoreductase activity,BP,
13851,GO:0051342,1,0.951515846885776,0,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13852,GO:0051343,1,0.976809772183735,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13853,GO:0051344,1,0.968410111122262,0,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13858,GO:0051349,1,0.90345151577745,0,15,positive regulation of lyase activity,BP,
13860,GO:0051351,1,0.962784332678957,0,7,positive regulation of ligase activity,BP,
13861,GO:0051352,1,0.988935434694763,0,2,negative regulation of ligase activity,BP,
13862,GO:0051353,1,0.76823323130595,0,41,positive regulation of oxidoreductase activity,BP,
13863,GO:0051354,1,0.87989417498748,0,20,negative regulation of oxidoreductase activity,BP,
13864,GO:0051355,1,0.993523884450797,0,1,proprioception involved in equilibrioception,BP,
13865,GO:0051365,1,0.982876143189581,0,3,cellular response to potassium ion starvation,BP,
13866,GO:0051371,1,0.851141574235116,0,18,muscle alpha-actinin binding,MF,
13867,GO:0051373,1,0.970801884937999,0,5,FATZ binding,MF,
13868,GO:0051377,1,0.980600915800383,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13869,GO:0051378,1,0.938596124958901,0,11,serotonin binding,MF,
13870,GO:0051379,1,0.96138646342518,0,7,epinephrine binding,MF,
13871,GO:0051380,1,0.971855995323052,0,5,norepinephrine binding,MF,
13872,GO:0051382,1,0.90628281321784,0,14,kinetochore assembly,BP,
13873,GO:0051383,1,0.876760186035127,0,19,kinetochore organization,BP,
13875,GO:0051385,1,0.842157595969867,0,28,response to mineralocorticoid,BP,
13876,GO:0051386,1,0.944883781493284,0,9,regulation of neurotrophin TRK receptor signaling pathway,BP,
13877,GO:0051387,1,0.983615502826509,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13878,GO:0051388,1,0.972893958514107,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13879,GO:0051389,1,0.978750472008015,0,2,inactivation of MAPKK activity,BP,
13880,GO:0051391,1,0.99338868812887,0,1,tRNA acetylation,BP,
13881,GO:0051392,1,0.99338868812887,0,1,tRNA N-acetyltransferase activity,MF,
13882,GO:0051393,1,0.753631840707325,0,33,alpha-actinin binding,MF,
13883,GO:0051400,1,0.947775038482482,0,9,BH domain binding,MF,
13885,GO:0051403,1,0.197935725829921,0,243,stress-activated MAPK cascade,BP,
13886,GO:0051409,1,0.937121220330897,0,10,response to nitrosative stress,BP,
13887,GO:0051410,1,0.971795369063152,0,5,detoxification of nitrogen compound,BP,
13888,GO:0051412,1,0.904459200406857,0,16,response to corticosterone,BP,
13889,GO:0051413,1,0.994451067786512,0,1,response to cortisone,BP,
13890,GO:0051414,1,0.961920684978369,0,5,response to cortisol,BP,
13891,GO:0051415,1,0.967564261759812,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13892,GO:0051417,1,0.994313214468247,0,1,microtubule nucleation by spindle pole body,BP,
13893,GO:0051418,1,0.948149518358329,0,7,microtubule nucleation by microtubule organizing center,BP,
13894,GO:0051424,1,0.994689149238764,0,1,corticotropin-releasing hormone binding,MF,
13895,GO:0051425,1,0.968837006543228,0,4,PTB domain binding,MF,
13896,GO:0051427,1,0.327922156870621,0,164,hormone receptor binding,MF,
13897,GO:0051428,1,0.905097548565459,0,17,peptide hormone receptor binding,MF,
13898,GO:0051429,1,0.971961824316145,0,5,corticotropin-releasing hormone receptor binding,MF,
13899,GO:0051430,1,0.977080575839713,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13900,GO:0051431,1,0.984471548427248,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13901,GO:0051433,1,0.992810701085725,0,1,BH2 domain binding,MF,
13902,GO:0051434,1,0.971322909126235,0,5,BH3 domain binding,MF,
13903,GO:0051438,1,0.721973018163591,0,51,regulation of ubiquitin-protein transferase activity,BP,
13904,GO:0051443,1,0.818111522781557,0,32,positive regulation of ubiquitin-protein transferase activity,BP,
13905,GO:0051444,1,0.91598432894806,0,14,negative regulation of ubiquitin-protein transferase activity,BP,
13906,GO:0051445,1,0.784879616009907,0,38,regulation of meiotic cell cycle,BP,
13907,GO:0051446,1,0.911017155163687,0,14,positive regulation of meiotic cell cycle,BP,
13908,GO:0051447,1,0.919492097022584,0,14,negative regulation of meiotic cell cycle,BP,
13909,GO:0051450,1,0.891849460449327,0,18,myoblast proliferation,BP,
13911,GO:0051452,1,0.749947179054414,0,47,intracellular pH reduction,BP,
13912,GO:0051453,1,0.572816386127764,0,85,regulation of intracellular pH,BP,
13913,GO:0051454,1,0.973930391758897,0,4,intracellular pH elevation,BP,
13914,GO:0051455,1,0.994313214468247,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13915,GO:0051456,1,0.994559765489272,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13916,GO:0051457,1,0.859692932559089,0,22,maintenance of protein location in nucleus,BP,
13917,GO:0051458,1,0.960738138475485,0,7,corticotropin secretion,BP,
13918,GO:0051459,1,0.9661250705703,0,6,regulation of corticotropin secretion,BP,
13919,GO:0051460,1,0.994689149238764,0,1,negative regulation of corticotropin secretion,BP,
13920,GO:0051461,1,0.971284920547615,0,5,positive regulation of corticotropin secretion,BP,
13921,GO:0051462,1,0.970110717844311,0,5,regulation of cortisol secretion,BP,
13922,GO:0051463,1,0.990989375303076,0,1,negative regulation of cortisol secretion,BP,
13923,GO:0051464,1,0.97893338868102,0,4,positive regulation of cortisol secretion,BP,
13924,GO:0051466,1,0.994016522465217,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13926,GO:0051481,1,0.93003165859575,0,9,negative regulation of cytosolic calcium ion concentration,BP,
13928,GO:0051489,1,0.759505874004312,0,39,regulation of filopodium assembly,BP,
13929,GO:0051490,1,0.989052407764101,0,2,negative regulation of filopodium assembly,BP,
13930,GO:0051491,1,0.826326349984868,0,28,positive regulation of filopodium assembly,BP,
13931,GO:0051492,1,0.588882297591543,0,75,regulation of stress fiber assembly,BP,
13932,GO:0051493,1,0.0336171072239811,0,475,regulation of cytoskeleton organization,BP,
13933,GO:0051494,1,0.410851715449243,0,126,negative regulation of cytoskeleton organization,BP,
13934,GO:0051495,1,0.262719457061697,0,199,positive regulation of cytoskeleton organization,BP,
13935,GO:0051496,1,0.729913239709677,0,47,positive regulation of stress fiber assembly,BP,
13936,GO:0051497,1,0.864760905998223,0,20,negative regulation of stress fiber assembly,BP,
13937,GO:0051499,1,0.989122457816744,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13938,GO:0051500,1,0.989122457816744,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13939,GO:0051503,1,0.927225587568353,0,13,adenine nucleotide transport,BP,
13940,GO:0051525,1,0.964034203022466,0,5,NFAT protein binding,MF,
13941,GO:0051536,1,0.683662638969789,0,61,iron-sulfur cluster binding,MF,
13942,GO:0051537,1,0.884585390630178,0,20,2 iron, 2 sulfur cluster binding,MF,
13943,GO:0051538,1,0.98296953826709,0,3,3 iron, 4 sulfur cluster binding,MF,
13944,GO:0051539,1,0.779035366739606,0,40,4 iron, 4 sulfur cluster binding,MF,
13945,GO:0051540,1,0.683662638969789,0,61,metal cluster binding,MF,
13946,GO:0051541,1,0.971742478333632,0,4,elastin metabolic process,BP,
13947,GO:0051542,1,0.983340142370247,0,2,elastin biosynthetic process,BP,
13948,GO:0051543,1,0.99451863213629,0,1,regulation of elastin biosynthetic process,BP,
13949,GO:0051545,1,0.99451863213629,0,1,negative regulation of elastin biosynthetic process,BP,
13951,GO:0051547,1,0.939223110950725,0,9,regulation of keratinocyte migration,BP,
13952,GO:0051548,1,0.991768466882196,0,1,negative regulation of keratinocyte migration,BP,
13953,GO:0051549,1,0.947022783780237,0,8,positive regulation of keratinocyte migration,BP,
13954,GO:0051552,1,0.990956155649264,0,1,flavone metabolic process,BP,
13955,GO:0051560,1,0.880928264149626,0,21,mitochondrial calcium ion homeostasis,BP,
13956,GO:0051561,1,0.944637232004348,0,10,positive regulation of mitochondrial calcium ion concentration,BP,
13957,GO:0051562,1,0.983416312363454,0,3,negative regulation of mitochondrial calcium ion concentration,BP,
13958,GO:0051563,1,0.985068716547904,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13959,GO:0051567,1,0.804757214008392,0,29,histone H3-K9 methylation,BP,
13960,GO:0051568,1,0.707320189620668,0,48,histone H3-K4 methylation,BP,
13961,GO:0051569,1,0.849812926810316,0,24,regulation of histone H3-K4 methylation,BP,
13962,GO:0051570,1,0.859284376352473,0,20,regulation of histone H3-K9 methylation,BP,
13963,GO:0051571,1,0.899059546984552,0,15,positive regulation of histone H3-K4 methylation,BP,
13964,GO:0051572,1,0.975893279220689,0,3,negative regulation of histone H3-K4 methylation,BP,
13965,GO:0051573,1,0.932445594051552,0,10,negative regulation of histone H3-K9 methylation,BP,
13966,GO:0051574,1,0.933532601181707,0,9,positive regulation of histone H3-K9 methylation,BP,
13967,GO:0051575,1,0.966053495233267,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13968,GO:0051580,1,0.910314168188276,0,15,regulation of neurotransmitter uptake,BP,
13969,GO:0051581,1,0.973739946355253,0,4,negative regulation of neurotransmitter uptake,BP,
13970,GO:0051582,1,0.978637540883505,0,4,positive regulation of neurotransmitter uptake,BP,
13971,GO:0051583,1,0.938057653247139,0,11,dopamine uptake involved in synaptic transmission,BP,
13972,GO:0051584,1,0.961942845923177,0,7,regulation of dopamine uptake involved in synaptic transmission,BP,
13973,GO:0051585,1,0.99405469576238,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13974,GO:0051586,1,0.983995678387173,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13976,GO:0051589,1,0.874471327211435,0,19,negative regulation of neurotransmitter transport,BP,
13977,GO:0051590,1,0.845658788928418,0,26,positive regulation of neurotransmitter transport,BP,
13980,GO:0051593,1,0.937527509481389,0,11,response to folic acid,BP,
13981,GO:0051594,1,0.978328877364322,0,4,detection of glucose,BP,
13982,GO:0051595,1,0.980295234032171,0,3,response to methylglyoxal,BP,
13983,GO:0051596,1,0.988958031364877,0,2,methylglyoxal catabolic process,BP,
13984,GO:0051597,1,0.95133446992405,0,7,response to methylmercury,BP,
13985,GO:0051598,1,0.992755578160833,0,1,meiotic recombination checkpoint,BP,
13986,GO:0051599,1,0.961751009743749,0,5,response to hydrostatic pressure,BP,
13987,GO:0051601,1,0.952435465618863,0,8,exocyst localization,BP,
13988,GO:0051602,1,0.780368745176192,0,39,response to electrical stimulus,BP,
13989,GO:0051603,1,0.0144553745262046,0,627,proteolysis involved in cellular protein catabolic process,BP,
13993,GO:0051608,1,0.94375795528014,0,10,histamine transport,BP,
13994,GO:0051610,1,0.971988812817218,0,4,serotonin uptake,BP,
13995,GO:0051611,1,0.979021866385105,0,3,regulation of serotonin uptake,BP,
13996,GO:0051612,1,0.979021866385105,0,3,negative regulation of serotonin uptake,BP,
13997,GO:0051615,1,0.991685085014903,0,1,histamine uptake,BP,
13998,GO:0051620,1,0.99405469576238,0,1,norepinephrine uptake,BP,
13999,GO:0051621,1,0.99405469576238,0,1,regulation of norepinephrine uptake,BP,
14000,GO:0051622,1,0.99405469576238,0,1,negative regulation of norepinephrine uptake,BP,
14001,GO:0051639,1,0.947353378440704,0,8,actin filament network formation,BP,
14004,GO:0051642,1,0.829977503209312,0,22,centrosome localization,BP,
14005,GO:0051643,1,0.95770594546228,0,5,endoplasmic reticulum localization,BP,
14006,GO:0051645,1,0.912479518054864,0,13,Golgi localization,BP,
14008,GO:0051647,1,0.835266473919374,0,22,nucleus localization,BP,
14012,GO:0051651,1,0.52461763767454,0,88,maintenance of location in cell,BP,
14013,GO:0051653,1,0.749074288877211,0,38,spindle localization,BP,
14014,GO:0051654,1,0.868024830138799,0,19,establishment of mitochondrion localization,BP,
14016,GO:0051657,1,0.91951141938818,0,10,maintenance of organelle location,BP,
14017,GO:0051659,1,0.988359708655721,0,2,maintenance of mitochondrion location,BP,
14018,GO:0051660,1,0.971862158518461,0,4,establishment of centrosome localization,BP,
14019,GO:0051661,1,0.952529953396702,0,5,maintenance of centrosome location,BP,
14020,GO:0051664,1,0.987516848126927,0,2,nuclear pore localization,BP,
14021,GO:0051665,1,0.942862649460565,0,10,membrane raft localization,BP,
14022,GO:0051666,1,0.966603074182044,0,5,actin cortical patch localization,BP,
14026,GO:0051683,1,0.957934284838726,0,7,establishment of Golgi localization,BP,
14027,GO:0051684,1,0.976656962376973,0,3,maintenance of Golgi location,BP,
14028,GO:0051685,1,0.994313214468247,0,1,maintenance of ER location,BP,
14029,GO:0051686,1,0.985315751785552,0,1,establishment of ER localization,BP,
14030,GO:0051691,1,0.99472470365035,0,1,cellular oligosaccharide metabolic process,BP,
14031,GO:0051692,1,0.99472470365035,0,1,cellular oligosaccharide catabolic process,BP,
14032,GO:0051693,1,0.795241650101374,0,31,actin filament capping,BP,
14033,GO:0051694,1,0.958836189633169,0,6,pointed-end actin filament capping,BP,
14034,GO:0051695,1,0.992814736003382,0,1,actin filament uncapping,BP,
14035,GO:0051697,1,0.978380124062122,0,4,protein delipidation,BP,
14042,GO:0051708,1,0.989547006477997,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14043,GO:0051709,1,0.943716504925229,0,10,regulation of killing of cells of other organism,BP,
14044,GO:0051710,1,0.994821753834788,0,1,regulation of cytolysis in other organism,BP,
14045,GO:0051712,1,0.949345956397915,0,9,positive regulation of killing of cells of other organism,BP,
14046,GO:0051714,1,0.994821753834788,0,1,positive regulation of cytolysis in other organism,BP,
14047,GO:0051715,1,0.978748417716275,0,4,cytolysis in other organism,BP,
14049,GO:0051717,1,0.986085788468155,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14050,GO:0051721,1,0.831987663342501,0,27,protein phosphatase 2A binding,MF,
14051,GO:0051722,1,0.994474099583678,0,1,protein C-terminal methylesterase activity,MF,
14052,GO:0051723,1,0.994474099583678,0,1,protein methylesterase activity,MF,
14053,GO:0051724,1,0.994555591563614,0,1,NAD transmembrane transporter activity,MF,
14054,GO:0051725,1,0.976256378772398,0,4,protein de-ADP-ribosylation,BP,
14056,GO:0051728,1,0.99417957762911,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14057,GO:0051729,1,0.99417957762911,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14058,GO:0051731,1,0.970734660584319,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14059,GO:0051732,1,0.994711067543834,0,1,polyribonucleotide kinase activity,MF,
14060,GO:0051733,1,0.979995952483681,0,3,polydeoxyribonucleotide kinase activity,MF,
14061,GO:0051734,1,0.979995952483681,0,3,ATP-dependent polynucleotide kinase activity,MF,
14062,GO:0051736,1,0.994711067543834,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14063,GO:0051747,1,0.98959560713877,0,2,cytosine C-5 DNA demethylase activity,MF,
14064,GO:0051748,1,0.994599281629308,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14065,GO:0051750,1,0.99479271690561,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14066,GO:0051754,1,0.976381714075984,0,4,meiotic sister chromatid cohesion, centromeric,BP,
14067,GO:0051758,1,0.990841149397006,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14068,GO:0051764,1,0.928349118589552,0,11,actin crosslink formation,BP,
14069,GO:0051765,1,0.988720990992244,0,2,inositol tetrakisphosphate kinase activity,MF,
14070,GO:0051766,1,0.962121428301789,0,6,inositol trisphosphate kinase activity,MF,
14074,GO:0051771,1,0.983861329568075,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
14075,GO:0051775,1,0.925962642578726,0,11,response to redox state,BP,
14076,GO:0051780,1,0.99321200732669,0,1,behavioral response to nutrient,BP,
14077,GO:0051781,1,0.630072600428623,0,71,positive regulation of cell division,BP,
14078,GO:0051782,1,0.906104203865516,0,14,negative regulation of cell division,BP,
14079,GO:0051783,1,0.30844482249813,0,171,regulation of nuclear division,BP,
14080,GO:0051784,1,0.695634618544717,0,54,negative regulation of nuclear division,BP,
14081,GO:0051785,1,0.680261562843384,0,55,positive regulation of nuclear division,BP,
14082,GO:0051786,1,0.99394298497277,0,1,all-trans-retinol 13,14-reductase activity,MF,
14083,GO:0051787,1,0.853768009131808,0,26,misfolded protein binding,MF,
14084,GO:0051788,1,0.856200682726287,0,23,response to misfolded protein,BP,
14085,GO:0051790,1,0.976660789997015,0,4,short-chain fatty acid biosynthetic process,BP,
14086,GO:0051791,1,0.94108825034126,0,10,medium-chain fatty acid metabolic process,BP,
14087,GO:0051792,1,0.967679477271392,0,5,medium-chain fatty acid biosynthetic process,BP,
14088,GO:0051793,1,0.967322541646605,0,5,medium-chain fatty acid catabolic process,BP,
14089,GO:0051794,1,0.97485582631457,0,4,regulation of timing of catagen,BP,
14090,GO:0051795,1,0.98165944178477,0,3,positive regulation of timing of catagen,BP,
14091,GO:0051796,1,0.993070549408301,0,1,negative regulation of timing of catagen,BP,
14093,GO:0051798,1,0.933432267397728,0,11,positive regulation of hair follicle development,BP,
14095,GO:0051800,1,0.986502137564701,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14096,GO:0051801,1,0.988946662515827,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14097,GO:0051805,1,0.98651960997864,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14099,GO:0051807,1,0.98651960997864,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14100,GO:0051808,1,0.994494248656162,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14102,GO:0051818,1,0.921510170781157,0,15,disruption of cells of other organism involved in symbiotic interaction,BP,
14103,GO:0051821,1,0.990879446124348,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14104,GO:0051823,1,0.932791287027975,0,9,regulation of synapse structural plasticity,BP,
14106,GO:0051832,1,0.972722566613264,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14107,GO:0051833,1,0.992124689597619,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
14108,GO:0051834,1,0.972722566613264,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14109,GO:0051835,1,0.968601395426477,0,4,positive regulation of synapse structural plasticity,BP,
14110,GO:0051836,1,0.949273350084708,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
14112,GO:0051852,1,0.943829400158943,0,11,disruption by host of symbiont cells,BP,
14113,GO:0051861,1,0.907738283590715,0,17,glycolipid binding,MF,
14114,GO:0051864,1,0.941196777895618,0,8,histone demethylase activity (H3-K36 specific),MF,
14115,GO:0051865,1,0.687065090218783,0,54,protein autoubiquitination,BP,
14116,GO:0051866,1,0.988591840256189,0,2,general adaptation syndrome,BP,
14117,GO:0051867,1,0.99479253815226,0,1,general adaptation syndrome, behavioral process,BP,
14118,GO:0051870,1,0.983140424437907,0,3,methotrexate binding,MF,
14119,GO:0051873,1,0.953650242241572,0,9,killing by host of symbiont cells,BP,
14120,GO:0051875,1,0.841604052118203,0,27,pigment granule localization,BP,
14121,GO:0051877,1,0.988498001899142,0,2,pigment granule aggregation in cell center,BP,
14123,GO:0051880,1,0.945504676351171,0,7,G-quadruplex DNA binding,MF,
14124,GO:0051881,1,0.705441561169773,0,59,regulation of mitochondrial membrane potential,BP,
14125,GO:0051882,1,0.881388071452896,0,20,mitochondrial depolarization,BP,
14126,GO:0051883,1,0.931101083463739,0,13,killing of cells in other organism involved in symbiotic interaction,BP,
14128,GO:0051885,1,0.986065610015733,0,2,positive regulation of timing of anagen,BP,
14130,GO:0051890,1,0.96185305637039,0,6,regulation of cardioblast differentiation,BP,
14131,GO:0051891,1,0.968536735152472,0,5,positive regulation of cardioblast differentiation,BP,
14132,GO:0051892,1,0.993101397325953,0,1,negative regulation of cardioblast differentiation,BP,
14133,GO:0051893,1,0.669856256107226,0,53,regulation of focal adhesion assembly,BP,
14134,GO:0051894,1,0.838323807080505,0,23,positive regulation of focal adhesion assembly,BP,
14135,GO:0051895,1,0.8989128228044,0,15,negative regulation of focal adhesion assembly,BP,
14138,GO:0051898,1,0.764402661740406,0,39,negative regulation of protein kinase B signaling,BP,
14139,GO:0051899,1,0.501018404550794,0,89,membrane depolarization,BP,
14140,GO:0051900,1,0.893434849878124,0,18,regulation of mitochondrial depolarization,BP,
14141,GO:0051901,1,0.953230677939193,0,8,positive regulation of mitochondrial depolarization,BP,
14142,GO:0051902,1,0.965562213925896,0,6,negative regulation of mitochondrial depolarization,BP,
14143,GO:0051903,1,0.994384596167024,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14145,GO:0051905,1,0.851141397346136,0,25,establishment of pigment granule localization,BP,
14146,GO:0051908,1,0.994030712388483,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14147,GO:0051916,1,0.994194455751236,0,1,granulocyte colony-stimulating factor binding,MF,
14150,GO:0051919,1,0.983786384354818,0,3,positive regulation of fibrinolysis,BP,
14151,GO:0051920,1,0.958661813526787,0,8,peroxiredoxin activity,MF,
14152,GO:0051923,1,0.913752381608778,0,15,sulfation,BP,
14154,GO:0051926,1,0.732829193233605,0,50,negative regulation of calcium ion transport,BP,
14156,GO:0051930,1,0.811886643525245,0,31,regulation of sensory perception of pain,BP,
14157,GO:0051931,1,0.811886643525245,0,31,regulation of sensory perception,BP,
14158,GO:0051932,1,0.73571050374765,0,43,synaptic transmission, GABAergic,BP,
14159,GO:0051933,1,0.975886220175155,0,3,amino acid neurotransmitter reuptake,BP,
14160,GO:0051934,1,0.938057653247139,0,11,catecholamine uptake involved in synaptic transmission,BP,
14161,GO:0051935,1,0.975886220175155,0,3,glutamate reuptake,BP,
14163,GO:0051938,1,0.91684847175122,0,12,L-glutamate import,BP,
14164,GO:0051939,1,0.992855001203746,0,1,gamma-aminobutyric acid import,BP,
14165,GO:0051940,1,0.961942845923177,0,7,regulation of catecholamine uptake involved in synaptic transmission,BP,
14166,GO:0051941,1,0.982843898419519,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14167,GO:0051944,1,0.983995678387173,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14168,GO:0051945,1,0.99405469576238,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14169,GO:0051946,1,0.982843898419519,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14171,GO:0051953,1,0.886771419994326,0,20,negative regulation of amine transport,BP,
14173,GO:0051955,1,0.838147777725021,0,28,regulation of amino acid transport,BP,
14174,GO:0051956,1,0.942209227515188,0,10,negative regulation of amino acid transport,BP,
14175,GO:0051957,1,0.915650482911867,0,14,positive regulation of amino acid transport,BP,
14176,GO:0051958,1,0.985115076947691,0,2,methotrexate transport,BP,
14177,GO:0051959,1,0.718813402947698,0,29,dynein light intermediate chain binding,MF,
14182,GO:0051964,1,0.95056956483753,0,6,negative regulation of synapse assembly,BP,
14185,GO:0051967,1,0.936360304285498,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14188,GO:0051970,1,0.982678895028337,0,3,negative regulation of transmission of nerve impulse,BP,
14190,GO:0051972,1,0.758768476534973,0,45,regulation of telomerase activity,BP,
14191,GO:0051973,1,0.808090835150158,0,35,positive regulation of telomerase activity,BP,
14192,GO:0051974,1,0.948868557351441,0,9,negative regulation of telomerase activity,BP,
14193,GO:0051977,1,0.994583420574961,0,1,lysophospholipid transport,BP,
14194,GO:0051978,1,0.994583420574961,0,1,lysophospholipid transporter activity,MF,
14195,GO:0051983,1,0.525555730722404,0,90,regulation of chromosome segregation,BP,
14196,GO:0051984,1,0.843454843427438,0,24,positive regulation of chromosome segregation,BP,
14197,GO:0051985,1,0.76731749253427,0,37,negative regulation of chromosome segregation,BP,
14198,GO:0051987,1,0.968040160946603,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14199,GO:0051988,1,0.921457238230622,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
14200,GO:0051990,1,0.988971361650112,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14201,GO:0051996,1,0.994611358350175,0,1,squalene synthase activity,MF,
14202,GO:0051998,1,0.963470345814211,0,6,protein carboxyl O-methyltransferase activity,MF,
14203,GO:0052025,1,0.989706709315901,0,2,modification by symbiont of host cell membrane,BP,
14204,GO:0052026,1,0.994254086098554,0,1,modulation by symbiont of host transcription,BP,
14205,GO:0052027,1,0.986143378005718,0,2,modulation by symbiont of host signal transduction pathway,BP,
14206,GO:0052029,1,0.992124689597619,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
14207,GO:0052031,1,0.9867462596652,0,2,modulation by symbiont of host defense response,BP,
14208,GO:0052037,1,0.992124689597619,0,1,negative regulation by symbiont of host defense response,BP,
14209,GO:0052040,1,0.964559460359232,0,6,modulation by symbiont of host programmed cell death,BP,
14210,GO:0052041,1,0.977012816296207,0,4,negative regulation by symbiont of host programmed cell death,BP,
14211,GO:0052042,1,0.982132563269689,0,3,positive regulation by symbiont of host programmed cell death,BP,
14212,GO:0052043,1,0.989706709315901,0,2,modification by symbiont of host cellular component,BP,
14213,GO:0052047,1,0.983439070945832,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14214,GO:0052053,1,0.994321238790888,0,1,negative regulation by symbiont of host catalytic activity,BP,
14215,GO:0052055,1,0.986490206245001,0,2,modulation by symbiont of host molecular function,BP,
14216,GO:0052056,1,0.986490206245001,0,2,negative regulation by symbiont of host molecular function,BP,
14217,GO:0052066,1,0.990317204894401,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14218,GO:0052097,1,0.993970144807525,0,1,interspecies quorum sensing,BP,
14219,GO:0052106,1,0.993970144807525,0,1,quorum sensing involved in interaction with host,BP,
14220,GO:0052111,1,0.989706709315901,0,2,modification by symbiont of host structure,BP,
14221,GO:0052126,1,0.811737459688886,0,33,movement in host environment,BP,
14222,GO:0052148,1,0.994321238790888,0,1,modulation by symbiont of host catalytic activity,BP,
14223,GO:0052150,1,0.969615833395074,0,5,modulation by symbiont of host apoptotic process,BP,
14224,GO:0052151,1,0.987280124484812,0,2,positive regulation by symbiont of host apoptotic process,BP,
14225,GO:0052167,1,0.992124689597619,0,1,modulation by symbiont of host innate immune response,BP,
14226,GO:0052170,1,0.992124689597619,0,1,negative regulation by symbiont of host innate immune response,BP,
14227,GO:0052173,1,0.96759066880801,0,5,response to defenses of other organism involved in symbiotic interaction,BP,
14228,GO:0052182,1,0.994512385942375,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14229,GO:0052185,1,0.989706709315901,0,2,modification of structure of other organism involved in symbiotic interaction,BP,
14230,GO:0052188,1,0.989706709315901,0,2,modification of cellular component in other organism involved in symbiotic interaction,BP,
14231,GO:0052190,1,0.990317204894401,0,1,modulation by symbiont of host phagocytosis,BP,
14232,GO:0052191,1,0.990317204894401,0,1,positive regulation by symbiont of host phagocytosis,BP,
14233,GO:0052192,1,0.811737459688886,0,33,movement in environment of other organism involved in symbiotic interaction,BP,
14235,GO:0052200,1,0.96759066880801,0,5,response to host defenses,BP,
14239,GO:0052212,1,0.994512385942375,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14240,GO:0052213,1,0.994512385942375,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14244,GO:0052231,1,0.990317204894401,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14245,GO:0052248,1,0.964559460359232,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14246,GO:0052250,1,0.986143378005718,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14247,GO:0052251,1,0.994579304502616,0,1,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14248,GO:0052255,1,0.9867462596652,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14249,GO:0052261,1,0.992124689597619,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
14250,GO:0052306,1,0.992124689597619,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14251,GO:0052309,1,0.992124689597619,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14252,GO:0052312,1,0.847155899500555,0,25,modulation of transcription in other organism involved in symbiotic interaction,BP,
14253,GO:0052314,1,0.989339040790745,0,2,phytoalexin metabolic process,BP,
14254,GO:0052330,1,0.982132563269689,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14255,GO:0052331,1,0.988946662515827,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14256,GO:0052332,1,0.989706709315901,0,2,modification by organism of membrane in other organism involved in symbiotic interaction,BP,
14262,GO:0052370,1,0.990317204894401,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14263,GO:0052381,1,0.994603353158766,0,1,tRNA dimethylallyltransferase activity,MF,
14272,GO:0052433,1,0.964559460359232,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14273,GO:0052472,1,0.852059584917843,0,24,modulation by host of symbiont transcription,BP,
14274,GO:0052490,1,0.977012816296207,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14275,GO:0052493,1,0.992124689597619,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
14276,GO:0052501,1,0.982132563269689,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14277,GO:0052509,1,0.994579304502616,0,1,positive regulation by symbiont of host defense response,BP,
14278,GO:0052510,1,0.994579304502616,0,1,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14279,GO:0052522,1,0.990317204894401,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14282,GO:0052550,1,0.99472564749793,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14283,GO:0052552,1,0.9867462596652,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14284,GO:0052553,1,0.9867462596652,0,2,modulation by symbiont of host immune response,BP,
14285,GO:0052561,1,0.992124689597619,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14286,GO:0052562,1,0.992124689597619,0,1,negative regulation by symbiont of host immune response,BP,
14287,GO:0052564,1,0.975995238285209,0,4,response to immune response of other organism involved in symbiotic interaction,BP,
14288,GO:0052567,1,0.99472564749793,0,1,response to defense-related host reactive oxygen species production,BP,
14289,GO:0052572,1,0.975995238285209,0,4,response to host immune response,BP,
14290,GO:0052590,1,0.991371390107253,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14291,GO:0052591,1,0.991371390107253,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14292,GO:0052593,1,0.987759890460277,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14293,GO:0052594,1,0.987759890460277,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14294,GO:0052595,1,0.987759890460277,0,2,aliphatic-amine oxidase activity,MF,
14295,GO:0052596,1,0.987759890460277,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14296,GO:0052629,1,0.908215462243053,0,12,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14297,GO:0052642,1,0.989168013473617,0,2,lysophosphatidic acid phosphatase activity,MF,
14298,GO:0052646,1,0.935771090923362,0,9,alditol phosphate metabolic process,BP,
14299,GO:0052650,1,0.957328557979536,0,8,NADP-retinol dehydrogenase activity,MF,
14300,GO:0052651,1,0.989046030670519,0,2,monoacylglycerol catabolic process,BP,
14302,GO:0052654,1,0.983785891489177,0,2,L-leucine transaminase activity,MF,
14303,GO:0052655,1,0.983785891489177,0,2,L-valine transaminase activity,MF,
14304,GO:0052656,1,0.983785891489177,0,2,L-isoleucine transaminase activity,MF,
14305,GO:0052657,1,0.994772523962849,0,1,guanine phosphoribosyltransferase activity,MF,
14306,GO:0052658,1,0.958735217081556,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14307,GO:0052659,1,0.938835477889225,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14308,GO:0052666,1,0.994657071538414,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14310,GO:0052692,1,0.994772076056773,0,1,raffinose alpha-galactosidase activity,MF,
14311,GO:0052695,1,0.980918168989482,0,3,cellular glucuronidation,BP,
14312,GO:0052717,1,0.991030940628369,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
14313,GO:0052718,1,0.991030940628369,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
14314,GO:0052723,1,0.966324614193425,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14315,GO:0052724,1,0.966324614193425,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14316,GO:0052725,1,0.99398930141819,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14317,GO:0052726,1,0.99398930141819,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14318,GO:0052731,1,0.994611523182229,0,1,phosphocholine phosphatase activity,MF,
14319,GO:0052732,1,0.994611523182229,0,1,phosphoethanolamine phosphatase activity,MF,
14320,GO:0052735,1,0.978299941975724,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
14321,GO:0052739,1,0.984211533126729,0,3,phosphatidylserine 1-acylhydrolase activity,MF,
14322,GO:0052740,1,0.989447459060386,0,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14323,GO:0052742,1,0.725212886136301,0,43,phosphatidylinositol kinase activity,MF,
14324,GO:0052743,1,0.92576413620331,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14325,GO:0052744,1,0.889666374776032,0,15,phosphatidylinositol monophosphate phosphatase activity,MF,
14326,GO:0052745,1,0.876062083260644,0,19,inositol phosphate phosphatase activity,MF,
14327,GO:0052746,1,0.986981246916491,0,2,inositol phosphorylation,BP,
14328,GO:0052794,1,0.983566475248283,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14329,GO:0052795,1,0.983566475248283,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14330,GO:0052796,1,0.983566475248283,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14331,GO:0052798,1,0.994614640011293,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14332,GO:0052803,1,0.94435328648363,0,10,imidazole-containing compound metabolic process,BP,
14333,GO:0052805,1,0.960619943510435,0,7,imidazole-containing compound catabolic process,BP,
14334,GO:0052810,1,0.987999992407391,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14335,GO:0052811,1,0.9740002952784,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14336,GO:0052812,1,0.980375609566545,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14337,GO:0052813,1,0.638531800007161,0,64,phosphatidylinositol bisphosphate kinase activity,MF,
14338,GO:0052815,1,0.988691669542829,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14339,GO:0052816,1,0.993855553218095,0,1,long-chain acyl-CoA hydrolase activity,MF,
14340,GO:0052817,1,0.993855553218095,0,1,very long chain acyl-CoA hydrolase activity,MF,
14341,GO:0052821,1,0.994811251181433,0,1,DNA-7-methyladenine glycosylase activity,MF,
14342,GO:0052822,1,0.994811251181433,0,1,DNA-3-methylguanine glycosylase activity,MF,
14343,GO:0052825,1,0.99398930141819,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14344,GO:0052826,1,0.994270628287957,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14345,GO:0052827,1,0.988294024643492,0,2,inositol pentakisphosphate phosphatase activity,MF,
14346,GO:0052828,1,0.983884906964313,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14347,GO:0052829,1,0.994616756225274,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14348,GO:0052830,1,0.99398930141819,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14349,GO:0052831,1,0.99398930141819,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14350,GO:0052832,1,0.973008887049923,0,4,inositol monophosphate 3-phosphatase activity,MF,
14351,GO:0052833,1,0.973008887049923,0,4,inositol monophosphate 4-phosphatase activity,MF,
14352,GO:0052834,1,0.973008887049923,0,4,inositol monophosphate phosphatase activity,MF,
14353,GO:0052835,1,0.99398930141819,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14354,GO:0052836,1,0.982274641105498,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14355,GO:0052839,1,0.982274641105498,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14356,GO:0052840,1,0.97668461576008,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14357,GO:0052841,1,0.97668461576008,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14358,GO:0052842,1,0.97668461576008,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14359,GO:0052843,1,0.97668461576008,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14360,GO:0052844,1,0.97668461576008,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14361,GO:0052845,1,0.97668461576008,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14362,GO:0052846,1,0.97668461576008,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14363,GO:0052847,1,0.97668461576008,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14364,GO:0052848,1,0.97668461576008,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14366,GO:0052852,1,0.994710614731861,0,1,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14367,GO:0052853,1,0.994710614731861,0,1,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14368,GO:0052854,1,0.994710614731861,0,1,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14369,GO:0052856,1,0.994819386677153,0,1,NADHX epimerase activity,MF,
14370,GO:0052857,1,0.994819386677153,0,1,NADPHX epimerase activity,MF,
14371,GO:0052858,1,0.993729755778845,0,1,peptidyl-lysine acetyltransferase activity,MF,
14372,GO:0052866,1,0.813508372628553,0,28,phosphatidylinositol phosphate phosphatase activity,MF,
14373,GO:0052870,1,0.994176244190549,0,1,tocopherol omega-hydroxylase activity,MF,
14374,GO:0052871,1,0.994176244190549,0,1,alpha-tocopherol omega-hydroxylase activity,MF,
14375,GO:0052884,1,0.994399069470243,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14376,GO:0052885,1,0.994399069470243,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14377,GO:0052890,1,0.99466767128089,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14378,GO:0052894,1,0.99462254756683,0,1,norspermine:oxygen oxidoreductase activity,MF,
14379,GO:0052895,1,0.99462254756683,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14380,GO:0052899,1,0.994722055363197,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14381,GO:0052901,1,0.989372702125472,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14382,GO:0052902,1,0.994722055363197,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14383,GO:0052903,1,0.994722055363197,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14384,GO:0052904,1,0.994722055363197,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14385,GO:0052905,1,0.98303551799545,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14386,GO:0052906,1,0.992054244883134,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14387,GO:0052907,1,0.994313214468247,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14388,GO:0052909,1,0.994313214468247,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14389,GO:0052917,1,0.994511127043614,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14390,GO:0052918,1,0.990986778974138,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14391,GO:0052925,1,0.994756296779206,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14392,GO:0052926,1,0.990986778974138,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14393,GO:0052927,1,0.994551376364011,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14394,GO:0052928,1,0.994551376364011,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14395,GO:0052929,1,0.994551376364011,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14397,GO:0055002,1,0.376517992811733,0,135,striated muscle cell development,BP,
14398,GO:0055003,1,0.833049072903939,0,20,cardiac myofibril assembly,BP,
14399,GO:0055005,1,0.980768558126213,0,3,ventricular cardiac myofibril assembly,BP,
14400,GO:0055006,1,0.608900384640768,0,64,cardiac cell development,BP,
14401,GO:0055007,1,0.490049322690694,0,95,cardiac muscle cell differentiation,BP,
14402,GO:0055008,1,0.600787538406715,0,64,cardiac muscle tissue morphogenesis,BP,
14403,GO:0055009,1,0.963579230226856,0,6,atrial cardiac muscle tissue morphogenesis,BP,
14404,GO:0055010,1,0.704745851366071,0,45,ventricular cardiac muscle tissue morphogenesis,BP,
14405,GO:0055011,1,0.989417164937793,0,2,atrial cardiac muscle cell differentiation,BP,
14406,GO:0055012,1,0.90731049902186,0,15,ventricular cardiac muscle cell differentiation,BP,
14407,GO:0055013,1,0.635077020323448,0,59,cardiac muscle cell development,BP,
14408,GO:0055014,1,0.989417164937793,0,2,atrial cardiac muscle cell development,BP,
14409,GO:0055015,1,0.943195071801669,0,10,ventricular cardiac muscle cell development,BP,
14410,GO:0055017,1,0.625891839143777,0,67,cardiac muscle tissue growth,BP,
14411,GO:0055018,1,0.994702757779098,0,1,regulation of cardiac muscle fiber development,BP,
14412,GO:0055020,1,0.994702757779098,0,1,positive regulation of cardiac muscle fiber development,BP,
14413,GO:0055021,1,0.718676383359985,0,47,regulation of cardiac muscle tissue growth,BP,
14414,GO:0055022,1,0.905150341589443,0,16,negative regulation of cardiac muscle tissue growth,BP,
14415,GO:0055023,1,0.804832996544943,0,29,positive regulation of cardiac muscle tissue growth,BP,
14416,GO:0055024,1,0.626236066740167,0,66,regulation of cardiac muscle tissue development,BP,
14418,GO:0055026,1,0.84617782739337,0,25,negative regulation of cardiac muscle tissue development,BP,
14419,GO:0055028,1,0.990054929762495,0,1,cortical microtubule,CC,
14420,GO:0055029,1,0.426241694997742,0,131,nuclear DNA-directed RNA polymerase complex,CC,
14421,GO:0055037,1,0.353495776794271,0,152,recycling endosome,CC,
14422,GO:0055038,1,0.655760341356395,0,67,recycling endosome membrane,CC,
14423,GO:0055048,1,0.990054929762495,0,1,anastral spindle assembly,BP,
14424,GO:0055056,1,0.944837660615797,0,9,D-glucose transmembrane transporter activity,MF,
14425,GO:0055057,1,0.909777702720219,0,13,neuroblast division,BP,
14426,GO:0055059,1,0.95934146739794,0,6,asymmetric neuroblast division,BP,
14427,GO:0055062,1,0.934757628481893,0,9,phosphate ion homeostasis,BP,
14428,GO:0055064,1,0.914959747426738,0,12,chloride ion homeostasis,BP,
14430,GO:0055067,1,0.389591378328489,0,143,monovalent inorganic cation homeostasis,BP,
14431,GO:0055069,1,0.819600825179445,0,33,zinc ion homeostasis,BP,
14432,GO:0055070,1,0.899262431026254,0,16,copper ion homeostasis,BP,
14434,GO:0055073,1,0.988347942785862,0,2,cadmium ion homeostasis,BP,
14436,GO:0055075,1,0.827716725269026,0,27,potassium ion homeostasis,BP,
14438,GO:0055077,1,0.9885126854756,0,2,gap junction hemi-channel activity,MF,
14439,GO:0055078,1,0.767038609763694,0,41,sodium ion homeostasis,BP,
14441,GO:0055081,1,0.732906606893644,0,44,anion homeostasis,BP,
14443,GO:0055083,1,0.855214324702497,0,21,monovalent inorganic anion homeostasis,BP,
14446,GO:0055087,1,0.980238313018386,0,3,Ski complex,CC,
14447,GO:0055088,1,0.531835826749419,0,96,lipid homeostasis,BP,
14448,GO:0055089,1,0.922027475547982,0,12,fatty acid homeostasis,BP,
14449,GO:0055090,1,0.856342094273441,0,25,acylglycerol homeostasis,BP,
14450,GO:0055091,1,0.945601084651741,0,8,phospholipid homeostasis,BP,
14451,GO:0055092,1,0.710082400465144,0,53,sterol homeostasis,BP,
14453,GO:0055094,1,0.856656094717543,0,23,response to lipoprotein particle,BP,
14454,GO:0055095,1,0.981811197457782,0,3,lipoprotein particle mediated signaling,BP,
14455,GO:0055096,1,0.981811197457782,0,3,low-density lipoprotein particle mediated signaling,BP,
14456,GO:0055100,1,0.981595590343248,0,3,adiponectin binding,MF,
14458,GO:0055103,1,0.993997664993241,0,1,ligase regulator activity,MF,
14459,GO:0055105,1,0.968951966483492,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14460,GO:0055106,1,0.914574604574351,0,16,ubiquitin-protein transferase regulator activity,MF,
14461,GO:0055108,1,0.994651614086683,0,1,Golgi to transport vesicle transport,BP,
14462,GO:0055111,1,0.991663981895247,0,1,ingression involved in gastrulation with mouth forming second,BP,
14463,GO:0055113,1,0.986405851477857,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14465,GO:0055117,1,0.600900956069229,0,69,regulation of cardiac muscle contraction,BP,
14466,GO:0055118,1,0.960429951860628,0,6,negative regulation of cardiac muscle contraction,BP,
14467,GO:0055119,1,0.886316234272877,0,17,relaxation of cardiac muscle,BP,
14468,GO:0055120,1,0.994814632277951,0,1,striated muscle dense body,CC,
14470,GO:0055129,1,0.97804731357361,0,4,L-proline biosynthetic process,BP,
14471,GO:0055130,1,0.994741410542591,0,1,D-alanine catabolic process,BP,
14472,GO:0055131,1,0.96719158325047,0,6,C3HC4-type RING finger domain binding,MF,
14473,GO:0060001,1,0.988578284484993,0,1,minus-end directed microfilament motor activity,MF,
14474,GO:0060002,1,0.977594539927501,0,2,plus-end directed microfilament motor activity,MF,
14475,GO:0060003,1,0.979797308921074,0,2,copper ion export,BP,
14476,GO:0060004,1,0.884854918906369,0,18,reflex,BP,
14477,GO:0060005,1,0.973520717219871,0,4,vestibular reflex,BP,
14478,GO:0060007,1,0.993176773258754,0,1,linear vestibuloocular reflex,BP,
14479,GO:0060008,1,0.891742516670249,0,17,Sertoli cell differentiation,BP,
14480,GO:0060009,1,0.912638040416766,0,13,Sertoli cell development,BP,
14481,GO:0060010,1,0.993940247473235,0,1,Sertoli cell fate commitment,BP,
14482,GO:0060011,1,0.98077954296299,0,3,Sertoli cell proliferation,BP,
14483,GO:0060012,1,0.960142953536507,0,7,synaptic transmission, glycinergic,BP,
14484,GO:0060013,1,0.943140091132861,0,8,righting reflex,BP,
14485,GO:0060014,1,0.994230284913538,0,1,granulosa cell differentiation,BP,
14486,GO:0060017,1,0.960720912171872,0,6,parathyroid gland development,BP,
14487,GO:0060018,1,0.980037428323562,0,3,astrocyte fate commitment,BP,
14488,GO:0060019,1,0.928335276924718,0,12,radial glial cell differentiation,BP,
14491,GO:0060022,1,0.95690853883917,0,6,hard palate development,BP,
14492,GO:0060023,1,0.961256286265588,0,5,soft palate development,BP,
14493,GO:0060024,1,0.972047850099057,0,4,rhythmic synaptic transmission,BP,
14494,GO:0060025,1,0.978259598624496,0,3,regulation of synaptic activity,BP,
14495,GO:0060026,1,0.903452190728047,0,15,convergent extension,BP,
14496,GO:0060027,1,0.946977175478792,0,8,convergent extension involved in gastrulation,BP,
14497,GO:0060028,1,0.95513408390535,0,7,convergent extension involved in axis elongation,BP,
14498,GO:0060029,1,0.961867582623762,0,6,convergent extension involved in organogenesis,BP,
14499,GO:0060031,1,0.986177278053938,0,2,mediolateral intercalation,BP,
14500,GO:0060032,1,0.984357559262886,0,2,notochord regression,BP,
14501,GO:0060033,1,0.934822550766171,0,10,anatomical structure regression,BP,
14502,GO:0060037,1,0.843580835338569,0,24,pharyngeal system development,BP,
14503,GO:0060038,1,0.726104645507894,0,46,cardiac muscle cell proliferation,BP,
14504,GO:0060039,1,0.854126880513526,0,19,pericardium development,BP,
14505,GO:0060040,1,0.977665555496663,0,4,retinal bipolar neuron differentiation,BP,
14507,GO:0060042,1,0.739861246809411,0,41,retina morphogenesis in camera-type eye,BP,
14508,GO:0060043,1,0.778484333944231,0,36,regulation of cardiac muscle cell proliferation,BP,
14509,GO:0060044,1,0.926683880009613,0,12,negative regulation of cardiac muscle cell proliferation,BP,
14510,GO:0060045,1,0.851463213147565,0,22,positive regulation of cardiac muscle cell proliferation,BP,
14511,GO:0060046,1,0.925806375847493,0,12,regulation of acrosome reaction,BP,
14513,GO:0060048,1,0.416481746388006,0,120,cardiac muscle contraction,BP,
14514,GO:0060049,1,0.912439605692452,0,13,regulation of protein glycosylation,BP,
14515,GO:0060050,1,0.936891832636738,0,9,positive regulation of protein glycosylation,BP,
14516,GO:0060051,1,0.98901899170654,0,2,negative regulation of protein glycosylation,BP,
14518,GO:0060053,1,0.984938805711836,0,2,neurofilament cytoskeleton,CC,
14519,GO:0060054,1,0.976408679417393,0,4,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14521,GO:0060056,1,0.950115428877175,0,8,mammary gland involution,BP,
14522,GO:0060057,1,0.980746071857235,0,3,apoptotic process involved in mammary gland involution,BP,
14523,GO:0060058,1,0.980746071857235,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
14524,GO:0060059,1,0.932950856645702,0,7,embryonic retina morphogenesis in camera-type eye,BP,
14525,GO:0060060,1,0.990122861140087,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14526,GO:0060061,1,0.985522378696742,0,2,Spemann organizer formation,BP,
14527,GO:0060064,1,0.994760088027326,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14528,GO:0060065,1,0.863423369820747,0,19,uterus development,BP,
14529,GO:0060066,1,0.98860588450132,0,2,oviduct development,BP,
14530,GO:0060067,1,0.991465911434634,0,1,cervix development,BP,
14531,GO:0060068,1,0.930781370442417,0,9,vagina development,BP,
14533,GO:0060071,1,0.498381975107887,0,106,Wnt signaling pathway, planar cell polarity pathway,BP,
14534,GO:0060072,1,0.984633283388791,0,2,large conductance calcium-activated potassium channel activity,MF,
14535,GO:0060073,1,0.95415493347555,0,7,micturition,BP,
14536,GO:0060074,1,0.876241748024565,0,17,synapse maturation,BP,
14537,GO:0060075,1,0.950164963412558,0,7,regulation of resting membrane potential,BP,
14539,GO:0060077,1,0.903833712450972,0,15,inhibitory synapse,CC,
14543,GO:0060081,1,0.929221441167316,0,11,membrane hyperpolarization,BP,
14544,GO:0060083,1,0.978370198299106,0,3,smooth muscle contraction involved in micturition,BP,
14545,GO:0060084,1,0.980564637967971,0,3,synaptic transmission involved in micturition,BP,
14546,GO:0060086,1,0.988433299098689,0,2,circadian temperature homeostasis,BP,
14547,GO:0060087,1,0.972375673116674,0,5,relaxation of vascular smooth muscle,BP,
14548,GO:0060088,1,0.931470442216894,0,10,auditory receptor cell stereocilium organization,BP,
14551,GO:0060091,1,0.95781141892454,0,7,kinocilium,CC,
14552,GO:0060092,1,0.994016522465217,0,1,regulation of synaptic transmission, glycinergic,BP,
14553,GO:0060099,1,0.92934820403986,0,11,regulation of phagocytosis, engulfment,BP,
14554,GO:0060100,1,0.939625786298679,0,9,positive regulation of phagocytosis, engulfment,BP,
14555,GO:0060101,1,0.994676276783979,0,1,negative regulation of phagocytosis, engulfment,BP,
14556,GO:0060112,1,0.989550192526713,0,2,generation of ovulation cycle rhythm,BP,
14558,GO:0060117,1,0.884484792713739,0,17,auditory receptor cell development,BP,
14560,GO:0060120,1,0.964832702252353,0,5,inner ear receptor cell fate commitment,BP,
14561,GO:0060122,1,0.848346901346219,0,23,inner ear receptor cell stereocilium organization,BP,
14562,GO:0060123,1,0.925327135666081,0,11,regulation of growth hormone secretion,BP,
14563,GO:0060124,1,0.954627767318563,0,8,positive regulation of growth hormone secretion,BP,
14564,GO:0060125,1,0.982201449562632,0,2,negative regulation of growth hormone secretion,BP,
14565,GO:0060126,1,0.982880743493177,0,3,somatotropin secreting cell differentiation,BP,
14566,GO:0060127,1,0.994566878406223,0,1,prolactin secreting cell differentiation,BP,
14567,GO:0060128,1,0.988914831600158,0,2,corticotropin hormone secreting cell differentiation,BP,
14568,GO:0060129,1,0.982424440073597,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14569,GO:0060133,1,0.994779158100935,0,1,somatotropin secreting cell development,BP,
14572,GO:0060136,1,0.962232232551569,0,6,embryonic process involved in female pregnancy,BP,
14573,GO:0060137,1,0.951119402191187,0,8,maternal process involved in parturition,BP,
14574,GO:0060139,1,0.987280124484812,0,2,positive regulation of apoptotic process by virus,BP,
14577,GO:0060147,1,0.560728845579689,0,86,regulation of posttranscriptional gene silencing,BP,
14578,GO:0060148,1,0.871784089815543,0,21,positive regulation of posttranscriptional gene silencing,BP,
14579,GO:0060149,1,0.903158668594976,0,14,negative regulation of posttranscriptional gene silencing,BP,
14580,GO:0060151,1,0.985854768378668,0,2,peroxisome localization,BP,
14581,GO:0060152,1,0.985854768378668,0,2,microtubule-based peroxisome localization,BP,
14582,GO:0060154,1,0.981824038651899,0,3,cellular process regulating host cell cycle in response to virus,BP,
14583,GO:0060155,1,0.949335781582154,0,8,platelet dense granule organization,BP,
14584,GO:0060156,1,0.994085496691891,0,1,milk ejection reflex,BP,
14585,GO:0060157,1,0.964781305465767,0,5,urinary bladder development,BP,
14586,GO:0060158,1,0.951286169806868,0,9,phospholipase C-activating dopamine receptor signaling pathway,BP,
14587,GO:0060159,1,0.941353478808317,0,9,regulation of dopamine receptor signaling pathway,BP,
14588,GO:0060160,1,0.988701970065946,0,2,negative regulation of dopamine receptor signaling pathway,BP,
14589,GO:0060161,1,0.9708026426563,0,4,positive regulation of dopamine receptor signaling pathway,BP,
14590,GO:0060163,1,0.989295886768868,0,2,subpallium neuron fate commitment,BP,
14591,GO:0060164,1,0.983313457540444,0,3,regulation of timing of neuron differentiation,BP,
14592,GO:0060165,1,0.994468201715917,0,1,regulation of timing of subpallium neuron differentiation,BP,
14593,GO:0060166,1,0.983128072851741,0,3,olfactory pit development,BP,
14594,GO:0060167,1,0.973787887067311,0,4,regulation of adenosine receptor signaling pathway,BP,
14595,GO:0060168,1,0.978925480005354,0,3,positive regulation of adenosine receptor signaling pathway,BP,
14596,GO:0060169,1,0.994752919170352,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14598,GO:0060171,1,0.977653256783989,0,2,stereocilium membrane,CC,
14600,GO:0060174,1,0.919727392875399,0,11,limb bud formation,BP,
14601,GO:0060175,1,0.990141132722455,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14602,GO:0060177,1,0.993905506281561,0,1,regulation of angiotensin metabolic process,BP,
14603,GO:0060178,1,0.994558252460162,0,1,regulation of exocyst localization,BP,
14605,GO:0060180,1,0.961648726443526,0,6,female mating behavior,BP,
14606,GO:0060183,1,0.994016522465217,0,1,apelin receptor signaling pathway,BP,
14607,GO:0060184,1,0.99417957762911,0,1,cell cycle switching,BP,
14608,GO:0060187,1,0.984717474192077,0,2,cell pole,CC,
14611,GO:0060193,1,0.703402820613768,0,54,positive regulation of lipase activity,BP,
14612,GO:0060197,1,0.982192486347833,0,3,cloacal septation,BP,
14613,GO:0060198,1,0.933564236780244,0,12,clathrin-sculpted vesicle,CC,
14614,GO:0060199,1,0.976288045791148,0,4,clathrin-sculpted glutamate transport vesicle,CC,
14615,GO:0060200,1,0.981899739450879,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14616,GO:0060201,1,0.981899739450879,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14617,GO:0060203,1,0.976288045791148,0,4,clathrin-sculpted glutamate transport vesicle membrane,CC,
14619,GO:0060211,1,0.915256628397253,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14620,GO:0060212,1,0.994693615343317,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14621,GO:0060213,1,0.915256628397253,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14622,GO:0060214,1,0.978297813433511,0,4,endocardium formation,BP,
14623,GO:0060215,1,0.949562222978083,0,8,primitive hemopoiesis,BP,
14624,GO:0060216,1,0.865185284293469,0,21,definitive hemopoiesis,BP,
14625,GO:0060217,1,0.99234549051893,0,1,hemangioblast cell differentiation,BP,
14626,GO:0060218,1,0.595563522167738,0,89,hematopoietic stem cell differentiation,BP,
14627,GO:0060219,1,0.902249564799982,0,15,camera-type eye photoreceptor cell differentiation,BP,
14628,GO:0060221,1,0.982414075471916,0,3,retinal rod cell differentiation,BP,
14629,GO:0060228,1,0.984547815891449,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14630,GO:0060229,1,0.939989749017059,0,10,lipase activator activity,MF,
14631,GO:0060230,1,0.989660272649936,0,2,lipoprotein lipase activator activity,MF,
14632,GO:0060231,1,0.885949510157082,0,20,mesenchymal to epithelial transition,BP,
14633,GO:0060232,1,0.98309787331142,0,3,delamination,BP,
14634,GO:0060235,1,0.962802565006039,0,4,lens induction in camera-type eye,BP,
14635,GO:0060236,1,0.766145914605774,0,36,regulation of mitotic spindle organization,BP,
14636,GO:0060242,1,0.949331917902445,0,8,contact inhibition,BP,
14637,GO:0060243,1,0.993119458307179,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14638,GO:0060244,1,0.982914792282318,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14639,GO:0060245,1,0.993584328135496,0,1,detection of cell density,BP,
14640,GO:0060246,1,0.993584328135496,0,1,detection of cell density by contact stimulus,BP,
14641,GO:0060248,1,0.993584328135496,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14643,GO:0060251,1,0.828859416802181,0,25,regulation of glial cell proliferation,BP,
14644,GO:0060252,1,0.926965155893058,0,11,positive regulation of glial cell proliferation,BP,
14645,GO:0060253,1,0.900835470494738,0,14,negative regulation of glial cell proliferation,BP,
14646,GO:0060254,1,0.994695328496284,0,1,regulation of N-terminal protein palmitoylation,BP,
14648,GO:0060259,1,0.891381162553001,0,17,regulation of feeding behavior,BP,
14649,GO:0060260,1,0.839847114603702,0,27,regulation of transcription initiation from RNA polymerase II promoter,BP,
14650,GO:0060261,1,0.877542564694251,0,20,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14651,GO:0060262,1,0.994695328496284,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14652,GO:0060263,1,0.937924417416236,0,10,regulation of respiratory burst,BP,
14653,GO:0060264,1,0.984166271008039,0,3,regulation of respiratory burst involved in inflammatory response,BP,
14654,GO:0060265,1,0.989545736978175,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14655,GO:0060266,1,0.989420008463673,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
14656,GO:0060267,1,0.972659317569786,0,4,positive regulation of respiratory burst,BP,
14657,GO:0060268,1,0.979907858737054,0,3,negative regulation of respiratory burst,BP,
14658,GO:0060271,1,0.0918369724755418,0,341,cilium assembly,BP,
14659,GO:0060272,1,0.932032719916779,0,12,embryonic skeletal joint morphogenesis,BP,
14660,GO:0060278,1,0.983248481894629,0,3,regulation of ovulation,BP,
14661,GO:0060279,1,0.988653375445307,0,2,positive regulation of ovulation,BP,
14662,GO:0060280,1,0.99453369805972,0,1,negative regulation of ovulation,BP,
14663,GO:0060281,1,0.936342670696801,0,10,regulation of oocyte development,BP,
14664,GO:0060282,1,0.973143099826844,0,4,positive regulation of oocyte development,BP,
14665,GO:0060283,1,0.973070192966339,0,4,negative regulation of oocyte development,BP,
14667,GO:0060285,1,0.796065804795687,0,30,cilium-dependent cell motility,BP,
14668,GO:0060287,1,0.945695503466988,0,9,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14669,GO:0060290,1,0.9626221064945,0,6,transdifferentiation,BP,
14672,GO:0060293,1,0.915673286007016,0,14,germ plasm,CC,
14673,GO:0060294,1,0.915854307645776,0,16,cilium movement involved in cell motility,BP,
14674,GO:0060295,1,0.97208697731865,0,5,regulation of cilium movement involved in cell motility,BP,
14675,GO:0060296,1,0.97208697731865,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14676,GO:0060297,1,0.954159826027829,0,5,regulation of sarcomere organization,BP,
14677,GO:0060298,1,0.978144817701646,0,3,positive regulation of sarcomere organization,BP,
14678,GO:0060300,1,0.977246455760356,0,4,regulation of cytokine activity,BP,
14679,GO:0060301,1,0.994463161779309,0,1,positive regulation of cytokine activity,BP,
14680,GO:0060302,1,0.989440280941314,0,2,negative regulation of cytokine activity,BP,
14681,GO:0060304,1,0.951739033856491,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14682,GO:0060305,1,0.994265759215158,0,1,regulation of cell diameter,BP,
14683,GO:0060306,1,0.804659370908395,0,29,regulation of membrane repolarization,BP,
14684,GO:0060307,1,0.878411136499547,0,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14685,GO:0060309,1,0.994831580179448,0,1,elastin catabolic process,BP,
14686,GO:0060310,1,0.994831580179448,0,1,regulation of elastin catabolic process,BP,
14687,GO:0060311,1,0.994831580179448,0,1,negative regulation of elastin catabolic process,BP,
14688,GO:0060312,1,0.945987313094869,0,8,regulation of blood vessel remodeling,BP,
14689,GO:0060313,1,0.9774494745206,0,3,negative regulation of blood vessel remodeling,BP,
14691,GO:0060315,1,0.937224418939296,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14692,GO:0060316,1,0.94683935042504,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14693,GO:0060317,1,0.818489250414456,0,31,cardiac epithelial to mesenchymal transition,BP,
14694,GO:0060318,1,0.966976311389757,0,5,definitive erythrocyte differentiation,BP,
14695,GO:0060319,1,0.976639000032953,0,4,primitive erythrocyte differentiation,BP,
14701,GO:0060327,1,0.994326919959383,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14703,GO:0060331,1,0.963628755437074,0,6,negative regulation of response to interferon-gamma,BP,
14704,GO:0060332,1,0.957925886961766,0,6,positive regulation of response to interferon-gamma,BP,
14707,GO:0060335,1,0.957925886961766,0,6,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14708,GO:0060336,1,0.963628755437074,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14709,GO:0060337,1,0.64260384459237,0,71,type I interferon signaling pathway,BP,
14710,GO:0060338,1,0.813372981091392,0,30,regulation of type I interferon-mediated signaling pathway,BP,
14711,GO:0060339,1,0.95229174746947,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
14712,GO:0060340,1,0.928358559269033,0,10,positive regulation of type I interferon-mediated signaling pathway,BP,
14714,GO:0060342,1,0.989026130312078,0,2,photoreceptor inner segment membrane,CC,
14716,GO:0060345,1,0.993911470462511,0,1,spleen trabecula formation,BP,
14718,GO:0060347,1,0.924692955595849,0,12,heart trabecula formation,BP,
14723,GO:0060352,1,0.959523252211615,0,7,cell adhesion molecule production,BP,
14724,GO:0060353,1,0.973014885376085,0,5,regulation of cell adhesion molecule production,BP,
14725,GO:0060354,1,0.99482518139384,0,1,negative regulation of cell adhesion molecule production,BP,
14726,GO:0060355,1,0.978077379045691,0,4,positive regulation of cell adhesion molecule production,BP,
14728,GO:0060363,1,0.951473075160476,0,8,cranial suture morphogenesis,BP,
14729,GO:0060364,1,0.972512417676039,0,4,frontal suture morphogenesis,BP,
14730,GO:0060366,1,0.989038110568869,0,1,lambdoid suture morphogenesis,BP,
14731,GO:0060367,1,0.989038110568869,0,1,sagittal suture morphogenesis,BP,
14732,GO:0060368,1,0.963922549404831,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14733,GO:0060369,1,0.97458132401335,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14734,GO:0060370,1,0.986408081466445,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14735,GO:0060371,1,0.943957307913094,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14736,GO:0060372,1,0.945746963461226,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14737,GO:0060373,1,0.962392599608528,0,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14738,GO:0060374,1,0.965013089035761,0,5,mast cell differentiation,BP,
14739,GO:0060375,1,0.986388644224552,0,2,regulation of mast cell differentiation,BP,
14740,GO:0060377,1,0.993997664993241,0,1,negative regulation of mast cell differentiation,BP,
14741,GO:0060378,1,0.984230353015891,0,2,regulation of brood size,BP,
14742,GO:0060379,1,0.930913897100896,0,10,cardiac muscle cell myoblast differentiation,BP,
14743,GO:0060380,1,0.994625879346492,0,1,regulation of single-stranded telomeric DNA binding,BP,
14744,GO:0060381,1,0.994625879346492,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14745,GO:0060382,1,0.984139417566299,0,2,regulation of DNA strand elongation,BP,
14746,GO:0060383,1,0.993256638461652,0,1,positive regulation of DNA strand elongation,BP,
14748,GO:0060385,1,0.967185092413506,0,5,axonogenesis involved in innervation,BP,
14749,GO:0060386,1,0.991579617001031,0,1,synapse assembly involved in innervation,BP,
14751,GO:0060390,1,0.893005008131853,0,17,regulation of SMAD protein signal transduction,BP,
14752,GO:0060391,1,0.914640229106595,0,13,positive regulation of SMAD protein signal transduction,BP,
14753,GO:0060392,1,0.983932061969355,0,3,negative regulation of SMAD protein signal transduction,BP,
14755,GO:0060394,1,0.942955081706905,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14757,GO:0060396,1,0.871197597091326,0,19,growth hormone receptor signaling pathway,BP,
14758,GO:0060397,1,0.914860910665331,0,12,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
14759,GO:0060398,1,0.97115882262403,0,4,regulation of growth hormone receptor signaling pathway,BP,
14760,GO:0060399,1,0.978285745698937,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14761,GO:0060400,1,0.992716478309701,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14764,GO:0060404,1,0.993659605855793,0,1,axonemal microtubule depolymerization,BP,
14765,GO:0060405,1,0.966861394175612,0,5,regulation of penile erection,BP,
14766,GO:0060406,1,0.98030572879841,0,3,positive regulation of penile erection,BP,
14767,GO:0060407,1,0.994752919170352,0,1,negative regulation of penile erection,BP,
14768,GO:0060411,1,0.633388171299851,0,63,cardiac septum morphogenesis,BP,
14769,GO:0060412,1,0.77605282543534,0,35,ventricular septum morphogenesis,BP,
14770,GO:0060413,1,0.90263703605928,0,14,atrial septum morphogenesis,BP,
14773,GO:0060416,1,0.807634735328686,0,30,response to growth hormone,BP,
14774,GO:0060419,1,0.596024968103436,0,74,heart growth,BP,
14775,GO:0060420,1,0.688016029441354,0,53,regulation of heart growth,BP,
14776,GO:0060421,1,0.781678804543723,0,33,positive regulation of heart growth,BP,
14777,GO:0060422,1,0.994543997724785,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14778,GO:0060423,1,0.982773303195056,0,3,foregut regionalization,BP,
14779,GO:0060424,1,0.982773303195056,0,3,lung field specification,BP,
14780,GO:0060425,1,0.717928597278774,0,50,lung morphogenesis,BP,
14781,GO:0060426,1,0.971348286990965,0,5,lung vasculature development,BP,
14782,GO:0060428,1,0.797943581445907,0,34,lung epithelium development,BP,
14784,GO:0060430,1,0.95334631888403,0,7,lung saccule development,BP,
14785,GO:0060431,1,0.97147979533795,0,5,primary lung bud formation,BP,
14786,GO:0060432,1,0.994837004944945,0,1,lung pattern specification process,BP,
14787,GO:0060433,1,0.940998402871481,0,10,bronchus development,BP,
14788,GO:0060434,1,0.987158918692802,0,2,bronchus morphogenesis,BP,
14789,GO:0060435,1,0.989648502811543,0,2,bronchiole development,BP,
14790,GO:0060436,1,0.994837004944945,0,1,bronchiole morphogenesis,BP,
14791,GO:0060437,1,0.968891630615784,0,5,lung growth,BP,
14792,GO:0060438,1,0.880710076726457,0,19,trachea development,BP,
14793,GO:0060439,1,0.93047511690674,0,11,trachea morphogenesis,BP,
14794,GO:0060440,1,0.964485028168409,0,6,trachea formation,BP,
14795,GO:0060441,1,0.824172853232022,0,29,epithelial tube branching involved in lung morphogenesis,BP,
14796,GO:0060442,1,0.922022082046336,0,12,branching involved in prostate gland morphogenesis,BP,
14797,GO:0060443,1,0.728128414352408,0,43,mammary gland morphogenesis,BP,
14798,GO:0060444,1,0.844045341803277,0,22,branching involved in mammary gland duct morphogenesis,BP,
14799,GO:0060445,1,0.85293795787722,0,22,branching involved in salivary gland morphogenesis,BP,
14800,GO:0060447,1,0.979351882160451,0,3,bud outgrowth involved in lung branching,BP,
14801,GO:0060448,1,0.972997253580998,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14802,GO:0060449,1,0.958455149525183,0,7,bud elongation involved in lung branching,BP,
14803,GO:0060452,1,0.937413558241738,0,11,positive regulation of cardiac muscle contraction,BP,
14804,GO:0060453,1,0.942250318367949,0,10,regulation of gastric acid secretion,BP,
14805,GO:0060454,1,0.987228797735299,0,2,positive regulation of gastric acid secretion,BP,
14806,GO:0060455,1,0.972458240414491,0,5,negative regulation of gastric acid secretion,BP,
14807,GO:0060456,1,0.944776791183116,0,10,positive regulation of digestive system process,BP,
14808,GO:0060457,1,0.917855486129907,0,13,negative regulation of digestive system process,BP,
14809,GO:0060458,1,0.989203984881769,0,2,right lung development,BP,
14810,GO:0060459,1,0.984017555748687,0,3,left lung development,BP,
14811,GO:0060460,1,0.989215003474696,0,2,left lung morphogenesis,BP,
14812,GO:0060461,1,0.994428550852589,0,1,right lung morphogenesis,BP,
14813,GO:0060462,1,0.961902490690755,0,6,lung lobe development,BP,
14814,GO:0060463,1,0.961902490690755,0,6,lung lobe morphogenesis,BP,
14815,GO:0060465,1,0.987768368949953,0,2,pharynx development,BP,
14816,GO:0060466,1,0.990477206308103,0,1,activation of meiosis involved in egg activation,BP,
14817,GO:0060467,1,0.989366848801841,0,2,negative regulation of fertilization,BP,
14818,GO:0060474,1,0.98879309869033,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
14819,GO:0060478,1,0.976937554426118,0,4,acrosomal vesicle exocytosis,BP,
14820,GO:0060479,1,0.871472545108742,0,21,lung cell differentiation,BP,
14821,GO:0060480,1,0.984332150534845,0,3,lung goblet cell differentiation,BP,
14822,GO:0060481,1,0.977865145148133,0,4,lobar bronchus epithelium development,BP,
14823,GO:0060482,1,0.971439297769966,0,5,lobar bronchus development,BP,
14824,GO:0060484,1,0.950149156787732,0,8,lung-associated mesenchyme development,BP,
14826,GO:0060486,1,0.972253071347824,0,4,Clara cell differentiation,BP,
14827,GO:0060487,1,0.876867834011148,0,20,lung epithelial cell differentiation,BP,
14828,GO:0060488,1,0.978120205820022,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14829,GO:0060489,1,0.978120205820022,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14830,GO:0060490,1,0.978120205820022,0,2,lateral sprouting involved in lung morphogenesis,BP,
14831,GO:0060491,1,0.372308420767814,0,143,regulation of cell projection assembly,BP,
14832,GO:0060492,1,0.982773303195056,0,3,lung induction,BP,
14833,GO:0060495,1,0.994837004944945,0,1,cell-cell signaling involved in lung development,BP,
14834,GO:0060496,1,0.994837004944945,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14835,GO:0060501,1,0.9640369224481,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14836,GO:0060502,1,0.936954913336875,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14837,GO:0060503,1,0.994702757779098,0,1,bud dilation involved in lung branching,BP,
14838,GO:0060509,1,0.956416768885331,0,5,Type I pneumocyte differentiation,BP,
14839,GO:0060510,1,0.96750422167322,0,5,Type II pneumocyte differentiation,BP,
14840,GO:0060512,1,0.828222800055268,0,27,prostate gland morphogenesis,BP,
14841,GO:0060513,1,0.934730252907209,0,10,prostatic bud formation,BP,
14842,GO:0060514,1,0.994144090797444,0,1,prostate induction,BP,
14843,GO:0060515,1,0.994144090797444,0,1,prostate field specification,BP,
14844,GO:0060516,1,0.988198772899939,0,2,primary prostatic bud elongation,BP,
14845,GO:0060517,1,0.993418082828812,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14846,GO:0060520,1,0.994144090797444,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14847,GO:0060523,1,0.979079128033091,0,3,prostate epithelial cord elongation,BP,
14848,GO:0060525,1,0.920242794933246,0,11,prostate glandular acinus development,BP,
14849,GO:0060526,1,0.956947385855017,0,6,prostate glandular acinus morphogenesis,BP,
14850,GO:0060527,1,0.956947385855017,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14851,GO:0060528,1,0.968716055367355,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14852,GO:0060529,1,0.986021420651503,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14853,GO:0060532,1,0.986502535346792,0,2,bronchus cartilage development,BP,
14854,GO:0060534,1,0.945508651101899,0,8,trachea cartilage development,BP,
14855,GO:0060535,1,0.969846964178323,0,4,trachea cartilage morphogenesis,BP,
14856,GO:0060536,1,0.928381669078282,0,11,cartilage morphogenesis,BP,
14858,GO:0060538,1,0.35060360040243,0,156,skeletal muscle organ development,BP,
14859,GO:0060539,1,0.958717375558216,0,7,diaphragm development,BP,
14861,GO:0060542,1,0.991531154941563,0,1,regulation of strand invasion,BP,
14862,GO:0060544,1,0.89060376653253,0,20,regulation of necroptotic process,BP,
14863,GO:0060545,1,0.988171883480503,0,2,positive regulation of necroptotic process,BP,
14864,GO:0060546,1,0.941332903804712,0,10,negative regulation of necroptotic process,BP,
14865,GO:0060547,1,0.926764572379656,0,13,negative regulation of necrotic cell death,BP,
14867,GO:0060556,1,0.954453240958672,0,8,regulation of vitamin D biosynthetic process,BP,
14868,GO:0060557,1,0.98951532430307,0,2,positive regulation of vitamin D biosynthetic process,BP,
14869,GO:0060558,1,0.964714346040143,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14870,GO:0060559,1,0.98951532430307,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14872,GO:0060561,1,0.855207088309988,0,23,apoptotic process involved in morphogenesis,BP,
14875,GO:0060566,1,0.986374012045264,0,1,positive regulation of DNA-templated transcription, termination,BP,
14876,GO:0060571,1,0.848477585912425,0,26,morphogenesis of an epithelial fold,BP,
14877,GO:0060572,1,0.897121331300114,0,17,morphogenesis of an epithelial bud,BP,
14878,GO:0060573,1,0.926339833846224,0,11,cell fate specification involved in pattern specification,BP,
14879,GO:0060574,1,0.977637594302922,0,4,intestinal epithelial cell maturation,BP,
14880,GO:0060575,1,0.90722215727965,0,16,intestinal epithelial cell differentiation,BP,
14881,GO:0060576,1,0.943952433944666,0,10,intestinal epithelial cell development,BP,
14882,GO:0060577,1,0.989336858188022,0,2,pulmonary vein morphogenesis,BP,
14883,GO:0060578,1,0.994566878406223,0,1,superior vena cava morphogenesis,BP,
14884,GO:0060579,1,0.905096551316015,0,15,ventral spinal cord interneuron fate commitment,BP,
14885,GO:0060580,1,0.994622706997525,0,1,ventral spinal cord interneuron fate determination,BP,
14886,GO:0060581,1,0.905096551316015,0,15,cell fate commitment involved in pattern specification,BP,
14887,GO:0060582,1,0.994622706997525,0,1,cell fate determination involved in pattern specification,BP,
14888,GO:0060584,1,0.982379938256439,0,3,regulation of prostaglandin-endoperoxide synthase activity,BP,
14889,GO:0060585,1,0.982379938256439,0,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14890,GO:0060586,1,0.948500452741546,0,8,multicellular organismal iron ion homeostasis,BP,
14891,GO:0060587,1,0.988694782132626,0,2,regulation of lipoprotein lipid oxidation,BP,
14892,GO:0060588,1,0.994807234511731,0,1,negative regulation of lipoprotein lipid oxidation,BP,
14893,GO:0060589,1,0.0955243005346654,0,334,nucleoside-triphosphatase regulator activity,MF,
14894,GO:0060590,1,0.783424023600419,0,41,ATPase regulator activity,MF,
14895,GO:0060591,1,0.973744668829011,0,4,chondroblast differentiation,BP,
14896,GO:0060592,1,0.952908908601085,0,7,mammary gland formation,BP,
14897,GO:0060594,1,0.977292251669616,0,3,mammary gland specification,BP,
14898,GO:0060595,1,0.988125257087153,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14899,GO:0060596,1,0.980249409791352,0,3,mammary placode formation,BP,
14900,GO:0060598,1,0.99479620414169,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14901,GO:0060599,1,0.985659481123447,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14902,GO:0060600,1,0.921669777604062,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14903,GO:0060601,1,0.908091556437635,0,13,lateral sprouting from an epithelium,BP,
14904,GO:0060602,1,0.87749053807993,0,19,branch elongation of an epithelium,BP,
14905,GO:0060603,1,0.794203367284697,0,30,mammary gland duct morphogenesis,BP,
14906,GO:0060605,1,0.966462715664965,0,5,tube lumen cavitation,BP,
14908,GO:0060611,1,0.994488349929807,0,1,mammary gland fat development,BP,
14909,GO:0060612,1,0.788469187297534,0,36,adipose tissue development,BP,
14910,GO:0060613,1,0.950878317136314,0,7,fat pad development,BP,
14911,GO:0060615,1,0.988125257087153,0,2,mammary gland bud formation,BP,
14912,GO:0060620,1,0.994313214468247,0,1,regulation of cholesterol import,BP,
14913,GO:0060623,1,0.988333751687863,0,2,regulation of chromosome condensation,BP,
14915,GO:0060628,1,0.923956072345705,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
14916,GO:0060629,1,0.994269413582916,0,1,regulation of homologous chromosome segregation,BP,
14917,GO:0060631,1,0.959272307309164,0,7,regulation of meiosis I,BP,
14918,GO:0060632,1,0.862808744512596,0,23,regulation of microtubule-based movement,BP,
14919,GO:0060633,1,0.969441665432926,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14920,GO:0060638,1,0.946288820731325,0,8,mesenchymal-epithelial cell signaling,BP,
14921,GO:0060644,1,0.889449951173143,0,16,mammary gland epithelial cell differentiation,BP,
14922,GO:0060648,1,0.982870570367304,0,3,mammary gland bud morphogenesis,BP,
14923,GO:0060661,1,0.989455652710118,0,2,submandibular salivary gland formation,BP,
14924,GO:0060662,1,0.966462715664965,0,5,salivary gland cavitation,BP,
14925,GO:0060664,1,0.97185709427898,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14926,GO:0060665,1,0.974795804370998,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14927,GO:0060666,1,0.957433514910967,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14928,GO:0060667,1,0.988125257087153,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14929,GO:0060668,1,0.99369271627694,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14932,GO:0060671,1,0.988694728855983,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14933,GO:0060672,1,0.988694728855983,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14935,GO:0060675,1,0.655707449760679,0,59,ureteric bud morphogenesis,BP,
14936,GO:0060676,1,0.962874554787693,0,6,ureteric bud formation,BP,
14937,GO:0060677,1,0.942373673088928,0,7,ureteric bud elongation,BP,
14938,GO:0060678,1,0.994556733991284,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14939,GO:0060681,1,0.973908530399615,0,4,branch elongation involved in ureteric bud branching,BP,
14940,GO:0060683,1,0.99431494092688,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14941,GO:0060684,1,0.961408383142839,0,7,epithelial-mesenchymal cell signaling,BP,
14942,GO:0060685,1,0.960686216679417,0,6,regulation of prostatic bud formation,BP,
14943,GO:0060686,1,0.971452030449193,0,4,negative regulation of prostatic bud formation,BP,
14944,GO:0060687,1,0.952412481526312,0,7,regulation of branching involved in prostate gland morphogenesis,BP,
14945,GO:0060688,1,0.719861296530558,0,51,regulation of morphogenesis of a branching structure,BP,
14946,GO:0060689,1,0.97798763982634,0,3,cell differentiation involved in salivary gland development,BP,
14947,GO:0060690,1,0.994697149405476,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14948,GO:0060691,1,0.994697149405476,0,1,epithelial cell maturation involved in salivary gland development,BP,
14949,GO:0060693,1,0.945091452304336,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14950,GO:0060694,1,0.994684466974914,0,1,regulation of cholesterol transporter activity,BP,
14951,GO:0060696,1,0.965430791138541,0,6,regulation of phospholipid catabolic process,BP,
14952,GO:0060697,1,0.989167191306549,0,2,positive regulation of phospholipid catabolic process,BP,
14953,GO:0060698,1,0.987313231895495,0,2,endoribonuclease inhibitor activity,MF,
14954,GO:0060699,1,0.976746950777818,0,4,regulation of endoribonuclease activity,BP,
14955,GO:0060700,1,0.946052355120815,0,9,regulation of ribonuclease activity,BP,
14956,GO:0060701,1,0.987313231895495,0,2,negative regulation of ribonuclease activity,BP,
14957,GO:0060702,1,0.987313231895495,0,2,negative regulation of endoribonuclease activity,BP,
14958,GO:0060703,1,0.994347577264868,0,1,deoxyribonuclease inhibitor activity,MF,
14962,GO:0060709,1,0.994259634540459,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14963,GO:0060710,1,0.959196165139753,0,7,chorio-allantoic fusion,BP,
14967,GO:0060715,1,0.9798057374585,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14968,GO:0060716,1,0.888950771254422,0,19,labyrinthine layer blood vessel development,BP,
14969,GO:0060717,1,0.951631302628191,0,7,chorion development,BP,
14970,GO:0060718,1,0.962930010086123,0,5,chorionic trophoblast cell differentiation,BP,
14971,GO:0060720,1,0.984057582642314,0,2,spongiotrophoblast cell proliferation,BP,
14972,GO:0060721,1,0.984057582642314,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14973,GO:0060722,1,0.984057582642314,0,2,cell proliferation involved in embryonic placenta development,BP,
14974,GO:0060723,1,0.984057582642314,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14975,GO:0060729,1,0.96857603167732,0,5,intestinal epithelial structure maintenance,BP,
14976,GO:0060730,1,0.988398060651382,0,2,regulation of intestinal epithelial structure maintenance,BP,
14977,GO:0060731,1,0.993970144807525,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14978,GO:0060732,1,0.942042338136094,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14979,GO:0060733,1,0.985391479050273,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14980,GO:0060734,1,0.99269917296645,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14981,GO:0060735,1,0.994779853095668,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14982,GO:0060736,1,0.917220688967277,0,11,prostate gland growth,BP,
14983,GO:0060737,1,0.97263355257445,0,4,prostate gland morphogenetic growth,BP,
14984,GO:0060738,1,0.988877616364357,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14985,GO:0060739,1,0.989634943444825,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14986,GO:0060740,1,0.832526169825032,0,26,prostate gland epithelium morphogenesis,BP,
14987,GO:0060741,1,0.983556399894494,0,3,prostate gland stromal morphogenesis,BP,
14988,GO:0060742,1,0.927642275716773,0,11,epithelial cell differentiation involved in prostate gland development,BP,
14989,GO:0060743,1,0.982781198277042,0,3,epithelial cell maturation involved in prostate gland development,BP,
14990,GO:0060744,1,0.965189727110533,0,5,mammary gland branching involved in thelarche,BP,
14991,GO:0060745,1,0.946070989815025,0,6,mammary gland branching involved in pregnancy,BP,
14992,GO:0060746,1,0.917816632153728,0,13,parental behavior,BP,
14993,GO:0060748,1,0.972412481103245,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14994,GO:0060749,1,0.885895120779372,0,17,mammary gland alveolus development,BP,
14995,GO:0060750,1,0.966710880927746,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14996,GO:0060751,1,0.961468866215005,0,5,branch elongation involved in mammary gland duct branching,BP,
14997,GO:0060752,1,0.994370341336446,0,1,intestinal phytosterol absorption,BP,
14998,GO:0060753,1,0.965679100425666,0,6,regulation of mast cell chemotaxis,BP,
14999,GO:0060754,1,0.970762889979496,0,5,positive regulation of mast cell chemotaxis,BP,
15001,GO:0060760,1,0.738236450605246,0,47,positive regulation of response to cytokine stimulus,BP,
15002,GO:0060761,1,0.735197932018336,0,48,negative regulation of response to cytokine stimulus,BP,
15003,GO:0060762,1,0.974304957542726,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
15004,GO:0060763,1,0.985412417267333,0,2,mammary duct terminal end bud growth,BP,
15005,GO:0060764,1,0.987023262518488,0,2,cell-cell signaling involved in mammary gland development,BP,
15006,GO:0060765,1,0.84944182991669,0,25,regulation of androgen receptor signaling pathway,BP,
15007,GO:0060766,1,0.933296858480929,0,11,negative regulation of androgen receptor signaling pathway,BP,
15008,GO:0060767,1,0.932745699244259,0,11,epithelial cell proliferation involved in prostate gland development,BP,
15009,GO:0060768,1,0.938929538553032,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
15010,GO:0060769,1,0.982843553599397,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
15011,GO:0060770,1,0.96696304373479,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
15012,GO:0060775,1,0.986177278053938,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
15013,GO:0060781,1,0.994746455661165,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
15014,GO:0060782,1,0.994746455661165,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
15015,GO:0060783,1,0.994746455661165,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
15016,GO:0060784,1,0.993418082828812,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
15017,GO:0060788,1,0.910964492080827,0,14,ectodermal placode formation,BP,
15018,GO:0060789,1,0.9637039009423,0,6,hair follicle placode formation,BP,
15019,GO:0060795,1,0.830135392383857,0,31,cell fate commitment involved in formation of primary germ layer,BP,
15020,GO:0060796,1,0.989313219928285,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15021,GO:0060800,1,0.980079238489373,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15022,GO:0060802,1,0.99461918156608,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15023,GO:0060803,1,0.994761244613654,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15024,GO:0060804,1,0.994069633134755,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
15025,GO:0060806,1,0.994723966062646,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15026,GO:0060807,1,0.994523571391181,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15027,GO:0060809,1,0.985849692114417,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
15028,GO:0060816,1,0.980761201062396,0,2,random inactivation of X chromosome,BP,
15029,GO:0060819,1,0.981853510982581,0,2,inactivation of X chromosome by genetic imprinting,BP,
15030,GO:0060821,1,0.988556908548808,0,1,inactivation of X chromosome by DNA methylation,BP,
15031,GO:0060823,1,0.987195046776235,0,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15032,GO:0060825,1,0.989433488487245,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15033,GO:0060827,1,0.993277651769872,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15035,GO:0060829,1,0.993277651769872,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15036,GO:0060830,1,0.981141525723185,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15037,GO:0060831,1,0.909693866540952,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
15039,GO:0060837,1,0.942471735245257,0,9,blood vessel endothelial cell differentiation,BP,
15043,GO:0060841,1,0.879299032156528,0,16,venous blood vessel development,BP,
15044,GO:0060842,1,0.960629983233476,0,6,arterial endothelial cell differentiation,BP,
15045,GO:0060843,1,0.987970401814337,0,1,venous endothelial cell differentiation,BP,
15046,GO:0060844,1,0.98849583586381,0,2,arterial endothelial cell fate commitment,BP,
15047,GO:0060846,1,0.983022062183312,0,3,blood vessel endothelial cell fate commitment,BP,
15048,GO:0060847,1,0.983022062183312,0,3,endothelial cell fate specification,BP,
15049,GO:0060849,1,0.987593688726603,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15050,GO:0060850,1,0.898136641282424,0,16,regulation of transcription involved in cell fate commitment,BP,
15051,GO:0060853,1,0.993944547516147,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
15052,GO:0060856,1,0.942289708084684,0,10,establishment of blood-brain barrier,BP,
15053,GO:0060857,1,0.994550991110029,0,1,establishment of glial blood-brain barrier,BP,
15054,GO:0060872,1,0.932685003199685,0,9,semicircular canal development,BP,
15055,GO:0060873,1,0.989038110568869,0,1,anterior semicircular canal development,BP,
15056,GO:0060875,1,0.989038110568869,0,1,lateral semicircular canal development,BP,
15057,GO:0060876,1,0.989348255635927,0,2,semicircular canal formation,BP,
15058,GO:0060879,1,0.994837004944945,0,1,semicircular canal fusion,BP,
15059,GO:0060896,1,0.934033032207935,0,9,neural plate pattern specification,BP,
15060,GO:0060897,1,0.952627125898248,0,7,neural plate regionalization,BP,
15061,GO:0060900,1,0.912436201798634,0,12,embryonic camera-type eye formation,BP,
15062,GO:0060901,1,0.993070549408301,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15063,GO:0060903,1,0.976302053687512,0,4,positive regulation of meiosis I,BP,
15064,GO:0060904,1,0.993376977639998,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15065,GO:0060907,1,0.956261353271393,0,7,positive regulation of macrophage cytokine production,BP,
15066,GO:0060911,1,0.944275485025418,0,10,cardiac cell fate commitment,BP,
15067,GO:0060912,1,0.988867619115716,0,2,cardiac cell fate specification,BP,
15068,GO:0060913,1,0.983764581477869,0,3,cardiac cell fate determination,BP,
15069,GO:0060914,1,0.868805745723901,0,22,heart formation,BP,
15070,GO:0060915,1,0.988125257087153,0,2,mesenchymal cell differentiation involved in lung development,BP,
15071,GO:0060916,1,0.964931505308706,0,5,mesenchymal cell proliferation involved in lung development,BP,
15072,GO:0060920,1,0.965973920721534,0,5,cardiac pacemaker cell differentiation,BP,
15073,GO:0060921,1,0.979394268308562,0,3,sinoatrial node cell differentiation,BP,
15074,GO:0060922,1,0.986300130337755,0,2,atrioventricular node cell differentiation,BP,
15075,GO:0060923,1,0.965357356593617,0,6,cardiac muscle cell fate commitment,BP,
15076,GO:0060926,1,0.971020229839947,0,4,cardiac pacemaker cell development,BP,
15077,GO:0060927,1,0.99466767128089,0,1,cardiac pacemaker cell fate commitment,BP,
15078,GO:0060928,1,0.986300130337755,0,2,atrioventricular node cell development,BP,
15079,GO:0060929,1,0.99466767128089,0,1,atrioventricular node cell fate commitment,BP,
15080,GO:0060931,1,0.984509978063014,0,2,sinoatrial node cell development,BP,
15081,GO:0060932,1,0.987306210862497,0,2,His-Purkinje system cell differentiation,BP,
15082,GO:0060935,1,0.979178342619775,0,3,cardiac fibroblast cell differentiation,BP,
15083,GO:0060936,1,0.979178342619775,0,3,cardiac fibroblast cell development,BP,
15084,GO:0060938,1,0.979178342619775,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15085,GO:0060939,1,0.979178342619775,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15086,GO:0060940,1,0.988222208437913,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15087,GO:0060947,1,0.943916668393925,0,8,cardiac vascular smooth muscle cell differentiation,BP,
15088,GO:0060948,1,0.976293578450596,0,3,cardiac vascular smooth muscle cell development,BP,
15089,GO:0060956,1,0.955243554797147,0,6,endocardial cell differentiation,BP,
15090,GO:0060957,1,0.994199043385735,0,1,endocardial cell fate commitment,BP,
15091,GO:0060964,1,0.574478839360236,0,83,regulation of gene silencing by miRNA,BP,
15092,GO:0060965,1,0.917733731341237,0,12,negative regulation of gene silencing by miRNA,BP,
15093,GO:0060966,1,0.560728845579689,0,86,regulation of gene silencing by RNA,BP,
15094,GO:0060967,1,0.903158668594976,0,14,negative regulation of gene silencing by RNA,BP,
15095,GO:0060968,1,0.484271289325459,0,106,regulation of gene silencing,BP,
15096,GO:0060969,1,0.846198918570463,0,22,negative regulation of gene silencing,BP,
15097,GO:0060971,1,0.969496728185281,0,4,embryonic heart tube left/right pattern formation,BP,
15098,GO:0060972,1,0.859150681874124,0,21,left/right pattern formation,BP,
15099,GO:0060973,1,0.887621364397862,0,17,cell migration involved in heart development,BP,
15100,GO:0060974,1,0.989645914081594,0,2,cell migration involved in heart formation,BP,
15101,GO:0060975,1,0.994804610227398,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15102,GO:0060976,1,0.730763137855942,0,41,coronary vasculature development,BP,
15103,GO:0060977,1,0.877047541446471,0,15,coronary vasculature morphogenesis,BP,
15104,GO:0060978,1,0.977131782705618,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15105,GO:0060979,1,0.962998999214286,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
15106,GO:0060980,1,0.993665731148129,0,1,cell migration involved in coronary vasculogenesis,BP,
15107,GO:0060981,1,0.991577509116684,0,1,cell migration involved in coronary angiogenesis,BP,
15108,GO:0060982,1,0.922933146981539,0,9,coronary artery morphogenesis,BP,
15109,GO:0060986,1,0.76040430577339,0,43,endocrine hormone secretion,BP,
15110,GO:0060987,1,0.99453369805972,0,1,lipid tube,CC,
15111,GO:0060988,1,0.987713634528467,0,2,lipid tube assembly,BP,
15112,GO:0060992,1,0.924753450097807,0,11,response to fungicide,BP,
15113,GO:0060993,1,0.533353977658827,0,86,kidney morphogenesis,BP,
15114,GO:0060994,1,0.98835264616175,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15115,GO:0060995,1,0.986249233417626,0,2,cell-cell signaling involved in kidney development,BP,
15120,GO:0061000,1,0.918018208612254,0,11,negative regulation of dendritic spine development,BP,
15122,GO:0061002,1,0.956918787893736,0,6,negative regulation of dendritic spine morphogenesis,BP,
15124,GO:0061004,1,0.950150000346899,0,9,pattern specification involved in kidney development,BP,
15125,GO:0061005,1,0.699530816687961,0,50,cell differentiation involved in kidney development,BP,
15127,GO:0061009,1,0.972226457738955,0,5,common bile duct development,BP,
15128,GO:0061010,1,0.976582358855925,0,3,gall bladder development,BP,
15129,GO:0061011,1,0.994709021742542,0,1,hepatic duct development,BP,
15131,GO:0061014,1,0.74453659387065,0,39,positive regulation of mRNA catabolic process,BP,
15132,GO:0061015,1,0.989561072284207,0,2,snRNA import into nucleus,BP,
15133,GO:0061017,1,0.994709021742542,0,1,hepatoblast differentiation,BP,
15136,GO:0061026,1,0.985579121476668,0,1,cardiac muscle tissue regeneration,BP,
15137,GO:0061027,1,0.988944109164873,0,2,umbilical cord development,BP,
15138,GO:0061028,1,0.769097258897985,0,38,establishment of endothelial barrier,BP,
15139,GO:0061029,1,0.914236598123546,0,13,eyelid development in camera-type eye,BP,
15140,GO:0061030,1,0.982651129112961,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15141,GO:0061031,1,0.983956810639164,0,3,endodermal digestive tract morphogenesis,BP,
15142,GO:0061032,1,0.988717934134767,0,2,visceral serous pericardium development,BP,
15143,GO:0061033,1,0.988279466285888,0,2,secretion by lung epithelial cell involved in lung growth,BP,
15144,GO:0061034,1,0.985246462617353,0,2,olfactory bulb mitral cell layer development,BP,
15145,GO:0061035,1,0.681551332877611,0,56,regulation of cartilage development,BP,
15146,GO:0061036,1,0.826317711665965,0,27,positive regulation of cartilage development,BP,
15147,GO:0061037,1,0.871580095394911,0,22,negative regulation of cartilage development,BP,
15148,GO:0061038,1,0.948588886409066,0,6,uterus morphogenesis,BP,
15149,GO:0061040,1,0.988496738198091,0,1,female gonad morphogenesis,BP,
15155,GO:0061046,1,0.966009932049968,0,6,regulation of branching involved in lung morphogenesis,BP,
15156,GO:0061047,1,0.977566411662071,0,4,positive regulation of branching involved in lung morphogenesis,BP,
15157,GO:0061048,1,0.994728551824984,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15158,GO:0061049,1,0.887635444077276,0,17,cell growth involved in cardiac muscle cell development,BP,
15159,GO:0061050,1,0.923358401845904,0,11,regulation of cell growth involved in cardiac muscle cell development,BP,
15160,GO:0061051,1,0.94532067435708,0,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,
15161,GO:0061052,1,0.976780288793628,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15162,GO:0061053,1,0.585726256813037,0,73,somite development,BP,
15163,GO:0061054,1,0.988121051589432,0,2,dermatome development,BP,
15164,GO:0061055,1,0.973077642853354,0,4,myotome development,BP,
15165,GO:0061056,1,0.97844039661542,0,4,sclerotome development,BP,
15167,GO:0061072,1,0.931795086348083,0,9,iris morphogenesis,BP,
15168,GO:0061073,1,0.980415190064964,0,3,ciliary body morphogenesis,BP,
15169,GO:0061074,1,0.97182206466789,0,5,regulation of neural retina development,BP,
15170,GO:0061075,1,0.989121887611133,0,2,positive regulation of neural retina development,BP,
15171,GO:0061076,1,0.994077586648902,0,1,negative regulation of neural retina development,BP,
15172,GO:0061077,1,0.658514125554312,0,71,chaperone-mediated protein folding,BP,
15173,GO:0061078,1,0.994838740001473,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15174,GO:0061081,1,0.933315314060872,0,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
15175,GO:0061082,1,0.868039253432024,0,22,myeloid leukocyte cytokine production,BP,
15176,GO:0061083,1,0.975758511310202,0,4,regulation of protein refolding,BP,
15177,GO:0061084,1,0.975758511310202,0,4,negative regulation of protein refolding,BP,
15178,GO:0061085,1,0.943278789125563,0,9,regulation of histone H3-K27 methylation,BP,
15179,GO:0061086,1,0.974188151425986,0,4,negative regulation of histone H3-K27 methylation,BP,
15180,GO:0061087,1,0.962230602076953,0,6,positive regulation of histone H3-K27 methylation,BP,
15181,GO:0061088,1,0.943348576768978,0,9,regulation of sequestering of zinc ion,BP,
15182,GO:0061090,1,0.9945000808197,0,1,positive regulation of sequestering of zinc ion,BP,
15183,GO:0061091,1,0.974854659679569,0,3,regulation of phospholipid translocation,BP,
15184,GO:0061092,1,0.974854659679569,0,3,positive regulation of phospholipid translocation,BP,
15185,GO:0061097,1,0.641879615632525,0,67,regulation of protein tyrosine kinase activity,BP,
15186,GO:0061098,1,0.775166225027402,0,38,positive regulation of protein tyrosine kinase activity,BP,
15187,GO:0061099,1,0.856602934869957,0,24,negative regulation of protein tyrosine kinase activity,BP,
15188,GO:0061100,1,0.994468201715917,0,1,lung neuroendocrine cell differentiation,BP,
15189,GO:0061101,1,0.956133592940363,0,8,neuroendocrine cell differentiation,BP,
15190,GO:0061102,1,0.989264040342559,0,2,stomach neuroendocrine cell differentiation,BP,
15191,GO:0061103,1,0.994468201715917,0,1,carotid body glomus cell differentiation,BP,
15192,GO:0061104,1,0.98878516470613,0,2,adrenal chromaffin cell differentiation,BP,
15193,GO:0061105,1,0.994767180013798,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15194,GO:0061106,1,0.994767180013798,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15195,GO:0061107,1,0.983707822920354,0,3,seminal vesicle development,BP,
15196,GO:0061108,1,0.994556924097726,0,1,seminal vesicle epithelium development,BP,
15197,GO:0061110,1,0.976945639569081,0,3,dense core granule biogenesis,BP,
15198,GO:0061113,1,0.980211992920499,0,3,pancreas morphogenesis,BP,
15199,GO:0061114,1,0.994125776747889,0,1,branching involved in pancreas morphogenesis,BP,
15200,GO:0061115,1,0.994837004944945,0,1,lung proximal/distal axis specification,BP,
15201,GO:0061117,1,0.905150341589443,0,16,negative regulation of heart growth,BP,
15202,GO:0061133,1,0.968237503472524,0,6,endopeptidase activator activity,MF,
15205,GO:0061136,1,0.341430624327503,0,165,regulation of proteasomal protein catabolic process,BP,
15207,GO:0061140,1,0.947069814620946,0,9,lung secretory cell differentiation,BP,
15208,GO:0061141,1,0.978422863035204,0,3,lung ciliated cell differentiation,BP,
15209,GO:0061143,1,0.994270021149309,0,1,alveolar primary septum development,BP,
15210,GO:0061144,1,0.994100475828729,0,1,alveolar secondary septum development,BP,
15211,GO:0061145,1,0.986502535346792,0,2,lung smooth muscle development,BP,
15212,GO:0061146,1,0.98130804184113,0,3,Peyer's patch morphogenesis,BP,
15213,GO:0061149,1,0.994702757779098,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15214,GO:0061150,1,0.994702757779098,0,1,renal system segmentation,BP,
15215,GO:0061151,1,0.994702757779098,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15216,GO:0061152,1,0.988625409938613,0,2,trachea submucosa development,BP,
15217,GO:0061153,1,0.988625409938613,0,2,trachea gland development,BP,
15219,GO:0061155,1,0.994702757779098,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15220,GO:0061156,1,0.950681908702983,0,6,pulmonary artery morphogenesis,BP,
15221,GO:0061157,1,0.845833503413693,0,22,mRNA destabilization,BP,
15222,GO:0061158,1,0.908857125404105,0,12,3'-UTR-mediated mRNA destabilization,BP,
15223,GO:0061162,1,0.870689260575396,0,19,establishment of monopolar cell polarity,BP,
15224,GO:0061178,1,0.728074503854191,0,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15225,GO:0061179,1,0.946188938058813,0,9,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15226,GO:0061180,1,0.62368425043819,0,64,mammary gland epithelium development,BP,
15227,GO:0061181,1,0.993120433379147,0,1,regulation of chondrocyte development,BP,
15228,GO:0061183,1,0.988121051589432,0,2,regulation of dermatome development,BP,
15229,GO:0061184,1,0.993437584411502,0,1,positive regulation of dermatome development,BP,
15230,GO:0061185,1,0.994648699027918,0,1,negative regulation of dermatome development,BP,
15231,GO:0061187,1,0.983252089823013,0,2,regulation of chromatin silencing at rDNA,BP,
15232,GO:0061188,1,0.983252089823013,0,2,negative regulation of chromatin silencing at rDNA,BP,
15233,GO:0061189,1,0.994746455661165,0,1,positive regulation of sclerotome development,BP,
15234,GO:0061190,1,0.994746455661165,0,1,regulation of sclerotome development,BP,
15235,GO:0061193,1,0.994818658650597,0,1,taste bud development,BP,
15236,GO:0061196,1,0.959753757061262,0,6,fungiform papilla development,BP,
15237,GO:0061197,1,0.965011384878954,0,5,fungiform papilla morphogenesis,BP,
15238,GO:0061198,1,0.979226036664662,0,3,fungiform papilla formation,BP,
15239,GO:0061200,1,0.95476576088816,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15240,GO:0061202,1,0.95476576088816,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15241,GO:0061205,1,0.987744834199782,0,2,paramesonephric duct development,BP,
15242,GO:0061209,1,0.977631276239224,0,4,cell proliferation involved in mesonephros development,BP,
15243,GO:0061213,1,0.884342154648967,0,20,positive regulation of mesonephros development,BP,
15244,GO:0061216,1,0.994702757779098,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
15245,GO:0061217,1,0.870184295115652,0,23,regulation of mesonephros development,BP,
15246,GO:0061218,1,0.971370607179042,0,5,negative regulation of mesonephros development,BP,
15247,GO:0061227,1,0.989406428114059,0,2,pattern specification involved in mesonephros development,BP,
15248,GO:0061245,1,0.736379872132446,0,45,establishment or maintenance of bipolar cell polarity,BP,
15249,GO:0061289,1,0.986249233417626,0,2,Wnt signaling pathway involved in kidney development,BP,
15250,GO:0061290,1,0.986249233417626,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15253,GO:0061300,1,0.984686679926269,0,2,cerebellum vasculature development,BP,
15254,GO:0061301,1,0.989878087535131,0,1,cerebellum vasculature morphogenesis,BP,
15256,GO:0061303,1,0.947262494067053,0,8,cornea development in camera-type eye,BP,
15258,GO:0061307,1,0.935113544570098,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15259,GO:0061308,1,0.935113544570098,0,11,cardiac neural crest cell development involved in heart development,BP,
15260,GO:0061309,1,0.946164027549969,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15261,GO:0061311,1,0.853801249558039,0,24,cell surface receptor signaling pathway involved in heart development,BP,
15262,GO:0061312,1,0.96696936437115,0,6,BMP signaling pathway involved in heart development,BP,
15263,GO:0061314,1,0.933616126835295,0,9,Notch signaling involved in heart development,BP,
15264,GO:0061316,1,0.9831657697556,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15265,GO:0061317,1,0.98924519313071,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15266,GO:0061318,1,0.898314055841339,0,15,renal filtration cell differentiation,BP,
15267,GO:0061323,1,0.903767767003189,0,15,cell proliferation involved in heart morphogenesis,BP,
15268,GO:0061324,1,0.993855145749219,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15269,GO:0061325,1,0.977825235723108,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15273,GO:0061339,1,0.870689260575396,0,19,establishment or maintenance of monopolar cell polarity,BP,
15274,GO:0061341,1,0.983515244596108,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15275,GO:0061343,1,0.969462453262296,0,4,cell adhesion involved in heart morphogenesis,BP,
15276,GO:0061346,1,0.983515244596108,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15277,GO:0061347,1,0.991465911434634,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15278,GO:0061348,1,0.991465911434634,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15279,GO:0061349,1,0.991465911434634,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15280,GO:0061350,1,0.991465911434634,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15281,GO:0061351,1,0.398488199680832,0,128,neural precursor cell proliferation,BP,
15282,GO:0061354,1,0.991465911434634,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15283,GO:0061355,1,0.97540871096755,0,4,Wnt protein secretion,BP,
15284,GO:0061356,1,0.97540871096755,0,4,regulation of Wnt protein secretion,BP,
15285,GO:0061357,1,0.980624157130309,0,3,positive regulation of Wnt protein secretion,BP,
15286,GO:0061358,1,0.994682541933244,0,1,negative regulation of Wnt protein secretion,BP,
15287,GO:0061360,1,0.993240355502953,0,1,optic chiasma development,BP,
15288,GO:0061364,1,0.975870995361961,0,3,apoptotic process involved in luteolysis,BP,
15289,GO:0061365,1,0.960871070586774,0,7,positive regulation of triglyceride lipase activity,BP,
15290,GO:0061366,1,0.980421253159363,0,3,behavioral response to chemical pain,BP,
15291,GO:0061368,1,0.980421253159363,0,3,behavioral response to formalin induced pain,BP,
15292,GO:0061369,1,0.993437584411502,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15293,GO:0061370,1,0.965619766842345,0,6,testosterone biosynthetic process,BP,
15294,GO:0061371,1,0.6742118381173,0,58,determination of heart left/right asymmetry,BP,
15295,GO:0061373,1,0.988112011393428,0,1,mammillary axonal complex development,BP,
15296,GO:0061377,1,0.885895120779372,0,17,mammary gland lobule development,BP,
15298,GO:0061384,1,0.796751518315441,0,31,heart trabecula morphogenesis,BP,
15299,GO:0061386,1,0.979733695723666,0,2,closure of optic fissure,BP,
15301,GO:0061394,1,0.98937721499842,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15302,GO:0061395,1,0.994717627223506,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15303,GO:0061400,1,0.994313214468247,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15304,GO:0061402,1,0.988867946771536,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15305,GO:0061408,1,0.983475614313849,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15306,GO:0061418,1,0.636735396181522,0,74,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15307,GO:0061419,1,0.96443832667553,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15308,GO:0061428,1,0.974202527489403,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15310,GO:0061433,1,0.994660463963978,0,1,cellular response to caloric restriction,BP,
15311,GO:0061436,1,0.902294278170531,0,16,establishment of skin barrier,BP,
15312,GO:0061437,1,0.855273472899027,0,23,renal system vasculature development,BP,
15313,GO:0061438,1,0.95375976531445,0,6,renal system vasculature morphogenesis,BP,
15314,GO:0061439,1,0.95375976531445,0,6,kidney vasculature morphogenesis,BP,
15315,GO:0061440,1,0.855273472899027,0,23,kidney vasculature development,BP,
15316,GO:0061441,1,0.986784205946423,0,2,renal artery morphogenesis,BP,
15317,GO:0061443,1,0.985535606375995,0,2,endocardial cushion cell differentiation,BP,
15318,GO:0061444,1,0.99128651804985,0,1,endocardial cushion cell development,BP,
15319,GO:0061445,1,0.994199043385735,0,1,endocardial cushion cell fate commitment,BP,
15323,GO:0061459,1,0.98968604934366,0,1,L-arginine transmembrane transporter activity,MF,
15324,GO:0061462,1,0.791765170577078,0,35,protein localization to lysosome,BP,
15325,GO:0061469,1,0.951366575651804,0,8,regulation of type B pancreatic cell proliferation,BP,
15326,GO:0061470,1,0.968729356727643,0,4,T follicular helper cell differentiation,BP,
15327,GO:0061474,1,0.994435346912507,0,1,phagolysosome membrane,CC,
15328,GO:0061476,1,0.967296700902583,0,5,response to anticoagulant,BP,
15329,GO:0061478,1,0.908711434764478,0,12,response to platelet aggregation inhibitor,BP,
15330,GO:0061481,1,0.994828327254872,0,1,response to TNF agonist,BP,
15331,GO:0061484,1,0.97338669898614,0,4,hematopoietic stem cell homeostasis,BP,
15332,GO:0061485,1,0.989761336169048,0,1,memory T cell proliferation,BP,
15333,GO:0061495,1,0.994313214468247,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
15334,GO:0061502,1,0.963458657424502,0,4,early endosome to recycling endosome transport,BP,
15335,GO:0061505,1,0.983765811461374,0,2,DNA topoisomerase II activity,MF,
15336,GO:0061507,1,0.99472354321251,0,1,cyclic-GMP-AMP binding,MF,
15337,GO:0061508,1,0.994313214468247,0,1,CDP phosphorylation,BP,
15338,GO:0061511,1,0.972132971570959,0,4,centriole elongation,BP,
15339,GO:0061512,1,0.797071506049996,0,34,protein localization to cilium,BP,
15340,GO:0061513,1,0.98199173187058,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15342,GO:0061517,1,0.988687160582554,0,2,macrophage proliferation,BP,
15343,GO:0061518,1,0.988687160582554,0,2,microglial cell proliferation,BP,
15344,GO:0061519,1,0.993714307228991,0,1,macrophage homeostasis,BP,
15345,GO:0061523,1,0.993659605855793,0,1,cilium disassembly,BP,
15346,GO:0061525,1,0.941524646350172,0,8,hindgut development,BP,
15347,GO:0061526,1,0.977857620059797,0,4,acetylcholine secretion,BP,
15348,GO:0061528,1,0.992431771564765,0,1,aspartate secretion,BP,
15349,GO:0061534,1,0.985146687563009,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15350,GO:0061535,1,0.971230813630277,0,3,glutamate secretion, neurotransmission,BP,
15351,GO:0061536,1,0.994016522465217,0,1,glycine secretion,BP,
15352,GO:0061537,1,0.994016522465217,0,1,glycine secretion, neurotransmission,BP,
15353,GO:0061542,1,0.99479271690561,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15354,GO:0061547,1,0.987950446984891,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15355,GO:0061548,1,0.924516906190331,0,12,ganglion development,BP,
15356,GO:0061549,1,0.94902449176252,0,8,sympathetic ganglion development,BP,
15357,GO:0061550,1,0.965868278922788,0,5,cranial ganglion development,BP,
15358,GO:0061551,1,0.971841805655901,0,4,trigeminal ganglion development,BP,
15359,GO:0061552,1,0.994463161779309,0,1,ganglion morphogenesis,BP,
15361,GO:0061565,1,0.994313214468247,0,1,dAMP phosphorylation,BP,
15362,GO:0061566,1,0.994313214468247,0,1,CMP phosphorylation,BP,
15363,GO:0061567,1,0.994313214468247,0,1,dCMP phosphorylation,BP,
15364,GO:0061568,1,0.994313214468247,0,1,GDP phosphorylation,BP,
15365,GO:0061569,1,0.994313214468247,0,1,UDP phosphorylation,BP,
15366,GO:0061570,1,0.994313214468247,0,1,dCDP phosphorylation,BP,
15367,GO:0061571,1,0.994313214468247,0,1,TDP phosphorylation,BP,
15368,GO:0061572,1,0.386207105789766,0,139,actin filament bundle organization,BP,
15369,GO:0061574,1,0.98182742811132,0,3,ASAP complex,CC,
15370,GO:0061575,1,0.97922231158484,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15371,GO:0061577,1,0.915624911151742,0,11,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15372,GO:0061578,1,0.9282511673132,0,10,Lys63-specific deubiquitinase activity,MF,
15373,GO:0061580,1,0.993229798622165,0,1,colon epithelial cell migration,BP,
15374,GO:0061582,1,0.984279573046416,0,2,intestinal epithelial cell migration,BP,
15375,GO:0061588,1,0.966265636662841,0,5,calcium activated phospholipid scrambling,BP,
15376,GO:0061589,1,0.974708830802998,0,4,calcium activated phosphatidylserine scrambling,BP,
15377,GO:0061590,1,0.966265636662841,0,5,calcium activated phosphatidylcholine scrambling,BP,
15378,GO:0061591,1,0.966265636662841,0,5,calcium activated galactosylceramide scrambling,BP,
15379,GO:0061598,1,0.993089170363745,0,1,molybdopterin adenylyltransferase activity,MF,
15380,GO:0061599,1,0.993089170363745,0,1,molybdopterin molybdotransferase activity,MF,
15381,GO:0061604,1,0.994477249259959,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15382,GO:0061605,1,0.994477249259959,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15383,GO:0061608,1,0.941581208952077,0,9,nuclear import signal receptor activity,MF,
15384,GO:0061609,1,0.994487910328372,0,1,fructose-1-phosphate aldolase activity,MF,
15385,GO:0061611,1,0.994704866976516,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15386,GO:0061614,1,0.765555453468512,0,38,pri-miRNA transcription by RNA polymerase II,BP,
15387,GO:0061615,1,0.861831628164878,0,25,glycolytic process through fructose-6-phosphate,BP,
15388,GO:0061617,1,0.956571725331184,0,8,MICOS complex,CC,
15389,GO:0061618,1,0.985979623711624,0,1,sublamina densa,CC,
15390,GO:0061620,1,0.861831628164878,0,25,glycolytic process through glucose-6-phosphate,BP,
15391,GO:0061621,1,0.866360278589644,0,24,canonical glycolysis,BP,
15392,GO:0061622,1,0.988832926508314,0,2,glycolytic process through glucose-1-phosphate,BP,
15393,GO:0061623,1,0.994780267667171,0,1,glycolytic process from galactose,BP,
15394,GO:0061624,1,0.977782588891809,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15395,GO:0061626,1,0.951237007552934,0,7,pharyngeal arch artery morphogenesis,BP,
15396,GO:0061627,1,0.994646935762422,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15397,GO:0061628,1,0.971988103127416,0,3,H3K27me3 modified histone binding,MF,
15398,GO:0061629,1,0.968502968200499,0,5,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15399,GO:0061630,1,0.2279187910148,0,212,ubiquitin protein ligase activity,MF,
15400,GO:0061631,1,0.84166658021633,0,27,ubiquitin conjugating enzyme activity,MF,
15401,GO:0061635,1,0.956330526077206,0,8,regulation of protein complex stability,BP,
15402,GO:0061640,1,0.585631742344003,0,77,cytoskeleton-dependent cytokinesis,BP,
15403,GO:0061641,1,0.841550403347816,0,30,CENP-A containing chromatin organization,BP,
15404,GO:0061642,1,0.991465911434634,0,1,chemoattraction of axon,BP,
15405,GO:0061643,1,0.97968086910305,0,3,chemorepulsion of axon,BP,
15406,GO:0061645,1,0.950090800788503,0,7,endocytic patch,CC,
15407,GO:0061646,1,0.992403746174346,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15408,GO:0061647,1,0.748334421288906,0,40,histone H3-K9 modification,BP,
15409,GO:0061649,1,0.978527879204404,0,3,ubiquitin modification-dependent histone binding,MF,
15410,GO:0061650,1,0.837282431442253,0,28,ubiquitin-like protein conjugating enzyme activity,MF,
15411,GO:0061656,1,0.994800064853307,0,1,SUMO conjugating enzyme activity,MF,
15412,GO:0061659,1,0.22112161973409,0,217,ubiquitin-like protein ligase activity,MF,
15413,GO:0061663,1,0.989888169827736,0,1,NEDD8 ligase activity,MF,
15414,GO:0061665,1,0.97060857666877,0,5,SUMO ligase activity,MF,
15415,GO:0061668,1,0.961989674552763,0,6,mitochondrial ribosome assembly,BP,
15417,GO:0061670,1,0.994759255262444,0,1,evoked neurotransmitter secretion,BP,
15418,GO:0061673,1,0.967542080979817,0,5,mitotic spindle astral microtubule,CC,
15419,GO:0061676,1,0.961330463143257,0,6,importin-alpha family protein binding,MF,
15420,GO:0061682,1,0.994525614349301,0,1,seminal vesicle morphogenesis,BP,
15421,GO:0061684,1,0.932135493918039,0,12,chaperone-mediated autophagy,BP,
15422,GO:0061685,1,0.994313214468247,0,1,diphthine methylesterase activity,MF,
15423,GO:0061687,1,0.926620342426237,0,13,detoxification of inorganic compound,BP,
15424,GO:0061689,1,0.973064492270388,0,4,tricellular tight junction,CC,
15425,GO:0061690,1,0.99480340398373,0,1,lipoamidase activity,MF,
15426,GO:0061695,1,0.181604427535355,0,251,transferase complex, transferring phosphorus-containing groups,CC,
15427,GO:0061697,1,0.994067456491409,0,1,protein-glutaryllysine deglutarylase activity,MF,
15428,GO:0061698,1,0.994067456491409,0,1,protein deglutarylation,BP,
15429,GO:0061699,1,0.994067456491409,0,1,peptidyl-lysine deglutarylation,BP,
15430,GO:0061700,1,0.949015485836882,0,9,GATOR2 complex,CC,
15431,GO:0061702,1,0.929521628751071,0,12,inflammasome complex,CC,
15432,GO:0061709,1,0.990589051255309,0,1,reticulophagy,BP,
15433,GO:0061711,1,0.989312947317957,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15434,GO:0061712,1,0.993970914998405,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15435,GO:0061713,1,0.994814632277951,0,1,anterior neural tube closure,BP,
15436,GO:0061714,1,0.989649368065142,0,2,folic acid receptor activity,MF,
15437,GO:0061718,1,0.866360278589644,0,24,glucose catabolic process to pyruvate,BP,
15438,GO:0061723,1,0.985119976950922,0,2,glycophagy,BP,
15439,GO:0061724,1,0.952787219006543,0,6,lipophagy,BP,
15440,GO:0061726,1,0.588475035867723,0,80,mitochondrion disassembly,BP,
15441,GO:0061727,1,0.988958031364877,0,2,methylglyoxal catabolic process to lactate,BP,
15442,GO:0061731,1,0.98049805936824,0,3,ribonucleoside-diphosphate reductase activity,MF,
15443,GO:0061732,1,0.965853471490611,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15444,GO:0061733,1,0.693025608497475,0,52,peptide-lysine-N-acetyltransferase activity,MF,
15445,GO:0061734,1,0.957284859253159,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15446,GO:0061736,1,0.991598063899804,0,1,engulfment of target by autophagosome,BP,
15447,GO:0061737,1,0.972812985863309,0,5,leukotriene signaling pathway,BP,
15448,GO:0061738,1,0.983205838834123,0,3,late endosomal microautophagy,BP,
15449,GO:0061739,1,0.975753231300869,0,4,protein lipidation involved in autophagosome assembly,BP,
15450,GO:0061740,1,0.982284082255838,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15451,GO:0061741,1,0.988936569538747,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15452,GO:0061743,1,0.977672427421805,0,4,motor learning,BP,
15453,GO:0061744,1,0.9702173833389,0,5,motor behavior,BP,
15454,GO:0061749,1,0.984407138741486,0,2,forked DNA-dependent helicase activity,MF,
15455,GO:0061750,1,0.994531690310349,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15456,GO:0061752,1,0.988831104703629,0,2,telomeric repeat-containing RNA binding,MF,
15457,GO:0061753,1,0.991598063899804,0,1,substrate localization to autophagosome,BP,
15458,GO:0061756,1,0.843377102317993,0,27,leukocyte adhesion to vascular endothelial cell,BP,
15459,GO:0061757,1,0.98897688714459,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15460,GO:0061760,1,0.989082601600213,0,2,antifungal innate immune response,BP,
15461,GO:0061762,1,0.967263258264548,0,4,CAMKK-AMPK signaling cascade,BP,
15462,GO:0061763,1,0.98873820143349,0,2,multivesicular body-lysosome fusion,BP,
15463,GO:0061767,1,0.991390800656278,0,1,negative regulation of lung blood pressure,BP,
15464,GO:0061768,1,0.992491826570297,0,1,magnesium:sodium antiporter activity,MF,
15465,GO:0061769,1,0.988658446617857,0,2,ribosylnicotinate kinase activity,MF,
15466,GO:0061770,1,0.994594127039949,0,1,translation elongation factor binding,MF,
15467,GO:0061771,1,0.981631511947781,0,3,response to caloric restriction,BP,
15468,GO:0061772,1,0.99386165650684,0,1,drug transport across blood-nerve barrier,BP,
15469,GO:0061778,1,0.888411335926326,0,18,intracellular chloride channel activity,MF,
15470,GO:0061780,1,0.987184818808559,0,1,mitotic cohesin loading,BP,
15471,GO:0061782,1,0.9932585515136,0,1,vesicle fusion with vesicle,BP,
15472,GO:0061783,1,0.979390678137877,0,4,peptidoglycan muralytic activity,MF,
15473,GO:0061789,1,0.967764220639317,0,3,dense core granule priming,BP,
15474,GO:0061792,1,0.978289837118511,0,3,secretory granule maturation,BP,
15475,GO:0061798,1,0.993190308254836,0,1,GTP 3',8'-cyclase activity,MF,
15476,GO:0061799,1,0.993190308254836,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15477,GO:0061809,1,0.98954981728533,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15478,GO:0061811,1,0.994762227386499,0,1,ADP-ribosyl cyclase activity,MF,
15479,GO:0061812,1,0.994762227386499,0,1,cyclic ADP-ribose hydrolase,MF,
15480,GO:0061817,1,0.977543137971814,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
15481,GO:0061819,1,0.979193861084705,0,3,telomeric DNA-containing double minutes formation,BP,
15482,GO:0061820,1,0.949331368442506,0,8,telomeric D-loop disassembly,BP,
15483,GO:0061821,1,0.971412937800218,0,4,telomeric D-loop binding,MF,
15484,GO:0061825,1,0.99341342827093,0,1,podosome core,CC,
15485,GO:0061827,1,0.972512959423686,0,5,sperm head,CC,
15486,GO:0061828,1,0.989603414057109,0,1,apical tubulobulbar complex,CC,
15487,GO:0061829,1,0.989603414057109,0,1,basal tubulobulbar complex,CC,
15488,GO:0061832,1,0.989424270835755,0,1,basal ectoplasmic specialization,CC,
15489,GO:0061833,1,0.98762721486123,0,2,protein localization to tricellular tight junction,BP,
15490,GO:0061842,1,0.820826131028004,0,24,microtubule organizing center localization,BP,
15492,GO:0061845,1,0.99398930141819,0,1,neuron projection branch point,CC,
15493,GO:0061846,1,0.99398930141819,0,1,dendritic spine cytoplasm,CC,
15494,GO:0061847,1,0.994538877298266,0,1,response to cholecystokinin,BP,
15495,GO:0061849,1,0.984407138741486,0,2,telomeric G-quadruplex DNA binding,MF,
15496,GO:0061850,1,0.994825831378211,0,1,growth cone leading edge,CC,
15498,GO:0061853,1,0.992335070383341,0,1,regulation of neuroblast migration,BP,
15499,GO:0061855,1,0.992335070383341,0,1,negative regulation of neuroblast migration,BP,
15500,GO:0061857,1,0.987817145483726,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15501,GO:0061880,1,0.994720985094143,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15502,GO:0061881,1,0.994720985094143,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15503,GO:0061884,1,0.994633983377533,0,1,regulation of mini excitatory postsynaptic potential,BP,
15504,GO:0061885,1,0.994633983377533,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
15505,GO:0061888,1,0.9710869636542,0,4,regulation of astrocyte activation,BP,
15506,GO:0061889,1,0.992058453951408,0,1,negative regulation of astrocyte activation,BP,
15507,GO:0061890,1,0.978862296593725,0,3,positive regulation of astrocyte activation,BP,
15508,GO:0061896,1,0.992668575539803,0,1,all-trans retinol 3,4-desaturase activity,MF,
15509,GO:0061897,1,0.992668575539803,0,1,all-trans retinal 3,4-desaturase activity,MF,
15510,GO:0061898,1,0.992668575539803,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15511,GO:0061899,1,0.992668575539803,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15512,GO:0061900,1,0.800064734048224,0,31,glial cell activation,BP,
15513,GO:0061901,1,0.99465763985542,0,1,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15514,GO:0061903,1,0.99465763985542,0,1,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15515,GO:0061912,1,0.758504694647679,0,40,selective autophagy,BP,
15516,GO:0061919,1,0.0486817140538102,0,457,process utilizing autophagic mechanism,BP,
15517,GO:0061920,1,0.988487043103078,0,1,protein propionyltransferase activity,MF,
15518,GO:0061921,1,0.988487043103078,0,1,peptidyl-lysine propionylation,BP,
15519,GO:0061930,1,0.992184511093937,0,1,regulation of erythrocyte enucleation,BP,
15520,GO:0061931,1,0.992184511093937,0,1,positive regulation of erythrocyte enucleation,BP,
15521,GO:0061944,1,0.993021343968801,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15522,GO:0061945,1,0.98148338766825,0,3,regulation of protein K48-linked ubiquitination,BP,
15523,GO:0061951,1,0.768655090063749,0,39,establishment of protein localization to plasma membrane,BP,
15524,GO:0061953,1,0.983099359241731,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15526,GO:0061980,1,0.818142708995182,0,30,regulatory RNA binding,MF,
15527,GO:0061981,1,0.994761655063573,0,1,3-hydroxykynureninase activity,MF,
15528,GO:0061982,1,0.533197650177702,0,98,meiosis I cell cycle process,BP,
15529,GO:0061983,1,0.95482072428167,0,8,meiosis II cell cycle process,BP,
15530,GO:0061986,1,0.994495333696586,0,1,negative regulation of transcription by glucose,BP,
15531,GO:0061987,1,0.994495333696586,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15532,GO:0062009,1,0.92903684449419,0,10,secondary palate development,BP,
15536,GO:0065001,1,0.972321672510944,0,4,specification of axis polarity,BP,
15537,GO:0065002,1,0.749916508654376,0,49,intracellular protein transmembrane transport,BP,
15539,GO:0065004,1,0.300883536572291,0,192,protein-DNA complex assembly,BP,
15540,GO:0065005,1,0.848745571011071,0,24,protein-lipid complex assembly,BP,
15541,GO:0065006,1,0.989627736475638,0,2,protein-carbohydrate complex assembly,BP,
15545,GO:0065010,1,0.972804822349636,0,5,extracellular membrane-bounded organelle,CC,
15546,GO:0070001,1,0.898562252003396,0,18,aspartic-type peptidase activity,MF,
15547,GO:0070003,1,0.910273711494247,0,18,threonine-type peptidase activity,MF,
15548,GO:0070004,1,0.994313214468247,0,1,cysteine-type exopeptidase activity,MF,
15549,GO:0070006,1,0.883667940068165,0,19,metalloaminopeptidase activity,MF,
15552,GO:0070012,1,0.988801607247867,0,2,oligopeptidase activity,MF,
15554,GO:0070016,1,0.932492230834293,0,10,armadillo repeat domain binding,MF,
15555,GO:0070022,1,0.970760241578471,0,4,transforming growth factor beta receptor complex,CC,
15556,GO:0070025,1,0.994406694608454,0,1,carbon monoxide binding,MF,
15557,GO:0070026,1,0.98925651634953,0,2,nitric oxide binding,MF,
15560,GO:0070034,1,0.85093500906583,0,22,telomerase RNA binding,MF,
15561,GO:0070035,1,0.548598519333501,0,91,purine NTP-dependent helicase activity,MF,
15562,GO:0070037,1,0.994814305474927,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15563,GO:0070039,1,0.992185559584738,0,1,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15564,GO:0070042,1,0.994148542159544,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15565,GO:0070044,1,0.977545772146894,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15566,GO:0070050,1,0.945301437441636,0,10,neuron cellular homeostasis,BP,
15567,GO:0070051,1,0.979955246710117,0,3,fibrinogen binding,MF,
15568,GO:0070052,1,0.985603622359023,0,2,collagen V binding,MF,
15569,GO:0070053,1,0.981155194451211,0,3,thrombospondin receptor activity,MF,
15570,GO:0070054,1,0.982046460552819,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15571,GO:0070055,1,0.982046460552819,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15572,GO:0070059,1,0.712895749586185,0,54,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
15573,GO:0070060,1,0.988152305735489,0,1,'de novo' actin filament nucleation,BP,
15574,GO:0070061,1,0.972158722038428,0,5,fructose binding,MF,
15576,GO:0070063,1,0.696004977342934,0,54,RNA polymerase binding,MF,
15577,GO:0070064,1,0.872583906384141,0,18,proline-rich region binding,MF,
15578,GO:0070069,1,0.87001900854626,0,25,cytochrome complex,CC,
15579,GO:0070070,1,0.923331509969625,0,10,proton-transporting V-type ATPase complex assembly,BP,
15580,GO:0070071,1,0.902625117173865,0,14,proton-transporting two-sector ATPase complex assembly,BP,
15581,GO:0070072,1,0.923331509969625,0,10,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15582,GO:0070075,1,0.994837004944945,0,1,tear secretion,BP,
15583,GO:0070076,1,0.818032852864412,0,25,histone lysine demethylation,BP,
15584,GO:0070077,1,0.993689247411896,0,1,histone arginine demethylation,BP,
15585,GO:0070078,1,0.993689247411896,0,1,histone H3-R2 demethylation,BP,
15586,GO:0070079,1,0.993689247411896,0,1,histone H4-R3 demethylation,BP,
15587,GO:0070080,1,0.987672720756983,0,2,titin Z domain binding,MF,
15588,GO:0070081,1,0.971165942035584,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15589,GO:0070083,1,0.971165942035584,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15591,GO:0070086,1,0.97475574528546,0,4,ubiquitin-dependent endocytosis,BP,
15592,GO:0070087,1,0.948951863595628,0,6,chromo shadow domain binding,MF,
15593,GO:0070091,1,0.959058235984781,0,7,glucagon secretion,BP,
15594,GO:0070092,1,0.964071242646503,0,6,regulation of glucagon secretion,BP,
15595,GO:0070093,1,0.983561318823036,0,3,negative regulation of glucagon secretion,BP,
15596,GO:0070094,1,0.99441572747786,0,1,positive regulation of glucagon secretion,BP,
15597,GO:0070095,1,0.983433441896361,0,3,fructose-6-phosphate binding,MF,
15598,GO:0070096,1,0.993889919208563,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15601,GO:0070099,1,0.950905591525315,0,7,regulation of chemokine-mediated signaling pathway,BP,
15602,GO:0070100,1,0.967485656399608,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
15603,GO:0070101,1,0.982868341696168,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15605,GO:0070103,1,0.98393401663923,0,3,regulation of interleukin-6-mediated signaling pathway,BP,
15606,GO:0070104,1,0.994720555227156,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15607,GO:0070105,1,0.989156783877631,0,2,positive regulation of interleukin-6-mediated signaling pathway,BP,
15608,GO:0070106,1,0.930522109324247,0,11,interleukin-27-mediated signaling pathway,BP,
15609,GO:0070110,1,0.982009752233141,0,3,ciliary neurotrophic factor receptor complex,CC,
15610,GO:0070119,1,0.993219706455683,0,1,ciliary neurotrophic factor binding,MF,
15611,GO:0070120,1,0.964230064254162,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15612,GO:0070121,1,0.99176582790506,0,1,Kupffer's vesicle development,BP,
15613,GO:0070122,1,0.969426397199129,0,5,isopeptidase activity,MF,
15614,GO:0070123,1,0.990849426493903,0,1,transforming growth factor beta receptor activity, type III,MF,
15615,GO:0070124,1,0.989171793449176,0,2,mitochondrial translational initiation,BP,
15616,GO:0070125,1,0.633962731659348,0,84,mitochondrial translational elongation,BP,
15617,GO:0070126,1,0.626755280732941,0,86,mitochondrial translational termination,BP,
15618,GO:0070127,1,0.953310430865785,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
15619,GO:0070129,1,0.900615730493978,0,18,regulation of mitochondrial translation,BP,
15620,GO:0070130,1,0.994313214468247,0,1,negative regulation of mitochondrial translation,BP,
15621,GO:0070131,1,0.939580496100571,0,11,positive regulation of mitochondrial translation,BP,
15622,GO:0070137,1,0.968608030926306,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
15623,GO:0070138,1,0.98020904049334,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15624,GO:0070139,1,0.968608030926306,0,4,SUMO-specific endopeptidase activity,MF,
15625,GO:0070140,1,0.98020904049334,0,3,SUMO-specific isopeptidase activity,MF,
15626,GO:0070141,1,0.962973343156438,0,6,response to UV-A,BP,
15627,GO:0070142,1,0.964936487615097,0,5,synaptic vesicle budding,BP,
15628,GO:0070143,1,0.992554753727519,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15629,GO:0070145,1,0.99390829171135,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15630,GO:0070150,1,0.98909447747533,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
15631,GO:0070159,1,0.994507754176953,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15632,GO:0070160,1,0.445066868104398,0,112,occluding junction,CC,
15634,GO:0070162,1,0.960352569549181,0,6,adiponectin secretion,BP,
15635,GO:0070163,1,0.960352569549181,0,6,regulation of adiponectin secretion,BP,
15636,GO:0070164,1,0.972016436640939,0,4,negative regulation of adiponectin secretion,BP,
15637,GO:0070165,1,0.988003724490823,0,2,positive regulation of adiponectin secretion,BP,
15638,GO:0070166,1,0.933689754776179,0,9,enamel mineralization,BP,
15640,GO:0070168,1,0.922323293784262,0,13,negative regulation of biomineral tissue development,BP,
15642,GO:0070170,1,0.974297093239389,0,4,regulation of tooth mineralization,BP,
15643,GO:0070171,1,0.985426256735511,0,2,negative regulation of tooth mineralization,BP,
15644,GO:0070172,1,0.988707892919565,0,2,positive regulation of tooth mineralization,BP,
15645,GO:0070176,1,0.994698955265191,0,1,DRM complex,CC,
15646,GO:0070178,1,0.989235682872542,0,2,D-serine metabolic process,BP,
15647,GO:0070179,1,0.994465458292206,0,1,D-serine biosynthetic process,BP,
15648,GO:0070180,1,0.994838304492942,0,1,large ribosomal subunit rRNA binding,MF,
15649,GO:0070181,1,0.955665539649624,0,8,small ribosomal subunit rRNA binding,MF,
15650,GO:0070182,1,0.902540387442227,0,16,DNA polymerase binding,MF,
15651,GO:0070183,1,0.994287156167378,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15652,GO:0070184,1,0.994594127039949,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15653,GO:0070187,1,0.96607147058128,0,6,shelterin complex,CC,
15654,GO:0070189,1,0.960981903093253,0,7,kynurenine metabolic process,BP,
15655,GO:0070191,1,0.989005828125695,0,2,methionine-R-sulfoxide reductase activity,MF,
15656,GO:0070192,1,0.695499413727913,0,55,chromosome organization involved in meiotic cell cycle,BP,
15657,GO:0070193,1,0.885450937285165,0,19,synaptonemal complex organization,BP,
15658,GO:0070194,1,0.988939425588738,0,2,synaptonemal complex disassembly,BP,
15659,GO:0070195,1,0.992994653896458,0,1,growth hormone receptor complex,CC,
15660,GO:0070197,1,0.96960953826279,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15661,GO:0070198,1,0.827836564884582,0,27,protein localization to chromosome, telomeric region,BP,
15662,GO:0070199,1,0.865288580703366,0,23,establishment of protein localization to chromosome,BP,
15663,GO:0070200,1,0.910132971367747,0,15,establishment of protein localization to telomere,BP,
15665,GO:0070202,1,0.940593774966867,0,11,regulation of establishment of protein localization to chromosome,BP,
15666,GO:0070203,1,0.945976322355981,0,10,regulation of establishment of protein localization to telomere,BP,
15668,GO:0070207,1,0.833133307352531,0,28,protein homotrimerization,BP,
15670,GO:0070209,1,0.993921767359053,0,1,ASTRA complex,CC,
15671,GO:0070212,1,0.969671142297321,0,4,protein poly-ADP-ribosylation,BP,
15672,GO:0070213,1,0.967281196034329,0,4,protein auto-ADP-ribosylation,BP,
15673,GO:0070221,1,0.979028685769929,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15676,GO:0070229,1,0.842339188084487,0,27,negative regulation of lymphocyte apoptotic process,BP,
15677,GO:0070230,1,0.920400044617289,0,14,positive regulation of lymphocyte apoptotic process,BP,
15680,GO:0070233,1,0.897302017384879,0,17,negative regulation of T cell apoptotic process,BP,
15681,GO:0070234,1,0.944435337426315,0,10,positive regulation of T cell apoptotic process,BP,
15682,GO:0070235,1,0.969777469355812,0,5,regulation of activation-induced cell death of T cells,BP,
15683,GO:0070236,1,0.9749787606391,0,4,negative regulation of activation-induced cell death of T cells,BP,
15684,GO:0070238,1,0.994727313045411,0,1,activated T cell autonomous cell death,BP,
15685,GO:0070239,1,0.994727313045411,0,1,regulation of activated T cell autonomous cell death,BP,
15686,GO:0070241,1,0.994727313045411,0,1,positive regulation of activated T cell autonomous cell death,BP,
15687,GO:0070242,1,0.895024404890984,0,17,thymocyte apoptotic process,BP,
15688,GO:0070243,1,0.9268459005562,0,12,regulation of thymocyte apoptotic process,BP,
15689,GO:0070244,1,0.955779179543448,0,7,negative regulation of thymocyte apoptotic process,BP,
15690,GO:0070245,1,0.969741555047737,0,5,positive regulation of thymocyte apoptotic process,BP,
15691,GO:0070246,1,0.994789061113326,0,1,natural killer cell apoptotic process,BP,
15692,GO:0070247,1,0.994789061113326,0,1,regulation of natural killer cell apoptotic process,BP,
15693,GO:0070251,1,0.994536095807949,0,1,pristanate-CoA ligase activity,MF,
15695,GO:0070253,1,0.978724998797969,0,4,somatostatin secretion,BP,
15696,GO:0070254,1,0.94252369146379,0,10,mucus secretion,BP,
15697,GO:0070255,1,0.947421630075651,0,9,regulation of mucus secretion,BP,
15698,GO:0070256,1,0.98905752656264,0,2,negative regulation of mucus secretion,BP,
15699,GO:0070257,1,0.963337927864572,0,6,positive regulation of mucus secretion,BP,
15700,GO:0070259,1,0.98801895248565,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15701,GO:0070260,1,0.994313214468247,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15702,GO:0070262,1,0.908272667098489,0,16,peptidyl-serine dephosphorylation,BP,
15703,GO:0070265,1,0.751308106445027,0,48,necrotic cell death,BP,
15704,GO:0070266,1,0.802965391434361,0,36,necroptotic process,BP,
15705,GO:0070267,1,0.993719465850929,0,1,oncosis,BP,
15706,GO:0070268,1,0.69324548599404,0,59,cornification,BP,
15707,GO:0070269,1,0.950426259351317,0,9,pyroptosis,BP,
15708,GO:0070273,1,0.863104865780702,0,22,phosphatidylinositol-4-phosphate binding,MF,
15709,GO:0070274,1,0.98942526226963,0,2,RES complex,CC,
15710,GO:0070278,1,0.972018482408357,0,5,extracellular matrix constituent secretion,BP,
15711,GO:0070279,1,0.764408908289859,0,45,vitamin B6 binding,MF,
15712,GO:0070280,1,0.993507489775592,0,1,pyridoxal binding,MF,
15713,GO:0070283,1,0.994726586318505,0,1,radical SAM enzyme activity,MF,
15714,GO:0070286,1,0.791876829049732,0,30,axonemal dynein complex assembly,BP,
15715,GO:0070287,1,0.993683167506713,0,1,ferritin receptor activity,MF,
15716,GO:0070288,1,0.989650724859325,0,2,ferritin complex,CC,
15717,GO:0070290,1,0.967322092820993,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15718,GO:0070291,1,0.98115763591065,0,3,N-acylethanolamine metabolic process,BP,
15719,GO:0070292,1,0.986284822189124,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15720,GO:0070293,1,0.915261819924143,0,15,renal absorption,BP,
15721,GO:0070294,1,0.972947609853426,0,4,renal sodium ion absorption,BP,
15722,GO:0070295,1,0.983338062970279,0,3,renal water absorption,BP,
15723,GO:0070296,1,0.77740392500514,0,31,sarcoplasmic reticulum calcium ion transport,BP,
15724,GO:0070300,1,0.880997855724616,0,18,phosphatidic acid binding,MF,
15726,GO:0070302,1,0.269178535884189,0,194,regulation of stress-activated protein kinase signaling cascade,BP,
15727,GO:0070303,1,0.774844075213539,0,39,negative regulation of stress-activated protein kinase signaling cascade,BP,
15728,GO:0070304,1,0.397134787743897,0,137,positive regulation of stress-activated protein kinase signaling cascade,BP,
15729,GO:0070305,1,0.954389079136423,0,6,response to cGMP,BP,
15732,GO:0070309,1,0.975346164234809,0,4,lens fiber cell morphogenesis,BP,
15733,GO:0070314,1,0.960992318970896,0,6,G1 to G0 transition,BP,
15734,GO:0070315,1,0.988082222297431,0,2,G1 to G0 transition involved in cell differentiation,BP,
15735,GO:0070316,1,0.754279569876145,0,40,regulation of G0 to G1 transition,BP,
15736,GO:0070317,1,0.775279808153125,0,36,negative regulation of G0 to G1 transition,BP,
15737,GO:0070318,1,0.97298059611547,0,4,positive regulation of G0 to G1 transition,BP,
15738,GO:0070320,1,0.994370607996823,0,1,inward rectifier potassium channel inhibitor activity,MF,
15739,GO:0070324,1,0.957527941323014,0,7,thyroid hormone binding,MF,
15740,GO:0070325,1,0.844159593244435,0,21,lipoprotein particle receptor binding,MF,
15741,GO:0070326,1,0.969389787377642,0,4,very-low-density lipoprotein particle receptor binding,MF,
15742,GO:0070327,1,0.958127668777996,0,7,thyroid hormone transport,BP,
15743,GO:0070328,1,0.856342094273441,0,25,triglyceride homeostasis,BP,
15744,GO:0070329,1,0.988994073781482,0,2,tRNA seleno-modification,BP,
15745,GO:0070330,1,0.911192528658569,0,16,aromatase activity,MF,
15746,GO:0070335,1,0.990113728742642,0,1,aspartate binding,MF,
15747,GO:0070336,1,0.985892051849756,0,2,flap-structured DNA binding,MF,
15748,GO:0070337,1,0.991531154941563,0,1,3'-flap-structured DNA binding,MF,
15749,GO:0070339,1,0.964179099448591,0,6,response to bacterial lipopeptide,BP,
15750,GO:0070340,1,0.979707859527473,0,3,detection of bacterial lipopeptide,BP,
15754,GO:0070345,1,0.966397877970091,0,5,negative regulation of fat cell proliferation,BP,
15758,GO:0070358,1,0.9594509200494,0,6,actin polymerization-dependent cell motility,BP,
15760,GO:0070366,1,0.989466500415233,0,2,regulation of hepatocyte differentiation,BP,
15761,GO:0070367,1,0.9946342909417,0,1,negative regulation of hepatocyte differentiation,BP,
15762,GO:0070368,1,0.994804610227398,0,1,positive regulation of hepatocyte differentiation,BP,
15763,GO:0070369,1,0.976318376028906,0,3,beta-catenin-TCF7L2 complex,CC,
15764,GO:0070370,1,0.973371198385459,0,5,cellular heat acclimation,BP,
15769,GO:0070375,1,0.980731982906899,0,3,ERK5 cascade,BP,
15770,GO:0070376,1,0.994240379830034,0,1,regulation of ERK5 cascade,BP,
15771,GO:0070377,1,0.994240379830034,0,1,negative regulation of ERK5 cascade,BP,
15772,GO:0070381,1,0.987444297910057,0,2,endosome to plasma membrane transport vesicle,CC,
15774,GO:0070383,1,0.956872982327541,0,8,DNA cytosine deamination,BP,
15775,GO:0070384,1,0.976533498280291,0,4,Harderian gland development,BP,
15776,GO:0070390,1,0.994718608345621,0,1,transcription export complex 2,CC,
15777,GO:0070391,1,0.937634536921743,0,11,response to lipoteichoic acid,BP,
15778,GO:0070392,1,0.99481422338587,0,1,detection of lipoteichoic acid,BP,
15779,GO:0070401,1,0.989325560988533,0,2,NADP+ binding,MF,
15780,GO:0070402,1,0.922246617328833,0,13,NADPH binding,MF,
15781,GO:0070403,1,0.92404218728573,0,14,NAD+ binding,MF,
15782,GO:0070404,1,0.984176112779636,0,3,NADH binding,MF,
15783,GO:0070405,1,0.700221702897045,0,59,ammonium ion binding,MF,
15784,GO:0070407,1,0.994087646390302,0,1,oxidation-dependent protein catabolic process,BP,
15785,GO:0070408,1,0.991553273734652,0,1,carbamoyl phosphate metabolic process,BP,
15786,GO:0070409,1,0.991553273734652,0,1,carbamoyl phosphate biosynthetic process,BP,
15787,GO:0070410,1,0.901163736061078,0,12,co-SMAD binding,MF,
15788,GO:0070411,1,0.919111575144938,0,11,I-SMAD binding,MF,
15789,GO:0070412,1,0.836438337099575,0,23,R-SMAD binding,MF,
15790,GO:0070413,1,0.994201329838088,0,1,trehalose metabolism in response to stress,BP,
15791,GO:0070417,1,0.950981730957032,0,7,cellular response to cold,BP,
15792,GO:0070418,1,0.992163533726013,0,1,DNA-dependent protein kinase complex,CC,
15793,GO:0070419,1,0.949890354899631,0,7,nonhomologous end joining complex,CC,
15794,GO:0070423,1,0.801171459822167,0,34,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15795,GO:0070424,1,0.944877898889635,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15796,GO:0070425,1,0.987135787058469,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15797,GO:0070426,1,0.980726609461581,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15798,GO:0070427,1,0.974005338363029,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15799,GO:0070428,1,0.984651531801209,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15800,GO:0070429,1,0.99292707905012,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15801,GO:0070430,1,0.991666092039416,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15802,GO:0070431,1,0.935159085928893,0,11,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15803,GO:0070432,1,0.968107893701869,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15804,GO:0070433,1,0.987135787058469,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15805,GO:0070434,1,0.980726609461581,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15806,GO:0070435,1,0.988392089833229,0,2,Shc-EGFR complex,CC,
15807,GO:0070436,1,0.987041503229421,0,2,Grb2-EGFR complex,CC,
15808,GO:0070442,1,0.994777752886812,0,1,integrin alphaIIb-beta3 complex,CC,
15809,GO:0070444,1,0.938041268943623,0,8,oligodendrocyte progenitor proliferation,BP,
15810,GO:0070445,1,0.938041268943623,0,8,regulation of oligodendrocyte progenitor proliferation,BP,
15811,GO:0070446,1,0.994660463963978,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15812,GO:0070447,1,0.971249857190923,0,3,positive regulation of oligodendrocyte progenitor proliferation,BP,
15813,GO:0070458,1,0.982945405465888,0,3,cellular detoxification of nitrogen compound,BP,
15815,GO:0070460,1,0.993467149498226,0,1,thyroid-stimulating hormone secretion,BP,
15816,GO:0070461,1,0.856268568606425,0,23,SAGA-type complex,CC,
15817,GO:0070462,1,0.993659605855793,0,1,plus-end specific microtubule depolymerization,BP,
15818,GO:0070463,1,0.993814865764142,0,1,tubulin-dependent ATPase activity,MF,
15819,GO:0070469,1,0.642357407283268,0,81,respiratory chain,CC,
15820,GO:0070470,1,0.978186554922451,0,4,plasma membrane respiratory chain,CC,
15821,GO:0070471,1,0.95300162317434,0,8,uterine smooth muscle contraction,BP,
15822,GO:0070472,1,0.958353217041334,0,7,regulation of uterine smooth muscle contraction,BP,
15823,GO:0070473,1,0.994659055545952,0,1,negative regulation of uterine smooth muscle contraction,BP,
15824,GO:0070474,1,0.963501133258801,0,6,positive regulation of uterine smooth muscle contraction,BP,
15825,GO:0070475,1,0.961919527137262,0,7,rRNA base methylation,BP,
15826,GO:0070476,1,0.994838304492942,0,1,rRNA (guanine-N7)-methylation,BP,
15827,GO:0070478,1,0.993162243439821,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15828,GO:0070481,1,0.994227744643279,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15830,GO:0070483,1,0.99404256551509,0,1,detection of hypoxia,BP,
15831,GO:0070486,1,0.925622169930115,0,12,leukocyte aggregation,BP,
15832,GO:0070487,1,0.966870611524114,0,5,monocyte aggregation,BP,
15833,GO:0070488,1,0.989706193824622,0,2,neutrophil aggregation,BP,
15834,GO:0070489,1,0.98806516522597,0,2,T cell aggregation,BP,
15835,GO:0070491,1,0.664219525726949,0,62,repressing transcription factor binding,MF,
15836,GO:0070492,1,0.94459226762159,0,10,oligosaccharide binding,MF,
15837,GO:0070493,1,0.925296075784427,0,12,thrombin-activated receptor signaling pathway,BP,
15838,GO:0070494,1,0.979533774713985,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15839,GO:0070495,1,0.979533774713985,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15840,GO:0070498,1,0.562100866484436,0,96,interleukin-1-mediated signaling pathway,BP,
15841,GO:0070506,1,0.988772002051958,0,2,high-density lipoprotein particle receptor activity,MF,
15842,GO:0070507,1,0.307163492644186,0,163,regulation of microtubule cytoskeleton organization,BP,
15843,GO:0070508,1,0.960212471559498,0,7,cholesterol import,BP,
15845,GO:0070510,1,0.990130473199481,0,1,regulation of histone H4-K20 methylation,BP,
15846,GO:0070512,1,0.990130473199481,0,1,positive regulation of histone H4-K20 methylation,BP,
15847,GO:0070513,1,0.944797848286707,0,10,death domain binding,MF,
15848,GO:0070522,1,0.973624227767469,0,4,ERCC4-ERCC1 complex,CC,
15849,GO:0070524,1,0.994773487962236,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15850,GO:0070525,1,0.928959012241303,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
15852,GO:0070528,1,0.841774351696799,0,27,protein kinase C signaling,BP,
15853,GO:0070530,1,0.892653922592567,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15854,GO:0070531,1,0.967909824581776,0,5,BRCA1-A complex,CC,
15855,GO:0070534,1,0.756194457984648,0,42,protein K63-linked ubiquitination,BP,
15856,GO:0070535,1,0.960119530110598,0,5,histone H2A K63-linked ubiquitination,BP,
15857,GO:0070536,1,0.843152449879958,0,24,protein K63-linked deubiquitination,BP,
15858,GO:0070537,1,0.982930352263057,0,3,histone H2A K63-linked deubiquitination,BP,
15859,GO:0070538,1,0.989609153878323,0,2,oleic acid binding,MF,
15860,GO:0070539,1,0.993780645804037,0,1,linoleic acid binding,MF,
15861,GO:0070541,1,0.978946013011411,0,3,response to platinum ion,BP,
15862,GO:0070542,1,0.613034666135382,0,75,response to fatty acid,BP,
15863,GO:0070543,1,0.994623025626187,0,1,response to linoleic acid,BP,
15864,GO:0070544,1,0.941196777895618,0,8,histone H3-K36 demethylation,BP,
15865,GO:0070545,1,0.981944654432064,0,3,PeBoW complex,CC,
15866,GO:0070547,1,0.994319526247071,0,1,L-tyrosine aminotransferase activity,MF,
15867,GO:0070548,1,0.982836181793336,0,2,L-glutamine aminotransferase activity,MF,
15868,GO:0070550,1,0.987184818808559,0,1,rDNA condensation,BP,
15869,GO:0070551,1,0.994313214468247,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15870,GO:0070552,1,0.983220740264017,0,3,BRISC complex,CC,
15871,GO:0070553,1,0.994313214468247,0,1,nicotinic acid receptor activity,MF,
15874,GO:0070557,1,0.989390480093731,0,2,PCNA-p21 complex,CC,
15875,GO:0070560,1,0.98861125856427,0,2,protein secretion by platelet,BP,
15876,GO:0070561,1,0.941034322229724,0,9,vitamin D receptor signaling pathway,BP,
15877,GO:0070562,1,0.959113523186822,0,6,regulation of vitamin D receptor signaling pathway,BP,
15878,GO:0070563,1,0.986914379527677,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15879,GO:0070564,1,0.989093344326079,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15880,GO:0070566,1,0.83823538700048,0,27,adenylyltransferase activity,MF,
15881,GO:0070567,1,0.945460557466993,0,9,cytidylyltransferase activity,MF,
15882,GO:0070568,1,0.969872644264712,0,5,guanylyltransferase activity,MF,
15883,GO:0070569,1,0.956026764754231,0,7,uridylyltransferase activity,MF,
15886,GO:0070572,1,0.95629998133816,0,8,positive regulation of neuron projection regeneration,BP,
15887,GO:0070573,1,0.983036473872153,0,3,metallodipeptidase activity,MF,
15888,GO:0070574,1,0.975529166684688,0,4,cadmium ion transmembrane transport,BP,
15889,GO:0070576,1,0.988487141510141,0,2,vitamin D 24-hydroxylase activity,MF,
15890,GO:0070577,1,0.868579841207441,0,17,lysine-acetylated histone binding,MF,
15891,GO:0070578,1,0.942707071907731,0,9,RISC-loading complex,CC,
15892,GO:0070579,1,0.957085632295098,0,4,methylcytosine dioxygenase activity,MF,
15893,GO:0070584,1,0.87705417780323,0,21,mitochondrion morphogenesis,BP,
15894,GO:0070585,1,0.339303163875173,0,177,protein localization to mitochondrion,BP,
15895,GO:0070586,1,0.951322094694568,0,9,cell-cell adhesion involved in gastrulation,BP,
15896,GO:0070587,1,0.95672600707755,0,8,regulation of cell-cell adhesion involved in gastrulation,BP,
15898,GO:0070589,1,0.994704866976516,0,1,cellular component macromolecule biosynthetic process,BP,
15899,GO:0070593,1,0.982521534038881,0,2,dendrite self-avoidance,BP,
15900,GO:0070601,1,0.941513199481176,0,10,centromeric sister chromatid cohesion,BP,
15901,GO:0070602,1,0.975563912208194,0,4,regulation of centromeric sister chromatid cohesion,BP,
15902,GO:0070603,1,0.589441579788281,0,73,SWI/SNF superfamily-type complex,CC,
15903,GO:0070611,1,0.994388763401318,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15904,GO:0070612,1,0.994388763401318,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15906,GO:0070615,1,0.993265720571909,0,1,nucleosome-dependent ATPase activity,MF,
15907,GO:0070618,1,0.994361754463475,0,1,Grb2-Sos complex,CC,
15908,GO:0070625,1,0.994620146783351,0,1,zymogen granule exocytosis,BP,
15909,GO:0070626,1,0.994762715811139,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15910,GO:0070627,1,0.993181610100549,0,1,ferrous iron import,BP,
15911,GO:0070628,1,0.871312671477191,0,21,proteasome binding,MF,
15912,GO:0070631,1,0.994313214468247,0,1,spindle pole body localization,BP,
15913,GO:0070632,1,0.994313214468247,0,1,establishment of spindle pole body localization,BP,
15914,GO:0070633,1,0.900962609975335,0,15,transepithelial transport,BP,
15915,GO:0070634,1,0.985095988324617,0,2,transepithelial ammonium transport,BP,
15916,GO:0070637,1,0.99449489995418,0,1,pyridine nucleoside metabolic process,BP,
15917,GO:0070638,1,0.99449489995418,0,1,pyridine nucleoside catabolic process,BP,
15918,GO:0070640,1,0.980987979892236,0,3,vitamin D3 metabolic process,BP,
15919,GO:0070643,1,0.994738533349941,0,1,vitamin D 25-hydroxylase activity,MF,
15920,GO:0070644,1,0.977680970598984,0,3,vitamin D response element binding,MF,
15921,GO:0070646,1,0.162457991690357,0,264,protein modification by small protein removal,BP,
15923,GO:0070649,1,0.976921569397835,0,3,formin-nucleated actin cable assembly,BP,
15924,GO:0070651,1,0.994227744643279,0,1,nonfunctional rRNA decay,BP,
15925,GO:0070652,1,0.949271665385292,0,8,HAUS complex,CC,
15926,GO:0070653,1,0.99482518139384,0,1,high-density lipoprotein particle receptor binding,MF,
15928,GO:0070662,1,0.978370365126956,0,3,mast cell proliferation,BP,
15930,GO:0070664,1,0.650546661375505,0,68,negative regulation of leukocyte proliferation,BP,
15932,GO:0070666,1,0.986108360526853,0,2,regulation of mast cell proliferation,BP,
15933,GO:0070667,1,0.99412890538322,0,1,negative regulation of mast cell proliferation,BP,
15934,GO:0070668,1,0.986108360526853,0,2,positive regulation of mast cell proliferation,BP,
15935,GO:0070669,1,0.917716611826596,0,13,response to interleukin-2,BP,
15936,GO:0070670,1,0.830067176043211,0,30,response to interleukin-4,BP,
15938,GO:0070672,1,0.908067572214064,0,14,response to interleukin-15,BP,
15939,GO:0070673,1,0.939232613110241,0,11,response to interleukin-18,BP,
15940,GO:0070676,1,0.984125182503911,0,3,intralumenal vesicle formation,BP,
15941,GO:0070678,1,0.994365524060913,0,1,preprotein binding,MF,
15942,GO:0070679,1,0.894926274563361,0,13,inositol 1,4,5 trisphosphate binding,MF,
15943,GO:0070681,1,0.982486913114351,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15944,GO:0070682,1,0.983261354621326,0,3,proteasome regulatory particle assembly,BP,
15945,GO:0070684,1,0.994806757818374,0,1,seminal clot liquefaction,BP,
15946,GO:0070685,1,0.994610202313159,0,1,macropinocytic cup,CC,
15947,GO:0070694,1,0.994313214468247,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15948,GO:0070695,1,0.958289388392076,0,5,FHF complex,CC,
15949,GO:0070696,1,0.892306858921303,0,18,transmembrane receptor protein serine/threonine kinase binding,MF,
15950,GO:0070697,1,0.963846946802617,0,6,activin receptor binding,MF,
15951,GO:0070698,1,0.988903262287042,0,2,type I activin receptor binding,MF,
15952,GO:0070699,1,0.98500979105509,0,2,type II activin receptor binding,MF,
15953,GO:0070700,1,0.925802807715161,0,12,BMP receptor binding,MF,
15954,GO:0070704,1,0.987291019116353,0,2,sterol desaturase activity,MF,
15955,GO:0070715,1,0.993970144807525,0,1,sodium-dependent organic cation transport,BP,
15956,GO:0070717,1,0.853236448260965,0,23,poly-purine tract binding,MF,
15957,GO:0070722,1,0.99379572595106,0,1,Tle3-Aes complex,CC,
15958,GO:0070723,1,0.853821633362619,0,20,response to cholesterol,BP,
15959,GO:0070724,1,0.994069633134755,0,1,BMP receptor complex,CC,
15961,GO:0070728,1,0.953539556537796,0,7,leucine binding,MF,
15962,GO:0070733,1,0.994732013676537,0,1,protein adenylyltransferase activity,MF,
15963,GO:0070734,1,0.878829290925214,0,19,histone H3-K27 methylation,BP,
15964,GO:0070735,1,0.988484195049334,0,2,protein-glycine ligase activity,MF,
15965,GO:0070736,1,0.99386895871136,0,1,protein-glycine ligase activity, initiating,MF,
15966,GO:0070739,1,0.956933913438271,0,7,protein-glutamic acid ligase activity,MF,
15967,GO:0070740,1,0.956933913438271,0,7,tubulin-glutamic acid ligase activity,MF,
15969,GO:0070742,1,0.906902014957549,0,14,C2H2 zinc finger domain binding,MF,
15970,GO:0070743,1,0.994815117839179,0,1,interleukin-23 complex,CC,
15971,GO:0070757,1,0.930313543784167,0,11,interleukin-35-mediated signaling pathway,BP,
15972,GO:0070761,1,0.969402044033534,0,5,pre-snoRNP complex,CC,
15973,GO:0070762,1,0.994313214468247,0,1,nuclear pore transmembrane ring,CC,
15974,GO:0070765,1,0.961923303481098,0,6,gamma-secretase complex,CC,
15975,GO:0070772,1,0.994098345805747,0,1,PAS complex,CC,
15976,GO:0070773,1,0.994782178411431,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15977,GO:0070774,1,0.992965896436137,0,1,phytoceramidase activity,MF,
15978,GO:0070775,1,0.952965245138172,0,7,H3 histone acetyltransferase complex,CC,
15979,GO:0070776,1,0.952965245138172,0,7,MOZ/MORF histone acetyltransferase complex,CC,
15980,GO:0070777,1,0.966384167321809,0,4,D-aspartate transport,BP,
15981,GO:0070778,1,0.964193406855846,0,6,L-aspartate transmembrane transport,BP,
15982,GO:0070779,1,0.966384167321809,0,4,D-aspartate import across plasma membrane,BP,
15983,GO:0070780,1,0.98878375310951,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
15984,GO:0070781,1,0.986055249686381,0,2,response to biotin,BP,
15985,GO:0070782,1,0.99459516377448,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
15986,GO:0070813,1,0.968718858656088,0,5,hydrogen sulfide metabolic process,BP,
15987,GO:0070814,1,0.973763513991833,0,4,hydrogen sulfide biosynthetic process,BP,
15988,GO:0070815,1,0.9755620905607,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15989,GO:0070816,1,0.908280376904982,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
15990,GO:0070818,1,0.994711406475216,0,1,protoporphyrinogen oxidase activity,MF,
15993,GO:0070822,1,0.898505931091477,0,15,Sin3-type complex,CC,
15994,GO:0070826,1,0.993181610100549,0,1,paraferritin complex,CC,
15995,GO:0070827,1,0.968964667022365,0,4,chromatin maintenance,BP,
15996,GO:0070828,1,0.894654312578699,0,15,heterochromatin organization,BP,
15997,GO:0070829,1,0.982822750973291,0,2,heterochromatin maintenance,BP,
15998,GO:0070830,1,0.720434037739292,0,48,bicellular tight junction assembly,BP,
15999,GO:0070831,1,0.937076659673841,0,8,basement membrane assembly,BP,
16000,GO:0070836,1,0.983104177578222,0,3,caveola assembly,BP,
16001,GO:0070837,1,0.981005006074081,0,3,dehydroascorbic acid transport,BP,
16003,GO:0070839,1,0.987427145126081,0,2,divalent metal ion export,BP,
16004,GO:0070840,1,0.855801402864879,0,20,dynein complex binding,MF,
16005,GO:0070841,1,0.869565237071875,0,20,inclusion body assembly,BP,
16006,GO:0070842,1,0.97501668167094,0,4,aggresome assembly,BP,
16007,GO:0070843,1,0.993229798622165,0,1,misfolded protein transport,BP,
16008,GO:0070844,1,0.993229798622165,0,1,polyubiquitinated protein transport,BP,
16009,GO:0070845,1,0.993229798622165,0,1,polyubiquitinated misfolded protein transport,BP,
16010,GO:0070846,1,0.993229798622165,0,1,Hsp90 deacetylation,BP,
16011,GO:0070847,1,0.953658020659895,0,8,core mediator complex,CC,
16014,GO:0070851,1,0.495304809291988,0,108,growth factor receptor binding,MF,
16015,GO:0070852,1,0.952606156222875,0,6,cell body fiber,CC,
16016,GO:0070853,1,0.979635187045382,0,2,myosin VI binding,MF,
16017,GO:0070856,1,0.991207054622152,0,1,myosin VI light chain binding,MF,
16018,GO:0070857,1,0.954829887719452,0,8,regulation of bile acid biosynthetic process,BP,
16019,GO:0070858,1,0.983131296456742,0,3,negative regulation of bile acid biosynthetic process,BP,
16020,GO:0070859,1,0.983335874539735,0,3,positive regulation of bile acid biosynthetic process,BP,
16021,GO:0070860,1,0.994539273260738,0,1,RNA polymerase I core factor complex,CC,
16022,GO:0070861,1,0.851232650064221,0,23,regulation of protein exit from endoplasmic reticulum,BP,
16023,GO:0070862,1,0.940710487522756,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
16024,GO:0070863,1,0.919521538288288,0,11,positive regulation of protein exit from endoplasmic reticulum,BP,
16025,GO:0070873,1,0.816620615623202,0,26,regulation of glycogen metabolic process,BP,
16026,GO:0070874,1,0.961948356440909,0,5,negative regulation of glycogen metabolic process,BP,
16027,GO:0070875,1,0.890324928442463,0,14,positive regulation of glycogen metabolic process,BP,
16028,GO:0070876,1,0.976005592366143,0,4,SOSS complex,CC,
16029,GO:0070877,1,0.987264234343962,0,2,microprocessor complex,CC,
16030,GO:0070878,1,0.942195681373053,0,8,primary miRNA binding,MF,
16031,GO:0070883,1,0.963794408927745,0,5,pre-miRNA binding,MF,
16032,GO:0070884,1,0.886418520152061,0,16,regulation of calcineurin-NFAT signaling cascade,BP,
16033,GO:0070885,1,0.977254752292586,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
16034,GO:0070886,1,0.937868513173416,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16036,GO:0070888,1,0.816891300732635,0,31,E-box binding,MF,
16037,GO:0070889,1,0.988935190565997,0,2,platelet alpha granule organization,BP,
16038,GO:0070890,1,0.990297826543863,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16039,GO:0070891,1,0.978384088858855,0,4,lipoteichoic acid binding,MF,
16040,GO:0070892,1,0.994623025626187,0,1,lipoteichoic acid receptor activity,MF,
16041,GO:0070893,1,0.986281366255878,0,2,transposon integration,BP,
16042,GO:0070894,1,0.986281366255878,0,2,regulation of transposon integration,BP,
16043,GO:0070895,1,0.986281366255878,0,2,negative regulation of transposon integration,BP,
16044,GO:0070897,1,0.755521285436391,0,42,DNA-templated transcriptional preinitiation complex assembly,BP,
16045,GO:0070898,1,0.986307707522115,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16046,GO:0070899,1,0.99416954787462,0,1,mitochondrial tRNA wobble uridine modification,BP,
16047,GO:0070900,1,0.9498119191713,0,9,mitochondrial tRNA modification,BP,
16048,GO:0070901,1,0.97609005603726,0,4,mitochondrial tRNA methylation,BP,
16049,GO:0070902,1,0.994728345978047,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
16050,GO:0070903,1,0.994654212406271,0,1,mitochondrial tRNA thio-modification,BP,
16051,GO:0070904,1,0.990297826543863,0,1,transepithelial L-ascorbic acid transport,BP,
16052,GO:0070905,1,0.98234419921203,0,3,serine binding,MF,
16053,GO:0070911,1,0.820129153627776,0,32,global genome nucleotide-excision repair,BP,
16054,GO:0070914,1,0.93220944831695,0,11,UV-damage excision repair,BP,
16055,GO:0070915,1,0.972653399775332,0,5,lysophosphatidic acid receptor activity,MF,
16056,GO:0070918,1,0.739673549138274,0,43,production of small RNA involved in gene silencing by RNA,BP,
16057,GO:0070920,1,0.903238041870364,0,15,regulation of production of small RNA involved in gene silencing by RNA,BP,
16058,GO:0070922,1,0.938948776631237,0,9,small RNA loading onto RISC,BP,
16060,GO:0070926,1,0.993470831937917,0,1,regulation of ATP:ADP antiporter activity,BP,
16061,GO:0070931,1,0.991575928249937,0,1,Golgi-associated vesicle lumen,CC,
16062,GO:0070932,1,0.872840277505721,0,20,histone H3 deacetylation,BP,
16063,GO:0070933,1,0.935570798480682,0,9,histone H4 deacetylation,BP,
16064,GO:0070934,1,0.95781884606125,0,5,CRD-mediated mRNA stabilization,BP,
16065,GO:0070935,1,0.908747165338042,0,15,3'-UTR-mediated mRNA stabilization,BP,
16066,GO:0070936,1,0.721208886921689,0,49,protein K48-linked ubiquitination,BP,
16067,GO:0070937,1,0.951324990887755,0,6,CRD-mediated mRNA stability complex,CC,
16068,GO:0070938,1,0.916391760215755,0,11,contractile ring,CC,
16069,GO:0070939,1,0.978501287999206,0,3,Dsl1/NZR complex,CC,
16070,GO:0070940,1,0.969452967886602,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16071,GO:0070942,1,0.957872559538315,0,8,neutrophil mediated cytotoxicity,BP,
16072,GO:0070943,1,0.968629185870847,0,6,neutrophil mediated killing of symbiont cell,BP,
16073,GO:0070944,1,0.973725567477508,0,5,neutrophil mediated killing of bacterium,BP,
16074,GO:0070945,1,0.983886578524816,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16075,GO:0070946,1,0.99482351746091,0,1,neutrophil mediated killing of gram-positive bacterium,BP,
16076,GO:0070947,1,0.989617889035375,0,2,neutrophil mediated killing of fungus,BP,
16077,GO:0070948,1,0.978067164617966,0,4,regulation of neutrophil mediated cytotoxicity,BP,
16078,GO:0070949,1,0.989048263495952,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
16079,GO:0070950,1,0.994250988864267,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16080,GO:0070951,1,0.994250988864267,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16081,GO:0070953,1,0.994767492406765,0,1,regulation of neutrophil mediated killing of fungus,BP,
16082,GO:0070960,1,0.989048263495952,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
16083,GO:0070961,1,0.989048263495952,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16084,GO:0070962,1,0.994250988864267,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16085,GO:0070963,1,0.994250988864267,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16086,GO:0070965,1,0.994767492406765,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
16087,GO:0070966,1,0.97870455927252,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16089,GO:0070971,1,0.880149422281213,0,17,endoplasmic reticulum exit site,CC,
16090,GO:0070972,1,0.47047169560581,0,129,protein localization to endoplasmic reticulum,BP,
16091,GO:0070973,1,0.953958057689283,0,6,protein localization to endoplasmic reticulum exit site,BP,
16092,GO:0070974,1,0.994144090797444,0,1,POU domain binding,MF,
16093,GO:0070975,1,0.98988010377105,0,1,FHA domain binding,MF,
16094,GO:0070976,1,0.994349227291388,0,1,TIR domain binding,MF,
16096,GO:0070979,1,0.855658635348183,0,27,protein K11-linked ubiquitination,BP,
16097,GO:0070981,1,0.994530884755522,0,1,L-asparagine biosynthetic process,BP,
16098,GO:0070982,1,0.994530884755522,0,1,L-asparagine metabolic process,BP,
16099,GO:0070984,1,0.993184510653443,0,1,SET domain binding,MF,
16100,GO:0070985,1,0.989560392914208,0,2,TFIIK complex,CC,
16101,GO:0070986,1,0.906386814387683,0,13,left/right axis specification,BP,
16102,GO:0070987,1,0.894973124640734,0,18,error-free translesion synthesis,BP,
16103,GO:0070988,1,0.647596437916717,0,59,demethylation,BP,
16104,GO:0070989,1,0.914466319422166,0,12,oxidative demethylation,BP,
16105,GO:0070990,1,0.968716405379564,0,6,snRNP binding,MF,
16106,GO:0070991,1,0.982650719085503,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
16107,GO:0070992,1,0.989001749061015,0,2,translation initiation complex,CC,
16108,GO:0070993,1,0.986100578311119,0,2,translation preinitiation complex,CC,
16109,GO:0070995,1,0.980936786972006,0,3,NADPH oxidation,BP,
16110,GO:0070996,1,0.984280563298604,0,3,type 1 melanocortin receptor binding,MF,
16112,GO:0071000,1,0.989209803287784,0,2,response to magnetism,BP,
16113,GO:0071001,1,0.982241162057876,0,3,U4/U6 snRNP,CC,
16114,GO:0071004,1,0.895434148896569,0,17,U2-type prespliceosome,CC,
16115,GO:0071005,1,0.994582529486301,0,1,U2-type precatalytic spliceosome,CC,
16116,GO:0071006,1,0.983098607769834,0,3,U2-type catalytic step 1 spliceosome,CC,
16117,GO:0071007,1,0.839175416917463,0,29,U2-type catalytic step 2 spliceosome,CC,
16118,GO:0071008,1,0.977696988648816,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16119,GO:0071010,1,0.870291563158222,0,22,prespliceosome,CC,
16120,GO:0071011,1,0.822192223670595,0,31,precatalytic spliceosome,CC,
16121,GO:0071012,1,0.965526927434805,0,6,catalytic step 1 spliceosome,CC,
16122,GO:0071013,1,0.538057666502516,0,97,catalytic step 2 spliceosome,CC,
16123,GO:0071014,1,0.949990065959131,0,9,post-mRNA release spliceosomal complex,CC,
16124,GO:0071020,1,0.989454332181509,0,2,post-spliceosomal complex,CC,
16125,GO:0071021,1,0.994719476150972,0,1,U2-type post-spliceosomal complex,CC,
16126,GO:0071025,1,0.915510101336908,0,15,RNA surveillance,BP,
16127,GO:0071026,1,0.994463621833979,0,1,cytoplasmic RNA surveillance,BP,
16128,GO:0071027,1,0.925960144964643,0,13,nuclear RNA surveillance,BP,
16129,GO:0071028,1,0.925960144964643,0,13,nuclear mRNA surveillance,BP,
16130,GO:0071029,1,0.96842730999615,0,6,nuclear ncRNA surveillance,BP,
16131,GO:0071030,1,0.989055513203158,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16132,GO:0071031,1,0.989414189686726,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16133,GO:0071033,1,0.973415006460316,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16134,GO:0071034,1,0.973589422857382,0,4,CUT catabolic process,BP,
16135,GO:0071035,1,0.96842730999615,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16136,GO:0071038,1,0.973974316365805,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16137,GO:0071042,1,0.977264581504997,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16138,GO:0071043,1,0.973589422857382,0,4,CUT metabolic process,BP,
16139,GO:0071044,1,0.911100354495917,0,11,histone mRNA catabolic process,BP,
16140,GO:0071045,1,0.994733018433186,0,1,nuclear histone mRNA catabolic process,BP,
16141,GO:0071046,1,0.96842730999615,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16142,GO:0071047,1,0.977264581504997,0,4,polyadenylation-dependent mRNA catabolic process,BP,
16143,GO:0071048,1,0.989055513203158,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16144,GO:0071049,1,0.989414189686726,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16145,GO:0071051,1,0.974024213483315,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16146,GO:0071062,1,0.980384655976321,0,3,alphav-beta3 integrin-vitronectin complex,CC,
16147,GO:0071065,1,0.988298038031611,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16148,GO:0071071,1,0.925953266394777,0,13,regulation of phospholipid biosynthetic process,BP,
16149,GO:0071072,1,0.975923769882175,0,4,negative regulation of phospholipid biosynthetic process,BP,
16150,GO:0071073,1,0.954030961211508,0,8,positive regulation of phospholipid biosynthetic process,BP,
16151,GO:0071074,1,0.994670120944888,0,1,eukaryotic initiation factor eIF2 binding,MF,
16152,GO:0071077,1,0.98316336736653,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16154,GO:0071104,1,0.973972062942436,0,4,response to interleukin-9,BP,
16155,GO:0071105,1,0.987432764039996,0,2,response to interleukin-11,BP,
16156,GO:0071106,1,0.98316336736653,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16157,GO:0071107,1,0.942356041720103,0,8,response to parathyroid hormone,BP,
16158,GO:0071108,1,0.819619575589784,0,24,protein K48-linked deubiquitination,BP,
16159,GO:0071109,1,0.977695517652069,0,2,superior temporal gyrus development,BP,
16160,GO:0071110,1,0.991278145749113,0,1,histone biotinylation,BP,
16161,GO:0071133,1,0.994068182395454,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16162,GO:0071139,1,0.985431054397498,0,2,resolution of recombination intermediates,BP,
16163,GO:0071140,1,0.985431054397498,0,2,resolution of mitotic recombination intermediates,BP,
16164,GO:0071141,1,0.932882036112636,0,8,SMAD protein complex,CC,
16165,GO:0071144,1,0.978415551569389,0,2,heteromeric SMAD protein complex,CC,
16166,GO:0071148,1,0.979992844824749,0,2,TEAD-1-YAP complex,CC,
16167,GO:0071149,1,0.98667069059774,0,2,TEAD-2-YAP complex,CC,
16168,GO:0071156,1,0.513337763082327,0,107,regulation of cell cycle arrest,BP,
16169,GO:0071157,1,0.877530482409402,0,21,negative regulation of cell cycle arrest,BP,
16170,GO:0071158,1,0.586748216027497,0,84,positive regulation of cell cycle arrest,BP,
16171,GO:0071159,1,0.98927536778299,0,2,NF-kappaB complex,CC,
16172,GO:0071163,1,0.983918332161043,0,3,DNA replication preinitiation complex assembly,BP,
16173,GO:0071164,1,0.993623499440701,0,1,RNA trimethylguanosine synthase activity,MF,
16174,GO:0071166,1,0.44743338669526,0,123,ribonucleoprotein complex localization,BP,
16175,GO:0071168,1,0.877628233107692,0,20,protein localization to chromatin,BP,
16176,GO:0071169,1,0.956213091914183,0,7,establishment of protein localization to chromatin,BP,
16177,GO:0071173,1,0.808741947625953,0,31,spindle assembly checkpoint,BP,
16178,GO:0071174,1,0.808741947625953,0,31,mitotic spindle checkpoint,BP,
16179,GO:0071203,1,0.962943088386562,0,5,WASH complex,CC,
16180,GO:0071204,1,0.962517333476129,0,6,histone pre-mRNA 3'end processing complex,CC,
16181,GO:0071205,1,0.950050532302918,0,5,protein localization to juxtaparanode region of axon,BP,
16182,GO:0071206,1,0.989602913812311,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16183,GO:0071207,1,0.987494166165733,0,2,histone pre-mRNA stem-loop binding,MF,
16184,GO:0071208,1,0.97929332022592,0,4,histone pre-mRNA DCP binding,MF,
16185,GO:0071209,1,0.984116800653401,0,3,U7 snRNA binding,MF,
16186,GO:0071211,1,0.974029525667365,0,4,protein targeting to vacuole involved in autophagy,BP,
16188,GO:0071215,1,0.993003559696667,0,1,cellular response to abscisic acid stimulus,BP,
16190,GO:0071217,1,0.993356305776653,0,1,cellular response to external biotic stimulus,BP,
16191,GO:0071218,1,0.865799561392787,0,21,cellular response to misfolded protein,BP,
16193,GO:0071220,1,0.964179099448591,0,6,cellular response to bacterial lipoprotein,BP,
16194,GO:0071221,1,0.964179099448591,0,6,cellular response to bacterial lipopeptide,BP,
16196,GO:0071223,1,0.937634536921743,0,11,cellular response to lipoteichoic acid,BP,
16197,GO:0071224,1,0.969945717539813,0,5,cellular response to peptidoglycan,BP,
16198,GO:0071225,1,0.967877526188656,0,5,cellular response to muramyl dipeptide,BP,
16199,GO:0071226,1,0.986748201095745,0,2,cellular response to molecule of fungal origin,BP,
16200,GO:0071228,1,0.994810722061292,0,1,cellular response to tumor cell,BP,
16203,GO:0071231,1,0.989649368065142,0,2,cellular response to folic acid,BP,
16204,GO:0071233,1,0.930493295801761,0,9,cellular response to leucine,BP,
16206,GO:0071241,1,0.334273811809097,0,164,cellular response to inorganic substance,BP,
16208,GO:0071243,1,0.912331486719726,0,16,cellular response to arsenic-containing substance,BP,
16209,GO:0071245,1,0.993672281030082,0,1,cellular response to carbon monoxide,BP,
16210,GO:0071247,1,0.994810499878824,0,1,cellular response to chromate,BP,
16211,GO:0071248,1,0.388960607740345,0,142,cellular response to metal ion,BP,
16212,GO:0071250,1,0.990956155649264,0,1,cellular response to nitrite,BP,
16213,GO:0071253,1,0.975521002354884,0,4,connexin binding,MF,
16214,GO:0071256,1,0.979148468683298,0,4,translocon complex,CC,
16215,GO:0071257,1,0.926250437684951,0,12,cellular response to electrical stimulus,BP,
16216,GO:0071258,1,0.99321200732669,0,1,cellular response to gravity,BP,
16217,GO:0071259,1,0.989209803287784,0,2,cellular response to magnetism,BP,
16219,GO:0071262,1,0.985391479050273,0,2,regulation of translational initiation in response to starvation,BP,
16220,GO:0071264,1,0.985391479050273,0,2,positive regulation of translational initiation in response to starvation,BP,
16221,GO:0071265,1,0.955386789947158,0,8,L-methionine biosynthetic process,BP,
16222,GO:0071266,1,0.994711632107073,0,1,'de novo' L-methionine biosynthetic process,BP,
16223,GO:0071267,1,0.96046814482731,0,7,L-methionine salvage,BP,
16224,GO:0071268,1,0.99454517104687,0,1,homocysteine biosynthetic process,BP,
16225,GO:0071275,1,0.994597228509885,0,1,cellular response to aluminum ion,BP,
16226,GO:0071276,1,0.832913360425959,0,32,cellular response to cadmium ion,BP,
16227,GO:0071277,1,0.65359557339863,0,59,cellular response to calcium ion,BP,
16228,GO:0071279,1,0.978409565730019,0,3,cellular response to cobalt ion,BP,
16229,GO:0071280,1,0.902598957539341,0,18,cellular response to copper ion,BP,
16230,GO:0071281,1,0.939774357698665,0,10,cellular response to iron ion,BP,
16231,GO:0071283,1,0.989463843233466,0,2,cellular response to iron(III) ion,BP,
16232,GO:0071284,1,0.969858015941583,0,4,cellular response to lead ion,BP,
16233,GO:0071285,1,0.93193729915193,0,12,cellular response to lithium ion,BP,
16234,GO:0071286,1,0.94198192824185,0,6,cellular response to magnesium ion,BP,
16235,GO:0071287,1,0.940156076122089,0,9,cellular response to manganese ion,BP,
16236,GO:0071288,1,0.994325787082341,0,1,cellular response to mercury ion,BP,
16237,GO:0071294,1,0.90392810619946,0,17,cellular response to zinc ion,BP,
16239,GO:0071298,1,0.993855960614235,0,1,cellular response to L-ascorbic acid,BP,
16241,GO:0071301,1,0.989888169827736,0,1,cellular response to vitamin B1,BP,
16242,GO:0071305,1,0.879111483749619,0,19,cellular response to vitamin D,BP,
16246,GO:0071312,1,0.793911713923648,0,31,cellular response to alkaloid,BP,
16247,GO:0071313,1,0.912661129417078,0,8,cellular response to caffeine,BP,
16248,GO:0071314,1,0.983865955210949,0,3,cellular response to cocaine,BP,
16249,GO:0071315,1,0.975413933595202,0,4,cellular response to morphine,BP,
16250,GO:0071316,1,0.955911689229591,0,8,cellular response to nicotine,BP,
16251,GO:0071317,1,0.975413933595202,0,4,cellular response to isoquinoline alkaloid,BP,
16252,GO:0071318,1,0.91208621179566,0,13,cellular response to ATP,BP,
16253,GO:0071320,1,0.704546716486511,0,48,cellular response to cAMP,BP,
16254,GO:0071321,1,0.954389079136423,0,6,cellular response to cGMP,BP,
16256,GO:0071324,1,0.992342365010487,0,1,cellular response to disaccharide stimulus,BP,
16258,GO:0071329,1,0.992342365010487,0,1,cellular response to sucrose stimulus,BP,
16260,GO:0071332,1,0.969305072753209,0,5,cellular response to fructose stimulus,BP,
16262,GO:0071335,1,0.989455652710118,0,2,hair follicle cell proliferation,BP,
16263,GO:0071336,1,0.989455652710118,0,2,regulation of hair follicle cell proliferation,BP,
16264,GO:0071338,1,0.989455652710118,0,2,positive regulation of hair follicle cell proliferation,BP,
16265,GO:0071339,1,0.826837742778007,0,28,MLL1 complex,CC,
16266,GO:0071340,1,0.934568067716048,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16267,GO:0071344,1,0.989557977073946,0,2,diphosphate metabolic process,BP,
16271,GO:0071348,1,0.992570702656523,0,1,cellular response to interleukin-11,BP,
16273,GO:0071350,1,0.915261211787561,0,13,cellular response to interleukin-15,BP,
16274,GO:0071351,1,0.955716570106431,0,8,cellular response to interleukin-18,BP,
16275,GO:0071352,1,0.922495303387039,0,12,cellular response to interleukin-2,BP,
16276,GO:0071353,1,0.840935127801294,0,28,cellular response to interleukin-4,BP,
16278,GO:0071355,1,0.979040658952527,0,3,cellular response to interleukin-9,BP,
16280,GO:0071357,1,0.64260384459237,0,71,cellular response to type I interferon,BP,
16281,GO:0071359,1,0.654776243255418,0,62,cellular response to dsRNA,BP,
16282,GO:0071360,1,0.918597614687793,0,13,cellular response to exogenous dsRNA,BP,
16283,GO:0071361,1,0.907135434837265,0,13,cellular response to ethanol,BP,
16284,GO:0071362,1,0.963306792307433,0,5,cellular response to ether,BP,
16287,GO:0071371,1,0.89857363997279,0,16,cellular response to gonadotropin stimulus,BP,
16288,GO:0071372,1,0.931858458366179,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16289,GO:0071373,1,0.988701592474459,0,2,cellular response to luteinizing hormone stimulus,BP,
16290,GO:0071374,1,0.957449953577971,0,6,cellular response to parathyroid hormone stimulus,BP,
16292,GO:0071376,1,0.969713337072914,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16293,GO:0071377,1,0.784671604901728,0,36,cellular response to glucagon stimulus,BP,
16294,GO:0071378,1,0.866287000382288,0,20,cellular response to growth hormone stimulus,BP,
16295,GO:0071379,1,0.857285356612531,0,21,cellular response to prostaglandin stimulus,BP,
16296,GO:0071380,1,0.897198637401157,0,16,cellular response to prostaglandin E stimulus,BP,
16300,GO:0071386,1,0.974491442276236,0,3,cellular response to corticosterone stimulus,BP,
16301,GO:0071387,1,0.992134142280457,0,1,cellular response to cortisol stimulus,BP,
16302,GO:0071389,1,0.953524910159918,0,7,cellular response to mineralocorticoid stimulus,BP,
16303,GO:0071391,1,0.922670080097328,0,12,cellular response to estrogen stimulus,BP,
16304,GO:0071392,1,0.80988498000941,0,33,cellular response to estradiol stimulus,BP,
16305,GO:0071393,1,0.987594502536957,0,2,cellular response to progesterone stimulus,BP,
16307,GO:0071395,1,0.979297022624437,0,4,cellular response to jasmonic acid stimulus,BP,
16309,GO:0071397,1,0.909825624158927,0,12,cellular response to cholesterol,BP,
16310,GO:0071398,1,0.712215602571853,0,49,cellular response to fatty acid,BP,
16311,GO:0071400,1,0.986076263914721,0,2,cellular response to oleic acid,BP,
16312,GO:0071401,1,0.994546146440205,0,1,cellular response to triglyceride,BP,
16313,GO:0071402,1,0.846324178964514,0,25,cellular response to lipoprotein particle stimulus,BP,
16314,GO:0071403,1,0.987957785054929,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16315,GO:0071404,1,0.885896898599241,0,18,cellular response to low-density lipoprotein particle stimulus,BP,
16317,GO:0071409,1,0.976350526946383,0,3,cellular response to cycloheximide,BP,
16318,GO:0071412,1,0.994549059691457,0,1,cellular response to genistein,BP,
16319,GO:0071413,1,0.994549059691457,0,1,cellular response to hydroxyisoflavone,BP,
16320,GO:0071415,1,0.904801983305642,0,9,cellular response to purine-containing compound,BP,
16322,GO:0071418,1,0.994780954590212,0,1,cellular response to amine stimulus,BP,
16324,GO:0071421,1,0.974623960992264,0,4,manganese ion transmembrane transport,BP,
16325,GO:0071422,1,0.98208710772751,0,3,succinate transmembrane transport,BP,
16326,GO:0071423,1,0.994676012241614,0,1,malate transmembrane transport,BP,
16327,GO:0071424,1,0.994313214468247,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16328,GO:0071425,1,0.88396057743265,0,19,hematopoietic stem cell proliferation,BP,
16329,GO:0071426,1,0.449890157491618,0,122,ribonucleoprotein complex export from nucleus,BP,
16330,GO:0071427,1,0.502164937036901,0,104,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16331,GO:0071428,1,0.913353160445289,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16332,GO:0071431,1,0.801411221728817,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16335,GO:0071438,1,0.968817057397147,0,5,invadopodium membrane,CC,
16336,GO:0071439,1,0.938438740413846,0,9,clathrin complex,CC,
16337,GO:0071440,1,0.965051999847191,0,6,regulation of histone H3-K14 acetylation,BP,
16338,GO:0071441,1,0.993492405533006,0,1,negative regulation of histone H3-K14 acetylation,BP,
16339,GO:0071442,1,0.976932043266063,0,4,positive regulation of histone H3-K14 acetylation,BP,
16340,GO:0071444,1,0.994842905813339,0,1,cellular response to pheromone,BP,
16341,GO:0071447,1,0.949237821573295,0,8,cellular response to hydroperoxide,BP,
16342,GO:0071449,1,0.994824020740684,0,1,cellular response to lipid hydroperoxide,BP,
16343,GO:0071450,1,0.869745373716857,0,24,cellular response to oxygen radical,BP,
16344,GO:0071451,1,0.869745373716857,0,24,cellular response to superoxide,BP,
16345,GO:0071453,1,0.261348334280565,0,205,cellular response to oxygen levels,BP,
16346,GO:0071454,1,0.989832751644873,0,1,cellular response to anoxia,BP,
16347,GO:0071455,1,0.961128031847786,0,6,cellular response to hyperoxia,BP,
16348,GO:0071456,1,0.306729584559889,0,183,cellular response to hypoxia,BP,
16349,GO:0071458,1,0.969409831781591,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16350,GO:0071459,1,0.890764262089946,0,20,protein localization to chromosome, centromeric region,BP,
16351,GO:0071460,1,0.989603643567085,0,2,cellular response to cell-matrix adhesion,BP,
16352,GO:0071461,1,0.989124614307729,0,2,cellular response to redox state,BP,
16353,GO:0071462,1,0.979352677651616,0,3,cellular response to water stimulus,BP,
16354,GO:0071464,1,0.992278717379728,0,1,cellular response to hydrostatic pressure,BP,
16356,GO:0071467,1,0.89408828152574,0,19,cellular response to pH,BP,
16357,GO:0071468,1,0.945927436712218,0,9,cellular response to acidic pH,BP,
16358,GO:0071469,1,0.98792308666935,0,2,cellular response to alkaline pH,BP,
16359,GO:0071470,1,0.811867482157676,0,32,cellular response to osmotic stress,BP,
16360,GO:0071471,1,0.992862031651417,0,1,cellular response to non-ionic osmotic stress,BP,
16361,GO:0071472,1,0.944282697552924,0,9,cellular response to salt stress,BP,
16362,GO:0071474,1,0.936925529743328,0,11,cellular hyperosmotic response,BP,
16363,GO:0071475,1,0.976773989139853,0,4,cellular hyperosmotic salinity response,BP,
16364,GO:0071476,1,0.949718347826923,0,7,cellular hypotonic response,BP,
16365,GO:0071477,1,0.983881256112613,0,2,cellular hypotonic salinity response,BP,
16366,GO:0071478,1,0.338905115185888,0,164,cellular response to radiation,BP,
16367,GO:0071479,1,0.644494331421921,0,66,cellular response to ionizing radiation,BP,
16368,GO:0071480,1,0.831604357103829,0,27,cellular response to gamma radiation,BP,
16369,GO:0071481,1,0.903508889503896,0,13,cellular response to X-ray,BP,
16370,GO:0071482,1,0.496969829465541,0,106,cellular response to light stimulus,BP,
16371,GO:0071483,1,0.987235834449658,0,2,cellular response to blue light,BP,
16372,GO:0071484,1,0.986070998551362,0,2,cellular response to light intensity,BP,
16373,GO:0071485,1,0.993960877222941,0,1,cellular response to absence of light,BP,
16374,GO:0071486,1,0.992062662615871,0,1,cellular response to high light intensity,BP,
16375,GO:0071492,1,0.980763015302675,0,3,cellular response to UV-A,BP,
16376,GO:0071493,1,0.95453042192067,0,8,cellular response to UV-B,BP,
16377,GO:0071494,1,0.967521599997673,0,4,cellular response to UV-C,BP,
16380,GO:0071498,1,0.891502414066981,0,18,cellular response to fluid shear stress,BP,
16381,GO:0071499,1,0.960452560553813,0,7,cellular response to laminar fluid shear stress,BP,
16382,GO:0071500,1,0.959470174757692,0,6,cellular response to nitrosative stress,BP,
16383,GO:0071501,1,0.944235238014271,0,9,cellular response to sterol depletion,BP,
16384,GO:0071502,1,0.969062934907987,0,5,cellular response to temperature stimulus,BP,
16385,GO:0071503,1,0.973031458043566,0,4,response to heparin,BP,
16386,GO:0071504,1,0.973031458043566,0,4,cellular response to heparin,BP,
16387,GO:0071505,1,0.988365458197265,0,2,response to mycophenolic acid,BP,
16388,GO:0071506,1,0.988365458197265,0,2,cellular response to mycophenolic acid,BP,
16389,GO:0071514,1,0.860369050872786,0,22,genetic imprinting,BP,
16390,GO:0071526,1,0.778012411726725,0,32,semaphorin-plexin signaling pathway,BP,
16391,GO:0071527,1,0.9945157272471,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16392,GO:0071528,1,0.993454237687236,0,1,tRNA re-export from nucleus,BP,
16393,GO:0071529,1,0.994416225569269,0,1,cementum mineralization,BP,
16394,GO:0071532,1,0.961658958052483,0,5,ankyrin repeat binding,MF,
16395,GO:0071535,1,0.976411149650675,0,4,RING-like zinc finger domain binding,MF,
16396,GO:0071538,1,0.994538877298266,0,1,SH2 domain-mediated complex assembly,BP,
16397,GO:0071539,1,0.807890855908401,0,27,protein localization to centrosome,BP,
16398,GO:0071540,1,0.992010026805561,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16399,GO:0071541,1,0.960620028437377,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16400,GO:0071542,1,0.814542782617298,0,32,dopaminergic neuron differentiation,BP,
16401,GO:0071543,1,0.97668461576008,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16402,GO:0071544,1,0.994782178411431,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16403,GO:0071545,1,0.922801296396921,0,12,inositol phosphate catabolic process,BP,
16404,GO:0071546,1,0.962832233397448,0,6,pi-body,CC,
16405,GO:0071547,1,0.970359659921169,0,5,piP-body,CC,
16406,GO:0071548,1,0.772515763600652,0,41,response to dexamethasone,BP,
16407,GO:0071549,1,0.819400697709274,0,32,cellular response to dexamethasone stimulus,BP,
16408,GO:0071550,1,0.950975550532835,0,9,death-inducing signaling complex assembly,BP,
16409,GO:0071553,1,0.98394626360317,0,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
16410,GO:0071554,1,0.973338260829255,0,5,cell wall organization or biogenesis,BP,
16412,GO:0071557,1,0.960623963114952,0,5,histone H3-K27 demethylation,BP,
16413,GO:0071558,1,0.960623963114952,0,5,histone demethylase activity (H3-K27 specific),MF,
16416,GO:0071561,1,0.992291252146574,0,1,nucleus-vacuole junction,CC,
16417,GO:0071564,1,0.920102592917951,0,12,npBAF complex,CC,
16418,GO:0071565,1,0.904046892437312,0,14,nBAF complex,CC,
16419,GO:0071566,1,0.994207186654721,0,1,UFM1 activating enzyme activity,MF,
16420,GO:0071567,1,0.989359277445861,0,2,UFM1 hydrolase activity,MF,
16421,GO:0071568,1,0.989150434835425,0,2,UFM1 transferase activity,MF,
16422,GO:0071569,1,0.967645774502537,0,6,protein ufmylation,BP,
16423,GO:0071573,1,0.994215910460644,0,1,shelterin complex assembly,BP,
16424,GO:0071577,1,0.882148098410056,0,20,zinc ion transmembrane transport,BP,
16425,GO:0071578,1,0.957344792061183,0,7,zinc ion import across plasma membrane,BP,
16426,GO:0071579,1,0.988938684023887,0,2,regulation of zinc ion transport,BP,
16427,GO:0071580,1,0.994640679724712,0,1,regulation of zinc ion transmembrane transport,BP,
16428,GO:0071581,1,0.994640679724712,0,1,regulation of zinc ion transmembrane import,BP,
16429,GO:0071582,1,0.994640679724712,0,1,negative regulation of zinc ion transport,BP,
16430,GO:0071583,1,0.994640679724712,0,1,negative regulation of zinc ion transmembrane transport,BP,
16431,GO:0071584,1,0.994640679724712,0,1,negative regulation of zinc ion transmembrane import,BP,
16432,GO:0071585,1,0.994640679724712,0,1,detoxification of cadmium ion,BP,
16433,GO:0071586,1,0.988857153787632,0,2,CAAX-box protein processing,BP,
16434,GO:0071593,1,0.974300083834802,0,4,lymphocyte aggregation,BP,
16435,GO:0071595,1,0.988658446617857,0,2,Nem1-Spo7 phosphatase complex,CC,
16436,GO:0071596,1,0.971048856336716,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16437,GO:0071598,1,0.970871411218655,0,5,neuronal ribonucleoprotein granule,CC,
16438,GO:0071599,1,0.907102668071971,0,15,otic vesicle development,BP,
16439,GO:0071600,1,0.938574162169497,0,10,otic vesicle morphogenesis,BP,
16440,GO:0071602,1,0.992965896436137,0,1,phytosphingosine biosynthetic process,BP,
16441,GO:0071603,1,0.974741217137293,0,4,endothelial cell-cell adhesion,BP,
16442,GO:0071604,1,0.829408560947793,0,28,transforming growth factor beta production,BP,
16443,GO:0071605,1,0.934243379945207,0,12,monocyte chemotactic protein-1 production,BP,
16444,GO:0071606,1,0.994650742674621,0,1,chemokine (C-C motif) ligand 4 production,BP,
16445,GO:0071608,1,0.976843343480339,0,4,macrophage inflammatory protein-1 alpha production,BP,
16446,GO:0071609,1,0.934619197781645,0,10,chemokine (C-C motif) ligand 5 production,BP,
16447,GO:0071610,1,0.994451067786512,0,1,chemokine (C-C motif) ligand 1 production,BP,
16448,GO:0071611,1,0.972694241465867,0,5,granulocyte colony-stimulating factor production,BP,
16449,GO:0071612,1,0.985721684494053,0,1,IP-10 production,BP,
16450,GO:0071613,1,0.989276706238167,0,2,granzyme B production,BP,
16451,GO:0071614,1,0.994683827021034,0,1,linoleic acid epoxygenase activity,MF,
16452,GO:0071616,1,0.741153266148195,0,46,acyl-CoA biosynthetic process,BP,
16453,GO:0071617,1,0.881286838622914,0,18,lysophospholipid acyltransferase activity,MF,
16454,GO:0071619,1,0.994552337999251,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16456,GO:0071622,1,0.78344756710299,0,43,regulation of granulocyte chemotaxis,BP,
16457,GO:0071623,1,0.986721474861037,0,2,negative regulation of granulocyte chemotaxis,BP,
16458,GO:0071624,1,0.849978226013792,0,30,positive regulation of granulocyte chemotaxis,BP,
16460,GO:0071626,1,0.994792478474093,0,1,mastication,BP,
16461,GO:0071629,1,0.994733018433186,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16462,GO:0071630,1,0.976101380834404,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16463,GO:0071633,1,0.994266979044633,0,1,dihydroceramidase activity,MF,
16464,GO:0071634,1,0.835454411830175,0,27,regulation of transforming growth factor beta production,BP,
16465,GO:0071635,1,0.956548973765098,0,7,negative regulation of transforming growth factor beta production,BP,
16466,GO:0071636,1,0.896619093509,0,17,positive regulation of transforming growth factor beta production,BP,
16467,GO:0071637,1,0.934243379945207,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16468,GO:0071638,1,0.971112678736003,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16469,GO:0071639,1,0.962044889139919,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16470,GO:0071640,1,0.976843343480339,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
16471,GO:0071641,1,0.988474336286076,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16472,GO:0071642,1,0.988234746098452,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16473,GO:0071643,1,0.994650742674621,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16474,GO:0071644,1,0.994650742674621,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16475,GO:0071649,1,0.939577946084111,0,9,regulation of chemokine (C-C motif) ligand 5 production,BP,
16476,GO:0071650,1,0.983949301940583,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16477,GO:0071651,1,0.954911967021193,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16478,GO:0071652,1,0.994451067786512,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16479,GO:0071654,1,0.994451067786512,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16480,GO:0071655,1,0.977863527937004,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16481,GO:0071656,1,0.994533297210656,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16482,GO:0071657,1,0.983239513210934,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16483,GO:0071658,1,0.985721684494053,0,1,regulation of IP-10 production,BP,
16484,GO:0071660,1,0.985721684494053,0,1,positive regulation of IP-10 production,BP,
16485,GO:0071661,1,0.989276706238167,0,2,regulation of granzyme B production,BP,
16486,GO:0071663,1,0.989276706238167,0,2,positive regulation of granzyme B production,BP,
16487,GO:0071664,1,0.97036250667173,0,4,catenin-TCF7L2 complex,CC,
16488,GO:0071665,1,0.993901121617639,0,1,gamma-catenin-TCF7L2 complex,CC,
16489,GO:0071670,1,0.950883537228695,0,8,smooth muscle cell chemotaxis,BP,
16490,GO:0071671,1,0.964663041940229,0,6,regulation of smooth muscle cell chemotaxis,BP,
16491,GO:0071672,1,0.976891656550711,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16492,GO:0071673,1,0.982385622538959,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16495,GO:0071676,1,0.960353963899878,0,6,negative regulation of mononuclear cell migration,BP,
16497,GO:0071678,1,0.989550926159662,0,1,olfactory bulb axon guidance,BP,
16498,GO:0071679,1,0.940080878554765,0,8,commissural neuron axon guidance,BP,
16499,GO:0071680,1,0.964475741160921,0,5,response to indole-3-methanol,BP,
16500,GO:0071681,1,0.964475741160921,0,5,cellular response to indole-3-methanol,BP,
16502,GO:0071684,1,0.993993108028265,0,1,organism emergence from protective structure,BP,
16503,GO:0071688,1,0.885708815558759,0,13,striated muscle myosin thick filament assembly,BP,
16504,GO:0071691,1,0.99032332647447,0,1,cardiac muscle thin filament assembly,BP,
16505,GO:0071692,1,0.949665182006093,0,6,protein localization to extracellular region,BP,
16506,GO:0071694,1,0.949665182006093,0,6,maintenance of protein location in extracellular region,BP,
16508,GO:0071696,1,0.905915934298037,0,15,ectodermal placode development,BP,
16509,GO:0071697,1,0.910964492080827,0,14,ectodermal placode morphogenesis,BP,
16510,GO:0071698,1,0.973696735107235,0,4,olfactory placode development,BP,
16511,GO:0071699,1,0.973696735107235,0,4,olfactory placode morphogenesis,BP,
16512,GO:0071701,1,0.992496993843296,0,1,regulation of MAPK export from nucleus,BP,
16517,GO:0071707,1,0.994792478474093,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16520,GO:0071712,1,0.923266924159048,0,12,ER-associated misfolded protein catabolic process,BP,
16521,GO:0071713,1,0.992647113988698,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
16522,GO:0071714,1,0.993126281215282,0,1,icosanoid transmembrane transporter activity,MF,
16524,GO:0071723,1,0.952581651245206,0,8,lipopeptide binding,MF,
16525,GO:0071724,1,0.974903216632078,0,4,response to diacyl bacterial lipopeptide,BP,
16526,GO:0071725,1,0.982987776684152,0,3,response to triacyl bacterial lipopeptide,BP,
16527,GO:0071726,1,0.974903216632078,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16528,GO:0071727,1,0.982987776684152,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16529,GO:0071731,1,0.891753885875367,0,18,response to nitric oxide,BP,
16530,GO:0071732,1,0.910230817143172,0,15,cellular response to nitric oxide,BP,
16531,GO:0071733,1,0.971002527499082,0,4,transcriptional activation by promoter-enhancer looping,BP,
16532,GO:0071763,1,0.964353480443742,0,6,nuclear membrane organization,BP,
16533,GO:0071765,1,0.993138936183902,0,1,nuclear inner membrane organization,BP,
16537,GO:0071782,1,0.8971436619667,0,18,endoplasmic reticulum tubular network,CC,
16538,GO:0071786,1,0.907731019185135,0,15,endoplasmic reticulum tubular network organization,BP,
16539,GO:0071787,1,0.977886703844041,0,4,endoplasmic reticulum tubular network formation,BP,
16540,GO:0071789,1,0.994313214468247,0,1,spindle pole body localization to nuclear envelope,BP,
16541,GO:0071790,1,0.994313214468247,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
16542,GO:0071791,1,0.988169618258161,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16543,GO:0071796,1,0.994789682286116,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16544,GO:0071797,1,0.977292998924209,0,4,LUBAC complex,CC,
16545,GO:0071798,1,0.965803187805753,0,5,response to prostaglandin D,BP,
16546,GO:0071799,1,0.965803187805753,0,5,cellular response to prostaglandin D stimulus,BP,
16547,GO:0071800,1,0.872031545413669,0,20,podosome assembly,BP,
16548,GO:0071801,1,0.919107809683599,0,13,regulation of podosome assembly,BP,
16549,GO:0071802,1,0.993159334022803,0,1,negative regulation of podosome assembly,BP,
16550,GO:0071803,1,0.941529094486831,0,9,positive regulation of podosome assembly,BP,
16553,GO:0071806,1,0.729096445028715,0,54,protein transmembrane transport,BP,
16554,GO:0071812,1,0.994083343736635,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16555,GO:0071813,1,0.86735581956174,0,21,lipoprotein particle binding,MF,
16556,GO:0071814,1,0.86735581956174,0,21,protein-lipid complex binding,MF,
16557,GO:0071816,1,0.978402927458128,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16558,GO:0071817,1,0.971465222335283,0,5,MMXD complex,CC,
16559,GO:0071818,1,0.98356103133407,0,3,BAT3 complex,CC,
16560,GO:0071819,1,0.98857165363358,0,2,DUBm complex,CC,
16561,GO:0071820,1,0.994767180013798,0,1,N-box binding,MF,
16562,GO:0071821,1,0.984988480773472,0,2,FANCM-MHF complex,CC,
16563,GO:0071823,1,0.989627736475638,0,2,protein-carbohydrate complex subunit organization,BP,
16564,GO:0071824,1,0.246953804720099,0,219,protein-DNA complex subunit organization,BP,
16566,GO:0071826,1,0.266653904604011,0,207,ribonucleoprotein complex subunit organization,BP,
16568,GO:0071830,1,0.950377157565617,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16569,GO:0071837,1,0.892937655130865,0,17,HMG box domain binding,MF,
16570,GO:0071838,1,0.960978243253598,0,6,cell proliferation in bone marrow,BP,
16571,GO:0071839,1,0.97757335075534,0,4,apoptotic process in bone marrow,BP,
16573,GO:0071846,1,0.994835988406935,0,1,actin filament debranching,BP,
16574,GO:0071847,1,0.9869871887056,0,2,TNFSF11-mediated signaling pathway,BP,
16575,GO:0071848,1,0.994083343736635,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16576,GO:0071850,1,0.9167694234607,0,14,mitotic cell cycle arrest,BP,
16577,GO:0071855,1,0.879105542461158,0,23,neuropeptide receptor binding,MF,
16578,GO:0071863,1,0.96034788482189,0,6,regulation of cell proliferation in bone marrow,BP,
16579,GO:0071864,1,0.96034788482189,0,6,positive regulation of cell proliferation in bone marrow,BP,
16580,GO:0071865,1,0.976373331694159,0,4,regulation of apoptotic process in bone marrow,BP,
16581,GO:0071866,1,0.976373331694159,0,4,negative regulation of apoptotic process in bone marrow,BP,
16582,GO:0071867,1,0.77467885444408,0,35,response to monoamine,BP,
16583,GO:0071868,1,0.790191254476137,0,32,cellular response to monoamine stimulus,BP,
16584,GO:0071869,1,0.77467885444408,0,35,response to catecholamine,BP,
16585,GO:0071870,1,0.790191254476137,0,32,cellular response to catecholamine stimulus,BP,
16586,GO:0071871,1,0.891578271392799,0,15,response to epinephrine,BP,
16587,GO:0071872,1,0.909406187419691,0,12,cellular response to epinephrine stimulus,BP,
16588,GO:0071873,1,0.97938337065799,0,3,response to norepinephrine,BP,
16589,GO:0071874,1,0.988322651498101,0,2,cellular response to norepinephrine stimulus,BP,
16590,GO:0071875,1,0.858326810169817,0,21,adrenergic receptor signaling pathway,BP,
16591,GO:0071877,1,0.994782178411431,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16592,GO:0071878,1,0.981987545948543,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16593,GO:0071879,1,0.97804085973878,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16594,GO:0071880,1,0.87349619759783,0,18,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16595,GO:0071881,1,0.988286739444059,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16596,GO:0071882,1,0.993470831937917,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16597,GO:0071885,1,0.989164979561403,0,2,N-terminal protein N-methyltransferase activity,MF,
16598,GO:0071886,1,0.98668375168056,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16600,GO:0071888,1,0.945458013636822,0,9,macrophage apoptotic process,BP,
16601,GO:0071889,1,0.836616641082831,0,25,14-3-3 protein binding,MF,
16602,GO:0071890,1,0.992116285090455,0,1,bicarbonate binding,MF,
16603,GO:0071893,1,0.994702757779098,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16604,GO:0071894,1,0.988492615792966,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16606,GO:0071896,1,0.962934154300493,0,4,protein localization to adherens junction,BP,
16607,GO:0071897,1,0.282272391771327,0,191,DNA biosynthetic process,BP,
16608,GO:0071898,1,0.982624857208262,0,3,regulation of estrogen receptor binding,BP,
16609,GO:0071899,1,0.982624857208262,0,3,negative regulation of estrogen receptor binding,BP,
16611,GO:0071901,1,0.44383032579572,0,125,negative regulation of protein serine/threonine kinase activity,BP,
16613,GO:0071907,1,0.948514859823019,0,7,determination of digestive tract left/right asymmetry,BP,
16614,GO:0071908,1,0.991935197019035,0,1,determination of intestine left/right asymmetry,BP,
16615,GO:0071909,1,0.991935197019035,0,1,determination of stomach left/right asymmetry,BP,
16616,GO:0071910,1,0.959159566643817,0,6,determination of liver left/right asymmetry,BP,
16617,GO:0071914,1,0.986951453932615,0,2,prominosome,CC,
16618,GO:0071918,1,0.975523505008161,0,4,urea transmembrane transport,BP,
16619,GO:0071920,1,0.989009241881301,0,2,cleavage body,CC,
16620,GO:0071921,1,0.963671782364701,0,5,cohesin loading,BP,
16621,GO:0071922,1,0.969185050166917,0,4,regulation of cohesin loading,BP,
16622,GO:0071926,1,0.973601835679965,0,4,endocannabinoid signaling pathway,BP,
16623,GO:0071929,1,0.988432723912149,0,2,alpha-tubulin acetylation,BP,
16624,GO:0071930,1,0.978626816612231,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16625,GO:0071931,1,0.983346945881887,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16626,GO:0071933,1,0.944595738829277,0,8,Arp2/3 complex binding,MF,
16627,GO:0071934,1,0.982080338413114,0,3,thiamine transmembrane transport,BP,
16628,GO:0071936,1,0.939790214143968,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16629,GO:0071938,1,0.994270021149309,0,1,vitamin A transport,BP,
16630,GO:0071939,1,0.994270021149309,0,1,vitamin A import,BP,
16631,GO:0071941,1,0.919341324154707,0,14,nitrogen cycle metabolic process,BP,
16632,GO:0071942,1,0.98183409988834,0,3,XPC complex,CC,
16634,GO:0071947,1,0.979609807037686,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16635,GO:0071949,1,0.851324821016047,0,25,FAD binding,MF,
16636,GO:0071951,1,0.994328051160662,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16637,GO:0071953,1,0.977533426356985,0,4,elastic fiber,CC,
16638,GO:0071954,1,0.993802399849716,0,1,chemokine (C-C motif) ligand 11 production,BP,
16639,GO:0071955,1,0.982840081292015,0,2,recycling endosome to Golgi transport,BP,
16640,GO:0071960,1,0.994825831378211,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16641,GO:0071962,1,0.983338099373513,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16642,GO:0071963,1,0.994711293562583,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
16643,GO:0071971,1,0.958711620163056,0,7,extracellular exosome assembly,BP,
16644,GO:0071976,1,0.99395855305886,0,1,cell gliding,BP,
16645,GO:0071985,1,0.830547334508366,0,28,multivesicular body sorting pathway,BP,
16646,GO:0071986,1,0.966474729896416,0,6,Ragulator complex,CC,
16647,GO:0071987,1,0.971332581965803,0,4,WD40-repeat domain binding,MF,
16648,GO:0071988,1,0.990054929762495,0,1,protein localization to spindle pole body,BP,
16649,GO:0071997,1,0.990869091843867,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16651,GO:0072003,1,0.98158533643046,0,3,kidney rudiment formation,BP,
16652,GO:0072004,1,0.986751226142549,0,2,kidney field specification,BP,
16653,GO:0072006,1,0.396116757261938,0,127,nephron development,BP,
16654,GO:0072007,1,0.955697741307998,0,7,mesangial cell differentiation,BP,
16655,GO:0072008,1,0.960815406273675,0,6,glomerular mesangial cell differentiation,BP,
16656,GO:0072009,1,0.490518923012077,0,99,nephron epithelium development,BP,
16657,GO:0072010,1,0.882735677910093,0,18,glomerular epithelium development,BP,
16658,GO:0072011,1,0.98910240709404,0,2,glomerular endothelium development,BP,
16659,GO:0072012,1,0.866744470614325,0,21,glomerulus vasculature development,BP,
16660,GO:0072014,1,0.96077780512598,0,5,proximal tubule development,BP,
16661,GO:0072015,1,0.930645979619504,0,9,glomerular visceral epithelial cell development,BP,
16662,GO:0072016,1,0.994389282500765,0,1,glomerular parietal epithelial cell development,BP,
16663,GO:0072017,1,0.910051548866879,0,11,distal tubule development,BP,
16664,GO:0072019,1,0.994600983713833,0,1,proximal convoluted tubule development,BP,
16665,GO:0072021,1,0.970932743964551,0,3,ascending thin limb development,BP,
16666,GO:0072023,1,0.994759755585877,0,1,thick ascending limb development,BP,
16667,GO:0072024,1,0.994759755585877,0,1,macula densa development,BP,
16668,GO:0072025,1,0.976119864294001,0,4,distal convoluted tubule development,BP,
16669,GO:0072027,1,0.994438716557873,0,1,connecting tubule development,BP,
16670,GO:0072028,1,0.595255372760478,0,72,nephron morphogenesis,BP,
16671,GO:0072033,1,0.937456754674371,0,8,renal vesicle formation,BP,
16672,GO:0072034,1,0.981116111250362,0,3,renal vesicle induction,BP,
16673,GO:0072036,1,0.993584328135496,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16674,GO:0072038,1,0.969753738499562,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16675,GO:0072039,1,0.980154592581062,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16676,GO:0072040,1,0.980154592581062,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16677,GO:0072044,1,0.909789510001049,0,12,collecting duct development,BP,
16678,GO:0072046,1,0.994765446471334,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16679,GO:0072047,1,0.973341400851549,0,5,proximal/distal pattern formation involved in nephron development,BP,
16680,GO:0072048,1,0.950150000346899,0,9,renal system pattern specification,BP,
16681,GO:0072049,1,0.969669946467799,0,5,comma-shaped body morphogenesis,BP,
16682,GO:0072050,1,0.956569417941216,0,7,S-shaped body morphogenesis,BP,
16683,GO:0072051,1,0.994759755585877,0,1,juxtaglomerular apparatus development,BP,
16684,GO:0072053,1,0.987325279598955,0,2,renal inner medulla development,BP,
16685,GO:0072054,1,0.987325279598955,0,2,renal outer medulla development,BP,
16686,GO:0072055,1,0.992278717379728,0,1,renal cortex development,BP,
16687,GO:0072059,1,0.992278717379728,0,1,cortical collecting duct development,BP,
16688,GO:0072060,1,0.993430164370044,0,1,outer medullary collecting duct development,BP,
16689,GO:0072061,1,0.982519140118838,0,3,inner medullary collecting duct development,BP,
16690,GO:0072069,1,0.981579720199621,0,3,DCT cell differentiation,BP,
16691,GO:0072070,1,0.929959049143513,0,10,loop of Henle development,BP,
16692,GO:0072071,1,0.989470510742929,0,2,kidney interstitial fibroblast differentiation,BP,
16693,GO:0072073,1,0.394180282859302,0,130,kidney epithelium development,BP,
16694,GO:0072074,1,0.888717225627361,0,18,kidney mesenchyme development,BP,
16695,GO:0072075,1,0.908406391297017,0,14,metanephric mesenchyme development,BP,
16696,GO:0072076,1,0.976542898340448,0,3,nephrogenic mesenchyme development,BP,
16697,GO:0072077,1,0.88337549006265,0,18,renal vesicle morphogenesis,BP,
16698,GO:0072078,1,0.612274013671638,0,68,nephron tubule morphogenesis,BP,
16699,GO:0072079,1,0.898149566222135,0,18,nephron tubule formation,BP,
16700,GO:0072080,1,0.541450139658602,0,85,nephron tubule development,BP,
16701,GO:0072081,1,0.973341400851549,0,5,specification of nephron tubule identity,BP,
16702,GO:0072086,1,0.978552590180212,0,4,specification of loop of Henle identity,BP,
16703,GO:0072087,1,0.878666352503838,0,19,renal vesicle development,BP,
16704,GO:0072088,1,0.604397741822697,0,70,nephron epithelium morphogenesis,BP,
16707,GO:0072092,1,0.967628718040169,0,3,ureteric bud invasion,BP,
16708,GO:0072093,1,0.961418695657557,0,4,metanephric renal vesicle formation,BP,
16709,GO:0072095,1,0.980265688326954,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16710,GO:0072096,1,0.994702757779098,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16711,GO:0072097,1,0.994702757779098,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16712,GO:0072098,1,0.989406428114059,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16713,GO:0072099,1,0.994702757779098,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16714,GO:0072100,1,0.994702757779098,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16715,GO:0072101,1,0.994702757779098,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16716,GO:0072102,1,0.944816710935747,0,7,glomerulus morphogenesis,BP,
16717,GO:0072103,1,0.966537643702543,0,4,glomerulus vasculature morphogenesis,BP,
16718,GO:0072104,1,0.966537643702543,0,4,glomerular capillary formation,BP,
16719,GO:0072106,1,0.974637165624391,0,4,regulation of ureteric bud formation,BP,
16720,GO:0072107,1,0.974637165624391,0,4,positive regulation of ureteric bud formation,BP,
16721,GO:0072108,1,0.975198325158971,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16722,GO:0072109,1,0.914219250929912,0,14,glomerular mesangium development,BP,
16723,GO:0072110,1,0.946049709205183,0,9,glomerular mesangial cell proliferation,BP,
16724,GO:0072111,1,0.894482614126019,0,18,cell proliferation involved in kidney development,BP,
16725,GO:0072112,1,0.898314055841339,0,15,glomerular visceral epithelial cell differentiation,BP,
16726,GO:0072114,1,0.99176582790506,0,1,pronephros morphogenesis,BP,
16727,GO:0072124,1,0.954089277585304,0,8,regulation of glomerular mesangial cell proliferation,BP,
16728,GO:0072125,1,0.9822930037497,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16729,GO:0072126,1,0.971292926936798,0,5,positive regulation of glomerular mesangial cell proliferation,BP,
16730,GO:0072127,1,0.994556733991284,0,1,renal capsule development,BP,
16731,GO:0072128,1,0.994556733991284,0,1,renal capsule morphogenesis,BP,
16732,GO:0072129,1,0.994556733991284,0,1,renal capsule formation,BP,
16733,GO:0072130,1,0.994556733991284,0,1,renal capsule specification,BP,
16734,GO:0072131,1,0.971303465402556,0,4,kidney mesenchyme morphogenesis,BP,
16735,GO:0072132,1,0.7368466041146,0,45,mesenchyme morphogenesis,BP,
16736,GO:0072133,1,0.971303465402556,0,4,metanephric mesenchyme morphogenesis,BP,
16737,GO:0072134,1,0.981888552912752,0,2,nephrogenic mesenchyme morphogenesis,BP,
16738,GO:0072135,1,0.981903939504645,0,3,kidney mesenchymal cell proliferation,BP,
16739,GO:0072136,1,0.981903939504645,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16740,GO:0072137,1,0.956256112118024,0,4,condensed mesenchymal cell proliferation,BP,
16741,GO:0072138,1,0.983407972215889,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16742,GO:0072139,1,0.987839298693979,0,2,glomerular parietal epithelial cell differentiation,BP,
16743,GO:0072141,1,0.989470510742929,0,2,renal interstitial fibroblast development,BP,
16744,GO:0072143,1,0.961133950353231,0,6,mesangial cell development,BP,
16745,GO:0072144,1,0.966280432647183,0,5,glomerular mesangial cell development,BP,
16747,GO:0072156,1,0.967592932878049,0,3,distal tubule morphogenesis,BP,
16748,GO:0072160,1,0.904094015582356,0,13,nephron tubule epithelial cell differentiation,BP,
16749,GO:0072161,1,0.959415760547274,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16750,GO:0072162,1,0.975315771209948,0,4,metanephric mesenchymal cell differentiation,BP,
16751,GO:0072163,1,0.517490037438534,0,93,mesonephric epithelium development,BP,
16752,GO:0072164,1,0.517490037438534,0,93,mesonephric tubule development,BP,
16753,GO:0072165,1,0.994675747418287,0,1,anterior mesonephric tubule development,BP,
16754,GO:0072166,1,0.988877030701941,0,2,posterior mesonephric tubule development,BP,
16755,GO:0072167,1,0.994675747418287,0,1,specification of mesonephric tubule identity,BP,
16756,GO:0072168,1,0.994675747418287,0,1,specification of anterior mesonephric tubule identity,BP,
16757,GO:0072169,1,0.994675747418287,0,1,specification of posterior mesonephric tubule identity,BP,
16758,GO:0072170,1,0.851301412770077,0,22,metanephric tubule development,BP,
16759,GO:0072171,1,0.652201566118383,0,60,mesonephric tubule morphogenesis,BP,
16760,GO:0072172,1,0.952730497195659,0,8,mesonephric tubule formation,BP,
16761,GO:0072173,1,0.924696570630304,0,11,metanephric tubule morphogenesis,BP,
16762,GO:0072174,1,0.963045774382921,0,6,metanephric tubule formation,BP,
16764,GO:0072176,1,0.907126943847208,0,13,nephric duct development,BP,
16765,GO:0072177,1,0.955371142183594,0,6,mesonephric duct development,BP,
16766,GO:0072178,1,0.934390569012211,0,10,nephric duct morphogenesis,BP,
16767,GO:0072179,1,0.977033116595261,0,4,nephric duct formation,BP,
16768,GO:0072180,1,0.984069671624507,0,3,mesonephric duct morphogenesis,BP,
16769,GO:0072181,1,0.994765446471334,0,1,mesonephric duct formation,BP,
16770,GO:0072182,1,0.91938701584827,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16771,GO:0072183,1,0.988441959169392,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16772,GO:0072184,1,0.994675747418287,0,1,renal vesicle progenitor cell differentiation,BP,
16773,GO:0072185,1,0.989221624044392,0,2,metanephric cap development,BP,
16774,GO:0072186,1,0.989221624044392,0,2,metanephric cap morphogenesis,BP,
16775,GO:0072189,1,0.91740846005602,0,13,ureter development,BP,
16776,GO:0072190,1,0.982893545202977,0,3,ureter urothelium development,BP,
16777,GO:0072191,1,0.977422933626662,0,4,ureter smooth muscle development,BP,
16778,GO:0072192,1,0.994702757779098,0,1,ureter epithelial cell differentiation,BP,
16779,GO:0072193,1,0.977422933626662,0,4,ureter smooth muscle cell differentiation,BP,
16780,GO:0072194,1,0.981809265990963,0,3,kidney smooth muscle tissue development,BP,
16781,GO:0072195,1,0.994746455661165,0,1,kidney smooth muscle cell differentiation,BP,
16782,GO:0072197,1,0.982365748410525,0,3,ureter morphogenesis,BP,
16783,GO:0072198,1,0.983899929821408,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16784,GO:0072199,1,0.983899929821408,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16785,GO:0072200,1,0.994702757779098,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16786,GO:0072201,1,0.947649860390972,0,8,negative regulation of mesenchymal cell proliferation,BP,
16787,GO:0072202,1,0.85307733972432,0,23,cell differentiation involved in metanephros development,BP,
16788,GO:0072203,1,0.936633500876488,0,10,cell proliferation involved in metanephros development,BP,
16789,GO:0072204,1,0.986249233417626,0,2,cell-cell signaling involved in metanephros development,BP,
16790,GO:0072205,1,0.944007577349482,0,7,metanephric collecting duct development,BP,
16791,GO:0072206,1,0.994759755585877,0,1,metanephric juxtaglomerular apparatus development,BP,
16792,GO:0072207,1,0.839098841706421,0,24,metanephric epithelium development,BP,
16793,GO:0072208,1,0.986995166353985,0,2,metanephric smooth muscle tissue development,BP,
16794,GO:0072209,1,0.988629677018474,0,2,metanephric mesangial cell differentiation,BP,
16795,GO:0072210,1,0.775400620044249,0,36,metanephric nephron development,BP,
16796,GO:0072213,1,0.994556733991284,0,1,metanephric capsule development,BP,
16797,GO:0072214,1,0.992278717379728,0,1,metanephric cortex development,BP,
16798,GO:0072215,1,0.871715277078991,0,20,regulation of metanephros development,BP,
16799,GO:0072216,1,0.92752532083124,0,12,positive regulation of metanephros development,BP,
16800,GO:0072217,1,0.958733524318004,0,7,negative regulation of metanephros development,BP,
16801,GO:0072218,1,0.970932743964551,0,3,metanephric ascending thin limb development,BP,
16802,GO:0072219,1,0.992278717379728,0,1,metanephric cortical collecting duct development,BP,
16803,GO:0072221,1,0.976119864294001,0,4,metanephric distal convoluted tubule development,BP,
16804,GO:0072223,1,0.968815677995243,0,5,metanephric glomerular mesangium development,BP,
16805,GO:0072224,1,0.925622252550458,0,11,metanephric glomerulus development,BP,
16806,GO:0072227,1,0.994759755585877,0,1,metanephric macula densa development,BP,
16807,GO:0072229,1,0.994600983713833,0,1,metanephric proximal convoluted tubule development,BP,
16808,GO:0072233,1,0.994759755585877,0,1,metanephric thick ascending limb development,BP,
16809,GO:0072234,1,0.866377876304391,0,19,metanephric nephron tubule development,BP,
16810,GO:0072235,1,0.952734961193222,0,6,metanephric distal tubule development,BP,
16811,GO:0072236,1,0.964552001809888,0,4,metanephric loop of Henle development,BP,
16812,GO:0072237,1,0.978333371636646,0,2,metanephric proximal tubule development,BP,
16813,GO:0072239,1,0.954672343756233,0,7,metanephric glomerulus vasculature development,BP,
16814,GO:0072240,1,0.981579720199621,0,3,metanephric DCT cell differentiation,BP,
16815,GO:0072243,1,0.858976313189593,0,20,metanephric nephron epithelium development,BP,
16816,GO:0072244,1,0.991469066106536,0,1,metanephric glomerular epithelium development,BP,
16817,GO:0072248,1,0.991469066106536,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16818,GO:0072249,1,0.991469066106536,0,1,metanephric glomerular visceral epithelial cell development,BP,
16819,GO:0072254,1,0.988629677018474,0,2,metanephric glomerular mesangial cell differentiation,BP,
16820,GO:0072255,1,0.99425129906114,0,1,metanephric glomerular mesangial cell development,BP,
16821,GO:0072257,1,0.941735893738305,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16822,GO:0072258,1,0.994675747418287,0,1,metanephric interstitial fibroblast differentiation,BP,
16823,GO:0072259,1,0.994675747418287,0,1,metanephric interstitial fibroblast development,BP,
16824,GO:0072262,1,0.979960387816365,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16825,GO:0072265,1,0.994556733991284,0,1,metanephric capsule morphogenesis,BP,
16826,GO:0072266,1,0.994556733991284,0,1,metanephric capsule formation,BP,
16827,GO:0072267,1,0.994556733991284,0,1,metanephric capsule specification,BP,
16828,GO:0072268,1,0.978459151971973,0,4,pattern specification involved in metanephros development,BP,
16829,GO:0072272,1,0.989081891491619,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16830,GO:0072273,1,0.834383265483679,0,25,metanephric nephron morphogenesis,BP,
16831,GO:0072274,1,0.991469066106536,0,1,metanephric glomerular basement membrane development,BP,
16832,GO:0072275,1,0.98233635763643,0,2,metanephric glomerulus morphogenesis,BP,
16833,GO:0072276,1,0.98233635763643,0,2,metanephric glomerulus vasculature morphogenesis,BP,
16834,GO:0072277,1,0.98233635763643,0,2,metanephric glomerular capillary formation,BP,
16835,GO:0072278,1,0.979880045415876,0,3,metanephric comma-shaped body morphogenesis,BP,
16836,GO:0072282,1,0.941059201188686,0,8,metanephric nephron tubule morphogenesis,BP,
16837,GO:0072283,1,0.900396148368675,0,15,metanephric renal vesicle morphogenesis,BP,
16838,GO:0072284,1,0.966642953506782,0,5,metanephric S-shaped body morphogenesis,BP,
16839,GO:0072285,1,0.993584328135496,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16840,GO:0072286,1,0.994438716557873,0,1,metanephric connecting tubule development,BP,
16841,GO:0072287,1,0.983644959114208,0,1,metanephric distal tubule morphogenesis,BP,
16842,GO:0072289,1,0.974511861568349,0,4,metanephric nephron tubule formation,BP,
16843,GO:0072298,1,0.974191380467934,0,4,regulation of metanephric glomerulus development,BP,
16844,GO:0072299,1,0.994170554817505,0,1,negative regulation of metanephric glomerulus development,BP,
16845,GO:0072300,1,0.979904838586247,0,3,positive regulation of metanephric glomerulus development,BP,
16846,GO:0072301,1,0.988285187197403,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16847,GO:0072302,1,0.994170554817505,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16848,GO:0072303,1,0.99408046807447,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16849,GO:0072304,1,0.986751226142549,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16850,GO:0072305,1,0.986751226142549,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16851,GO:0072307,1,0.941735893738305,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16852,GO:0072308,1,0.993733177605647,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16853,GO:0072309,1,0.986751226142549,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16854,GO:0072310,1,0.92542064444549,0,10,glomerular epithelial cell development,BP,
16855,GO:0072311,1,0.893268475813073,0,16,glomerular epithelial cell differentiation,BP,
16856,GO:0072312,1,0.991469066106536,0,1,metanephric glomerular epithelial cell differentiation,BP,
16857,GO:0072313,1,0.991469066106536,0,1,metanephric glomerular epithelial cell development,BP,
16860,GO:0072320,1,0.974653949865193,0,4,volume-sensitive chloride channel activity,MF,
16861,GO:0072321,1,0.94639286739953,0,10,chaperone-mediated protein transport,BP,
16862,GO:0072329,1,0.467881795462704,0,123,monocarboxylic acid catabolic process,BP,
16864,GO:0072331,1,0.181659512066717,0,259,signal transduction by p53 class mediator,BP,
16865,GO:0072332,1,0.599591091213684,0,79,intrinsic apoptotic signaling pathway by p53 class mediator,BP,
16866,GO:0072334,1,0.989544629504097,0,2,UDP-galactose transmembrane transport,BP,
16867,GO:0072337,1,0.885495639162835,0,17,modified amino acid transport,BP,
16868,GO:0072338,1,0.957657711923685,0,6,cellular lactam metabolic process,BP,
16869,GO:0072340,1,0.994722055363197,0,1,cellular lactam catabolic process,BP,
16870,GO:0072341,1,0.649688441272088,0,68,modified amino acid binding,MF,
16871,GO:0072343,1,0.98950279054613,0,2,pancreatic stellate cell proliferation,BP,
16872,GO:0072344,1,0.977581783649552,0,4,rescue of stalled ribosome,BP,
16873,GO:0072345,1,0.962342311912028,0,6,NAADP-sensitive calcium-release channel activity,MF,
16876,GO:0072349,1,0.912129063792513,0,13,modified amino acid transmembrane transporter activity,MF,
16877,GO:0072350,1,0.807500465368553,0,36,tricarboxylic acid metabolic process,BP,
16878,GO:0072354,1,0.994719259578768,0,1,histone kinase activity (H3-T3 specific),MF,
16879,GO:0072355,1,0.994719259578768,0,1,histone H3-T3 phosphorylation,BP,
16880,GO:0072356,1,0.993320421893173,0,1,chromosome passenger complex localization to kinetochore,BP,
16881,GO:0072357,1,0.953084410965492,0,7,PTW/PP1 phosphatase complex,CC,
16884,GO:0072361,1,0.976756652621595,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
16885,GO:0072362,1,0.989302029417926,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16886,GO:0072363,1,0.987320313220816,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16887,GO:0072364,1,0.976075121492263,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16888,GO:0072365,1,0.988611832401559,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16889,GO:0072366,1,0.987320313220816,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16890,GO:0072367,1,0.964332637903306,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
16891,GO:0072368,1,0.982415825752981,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
16892,GO:0072369,1,0.981596372092792,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
16895,GO:0072379,1,0.98356103133407,0,3,ER membrane insertion complex,CC,
16896,GO:0072382,1,0.983450449751365,0,1,minus-end-directed vesicle transport along microtubule,BP,
16897,GO:0072383,1,0.943158871612596,0,7,plus-end-directed vesicle transport along microtubule,BP,
16898,GO:0072384,1,0.605180685677779,0,69,organelle transport along microtubule,BP,
16899,GO:0072385,1,0.963434013644215,0,4,minus-end-directed organelle transport along microtubule,BP,
16900,GO:0072386,1,0.935174210046732,0,8,plus-end-directed organelle transport along microtubule,BP,
16901,GO:0072387,1,0.988154936636945,0,2,flavin adenine dinucleotide metabolic process,BP,
16902,GO:0072388,1,0.994653204781261,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16903,GO:0072389,1,0.993467149498226,0,1,flavin adenine dinucleotide catabolic process,BP,
16904,GO:0072393,1,0.911438892781678,0,11,microtubule anchoring at microtubule organizing center,BP,
16905,GO:0072395,1,0.61259094542332,0,74,signal transduction involved in cell cycle checkpoint,BP,
16906,GO:0072396,1,0.961668730422343,0,5,response to cell cycle checkpoint signaling,BP,
16907,GO:0072401,1,0.619716184821631,0,73,signal transduction involved in DNA integrity checkpoint,BP,
16908,GO:0072402,1,0.961668730422343,0,5,response to DNA integrity checkpoint signaling,BP,
16909,GO:0072413,1,0.665449866814947,0,62,signal transduction involved in mitotic cell cycle checkpoint,BP,
16910,GO:0072414,1,0.990184818148884,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16911,GO:0072422,1,0.619716184821631,0,73,signal transduction involved in DNA damage checkpoint,BP,
16912,GO:0072423,1,0.961668730422343,0,5,response to DNA damage checkpoint signaling,BP,
16913,GO:0072425,1,0.923861257210967,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16914,GO:0072428,1,0.994681767558612,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16915,GO:0072429,1,0.983428364015195,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16916,GO:0072431,1,0.669359665725731,0,61,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16917,GO:0072432,1,0.990184818148884,0,1,response to G1 DNA damage checkpoint signaling,BP,
16918,GO:0072434,1,0.9805706197527,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16919,GO:0072487,1,0.975647963187742,0,4,MSL complex,CC,
16920,GO:0072488,1,0.932199437705309,0,12,ammonium transmembrane transport,BP,
16921,GO:0072492,1,0.994709706005916,0,1,host cell mitochondrial intermembrane space,CC,
16922,GO:0072497,1,0.941209198020151,0,8,mesenchymal stem cell differentiation,BP,
16923,GO:0072498,1,0.921519865949968,0,14,embryonic skeletal joint development,BP,
16924,GO:0072501,1,0.95383772737283,0,6,cellular divalent inorganic anion homeostasis,BP,
16925,GO:0072502,1,0.95383772737283,0,6,cellular trivalent inorganic anion homeostasis,BP,
16927,GO:0072505,1,0.934757628481893,0,9,divalent inorganic anion homeostasis,BP,
16928,GO:0072506,1,0.934757628481893,0,9,trivalent inorganic anion homeostasis,BP,
16930,GO:0072509,1,0.866294919468493,0,23,divalent inorganic cation transmembrane transporter activity,MF,
16931,GO:0072510,1,0.980828331126721,0,3,trivalent inorganic cation transmembrane transporter activity,MF,
16934,GO:0072513,1,0.976480410556897,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
16935,GO:0072517,1,0.993843297646569,0,1,host cell viral assembly compartment,CC,
16936,GO:0072518,1,0.990848391757946,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
16937,GO:0072520,1,0.923613588013612,0,11,seminiferous tubule development,BP,
16940,GO:0072523,1,0.720554804419412,0,49,purine-containing compound catabolic process,BP,
16943,GO:0072526,1,0.967763409478378,0,6,pyridine-containing compound catabolic process,BP,
16947,GO:0072530,1,0.95652947670299,0,8,purine-containing compound transmembrane transport,BP,
16948,GO:0072531,1,0.948389614136386,0,9,pyrimidine-containing compound transmembrane transport,BP,
16951,GO:0072536,1,0.994649138174134,0,1,interleukin-23 receptor complex,CC,
16952,GO:0072537,1,0.945335995097285,0,9,fibroblast activation,BP,
16953,GO:0072538,1,0.896339167764486,0,17,T-helper 17 type immune response,BP,
16954,GO:0072539,1,0.901776806689634,0,16,T-helper 17 cell differentiation,BP,
16955,GO:0072540,1,0.942511518868843,0,10,T-helper 17 cell lineage commitment,BP,
16956,GO:0072542,1,0.957976943130056,0,7,protein phosphatase activator activity,MF,
16957,GO:0072544,1,0.994721628008858,0,1,L-DOPA binding,MF,
16958,GO:0072545,1,0.989344005049226,0,2,tyrosine binding,MF,
16959,GO:0072546,1,0.94393882876529,0,10,ER membrane protein complex,CC,
16960,GO:0072553,1,0.958791921636348,0,6,terminal button organization,BP,
16961,GO:0072554,1,0.988436711070339,0,2,blood vessel lumenization,BP,
16962,GO:0072556,1,0.993166120876802,0,1,other organism presynaptic membrane,CC,
16963,GO:0072557,1,0.97847120998762,0,4,IPAF inflammasome complex,CC,
16964,GO:0072558,1,0.976471262410917,0,4,NLRP1 inflammasome complex,CC,
16965,GO:0072559,1,0.953277020306659,0,8,NLRP3 inflammasome complex,CC,
16966,GO:0072560,1,0.988923913110916,0,2,type B pancreatic cell maturation,BP,
16968,GO:0072563,1,0.988849241790026,0,2,endothelial microparticle,CC,
16969,GO:0072564,1,0.98937963956278,0,2,blood microparticle formation,BP,
16970,GO:0072566,1,0.988796391037817,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
16972,GO:0072570,1,0.994000317678673,0,1,ADP-D-ribose binding,MF,
16973,GO:0072572,1,0.994600643939373,0,1,poly-ADP-D-ribose binding,MF,
16974,GO:0072573,1,0.99292707905012,0,1,tolerance induction to lipopolysaccharide,BP,
16975,GO:0072574,1,0.915969867947591,0,14,hepatocyte proliferation,BP,
16976,GO:0072575,1,0.915969867947591,0,14,epithelial cell proliferation involved in liver morphogenesis,BP,
16977,GO:0072576,1,0.90723449421653,0,15,liver morphogenesis,BP,
16980,GO:0072579,1,0.993089170363745,0,1,glycine receptor clustering,BP,
16982,GO:0072584,1,0.942699671890105,0,9,caveolin-mediated endocytosis,BP,
16983,GO:0072586,1,0.992850981645305,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
16984,GO:0072587,1,0.992850981645305,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
16985,GO:0072588,1,0.973947915496292,0,5,box H/ACA RNP complex,CC,
16986,GO:0072589,1,0.97905942403606,0,4,box H/ACA scaRNP complex,CC,
16987,GO:0072590,1,0.978384121923522,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16988,GO:0072591,1,0.991471169358442,0,1,citrate-L-glutamate ligase activity,MF,
16989,GO:0072592,1,0.971334414511708,0,5,oxygen metabolic process,BP,
16991,GO:0072594,1,0.0428760978233697,0,493,establishment of protein localization to organelle,BP,
16992,GO:0072595,1,0.768754256622932,0,40,maintenance of protein localization in organelle,BP,
16993,GO:0072599,1,0.557311538151425,0,104,establishment of protein localization to endoplasmic reticulum,BP,
16994,GO:0072602,1,0.960039205761331,0,6,interleukin-4 secretion,BP,
16995,GO:0072603,1,0.965847626621096,0,6,interleukin-5 secretion,BP,
16996,GO:0072604,1,0.837487661864237,0,28,interleukin-6 secretion,BP,
16998,GO:0072608,1,0.956617246473075,0,8,interleukin-10 secretion,BP,
16999,GO:0072610,1,0.948711609840061,0,9,interleukin-12 secretion,BP,
17000,GO:0072611,1,0.960946222273645,0,7,interleukin-13 secretion,BP,
17001,GO:0072615,1,0.989276925339677,0,2,interleukin-17 secretion,BP,
17002,GO:0072616,1,0.993345469561611,0,1,interleukin-18 secretion,BP,
17003,GO:0072619,1,0.993739582468635,0,1,interleukin-21 secretion,BP,
17004,GO:0072641,1,0.94778261601328,0,7,type I interferon secretion,BP,
17005,GO:0072642,1,0.953256683952172,0,6,interferon-alpha secretion,BP,
17006,GO:0072643,1,0.913239515279676,0,15,interferon-gamma secretion,BP,
17007,GO:0072655,1,0.346038677173769,0,174,establishment of protein localization to mitochondrion,BP,
17008,GO:0072656,1,0.967551838081665,0,5,maintenance of protein location in mitochondrion,BP,
17010,GO:0072658,1,0.987378888931516,0,1,maintenance of protein location in membrane,BP,
17012,GO:0072660,1,0.987378888931516,0,1,maintenance of protein location in plasma membrane,BP,
17013,GO:0072662,1,0.900963300947449,0,17,protein localization to peroxisome,BP,
17014,GO:0072663,1,0.900963300947449,0,17,establishment of protein localization to peroxisome,BP,
17015,GO:0072665,1,0.68183626560539,0,54,protein localization to vacuole,BP,
17016,GO:0072666,1,0.736075181039196,0,42,establishment of protein localization to vacuole,BP,
17017,GO:0072669,1,0.962819618366585,0,7,tRNA-splicing ligase complex,CC,
17018,GO:0072671,1,0.994432201029796,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
17019,GO:0072672,1,0.95479208739701,0,7,neutrophil extravasation,BP,
17021,GO:0072674,1,0.961746356931405,0,4,multinuclear osteoclast differentiation,BP,
17022,GO:0072675,1,0.961746356931405,0,4,osteoclast fusion,BP,
17026,GO:0072679,1,0.972528611958346,0,5,thymocyte migration,BP,
17027,GO:0072680,1,0.994068182395454,0,1,extracellular matrix-dependent thymocyte migration,BP,
17028,GO:0072681,1,0.994068182395454,0,1,fibronectin-dependent thymocyte migration,BP,
17029,GO:0072682,1,0.993866527288167,0,1,eosinophil extravasation,BP,
17031,GO:0072684,1,0.99351478421571,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17032,GO:0072686,1,0.543021619871722,0,85,mitotic spindle,CC,
17033,GO:0072687,1,0.965276787416479,0,5,meiotic spindle,CC,
17034,GO:0072695,1,0.988878618262509,0,2,regulation of DNA recombination at telomere,BP,
17035,GO:0072697,1,0.926915201935089,0,11,protein localization to cell cortex,BP,
17036,GO:0072698,1,0.719506115597536,0,43,protein localization to microtubule cytoskeleton,BP,
17037,GO:0072702,1,0.991682446931668,0,1,response to methyl methanesulfonate,BP,
17038,GO:0072703,1,0.991682446931668,0,1,cellular response to methyl methanesulfonate,BP,
17039,GO:0072706,1,0.994422911496101,0,1,response to sodium dodecyl sulfate,BP,
17040,GO:0072707,1,0.994422911496101,0,1,cellular response to sodium dodecyl sulfate,BP,
17041,GO:0072708,1,0.971932385501014,0,5,response to sorbitol,BP,
17042,GO:0072709,1,0.983031194971961,0,3,cellular response to sorbitol,BP,
17043,GO:0072710,1,0.942305073472022,0,8,response to hydroxyurea,BP,
17044,GO:0072711,1,0.94769731238978,0,7,cellular response to hydroxyurea,BP,
17045,GO:0072714,1,0.994712644263035,0,1,response to selenite ion,BP,
17046,GO:0072715,1,0.994712644263035,0,1,cellular response to selenite ion,BP,
17047,GO:0072716,1,0.973705487656327,0,4,response to actinomycin D,BP,
17048,GO:0072717,1,0.979275581173167,0,3,cellular response to actinomycin D,BP,
17049,GO:0072718,1,0.941914567088353,0,9,response to cisplatin,BP,
17050,GO:0072719,1,0.962377529503766,0,6,cellular response to cisplatin,BP,
17051,GO:0072720,1,0.988658446617857,0,2,response to dithiothreitol,BP,
17052,GO:0072721,1,0.994313214468247,0,1,cellular response to dithiothreitol,BP,
17053,GO:0072733,1,0.983650563430804,0,3,response to staurosporine,BP,
17054,GO:0072734,1,0.983650563430804,0,3,cellular response to staurosporine,BP,
17055,GO:0072737,1,0.989040979649372,0,2,response to diamide,BP,
17056,GO:0072738,1,0.989040979649372,0,2,cellular response to diamide,BP,
17057,GO:0072739,1,0.989018146635244,0,2,response to anisomycin,BP,
17058,GO:0072740,1,0.994674951261021,0,1,cellular response to anisomycin,BP,
17059,GO:0072741,1,0.977931136551398,0,3,protein localization to cell division site,BP,
17060,GO:0072749,1,0.994696544111254,0,1,cellular response to cytochalasin B,BP,
17061,GO:0072750,1,0.994790421393158,0,1,cellular response to leptomycin B,BP,
17062,GO:0072752,1,0.990668777310034,0,1,cellular response to rapamycin,BP,
17063,GO:0072755,1,0.993566383541989,0,1,cellular response to benomyl,BP,
17064,GO:0072757,1,0.975541669592674,0,4,cellular response to camptothecin,BP,
17065,GO:0075044,1,0.964431821885518,0,5,autophagy of host cells involved in interaction with symbiont,BP,
17066,GO:0075071,1,0.964431821885518,0,5,autophagy involved in symbiotic interaction,BP,
17067,GO:0075109,1,0.992124689597619,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
17068,GO:0075111,1,0.992124689597619,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
17069,GO:0075112,1,0.992124689597619,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17070,GO:0075114,1,0.992124689597619,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17071,GO:0075136,1,0.96759066880801,0,5,response to host,BP,
17072,GO:0075341,1,0.994543801868554,0,1,host cell PML body,CC,
17073,GO:0075509,1,0.981072252761759,0,3,endocytosis involved in viral entry into host cell,BP,
17074,GO:0075519,1,0.99483472186973,0,1,microtubule-dependent intracellular transport of viral material,BP,
17075,GO:0075521,1,0.99483472186973,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17076,GO:0075522,1,0.936310923566774,0,10,IRES-dependent viral translational initiation,BP,
17077,GO:0075525,1,0.970612879603747,0,5,viral translational termination-reinitiation,BP,
17078,GO:0075528,1,0.9867462596652,0,2,modulation by virus of host immune response,BP,
17079,GO:0075606,1,0.99483472186973,0,1,transport of viral material towards nucleus,BP,
17080,GO:0075713,1,0.955258497385224,0,8,establishment of integrated proviral latency,BP,
17081,GO:0075732,1,0.984538271588376,0,2,viral penetration into host nucleus,BP,
17082,GO:0075733,1,0.699950455029413,0,53,intracellular transport of virus,BP,
17083,GO:0080008,1,0.801345347517627,0,34,Cul4-RING E3 ubiquitin ligase complex,CC,
17084,GO:0080009,1,0.945816379872594,0,10,mRNA methylation,BP,
17085,GO:0080019,1,0.986709230365435,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17086,GO:0080023,1,0.988658446617857,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
17087,GO:0080025,1,0.855267727187616,0,22,phosphatidylinositol-3,5-bisphosphate binding,MF,
17088,GO:0080033,1,0.990956155649264,0,1,response to nitrite,BP,
17089,GO:0080048,1,0.994313214468247,0,1,GDP-D-glucose phosphorylase activity,MF,
17090,GO:0080058,1,0.99478068042453,0,1,protein deglutathionylation,BP,
17091,GO:0080084,1,0.959095722062837,0,5,5S rDNA binding,MF,
17093,GO:0080101,1,0.994818732113291,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17094,GO:0080111,1,0.851666508423031,0,22,DNA demethylation,BP,
17095,GO:0080120,1,0.988857153787632,0,2,CAAX-box protein maturation,BP,
17096,GO:0080121,1,0.988666535007313,0,2,AMP transport,BP,
17097,GO:0080122,1,0.98316336736653,0,3,AMP transmembrane transporter activity,MF,
17098,GO:0080129,1,0.994810722061292,0,1,proteasome core complex assembly,BP,
17099,GO:0080132,1,0.994489228030668,0,1,fatty acid alpha-hydroxylase activity,MF,
17102,GO:0080144,1,0.987780683722722,0,2,amino acid homeostasis,BP,
17103,GO:0080146,1,0.994711632107073,0,1,L-cysteine desulfhydrase activity,MF,
17104,GO:0080147,1,0.994831355742962,0,1,root hair cell development,BP,
17105,GO:0080154,1,0.903866797747574,0,16,regulation of fertilization,BP,
17106,GO:0080163,1,0.994503718951123,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17107,GO:0080171,1,0.677595419757375,0,58,lytic vacuole organization,BP,
17108,GO:0080182,1,0.88814659530517,0,16,histone H3-K4 trimethylation,BP,
17109,GO:0080184,1,0.972760715746544,0,5,response to phenylpropanoid,BP,
17110,GO:0085018,1,0.994325787082341,0,1,maintenance of symbiont-containing vacuole by host,BP,
17111,GO:0085020,1,0.957787516402578,0,7,protein K6-linked ubiquitination,BP,
17113,GO:0085032,1,0.993971684863889,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17115,GO:0086002,1,0.698330353970701,0,46,cardiac muscle cell action potential involved in contraction,BP,
17116,GO:0086003,1,0.651770930927885,0,56,cardiac muscle cell contraction,BP,
17117,GO:0086004,1,0.757366629512311,0,33,regulation of cardiac muscle cell contraction,BP,
17118,GO:0086005,1,0.796827025964157,0,29,ventricular cardiac muscle cell action potential,BP,
17119,GO:0086006,1,0.960953059821731,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17120,GO:0086007,1,0.950930024949933,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17123,GO:0086010,1,0.664230293052418,0,45,membrane depolarization during action potential,BP,
17125,GO:0086012,1,0.840170131656512,0,20,membrane depolarization during cardiac muscle cell action potential,BP,
17127,GO:0086014,1,0.856828496027384,0,18,atrial cardiac muscle cell action potential,BP,
17128,GO:0086015,1,0.917679847882201,0,8,SA node cell action potential,BP,
17129,GO:0086016,1,0.913085394144775,0,9,AV node cell action potential,BP,
17130,GO:0086017,1,0.977004101386809,0,3,Purkinje myocyte action potential,BP,
17131,GO:0086018,1,0.917679847882201,0,8,SA node cell to atrial cardiac muscle cell signaling,BP,
17132,GO:0086019,1,0.789341652333044,0,29,cell-cell signaling involved in cardiac conduction,BP,
17133,GO:0086020,1,0.989616923284924,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17134,GO:0086021,1,0.989616923284924,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17135,GO:0086023,1,0.942756437952837,0,6,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17136,GO:0086024,1,0.989128827457466,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17137,GO:0086026,1,0.856828496027384,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
17138,GO:0086027,1,0.913085394144775,0,9,AV node cell to bundle of His cell signaling,BP,
17139,GO:0086028,1,0.956801697798604,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
17140,GO:0086029,1,0.953812564199362,0,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
17141,GO:0086030,1,0.994631821892262,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
17142,GO:0086036,1,0.9469371394446,0,8,regulation of cardiac muscle cell membrane potential,BP,
17143,GO:0086037,1,0.993737449121973,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17144,GO:0086038,1,0.994313214468247,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17145,GO:0086039,1,0.989015467670684,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17146,GO:0086040,1,0.992780391725437,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17147,GO:0086041,1,0.990028602072303,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17148,GO:0086042,1,0.948683214985845,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
17149,GO:0086043,1,0.956801697798604,0,6,bundle of His cell action potential,BP,
17150,GO:0086045,1,0.950026309668525,0,5,membrane depolarization during AV node cell action potential,BP,
17151,GO:0086046,1,0.948214340306095,0,5,membrane depolarization during SA node cell action potential,BP,
17152,GO:0086047,1,0.977004101386809,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17153,GO:0086048,1,0.975717086678989,0,3,membrane depolarization during bundle of His cell action potential,BP,
17154,GO:0086050,1,0.994262702189102,0,1,membrane repolarization during bundle of His cell action potential,BP,
17155,GO:0086052,1,0.994262702189102,0,1,membrane repolarization during SA node cell action potential,BP,
17156,GO:0086053,1,0.989616923284924,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
17157,GO:0086056,1,0.967327086426462,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17158,GO:0086057,1,0.993480943220778,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17159,GO:0086059,1,0.979292266785046,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17160,GO:0086060,1,0.98876833012091,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17161,GO:0086061,1,0.98876833012091,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17162,GO:0086062,1,0.983617407899505,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17163,GO:0086063,1,0.98876833012091,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17164,GO:0086064,1,0.844655197019128,0,22,cell communication by electrical coupling involved in cardiac conduction,BP,
17165,GO:0086065,1,0.674338355999493,0,52,cell communication involved in cardiac conduction,BP,
17166,GO:0086066,1,0.856828496027384,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
17167,GO:0086067,1,0.903596199003812,0,10,AV node cell to bundle of His cell communication,BP,
17168,GO:0086068,1,0.953812564199362,0,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
17169,GO:0086069,1,0.907310344542501,0,13,bundle of His cell to Purkinje myocyte communication,BP,
17170,GO:0086070,1,0.908143381158792,0,9,SA node cell to atrial cardiac muscle cell communication,BP,
17171,GO:0086072,1,0.994469113191983,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17172,GO:0086073,1,0.953961951006506,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
17173,GO:0086075,1,0.983763222136202,0,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17174,GO:0086077,1,0.989616923284924,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17175,GO:0086080,1,0.921620518511564,0,10,protein binding involved in heterotypic cell-cell adhesion,MF,
17176,GO:0086082,1,0.994469113191983,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17177,GO:0086083,1,0.959709588963117,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
17178,GO:0086087,1,0.994262702189102,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17179,GO:0086089,1,0.97702351796457,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17180,GO:0086090,1,0.994262702189102,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17181,GO:0086091,1,0.763484529762027,0,35,regulation of heart rate by cardiac conduction,BP,
17182,GO:0086092,1,0.987537397156013,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17183,GO:0086096,1,0.994782178411431,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17184,GO:0086097,1,0.987385327018174,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
17185,GO:0086098,1,0.987702300522849,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17186,GO:0086100,1,0.986627249552027,0,2,endothelin receptor signaling pathway,BP,
17187,GO:0086103,1,0.921457795471554,0,10,G-protein coupled receptor signaling pathway involved in heart process,BP,
17188,GO:0089700,1,0.973047964287551,0,4,protein kinase D signaling,BP,
17189,GO:0089701,1,0.973021325199969,0,5,U2AF,CC,
17190,GO:0089709,1,0.983390295357406,0,3,L-histidine transmembrane transport,BP,
17191,GO:0089717,1,0.923615473853333,0,10,spanning component of membrane,CC,
17192,GO:0089718,1,0.873974145606776,0,19,amino acid import across plasma membrane,BP,
17193,GO:0089720,1,0.951608035308348,0,9,caspase binding,MF,
17194,GO:0090009,1,0.940222226796439,0,9,primitive streak formation,BP,
17195,GO:0090010,1,0.99461918156608,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17196,GO:0090022,1,0.828815922525687,0,34,regulation of neutrophil chemotaxis,BP,
17197,GO:0090023,1,0.854415166567101,0,29,positive regulation of neutrophil chemotaxis,BP,
17198,GO:0090024,1,0.986721474861037,0,2,negative regulation of neutrophil chemotaxis,BP,
17201,GO:0090027,1,0.974865072173382,0,4,negative regulation of monocyte chemotaxis,BP,
17202,GO:0090030,1,0.946225288991783,0,9,regulation of steroid hormone biosynthetic process,BP,
17203,GO:0090031,1,0.98209593909719,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17204,GO:0090032,1,0.970564983755838,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17205,GO:0090034,1,0.988006078789168,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17206,GO:0090035,1,0.988006078789168,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17207,GO:0090036,1,0.901601096756105,0,15,regulation of protein kinase C signaling,BP,
17208,GO:0090037,1,0.95062931088529,0,8,positive regulation of protein kinase C signaling,BP,
17209,GO:0090038,1,0.98756434560858,0,2,negative regulation of protein kinase C signaling,BP,
17210,GO:0090042,1,0.93498440776838,0,9,tubulin deacetylation,BP,
17211,GO:0090043,1,0.946417659271892,0,7,regulation of tubulin deacetylation,BP,
17212,GO:0090044,1,0.99474103000378,0,1,positive regulation of tubulin deacetylation,BP,
17213,GO:0090045,1,0.945146639916955,0,8,positive regulation of deacetylase activity,BP,
17216,GO:0090051,1,0.900210319736991,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17217,GO:0090063,1,0.973576173590369,0,4,positive regulation of microtubule nucleation,BP,
17218,GO:0090065,1,0.993341223717095,0,1,regulation of production of siRNA involved in RNA interference,BP,
17220,GO:0090067,1,0.992817761201889,0,1,regulation of thalamus size,BP,
17222,GO:0090069,1,0.917097392678889,0,13,regulation of ribosome biogenesis,BP,
17223,GO:0090070,1,0.951148807442856,0,8,positive regulation of ribosome biogenesis,BP,
17224,GO:0090071,1,0.971909316783143,0,4,negative regulation of ribosome biogenesis,BP,
17225,GO:0090073,1,0.943667451712857,0,9,positive regulation of protein homodimerization activity,BP,
17226,GO:0090074,1,0.963249824970594,0,5,negative regulation of protein homodimerization activity,BP,
17227,GO:0090075,1,0.83595623875864,0,27,relaxation of muscle,BP,
17228,GO:0090076,1,0.985763241011046,0,2,relaxation of skeletal muscle,BP,
17230,GO:0090079,1,0.852501589280314,0,24,translation regulator activity, nucleic acid binding,MF,
17231,GO:0090080,1,0.978983369739582,0,3,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17232,GO:0090081,1,0.989529875795574,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17233,GO:0090082,1,0.989529875795574,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17234,GO:0090083,1,0.899490924163782,0,15,regulation of inclusion body assembly,BP,
17235,GO:0090084,1,0.926934842715006,0,10,negative regulation of inclusion body assembly,BP,
17236,GO:0090085,1,0.930740801675285,0,11,regulation of protein deubiquitination,BP,
17237,GO:0090086,1,0.984358912373437,0,3,negative regulation of protein deubiquitination,BP,
17239,GO:0090088,1,0.989136565088683,0,2,regulation of oligopeptide transport,BP,
17240,GO:0090089,1,0.989136565088683,0,2,regulation of dipeptide transport,BP,
17244,GO:0090094,1,0.989221624044392,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17245,GO:0090095,1,0.994516974339215,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17246,GO:0090096,1,0.994516974339215,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17248,GO:0090101,1,0.476924676917672,0,103,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17250,GO:0090103,1,0.865149587730767,0,22,cochlea morphogenesis,BP,
17251,GO:0090107,1,0.976476208103327,0,3,regulation of high-density lipoprotein particle assembly,BP,
17252,GO:0090108,1,0.994623343944697,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17253,GO:0090109,1,0.669856256107226,0,53,regulation of cell-substrate junction assembly,BP,
17254,GO:0090110,1,0.912508800649291,0,13,cargo loading into COPII-coated vesicle,BP,
17255,GO:0090113,1,0.994590999317122,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17256,GO:0090114,1,0.625553153728043,0,69,COPII-coated vesicle budding,BP,
17257,GO:0090116,1,0.978530392639415,0,3,C-5 methylation of cytosine,BP,
17259,GO:0090119,1,0.987504271370098,0,2,vesicle-mediated cholesterol transport,BP,
17260,GO:0090122,1,0.994640378518815,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17261,GO:0090128,1,0.925195524543622,0,10,regulation of synapse maturation,BP,
17262,GO:0090129,1,0.939043823748275,0,8,positive regulation of synapse maturation,BP,
17264,GO:0090131,1,0.972645478205567,0,5,mesenchyme migration,BP,
17266,GO:0090133,1,0.99481475418972,0,1,mesendoderm migration,BP,
17267,GO:0090134,1,0.99481475418972,0,1,cell migration involved in mesendoderm migration,BP,
17268,GO:0090135,1,0.981053779404351,0,3,actin filament branching,BP,
17269,GO:0090136,1,0.904622725870301,0,15,epithelial cell-cell adhesion,BP,
17270,GO:0090138,1,0.993649078481915,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17271,GO:0090140,1,0.855117326478801,0,21,regulation of mitochondrial fission,BP,
17272,GO:0090141,1,0.909363449253361,0,14,positive regulation of mitochondrial fission,BP,
17274,GO:0090149,1,0.987380914210768,0,2,mitochondrial membrane fission,BP,
17276,GO:0090151,1,0.936701432947455,0,12,establishment of protein localization to mitochondrial membrane,BP,
17277,GO:0090153,1,0.926337183895722,0,13,regulation of sphingolipid biosynthetic process,BP,
17278,GO:0090154,1,0.95370240120272,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17279,GO:0090155,1,0.976438557646239,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17280,GO:0090156,1,0.9840855251832,0,3,cellular sphingolipid homeostasis,BP,
17281,GO:0090158,1,0.965598635015868,0,6,endoplasmic reticulum membrane organization,BP,
17282,GO:0090160,1,0.948196577982291,0,8,Golgi to lysosome transport,BP,
17283,GO:0090161,1,0.922473648877116,0,11,Golgi ribbon formation,BP,
17285,GO:0090164,1,0.984085379201587,0,2,asymmetric Golgi ribbon formation,BP,
17286,GO:0090166,1,0.963155447748484,0,6,Golgi disassembly,BP,
17287,GO:0090168,1,0.972905835044169,0,4,Golgi reassembly,BP,
17288,GO:0090169,1,0.830137755701635,0,25,regulation of spindle assembly,BP,
17289,GO:0090170,1,0.977608846490379,0,4,regulation of Golgi inheritance,BP,
17290,GO:0090171,1,0.993503837846473,0,1,chondrocyte morphogenesis,BP,
17292,GO:0090175,1,0.491908718005384,0,108,regulation of establishment of planar polarity,BP,
17293,GO:0090176,1,0.991695637841186,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17294,GO:0090177,1,0.897551712825658,0,15,establishment of planar polarity involved in neural tube closure,BP,
17295,GO:0090178,1,0.902249740101193,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17296,GO:0090179,1,0.908847929375744,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17297,GO:0090181,1,0.710518240326193,0,51,regulation of cholesterol metabolic process,BP,
17298,GO:0090182,1,0.989400300212156,0,2,regulation of secretion of lysosomal enzymes,BP,
17299,GO:0090183,1,0.733787525548785,0,48,regulation of kidney development,BP,
17300,GO:0090184,1,0.80633915303906,0,35,positive regulation of kidney development,BP,
17301,GO:0090185,1,0.914948788305633,0,15,negative regulation of kidney development,BP,
17302,GO:0090186,1,0.949049662980075,0,7,regulation of pancreatic juice secretion,BP,
17303,GO:0090187,1,0.989490545174921,0,2,positive regulation of pancreatic juice secretion,BP,
17304,GO:0090188,1,0.959133821272369,0,5,negative regulation of pancreatic juice secretion,BP,
17305,GO:0090189,1,0.885166575141976,0,20,regulation of branching involved in ureteric bud morphogenesis,BP,
17306,GO:0090190,1,0.899565715043995,0,17,positive regulation of branching involved in ureteric bud morphogenesis,BP,
17307,GO:0090191,1,0.977110679636347,0,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17308,GO:0090192,1,0.935468710294976,0,11,regulation of glomerulus development,BP,
17309,GO:0090193,1,0.952339958284345,0,8,positive regulation of glomerulus development,BP,
17310,GO:0090194,1,0.9822930037497,0,3,negative regulation of glomerulus development,BP,
17314,GO:0090198,1,0.994250988864267,0,1,negative regulation of chemokine secretion,BP,
17315,GO:0090199,1,0.778286384064107,0,42,regulation of release of cytochrome c from mitochondria,BP,
17316,GO:0090200,1,0.850855659981103,0,28,positive regulation of release of cytochrome c from mitochondria,BP,
17317,GO:0090201,1,0.909880121307219,0,15,negative regulation of release of cytochrome c from mitochondria,BP,
17318,GO:0090202,1,0.971002527499082,0,4,gene looping,BP,
17319,GO:0090204,1,0.979744542496257,0,3,protein localization to nuclear pore,BP,
17320,GO:0090205,1,0.961595609244147,0,6,positive regulation of cholesterol metabolic process,BP,
17321,GO:0090206,1,0.971677457338694,0,5,negative regulation of cholesterol metabolic process,BP,
17322,GO:0090207,1,0.856650114038588,0,25,regulation of triglyceride metabolic process,BP,
17323,GO:0090208,1,0.910034924934469,0,16,positive regulation of triglyceride metabolic process,BP,
17324,GO:0090209,1,0.962598536161984,0,6,negative regulation of triglyceride metabolic process,BP,
17325,GO:0090210,1,0.987644884410378,0,2,regulation of establishment of blood-brain barrier,BP,
17326,GO:0090212,1,0.987644884410378,0,2,negative regulation of establishment of blood-brain barrier,BP,
17327,GO:0090214,1,0.984057582642314,0,2,spongiotrophoblast layer developmental growth,BP,
17328,GO:0090218,1,0.805345951925728,0,32,positive regulation of lipid kinase activity,BP,
17329,GO:0090219,1,0.98155195924512,0,3,negative regulation of lipid kinase activity,BP,
17330,GO:0090220,1,0.933943561865393,0,10,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17331,GO:0090222,1,0.979940955634095,0,2,centrosome-templated microtubule nucleation,BP,
17332,GO:0090224,1,0.749622293209134,0,39,regulation of spindle organization,BP,
17333,GO:0090226,1,0.994828949680571,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17334,GO:0090230,1,0.971995930973274,0,4,regulation of centromere complex assembly,BP,
17335,GO:0090231,1,0.907380311913289,0,15,regulation of spindle checkpoint,BP,
17336,GO:0090232,1,0.946693612221658,0,8,positive regulation of spindle checkpoint,BP,
17337,GO:0090233,1,0.994366597416677,0,1,negative regulation of spindle checkpoint,BP,
17338,GO:0090234,1,0.979281384983435,0,3,regulation of kinetochore assembly,BP,
17339,GO:0090235,1,0.94011203903208,0,7,regulation of metaphase plate congression,BP,
17340,GO:0090237,1,0.967174611026159,0,5,regulation of arachidonic acid secretion,BP,
17341,GO:0090238,1,0.97467119804912,0,4,positive regulation of arachidonic acid secretion,BP,
17342,GO:0090239,1,0.928092723882948,0,12,regulation of histone H4 acetylation,BP,
17343,GO:0090240,1,0.95555982799077,0,7,positive regulation of histone H4 acetylation,BP,
17344,GO:0090241,1,0.971881788101411,0,5,negative regulation of histone H4 acetylation,BP,
17345,GO:0090244,1,0.969804314920573,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17346,GO:0090245,1,0.965240853489076,0,4,axis elongation involved in somitogenesis,BP,
17347,GO:0090246,1,0.992894108735709,0,1,convergent extension involved in somitogenesis,BP,
17348,GO:0090247,1,0.994412229846995,0,1,cell motility involved in somitogenic axis elongation,BP,
17349,GO:0090249,1,0.994412229846995,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17350,GO:0090251,1,0.98602769456245,0,1,protein localization involved in establishment of planar polarity,BP,
17351,GO:0090257,1,0.246572261884565,0,200,regulation of muscle system process,BP,
17352,GO:0090258,1,0.977043684752551,0,3,negative regulation of mitochondrial fission,BP,
17353,GO:0090259,1,0.968402641550149,0,5,regulation of retinal ganglion cell axon guidance,BP,
17354,GO:0090260,1,0.985733836687052,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17355,GO:0090261,1,0.97859123957198,0,4,positive regulation of inclusion body assembly,BP,
17357,GO:0090264,1,0.989225635570567,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17358,GO:0090265,1,0.99445621570624,0,1,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17359,GO:0090266,1,0.912896651625669,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17360,GO:0090267,1,0.952446504795196,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17361,GO:0090269,1,0.95672381302745,0,6,fibroblast growth factor production,BP,
17362,GO:0090270,1,0.95672381302745,0,6,regulation of fibroblast growth factor production,BP,
17363,GO:0090271,1,0.975485504236704,0,3,positive regulation of fibroblast growth factor production,BP,
17364,GO:0090272,1,0.980771541046945,0,3,negative regulation of fibroblast growth factor production,BP,
17365,GO:0090273,1,0.988923344568684,0,2,regulation of somatostatin secretion,BP,
17366,GO:0090274,1,0.988923344568684,0,2,positive regulation of somatostatin secretion,BP,
17368,GO:0090277,1,0.619721344854021,0,79,positive regulation of peptide hormone secretion,BP,
17372,GO:0090281,1,0.973509140554411,0,5,negative regulation of calcium ion import,BP,
17373,GO:0090282,1,0.994160784313231,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17374,GO:0090283,1,0.979139990603139,0,3,regulation of protein glycosylation in Golgi,BP,
17375,GO:0090284,1,0.990012409788298,0,1,positive regulation of protein glycosylation in Golgi,BP,
17376,GO:0090285,1,0.98901899170654,0,2,negative regulation of protein glycosylation in Golgi,BP,
17377,GO:0090286,1,0.942421310148104,0,6,cytoskeletal anchoring at nuclear membrane,BP,
17379,GO:0090288,1,0.407268807517274,0,126,negative regulation of cellular response to growth factor stimulus,BP,
17380,GO:0090289,1,0.981082709830754,0,3,regulation of osteoclast proliferation,BP,
17381,GO:0090290,1,0.994815198226221,0,1,positive regulation of osteoclast proliferation,BP,
17382,GO:0090291,1,0.986196653318246,0,2,negative regulation of osteoclast proliferation,BP,
17383,GO:0090292,1,0.967082076900176,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17384,GO:0090293,1,0.99459757150219,0,1,nitrogen catabolite regulation of transcription,BP,
17385,GO:0090294,1,0.99459757150219,0,1,nitrogen catabolite activation of transcription,BP,
17386,GO:0090296,1,0.975613754508581,0,4,regulation of mitochondrial DNA replication,BP,
17387,GO:0090297,1,0.994791275038158,0,1,positive regulation of mitochondrial DNA replication,BP,
17388,GO:0090298,1,0.980723063824926,0,3,negative regulation of mitochondrial DNA replication,BP,
17389,GO:0090299,1,0.99472916788927,0,1,regulation of neural crest formation,BP,
17390,GO:0090301,1,0.99472916788927,0,1,negative regulation of neural crest formation,BP,
17393,GO:0090305,1,0.184415775901476,0,265,nucleic acid phosphodiester bond hydrolysis,BP,
17394,GO:0090306,1,0.969062182582611,0,4,spindle assembly involved in meiosis,BP,
17395,GO:0090307,1,0.653301096311991,0,62,mitotic spindle assembly,BP,
17396,GO:0090308,1,0.948789386328753,0,7,regulation of methylation-dependent chromatin silencing,BP,
17397,GO:0090309,1,0.972243388207632,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17398,GO:0090310,1,0.982087912491318,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
17399,GO:0090311,1,0.771283099154299,0,36,regulation of protein deacetylation,BP,
17400,GO:0090312,1,0.871942274416434,0,20,positive regulation of protein deacetylation,BP,
17403,GO:0090315,1,0.971795429608004,0,5,negative regulation of protein targeting to membrane,BP,
17405,GO:0090317,1,0.801235073137124,0,36,negative regulation of intracellular protein transport,BP,
17406,GO:0090322,1,0.854939549140104,0,27,regulation of superoxide metabolic process,BP,
17407,GO:0090323,1,0.994838740001473,0,1,prostaglandin secretion involved in immune response,BP,
17408,GO:0090324,1,0.970986406632481,0,5,negative regulation of oxidative phosphorylation,BP,
17409,GO:0090325,1,0.981639957867783,0,3,regulation of locomotion involved in locomotory behavior,BP,
17410,GO:0090326,1,0.993959328102125,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17411,GO:0090327,1,0.993190308254836,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17412,GO:0090329,1,0.740464383823255,0,45,regulation of DNA-dependent DNA replication,BP,
17414,GO:0090331,1,0.93095415609861,0,11,negative regulation of platelet aggregation,BP,
17417,GO:0090340,1,0.994623343944697,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17418,GO:0090341,1,0.994749004697104,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17419,GO:0090342,1,0.768274207711772,0,39,regulation of cell aging,BP,
17420,GO:0090343,1,0.943668675822163,0,10,positive regulation of cell aging,BP,
17421,GO:0090344,1,0.861340239703616,0,21,negative regulation of cell aging,BP,
17422,GO:0090345,1,0.989225295605158,0,2,cellular organohalogen metabolic process,BP,
17423,GO:0090346,1,0.989225295605158,0,2,cellular organofluorine metabolic process,BP,
17424,GO:0090347,1,0.994744420879121,0,1,regulation of cellular organohalogen metabolic process,BP,
17425,GO:0090348,1,0.994744420879121,0,1,regulation of cellular organofluorine metabolic process,BP,
17426,GO:0090349,1,0.994744420879121,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17427,GO:0090350,1,0.994744420879121,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17428,GO:0090360,1,0.982203351521756,0,3,platelet-derived growth factor production,BP,
17429,GO:0090361,1,0.982203351521756,0,3,regulation of platelet-derived growth factor production,BP,
17430,GO:0090362,1,0.987511962347244,0,2,positive regulation of platelet-derived growth factor production,BP,
17431,GO:0090365,1,0.99458608151339,0,1,regulation of mRNA modification,BP,
17432,GO:0090367,1,0.99458608151339,0,1,negative regulation of mRNA modification,BP,
17433,GO:0090370,1,0.980369304348615,0,3,negative regulation of cholesterol efflux,BP,
17434,GO:0090381,1,0.989529875795574,0,2,regulation of heart induction,BP,
17435,GO:0090382,1,0.779176945870869,0,40,phagosome maturation,BP,
17436,GO:0090383,1,0.85961037696541,0,26,phagosome acidification,BP,
17437,GO:0090385,1,0.956374779723729,0,7,phagosome-lysosome fusion,BP,
17438,GO:0090386,1,0.982670192334707,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17439,GO:0090387,1,0.982670192334707,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17440,GO:0090389,1,0.989604414567483,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17441,GO:0090394,1,0.929805696937284,0,10,negative regulation of excitatory postsynaptic potential,BP,
17442,GO:0090398,1,0.684079108486869,0,58,cellular senescence,BP,
17444,GO:0090400,1,0.951957292428665,0,8,stress-induced premature senescence,BP,
17445,GO:0090402,1,0.988964107994494,0,2,oncogene-induced cell senescence,BP,
17446,GO:0090403,1,0.97541472584671,0,4,oxidative stress-induced premature senescence,BP,
17448,GO:0090409,1,0.994546341260019,0,1,malonyl-CoA synthetase activity,MF,
17449,GO:0090410,1,0.994546341260019,0,1,malonate catabolic process,BP,
17450,GO:0090416,1,0.994425124328196,0,1,nicotinate transmembrane transporter activity,MF,
17451,GO:0090420,1,0.994774589322036,0,1,naphthalene-containing compound metabolic process,BP,
17452,GO:0090422,1,0.989145855939088,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17453,GO:0090425,1,0.994125776747889,0,1,acinar cell differentiation,BP,
17454,GO:0090427,1,0.979849868869697,0,3,activation of meiosis,BP,
17455,GO:0090435,1,0.956870745805789,0,7,protein localization to nuclear envelope,BP,
17456,GO:0090461,1,0.993067605326437,0,1,glutamate homeostasis,BP,
17457,GO:0090472,1,0.993164182413726,0,1,dibasic protein processing,BP,
17458,GO:0090480,1,0.978927119602001,0,3,purine nucleotide-sugar transmembrane transport,BP,
17459,GO:0090481,1,0.934469958196671,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17460,GO:0090482,1,0.871029539773269,0,22,vitamin transmembrane transporter activity,MF,
17461,GO:0090493,1,0.938057653247139,0,11,catecholamine uptake,BP,
17462,GO:0090494,1,0.938057653247139,0,11,dopamine uptake,BP,
17463,GO:0090498,1,0.979747753764277,0,3,extrinsic component of Golgi membrane,CC,
17464,GO:0090500,1,0.970534159455595,0,5,endocardial cushion to mesenchymal transition,BP,
17465,GO:0090501,1,0.443121296114932,0,129,RNA phosphodiester bond hydrolysis,BP,
17466,GO:0090502,1,0.685050919676107,0,62,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17467,GO:0090503,1,0.789743281017569,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17470,GO:0090520,1,0.932429619954583,0,12,sphingolipid mediated signaling pathway,BP,
17471,GO:0090521,1,0.973057806242039,0,4,glomerular visceral epithelial cell migration,BP,
17472,GO:0090527,1,0.919174692104647,0,11,actin filament reorganization,BP,
17473,GO:0090529,1,0.994686629942592,0,1,cell septum assembly,BP,
17474,GO:0090533,1,0.912665982419849,0,15,cation-transporting ATPase complex,CC,
17475,GO:0090534,1,0.994719259578768,0,1,calcium ion-transporting ATPase complex,CC,
17476,GO:0090537,1,0.984985282844406,0,2,CERF complex,CC,
17477,GO:0090541,1,0.987328585689368,0,2,MIT domain binding,MF,
17478,GO:0090543,1,0.841446164631776,0,26,Flemming body,CC,
17479,GO:0090545,1,0.874164894137081,0,17,CHD-type complex,CC,
17480,GO:0090554,1,0.963614575532339,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17481,GO:0090555,1,0.982419289041465,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17482,GO:0090556,1,0.977438176542627,0,2,phosphatidylserine-translocating ATPase activity,MF,
17483,GO:0090557,1,0.939531044597669,0,8,establishment of endothelial intestinal barrier,BP,
17484,GO:0090558,1,0.994831355742962,0,1,plant epidermis development,BP,
17485,GO:0090559,1,0.628872997614344,0,76,regulation of membrane permeability,BP,
17486,GO:0090560,1,0.994594991187779,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17487,GO:0090568,1,0.803042366609324,0,29,nuclear transcriptional repressor complex,CC,
17488,GO:0090571,1,0.977191709285994,0,4,RNA polymerase II transcription repressor complex,CC,
17489,GO:0090575,1,0.375727806543486,0,147,RNA polymerase II transcription factor complex,CC,
17490,GO:0090576,1,0.942031303554069,0,8,RNA polymerase III transcription factor complex,CC,
17491,GO:0090579,1,0.971002527499082,0,4,dsDNA loop formation,BP,
17492,GO:0090594,1,0.960087085557674,0,7,inflammatory response to wounding,BP,
17493,GO:0090596,1,0.200334885830563,0,229,sensory organ morphogenesis,BP,
17494,GO:0090598,1,0.9809024671322,0,3,male anatomical structure morphogenesis,BP,
17495,GO:0090599,1,0.961292730219606,0,5,alpha-glucosidase activity,MF,
17496,GO:0090600,1,0.993434803223848,0,1,alpha-1,3-glucosidase activity,MF,
17497,GO:0090601,1,0.992184511093937,0,1,enucleation,BP,
17498,GO:0090611,1,0.969952546171566,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17499,GO:0090615,1,0.987462270695811,0,2,mitochondrial mRNA processing,BP,
17500,GO:0090616,1,0.992756085097393,0,1,mitochondrial mRNA 3'-end processing,BP,
17501,GO:0090624,1,0.994313214468247,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17502,GO:0090625,1,0.994313214468247,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17503,GO:0090627,1,0.994831355742962,0,1,plant epidermal cell differentiation,BP,
17504,GO:0090630,1,0.569279339568925,0,79,activation of GTPase activity,BP,
17505,GO:0090634,1,0.994756723610098,0,1,microglial cell mediated cytotoxicity,BP,
17506,GO:0090646,1,0.933247499406067,0,12,mitochondrial tRNA processing,BP,
17507,GO:0090647,1,0.95269445738878,0,7,modulation of age-related behavioral decline,BP,
17508,GO:0090648,1,0.991041339038764,0,1,response to environmental enrichment,BP,
17509,GO:0090649,1,0.957610737208576,0,5,response to oxygen-glucose deprivation,BP,
17510,GO:0090650,1,0.957610737208576,0,5,cellular response to oxygen-glucose deprivation,BP,
17511,GO:0090651,1,0.990511545130804,0,1,apical cytoplasm,CC,
17512,GO:0090656,1,0.913739601252945,0,14,t-circle formation,BP,
17513,GO:0090657,1,0.937196968227062,0,10,telomeric loop disassembly,BP,
17514,GO:0090659,1,0.814343307245105,0,27,walking behavior,BP,
17515,GO:0090661,1,0.97905942403606,0,4,box H/ACA telomerase RNP complex,CC,
17516,GO:0090662,1,0.838823471904883,0,29,ATP hydrolysis coupled transmembrane transport,BP,
17517,GO:0090663,1,0.989620894592879,0,2,galanin-activated signaling pathway,BP,
17518,GO:0090665,1,0.863180246919007,0,20,glycoprotein complex,CC,
17519,GO:0090666,1,0.978532526167439,0,4,scaRNA localization to Cajal body,BP,
17520,GO:0090667,1,0.989386957859997,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17521,GO:0090668,1,0.989386957859997,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17522,GO:0090669,1,0.977158412158408,0,4,telomerase RNA stabilization,BP,
17523,GO:0090670,1,0.895393699389713,0,19,RNA localization to Cajal body,BP,
17524,GO:0090671,1,0.895393699389713,0,19,telomerase RNA localization to Cajal body,BP,
17525,GO:0090672,1,0.895393699389713,0,19,telomerase RNA localization,BP,
17526,GO:0090673,1,0.989912378685018,0,1,endothelial cell-matrix adhesion,BP,
17527,GO:0090675,1,0.993119458307179,0,1,intermicrovillar adhesion,BP,
17528,GO:0090677,1,0.988965127905062,0,2,reversible differentiation,BP,
17529,GO:0090678,1,0.988965127905062,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17530,GO:0090685,1,0.895393699389713,0,19,RNA localization to nucleus,BP,
17531,GO:0090694,1,0.981570189219491,0,2,Scc2-Scc4 cohesin loading complex,CC,
17532,GO:0090713,1,0.960321137928364,0,6,immunological memory process,BP,
17533,GO:0090715,1,0.960321137928364,0,6,immunological memory formation process,BP,
17534,GO:0090722,1,0.972063903740188,0,4,receptor-receptor interaction,MF,
17535,GO:0090723,1,0.912188834434115,0,14,growth cone part,CC,
17536,GO:0090724,1,0.981007761653478,0,3,central region of growth cone,CC,
17537,GO:0090725,1,0.994825831378211,0,1,peripheral region of growth cone,CC,
17538,GO:0090731,1,0.99480248296677,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17539,GO:0090734,1,0.800113057150557,0,33,site of DNA damage,CC,
17540,GO:0090735,1,0.945462601623747,0,10,DNA repair complex assembly,BP,
17541,GO:0090737,1,0.913739601252945,0,14,telomere maintenance via telomere trimming,BP,
17542,GO:0090741,1,0.941599540174137,0,11,pigment granule membrane,CC,
17543,GO:0093001,1,0.994021764681185,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17544,GO:0095500,1,0.875913943703332,0,21,acetylcholine receptor signaling pathway,BP,
17545,GO:0097001,1,0.943697762251285,0,10,ceramide binding,MF,
17546,GO:0097003,1,0.988016482577244,0,2,adipokinetic hormone receptor activity,MF,
17548,GO:0097009,1,0.885350550697969,0,18,energy homeostasis,BP,
17549,GO:0097010,1,0.979993664438772,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17550,GO:0097011,1,0.953767802020049,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17551,GO:0097012,1,0.953767802020049,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17553,GO:0097014,1,0.462523948359005,0,102,ciliary plasm,CC,
17554,GO:0097016,1,0.974698416410043,0,4,L27 domain binding,MF,
17555,GO:0097017,1,0.988819695847527,0,2,renal protein absorption,BP,
17556,GO:0097018,1,0.994452945073479,0,1,renal albumin absorption,BP,
17557,GO:0097020,1,0.993903514396179,0,1,COPII adaptor activity,MF,
17558,GO:0097021,1,0.981849174629996,0,3,lymphocyte migration into lymphoid organs,BP,
17559,GO:0097022,1,0.994590650166733,0,1,lymphocyte migration into lymph node,BP,
17560,GO:0097025,1,0.967012211263273,0,5,MPP7-DLG1-LIN7 complex,CC,
17561,GO:0097026,1,0.973642106390491,0,4,dendritic cell dendrite assembly,BP,
17562,GO:0097027,1,0.961239476629069,0,7,ubiquitin-protein transferase activator activity,MF,
17563,GO:0097028,1,0.805526123827348,0,37,dendritic cell differentiation,BP,
17564,GO:0097029,1,0.978665982485292,0,4,mature conventional dendritic cell differentiation,BP,
17565,GO:0097035,1,0.75068045580666,0,37,regulation of membrane lipid distribution,BP,
17566,GO:0097036,1,0.994769348797587,0,1,regulation of plasma membrane sterol distribution,BP,
17567,GO:0097037,1,0.993846981143619,0,1,heme export,BP,
17568,GO:0097038,1,0.926269753504148,0,11,perinuclear endoplasmic reticulum,CC,
17569,GO:0097039,1,0.963763834029737,0,5,protein linear polyubiquitination,BP,
17570,GO:0097045,1,0.992568131403646,0,1,phosphatidylserine exposure on blood platelet,BP,
17571,GO:0097048,1,0.941128995092377,0,10,dendritic cell apoptotic process,BP,
17573,GO:0097050,1,0.919483087582367,0,12,type B pancreatic cell apoptotic process,BP,
17574,GO:0097051,1,0.976036236041386,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17575,GO:0097052,1,0.983896880825928,0,3,L-kynurenine metabolic process,BP,
17576,GO:0097053,1,0.994761655063573,0,1,L-kynurenine catabolic process,BP,
17577,GO:0097055,1,0.988924110316388,0,2,agmatine biosynthetic process,BP,
17578,GO:0097056,1,0.97589431243242,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17579,GO:0097057,1,0.989398151440021,0,2,TRAF2-GSTP1 complex,CC,
17580,GO:0097058,1,0.984156693446431,0,3,CRLF-CLCF1 complex,CC,
17581,GO:0097059,1,0.989376387990073,0,2,CNTFR-CLCF1 complex,CC,
17584,GO:0097062,1,0.882894483024778,0,17,dendritic spine maintenance,BP,
17585,GO:0097064,1,0.775672447998252,0,36,ncRNA export from nucleus,BP,
17586,GO:0097065,1,0.961512915719456,0,6,anterior head development,BP,
17588,GO:0097067,1,0.897909794550321,0,16,cellular response to thyroid hormone stimulus,BP,
17589,GO:0097068,1,0.969098568314298,0,5,response to thyroxine,BP,
17590,GO:0097069,1,0.987755890252162,0,2,cellular response to thyroxine stimulus,BP,
17591,GO:0097070,1,0.96548320751774,0,5,ductus arteriosus closure,BP,
17593,GO:0097086,1,0.993656100488896,0,1,amniotic stem cell differentiation,BP,
17594,GO:0097089,1,0.989293367944536,0,2,methyl-branched fatty acid metabolic process,BP,
17595,GO:0097090,1,0.909488935537873,0,12,presynaptic membrane organization,BP,
17596,GO:0097091,1,0.933305519023446,0,9,synaptic vesicle clustering,BP,
17597,GO:0097094,1,0.897368599868353,0,15,craniofacial suture morphogenesis,BP,
17598,GO:0097100,1,0.971252040247105,0,5,supercoiled DNA binding,MF,
17599,GO:0097101,1,0.983022062183312,0,3,blood vessel endothelial cell fate specification,BP,
17600,GO:0097102,1,0.988440903756745,0,2,endothelial tip cell fate specification,BP,
17601,GO:0097104,1,0.911877066498828,0,11,postsynaptic membrane assembly,BP,
17602,GO:0097105,1,0.923857979396445,0,10,presynaptic membrane assembly,BP,
17605,GO:0097108,1,0.976657575080933,0,3,hedgehog family protein binding,MF,
17606,GO:0097109,1,0.960092305897001,0,5,neuroligin family protein binding,MF,
17608,GO:0097111,1,0.981308196982538,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17609,GO:0097112,1,0.987270941052782,0,2,gamma-aminobutyric acid receptor clustering,BP,
17611,GO:0097114,1,0.963650525309017,0,4,NMDA glutamate receptor clustering,BP,
17612,GO:0097115,1,0.992429697060513,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17613,GO:0097116,1,0.971778271909864,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17614,GO:0097117,1,0.990096484830148,0,1,guanylate kinase-associated protein clustering,BP,
17615,GO:0097118,1,0.96267496053972,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17616,GO:0097119,1,0.926305476243317,0,9,postsynaptic density protein 95 clustering,BP,
17618,GO:0097123,1,0.989264501985185,0,2,cyclin A1-CDK2 complex,CC,
17619,GO:0097124,1,0.988893447542778,0,2,cyclin A2-CDK2 complex,CC,
17620,GO:0097125,1,0.989356173180565,0,2,cyclin B1-CDK1 complex,CC,
17621,GO:0097129,1,0.980436457401483,0,3,cyclin D2-CDK4 complex,CC,
17622,GO:0097134,1,0.98927383059968,0,2,cyclin E1-CDK2 complex,CC,
17623,GO:0097135,1,0.988933267376157,0,2,cyclin E2-CDK2 complex,CC,
17624,GO:0097136,1,0.964069735385222,0,6,Bcl-2 family protein complex,CC,
17625,GO:0097144,1,0.994829850254701,0,1,BAX complex,CC,
17626,GO:0097145,1,0.994582172474536,0,1,BAK complex,CC,
17627,GO:0097149,1,0.981278313331703,0,3,centralspindlin complex,CC,
17628,GO:0097150,1,0.834111775701614,0,22,neuronal stem cell population maintenance,BP,
17630,GO:0097152,1,0.928533886193539,0,12,mesenchymal cell apoptotic process,BP,
17631,GO:0097153,1,0.928591776964919,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17632,GO:0097154,1,0.929833329808345,0,12,GABAergic neuron differentiation,BP,
17633,GO:0097155,1,0.970707252325274,0,3,fasciculation of sensory neuron axon,BP,
17634,GO:0097156,1,0.984087206625866,0,2,fasciculation of motor neuron axon,BP,
17635,GO:0097157,1,0.944386900937538,0,8,pre-mRNA intronic binding,MF,
17636,GO:0097158,1,0.994733218655072,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17638,GO:0097161,1,0.990920891506829,0,1,DH domain binding,MF,
17639,GO:0097162,1,0.993973223617764,0,1,MADS box domain binding,MF,
17641,GO:0097165,1,0.968356500573701,0,5,nuclear stress granule,CC,
17642,GO:0097166,1,0.983269691129304,0,2,lens epithelial cell proliferation,BP,
17643,GO:0097167,1,0.973145400685514,0,4,circadian regulation of translation,BP,
17644,GO:0097168,1,0.987412212557465,0,2,mesenchymal stem cell proliferation,BP,
17645,GO:0097169,1,0.974248455773756,0,5,AIM2 inflammasome complex,CC,
17646,GO:0097176,1,0.978674273944801,0,4,epoxide metabolic process,BP,
17647,GO:0097177,1,0.983913636037267,0,3,mitochondrial ribosome binding,MF,
17648,GO:0097178,1,0.812456316915106,0,34,ruffle assembly,BP,
17649,GO:0097179,1,0.979079902947047,0,4,protease inhibitor complex,CC,
17650,GO:0097180,1,0.989297799334892,0,2,serine protease inhibitor complex,CC,
17651,GO:0097181,1,0.994536892262681,0,1,protein C inhibitor-coagulation factor V complex,CC,
17652,GO:0097182,1,0.994536892262681,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17653,GO:0097183,1,0.994536892262681,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17654,GO:0097186,1,0.890341435305997,0,16,amelogenesis,BP,
17658,GO:0097192,1,0.652422258823155,0,67,extrinsic apoptotic signaling pathway in absence of ligand,BP,
17659,GO:0097193,1,0.178758107720286,0,269,intrinsic apoptotic signaling pathway,BP,
17660,GO:0097194,1,0.60649868280984,0,77,execution phase of apoptosis,BP,
17661,GO:0097195,1,0.982080053533344,0,3,pilomotor reflex,BP,
17662,GO:0097196,1,0.989005550765279,0,2,Shu complex,CC,
17664,GO:0097198,1,0.983048670031778,0,2,histone H3-K36 trimethylation,BP,
17665,GO:0097199,1,0.965398774556846,0,6,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17666,GO:0097200,1,0.938272760006141,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17667,GO:0097201,1,0.930565517501145,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17668,GO:0097202,1,0.915387107247032,0,13,activation of cysteine-type endopeptidase activity,BP,
17669,GO:0097205,1,0.902038703662703,0,16,renal filtration,BP,
17670,GO:0097208,1,0.96363641599132,0,6,alveolar lamellar body,CC,
17671,GO:0097209,1,0.972004104943296,0,4,epidermal lamellar body,CC,
17672,GO:0097210,1,0.969355981619521,0,5,response to gonadotropin-releasing hormone,BP,
17673,GO:0097211,1,0.969355981619521,0,5,cellular response to gonadotropin-releasing hormone,BP,
17674,GO:0097212,1,0.984138995505342,0,3,lysosomal membrane organization,BP,
17675,GO:0097213,1,0.989431418110919,0,2,regulation of lysosomal membrane permeability,BP,
17676,GO:0097214,1,0.994838254403445,0,1,positive regulation of lysosomal membrane permeability,BP,
17677,GO:0097222,1,0.992756085097393,0,1,mitochondrial mRNA polyadenylation,BP,
17678,GO:0097223,1,0.417418698930377,0,140,sperm part,CC,
17679,GO:0097224,1,0.989418356810579,0,2,sperm connecting piece,CC,
17680,GO:0097225,1,0.913214902399105,0,16,sperm midpiece,CC,
17681,GO:0097226,1,0.994547896715614,0,1,sperm mitochondrial sheath,CC,
17682,GO:0097227,1,0.968606918752646,0,5,sperm annulus,CC,
17683,GO:0097228,1,0.893363413632025,0,18,sperm principal piece,CC,
17684,GO:0097229,1,0.994784709095009,0,1,sperm end piece,CC,
17685,GO:0097231,1,0.994717954834515,0,1,cell motility in response to calcium ion,BP,
17686,GO:0097232,1,0.984599163094315,0,2,lamellar body membrane,CC,
17687,GO:0097233,1,0.984599163094315,0,2,alveolar lamellar body membrane,CC,
17689,GO:0097238,1,0.989624248420674,0,2,cellular response to methylglyoxal,BP,
17690,GO:0097240,1,0.96960953826279,0,5,chromosome attachment to the nuclear envelope,BP,
17691,GO:0097241,1,0.989029043127758,0,2,hematopoietic stem cell migration to bone marrow,BP,
17692,GO:0097242,1,0.853532800918875,0,19,amyloid-beta clearance,BP,
17693,GO:0097252,1,0.982646024987019,0,3,oligodendrocyte apoptotic process,BP,
17694,GO:0097254,1,0.99460920833876,0,1,renal tubular secretion,BP,
17695,GO:0097255,1,0.967790941008117,0,6,R2TP complex,CC,
17696,GO:0097258,1,0.994176244190549,0,1,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17697,GO:0097259,1,0.994176244190549,0,1,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17698,GO:0097260,1,0.994362833533223,0,1,eoxin A4 synthase activity,MF,
17699,GO:0097264,1,0.958835410054583,0,7,self proteolysis,BP,
17700,GO:0097267,1,0.974113251238329,0,4,omega-hydroxylase P450 pathway,BP,
17701,GO:0097272,1,0.986311129488637,0,2,ammonia homeostasis,BP,
17702,GO:0097273,1,0.991535367327897,0,1,creatinine homeostasis,BP,
17703,GO:0097274,1,0.985410274957174,0,2,urea homeostasis,BP,
17704,GO:0097275,1,0.991535367327897,0,1,cellular ammonia homeostasis,BP,
17705,GO:0097276,1,0.991535367327897,0,1,cellular creatinine homeostasis,BP,
17706,GO:0097277,1,0.991535367327897,0,1,cellular urea homeostasis,BP,
17707,GO:0097278,1,0.983612356677493,0,3,complement-dependent cytotoxicity,BP,
17708,GO:0097283,1,0.97241739537923,0,5,keratinocyte apoptotic process,BP,
17709,GO:0097284,1,0.926602598528046,0,12,hepatocyte apoptotic process,BP,
17711,GO:0097291,1,0.994643973158254,0,1,renal phosphate ion absorption,BP,
17712,GO:0097296,1,0.924563655735684,0,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17713,GO:0097298,1,0.99341342827093,0,1,regulation of nucleus size,BP,
17714,GO:0097300,1,0.780134980464836,0,41,programmed necrotic cell death,BP,
17716,GO:0097306,1,0.679604251003524,0,53,cellular response to alcohol,BP,
17717,GO:0097309,1,0.988658446617857,0,2,cap1 mRNA methylation,BP,
17718,GO:0097310,1,0.994313214468247,0,1,cap2 mRNA methylation,BP,
17719,GO:0097320,1,0.892672651385523,0,17,plasma membrane tubulation,BP,
17720,GO:0097322,1,0.955101267599528,0,7,7SK snRNA binding,MF,
17721,GO:0097323,1,0.988003575419576,0,2,B cell adhesion,BP,
17722,GO:0097324,1,0.980358451115112,0,2,melanocyte migration,BP,
17723,GO:0097325,1,0.985812762995611,0,2,melanocyte proliferation,BP,
17724,GO:0097326,1,0.992154089340602,0,1,melanocyte adhesion,BP,
17725,GO:0097327,1,0.575305123905848,0,84,response to antineoplastic agent,BP,
17726,GO:0097329,1,0.918791482949712,0,12,response to antimetabolite,BP,
17727,GO:0097332,1,0.981459314287446,0,3,response to antipsychotic drug,BP,
17728,GO:0097338,1,0.986569577694023,0,2,response to clozapine,BP,
17729,GO:0097340,1,0.905933465582805,0,13,inhibition of cysteine-type endopeptidase activity,BP,
17730,GO:0097341,1,0.905933465582805,0,13,zymogen inhibition,BP,
17731,GO:0097342,1,0.963573054288156,0,6,ripoptosome,CC,
17732,GO:0097343,1,0.975907141716127,0,3,ripoptosome assembly,BP,
17733,GO:0097344,1,0.988903609716527,0,2,Rix1 complex,CC,
17734,GO:0097345,1,0.733074879581615,0,53,mitochondrial outer membrane permeabilization,BP,
17735,GO:0097346,1,0.860165957621549,0,23,INO80-type complex,CC,
17737,GO:0097352,1,0.804219935016956,0,34,autophagosome maturation,BP,
17738,GO:0097354,1,0.939534328425072,0,9,prenylation,BP,
17739,GO:0097359,1,0.978996318991696,0,2,UDP-glucosylation,BP,
17740,GO:0097360,1,0.968669254389989,0,4,chorionic trophoblast cell proliferation,BP,
17741,GO:0097361,1,0.976584290162193,0,4,CIA complex,CC,
17742,GO:0097362,1,0.988120538645905,0,2,MCM8-MCM9 complex,CC,
17743,GO:0097363,1,0.986197301329826,0,2,protein O-GlcNAc transferase activity,MF,
17746,GO:0097368,1,0.972118879162757,0,4,establishment of Sertoli cell barrier,BP,
17747,GO:0097371,1,0.950895866594879,0,7,MDM2/MDM4 family protein binding,MF,
17748,GO:0097372,1,0.994717517892978,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17749,GO:0097374,1,0.994463161779309,0,1,sensory neuron axon guidance,BP,
17750,GO:0097376,1,0.98934353335753,0,2,interneuron axon guidance,BP,
17751,GO:0097377,1,0.994543213780754,0,1,spinal cord interneuron axon guidance,BP,
17752,GO:0097378,1,0.994543213780754,0,1,dorsal spinal cord interneuron axon guidance,BP,
17753,GO:0097380,1,0.994543213780754,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17754,GO:0097381,1,0.905040548843729,0,15,photoreceptor disc membrane,CC,
17755,GO:0097382,1,0.991266113753993,0,1,deoxynucleoside-diphosphatase activity,MF,
17756,GO:0097383,1,0.991266113753993,0,1,dIDP diphosphatase activity,MF,
17757,GO:0097384,1,0.955590819947486,0,7,cellular lipid biosynthetic process,BP,
17758,GO:0097386,1,0.89914310399596,0,16,glial cell projection,CC,
17759,GO:0097393,1,0.986267357554897,0,1,telomeric repeat-containing RNA transcription,BP,
17760,GO:0097394,1,0.986267357554897,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17761,GO:0097396,1,0.971262329004334,0,5,response to interleukin-17,BP,
17762,GO:0097398,1,0.971262329004334,0,5,cellular response to interleukin-17,BP,
17763,GO:0097400,1,0.971262329004334,0,5,interleukin-17-mediated signaling pathway,BP,
17764,GO:0097401,1,0.994184890625447,0,1,synaptic vesicle lumen acidification,BP,
17765,GO:0097402,1,0.986824503587667,0,2,neuroblast migration,BP,
17766,GO:0097403,1,0.994160107474255,0,1,cellular response to raffinose,BP,
17767,GO:0097409,1,0.994657213727128,0,1,glial cytoplasmic inclusion,CC,
17768,GO:0097411,1,0.964422253739827,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17769,GO:0097413,1,0.960153168103121,0,7,Lewy body,CC,
17770,GO:0097414,1,0.994657213727128,0,1,classical Lewy body,CC,
17771,GO:0097418,1,0.967615376072076,0,5,neurofibrillary tangle,CC,
17772,GO:0097421,1,0.820175108838127,0,32,liver regeneration,BP,
17773,GO:0097422,1,0.970345678500673,0,5,tubular endosome,CC,
17774,GO:0097425,1,0.969484020444027,0,5,smooth endoplasmic reticulum part,CC,
17775,GO:0097427,1,0.958318789293483,0,6,microtubule bundle,CC,
17776,GO:0097428,1,0.947909375733927,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17777,GO:0097431,1,0.826664135776253,0,25,mitotic spindle pole,CC,
17778,GO:0097433,1,0.971282305257336,0,5,dense body,CC,
17780,GO:0097440,1,0.890798571906681,0,15,apical dendrite,CC,
17781,GO:0097441,1,0.960374500019453,0,5,basal dendrite,CC,
17782,GO:0097442,1,0.975884995923221,0,3,CA3 pyramidal cell dendrite,CC,
17783,GO:0097443,1,0.958195775153594,0,6,sorting endosome,CC,
17784,GO:0097444,1,0.992203902156375,0,1,spine apparatus,CC,
17786,GO:0097449,1,0.941448510593176,0,10,astrocyte projection,CC,
17787,GO:0097450,1,0.976144722812393,0,4,astrocyte end-foot,CC,
17788,GO:0097451,1,0.986659582077741,0,2,glial limiting end-foot,CC,
17789,GO:0097452,1,0.972657384772352,0,4,GAIT complex,CC,
17790,GO:0097453,1,0.994497065019547,0,1,mesaxon,CC,
17791,GO:0097454,1,0.976301593081924,0,3,Schwann cell microvillus,CC,
17792,GO:0097457,1,0.97186369720089,0,3,hippocampal mossy fiber,CC,
17794,GO:0097462,1,0.994657213727128,0,1,Lewy neurite,CC,
17795,GO:0097466,1,0.971065754094431,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17796,GO:0097468,1,0.927152146554331,0,12,programmed cell death in response to reactive oxygen species,BP,
17797,GO:0097470,1,0.960868804013259,0,5,ribbon synapse,CC,
17798,GO:0097472,1,0.798626823529858,0,35,cyclin-dependent protein kinase activity,MF,
17799,GO:0097473,1,0.992062662615871,0,1,retinal rod cell apoptotic process,BP,
17800,GO:0097475,1,0.959151325436712,0,5,motor neuron migration,BP,
17801,GO:0097476,1,0.980332623307096,0,2,spinal cord motor neuron migration,BP,
17802,GO:0097477,1,0.980332623307096,0,2,lateral motor column neuron migration,BP,
17807,GO:0097486,1,0.974182837197396,0,5,multivesicular body lumen,CC,
17808,GO:0097487,1,0.97210925684653,0,4,multivesicular body, internal vesicle,CC,
17809,GO:0097489,1,0.9944265951705,0,1,multivesicular body, internal vesicle lumen,CC,
17810,GO:0097490,1,0.972119402785892,0,4,sympathetic neuron projection extension,BP,
17811,GO:0097491,1,0.972119402785892,0,4,sympathetic neuron projection guidance,BP,
17813,GO:0097494,1,0.971850715177556,0,4,regulation of vesicle size,BP,
17814,GO:0097497,1,0.994062729449467,0,1,blood vessel endothelial cell delamination,BP,
17815,GO:0097498,1,0.98614363262658,0,2,endothelial tube lumen extension,BP,
17816,GO:0097499,1,0.944180896896777,0,9,protein localization to non-motile cilium,BP,
17817,GO:0097500,1,0.974582443972904,0,4,receptor localization to non-motile cilium,BP,
17818,GO:0097501,1,0.927659342775037,0,13,stress response to metal ion,BP,
17819,GO:0097502,1,0.830902798312158,0,29,mannosylation,BP,
17821,GO:0097504,1,0.929119607020409,0,12,Gemini of coiled bodies,CC,
17822,GO:0097505,1,0.991562755954625,0,1,Rad6-Rad18 complex,CC,
17823,GO:0097506,1,0.973193032978354,0,5,deaminated base DNA N-glycosylase activity,MF,
17824,GO:0097510,1,0.994629489393325,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17825,GO:0097512,1,0.963416682171708,0,6,cardiac myofibril,CC,
17826,GO:0097513,1,0.970035465173034,0,3,myosin II filament,CC,
17827,GO:0097517,1,0.681647400374916,0,52,contractile actin filament bundle,CC,
17828,GO:0097524,1,0.976859963108083,0,3,sperm plasma membrane,CC,
17829,GO:0097525,1,0.681392676224686,0,61,spliceosomal snRNP complex,CC,
17830,GO:0097526,1,0.842542686313466,0,28,spliceosomal tri-snRNP complex,CC,
17831,GO:0097527,1,0.966602899029789,0,6,necroptotic signaling pathway,BP,
17834,GO:0097531,1,0.93273522974259,0,11,mast cell migration,BP,
17835,GO:0097532,1,0.988542132249372,0,2,stress response to acid chemical,BP,
17836,GO:0097533,1,0.988542132249372,0,2,cellular stress response to acid chemical,BP,
17837,GO:0097534,1,0.989550926159662,0,1,lymphoid lineage cell migration,BP,
17838,GO:0097535,1,0.989550926159662,0,1,lymphoid lineage cell migration into thymus,BP,
17839,GO:0097536,1,0.99460920833876,0,1,thymus epithelium morphogenesis,BP,
17840,GO:0097539,1,0.926057701026329,0,10,ciliary transition fiber,CC,
17841,GO:0097541,1,0.994313214468247,0,1,axonemal basal plate,CC,
17842,GO:0097542,1,0.741456814797663,0,43,ciliary tip,CC,
17843,GO:0097543,1,0.986240056915514,0,2,ciliary inversin compartment,CC,
17844,GO:0097546,1,0.837840948053443,0,27,ciliary base,CC,
17845,GO:0097550,1,0.964565677606306,0,6,transcriptional preinitiation complex,CC,
17847,GO:0097573,1,0.99478068042453,0,1,glutathione oxidoreductase activity,MF,
17848,GO:0097574,1,0.984257020247725,0,2,lateral part of cell,CC,
17849,GO:0097575,1,0.984257020247725,0,2,lateral cell cortex,CC,
17850,GO:0097576,1,0.986957559226236,0,2,vacuole fusion,BP,
17851,GO:0097577,1,0.98434957823225,0,3,sequestering of iron ion,BP,
17853,GO:0097598,1,0.986283332332388,0,2,sperm cytoplasmic droplet,CC,
17854,GO:0097602,1,0.897339791351579,0,17,cullin family protein binding,MF,
17855,GO:0097603,1,0.987947541453323,0,2,temperature-gated ion channel activity,MF,
17856,GO:0097604,1,0.994696058670233,0,1,temperature-gated cation channel activity,MF,
17858,GO:0097621,1,0.994542428451779,0,1,monoamine oxidase activity,MF,
17860,GO:0097625,1,0.98968604934366,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17861,GO:0097626,1,0.98968604934366,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17862,GO:0097627,1,0.98968604934366,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17863,GO:0097629,1,0.969524696796075,0,5,extrinsic component of omegasome membrane,CC,
17864,GO:0097630,1,0.994313214468247,0,1,intrinsic component of omegasome membrane,CC,
17865,GO:0097631,1,0.994313214468247,0,1,integral component of omegasome membrane,CC,
17866,GO:0097632,1,0.986448804330866,0,2,extrinsic component of phagophore assembly site membrane,CC,
17867,GO:0097635,1,0.984848412992193,0,2,extrinsic component of autophagosome membrane,CC,
17868,GO:0097636,1,0.987529861294295,0,2,intrinsic component of autophagosome membrane,CC,
17869,GO:0097637,1,0.987529861294295,0,2,integral component of autophagosome membrane,CC,
17870,GO:0097638,1,0.968930229248179,0,4,L-arginine import across plasma membrane,BP,
17871,GO:0097639,1,0.984161262860976,0,2,L-lysine import across plasma membrane,BP,
17872,GO:0097640,1,0.98968604934366,0,1,L-ornithine import across plasma membrane,BP,
17873,GO:0097642,1,0.965334147526871,0,6,calcitonin family receptor activity,MF,
17874,GO:0097643,1,0.97830895394002,0,4,amylin receptor activity,MF,
17875,GO:0097644,1,0.975908220798861,0,4,calcitonin family binding,MF,
17879,GO:0097651,1,0.970262434423914,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17880,GO:0097655,1,0.994313214468247,0,1,serpin family protein binding,MF,
17882,GO:0097676,1,0.969397456619241,0,3,histone H3-K36 dimethylation,BP,
17883,GO:0097677,1,0.963858263696379,0,5,STAT family protein binding,MF,
17884,GO:0097679,1,0.98933508806249,0,2,other organism cytoplasm,CC,
17885,GO:0097680,1,0.980188120703388,0,3,double-strand break repair via classical nonhomologous end joining,BP,
17886,GO:0097681,1,0.972827847187272,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
17887,GO:0097682,1,0.994612017204712,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17889,GO:0097689,1,0.993911470462511,0,1,iron channel activity,MF,
17890,GO:0097692,1,0.991031980341954,0,1,histone H3-K4 monomethylation,BP,
17891,GO:0097694,1,0.969784931216443,0,3,establishment of RNA localization to telomere,BP,
17892,GO:0097695,1,0.969784931216443,0,3,establishment of protein-containing complex localization to telomere,BP,
17894,GO:0097698,1,0.994760915263259,0,1,telomere maintenance via base-excision repair,BP,
17895,GO:0097699,1,0.992897110667626,0,1,vascular endothelial cell response to fluid shear stress,BP,
17896,GO:0097707,1,0.994822418837371,0,1,ferroptosis,BP,
17898,GO:0097709,1,0.963708050391479,0,6,connective tissue replacement,BP,
17899,GO:0097711,1,0.511078486851945,0,96,ciliary basal body-plasma membrane docking,BP,
17900,GO:0097712,1,0.994313214468247,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17901,GO:0097718,1,0.800869756598261,0,30,disordered domain specific binding,MF,
17902,GO:0097720,1,0.830519854802506,0,26,calcineurin-mediated signaling,BP,
17903,GO:0097722,1,0.65126078664546,0,63,sperm motility,BP,
17904,GO:0097724,1,0.994691517302911,0,1,sperm flagellum movement,BP,
17905,GO:0097726,1,0.994808128724936,0,1,LEM domain binding,MF,
17906,GO:0097729,1,0.674681426969952,0,64,9+2 motile cilium,CC,
17909,GO:0097732,1,0.95781141892454,0,7,9+2 non-motile cilium,CC,
17911,GO:0097734,1,0.898935184654518,0,18,extracellular exosome biogenesis,BP,
17912,GO:0097742,1,0.972765601667308,0,4,de novo centriole assembly,BP,
17913,GO:0097745,1,0.98362627515828,0,3,mitochondrial tRNA 5'-end processing,BP,
17915,GO:0097747,1,0.774165988102923,0,43,RNA polymerase activity,MF,
17917,GO:0097752,1,0.983024619000779,0,3,regulation of DNA stability,BP,
17921,GO:0098501,1,0.972197350476256,0,5,polynucleotide dephosphorylation,BP,
17922,GO:0098502,1,0.984350458453219,0,3,DNA dephosphorylation,BP,
17923,GO:0098503,1,0.994715539073901,0,1,DNA 3' dephosphorylation,BP,
17924,GO:0098504,1,0.994715539073901,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
17925,GO:0098505,1,0.942508484238532,0,10,G-rich strand telomeric DNA binding,MF,
17926,GO:0098506,1,0.994715539073901,0,1,polynucleotide 3' dephosphorylation,BP,
17927,GO:0098507,1,0.987655614733499,0,2,polynucleotide 5' dephosphorylation,BP,
17928,GO:0098508,1,0.988970307471294,0,2,endothelial to hematopoietic transition,BP,
17929,GO:0098518,1,0.982435740056811,0,3,polynucleotide phosphatase activity,MF,
17930,GO:0098519,1,0.969411075611272,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
17931,GO:0098528,1,0.967635674985762,0,5,skeletal muscle fiber differentiation,BP,
17932,GO:0098530,1,0.991531154941563,0,1,positive regulation of strand invasion,BP,
17933,GO:0098531,1,0.727320555138037,0,46,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
17934,GO:0098532,1,0.951095767404046,0,7,histone H3-K27 trimethylation,BP,
17935,GO:0098533,1,0.867078248356207,0,22,ATPase dependent transmembrane transport complex,CC,
17936,GO:0098534,1,0.807131315119314,0,32,centriole assembly,BP,
17937,GO:0098535,1,0.972765601667308,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17938,GO:0098536,1,0.974157446588694,0,4,deuterosome,CC,
17940,GO:0098543,1,0.92394206091897,0,11,detection of other organism,BP,
17941,GO:0098547,1,0.994561273088904,0,1,lumenal side of Golgi membrane,CC,
17944,GO:0098554,1,0.925491088967119,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
17945,GO:0098556,1,0.974340892944897,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17946,GO:0098559,1,0.983362767137059,0,3,cytoplasmic side of early endosome membrane,CC,
17947,GO:0098560,1,0.988778209006875,0,2,cytoplasmic side of late endosome membrane,CC,
17949,GO:0098563,1,0.854668437811531,0,26,intrinsic component of synaptic vesicle membrane,CC,
17950,GO:0098573,1,0.681752731256373,0,66,intrinsic component of mitochondrial membrane,CC,
17951,GO:0098574,1,0.972010638014572,0,5,cytoplasmic side of lysosomal membrane,CC,
17952,GO:0098575,1,0.989225814714462,0,2,lumenal side of lysosomal membrane,CC,
17953,GO:0098576,1,0.977823258973405,0,4,lumenal side of membrane,CC,
17954,GO:0098577,1,0.990439316474678,0,1,inactive sex chromosome,CC,
17955,GO:0098581,1,0.89703994837362,0,16,detection of external biotic stimulus,BP,
17956,GO:0098582,1,0.985074723886713,0,2,innate vocalization behavior,BP,
17957,GO:0098583,1,0.994792478474093,0,1,learned vocalization behavior,BP,
17958,GO:0098586,1,0.766522786564882,0,40,cellular response to virus,BP,
17962,GO:0098592,1,0.981942810689985,0,3,cytoplasmic side of apical plasma membrane,CC,
17963,GO:0098594,1,0.994833031278284,0,1,mucin granule,CC,
17964,GO:0098595,1,0.99456240023169,0,1,perivitelline space,CC,
17965,GO:0098596,1,0.930538526782743,0,7,imitative learning,BP,
17966,GO:0098597,1,0.916707096581822,0,8,observational learning,BP,
17967,GO:0098598,1,0.925689248038126,0,8,learned vocalization behavior or vocal learning,BP,
17968,GO:0098599,1,0.944174318306776,0,10,palmitoyl hydrolase activity,MF,
17969,GO:0098601,1,0.993870578186373,0,1,selenomethionine adenosyltransferase activity,MF,
17971,GO:0098619,1,0.994673083697529,0,1,selenocysteine-tRNA ligase activity,MF,
17972,GO:0098621,1,0.991662926838147,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
17973,GO:0098625,1,0.993530242720311,0,1,methylselenol reductase activity,MF,
17974,GO:0098626,1,0.993530242720311,0,1,methylseleninic acid reductase activity,MF,
17975,GO:0098629,1,0.994313214468247,0,1,trans-Golgi network membrane organization,BP,
17978,GO:0098633,1,0.994440633602804,0,1,collagen fibril binding,MF,
17979,GO:0098634,1,0.9492291402337,0,7,cell-matrix adhesion mediator activity,MF,
17980,GO:0098636,1,0.776845319470448,0,35,protein complex involved in cell adhesion,CC,
17981,GO:0098637,1,0.993409701531341,0,1,protein complex involved in cell-matrix adhesion,CC,
17982,GO:0098639,1,0.960550786355591,0,5,collagen binding involved in cell-matrix adhesion,MF,
17983,GO:0098640,1,0.988218094639428,0,2,integrin binding involved in cell-matrix adhesion,MF,
17989,GO:0098646,1,0.994394193991265,0,1,collagen sheet,CC,
17990,GO:0098647,1,0.976513428405316,0,3,collagen beaded filament,CC,
17991,GO:0098648,1,0.988009572257169,0,1,collagen anchoring fibril,CC,
17993,GO:0098652,1,0.988009572257169,0,1,collagen type VII anchoring fibril,CC,
18001,GO:0098664,1,0.928906582872151,0,13,G-protein coupled serotonin receptor signaling pathway,BP,
18002,GO:0098679,1,0.976756652621595,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18003,GO:0098680,1,0.993341223717095,0,1,template-free RNA nucleotidyltransferase,MF,
18004,GO:0098687,1,0.12329963279855,0,310,chromosomal region,CC,
18007,GO:0098700,1,0.954617222193051,0,8,neurotransmitter loading into synaptic vesicle,BP,
18009,GO:0098704,1,0.99453369805972,0,1,carbohydrate import across plasma membrane,BP,
18010,GO:0098705,1,0.992577385814701,0,1,copper ion import across plasma membrane,BP,
18013,GO:0098712,1,0.922215587884736,0,11,L-glutamate import across plasma membrane,BP,
18014,GO:0098713,1,0.994555972713727,0,1,leucine import across plasma membrane,BP,
18015,GO:0098719,1,0.904878630249904,0,14,sodium ion import across plasma membrane,BP,
18016,GO:0098722,1,0.942722022744174,0,9,asymmetric stem cell division,BP,
18017,GO:0098725,1,0.994313214468247,0,1,symmetric cell division,BP,
18018,GO:0098727,1,0.342429628944168,0,150,maintenance of cell number,BP,
18019,GO:0098728,1,0.982683323199068,0,3,germline stem cell asymmetric division,BP,
18020,GO:0098732,1,0.479504370222114,0,106,macromolecule deacylation,BP,
18021,GO:0098734,1,0.944174318306776,0,10,macromolecule depalmitoylation,BP,
18022,GO:0098735,1,0.956638926404979,0,4,positive regulation of the force of heart contraction,BP,
18023,GO:0098736,1,0.988441996649535,0,1,negative regulation of the force of heart contraction,BP,
18026,GO:0098743,1,0.884791986705557,0,18,cell aggregation,BP,
18027,GO:0098745,1,0.994712195059427,0,1,Dcp1-Dcp2 complex,CC,
18028,GO:0098746,1,0.992538272635427,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18029,GO:0098748,1,0.927943003783169,0,11,endocytic adaptor activity,MF,
18030,GO:0098749,1,0.992734774792368,0,1,cerebellar neuron development,BP,
18032,GO:0098754,1,0.557455511768918,0,100,detoxification,BP,
18033,GO:0098756,1,0.954213295548927,0,7,response to interleukin-21,BP,
18034,GO:0098757,1,0.954213295548927,0,7,cellular response to interleukin-21,BP,
18035,GO:0098758,1,0.982961954116852,0,3,response to interleukin-8,BP,
18036,GO:0098759,1,0.982961954116852,0,3,cellular response to interleukin-8,BP,
18037,GO:0098760,1,0.87558434649382,0,19,response to interleukin-7,BP,
18038,GO:0098761,1,0.87558434649382,0,19,cellular response to interleukin-7,BP,
18039,GO:0098770,1,0.979483080389544,0,2,FBXO family protein binding,MF,
18043,GO:0098779,1,0.941981911376881,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
18044,GO:0098780,1,0.889939196476202,0,17,response to mitochondrial depolarisation,BP,
18045,GO:0098781,1,0.554754854877501,0,94,ncRNA transcription,BP,
18046,GO:0098782,1,0.994696058670233,0,1,mechanosensitived potassium channel activity,MF,
18047,GO:0098787,1,0.913589363058198,0,14,mRNA cleavage involved in mRNA processing,BP,
18048,GO:0098789,1,0.930303569795636,0,11,pre-mRNA cleavage required for polyadenylation,BP,
18050,GO:0098792,1,0.940587940827906,0,10,xenophagy,BP,
18053,GO:0098795,1,0.9880633393777,0,2,mRNA cleavage involved in gene silencing,BP,
18056,GO:0098798,1,0.301741323312613,0,217,mitochondrial protein complex,CC,
18057,GO:0098799,1,0.935456013952446,0,12,outer mitochondrial membrane protein complex,CC,
18058,GO:0098800,1,0.581286774664239,0,100,inner mitochondrial membrane protein complex,CC,
18059,GO:0098801,1,0.850201391742625,0,27,regulation of renal system process,BP,
18061,GO:0098803,1,0.691423377056994,0,69,respiratory chain complex,CC,
18063,GO:0098808,1,0.9890006502887,0,2,mRNA cap binding,MF,
18064,GO:0098809,1,0.994406694608454,0,1,nitrite reductase activity,MF,
18065,GO:0098810,1,0.901568218646221,0,16,neurotransmitter reuptake,BP,
18066,GO:0098813,1,0.151222689283367,0,279,nuclear chromosome segregation,BP,
18069,GO:0098816,1,0.994633983377533,0,1,mini excitatory postsynaptic potential,BP,
18070,GO:0098821,1,0.95968919109263,0,5,BMP receptor activity,MF,
18071,GO:0098822,1,0.994477249259959,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18072,GO:0098826,1,0.977844657279131,0,4,endoplasmic reticulum tubular network membrane,CC,
18075,GO:0098829,1,0.990787392311018,0,1,intestinal folate absorption,BP,
18076,GO:0098830,1,0.992525900258898,0,1,presynaptic endosome,CC,
18078,GO:0098833,1,0.992397512662121,0,1,presynaptic endocytic zone,CC,
18079,GO:0098835,1,0.992397512662121,0,1,presynaptic endocytic zone membrane,CC,
18080,GO:0098837,1,0.983349156167461,0,3,postsynaptic recycling endosome,CC,
18081,GO:0098838,1,0.994275469969769,0,1,reduced folate transmembrane transport,BP,
18083,GO:0098840,1,0.968235079942851,0,4,protein transport along microtubule,BP,
18084,GO:0098842,1,0.98908186636587,0,2,postsynaptic early endosome,CC,
18085,GO:0098843,1,0.959118736969546,0,6,postsynaptic endocytic zone,CC,
18086,GO:0098844,1,0.977433766803295,0,3,postsynaptic endocytic zone membrane,CC,
18087,GO:0098845,1,0.965956817838976,0,6,postsynaptic endosome,CC,
18088,GO:0098847,1,0.924473530376842,0,13,sequence-specific single stranded DNA binding,MF,
18089,GO:0098850,1,0.994660463963978,0,1,extrinsic component of synaptic vesicle membrane,CC,
18091,GO:0098855,1,0.976043175189812,0,3,HCN channel complex,CC,
18092,GO:0098856,1,0.952350770607744,0,8,intestinal lipid absorption,BP,
18096,GO:0098868,1,0.85304813865226,0,24,bone growth,BP,
18097,GO:0098869,1,0.615960501642385,0,82,cellular oxidant detoxification,BP,
18098,GO:0098870,1,0.956367861135742,0,6,action potential propagation,BP,
18099,GO:0098871,1,0.994722694514454,0,1,postsynaptic actin cytoskeleton,CC,
18100,GO:0098875,1,0.992614344239443,0,1,epididymosome,CC,
18105,GO:0098883,1,0.994697994008713,0,1,synapse disassembly,BP,
18106,GO:0098884,1,0.977433766803295,0,3,postsynaptic neurotransmitter receptor internalization,BP,
18107,GO:0098885,1,0.990036700891625,0,1,modification of postsynaptic actin cytoskeleton,BP,
18108,GO:0098886,1,0.986561011031289,0,2,modification of dendritic spine,BP,
18109,GO:0098887,1,0.97523636740353,0,4,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18110,GO:0098888,1,0.989993190721944,0,1,extrinsic component of presynaptic membrane,CC,
18111,GO:0098889,1,0.976014414600066,0,4,intrinsic component of presynaptic membrane,CC,
18112,GO:0098890,1,0.989993190721944,0,1,extrinsic component of postsynaptic membrane,CC,
18113,GO:0098895,1,0.993160303955826,0,1,postsynaptic endosome membrane,CC,
18115,GO:0098901,1,0.800422355475812,0,25,regulation of cardiac muscle cell action potential,BP,
18116,GO:0098902,1,0.966218587123502,0,4,regulation of membrane depolarization during action potential,BP,
18117,GO:0098903,1,0.944986997115499,0,8,regulation of membrane repolarization during action potential,BP,
18118,GO:0098904,1,0.976382005751599,0,2,regulation of AV node cell action potential,BP,
18119,GO:0098905,1,0.994828949680571,0,1,regulation of bundle of His cell action potential,BP,
18120,GO:0098907,1,0.971145649833658,0,2,regulation of SA node cell action potential,BP,
18121,GO:0098908,1,0.976337461256454,0,4,regulation of neuronal action potential,BP,
18122,GO:0098909,1,0.942514699784082,0,7,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18123,GO:0098910,1,0.94740950153269,0,5,regulation of atrial cardiac muscle cell action potential,BP,
18124,GO:0098911,1,0.885774693775882,0,14,regulation of ventricular cardiac muscle cell action potential,BP,
18125,GO:0098912,1,0.966436751876973,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18126,GO:0098914,1,0.96083497062516,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18127,GO:0098915,1,0.929386424035942,0,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18129,GO:0098917,1,0.95087783011924,0,7,retrograde trans-synaptic signaling,BP,
18130,GO:0098918,1,0.994696544111254,0,1,structural constituent of synapse,MF,
18131,GO:0098920,1,0.985929796031298,0,2,retrograde trans-synaptic signaling by lipid,BP,
18132,GO:0098921,1,0.985929796031298,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
18133,GO:0098923,1,0.990109670625449,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18134,GO:0098924,1,0.990109670625449,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18135,GO:0098926,1,0.990302925129446,0,1,postsynaptic signal transduction,BP,
18136,GO:0098927,1,0.753544965795214,0,40,vesicle-mediated transport between endosomal compartments,BP,
18137,GO:0098928,1,0.962691232057404,0,2,presynaptic signal transduction,BP,
18138,GO:0098930,1,0.729047187621211,0,45,axonal transport,BP,
18139,GO:0098935,1,0.960049200784288,0,5,dendritic transport,BP,
18140,GO:0098936,1,0.92369796386333,0,10,intrinsic component of postsynaptic membrane,CC,
18141,GO:0098937,1,0.960049200784288,0,5,anterograde dendritic transport,BP,
18142,GO:0098939,1,0.990736806418819,0,1,dendritic transport of mitochondrion,BP,
18143,GO:0098942,1,0.992429697060513,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18144,GO:0098943,1,0.960535994680281,0,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
18145,GO:0098945,1,0.992980782531353,0,1,intrinsic component of presynaptic active zone membrane,CC,
18146,GO:0098948,1,0.960213654086007,0,4,intrinsic component of postsynaptic specialization membrane,CC,
18147,GO:0098953,1,0.954776674872458,0,8,receptor diffusion trapping,BP,
18148,GO:0098957,1,0.971685538024951,0,4,anterograde axonal transport of mitochondrion,BP,
18150,GO:0098961,1,0.990311084322849,0,1,dendritic transport of ribonucleoprotein complex,BP,
18151,GO:0098963,1,0.990311084322849,0,1,dendritic transport of messenger ribonucleoprotein complex,BP,
18152,GO:0098964,1,0.990311084322849,0,1,anterograde dendritic transport of messenger ribonucleoprotein complex,BP,
18154,GO:0098968,1,0.992124689597619,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18156,GO:0098970,1,0.954776674872458,0,8,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18157,GO:0098971,1,0.969028304739203,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18158,GO:0098972,1,0.990736806418819,0,1,anterograde dendritic transport of mitochondrion,BP,
18159,GO:0098973,1,0.994696544111254,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18160,GO:0098974,1,0.994696544111254,0,1,postsynaptic actin cytoskeleton organization,BP,
18163,GO:0098982,1,0.964508600385294,0,5,GABA-ergic synapse,CC,
18164,GO:0098983,1,0.970194015234996,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18167,GO:0098988,1,0.95439152377542,0,6,G-protein coupled glutamate receptor activity,MF,
18168,GO:0098989,1,0.984846739900377,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18169,GO:0098992,1,0.994469568368506,0,1,neuronal dense core vesicle,CC,
18170,GO:0098993,1,0.951508776388382,0,9,anchored component of synaptic vesicle membrane,CC,
18171,GO:0098999,1,0.993160303955826,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18173,GO:0099004,1,0.962269460065837,0,5,calmodulin dependent kinase signaling pathway,BP,
18174,GO:0099010,1,0.976730286838117,0,3,modification of postsynaptic structure,BP,
18175,GO:0099011,1,0.953644891680956,0,5,neuronal dense core vesicle exocytosis,BP,
18176,GO:0099022,1,0.989040043860026,0,2,vesicle tethering,BP,
18177,GO:0099023,1,0.631505570167833,0,69,tethering complex,CC,
18178,GO:0099024,1,0.709445738463717,0,53,plasma membrane invagination,BP,
18179,GO:0099038,1,0.992454575386118,0,1,ceramide-translocating ATPase activity,MF,
18180,GO:0099039,1,0.983391881498851,0,2,sphingolipid translocation,BP,
18181,GO:0099040,1,0.992454575386118,0,1,ceramide translocation,BP,
18182,GO:0099044,1,0.989040043860026,0,2,vesicle tethering to endoplasmic reticulum,BP,
18183,GO:0099046,1,0.99476842444519,0,1,clearance of foreign intracellular nucleic acids,BP,
18185,GO:0099053,1,0.980828409116206,0,3,activating signal cointegrator 1 complex,CC,
18186,GO:0099054,1,0.872236782212514,0,18,presynapse assembly,BP,
18187,GO:0099055,1,0.92369796386333,0,10,integral component of postsynaptic membrane,CC,
18188,GO:0099056,1,0.976014414600066,0,4,integral component of presynaptic membrane,CC,
18189,GO:0099059,1,0.992980782531353,0,1,integral component of presynaptic active zone membrane,CC,
18190,GO:0099060,1,0.960213654086007,0,4,integral component of postsynaptic specialization membrane,CC,
18191,GO:0099061,1,0.967003528391273,0,3,integral component of postsynaptic density membrane,CC,
18194,GO:0099073,1,0.986813025998429,0,2,mitochondrion-derived vesicle,CC,
18195,GO:0099074,1,0.988368620178847,0,2,mitochondrion to lysosome transport,BP,
18196,GO:0099075,1,0.988368620178847,0,2,mitochondrion-derived vesicle mediated transport,BP,
18197,GO:0099077,1,0.991539053448329,0,1,histone-dependent DNA binding,MF,
18198,GO:0099078,1,0.97878441275444,0,4,BORC complex,CC,
18201,GO:0099082,1,0.981521123174159,0,3,retrograde trans-synaptic signaling by neuropeptide,BP,
18202,GO:0099083,1,0.988183702069777,0,2,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18204,GO:0099086,1,0.819970752117944,0,31,synaptonemal structure,CC,
18205,GO:0099089,1,0.985315751785552,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18206,GO:0099093,1,0.986213042995201,0,2,calcium export from the mitochondrion,BP,
18209,GO:0099098,1,0.994011263608766,0,1,microtubule polymerization based movement,BP,
18210,GO:0099103,1,0.976058023789363,0,4,channel activator activity,MF,
18211,GO:0099104,1,0.976058023789363,0,4,potassium channel activator activity,MF,
18213,GO:0099111,1,0.375367034105175,0,137,microtubule-based transport,BP,
18214,GO:0099116,1,0.9135443549763,0,16,tRNA 5'-end processing,BP,
18215,GO:0099118,1,0.968235079942851,0,4,microtubule-based protein transport,BP,
18216,GO:0099122,1,0.977512651421793,0,3,RNA polymerase II C-terminal domain binding,MF,
18217,GO:0099130,1,0.994570940851211,0,1,estrogen binding,MF,
18218,GO:0099131,1,0.843183187444993,0,28,ATP hydrolysis coupled ion transmembrane transport,BP,
18219,GO:0099132,1,0.726956481524054,0,45,ATP hydrolysis coupled cation transmembrane transport,BP,
18221,GO:0099142,1,0.991137137372775,0,1,intracellularly ATP-gated ion channel activity,MF,
18222,GO:0099146,1,0.967003528391273,0,3,intrinsic component of postsynaptic density membrane,CC,
18223,GO:0099159,1,0.990036700891625,0,1,regulation of modification of postsynaptic structure,BP,
18224,GO:0099163,1,0.990109670625449,0,1,synaptic signaling by nitric oxide,BP,
18225,GO:0099170,1,0.981587068232862,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
18226,GO:0099172,1,0.859664934641786,0,20,presynapse organization,BP,
18228,GO:0099174,1,0.96641668486588,0,5,regulation of presynapse organization,BP,
18231,GO:0099186,1,0.994696544111254,0,1,structural constituent of postsynapse,MF,
18232,GO:0099188,1,0.994696544111254,0,1,postsynaptic cytoskeleton organization,BP,
18233,GO:0099240,1,0.92369796386333,0,10,intrinsic component of synaptic membrane,CC,
18234,GO:0099243,1,0.989993190721944,0,1,extrinsic component of synaptic membrane,CC,
18235,GO:0099400,1,0.988022957922514,0,1,caveola neck,CC,
18236,GO:0099402,1,0.994831355742962,0,1,plant organ development,BP,
18237,GO:0099403,1,0.974122777451923,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18238,GO:0099404,1,0.974122777451923,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18243,GO:0099509,1,0.984057308710459,0,3,regulation of presynaptic cytosolic calcium ion concentration,BP,
18246,GO:0099514,1,0.901469087337393,0,17,synaptic vesicle cytoskeletal transport,BP,
18247,GO:0099515,1,0.919397331572492,0,10,actin filament-based transport,BP,
18249,GO:0099517,1,0.901469087337393,0,17,synaptic vesicle transport along microtubule,BP,
18250,GO:0099518,1,0.713900196380538,0,46,vesicle cytoskeletal trafficking,BP,
18251,GO:0099519,1,0.994313214468247,0,1,dense core granule cytoskeletal transport,BP,
18252,GO:0099522,1,0.994634905157056,0,1,region of cytosol,CC,
18253,GO:0099523,1,0.994634905157056,0,1,presynaptic cytosol,CC,
18254,GO:0099524,1,0.994634905157056,0,1,postsynaptic cytosol,CC,
18255,GO:0099525,1,0.953644891680956,0,5,presynaptic dense core vesicle exocytosis,BP,
18256,GO:0099526,1,0.962691232057404,0,2,presynapse to nucleus signaling pathway,BP,
18257,GO:0099527,1,0.990302925129446,0,1,postsynapse to nucleus signaling pathway,BP,
18260,GO:0099530,1,0.979827241010856,0,2,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18262,GO:0099532,1,0.98183724498605,0,2,synaptic vesicle endosomal processing,BP,
18265,GO:0099538,1,0.97184264225544,0,4,synaptic signaling via neuropeptide,BP,
18266,GO:0099540,1,0.97184264225544,0,4,trans-synaptic signaling by neuropeptide,BP,
18267,GO:0099541,1,0.960875917595956,0,5,trans-synaptic signaling by lipid,BP,
18268,GO:0099542,1,0.960875917595956,0,5,trans-synaptic signaling by endocannabinoid,BP,
18269,GO:0099543,1,0.990109670625449,0,1,trans-synaptic signaling by soluble gas,BP,
18270,GO:0099545,1,0.984959836755103,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18271,GO:0099547,1,0.981587068232862,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18272,GO:0099548,1,0.990109670625449,0,1,trans-synaptic signaling by nitric oxide,BP,
18273,GO:0099550,1,0.946394493746142,0,7,trans-synaptic signaling, modulating synaptic transmission,BP,
18274,GO:0099551,1,0.978440178619959,0,3,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18275,GO:0099552,1,0.974592128779332,0,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18276,GO:0099553,1,0.974592128779332,0,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18277,GO:0099557,1,0.992473728510381,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18278,GO:0099558,1,0.989546530743429,0,2,maintenance of synapse structure,BP,
18279,GO:0099560,1,0.974680123986459,0,3,synaptic membrane adhesion,BP,
18280,GO:0099563,1,0.926487722320876,0,11,modification of synaptic structure,BP,
18282,GO:0099566,1,0.97156368815877,0,3,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18285,GO:0099571,1,0.994722694514454,0,1,postsynaptic cytoskeleton,CC,
18287,GO:0099578,1,0.981587068232862,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18288,GO:0099580,1,0.983402678480412,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18289,GO:0099583,1,0.97156368815877,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18291,GO:0099589,1,0.928906582872151,0,13,serotonin receptor activity,MF,
18294,GO:0099602,1,0.960867326942178,0,7,neurotransmitter receptor regulator activity,MF,
18296,GO:0099606,1,0.988613291742702,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18297,GO:0099607,1,0.988613291742702,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18298,GO:0099609,1,0.983002495302164,0,2,microtubule lateral binding,MF,
18299,GO:0099612,1,0.938967765398705,0,7,protein localization to axon,BP,
18300,GO:0099617,1,0.993880270164267,0,1,matrix side of mitochondrial inner membrane,CC,
18302,GO:0099623,1,0.850004140237797,0,22,regulation of cardiac muscle cell membrane repolarization,BP,
18303,GO:0099624,1,0.929877086699102,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18304,GO:0099625,1,0.858673508247232,0,22,ventricular cardiac muscle cell membrane repolarization,BP,
18305,GO:0099628,1,0.954776674872458,0,8,neurotransmitter receptor diffusion trapping,BP,
18306,GO:0099631,1,0.989635795011166,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18310,GO:0099638,1,0.969343811050592,0,5,endosome to plasma membrane protein transport,BP,
18311,GO:0099639,1,0.969343811050592,0,5,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18312,GO:0099640,1,0.985186024772744,0,2,axo-dendritic protein transport,BP,
18313,GO:0099641,1,0.994825300762046,0,1,anterograde axonal protein transport,BP,
18315,GO:0099699,1,0.92369796386333,0,10,integral component of synaptic membrane,CC,
18317,GO:0100001,1,0.991946795904036,0,1,regulation of skeletal muscle contraction by action potential,BP,
18318,GO:0100002,1,0.994259634540459,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18319,GO:0100012,1,0.989529875795574,0,2,regulation of heart induction by canonical Wnt signaling pathway,BP,
18320,GO:0100057,1,0.989631438821561,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18323,GO:0101005,1,0.518355466641666,0,88,ubiquitinyl hydrolase activity,MF,
18324,GO:0101006,1,0.983888889598964,0,3,protein histidine phosphatase activity,MF,
18325,GO:0101020,1,0.983874123969251,0,3,estrogen 16-alpha-hydroxylase activity,MF,
18326,GO:0101023,1,0.902835536293956,0,14,vascular endothelial cell proliferation,BP,
18327,GO:0101030,1,0.994783652257647,0,1,tRNA-guanine transglycosylation,BP,
18328,GO:0101031,1,0.930381385508944,0,12,chaperone complex,CC,
18329,GO:0102005,1,0.994757742293972,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18330,GO:0102007,1,0.984326190869203,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18331,GO:0102008,1,0.992331943360382,0,1,cytosolic dipeptidase activity,MF,
18332,GO:0102009,1,0.994674685312294,0,1,proline dipeptidase activity,MF,
18333,GO:0102076,1,0.9942639262759,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18334,GO:0102077,1,0.98928131287472,0,2,oleamide hydrolase activity,MF,
18335,GO:0102084,1,0.988720978394891,0,2,L-dopa O-methyltransferase activity,MF,
18336,GO:0102092,1,0.98376503054785,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18337,GO:0102102,1,0.993386348085117,0,1,homocarnosine synthase activity,MF,
18338,GO:0102113,1,0.990349864977928,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18339,GO:0102121,1,0.983297743350202,0,3,ceramidase activity,MF,
18340,GO:0102131,1,0.988770284686703,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18341,GO:0102132,1,0.988770284686703,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18342,GO:0102148,1,0.983809224268078,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
18343,GO:0102158,1,0.977444251132158,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18344,GO:0102166,1,0.992207569279162,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18345,GO:0102167,1,0.992207569279162,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18346,GO:0102200,1,0.99212363914236,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
18347,GO:0102250,1,0.981413766829249,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18348,GO:0102279,1,0.992464931057538,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18349,GO:0102336,1,0.964347280122246,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18350,GO:0102337,1,0.964347280122246,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18351,GO:0102338,1,0.964347280122246,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18352,GO:0102339,1,0.994436311594978,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18353,GO:0102340,1,0.994436311594978,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18354,GO:0102341,1,0.994436311594978,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18355,GO:0102342,1,0.994436311594978,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18356,GO:0102343,1,0.977444251132158,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18357,GO:0102344,1,0.977444251132158,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18358,GO:0102345,1,0.977444251132158,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18359,GO:0102389,1,0.994376713196624,0,1,polyprenol reductase activity,MF,
18360,GO:0102390,1,0.994386161890337,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18361,GO:0102391,1,0.956372099357041,0,7,decanoate-CoA ligase activity,MF,
18362,GO:0102420,1,0.985217339120636,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18363,GO:0102483,1,0.99472470365035,0,1,scopolin beta-glucosidase activity,MF,
18364,GO:0102485,1,0.974076075978826,0,3,dATP phosphohydrolase activity,MF,
18365,GO:0102486,1,0.974076075978826,0,3,dCTP phosphohydrolase activity,MF,
18366,GO:0102487,1,0.974076075978826,0,3,dUTP phosphohydrolase activity,MF,
18367,GO:0102488,1,0.974076075978826,0,3,dTTP phosphohydrolase activity,MF,
18368,GO:0102489,1,0.974076075978826,0,3,GTP phosphohydrolase activity,MF,
18369,GO:0102490,1,0.974076075978826,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18370,GO:0102491,1,0.974076075978826,0,3,dGTP phosphohydrolase activity,MF,
18371,GO:0102499,1,0.981413766829249,0,3,SHG alpha-glucan phosphorylase activity,MF,
18372,GO:0102500,1,0.990048852467886,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18373,GO:0102521,1,0.993924925103241,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18374,GO:0102522,1,0.994574962817661,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18375,GO:0102524,1,0.994313214468247,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18376,GO:0102555,1,0.994821348087557,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18379,GO:0102571,1,0.992207569279162,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18380,GO:0102704,1,0.99423408293677,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18381,GO:0102707,1,0.994429038802581,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18382,GO:0102751,1,0.988641254660087,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18383,GO:0102752,1,0.994096923959342,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18384,GO:0102756,1,0.964347280122246,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18385,GO:0102758,1,0.994803302342463,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18386,GO:0102769,1,0.994735207544296,0,1,dihydroceramide glucosyltransferase activity,MF,
18387,GO:0102773,1,0.992907110459704,0,1,dihydroceramide kinase activity,MF,
18388,GO:0102797,1,0.992387119019582,0,1,geranial:oxygen oxidoreductase activity,MF,
18389,GO:0102798,1,0.992387119019582,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18390,GO:0102867,1,0.994335363210544,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18391,GO:0102938,1,0.988720978394891,0,2,orcinol O-methyltransferase activity,MF,
18392,GO:0102953,1,0.983445508560032,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18393,GO:0102965,1,0.986709230365435,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18394,GO:0102991,1,0.967807693988675,0,6,myristoyl-CoA hydrolase activity,MF,
18395,GO:0103025,1,0.989349393006347,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18396,GO:0103045,1,0.994622706997525,0,1,methione N-acyltransferase activity,MF,
18397,GO:0103046,1,0.992331943360382,0,1,alanylglutamate dipeptidase activity,MF,
18398,GO:0103053,1,0.989265582199122,0,2,1-ethyladenine demethylase activity,MF,
18399,GO:0103066,1,0.994741600457001,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18400,GO:0103067,1,0.994741600457001,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18401,GO:0103068,1,0.983445508560032,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18402,GO:0103073,1,0.98928131287472,0,2,anandamide amidohydrolase activity,MF,
18404,GO:0104005,1,0.657303284578201,0,64,hijacked molecular function,MF,
18405,GO:0106001,1,0.963363122402681,0,6,intestinal hexose absorption,BP,
18406,GO:0106003,1,0.920131725019191,0,11,amyloid-beta complex,CC,
18407,GO:0106004,1,0.989518126006726,0,2,tRNA (guanine-N7)-methylation,BP,
18408,GO:0106005,1,0.991075673892161,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18409,GO:0106014,1,0.989006712427557,0,2,regulation of inflammatory response to wounding,BP,
18410,GO:0106015,1,0.989006712427557,0,2,negative regulation of inflammatory response to wounding,BP,
18411,GO:0106017,1,0.970602422305026,0,4,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18412,GO:0106018,1,0.887978429127502,0,15,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18413,GO:0106019,1,0.928804942329831,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18414,GO:0106020,1,0.988016883654674,0,2,regulation of vesicle docking,BP,
18415,GO:0106022,1,0.993423197847327,0,1,positive regulation of vesicle docking,BP,
18417,GO:0106028,1,0.992473728510381,0,1,neuron projection retraction,BP,
18419,GO:0106044,1,0.994822876044542,0,1,guanine deglycation,BP,
18420,GO:0106045,1,0.994822876044542,0,1,guanine deglycation, methylglyoxal removal,BP,
18421,GO:0106046,1,0.994822876044542,0,1,guanine deglycation, glyoxal removal,BP,
18422,GO:0106049,1,0.963645944844444,0,6,regulation of cellular response to osmotic stress,BP,
18423,GO:0106050,1,0.994657071538414,0,1,tRNA 2'-O-methyltransferase activity,MF,
18424,GO:0106056,1,0.886418520152061,0,16,regulation of calcineurin-mediated signaling,BP,
18425,GO:0106057,1,0.977254752292586,0,3,negative regulation of calcineurin-mediated signaling,BP,
18426,GO:0106058,1,0.937868513173416,0,9,positive regulation of calcineurin-mediated signaling,BP,
18427,GO:0106064,1,0.991533261091361,0,1,regulation of cobalamin metabolic process,BP,
18428,GO:0106068,1,0.963133109237668,0,6,SUMO ligase complex,CC,
18429,GO:0106070,1,0.929894025145254,0,10,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18430,GO:0106071,1,0.963124288779464,0,5,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18431,GO:0106072,1,0.955304691216474,0,7,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18432,GO:0106073,1,0.981425913962078,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18433,GO:0106074,1,0.933228328337,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18434,GO:0106075,1,0.994086213620219,0,1,peptide N-succinyltransferase activity,MF,
18435,GO:0106077,1,0.975353402862116,0,4,histone succinylation,BP,
18436,GO:0106078,1,0.994086213620219,0,1,histone succinyltransferase activity,MF,
18437,GO:0106083,1,0.937058794208955,0,7,nuclear membrane protein complex,CC,
18438,GO:0106088,1,0.990391752657085,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18439,GO:0106089,1,0.990391752657085,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18440,GO:0106094,1,0.937058794208955,0,7,nuclear membrane microtubule tethering complex,CC,
18441,GO:0106101,1,0.994687514808973,0,1,ER-dependent peroxisome localization,BP,
18443,GO:0110008,1,0.994137211084186,0,1,ncRNA deadenylation,BP,
18444,GO:0110009,1,0.976921569397835,0,3,formin-nucleated actin cable organization,BP,
18445,GO:0110011,1,0.954863076050526,0,5,regulation of basement membrane organization,BP,
18446,GO:0110017,1,0.989587659234027,0,2,cap-independent translational initiation of linear mRNA,BP,
18447,GO:0110020,1,0.555248976828755,0,81,regulation of actomyosin structure organization,BP,
18448,GO:0110021,1,0.982221406211255,0,3,cardiac muscle myoblast proliferation,BP,
18449,GO:0110022,1,0.982221406211255,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18450,GO:0110024,1,0.982221406211255,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18451,GO:0110025,1,0.994134102824805,0,1,DNA strand resection involved in replication fork processing,BP,
18452,GO:0110026,1,0.994134102824805,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18453,GO:0110028,1,0.990054929762495,0,1,positive regulation of mitotic spindle organization,BP,
18454,GO:0110029,1,0.994063821636701,0,1,negative regulation of meiosis I,BP,
18455,GO:0110053,1,0.196722690173533,0,236,regulation of actin filament organization,BP,
18456,GO:0110057,1,0.991834966603394,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18457,GO:0110059,1,0.991834966603394,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18458,GO:0110075,1,0.994822418837371,0,1,regulation of ferroptosis,BP,
18459,GO:0110076,1,0.994822418837371,0,1,negative regulation of ferroptosis,BP,
18460,GO:0110095,1,0.984092261833828,0,3,cellular detoxification of aldehyde,BP,
18461,GO:0110096,1,0.973637899715228,0,5,cellular response to aldehyde,BP,
18462,GO:0120009,1,0.970150899759556,0,5,intermembrane lipid transfer,BP,
18463,GO:0120012,1,0.991919377612401,0,1,intermembrane sphingolipid transfer,BP,
18464,GO:0120013,1,0.970150899759556,0,5,intermembrane lipid transfer activity,MF,
18465,GO:0120016,1,0.991919377612401,0,1,intermembrane sphingolipid transfer activity,MF,
18466,GO:0120017,1,0.991919377612401,0,1,intermembrane ceramide transfer activity,MF,
18469,GO:0120032,1,0.377366844309945,0,141,regulation of plasma membrane bounded cell projection assembly,BP,
18470,GO:0120033,1,0.883454284360446,0,20,negative regulation of plasma membrane bounded cell projection assembly,BP,
18471,GO:0120034,1,0.570583498124207,0,81,positive regulation of plasma membrane bounded cell projection assembly,BP,
18476,GO:0120043,1,0.992608191192519,0,1,stereocilium shaft,CC,
18477,GO:0120044,1,0.992608191192519,0,1,stereocilium base,CC,
18478,GO:0120048,1,0.994313214468247,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18479,GO:0120049,1,0.994313214468247,0,1,snRNA (adenine-N6)-methylation,BP,
18480,GO:0120054,1,0.994834055115578,0,1,intestinal motility,BP,
18481,GO:0120055,1,0.994834055115578,0,1,small intestinal transit,BP,
18482,GO:0120057,1,0.994834055115578,0,1,regulation of small intestinal transit,BP,
18483,GO:0120058,1,0.994834055115578,0,1,positive regulation of small intestinal transit,BP,
18484,GO:0120060,1,0.994829653520256,0,1,regulation of gastric emptying,BP,
18485,GO:0120061,1,0.994829653520256,0,1,negative regulation of gastric emptying,BP,
18486,GO:0120063,1,0.987023905804704,0,2,stomach smooth muscle contraction,BP,
18487,GO:0120064,1,0.992154089340602,0,1,stomach pylorus smooth muscle contraction,BP,
18488,GO:0120065,1,0.992154089340602,0,1,pyloric antrum smooth muscle contraction,BP,
18489,GO:0120068,1,0.994829653520256,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18490,GO:0120069,1,0.994829653520256,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18491,GO:0120071,1,0.992154089340602,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18492,GO:0120072,1,0.992154089340602,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18493,GO:0120077,1,0.990391752657085,0,1,angiogenic sprout fusion,BP,
18494,GO:0120078,1,0.990391752657085,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18495,GO:0120092,1,0.993904311379295,0,1,crotonyl-CoA hydratase activity,MF,
18496,GO:0120093,1,0.993904311379295,0,1,regulation of peptidyl-lysine crotonylation,BP,
18497,GO:0120094,1,0.993904311379295,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18498,GO:0120103,1,0.939228302302788,0,9,centriolar subdistal appendage,CC,
18499,GO:0120108,1,0.994638867968558,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
18500,GO:0120111,1,0.629430137489429,0,67,neuron projection cytoplasm,CC,
18501,GO:0120114,1,0.606935794201865,0,79,Sm-like protein family complex,CC,
18502,GO:0140007,1,0.978139262181034,0,4,KICSTOR complex,CC,
18503,GO:0140009,1,0.987297492643979,0,2,L-aspartate import across plasma membrane,BP,
18504,GO:0140013,1,0.396843088428451,0,143,meiotic nuclear division,BP,
18505,GO:0140014,1,0.173237363034193,0,252,mitotic nuclear division,BP,
18507,GO:0140030,1,0.448055620497458,0,113,modification-dependent protein binding,MF,
18508,GO:0140031,1,0.988719165435943,0,2,phosphorylation-dependent protein binding,MF,
18509,GO:0140033,1,0.868579841207441,0,17,acetylation-dependent protein binding,MF,
18510,GO:0140034,1,0.670257745140231,0,56,methylation-dependent protein binding,MF,
18511,GO:0140035,1,0.965306727426795,0,5,ubiquitination-like modification-dependent protein binding,MF,
18512,GO:0140036,1,0.965306727426795,0,5,ubiquitin-dependent protein binding,MF,
18513,GO:0140041,1,0.994822876044542,0,1,cellular detoxification of methylglyoxal,BP,
18514,GO:0140049,1,0.994729577369819,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18515,GO:0140051,1,0.994729577369819,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18516,GO:0140052,1,0.966857793870142,0,5,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18517,GO:0140053,1,0.422750528946465,0,151,mitochondrial gene expression,BP,
18519,GO:0140058,1,0.876164156466242,0,16,neuron projection arborization,BP,
18520,GO:0140059,1,0.96782752173482,0,5,dendrite arborization,BP,
18521,GO:0140064,1,0.988487043103078,0,1,peptide crotonyltransferase activity,MF,
18522,GO:0140065,1,0.988487043103078,0,1,peptide butyryltransferase activity,MF,
18523,GO:0140066,1,0.982460839067586,0,2,peptidyl-lysine crotonylation,BP,
18524,GO:0140067,1,0.988487043103078,0,1,peptidyl-lysine butyrylation,BP,
18525,GO:0140068,1,0.988487043103078,0,1,histone crotonyltransferase activity,MF,
18526,GO:0140069,1,0.988487043103078,0,1,histone butyryltransferase activity,MF,
18527,GO:0140074,1,0.992151990213815,0,1,cardiac endothelial to mesenchymal transition,BP,
18528,GO:0140078,1,0.94670677898524,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18529,GO:0140080,1,0.94670677898524,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18532,GO:0140098,1,0.124138884860864,0,338,catalytic activity, acting on RNA,MF,
18533,GO:0140101,1,0.508896893539735,0,115,catalytic activity, acting on a tRNA,MF,
18534,GO:0140102,1,0.916621273404013,0,15,catalytic activity, acting on a rRNA,MF,
18535,GO:0140103,1,0.884656767966742,0,20,catalytic activity, acting on a glycoprotein,MF,
18536,GO:0140104,1,0.771173479345172,0,40,molecular carrier activity,MF,
18538,GO:0140112,1,0.888188757465118,0,20,extracellular vesicle biogenesis,BP,
18540,GO:0140131,1,0.931167979254887,0,12,positive regulation of lymphocyte chemotaxis,BP,
18542,GO:0140142,1,0.878588301452199,0,18,nucleocytoplasmic carrier activity,MF,
18543,GO:0140161,1,0.955764787714461,0,8,monocarboxylate:sodium symporter activity,MF,
18544,GO:0140192,1,0.978664851625576,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18545,GO:0140193,1,0.994782178411431,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18546,GO:0140194,1,0.994782178411431,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18547,GO:0140196,1,0.990109670625449,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18548,GO:0140199,1,0.988441996649535,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18549,GO:0140200,1,0.989128827457466,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18550,GO:0150003,1,0.968990044441701,0,4,regulation of spontaneous synaptic transmission,BP,
18551,GO:0150005,1,0.933457273193058,0,11,enzyme activator complex,CC,
18552,GO:0150011,1,0.948848241161422,0,7,regulation of neuron projection arborization,BP,
18553,GO:0150012,1,0.948848241161422,0,7,positive regulation of neuron projection arborization,BP,
18554,GO:0150018,1,0.97883264661036,0,3,basal dendrite development,BP,
18555,GO:0150019,1,0.97883264661036,0,3,basal dendrite morphogenesis,BP,
18556,GO:0150020,1,0.97883264661036,0,3,basal dendrite arborization,BP,
18557,GO:0150024,1,0.994623025626187,0,1,oxidised low-density lipoprotein particle clearance,BP,
18558,GO:0150025,1,0.994623025626187,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18559,GO:0150031,1,0.990848391757946,0,1,regulation of protein localization to lysosome,BP,
18560,GO:0150033,1,0.990848391757946,0,1,negative regulation of protein localization to lysosome,BP,
18563,GO:1900003,1,0.961581771188904,0,6,regulation of serine-type endopeptidase activity,BP,
18564,GO:1900004,1,0.961581771188904,0,6,negative regulation of serine-type endopeptidase activity,BP,
18565,GO:1900005,1,0.987965628034237,0,1,positive regulation of serine-type endopeptidase activity,BP,
18567,GO:1900010,1,0.994689149238764,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18568,GO:1900011,1,0.994689149238764,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18569,GO:1900015,1,0.843662882688763,0,27,regulation of cytokine production involved in inflammatory response,BP,
18570,GO:1900016,1,0.946413464822242,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18571,GO:1900017,1,0.922114910512456,0,13,positive regulation of cytokine production involved in inflammatory response,BP,
18572,GO:1900019,1,0.973719937865385,0,4,regulation of protein kinase C activity,BP,
18573,GO:1900020,1,0.973719937865385,0,4,positive regulation of protein kinase C activity,BP,
18577,GO:1900027,1,0.863968573801759,0,24,regulation of ruffle assembly,BP,
18578,GO:1900028,1,0.971241222307512,0,5,negative regulation of ruffle assembly,BP,
18579,GO:1900029,1,0.933619506451217,0,11,positive regulation of ruffle assembly,BP,
18580,GO:1900034,1,0.59373517550176,0,75,regulation of cellular response to heat,BP,
18581,GO:1900035,1,0.99434619940342,0,1,negative regulation of cellular response to heat,BP,
18582,GO:1900036,1,0.994527648475167,0,1,positive regulation of cellular response to heat,BP,
18583,GO:1900037,1,0.931445405714738,0,12,regulation of cellular response to hypoxia,BP,
18584,GO:1900038,1,0.959181749961432,0,7,negative regulation of cellular response to hypoxia,BP,
18585,GO:1900039,1,0.988711239273445,0,2,positive regulation of cellular response to hypoxia,BP,
18588,GO:1900042,1,0.973932738064233,0,3,positive regulation of interleukin-2 secretion,BP,
18589,GO:1900044,1,0.931608390395126,0,9,regulation of protein K63-linked ubiquitination,BP,
18590,GO:1900045,1,0.959961867659056,0,5,negative regulation of protein K63-linked ubiquitination,BP,
18594,GO:1900052,1,0.994797329784172,0,1,regulation of retinoic acid biosynthetic process,BP,
18595,GO:1900053,1,0.994797329784172,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18596,GO:1900060,1,0.976438557646239,0,4,negative regulation of ceramide biosynthetic process,BP,
18597,GO:1900062,1,0.99360752665301,0,1,regulation of replicative cell aging,BP,
18598,GO:1900063,1,0.973388080887853,0,3,regulation of peroxisome organization,BP,
18599,GO:1900073,1,0.994745811293282,0,1,regulation of neuromuscular synaptic transmission,BP,
18600,GO:1900075,1,0.994745811293282,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18603,GO:1900078,1,0.826678611051665,0,26,positive regulation of cellular response to insulin stimulus,BP,
18604,GO:1900081,1,0.988441996649535,0,1,regulation of arginine catabolic process,BP,
18605,GO:1900082,1,0.988441996649535,0,1,negative regulation of arginine catabolic process,BP,
18606,GO:1900084,1,0.958329753132413,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18607,GO:1900085,1,0.994370607996823,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18608,GO:1900086,1,0.96375711747893,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18610,GO:1900094,1,0.955904749570257,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18611,GO:1900095,1,0.98677708404685,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18612,GO:1900098,1,0.994697149405476,0,1,regulation of plasma cell differentiation,BP,
18613,GO:1900100,1,0.994697149405476,0,1,positive regulation of plasma cell differentiation,BP,
18614,GO:1900101,1,0.85613927758923,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
18615,GO:1900102,1,0.935878986050007,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18616,GO:1900103,1,0.918940735645469,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
18617,GO:1900104,1,0.982429774209115,0,3,regulation of hyaluranon cable assembly,BP,
18618,GO:1900106,1,0.982429774209115,0,3,positive regulation of hyaluranon cable assembly,BP,
18619,GO:1900107,1,0.955421122488628,0,7,regulation of nodal signaling pathway,BP,
18620,GO:1900108,1,0.983815402634984,0,3,negative regulation of nodal signaling pathway,BP,
18621,GO:1900109,1,0.984062083899113,0,3,regulation of histone H3-K9 dimethylation,BP,
18622,GO:1900110,1,0.989544805908279,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18623,GO:1900111,1,0.994459930849579,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18624,GO:1900112,1,0.935711313858461,0,9,regulation of histone H3-K9 trimethylation,BP,
18625,GO:1900113,1,0.96934470875562,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18626,GO:1900114,1,0.984338568323597,0,2,positive regulation of histone H3-K9 trimethylation,BP,
18627,GO:1900115,1,0.90198155365644,0,15,extracellular regulation of signal transduction,BP,
18628,GO:1900116,1,0.90198155365644,0,15,extracellular negative regulation of signal transduction,BP,
18629,GO:1900117,1,0.875624507805568,0,21,regulation of execution phase of apoptosis,BP,
18630,GO:1900118,1,0.95686096880416,0,7,negative regulation of execution phase of apoptosis,BP,
18631,GO:1900119,1,0.929259635377704,0,12,positive regulation of execution phase of apoptosis,BP,
18635,GO:1900125,1,0.951982545383568,0,7,regulation of hyaluronan biosynthetic process,BP,
18636,GO:1900126,1,0.97721698137638,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18637,GO:1900127,1,0.974183114346713,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18638,GO:1900130,1,0.993694882327013,0,1,regulation of lipid binding,BP,
18639,GO:1900131,1,0.993694882327013,0,1,negative regulation of lipid binding,BP,
18640,GO:1900133,1,0.982192274480775,0,3,regulation of renin secretion into blood stream,BP,
18641,GO:1900134,1,0.99352661062909,0,1,negative regulation of renin secretion into blood stream,BP,
18642,GO:1900135,1,0.988592551185063,0,2,positive regulation of renin secretion into blood stream,BP,
18644,GO:1900139,1,0.99230378026243,0,1,negative regulation of arachidonic acid secretion,BP,
18645,GO:1900141,1,0.994452945073479,0,1,regulation of oligodendrocyte apoptotic process,BP,
18646,GO:1900142,1,0.994452945073479,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18647,GO:1900145,1,0.966230640990035,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18648,GO:1900146,1,0.989542475272259,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18649,GO:1900147,1,0.984406012703786,0,2,regulation of Schwann cell migration,BP,
18650,GO:1900148,1,0.994313214468247,0,1,negative regulation of Schwann cell migration,BP,
18651,GO:1900149,1,0.990036700891625,0,1,positive regulation of Schwann cell migration,BP,
18652,GO:1900150,1,0.989017519116373,0,2,regulation of defense response to fungus,BP,
18653,GO:1900151,1,0.888185879114411,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18654,GO:1900152,1,0.994693615343317,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18655,GO:1900153,1,0.888185879114411,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18656,GO:1900154,1,0.987980429568047,0,2,regulation of bone trabecula formation,BP,
18657,GO:1900155,1,0.987980429568047,0,2,negative regulation of bone trabecula formation,BP,
18659,GO:1900158,1,0.993222110688116,0,1,negative regulation of bone mineralization involved in bone maturation,BP,
18661,GO:1900161,1,0.994304233720245,0,1,regulation of phospholipid scramblase activity,BP,
18662,GO:1900163,1,0.994304233720245,0,1,positive regulation of phospholipid scramblase activity,BP,
18663,GO:1900164,1,0.955904749570257,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18664,GO:1900165,1,0.957809665553122,0,7,negative regulation of interleukin-6 secretion,BP,
18665,GO:1900166,1,0.988755964088269,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18666,GO:1900168,1,0.988755964088269,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18667,GO:1900169,1,0.978764483140643,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18668,GO:1900170,1,0.994313214468247,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18669,GO:1900175,1,0.966230640990035,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18670,GO:1900176,1,0.989542475272259,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18671,GO:1900180,1,0.536531052988101,0,93,regulation of protein localization to nucleus,BP,
18672,GO:1900181,1,0.867186897123021,0,21,negative regulation of protein localization to nucleus,BP,
18673,GO:1900182,1,0.657060484065831,0,62,positive regulation of protein localization to nucleus,BP,
18674,GO:1900186,1,0.980829860789987,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18677,GO:1900193,1,0.961473610999982,0,7,regulation of oocyte maturation,BP,
18678,GO:1900194,1,0.982904134001721,0,3,negative regulation of oocyte maturation,BP,
18679,GO:1900195,1,0.989255694434788,0,2,positive regulation of oocyte maturation,BP,
18680,GO:1900200,1,0.986751226142549,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18681,GO:1900204,1,0.986751226142549,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18682,GO:1900205,1,0.986751226142549,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18683,GO:1900208,1,0.989501494465836,0,2,regulation of cardiolipin metabolic process,BP,
18684,GO:1900210,1,0.989501494465836,0,2,positive regulation of cardiolipin metabolic process,BP,
18685,GO:1900211,1,0.986751226142549,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18686,GO:1900212,1,0.986751226142549,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18687,GO:1900214,1,0.986751226142549,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18688,GO:1900215,1,0.986751226142549,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18689,GO:1900217,1,0.986751226142549,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18690,GO:1900218,1,0.986751226142549,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18691,GO:1900220,1,0.982900105562513,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18692,GO:1900221,1,0.919859942969983,0,10,regulation of amyloid-beta clearance,BP,
18693,GO:1900222,1,0.97838917345336,0,3,negative regulation of amyloid-beta clearance,BP,
18694,GO:1900223,1,0.945557717087068,0,6,positive regulation of amyloid-beta clearance,BP,
18695,GO:1900224,1,0.981602098097878,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18696,GO:1900225,1,0.929006316614183,0,11,regulation of NLRP3 inflammasome complex assembly,BP,
18697,GO:1900226,1,0.973883031727738,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18698,GO:1900227,1,0.959353470838786,0,6,positive regulation of NLRP3 inflammasome complex assembly,BP,
18701,GO:1900238,1,0.98027118327346,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18702,GO:1900239,1,0.969363241030828,0,4,regulation of phenotypic switching,BP,
18703,GO:1900241,1,0.99425129906114,0,1,positive regulation of phenotypic switching,BP,
18704,GO:1900242,1,0.935476806780166,0,8,regulation of synaptic vesicle endocytosis,BP,
18705,GO:1900243,1,0.992086854297677,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18706,GO:1900244,1,0.968245396552537,0,4,positive regulation of synaptic vesicle endocytosis,BP,
18707,GO:1900245,1,0.974050803656387,0,3,positive regulation of MDA-5 signaling pathway,BP,
18708,GO:1900246,1,0.957645127391835,0,5,positive regulation of RIG-I signaling pathway,BP,
18709,GO:1900247,1,0.93896126745968,0,10,regulation of cytoplasmic translational elongation,BP,
18710,GO:1900248,1,0.983256340086142,0,2,negative regulation of cytoplasmic translational elongation,BP,
18711,GO:1900259,1,0.994674951261021,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18712,GO:1900260,1,0.994674951261021,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18713,GO:1900262,1,0.96783653338521,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18714,GO:1900264,1,0.96783653338521,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18716,GO:1900272,1,0.943050221816848,0,8,negative regulation of long-term synaptic potentiation,BP,
18718,GO:1900274,1,0.797644446011826,0,33,regulation of phospholipase C activity,BP,
18719,GO:1900275,1,0.985570152563608,0,2,negative regulation of phospholipase C activity,BP,
18720,GO:1900276,1,0.993843297646569,0,1,regulation of proteinase activated receptor activity,BP,
18721,GO:1900279,1,0.993802399849716,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18722,GO:1900281,1,0.993802399849716,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18723,GO:1900363,1,0.92605745331834,0,12,regulation of mRNA polyadenylation,BP,
18724,GO:1900364,1,0.950795577979881,0,8,negative regulation of mRNA polyadenylation,BP,
18725,GO:1900365,1,0.97914536496475,0,3,positive regulation of mRNA polyadenylation,BP,
18726,GO:1900368,1,0.976195909792532,0,3,regulation of RNA interference,BP,
18727,GO:1900369,1,0.984131926960997,0,2,negative regulation of RNA interference,BP,
18728,GO:1900370,1,0.991937306038735,0,1,positive regulation of RNA interference,BP,
18731,GO:1900373,1,0.696385794984039,0,56,positive regulation of purine nucleotide biosynthetic process,BP,
18732,GO:1900376,1,0.943198680014196,0,7,regulation of secondary metabolite biosynthetic process,BP,
18733,GO:1900377,1,0.981975357787741,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
18734,GO:1900378,1,0.960518585896693,0,5,positive regulation of secondary metabolite biosynthetic process,BP,
18735,GO:1900383,1,0.993983193638579,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18736,GO:1900387,1,0.994615292566471,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18737,GO:1900390,1,0.983864188877794,0,3,regulation of iron ion import,BP,
18738,GO:1900402,1,0.936929002524022,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18739,GO:1900407,1,0.65864601585839,0,66,regulation of cellular response to oxidative stress,BP,
18740,GO:1900408,1,0.779695731357342,0,39,negative regulation of cellular response to oxidative stress,BP,
18741,GO:1900409,1,0.9082142936049,0,15,positive regulation of cellular response to oxidative stress,BP,
18742,GO:1900424,1,0.925352877133641,0,12,regulation of defense response to bacterium,BP,
18743,GO:1900425,1,0.967896163662345,0,5,negative regulation of defense response to bacterium,BP,
18744,GO:1900426,1,0.964458194736796,0,6,positive regulation of defense response to bacterium,BP,
18746,GO:1900450,1,0.992473728510381,0,1,negative regulation of glutamate receptor signaling pathway,BP,
18747,GO:1900451,1,0.929484134359265,0,9,positive regulation of glutamate receptor signaling pathway,BP,
18749,GO:1900453,1,0.982147249286957,0,3,negative regulation of long term synaptic depression,BP,
18751,GO:1900477,1,0.994621109196245,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18752,GO:1900533,1,0.994754228421442,0,1,palmitic acid metabolic process,BP,
18753,GO:1900535,1,0.994754228421442,0,1,palmitic acid biosynthetic process,BP,
18757,GO:1900558,1,0.994653493041565,0,1,austinol metabolic process,BP,
18758,GO:1900560,1,0.994653493041565,0,1,austinol biosynthetic process,BP,
18759,GO:1900561,1,0.994653493041565,0,1,dehydroaustinol metabolic process,BP,
18760,GO:1900563,1,0.994653493041565,0,1,dehydroaustinol biosynthetic process,BP,
18761,GO:1900619,1,0.983059239152937,0,3,acetate ester metabolic process,BP,
18762,GO:1900620,1,0.994383550341847,0,1,acetate ester biosynthetic process,BP,
18763,GO:1900623,1,0.978507789920413,0,3,regulation of monocyte aggregation,BP,
18764,GO:1900625,1,0.978507789920413,0,3,positive regulation of monocyte aggregation,BP,
18766,GO:1900719,1,0.992335070383341,0,1,regulation of uterine smooth muscle relaxation,BP,
18767,GO:1900721,1,0.992335070383341,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18768,GO:1900736,1,0.978289079920628,0,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18769,GO:1900737,1,0.993843297646569,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18770,GO:1900738,1,0.984350386179096,0,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18771,GO:1900739,1,0.837193068833917,0,30,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18772,GO:1900740,1,0.837193068833917,0,30,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18773,GO:1900744,1,0.815922176982341,0,31,regulation of p38MAPK cascade,BP,
18774,GO:1900745,1,0.872977930383423,0,21,positive regulation of p38MAPK cascade,BP,
18775,GO:1900746,1,0.929918386937278,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
18776,GO:1900747,1,0.979333505302926,0,3,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18777,GO:1900748,1,0.965351263065594,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18778,GO:1900750,1,0.934913957013136,0,12,oligopeptide binding,MF,
18779,GO:1900753,1,0.993000592102792,0,1,doxorubicin transport,BP,
18780,GO:1900756,1,0.984109462323214,0,2,protein processing in phagocytic vesicle,BP,
18781,GO:1900825,1,0.975319763878599,0,3,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18782,GO:1900827,1,0.987378888931516,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18783,GO:1900864,1,0.9498119191713,0,9,mitochondrial RNA modification,BP,
18784,GO:1901004,1,0.994791879110063,0,1,ubiquinone-6 metabolic process,BP,
18785,GO:1901006,1,0.994791879110063,0,1,ubiquinone-6 biosynthetic process,BP,
18786,GO:1901016,1,0.699980763221758,0,49,regulation of potassium ion transmembrane transporter activity,BP,
18787,GO:1901017,1,0.900629705128838,0,15,negative regulation of potassium ion transmembrane transporter activity,BP,
18788,GO:1901018,1,0.845208944517598,0,22,positive regulation of potassium ion transmembrane transporter activity,BP,
18790,GO:1901020,1,0.830660313921814,0,31,negative regulation of calcium ion transmembrane transporter activity,BP,
18791,GO:1901021,1,0.80004698105258,0,31,positive regulation of calcium ion transmembrane transporter activity,BP,
18792,GO:1901026,1,0.975907141716127,0,3,ripoptosome assembly involved in necroptotic process,BP,
18793,GO:1901028,1,0.762730897564732,0,46,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18794,GO:1901029,1,0.957363954034971,0,8,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18795,GO:1901030,1,0.80101496869658,0,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18796,GO:1901031,1,0.804760433444502,0,35,regulation of response to reactive oxygen species,BP,
18797,GO:1901032,1,0.897258674742192,0,17,negative regulation of response to reactive oxygen species,BP,
18798,GO:1901033,1,0.95136181575867,0,8,positive regulation of response to reactive oxygen species,BP,
18799,GO:1901052,1,0.993946498910126,0,1,sarcosine metabolic process,BP,
18800,GO:1901053,1,0.993946498910126,0,1,sarcosine catabolic process,BP,
18801,GO:1901068,1,0.723349703295712,0,50,guanosine-containing compound metabolic process,BP,
18802,GO:1901069,1,0.994772523962849,0,1,guanosine-containing compound catabolic process,BP,
18803,GO:1901070,1,0.928322812875296,0,14,guanosine-containing compound biosynthetic process,BP,
18806,GO:1901073,1,0.985619573384287,0,2,glucosamine-containing compound biosynthetic process,BP,
18807,GO:1901074,1,0.984823463194821,0,2,regulation of engulfment of apoptotic cell,BP,
18808,GO:1901076,1,0.990407089195843,0,1,positive regulation of engulfment of apoptotic cell,BP,
18809,GO:1901077,1,0.931682731996801,0,11,regulation of relaxation of muscle,BP,
18810,GO:1901078,1,0.977171826437761,0,3,negative regulation of relaxation of muscle,BP,
18811,GO:1901079,1,0.981586451611714,0,3,positive regulation of relaxation of muscle,BP,
18812,GO:1901080,1,0.992335070383341,0,1,regulation of relaxation of smooth muscle,BP,
18813,GO:1901082,1,0.992335070383341,0,1,positive regulation of relaxation of smooth muscle,BP,
18814,GO:1901086,1,0.992265130732741,0,1,benzylpenicillin metabolic process,BP,
18815,GO:1901090,1,0.988742711466587,0,2,regulation of protein tetramerization,BP,
18816,GO:1901091,1,0.988742711466587,0,2,negative regulation of protein tetramerization,BP,
18817,GO:1901093,1,0.988742711466587,0,2,regulation of protein homotetramerization,BP,
18818,GO:1901094,1,0.988742711466587,0,2,negative regulation of protein homotetramerization,BP,
18819,GO:1901096,1,0.927894647766569,0,10,regulation of autophagosome maturation,BP,
18820,GO:1901097,1,0.978918592660151,0,3,negative regulation of autophagosome maturation,BP,
18821,GO:1901098,1,0.944868679770106,0,7,positive regulation of autophagosome maturation,BP,
18822,GO:1901099,1,0.827473278661399,0,32,negative regulation of signal transduction in absence of ligand,BP,
18826,GO:1901142,1,0.95118702777263,0,7,insulin metabolic process,BP,
18827,GO:1901143,1,0.985998821002248,0,2,insulin catabolic process,BP,
18828,GO:1901145,1,0.980154592581062,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18829,GO:1901147,1,0.986751226142549,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18830,GO:1901159,1,0.972717732358086,0,5,xylulose 5-phosphate biosynthetic process,BP,
18831,GO:1901160,1,0.909114324142214,0,13,primary amino compound metabolic process,BP,
18832,GO:1901162,1,0.973034422330999,0,5,primary amino compound biosynthetic process,BP,
18835,GO:1901165,1,0.971591329932351,0,5,positive regulation of trophoblast cell migration,BP,
18836,GO:1901166,1,0.980011151771409,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
18839,GO:1901186,1,0.802526408632745,0,34,positive regulation of ERBB signaling pathway,BP,
18840,GO:1901187,1,0.985479312116033,0,2,regulation of ephrin receptor signaling pathway,BP,
18841,GO:1901189,1,0.99451842522338,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18842,GO:1901193,1,0.99480751851956,0,1,regulation of formation of translation preinitiation complex,BP,
18843,GO:1901194,1,0.99480751851956,0,1,negative regulation of formation of translation preinitiation complex,BP,
18844,GO:1901201,1,0.903163603999745,0,13,regulation of extracellular matrix assembly,BP,
18845,GO:1901202,1,0.99452110815468,0,1,negative regulation of extracellular matrix assembly,BP,
18846,GO:1901203,1,0.929981403216319,0,9,positive regulation of extracellular matrix assembly,BP,
18847,GO:1901207,1,0.987301888957993,0,2,regulation of heart looping,BP,
18848,GO:1901208,1,0.993892324713308,0,1,negative regulation of heart looping,BP,
18849,GO:1901210,1,0.993892324713308,0,1,regulation of cardiac chamber formation,BP,
18850,GO:1901211,1,0.993892324713308,0,1,negative regulation of cardiac chamber formation,BP,
18851,GO:1901213,1,0.922452913889606,0,12,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18854,GO:1901216,1,0.599054822046849,0,76,positive regulation of neuron death,BP,
18855,GO:1901219,1,0.993892324713308,0,1,regulation of cardiac chamber morphogenesis,BP,
18856,GO:1901220,1,0.993892324713308,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18858,GO:1901223,1,0.944443667262035,0,9,negative regulation of NIK/NF-kappaB signaling,BP,
18860,GO:1901228,1,0.976889466537433,0,3,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18861,GO:1901229,1,0.994412229846995,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18862,GO:1901231,1,0.994412229846995,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18863,GO:1901232,1,0.994412229846995,0,1,regulation of convergent extension involved in axis elongation,BP,
18864,GO:1901233,1,0.994412229846995,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18865,GO:1901246,1,0.989209128498299,0,2,regulation of lung ciliated cell differentiation,BP,
18866,GO:1901247,1,0.994790910327561,0,1,negative regulation of lung ciliated cell differentiation,BP,
18867,GO:1901248,1,0.994389282500765,0,1,positive regulation of lung ciliated cell differentiation,BP,
18868,GO:1901249,1,0.994790910327561,0,1,regulation of lung goblet cell differentiation,BP,
18869,GO:1901251,1,0.994790910327561,0,1,positive regulation of lung goblet cell differentiation,BP,
18870,GO:1901252,1,0.987842271942558,0,2,regulation of intracellular transport of viral material,BP,
18871,GO:1901253,1,0.994822550162066,0,1,negative regulation of intracellular transport of viral material,BP,
18872,GO:1901254,1,0.9929837567906,0,1,positive regulation of intracellular transport of viral material,BP,
18873,GO:1901255,1,0.985294118237564,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18874,GO:1901256,1,0.971740326877283,0,5,regulation of macrophage colony-stimulating factor production,BP,
18875,GO:1901257,1,0.994533297210656,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18876,GO:1901258,1,0.983239513210934,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18877,GO:1901264,1,0.682499471078229,0,65,carbohydrate derivative transport,BP,
18879,GO:1901269,1,0.989698593754242,0,2,lipooligosaccharide metabolic process,BP,
18880,GO:1901271,1,0.989698593754242,0,2,lipooligosaccharide biosynthetic process,BP,
18881,GO:1901291,1,0.994669442799066,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18882,GO:1901292,1,0.339693851937978,0,162,nucleoside phosphate catabolic process,BP,
18884,GO:1901295,1,0.98924519313071,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18885,GO:1901296,1,0.994697994008713,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18886,GO:1901297,1,0.99451842522338,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18887,GO:1901298,1,0.93707653685496,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18888,GO:1901299,1,0.963192362703439,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18889,GO:1901300,1,0.972896206367022,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18890,GO:1901301,1,0.987135123995397,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18891,GO:1901303,1,0.994347577264868,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18892,GO:1901304,1,0.994722055363197,0,1,regulation of spermidine biosynthetic process,BP,
18893,GO:1901307,1,0.994722055363197,0,1,positive regulation of spermidine biosynthetic process,BP,
18894,GO:1901314,1,0.973390693281286,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18895,GO:1901315,1,0.973390693281286,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18896,GO:1901317,1,0.952064808590834,0,9,regulation of flagellated sperm motility,BP,
18897,GO:1901318,1,0.994665887682369,0,1,negative regulation of flagellated sperm motility,BP,
18898,GO:1901321,1,0.989529875795574,0,2,positive regulation of heart induction,BP,
18899,GO:1901328,1,0.994696544111254,0,1,response to cytochalasin B,BP,
18902,GO:1901337,1,0.994376713196624,0,1,thioester transport,BP,
18903,GO:1901338,1,0.923525744964524,0,14,catecholamine binding,MF,
18904,GO:1901339,1,0.955658693251593,0,7,regulation of store-operated calcium channel activity,BP,
18905,GO:1901340,1,0.993222591434604,0,1,negative regulation of store-operated calcium channel activity,BP,
18906,GO:1901341,1,0.967928203384895,0,5,positive regulation of store-operated calcium channel activity,BP,
18909,GO:1901344,1,0.994790421393158,0,1,response to leptomycin B,BP,
18910,GO:1901350,1,0.990196510220358,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18911,GO:1901355,1,0.985313189898067,0,2,response to rapamycin,BP,
18916,GO:1901373,1,0.994771926335018,0,1,lipid hydroperoxide transport,BP,
18917,GO:1901374,1,0.961932147901788,0,7,acetate ester transport,BP,
18918,GO:1901375,1,0.98371753574617,0,3,acetate ester transmembrane transporter activity,MF,
18919,GO:1901376,1,0.994333682075354,0,1,organic heteropentacyclic compound metabolic process,BP,
18920,GO:1901377,1,0.994333682075354,0,1,organic heteropentacyclic compound catabolic process,BP,
18922,GO:1901380,1,0.885190934719746,0,18,negative regulation of potassium ion transmembrane transport,BP,
18923,GO:1901381,1,0.788769290788834,0,32,positive regulation of potassium ion transmembrane transport,BP,
18924,GO:1901382,1,0.968669254389989,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18925,GO:1901383,1,0.983249615534822,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18926,GO:1901385,1,0.822503033623598,0,31,regulation of voltage-gated calcium channel activity,BP,
18927,GO:1901386,1,0.934556434301621,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18928,GO:1901387,1,0.953863641068904,0,8,positive regulation of voltage-gated calcium channel activity,BP,
18929,GO:1901388,1,0.994434863992636,0,1,regulation of transforming growth factor beta activation,BP,
18930,GO:1901389,1,0.994434863992636,0,1,negative regulation of transforming growth factor beta activation,BP,
18931,GO:1901401,1,0.991533261091361,0,1,regulation of tetrapyrrole metabolic process,BP,
18932,GO:1901407,1,0.948237029340899,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18933,GO:1901409,1,0.96079702780801,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18934,GO:1901419,1,0.993003559696667,0,1,regulation of response to alcohol,BP,
18935,GO:1901421,1,0.993003559696667,0,1,positive regulation of response to alcohol,BP,
18936,GO:1901474,1,0.960134950995234,0,7,azole transmembrane transporter activity,MF,
18937,GO:1901475,1,0.977279070398313,0,4,pyruvate transmembrane transport,BP,
18938,GO:1901490,1,0.971052771831235,0,4,regulation of lymphangiogenesis,BP,
18939,GO:1901491,1,0.985155940325279,0,2,negative regulation of lymphangiogenesis,BP,
18940,GO:1901492,1,0.98568645276546,0,2,positive regulation of lymphangiogenesis,BP,
18941,GO:1901503,1,0.965987316046413,0,5,ether biosynthetic process,BP,
18942,GO:1901505,1,0.817947017491642,0,34,carbohydrate derivative transmembrane transporter activity,MF,
18944,GO:1901522,1,0.845301509399863,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
18945,GO:1901523,1,0.983296522650251,0,3,icosanoid catabolic process,BP,
18946,GO:1901524,1,0.908642615720363,0,13,regulation of mitophagy,BP,
18947,GO:1901525,1,0.964628043923553,0,5,negative regulation of mitophagy,BP,
18948,GO:1901526,1,0.941981911376881,0,8,positive regulation of mitophagy,BP,
18949,GO:1901529,1,0.971422601297307,0,4,positive regulation of anion channel activity,BP,
18950,GO:1901532,1,0.593380003074391,0,88,regulation of hematopoietic progenitor cell differentiation,BP,
18951,GO:1901533,1,0.95615116498189,0,7,negative regulation of hematopoietic progenitor cell differentiation,BP,
18952,GO:1901534,1,0.987252081652269,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18953,GO:1901535,1,0.956280824450832,0,5,regulation of DNA demethylation,BP,
18954,GO:1901536,1,0.988352746223459,0,2,negative regulation of DNA demethylation,BP,
18955,GO:1901537,1,0.967553862377976,0,3,positive regulation of DNA demethylation,BP,
18956,GO:1901538,1,0.956000897929254,0,6,changes to DNA methylation involved in embryo development,BP,
18957,GO:1901545,1,0.994160107474255,0,1,response to raffinose,BP,
18958,GO:1901550,1,0.924411156755554,0,12,regulation of endothelial cell development,BP,
18959,GO:1901551,1,0.993153511756004,0,1,negative regulation of endothelial cell development,BP,
18960,GO:1901552,1,0.969988112965729,0,5,positive regulation of endothelial cell development,BP,
18961,GO:1901555,1,0.990315164591827,0,1,response to paclitaxel,BP,
18962,GO:1901557,1,0.993356305776653,0,1,response to fenofibrate,BP,
18963,GO:1901558,1,0.985688218283885,0,2,response to metformin,BP,
18964,GO:1901561,1,0.993566383541989,0,1,response to benomyl,BP,
18965,GO:1901563,1,0.967960435625475,0,5,response to camptothecin,BP,
18969,GO:1901567,1,0.875150729052417,0,24,fatty acid derivative binding,MF,
18971,GO:1901569,1,0.955740775875493,0,8,fatty acid derivative catabolic process,BP,
18976,GO:1901580,1,0.986267357554897,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18977,GO:1901581,1,0.986267357554897,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18978,GO:1901582,1,0.986267357554897,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18979,GO:1901585,1,0.994284473897226,0,1,regulation of acid-sensing ion channel activity,BP,
18980,GO:1901588,1,0.992674700915297,0,1,dendritic microtubule,CC,
18981,GO:1901594,1,0.993215857953393,0,1,response to capsazepine,BP,
18983,GO:1901606,1,0.571006858581718,0,96,alpha-amino acid catabolic process,BP,
18984,GO:1901607,1,0.693687125592691,0,59,alpha-amino acid biosynthetic process,BP,
18985,GO:1901608,1,0.994784577680379,0,1,regulation of vesicle transport along microtubule,BP,
18986,GO:1901609,1,0.994784577680379,0,1,negative regulation of vesicle transport along microtubule,BP,
18987,GO:1901611,1,0.940001208078385,0,10,phosphatidylglycerol binding,MF,
18988,GO:1901612,1,0.95614853768723,0,7,cardiolipin binding,MF,
18993,GO:1901620,1,0.957093744643562,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18994,GO:1901621,1,0.967796007919732,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18995,GO:1901622,1,0.994416225569269,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18999,GO:1901627,1,0.994527242355616,0,1,negative regulation of postsynaptic membrane organization,BP,
19000,GO:1901628,1,0.973533564418866,0,4,positive regulation of postsynaptic membrane organization,BP,
19001,GO:1901629,1,0.984103347738741,0,2,regulation of presynaptic membrane organization,BP,
19002,GO:1901630,1,0.99480248296677,0,1,negative regulation of presynaptic membrane organization,BP,
19003,GO:1901631,1,0.989245522452215,0,1,positive regulation of presynaptic membrane organization,BP,
19004,GO:1901639,1,0.991266113753993,0,1,XDP catabolic process,BP,
19005,GO:1901640,1,0.991266113753993,0,1,XTP binding,MF,
19006,GO:1901641,1,0.991266113753993,0,1,ITP binding,MF,
19007,GO:1901642,1,0.967438675433496,0,6,nucleoside transmembrane transport,BP,
19012,GO:1901656,1,0.98079271010064,0,3,glycoside transport,BP,
19016,GO:1901660,1,0.938531176158231,0,8,calcium ion export,BP,
19017,GO:1901661,1,0.862228362265122,0,27,quinone metabolic process,BP,
19018,GO:1901662,1,0.988877683612912,0,2,quinone catabolic process,BP,
19019,GO:1901663,1,0.926555882419654,0,14,quinone biosynthetic process,BP,
19020,GO:1901664,1,0.981026448655259,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
19021,GO:1901666,1,0.981026448655259,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
19022,GO:1901668,1,0.978700988157808,0,4,regulation of superoxide dismutase activity,BP,
19023,GO:1901671,1,0.984299371985835,0,3,positive regulation of superoxide dismutase activity,BP,
19024,GO:1901673,1,0.87653301655228,0,19,regulation of mitotic spindle assembly,BP,
19025,GO:1901674,1,0.978463074692003,0,3,regulation of histone H3-K27 acetylation,BP,
19026,GO:1901675,1,0.990574153537709,0,1,negative regulation of histone H3-K27 acetylation,BP,
19027,GO:1901676,1,0.9934245919392,0,1,positive regulation of histone H3-K27 acetylation,BP,
19028,GO:1901678,1,0.934520185385803,0,11,iron coordination entity transport,BP,
19029,GO:1901679,1,0.954850884442018,0,8,nucleotide transmembrane transport,BP,
19030,GO:1901680,1,0.987654884655252,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19032,GO:1901682,1,0.834758077951105,0,27,sulfur compound transmembrane transporter activity,MF,
19033,GO:1901685,1,0.908896565160545,0,18,glutathione derivative metabolic process,BP,
19034,GO:1901687,1,0.908896565160545,0,18,glutathione derivative biosynthetic process,BP,
19039,GO:1901702,1,0.973261197513924,0,5,salt transmembrane transporter activity,MF,
19040,GO:1901706,1,0.994413231134376,0,1,mesenchymal cell differentiation involved in bone development,BP,
19041,GO:1901707,1,0.994790421393158,0,1,leptomycin B binding,MF,
19042,GO:1901722,1,0.937942802111013,0,11,regulation of cell proliferation involved in kidney development,BP,
19043,GO:1901723,1,0.970999609258767,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19044,GO:1901724,1,0.965965754270139,0,6,positive regulation of cell proliferation involved in kidney development,BP,
19045,GO:1901725,1,0.935834468060866,0,8,regulation of histone deacetylase activity,BP,
19046,GO:1901726,1,0.986491522360927,0,1,negative regulation of histone deacetylase activity,BP,
19047,GO:1901727,1,0.955141602453494,0,6,positive regulation of histone deacetylase activity,BP,
19052,GO:1901748,1,0.983445508560032,0,3,leukotriene D4 metabolic process,BP,
19053,GO:1901750,1,0.983445508560032,0,3,leukotriene D4 biosynthetic process,BP,
19054,GO:1901751,1,0.994515310835667,0,1,leukotriene A4 metabolic process,BP,
19055,GO:1901796,1,0.330178920601,0,167,regulation of signal transduction by p53 class mediator,BP,
19056,GO:1901797,1,0.85417769261206,0,26,negative regulation of signal transduction by p53 class mediator,BP,
19057,GO:1901798,1,0.8692529518038,0,20,positive regulation of signal transduction by p53 class mediator,BP,
19058,GO:1901799,1,0.751877625001457,0,44,negative regulation of proteasomal protein catabolic process,BP,
19059,GO:1901800,1,0.527255051716285,0,99,positive regulation of proteasomal protein catabolic process,BP,
19060,GO:1901804,1,0.994499220980243,0,1,beta-glucoside metabolic process,BP,
19061,GO:1901805,1,0.994499220980243,0,1,beta-glucoside catabolic process,BP,
19062,GO:1901810,1,0.994313214468247,0,1,beta-carotene metabolic process,BP,
19063,GO:1901825,1,0.994399069470243,0,1,zeaxanthin metabolic process,BP,
19064,GO:1901827,1,0.994399069470243,0,1,zeaxanthin biosynthetic process,BP,
19065,GO:1901834,1,0.994712195059427,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19066,GO:1901835,1,0.994712195059427,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19067,GO:1901836,1,0.930930386061422,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19068,GO:1901837,1,0.989282061922936,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19069,GO:1901838,1,0.941022308160983,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19070,GO:1901841,1,0.937040329905072,0,11,regulation of high voltage-gated calcium channel activity,BP,
19071,GO:1901842,1,0.978951690728168,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19072,GO:1901843,1,0.981072331657787,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
19073,GO:1901844,1,0.942660308939461,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19074,GO:1901846,1,0.992847965950315,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19075,GO:1901856,1,0.988625717977188,0,2,negative regulation of cellular respiration,BP,
19076,GO:1901857,1,0.964800443256624,0,6,positive regulation of cellular respiration,BP,
19077,GO:1901858,1,0.961079341055348,0,6,regulation of mitochondrial DNA metabolic process,BP,
19078,GO:1901859,1,0.980723063824926,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
19079,GO:1901860,1,0.985794069918015,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
19080,GO:1901861,1,0.438715386392878,0,117,regulation of muscle tissue development,BP,
19081,GO:1901862,1,0.748052523000638,0,44,negative regulation of muscle tissue development,BP,
19082,GO:1901863,1,0.645849174255682,0,61,positive regulation of muscle tissue development,BP,
19083,GO:1901873,1,0.984984386887675,0,2,regulation of post-translational protein modification,BP,
19084,GO:1901874,1,0.984984386887675,0,2,negative regulation of post-translational protein modification,BP,
19085,GO:1901876,1,0.989580094286976,0,2,regulation of calcium ion binding,BP,
19086,GO:1901877,1,0.989580094286976,0,2,negative regulation of calcium ion binding,BP,
19087,GO:1901879,1,0.578649884928184,0,73,regulation of protein depolymerization,BP,
19088,GO:1901880,1,0.656591662294177,0,56,negative regulation of protein depolymerization,BP,
19089,GO:1901881,1,0.907795534266728,0,15,positive regulation of protein depolymerization,BP,
19090,GO:1901888,1,0.561529308394581,0,80,regulation of cell junction assembly,BP,
19091,GO:1901889,1,0.866522900190139,0,20,negative regulation of cell junction assembly,BP,
19092,GO:1901890,1,0.803514333507862,0,30,positive regulation of cell junction assembly,BP,
19093,GO:1901894,1,0.941113171903112,0,8,regulation of calcium-transporting ATPase activity,BP,
19094,GO:1901895,1,0.979362582725894,0,3,negative regulation of calcium-transporting ATPase activity,BP,
19095,GO:1901896,1,0.965944526810797,0,4,positive regulation of calcium-transporting ATPase activity,BP,
19096,GO:1901897,1,0.953816265034995,0,7,regulation of relaxation of cardiac muscle,BP,
19097,GO:1901898,1,0.982288024216061,0,2,negative regulation of relaxation of cardiac muscle,BP,
19098,GO:1901899,1,0.989169186443576,0,2,positive regulation of relaxation of cardiac muscle,BP,
19099,GO:1901906,1,0.97668461576008,0,4,diadenosine pentaphosphate metabolic process,BP,
19100,GO:1901907,1,0.97668461576008,0,4,diadenosine pentaphosphate catabolic process,BP,
19101,GO:1901908,1,0.97668461576008,0,4,diadenosine hexaphosphate metabolic process,BP,
19102,GO:1901909,1,0.97668461576008,0,4,diadenosine hexaphosphate catabolic process,BP,
19103,GO:1901910,1,0.97668461576008,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19104,GO:1901911,1,0.97668461576008,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19105,GO:1901917,1,0.994328051160662,0,1,regulation of exoribonuclease activity,BP,
19106,GO:1901919,1,0.994328051160662,0,1,positive regulation of exoribonuclease activity,BP,
19107,GO:1901950,1,0.994313214468247,0,1,dense core granule transport,BP,
19108,GO:1901962,1,0.994569468293183,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19109,GO:1901963,1,0.988590130371244,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19110,GO:1901964,1,0.994702757779098,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19111,GO:1901970,1,0.94746360602429,0,8,positive regulation of mitotic sister chromatid separation,BP,
19112,GO:1901976,1,0.820141260264615,0,32,regulation of cell cycle checkpoint,BP,
19113,GO:1901977,1,0.965708001626555,0,6,negative regulation of cell cycle checkpoint,BP,
19114,GO:1901978,1,0.93577424226553,0,10,positive regulation of cell cycle checkpoint,BP,
19115,GO:1901979,1,0.976629283686087,0,3,regulation of inward rectifier potassium channel activity,BP,
19116,GO:1901980,1,0.987263711215097,0,1,positive regulation of inward rectifier potassium channel activity,BP,
19118,GO:1901983,1,0.659244320000047,0,65,regulation of protein acetylation,BP,
19119,GO:1901984,1,0.864564058123177,0,23,negative regulation of protein acetylation,BP,
19120,GO:1901985,1,0.798368499680404,0,35,positive regulation of protein acetylation,BP,
19121,GO:1901986,1,0.994774443149678,0,1,response to ketamine,BP,
19123,GO:1901988,1,0.249080572425104,0,219,negative regulation of cell cycle phase transition,BP,
19126,GO:1901991,1,0.26950252502054,0,206,negative regulation of mitotic cell cycle phase transition,BP,
19128,GO:1901993,1,0.988364893434694,0,2,regulation of meiotic cell cycle phase transition,BP,
19129,GO:1901994,1,0.988364893434694,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19130,GO:1901998,1,0.799336560909118,0,36,toxin transport,BP,
19131,GO:1902001,1,0.900519078642403,0,14,fatty acid transmembrane transport,BP,
19132,GO:1902003,1,0.878561220004349,0,18,regulation of amyloid-beta formation,BP,
19133,GO:1902004,1,0.935276425931196,0,10,positive regulation of amyloid-beta formation,BP,
19134,GO:1902010,1,0.993803232849097,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19135,GO:1902017,1,0.760245053265681,0,39,regulation of cilium assembly,BP,
19136,GO:1902018,1,0.94588842014351,0,9,negative regulation of cilium assembly,BP,
19137,GO:1902019,1,0.97208697731865,0,5,regulation of cilium-dependent cell motility,BP,
19138,GO:1902022,1,0.968257649665535,0,5,L-lysine transport,BP,
19139,GO:1902023,1,0.958569889312476,0,6,L-arginine transport,BP,
19140,GO:1902031,1,0.966133717682212,0,6,regulation of NADP metabolic process,BP,
19141,GO:1902033,1,0.957932159240026,0,7,regulation of hematopoietic stem cell proliferation,BP,
19142,GO:1902035,1,0.969285563711275,0,5,positive regulation of hematopoietic stem cell proliferation,BP,
19143,GO:1902036,1,0.633973949143046,0,79,regulation of hematopoietic stem cell differentiation,BP,
19144,GO:1902037,1,0.983066418004373,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19145,GO:1902038,1,0.993841248743405,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19148,GO:1902043,1,0.886897387913227,0,17,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19149,GO:1902044,1,0.987334495885672,0,2,regulation of Fas signaling pathway,BP,
19150,GO:1902045,1,0.994519458898102,0,1,negative regulation of Fas signaling pathway,BP,
19151,GO:1902047,1,0.965532047138671,0,6,polyamine transmembrane transport,BP,
19152,GO:1902065,1,0.928748034404334,0,11,response to L-glutamate,BP,
19153,GO:1902071,1,0.994802688853677,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19154,GO:1902073,1,0.994802688853677,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19155,GO:1902074,1,0.93020691904333,0,13,response to salt,BP,
19156,GO:1902075,1,0.962526547811054,0,7,cellular response to salt,BP,
19157,GO:1902076,1,0.985842561509858,0,1,regulation of lateral motor column neuron migration,BP,
19158,GO:1902078,1,0.985842561509858,0,1,positive regulation of lateral motor column neuron migration,BP,
19159,GO:1902080,1,0.994719259578768,0,1,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19160,GO:1902081,1,0.994719259578768,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19161,GO:1902083,1,0.958257058553891,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19162,GO:1902093,1,0.957172707502352,0,8,positive regulation of flagellated sperm motility,BP,
19163,GO:1902098,1,0.992638417255533,0,1,calcitriol binding,MF,
19164,GO:1902099,1,0.720428382112345,0,48,regulation of metaphase/anaphase transition of cell cycle,BP,
19165,GO:1902100,1,0.803530706798409,0,32,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19166,GO:1902101,1,0.94746360602429,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19167,GO:1902102,1,0.994151614391548,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19168,GO:1902103,1,0.994151614391548,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19172,GO:1902108,1,0.707425286657006,0,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19173,GO:1902109,1,0.984276477716203,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19174,GO:1902110,1,0.724950516742682,0,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19175,GO:1902115,1,0.345167352491837,0,149,regulation of organelle assembly,BP,
19176,GO:1902116,1,0.810625085883053,0,31,negative regulation of organelle assembly,BP,
19177,GO:1902117,1,0.652414117185155,0,58,positive regulation of organelle assembly,BP,
19178,GO:1902121,1,0.992638417255533,0,1,lithocholic acid binding,MF,
19179,GO:1902122,1,0.99459757150219,0,1,chenodeoxycholic acid binding,MF,
19180,GO:1902159,1,0.986012834162569,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19181,GO:1902161,1,0.991137137372775,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19182,GO:1902162,1,0.984091794306806,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19183,GO:1902164,1,0.984091794306806,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19184,GO:1902165,1,0.924028174324003,0,14,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19185,GO:1902166,1,0.934245352264507,0,12,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19186,GO:1902167,1,0.994838203969693,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19187,GO:1902170,1,0.888920188927751,0,18,cellular response to reactive nitrogen species,BP,
19188,GO:1902172,1,0.97241739537923,0,5,regulation of keratinocyte apoptotic process,BP,
19189,GO:1902174,1,0.98333137230819,0,3,positive regulation of keratinocyte apoptotic process,BP,
19190,GO:1902175,1,0.857975315395325,0,26,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19191,GO:1902176,1,0.900626855142457,0,18,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19192,GO:1902177,1,0.971152861217707,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19193,GO:1902178,1,0.993057784043011,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19194,GO:1902186,1,0.82977772802553,0,29,regulation of viral release from host cell,BP,
19195,GO:1902187,1,0.910464960374934,0,14,negative regulation of viral release from host cell,BP,
19196,GO:1902188,1,0.912208064598447,0,15,positive regulation of viral release from host cell,BP,
19197,GO:1902202,1,0.97589488735059,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19198,GO:1902203,1,0.99237463941337,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19199,GO:1902204,1,0.994642031428577,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19200,GO:1902205,1,0.994720555227156,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19201,GO:1902206,1,0.994720555227156,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19202,GO:1902211,1,0.994313214468247,0,1,regulation of prolactin signaling pathway,BP,
19203,GO:1902213,1,0.994313214468247,0,1,positive regulation of prolactin signaling pathway,BP,
19204,GO:1902214,1,0.97910249120461,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19205,GO:1902215,1,0.994720555227156,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19206,GO:1902216,1,0.984299868350983,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19207,GO:1902217,1,0.994784971334287,0,1,erythrocyte apoptotic process,BP,
19208,GO:1902218,1,0.963645944844444,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19209,GO:1902219,1,0.968674478528006,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19210,GO:1902220,1,0.994810499878824,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19211,GO:1902221,1,0.947577744697086,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19212,GO:1902222,1,0.947577744697086,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19213,GO:1902224,1,0.933753291699517,0,12,ketone body metabolic process,BP,
19214,GO:1902226,1,0.984050306489381,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19215,GO:1902227,1,0.989504684655112,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19216,GO:1902228,1,0.994488349929807,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19217,GO:1902229,1,0.818839366150926,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19218,GO:1902230,1,0.850949801344655,0,28,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19219,GO:1902231,1,0.967937629539144,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19220,GO:1902232,1,0.994720555227156,0,1,regulation of positive thymic T cell selection,BP,
19221,GO:1902233,1,0.994720555227156,0,1,negative regulation of positive thymic T cell selection,BP,
19222,GO:1902235,1,0.837837557683095,0,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19223,GO:1902236,1,0.898869188769628,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19224,GO:1902237,1,0.943966710222499,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19225,GO:1902238,1,0.993160303955826,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19226,GO:1902239,1,0.993160303955826,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19227,GO:1902250,1,0.994784971334287,0,1,regulation of erythrocyte apoptotic process,BP,
19228,GO:1902251,1,0.994784971334287,0,1,negative regulation of erythrocyte apoptotic process,BP,
19229,GO:1902253,1,0.872154832926789,0,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19230,GO:1902254,1,0.90050443382867,0,17,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19231,GO:1902255,1,0.979317606010087,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19232,GO:1902256,1,0.980828727374699,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19233,GO:1902257,1,0.988600092859091,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19234,GO:1902259,1,0.90211885008524,0,15,regulation of delayed rectifier potassium channel activity,BP,
19235,GO:1902260,1,0.954231403620436,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19236,GO:1902261,1,0.968409060215619,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19237,GO:1902262,1,0.97052359543362,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19238,GO:1902263,1,0.975421008686255,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19239,GO:1902267,1,0.97200532811039,0,5,regulation of polyamine transmembrane transport,BP,
19240,GO:1902268,1,0.984382785402669,0,3,negative regulation of polyamine transmembrane transport,BP,
19241,GO:1902269,1,0.987428142829261,0,2,positive regulation of polyamine transmembrane transport,BP,
19242,GO:1902271,1,0.992638417255533,0,1,D3 vitamins binding,MF,
19243,GO:1902275,1,0.327418005062987,0,157,regulation of chromatin organization,BP,
19244,GO:1902282,1,0.955201467551896,0,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19245,GO:1902283,1,0.993326102345204,0,1,negative regulation of primary amine oxidase activity,BP,
19246,GO:1902284,1,0.765017199305511,0,32,neuron projection extension involved in neuron projection guidance,BP,
19247,GO:1902285,1,0.890541594837863,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19248,GO:1902287,1,0.897777442024031,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19249,GO:1902292,1,0.994802379761908,0,1,cell cycle DNA replication initiation,BP,
19250,GO:1902296,1,0.993962425054509,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19251,GO:1902298,1,0.980677556805434,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19252,GO:1902299,1,0.983817213440429,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19253,GO:1902302,1,0.968288703237816,0,5,regulation of potassium ion export,BP,
19254,GO:1902303,1,0.988199182658167,0,2,negative regulation of potassium ion export,BP,
19255,GO:1902304,1,0.987433983302333,0,2,positive regulation of potassium ion export,BP,
19256,GO:1902305,1,0.669734741318828,0,55,regulation of sodium ion transmembrane transport,BP,
19257,GO:1902306,1,0.912727057834083,0,12,negative regulation of sodium ion transmembrane transport,BP,
19258,GO:1902307,1,0.877653676174469,0,18,positive regulation of sodium ion transmembrane transport,BP,
19259,GO:1902308,1,0.967936115867466,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19260,GO:1902309,1,0.978435744694026,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19261,GO:1902310,1,0.989271291700969,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19262,GO:1902311,1,0.994705332797312,0,1,regulation of copper ion transmembrane transport,BP,
19263,GO:1902315,1,0.994802379761908,0,1,nuclear cell cycle DNA replication initiation,BP,
19264,GO:1902319,1,0.993962425054509,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19265,GO:1902336,1,0.988274137580037,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19266,GO:1902337,1,0.942842868586219,0,9,regulation of apoptotic process involved in morphogenesis,BP,
19267,GO:1902338,1,0.968978693269276,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19268,GO:1902339,1,0.980746071857235,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
19269,GO:1902356,1,0.994676012241614,0,1,oxaloacetate(2-) transmembrane transport,BP,
19270,GO:1902358,1,0.929857375807714,0,11,sulfate transmembrane transport,BP,
19271,GO:1902359,1,0.989020756048892,0,2,Notch signaling pathway involved in somitogenesis,BP,
19272,GO:1902362,1,0.99429867892924,0,1,melanocyte apoptotic process,BP,
19273,GO:1902363,1,0.990054929762495,0,1,regulation of protein localization to spindle pole body,BP,
19274,GO:1902365,1,0.990054929762495,0,1,positive regulation of protein localization to spindle pole body,BP,
19275,GO:1902366,1,0.989020756048892,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19276,GO:1902367,1,0.989020756048892,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19277,GO:1902369,1,0.735423740625739,0,45,negative regulation of RNA catabolic process,BP,
19278,GO:1902373,1,0.764169274917111,0,39,negative regulation of mRNA catabolic process,BP,
19279,GO:1902378,1,0.994463161779309,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19280,GO:1902379,1,0.991465911434634,0,1,chemoattractant activity involved in axon guidance,MF,
19281,GO:1902380,1,0.994490979828834,0,1,positive regulation of endoribonuclease activity,BP,
19282,GO:1902387,1,0.994313214468247,0,1,ceramide 1-phosphate binding,MF,
19283,GO:1902388,1,0.994313214468247,0,1,ceramide 1-phosphate transporter activity,MF,
19284,GO:1902389,1,0.994313214468247,0,1,ceramide 1-phosphate transport,BP,
19285,GO:1902396,1,0.993432020441298,0,1,protein localization to bicellular tight junction,BP,
19286,GO:1902400,1,0.669359665725731,0,61,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19287,GO:1902402,1,0.665449866814947,0,62,signal transduction involved in mitotic DNA damage checkpoint,BP,
19288,GO:1902403,1,0.665449866814947,0,62,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19289,GO:1902410,1,0.963037779391556,0,6,mitotic cytokinetic process,BP,
19290,GO:1902412,1,0.969768520514712,0,4,regulation of mitotic cytokinesis,BP,
19291,GO:1902414,1,0.939701093765246,0,8,protein localization to cell junction,BP,
19292,GO:1902415,1,0.947996956154049,0,9,regulation of mRNA binding,BP,
19293,GO:1902416,1,0.958612679982562,0,7,positive regulation of mRNA binding,BP,
19294,GO:1902423,1,0.985087686679664,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19295,GO:1902425,1,0.985087686679664,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19296,GO:1902426,1,0.994366597416677,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19297,GO:1902430,1,0.93531677677048,0,9,negative regulation of amyloid-beta formation,BP,
19298,GO:1902442,1,0.993586117873967,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19299,GO:1902443,1,0.993586117873967,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19300,GO:1902444,1,0.994801600154055,0,1,riboflavin binding,MF,
19301,GO:1902445,1,0.984302155355324,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19302,GO:1902455,1,0.9632057402297,0,6,negative regulation of stem cell population maintenance,BP,
19303,GO:1902459,1,0.949840303101579,0,7,positive regulation of stem cell population maintenance,BP,
19304,GO:1902460,1,0.992776344228489,0,1,regulation of mesenchymal stem cell proliferation,BP,
19305,GO:1902462,1,0.992776344228489,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19306,GO:1902463,1,0.989501975338569,0,2,protein localization to cell leading edge,BP,
19307,GO:1902464,1,0.992947005684634,0,1,regulation of histone H3-K27 trimethylation,BP,
19308,GO:1902466,1,0.992947005684634,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19309,GO:1902473,1,0.946031484908788,0,8,regulation of protein localization to synapse,BP,
19310,GO:1902474,1,0.951444834145592,0,7,positive regulation of protein localization to synapse,BP,
19311,GO:1902475,1,0.740764149302579,0,44,L-alpha-amino acid transmembrane transport,BP,
19313,GO:1902480,1,0.99448966653042,0,1,protein localization to mitotic spindle,BP,
19314,GO:1902488,1,0.988495768566121,0,1,cholangiocyte apoptotic process,BP,
19315,GO:1902490,1,0.994650742674621,0,1,regulation of sperm capacitation,BP,
19316,GO:1902493,1,0.568934374520389,0,85,acetyltransferase complex,CC,
19319,GO:1902498,1,0.961928292666193,0,4,regulation of protein autoubiquitination,BP,
19320,GO:1902499,1,0.982361527685319,0,2,positive regulation of protein autoubiquitination,BP,
19321,GO:1902504,1,0.994182237287637,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19322,GO:1902510,1,0.958870248996798,0,7,regulation of apoptotic DNA fragmentation,BP,
19323,GO:1902511,1,0.994347577264868,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19324,GO:1902512,1,0.984311974298671,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19325,GO:1902513,1,0.957962988503193,0,7,regulation of organelle transport along microtubule,BP,
19326,GO:1902514,1,0.935669649171137,0,9,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19327,GO:1902523,1,0.980744294325313,0,3,positive regulation of protein K63-linked ubiquitination,BP,
19328,GO:1902524,1,0.988381767450946,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19329,GO:1902525,1,0.971889568857401,0,5,regulation of protein monoubiquitination,BP,
19330,GO:1902527,1,0.978132339553327,0,4,positive regulation of protein monoubiquitination,BP,
19331,GO:1902528,1,0.988849536534572,0,1,regulation of protein linear polyubiquitination,BP,
19332,GO:1902530,1,0.988849536534572,0,1,positive regulation of protein linear polyubiquitination,BP,
19336,GO:1902544,1,0.988854460016064,0,2,regulation of DNA N-glycosylase activity,BP,
19337,GO:1902546,1,0.994828327254872,0,1,positive regulation of DNA N-glycosylase activity,BP,
19338,GO:1902547,1,0.922822293735673,0,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19339,GO:1902548,1,0.971864181557702,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19340,GO:1902554,1,0.586226483526527,0,80,serine/threonine protein kinase complex,CC,
19341,GO:1902555,1,0.840915716429304,0,29,endoribonuclease complex,CC,
19342,GO:1902559,1,0.989286217302936,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19343,GO:1902560,1,0.989462300783792,0,2,GMP reductase complex,CC,
19344,GO:1902562,1,0.777144869068252,0,39,H4 histone acetyltransferase complex,CC,
19345,GO:1902563,1,0.935234063925375,0,10,regulation of neutrophil activation,BP,
19346,GO:1902564,1,0.972155639108287,0,4,negative regulation of neutrophil activation,BP,
19347,GO:1902565,1,0.974762053342644,0,4,positive regulation of neutrophil activation,BP,
19348,GO:1902566,1,0.978336188494031,0,4,regulation of eosinophil activation,BP,
19349,GO:1902567,1,0.989161712165168,0,2,negative regulation of eosinophil activation,BP,
19350,GO:1902568,1,0.98905704805041,0,2,positive regulation of eosinophil activation,BP,
19351,GO:1902569,1,0.994676276783979,0,1,negative regulation of activation of Janus kinase activity,BP,
19352,GO:1902570,1,0.938392907209372,0,10,protein localization to nucleolus,BP,
19353,GO:1902571,1,0.961581771188904,0,6,regulation of serine-type peptidase activity,BP,
19354,GO:1902572,1,0.961581771188904,0,6,negative regulation of serine-type peptidase activity,BP,
19355,GO:1902573,1,0.987965628034237,0,1,positive regulation of serine-type peptidase activity,BP,
19356,GO:1902576,1,0.977098783902468,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19357,GO:1902579,1,0.637591066942883,0,69,multi-organism localization,BP,
19358,GO:1902581,1,0.968951454841549,0,5,multi-organism cellular localization,BP,
19359,GO:1902583,1,0.968951454841549,0,5,multi-organism intracellular transport,BP,
19360,GO:1902594,1,0.984538271588376,0,2,multi-organism nuclear import,BP,
19361,GO:1902595,1,0.989167905559264,0,2,regulation of DNA replication origin binding,BP,
19362,GO:1902600,1,0.512668838915981,0,111,proton transmembrane transport,BP,
19363,GO:1902603,1,0.978066397647049,0,4,carnitine transmembrane transport,BP,
19364,GO:1902605,1,0.994331997186954,0,1,heterotrimeric G-protein complex assembly,BP,
19365,GO:1902606,1,0.989647205959598,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19366,GO:1902608,1,0.989647205959598,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19367,GO:1902612,1,0.994329180687455,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19368,GO:1902613,1,0.994329180687455,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19369,GO:1902616,1,0.994680990687208,0,1,acyl carnitine transmembrane transport,BP,
19372,GO:1902622,1,0.812912051004935,0,37,regulation of neutrophil migration,BP,
19373,GO:1902623,1,0.986721474861037,0,2,negative regulation of neutrophil migration,BP,
19374,GO:1902624,1,0.838025019620771,0,32,positive regulation of neutrophil migration,BP,
19375,GO:1902626,1,0.984495044936525,0,3,assembly of large subunit precursor of preribosome,BP,
19376,GO:1902629,1,0.994779853095668,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19377,GO:1902630,1,0.981824721688758,0,2,regulation of membrane hyperpolarization,BP,
19378,GO:1902631,1,0.990286102454039,0,1,negative regulation of membrane hyperpolarization,BP,
19379,GO:1902636,1,0.989256915226047,0,2,kinociliary basal body,CC,
19380,GO:1902652,1,0.443063343161824,0,123,secondary alcohol metabolic process,BP,
19381,GO:1902653,1,0.657445229775192,0,63,secondary alcohol biosynthetic process,BP,
19383,GO:1902659,1,0.981608347363143,0,3,regulation of glucose mediated signaling pathway,BP,
19384,GO:1902661,1,0.981608347363143,0,3,positive regulation of glucose mediated signaling pathway,BP,
19385,GO:1902667,1,0.750483741500854,0,36,regulation of axon guidance,BP,
19386,GO:1902668,1,0.853906484445603,0,21,negative regulation of axon guidance,BP,
19387,GO:1902669,1,0.927501179217025,0,8,positive regulation of axon guidance,BP,
19390,GO:1902683,1,0.982519058830419,0,3,regulation of receptor localization to synapse,BP,
19391,GO:1902684,1,0.994784577680379,0,1,negative regulation of receptor localization to synapse,BP,
19392,GO:1902685,1,0.993082315034716,0,1,positive regulation of receptor localization to synapse,BP,
19393,GO:1902686,1,0.716926415770223,0,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
19394,GO:1902691,1,0.994100475828729,0,1,respiratory basal cell differentiation,BP,
19395,GO:1902692,1,0.820177061628426,0,27,regulation of neuroblast proliferation,BP,
19398,GO:1902713,1,0.952103975046554,0,8,regulation of interferon-gamma secretion,BP,
19399,GO:1902714,1,0.988974833668083,0,2,negative regulation of interferon-gamma secretion,BP,
19400,GO:1902715,1,0.962722160436824,0,6,positive regulation of interferon-gamma secretion,BP,
19401,GO:1902722,1,0.981796841197787,0,3,positive regulation of prolactin secretion,BP,
19402,GO:1902723,1,0.98101497006438,0,3,negative regulation of skeletal muscle satellite cell proliferation,BP,
19403,GO:1902724,1,0.984468947746071,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19404,GO:1902725,1,0.978190756579933,0,3,negative regulation of satellite cell differentiation,BP,
19405,GO:1902728,1,0.984468947746071,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19406,GO:1902730,1,0.981642441560433,0,3,positive regulation of proteoglycan biosynthetic process,BP,
19407,GO:1902731,1,0.971852192953819,0,3,negative regulation of chondrocyte proliferation,BP,
19409,GO:1902737,1,0.9929837567906,0,1,dendritic filopodium,CC,
19410,GO:1902739,1,0.953256683952172,0,6,regulation of interferon-alpha secretion,BP,
19411,GO:1902741,1,0.953256683952172,0,6,positive regulation of interferon-alpha secretion,BP,
19412,GO:1902742,1,0.816531444887638,0,29,apoptotic process involved in development,BP,
19414,GO:1902744,1,0.970148769996516,0,4,negative regulation of lamellipodium organization,BP,
19415,GO:1902745,1,0.853954992625881,0,22,positive regulation of lamellipodium organization,BP,
19416,GO:1902746,1,0.977416931547621,0,3,regulation of lens fiber cell differentiation,BP,
19417,GO:1902747,1,0.99465219355243,0,1,negative regulation of lens fiber cell differentiation,BP,
19418,GO:1902748,1,0.988112011393428,0,1,positive regulation of lens fiber cell differentiation,BP,
19419,GO:1902749,1,0.267970541941301,0,202,regulation of cell cycle G2/M phase transition,BP,
19420,GO:1902750,1,0.563030748176311,0,96,negative regulation of cell cycle G2/M phase transition,BP,
19421,GO:1902751,1,0.853988320948146,0,25,positive regulation of cell cycle G2/M phase transition,BP,
19422,GO:1902766,1,0.989480717384479,0,2,skeletal muscle satellite cell migration,BP,
19423,GO:1902767,1,0.988338442614443,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19424,GO:1902769,1,0.986436812014992,0,1,regulation of choline O-acetyltransferase activity,BP,
19425,GO:1902771,1,0.986436812014992,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19426,GO:1902773,1,0.99414683200963,0,1,GTPase activator complex,CC,
19427,GO:1902774,1,0.951854350825423,0,7,late endosome to lysosome transport,BP,
19428,GO:1902775,1,0.978134113973838,0,3,mitochondrial large ribosomal subunit assembly,BP,
19430,GO:1902804,1,0.97685370304894,0,4,negative regulation of synaptic vesicle transport,BP,
19431,GO:1902805,1,0.976302448532808,0,3,positive regulation of synaptic vesicle transport,BP,
19433,GO:1902807,1,0.521733198276339,0,99,negative regulation of cell cycle G1/S phase transition,BP,
19435,GO:1902809,1,0.981939194896848,0,3,regulation of skeletal muscle fiber differentiation,BP,
19436,GO:1902811,1,0.987620194965483,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19437,GO:1902816,1,0.974854043792787,0,4,regulation of protein localization to microtubule,BP,
19438,GO:1902817,1,0.974854043792787,0,4,negative regulation of protein localization to microtubule,BP,
19439,GO:1902822,1,0.971735332098699,0,4,regulation of late endosome to lysosome transport,BP,
19440,GO:1902823,1,0.98205391928189,0,2,negative regulation of late endosome to lysosome transport,BP,
19441,GO:1902824,1,0.98949474294064,0,2,positive regulation of late endosome to lysosome transport,BP,
19442,GO:1902838,1,0.992184511093937,0,1,regulation of nuclear migration along microtubule,BP,
19443,GO:1902846,1,0.990054929762495,0,1,positive regulation of mitotic spindle elongation,BP,
19444,GO:1902847,1,0.994271234998612,0,1,regulation of neuronal signal transduction,BP,
19445,GO:1902850,1,0.412477726653386,0,125,microtubule cytoskeleton organization involved in mitosis,BP,
19446,GO:1902855,1,0.936711062147747,0,10,regulation of non-motile cilium assembly,BP,
19447,GO:1902856,1,0.985900545359487,0,2,negative regulation of non-motile cilium assembly,BP,
19448,GO:1902857,1,0.955413868681777,0,7,positive regulation of non-motile cilium assembly,BP,
19449,GO:1902858,1,0.994600983713833,0,1,propionyl-CoA metabolic process,BP,
19450,GO:1902860,1,0.994600983713833,0,1,propionyl-CoA biosynthetic process,BP,
19451,GO:1902866,1,0.965301629030606,0,6,regulation of retina development in camera-type eye,BP,
19452,GO:1902867,1,0.994077586648902,0,1,negative regulation of retina development in camera-type eye,BP,
19453,GO:1902868,1,0.989121887611133,0,2,positive regulation of retina development in camera-type eye,BP,
19454,GO:1902869,1,0.983263259502954,0,3,regulation of amacrine cell differentiation,BP,
19455,GO:1902870,1,0.994077586648902,0,1,negative regulation of amacrine cell differentiation,BP,
19456,GO:1902871,1,0.989121887611133,0,2,positive regulation of amacrine cell differentiation,BP,
19457,GO:1902882,1,0.628826595716403,0,74,regulation of response to oxidative stress,BP,
19458,GO:1902883,1,0.770293013966255,0,41,negative regulation of response to oxidative stress,BP,
19459,GO:1902884,1,0.90324603953162,0,16,positive regulation of response to oxidative stress,BP,
19460,GO:1902889,1,0.990439316474678,0,1,protein localization to spindle microtubule,BP,
19461,GO:1902890,1,0.994831355742962,0,1,regulation of root hair elongation,BP,
19462,GO:1902891,1,0.994831355742962,0,1,negative regulation of root hair elongation,BP,
19463,GO:1902893,1,0.798700214385226,0,32,regulation of pri-miRNA transcription by RNA polymerase II,BP,
19464,GO:1902894,1,0.91688838750041,0,11,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19465,GO:1902895,1,0.860149634008476,0,23,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
19466,GO:1902896,1,0.98210436309896,0,3,terminal web assembly,BP,
19467,GO:1902897,1,0.980548006239187,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19468,GO:1902902,1,0.930135643700745,0,11,negative regulation of autophagosome assembly,BP,
19469,GO:1902903,1,0.115613448631409,0,308,regulation of supramolecular fiber organization,BP,
19470,GO:1902904,1,0.440796663517129,0,116,negative regulation of supramolecular fiber organization,BP,
19471,GO:1902905,1,0.305756329938869,0,178,positive regulation of supramolecular fiber organization,BP,
19472,GO:1902908,1,0.987828389908635,0,2,regulation of melanosome transport,BP,
19473,GO:1902910,1,0.993070549408301,0,1,positive regulation of melanosome transport,BP,
19474,GO:1902911,1,0.528886844593244,0,93,protein kinase complex,CC,
19475,GO:1902912,1,0.994313214468247,0,1,pyruvate kinase complex,CC,
19477,GO:1902914,1,0.889199787630185,0,16,regulation of protein polyubiquitination,BP,
19478,GO:1902915,1,0.953259897969799,0,6,negative regulation of protein polyubiquitination,BP,
19479,GO:1902916,1,0.942704003252942,0,9,positive regulation of protein polyubiquitination,BP,
19480,GO:1902930,1,0.67641672506294,0,59,regulation of alcohol biosynthetic process,BP,
19481,GO:1902931,1,0.948872956271156,0,9,negative regulation of alcohol biosynthetic process,BP,
19482,GO:1902932,1,0.901557294480211,0,17,positive regulation of alcohol biosynthetic process,BP,
19484,GO:1902937,1,0.981632606333894,0,3,inward rectifier potassium channel complex,CC,
19485,GO:1902938,1,0.97809522784062,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19486,GO:1902939,1,0.994242260789539,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19487,GO:1902941,1,0.984408709418832,0,2,regulation of voltage-gated chloride channel activity,BP,
19488,GO:1902943,1,0.984408709418832,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19489,GO:1902946,1,0.937461403930498,0,8,protein localization to early endosome,BP,
19490,GO:1902947,1,0.959156789389712,0,6,regulation of tau-protein kinase activity,BP,
19491,GO:1902948,1,0.986436812014992,0,1,negative regulation of tau-protein kinase activity,BP,
19492,GO:1902949,1,0.977587233588422,0,4,positive regulation of tau-protein kinase activity,BP,
19493,GO:1902950,1,0.944947287069948,0,9,regulation of dendritic spine maintenance,BP,
19494,GO:1902951,1,0.980432369818281,0,3,negative regulation of dendritic spine maintenance,BP,
19495,GO:1902952,1,0.980377519295567,0,3,positive regulation of dendritic spine maintenance,BP,
19496,GO:1902953,1,0.968926344155619,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19497,GO:1902954,1,0.976234671499977,0,2,regulation of early endosome to recycling endosome transport,BP,
19498,GO:1902955,1,0.986436812014992,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19499,GO:1902956,1,0.983345465926054,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19500,GO:1902957,1,0.99405469576238,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19501,GO:1902958,1,0.989227359261336,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19502,GO:1902959,1,0.941375290538727,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19503,GO:1902960,1,0.981043916961789,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19504,GO:1902961,1,0.95957245357882,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19505,GO:1902962,1,0.980055728414888,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19506,GO:1902963,1,0.980055728414888,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19507,GO:1902965,1,0.950170659589563,0,6,regulation of protein localization to early endosome,BP,
19508,GO:1902966,1,0.950170659589563,0,6,positive regulation of protein localization to early endosome,BP,
19509,GO:1902969,1,0.93987402514845,0,9,mitotic DNA replication,BP,
19510,GO:1902975,1,0.994802379761908,0,1,mitotic DNA replication initiation,BP,
19511,GO:1902977,1,0.994667123770059,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19512,GO:1902983,1,0.993962425054509,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19513,GO:1902988,1,0.972485008951993,0,3,neurofibrillary tangle assembly,BP,
19514,GO:1902990,1,0.980615785919992,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19515,GO:1902991,1,0.84857616503759,0,23,regulation of amyloid precursor protein catabolic process,BP,
19516,GO:1902992,1,0.924045037677391,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
19517,GO:1902993,1,0.924854767849682,0,12,positive regulation of amyloid precursor protein catabolic process,BP,
19518,GO:1902994,1,0.985258936680966,0,2,regulation of phospholipid efflux,BP,
19519,GO:1902995,1,0.985258936680966,0,2,positive regulation of phospholipid efflux,BP,
19520,GO:1902996,1,0.980784978746954,0,2,regulation of neurofibrillary tangle assembly,BP,
19521,GO:1902997,1,0.986436812014992,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19522,GO:1902998,1,0.994271234998612,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19523,GO:1903000,1,0.99480248296677,0,1,regulation of lipid transport across blood brain barrier,BP,
19524,GO:1903002,1,0.99480248296677,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19525,GO:1903003,1,0.963711979920663,0,6,positive regulation of protein deubiquitination,BP,
19526,GO:1903004,1,0.993467149498226,0,1,regulation of protein K63-linked deubiquitination,BP,
19527,GO:1903006,1,0.993467149498226,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19528,GO:1903007,1,0.993467149498226,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19529,GO:1903008,1,0.516644767137215,0,100,organelle disassembly,BP,
19535,GO:1903017,1,0.99472470365035,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19538,GO:1903020,1,0.867941943190519,0,21,positive regulation of glycoprotein metabolic process,BP,
19539,GO:1903025,1,0.937388207279638,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19540,GO:1903026,1,0.969241960591946,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19541,GO:1903027,1,0.98427927943749,0,2,regulation of opsonization,BP,
19542,GO:1903028,1,0.98965898429524,0,1,positive regulation of opsonization,BP,
19543,GO:1903031,1,0.989105984840801,0,2,regulation of microtubule plus-end binding,BP,
19544,GO:1903033,1,0.989105984840801,0,2,positive regulation of microtubule plus-end binding,BP,
19551,GO:1903044,1,0.953422431175828,0,8,protein localization to membrane raft,BP,
19552,GO:1903045,1,0.991647102247033,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19553,GO:1903046,1,0.361559261639915,0,156,meiotic cell cycle process,BP,
19555,GO:1903050,1,0.284834989530616,0,190,regulation of proteolysis involved in cellular protein catabolic process,BP,
19556,GO:1903051,1,0.686021815375507,0,56,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19557,GO:1903052,1,0.480372777109708,0,112,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
19559,GO:1903054,1,0.966564215531649,0,6,negative regulation of extracellular matrix organization,BP,
19561,GO:1903056,1,0.98289576694883,0,2,regulation of melanosome organization,BP,
19562,GO:1903059,1,0.966712384416697,0,5,regulation of protein lipidation,BP,
19563,GO:1903060,1,0.994695328496284,0,1,negative regulation of protein lipidation,BP,
19564,GO:1903061,1,0.971869299759948,0,4,positive regulation of protein lipidation,BP,
19565,GO:1903069,1,0.948870779242636,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19566,GO:1903070,1,0.982648417747334,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19567,GO:1903071,1,0.960351168195504,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19568,GO:1903072,1,0.994822876044542,0,1,regulation of death-inducing signaling complex assembly,BP,
19569,GO:1903073,1,0.994822876044542,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19572,GO:1903078,1,0.72031490611138,0,47,positive regulation of protein localization to plasma membrane,BP,
19573,GO:1903080,1,0.99481422338587,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19574,GO:1903082,1,0.99481422338587,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19575,GO:1903093,1,0.979920744019679,0,3,regulation of protein K48-linked deubiquitination,BP,
19576,GO:1903094,1,0.989639264020063,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19577,GO:1903095,1,0.987264234343962,0,2,ribonuclease III complex,CC,
19578,GO:1903096,1,0.994151614391548,0,1,protein localization to meiotic spindle midzone,BP,
19579,GO:1903108,1,0.992230608764739,0,1,regulation of mitochondrial transcription,BP,
19580,GO:1903109,1,0.992230608764739,0,1,positive regulation of mitochondrial transcription,BP,
19582,GO:1903116,1,0.979675043661893,0,3,positive regulation of actin filament-based movement,BP,
19583,GO:1903119,1,0.977931136551398,0,3,protein localization to actin cytoskeleton,BP,
19584,GO:1903121,1,0.973324020691213,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19585,GO:1903122,1,0.994822876044542,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19586,GO:1903123,1,0.988022957922514,0,1,regulation of thioredoxin peroxidase activity,BP,
19587,GO:1903124,1,0.988022957922514,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19588,GO:1903125,1,0.988022957922514,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19589,GO:1903126,1,0.994603015627253,0,1,negative regulation of centriole-centriole cohesion,BP,
19590,GO:1903131,1,0.8180431951873,0,30,mononuclear cell differentiation,BP,
19591,GO:1903135,1,0.982603477464002,0,3,cupric ion binding,MF,
19592,GO:1903136,1,0.962186010546758,0,6,cuprous ion binding,MF,
19593,GO:1903140,1,0.924411156755554,0,12,regulation of establishment of endothelial barrier,BP,
19594,GO:1903141,1,0.993153511756004,0,1,negative regulation of establishment of endothelial barrier,BP,
19595,GO:1903142,1,0.969988112965729,0,5,positive regulation of establishment of endothelial barrier,BP,
19596,GO:1903143,1,0.982061893830096,0,3,adrenomedullin receptor complex,CC,
19597,GO:1903146,1,0.740876926821096,0,44,regulation of autophagy of mitochondrion,BP,
19598,GO:1903147,1,0.954241710676405,0,7,negative regulation of autophagy of mitochondrion,BP,
19599,GO:1903165,1,0.994358236185322,0,1,response to polycyclic arene,BP,
19600,GO:1903167,1,0.994822876044542,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19601,GO:1903168,1,0.994822876044542,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19603,GO:1903170,1,0.809772091205229,0,34,negative regulation of calcium ion transmembrane transport,BP,
19604,GO:1903173,1,0.988274779360279,0,2,fatty alcohol metabolic process,BP,
19605,GO:1903176,1,0.994822876044542,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19606,GO:1903178,1,0.994822876044542,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19607,GO:1903179,1,0.98881316614762,0,2,regulation of dopamine biosynthetic process,BP,
19608,GO:1903181,1,0.98881316614762,0,2,positive regulation of dopamine biosynthetic process,BP,
19609,GO:1903182,1,0.994800064853307,0,1,regulation of SUMO transferase activity,BP,
19610,GO:1903184,1,0.994822876044542,0,1,L-dopa metabolic process,BP,
19611,GO:1903185,1,0.994822876044542,0,1,L-dopa biosynthetic process,BP,
19612,GO:1903189,1,0.994822876044542,0,1,glyoxal metabolic process,BP,
19613,GO:1903195,1,0.994822876044542,0,1,regulation of L-dopa biosynthetic process,BP,
19614,GO:1903197,1,0.994822876044542,0,1,positive regulation of L-dopa biosynthetic process,BP,
19615,GO:1903198,1,0.994822876044542,0,1,regulation of L-dopa decarboxylase activity,BP,
19616,GO:1903200,1,0.994822876044542,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19617,GO:1903201,1,0.693992017440789,0,57,regulation of oxidative stress-induced cell death,BP,
19618,GO:1903202,1,0.779695731357342,0,39,negative regulation of oxidative stress-induced cell death,BP,
19619,GO:1903203,1,0.87163439048554,0,20,regulation of oxidative stress-induced neuron death,BP,
19620,GO:1903204,1,0.904207443186998,0,15,negative regulation of oxidative stress-induced neuron death,BP,
19621,GO:1903205,1,0.857443367431157,0,24,regulation of hydrogen peroxide-induced cell death,BP,
19622,GO:1903206,1,0.897258674742192,0,17,negative regulation of hydrogen peroxide-induced cell death,BP,
19623,GO:1903207,1,0.976166831642324,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19624,GO:1903208,1,0.976166831642324,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19625,GO:1903209,1,0.917932204944582,0,13,positive regulation of oxidative stress-induced cell death,BP,
19626,GO:1903210,1,0.990956155649264,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19627,GO:1903214,1,0.594262625525274,0,82,regulation of protein targeting to mitochondrion,BP,
19628,GO:1903215,1,0.971070597837947,0,4,negative regulation of protein targeting to mitochondrion,BP,
19629,GO:1903216,1,0.982887985094879,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19630,GO:1903217,1,0.982887985094879,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19631,GO:1903223,1,0.970472136333139,0,4,positive regulation of oxidative stress-induced neuron death,BP,
19632,GO:1903224,1,0.963488452243205,0,5,regulation of endodermal cell differentiation,BP,
19633,GO:1903225,1,0.974072755906558,0,3,negative regulation of endodermal cell differentiation,BP,
19634,GO:1903232,1,0.972131845382136,0,5,melanosome assembly,BP,
19635,GO:1903233,1,0.981501829906947,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19636,GO:1903236,1,0.953779098966902,0,8,regulation of leukocyte tethering or rolling,BP,
19637,GO:1903237,1,0.979307734362424,0,4,negative regulation of leukocyte tethering or rolling,BP,
19638,GO:1903238,1,0.973937340620393,0,4,positive regulation of leukocyte tethering or rolling,BP,
19639,GO:1903242,1,0.941923961951125,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19640,GO:1903243,1,0.954735767908726,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19641,GO:1903244,1,0.986586952457581,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19642,GO:1903248,1,0.988441996649535,0,1,regulation of citrulline biosynthetic process,BP,
19643,GO:1903249,1,0.988441996649535,0,1,negative regulation of citrulline biosynthetic process,BP,
19644,GO:1903251,1,0.956987173624279,0,7,multi-ciliated epithelial cell differentiation,BP,
19645,GO:1903265,1,0.955918141657869,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19646,GO:1903276,1,0.978308751098082,0,4,regulation of sodium ion export across plasma membrane,BP,
19647,GO:1903278,1,0.978308751098082,0,4,positive regulation of sodium ion export across plasma membrane,BP,
19648,GO:1903279,1,0.979447838265849,0,3,regulation of calcium:sodium antiporter activity,BP,
19649,GO:1903280,1,0.991849742319479,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19650,GO:1903281,1,0.987497202921311,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19651,GO:1903282,1,0.99405469576238,0,1,regulation of glutathione peroxidase activity,BP,
19652,GO:1903284,1,0.99405469576238,0,1,positive regulation of glutathione peroxidase activity,BP,
19653,GO:1903285,1,0.99405469576238,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19654,GO:1903286,1,0.975835425610613,0,4,regulation of potassium ion import,BP,
19655,GO:1903288,1,0.983384510520476,0,3,positive regulation of potassium ion import,BP,
19656,GO:1903292,1,0.987982657154223,0,2,protein localization to Golgi membrane,BP,
19657,GO:1903293,1,0.753255183428168,0,44,phosphatase complex,CC,
19658,GO:1903294,1,0.985876407269884,0,2,regulation of glutamate secretion, neurotransmission,BP,
19659,GO:1903296,1,0.985876407269884,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
19660,GO:1903297,1,0.971102615784058,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19661,GO:1903298,1,0.971102615784058,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19662,GO:1903299,1,0.941059141082841,0,9,regulation of hexokinase activity,BP,
19663,GO:1903300,1,0.977610231508059,0,4,negative regulation of hexokinase activity,BP,
19664,GO:1903301,1,0.962620102775837,0,5,positive regulation of hexokinase activity,BP,
19666,GO:1903306,1,0.877806436114848,0,20,negative regulation of regulated secretory pathway,BP,
19669,GO:1903312,1,0.638024729909101,0,69,negative regulation of mRNA metabolic process,BP,
19670,GO:1903313,1,0.642606677635578,0,63,positive regulation of mRNA metabolic process,BP,
19671,GO:1903314,1,0.99459757150219,0,1,regulation of nitrogen cycle metabolic process,BP,
19674,GO:1903319,1,0.876502296409281,0,20,positive regulation of protein maturation,BP,
19675,GO:1903320,1,0.283116805601456,0,195,regulation of protein modification by small protein conjugation or removal,BP,
19676,GO:1903321,1,0.635885764957077,0,70,negative regulation of protein modification by small protein conjugation or removal,BP,
19677,GO:1903322,1,0.487761259859832,0,114,positive regulation of protein modification by small protein conjugation or removal,BP,
19678,GO:1903332,1,0.958917558458155,0,7,regulation of protein folding,BP,
19679,GO:1903333,1,0.970721133877627,0,5,negative regulation of protein folding,BP,
19680,GO:1903335,1,0.971735332098699,0,4,regulation of vacuolar transport,BP,
19681,GO:1903336,1,0.98205391928189,0,2,negative regulation of vacuolar transport,BP,
19682,GO:1903337,1,0.98949474294064,0,2,positive regulation of vacuolar transport,BP,
19683,GO:1903347,1,0.96991829330855,0,4,negative regulation of bicellular tight junction assembly,BP,
19684,GO:1903348,1,0.980670940684317,0,3,positive regulation of bicellular tight junction assembly,BP,
19685,GO:1903349,1,0.964009514973576,0,6,omegasome membrane,CC,
19686,GO:1903350,1,0.910646119831131,0,13,response to dopamine,BP,
19687,GO:1903351,1,0.910646119831131,0,13,cellular response to dopamine,BP,
19688,GO:1903352,1,0.957522322553041,0,6,L-ornithine transmembrane transport,BP,
19689,GO:1903358,1,0.904953017424999,0,15,regulation of Golgi organization,BP,
19690,GO:1903361,1,0.96021223987952,0,7,protein localization to basolateral plasma membrane,BP,
19693,GO:1903364,1,0.41694982634569,0,131,positive regulation of cellular protein catabolic process,BP,
19694,GO:1903365,1,0.955829079334407,0,7,regulation of fear response,BP,
19695,GO:1903367,1,0.969849630001496,0,5,positive regulation of fear response,BP,
19696,GO:1903371,1,0.966803866931915,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
19697,GO:1903373,1,0.977028936516749,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19698,GO:1903375,1,0.986156053460746,0,2,facioacoustic ganglion development,BP,
19699,GO:1903376,1,0.957831208739901,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19700,GO:1903377,1,0.97685973155334,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19701,GO:1903378,1,0.987095209537772,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19702,GO:1903381,1,0.992797577257253,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19703,GO:1903382,1,0.992797577257253,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19704,GO:1903383,1,0.989227359261336,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19705,GO:1903384,1,0.989227359261336,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19706,GO:1903385,1,0.985915229083559,0,2,regulation of homophilic cell adhesion,BP,
19707,GO:1903387,1,0.99205003541711,0,1,positive regulation of homophilic cell adhesion,BP,
19708,GO:1903391,1,0.655331333284619,0,56,regulation of adherens junction organization,BP,
19709,GO:1903392,1,0.892489598295959,0,16,negative regulation of adherens junction organization,BP,
19710,GO:1903393,1,0.826094018096403,0,25,positive regulation of adherens junction organization,BP,
19711,GO:1903394,1,0.99452110815468,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19712,GO:1903400,1,0.963613871169737,0,5,L-arginine transmembrane transport,BP,
19713,GO:1903401,1,0.968257649665535,0,5,L-lysine transmembrane transport,BP,
19714,GO:1903402,1,0.993462542276915,0,1,regulation of renal phosphate excretion,BP,
19715,GO:1903403,1,0.993462542276915,0,1,negative regulation of renal phosphate excretion,BP,
19716,GO:1903405,1,0.951669052067962,0,9,protein localization to nuclear body,BP,
19717,GO:1903406,1,0.993672281030082,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19718,GO:1903408,1,0.993672281030082,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19720,GO:1903412,1,0.983049289125089,0,3,response to bile acid,BP,
19721,GO:1903413,1,0.983049289125089,0,3,cellular response to bile acid,BP,
19722,GO:1903414,1,0.993911470462511,0,1,iron cation export,BP,
19723,GO:1903416,1,0.962356648692812,0,6,response to glycoside,BP,
19724,GO:1903420,1,0.990867021326803,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19725,GO:1903421,1,0.891410651826593,0,15,regulation of synaptic vesicle recycling,BP,
19726,GO:1903422,1,0.98495288017366,0,2,negative regulation of synaptic vesicle recycling,BP,
19727,GO:1903423,1,0.945163187370882,0,7,positive regulation of synaptic vesicle recycling,BP,
19729,GO:1903427,1,0.876706588858693,0,21,negative regulation of reactive oxygen species biosynthetic process,BP,
19731,GO:1903429,1,0.870371424796876,0,20,regulation of cell maturation,BP,
19732,GO:1903430,1,0.959507946029743,0,7,negative regulation of cell maturation,BP,
19733,GO:1903431,1,0.947920862794524,0,7,positive regulation of cell maturation,BP,
19734,GO:1903432,1,0.84806121808995,0,25,regulation of TORC1 signaling,BP,
19735,GO:1903433,1,0.987812221306226,0,2,regulation of constitutive secretory pathway,BP,
19736,GO:1903434,1,0.99347818785335,0,1,negative regulation of constitutive secretory pathway,BP,
19737,GO:1903435,1,0.994297210746049,0,1,positive regulation of constitutive secretory pathway,BP,
19738,GO:1903436,1,0.984938032273025,0,2,regulation of mitotic cytokinetic process,BP,
19739,GO:1903438,1,0.984938032273025,0,2,positive regulation of mitotic cytokinetic process,BP,
19740,GO:1903439,1,0.970815784146973,0,5,calcitonin family receptor complex,CC,
19741,GO:1903440,1,0.97830895394002,0,4,amylin receptor complex,CC,
19742,GO:1903441,1,0.952336994467102,0,8,protein localization to ciliary membrane,BP,
19743,GO:1903442,1,0.993507489775592,0,1,response to lipoic acid,BP,
19744,GO:1903444,1,0.994062729449467,0,1,negative regulation of brown fat cell differentiation,BP,
19745,GO:1903445,1,0.984028039594873,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19746,GO:1903450,1,0.988633728961322,0,1,regulation of G1 to G0 transition,BP,
19747,GO:1903452,1,0.988633728961322,0,1,positive regulation of G1 to G0 transition,BP,
19748,GO:1903461,1,0.994099766187605,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19749,GO:1903463,1,0.980246435737138,0,3,regulation of mitotic cell cycle DNA replication,BP,
19750,GO:1903464,1,0.98848007260518,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19751,GO:1903465,1,0.991671367570111,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19752,GO:1903487,1,0.983347276541953,0,3,regulation of lactation,BP,
19753,GO:1903489,1,0.989525518803773,0,2,positive regulation of lactation,BP,
19754,GO:1903490,1,0.984938032273025,0,2,positive regulation of mitotic cytokinesis,BP,
19755,GO:1903494,1,0.994819816488085,0,1,response to dehydroepiandrosterone,BP,
19756,GO:1903496,1,0.994819816488085,0,1,response to 11-deoxycorticosterone,BP,
19757,GO:1903504,1,0.912896651625669,0,14,regulation of mitotic spindle checkpoint,BP,
19763,GO:1903513,1,0.849095263628216,0,26,endoplasmic reticulum to cytosol transport,BP,
19764,GO:1903514,1,0.790064385867306,0,29,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
19765,GO:1903515,1,0.989015467670684,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19766,GO:1903516,1,0.982296895136111,0,3,regulation of single strand break repair,BP,
19767,GO:1903517,1,0.994238495123187,0,1,negative regulation of single strand break repair,BP,
19768,GO:1903518,1,0.987989889986966,0,2,positive regulation of single strand break repair,BP,
19769,GO:1903519,1,0.980746071857235,0,3,regulation of mammary gland involution,BP,
19770,GO:1903521,1,0.980746071857235,0,3,positive regulation of mammary gland involution,BP,
19774,GO:1903525,1,0.962520710274768,0,5,regulation of membrane tubulation,BP,
19775,GO:1903526,1,0.986651596813303,0,2,negative regulation of membrane tubulation,BP,
19776,GO:1903527,1,0.975545890531475,0,3,positive regulation of membrane tubulation,BP,
19781,GO:1903537,1,0.98882588964879,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19782,GO:1903538,1,0.98882588964879,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19785,GO:1903541,1,0.919089745131735,0,14,regulation of exosomal secretion,BP,
19786,GO:1903542,1,0.988491199083426,0,2,negative regulation of exosomal secretion,BP,
19787,GO:1903543,1,0.919089745131735,0,14,positive regulation of exosomal secretion,BP,
19788,GO:1903544,1,0.99386165650684,0,1,response to butyrate,BP,
19789,GO:1903545,1,0.99386165650684,0,1,cellular response to butyrate,BP,
19790,GO:1903546,1,0.960031854087309,0,6,protein localization to photoreceptor outer segment,BP,
19791,GO:1903547,1,0.989630361751128,0,2,regulation of growth hormone activity,BP,
19792,GO:1903551,1,0.964164801070222,0,6,regulation of extracellular exosome assembly,BP,
19793,GO:1903553,1,0.974918139418533,0,4,positive regulation of extracellular exosome assembly,BP,
19796,GO:1903557,1,0.64951603964574,0,66,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19798,GO:1903564,1,0.966886665764535,0,4,regulation of protein localization to cilium,BP,
19799,GO:1903565,1,0.9938738135908,0,1,negative regulation of protein localization to cilium,BP,
19800,GO:1903566,1,0.972848149427277,0,3,positive regulation of protein localization to cilium,BP,
19801,GO:1903567,1,0.98842114655326,0,2,regulation of protein localization to ciliary membrane,BP,
19802,GO:1903568,1,0.9938738135908,0,1,negative regulation of protein localization to ciliary membrane,BP,
19803,GO:1903569,1,0.994514059456956,0,1,positive regulation of protein localization to ciliary membrane,BP,
19804,GO:1903570,1,0.993776862070028,0,1,regulation of protein kinase D signaling,BP,
19805,GO:1903572,1,0.993776862070028,0,1,positive regulation of protein kinase D signaling,BP,
19806,GO:1903573,1,0.779235257915046,0,40,negative regulation of response to endoplasmic reticulum stress,BP,
19807,GO:1903575,1,0.988676714901453,0,2,cornified envelope assembly,BP,
19808,GO:1903576,1,0.994623979651904,0,1,response to L-arginine,BP,
19809,GO:1903578,1,0.560778837653005,0,83,regulation of ATP metabolic process,BP,
19810,GO:1903579,1,0.880499195383857,0,19,negative regulation of ATP metabolic process,BP,
19811,GO:1903580,1,0.819734994680026,0,29,positive regulation of ATP metabolic process,BP,
19812,GO:1903584,1,0.992974831045404,0,1,regulation of histone deubiquitination,BP,
19813,GO:1903586,1,0.992974831045404,0,1,positive regulation of histone deubiquitination,BP,
19814,GO:1903587,1,0.943866568874742,0,9,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19815,GO:1903588,1,0.974292667613232,0,4,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19816,GO:1903589,1,0.968779094629618,0,5,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19817,GO:1903593,1,0.984185154114018,0,3,regulation of histamine secretion by mast cell,BP,
19818,GO:1903595,1,0.984185154114018,0,3,positive regulation of histamine secretion by mast cell,BP,
19819,GO:1903596,1,0.976675370221011,0,4,regulation of gap junction assembly,BP,
19820,GO:1903597,1,0.993905506281561,0,1,negative regulation of gap junction assembly,BP,
19821,GO:1903598,1,0.982665262225146,0,3,positive regulation of gap junction assembly,BP,
19822,GO:1903599,1,0.880423384098113,0,17,positive regulation of autophagy of mitochondrion,BP,
19823,GO:1903608,1,0.961804517266379,0,6,protein localization to cytoplasmic stress granule,BP,
19824,GO:1903609,1,0.994370607996823,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19825,GO:1903610,1,0.994665887682369,0,1,regulation of calcium-dependent ATPase activity,BP,
19826,GO:1903611,1,0.994665887682369,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19827,GO:1903613,1,0.991978946415223,0,1,regulation of protein tyrosine phosphatase activity,BP,
19828,GO:1903615,1,0.991978946415223,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19829,GO:1903618,1,0.993341223717095,0,1,regulation of transdifferentiation,BP,
19830,GO:1903620,1,0.993341223717095,0,1,positive regulation of transdifferentiation,BP,
19831,GO:1903621,1,0.994660885074235,0,1,protein localization to photoreceptor connecting cilium,BP,
19832,GO:1903624,1,0.940689909608881,0,9,regulation of DNA catabolic process,BP,
19833,GO:1903625,1,0.989043315404173,0,2,negative regulation of DNA catabolic process,BP,
19834,GO:1903626,1,0.970834158658042,0,4,positive regulation of DNA catabolic process,BP,
19835,GO:1903627,1,0.994665887682369,0,1,regulation of dUTP diphosphatase activity,BP,
19836,GO:1903629,1,0.994665887682369,0,1,positive regulation of dUTP diphosphatase activity,BP,
19837,GO:1903630,1,0.989491684926813,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19838,GO:1903631,1,0.994665887682369,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19839,GO:1903632,1,0.994798327349128,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19840,GO:1903633,1,0.994665887682369,0,1,regulation of leucine-tRNA ligase activity,BP,
19841,GO:1903634,1,0.994665887682369,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19842,GO:1903636,1,0.994838740001473,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19843,GO:1903638,1,0.994838740001473,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19844,GO:1903639,1,0.994839732645327,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19845,GO:1903640,1,0.994839732645327,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19846,GO:1903644,1,0.989297699662676,0,2,regulation of chaperone-mediated protein folding,BP,
19847,GO:1903645,1,0.994838740001473,0,1,negative regulation of chaperone-mediated protein folding,BP,
19848,GO:1903649,1,0.868100918830614,0,20,regulation of cytoplasmic transport,BP,
19849,GO:1903650,1,0.989636289506822,0,2,negative regulation of cytoplasmic transport,BP,
19850,GO:1903651,1,0.934509693504727,0,9,positive regulation of cytoplasmic transport,BP,
19851,GO:1903659,1,0.989254474901413,0,2,regulation of complement-dependent cytotoxicity,BP,
19852,GO:1903660,1,0.989254474901413,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19854,GO:1903671,1,0.846155176144848,0,23,negative regulation of sprouting angiogenesis,BP,
19856,GO:1903673,1,0.994668217648025,0,1,mitotic cleavage furrow formation,BP,
19857,GO:1903674,1,0.994670120944888,0,1,regulation of cap-dependent translational initiation,BP,
19858,GO:1903676,1,0.994670120944888,0,1,positive regulation of cap-dependent translational initiation,BP,
19859,GO:1903677,1,0.983698631541099,0,3,regulation of cap-independent translational initiation,BP,
19860,GO:1903679,1,0.983698631541099,0,3,positive regulation of cap-independent translational initiation,BP,
19861,GO:1903689,1,0.941051710271937,0,6,regulation of wound healing, spreading of epidermal cells,BP,
19862,GO:1903690,1,0.962883529247121,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19863,GO:1903691,1,0.977335082167253,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19864,GO:1903697,1,0.993913851299157,0,1,negative regulation of microvillus assembly,BP,
19865,GO:1903699,1,0.985690539081339,0,1,tarsal gland development,BP,
19866,GO:1903701,1,0.992139917647162,0,1,substantia propria of cornea development,BP,
19867,GO:1903704,1,0.993341223717095,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19871,GO:1903709,1,0.985690539081339,0,1,uterine gland development,BP,
19872,GO:1903712,1,0.993595945906608,0,1,cysteine transmembrane transport,BP,
19873,GO:1903715,1,0.961827577582678,0,6,regulation of aerobic respiration,BP,
19874,GO:1903717,1,0.991553273734652,0,1,response to ammonia,BP,
19875,GO:1903718,1,0.991553273734652,0,1,cellular response to ammonia,BP,
19876,GO:1903719,1,0.983691557779349,0,3,regulation of I-kappaB phosphorylation,BP,
19877,GO:1903721,1,0.983691557779349,0,3,positive regulation of I-kappaB phosphorylation,BP,
19878,GO:1903722,1,0.988746722592455,0,2,regulation of centriole elongation,BP,
19879,GO:1903723,1,0.994824698598226,0,1,negative regulation of centriole elongation,BP,
19880,GO:1903724,1,0.993890721344781,0,1,positive regulation of centriole elongation,BP,
19881,GO:1903725,1,0.643618513289277,0,66,regulation of phospholipid metabolic process,BP,
19882,GO:1903726,1,0.95864975133482,0,7,negative regulation of phospholipid metabolic process,BP,
19883,GO:1903727,1,0.760001307951841,0,42,positive regulation of phospholipid metabolic process,BP,
19884,GO:1903729,1,0.928793682357089,0,11,regulation of plasma membrane organization,BP,
19885,GO:1903742,1,0.994784577680379,0,1,regulation of anterograde synaptic vesicle transport,BP,
19886,GO:1903743,1,0.994784577680379,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19887,GO:1903747,1,0.487072062383027,0,115,regulation of establishment of protein localization to mitochondrion,BP,
19888,GO:1903748,1,0.951704177096289,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19889,GO:1903749,1,0.524641613825121,0,104,positive regulation of establishment of protein localization to mitochondrion,BP,
19890,GO:1903750,1,0.977567483659896,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19891,GO:1903751,1,0.977567483659896,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19892,GO:1903753,1,0.969156074860456,0,5,negative regulation of p38MAPK cascade,BP,
19893,GO:1903755,1,0.994800064853307,0,1,positive regulation of SUMO transferase activity,BP,
19894,GO:1903756,1,0.987317831546955,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19895,GO:1903758,1,0.987317831546955,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19896,GO:1903759,1,0.994062729449467,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19897,GO:1903760,1,0.978734959111909,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19898,GO:1903762,1,0.986306248648636,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19899,GO:1903763,1,0.978416347252256,0,3,gap junction channel activity involved in cell communication by electrical coupling,MF,
19900,GO:1903764,1,0.981394073842072,0,3,regulation of potassium ion export across plasma membrane,BP,
19901,GO:1903765,1,0.994127863350714,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19902,GO:1903766,1,0.994827794879995,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19903,GO:1903767,1,0.994428062514543,0,1,sweet taste receptor complex,CC,
19904,GO:1903768,1,0.994428062514543,0,1,taste receptor complex,CC,
19905,GO:1903770,1,0.994238495123187,0,1,negative regulation of beta-galactosidase activity,BP,
19906,GO:1903772,1,0.973073980983994,0,5,regulation of viral budding via host ESCRT complex,BP,
19907,GO:1903774,1,0.983758200361407,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19908,GO:1903775,1,0.988532752547191,0,2,regulation of DNA double-strand break processing,BP,
19909,GO:1903778,1,0.990903271693396,0,1,protein localization to vacuolar membrane,BP,
19911,GO:1903781,1,0.979633460178032,0,3,positive regulation of cardiac conduction,BP,
19912,GO:1903786,1,0.994333682075354,0,1,regulation of glutathione biosynthetic process,BP,
19913,GO:1903788,1,0.994333682075354,0,1,positive regulation of glutathione biosynthetic process,BP,
19914,GO:1903789,1,0.949940597330669,0,8,regulation of amino acid transmembrane transport,BP,
19915,GO:1903792,1,0.8628046365532,0,22,negative regulation of anion transport,BP,
19916,GO:1903793,1,0.802589032744257,0,34,positive regulation of anion transport,BP,
19917,GO:1903795,1,0.951761190659287,0,6,regulation of inorganic anion transmembrane transport,BP,
19918,GO:1903796,1,0.982803611678548,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19919,GO:1903797,1,0.984408709418832,0,2,positive regulation of inorganic anion transmembrane transport,BP,
19920,GO:1903798,1,0.909298597053989,0,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19921,GO:1903799,1,0.940648829266808,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19922,GO:1903800,1,0.961449824973904,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19923,GO:1903801,1,0.994555972713727,0,1,L-leucine import across plasma membrane,BP,
19924,GO:1903803,1,0.994666025312145,0,1,L-glutamine import across plasma membrane,BP,
19925,GO:1903804,1,0.994255322042818,0,1,glycine import across plasma membrane,BP,
19926,GO:1903814,1,0.994827794879995,0,1,regulation of collecting lymphatic vessel constriction,BP,
19927,GO:1903815,1,0.994827794879995,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19928,GO:1903817,1,0.948857149922631,0,8,negative regulation of voltage-gated potassium channel activity,BP,
19929,GO:1903818,1,0.903567218039757,0,13,positive regulation of voltage-gated potassium channel activity,BP,
19930,GO:1903823,1,0.994238495123187,0,1,telomere single strand break repair,BP,
19931,GO:1903824,1,0.994238495123187,0,1,negative regulation of telomere single strand break repair,BP,
19932,GO:1903825,1,0.479361331418765,0,107,organic acid transmembrane transport,BP,
19933,GO:1903826,1,0.958482215116421,0,6,arginine transmembrane transport,BP,
19937,GO:1903830,1,0.900175595939972,0,16,magnesium ion transmembrane transport,BP,
19938,GO:1903831,1,0.875913943703332,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19939,GO:1903837,1,0.994468201715917,0,1,regulation of mRNA 3'-UTR binding,BP,
19940,GO:1903839,1,0.994468201715917,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19942,GO:1903845,1,0.61289228135705,0,68,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
19944,GO:1903847,1,0.981094348202968,0,2,regulation of aorta morphogenesis,BP,
19945,GO:1903849,1,0.981094348202968,0,2,positive regulation of aorta morphogenesis,BP,
19946,GO:1903850,1,0.994375655271215,0,1,regulation of cristae formation,BP,
19947,GO:1903852,1,0.994375655271215,0,1,positive regulation of cristae formation,BP,
19949,GO:1903860,1,0.982808879683752,0,3,negative regulation of dendrite extension,BP,
19951,GO:1903862,1,0.967159655095861,0,6,positive regulation of oxidative phosphorylation,BP,
19952,GO:1903867,1,0.940150672153518,0,9,extraembryonic membrane development,BP,
19953,GO:1903874,1,0.979890098705127,0,3,ferrous iron transmembrane transport,BP,
19954,GO:1903881,1,0.993608860486893,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19955,GO:1903883,1,0.993608860486893,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19956,GO:1903884,1,0.993608860486893,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19957,GO:1903886,1,0.993608860486893,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19958,GO:1903888,1,0.994831355742962,0,1,regulation of plant epidermal cell differentiation,BP,
19959,GO:1903889,1,0.994831355742962,0,1,negative regulation of plant epidermal cell differentiation,BP,
19960,GO:1903891,1,0.9761191213012,0,4,regulation of ATF6-mediated unfolded protein response,BP,
19961,GO:1903892,1,0.988105806706387,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
19962,GO:1903893,1,0.994457146761456,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
19963,GO:1903894,1,0.921302533173216,0,13,regulation of IRE1-mediated unfolded protein response,BP,
19964,GO:1903895,1,0.97636645399543,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
19965,GO:1903896,1,0.953614380252568,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
19966,GO:1903897,1,0.943227217578571,0,9,regulation of PERK-mediated unfolded protein response,BP,
19967,GO:1903898,1,0.970084076595942,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19968,GO:1903899,1,0.978807252870337,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
19971,GO:1903902,1,0.700293084886933,0,55,positive regulation of viral life cycle,BP,
19972,GO:1903903,1,0.978631196958847,0,3,regulation of establishment of T cell polarity,BP,
19973,GO:1903905,1,0.984206981538111,0,2,positive regulation of establishment of T cell polarity,BP,
19974,GO:1903906,1,0.994335643035159,0,1,regulation of plasma membrane raft polarization,BP,
19976,GO:1903910,1,0.994527242355616,0,1,negative regulation of receptor clustering,BP,
19977,GO:1903911,1,0.973315110484043,0,4,positive regulation of receptor clustering,BP,
19978,GO:1903912,1,0.973270642821803,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19979,GO:1903916,1,0.9945094434866,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19980,GO:1903917,1,0.9945094434866,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19981,GO:1903918,1,0.98971614533843,0,1,regulation of actin filament severing,BP,
19982,GO:1903919,1,0.98971614533843,0,1,negative regulation of actin filament severing,BP,
19983,GO:1903921,1,0.984109462323214,0,2,regulation of protein processing in phagocytic vesicle,BP,
19984,GO:1903923,1,0.984109462323214,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19985,GO:1903924,1,0.994570940851211,0,1,estradiol binding,MF,
19986,GO:1903925,1,0.994681767558612,0,1,response to bisphenol A,BP,
19987,GO:1903926,1,0.994681767558612,0,1,cellular response to bisphenol A,BP,
19988,GO:1903929,1,0.98860488751952,0,2,primary palate development,BP,
19989,GO:1903935,1,0.973012438075281,0,5,response to sodium arsenite,BP,
19990,GO:1903936,1,0.973012438075281,0,5,cellular response to sodium arsenite,BP,
19991,GO:1903937,1,0.992390237692834,0,1,response to acrylamide,BP,
19992,GO:1903939,1,0.993921767359053,0,1,regulation of TORC2 signaling,BP,
19993,GO:1903943,1,0.994656786941954,0,1,regulation of hepatocyte apoptotic process,BP,
19994,GO:1903944,1,0.994656786941954,0,1,negative regulation of hepatocyte apoptotic process,BP,
19995,GO:1903946,1,0.994127863350714,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19996,GO:1903947,1,0.986306248648636,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19997,GO:1903949,1,0.986691251392427,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19998,GO:1903952,1,0.993369469569073,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19999,GO:1903954,1,0.993369469569073,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20000,GO:1903955,1,0.627189008693773,0,74,positive regulation of protein targeting to mitochondrion,BP,
20001,GO:1903959,1,0.847266785718338,0,23,regulation of anion transmembrane transport,BP,
20002,GO:1903960,1,0.923875205263689,0,11,negative regulation of anion transmembrane transport,BP,
20003,GO:1903961,1,0.960737652788891,0,6,positive regulation of anion transmembrane transport,BP,
20005,GO:1903964,1,0.981161638184218,0,3,monounsaturated fatty acid metabolic process,BP,
20006,GO:1903965,1,0.994778317414883,0,1,monounsaturated fatty acid catabolic process,BP,
20007,GO:1903966,1,0.98631255769375,0,2,monounsaturated fatty acid biosynthetic process,BP,
20008,GO:1903969,1,0.984050306489381,0,3,regulation of response to macrophage colony-stimulating factor,BP,
20009,GO:1903970,1,0.989504684655112,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
20010,GO:1903971,1,0.994488349929807,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
20011,GO:1903972,1,0.984050306489381,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20012,GO:1903973,1,0.989504684655112,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20013,GO:1903974,1,0.994488349929807,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20014,GO:1903975,1,0.94804886815,0,9,regulation of glial cell migration,BP,
20015,GO:1903976,1,0.978556975981335,0,4,negative regulation of glial cell migration,BP,
20016,GO:1903977,1,0.97912027852456,0,3,positive regulation of glial cell migration,BP,
20017,GO:1903978,1,0.929513877407911,0,9,regulation of microglial cell activation,BP,
20018,GO:1903979,1,0.986909535528624,0,2,negative regulation of microglial cell activation,BP,
20019,GO:1903980,1,0.949971791834593,0,7,positive regulation of microglial cell activation,BP,
20020,GO:1903984,1,0.978390373261678,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
20021,GO:1903988,1,0.993911470462511,0,1,ferrous iron export across plasma membrane,BP,
20022,GO:1903995,1,0.989370733142831,0,2,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20023,GO:1903997,1,0.989370733142831,0,2,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20024,GO:1903998,1,0.970596202670448,0,4,regulation of eating behavior,BP,
20025,GO:1903999,1,0.986993611490249,0,2,negative regulation of eating behavior,BP,
20026,GO:1904000,1,0.983388664879495,0,2,positive regulation of eating behavior,BP,
20027,GO:1904008,1,0.994774443149678,0,1,response to monosodium glutamate,BP,
20028,GO:1904009,1,0.994774443149678,0,1,cellular response to monosodium glutamate,BP,
20029,GO:1904010,1,0.994774443149678,0,1,response to Aroclor 1254,BP,
20030,GO:1904016,1,0.969899586428614,0,4,response to Thyroglobulin triiodothyronine,BP,
20031,GO:1904017,1,0.981552982435924,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20034,GO:1904020,1,0.982720809865555,0,3,regulation of G-protein coupled receptor internalization,BP,
20035,GO:1904021,1,0.988636971482897,0,2,negative regulation of G-protein coupled receptor internalization,BP,
20036,GO:1904022,1,0.994016522465217,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20037,GO:1904026,1,0.988785148312362,0,2,regulation of collagen fibril organization,BP,
20038,GO:1904027,1,0.994440633602804,0,1,negative regulation of collagen fibril organization,BP,
20039,GO:1904028,1,0.994313214468247,0,1,positive regulation of collagen fibril organization,BP,
20040,GO:1904029,1,0.572212942761667,0,88,regulation of cyclin-dependent protein kinase activity,BP,
20041,GO:1904030,1,0.804567308322462,0,32,negative regulation of cyclin-dependent protein kinase activity,BP,
20042,GO:1904031,1,0.797431088585629,0,36,positive regulation of cyclin-dependent protein kinase activity,BP,
20046,GO:1904041,1,0.993960877222941,0,1,regulation of cystathionine beta-synthase activity,BP,
20047,GO:1904042,1,0.993960877222941,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20048,GO:1904044,1,0.976003478016834,0,4,response to aldosterone,BP,
20049,GO:1904045,1,0.994575689752042,0,1,cellular response to aldosterone,BP,
20050,GO:1904046,1,0.989526202848573,0,2,negative regulation of vascular endothelial growth factor production,BP,
20051,GO:1904047,1,0.983278142589384,0,3,S-adenosyl-L-methionine binding,MF,
20052,GO:1904048,1,0.980137172163435,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20053,GO:1904049,1,0.987236614275326,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20054,GO:1904050,1,0.992809692121295,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20055,GO:1904054,1,0.988495768566121,0,1,regulation of cholangiocyte proliferation,BP,
20056,GO:1904056,1,0.988495768566121,0,1,positive regulation of cholangiocyte proliferation,BP,
20057,GO:1904057,1,0.989172343464006,0,2,negative regulation of sensory perception of pain,BP,
20058,GO:1904058,1,0.965751608857444,0,5,positive regulation of sensory perception of pain,BP,
20059,GO:1904059,1,0.977514719698182,0,2,regulation of locomotor rhythm,BP,
20061,GO:1904063,1,0.637161894486252,0,69,negative regulation of cation transmembrane transport,BP,
20063,GO:1904071,1,0.981759761609579,0,2,presynaptic active zone assembly,BP,
20064,GO:1904073,1,0.989996730320086,0,1,regulation of trophectodermal cell proliferation,BP,
20065,GO:1904075,1,0.989996730320086,0,1,positive regulation of trophectodermal cell proliferation,BP,
20066,GO:1904090,1,0.979079902947047,0,4,peptidase inhibitor complex,CC,
20067,GO:1904098,1,0.981402490696324,0,3,regulation of protein O-linked glycosylation,BP,
20068,GO:1904100,1,0.981402490696324,0,3,positive regulation of protein O-linked glycosylation,BP,
20069,GO:1904106,1,0.994322093643211,0,1,protein localization to microvillus,BP,
20070,GO:1904115,1,0.75549676769164,0,40,axon cytoplasm,CC,
20071,GO:1904116,1,0.979469083925279,0,3,response to vasopressin,BP,
20072,GO:1904117,1,0.979469083925279,0,3,cellular response to vasopressin,BP,
20073,GO:1904118,1,0.994096923959342,0,1,regulation of otic vesicle morphogenesis,BP,
20074,GO:1904120,1,0.994096923959342,0,1,positive regulation of otic vesicle morphogenesis,BP,
20075,GO:1904121,1,0.977237259897759,0,3,phosphatidylethanolamine transporter activity,MF,
20076,GO:1904124,1,0.984091131882542,0,3,microglial cell migration,BP,
20077,GO:1904139,1,0.984091131882542,0,3,regulation of microglial cell migration,BP,
20078,GO:1904140,1,0.994756723610098,0,1,negative regulation of microglial cell migration,BP,
20079,GO:1904141,1,0.994488349929807,0,1,positive regulation of microglial cell migration,BP,
20080,GO:1904149,1,0.994756723610098,0,1,regulation of microglial cell mediated cytotoxicity,BP,
20081,GO:1904151,1,0.994756723610098,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
20082,GO:1904152,1,0.921991374670644,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20083,GO:1904153,1,0.946060983552831,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20084,GO:1904154,1,0.980671511893788,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20085,GO:1904155,1,0.993921372291441,0,1,DN2 thymocyte differentiation,BP,
20086,GO:1904156,1,0.993921372291441,0,1,DN3 thymocyte differentiation,BP,
20087,GO:1904158,1,0.972603337775788,0,3,axonemal central apparatus assembly,BP,
20088,GO:1904167,1,0.986875303594688,0,1,regulation of thyroid hormone receptor activity,BP,
20089,GO:1904168,1,0.986875303594688,0,1,negative regulation of thyroid hormone receptor activity,BP,
20090,GO:1904170,1,0.986683971860714,0,2,regulation of bleb assembly,BP,
20091,GO:1904172,1,0.986683971860714,0,2,positive regulation of bleb assembly,BP,
20092,GO:1904177,1,0.961099237218291,0,6,regulation of adipose tissue development,BP,
20093,GO:1904179,1,0.9661292222387,0,5,positive regulation of adipose tissue development,BP,
20094,GO:1904180,1,0.965562213925896,0,6,negative regulation of membrane depolarization,BP,
20095,GO:1904181,1,0.934863270828757,0,10,positive regulation of membrane depolarization,BP,
20096,GO:1904182,1,0.99480340398373,0,1,regulation of pyruvate dehydrogenase activity,BP,
20097,GO:1904192,1,0.988495768566121,0,1,regulation of cholangiocyte apoptotic process,BP,
20098,GO:1904193,1,0.988495768566121,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20099,GO:1904195,1,0.988495768566121,0,1,regulation of granulosa cell proliferation,BP,
20100,GO:1904197,1,0.988495768566121,0,1,positive regulation of granulosa cell proliferation,BP,
20101,GO:1904199,1,0.993277651769872,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
20102,GO:1904200,1,0.988495768566121,0,1,iodide transmembrane transport,BP,
20103,GO:1904201,1,0.988495768566121,0,1,regulation of iodide transport,BP,
20104,GO:1904202,1,0.988495768566121,0,1,negative regulation of iodide transport,BP,
20105,GO:1904204,1,0.979645321613242,0,2,regulation of skeletal muscle hypertrophy,BP,
20106,GO:1904205,1,0.991047579444571,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20107,GO:1904206,1,0.988495768566121,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20110,GO:1904210,1,0.994777042630614,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20111,GO:1904211,1,0.987083053959425,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20112,GO:1904212,1,0.988495768566121,0,1,regulation of iodide transmembrane transport,BP,
20113,GO:1904213,1,0.988495768566121,0,1,negative regulation of iodide transmembrane transport,BP,
20114,GO:1904217,1,0.983478004887574,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20115,GO:1904219,1,0.983478004887574,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20116,GO:1904220,1,0.977884246299212,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20117,GO:1904222,1,0.983478004887574,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20118,GO:1904226,1,0.994585019354448,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20119,GO:1904227,1,0.994585019354448,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20120,GO:1904229,1,0.990091414626842,0,1,regulation of succinate dehydrogenase activity,BP,
20121,GO:1904231,1,0.990091414626842,0,1,positive regulation of succinate dehydrogenase activity,BP,
20122,GO:1904232,1,0.990091414626842,0,1,regulation of aconitate hydratase activity,BP,
20123,GO:1904234,1,0.990091414626842,0,1,positive regulation of aconitate hydratase activity,BP,
20124,GO:1904235,1,0.988866192432089,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20125,GO:1904237,1,0.988866192432089,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20126,GO:1904238,1,0.955697741307998,0,7,pericyte cell differentiation,BP,
20127,GO:1904239,1,0.994777042630614,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20128,GO:1904240,1,0.994777042630614,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20129,GO:1904245,1,0.988863172785782,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20130,GO:1904246,1,0.994712195059427,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20131,GO:1904247,1,0.994120195974473,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20132,GO:1904251,1,0.942318151515815,0,10,regulation of bile acid metabolic process,BP,
20133,GO:1904252,1,0.983131296456742,0,3,negative regulation of bile acid metabolic process,BP,
20134,GO:1904253,1,0.983335874539735,0,3,positive regulation of bile acid metabolic process,BP,
20135,GO:1904259,1,0.954863076050526,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20136,GO:1904261,1,0.954863076050526,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20137,GO:1904262,1,0.930318944481048,0,11,negative regulation of TORC1 signaling,BP,
20138,GO:1904263,1,0.94384728134558,0,9,positive regulation of TORC1 signaling,BP,
20139,GO:1904265,1,0.991021584480449,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20140,GO:1904266,1,0.990036700891625,0,1,regulation of Schwann cell chemotaxis,BP,
20141,GO:1904268,1,0.990036700891625,0,1,positive regulation of Schwann cell chemotaxis,BP,
20142,GO:1904271,1,0.994470477599369,0,1,L-proline import across plasma membrane,BP,
20143,GO:1904274,1,0.994571308153985,0,1,tricellular tight junction assembly,BP,
20144,GO:1904282,1,0.994660744776641,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20145,GO:1904283,1,0.994660744776641,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20146,GO:1904288,1,0.971320181486848,0,4,BAT3 complex binding,MF,
20147,GO:1904289,1,0.987049384470826,0,2,regulation of mitotic DNA damage checkpoint,BP,
20148,GO:1904290,1,0.992825824229612,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20149,GO:1904292,1,0.839509644458185,0,27,regulation of ERAD pathway,BP,
20150,GO:1904293,1,0.922540509653558,0,13,negative regulation of ERAD pathway,BP,
20151,GO:1904294,1,0.917239880923811,0,13,positive regulation of ERAD pathway,BP,
20152,GO:1904298,1,0.99321200732669,0,1,regulation of transcytosis,BP,
20153,GO:1904300,1,0.99321200732669,0,1,positive regulation of transcytosis,BP,
20154,GO:1904301,1,0.99321200732669,0,1,regulation of maternal process involved in parturition,BP,
20155,GO:1904303,1,0.99321200732669,0,1,positive regulation of maternal process involved in parturition,BP,
20156,GO:1904304,1,0.969710354306364,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20157,GO:1904306,1,0.969710354306364,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20158,GO:1904313,1,0.993376977639998,0,1,response to methamphetamine hydrochloride,BP,
20160,GO:1904316,1,0.99321200732669,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20161,GO:1904317,1,0.99321200732669,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20162,GO:1904321,1,0.913560835001569,0,11,response to forskolin,BP,
20163,GO:1904322,1,0.913560835001569,0,11,cellular response to forskolin,BP,
20164,GO:1904323,1,0.994235345635034,0,1,regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20165,GO:1904325,1,0.994235345635034,0,1,positive regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20166,GO:1904327,1,0.984918994980376,0,2,protein localization to cytosolic proteasome complex,BP,
20168,GO:1904338,1,0.942477138771341,0,9,regulation of dopaminergic neuron differentiation,BP,
20169,GO:1904339,1,0.984955032997778,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20170,GO:1904340,1,0.978669814568908,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20171,GO:1904341,1,0.992154089340602,0,1,regulation of colon smooth muscle contraction,BP,
20172,GO:1904343,1,0.992154089340602,0,1,positive regulation of colon smooth muscle contraction,BP,
20173,GO:1904344,1,0.994834055115578,0,1,regulation of gastric mucosal blood circulation,BP,
20174,GO:1904346,1,0.994834055115578,0,1,positive regulation of gastric mucosal blood circulation,BP,
20175,GO:1904347,1,0.987028273206434,0,2,regulation of small intestine smooth muscle contraction,BP,
20176,GO:1904349,1,0.987028273206434,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20177,GO:1904350,1,0.925303583737955,0,9,regulation of protein catabolic process in the vacuole,BP,
20178,GO:1904351,1,0.981974817566593,0,3,negative regulation of protein catabolic process in the vacuole,BP,
20179,GO:1904352,1,0.947513551296585,0,5,positive regulation of protein catabolic process in the vacuole,BP,
20180,GO:1904353,1,0.83164884116085,0,26,regulation of telomere capping,BP,
20181,GO:1904354,1,0.936685811823008,0,8,negative regulation of telomere capping,BP,
20182,GO:1904355,1,0.895203300391327,0,17,positive regulation of telomere capping,BP,
20183,GO:1904356,1,0.672761990344308,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20184,GO:1904357,1,0.830559011250485,0,25,negative regulation of telomere maintenance via telomere lengthening,BP,
20185,GO:1904358,1,0.792051284625741,0,36,positive regulation of telomere maintenance via telomere lengthening,BP,
20186,GO:1904373,1,0.99475168566632,0,1,response to kainic acid,BP,
20189,GO:1904377,1,0.69045526046731,0,53,positive regulation of protein localization to cell periphery,BP,
20190,GO:1904378,1,0.978386935365964,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20191,GO:1904379,1,0.984918994980376,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20192,GO:1904380,1,0.873043416765708,0,20,endoplasmic reticulum mannose trimming,BP,
20193,GO:1904381,1,0.979322137839249,0,3,Golgi apparatus mannose trimming,BP,
20194,GO:1904382,1,0.971065754094431,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20195,GO:1904383,1,0.9888780785347,0,2,response to sodium phosphate,BP,
20196,GO:1904385,1,0.882592603904708,0,20,cellular response to angiotensin,BP,
20197,GO:1904386,1,0.969098568314298,0,5,response to L-phenylalanine derivative,BP,
20198,GO:1904387,1,0.987755890252162,0,2,cellular response to L-phenylalanine derivative,BP,
20199,GO:1904389,1,0.99475168566632,0,1,rod bipolar cell differentiation,BP,
20200,GO:1904391,1,0.99475168566632,0,1,response to ciliary neurotrophic factor,BP,
20201,GO:1904393,1,0.978666743866194,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20202,GO:1904394,1,0.994527242355616,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20203,GO:1904395,1,0.984053091355404,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20204,GO:1904396,1,0.943880164988548,0,8,regulation of neuromuscular junction development,BP,
20205,GO:1904397,1,0.98930736470056,0,2,negative regulation of neuromuscular junction development,BP,
20206,GO:1904398,1,0.974119786174702,0,3,positive regulation of neuromuscular junction development,BP,
20207,GO:1904399,1,0.99475168566632,0,1,heparan sulfate binding,MF,
20208,GO:1904400,1,0.99410790486687,0,1,response to Thyroid stimulating hormone,BP,
20209,GO:1904404,1,0.989888169827736,0,1,response to formaldehyde,BP,
20210,GO:1904406,1,0.923996241601758,0,12,negative regulation of nitric oxide metabolic process,BP,
20212,GO:1904408,1,0.994806180241139,0,1,melatonin binding,MF,
20213,GO:1904412,1,0.993689247411896,0,1,regulation of cardiac ventricle development,BP,
20214,GO:1904414,1,0.993689247411896,0,1,positive regulation of cardiac ventricle development,BP,
20215,GO:1904415,1,0.964467805790965,0,6,regulation of xenophagy,BP,
20216,GO:1904417,1,0.964467805790965,0,6,positive regulation of xenophagy,BP,
20217,GO:1904424,1,0.930707889413602,0,10,regulation of GTP binding,BP,
20218,GO:1904425,1,0.993557379436004,0,1,negative regulation of GTP binding,BP,
20219,GO:1904426,1,0.985271981857708,0,2,positive regulation of GTP binding,BP,
20221,GO:1904428,1,0.97317636400931,0,3,negative regulation of tubulin deacetylation,BP,
20222,GO:1904429,1,0.963976282638631,0,6,regulation of t-circle formation,BP,
20223,GO:1904430,1,0.980978912964217,0,3,negative regulation of t-circle formation,BP,
20224,GO:1904431,1,0.982670991079987,0,3,positive regulation of t-circle formation,BP,
20225,GO:1904432,1,0.989507444744733,0,2,regulation of ferrous iron binding,BP,
20226,GO:1904434,1,0.989507444744733,0,2,positive regulation of ferrous iron binding,BP,
20227,GO:1904435,1,0.989507444744733,0,2,regulation of transferrin receptor binding,BP,
20228,GO:1904437,1,0.989507444744733,0,2,positive regulation of transferrin receptor binding,BP,
20229,GO:1904447,1,0.973274924556069,0,2,folic acid import across plasma membrane,BP,
20230,GO:1904448,1,0.992431771564765,0,1,regulation of aspartate secretion,BP,
20231,GO:1904450,1,0.992431771564765,0,1,positive regulation of aspartate secretion,BP,
20232,GO:1904454,1,0.989309967387124,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20233,GO:1904455,1,0.983449569707667,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20234,GO:1904456,1,0.994680990687208,0,1,negative regulation of neuronal action potential,BP,
20235,GO:1904457,1,0.994499220980243,0,1,positive regulation of neuronal action potential,BP,
20236,GO:1904464,1,0.994713762775742,0,1,regulation of matrix metallopeptidase secretion,BP,
20237,GO:1904465,1,0.994713762775742,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20238,GO:1904467,1,0.885807743544829,0,17,regulation of tumor necrosis factor secretion,BP,
20239,GO:1904468,1,0.970855990179001,0,5,negative regulation of tumor necrosis factor secretion,BP,
20240,GO:1904469,1,0.912423443896283,0,12,positive regulation of tumor necrosis factor secretion,BP,
20241,GO:1904475,1,0.98158995833346,0,2,regulation of Ras GTPase binding,BP,
20242,GO:1904477,1,0.990920891506829,0,1,positive regulation of Ras GTPase binding,BP,
20243,GO:1904478,1,0.971573738388618,0,5,regulation of intestinal absorption,BP,
20244,GO:1904479,1,0.989240328476484,0,2,negative regulation of intestinal absorption,BP,
20245,GO:1904481,1,0.99447500135137,0,1,response to tetrahydrofolate,BP,
20246,GO:1904482,1,0.99447500135137,0,1,cellular response to tetrahydrofolate,BP,
20247,GO:1904491,1,0.978909562302322,0,4,protein localization to ciliary transition zone,BP,
20248,GO:1904492,1,0.994407199784247,0,1,Ac-Asp-Glu binding,MF,
20249,GO:1904493,1,0.994407199784247,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20250,GO:1904498,1,0.977931136551398,0,3,protein localization to mitotic actomyosin contractile ring,BP,
20251,GO:1904499,1,0.993855145749219,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20252,GO:1904501,1,0.993855145749219,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20253,GO:1904502,1,0.957993631766833,0,5,regulation of lipophagy,BP,
20254,GO:1904504,1,0.957993631766833,0,5,positive regulation of lipophagy,BP,
20255,GO:1904505,1,0.972122489207732,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20256,GO:1904506,1,0.972122489207732,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20257,GO:1904515,1,0.993921767359053,0,1,positive regulation of TORC2 signaling,BP,
20258,GO:1904526,1,0.945534002231382,0,9,regulation of microtubule binding,BP,
20259,GO:1904527,1,0.980292829039936,0,3,negative regulation of microtubule binding,BP,
20260,GO:1904528,1,0.964925202827813,0,6,positive regulation of microtubule binding,BP,
20261,GO:1904529,1,0.985829075480642,0,2,regulation of actin filament binding,BP,
20262,GO:1904530,1,0.994104372291201,0,1,negative regulation of actin filament binding,BP,
20263,GO:1904531,1,0.991676115748014,0,1,positive regulation of actin filament binding,BP,
20264,GO:1904533,1,0.981349583682414,0,3,regulation of telomeric loop disassembly,BP,
20265,GO:1904534,1,0.988487399051714,0,2,negative regulation of telomeric loop disassembly,BP,
20266,GO:1904535,1,0.99277988586789,0,1,positive regulation of telomeric loop disassembly,BP,
20267,GO:1904542,1,0.994375655271215,0,1,regulation of free ubiquitin chain polymerization,BP,
20268,GO:1904544,1,0.994375655271215,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20269,GO:1904550,1,0.994624297040918,0,1,response to arachidonic acid,BP,
20270,GO:1904555,1,0.994470477599369,0,1,L-proline transmembrane transport,BP,
20271,GO:1904556,1,0.994470477599369,0,1,L-tryptophan transmembrane transport,BP,
20272,GO:1904562,1,0.979763577280793,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20273,GO:1904565,1,0.994085138092015,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20274,GO:1904566,1,0.994085138092015,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20275,GO:1904567,1,0.994166185056504,0,1,response to wortmannin,BP,
20276,GO:1904568,1,0.994166185056504,0,1,cellular response to wortmannin,BP,
20277,GO:1904569,1,0.994712644263035,0,1,regulation of selenocysteine incorporation,BP,
20278,GO:1904570,1,0.994712644263035,0,1,negative regulation of selenocysteine incorporation,BP,
20279,GO:1904572,1,0.994712644263035,0,1,negative regulation of mRNA binding,BP,
20280,GO:1904573,1,0.994712644263035,0,1,regulation of selenocysteine insertion sequence binding,BP,
20281,GO:1904574,1,0.994712644263035,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20282,GO:1904576,1,0.989032323642248,0,2,response to tunicamycin,BP,
20283,GO:1904577,1,0.989032323642248,0,2,cellular response to tunicamycin,BP,
20284,GO:1904578,1,0.982021700845214,0,3,response to thapsigargin,BP,
20285,GO:1904579,1,0.982021700845214,0,3,cellular response to thapsigargin,BP,
20286,GO:1904580,1,0.988902875328723,0,2,regulation of intracellular mRNA localization,BP,
20287,GO:1904582,1,0.988902875328723,0,2,positive regulation of intracellular mRNA localization,BP,
20288,GO:1904585,1,0.994594472942022,0,1,response to putrescine,BP,
20289,GO:1904586,1,0.994594472942022,0,1,cellular response to putrescine,BP,
20290,GO:1904587,1,0.96031614885429,0,6,response to glycoprotein,BP,
20291,GO:1904588,1,0.994795060212627,0,1,cellular response to glycoprotein,BP,
20292,GO:1904589,1,0.702850747418618,0,51,regulation of protein import,BP,
20293,GO:1904590,1,0.941320762813455,0,10,negative regulation of protein import,BP,
20294,GO:1904591,1,0.781067046005132,0,33,positive regulation of protein import,BP,
20295,GO:1904594,1,0.986374012045264,0,1,regulation of termination of RNA polymerase II transcription,BP,
20296,GO:1904595,1,0.986374012045264,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20297,GO:1904596,1,0.994783252682507,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20298,GO:1904597,1,0.994783252682507,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20299,GO:1904599,1,0.994783252682507,0,1,advanced glycation end-product binding,MF,
20300,GO:1904602,1,0.989287801552542,0,2,serotonin-activated cation-selective channel complex,CC,
20301,GO:1904603,1,0.994783252682507,0,1,regulation of advanced glycation end-product receptor activity,BP,
20302,GO:1904604,1,0.994783252682507,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20303,GO:1904606,1,0.993855960614235,0,1,fat cell apoptotic process,BP,
20304,GO:1904612,1,0.978442195525586,0,3,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20305,GO:1904613,1,0.984242363377261,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20306,GO:1904616,1,0.985829075480642,0,2,regulation of actin binding,BP,
20307,GO:1904617,1,0.994104372291201,0,1,negative regulation of actin binding,BP,
20308,GO:1904618,1,0.991676115748014,0,1,positive regulation of actin binding,BP,
20309,GO:1904627,1,0.989121624724943,0,2,response to phorbol 13-acetate 12-myristate,BP,
20310,GO:1904628,1,0.989121624724943,0,2,cellular response to phorbol 13-acetate 12-myristate,BP,
20311,GO:1904631,1,0.994564831937596,0,1,response to glucoside,BP,
20312,GO:1904633,1,0.990956155649264,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20313,GO:1904635,1,0.990956155649264,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20314,GO:1904636,1,0.972382839676633,0,4,response to ionomycin,BP,
20315,GO:1904637,1,0.972382839676633,0,4,cellular response to ionomycin,BP,
20316,GO:1904638,1,0.990956155649264,0,1,response to resveratrol,BP,
20317,GO:1904639,1,0.990956155649264,0,1,cellular response to resveratrol,BP,
20318,GO:1904640,1,0.980271424428623,0,3,response to methionine,BP,
20319,GO:1904645,1,0.811245405814074,0,27,response to amyloid-beta,BP,
20320,GO:1904646,1,0.820083647100151,0,25,cellular response to amyloid-beta,BP,
20321,GO:1904647,1,0.988136470124216,0,1,response to rotenone,BP,
20322,GO:1904649,1,0.993855960614235,0,1,regulation of fat cell apoptotic process,BP,
20323,GO:1904651,1,0.993855960614235,0,1,positive regulation of fat cell apoptotic process,BP,
20324,GO:1904659,1,0.524839581469099,0,94,glucose transmembrane transport,BP,
20325,GO:1904666,1,0.895706278080954,0,19,regulation of ubiquitin protein ligase activity,BP,
20326,GO:1904667,1,0.963362785757174,0,7,negative regulation of ubiquitin protein ligase activity,BP,
20327,GO:1904668,1,0.929795776174337,0,12,positive regulation of ubiquitin protein ligase activity,BP,
20328,GO:1904672,1,0.967386191863946,0,5,regulation of somatic stem cell population maintenance,BP,
20329,GO:1904673,1,0.980154592581062,0,3,negative regulation of somatic stem cell population maintenance,BP,
20330,GO:1904674,1,0.986975668336024,0,2,positive regulation of somatic stem cell population maintenance,BP,
20331,GO:1904675,1,0.994214944803451,0,1,regulation of somatic stem cell division,BP,
20332,GO:1904677,1,0.994214944803451,0,1,positive regulation of somatic stem cell division,BP,
20333,GO:1904680,1,0.877180606498019,0,22,peptide transmembrane transporter activity,MF,
20334,GO:1904681,1,0.994358236185322,0,1,response to 3-methylcholanthrene,BP,
20335,GO:1904683,1,0.952608923447139,0,6,regulation of metalloendopeptidase activity,BP,
20336,GO:1904684,1,0.96518165390498,0,4,negative regulation of metalloendopeptidase activity,BP,
20337,GO:1904685,1,0.986978297398164,0,2,positive regulation of metalloendopeptidase activity,BP,
20338,GO:1904688,1,0.967329609807593,0,5,regulation of cytoplasmic translational initiation,BP,
20339,GO:1904689,1,0.99480751851956,0,1,negative regulation of cytoplasmic translational initiation,BP,
20340,GO:1904690,1,0.972380086869657,0,4,positive regulation of cytoplasmic translational initiation,BP,
20341,GO:1904691,1,0.994604363835271,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20342,GO:1904692,1,0.993667479095204,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20343,GO:1904693,1,0.976101346299106,0,3,midbrain morphogenesis,BP,
20344,GO:1904694,1,0.973083195903632,0,3,negative regulation of vascular smooth muscle contraction,BP,
20345,GO:1904695,1,0.994668217648025,0,1,positive regulation of vascular smooth muscle contraction,BP,
20346,GO:1904700,1,0.994408208951175,0,1,granulosa cell apoptotic process,BP,
20347,GO:1904701,1,0.994697994008713,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20348,GO:1904705,1,0.786226075677757,0,36,regulation of vascular smooth muscle cell proliferation,BP,
20349,GO:1904706,1,0.917256504224173,0,14,negative regulation of vascular smooth muscle cell proliferation,BP,
20350,GO:1904707,1,0.85274420137961,0,23,positive regulation of vascular smooth muscle cell proliferation,BP,
20351,GO:1904708,1,0.994408208951175,0,1,regulation of granulosa cell apoptotic process,BP,
20352,GO:1904711,1,0.994697994008713,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20353,GO:1904713,1,0.982403608826931,0,2,beta-catenin destruction complex binding,MF,
20354,GO:1904714,1,0.954990310639223,0,8,regulation of chaperone-mediated autophagy,BP,
20355,GO:1904715,1,0.983374700857656,0,3,negative regulation of chaperone-mediated autophagy,BP,
20356,GO:1904716,1,0.994514894066942,0,1,positive regulation of chaperone-mediated autophagy,BP,
20358,GO:1904719,1,0.994480826609426,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20359,GO:1904720,1,0.988645329562428,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20360,GO:1904721,1,0.994122291572137,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20361,GO:1904722,1,0.994490979828834,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20362,GO:1904723,1,0.994697994008713,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20364,GO:1904729,1,0.983145874587478,0,3,regulation of intestinal lipid absorption,BP,
20365,GO:1904730,1,0.994370341336446,0,1,negative regulation of intestinal lipid absorption,BP,
20366,GO:1904732,1,0.983659167591085,0,2,regulation of electron transfer activity,BP,
20367,GO:1904734,1,0.994841247687394,0,1,positive regulation of electron transfer activity,BP,
20368,GO:1904738,1,0.878998449621097,0,16,vascular associated smooth muscle cell migration,BP,
20369,GO:1904742,1,0.967998194757028,0,4,regulation of telomeric DNA binding,BP,
20370,GO:1904743,1,0.978304080121623,0,2,negative regulation of telomeric DNA binding,BP,
20371,GO:1904744,1,0.989467857246394,0,2,positive regulation of telomeric DNA binding,BP,
20372,GO:1904746,1,0.968978693269276,0,5,negative regulation of apoptotic process involved in development,BP,
20373,GO:1904747,1,0.980746071857235,0,3,positive regulation of apoptotic process involved in development,BP,
20374,GO:1904748,1,0.942842868586219,0,9,regulation of apoptotic process involved in development,BP,
20375,GO:1904749,1,0.968183370257664,0,5,regulation of protein localization to nucleolus,BP,
20376,GO:1904750,1,0.990606011025283,0,1,negative regulation of protein localization to nucleolus,BP,
20377,GO:1904751,1,0.977366834633489,0,4,positive regulation of protein localization to nucleolus,BP,
20378,GO:1904752,1,0.878998449621097,0,16,regulation of vascular associated smooth muscle cell migration,BP,
20379,GO:1904753,1,0.964484203496488,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20380,GO:1904754,1,0.911396914700425,0,11,positive regulation of vascular associated smooth muscle cell migration,BP,
20381,GO:1904760,1,0.978867698366143,0,3,regulation of myofibroblast differentiation,BP,
20382,GO:1904761,1,0.985426674079474,0,2,negative regulation of myofibroblast differentiation,BP,
20383,GO:1904762,1,0.99334499795535,0,1,positive regulation of myofibroblast differentiation,BP,
20384,GO:1904764,1,0.994634905157056,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20385,GO:1904766,1,0.990357013196643,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20386,GO:1904768,1,0.987531259088837,0,2,all-trans-retinol binding,MF,
20387,GO:1904772,1,0.994390578497391,0,1,response to tetrachloromethane,BP,
20388,GO:1904776,1,0.958485612729587,0,6,regulation of protein localization to cell cortex,BP,
20389,GO:1904777,1,0.994313214468247,0,1,negative regulation of protein localization to cell cortex,BP,
20390,GO:1904778,1,0.963969506974678,0,5,positive regulation of protein localization to cell cortex,BP,
20391,GO:1904779,1,0.944027157170496,0,7,regulation of protein localization to centrosome,BP,
20392,GO:1904781,1,0.949257694538797,0,6,positive regulation of protein localization to centrosome,BP,
20393,GO:1904782,1,0.992473728510381,0,1,negative regulation of NMDA glutamate receptor activity,BP,
20394,GO:1904783,1,0.986891293578065,0,2,positive regulation of NMDA glutamate receptor activity,BP,
20395,GO:1904784,1,0.991830744769941,0,1,NLRP1 inflammasome complex assembly,BP,
20396,GO:1904790,1,0.994215910460644,0,1,regulation of shelterin complex assembly,BP,
20397,GO:1904792,1,0.994215910460644,0,1,positive regulation of shelterin complex assembly,BP,
20398,GO:1904793,1,0.993855145749219,0,1,regulation of euchromatin binding,BP,
20399,GO:1904796,1,0.968251115018753,0,5,regulation of core promoter binding,BP,
20400,GO:1904797,1,0.991200788181521,0,1,negative regulation of core promoter binding,BP,
20401,GO:1904798,1,0.976848616670555,0,4,positive regulation of core promoter binding,BP,
20402,GO:1904799,1,0.99338728422651,0,1,regulation of neuron remodeling,BP,
20403,GO:1904800,1,0.99338728422651,0,1,negative regulation of neuron remodeling,BP,
20404,GO:1904803,1,0.994838203969693,0,1,regulation of translation involved in cellular response to UV,BP,
20405,GO:1904806,1,0.988658446617857,0,2,regulation of protein oxidation,BP,
20406,GO:1904808,1,0.988658446617857,0,2,positive regulation of protein oxidation,BP,
20407,GO:1904812,1,0.99338868812887,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20408,GO:1904813,1,0.479271286993101,0,123,ficolin-1-rich granule lumen,CC,
20409,GO:1904814,1,0.926909556107565,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20410,GO:1904815,1,0.988913845316947,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20411,GO:1904816,1,0.937307389067021,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20412,GO:1904823,1,0.983452797390589,0,3,purine nucleobase transmembrane transport,BP,
20413,GO:1904826,1,0.989631438821561,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20414,GO:1904828,1,0.989631438821561,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20415,GO:1904829,1,0.994711632107073,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20416,GO:1904831,1,0.994711632107073,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20417,GO:1904833,1,0.984299371985835,0,3,positive regulation of removal of superoxide radicals,BP,
20418,GO:1904835,1,0.994463161779309,0,1,dorsal root ganglion morphogenesis,BP,
20419,GO:1904837,1,0.789571667366909,0,34,beta-catenin-TCF complex assembly,BP,
20420,GO:1904842,1,0.994594127039949,0,1,response to nitroglycerin,BP,
20421,GO:1904843,1,0.994594127039949,0,1,cellular response to nitroglycerin,BP,
20422,GO:1904844,1,0.98256167125261,0,3,response to L-glutamine,BP,
20423,GO:1904845,1,0.98256167125261,0,3,cellular response to L-glutamine,BP,
20424,GO:1904847,1,0.965707956149808,0,5,regulation of cell chemotaxis to fibroblast growth factor,BP,
20425,GO:1904848,1,0.994800064853307,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20426,GO:1904849,1,0.977094120231338,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20427,GO:1904850,1,0.994215910460644,0,1,negative regulation of establishment of protein localization to telomere,BP,
20428,GO:1904851,1,0.951482514814898,0,9,positive regulation of establishment of protein localization to telomere,BP,
20429,GO:1904854,1,0.988584379309192,0,2,proteasome core complex binding,MF,
20431,GO:1904862,1,0.97828684425173,0,3,inhibitory synapse assembly,BP,
20432,GO:1904863,1,0.993529788885181,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20433,GO:1904864,1,0.993529788885181,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20434,GO:1904867,1,0.951669052067962,0,9,protein localization to Cajal body,BP,
20435,GO:1904868,1,0.975428293962561,0,2,telomerase catalytic core complex assembly,BP,
20436,GO:1904869,1,0.95675697082506,0,8,regulation of protein localization to Cajal body,BP,
20437,GO:1904871,1,0.95675697082506,0,8,positive regulation of protein localization to Cajal body,BP,
20438,GO:1904872,1,0.900183681676889,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20439,GO:1904874,1,0.921453062249476,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20440,GO:1904875,1,0.988879243558789,0,2,regulation of DNA ligase activity,BP,
20441,GO:1904876,1,0.994239123774774,0,1,negative regulation of DNA ligase activity,BP,
20442,GO:1904877,1,0.994609374199149,0,1,positive regulation of DNA ligase activity,BP,
20443,GO:1904878,1,0.986903025264768,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20444,GO:1904879,1,0.987722226902511,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20445,GO:1904880,1,0.98017740515514,0,3,response to hydrogen sulfide,BP,
20446,GO:1904881,1,0.98563686735638,0,2,cellular response to hydrogen sulfide,BP,
20447,GO:1904882,1,0.975428293962561,0,2,regulation of telomerase catalytic core complex assembly,BP,
20448,GO:1904884,1,0.975428293962561,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20449,GO:1904885,1,0.959625348800278,0,5,beta-catenin destruction complex assembly,BP,
20450,GO:1904886,1,0.877031199606874,0,18,beta-catenin destruction complex disassembly,BP,
20451,GO:1904887,1,0.988022957922514,0,1,Wnt signalosome assembly,BP,
20452,GO:1904888,1,0.652300001741636,0,59,cranial skeletal system development,BP,
20453,GO:1904889,1,0.989061557907145,0,2,regulation of excitatory synapse assembly,BP,
20454,GO:1904891,1,0.989061557907145,0,2,positive regulation of excitatory synapse assembly,BP,
20458,GO:1904895,1,0.994728551824984,0,1,ESCRT complex assembly,BP,
20459,GO:1904896,1,0.944697032018658,0,10,ESCRT complex disassembly,BP,
20460,GO:1904897,1,0.993939464618985,0,1,regulation of hepatic stellate cell proliferation,BP,
20461,GO:1904899,1,0.993939464618985,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20462,GO:1904902,1,0.994728551824984,0,1,ESCRT III complex assembly,BP,
20463,GO:1904903,1,0.944697032018658,0,10,ESCRT III complex disassembly,BP,
20464,GO:1904907,1,0.974122777451923,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20465,GO:1904908,1,0.974122777451923,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20466,GO:1904910,1,0.994215910460644,0,1,regulation of establishment of RNA localization to telomere,BP,
20467,GO:1904911,1,0.994215910460644,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20468,GO:1904913,1,0.994215910460644,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20469,GO:1904914,1,0.994215910460644,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20470,GO:1904923,1,0.91736819241886,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20471,GO:1904924,1,0.99449814413672,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20472,GO:1904925,1,0.922447453432504,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20473,GO:1904928,1,0.979534274300456,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20474,GO:1904929,1,0.9594337612076,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20475,GO:1904933,1,0.991465911434634,0,1,regulation of cell proliferation in midbrain,BP,
20476,GO:1904934,1,0.991465911434634,0,1,negative regulation of cell proliferation in midbrain,BP,
20477,GO:1904936,1,0.966529424803856,0,5,interneuron migration,BP,
20478,GO:1904938,1,0.957323386255727,0,5,planar cell polarity pathway involved in axon guidance,BP,
20479,GO:1904947,1,0.994156038316954,0,1,folic acid import into mitochondrion,BP,
20480,GO:1904948,1,0.906908252352746,0,15,midbrain dopaminergic neuron differentiation,BP,
20481,GO:1904949,1,0.507346868505132,0,96,ATPase complex,CC,
20484,GO:1904953,1,0.934514048996343,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20485,GO:1904954,1,0.982967005359635,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20486,GO:1904955,1,0.991465911434634,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20487,GO:1904956,1,0.971549412888924,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20488,GO:1904958,1,0.983769368901074,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20489,GO:1904959,1,0.983659167591085,0,2,regulation of cytochrome-c oxidase activity,BP,
20490,GO:1904960,1,0.994841247687394,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20491,GO:1904970,1,0.978109395221379,0,3,brush border assembly,BP,
20492,GO:1904971,1,0.99273172731714,0,1,regulation of viral translation,BP,
20493,GO:1904973,1,0.99273172731714,0,1,positive regulation of viral translation,BP,
20494,GO:1904975,1,0.985627732319434,0,2,response to bleomycin,BP,
20495,GO:1904976,1,0.985627732319434,0,2,cellular response to bleomycin,BP,
20496,GO:1904977,1,0.994250988864267,0,1,lymphatic endothelial cell migration,BP,
20497,GO:1904978,1,0.977498481295194,0,3,regulation of endosome organization,BP,
20498,GO:1904979,1,0.994567620053009,0,1,negative regulation of endosome organization,BP,
20499,GO:1904980,1,0.990166524937751,0,1,positive regulation of endosome organization,BP,
20500,GO:1904983,1,0.994605371638092,0,1,glycine import into mitochondrion,BP,
20501,GO:1904990,1,0.994483715760438,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20502,GO:1904992,1,0.994483715760438,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20503,GO:1904994,1,0.930267746843608,0,12,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20504,GO:1904995,1,0.97364435184066,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20505,GO:1904996,1,0.955460869414436,0,7,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20506,GO:1904997,1,0.98897688714459,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20507,GO:1904998,1,0.994218160095954,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20508,GO:1904999,1,0.994728551824984,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20509,GO:1905000,1,0.988725845361741,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20510,GO:1905005,1,0.959396475016898,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20511,GO:1905006,1,0.98685788578224,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20512,GO:1905007,1,0.964532976984827,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20513,GO:1905008,1,0.994418214015936,0,1,regulation of L-lysine import across plasma membrane,BP,
20514,GO:1905010,1,0.994418214015936,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20515,GO:1905024,1,0.972986461813563,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20516,GO:1905025,1,0.994127863350714,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20517,GO:1905026,1,0.986306248648636,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20518,GO:1905030,1,0.991996332460478,0,1,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20519,GO:1905031,1,0.962013879001135,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20520,GO:1905032,1,0.994127863350714,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20521,GO:1905033,1,0.986306248648636,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20522,GO:1905034,1,0.994220084376416,0,1,regulation of antifungal innate immune response,BP,
20523,GO:1905035,1,0.994220084376416,0,1,negative regulation of antifungal innate immune response,BP,
20524,GO:1905037,1,0.540451975748344,0,91,autophagosome organization,BP,
20525,GO:1905038,1,0.926337183895722,0,13,regulation of membrane lipid metabolic process,BP,
20526,GO:1905039,1,0.479361331418765,0,107,carboxylic acid transmembrane transport,BP,
20527,GO:1905040,1,0.994463161779309,0,1,otic placode development,BP,
20528,GO:1905041,1,0.994564272040715,0,1,regulation of epithelium regeneration,BP,
20529,GO:1905042,1,0.994564272040715,0,1,negative regulation of epithelium regeneration,BP,
20530,GO:1905044,1,0.994313214468247,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20531,GO:1905045,1,0.994313214468247,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20534,GO:1905050,1,0.959299483658245,0,7,positive regulation of metallopeptidase activity,BP,
20535,GO:1905051,1,0.989561231923159,0,2,regulation of base-excision repair,BP,
20536,GO:1905053,1,0.989561231923159,0,2,positive regulation of base-excision repair,BP,
20537,GO:1905062,1,0.994350873605025,0,1,positive regulation of cardioblast proliferation,BP,
20538,GO:1905063,1,0.949171739801015,0,8,regulation of vascular smooth muscle cell differentiation,BP,
20539,GO:1905064,1,0.982417350879042,0,3,negative regulation of vascular smooth muscle cell differentiation,BP,
20540,GO:1905065,1,0.966165282594185,0,5,positive regulation of vascular smooth muscle cell differentiation,BP,
20541,GO:1905066,1,0.98924519313071,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20542,GO:1905067,1,0.994697994008713,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20543,GO:1905068,1,0.99451842522338,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20544,GO:1905069,1,0.987941785316313,0,2,allantois development,BP,
20545,GO:1905071,1,0.97746476549145,0,3,occluding junction disassembly,BP,
20546,GO:1905073,1,0.97746476549145,0,3,regulation of occluding junction disassembly,BP,
20547,GO:1905075,1,0.97746476549145,0,3,positive regulation of occluding junction disassembly,BP,
20548,GO:1905076,1,0.994650742674621,0,1,regulation of interleukin-17 secretion,BP,
20549,GO:1905077,1,0.994650742674621,0,1,negative regulation of interleukin-17 secretion,BP,
20550,GO:1905089,1,0.985260021329238,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20551,GO:1905090,1,0.985260021329238,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20552,GO:1905097,1,0.955424260652057,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
20553,GO:1905098,1,0.973348437469091,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20554,GO:1905099,1,0.990920891506829,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20555,GO:1905103,1,0.993342167507596,0,1,integral component of lysosomal membrane,CC,
20557,GO:1905123,1,0.985990929512367,0,2,regulation of glucosylceramidase activity,BP,
20558,GO:1905132,1,0.994151614391548,0,1,regulation of meiotic chromosome separation,BP,
20559,GO:1905133,1,0.994151614391548,0,1,negative regulation of meiotic chromosome separation,BP,
20560,GO:1905143,1,0.994750083282648,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20561,GO:1905144,1,0.875913943703332,0,21,response to acetylcholine,BP,
20562,GO:1905145,1,0.875913943703332,0,21,cellular response to acetylcholine,BP,
20563,GO:1905146,1,0.91946223483444,0,10,lysosomal protein catabolic process,BP,
20564,GO:1905150,1,0.978431705994679,0,3,regulation of voltage-gated sodium channel activity,BP,
20565,GO:1905152,1,0.991391325400944,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20566,GO:1905153,1,0.921988770740702,0,12,regulation of membrane invagination,BP,
20567,GO:1905154,1,0.986804839934084,0,2,negative regulation of membrane invagination,BP,
20568,GO:1905155,1,0.939625786298679,0,9,positive regulation of membrane invagination,BP,
20569,GO:1905161,1,0.992086854297677,0,1,protein localization to phagocytic vesicle,BP,
20570,GO:1905162,1,0.992086854297677,0,1,regulation of phagosome maturation,BP,
20571,GO:1905165,1,0.935496452348309,0,7,regulation of lysosomal protein catabolic process,BP,
20572,GO:1905166,1,0.981974817566593,0,3,negative regulation of lysosomal protein catabolic process,BP,
20573,GO:1905167,1,0.957948587266995,0,3,positive regulation of lysosomal protein catabolic process,BP,
20574,GO:1905168,1,0.993612858981393,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
20575,GO:1905169,1,0.992086854297677,0,1,regulation of protein localization to phagocytic vesicle,BP,
20576,GO:1905171,1,0.992086854297677,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20577,GO:1905172,1,0.99273172731714,0,1,RISC complex binding,MF,
20578,GO:1905174,1,0.988965127905062,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
20579,GO:1905176,1,0.99425129906114,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
20580,GO:1905202,1,0.98810571730964,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20581,GO:1905203,1,0.987524186562049,0,2,regulation of connective tissue replacement,BP,
20582,GO:1905204,1,0.994783252682507,0,1,negative regulation of connective tissue replacement,BP,
20583,GO:1905205,1,0.992703247000394,0,1,positive regulation of connective tissue replacement,BP,
20584,GO:1905206,1,0.966542263892877,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20585,GO:1905207,1,0.761607735064332,0,39,regulation of cardiocyte differentiation,BP,
20586,GO:1905208,1,0.906180807906253,0,14,negative regulation of cardiocyte differentiation,BP,
20587,GO:1905209,1,0.845239483771618,0,24,positive regulation of cardiocyte differentiation,BP,
20588,GO:1905214,1,0.931707254131341,0,11,regulation of RNA binding,BP,
20589,GO:1905215,1,0.994712644263035,0,1,negative regulation of RNA binding,BP,
20590,GO:1905216,1,0.950874358259148,0,8,positive regulation of RNA binding,BP,
20591,GO:1905217,1,0.99410790486687,0,1,response to astaxanthin,BP,
20592,GO:1905222,1,0.994077947141765,0,1,atrioventricular canal morphogenesis,BP,
20593,GO:1905223,1,0.990919854821051,0,1,epicardium morphogenesis,BP,
20594,GO:1905224,1,0.984948875007727,0,2,clathrin-coated pit assembly,BP,
20595,GO:1905225,1,0.988933327760932,0,2,response to thyrotropin-releasing hormone,BP,
20596,GO:1905226,1,0.994790543911509,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20597,GO:1905229,1,0.994795060212627,0,1,cellular response to thyrotropin-releasing hormone,BP,
20598,GO:1905230,1,0.993356305776653,0,1,response to borneol,BP,
20599,GO:1905231,1,0.993356305776653,0,1,cellular response to borneol,BP,
20600,GO:1905232,1,0.966697605232577,0,5,cellular response to L-glutamate,BP,
20601,GO:1905233,1,0.993356305776653,0,1,response to codeine,BP,
20602,GO:1905235,1,0.993356305776653,0,1,response to quercetin,BP,
20603,GO:1905237,1,0.993356305776653,0,1,response to cyclosporin A,BP,
20604,GO:1905239,1,0.99232360244515,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20605,GO:1905240,1,0.99232360244515,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20606,GO:1905242,1,0.98828845940302,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20607,GO:1905243,1,0.994364449074187,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20608,GO:1905244,1,0.944226618540577,0,8,regulation of modification of synaptic structure,BP,
20609,GO:1905245,1,0.941375290538727,0,8,regulation of aspartic-type peptidase activity,BP,
20610,GO:1905246,1,0.981043916961789,0,2,negative regulation of aspartic-type peptidase activity,BP,
20611,GO:1905247,1,0.95957245357882,0,6,positive regulation of aspartic-type peptidase activity,BP,
20612,GO:1905255,1,0.990821498534944,0,1,regulation of RNA binding transcription factor activity,BP,
20613,GO:1905258,1,0.98960198946142,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20614,GO:1905259,1,0.98960198946142,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20615,GO:1905267,1,0.988118019550024,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20616,GO:1905268,1,0.721223034575507,0,45,negative regulation of chromatin organization,BP,
20617,GO:1905269,1,0.547197894485565,0,88,positive regulation of chromatin organization,BP,
20618,GO:1905271,1,0.994836975652953,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20619,GO:1905273,1,0.994836975652953,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20620,GO:1905274,1,0.990036700891625,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20621,GO:1905276,1,0.879342885218058,0,18,regulation of epithelial tube formation,BP,
20622,GO:1905277,1,0.994126820472005,0,1,negative regulation of epithelial tube formation,BP,
20623,GO:1905278,1,0.974637165624391,0,4,positive regulation of epithelial tube formation,BP,
20624,GO:1905279,1,0.982403608826931,0,2,regulation of retrograde transport, endosome to Golgi,BP,
20625,GO:1905285,1,0.993689247411896,0,1,fibrous ring of heart morphogenesis,BP,
20626,GO:1905286,1,0.983220884462657,0,3,serine-type peptidase complex,CC,
20627,GO:1905288,1,0.955238555649712,0,6,vascular associated smooth muscle cell apoptotic process,BP,
20628,GO:1905289,1,0.988022957922514,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20629,GO:1905292,1,0.980298316552276,0,3,regulation of neural crest cell differentiation,BP,
20630,GO:1905294,1,0.980298316552276,0,3,positive regulation of neural crest cell differentiation,BP,
20631,GO:1905301,1,0.992809692121295,0,1,regulation of macropinocytosis,BP,
20632,GO:1905302,1,0.992809692121295,0,1,negative regulation of macropinocytosis,BP,
20633,GO:1905304,1,0.988496738198091,0,1,regulation of cardiac myofibril assembly,BP,
20634,GO:1905305,1,0.988496738198091,0,1,negative regulation of cardiac myofibril assembly,BP,
20635,GO:1905309,1,0.987184818808559,0,1,positive regulation of cohesin loading,BP,
20636,GO:1905310,1,0.980298316552276,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20637,GO:1905312,1,0.980298316552276,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20638,GO:1905313,1,0.994579304502616,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20639,GO:1905314,1,0.892258265530554,0,15,semi-lunar valve development,BP,
20640,GO:1905317,1,0.992691020896154,0,1,inferior endocardial cushion morphogenesis,BP,
20641,GO:1905319,1,0.994313214468247,0,1,mesenchymal stem cell migration,BP,
20642,GO:1905320,1,0.994313214468247,0,1,regulation of mesenchymal stem cell migration,BP,
20643,GO:1905322,1,0.994313214468247,0,1,positive regulation of mesenchymal stem cell migration,BP,
20644,GO:1905323,1,0.953651428117437,0,6,telomerase holoenzyme complex assembly,BP,
20645,GO:1905327,1,0.994746455661165,0,1,tracheoesophageal septum formation,BP,
20647,GO:1905331,1,0.882285945506635,0,18,negative regulation of morphogenesis of an epithelium,BP,
20648,GO:1905332,1,0.819620336001485,0,30,positive regulation of morphogenesis of an epithelium,BP,
20650,GO:1905335,1,0.984181827927535,0,1,regulation of aggrephagy,BP,
20651,GO:1905337,1,0.984181827927535,0,1,positive regulation of aggrephagy,BP,
20652,GO:1905340,1,0.97815929222976,0,4,regulation of protein localization to kinetochore,BP,
20653,GO:1905341,1,0.994366597416677,0,1,negative regulation of protein localization to kinetochore,BP,
20654,GO:1905342,1,0.97815929222976,0,4,positive regulation of protein localization to kinetochore,BP,
20655,GO:1905344,1,0.994313214468247,0,1,prostaglandin catabolic process,BP,
20656,GO:1905348,1,0.840915716429304,0,29,endonuclease complex,CC,
20657,GO:1905349,1,0.989566804663311,0,2,ciliary transition zone assembly,BP,
20658,GO:1905354,1,0.87407741101552,0,22,exoribonuclease complex,CC,
20659,GO:1905355,1,0.992203902156375,0,1,spine apparatus assembly,BP,
20660,GO:1905359,1,0.994151614391548,0,1,protein localization to meiotic spindle,BP,
20662,GO:1905365,1,0.994567620053009,0,1,regulation of intralumenal vesicle formation,BP,
20663,GO:1905366,1,0.994567620053009,0,1,negative regulation of intralumenal vesicle formation,BP,
20664,GO:1905368,1,0.620946123002489,0,83,peptidase complex,CC,
20665,GO:1905369,1,0.696731649275301,0,63,endopeptidase complex,CC,
20666,GO:1905370,1,0.99449814413672,0,1,serine-type endopeptidase complex,CC,
20667,GO:1905371,1,0.985947233996835,0,2,ceramide phosphoethanolamine metabolic process,BP,
20668,GO:1905373,1,0.985947233996835,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20669,GO:1905383,1,0.983847555094613,0,3,protein localization to presynapse,BP,
20670,GO:1905384,1,0.98896572241266,0,2,regulation of protein localization to presynapse,BP,
20671,GO:1905386,1,0.98896572241266,0,2,positive regulation of protein localization to presynapse,BP,
20672,GO:1905392,1,0.994831355742962,0,1,plant organ morphogenesis,BP,
20673,GO:1905394,1,0.979814316252654,0,3,retromer complex binding,MF,
20674,GO:1905395,1,0.981117932018076,0,3,response to flavonoid,BP,
20675,GO:1905397,1,0.989431100805935,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20676,GO:1905402,1,0.989431100805935,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20677,GO:1905403,1,0.994650742674621,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20678,GO:1905404,1,0.994752567879549,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20679,GO:1905405,1,0.987184818808559,0,1,regulation of mitotic cohesin loading,BP,
20680,GO:1905406,1,0.987184818808559,0,1,positive regulation of mitotic cohesin loading,BP,
20681,GO:1905407,1,0.988673841672315,0,2,regulation of creatine transmembrane transporter activity,BP,
20682,GO:1905408,1,0.988673841672315,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20683,GO:1905419,1,0.994691517302911,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20684,GO:1905421,1,0.994831355742962,0,1,regulation of plant organ morphogenesis,BP,
20685,GO:1905422,1,0.994831355742962,0,1,negative regulation of plant organ morphogenesis,BP,
20686,GO:1905424,1,0.989013703990293,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20687,GO:1905426,1,0.989013703990293,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20689,GO:1905430,1,0.994621429378093,0,1,cellular response to glycine,BP,
20690,GO:1905432,1,0.9932585515136,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20691,GO:1905433,1,0.9932585515136,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20692,GO:1905435,1,0.994313214468247,0,1,regulation of histone H3-K4 trimethylation,BP,
20693,GO:1905437,1,0.994313214468247,0,1,positive regulation of histone H3-K4 trimethylation,BP,
20694,GO:1905438,1,0.986275586394649,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20695,GO:1905443,1,0.992859019192957,0,1,regulation of clathrin coat assembly,BP,
20696,GO:1905445,1,0.992859019192957,0,1,positive regulation of clathrin coat assembly,BP,
20697,GO:1905446,1,0.972877156366495,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20698,GO:1905447,1,0.99405469576238,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20699,GO:1905448,1,0.978697058652531,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20700,GO:1905449,1,0.985870861746768,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20701,GO:1905451,1,0.985870861746768,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20702,GO:1905456,1,0.946107264952182,0,7,regulation of lymphoid progenitor cell differentiation,BP,
20703,GO:1905457,1,0.977676847647828,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20704,GO:1905458,1,0.993370408642721,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20705,GO:1905459,1,0.955238555649712,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20706,GO:1905460,1,0.989996730320086,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20707,GO:1905461,1,0.96489407921097,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20708,GO:1905462,1,0.984896661930362,0,2,regulation of DNA duplex unwinding,BP,
20709,GO:1905463,1,0.991583832979523,0,1,negative regulation of DNA duplex unwinding,BP,
20710,GO:1905464,1,0.993256638461652,0,1,positive regulation of DNA duplex unwinding,BP,
20711,GO:1905468,1,0.992086854297677,0,1,regulation of clathrin-coated pit assembly,BP,
20712,GO:1905469,1,0.992086854297677,0,1,negative regulation of clathrin-coated pit assembly,BP,
20713,GO:1905474,1,0.994760088027326,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20717,GO:1905483,1,0.985842561509858,0,1,regulation of motor neuron migration,BP,
20718,GO:1905485,1,0.985842561509858,0,1,positive regulation of motor neuron migration,BP,
20719,GO:1905502,1,0.994801127652818,0,1,acetyl-CoA binding,MF,
20720,GO:1905508,1,0.79983928048896,0,28,protein localization to microtubule organizing center,BP,
20721,GO:1905512,1,0.994425124328196,0,1,regulation of short-term synaptic potentiation,BP,
20722,GO:1905513,1,0.994425124328196,0,1,negative regulation of short-term synaptic potentiation,BP,
20723,GO:1905515,1,0.732439967852607,0,48,non-motile cilium assembly,BP,
20724,GO:1905516,1,0.944363028801756,0,8,positive regulation of fertilization,BP,
20726,GO:1905518,1,0.992429697060513,0,1,regulation of presynaptic active zone assembly,BP,
20727,GO:1905520,1,0.992429697060513,0,1,positive regulation of presynaptic active zone assembly,BP,
20728,GO:1905521,1,0.883780291620449,0,20,regulation of macrophage migration,BP,
20729,GO:1905522,1,0.969521226921214,0,5,negative regulation of macrophage migration,BP,
20730,GO:1905523,1,0.934165827334552,0,11,positive regulation of macrophage migration,BP,
20731,GO:1905524,1,0.9895634163553,0,1,negative regulation of protein autoubiquitination,BP,
20732,GO:1905535,1,0.992101572546366,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20733,GO:1905537,1,0.992101572546366,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20734,GO:1905538,1,0.99273172731714,0,1,polysome binding,MF,
20735,GO:1905541,1,0.994418214015936,0,1,regulation of L-arginine import across plasma membrane,BP,
20736,GO:1905546,1,0.994549059691457,0,1,cellular response to phenylpropanoid,BP,
20737,GO:1905547,1,0.99473421612549,0,1,regulation of telomeric heterochromatin assembly,BP,
20738,GO:1905549,1,0.99473421612549,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20739,GO:1905550,1,0.98930496478629,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20740,GO:1905552,1,0.98930496478629,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20741,GO:1905553,1,0.98130734214906,0,3,regulation of blood vessel branching,BP,
20742,GO:1905555,1,0.986453728284834,0,2,positive regulation blood vessel branching,BP,
20743,GO:1905562,1,0.902835536293956,0,14,regulation of vascular endothelial cell proliferation,BP,
20744,GO:1905563,1,0.978430815630302,0,3,negative regulation of vascular endothelial cell proliferation,BP,
20745,GO:1905564,1,0.922754419724944,0,11,positive regulation of vascular endothelial cell proliferation,BP,
20746,GO:1905572,1,0.994277278513962,0,1,ganglioside GM1 transport to membrane,BP,
20747,GO:1905573,1,0.98897705790062,0,2,ganglioside GM1 binding,MF,
20748,GO:1905574,1,0.994277278513962,0,1,ganglioside GM2 binding,MF,
20749,GO:1905575,1,0.994277278513962,0,1,ganglioside GM3 binding,MF,
20750,GO:1905576,1,0.983534179186805,0,3,ganglioside GT1b binding,MF,
20751,GO:1905577,1,0.994277278513962,0,1,ganglioside GP1c binding,MF,
20752,GO:1905578,1,0.994482162004173,0,1,regulation of ERBB3 signaling pathway,BP,
20753,GO:1905580,1,0.994482162004173,0,1,positive regulation of ERBB3 signaling pathway,BP,
20755,GO:1905589,1,0.994418214015936,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20756,GO:1905590,1,0.994082625362248,0,1,fibronectin fibril organization,BP,
20757,GO:1905594,1,0.994806180241139,0,1,resveratrol binding,MF,
20759,GO:1905596,1,0.993671844789405,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20761,GO:1905598,1,0.993671844789405,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20764,GO:1905601,1,0.993671844789405,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20766,GO:1905603,1,0.992335070383341,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20767,GO:1905604,1,0.992335070383341,0,1,negative regulation of maintenance of permeability of blood-brain barrier,BP,
20768,GO:1905606,1,0.972822385044519,0,4,regulation of presynapse assembly,BP,
20769,GO:1905608,1,0.992429697060513,0,1,positive regulation of presynapse assembly,BP,
20770,GO:1905610,1,0.992101572546366,0,1,regulation of mRNA cap binding,BP,
20771,GO:1905612,1,0.992101572546366,0,1,positive regulation of mRNA cap binding,BP,
20772,GO:1905616,1,0.986459257606293,0,2,regulation of miRNA mediated inhibition of translation,BP,
20773,GO:1905618,1,0.986459257606293,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20774,GO:1905634,1,0.958343506294561,0,5,regulation of protein localization to chromatin,BP,
20775,GO:1905636,1,0.994794365016368,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20776,GO:1905642,1,0.994313214468247,0,1,negative regulation of DNA methylation,BP,
20777,GO:1905643,1,0.991331026411209,0,1,positive regulation of DNA methylation,BP,
20778,GO:1905647,1,0.994470477599369,0,1,proline import across plasma membrane,BP,
20779,GO:1905651,1,0.975579428567574,0,3,regulation of artery morphogenesis,BP,
20780,GO:1905653,1,0.975579428567574,0,3,positive regulation of artery morphogenesis,BP,
20781,GO:1905661,1,0.988259574890341,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20782,GO:1905663,1,0.988259574890341,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20783,GO:1905664,1,0.977624273727238,0,4,regulation of calcium ion import across plasma membrane,BP,
20784,GO:1905665,1,0.988509274412119,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20785,GO:1905666,1,0.934043337777283,0,9,regulation of protein localization to endosome,BP,
20786,GO:1905668,1,0.934043337777283,0,9,positive regulation of protein localization to endosome,BP,
20787,GO:1905671,1,0.98187086099736,0,3,regulation of lysosome organization,BP,
20788,GO:1905672,1,0.994597228509885,0,1,negative regulation of lysosome organization,BP,
20789,GO:1905687,1,0.991539053448329,0,1,regulation of diacylglycerol kinase activity,BP,
20790,GO:1905689,1,0.991539053448329,0,1,positive regulation of diacylglycerol kinase activity,BP,
20791,GO:1905693,1,0.99459757150219,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20792,GO:1905695,1,0.99459757150219,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20793,GO:1905696,1,0.984890138564705,0,2,regulation of polysome binding,BP,
20794,GO:1905698,1,0.99273172731714,0,1,positive regulation of polysome binding,BP,
20795,GO:1905705,1,0.990315164591827,0,1,cellular response to paclitaxel,BP,
20796,GO:1905709,1,0.969555765209962,0,5,negative regulation of membrane permeability,BP,
20797,GO:1905710,1,0.704345997230877,0,60,positive regulation of membrane permeability,BP,
20798,GO:1905711,1,0.993530696504981,0,1,response to phosphatidylethanolamine,BP,
20799,GO:1905719,1,0.988578198840208,0,2,protein localization to perinuclear region of cytoplasm,BP,
20800,GO:1905720,1,0.990054929762495,0,1,cytoplasmic microtubule bundle,CC,
20801,GO:1905747,1,0.994792478474093,0,1,negative regulation of saliva secretion,BP,
20802,GO:1905748,1,0.994792478474093,0,1,hard palate morphogenesis,BP,
20803,GO:1905764,1,0.979193861084705,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20804,GO:1905765,1,0.979193861084705,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20805,GO:1905767,1,0.990500266220113,0,1,regulation of double-stranded telomeric DNA binding,BP,
20806,GO:1905768,1,0.990500266220113,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20807,GO:1905770,1,0.964561348124469,0,6,regulation of mesodermal cell differentiation,BP,
20808,GO:1905771,1,0.978843104056013,0,4,negative regulation of mesodermal cell differentiation,BP,
20809,GO:1905773,1,0.977767886406901,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
20810,GO:1905774,1,0.993256638461652,0,1,regulation of DNA helicase activity,BP,
20811,GO:1905776,1,0.993256638461652,0,1,positive regulation of DNA helicase activity,BP,
20812,GO:1905777,1,0.982880101145214,0,3,regulation of exonuclease activity,BP,
20813,GO:1905778,1,0.988487399051714,0,2,negative regulation of exonuclease activity,BP,
20814,GO:1905779,1,0.994328051160662,0,1,positive regulation of exonuclease activity,BP,
20815,GO:1905793,1,0.978762288302379,0,2,protein localization to pericentriolar material,BP,
20816,GO:1905794,1,0.987230076992325,0,1,response to puromycin,BP,
20817,GO:1905795,1,0.987230076992325,0,1,cellular response to puromycin,BP,
20818,GO:1905799,1,0.994835491488681,0,1,regulation of intraciliary retrograde transport,BP,
20819,GO:1905802,1,0.994267588319634,0,1,regulation of cellular response to manganese ion,BP,
20820,GO:1905809,1,0.854652797300938,0,22,negative regulation of synapse organization,BP,
20821,GO:1905818,1,0.68566046073443,0,55,regulation of chromosome separation,BP,
20822,GO:1905819,1,0.79937066985604,0,33,negative regulation of chromosome separation,BP,
20823,GO:1905820,1,0.938035958992586,0,9,positive regulation of chromosome separation,BP,
20824,GO:1905832,1,0.961680656163854,0,4,positive regulation of spindle assembly,BP,
20825,GO:1905838,1,0.988487399051714,0,2,regulation of telomeric D-loop disassembly,BP,
20826,GO:1905839,1,0.988487399051714,0,2,negative regulation of telomeric D-loop disassembly,BP,
20827,GO:1905843,1,0.986309522222455,0,1,regulation of cellular response to gamma radiation,BP,
20828,GO:1905853,1,0.99480248296677,0,1,regulation of heparan sulfate binding,BP,
20829,GO:1905855,1,0.99480248296677,0,1,positive regulation of heparan sulfate binding,BP,
20830,GO:1905858,1,0.99480248296677,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20831,GO:1905860,1,0.99480248296677,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20833,GO:1905867,1,0.978321176153262,0,4,epididymis development,BP,
20834,GO:1905874,1,0.974877208810968,0,4,regulation of postsynaptic density organization,BP,
20835,GO:1905875,1,0.994217839025302,0,1,negative regulation of postsynaptic density organization,BP,
20836,GO:1905878,1,0.987527433839928,0,1,invadopodium disassembly,BP,
20837,GO:1905879,1,0.936342670696801,0,10,regulation of oogenesis,BP,
20838,GO:1905880,1,0.973070192966339,0,4,negative regulation of oogenesis,BP,
20839,GO:1905881,1,0.973143099826844,0,4,positive regulation of oogenesis,BP,
20840,GO:1905890,1,0.99480248296677,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20841,GO:1905891,1,0.994271234998612,0,1,regulation of cellular response to thapsigargin,BP,
20842,GO:1905892,1,0.994271234998612,0,1,negative regulation of cellular response to thapsigargin,BP,
20843,GO:1905894,1,0.994271234998612,0,1,regulation of cellular response to tunicamycin,BP,
20844,GO:1905895,1,0.994271234998612,0,1,negative regulation of cellular response to tunicamycin,BP,
20845,GO:1905897,1,0.629232634010218,0,73,regulation of response to endoplasmic reticulum stress,BP,
20846,GO:1905898,1,0.801701396818417,0,35,positive regulation of response to endoplasmic reticulum stress,BP,
20847,GO:1905899,1,0.994746455661165,0,1,regulation of smooth muscle tissue development,BP,
20848,GO:1905900,1,0.994746455661165,0,1,negative regulation of smooth muscle tissue development,BP,
20849,GO:1905901,1,0.994746455661165,0,1,positive regulation of smooth muscle tissue development,BP,
20850,GO:1905902,1,0.964561348124469,0,6,regulation of mesoderm formation,BP,
20851,GO:1905903,1,0.978843104056013,0,4,negative regulation of mesoderm formation,BP,
20852,GO:1905906,1,0.956398440522235,0,7,regulation of amyloid fibril formation,BP,
20853,GO:1905907,1,0.981279346822372,0,3,negative regulation of amyloid fibril formation,BP,
20854,GO:1905908,1,0.974333010228862,0,4,positive regulation of amyloid fibril formation,BP,
20855,GO:1905912,1,0.994688144802443,0,1,regulation of calcium ion export across plasma membrane,BP,
20856,GO:1905913,1,0.994688144802443,0,1,negative regulation of calcium ion export across plasma membrane,BP,
20857,GO:1905918,1,0.994593780813773,0,1,regulation of CoA-transferase activity,BP,
20858,GO:1905920,1,0.994593780813773,0,1,positive regulation of CoA-transferase activity,BP,
20859,GO:1905927,1,0.987527433839928,0,1,regulation of invadopodium disassembly,BP,
20860,GO:1905929,1,0.987527433839928,0,1,positive regulation of invadopodium disassembly,BP,
20861,GO:1905936,1,0.978862988176901,0,4,regulation of germ cell proliferation,BP,
20862,GO:1905937,1,0.983960909528943,0,3,negative regulation of germ cell proliferation,BP,
20863,GO:1905938,1,0.994819816488085,0,1,positive regulation of germ cell proliferation,BP,
20864,GO:1905939,1,0.892332764222644,0,18,regulation of gonad development,BP,
20865,GO:1905940,1,0.970146291314098,0,5,negative regulation of gonad development,BP,
20866,GO:1905941,1,0.94074413617734,0,10,positive regulation of gonad development,BP,
20867,GO:1905942,1,0.994482162004173,0,1,regulation of formation of growth cone in injured axon,BP,
20868,GO:1905943,1,0.994482162004173,0,1,negative regulation of formation of growth cone in injured axon,BP,
20870,GO:1905953,1,0.802678862956091,0,31,negative regulation of lipid localization,BP,
20872,GO:1905957,1,0.993003559696667,0,1,regulation of cellular response to alcohol,BP,
20873,GO:1905959,1,0.993003559696667,0,1,positive regulation of cellular response to alcohol,BP,
20874,GO:1905961,1,0.951837456710385,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
20875,GO:1990000,1,0.912596117907366,0,14,amyloid fibril formation,BP,
20876,GO:1990001,1,0.924395284184055,0,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
20877,GO:1990003,1,0.991266113753993,0,1,IDP phosphatase activity,MF,
20878,GO:1990005,1,0.989061774014079,0,2,granular vesicle,CC,
20879,GO:1990008,1,0.994718825676242,0,1,neurosecretory vesicle,CC,
20880,GO:1990009,1,0.985738028581301,0,2,retinal cell apoptotic process,BP,
20881,GO:1990015,1,0.994497065019547,0,1,ensheathing process,CC,
20882,GO:1990023,1,0.911215847232457,0,12,mitotic spindle midzone,CC,
20883,GO:1990026,1,0.986137721980595,0,2,hippocampal mossy fiber expansion,CC,
20884,GO:1990030,1,0.993427843291049,0,1,pericellular basket,CC,
20885,GO:1990031,1,0.994060542683534,0,1,pinceau fiber,CC,
20886,GO:1990032,1,0.992873571154147,0,1,parallel fiber,CC,
20887,GO:1990034,1,0.9627902185436,0,5,calcium ion export across plasma membrane,BP,
20888,GO:1990036,1,0.983792158680971,0,2,calcium ion import into sarcoplasmic reticulum,BP,
20889,GO:1990037,1,0.984047759767448,0,3,Lewy body core,CC,
20890,GO:1990038,1,0.994657213727128,0,1,Lewy body corona,CC,
20891,GO:1990046,1,0.994791275038158,0,1,stress-induced mitochondrial fusion,BP,
20892,GO:1990047,1,0.99454983328927,0,1,spindle matrix,CC,
20893,GO:1990048,1,0.994313214468247,0,1,anterograde neuronal dense core vesicle transport,BP,
20894,GO:1990050,1,0.979093756890266,0,4,phosphatidic acid transporter activity,MF,
20895,GO:1990051,1,0.985582711165383,0,2,activation of protein kinase C activity,BP,
20896,GO:1990070,1,0.994831845721379,0,1,TRAPPI protein complex,CC,
20897,GO:1990071,1,0.985159033993107,0,2,TRAPPII protein complex,CC,
20898,GO:1990072,1,0.989174157696526,0,2,TRAPPIII protein complex,CC,
20899,GO:1990074,1,0.993779805445121,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20900,GO:1990075,1,0.966563013882871,0,4,periciliary membrane compartment,CC,
20901,GO:1990079,1,0.994818437378662,0,1,cartilage homeostasis,BP,
20902,GO:1990086,1,0.973891547742198,0,4,lens fiber cell apoptotic process,BP,
20905,GO:1990108,1,0.983040961889679,0,2,protein linear deubiquitination,BP,
20906,GO:1990111,1,0.974768660002642,0,4,spermatoproteasome complex,CC,
20907,GO:1990112,1,0.988658446617857,0,2,RQC complex,CC,
20908,GO:1990116,1,0.988658446617857,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
20909,GO:1990117,1,0.994829850254701,0,1,B cell receptor apoptotic signaling pathway,BP,
20910,GO:1990124,1,0.94223709901223,0,8,messenger ribonucleoprotein complex,CC,
20911,GO:1990126,1,0.899641137452114,0,16,retrograde transport, endosome to plasma membrane,BP,
20912,GO:1990127,1,0.993160303955826,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20913,GO:1990130,1,0.970378467575499,0,5,GATOR1 complex,CC,
20914,GO:1990131,1,0.976718972334419,0,4,Gtr1-Gtr2 GTPase complex,CC,
20915,GO:1990134,1,0.992305345801144,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
20916,GO:1990136,1,0.994450597513859,0,1,linoleate 9S-lipoxygenase activity,MF,
20918,GO:1990144,1,0.966006180011457,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20919,GO:1990145,1,0.987953935751362,0,2,maintenance of translational fidelity,BP,
20920,GO:1990164,1,0.988422693985723,0,2,histone H2A phosphorylation,BP,
20921,GO:1990165,1,0.994638867968558,0,1,single-strand break-containing DNA binding,MF,
20922,GO:1990166,1,0.99451718187572,0,1,protein localization to site of double-strand break,BP,
20923,GO:1990167,1,0.981869378099899,0,2,protein K27-linked deubiquitination,BP,
20924,GO:1990168,1,0.983492857495264,0,2,protein K33-linked deubiquitination,BP,
20925,GO:1990169,1,0.938883410062684,0,11,stress response to copper ion,BP,
20926,GO:1990170,1,0.994640679724712,0,1,stress response to cadmium ion,BP,
20927,GO:1990172,1,0.991424923868559,0,1,G-protein coupled receptor catabolic process,BP,
20928,GO:1990173,1,0.944286459430462,0,10,protein localization to nucleoplasm,BP,
20929,GO:1990174,1,0.993480943220778,0,1,phosphodiesterase decapping endonuclease activity,MF,
20930,GO:1990175,1,0.993411565243724,0,1,EH domain binding,MF,
20931,GO:1990179,1,0.977931136551398,0,3,protein localization to actomyosin contractile ring,BP,
20932,GO:1990180,1,0.983773920031755,0,3,mitochondrial tRNA 3'-end processing,BP,
20933,GO:1990182,1,0.904051660119653,0,17,exosomal secretion,BP,
20934,GO:1990183,1,0.994827794879995,0,1,lymphatic vascular process in circulatory system,BP,
20935,GO:1990186,1,0.994827794879995,0,1,regulation of lymphatic vessel size,BP,
20936,GO:1990188,1,0.994394708893027,0,1,euchromatin binding,MF,
20937,GO:1990189,1,0.983599069528873,0,3,peptide-serine-N-acetyltransferase activity,MF,
20938,GO:1990190,1,0.989610090810955,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20939,GO:1990192,1,0.994827794879995,0,1,collecting lymphatic vessel constriction,BP,
20940,GO:1990204,1,0.576668751080761,0,96,oxidoreductase complex,CC,
20941,GO:1990226,1,0.966390239879356,0,6,histone methyltransferase binding,MF,
20942,GO:1990234,1,0.00641757651066285,0,744,transferase complex,CC,
20943,GO:1990239,1,0.959606712375182,0,6,steroid hormone binding,MF,
20944,GO:1990246,1,0.977444251132158,0,4,uniplex complex,CC,
20945,GO:1990247,1,0.951148235846136,0,7,N6-methyladenosine-containing RNA binding,MF,
20946,GO:1990253,1,0.93784933338828,0,9,cellular response to leucine starvation,BP,
20948,GO:1990256,1,0.985663868288423,0,1,signal clustering,BP,
20949,GO:1990258,1,0.994803505452008,0,1,histone glutamine methylation,BP,
20950,GO:1990259,1,0.994803505452008,0,1,histone-glutamine methyltransferase activity,MF,
20951,GO:1990261,1,0.994313214468247,0,1,pre-mRNA catabolic process,BP,
20952,GO:1990262,1,0.994329180687455,0,1,anti-Mullerian hormone signaling pathway,BP,
20953,GO:1990264,1,0.988537520104994,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20955,GO:1990267,1,0.994015021629261,0,1,response to transition metal nanoparticle,BP,
20956,GO:1990268,1,0.994015021629261,0,1,response to gold nanoparticle,BP,
20957,GO:1990269,1,0.986949798457055,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20958,GO:1990275,1,0.994246946751649,0,1,preribosome binding,MF,
20959,GO:1990280,1,0.990439316474678,0,1,RNA localization to chromatin,BP,
20960,GO:1990298,1,0.994596025494779,0,1,bub1-bub3 complex,CC,
20961,GO:1990314,1,0.938670727792251,0,8,cellular response to insulin-like growth factor stimulus,BP,
20962,GO:1990316,1,0.940810225649709,0,8,Atg1/ULK1 kinase complex,CC,
20963,GO:1990332,1,0.993326102345204,0,1,Ire1 complex,CC,
20964,GO:1990349,1,0.994644568067902,0,1,gap junction-mediated intercellular transport,BP,
20966,GO:1990356,1,0.994800064853307,0,1,sumoylated E2 ligase complex,CC,
20967,GO:1990357,1,0.983114529783907,0,3,terminal web,CC,
20968,GO:1990379,1,0.98941377587211,0,2,lipid transport across blood brain barrier,BP,
20969,GO:1990380,1,0.936272561116238,0,7,Lys48-specific deubiquitinase activity,MF,
20970,GO:1990381,1,0.914902678585168,0,13,ubiquitin-specific protease binding,MF,
20971,GO:1990384,1,0.994791153657207,0,1,hyaloid vascular plexus regression,BP,
20972,GO:1990386,1,0.994651614086683,0,1,mitotic cleavage furrow ingression,BP,
20973,GO:1990390,1,0.993819834584721,0,1,protein K33-linked ubiquitination,BP,
20974,GO:1990391,1,0.791295371729082,0,33,DNA repair complex,CC,
20975,GO:1990393,1,0.964947767890439,0,5,3M complex,CC,
20976,GO:1990399,1,0.994564272040715,0,1,epithelium regeneration,BP,
20977,GO:1990401,1,0.99431494092688,0,1,embryonic lung development,BP,
20978,GO:1990402,1,0.994579304502616,0,1,embryonic liver development,BP,
20979,GO:1990403,1,0.936483579424514,0,10,embryonic brain development,BP,
20980,GO:1990404,1,0.988059353916983,0,2,protein ADP-ribosylase activity,MF,
20981,GO:1990405,1,0.955105329748735,0,6,protein antigen binding,MF,
20982,GO:1990406,1,0.98720623979324,0,2,CGRP receptor complex,CC,
20983,GO:1990407,1,0.994824637647523,0,1,calcitonin gene-related peptide binding,MF,
20984,GO:1990408,1,0.98720623979324,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
20985,GO:1990409,1,0.987212726703714,0,2,adrenomedullin binding,MF,
20987,GO:1990414,1,0.970296742564436,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
20988,GO:1990415,1,0.981984997875499,0,3,Pex17p-Pex14p docking complex,CC,
20990,GO:1990418,1,0.983302435219949,0,3,response to insulin-like growth factor stimulus,BP,
20991,GO:1990421,1,0.986267357554897,0,1,subtelomeric heterochromatin,CC,
20992,GO:1990423,1,0.978631796016569,0,3,RZZ complex,CC,
20993,GO:1990425,1,0.967797156877331,0,3,ryanodine receptor complex,CC,
20994,GO:1990426,1,0.980677556805434,0,2,mitotic recombination-dependent replication fork processing,BP,
20995,GO:1990427,1,0.989874055397202,0,1,stereocilia tip-link density,CC,
20996,GO:1990428,1,0.986368126195748,0,2,miRNA transport,BP,
20997,GO:1990429,1,0.981984997875499,0,3,peroxisomal importomer complex,CC,
20998,GO:1990430,1,0.968389026783822,0,4,extracellular matrix protein binding,MF,
20999,GO:1990435,1,0.989874055397202,0,1,upper tip-link density,CC,
21000,GO:1990439,1,0.99420751107539,0,1,MAP kinase serine/threonine phosphatase activity,MF,
21001,GO:1990440,1,0.938866683481142,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21002,GO:1990441,1,0.977466315596537,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21003,GO:1990442,1,0.9844797240093,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
21004,GO:1990446,1,0.979090107925163,0,4,U1 snRNP binding,MF,
21005,GO:1990448,1,0.990651274536966,0,1,exon-exon junction complex binding,MF,
21006,GO:1990452,1,0.98763690535314,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
21007,GO:1990454,1,0.940159428698833,0,7,L-type voltage-gated calcium channel complex,CC,
21008,GO:1990456,1,0.993498354109069,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
21009,GO:1990459,1,0.956841533909004,0,7,transferrin receptor binding,MF,
21010,GO:1990460,1,0.97838364849294,0,3,leptin receptor binding,MF,
21011,GO:1990462,1,0.958102433032823,0,7,omegasome,CC,
21012,GO:1990478,1,0.994665198456942,0,1,response to ultrasound,BP,
21013,GO:1990481,1,0.977883583239062,0,4,mRNA pseudouridine synthesis,BP,
21014,GO:1990498,1,0.979212477612168,0,2,mitotic spindle microtubule,CC,
21015,GO:1990502,1,0.984930700983592,0,2,dense core granule maturation,BP,
21016,GO:1990504,1,0.945261567832572,0,6,dense core granule exocytosis,BP,
21017,GO:1990505,1,0.980677556805434,0,2,mitotic DNA replication maintenance of fidelity,BP,
21018,GO:1990511,1,0.974642728252221,0,4,piRNA biosynthetic process,BP,
21019,GO:1990518,1,0.99273172731714,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
21020,GO:1990519,1,0.98749906620752,0,2,pyrimidine nucleotide import into mitochondrion,BP,
21022,GO:1990535,1,0.961890731649135,0,5,neuron projection maintenance,BP,
21023,GO:1990539,1,0.99453369805972,0,1,fructose import across plasma membrane,BP,
21024,GO:1990542,1,0.670422141529367,0,67,mitochondrial transmembrane transport,BP,
21025,GO:1990546,1,0.99474103000378,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21026,GO:1990564,1,0.972827034421212,0,5,protein polyufmylation,BP,
21027,GO:1990565,1,0.99472689814391,0,1,HSP90-CDC37 chaperone complex,CC,
21028,GO:1990569,1,0.985094642420816,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
21029,GO:1990570,1,0.994313214468247,0,1,GDP-mannose transmembrane transport,BP,
21030,GO:1990572,1,0.993341223717095,0,1,TERT-RMRP complex,CC,
21031,GO:1990573,1,0.943289361823189,0,9,potassium ion import across plasma membrane,BP,
21032,GO:1990575,1,0.987877239418071,0,2,mitochondrial L-ornithine transmembrane transport,BP,
21033,GO:1990578,1,0.991494312155284,0,1,perinuclear endoplasmic reticulum membrane,CC,
21034,GO:1990579,1,0.993326102345204,0,1,peptidyl-serine trans-autophosphorylation,BP,
21035,GO:1990583,1,0.994651614086683,0,1,phospholipase D activator activity,MF,
21036,GO:1990584,1,0.984548936588963,0,3,cardiac Troponin complex,CC,
21037,GO:1990589,1,0.982338894657882,0,2,ATF4-CREB1 transcription factor complex,CC,
21038,GO:1990590,1,0.989229971331867,0,2,ATF1-ATF4 transcription factor complex,CC,
21039,GO:1990592,1,0.972827034421212,0,5,protein K69-linked ufmylation,BP,
21040,GO:1990597,1,0.980870047345065,0,3,AIP1-IRE1 complex,CC,
21041,GO:1990599,1,0.979193861084705,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21042,GO:1990603,1,0.993960877222941,0,1,dark adaptation,BP,
21043,GO:1990604,1,0.980122864025224,0,3,IRE1-TRAF2-ASK1 complex,CC,
21044,GO:1990613,1,0.993773915406647,0,1,mitochondrial membrane fusion,BP,
21045,GO:1990617,1,0.989569147995911,0,2,CHOP-ATF4 complex,CC,
21046,GO:1990619,1,0.98826054833302,0,2,histone H3-K9 deacetylation,BP,
21047,GO:1990622,1,0.989483473942314,0,2,CHOP-ATF3 complex,CC,
21048,GO:1990630,1,0.993326102345204,0,1,IRE1-RACK1-PP2A complex,CC,
21049,GO:1990635,1,0.972333915699616,0,4,proximal dendrite,CC,
21050,GO:1990637,1,0.978859849400476,0,3,response to prolactin,BP,
21051,GO:1990641,1,0.982490583637563,0,3,response to iron ion starvation,BP,
21052,GO:1990646,1,0.994166185056504,0,1,cellular response to prolactin,BP,
21053,GO:1990654,1,0.992431252960778,0,1,sebum secreting cell proliferation,BP,
21054,GO:1990666,1,0.985780055347748,0,2,PCSK9-LDLR complex,CC,
21056,GO:1990668,1,0.971094071230247,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21057,GO:1990682,1,0.987866848175286,0,2,CSF1-CSF1R complex,CC,
21058,GO:1990696,1,0.979666327862907,0,2,USH2 complex,CC,
21059,GO:1990697,1,0.994571675122387,0,1,protein depalmitoleylation,BP,
21060,GO:1990698,1,0.988124485104351,0,2,palmitoleoyltransferase activity,MF,
21061,GO:1990699,1,0.994571675122387,0,1,palmitoleyl hydrolase activity,MF,
21062,GO:1990700,1,0.993399438949986,0,1,nucleolar chromatin organization,BP,
21063,GO:1990705,1,0.988495768566121,0,1,cholangiocyte proliferation,BP,
21064,GO:1990707,1,0.986267357554897,0,1,nuclear subtelomeric heterochromatin,CC,
21065,GO:1990708,1,0.992390237692834,0,1,conditioned place preference,BP,
21066,GO:1990709,1,0.976613664730101,0,3,presynaptic active zone organization,BP,
21067,GO:1990712,1,0.956457730485461,0,7,HFE-transferrin receptor complex,CC,
21068,GO:1990715,1,0.993290037190001,0,1,mRNA CDS binding,MF,
21069,GO:1990716,1,0.972641016551499,0,3,axonemal central apparatus,CC,
21070,GO:1990718,1,0.987594874711917,0,1,axonemal central pair projection,CC,
21071,GO:1990723,1,0.979980223422061,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21072,GO:1990726,1,0.974122055948486,0,5,Lsm1-7-Pat1 complex,CC,
21073,GO:1990729,1,0.994656786941954,0,1,primary miRNA modification,BP,
21074,GO:1990730,1,0.987257797556896,0,2,VCP-NSFL1C complex,CC,
21075,GO:1990736,1,0.993277651769872,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
21076,GO:1990737,1,0.98072701024071,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21077,GO:1990739,1,0.988495768566121,0,1,granulosa cell proliferation,BP,
21078,GO:1990742,1,0.980834780800939,0,3,microvesicle,CC,
21080,GO:1990744,1,0.994656786941954,0,1,primary miRNA methylation,BP,
21081,GO:1990745,1,0.979417556539266,0,3,EARP complex,CC,
21082,GO:1990748,1,0.601998884144192,0,86,cellular detoxification,BP,
21083,GO:1990751,1,0.990036700891625,0,1,Schwann cell chemotaxis,BP,
21084,GO:1990752,1,0.801005472640626,0,25,microtubule end,CC,
21085,GO:1990755,1,0.994313214468247,0,1,mitotic spindle microtubule depolymerization,BP,
21086,GO:1990756,1,0.982674981035714,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
21087,GO:1990758,1,0.994690398648172,0,1,mitotic sister chromatid biorientation,BP,
21088,GO:1990761,1,0.975621157135766,0,3,growth cone lamellipodium,CC,
21089,GO:1990763,1,0.957622107511511,0,6,arrestin family protein binding,MF,
21091,GO:1990765,1,0.992154089340602,0,1,colon smooth muscle contraction,BP,
21092,GO:1990768,1,0.994834055115578,0,1,gastric mucosal blood circulation,BP,
21093,GO:1990769,1,0.983419221971019,0,3,proximal neuron projection,CC,
21094,GO:1990770,1,0.987028273206434,0,2,small intestine smooth muscle contraction,BP,
21095,GO:1990771,1,0.991193478625975,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21096,GO:1990773,1,0.994713762775742,0,1,matrix metallopeptidase secretion,BP,
21097,GO:1990774,1,0.88035944612922,0,18,tumor necrosis factor secretion,BP,
21098,GO:1990776,1,0.861470731674188,0,23,response to angiotensin,BP,
21099,GO:1990777,1,0.807509640473389,0,32,lipoprotein particle,CC,
21101,GO:1990782,1,0.626517800175434,0,67,protein tyrosine kinase binding,MF,
21102,GO:1990784,1,0.993309993896024,0,1,response to dsDNA,BP,
21103,GO:1990785,1,0.974023346589359,0,3,response to water-immersion restraint stress,BP,
21104,GO:1990786,1,0.993309993896024,0,1,cellular response to dsDNA,BP,
21105,GO:1990791,1,0.982497878811034,0,3,dorsal root ganglion development,BP,
21106,GO:1990796,1,0.994209131662561,0,1,photoreceptor cell terminal bouton,CC,
21107,GO:1990809,1,0.977844282470066,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21108,GO:1990812,1,0.981301353132832,0,3,growth cone filopodium,CC,
21109,GO:1990817,1,0.994551376364011,0,1,RNA adenylyltransferase activity,MF,
21110,GO:1990822,1,0.948050301873753,0,8,basic amino acid transmembrane transport,BP,
21112,GO:1990825,1,0.946940187050149,0,9,sequence-specific mRNA binding,MF,
21113,GO:1990828,1,0.994594472942022,0,1,hepatocyte dedifferentiation,BP,
21114,GO:1990829,1,0.994657497885612,0,1,C-rich single-stranded DNA binding,MF,
21116,GO:1990832,1,0.994634905157056,0,1,slow axonal transport,BP,
21117,GO:1990833,1,0.994634905157056,0,1,clathrin-uncoating ATPase activity,MF,
21118,GO:1990834,1,0.977340183631002,0,4,response to odorant,BP,
21120,GO:1990839,1,0.987648844569169,0,2,response to endothelin,BP,
21122,GO:1990843,1,0.990956155649264,0,1,subsarcolemmal mitochondrion,CC,
21123,GO:1990844,1,0.990956155649264,0,1,interfibrillar mitochondrion,CC,
21124,GO:1990845,1,0.920553933543802,0,13,adaptive thermogenesis,BP,
21125,GO:1990851,1,0.973699728669305,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21126,GO:1990859,1,0.994538877298266,0,1,cellular response to endothelin,BP,
21127,GO:1990868,1,0.964940427878982,0,5,response to chemokine,BP,
21128,GO:1990869,1,0.964940427878982,0,5,cellular response to chemokine,BP,
21129,GO:1990874,1,0.786226075677757,0,36,vascular smooth muscle cell proliferation,BP,
21130,GO:1990876,1,0.990639953549758,0,1,cytoplasmic side of nuclear pore,CC,
21131,GO:1990879,1,0.988658446617857,0,2,CST complex,CC,
21132,GO:1990882,1,0.99338868812887,0,1,rRNA acetylation,BP,
21133,GO:1990883,1,0.99338868812887,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21134,GO:1990884,1,0.99338868812887,0,1,RNA acetylation,BP,
21135,GO:1990889,1,0.994683056798052,0,1,H4K20me3 modified histone binding,MF,
21137,GO:1990907,1,0.920600290281944,0,11,beta-catenin-TCF complex,CC,
21138,GO:1990909,1,0.917422425179711,0,10,Wnt signalosome,CC,
21139,GO:1990910,1,0.982340654242599,0,3,response to hypobaric hypoxia,BP,
21140,GO:1990911,1,0.977574467248987,0,4,response to psychosocial stress,BP,
21141,GO:1990913,1,0.994434863992636,0,1,sperm head plasma membrane,CC,
21142,GO:1990917,1,0.994434863992636,0,1,ooplasm,CC,
21143,GO:1990918,1,0.987134254584689,0,2,double-strand break repair involved in meiotic recombination,BP,
21144,GO:1990922,1,0.993939464618985,0,1,hepatic stellate cell proliferation,BP,
21145,GO:1990923,1,0.982552967795116,0,3,PET complex,CC,
21147,GO:1990927,1,0.984968885883917,0,2,calcium ion regulated lysosome exocytosis,BP,
21148,GO:1990928,1,0.984181659193793,0,2,response to amino acid starvation,BP,
21149,GO:1990930,1,0.994746455661165,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21150,GO:1990931,1,0.99306269615796,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
21151,GO:1990936,1,0.988965127905062,0,2,vascular smooth muscle cell dedifferentiation,BP,
21152,GO:1990938,1,0.993342167507596,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21153,GO:1990939,1,0.631635478332589,0,48,ATP-dependent microtubule motor activity,MF,
21154,GO:1990948,1,0.974182920212091,0,5,ubiquitin ligase inhibitor activity,MF,
21155,GO:1990955,1,0.993256638461652,0,1,G-rich single-stranded DNA binding,MF,
21156,GO:1990962,1,0.993356305776653,0,1,drug transport across blood-brain barrier,BP,
21157,GO:1990963,1,0.993356305776653,0,1,establishment of blood-retinal barrier,BP,
21158,GO:1990966,1,0.975021746846999,0,4,ATP generation from poly-ADP-D-ribose,BP,
21159,GO:1990967,1,0.989051342549327,0,2,multi-organism toxin transport,BP,
21160,GO:1990968,1,0.990821498534944,0,1,modulation by host of RNA binding by virus,BP,
21161,GO:1990969,1,0.990821498534944,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21162,GO:1990971,1,0.993409701531341,0,1,EMILIN complex,CC,
21163,GO:1990983,1,0.994414730118229,0,1,tRNA demethylation,BP,
21164,GO:1990984,1,0.994414730118229,0,1,tRNA demethylase activity,MF,
21165,GO:2000001,1,0.909291417021773,0,16,regulation of DNA damage checkpoint,BP,
21166,GO:2000002,1,0.971180650135014,0,5,negative regulation of DNA damage checkpoint,BP,
21167,GO:2000003,1,0.994313214468247,0,1,positive regulation of DNA damage checkpoint,BP,
21168,GO:2000004,1,0.994702757779098,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21169,GO:2000005,1,0.994702757779098,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21170,GO:2000006,1,0.994702757779098,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21171,GO:2000007,1,0.994702757779098,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21172,GO:2000008,1,0.799639332702833,0,33,regulation of protein localization to cell surface,BP,
21173,GO:2000009,1,0.922651738214616,0,12,negative regulation of protein localization to cell surface,BP,
21174,GO:2000010,1,0.913635875519587,0,13,positive regulation of protein localization to cell surface,BP,
21175,GO:2000011,1,0.994578223558621,0,1,regulation of adaxial/abaxial pattern formation,BP,
21176,GO:2000015,1,0.977747395046512,0,4,regulation of determination of dorsal identity,BP,
21177,GO:2000016,1,0.989534498744818,0,2,negative regulation of determination of dorsal identity,BP,
21178,GO:2000017,1,0.988089480635108,0,2,positive regulation of determination of dorsal identity,BP,
21179,GO:2000018,1,0.950731186441219,0,8,regulation of male gonad development,BP,
21180,GO:2000019,1,0.993437584411502,0,1,negative regulation of male gonad development,BP,
21181,GO:2000020,1,0.957014262868874,0,7,positive regulation of male gonad development,BP,
21183,GO:2000027,1,0.222046221269645,0,231,regulation of organ morphogenesis,BP,
21184,GO:2000035,1,0.951699693312595,0,8,regulation of stem cell division,BP,
21185,GO:2000036,1,0.848172649980968,0,24,regulation of stem cell population maintenance,BP,
21186,GO:2000040,1,0.987580455480399,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
21187,GO:2000041,1,0.987580455480399,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
21188,GO:2000042,1,0.931504167800063,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
21189,GO:2000043,1,0.994523571391181,0,1,regulation of cardiac cell fate specification,BP,
21191,GO:2000047,1,0.943442467624593,0,10,regulation of cell-cell adhesion mediated by cadherin,BP,
21192,GO:2000048,1,0.978522450939603,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21193,GO:2000049,1,0.964157696740155,0,6,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21194,GO:2000050,1,0.852478928786312,0,22,regulation of non-canonical Wnt signaling pathway,BP,
21195,GO:2000051,1,0.951935026685826,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
21196,GO:2000052,1,0.924697866454536,0,12,positive regulation of non-canonical Wnt signaling pathway,BP,
21197,GO:2000053,1,0.974871525289865,0,3,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21198,GO:2000054,1,0.987475712396863,0,2,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21199,GO:2000055,1,0.98723754827948,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21200,GO:2000056,1,0.99467890679076,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21201,GO:2000057,1,0.99467890679076,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21202,GO:2000058,1,0.411798211223681,0,135,regulation of ubiquitin-dependent protein catabolic process,BP,
21203,GO:2000059,1,0.777346028572965,0,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,
21204,GO:2000060,1,0.555743212232256,0,90,positive regulation of ubiquitin-dependent protein catabolic process,BP,
21205,GO:2000061,1,0.994746455661165,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21206,GO:2000062,1,0.994746455661165,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21207,GO:2000063,1,0.994746455661165,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21208,GO:2000064,1,0.963352594829926,0,6,regulation of cortisol biosynthetic process,BP,
21209,GO:2000065,1,0.976846717950336,0,4,negative regulation of cortisol biosynthetic process,BP,
21210,GO:2000066,1,0.993437584411502,0,1,positive regulation of cortisol biosynthetic process,BP,
21211,GO:2000067,1,0.994831355742962,0,1,regulation of root morphogenesis,BP,
21212,GO:2000074,1,0.949955178614391,0,8,regulation of type B pancreatic cell development,BP,
21213,GO:2000077,1,0.984795169986818,0,2,negative regulation of type B pancreatic cell development,BP,
21214,GO:2000078,1,0.98379132144954,0,3,positive regulation of type B pancreatic cell development,BP,
21215,GO:2000079,1,0.992894108735709,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21216,GO:2000080,1,0.992894108735709,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21217,GO:2000095,1,0.919296716774883,0,13,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21218,GO:2000096,1,0.949781775138411,0,8,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21221,GO:2000101,1,0.994214944803451,0,1,regulation of mammary stem cell proliferation,BP,
21222,GO:2000103,1,0.994214944803451,0,1,positive regulation of mammary stem cell proliferation,BP,
21223,GO:2000104,1,0.87455756096206,0,19,negative regulation of DNA-dependent DNA replication,BP,
21224,GO:2000105,1,0.906934654720273,0,14,positive regulation of DNA-dependent DNA replication,BP,
21226,GO:2000107,1,0.763346351057998,0,43,negative regulation of leukocyte apoptotic process,BP,
21228,GO:2000109,1,0.955899814932693,0,7,regulation of macrophage apoptotic process,BP,
21229,GO:2000110,1,0.981398592971316,0,3,negative regulation of macrophage apoptotic process,BP,
21230,GO:2000111,1,0.979416275184368,0,3,positive regulation of macrophage apoptotic process,BP,
21233,GO:2000114,1,0.871785082258987,0,18,regulation of establishment of cell polarity,BP,
21236,GO:2000118,1,0.987442842704698,0,2,regulation of sodium-dependent phosphate transport,BP,
21237,GO:2000119,1,0.994190837446837,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21238,GO:2000121,1,0.944684838473418,0,10,regulation of removal of superoxide radicals,BP,
21239,GO:2000124,1,0.987497867674906,0,2,regulation of endocannabinoid signaling pathway,BP,
21240,GO:2000134,1,0.530685223777406,0,96,negative regulation of G1/S transition of mitotic cell cycle,BP,
21241,GO:2000136,1,0.897767813445667,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21242,GO:2000137,1,0.9802207494799,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21243,GO:2000138,1,0.965942094049742,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21244,GO:2000142,1,0.78560873095026,0,36,regulation of DNA-templated transcription, initiation,BP,
21245,GO:2000143,1,0.963179975230121,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21246,GO:2000144,1,0.831595324089908,0,27,positive regulation of DNA-templated transcription, initiation,BP,
21250,GO:2000152,1,0.978038182235335,0,4,regulation of ubiquitin-specific protease activity,BP,
21251,GO:2000156,1,0.987763210220538,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21252,GO:2000157,1,0.989639264020063,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21253,GO:2000158,1,0.988278679129672,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21254,GO:2000167,1,0.991935197019035,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21255,GO:2000169,1,0.945639630495421,0,7,regulation of peptidyl-cysteine S-nitrosylation,BP,
21256,GO:2000170,1,0.986838511800803,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21257,GO:2000171,1,0.821422628742159,0,26,negative regulation of dendrite development,BP,
21258,GO:2000172,1,0.970280676635978,0,4,regulation of branching morphogenesis of a nerve,BP,
21259,GO:2000173,1,0.99338728422651,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21260,GO:2000174,1,0.993370408642721,0,1,regulation of pro-T cell differentiation,BP,
21261,GO:2000176,1,0.993370408642721,0,1,positive regulation of pro-T cell differentiation,BP,
21262,GO:2000177,1,0.60293088425503,0,71,regulation of neural precursor cell proliferation,BP,
21263,GO:2000178,1,0.872485875281962,0,20,negative regulation of neural precursor cell proliferation,BP,
21264,GO:2000179,1,0.750768987190608,0,40,positive regulation of neural precursor cell proliferation,BP,
21266,GO:2000182,1,0.977901600459148,0,3,regulation of progesterone biosynthetic process,BP,
21267,GO:2000184,1,0.990956155649264,0,1,positive regulation of progesterone biosynthetic process,BP,
21268,GO:2000191,1,0.896309245411942,0,16,regulation of fatty acid transport,BP,
21269,GO:2000192,1,0.961006252161516,0,5,negative regulation of fatty acid transport,BP,
21270,GO:2000193,1,0.942789152765645,0,10,positive regulation of fatty acid transport,BP,
21271,GO:2000194,1,0.926480053054659,0,12,regulation of female gonad development,BP,
21272,GO:2000195,1,0.976556375969833,0,4,negative regulation of female gonad development,BP,
21273,GO:2000196,1,0.983006484764826,0,3,positive regulation of female gonad development,BP,
21274,GO:2000197,1,0.957795565741648,0,6,regulation of ribonucleoprotein complex localization,BP,
21275,GO:2000199,1,0.994104725963417,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21276,GO:2000200,1,0.994104725963417,0,1,regulation of ribosomal subunit export from nucleus,BP,
21277,GO:2000202,1,0.994104725963417,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21278,GO:2000206,1,0.994104725963417,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21279,GO:2000208,1,0.994104725963417,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21280,GO:2000209,1,0.866499981208766,0,21,regulation of anoikis,BP,
21281,GO:2000210,1,0.965167803851963,0,6,positive regulation of anoikis,BP,
21284,GO:2000213,1,0.99459757150219,0,1,positive regulation of glutamate metabolic process,BP,
21285,GO:2000224,1,0.983144921610116,0,3,regulation of testosterone biosynthetic process,BP,
21286,GO:2000225,1,0.988287259214081,0,2,negative regulation of testosterone biosynthetic process,BP,
21287,GO:2000226,1,0.994767180013798,0,1,regulation of pancreatic A cell differentiation,BP,
21288,GO:2000227,1,0.994767180013798,0,1,negative regulation of pancreatic A cell differentiation,BP,
21289,GO:2000229,1,0.98950279054613,0,2,regulation of pancreatic stellate cell proliferation,BP,
21290,GO:2000230,1,0.994684466974914,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21291,GO:2000231,1,0.994790910327561,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21292,GO:2000232,1,0.93000773156113,0,11,regulation of rRNA processing,BP,
21293,GO:2000233,1,0.985583271450674,0,2,negative regulation of rRNA processing,BP,
21294,GO:2000234,1,0.951148807442856,0,8,positive regulation of rRNA processing,BP,
21297,GO:2000243,1,0.738639498503108,0,47,positive regulation of reproductive process,BP,
21298,GO:2000249,1,0.796779767172121,0,35,regulation of actin cytoskeleton reorganization,BP,
21299,GO:2000251,1,0.900814951250154,0,18,positive regulation of actin cytoskeleton reorganization,BP,
21300,GO:2000252,1,0.960414121145009,0,7,negative regulation of feeding behavior,BP,
21301,GO:2000253,1,0.962853547004309,0,5,positive regulation of feeding behavior,BP,
21302,GO:2000254,1,0.978862988176901,0,4,regulation of male germ cell proliferation,BP,
21303,GO:2000255,1,0.983960909528943,0,3,negative regulation of male germ cell proliferation,BP,
21304,GO:2000256,1,0.994819816488085,0,1,positive regulation of male germ cell proliferation,BP,
21307,GO:2000259,1,0.980687956791374,0,3,positive regulation of protein activation cascade,BP,
21308,GO:2000269,1,0.90206664935888,0,15,regulation of fibroblast apoptotic process,BP,
21309,GO:2000270,1,0.951630251506837,0,7,negative regulation of fibroblast apoptotic process,BP,
21310,GO:2000271,1,0.95175122579769,0,7,positive regulation of fibroblast apoptotic process,BP,
21311,GO:2000272,1,0.8252450349558,0,28,negative regulation of signaling receptor activity,BP,
21312,GO:2000273,1,0.815648556589066,0,29,positive regulation of signaling receptor activity,BP,
21313,GO:2000275,1,0.978884013686146,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21314,GO:2000276,1,0.989338952264838,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21315,GO:2000277,1,0.994822876044542,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21316,GO:2000278,1,0.534558346268257,0,96,regulation of DNA biosynthetic process,BP,
21317,GO:2000279,1,0.802000265242657,0,32,negative regulation of DNA biosynthetic process,BP,
21318,GO:2000280,1,0.994831355742962,0,1,regulation of root development,BP,
21319,GO:2000282,1,0.983324116877974,0,2,regulation of cellular amino acid biosynthetic process,BP,
21320,GO:2000283,1,0.988441996649535,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21321,GO:2000284,1,0.994822876044542,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21322,GO:2000286,1,0.982435085145479,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21323,GO:2000287,1,0.994563524330487,0,1,positive regulation of myotome development,BP,
21324,GO:2000288,1,0.949529741068389,0,9,positive regulation of myoblast proliferation,BP,
21325,GO:2000290,1,0.994563524330487,0,1,regulation of myotome development,BP,
21326,GO:2000291,1,0.918318466378925,0,14,regulation of myoblast proliferation,BP,
21327,GO:2000295,1,0.983763199649036,0,3,regulation of hydrogen peroxide catabolic process,BP,
21328,GO:2000296,1,0.989647566671273,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21329,GO:2000297,1,0.979501265285896,0,3,negative regulation of synapse maturation,BP,
21330,GO:2000298,1,0.988442940446181,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21331,GO:2000299,1,0.993906700496187,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21333,GO:2000301,1,0.9819760529493,0,3,negative regulation of synaptic vesicle exocytosis,BP,
21334,GO:2000302,1,0.976302448532808,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21335,GO:2000303,1,0.926337183895722,0,13,regulation of ceramide biosynthetic process,BP,
21336,GO:2000304,1,0.95370240120272,0,8,positive regulation of ceramide biosynthetic process,BP,
21339,GO:2000309,1,0.994068182395454,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21340,GO:2000310,1,0.877642915009217,0,18,regulation of NMDA receptor activity,BP,
21342,GO:2000312,1,0.97826838430144,0,3,regulation of kainate selective glutamate receptor activity,BP,
21343,GO:2000313,1,0.989433488487245,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21344,GO:2000314,1,0.99472916788927,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21345,GO:2000316,1,0.948556868935047,0,9,regulation of T-helper 17 type immune response,BP,
21346,GO:2000317,1,0.971178034411265,0,5,negative regulation of T-helper 17 type immune response,BP,
21347,GO:2000318,1,0.976714235107528,0,4,positive regulation of T-helper 17 type immune response,BP,
21348,GO:2000319,1,0.954308019403864,0,8,regulation of T-helper 17 cell differentiation,BP,
21349,GO:2000320,1,0.971178034411265,0,5,negative regulation of T-helper 17 cell differentiation,BP,
21350,GO:2000321,1,0.982634366981389,0,3,positive regulation of T-helper 17 cell differentiation,BP,
21351,GO:2000322,1,0.94976430658092,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21352,GO:2000323,1,0.960937112756547,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21353,GO:2000324,1,0.988377616451842,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21354,GO:2000325,1,0.991104830696571,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21355,GO:2000327,1,0.991104830696571,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21356,GO:2000328,1,0.978147485847058,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21357,GO:2000329,1,0.988536493750857,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21358,GO:2000330,1,0.989491723217368,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21359,GO:2000331,1,0.987415849967547,0,2,regulation of terminal button organization,BP,
21360,GO:2000332,1,0.98937963956278,0,2,regulation of blood microparticle formation,BP,
21361,GO:2000334,1,0.98937963956278,0,2,positive regulation of blood microparticle formation,BP,
21362,GO:2000338,1,0.988796391037817,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21363,GO:2000340,1,0.988796391037817,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21365,GO:2000342,1,0.988765487795338,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21367,GO:2000344,1,0.951693066131875,0,7,positive regulation of acrosome reaction,BP,
21368,GO:2000345,1,0.931855033672749,0,11,regulation of hepatocyte proliferation,BP,
21369,GO:2000346,1,0.982115345356934,0,3,negative regulation of hepatocyte proliferation,BP,
21370,GO:2000347,1,0.961371664628598,0,6,positive regulation of hepatocyte proliferation,BP,
21371,GO:2000348,1,0.963511999857049,0,6,regulation of CD40 signaling pathway,BP,
21372,GO:2000349,1,0.98760914907288,0,2,negative regulation of CD40 signaling pathway,BP,
21373,GO:2000350,1,0.99481422338587,0,1,positive regulation of CD40 signaling pathway,BP,
21376,GO:2000353,1,0.912070191354708,0,14,positive regulation of endothelial cell apoptotic process,BP,
21377,GO:2000354,1,0.964864262712324,0,6,regulation of ovarian follicle development,BP,
21378,GO:2000355,1,0.989330246824146,0,2,negative regulation of ovarian follicle development,BP,
21379,GO:2000356,1,0.994746455661165,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21380,GO:2000357,1,0.994746455661165,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21381,GO:2000358,1,0.994746455661165,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21382,GO:2000359,1,0.989366848801841,0,2,regulation of binding of sperm to zona pellucida,BP,
21383,GO:2000360,1,0.989366848801841,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21384,GO:2000361,1,0.985507569345875,0,2,regulation of prostaglandin-E synthase activity,BP,
21385,GO:2000363,1,0.985507569345875,0,2,positive regulation of prostaglandin-E synthase activity,BP,
21386,GO:2000367,1,0.989466077189167,0,2,regulation of acrosomal vesicle exocytosis,BP,
21387,GO:2000368,1,0.989466077189167,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21389,GO:2000370,1,0.973011059340639,0,4,positive regulation of clathrin-dependent endocytosis,BP,
21390,GO:2000371,1,0.965663553771627,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21391,GO:2000373,1,0.965663553771627,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21392,GO:2000374,1,0.984372859087933,0,3,regulation of oxygen metabolic process,BP,
21393,GO:2000376,1,0.989686067014599,0,2,positive regulation of oxygen metabolic process,BP,
21395,GO:2000378,1,0.754536510344723,0,45,negative regulation of reactive oxygen species metabolic process,BP,
21397,GO:2000380,1,0.905533114612636,0,15,regulation of mesoderm development,BP,
21398,GO:2000381,1,0.951005502141636,0,8,negative regulation of mesoderm development,BP,
21399,GO:2000382,1,0.971413892541873,0,4,positive regulation of mesoderm development,BP,
21400,GO:2000383,1,0.993489199089586,0,1,regulation of ectoderm development,BP,
21401,GO:2000384,1,0.993489199089586,0,1,negative regulation of ectoderm development,BP,
21402,GO:2000386,1,0.98810532603212,0,2,positive regulation of ovarian follicle development,BP,
21403,GO:2000387,1,0.994776327250428,0,1,regulation of antral ovarian follicle growth,BP,
21404,GO:2000388,1,0.994776327250428,0,1,positive regulation of antral ovarian follicle growth,BP,
21405,GO:2000389,1,0.980847005260713,0,3,regulation of neutrophil extravasation,BP,
21406,GO:2000391,1,0.980847005260713,0,3,positive regulation of neutrophil extravasation,BP,
21408,GO:2000393,1,0.986538079813154,0,2,negative regulation of lamellipodium morphogenesis,BP,
21409,GO:2000394,1,0.951494585223074,0,7,positive regulation of lamellipodium morphogenesis,BP,
21410,GO:2000395,1,0.989597667280872,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21411,GO:2000397,1,0.989597667280872,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21416,GO:2000405,1,0.986683128968374,0,2,negative regulation of T cell migration,BP,
21418,GO:2000407,1,0.983895509572644,0,3,regulation of T cell extravasation,BP,
21419,GO:2000409,1,0.989171756451026,0,2,positive regulation of T cell extravasation,BP,
21420,GO:2000410,1,0.98356519842022,0,3,regulation of thymocyte migration,BP,
21421,GO:2000412,1,0.98889672899329,0,2,positive regulation of thymocyte migration,BP,
21422,GO:2000413,1,0.994068182395454,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21423,GO:2000415,1,0.994068182395454,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21424,GO:2000416,1,0.977196761230186,0,4,regulation of eosinophil migration,BP,
21425,GO:2000417,1,0.988575132035117,0,2,negative regulation of eosinophil migration,BP,
21426,GO:2000418,1,0.988491446391808,0,2,positive regulation of eosinophil migration,BP,
21427,GO:2000419,1,0.993866527288167,0,1,regulation of eosinophil extravasation,BP,
21428,GO:2000420,1,0.993866527288167,0,1,negative regulation of eosinophil extravasation,BP,
21429,GO:2000422,1,0.994390319498222,0,1,regulation of eosinophil chemotaxis,BP,
21430,GO:2000424,1,0.994390319498222,0,1,positive regulation of eosinophil chemotaxis,BP,
21432,GO:2000426,1,0.988597066714394,0,2,negative regulation of apoptotic cell clearance,BP,
21434,GO:2000434,1,0.989679663581586,0,2,regulation of protein neddylation,BP,
21435,GO:2000435,1,0.989679663581586,0,2,negative regulation of protein neddylation,BP,
21436,GO:2000437,1,0.978445395617349,0,3,regulation of monocyte extravasation,BP,
21437,GO:2000438,1,0.990477206308103,0,1,negative regulation of monocyte extravasation,BP,
21438,GO:2000439,1,0.987853665549307,0,2,positive regulation of monocyte extravasation,BP,
21439,GO:2000446,1,0.993017395077594,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21440,GO:2000449,1,0.983895509572644,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21441,GO:2000451,1,0.989171756451026,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21442,GO:2000452,1,0.989381009148301,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21443,GO:2000454,1,0.994686376506592,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21444,GO:2000458,1,0.989188515777733,0,2,regulation of astrocyte chemotaxis,BP,
21446,GO:2000464,1,0.99445621570624,0,1,positive regulation of astrocyte chemotaxis,BP,
21447,GO:2000465,1,0.955812946545053,0,6,regulation of glycogen (starch) synthase activity,BP,
21448,GO:2000466,1,0.978901770222155,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21449,GO:2000467,1,0.976784559704348,0,3,positive regulation of glycogen (starch) synthase activity,BP,
21450,GO:2000468,1,0.982148155953327,0,2,regulation of peroxidase activity,BP,
21451,GO:2000469,1,0.988022957922514,0,1,negative regulation of peroxidase activity,BP,
21452,GO:2000470,1,0.99405469576238,0,1,positive regulation of peroxidase activity,BP,
21453,GO:2000471,1,0.986800681236145,0,2,regulation of hematopoietic stem cell migration,BP,
21454,GO:2000473,1,0.986800681236145,0,2,positive regulation of hematopoietic stem cell migration,BP,
21455,GO:2000474,1,0.987819945223831,0,2,regulation of opioid receptor signaling pathway,BP,
21456,GO:2000479,1,0.913889526574901,0,14,regulation of cAMP-dependent protein kinase activity,BP,
21457,GO:2000480,1,0.954752815446068,0,8,negative regulation of cAMP-dependent protein kinase activity,BP,
21458,GO:2000481,1,0.967387473426701,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21461,GO:2000484,1,0.922585945949363,0,14,positive regulation of interleukin-8 secretion,BP,
21462,GO:2000485,1,0.988362776000787,0,2,regulation of glutamine transport,BP,
21463,GO:2000486,1,0.993855960614235,0,1,negative regulation of glutamine transport,BP,
21464,GO:2000487,1,0.994473196325914,0,1,positive regulation of glutamine transport,BP,
21465,GO:2000489,1,0.962280365625364,0,6,regulation of hepatic stellate cell activation,BP,
21466,GO:2000490,1,0.98829120017417,0,2,negative regulation of hepatic stellate cell activation,BP,
21467,GO:2000491,1,0.9736840611295,0,4,positive regulation of hepatic stellate cell activation,BP,
21468,GO:2000492,1,0.994182237287637,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21469,GO:2000494,1,0.994182237287637,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21472,GO:2000503,1,0.984363540807939,0,3,positive regulation of natural killer cell chemotaxis,BP,
21473,GO:2000504,1,0.986916841977316,0,2,positive regulation of blood vessel remodeling,BP,
21474,GO:2000508,1,0.957562231145663,0,8,regulation of dendritic cell chemotaxis,BP,
21475,GO:2000510,1,0.957562231145663,0,8,positive regulation of dendritic cell chemotaxis,BP,
21476,GO:2000511,1,0.994797996453385,0,1,regulation of granzyme A production,BP,
21477,GO:2000513,1,0.994797996453385,0,1,positive regulation of granzyme A production,BP,
21481,GO:2000517,1,0.994797996453385,0,1,regulation of T-helper 1 cell activation,BP,
21482,GO:2000518,1,0.994797996453385,0,1,negative regulation of T-helper 1 cell activation,BP,
21485,GO:2000522,1,0.994590650166733,0,1,positive regulation of immunological synapse formation,BP,
21486,GO:2000523,1,0.988426241434129,0,2,regulation of T cell costimulation,BP,
21487,GO:2000525,1,0.988426241434129,0,2,positive regulation of T cell costimulation,BP,
21488,GO:2000526,1,0.994590650166733,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21489,GO:2000527,1,0.994826408496728,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21490,GO:2000529,1,0.994826408496728,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21491,GO:2000532,1,0.994452945073479,0,1,regulation of renal albumin absorption,BP,
21492,GO:2000533,1,0.994452945073479,0,1,negative regulation of renal albumin absorption,BP,
21493,GO:2000535,1,0.959723374408101,0,6,regulation of entry of bacterium into host cell,BP,
21494,GO:2000536,1,0.990317204894401,0,1,negative regulation of entry of bacterium into host cell,BP,
21495,GO:2000537,1,0.987842507997508,0,2,regulation of B cell chemotaxis,BP,
21496,GO:2000538,1,0.987842507997508,0,2,positive regulation of B cell chemotaxis,BP,
21497,GO:2000539,1,0.994454349049344,0,1,regulation of protein geranylgeranylation,BP,
21498,GO:2000541,1,0.994454349049344,0,1,positive regulation of protein geranylgeranylation,BP,
21499,GO:2000542,1,0.952197769833134,0,7,negative regulation of gastrulation,BP,
21500,GO:2000543,1,0.978266067594643,0,4,positive regulation of gastrulation,BP,
21501,GO:2000544,1,0.965707956149808,0,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21502,GO:2000545,1,0.994800064853307,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21503,GO:2000546,1,0.977094120231338,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21504,GO:2000547,1,0.98433395673092,0,3,regulation of dendritic cell dendrite assembly,BP,
21505,GO:2000548,1,0.994826408496728,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21506,GO:2000549,1,0.994835217305037,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21507,GO:2000551,1,0.955266332767474,0,8,regulation of T-helper 2 cell cytokine production,BP,
21508,GO:2000552,1,0.989217577836705,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21509,GO:2000553,1,0.965682348224912,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21510,GO:2000554,1,0.994797996453385,0,1,regulation of T-helper 1 cell cytokine production,BP,
21511,GO:2000556,1,0.994797996453385,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21512,GO:2000557,1,0.994797996453385,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21513,GO:2000558,1,0.994797996453385,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21514,GO:2000559,1,0.990477206308103,0,1,regulation of CD24 biosynthetic process,BP,
21515,GO:2000560,1,0.990477206308103,0,1,positive regulation of CD24 biosynthetic process,BP,
21516,GO:2000561,1,0.965211694312323,0,6,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21517,GO:2000562,1,0.977931386751209,0,4,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21518,GO:2000563,1,0.976683131018669,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21519,GO:2000564,1,0.9833600031658,0,3,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21520,GO:2000566,1,0.989551015784229,0,2,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21521,GO:2000567,1,0.994578223558621,0,1,regulation of memory T cell activation,BP,
21522,GO:2000568,1,0.994578223558621,0,1,positive regulation of memory T cell activation,BP,
21523,GO:2000569,1,0.993976297210417,0,1,regulation of T-helper 2 cell activation,BP,
21524,GO:2000570,1,0.993976297210417,0,1,positive regulation of T-helper 2 cell activation,BP,
21525,GO:2000571,1,0.993802399849716,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21526,GO:2000572,1,0.993802399849716,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21527,GO:2000573,1,0.67487466923657,0,63,positive regulation of DNA biosynthetic process,BP,
21528,GO:2000574,1,0.948370762386168,0,9,regulation of microtubule motor activity,BP,
21529,GO:2000576,1,0.967672958941439,0,6,positive regulation of microtubule motor activity,BP,
21530,GO:2000580,1,0.973208889650507,0,5,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21531,GO:2000582,1,0.973208889650507,0,5,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21532,GO:2000583,1,0.993491031630363,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21533,GO:2000584,1,0.993491031630363,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21534,GO:2000586,1,0.918964385783834,0,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21535,GO:2000587,1,0.934941047122074,0,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21536,GO:2000588,1,0.982922960864386,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21537,GO:2000589,1,0.98027118327346,0,3,regulation of metanephric mesenchymal cell migration,BP,
21538,GO:2000591,1,0.98027118327346,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21539,GO:2000592,1,0.986751226142549,0,2,regulation of metanephric DCT cell differentiation,BP,
21540,GO:2000594,1,0.986751226142549,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21541,GO:2000595,1,0.993240355502953,0,1,regulation of optic nerve formation,BP,
21542,GO:2000597,1,0.993240355502953,0,1,positive regulation of optic nerve formation,BP,
21543,GO:2000601,1,0.960204712114748,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21544,GO:2000606,1,0.994126820472005,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21545,GO:2000607,1,0.994126820472005,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21546,GO:2000609,1,0.977088857435358,0,4,regulation of thyroid hormone generation,BP,
21547,GO:2000611,1,0.98231782344654,0,3,positive regulation of thyroid hormone generation,BP,
21548,GO:2000612,1,0.993467149498226,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21549,GO:2000615,1,0.928143752601435,0,11,regulation of histone H3-K9 acetylation,BP,
21550,GO:2000616,1,0.98687942183963,0,2,negative regulation of histone H3-K9 acetylation,BP,
21551,GO:2000617,1,0.951237469678626,0,7,positive regulation of histone H3-K9 acetylation,BP,
21552,GO:2000618,1,0.964274517842983,0,5,regulation of histone H4-K16 acetylation,BP,
21553,GO:2000619,1,0.98238761437879,0,3,negative regulation of histone H4-K16 acetylation,BP,
21554,GO:2000620,1,0.981565412973914,0,2,positive regulation of histone H4-K16 acetylation,BP,
21555,GO:2000622,1,0.971277269407906,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21556,GO:2000623,1,0.971277269407906,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21557,GO:2000625,1,0.987143654267669,0,2,regulation of miRNA catabolic process,BP,
21558,GO:2000627,1,0.987143654267669,0,2,positive regulation of miRNA catabolic process,BP,
21559,GO:2000628,1,0.958618461355729,0,7,regulation of miRNA metabolic process,BP,
21560,GO:2000630,1,0.969940085911976,0,5,positive regulation of miRNA metabolic process,BP,
21561,GO:2000631,1,0.993997664993241,0,1,regulation of pre-miRNA processing,BP,
21562,GO:2000632,1,0.993997664993241,0,1,negative regulation of pre-miRNA processing,BP,
21563,GO:2000637,1,0.878879337101485,0,20,positive regulation of gene silencing by miRNA,BP,
21564,GO:2000638,1,0.987969588571473,0,2,regulation of SREBP signaling pathway,BP,
21565,GO:2000639,1,0.987969588571473,0,2,negative regulation of SREBP signaling pathway,BP,
21566,GO:2000641,1,0.895832975141537,0,17,regulation of early endosome to late endosome transport,BP,
21567,GO:2000642,1,0.989636289506822,0,2,negative regulation of early endosome to late endosome transport,BP,
21568,GO:2000643,1,0.947365885114067,0,8,positive regulation of early endosome to late endosome transport,BP,
21571,GO:2000646,1,0.965316993542445,0,5,positive regulation of receptor catabolic process,BP,
21573,GO:2000648,1,0.782149322412543,0,35,positive regulation of stem cell proliferation,BP,
21574,GO:2000649,1,0.71704925433109,0,46,regulation of sodium ion transmembrane transporter activity,BP,
21575,GO:2000650,1,0.91747063103719,0,11,negative regulation of sodium ion transmembrane transporter activity,BP,
21576,GO:2000651,1,0.906129779251284,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21577,GO:2000653,1,0.980942497553996,0,3,regulation of genetic imprinting,BP,
21578,GO:2000654,1,0.993492405533006,0,1,regulation of cellular response to testosterone stimulus,BP,
21579,GO:2000655,1,0.993492405533006,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21580,GO:2000656,1,0.99467890679076,0,1,regulation of apolipoprotein binding,BP,
21581,GO:2000657,1,0.99467890679076,0,1,negative regulation of apolipoprotein binding,BP,
21582,GO:2000659,1,0.956925041189321,0,7,regulation of interleukin-1-mediated signaling pathway,BP,
21583,GO:2000660,1,0.969402668701211,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21584,GO:2000661,1,0.99243799366005,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21585,GO:2000662,1,0.965847626621096,0,6,regulation of interleukin-5 secretion,BP,
21586,GO:2000663,1,0.993679687934744,0,1,negative regulation of interleukin-5 secretion,BP,
21587,GO:2000664,1,0.971992664364835,0,5,positive regulation of interleukin-5 secretion,BP,
21588,GO:2000665,1,0.960946222273645,0,7,regulation of interleukin-13 secretion,BP,
21589,GO:2000666,1,0.988363903207507,0,2,negative regulation of interleukin-13 secretion,BP,
21590,GO:2000667,1,0.972262732499601,0,5,positive regulation of interleukin-13 secretion,BP,
21591,GO:2000668,1,0.941128995092377,0,10,regulation of dendritic cell apoptotic process,BP,
21592,GO:2000669,1,0.96091163921565,0,7,negative regulation of dendritic cell apoptotic process,BP,
21593,GO:2000670,1,0.979420754012467,0,3,positive regulation of dendritic cell apoptotic process,BP,
21595,GO:2000672,1,0.976690697978608,0,4,negative regulation of motor neuron apoptotic process,BP,
21596,GO:2000674,1,0.936526468660437,0,11,regulation of type B pancreatic cell apoptotic process,BP,
21597,GO:2000675,1,0.963702399984605,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21598,GO:2000676,1,0.971810777560548,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
21599,GO:2000677,1,0.741889966188307,0,44,regulation of transcription regulatory region DNA binding,BP,
21600,GO:2000678,1,0.876596738926832,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21601,GO:2000679,1,0.879734809691536,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21602,GO:2000683,1,0.988441853341434,0,2,regulation of cellular response to X-ray,BP,
21603,GO:2000685,1,0.994281782907077,0,1,positive regulation of cellular response to X-ray,BP,
21604,GO:2000690,1,0.993101397325953,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21605,GO:2000691,1,0.993101397325953,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21606,GO:2000696,1,0.897158499577654,0,15,regulation of epithelial cell differentiation involved in kidney development,BP,
21607,GO:2000697,1,0.977281775685106,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21608,GO:2000698,1,0.968773503315509,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21609,GO:2000699,1,0.994126820472005,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21610,GO:2000701,1,0.994126820472005,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21611,GO:2000702,1,0.994126820472005,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21612,GO:2000703,1,0.994126820472005,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21613,GO:2000705,1,0.976945639569081,0,3,regulation of dense core granule biogenesis,BP,
21614,GO:2000706,1,0.993656100488896,0,1,negative regulation of dense core granule biogenesis,BP,
21615,GO:2000707,1,0.98318391330505,0,2,positive regulation of dense core granule biogenesis,BP,
21616,GO:2000718,1,0.994825831378211,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21617,GO:2000719,1,0.994825831378211,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21618,GO:2000721,1,0.977354845474568,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21619,GO:2000722,1,0.979274569634906,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21620,GO:2000723,1,0.994370874555643,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21621,GO:2000724,1,0.984819085512156,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21622,GO:2000725,1,0.821809595491528,0,27,regulation of cardiac muscle cell differentiation,BP,
21623,GO:2000726,1,0.922798657706328,0,11,negative regulation of cardiac muscle cell differentiation,BP,
21624,GO:2000727,1,0.890645081999414,0,16,positive regulation of cardiac muscle cell differentiation,BP,
21625,GO:2000729,1,0.989140216533058,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21626,GO:2000733,1,0.994126820472005,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21627,GO:2000734,1,0.994126820472005,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21628,GO:2000736,1,0.49164117678037,0,115,regulation of stem cell differentiation,BP,
21629,GO:2000737,1,0.87642575629046,0,18,negative regulation of stem cell differentiation,BP,
21630,GO:2000738,1,0.893500489550652,0,17,positive regulation of stem cell differentiation,BP,
21631,GO:2000739,1,0.952829984856181,0,6,regulation of mesenchymal stem cell differentiation,BP,
21632,GO:2000740,1,0.993656100488896,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21633,GO:2000741,1,0.96793880347322,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21634,GO:2000742,1,0.994618536527764,0,1,regulation of anterior head development,BP,
21635,GO:2000744,1,0.994618536527764,0,1,positive regulation of anterior head development,BP,
21636,GO:2000752,1,0.994304233720245,0,1,regulation of glucosylceramide catabolic process,BP,
21637,GO:2000753,1,0.994304233720245,0,1,positive regulation of glucosylceramide catabolic process,BP,
21638,GO:2000754,1,0.994304233720245,0,1,regulation of sphingomyelin catabolic process,BP,
21639,GO:2000755,1,0.994304233720245,0,1,positive regulation of sphingomyelin catabolic process,BP,
21640,GO:2000756,1,0.691390601642991,0,57,regulation of peptidyl-lysine acetylation,BP,
21641,GO:2000757,1,0.873671798117198,0,21,negative regulation of peptidyl-lysine acetylation,BP,
21642,GO:2000758,1,0.828491065598012,0,29,positive regulation of peptidyl-lysine acetylation,BP,
21643,GO:2000759,1,0.992479418567146,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21644,GO:2000761,1,0.992479418567146,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21645,GO:2000763,1,0.9945157272471,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21646,GO:2000764,1,0.9945157272471,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21647,GO:2000765,1,0.864979483141298,0,22,regulation of cytoplasmic translation,BP,
21648,GO:2000766,1,0.948958327830918,0,7,negative regulation of cytoplasmic translation,BP,
21649,GO:2000767,1,0.954111447697346,0,7,positive regulation of cytoplasmic translation,BP,
21650,GO:2000768,1,0.99341342827093,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21651,GO:2000772,1,0.798435248460674,0,33,regulation of cellular senescence,BP,
21652,GO:2000773,1,0.889805805749455,0,16,negative regulation of cellular senescence,BP,
21653,GO:2000774,1,0.949296463587091,0,9,positive regulation of cellular senescence,BP,
21654,GO:2000775,1,0.994616918462153,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21655,GO:2000777,1,0.989204354286072,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21656,GO:2000778,1,0.885935711161467,0,19,positive regulation of interleukin-6 secretion,BP,
21657,GO:2000779,1,0.70909674745181,0,50,regulation of double-strand break repair,BP,
21658,GO:2000780,1,0.863193387748571,0,20,negative regulation of double-strand break repair,BP,
21659,GO:2000781,1,0.919600872255393,0,12,positive regulation of double-strand break repair,BP,
21660,GO:2000785,1,0.78676399195136,0,35,regulation of autophagosome assembly,BP,
21661,GO:2000786,1,0.928687151257131,0,10,positive regulation of autophagosome assembly,BP,
21662,GO:2000790,1,0.982658542091145,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21663,GO:2000791,1,0.982658542091145,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21664,GO:2000793,1,0.968968911165202,0,3,cell proliferation involved in heart valve development,BP,
21665,GO:2000794,1,0.94724345830398,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21666,GO:2000795,1,0.989097247378027,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21667,GO:2000797,1,0.993656100488896,0,1,regulation of amniotic stem cell differentiation,BP,
21668,GO:2000798,1,0.993656100488896,0,1,negative regulation of amniotic stem cell differentiation,BP,
21669,GO:2000800,1,0.994729577369819,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21670,GO:2000802,1,0.994729577369819,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21671,GO:2000804,1,0.986374012045264,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21672,GO:2000806,1,0.986374012045264,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21673,GO:2000807,1,0.944284594178699,0,7,regulation of synaptic vesicle clustering,BP,
21674,GO:2000808,1,0.991768466882196,0,1,negative regulation of synaptic vesicle clustering,BP,
21675,GO:2000809,1,0.962476927343964,0,5,positive regulation of synaptic vesicle clustering,BP,
21676,GO:2000810,1,0.872753636354507,0,20,regulation of bicellular tight junction assembly,BP,
21677,GO:2000811,1,0.900699411148073,0,15,negative regulation of anoikis,BP,
21678,GO:2000812,1,0.993457930447994,0,1,regulation of barbed-end actin filament capping,BP,
21679,GO:2000816,1,0.79937066985604,0,33,negative regulation of mitotic sister chromatid separation,BP,
21680,GO:2000818,1,0.989017207404361,0,2,negative regulation of myoblast proliferation,BP,
21681,GO:2000819,1,0.987961169186418,0,2,regulation of nucleotide-excision repair,BP,
21682,GO:2000820,1,0.980370030022615,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21683,GO:2000821,1,0.964219164582655,0,5,regulation of grooming behavior,BP,
21684,GO:2000822,1,0.955829079334407,0,7,regulation of behavioral fear response,BP,
21685,GO:2000823,1,0.962415491701389,0,6,regulation of androgen receptor activity,BP,
21686,GO:2000824,1,0.98786276747512,0,2,negative regulation of androgen receptor activity,BP,
21687,GO:2000825,1,0.974243175486521,0,4,positive regulation of androgen receptor activity,BP,
21688,GO:2000826,1,0.805345770615374,0,32,regulation of heart morphogenesis,BP,
21689,GO:2000827,1,0.994463621833979,0,1,mitochondrial RNA surveillance,BP,
21690,GO:2000828,1,0.986390623833295,0,2,regulation of parathyroid hormone secretion,BP,
21691,GO:2000830,1,0.991671367570111,0,1,positive regulation of parathyroid hormone secretion,BP,
21692,GO:2000831,1,0.912384783652057,0,16,regulation of steroid hormone secretion,BP,
21693,GO:2000832,1,0.985025488247195,0,2,negative regulation of steroid hormone secretion,BP,
21694,GO:2000833,1,0.951884148256516,0,9,positive regulation of steroid hormone secretion,BP,
21695,GO:2000834,1,0.993973223617764,0,1,regulation of androgen secretion,BP,
21696,GO:2000836,1,0.993973223617764,0,1,positive regulation of androgen secretion,BP,
21697,GO:2000843,1,0.984372617208178,0,2,regulation of testosterone secretion,BP,
21698,GO:2000845,1,0.984372617208178,0,2,positive regulation of testosterone secretion,BP,
21699,GO:2000846,1,0.927662068943004,0,13,regulation of corticosteroid hormone secretion,BP,
21700,GO:2000847,1,0.985025488247195,0,2,negative regulation of corticosteroid hormone secretion,BP,
21701,GO:2000848,1,0.962626895960265,0,7,positive regulation of corticosteroid hormone secretion,BP,
21702,GO:2000849,1,0.948942535400448,0,9,regulation of glucocorticoid secretion,BP,
21703,GO:2000850,1,0.985025488247195,0,2,negative regulation of glucocorticoid secretion,BP,
21704,GO:2000851,1,0.973848234261805,0,5,positive regulation of glucocorticoid secretion,BP,
21705,GO:2000852,1,0.978982533398333,0,4,regulation of corticosterone secretion,BP,
21706,GO:2000854,1,0.989624815772467,0,2,positive regulation of corticosterone secretion,BP,
21707,GO:2000855,1,0.977586174181281,0,4,regulation of mineralocorticoid secretion,BP,
21708,GO:2000857,1,0.988480362223273,0,2,positive regulation of mineralocorticoid secretion,BP,
21709,GO:2000858,1,0.977586174181281,0,4,regulation of aldosterone secretion,BP,
21710,GO:2000860,1,0.988480362223273,0,2,positive regulation of aldosterone secretion,BP,
21713,GO:2000870,1,0.989507852681293,0,2,regulation of progesterone secretion,BP,
21714,GO:2000872,1,0.994840396098026,0,1,positive regulation of progesterone secretion,BP,
21715,GO:2000878,1,0.989136565088683,0,2,positive regulation of oligopeptide transport,BP,
21716,GO:2000880,1,0.989136565088683,0,2,positive regulation of dipeptide transport,BP,
21717,GO:2000896,1,0.994065276644534,0,1,amylopectin metabolic process,BP,
21718,GO:2000909,1,0.994313214468247,0,1,regulation of sterol import,BP,
21719,GO:2000969,1,0.958861691436111,0,5,positive regulation of AMPA receptor activity,BP,
21720,GO:2000970,1,0.994495333696586,0,1,regulation of detection of glucose,BP,
21721,GO:2000971,1,0.994495333696586,0,1,negative regulation of detection of glucose,BP,
21722,GO:2000973,1,0.95242451645311,0,6,regulation of pro-B cell differentiation,BP,
21723,GO:2000974,1,0.977676847647828,0,3,negative regulation of pro-B cell differentiation,BP,
21724,GO:2000977,1,0.977763146542416,0,4,regulation of forebrain neuron differentiation,BP,
21725,GO:2000978,1,0.989582364206258,0,2,negative regulation of forebrain neuron differentiation,BP,
21726,GO:2000979,1,0.994125776747889,0,1,positive regulation of forebrain neuron differentiation,BP,
21727,GO:2000980,1,0.955410498633955,0,7,regulation of inner ear receptor cell differentiation,BP,
21728,GO:2000981,1,0.971755239575628,0,4,negative regulation of inner ear receptor cell differentiation,BP,
21729,GO:2000983,1,0.989659847713534,0,2,regulation of ATP citrate synthase activity,BP,
21730,GO:2000984,1,0.989659847713534,0,2,negative regulation of ATP citrate synthase activity,BP,
21731,GO:2000987,1,0.969849630001496,0,5,positive regulation of behavioral fear response,BP,
21732,GO:2001012,1,0.959415760547274,0,7,mesenchymal cell differentiation involved in renal system development,BP,
21733,GO:2001013,1,0.969969937407169,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21734,GO:2001014,1,0.886392802576792,0,18,regulation of skeletal muscle cell differentiation,BP,
21735,GO:2001015,1,0.958028909936244,0,6,negative regulation of skeletal muscle cell differentiation,BP,
21736,GO:2001016,1,0.966927485255217,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21737,GO:2001020,1,0.327235856713614,0,171,regulation of response to DNA damage stimulus,BP,
21738,GO:2001021,1,0.658320752177479,0,65,negative regulation of response to DNA damage stimulus,BP,
21739,GO:2001022,1,0.629668972299149,0,72,positive regulation of response to DNA damage stimulus,BP,
21740,GO:2001023,1,0.623796945472004,0,74,regulation of response to drug,BP,
21741,GO:2001024,1,0.85037734348588,0,25,negative regulation of response to drug,BP,
21742,GO:2001025,1,0.860842326625166,0,25,positive regulation of response to drug,BP,
21743,GO:2001026,1,0.884514994053993,0,16,regulation of endothelial cell chemotaxis,BP,
21744,GO:2001027,1,0.974475432683601,0,3,negative regulation of endothelial cell chemotaxis,BP,
21745,GO:2001028,1,0.913635134128027,0,12,positive regulation of endothelial cell chemotaxis,BP,
21746,GO:2001029,1,0.991790634316339,0,1,regulation of cellular glucuronidation,BP,
21747,GO:2001031,1,0.991790634316339,0,1,positive regulation of cellular glucuronidation,BP,
21748,GO:2001032,1,0.925285930863063,0,12,regulation of double-strand break repair via nonhomologous end joining,BP,
21749,GO:2001033,1,0.972519240792318,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21750,GO:2001034,1,0.963703835030284,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21751,GO:2001035,1,0.987620194965483,0,2,regulation of tongue muscle cell differentiation,BP,
21752,GO:2001037,1,0.987620194965483,0,2,positive regulation of tongue muscle cell differentiation,BP,
21753,GO:2001038,1,0.839488452255525,0,27,regulation of cellular response to drug,BP,
21754,GO:2001039,1,0.897258674742192,0,17,negative regulation of cellular response to drug,BP,
21755,GO:2001040,1,0.961043879311956,0,6,positive regulation of cellular response to drug,BP,
21757,GO:2001045,1,0.984689085702318,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21758,GO:2001046,1,0.959387237271952,0,6,positive regulation of integrin-mediated signaling pathway,BP,
21759,GO:2001049,1,0.994647818732383,0,1,regulation of tendon cell differentiation,BP,
21760,GO:2001051,1,0.994647818732383,0,1,positive regulation of tendon cell differentiation,BP,
21761,GO:2001053,1,0.936672419280862,0,11,regulation of mesenchymal cell apoptotic process,BP,
21762,GO:2001054,1,0.946836068027441,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
21763,GO:2001055,1,0.989271508344407,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21766,GO:2001065,1,0.994782985307669,0,1,mannan binding,MF,
21767,GO:2001069,1,0.988723485831665,0,2,glycogen binding,MF,
21768,GO:2001070,1,0.986373776970521,0,2,starch binding,MF,
21769,GO:2001074,1,0.98890318144194,0,2,regulation of metanephric ureteric bud development,BP,
21770,GO:2001076,1,0.98890318144194,0,2,positive regulation of metanephric ureteric bud development,BP,
21771,GO:2001106,1,0.98158995833346,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21772,GO:2001108,1,0.990920891506829,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21773,GO:2001109,1,0.983269691129304,0,2,regulation of lens epithelial cell proliferation,BP,
21774,GO:2001111,1,0.983269691129304,0,2,positive regulation of lens epithelial cell proliferation,BP,
21775,GO:2001112,1,0.99237463941337,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21776,GO:2001113,1,0.99237463941337,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21777,GO:2001135,1,0.937043256014024,0,9,regulation of endocytic recycling,BP,
21778,GO:2001136,1,0.993916229362923,0,1,negative regulation of endocytic recycling,BP,
21779,GO:2001137,1,0.967192781100783,0,4,positive regulation of endocytic recycling,BP,
21780,GO:2001138,1,0.945100241715592,0,8,regulation of phospholipid transport,BP,
21781,GO:2001140,1,0.945100241715592,0,8,positive regulation of phospholipid transport,BP,
21783,GO:2001142,1,0.994425124328196,0,1,nicotinate transport,BP,
21784,GO:2001144,1,0.99458608151339,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21785,GO:2001145,1,0.99458608151339,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21786,GO:2001148,1,0.989136565088683,0,2,regulation of dipeptide transmembrane transport,BP,
21787,GO:2001150,1,0.989136565088683,0,2,positive regulation of dipeptide transmembrane transport,BP,
21788,GO:2001151,1,0.994016522465217,0,1,regulation of renal water transport,BP,
21789,GO:2001153,1,0.994016522465217,0,1,positive regulation of renal water transport,BP,
21790,GO:2001160,1,0.987864947779375,0,2,regulation of histone H3-K79 methylation,BP,
21791,GO:2001162,1,0.987864947779375,0,2,positive regulation of histone H3-K79 methylation,BP,
21792,GO:2001163,1,0.994552337999251,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21793,GO:2001165,1,0.994552337999251,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21794,GO:2001166,1,0.968988134652633,0,5,regulation of histone H2B ubiquitination,BP,
21795,GO:2001168,1,0.974247502324064,0,4,positive regulation of histone H2B ubiquitination,BP,
21796,GO:2001169,1,0.613624527126963,0,69,regulation of ATP biosynthetic process,BP,
21797,GO:2001170,1,0.911550142836192,0,13,negative regulation of ATP biosynthetic process,BP,
21798,GO:2001171,1,0.845275928762228,0,24,positive regulation of ATP biosynthetic process,BP,
21799,GO:2001173,1,0.994603015627253,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
21800,GO:2001176,1,0.988920712607725,0,2,regulation of mediator complex assembly,BP,
21801,GO:2001178,1,0.988920712607725,0,2,positive regulation of mediator complex assembly,BP,
21802,GO:2001179,1,0.962150792667932,0,7,regulation of interleukin-10 secretion,BP,
21803,GO:2001180,1,0.982716290436967,0,3,negative regulation of interleukin-10 secretion,BP,
21804,GO:2001181,1,0.979076416747893,0,4,positive regulation of interleukin-10 secretion,BP,
21805,GO:2001182,1,0.958828098378492,0,7,regulation of interleukin-12 secretion,BP,
21806,GO:2001183,1,0.982187215613202,0,3,negative regulation of interleukin-12 secretion,BP,
21807,GO:2001184,1,0.982372624909438,0,3,positive regulation of interleukin-12 secretion,BP,
21808,GO:2001185,1,0.960004794965326,0,7,regulation of CD8-positive, alpha-beta T cell activation,BP,
21809,GO:2001186,1,0.988951334590569,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21810,GO:2001187,1,0.983042712595688,0,3,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21813,GO:2001190,1,0.989535511873173,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21814,GO:2001191,1,0.994260248918568,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21815,GO:2001193,1,0.994260248918568,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21816,GO:2001197,1,0.954863076050526,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21817,GO:2001198,1,0.945297369406755,0,10,regulation of dendritic cell differentiation,BP,
21818,GO:2001199,1,0.966795700929641,0,6,negative regulation of dendritic cell differentiation,BP,
21819,GO:2001200,1,0.97655590243663,0,4,positive regulation of dendritic cell differentiation,BP,
21821,GO:2001202,1,0.9831897135323,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21825,GO:2001206,1,0.9833114145074,0,3,positive regulation of osteoclast development,BP,
21826,GO:2001207,1,0.993523884450797,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21827,GO:2001208,1,0.993523884450797,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
21829,GO:2001213,1,0.991559595039779,0,1,negative regulation of vasculogenesis,BP,
21833,GO:2001224,1,0.886639651375695,0,13,positive regulation of neuron migration,BP,
21834,GO:2001225,1,0.934198460340058,0,10,regulation of chloride transport,BP,
21835,GO:2001226,1,0.982334138966169,0,3,negative regulation of chloride transport,BP,
21836,GO:2001228,1,0.970701615097472,0,2,regulation of response to gamma radiation,BP,
21837,GO:2001229,1,0.984177603504543,0,1,negative regulation of response to gamma radiation,BP,
21844,GO:2001239,1,0.763520193043568,0,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21845,GO:2001240,1,0.827473278661399,0,32,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21846,GO:2001241,1,0.924608877887326,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21847,GO:2001242,1,0.4222863567849,0,144,regulation of intrinsic apoptotic signaling pathway,BP,
21848,GO:2001243,1,0.582005605491732,0,90,negative regulation of intrinsic apoptotic signaling pathway,BP,
21849,GO:2001244,1,0.757251805092655,0,48,positive regulation of intrinsic apoptotic signaling pathway,BP,
21850,GO:2001245,1,0.981356496179032,0,3,regulation of phosphatidylcholine biosynthetic process,BP,
21851,GO:2001246,1,0.993391027138226,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21852,GO:2001247,1,0.993040076215397,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21853,GO:2001248,1,0.99459757150219,0,1,regulation of ammonia assimilation cycle,BP,
21854,GO:2001250,1,0.99459757150219,0,1,positive regulation of ammonia assimilation cycle,BP,
21855,GO:2001251,1,0.433293864274465,0,116,negative regulation of chromosome organization,BP,
21856,GO:2001252,1,0.358091503658578,0,152,positive regulation of chromosome organization,BP,
21857,GO:2001253,1,0.994166858399795,0,1,regulation of histone H3-K36 trimethylation,BP,
21858,GO:2001256,1,0.929636101155915,0,12,regulation of store-operated calcium entry,BP,
21860,GO:2001258,1,0.80548004814608,0,36,negative regulation of cation channel activity,BP,
21861,GO:2001259,1,0.676890508340234,0,54,positive regulation of cation channel activity,BP,
21862,GO:2001260,1,0.9945157272471,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21863,GO:2001262,1,0.9945157272471,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21864,GO:2001267,1,0.872596427663768,0,23,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21865,GO:2001268,1,0.973574864542753,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21866,GO:2001269,1,0.896307085967707,0,18,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21867,GO:2001270,1,0.974077503609731,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21868,GO:2001271,1,0.979142372835914,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21869,GO:2001272,1,0.994828327254872,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21870,GO:2001273,1,0.864708072824529,0,20,regulation of glucose import in response to insulin stimulus,BP,
21871,GO:2001274,1,0.981010206072459,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21872,GO:2001275,1,0.886908478234185,0,16,positive regulation of glucose import in response to insulin stimulus,BP,
21875,GO:2001286,1,0.970710065288054,0,4,regulation of caveolin-mediated endocytosis,BP,
21876,GO:2001287,1,0.988285928787623,0,2,negative regulation of caveolin-mediated endocytosis,BP,
21877,GO:2001288,1,0.988849536534572,0,1,positive regulation of caveolin-mediated endocytosis,BP,
21878,GO:2001293,1,0.982644655661981,0,2,malonyl-CoA metabolic process,BP,
21879,GO:2001294,1,0.994582172474536,0,1,malonyl-CoA catabolic process,BP,
21880,GO:2001295,1,0.987998103041228,0,1,malonyl-CoA biosynthetic process,BP,
21881,GO:2001300,1,0.967728923983098,0,6,lipoxin metabolic process,BP,
21882,GO:2001301,1,0.967728923983098,0,6,lipoxin biosynthetic process,BP,
21883,GO:2001302,1,0.988908754683083,0,2,lipoxin A4 metabolic process,BP,
21884,GO:2001303,1,0.988908754683083,0,2,lipoxin A4 biosynthetic process,BP,
21885,GO:2001304,1,0.994515310835667,0,1,lipoxin B4 metabolic process,BP,
21886,GO:2001306,1,0.994515310835667,0,1,lipoxin B4 biosynthetic process,BP,
21887,GO:2001311,1,0.994695572156137,0,1,lysobisphosphatidic acid metabolic process,BP,
5927,GO:0016559,1,0.949598037590606,0,9,peroxisome fission,BP,
11513,GO:0044144,1,0.929954833139343,0,13,modulation of growth of symbiont involved in interaction with host,BP,
3266,GO:0006572,1,0.968383465219043,0,6,tyrosine catabolic process,BP,
5390,GO:0015248,1,0.843935847024642,0,25,sterol transporter activity,MF,
8121,GO:0031958,1,0.883772928151643,0,17,corticosteroid receptor signaling pathway,BP,
13596,GO:0050927,1,0.858793185207074,0,24,positive regulation of positive chemotaxis,BP,
4721,GO:0010259,1,0.826856587022587,0,25,multicellular organism aging,BP,
878,GO:0002098,1.00000000000001,0.934913498724114,0,12,tRNA wobble uridine modification,BP,
12247,GO:0045910,1.00000000000001,0.854013372700631,0,23,negative regulation of DNA recombination,BP,
9051,GO:0033604,1.00000000000001,0.939658422216656,0,10,negative regulation of catecholamine secretion,BP,
18576,GO:1900026,1.00000000000001,0.812681313524738,0,31,positive regulation of substrate adhesion-dependent cell spreading,BP,
16875,GO:0072348,1.00000000000001,0.825711952900849,0,30,sulfur compound transport,BP,
